PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sinding, C; Thomas-Danguin, T; Chambault, A; Beno, N; Dosne, T; Chabanet, C; Schaal, B; Coureaud, G				Sinding, Charlotte; Thomas-Danguin, Thierry; Chambault, Adeline; Beno, Noelle; Dosne, Thibaut; Chabanet, Claire; Schaal, Benoist; Coureaud, Gerard			Rabbit Neonates and Human Adults Perceive a Blending 6-Component Odor Mixture in a Comparable Manner	PLOS ONE			English	Article							NEWBORN RABBITS; MAMMARY PHEROMONE; APIS-MELLIFERA; PERCEPTION; DISCRIMINATION; QUALITY; RECOGNITION; EXPERIENCE; COMPONENTS; HONEYBEES	(Young and adult mammals are constantly exposed to chemically complex stimuli. The olfactory system allows for a dual processing of relevant information from the environment either as single odorants in mixtures (elemental perception) or as mixtures of odorants as a whole (configural perception). However, it seems that human adults have certain limits in elemental perception of odor mixtures, as suggested by their inability to identify each odorant in mixtures of more than 4 components. Here, we explored some of these limits by evaluating the perception of three 6-odorant mixtures in human adults and newborn rabbits. Using free-sorting tasks in humans, we investigated the configural or elemental perception of these mixtures, or of 5-component sub-mixtures, or of the 6-odorant mixtures with modified odorants' proportion. In rabbit pups, the perception of the same mixtures was evaluated by measuring the orocephalic sucking response to the mixtures or their components after conditioning to one of these stimuli. The results revealed that one mixture, previously shown to carry the specific odor of red cordial in humans, was indeed configurally processed in humans and in rabbits while the two other 6-component mixtures were not. Moreover, in both species, such configural perception was specific not only to the 6 odorants included in the mixture but also to their respective proportion. Interestingly, rabbit neonates also responded to each odorant after conditioning to the red cordial mixture, which demonstrates their ability to perceive elements in addition to configuration in this complex mixture. Taken together, the results provide new insights related to the processing of relatively complex odor mixtures in mammals and the inter-species conservation of certain perceptual mechanisms; the results also revealed some differences in the expression of these capacities between species putatively linked to developmental and ecological constraints.	[Sinding, Charlotte; Thomas-Danguin, Thierry; Chambault, Adeline; Beno, Noelle; Dosne, Thibaut; Chabanet, Claire; Schaal, Benoist; Coureaud, Gerard] Ctr Sci Gout & Alimentat, Dijon, France	Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Thomas-Danguin, T (corresponding author), Ctr Sci Gout & Alimentat, Dijon, France.	thierry.thomas-danguin@dijon.inra.fr; gerard.coureaud@u-bourgogne.fr	Thomas-Danguin, Thierry/D-9234-2011; Coureaud, Gérard/N-9108-2017; Coureaud, Gérard/ABF-1205-2020	Thomas-Danguin, Thierry/0000-0002-9756-355X; Coureaud, Gérard/0000-0001-6754-3884; Coureaud, Gérard/0000-0001-6754-3884; Sinding, Charlotte/0000-0002-0887-4429	Burgundy Regional council; EU-ERDF; IFR [92]; French MESR	Burgundy Regional council(Region Bourgogne-Franche-Comte); EU-ERDF(European Commission); IFR; French MESR	The work was supported by grants from the Burgundy Regional council, EU-ERDF and IFR 92 to G.C. and T.T.D., and a fellowship from the French MESR to C.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkat S, 2012, CHEM SENSES, V37, P159, DOI 10.1093/chemse/bjr086; Bult JHF, 2002, CHEM SENSES, V27, P485, DOI 10.1093/chemse/27.6.485; Chrea C, 2005, CHEM SENSES, V30, P37, DOI 10.1093/chemse/bjh255; Cleland TA, 2009, BEHAV NEUROSCI, V123, P26, DOI 10.1037/a0013991; Counet C, 2002, J AGR FOOD CHEM, V50, P2385, DOI 10.1021/jf0114177; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Coureaud G, 2011, CHEM SENSES, V36, P693, DOI [10.1093/chemse/bjr049, 10.1093/chemse/bjr040]; Coureaud G, 2009, J EXP BIOL, V212, P2525, DOI 10.1242/jeb.032235; Coureaud G, 2008, PHYSIOL BEHAV, V95, P194, DOI 10.1016/j.physbeh.2008.05.018; Coureauld G, 2007, ANIMAL, V1, P1026, DOI 10.1017/S1751731107000389; Dreumont-Boudreau SE, 2006, PHYSIOL BEHAV, V87, P634, DOI 10.1016/j.physbeh.2006.01.001; Escanilla O, 2008, PHYSIOL BEHAV, V94, P621, DOI 10.1016/j.physbeh.2008.03.008; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faye P, 2004, FOOD QUAL PREFER, V15, P781, DOI 10.1016/j.foodqual.2004.04.009; HUDSON R, 1983, BEHAVIOUR, V85, P260, DOI 10.1163/156853983X00255; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Jinks A, 1999, COGNITIVE BRAIN RES, V8, P311, DOI 10.1016/S0926-6410(99)00034-8; Kay LM, 2005, BEHAV NEUROSCI, V119, P726, DOI 10.1037/0735-7044.119.3.726; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAING DG, 1992, CHEM SENSES, V17, P337, DOI 10.1093/chemse/17.3.337; LAING DG, 1994, BRAIN RES, V651, P317, DOI 10.1016/0006-8993(94)90712-9; Laloi D, 1999, J INSECT BEHAV, V12, P585, DOI 10.1023/A:1020919501871; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; LASKA M, 1993, J COMP PHYSIOL A, V173, P249; Le Berre E, 2008, CHEM SENSES, V33, P389, DOI 10.1093/chemse/bjn006; Le Berre E, 2008, CHEM SENSES, V33, P193, DOI 10.1093/chemse/bjm080; Le Berre E, 2010, CHEMOSENS PERCEPT, V3, P156, DOI 10.1007/s12078-010-9076-y; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Livermore A, 1998, PHYSIOL BEHAV, V65, P311, DOI 10.1016/S0031-9384(98)00168-1; Livermore A, 1996, J EXP PSYCHOL HUMAN, V22, P267, DOI 10.1037/0096-1523.22.2.267; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Montigny D, 2006, PHYSIOL BEHAV, V89, P742, DOI 10.1016/j.physbeh.2006.08.022; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Reinhard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009110; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; SCHLEY P, 1977, BERL MUNCH TIERARZTL, V90, P402; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Sinding C, 2011, J EXP BIOL, V214, P4171, DOI 10.1242/jeb.063610; Sobel N, 2012, HUM OLF S ISOT 2012; Teillet E, 2010, FOOD QUAL PREFER, V21, P967, DOI 10.1016/j.foodqual.2010.04.012; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	46	32	33	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53534	10.1371/journal.pone.0053534	http://dx.doi.org/10.1371/journal.pone.0053534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341948	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700028
J	Kelly, PJ; Xu, CL; Lucas, H; Loftis, A; Abete, J; Zeoli, F; Stevens, A; Jaegersen, K; Ackerson, K; Gessner, A; Kaltenboeck, B; Wang, CM				Kelly, Patrick J.; Xu, Chuanling; Lucas, Helene; Loftis, Amanda; Abete, Jamie; Zeoli, Frank; Stevens, Audrey; Jaegersen, Kirsten; Ackerson, Kate; Gessner, April; Kaltenboeck, Bernhard; Wang, Chengming			Ehrlichiosis, Babesiosis, Anaplasmosis and Hepatozoonosis in Dogs from St. Kitts, West Indies	PLOS ONE			English	Article							TROPICAL CANINE PANCYTOPENIA; SEROLOGICAL DETECTION; RICKETTSIA-AFRICAE; SPP. INFECTION; DOXYCYCLINE; DIAGNOSIS; BLOOD; PCR; THERAPY; GIBSONI	Background: Although tick-borne diseases are important causes of morbidity and mortality in dogs in tropical areas, there is little information on the agents causing these infections in the Caribbean. Methodology: We used PCRs to test blood from a cross-section of dogs on St Kitts for Ehrlichia (E.) canis, Babesia (B.) spp., Anaplasma (A.) spp. and Hepatozoon (H.) spp. Antibodies against E. canis and A. phagocytophilum/platys were detected using commercial immunochromatography tests. Records of the dogs were examined retrospectively to obtain clinical and laboratory data. Principal findings: There was serological and/or PCR evidence of infections of dogs with E. canis (27%; 46/170), Babesia spp. (24%; 90/372) including B. canis vogeli (12%; 43/372) and B. gibsoni (10%; 36/372), A. platys (11%; 17/157) and H. canis (6%; 15/266). We could not identify the Babesia sp. detected in nine dogs. There was evidence of multiple infections with dual infections with E. canis and B. canis vogeli (8%; 14/179) or B. gibsoni (7%; 11/170) being the most common. There was agreement between immunochromatography and PCR test results for E. canis for 87% of dogs. Only 13% of exposed dogs had signs of a tick-borne disease and 38% had laboratory abnormalities. All 10 dogs presenting for a recheck after treatment of E. canis with doxycycline were apparently healthy although all remained seropositive and six still had laboratory abnormalities despite an average of two treatments with the most recent being around 12 months previously. Infections with Babesia spp. were also mainly subclinical with only 6% (4/67) showing clinical signs and 13% (9/67) having laboratory abnormalities. Similarly, animals with evidence of infections with A. platys and H. canis were largely apparently healthy with only occasional laboratory abnormalities. Conclusions: Dogs are commonly infected with tick-borne pathogens in the Caribbean with most having no clinical signs or laboratory abnormalities.	[Xu, Chuanling; Wang, Chengming] Yangzhou Univ, Yangzhou, Jiangsu, Peoples R China; [Kaltenboeck, Bernhard] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA	Yangzhou University; Auburn University System; Auburn University	Wang, CM (corresponding author), Yangzhou Univ, Yangzhou, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Wang, Chengming/G-2673-2010		Ross University School of Veterinary Medicine	Ross University School of Veterinary Medicine	This study was funded by the Ross University School of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanaskevich DA, 2007, ONDERSTEPOORT J VET, V74, P181; Ayoob AL, 2010, J VET EMERG CRIT CAR, V20, P77, DOI 10.1111/j.1476-4431.2009.00489.x; Baneth G, 2009, VET MICROBIOL, V136, P321, DOI 10.1016/j.vetmic.2008.11.022; Bartsch RC, 1996, J VET INTERN MED, V10, P271, DOI 10.1111/j.1939-1676.1996.tb02061.x; Beck R, 2009, INT J PARASITOL, V39, P843, DOI 10.1016/j.ijpara.2008.12.005; Belanger M, 2002, J CLIN MICROBIOL, V40, P3506, DOI 10.1128/JCM.40.9.3506-3508.2002; Birkenheuer AJ, 1999, J AM ANIM HOSP ASSOC, V35, P125, DOI 10.5326/15473317-35-2-125; BOOL P. H., 1957, JOUR AMER VET MED ASSOC, V130, P418; Breitschwerdt EB, 1998, J CLIN MICROBIOL, V36, P2645, DOI 10.1128/JCM.36.9.2645-2651.1998; Breitschwerdt EB, 1998, ANTIMICROB AGENTS CH, V42, P362; Brown GK, 2006, AUST VET J, V84, P321, DOI 10.1111/j.1751-0813.2006.00029.x; BUHLES WC, 1975, J COMP PATHOL, V85, P511, DOI 10.1016/0021-9975(75)90118-8; BUHLES WC, 1974, J INFECT DIS, V130, P357, DOI 10.1093/infdis/130.4.357; Criado-Fornelio A, 2003, VET PARASITOL, V113, P189, DOI 10.1016/S0304-4017(03)00078-5; Eddlestone SM, 2007, J VET INTERN MED, V21, P1237, DOI 10.1892/07-061.1; Georges K, 2008, ANN NY ACAD SCI, V1149, P196, DOI 10.1196/annals.1428.082; GROVES MG, 1975, AM J VET RES, V36, P937; Harrus S, 2004, ANTIMICROB AGENTS CH, V48, P4488, DOI 10.1128/AAC.48.11.4488-4490.2004; Harrus S, 1998, J CLIN MICROBIOL, V36, P2140, DOI 10.1128/JCM.36.7.2140-2142.1998; Harrus S, 2002, VET MICROBIOL, V86, P361, DOI 10.1016/S0378-1135(02)00022-6; Harrus S, 1998, J CLIN MICROBIOL, V36, P73, DOI 10.1128/JCM.36.1.73-76.1998; Harrus S, 1997, VET REC, V141, P247, DOI 10.1136/vr.141.10.247; Harrus S, 2011, VET J, V187, P292, DOI 10.1016/j.tvjl.2010.02.001; Hoff B, 2008, CAN VET J, V49, P593; HUXSOLL D L, 1970, Journal of Wildlife Diseases, V6, P220; HUXSOLL DL, 1972, EXP PARASITOL, V31, P53, DOI 10.1016/0014-4894(72)90046-X; IQBAL Z, 1994, J CLIN MICROBIOL, V32, P1644, DOI 10.1128/JCM.32.7.1644-1649.1994; IQBAL Z, 1994, J CLIN MICROBIOL, V32, P1658, DOI 10.1128/JCM.32.7.1658-1662.1994; Jefferies R, 2007, AUST VET J, V85, P459, DOI 10.1111/j.1751-0813.2007.00220.x; Kelly PJ, 2009, J INFECT DEV COUNTR, V3, P561, DOI 10.3855/jidc.475; Kelly PJ, 2006, EMERG INFECT DIS, V12, P224, DOI 10.3201/eid1202.050903; Kelly PJ, 1998, J S AFR VET ASSOC, V69, P55; Kelly PJ, 2000, J S AFR VET ASSOC, V71, P77; Kelly PJ, 2009, P 23 M AM SOC RICK; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Kordick SK, 1999, J CLIN MICROBIOL, V37, P2631, DOI 10.1128/JCM.37.8.2631-2638.1999; Lehtinen LE, 2008, VET PARASITOL, V151, P150, DOI 10.1016/j.vetpar.2007.10.022; Li YH, 2008, VET PARASITOL, V157, P50, DOI 10.1016/j.vetpar.2008.06.027; MATTHEWMAN LA, 1993, J S AFR VET ASSOC, V64, P111; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; McClure JC, 2010, ANTIMICROB AGENTS CH, V54, P5012, DOI 10.1128/AAC.01622-09; Mylonakis ME, 2004, J AM ANIM HOSP ASSOC, V40, P174, DOI 10.5326/0400174; Neer T. M., 2006, INFECT DIS DOG CAT, P203; Neer TM, 2002, J VET INTERN MED, V16, P309, DOI 10.1892/0891-6640(2002)016<0309:CSOEDO>2.3.CO;2; O'Dwyer LH, 2011, REV BRAS PARASITOL V, V20, P181, DOI 10.1590/S1984-29612011000300002; Parola P, 2003, ANN TROP MED PARASIT, V97, P535, DOI 10.1179/000349803225001382; PERILLE AL, 1991, J VET INTERN MED, V5, P195, DOI 10.1111/j.1939-1676.1991.tb00947.x; Schaefer JJ, 2008, ANN NY ACAD SCI, V1149, P263, DOI 10.1196/annals.1428.087; Solano-Gallego L, 2011, VET PARASITOL, V181, P48, DOI 10.1016/j.vetpar.2011.04.023; Taboada J, 2006, INFECT DIS DOG CAT, P722; UILENBERG G, 1989, VET QUART, V11, P33, DOI 10.1080/01652176.1989.9694194; Vargas-Hernandez G, 2012, VET PARASITOL, V186, P254, DOI 10.1016/j.vetpar.2011.11.011; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; Wen BH, 1997, J CLIN MICROBIOL, V35, P1852, DOI 10.1128/JCM.35.7.1852-1855.1997; Wong SSY, 2011, VECTOR-BORNE ZOONOT, V11, P1269, DOI 10.1089/vbz.2010.0265; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Yabsley MJ, 2008, VET PARASITOL, V151, P279, DOI 10.1016/j.vetpar.2007.11.008; Yeagley TJ, 2009, JAVMA-J AM VET MED A, V235, P535, DOI 10.2460/javma.235.5.535; Zandvliet MMJM, 2004, TIJDSCHR DIERGENEESK, V129, P740	59	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53450	10.1371/journal.pone.0053450	http://dx.doi.org/10.1371/journal.pone.0053450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335965	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700019
J	Kristensen, JM; Larsen, S; Helge, JW; Dela, F; Wojtaszewski, JFP				Kristensen, Jonas M.; Larsen, Steen; Helge, Jorn W.; Dela, Flemming; Wojtaszewski, Jorgen F. P.			Two Weeks of Metformin Treatment Enhances Mitochondrial Respiration in Skeletal Muscle of AMPK Kinase Dead but Not Wild Type Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; COMPLEX-I; RAT-LIVER; INSULIN; EXERCISE; EXPRESSION; BIOGENESIS; AMPK-ALPHA-2; MECHANISM	Metformin is used as an anti-diabetic drug. Metformin ameliorates insulin resistance by improving insulin sensitivity in liver and skeletal muscle. Reduced mitochondrial content has been reported in type 2 diabetic muscles and it may contribute to decreased insulin sensitivity characteristic for diabetic muscles. The molecular mechanism behind the effect of metformin is not fully clarified but inhibition of complex I in the mitochondria and also activation of the 5'AMP activated protein kinase (AMPK) has been reported in muscle. Furthermore, both AMPK activation and metformin treatment have been associated with stimulation of mitochondrial function and biogenesis. However, a causal relationship in skeletal muscle has not been investigated. We hypothesized that potential effects of in vivo metformin treatment on mitochondrial function and protein expressions in skeletal muscle are dependent upon AMPK signaling. We investigated this by two weeks of oral metformin treatment of muscle specific kinase dead alpha(2) (KD) AMPK mice and wild type (WT) littermates. We measured mitochondrial respiration and protein activity and expressions of key enzymes involved in mitochondrial carbohydrate and fat metabolism and oxidative phosphorylation. Mitochondrial respiration, HAD and CS activity, PDH and complex I-V and cytochrome c protein expression were all reduced in AMPK KD compared to WT tibialis anterior muscles. Surprisingly, metformin treatment only enhanced respiration in AMPK KD mice and thereby rescued the respiration defect compared to the WT mice. Metformin did not influence protein activities or expressions in either WT or AMPK KD mice. We conclude that two weeks of in vivo metformin treatment enhances mitochondrial respiration in the mitochondrial deficient AMPK KD but not WT mice. The improvement seems to be unrelated to AMPK, and does not involve changes in key mitochondrial proteins.	[Kristensen, Jonas M.; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Dept Nutr Exercise & Sport Sci, August Krogh Ctr, Sect Mol Physiol Grp, DK-1168 Copenhagen, Denmark; [Larsen, Steen; Helge, Jorn W.; Dela, Flemming] Univ Copenhagen, Xlab, Ctr Hlth Aging, Dept Biomed Sci,Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Kristensen, Jonas M.] Univ So Denmark, Inst Clin Res, Sect Mol Diabet & Metab, Endocrinol Res Unit, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark	Kristensen, JM (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sport Sci, August Krogh Ctr, Sect Mol Physiol Grp, DK-1168 Copenhagen, Denmark.	jmkristensen@ifi.ku.dk	Helge, Jørn Wulff/I-7096-2012; Larsen, Steen/L-2069-2013; Dela, Flemming/B-3239-2008; Wojtaszewski, Jørgen FP/P-6583-2014; Dela, Flemming/AAU-1691-2021; Kristensen, Jonas/A-3249-2017	Helge, Jørn Wulff/0000-0001-9724-5423; Dela, Flemming/0000-0001-9970-9535; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Dela, Flemming/0000-0001-9970-9535; wojtaszewski, jorgen/0000-0001-8185-3408; Larsen, Steen/0000-0002-5170-4337; Kristensen, Jonas/0000-0002-8296-975X	Danish Medical Research Council; Novo Nordisk Foundation; Danish Diabetes Association; Lundbeck Foundation; Nordea Foundation; Danish Ministry of Science, Technology and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; Danish Ministry of Science, Technology and Innovation	The study was supported by: Danish Medical Research Council; The Novo Nordisk Foundation; The Danish Diabetes Association; The Lundbeck Foundation; The Nordea Foundation. Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2010, DIABETOLOGIA, V53, P1151, DOI 10.1007/s00125-010-1708-x; Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; BAILEY CJ, 1986, DIABETES METAB, V12, P212; Bamford JA, 2003, CAN J PHYSIOL PHARM, V81, P1072, DOI 10.1139/Y03-110; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bikman BT, 2010, J OBES, V2010, DOI 10.1155/2010/970865; Bland ML, 2011, SCIENCE, V332, P1387, DOI 10.1126/science.1208444; Borst SE, 2001, LIFE SCI, V69, P1497, DOI 10.1016/S0024-3205(01)01225-5; Borst SE, 2000, LIFE SCI, V67, P165, DOI 10.1016/S0024-3205(00)00612-3; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brown JD, 2011, ACTA PHYSIOL, V201, P457, DOI 10.1111/j.1748-1716.2010.02226.x; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Cusi K, 1998, DIABETES REV, V6, P89; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Halimi S, 2006, DIABETES METAB, V32, P555, DOI 10.1016/S1262-3636(07)70309-9; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hojlund K, 2004, AM J PHYSIOL-ENDOC M, V286, pE239, DOI 10.1152/ajpendo.00326.2003; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2006, AM J PHYSL ENDOCRINO; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Larsen S, 2012, ACTA PHYSIOL, V205, P314, DOI 10.1111/j.1748-1716.2011.02399.x; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luna V, 2006, DIABETOLOGIA, V49, P375, DOI 10.1007/s00125-005-0112-4; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; Moreira PI, 2011, HANDB EXP PHARMACOL, V203, P331, DOI 10.1007/978-3-642-17214-4_14; Mortensen B, 2009, AM J PHYSIOL-ENDOC M, V297, pE956, DOI 10.1152/ajpendo.00058.2009; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Suwa M, 2006, J APPL PHYSL; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Williams DB, 2009, AM J PHYSIOL-ENDOC M, V296, pE1400, DOI 10.1152/ajpendo.90913.2008; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang L, 2007, AM J PHYSL HEART CIR; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	78	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53533	10.1371/journal.pone.0053533	http://dx.doi.org/10.1371/journal.pone.0053533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341947	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400047
J	Stech, M; Veldman, S; Larrain, J; Munoz, J; Quandt, D; Hassel, K; Kruijer, H				Stech, Michael; Veldman, Sarina; Larrain, Juan; Munoz, Jesus; Quandt, Dietmar; Hassel, Kristian; Kruijer, Hans			Molecular Species Delimitation in the Racomitrium canescens Complex (Grimmiaceae) and Implications for DNA Barcoding of Species Complexes in Mosses	PLOS ONE			English	Article							CRYPTIC SPECIATION; EVOLUTION; BRYOPHYTA; TAXONOMY; CIRCUMSCRIPTIONS; CLASSIFICATION; BIOGEOGRAPHY; LEJEUNEACEAE; PHYLOGENY; INFERENCE	In bryophytes a morphological species concept is still most commonly employed, but delimitation of closely related species based on morphological characters is often difficult. Here we test morphological species circumscriptions in a species complex of the moss genus Racomitrium, the R. canescens complex, based on variable DNA sequence markers from the plastid (rps4-trnT-trnL region) and nuclear (nrITS) genomes. The extensive morphological variability within the complex has led to different opinions about the number of species and intraspecific taxa to be distinguished. Molecular phylogenetic reconstructions allowed to clearly distinguish all eight currently recognised species of the complex plus a ninth species that was inferred to belong to the complex in earlier molecular analyses. The taxonomic significance of intraspecific sequence variation is discussed. The present molecular data do not support the division of the R. canescens complex into two groups of species (subsections or sections). Most morphological characters, albeit being in part difficult to apply, are reliable for species identification in the R. canescens complex. However, misidentification of collections that were morphologically intermediate between species questioned the suitability of leaf shape as diagnostic character. Four partitions of the molecular markers (rps4-trnT, trnT-trnL, ITS1, ITS2) that could potentially be used for molecular species identification (DNA barcoding) performed almost equally well concerning amplification and sequencing success. Of these, ITS1 provided the highest species discrimination capacity and should be considered as a DNA barcoding marker for mosses, especially in complexes of closely related species. Molecular species identification should be complemented by redefining morphological characters, to develop a set of easy-to-use molecular and non-molecular identification tools for improving biodiversity assessments and ecological research including mosses.	[Stech, Michael; Veldman, Sarina; Kruijer, Hans] Leiden Univ, Naturalis Biodivers Ctr, Sect Natl Herbarium Netherlands, Leiden, Netherlands; [Larrain, Juan] Univ Concepcion, Dept Bot, Concepcion, Chile; [Munoz, Jesus] Consejo Super Invest Cient RJB CSIC, Real Jardin Bot, Madrid, Spain; [Munoz, Jesus] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat, Quito, Ecuador; [Quandt, Dietmar] Univ Bonn, Nees Inst Plant Biodivers, Bonn, Germany; [Hassel, Kristian] Norwegian Univ Sci & Technol, Museum Nat Hist & Archaeol, N-7034 Trondheim, Norway	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Universidad de Concepcion; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Bonn; Norwegian University of Science & Technology (NTNU)	Stech, M (corresponding author), Leiden Univ, Naturalis Biodivers Ctr, Sect Natl Herbarium Netherlands, Leiden, Netherlands.	michael.stech@naturalis.nl	Quandt, Dietmar/F-1821-2010; Munoz, Jesus/B-7809-2008; Hassel, Kristian/AAD-7241-2022	Quandt, Dietmar/0000-0003-4304-6028; Hassel, Kristian/0000-0002-1906-8166; Kruijer, Hans/0000-0002-6768-5230; Larrain, Juan B./0000-0002-9423-6561; Munoz, Jesus/0000-0002-9266-2268	European Centre for Arctic Environmental Research [ARCFAC-026129-2008-31, ARCFAC-026129-2009-123]; Dutch Organization for Scientific Research (NWO) [ALW-NAP/08-01]; Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	European Centre for Arctic Environmental Research; Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MS and HK received financial support from the European Centre for Arctic Environmental Research (projects ARCFAC-026129-2008-31, ARCFAC-026129-2009-123) and the Dutch Organization for Scientific Research (NWO, project ALW-NAP/08-01). JM received financial support from the Ministry of Science and Technology of Spain (grant CGL2009-09530-BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond A.J., 2007, TRACER VERSION 15; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Frisvoll A. A., 1983, GUNNERIA, V41, P1; Gao C, 2003, MOSS FLORA CHINA, V3; Hedenas L, 2011, TAXON, V60, P1596, DOI 10.1002/tax.606005; HEINONEN K, 1971, Annales Botanici Fennici, V8, P142; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hernandez-Maqueda R, 2008, MOL PHYLOGENET EVOL, V46, P863, DOI 10.1016/j.ympev.2007.12.017; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huttunen S, 2010, TAXON, V59, P791, DOI 10.1002/tax.593010; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larrain J, 2011, THESIS U CONCEPCION; Larrain J, 2011, BRYOLOGIST, V114, P732, DOI 10.1639/0007-2745-114.4.732; Liu Y, 2011, TAXON, V60, P185, DOI 10.1002/tax.601016; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Noguchi A., 1974, J HATTORI BOT LAB, V38, P337; Nuin PAS., 2005, MTGUI SIMPLE INTERFA; Ochyra R., 2003, BIODIVERSITY POLAND, V3, P1; Ochyra R, 2007, FLORA N AM, V27, P285; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quandt D, 2005, MOL PHYLOGENET EVOL, V36, P429, DOI 10.1016/j.ympev.2005.03.014; Qut D., 2006, PHYDE PHYLOGENETIC D; Shaw A. J., 2009, BRYOPHYTE BIOL; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stech M, 2004, MONOG SYST BOTAN, V98, P415; Stech M, 2005, TAXON, V54, P377, DOI 10.2307/25065366; Stech M, 1999, J BRYOL, V21, P191, DOI 10.1179/jbr.1999.21.3.191; Stech M, 2008, NOVA HEDWIGIA, V86, P1, DOI 10.1127/0029-5035/2008/0086-0001; Stech M, 2011, TAXON, V60, P79, DOI 10.1002/tax.601007; Stech M, 2010, PHYTOTAXA, V9, P196; Stenoien HK, 2008, J EVOLUTION BIOL, V21, P566, DOI 10.1111/j.1420-9101.2007.01479.x; Sukkharak P, 2011, TAXON, V60, P1607, DOI 10.1002/tax.606006; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vanderpoorten A, 2006, PLANT GENOME BIODI B, P385; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; VITT DH, 1993, NOVA HEDWIGIA, V57, P457; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102	50	32	34	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53134	10.1371/journal.pone.0053134	http://dx.doi.org/10.1371/journal.pone.0053134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341927	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400032
J	Luo, F; Hou, TY; Zhang, ZH; Xie, Z; Wu, XH; Xu, JZ				Luo, Fei; Hou, Tian-Yong; Zhang, Ze-Hua; Xie, Zhao; Wu, Xue-Hui; Xu, Jian-Zhong			Effects of Initial Cell Density and Hydrodynamic Culture on Osteogenic Activity of Tissue-Engineered Bone Grafts	PLOS ONE			English	Article							POLYMER SCAFFOLDS; STEM-CELLS; IN-VIVO; BIOREACTOR; VASCULARIZATION; STIMULATION; PERFUSION; WALL	This study aimed to study the effects of initial cell density and in vitro culture method on the construction of tissue-engineered bone grafts and osteogenic activities. Human mesenchymal stem cells (hMSCs) were seeded onto cubic scaffolds prepared from demineralized bone matrix (DBM) by three methods - static, hydrodynamic, or fibrin hydrogel-assisted seeding. The resulting cell-scaffold constructs were cultured in vitro by static flask culture or hydrodynamic culture. The initial cell density and the subsequent in vitro proliferation and alkaline phosphate activities of the constructs were analyzed. The constructs were also subcutaneously implanted in nude mice to examine their in vivo osteogenic activities. Hydrogel-assisted seeding gave the highest seeding efficiency, followed by hydrodynamic and conventional static seeding. During in vitro culture, hydrodynamic culture produced higher plateau cell densities, alkaline phosphatase (ALP) activities, and extracellular matrix production than static culture. After subcutaneous implantation in nude mice, the implants prepared by the combination of hydrogel-assisted seeding and hydrodynamic culture produced higher wet weight and bone mineral density than implants prepared by other methods. The results suggest that the hydrogel-assisted seeding can substantially increase the initial seed cell density in scaffolds. Subsequent hydrodynamic culture can promote the proliferation and osteoblastic differentiation of the seeded cells. Correspondingly, bone grafts produced by the combination of these two methods achieved the highest osteogenic activity among the three methods employed.	[Luo, Fei; Hou, Tian-Yong; Zhang, Ze-Hua; Xie, Zhao; Wu, Xue-Hui; Xu, Jian-Zhong] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Chongqing, Peoples R China	Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Chongqing, Peoples R China.	xujianzhong1962@163.com		Hou, Tianyong/0000-0002-7685-2088; Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [31100694]; Natural Science Foundation of Chongqing, China [2010BB5163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	The Project was supported by National Natural Science Foundation of China (Grant No. 31100694) and by the Natural Science Foundation of Chongqing, China (Grant No. 2010BB5163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; ATRAH HI, 1994, BRIT MED J, V308, P933, DOI 10.1136/bmj.308.6934.933; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Bittner S, 2010, ANN NEUROL, V68, P58, DOI 10.1002/ana.22010; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Canziani M, 2009, HERNIA, V13, P625, DOI 10.1007/s10029-009-0555-5; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Duty AO, 2007, J BIOMECH ENG-T ASME, V129, P531, DOI 10.1115/1.2746375; Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099; Fuchs JR, 2003, J PEDIATR SURG, V38, P1348, DOI 10.1016/S0022-3468(03)00394-4; Hou TY, 2010, TISSUE ENG PT A, V16, P201, DOI [10.1089/ten.tea.2009.0291, 10.1089/ten.TEA.2009.0291]; Jaasma MJ, 2008, J BIOTECHNOL, V133, P490, DOI 10.1016/j.jbiotec.2007.11.010; Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023; Kilic E, 2004, ACTA ORTHOP TRAUMATO, V41, P295; Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721; Liu Y, 2006, J BIOTECHNOL, V124, P592, DOI 10.1016/j.jbiotec.2006.01.020; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Lopez-Perez PM, 2010, ACTA BIOMATER, V6, P3704, DOI 10.1016/j.actbio.2010.03.008; Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Ouyang A, 2007, BIOTECHNOL BIOENG, V96, P371, DOI 10.1002/bit.21091; Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1; Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017; Shimizu K, 2007, J BIOSCI BIOENG, V104, P171, DOI 10.1263/jbb.104.171; Skardal A, 2010, BIOMATERIALS; Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7; Tan HB, 2009, BIOMATERIALS, V30, P3560, DOI 10.1016/j.biomaterials.2009.03.029; Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259; Wang B, 2008, BIOMATERIALS, V29, P2954, DOI 10.1016/j.biomaterials.2008.03.038; Wang JY, 2006, BIOMATERIALS, V27, P2738, DOI 10.1016/j.biomaterials.2005.12.005; Wysocka Aleksandra, 2010, Cell Tissue Bank, V11, P209, DOI 10.1007/s10561-009-9163-y; Xu ZC, 2008, BIOMATERIALS, V29, P1464, DOI 10.1016/j.biomaterials.2007.11.037; Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	34	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53697	10.1371/journal.pone.0053697	http://dx.doi.org/10.1371/journal.pone.0053697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326488	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800070
J	So, JY; Smolarek, AK; Salerno, DM; Maehr, H; Uskokovic, M; Liu, F; Suh, N				So, Jae Young; Smolarek, Amanda K.; Salerno, David M.; Maehr, Hubert; Uskokovic, Milan; Liu, Fang; Suh, Nanjoo			Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMARY TUMORIGENESIS; STAT3; CD44; ACTIVATION; GROWTH; CELLS; PATHWAY; CARCINOGENESIS	Background: CD44, a transmembrane glycoprotein, is a major receptor for extracellular proteins involved in invasion and metastasis of human cancers. We have previously demonstrated that the novel Gemini vitamin D analog BXL0124 [1 alpha,25-dihydroxy-20R-21(3-hydroxy-3-deuteromethyl-4,4,4-trideuterobutyl)-23-yne-26,27-hexafluro-cholecalciferol] repressed CD44 expression in MCF10DCIS.com basal-like human breast cancer cells and inhibited MCF10DCIS xenograft tumor growth. In the present study, we investigated potential factors downstream of CD44 and the biological role of CD44 repression by BXL0124 in MCF10DCIS cells. Methods and Findings: The treatment with Gemini vitamin D BXL0124 decreased CD44 protein level, suppressed STAT3 signaling, and inhibited invasion and proliferation of MCF10DCIS cells. The interaction between CD44 and STAT3 was determined by co-immunoprecipitation. CD44 forms a complex with STAT3 and Janus kinase 2 (JAK2) to activate STAT3 signaling, which was inhibited by BXL0124 in MCF10DCIS cells. The role of CD44 in STAT3 signaling and invasion of MCF10DCIS cells was further determined by the knockdown of CD44 using small hairpin RNA in vitro and in vivo. MCF10DCIS cell invasion was markedly decreased by the knockdown of CD44 in vitro. The knockdown of CD44 also significantly decreased mRNA expression levels of invasion markers, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA), in MCF10DCIS cells. In MCF10DCIS xenograft tumors, CD44 knockdown decreased tumor size and weight as well as invasion markers. Conclusions: The present study identifies STAT3 as an important signaling molecule interacting with CD44 and demonstrates the essential role of CD44-STAT3 signaling in breast cancer invasion. It also suggests that repression of CD44-STAT3 signaling is a key molecular mechanism in the inhibition of breast cancer invasion by the Gemini vitamin D analog BXL0124.	[So, Jae Young; Smolarek, Amanda K.; Salerno, David M.; Maehr, Hubert; Uskokovic, Milan; Liu, Fang; Suh, Nanjoo] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08855 USA; [So, Jae Young] Rutgers State Univ, Grad Program Cellular & Mol Pharmacol, Piscataway, NJ USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Liu, Fang; Suh, Nanjoo] Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Suh, N (corresponding author), Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08855 USA.	nsuh@pharmacy.rutgers.edu	Salerno, David/L-7826-2019		National Institutes of Health [R01 CA127645]; Rutgers, The State University of New Jersey; Charles and Johanna Busch Memorial Fund; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA127645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers, The State University of New Jersey; Charles and Johanna Busch Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health [R01 CA127645 to NS]; the Trustees Research Fellowship Program at Rutgers, The State University of New Jersey, to NS; and the Charles and Johanna Busch Memorial Fund to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HJ, 2006, BIOCHEM PHARMACOL, V72, P332, DOI 10.1016/j.bcp.2006.04.030; Lee HJ, 2009, CLIN CANCER RES, V15, P4242, DOI 10.1158/1078-0432.CCR-08-3028; Lee HJ, 2008, CANCER PREV RES, V1, P476, DOI 10.1158/1940-6207.CAPR-08-0084; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Maehr H, 2009, J MED CHEM, V52, P5505, DOI 10.1021/jm900780q; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Montgomery N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3199; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; So JY, 2011, MOL PHARMACOL, V79, P360, DOI 10.1124/mol.110.068403; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	45	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54020	10.1371/journal.pone.0054020	http://dx.doi.org/10.1371/journal.pone.0054020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326564	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800103
J	Niemi, NM; Lanning, NJ; Westrate, LM; MacKeigan, JP				Niemi, Natalie M.; Lanning, Nathan J.; Westrate, Laura M.; MacKeigan, Jeffrey P.			Downregulation of the Mitochondrial Phosphatase PTPMT1 Is Sufficient to Promote Cancer Cell Death	PLOS ONE			English	Article							CYTOCHROME-C; SIGNALING CASCADES; CARDIOLIPIN; APOPTOSIS; SPECIFICITY; RELEASE	Protein Tyrosine Phosphatase localized to the Mitochondrion 1 (PTPMT1) is a dual specificity phosphatase exclusively localized to the mitochondria, and has recently been shown to be a critical component in the cardiolipin biosynthetic pathway. The downregulation of PTPMT1 in pancreatic beta cells has been shown to increase cellular ATP levels and insulin production, however, the generalized role of PTPMT1 in cancer cells has not been characterized. Here we report that downregulation of PTPMT1 activity is sufficient to induce apoptosis of cancer cells. Additionally, the silencing of PTPMT1 decreases cardiolipin levels in cancer cells, while selectively increasing ATP levels in glycolytic media. Additionally, sublethal downregulation of PTPMT1 synergizes with low doses of paclitaxel to promote cancer cell death. Our data suggest that inhibition of PTPMT1 causes a metabolic crisis in cancer cells that induces cell death, and may be a mechanism by which cancer cells can be sensitized to currently available therapies.	[Niemi, Natalie M.; Lanning, Nathan J.; Westrate, Laura M.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Dept Syst Biol, Grand Rapids, MI USA; [Niemi, Natalie M.] Van Andel Inst, Grad Sch, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	MacKeigan, JP (corresponding author), Van Andel Res Inst, Dept Syst Biol, Grand Rapids, MI USA.	jeff.mackeigan@vai.org	Lanning, Nathan/AAI-2532-2019; Niemi, Natalie/AAH-6963-2021	Lanning, Nathan/0000-0002-0983-7451; Niemi, Natalie/0000-0002-5174-4005; MacKeigan, Jeffrey/0000-0002-0198-5679	National Cancer Institute [R01CA138651]; NATIONAL CANCER INSTITUTE [F32CA159709, R01CA138651] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by award number R01CA138651 from the National Cancer Institute to J.P. MacKeigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Doughty-Shenton D, 2010, J PHARMACOL EXP THER, V333, P584, DOI 10.1124/jpet.109.163329; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Martin KR, 2011, J CELL SCI, V124, P812, DOI 10.1242/jcs.080341; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016; Yip KW, 2006, MOL CANCER THER, V5, P2234, DOI 10.1158/1535-7163.MCT-06-0134; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	28	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53803	10.1371/journal.pone.0053803	http://dx.doi.org/10.1371/journal.pone.0053803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326511	gold, Green Submitted, Green Published			2022-12-27	WOS:000313552400049
J	Tang, F; Zhang, W; Lu, CP				Tang, Fang; Zhang, Wei; Lu, Chengping			Lysogenic Streptococcus suis Isolate SS2-4 Containing Prophage SMP Showed Increased Mortality in Zebra Fish Compared to the Wild-Type Isolate	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; REPRODUCTIVE FITNESS; FUNCTIONAL-ANALYSIS; VIRULENCE; STRAIN; PHAGE; BACTERIOPHAGE; ENVIRONMENTS; PNEUMONIAE	Streptococcus suis (S. suis) infection is considered to be a major problem in the swine industry worldwide. Based on the capsular type, 33 serotypes of S. suis have been described, with serotype 2 (SS2) being the most frequently isolated from diseased piglets. Little is known, however, about the pathogenesis and virulence factors of S. suis. Research on bacteriophages highlights a new area in S. suis research. A S. suis serotype 2 bacteriophage, designated SMP, has been previously isolated in our laboratory. Here, we selected a lysogenic isolate in which the SMP phage was integrated into the chromosome of strain SS2-4. Compared to the wild-type isolate, the lysogenic strain showed increased mortality in zebra fish. Moreover the sensitivity of the lysogenic strain to lysozyme was seven times higher than that of the wild-type.	[Tang, Fang; Zhang, Wei; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Lu, CP (corresponding author), Nanjing Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	lucp@njau.edu.cn			Chinese National Programs for Fundamental Research and Development [2012CB518804]	Chinese National Programs for Fundamental Research and Development	This study was supported by grants from Chinese National Programs for Fundamental Research and Development (2012CB518804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Beutin L, 2002, DIAGN MICR INFEC DIS, V44, P337, DOI 10.1016/S0732-8893(02)00474-1; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Harel J, 2003, INFECT IMMUN, V71, P6104, DOI 10.1128/IAI.71.10.6104-6108.2003; Hu P, 2011, J BACTERIOL, V193, P3428, DOI 10.1128/JB.05018-11; Hu P, 2011, J BACTERIOL, V193, P2375, DOI 10.1128/JB.00083-11; Hu Xiaoshu, 2000, Zhonghua Yufang Yixue Zazhi, V34, P150; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Lin H, 2012, CLIN RHEUMATOL; LIN L, 1977, J VIROL, V21, P554, DOI 10.1128/JVI.21.2.554-559.1977; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Ma YL, 2008, VET MICROBIOL, V132, P340, DOI 10.1016/j.vetmic.2008.05.013; MARSH P, 1994, FEMS MICROBIOL ECOL, V15, P99, DOI 10.1016/0168-6496(94)90030-2; METCALF RH, 1973, J BACTERIOL, V113, P278, DOI 10.1128/JB.113.1.278-286.1973; Nagiec MJ, 2004, J BIOL CHEM, V279, P45909, DOI 10.1074/jbc.M405434200; Pasharawipas T, 2005, VIRUS RES, V114, P63, DOI 10.1016/j.virusres.2005.05.012; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pu JunYi, 2007, Scientia Agricultura Sinica, V40, P2655; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehm HJ, 2010, BIOTECHNOLOGY SET; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; THIBODEAU EA, 1991, ORAL MICROBIOL IMMUN, V6, P313, DOI 10.1111/j.1399-302X.1991.tb00500.x; Tran VTN, 2011, DIAGN MICR INFEC DIS, V70, P461, DOI 10.1016/j.diagmicrobio.2010.12.015; TROTTIER S, 1991, REV INFECT DIS, V13, P1251; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wang Y, 2011, VET MICROBIOL, V152, P151, DOI 10.1016/j.vetmic.2011.04.029; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	40	12	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54227	10.1371/journal.pone.0054227	http://dx.doi.org/10.1371/journal.pone.0054227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326601	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400085
J	Tsolis, AC; Papandreou, NC; Iconomidou, VA; Hamodrakas, SJ				Tsolis, Antonios C.; Papandreou, Nikos C.; Iconomidou, Vassiliki A.; Hamodrakas, Stavros J.			A Consensus Method for the Prediction of 'Aggregation-Prone' Peptides in Globular Proteins	PLOS ONE			English	Article							FIBRIL-FORMING SEGMENTS; AMYLOID FORMATION; INCLUSION-BODIES; SEQUENCE DETERMINANTS; SECONDARY STRUCTURE; PROPENSITY; BETA; IDENTIFICATION; REGIONS; SERVER	The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual methods are combined and produce AMYLPRED2, a publicly, freely available web tool to academic users (http://biophysics.biol.uoa.gr/AMYLPRED2), for the consensus prediction of amyloidogenic determinants/'aggregation-prone' peptides in proteins, from sequence alone. The performance of AMYLPRED2 indicates that it functions better than individual aggregation-prediction algorithms, as perhaps expected. AMYLPRED2 is a useful tool for identifying amyloid-forming regions in proteins that are associated with several conformational diseases, called amyloidoses, such as Altzheimer's, Parkinson's, prion diseases and type II diabetes. It may also be useful for understanding the properties of protein folding and misfolding and for helping to the control of protein aggregation/solubility in biotechnology (recombinant proteins forming bacterial inclusion bodies) and biotherapeutics (monoclonal antibodies and biopharmaceutical proteins).	[Tsolis, Antonios C.; Papandreou, Nikos C.; Iconomidou, Vassiliki A.; Hamodrakas, Stavros J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece	National & Kapodistrian University of Athens	Hamodrakas, SJ (corresponding author), Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece.	shamodr@biol.uoa.gr	Iconomidou, Vassiliki/AAM-2003-2020; Papandreou, Nikos/AAM-9403-2021	Papandreou, Nikos/0000-0002-3533-2182; Tsolis, Antonios/0000-0001-7446-4412	University of Athens; General Secretariat for Research and Technology of the Greek Ministry of Education [11SYN_1_1230]; Religious Affairs, Culture and Sports, under the NSRF	University of Athens; General Secretariat for Research and Technology of the Greek Ministry of Education; Religious Affairs, Culture and Sports, under the NSRF	The authors thank the University of Athens for support. They also thank the Cooperation 2011 program (11SYN_1_1230) of the General Secretariat for Research and Technology of the Greek Ministry of Education and Religious Affairs, Culture and Sports, under the NSRF 2007-2013, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clarke OJ, 2009, J COMPUT CHEM, V30, P621, DOI 10.1002/jcc.21085; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; David MPC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-79; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; HAMODRAKAS SJ, 1988, COMPUT APPL BIOSCI, V4, P473; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Idicula-Thomas S, 2005, PROTEIN ENG DES SEL, V18, P175, DOI 10.1093/protein/gzi022; Jefferis R, 2011, MABS-AUSTIN, V3, P503, DOI 10.4161/mabs.3.6.17611; Johnson SM, 2012, J MOL BIOL; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Kumar S, 2011, PHARM RES-DORDR, V28, P949, DOI 10.1007/s11095-011-0414-9; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Nair SSK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S21; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Donnell CW, 2011, BIOINFORMATICS, V27, pI34, DOI 10.1093/bioinformatics/btr238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saiki M, 2006, BIOCHEM BIOPH RES CO, V343, P1262, DOI 10.1016/j.bbrc.2006.03.089; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Pastor MT, 2007, PRION, V1, P9, DOI 10.4161/pri.1.1.4100; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	60	196	198	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54175	10.1371/journal.pone.0054175	http://dx.doi.org/10.1371/journal.pone.0054175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326595	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400082
J	Ciantar, J; Finch, E; Copland, DA				Ciantar, Jessica; Finch, Emma; Copland, David A.			Hand Movement Effects on Word Learning and Retrieval in Adults	PLOS ONE			English	Article							CONCURRENT TASK-PERFORMANCE; SHORT-TERM-MEMORY; DIVIDED ATTENTION; EXPLAINING MATH; LANGUAGE; APHASIA; OBJECTS; INTERFERENCE; ACQUISITION; GESTURE	The present study investigated the effect of performing an intentional non-meaningful hand movement on subsequent lexical acquisition and retrieval in healthy adults. Twenty-five right-handed healthy individuals were required to learn the names (2-syllable legal nonwords) for a series of unfamiliar objects. Participants also completed a familiar picture naming task to investigate the effects of the intentional non-meaningful movement on lexical retrieval. Results revealed that performing this hand movement immediately before linguistic tasks interfered with both new word learning and familiar picture naming when compared with no movement. These results extend previous findings of dual task interference effects in healthy individuals, suggesting that complex, non-meaningful, hand movements can also interfere with subsequent lexical acquisition and retrieval.	[Ciantar, Jessica; Finch, Emma; Copland, David A.] Univ Queensland, Div Speech Pathol, Brisbane, Qld, Australia; [Finch, Emma] Princess Alexandra Hosp, Speech Pathol Dept, Brisbane, Qld 4102, Australia; [Finch, Emma] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Copland, David A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	University of Queensland; Queensland Health; University of Queensland	Finch, E (corresponding author), Univ Queensland, Div Speech Pathol, Brisbane, Qld, Australia.	e.whiting@uq.edu.au	Copland, David A/F-1409-2010; Finch, Emma/B-3067-2011; Copland, David/AAE-5334-2020	Copland, David A/0000-0002-2257-4270; Finch, Emma/0000-0002-9690-8165; Copland, David/0000-0002-2257-4270				Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Basso A, 2001, BRAIN LANG, V77, P45, DOI 10.1006/brln.2000.2422; Breitenstein C, 2004, RESTOR NEUROL NEUROS, V22, P445; Breitenstein C, 2004, NEUROPSYCHOPHARMACOL, V29, P1704, DOI 10.1038/sj.npp.1300464; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Caroselli JS, 1997, NEUROPSYCHOLOGIA, V35, P457; Carson DH, 1968, CORTEX, V4, P92; Conway CM, 2007, J DEAF STUD DEAF EDU, V12, P317, DOI 10.1093/deafed/enm019; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Cook SW, 2012, LANG COGNITIVE PROC, V27, P594, DOI 10.1080/01690965.2011.567074; Cornelissen K, 2004, BRAIN LANG, V89, P617, DOI 10.1016/j.bandl.2003.12.007; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Crosson B, 2005, J COGNITIVE NEUROSCI, V17, P392, DOI 10.1162/0898929053279487; Crosson B, 2007, J INT NEUROPSYCH SOC, V13, P582, DOI 10.1017/S1355617707070737; Filoteo JV, 2010, PSYCHOL SCI, V21, P415, DOI 10.1177/0956797610362646; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Guez J, 2006, EUR J COGN PSYCHOL, V18, P874, DOI 10.1080/09541440500485854; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Gupta P, 2003, Q J EXP PSYCHOL-A, V56, P1213, DOI 10.1080/02724980343000071; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Hiscock M, 1995, BRAIN COGNITION, V29, P307, DOI 10.1006/brcg.1995.1284; Kelly SD, 2009, LANG COGNITIVE PROC, V24, P313, DOI 10.1080/01690960802365567; Kiefer M, 2005, NEUROPSYCHOLOGY, V19, P332, DOI 10.1037/0894-4105.19.3.332; Laine M, 2003, BRAIN LANG, V87, P128, DOI 10.1016/S0093-934X(03)00232-3; Laine M, 2010, LANG LEARN, V60, P25, DOI 10.1111/j.1467-9922.2010.00599.x; LOMAS J, 1980, NEUROPSYCHOLOGIA, V18, P141, DOI 10.1016/0028-3932(80)90060-3; LOMAS J, 1976, NEUROPSYCHOLOGIA, V14, P23, DOI 10.1016/0028-3932(76)90004-X; Martin N, 2004, COGN NEUROPSYCHOL, V21, P213, DOI 10.1080/02643290342000447; McCafferty SG, 2002, MOD LANG J, V86, P192, DOI 10.1111/1540-4781.00144; MCFARLAND K, 1982, NEUROPSYCHOLOGIA, V20, P365, DOI 10.1016/0028-3932(82)90112-9; MCFARLAND K, 1982, NEUROPSYCHOLOGIA, V20, P383, DOI 10.1016/0028-3932(82)90038-0; Medland SE, 2002, NEUROPSYCHOLOGIA, V40, P1233, DOI 10.1016/S0028-3932(01)00228-7; Meinzer M, 2011, NEUROREHAB NEURAL RE, V25, P178, DOI 10.1177/1545968310376577; Naveh-Benjamin M, 2006, MEM COGNITION, V34, P90, DOI 10.3758/BF03193389; Naveh-Benjamin M, 2005, J EXP PSYCHOL LEARN, V31, P520, DOI 10.1037/0278-7393.31.3.520; Naveh-Benjamin M, 2007, CAN J EXP PSYCHOL, V61, P1, DOI 10.1037/cjep2007001; Nemeth D, 2012, CEREBRAL CORTEX; Nemeth D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017577; Ping R, 2010, COGNITIVE SCI, V34, P602, DOI 10.1111/j.1551-6709.2010.01102.x; *PSYCH SOFTW TOOLS, 2002, E PRIM VERS 1 1 COMP; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Richards K, 2002, J REHABIL RES DEV, V39, P445; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Tikofsky R S, 1971, Cortex, V7, P106; Wagner SM, 2004, J MEM LANG, V50, P395, DOI 10.1016/j.jml.2004.01.002; Whiting E, 2007, INT J NEUROPSYCHOPH, V10, P805, DOI 10.1017/S1461145706007516; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003	48	1	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53861	10.1371/journal.pone.0053861	http://dx.doi.org/10.1371/journal.pone.0053861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342020	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700052
J	Matsuura, S; Shimizu, K; Shinoda, M; Ohara, K; Ogiso, B; Honda, K; Katagiri, A; Sessle, BJ; Urata, K; Iwata, K				Matsuura, Shingo; Shimizu, Kohei; Shinoda, Masamichi; Ohara, Kinuyo; Ogiso, Bunnai; Honda, Kuniya; Katagiri, Ayano; Sessle, Barry J.; Urata, Kentaro; Iwata, Koichi			Mechanisms Underlying Ectopic Persistent Tooth-Pulp Pain following Pulpal Inflammation	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; TEMPOROMANDIBULAR-JOINT INFLAMMATION; TRIGEMINAL ROOT GANGLION; PRIMARY AFFERENT NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD NEURONS; PERIPHERAL SENSITIZATION; NEUROPATHIC PAIN; OROFACIAL DEEP; RATS	In order to clarify the peripheral mechanisms of ectopic persistent pain in a tooth pulp following pulpal inflammation of an adjacent tooth, masseter muscle activity, phosphorylated extracellular signal-regulated protein kinase (pERK) and TRPV1 immunohistochemistries and satellite cell activation using glial fibrillary acidic protein (GFAP) immunohistochemistry in the trigeminal ganglion (TG) were studied in the rats with molar tooth-pulp inflammation. And, Fluorogold (FG) and DiI were also used in a neuronal tracing study to analyze if some TG neurons innervate more than one tooth pulp. Complete Freund's adjuvant (CFA) or saline was applied into the upper first molar tooth pulp (M1) in pentobarbital-anesthetized rats, and capsaicin was applied into the upper second molar tooth pulp (M2) on day 3 after the CFA or saline application. Mean EMG activity elicited in the masseter muscle by capsaicin application to M2 was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats. The mean number of pERK-immunoreactive (IR) TG cells was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats. Application of the satellite cell inhibitor fluorocitrate (FC) into TG caused a significant depression of capsaicin-induced masseter muscle activity and a significant reduction of satellite cell activation. The number of TRPV1-IR TG cells innervating M2 was significantly larger in M1 CFA-applied rats compared with M1 vehicle-applied rats, and that was decreased following FC injection into TG. Furthermore, 6% of TG neurons innervating M1 and/or M2 innervated both M1 and M2. These findings suggest that satellite cell activation following tooth pulp inflammation and innervation of multiple tooth pulps by single TG neurons may be involved in the enhancement of the activity of TG neurons innervating adjacent non-inflamed teeth that also show enhancement of TRPV1 expression in TG neurons, resulting in the ectopic persistent tooth-pulp pain following pulpal inflammation of adjacent teeth.	[Matsuura, Shingo; Shimizu, Kohei; Ohara, Kinuyo; Ogiso, Bunnai] Nihon Univ, Sch Dent, Dept Endodont, Tokyo 101, Japan; [Shinoda, Masamichi; Honda, Kuniya; Katagiri, Ayano; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Sessle, Barry J.] Univ Toronto, Fac Dent, Dept Oral Physiol, Toronto, ON, Canada; [Shinoda, Masamichi; Urata, Kentaro] Nihon Univ, Sch Dent, Dept Complete Denture Prosthodont, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Div Appl Syst Neurosci, Adv Med Res Ctr, Tokyo, Japan	Nihon University; Nihon University; University of Toronto; Nihon University; Nihon University	Iwata, K (corresponding author), Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan.	iwata.kouichi@nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022		Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology [22792021, 24659832]; Japan-Canada (CIHR) Joint Health Research Program; NIH [DE04786]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004786] Funding Source: NIH RePORTER	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by Research grants from Sato and Uemura Funds from Nihon University School of Dentistry, and a Grant from the Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant and Individual Research Grant; a Grant from the Ministry of Education, Culture, Sports, Science and Technology to promote multi-disciplinary research Projects (KAKENHI (Grant-in-Aid for Young Scientist (B)) #22792021 to MS, #24659832 to KI); grants from the Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research projects "Brain Mechanisms for Cognition, Memory and Behavior" and "Translational Research Network on Orofacial Neurological Disorders" at Nihon University, and Japan-Canada (CIHR) Joint Health Research Program, and NIH grant DE04786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-59; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Cherkas PS, 2004, PAIN, V110, P290, DOI 10.1016/j.pain.2004.04.007; Chiang CY, 2011, NEUROSCIENTIST, V17, P303, DOI 10.1177/1073858410386801; Dai Y, 2002, J NEUROSCI, V22, P7737; GLICK D H, 1962, Oral Surg Oral Med Oral Pathol, V15, P613, DOI 10.1016/0030-4220(62)90181-0; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; HOLLAND GR, 1987, EXP NEUROL, V98, P489, DOI 10.1016/0014-4886(87)90258-5; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jasmin L, 2010, NEURON GLIA BIOL, V6, P63, DOI 10.1017/S1740925X10000098; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Lam DK, 2009, BRAIN RES, V1253, P48, DOI 10.1016/j.brainres.2008.11.056; Lam DK, 2009, BRAIN RES, V1251, P130, DOI 10.1016/j.brainres.2008.11.029; LISNEY SJW, 1978, J PHYSIOL-LONDON, V279, P509, DOI 10.1113/jphysiol.1978.sp012359; Nebe J, 1997, EUR J NEUROSCI, V9, P2193, DOI 10.1111/j.1460-9568.1997.tb01386.x; SCHAIBLE HG, 1991, J NEUROPHYSIOL, V66, P1021, DOI 10.1152/jn.1991.66.3.1021; Schaible HG, 1996, PROG BRAIN RES, V113, P423, DOI 10.1016/S0079-6123(08)61102-4; SCHEPELMANN K, 1992, NEUROSCIENCE, V50, P237, DOI 10.1016/0306-4522(92)90395-I; SHIGENAGA Y, 1989, BRAIN RES, V477, P66, DOI 10.1016/0006-8993(89)91395-4; Shimizu K, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-75; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Sunakawa M, 1999, PAIN, V80, P493, DOI 10.1016/S0304-3959(98)00241-3; Takeda M, 2005, PAIN, V116, P375, DOI 10.1016/j.pain.2005.05.007; Takeda M, 2005, J NEUROPHYSIOL, V93, P2723, DOI 10.1152/jn.00631.2004; Tarsa L, 2010, NEUROSCIENCE, V167, P1205, DOI 10.1016/j.neuroscience.2010.03.002; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Vit JP, 2006, NEURON GLIA BIOL, V2, P247, DOI 10.1017/S1740925X07000427; Zhang S, 2006, NEUROSCIENCE, V142, P833, DOI 10.1016/j.neuroscience.2006.06.063; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	31	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52840	10.1371/journal.pone.0052840	http://dx.doi.org/10.1371/journal.pone.0052840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341909	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700016
J	Pan, D; Marcato, P; Ahn, DG; Gujar, S; Pan, LZ; Shmulevitz, M; Lee, PWK				Pan, Da; Marcato, Paola; Ahn, Dae-Gyun; Gujar, Shashi; Pan, Lu-Zhe; Shmulevitz, Maya; Lee, Patrick W. K.			Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOTIC RESPONSE; PHASE-I; CANCER; THERAPY; CYTOTOXICITY; PROMOTES; ARREST; SPREAD; TRIAL	Mammalian reovirus is a benign virus that possesses the natural ability to preferentially infect and kill cancer cells (reovirus oncolysis). Reovirus exploits aberrant Ras signalling in many human cancers to promote its own replication and spread. In vitro and in vivo studies using reovirus either singly or in combination with anti-cancer drugs have shown very encouraging results. Presently, a number of reovirus combination therapies are undergoing clinical trials for a variety of cancers. Previously we showed that accumulation of the tumor suppressor protein p53 by Nutlin-3a (a specific p53 stabilizer) enhanced reovirus-induced apoptosis, and resulted in significantly higher levels of reovirus dissemination. In this study, we examined the role of p53 in combination therapies involving reovirus and chemotherapeutic drugs. We showed that sublethal concentrations of traditional chemotherapy drugs actinomycin D or etoposide, but not doxorubicin, enhanced reovirus-induced apoptosis in a p53-dependent manner. Furthermore, NF-kappa B activation and expression of p53-target genes (p21 and bax) were important for the p53-dependent enhancement of cell death. Our results show that p53 status affects the efficacy of combination therapy involving reovirus. Choosing the right combination partner for reovirus and a low dosage of the drug may help to both enhance reovirus-induced cancer elimination and reduce drug toxicity.	[Pan, Da; Ahn, Dae-Gyun; Gujar, Shashi; Pan, Lu-Zhe; Lee, Patrick W. K.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Marcato, Paola; Lee, Patrick W. K.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Shmulevitz, Maya] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	Dalhousie University; Dalhousie University; University of Alberta	Lee, PWK (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	patrick.lee@dal.ca	; Ahn, Dae-Gyun/L-7106-2015	Shmulevitz, Maya/0000-0002-8627-068X; Marcato, Paola/0000-0001-8619-283X; Gujar, Shashi/0000-0002-5427-0829; Ahn, Dae-Gyun/0000-0001-8251-8820	Canadian Institutes for Health Research (CIHR); Cancer Research Training Program (CRTP) through Dalhousie University; Alberta Heritage Foundation for Medical Research; CRTP	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Training Program (CRTP) through Dalhousie University; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); CRTP	This work was supported by an operating grant from the Canadian Institutes for Health Research (CIHR) (P.W.K Lee), doctoral scholarships from the Cancer Research Training Program (CRTP) through Dalhousie University (D. Pan), and postdoctoral fellowships from the Alberta Heritage Foundation for Medical Research (P. Marcato) and CRTP (P. Marcato and S. Gujar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2002, BLOOD, V100, P4146, DOI 10.1182/blood-2002-02-0503; Bagnyukova T, 2010, CANCER BIOL THER, V10, P843, DOI 10.4161/cbt.10.9.13738; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Berard Alicia, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c01s14; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; DUNCAN MR, 1978, J VIROL, V28, P444, DOI 10.1128/JVI.28.2.444-449.1978; Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403; Gollamudi R, 2010, INVEST NEW DRUG, V28, P641, DOI 10.1007/s10637-009-9279-8; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Harrison C, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3782; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Hingorani P, 2011, CANCER-AM CANCER SOC, V117, P1764, DOI 10.1002/cncr.25741; Hirasawa K, 2002, CANCER RES, V62, P1696; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Marcato P, 2009, MOL THER, V17, P972, DOI 10.1038/mt.2009.58; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Norman KL, 2002, HUM GENE THER, V13, P641, DOI 10.1089/10430340252837233; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Pandha HS, 2009, CLIN CANCER RES, V15, P6158, DOI 10.1158/1078-0432.CCR-09-0796; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Twigger K, 2008, CLIN CANCER RES, V14, P912, DOI 10.1158/1078-0432.CCR-07-1400; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	40	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							Citation: e54006	10.1371/journal.pone.0054006	http://dx.doi.org/10.1371/journal.pone.0054006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342061	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700075
J	Reboredo, M; Chang, HCY; Barbero, R; Rodriguez-Ortigosa, CM; Perez-Vizcaino, F; Moran, A; Garcia, M; Banales, JM; Carreno, N; Alegre, F; Herrero, I; Quiroga, J; Prieto, J; Sangro, B				Reboredo, Mercedes; Chang, Haisul C. Y.; Barbero, Roberto; Rodriguez-Ortigosa, Carlos M.; Perez-Vizcaino, Francisco; Moran, Asuncion; Garcia, Monica; Banales, Jesus M.; Carreno, Norberto; Alegre, Felix; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno			Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure	PLOS ONE			English	Article							SYSTEMIC HEMODYNAMICS; MESENTERIC-ARTERY; RAT MESENTERY; HEALTHY-VOLUNTEERS; RECEPTOR SUBTYPES; CIRRHOTIC RATS; PHARMACOKINETICS; HYPERTENSION; 311C90; MODEL	Objective: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure and its potential interaction with propranolol. Methods: Zolmitriptan, propranolol or both were tested in two rat models of portal hypertension: common bile duct ligation (CBDL) and CCl4-induced cirrhosis. In these animals we measured different hemodynamic parameters including portal venous pressure, arterial renal flow, portal blood flow and cardiac output. We also studied the changes in superior mesenteric artery perfusion pressure and in arterial wall cAMP levels induced by zolmitriptan, propranolol or both. Moreover, we determined the effect of splanchnic sympathectomy on the response of PVP to zolmitriptan. Results: In both models of portal hypertension zolmitriptan induced a dose-dependent transient descent of portal pressure accompanied by reduction of portal flow with only slight decrease in renal flow. In cirrhotic rats, splanchnic sympathectomy intensified and prolonged zolmitriptan-induced portal pressure descent. Also, propranolol caused more intense and durable portal pressure fall when combined with zolmitriptan. Mesenteric artery perfusion pressure peaked for about 1 min upon zolmitriptan administration but showed no change with propranolol. However propranolol enhanced and prolonged the elevation in mesenteric artery perfusion pressure induced by zolmitriptan. In vitro studies showed that propranolol prevented the inhibitory effects of beta 2-agonists on zolmitriptan-induced vasoconstriction and the combination of propranolol and zolmitriptan significantly reduced the elevation of cAMP caused by beta 2-agonists. Conclusion: Zolmitriptan reduces portal hypertension and non-selective beta-blockers can improve this effect. Combination therapy deserves consideration for patients with portal hypertension failing to respond to non-selective beta-blockers.	[Reboredo, Mercedes; Barbero, Roberto; Rodriguez-Ortigosa, Carlos M.; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno] CIBERehd, Pamplona, Spain; [Chang, Haisul C. Y.; Rodriguez-Ortigosa, Carlos M.; Prieto, Jesus] Univ Navarra, Ctr Appl Med Res CIMA, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain; [Perez-Vizcaino, Francisco] Univ Complutense, Dept Pharmacol, E-28040 Madrid, Spain; [Perez-Vizcaino, Francisco] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Moran, Asuncion; Garcia, Monica] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Banales, Jesus M.] Univ Basque Country UPV EHU, Donostia Univ Hosp, Biodonostia Res Inst, IKERBASQUE,Div Hepatol & Gastroenterol, San Sebastian, Spain; [Carreno, Norberto; Alegre, Felix; Herrero, Ignacio; Quiroga, Jorge; Prieto, Jesus; Sangro, Bruno] Univ Navarra Clin, Liver Unit, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Salamanca; Basque Foundation for Science; University Hospital Donostia; University of Basque Country; University of Navarra	Reboredo, M (corresponding author), CIBERehd, Pamplona, Spain.	mmreboredo@unav.es	Morán, Asunción/B-1817-2017; Sangro, Bruno/AFW-4106-2022; Perez-Vizcaino, Francisco/A-9735-2011; Rodriguez-Ortigosa, Carlos/K-9895-2014; Banales, Jesus M/R-9739-2019; Garcia Domingo, Monica/B-1794-2017	Morán, Asunción/0000-0001-7509-1232; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Rodriguez-Ortigosa, Carlos/0000-0002-4931-4719; Sangro, Bruno/0000-0002-4177-6417; Banales, Jesus/0000-0002-5224-2373; Garcia Domingo, Monica/0000-0001-6140-4322; Prieto, Jesus/0000-0002-1091-9593	Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion; FIMA project UTE; Condesa de FENOSA; Pedro Barrie de la Maza; Fundacion Mario Losantos and Ministerio de Economia y Competitividad [SAF 2011-28150]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FIMA project UTE; Condesa de FENOSA; Pedro Barrie de la Maza; Fundacion Mario Losantos and Ministerio de Economia y Competitividad	CIBEREHD is funded by the Instituto de Salud Carlos III (http://www.ciberehd.org), Ministerio de Ciencia e Innovacion; grants by FIMA project UTE, Condesa de FENOSA, Pedro Barrie de la Maza, Fundacion Mario Losantos and Ministerio de Economia y Competitividad (SAF 2011-28150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli P, 2011, J HEPATOL, V55, P743, DOI 10.1016/j.jhep.2011.02.026; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; DEBAENE B, 1990, ANESTHESIOLOGY, V73, P118, DOI 10.1097/00000542-199007000-00017; Dixon R, 1997, BRIT J CLIN PHARMACO, V43, P273, DOI 10.1046/j.1365-2125.1997.00547.x; Dixon RM, 1997, CEPHALALGIA, V17, P639, DOI 10.1046/j.1468-2982.1997.1706639.x; Dowson AJ, 2002, INFORM HEALTHCARE, V3, P993; Fernandez MD, 2000, EUR J PHARMACOL, V401, P221, DOI 10.1016/S0014-2999(00)00444-1; Fizanne L, 2008, HEPATOL INT, V2, P457, DOI 10.1007/s12072-008-9070-5; Goldberg MR, 2001, BRIT J CLIN PHARMACO, V52, P69, DOI 10.1046/j.0306-5251.2001.01417.x; Gul H, 2003, J CARDIOVASC PHARM, V41, P307, DOI 10.1097/00005344-200302000-00021; Gul H, 2002, N-S ARCH PHARMACOL, V366, P254, DOI 10.1007/s00210-002-0587-1; Hansen MB, 2006, SCAND J CLIN LAB INV, V66, P395, DOI 10.1080/00365510600763301; Hernandez FT, 2006, VASC PHARMACOL, V44, P464, DOI 10.1016/j.vph.2006.03.001; JACKSON EK, 1980, EUR J PHARMACOL, V66, P217, DOI 10.1016/0014-2999(80)90145-4; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Knapton AD, 2010, METHOD FIND EXP CLIN, V32, P489, DOI 10.1358/mf.2010.32.7.1507854; KROEGER RJ, 1985, GASTROENTEROLOGY, V88, P896, DOI 10.1016/S0016-5085(85)80005-6; Loder E, 2010, NEW ENGL J MED, V363, P63, DOI 10.1056/NEJMct0910887; Martin GR, 1997, BRIT J PHARMACOL, V121, P157, DOI 10.1038/sj.bjp.0701041; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Minano C, 2010, GASTROENTEROL CLIN N, V39, P681, DOI 10.1016/j.gtc.2010.08.015; Peck RW, 1997, BRIT J CLIN PHARMACO, V44, P595, DOI 10.1046/j.1365-2125.1997.t01-1-00632.x; PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183; Reuter U, 2004, CEPHALALGIA, V24, P398, DOI 10.1111/j.1468-2982.2004.00683.x; RINGLARSEN H, 1982, HEPATOLOGY, V2, P304; Spencer CM, 1999, DRUGS, V58, P347, DOI 10.2165/00003495-199958020-00016; Tanaka Y, 2005, CLIN EXP PHARMACOL P, V32, P503, DOI 10.1111/j.1440-1681.2005.04222.x; Veal N, 2001, J APPL PHYSIOL, V91, P1274, DOI 10.1152/jappl.2001.91.3.1274; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413; Wurch T, 2000, J NEUROCHEM, V75, P1180, DOI 10.1046/j.1471-4159.2000.0751180.x	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52683	10.1371/journal.pone.0052683	http://dx.doi.org/10.1371/journal.pone.0052683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341903	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000313682700013
J	Varzari, A; Kharkov, V; Nikitin, AG; Raicu, F; Simonova, K; Stephan, W; Weiss, EH; Stepanov, V				Varzari, Alexander; Kharkov, Vladimir; Nikitin, Alexey G.; Raicu, Florina; Simonova, Kseniya; Stephan, Wolfgang; Weiss, Elisabeth H.; Stepanov, Vadim			Paleo-Balkan and Slavic Contributions to the Genetic Pool of Moldavians: Insights from the Y Chromosome	PLOS ONE			English	Article							LINEAGES; POPULATIONS; REVEALS; E-M78; DNA	Moldova has a rich historical and cultural heritage, which may be reflected in the current genetic makeup of its population. To date, no comprehensive studies exist about the population genetic structure of modern Moldavians. To bridge this gap with respect to paternal lineages, we analyzed 37 binary and 17 multiallelic (STRs) polymorphisms on the non-recombining portion of the Y chromosome in 125 Moldavian males. In addition, 53 Ukrainians from eastern Moldova and 54 Romanians from the neighboring eastern Romania were typed using the same set of markers. In Moldavians, 19 Y chromosome haplogroups were identified, the most common being I-M423 (20.8%), R-M17* (17.6%), R-M458 (12.8%), E-v13 (8.8%), R-M269* and R-M412* (both 7.2%). In Romanians, 14 haplogroups were found including I-M423 (40.7%), R-M17* (16.7%), R-M405 (7.4%), E-v13 and R-M412* (both 5.6%). In Ukrainians, 13 haplogroups were identified including R-M17 (34.0%), I-M423 (20.8%), R-M269* (9.4%), N-M178, R-M458 and R-M73 (each 5.7%). Our results show that a significant majority of the Moldavian paternal gene pool belongs to eastern/central European and Balkan/eastern Mediterranean Y lineages. Phylogenetic and AMOVA analyses based on Y-STR loci also revealed that Moldavians are close to both eastern/central European and Balkan-Carpathian populations. The data correlate well with historical accounts and geographical location of the region and thus allow to hypothesize that extant Moldavian paternal genetic lineages arose from extensive recent admixture between genetically autochthonous populations of the Balkan-Carpathian zone and neighboring Slavic groups.	[Varzari, Alexander] Phthisiopneumol Inst Chiril Draganiuc, Kishinev, Moldova; [Varzari, Alexander; Kharkov, Vladimir; Simonova, Kseniya; Stepanov, Vadim] Russian Acad Med Sci, Res Inst Med Genet, Tomsk, Russia; [Varzari, Alexander; Stephan, Wolfgang; Weiss, Elisabeth H.] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Nikitin, Alexey G.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Raicu, Florina] Romanian Acad, Anthropol Res Ctr Francisc Rainer, Bucharest, Romania; [Raicu, Florina] Carol Davila Univ Med & Pharm, Fac Med, Genet Chair, Bucharest, Romania; [Stepanov, Vadim] Genomnaya Diagnost Ltd, Tomsk, Russia	Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; University of Munich; Grand Valley State University; Romanian Academy of Sciences; Carol Davila University of Medicine & Pharmacy	Varzari, A (corresponding author), Phthisiopneumol Inst Chiril Draganiuc, Kishinev, Moldova.	varsahr@yahoo.com	Вагайцева, Ксения/A-7894-2014; Stepanov, Vadim/G-4320-2013; Kharkov, Vladimir/A-7884-2014; Vagaytseva, Kseniya/GZL-0221-2022; Stepanov, Vadim A./N-7657-2014; Stephan, Wolfgang/GOV-6503-2022; Nikitin, Alexey G/I-2651-2019; Raicu, Florina/A-4531-2011	Вагайцева, Ксения/0000-0003-4877-9749; Stepanov, Vadim/0000-0002-5166-331X; Kharkov, Vladimir/0000-0002-1679-2212; Vagaytseva, Kseniya/0000-0003-4877-9749; Nikitin, Alexey G/0000-0002-3897-4607; 	Russian Ministry of Science and Education [16.512.11.2033, 11.519.11.2036, P321]; DAAD	Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Russian Ministry of Science and Education (contracts # 16.512.11.2033, 11.519.11.2036 and P321). AV was supported by a DAAD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445; Csanyi B, 2008, ANN HUM GENET, V72, P519, DOI 10.1111/j.1469-1809.2008.00440.x; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Dergachev V, 2000, J INDO-EUR STUD, V28, P257; Dumitrescu VL, 1982, PREHISTORY BALKANS M, P1; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Fyodorov GB, 1999, STRATUM PLUS, V5, P14; Garasanin M, 1982, PREHISTORY BALKANS M, P75; Gimbutas, 1973, J INDOEUROPEAN STUDI, V1, P163; Guboglo MN, 2010, MOLDAVIANS; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Hurles ME, 1999, AM J HUM GENET, V67, P1055; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Kasuba M, 2010, ISTORIA MOLDOVEI EPO, P313; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Khar'kov V N, 2011, Mol Biol (Mosk), V45, P446; KHARKOV NV, 2005, RUSS J GENET, V41, P938; Kharkov VN, 2007, RUSS J GENET+, V43, P551, DOI 10.1134/S1022795407050110; Kharkov VN, 2004, RUSS J GENET+, V40, P326, DOI 10.1023/B:RUGE.0000021635.80528.2f; Klepper N, 2002, ROMANIA ILLUSTRATED; Larina O, 2010, ISTORIA MOLDOVEI EPO, P177; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myres NM, 2007, CROAT MED J, V48, P450; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nasidze I, 2007, ANN HUM GENET, V71, P379, DOI 10.1111/j.1469-1809.2006.00330.x; Renfrew AC, 1987, ARCHAEOLOGY LANGUAGE; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Russev ND, 1999, STRATUM PLUS, V5, P379; Sedov VV, 2002, SLAVS HIST ARCHAEOLO; Shchukin MB, 1989, ROME BARBARIANS CENT; Sims LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005792; Stefan M, 2001, EUR J HUM GENET, V9, P27, DOI 10.1038/sj.ejhg.5200580; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Varsahr A. M., 2006, Anthropologischer Anzeiger, V64, P51; Varzari A, 2007, J HUM GENET, V52, P308, DOI 10.1007/s10038-007-0113-x; Varzari A, 2009, AM J HUM BIOL, V21, P326, DOI 10.1002/ajhb.20863; Zbenovich VG, 1996, J WORLD PREHIST, V10, P199, DOI 10.1007/BF02221076; Zerjal T, 1997, AM J HUM GENET, V60, P1174	51	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53731	10.1371/journal.pone.0053731	http://dx.doi.org/10.1371/journal.pone.0053731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341985	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700040
J	Samuel, P; Khan, MA; Nag, S; Inagami, T; Hussain, T				Samuel, Preethi; Khan, Mohammad Azhar; Nag, Sourashish; Inagami, Tadashi; Hussain, Tahir			Angiotensin AT(2) Receptor Contributes towards Gender Bias in Weight Gain	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; FREE FATTY-ACIDS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-GAMMA; ENERGY-EXPENDITURE; BODY-WEIGHT; ESTROGEN; MICE; OBESITY	Obesity is a major disease condition, in turn leading to pathological changes collectively recognized as metabolic syndrome. Recently angiotensin receptor AT(2)R has been associated negatively with body weight (BW) gain in male mice. However, the gender differences in AT(2)R and BW changes have not been studied. To understand the gender based role of AT(2)R involving BW changes, we fed male and female wild type (WT) and AT(2)R knock out (AT(2)KO) mice with C57BL6 background with high fat diet (HFD) for 16 weeks. The male AT(2)KO had higher HFD calorie intake (WT: 1280 +/- 80; AT(2)KO: 1680 +/- 80 kcal) but gained less BW compared with the WT (WT: 13; AT(2)KO: 6 g). Contrary to the male animals, the female AT(2)KO mice with equivalent caloric intake (WT: 1424 +/- 48; AT(2)KO: 1456 +/- 80 kcal) gained significantly more BW than the WT mice (WT: 9 g; AT(2)KO: 15 g). The male AT(2)KO on HFD displayed lower plasma insulin level, less impaired glucose tolerance (GT), and higher plasma T3 compared with WT males on HFD; whereas the female AT(2)KO mice on HFD showed elevated levels of plasma insulin, more impaired GT, lower plasma T3 and higher free fatty acid and hepatic triglycerides compared with WT females on HFD. Interestingly, compared with WT, AT(2)KO female mice had significantly lower estrogen, which was further reduced by HFD. These results suggest that AT(2)R in female mice via potentially regulating estrogen may have protective role against BW gain and impaired glucose tolerance and lipid metabolism.	[Samuel, Preethi; Khan, Mohammad Azhar; Nag, Sourashish; Hussain, Tahir] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA; [Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	University of Houston System; University of Houston; Vanderbilt University	Hussain, T (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.	thussain@central.uh.edu	Khan, Mohammed/AAV-9189-2021		Norman Hackerman Advance Research Program, State of Texas [ROI DK-61578, ROI HL-58205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061578] Funding Source: NIH RePORTER	Norman Hackerman Advance Research Program, State of Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the Norman Hackerman Advance Research Program, State of Texas and ROI DK-61578 awarded to TH, and ROI HL-58205 awarded to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Armando I, 2002, AM J PHYSIOL-RENAL, V283, pF934, DOI 10.1152/ajprenal.00145.2002; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Baiardi G, 2005, REGUL PEPTIDES, V124, P7, DOI 10.1016/j.regpep.2004.06.021; BLACK AE, 1991, EUR J CLIN NUTR, V45, P583; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; BRUCH HR, 1992, J CLIN ENDOCR METAB, V75, P101, DOI 10.1210/jc.75.1.101; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Clasen R, 2005, HYPERTENSION, V46, P137, DOI 10.1161/01.HYP.0000168046.19884.6a; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Erbe DV, 2006, VASC PHARMACOL, V45, P154, DOI 10.1016/j.vph.2006.05.002; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kim S, 2001, BIOCHEM J, V357, P899, DOI 10.1042/0264-6021:3570899; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Kotani K, 2007, ANN CLIN BIOCHEM, V44, P83, DOI 10.1258/000456307779595959; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lu H, 2007, AM J PHYSIOL-ENDOC M, V292, pE1280, DOI 10.1152/ajpendo.00277.2006; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Miller JA, 1999, KIDNEY INT, V55, P278, DOI 10.1046/j.1523-1755.1999.00260.x; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; NITTA H, 1993, ENDOCRINOLOGY, V132, P1396, DOI 10.1210/en.132.3.1396; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Pelleymounter MA, 1999, AM J PHYSIOL-ENDOC M, V276, pE955, DOI 10.1152/ajpendo.1999.276.5.E955; Poehlman ET, 1998, CORONARY ARTERY DIS, V9, P799, DOI 10.1097/00019501-199809120-00004; RANDLE PJ, 1963, LANCET, V1, P785; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Sampson AK, 2008, CLIN EXP PHARMACOL P, V35, P391, DOI 10.1111/j.1440-1681.2008.04884.x; Sandberg K, 2008, HYPERTENSION, V52, P615, DOI 10.1161/HYPERTENSIONAHA.108.115063; Shimizu H, 1997, J ENDOCRINOL, V154, P285, DOI 10.1677/joe.0.1540285; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Thomas HV, 1997, CANCER CAUSE CONTROL, V8, P922, DOI 10.1023/A:1018476631561; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoshimura Y, 1996, ENDOCRINOLOGY, V137, P1204, DOI 10.1210/en.137.4.1204; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991; Yvan-Charvet L, 2006, ENDOCRINOLOGY, V147, P5078, DOI 10.1210/en.2006-0754; Yvan-Charvet L, 2009, ENDOCRINOLOGY, V150, P1421, DOI 10.1210/en.2008-1120	52	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e48425	10.1371/journal.pone.0048425	http://dx.doi.org/10.1371/journal.pone.0048425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341867	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700001
J	Shin, J; Kho, SA; Choi, YS; Kim, YC; Rhyu, IC; Choi, Y				Shin, Jieun; Kho, Sang-A; Choi, Yun S.; Kim, Yong C.; Rhyu, In-Chul; Choi, Youngnim			Antibody and T Cell Responses to Fusobacterium nucleatum and Treponema denticola in Health and Chronic Periodontitis	PLOS ONE			English	Article							INFLAMED GINGIVAL TISSUE; CENTRAL MEMORY; PORPHYROMONAS-GINGIVALIS; ANTIGEN-SPECIFICITY; CYTOKINE PROFILES; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; ORAL BACTERIA; INDUCE TH1; LYMPHOCYTES	The characteristics of the T cell response to the members of oral flora are poorly understood. We characterized the antibody and T cell responses to FadA and Td92, adhesins from Fusobacterium nucleatum, an oral commensal, and Treponema denticola, a periodontal pathogen, respectively. Peripheral blood and saliva were obtained from healthy individuals and patients with untreated chronic periodontitis (CP, n = 11 paris) and after successful treatment of the disease (n = 9). The levels of antigen-specific antibody were measured by ELISA. In plasma, IgG1 was the most abundant isotype of Ab for both Ags, followed by IgA and then IgG4. The levels of FadA-specific salivary IgA (sIgA) were higher than Td92-specific sIgA and the FadA-specific IgA levels observed in plasma. However, the periodontal health status of the individuals did not affect the levels of FadA-or Td92-specific antibody. Even healthy individuals contained FadA-and Td92-specific CD4(+) T cells, as determined by the detection of intracytoplasmic CD154 after short-term in vitro stimulation of peripheral blood mononuclear cells (PBMCs) with the antigens. Patients with CP tended to possess increased numbers of FadA-and Td92-specific CD4+ T cells but reduced numbers of Td92-specific Foxp(3+)CD(4+) Tregs than the healthy subjects. Both FadA and Td92 induced the production of IFN gamma and IL-10 but inhibited the secretion of IL-4 by PBMCs. In conclusion, F. nucleatum induced Th3 (sIgA)-and Th1 (IFN gamma and IgG1)-dominant immune responses, whereas T. denticola induced a Th1 (IFN gamma and IgG1)-dominant response. This IFN gamma-dominant cytokine response was impaired in CP patients, and the Td92-induced IFN gamma levels were negatively associated with periodontal destruction in patients. These findings may provide new insights into the homeostatic interaction between the immune system and oral bacteria and the pathogenesis of periodontitis.	[Shin, Jieun; Choi, Yun S.; Kim, Yong C.; Choi, Youngnim] Seoul Natl Univ, Sch Dent, CLS BK21, Dept Immunol & Mol Microbiol, Seoul, South Korea; [Shin, Jieun; Kho, Sang-A; Choi, Yun S.; Kim, Yong C.; Rhyu, In-Chul; Choi, Youngnim] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea; [Kho, Sang-A; Rhyu, In-Chul] Seoul Natl Univ, Sch Dent, CLS BK21, Dept Periodontol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, Y (corresponding author), Seoul Natl Univ, Sch Dent, CLS BK21, Dept Immunol & Mol Microbiol, Seoul, South Korea.	youngnim@snu.ac.kr	Choi, Youngnim/AAL-8140-2020	Choi, Youngnim/0000-0002-6496-5560	National Research Foundation of Korea by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University [2011-0028235]	National Research Foundation of Korea by the Korean Government through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea Grant (2011-0028235) by the Korean Government funded through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Berglundh T, 2005, J CLIN PERIODONTOL, V32, P87, DOI 10.1111/j.1600-051X.2005.00820.x; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P705, DOI 10.1034/j.1600-051X.2002.290807.x; Brage M, 2011, J PERIODONTAL RES, V46, P170, DOI 10.1111/j.1600-0765.2010.01325.x; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Costalonga M, 2009, MUCOSAL IMMUNOL, V2, P85, DOI 10.1038/mi.2008.67; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; GASCAN H, 1991, J IMMUNOL, V147, P8; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Gemmell E, 2002, J DENT RES, V81, P303, DOI 10.1177/154405910208100503; Gorska R, 2003, J CLIN PERIODONTOL, V30, P1046, DOI 10.1046/j.0303-6979.2003.00425.x; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x; Hall LM, 2012, J PERIODONTOL, V83, P228, DOI 10.1902/jop.2011.110116; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Ji S, 2010, MOL CELLS, V30, P519, DOI 10.1007/s10059-010-0142-8; Jun HK, 2008, INFECT IMMUN, V76, P2428, DOI 10.1128/IAI.01128-07; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Kopitar AN, 2006, ORAL MICROBIOL IMMUN, V21, P1, DOI 10.1111/j.1399-302X.2005.00237.x; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Lappin DF, 2001, CLIN EXP IMMUNOL, V123, P294, DOI 10.1046/j.1365-2249.2001.01448.x; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001; MAHANONDA R, 1989, CLIN EXP IMMUNOL, V75, P245; Nakajima T, 1999, ARCH ORAL BIOL, V44, P1045, DOI 10.1016/S0003-9969(99)00094-1; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shin J, 2008, ORAL DIS, V14, P327, DOI 10.1111/j.1601-0825.2007.01382.x; Sigusch B, 1998, J PERIODONTOL, V69, P1098, DOI 10.1902/jop.1998.69.10.1098; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; STAVNEZER J, 1995, J IMMUNOL, V155, P1647; Stubbe M, 2008, EUR J IMMUNOL, V38, P273, DOI 10.1002/eji.200737611; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Takeuchi Y, 2006, ORAL MICROBIOL IMMUN, V21, P314, DOI 10.1111/j.1399-302X.2006.00296.x; TEW JG, 1985, J PERIODONTAL RES, V20, P580, DOI 10.1111/j.1600-0765.1985.tb00842.x; Tokoro Y, 1997, CLIN EXP IMMUNOL, V107, P166, DOI 10.1046/j.1365-2249.1997.d01-880.x; Vaughan AT, 2010, J IMMUNOL, V185, P3652, DOI 10.4049/jimmunol.0902468; WASSENAAR A, 1995, INFECT IMMUN, V63, P2147, DOI 10.1128/IAI.63.6.2147-2153.1995; Wassenaar A, 1998, CLIN EXP IMMUNOL, V113, P105, DOI 10.1046/j.1365-2249.1998.00630.x; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Yamamoto M, 1997, J PERIODONTAL RES, V32, P115, DOI 10.1111/j.1600-0765.1997.tb01391.x	50	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53703	10.1371/journal.pone.0053703	http://dx.doi.org/10.1371/journal.pone.0053703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335969	Green Submitted, gold, Green Published			2022-12-27	WOS:000314707700025
J	Siero, JCW; Ramsey, NF; Hoogduin, H; Klomp, DWJ; Luijten, PR; Petridou, N				Siero, Jeroen C. W.; Ramsey, Nick F.; Hoogduin, Hans; Klomp, Dennis W. J.; Luijten, Peter R.; Petridou, Natalia			BOLD Specificity and Dynamics Evaluated in Humans at 7 T: Comparing Gradient-Echo and Spin-Echo Hemodynamic Responses	PLOS ONE			English	Article							OCULAR DOMINANCE COLUMNS; INDUCED SIGNAL CHANGES; HUMAN CEREBRAL-CORTEX; FUNCTIONAL MRI; HUMAN-BRAIN; LAMINAR SPECIFICITY; BLOOD-FLOW; FMRI; TESLA; SUPPRESSION	High-field gradient-echo (GE) BOLD fMRI enables very high resolution imaging, and has great potential for detailed investigations of brain function. However, as spatial resolution increases, confounds due to signal from non-capillary vessels increasingly impact the fidelity of GE BOLD fMRI signals. Here we report on an assessment of the microvascular weighting of the GE BOLD response across the cortical depth in human cortex using spin-echo fMRI which is thought to be dominated by microvasculature (albeit not completely). BOLD responses were measured with a hemodynamic impulse response (HRF) obtained from the spin-echo (SE) and gradient-echo (GE) BOLD contrast using very short stimuli (0.25 s) and a fast event-related functional paradigm. We show that the onset (similar to 1.25 s) and the rising slope of the GE and SE HRFs are strikingly similar for voxels in deep gray matter presumably containing the most metabolically demanding neurons (layers III-IV). This finding provides a strong indication that the onset of the GE HRF in deep gray matter is predominantly associated with microvasculature.	[Siero, Jeroen C. W.; Ramsey, Nick F.; Hoogduin, Hans; Petridou, Natalia] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Hoogduin, Hans; Klomp, Dennis W. J.; Luijten, Peter R.; Petridou, Natalia] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Ramsey, NF (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst, Dept Neurol & Neurosurg, Utrecht, Netherlands.	n.ramsey@umcutrecht.nl	Siero, Jeroen Cornelis Willem/I-4841-2019	Siero, Jeroen Cornelis Willem/0000-0001-5079-2868; , Natalia/0000-0002-0783-0387; ramsey, nick/0000-0002-7136-259X	BrainGain Smart Mix Programme; Dutch Technology Foundation STW; Applied Science Division of Netherlands Organisation for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht [UGT7685]	BrainGain Smart Mix Programme; Dutch Technology Foundation STW(Technologiestichting STW); Applied Science Division of Netherlands Organisation for Scientific Research; Technology Program of the Ministry of Economic Affairs; University of Utrecht	This study was funded by the BrainGain Smart Mix Programme, the Dutch Technology Foundation STW, the Applied Science Division of Netherlands Organisation for Scientific Research, the Technology Program of the Ministry of Economic Affairs, and the University of Utrecht (grant UGT7685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ari N, 2001, P 23 ANN C IEEE EMBS; Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Chen BR, 2011, NEUROIMAGE, V54, P1021, DOI 10.1016/j.neuroimage.2010.09.036; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Duvernoy HM, 1999, HUMAN BRAIN; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2010, NEUROIMAGE; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goense JBM, 2006, MAGN RESON IMAGING, V24, P381, DOI 10.1016/j.mri.2005.12.032; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Koopmans PJ, 2011, NEUROIMAGE, V56, P1276, DOI 10.1016/j.neuroimage.2011.02.042; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; MENON RS, 1993, MAGNET RESON MED, V30, P380, DOI 10.1002/mrm.1910300317; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Norris DG, 2012, NEUROIMAGE, V62, P1109, DOI 10.1016/j.neuroimage.2012.01.003; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Osman L, 2007, CIRCULATION, V116, pI282, DOI 10.1161/CIRCULATIONAHA.106.681072; Petridou N, 2013, NMR BIOMED, V26, P65, DOI 10.1002/nbm.2820; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Rossi DJ, 2006, NAT NEUROSCI, V9, P159, DOI 10.1038/nn0206-159; Siero JCW, 2011, J CEREBR BLOOD F MET, V31, P1999, DOI 10.1038/jcbfm.2011.57; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Yacoub E, 2003, MAGNET RESON MED, V49, P655, DOI 10.1002/mrm.10433; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; Yu X, 2011, NEUROIMAGE; Zhang NY, 2009, NEUROIMAGE, V48, P313, DOI 10.1016/j.neuroimage.2009.06.071; Zwanenburg JJM, 2011, NEUROIMAGE, V56, P1902, DOI 10.1016/j.neuroimage.2011.03.046	40	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54560	10.1371/journal.pone.0054560	http://dx.doi.org/10.1371/journal.pone.0054560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336008	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700066
J	Al-Maskari, F; El-Sadig, M; Al-Kaabi, JM; Afandi, B; Nagelkerke, N; Yeatts, KB				Al-Maskari, Fatma; El-Sadig, Mohamed; Al-Kaabi, Juma M.; Afandi, Bachar; Nagelkerke, Nicolas; Yeatts, Karin B.			Knowledge, Attitude and Practices of Diabetic Patients in the United Arab Emirates	PLOS ONE			English	Article							GLYCEMIC CONTROL; ASSOCIATION; MANAGEMENT; EDUCATION; CARE	Introduction: Diabetes self-management education is a cornerstone of diabetes care. However, many diabetics in the United Arab Emirates (UAE) lack sufficient knowledge about their disease due to illiteracy. Thus, before considering any possible intervention it was imperative to assess present knowledge, attitudes, and practices of patients towards the management of diabetes. Methods: A random sample of 575 DM patients was selected from diabetes outpatient's clinics of Tawam and Al-Ain hospitals in Al-Ain city (UAE) during 2006-2007, and their knowledge attitude and practice assessed using a questionnaire modified from the Michigan Diabetes Research Training Center instrument. Results: Thirty-one percent of patients had poor knowledge of diabetes. Seventy-two had negative attitudes towards having the disease and 57% had HbA(1c) levels reflecting poor glycemic control. Only seventeen percent reported having adequate blood sugar control, while 10% admitted non-compliance with their medications. Knowledge, practice and attitude scores were all statistically significantly positively, but rather weakly, associated, but none of these scores was significantly correlated with HbA1c. Conclusions: The study showed low levels of diabetes awareness but positive attitudes towards the importance of DM care and satisfactory diabetes practices in the UAE. Programs to increase patients' awareness about DM are essential for all diabetics in the UAE in order to improve their understanding, compliance and management and, thereby, their ability to cope with the disease.	[Al-Maskari, Fatma; El-Sadig, Mohamed; Nagelkerke, Nicolas] UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Al-Kaabi, Juma M.] UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates; [Afandi, Bachar] John Hopkins Med, Tawam Hosp, Ctr Diabet, Al Ain, U Arab Emirates; [Yeatts, Karin B.] Univ N Carolina, Gillings Sch Publ Hlth, Chapel Hill, NC USA	United Arab Emirates University; United Arab Emirates University; University of North Carolina; University of North Carolina Chapel Hill	Al-Maskari, F (corresponding author), UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	fatma.am@uaeu.ac.ae	Elsadig, Mohamed/AAX-7935-2020	Elsadig, Mohamed/0000-0001-5795-8189; Al-Maskari, Fatma/0000-0001-6598-4942; Alkaabi, Juma/0000-0003-2477-0408	UAE University	UAE University	UAE University funded this research. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah L, 2001, East Mediterr Health J, V7, P662; Al-Adsani AMS, 2009, DIABETES METAB, V35, P121, DOI 10.1016/j.diabet.2008.09.005; Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Al-Kaabi Juma, 2008, Rev Diabet Stud, V5, P110, DOI 10.1900/RDS.2008.5.110; Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI [10.2337/diacare.25.2007.S33, DOI 10.2337/DIACARE.25.2007.S33, 10.2337/diacare.25.2007.s33]; Ardena GJRA, 2010, DIABETES RES CLIN PR, V90, P160, DOI 10.1016/j.diabres.2010.08.003; Ben Abdelaziz A., 2007, Eastern Mediterranean Health Journal, V13, P505; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Ezenwaka CE, 2003, ACTA DIABETOL, V40, P173, DOI 10.1007/s00592-003-0107-x; Harrison TA, 2003, AM J PREV MED, V24, P152, DOI 10.1016/S0749-3797(02)00588-3; Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x; He X, 2007, INT NURS REV, V54, P280, DOI 10.1111/j.1466-7657.2007.00570.x; International Diabetes Federation (IDF), ATLAS; Kamel N M, 1999, East Mediterr Health J, V5, P974; Khan LA, 2000, ANN SAUDI MED, V20, P300, DOI 10.5144/0256-4947.2000.300; McPherson ML, 2008, RES SOC ADMIN PHARM, V4, P37, DOI 10.1016/j.sapharm.2007.01.002; Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ozcelik F, 2010, POL ARCH MED WEWN, V120, P399, DOI 10.20452/pamw.979; Panja S, 2005, J INVEST MED, V53, P264, DOI 10.2310/6650.2005.53509; Rhee MK, 2005, DIABETES EDUCATOR, V31, P410, DOI 10.1177/0145721705277022; Speight J, 2001, DIABETIC MED, V18, P626, DOI 10.1046/j.1464-5491.2001.00537.x	23	119	124	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52857	10.1371/journal.pone.0052857	http://dx.doi.org/10.1371/journal.pone.0052857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341913	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400024
J	Cantrell, J; Vallone, DM; Thrasher, JF; Nagler, RH; Feirman, SP; Muenz, LR; He, DY; Viswanath, K				Cantrell, Jennifer; Vallone, Donna M.; Thrasher, James F.; Nagler, Rebekah H.; Feirman, Shari P.; Muenz, Larry R.; He, David Y.; Viswanath, Kasisomayajula			Impact of Tobacco-Related Health Warning Labels across Socioeconomic, Race and Ethnic Groups: Results from a Randomized Web-Based Experiment	PLOS ONE			English	Article							PICTORIAL WARNINGS; CIGARETTE PACKAGES; SMOKING-CESSATION; QUITTING FINDINGS; MEDIA CAMPAIGNS; UNITED-STATES; DISPARITIES; SMOKERS; INFORMATION; KNOWLEDGE	Background: The U. S. Family Smoking Prevention and Tobacco Control Act of 2009 requires updating of the existing text-only health warning labels on tobacco packaging with nine new warning statements accompanied by pictorial images. Survey and experimental research in the U. S. and other countries supports the effectiveness of pictorial health warning labels compared with text-only warnings for informing smokers about the risks of smoking and encouraging cessation. Yet very little research has examined differences in reactions to warning labels by race/ethnicity, education or income despite evidence that population subgroups may differ in their ability to process health information. The purpose of the present study was to evaluate the potential impact of pictorial warning labels compared with text-only labels among U. S. adult smokers from diverse racial/ethnic and socioeconomic subgroups. Methods/Findings: Participants were adult smokers recruited from two online research panels (n = 3,371) into a web-based experimental study to view either the new pictorial warnings or text-only warnings. Participants viewed the labels and reported their reactions. Adjusted regression models demonstrated significantly stronger reactions for the pictorial condition for each outcome salience (b = 0.62, p < .001); perceived impact (b = 0.44, p < .001); credibility (OR = 1.41, 95% CI = 1.22-1.62), and intention to quit (OR = 1.30, 95% CI = 1.10-1.53). No significant results were found for interactions between condition and race/ethnicity, education, or income. The only exception concerned the intention to quit outcome, where the condition-by-education interaction was nearly significant (p = 0.057). Conclusions: Findings suggest that the greater impact of the pictorial warning label compared to the text-only warning is consistent across diverse racial/ethnic and socioeconomic populations. Given their great reach, pictorial health warning labels may be one of the few tobacco control policies that have the potential to reduce communication inequalities across groups. Policies that establish strong pictorial warning labels on tobacco packaging may be instrumental in reducing the toll of the tobacco epidemic, particularly within vulnerable communities.	[Cantrell, Jennifer; Vallone, Donna M.; Feirman, Shari P.] Legacy Fdn, Dept Res & Evaluat, Washington, DC USA; [Thrasher, James F.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Nagler, Rebekah H.; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Ctr Community Based Res, Dept Soc Human Dev & Hlth,Dana Farber Canc Inst, Boston, MA 02115 USA; [Muenz, Larry R.; He, David Y.] Larry R Muenz & Associates, Gaithersburg, MD USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Cantrell, J (corresponding author), Legacy Fdn, Dept Res & Evaluat, Washington, DC USA.	jcantrell@legacyforhealth.org			Legacy; Legacy Foundation	Legacy; Legacy Foundation	This study was supported by internal funding at Legacy. Legacy Foundation funded the study. Research and Evaluation Department staff within Legacy Foundation along with external collaborators listed as co-authors designed and conducted the study, organized data collection, conducted analysis and wrote the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; [Anonymous], 1995, SAGE U SERIES QUANTI; [Anonymous], 1999, CONSTRUCTING SOCIAL; Argo JJ, 2004, J PUBLIC POLICY MARK, V23, P193, DOI 10.1509/jppm.23.2.193.51400; Azagba S, 2012, EFFECT GRAPHIC CIGAR; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Borland R, 2009, PREV MED, V49, P219, DOI 10.1016/j.ypmed.2009.06.015; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Callegaro M, 2008, PUBLIC OPIN QUART, V72, P1008, DOI 10.1093/poq/nfn065; Carney RN, 2002, EDUC PSYCHOL REV, V14, P5, DOI 10.1023/A:1013176309260; Chatterjee S., 1991, BIOMETRICAL J, DOI DOI 10.1002/BIMJ.4710340613; Clayman ML, 2010, J HEALTH COMMUN, V15, P252, DOI 10.1080/10810730.2010.522697; Committee on Communication for Behavior Change in the 21st Century, 2002, SPEAK HLTH ASS HLTH; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Crawford MA, 2002, TOB CONTROL, V11, P14, DOI 10.1136/tc.11.1.14; Dewar RE, 1999, VISUAL INFORM EVERYD, P285; Durkin SJ, 2011, HEALTH EDUC RES, V26, P998, DOI 10.1093/her/cyr048; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Fagan P, 2007, ADDICTION, V102, P5, DOI 10.1111/j.1360-0443.2007.01952.x; Fathelrahman AI, 2010, INT J ENV RES PUB HE, V7, P4089, DOI 10.3390/ijerph7114089; Fathelrahman AI, 2009, NICOTINE TOB RES, V11, P248, DOI 10.1093/ntr/ntn029; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; Gunja M, 2002, TOB CONTROL, V11, P346, DOI 10.1136/tc.11.4.346; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; Hammond D, 2012, NICOTINE TOB RES; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hammond D, 2012, CANCER CAUSE CONTROL, V23, P57, DOI 10.1007/s10552-012-9902-4; Hammond D, 2012, NICOTINE TOB RES, V14, P62, DOI 10.1093/ntr/ntr182; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Hassan LM, 2008, INT J NONPROFIT VOLU, V13, P263, DOI 10.1002/nvsm.328; Hoek J, 2012, QUAL HEALTH RES, V22, P630, DOI 10.1177/1049732311431070; Hornik RC, 2006, AM BEHAV SCI, V49, P868, DOI 10.1177/0002764205283806; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; *I MED, 2007, END TOB PROBL BLUEPR; Institute of Medicine, 1994, GROW TOB FREE PREV I; International Agency for Research on Cancer, 2009, IARC HDB CANC PREV T, V12; Kalsher MJ, 1996, INT J IND ERGONOM, V18, P83, DOI 10.1016/0169-8141(95)00033-X; Kaphingst KA, 2005, J HEALTH COMMUN, V10, P609, DOI 10.1080/10810730500267647; Kees J, 2006, J PUBLIC POLICY MARK, V25, P212, DOI 10.1509/jppm.25.2.212; Kontos EZ, 2011, NAT REV CANCER, V11, P142, DOI 10.1038/nrc2999; Kreuter MW, 2004, ANNU REV PUBL HEALTH, V25, P439, DOI 10.1146/annurev.publhealth.25.101802.123000; Leonard SD, 1999, WARNINGS AND RISK COMMUNICATION, P149; Leventhal H., 1970, ADV EXP SOC PSYCHOL, V5, P119, DOI [https://doi.org/10.1016/S0065-2601(08)60091-X, DOI 10.1016/S0065-2601(08)60091-X]; LEVIE WH, 1982, ECTJ-EDUC COMMUN TEC, V30, P195; Loeber S, 2011, PHARMACOL BIOCHEM BE, V98, P292, DOI 10.1016/j.pbb.2011.01.010; Morrow N., 2011, J PET TECHNOL, V63, P106, DOI DOI 10.2118/129421-JPT; National Cancer Institute, 2008, ROL MED PROM RED TOB; National Cancer Institute, 2008, NAT CANC I TOB CONTR, V19; Niederdeppe J, 2008, AM J PUBLIC HEALTH, V98, P916, DOI 10.2105/AJPH.2007.117499; Niederdeppe J, 2011, SOC SCI MED, V72, P773, DOI 10.1016/j.socscimed.2010.12.025; Nonnemaker J, 2010, EXPT STUDY GRAPHIC C; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; Reimer RA, 2010, PSYCHOL HEALTH, V25, P943, DOI 10.1080/08870440902935913; Rutten LJF, 2008, NICOTINE TOB RES, V10, P1559, DOI 10.1080/14622200802325873; Schneider S, 2012, PATIENT EDUC COUNS, V86, P77, DOI 10.1016/j.pec.2011.03.005; Severtson DJ, 2009, RISK ANAL, V29, P1549, DOI 10.1111/j.1539-6924.2009.01299.x; SHERMAN SJ, 1985, PERS SOC PSYCHOL B, V11, P118, DOI 10.1177/0146167285111011; Siahpush M, 2006, TOB CONTROL, V15, P65, DOI 10.1136/tc.2005.013276; Slovic P, 2000, PERCEPTION RISK; Strahan EJ, 2002, TOB CONTROL, V11, P183, DOI 10.1136/tc.11.3.183; Thompson ME, 2006, TOB CONTROL, V15, P12, DOI 10.1136/tc.2005.013870; Thrasher JF, 2007, SALUD PUBLICA MEXICO, V49, pS233, DOI 10.1590/S0036-36342007000800013; Thrasher JF, 2012, AM J PREV MED, V43, P590, DOI 10.1016/j.amepre.2012.08.025; Thrasher JF, 2012, CANCER CAUSE CONTROL, V23, P69, DOI 10.1007/s10552-012-9899-8; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; Thrasher JF, 2010, SALUD PUBLICA MEXICO, V52, pS206, DOI 10.1590/S0036-36342010000800016; TICHENOR PJ, 1970, PUBLIC OPIN QUART, V34, P159, DOI 10.1086/267786; Viswanath K, 2006, J COMMUN, V56, pS238, DOI 10.1111/j.1460-2466.2006.00292.x; Viswanath K, 2006, J HEALTH COMMUN, V11, P1, DOI 10.1080/10810730600637426; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Wakefield M, 2012, COMMUNICATION TOBACC; Winder C, 2000, J HAZARD MATER, V125, P149; Wogalter MS, 2002, APPL ERGON, V33, P219, DOI 10.1016/S0003-6870(02)00009-1	76	100	101	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52206	10.1371/journal.pone.0052206	http://dx.doi.org/10.1371/journal.pone.0052206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23341895	Green Published, gold			2022-12-27	WOS:000314759400012
J	Gajiwala, KS; Maegley, K; Ferre, R; He, YA; Yu, X				Gajiwala, Ketan S.; Maegley, Karen; Ferre, RoseAnn; He, You-Ai; Yu, Xiu			Ack1: Activation and Regulation by Allostery	PLOS ONE			English	Article							TYROSINE KINASE ACK1; GROWTH-FACTOR RECEPTOR; CDC42-ASSOCIATED KINASE; CRYSTAL-STRUCTURE; EGF RECEPTOR; SH3 DOMAINS; MECHANISM; SRC; SPECIFICITY; BINDING	The non-receptor tyrosine kinase Ack1 belongs to a unique multi-domain protein kinase family, Ack. Ack is the only family of SH3 domain containing kinases to have an SH3 domain following the kinase domain; others have their SH3 domains preceding the kinase domain. Previous reports have suggested that Ack1 does not require phosphorylation for activation and the enzyme activity of the isolated kinase domain is low relative to other kinases. It has been shown to dimerize in the cellular environment, which augments its enzyme activity. The molecular mechanism of activation, however, remains unknown. Here we present structural and biochemical data on Ack1 kinase domain, and kinase domain+SH3 domain that suggest that Ack1 in its monomeric state is autoinhibited, like EGFR and CDK. The activation of the kinase domain may require N-lobe mediated symmetric dimerization, which may be facilitated by the N-terminal SAM domain. Results presented here show that SH3 domain, unlike in Src family tyrosine kinases, does not directly control the activation state of the enzyme. Instead we speculate that the SH3 domain may play a regulatory role by facilitating binding of the MIG6 homologous region to the kinase domain. We postulate that features of Ack1 activation and regulation parallel those of receptor tyrosine kinase EGFR with some interesting differences.	[Gajiwala, Ketan S.; Ferre, RoseAnn; He, You-Ai; Yu, Xiu] Pfizer Worldwide Res & Dev, Canc Struct Biol Oncol Med Chem, San Diego, CA USA; [Maegley, Karen] Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Gajiwala, KS (corresponding author), Pfizer Worldwide Res & Dev, Canc Struct Biol Oncol Med Chem, San Diego, CA USA.	Ketan.gajiwala@pfizer.com			Pfizer	Pfizer(Pfizer)	Funding for this research was provided by Pfizer, and all authors are paid employees of the company. However, the study was designed, data collected and analyzed, and the manuscript prepared exclusively by the authors of this work.	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chan W, 2011, BIOCHEM J, V435, P355, DOI 10.1042/BJ20102156; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Endres NF, 2011, CURR OPIN STRUCT BIO; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kopecky DJ, 2008, BIOORG MED CHEM LETT, V18, P6352, DOI 10.1016/j.bmcl.2008.10.092; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Prieto-Echague V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-42; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	34	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53994	10.1371/journal.pone.0053994	http://dx.doi.org/10.1371/journal.pone.0053994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342057	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400109
J	Harjanto, D; Zaman, MH				Harjanto, Dewi; Zaman, Muhammad H.			Modeling Extracellular Matrix Reorganization in 3D Environments	PLOS ONE			English	Article							CELL-MIGRATION; PROSTATE-CANCER; MECHANICAL-PROPERTIES; COLLAGEN GELS; COMPUTATIONAL-MODEL; ELASTIC-MODULI; PROTEOLYSIS; INVASION; BREAST; METALLOPROTEINASES	Extracellular matrix (ECM) remodeling is a key physiological process that occurs in a number of contexts, including cell migration, and is especially important for cellular form and function in three-dimensional (3D) matrices. However, there have been few attempts to computationally model how cells modify their environment in a manner that accounts for both cellular properties and the architecture of the surrounding ECM. To this end, we have developed and validated a novel model to simulate matrix remodeling that explicitly defines cells in a 3D collagenous matrix. In our simulation, cells can degrade, deposit, or pull on local fibers, depending on the fiber density around each cell. The cells can also move within the 3D matrix. Different cell phenotypes can be modeled by varying key cellular parameters. Using the model we have studied how two model cancer cell lines, of differing invasiveness, modify matrices with varying fiber density in their vicinity by tracking the metric of fraction of matrix occupied by fibers. Our results quantitatively demonstrate that in low density environments, cells deposit more collagen to uniformly increase fibril fraction. On the other hand, in higher density environments, the less invasive model cell line reduced the fibril fraction as compared to the highly invasive phenotype. These results show good qualitative and quantitative agreement with existing experimental literature. Our simulation is therefore able to function as a novel platform to provide new insights into the clinically relevant and physiologically critical process of matrix remodeling by helping identify critical parameters that dictate cellular behavior in complex native-like environments.	[Harjanto, Dewi; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Zaman, MH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [1R01CA132633]; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 1R01CA132633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Berry H, 1999, BIOPHYS J, V77, P655, DOI 10.1016/S0006-3495(99)76921-3; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Burns-Cox N, 2001, J UROLOGY, V166, P1698, DOI 10.1016/S0022-5347(05)65656-X; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Driessen NJB, 2004, J THEOR BIOL, V226, P53, DOI 10.1016/j.jtbi.2003.08.004; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891; HOOSEIN NM, 1991, CANCER COMMUN, V3, P255, DOI 10.3727/095535491820873146; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Israelowitz M, 2005, PROTEIN ENG DES SEL, V18, P329, DOI 10.1093/protein/gzi037; Karamichos D, 2008, J TISSUE ENG REGEN M, V2, P97, DOI 10.1002/term.69; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Maaser K, 1999, MOL BIOL CELL, V10, P3067, DOI 10.1091/mbc.10.10.3067; Maini PK, 2002, MATH MODELS CELL MAT; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramtani S, 2002, COMPUT BIOL MED, V32, P283, DOI 10.1016/S0010-4825(02)00018-5; Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Stuart K, 2008, BIOPOLYMERS, V89, P841, DOI 10.1002/bip.21024; Tosin A, 2010, MATH COMPUT MODEL, V52, P969, DOI 10.1016/j.mcm.2010.01.015; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Werb Z, 1999, APMIS, V107, P11, DOI 10.1111/j.1699-0463.1999.tb01521.x; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	56	25	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52509	10.1371/journal.pone.0052509	http://dx.doi.org/10.1371/journal.pone.0052509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341900	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400017
J	Mai, V; Torrazza, RM; Ukhanova, M; Wang, XY; Sun, YJ; Li, N; Shuster, J; Sharma, R; Hudak, ML; Neu, J				Mai, Volker; Torrazza, Roberto Murgas; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun; Li, Nan; Shuster, Jonathan; Sharma, Renu; Hudak, Mark Lawrence; Neu, Josef			Distortions in Development of Intestinal Microbiota Associated with Late Onset Sepsis in Preterm Infants	PLOS ONE			English	Article							PREVENTION; NEONATE	Late onset sepsis (LOS) is a major contributor to neonatal morbidity and mortality, especially in premature infants. Distortions in the establishment of normal gut microbiota, commensal microbes that colonize the digestive tract, might increase the risk of LOS via disruption of the mucosal barrier with resultant translocation of luminal contents. Correlation of distortions of the intestinal microbiota with LOS is a necessary first step to design novel microbiota-based screening approaches that might lead to early interventions to prevent LOS in high risk infants. Using a case/control design nested in a cohort study of preterm infants, we analyzed stool samples that had been prospectively collected from ten preterm infants with LOS and from 18 matched controls. A 16S rRNA based approach was utilized to compare microbiota diversity and identify specific bacterial signatures that differed in their prevalence between cases and controls. Overall alpha-diversity (Chao1) was lower in cases two weeks before (p<0.05) but not one week before or at the time of diagnosis of LOS. Overall microbiota structure (Unifrac) appeared distinct in cases 2 weeks and 1 week before but not at diagnosis (p<0.05). Although we detected few operational taxonomic units (OTUs) unique or enriched in cases, we found many OTUs common in controls that were lacking in cases (p<0.01). Bifidobacteria counts were lower in cases at all time points. Our results support the hypothesis that a distortion in normal microbiota composition, and not an enrichment of potential pathogens, is associated with LOS in preterm infants.	[Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Coll Med, Gainesville, FL USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Torrazza, Roberto Murgas; Li, Nan; Neu, Josef] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Shuster, Jonathan] Univ Florida, Coll Med, Dept Hlth Outcomes & Policy, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark Lawrence] Univ Florida, Coll Med, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	vmai@ufl.edu	Wang, Xiaoyu/J-4101-2018; Neu, Josef/AAI-2799-2020; Shuster, Jonathan/ABB-5773-2021	Shuster, Jonathan/0000-0001-9499-5616; Wang, Xiaoyu/0000-0002-4504-7799	United States National Institutes of Health [HD059153]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by United States National Institutes of Health grant # HD059153 to JN, VM, and RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Bancalari E, 2001, AM J PERINAT, V18, P1, DOI 10.1055/s-2001-12940; Bezirtzoglou E, 2011, ANAEROBE, V17, P369, DOI 10.1016/j.anaerobe.2011.03.010; Bordon Y, 2012, NAT REV IMMUNOL, V12, P4, DOI [10.1038/nri3135, 10.1038/nri3235]; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Kansagra K, 2003, AM J PHYSIOL-GASTR L, V285, pG1162, DOI 10.1152/ajpgi.00243.2003; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2009, WORLD J GASTROENTERO, V15, P81, DOI 10.3748/wjg.15.81; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paviour S, 2002, CLIN INFECT DIS, V35, P1434, DOI 10.1086/344463; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Sherman MP, 2010, CLIN PERINATOL, V37, P565, DOI 10.1016/j.clp.2010.05.006; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Strodtbeck Frances, 2003, Crit Care Nurs Clin North Am, V15, P79, DOI 10.1016/S0899-5885(02)00043-6; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285	29	153	161	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52876	10.1371/journal.pone.0052876	http://dx.doi.org/10.1371/journal.pone.0052876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341915	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400027
J	Spahr, L; Chalandon, Y; Terraz, S; Kindler, V; Rubbia-Brandt, L; Frossard, JL; Breguet, R; Lanthier, N; Farina, A; Passweg, J; Becker, CD; Hadengue, A				Spahr, Laurent; Chalandon, Yves; Terraz, Sylvain; Kindler, Vincent; Rubbia-Brandt, Laura; Frossard, Jean-Louis; Breguet, Romain; Lanthier, Nicolas; Farina, Annarita; Passweg, Jakob; Becker, Christoph D.; Hadengue, Antoine			Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; HEPATOCYTE GROWTH-FACTOR; STEM-CELLS; SHORT-TERM; HEPATOCELLULAR-CARCINOMA; REGENERATING LIVER; PROGENITOR CELLS; HEPATITIS; FAILURE; CIRRHOSIS	Objective: Impaired liver regeneration is associated with a poor outcome in patients with decompensated alcoholic liver disease (ALD). We assessed whether autologous bone marrow mononuclear cell transplantation (BMMCT) improved liver function in decompensated ALD. Design: 58 patients (mean age 54 yrs; mean MELD score 19, all with cirrhosis, 81% with alcoholic steatohepatitis at baseline liver biopsy) were randomized early after hospital admission to standard medical therapy (SMT) alone (n = 30), including steroids in patients with a Maddrey's score >= 32, or combined with G-CSF injections and autologous BMMCT into the hepatic artery (n = 28). Bone marrow cells were harvested, isolated and reinfused the same day. The primary endpoint was a >= 3 points decrease in the MELD score at 3 months, corresponding to a clinically relevant improvement in liver function. Liver biopsy was repeated at week 4 to assess changes in Ki67+/CK7+ hepatic progenitor cells (HPC) compartment. Results: Both study groups were comparable at baseline. After 3 months, 2 and 4 patients died in the BMMCT and SMT groups, respectively. Adverse events were equally distributed between groups. Moderate alcohol relapse occurred in 31% of patients. The MELD score improved in parallel in both groups during follow-up with 18 patients (64%) from the BMMCT group and 18 patients (53%) from the SMT group reaching the primary endpoint (p = 0.43 (OR 1.6, CI 0.49-5.4) in an intention to treat analysis. Comparing liver biopsy at 4 weeks to baseline, steatosis improved (p<0.001), and proliferating HPC tended to decrease in both groups (-35 and -33%, respectively). Conclusion: Autologous BMMCT, compared to SMT is a safe procedure but did not result in an expanded HPC compartment or improved liver function. These data suggest either insufficient regenerative stimulation after BMMCT or resistance to liver regenerative drive in patients with decompensated alcoholic cirrhosis.	[Spahr, Laurent; Frossard, Jean-Louis; Lanthier, Nicolas; Hadengue, Antoine] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Spahr, Laurent; Chalandon, Yves; Terraz, Sylvain; Kindler, Vincent; Rubbia-Brandt, Laura; Frossard, Jean-Louis; Breguet, Romain; Lanthier, Nicolas; Farina, Annarita; Passweg, Jakob; Becker, Christoph D.; Hadengue, Antoine] Fac Med, Geneva, Switzerland; [Chalandon, Yves; Kindler, Vincent; Passweg, Jakob] Univ Hosp, Div Hematol, Geneva, Switzerland; [Terraz, Sylvain; Breguet, Romain; Becker, Christoph D.] Univ Hosp, Dept Radiol, Geneva, Switzerland; [Rubbia-Brandt, Laura] Univ Hosp, Div Clin Pathol, Geneva, Switzerland; [Farina, Annarita] Univ Hosp, Dept Bioinformat & Struct Biol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Spahr, L (corresponding author), Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland.	Laurent.Spahr@hcuge.ch	Farina, Annarita/Y-7835-2019; passweg, jakob/AAG-3911-2020; Breguet, Romain/AAK-9260-2020; Lanthier, Nicolas/AAT-2930-2021; huijuan, Cao/A-2427-2014; Chalandon, Yves/AAF-5125-2019	Farina, Annarita/0000-0002-0099-4557; Lanthier, Nicolas/0000-0002-7651-9314; Breguet, Romain/0000-0002-8927-8134; Frossard, jean louis/0000-0002-6309-1603; Chalandon, Yves/0000-0001-9341-8104; Kindler, Vincent/0000-0002-5349-1857; Passweg, Jakob R/0000-0001-7092-3351	Clinical Research Center, University Hospital and Faculty of Medicine, Geneva; Louis-Jeantet Foundation; FLAGS (Foundation for Liver and Gut Studoies in Geneva); la Loterie Romande	Clinical Research Center, University Hospital and Faculty of Medicine, Geneva; Louis-Jeantet Foundation; FLAGS (Foundation for Liver and Gut Studoies in Geneva); la Loterie Romande	This study has been financially supported by the Clinical Research Center, University Hospital and Faculty of Medicine, Geneva, and the Louis-Jeantet Foundation, and FLAGS (Foundation for Liver and Gut Studoies in Geneva), and la Loterie Romande. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Porada G, 2010, EXP HEMATOL, V38, P574, DOI 10.1016/j.exphem.2010.04.007; Amer MEM, 2011, EUR J GASTROEN HEPAT, V23, P936, DOI 10.1097/MEG.0b013e3283488b00; Bernhard OK, 2011, METHODS MOL BIOL, V728, P195, DOI 10.1007/978-1-61779-068-3_12; BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x; Chen JP, 1998, BIOCHEM J, V334, P669, DOI 10.1042/bj3340669; Cui SJ, 1996, PATHOL INT, V46, P751, DOI 10.1111/j.1440-1827.1996.tb03544.x; Dalakas E, 2010, STEM CELLS DEV, V19, P1417, DOI 10.1089/scd.2009.0387; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Farinati F, 1996, HEPATOLOGY, V23, P1468; FAUSER AA, 1979, BLOOD, V54, P1384; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fujii K, 2004, BRIT J HAEMATOL, V124, P190, DOI 10.1046/j.1365-2141.2003.04745.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Garg V, 2012, GASTROENTEROLOGY, V142, P505, DOI 10.1053/j.gastro.2011.11.027; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Gordon MY, 2006, STEM CELLS, V24, P1822, DOI 10.1634/stemcells.2005-0629; Hillan KJ, 1996, J HEPATOL, V24, P385, DOI 10.1016/S0168-8278(96)80157-7; Horiguchi N, 2007, ALCOHOL, V41, P271, DOI 10.1016/j.alcohol.2007.04.008; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Ji SQ, 2002, BIOL BLOOD MARROW TR, V8, P261, DOI 10.1053/bbmt.2002.v8.pm12064363; Jin SZ, 2010, DIGEST DIS SCI, V55, P2805, DOI 10.1007/s10620-009-1117-5; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Kiefer F, 2005, EUR ADDICT RES, V11, P83, DOI 10.1159/000083037; Kisseleva T, 2012, J HEPATOL, V56, P965, DOI 10.1016/j.jhep.2011.09.021; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lyra AC, 2010, EUR J GASTROEN HEPAT, V22, P33, DOI 10.1097/MEG.0b013e32832eb69a; Mathurin P, 2002, J HEPATOL, V36, P480, DOI 10.1016/S0168-8278(01)00289-6; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Piscaglia AC, 2007, GASTROENTEROLOGY, V133, P619, DOI 10.1053/j.gastro.2007.05.018; RAMOND MJ, 1992, NEW ENGL J MED, V326, P507, DOI 10.1056/NEJM199202203260802; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Saito T, 2011, STEM CELLS DEV, V20, P1504, DOI 10.1089/scd.2011.0074; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Spahr L, 2001, J HEPATOL, V35, P582, DOI 10.1016/S0168-8278(01)00190-8; Spahr L, 2008, HEPATOLOGY, V48, P221, DOI 10.1002/hep.22317; Spahr L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-115; Srikureja W, 2005, J HEPATOL, V42, P700, DOI 10.1016/j.jhep.2004.12.022; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Thenappan A, 2010, HEPATOLOGY, V51, P1373, DOI 10.1002/hep.23449; Yip WW, 2006, SEMIN DIAGN PATHOL, V23, P149, DOI 10.1053/j.semdp.2006.11.002	47	79	82	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53719	10.1371/journal.pone.0053719	http://dx.doi.org/10.1371/journal.pone.0053719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341981	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400071
J	Lopez-Rios, F; Angulo, B; Gomez, B; Mair, D; Martinez, R; Conde, E; Shieh, F; Vaks, J; Langland, R; Lawrence, HJ; de Castro, DG				Lopez-Rios, Fernando; Angulo, Barbara; Gomez, Belen; Mair, Debbie; Martinez, Rebeca; Conde, Esther; Shieh, Felice; Vaks, Jeffrey; Langland, Rachel; Lawrence, H. Jeffrey; de Castro, David Gonzalez			Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib	PLOS ONE			English	Article							COLORECTAL-CARCINOMA; METASTATIC MELANOMA; INHIBITOR; SENSITIVITY; PLX4032; GENE; KRAS	Background: The cobas 4800 BRAF V600 Mutation Test is a CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib. We describe the pre-approval validation of this test in two external laboratories. Methods: Melanoma specimens were tested for BRAF V600 mutations at two laboratories with the: cobas BRAF Mutation Test; ABI BRAF test; and bidirectional direct sequencing. Positive (PPA) and negative (NPA) percent agreements were determined between the cobas test and the other assays. Specimens with discordant results were tested with massively parallel pyrosequencing (454). DNA blends with 5% mutant alleles were tested to assess detection rates. Results: Invalid results were observed in 8/116 specimens (6.9%) with Sanger, 10/116 (8.6%) with ABI BRAF, and 0/232 (0%) with the cobas BRAF test. PPA was 97.7% for V600E mutation for the cobas BRAF test and Sanger, and NPA was 95.3%. For the cobas BRAF test and ABI BRAF, PPA was 71.9% and NPA 83.7%. For 16 cobas BRAF test-negative/ABI BRAF-positive specimens, 454 sequencing detected no codon 600 mutations in 12 and variant codon 600 mutations in four. For eight cobas BRAF test-positive/ABI BRAF-negative specimens, four were V600E and four V600K by 454 sequencing. Detection rates for 5% mutation blends were 100% for the cobas BRAF test, 33% for Sanger, and 21% for the ABI BRAF. Reproducibility of the cobas BRAF test was 111/116 (96%) between the two sites. Conclusions: It is feasible to evaluate potential companion diagnostic tests in external laboratories simultaneously to the pivotal clinical trial validation. The health authority approved assay had substantially better performance characteristics than the two other methods. The overall success of the cobas BRAF test is a proof of concept for future biomarker development.	[Lopez-Rios, Fernando; Angulo, Barbara; Martinez, Rebeca; Conde, Esther] Hosp Univ Sanchinarro, Lab Dianas Terapeut, Madrid, Spain; [Gomez, Belen; Mair, Debbie; de Castro, David Gonzalez] Royal Marsden NHS Trust, London, England; [Gomez, Belen; Mair, Debbie; de Castro, David Gonzalez] Inst Canc Res, London SW3 6JB, England; [Shieh, Felice; Vaks, Jeffrey; Langland, Rachel; Lawrence, H. Jeffrey] Roche Mol Syst, Pleasanton, CA USA	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Roche Holding	Lopez-Rios, F (corresponding author), Hosp Univ Sanchinarro, Lab Dianas Terapeut, Madrid, Spain.	flopezrios@hospitaldemadrid.com			Roche Molecular Systems	Roche Molecular Systems	We would like to acknowledge Kelli DeMartin, Harry Halait, Shannon Walter, Mari Christensen, Malathy Nagarajan for their contributions to this study and manuscript. We are most grateful to the Sequencing Service at the Spanish National Cancer Centre (CNIO) for performing the direct sequencing assays. Miller Medical was contracted by Roche Molecular Systems and contributed in the drafting of this manuscript.	Anderson S., 2012, ARCH PATHOL LAB MED; Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; [Anonymous], 2002, US PROT EV QUAL TEST; Applied Biosystems, 2010, BRAF MUT AN REAG PAC; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheng S, 2012, N BIOTECHNOL    0225; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Luke JJ, 2012, CLIN CANCER RES, V18, P9, DOI 10.1158/1078-0432.CCR-11-2197; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Roche Molecular Systems Inc, 2011, COB 4800 BRAF V600 M; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Schubert C, 2011, NAT MED, V17, P1157, DOI 10.1038/nm1011-1157; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Ziai J, 2012, EXPERT REV MOL DIAGN, V12, P127, DOI [10.1586/erm.12.1, 10.1586/ERM.12.1]	20	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53733	10.1371/journal.pone.0053733	http://dx.doi.org/10.1371/journal.pone.0053733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326492	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400037
J	Mao, LL; Wang, J; DeGrado, WF; Inouye, M				Mao, Lili; Wang, Jun; DeGrado, William F.; Inouye, Masayori			An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs	PLOS ONE			English	Article							INFLUENZA-A VIRUS; ION-CHANNEL; THERAPY; PROTEIN; PORE	We developed a novel drug screening system for anti-influenza A virus by targeting the M2 proton channel. In the SPP (Single Protein Production) system, E. coli cell growth occurs only in the presence of effective M2 channel inhibitors, and thus simple measurement of cell growth was used as readouts for drug screening. Two potential inhibitors for M2 (V27A) mutant were verified using this method, which inhibit both the mutant and wild-type M2 channels.	[Mao, Lili; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Mao, Lili; Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@cabm.rutgers.edu	Wang, Jun/G-6504-2010; Mao, Lili/D-9938-2013	Wang, Jun/0000-0002-4845-4621; 	National Institutes of Health [1R01GM085449, AI074571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085449, R01GM056423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partially supported by the National Institutes of Health grants 1R01GM085449 (to MI) and AI074571 to (WFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrahan P, 2011, BBA-BIOMEMBRANES, V1808, P394, DOI 10.1016/j.bbamem.2010.08.021; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Centers for Disease Control, 2010, UPD CDC EST 2009 H1N; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Griffin SDC, 2009, P NATL ACAD SCI USA, V106, P12567, DOI 10.1073/pnas.0906760106; Hout DR, 2004, CURR HIV RES, V2, P255, DOI 10.2174/1570162043351246; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mould JA, 2000, J BIOL CHEM, V275, P31038, DOI 10.1074/jbc.M003663200; Ohshima M, 2010, PROTEIN ENG DES SEL, V23, P881, DOI 10.1093/protein/gzq066; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Suzuki M, 2007, NAT PROTOC, V2, P1802, DOI 10.1038/nprot.2007.252; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang J, 2011, J AM CHEM SOC, V133, P13844, DOI 10.1021/ja2050666; Wang J, 2011, J AM CHEM SOC, V133, P12834, DOI 10.1021/ja204969m	17	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54070	10.1371/journal.pone.0054070	http://dx.doi.org/10.1371/journal.pone.0054070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326573	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400072
J	Saito, M; Kurosawa, Y; Okuyama, T				Saito, Maiko; Kurosawa, Yae; Okuyama, Tsuneo			Scanning Electron Microscopy-Based Approach to Understand the Mechanism Underlying the Adhesion of Dengue Viruses on Ceramic Hydroxyapatite Columns	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ION-EXCHANGE CHROMATOGRAPHY; PURIFICATION; BINDING; PARTICLES; FUSION; PH	Although ceramic hydroxyapatite (HAp) chromatography has been used as an alternative method ultracentrifugation for the production of vaccines, the mechanism of virus separation is still obscure. In order to begin to understand the mechanisms of virus separation, HAp surfaces were observed by scanning electron microscopy after chromatography with dengue viruses. When these processes were performed without elution and with a 10-207 mM sodium phosphate buffer gradient elution, dengue viruses that were adsorbed to HAp were disproportionately located in the columns. However, when eluted with a 10-600 mM sodium phosphate buffer gradient, few viruses were observed on the HAp surface. After incubating the dengue viruses that were adsorbed on HAp beads at 37 degrees C and 2 degrees C, the sphericity of the dengue viruses were reduced with an increase in incubation temperature. These results suggested that dengue virus was adsorbed to the HAp surface by electronic interactions and could be eluted by high-salt concentration buffers, which are commonly used in protein purification. Furthermore, virus fusion was thought to occur with increasing temperature, which implied that virus-HAp adhesion was similar to virus-cell adhesion.	[Saito, Maiko; Kurosawa, Yae] HOYA Corp, PENTAX New Ceram Div, R&D Dept, Tokyo, Japan; [Okuyama, Tsuneo] Prot Technos Inst, Kanagawa, Japan		Saito, M (corresponding author), HOYA Corp, PENTAX New Ceram Div, R&D Dept, Tokyo, Japan.	maiko.saito@pc.hoya.co.jp						Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; DOWNING LA, 1992, J VIROL METHODS, V38, P215, DOI 10.1016/0166-0934(92)90112-Q; GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157; HAYWOOD AM, 1994, J VIROL, V68, P1; HAYWOOD AM, 1986, J GEN VIROL, V67, P2813, DOI 10.1099/0022-1317-67-12-2813; He CY, 2011, J CHROMATOGR A, V1218, P5279, DOI 10.1016/j.chroma.2011.06.043; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Iyer G, 2011, J CHROMATOGR A, V1218, P3973, DOI 10.1016/j.chroma.2011.04.086; Jiang ZJ, 2011, PROTEIN EXPRES PURIF, V80, P203, DOI 10.1016/j.pep.2011.07.009; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V96, P932, DOI 10.1002/bit.21109; Kuiper M, 2002, BIOTECHNOL BIOENG, V80, P445, DOI 10.1002/bit.10388; Kurosawa Y, 2009, MED BIOL, V153, P607; LAMBERT DM, 1980, J VIROL, V36, P837, DOI 10.1128/JVI.36.3.837-846.1980; Morenweiser R, 2005, GENE THER, V12, pS103, DOI 10.1038/sj.gt.3302624; Parris NA, 1984, INSTRUMENTAL LIQUID; Raviprakash K, 2009, HUM VACCINES, V5, P520, DOI 10.4161/hv.5.8.9008; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Sakamoto M, 2007, J BIOMED MATER RES A, V82A, P238, DOI 10.1002/jbm.a.31013; Smith GP, 2005, BIOTECHNIQUES, V39, P879, DOI 10.2144/000112032; Song Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-126; Sugo K., 2007, TISSUE CULT RES COMM, V26, P125; Trilisky EI, 2007, J CHROMATOGR A, V1142, P2, DOI 10.1016/j.chroma.2006.12.094; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244	23	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53893	10.1371/journal.pone.0053893	http://dx.doi.org/10.1371/journal.pone.0053893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326529	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400054
J	Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brummendorf, TH; Schuppert, A				Balabanov, Stefan; Wilhelm, Thomas; Venz, Simone; Keller, Gunhild; Scharf, Christian; Pospisil, Heike; Braig, Melanie; Barett, Christine; Bokemeyer, Carsten; Walther, Reinhard; Bruemmendorf, Tim H.; Schuppert, Andreas			Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; BCR-ABL KINASE; CHRONIC-PHASE; GENE-EXPRESSION; AURORA KINASES; IMATINIB; CANCER; DASATINIB; NILOTINIB; THERAPY	In drug discovery, the characterisation of the precise modes of action (MoA) and of unwanted off-target effects of novel molecularly targeted compounds is of highest relevance. Recent approaches for identification of MoA have employed various techniques for modeling of well defined signaling pathways including structural information, changes in phenotypic behavior of cells and gene expression patterns after drug treatment. However, efficient approaches focusing on proteome wide data for the identification of MoA including interference with mutations are underrepresented. As mutations are key drivers of drug resistance in molecularly targeted tumor therapies, efficient analysis and modeling of downstream effects of mutations on drug MoA is a key to efficient development of improved targeted anti-cancer drugs. Here we present a combination of a global proteome analysis, reengineering of network models and integration of apoptosis data used to infer the mode-of-action of various tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) cell lines expressing wild type as well as TKI resistance conferring mutants of BCR-ABL. The inferred network models provide a tool to predict the main MoA of drugs as well as to grouping of drugs with known similar kinase inhibitory activity patterns in comparison to drugs with an additional MoA. We believe that our direct network reconstruction approach, demonstrated on proteomics data, can provide a complementary method to the established network reconstruction approaches for the preclinical modeling of the MoA of various types of targeted drugs in cancer treatment. Hence it may contribute to the more precise prediction of clinically relevant on- and off-target effects of TKIs.	[Balabanov, Stefan; Wilhelm, Thomas; Keller, Gunhild; Braig, Melanie; Barett, Christine; Bokemeyer, Carsten; Bruemmendorf, Tim H.] Univ Hosp Eppendorf UKE, Hubertus Wald Tumor Zentrum UCCH, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Balabanov, Stefan] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Wilhelm, Thomas] Rhein Westfal TH Aachen, Univ Hosp Aachen UKA, Dept Biochem, Aachen, Germany; [Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, UKA, D-52062 Aachen, Germany; [Schuppert, Andreas] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Applied Sciences Wildau; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University	Schuppert, A (corresponding author), Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany.	schuppert@aices.rwth-aachen.de	Balabanov, Stefan/E-9765-2014; Scharf, Christian/A-7931-2011; Pospisil, Heike/G-7377-2016	Scharf, Christian/0000-0001-6806-6450; Schuppert, Andreas/0000-0003-3783-6605	German Federal Ministry for Education and Research [0315416A]; Eppendorfer Krebsund Leukamiehilfe e.V	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Eppendorfer Krebsund Leukamiehilfe e.V	This work was supported by the German Federal Ministry for Education and Research (grant: 0315416A) and by a grant from the Eppendorfer Krebsund Leukamiehilfe e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Atias N, 2011, J COMPUT BIOL, V18, P207, DOI 10.1089/cmb.2010.0255; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bhojani N, 2008, EUR UROL, V53, P917, DOI 10.1016/j.eururo.2007.11.037; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Breitkopf SB, 2010, J PROTEOME RES, V9, P6033, DOI 10.1021/pr1008527; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cortes JE, 2011, BLOOD; Cortes JE, 2012, J CLIN ONCOL, V30; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dyshlovoy SA, 2012, J PROTEOME RES, V11, P2316, DOI 10.1021/pr300170p; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fiedler B, 2008, IMA J APPL MATH, V73, P449, DOI 10.1093/imamat/hxn011; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Fukuzaki M, 2009, IEEE INT C BIOINFORM, P142, DOI 10.1109/BIBM.2009.26; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin GX, 2012, CANCER RES, V72, P33, DOI 10.1158/0008-5472.CAN-11-2333; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keller G, 2009, EXPERT REV HEMATOL, V2, P489, DOI [10.1586/ehm.09.42, 10.1586/EHM.09.42]; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; Peifer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008919; Preisinger C, 2010, CELL SIGNAL, V22, P848, DOI 10.1016/j.cellsig.2009.12.012; Preukschas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043468; Quintas-Cardama A, 2008, CLIN LYMPHOMA MYELOM, V8, pS82, DOI 10.3816/CLM.2008.s.003; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Schopfer G, 2005, COMP AID CH, V20a-20b, P595; Schuppert A, 1999, EXTRAPOLABILITY STRU; Schuppert AA, 2011, J MATH IND, V1, DOI 10.1186/2190-5983-1-6; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; Sirota M, 2011, SCI TRANSLATIONAL ME, V3; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Winkler DA, 2009, ARTIF LIFE, V15, P411, DOI 10.1162/artl.2009.Winkler.011; Xing HM, 2006, NAT PROTOC, V1, P2551, DOI 10.1038/nprot.2006.300; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	63	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53668	10.1371/journal.pone.0053668	http://dx.doi.org/10.1371/journal.pone.0053668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326482	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000313551500091
J	Messiaen, P; Wensing, AMJ; Fun, A; Nijhuis, M; Brusselaers, N; Vandekerckhove, L				Messiaen, Peter; Wensing, Annemarie M. J.; Fun, Axel; Nijhuis, Monique; Brusselaers, Nele; Vandekerckhove, Linos			Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; NAIVE HIV-1-INFECTED PATIENTS; OPTIMIZED BACKGROUND THERAPY; CO-FORMULATED ELVITEGRAVIR; CROSS-RESISTANCE PROFILE; TWICE-DAILY RALTEGRAVIR; LONG-TERM EFFICACY; DOUBLE-BLIND; ANTIRETROVIRAL TREATMENT; COMBINATION THERAPY	Background: Optimal regimen choice of antiretroviral therapy is essential to achieve long-term clinical success. Integrase inhibitors have swiftly been adopted as part of current antiretroviral regimens. The purpose of this study was to review the evidence for integrase inhibitor use in clinical settings. Methods: MEDLINE and Web-of-Science were screened from April 2006 until November 2012, as were hand-searched scientific meeting proceedings. Multiple reviewers independently screened 1323 citations in duplicate to identify randomized controlled trials, nonrandomized controlled trials and cohort studies on integrase inhibitor use in clinical practice. Independent, duplicate data extraction and quality assessment were conducted. Results: 48 unique studies were included on the use of integrase inhibitors in antiretroviral therapy-naive patients and treatment-experienced patients with either virological failure or switching to integrase inhibitors while virologically suppressed. On the selected studies with comparable outcome measures and indication (n = 16), a meta-analysis was performed based on modified intention-to-treat (mITT), on-treatment (OT) and as-treated (AT) virological outcome data. In therapy-naive patients, favorable odds ratios (OR) for integrase inhibitor-based regimens were observed, (mITT OR 0.71, 95% CI 0.59-0.86). However, integrase inhibitors combined with protease inhibitors only did not result in a significant better virological outcome. Evidence further supported integrase inhibitor use following virological failure (mITT OR 0.27; 95% CI 0.11-0.66), but switching to integrase inhibitors from a high genetic barrier drug during successful treatment was not supported (mITT OR 1.43; 95% CI 0.89-2.31). Integrase inhibitor-based regimens result in similar immunological responses compared to other regimens. A low genetic barrier to drug-resistance development was observed for raltegravir and elvitegravir, but not for dolutegravir. Conclusion: In first-line therapy, integrase inhibitors are superior to other regimens. Integrase inhibitor use after virological failure is supported as well by the meta-analysis. Careful use is however warranted when replacing a high genetic barrier drug in treatment-experienced patients switching successful treatment.	[Messiaen, Peter; Brusselaers, Nele; Vandekerckhove, Linos] Ghent Univ Hosp, Gen Internal Med & Infect Dis, Ghent, Belgium; [Wensing, Annemarie M. J.; Fun, Axel; Nijhuis, Monique] Univ Med Ctr Utrecht, Dept Microbiol, Utrecht, Netherlands	Ghent University; Ghent University Hospital; Utrecht University; Utrecht University Medical Center	Vandekerckhove, L (corresponding author), Ghent Univ Hosp, Gen Internal Med & Infect Dis, Ghent, Belgium.	Linos.Vandekerckhove@ugent.be	Vandekerckhove, Linos/J-6420-2013; Brusselaers, Nele/I-3501-2012	Vandekerckhove, Linos/0000-0002-8600-1631; Brusselaers, Nele/0000-0003-0137-447X	MSD; Pfizer; Viiv Healthcare; GSK; BMS; Abbott; European Commission; Roche	MSD; Pfizer(Pfizer); Viiv Healthcare; GSK(GlaxoSmithKline); BMS(Bristol-Myers Squibb); Abbott(Abbott Laboratories); European Commission(European CommissionEuropean Commission Joint Research Centre); Roche(Roche Holding)	The authors have read the journal's policy and have the following conflicts: PM, AF and NB do not have conflict of interest nor relevant financial interests. AMJW has served as a consultant to BMS, Gilead, ViiV Health Care, has received grants from MSD, Pfizer, Viiv Healthcare, and has received travel accommodations, and meeting expenses from Bristol-Myers Squibb, Jansen. LV has served as a consultant to and has received travel, accommodations, and meeting expenses from European Medical Agency, GSK, ViiV Healthcare, Pfizer, Gilead, Jansen, MSD, and BMS. MN has served as a consultant to MSD, has received grants from MSD, GSK, BMS, Abbott, European Commission and Roche and has received travel, accomodations and meeting expenses from Jansen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allavena C, 2009, 12 EUR AIDS CLIN SOC; Bedimo R, 2011, 6 IAS C HIV PATH TRE; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Caby F, 2010, SCAND J INFECT DIS, V42, P527, DOI 10.3109/00365541003621502; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Canestri A, 2008, 9 INT C DRUG THER HI; Cesar C, 2011, 6 IAS C HIV PATH TRE; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Dahl V, 2011, J INFECT DIS, V204, P1936, DOI 10.1093/infdis/jir667; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Department of Health and Human Services, 2011, DHHS GUID US ANT AG; Di Giambenedetto S, 2011, 6 IAS C HIV PATH TRE; Eron J KP, 2011, 18 C RETR OPP INF BO; Eron JJ, 2010, 10 INT C DRUG THER H; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Eron JJ, 2011, LANCET INFECT DIS, V11, P907, DOI 10.1016/S1473-3099(11)70196-7; European AIDS Clinical Society, EACS EUR GUID TREATM; Fagard G, 2011, 18 C RETR OPP INF BO; Fallon JP, 2010, 18 INT AIDS C VIENN; Gallien S, 2011, J ANTIMICROB CHEMOTH, V66, P2099, DOI 10.1093/jac/dkr269; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gandhi RT, 1999, J ACQUIRED IMMUNE DE; Gardner Edward M, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P34, DOI 10.1177/1545109711422124; Garrido C, 2010, J ANTIMICROB CHEMOTH, V65, P320, DOI 10.1093/jac/dkp423; Gatell JM, 2010, JAIDS-J ACQ IMM DEF, V53, P456, DOI 10.1097/QAI.0b013e3181c9c967; Glotet B, 2011, 9 EUR WORKSH HIV HEP; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Gotuzzo E, 2011, 6 IAS C HIV PATH TRE; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Harris M, 2008, AIDS, V22, P1224, DOI 10.1097/QAD.0b013e328302f3b5; Hatano H, 2010, JAIDS-J ACQ IMM DEF, V54, P389, DOI 10.1097/QAI.0b013e3181c42ea4; Hightower K, 2011, 9 EUR WORKSH HIV HEP; Joint United Nations Programme on HIV/AIDS, GLOB REP UNAIDS REP; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lichtenstein K, 2010, 18 INT AIDS C VIENN; MANTEL N, 1959, J NATL CANCER I, V22, P719; Margot NA, 2012, 19 INT AIDS C WASH D; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2009, JAIDS-J ACQ IMM DEF, V52, P350, DOI 10.1097/QAI.0b013e3181b064b0; Martinez E, 2011, AIDS LONDON ENGLAND, V24, P1697; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Nozza S, 2010, AIDS, V24, P924, DOI 10.1097/QAD.0b013e3283372d76; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Perinatal HIV Guidelines Working Group, 2011, PUBL HLTH SERV TASK; Qaqish R, 2010, J INT AIDS SOC S4, pP58; Raffi F, 2012, 19 INT AIDS C WASH D; Relevo R, 2011, J CLIN EPIDEMIOL, V64, P1168, DOI 10.1016/j.jclinepi.2010.11.022; Reliquet V, 2011, 6 IAS C HIV PATH TRE; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Ripamonti D, 2009, 5 IAS C HIV PATH TRE; Rockstroh J, 2012, 19 INT AIDS C WASH D; Rockstroh J, 2010, 10 INT C DRUG THER H; Rockstroh J, 2011, 13 EUR AIDS CLIN SOC; Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510; Santos JR, 2009, HIV CLIN TRIALS, V10, P432, DOI 10.1310/hct1006-432; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Soriano V, 2011, 13 EUR AIDS CLIN SOC; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Talbot A, 2009, JAIDS-J ACQ IMM DEF, V51, P362, DOI 10.1097/QAI.0b013e3181aa1398; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Towner W, 2009, JAIDS-J ACQ IMM DEF, V51, P367, DOI 10.1097/QAI.0b013e3181ae35de; Tsukada K, 2011, 6 IAS C HIV PATH TRE; US Department of Health and Human Services Food and Drug Administration CfDEaR, 2002, GUID INDANT DRUGS US; van Lunzen J, 2011, 6 IAS C HIV PATH TRE; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Van Wesenbeeck L, 2011, ANTIMICROB AGENTS CH, V55, P321, DOI 10.1128/AAC.01733-09; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Vispo E, 2010, HIV CLIN TRIALS, V11, P197, DOI 10.1310/hct1104-197; Walmsley S, 2012, 52 INT C ANT AG CHEM; Wittkop L, 2010, CLIN TRIALS, V7, P19, DOI 10.1177/1740774509356117; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Young B, 2011, HIV CLIN TRIALS, V12, P228, DOI [10.1310/hct1204-228, 10.1310/HCT1204-228]; Zhang W, 2011, 2011 JOINT STAT M MI; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	83	77	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e52562	10.1371/journal.pone.0052562	http://dx.doi.org/10.1371/journal.pone.0052562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23341902	Green Published, gold			2022-12-27	WOS:000313551500020
J	Agnarson, AM; Levira, F; Masanja, H; Ekstrom, AM; Thorson, A				Agnarson, Abela Mpobela; Levira, Francis; Masanja, Honorati; Ekstrom, Anna Mia; Thorson, Anna			Antiretroviral Treatment Knowledge and Stigma-Implications for Programs and HIV Treatment Interventions in Rural Tanzanian Populations	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; 5 AFRICAN COUNTRIES; SOUTH-AFRICA; HIV/AIDS STIGMA; PEOPLE; CARE; RESPONSES; PATTERNS; THERAPY; SCALE	Objective: To analyse antiretroviral treatment (ART) knowledge and HIV- and ART-related stigma among the adult population in a rural Tanzanian community. Design: Population-based cross-sectional survey of 694 adults (15-49 years of age). Methods: Latent class analysis (LCA) categorized respondents' levels of ART knowledge and of ART-related stigma. Multinomial logistic regression assessed the association between the levels of ART knowledge and HIV- and ART-related stigma, while controlling for the effects of age, gender, education, marital status and occupation. Results: More than one-third of men and women in the study reported that they had never heard of ART. Among those who had heard of ART, 24% were east informed about ART, 8% moderately informed, and 68% highly informed. Regarding ART-related stigma, 28% were least stigmatizing, 41% moderately stigmatizing, and 31% highly stigmatizing toward persons taking ART. Respondents that had at least primary education were more likely to have high levels of knowledge about ART (OR 3.09, 95% CI 1.61-5.94). Participants highly informed about ART held less HIV- and ART-related stigma towards ART patients (OR 0.26, 95% CI 0.09-0.74). Conclusion: The lack of ART knowledge is broad, and there is a strong association between ART knowledge and individual education level. These are relevant findings for both HIV prevention and HIV treatment program interventions that address ART-related stigma across the entire spectrum of the community.	[Agnarson, Abela Mpobela; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Levira, Francis; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Karolinska Institutet; Ifakara Health Institute	Agnarson, AM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	abela.agnarson@ki.se	Ekström, Anna Mia/H-6901-2013	Thorson, Anna/0000-0002-8703-6561; Levira, Francis/0000-0002-7063-2447	Sida/SAREC (Swedish International Development Cooperation Agency); European Community	Sida/SAREC (Swedish International Development Cooperation Agency); European Community(European Commission)	Sida/SAREC (Swedish International Development Cooperation Agency) is especially appreciated for providing financial support to the study (http://www.sida.se). This research is part of the Effects of Antiretrovirals for HIV on African Health Systems project, Maternal and Child Health (ARVMAC), and was in part supported by the European Community's FP6 funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarson AM, 2010, TROP MED INT HEALTH, V15, P1000, DOI 10.1111/j.1365-3156.2010.02587.x; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; Chopra M, 2006, AIDS, V20, P1975, DOI 10.1097/01.aids.0000247120.12327.6b; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; de Walque D, 2010, ANTIRETROVIRAL THERA; Dennis ML, 2001, EVAL PROGRAM PLANN, V24, P187, DOI 10.1016/s0149-7189(01)00014-3; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Ezekiel MJ, 2009, SOC SCI MED; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Hutchinson PL, 2007, AIDS EDUC PREV, V19, P489, DOI 10.1521/aeap.2007.19.6.489; ICRW/USAID, 2005, WORK REP MEAS HIV ST; International Development Research C Network I, 2002, POP HLTH DEV COUNTR, V1; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kattumuri R, 2003, INT J STD AIDS, V14, P552, DOI 10.1258/095646203767869174; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Kudel I, 2006, J GEN INTERN MED, V21, pS48, DOI 10.1111/j.1525-1497.2006.00645.x; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Macro, 2002, HOUS BUDG SURV 2000; Makoae LN, 2009, AIDS CARE, V21, P1357, DOI 10.1080/09540120902862576; Messer LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-504; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; *NAT BUR STAT TANZ, 2008, TANZ HIV AIDS MAL IN; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Pharris A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-705; Rosenburg N, 2012, J ASSOC NURSE AIDS C, V23, P170, DOI 10.1016/j.jana.2011.09.003; Roura M, 2008, SEX TRANSM INFECT; Rumisha S.F., 2006, TANZANIA HLTH RES B, V8, P101; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Somi G, 2012, LOW MORTALITY RISK; URT, 2003, GUID FORM AIDS COM L; WHO-UNAIDS, 2010, UNAIDS REP GLOB AIDS	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53993	10.1371/journal.pone.0053993	http://dx.doi.org/10.1371/journal.pone.0053993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342056	Green Published, gold			2022-12-27	WOS:000313682700071
J	Banerjee, K; Jhala, YV; Chauhan, KS; Dave, CV				Banerjee, Kausik; Jhala, Yadvendradev V.; Chauhan, Kartikeya S.; Dave, Chittranjan V.			Living with Lions: The Economics of Coexistence in the Gir Forests, India	PLOS ONE			English	Article							PANTHERA-LEO-PERSICA; NATIONAL-PARK; ASIATIC LIONS; MOVEMENT PATTERNS; LARGE CARNIVORES; FOOD-HABITS; PREY; CONSERVATION; CONFLICT; LIVESTOCK	Rarely human communities coexist in harmony with large predators. Most often communities suffer due to predation on their stock while large carnivores suffer losses and at times extirpation due to retaliation. We examine the mechanisms permitting the coexistence of Asiatic lions (Panthera leo persica) and pastoral communities (Maldharis) in the Gir forests, India. We monitored six Maldhari settlements between 2005 and 2007 to quantify seasonal livestock holding, density and losses due to predation and other causes. Lion density, estimated by mark recapture, was 15 +/- 0.1 SE/100 km(2). Livestock density, estimated by total counts, ranged between 25/km(2)-31/km(2) with buffaloes being most abundant. Average livestock holding of Maldhari families was 33 +/- 3 SE. Lions predated mostly on unproductive cattle (30%). Scat analysis (n = 165), predation events (n = 180) and seven continuous monitoring sessions of 1,798 hours on four radio-collared lions estimated livestock to contribute between 25 to 42% of lions' biomass consumptions, of which only 16% was predated; rest scavenged. With free grazing rights within Gir forests, Maldharis offset 58 +/- 0.2 SE% of annual livestock rearing cost in comparison to non-forest dwelling pastoralists. With government compensation scheme for livestock predation, this profit margin augmented to 76 +/- 0.05 SE%. Lion density was higher in areas with Maldhari livestock in comparison to areas without livestock. Thus, the current lifestyles and livestock holdings of Maldharis seem to be beneficial to both lions and local pastoralists. We conclude that a combination of strict protection regime for lions, Maldharis' traditional reverence towards lions and the livelihood economics permit the delicate balance of lion-Maldhari coexistence. Indefinite increase in human and livestock population within Gir might upset this equilibrium undermining the conservation objectives. We see no end to compensation programs worldwide as they constitute a crucial element needed for human-carnivore coexistence.	[Jhala, Yadvendradev V.] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttar Pradesh, India	Wildlife Institute of India	Jhala, YV (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttar Pradesh, India.	jhalay@wii.gov.in	Jhala, Yadvendradev/AAL-9711-2020; Dave, Chittaranjan/GPX-0631-2022	Dave, Chittaranjan/0000-0002-2006-383X	Wildlife Institute of India	Wildlife Institute of India	The research was funded by the Wildlife Institute of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; [Anonymous], 1991, USERS GUIDE INTERACT; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2012, RANGING PATTERNS HAB; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Banerjee K, 2010, ORYX, V44, P248, DOI 10.1017/S0030605309990949; BASU P., 2011, TR2011001 WILDL I IN, VI; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Berwick S, 1974, COMMUNITY WILD RUMIN; Buchanan J. M., 2003, ENCY PUBLIC CHOICE, P454; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Casimir MJ, 2001, NOMADIC PEOPLES, V5, P154, DOI DOI 10.3167/082279401782310808; Census of India, 2011, RUR URB DISTR IND SE, V1; Champion H. G., 1968, REVISED SURVEY FORES, P404; Check E, 2006, NATURE, V441, P927, DOI 10.1038/441927a; Chellam R, 1993, ECOLOGY ASIATIC LION; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Dave C, 2011, J TROP ECOL, V27, P239, DOI 10.1017/S0266467410000738; Dave CV, 2008, ECOLOGY CHITAL AXIS; FAIR J., 2009, BBC WILDLIFE     MAR, P39; Fenton L L, 1924, RIFLE INDIA BEING SP; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; GADGIL M, 1990, INTERDISCIPL SCI REV, V15, P209; Gee EP, 1964, WILDLIFE INDIA; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Guha R, 2003, BATTLES NATURE SCI P, P139; GUJARAT FOREST DEPARTMENT, 2010, DISTR AS LIONS GIR N; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; HINES JE, 1994, SCATMAN; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P1, DOI 10.1007/978-0-387-87492-0; Ikanda Dennis, 2008, Endangered Species Research, V6, P67, DOI 10.3354/esr00120; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jethva BD, 2003, MAMMALIA, V67, P589, DOI 10.1515/mamm-2003-0415; Jethva BD, 2004, BIOL CONSERV, V116, P351, DOI 10.1016/S0006-3207(03)00218-0; Jhala Yadvendradev V., 1999, Journal of the Bombay Natural History Society, V96, P3; Jhala YV, 2011, 2011003 TR WILDL I I; Jhala YV, 2004, MONITORING GIR, P55; Joslin P., 1973, ASIATIC LION STUDY E; Kaavya Varma, 2009, Journal of Environment & Development, V18, P154, DOI 10.1177/1070496508329352; Karanth K.U., 2003, CONSERV SOC, V1, P65; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 1998, ECOLOGY, V79, P2852; Kinnear N. B., 1920, J BOMBAY NATURAL HIS, V27, P34; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Korschgen LJ., 1980, WILDLIFE MANAGEMENT, P113; Kothari A., 1995, Ecologist, V25, P188; Krebs C.J., 2014, ECOLOGICAL METHODOLO; LINK WA, 1994, ECOLOGY, V75, P2456, DOI 10.2307/1940899; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; Manly BF, 1992, RESOURCE SELECTION A; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; MECH LD, 1991, GREATER YELLOWSTONE ECOSYSTEM, P309; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; MILLS MGL, 1992, WILDLIFE 2001 : POPULATIONS, P1112; Ministry of Finance-Government of India, 2009, PUBL PRIV PARTN IND; Mukherjee A, 2004, BIODIVERS CONSERV, V13, P2165, DOI 10.1023/B:BIOC.0000040009.75090.8c; MUKHERJEE S, 1994, MAMMALIA, V58, P139, DOI 10.1515/mamm.1994.58.1.139; MUKHERJEE S, 1994, ACTA THERIOL, V39, P425, DOI 10.4098/AT.arch.94-50; Narain S.P., 2005, JOINING DOTS REPORT; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Pathak B., 2002, BIODIVERSITY CONSERV; Pati B. P., 2000, Indian Forester, V126, P1120; Peladeau N, 1995, SIMSTAT 3 5; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Rai N., 2007, MAKING CONSERVATION, P147; Rangarajan Mahesh, 1996, FENCING FOREST CONSE; Raval SR, 1991, RESIDENT PEOPLES NAT, P68; Renugadevi, 2012, AFR J HIST CULT, V4, P1, DOI [10.5897/AJHC11.042, DOI 10.5897/AJHC11.042]; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Saberwal V., 2003, BATTLES NATURE SCI P; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; SAWARKAR V B, 1986, Indian Forester, V112, P858; Schaller G. B., 1972, SERENGETI LION STUDY; Schaller GB., 1967, DEER TIGER; Singh HS, 2011, BIOL CONSERV, V144, P1753, DOI 10.1016/j.biocon.2011.02.009; SINGH H. S., 2007, GIR LION PANTHERA LE; Singh HS, 1996, BIODIVERSITY CONSERV, VI; Sinha Satya Priya, 2004, Tigerpaper (Bangkok), V31, P27; Sinha SP, 1987, ECOLOGY WILDLIFE SPE; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stephens D.W., 1986, pi; Tambling CJ, 2012, ECOLOGY, V93, P1297; Thapar R, 1994, KING ASOKA BUDDHISM, P15; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; VANORSDOL KG, 1985, J ZOOL, V206, P97; Vitterso J, 1998, ANTHROZOOS, V11, P210, DOI 10.2752/089279398787000490; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; WWF-India, 2007, LANDSC HOP CONS TIG; Zar JH., 2010, BIOSTAT ANAL, V5th	103	47	49	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49457	10.1371/journal.pone.0049457	http://dx.doi.org/10.1371/journal.pone.0049457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341871	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700004
J	Chan, ST; Yang, NC; Huang, CS; Liao, JW; Yeh, SL				Chan, Shu-Ting; Yang, Nae-Cherng; Huang, Chin-Shiu; Liao, Jiunn-Wang; Yeh, Shu-Lan			Quercetin Enhances the Antitumor Activity of Trichostatin A through Upregulation of p53 Protein Expression In Vitro and In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE ARREST; LUNG-CANCER-CELLS; APOPTOSIS; MITOCHONDRIA; HYPERACETYLATION; SUPPRESSES; MODULATION; ACTIVATION; INDUCTION	This study investigated the effects of quercetin on the anti-tumor effect of trichostatin A (TSA), a novel anticancer drug, in vitro and in vivo and the possible mechanisms of these effects in human lung cancer cells. We first showed that quercetin (5 mu M) significantly increased the growth arrest and apoptosis in A549 cells (expressing wild-type p53) induced by 25 ng/mL of (82.5 nM) TSA at 48 h by about 25% and 101%, respectively. However, such enhancing effects of quercetin (5 mu M) were not significant in TSA-exposed H1299 cells (a p53 null mutant) or were much lower than in A549 cells. In addition, quercetin significantly increased TSA-induced p53 expression in A549 cells. Transfection of p53 siRNA into A549 cells significantly but not completely diminished the enhancing effects of quercetin on TSA-induced apoptosis. Furthermore, we demonstrated that quercetin enhanced TSA-induced apoptosis through the mitochondrial pathway. Transfection of p53 siRNA abolished such enhancing effects of quercetin. However, quercetin increased the acetylation of histones H3 and H4 induced by TSA in A549 cells, even with p53 siRNA transfection as well as in H1299 cells. In a xenograft mouse model of lung cancer, quercetin enhanced the antitumor effect of TSA. Tumors from mice treated with TSA in combination with quercetin had higher p53 and apoptosis levels than did those from control and TSA-treated mice. These data indicate that regulation of the expression of p53 by quercetin plays an important role in enhancing TSA-induced apoptosis in A549 cells. However, p53-independent mechanisms may also contribute to the enhancing effect of quercetin.	[Chan, Shu-Ting; Yang, Nae-Cherng; Yeh, Shu-Lan] Chung Shan Med Univ, Dept Nutr Sci, Taichung, Taiwan; [Huang, Chin-Shiu] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Vet Pathol, Taichung 40227, Taiwan; [Yeh, Shu-Lan] Chung Shan Med Univ Hosp, Dept Nutr, Taichung, Taiwan	Chung Shan Medical University; Asia University Taiwan; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, SL (corresponding author), Chung Shan Med Univ, Dept Nutr Sci, Taichung, Taiwan.	suzyyeh@csmu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203	National Science Council, Republic of China [NSC-99-2320-B-040-006-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants (NSC-99-2320-B-040-006-MY3) from the National Science Council, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2010, DISCOV MED, V9, P145; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Beniston RG, 2001, CARCINOGENESIS, V22, P1069, DOI 10.1093/carcin/22.7.1069; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Chan ST, 2012, J NUTR BIOCHEM, V23, P179, DOI 10.1016/j.jnutbio.2010.11.014; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen J, 2005, PHARMAZIE, V60, P856; Choi YH, 2005, INT J ONCOL, V27, P473; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Divisi Duilio, 2006, Acta Biomed, V77, P118; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Gahr S, 2008, ONCOL REP, V20, P1249, DOI 10.3892/or_00000137; Ganslmayer M, 2004, ONCOL REP, V11, P943; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Jia J, 2008, PHARMAZIE, V63, P379, DOI 10.1691/ph.2008.7693; Karagiannis TC, 2010, AGING-US, V2, P659, DOI 10.18632/aging.100203; Kim HR, 2006, EXP MOL MED, V38, P616, DOI 10.1038/emm.2006.73; Lamson D W, 2000, Altern Med Rev, V5, P196; Lee E, 1996, FEBS LETT, V395, P183, DOI 10.1016/0014-5793(96)01033-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; MIYASHITA T, 1995, CELL, V80, P293; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Pfahl M, 1998, Expert Opin Investig Drugs, V7, P601, DOI 10.1517/13543784.7.4.601; Platta CS, 2007, J SURG RES, V142, P219, DOI 10.1016/j.jss.2006.12.555; Priyadarsini RV, 2010, EUR J PHARMACOL, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Roos WP, 2012, CANC LETT; Samuel T, 2012, ANTICANCER RES, V32, P61; Seo SK, 2011, J THORAC ONCOL, V6, P1313, DOI 10.1097/JTO.0b013e318220caff; Shiau RJ, 2010, EUR J NUTR, V49, P19, DOI 10.1007/s00394-009-0044-8; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Tanigawa S, 2008, BIOSCI BIOTECH BIOCH, V72, P797, DOI 10.1271/bbb.70680; Thangasamy T, 2007, NUTR CANCER, V59, P258, DOI 10.1080/01635580701499545; Wang X, 2011, MOL CARCINOG; Xavier CPR, 2011, CANCER CHEMOTH PHARM, V68, P1449, DOI 10.1007/s00280-011-1641-9; Zhu WG, 2001, CANCER RES, V61, P1327; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	47	72	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54255	10.1371/journal.pone.0054255	http://dx.doi.org/10.1371/journal.pone.0054255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342112	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700098
J	De Lima, YV; Evans, D; Page-Shipp, L; Barnard, A; Sanne, I; Menezes, CN; Van Rie, A				De Lima, Yara Voss; Evans, Denise; Page-Shipp, Liesl; Barnard, Antonia; Sanne, Ian; Menezes, Colin N.; Van Rie, Annelies			Linkage to Care and Treatment for TB and HIV among People Newly Diagnosed with TB or HIV-Associated TB at a Large, Inner City South African Hospital	PLOS ONE			English	Article							POTENT ANTIRETROVIRAL THERAPY; TUBERCULOSIS TREATMENT; TREATMENT INITIATION; INFECTED PATIENTS; RISK-FACTORS; DEFAULT; MORTALITY; PREVENTION; REFERRALS; PATIENT	Objective: To assess the outcomes of linkage to TB and HIV care and identify risk factors for poor referral outcomes. Design: Cohort study of TB patients diagnosed at an urban hospital. Methods: Linkage to care was determined by review of clinic files, national death register, and telephone contact, and classified as linked to care, delayed linkage to care (>7 days for TB treatment, >30 days for HIV care), or failed linkage to care. We performed log-binomial regression to identify patient and referral characteristics associated with poor referral outcomes. Results: Among 593 TB patients, 23% failed linkage to TB treatment and 30.3% of the 77.0% who linked to care arrived late. Among 486 (86.9%) HIV-infected TB patients, 38.3% failed linkage to HIV care, and 32% of the 61.7% who linked to care presented late. One in six HIV-infected patients failed linkage to both TB and HIV care. Only 20.2% of HIV-infected patients were referred to a single clinic for integrated care. A referral letter was present in 90.3%, but only 23.7% included HIV status and 18.8% CD4 cell count. Lack of education (RR 1.85) and low CD4 count (CD4 <= 50 vs. >250cells/mm(3); RR 1.66) were associated with failed linkage to TB care. Risk factors for failed linkage to HIV care were antiretroviral-naive status (RR 1.29), and absence of referral letter with HIV or CD4 cell count (RR1.23). Conclusions: Linkage to TB/HIV care should be strengthened by communication of HIV and CD4 results, ART initiation during hospitalization and TB/HIV integration at primary care.	[De Lima, Yara Voss; Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Evans, Denise] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Page-Shipp, Liesl] Right To Care, Johannesburg, South Africa; [Barnard, Antonia] Gauteng Dept Hlth & Social Dev, Johannesburg, South Africa; [Menezes, Colin N.] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Infect Dis Unit, Johannesburg, South Africa; [Van Rie, Annelies] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Van Rie, A (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	vanrie@email.unc.edu	Van Rie, Annelies/C-2082-2017; Sanne, Ian/ABH-2231-2020	Van Rie, Annelies/0000-0001-7666-3263; Menezes, Colin/0000-0003-3838-5359	United States Agency for International Development (PEPFAR) [674-A-00-08-00007-00]; National Institutes of Health [ICOHRTA AIDS/TB U2RTW007370]	United States Agency for International Development (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States Agency for International Development (PEPFAR in a grant to Right to Care 674-A-00-08-00007-00) and the National Institutes of Health (ICOHRTA AIDS/TB U2RTW007370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu BS, 2008, INT J TUBERC LUNG D, V12, P1055; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Buu TN, 2003, INT J TUBERC LUNG D, V7, P735; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; Daniel OJ, 2006, NIGERIAN J MED, V15, P64; Department of Health, 2009, NAT TUB MAN GUID; Edginton ME, 2006, INT J TUBERC LUNG D, V10, P1018; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Elbireer S, 2011, TROP MED INT HEALTH, V16, P981, DOI 10.1111/j.1365-3156.2011.02800.x; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Kapella BK, 2009, INT J TUBERC LUNG D, V13, P232; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Nuwaha F, 1999, INT J TUBERC LUNG D, V3, P224; de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; SANS 5999, 2004, TIN DET TIMB; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Terris-Prestholt Fern, 2008, Cost Eff Resour Alloc, V6, P2, DOI 10.1186/1478-7547-6-2; Tsiouris SJ, 2005, TUBERCULOSIS HIV OPE; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Walensky RP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001101; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; World Health Organization, 2010, GLOB TUB CONTR SURV; World Health Organization, 2009, GLOB TUB CONTR EP ST	35	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49140	10.1371/journal.pone.0049140	http://dx.doi.org/10.1371/journal.pone.0049140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341869	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700002
J	Ellwood, ER; Temple, SA; Primack, RB; Bradley, NL; Davis, CC				Ellwood, Elizabeth R.; Temple, Stanley A.; Primack, Richard B.; Bradley, Nina L.; Davis, Charles C.			Record-Breaking Early Flowering in the Eastern United States	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOLOGICAL RESPONSES; TEMPERATURE; PLANT; IMPACTS; SUCCESS; TIMES; DATES	Flowering times are well-documented indicators of the ecological effects of climate change and are linked to numerous ecosystem processes and trophic interactions. Dozens of studies have shown that flowering times for many spring-flowering plants have become earlier as a result of recent climate change, but it is uncertain if flowering times will continue to advance as temperatures rise. Here, we used long-term flowering records initiated by Henry David Thoreau in 1852 and Aldo Leopold in 1935 to investigate this question. Our analyses demonstrate that record-breaking spring temperatures in 2010 and 2012 in Massachusetts, USA, and 2012 in Wisconsin, USA, resulted in the earliest flowering times in recorded history for dozens of spring-flowering plants of the eastern United States. These dramatic advances in spring flowering were successfully predicted by historical relationships between flowering and spring temperature spanning up to 161 years of ecological change. These results demonstrate that numerous temperate plant species have yet to show obvious signs of physiological constraints on phenological advancement in the face of climate change.	[Ellwood, Elizabeth R.; Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Temple, Stanley A.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Temple, Stanley A.; Bradley, Nina L.] Aldo Leopold Fdn, Baraboo, WI USA; [Davis, Charles C.] Harvard Univ Herbaria, Dept Organism & Evolutionary Biol, Cambridge, MA USA	Boston University; University of Wisconsin System; University of Wisconsin Madison; Harvard University	Ellwood, ER (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	eellwood@bu.edu; satemple@wisc.edu; primack@bu.edu; cdavis@oeb.harvard.edu		Ellwood, Elizabeth/0000-0003-1602-1917	National Science Foundation Grant Assembling the Tree of Life (AToL) [EF 04-31242]; National Science Foundation [DEB-0842749]; Division Of Environmental Biology [0842749] Funding Source: National Science Foundation	National Science Foundation Grant Assembling the Tree of Life (AToL); National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	CCD: National Science Foundation Grant Assembling the Tree of Life (AToL) EF 04-31242; RBP: National Science Foundation Grant DEB-0842749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 1975, STAT PREDICTION ANAL; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Beaubien E, 2011, BIOSCIENCE, V61, P514, DOI 10.1525/bio.2011.61.7.6; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Doi H, 2010, GLOBAL CHANGE BIOL, V16, P373, DOI 10.1111/j.1365-2486.2009.01993.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Forrest JRK, 2011, ECOL MONOGR, V81, P469, DOI 10.1890/10-1885.1; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; INOUYE DW, 1991, AM J BOT, V78, P997, DOI 10.2307/2445179; LEOPOLD A, 1947, ECOL MONOGR, V17, P81, DOI 10.2307/1948614; Leopold Aldo, 1949, S COUNTY ALMANAC; McEwan RW, 2011, PLANT ECOL, V212, P55, DOI 10.1007/s11258-010-9801-2; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; New England Regional Assessment Group, 2001, NEW ENGLAND REGIONAL; Nielsen CCN, 2009, FORESTRY, V82, P43, DOI 10.1093/forestry/cpn048; NOAA National Climatic Data Center, 2012, STAT CLIM NAT OV MAR; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Primack RB, 2012, BIOSCIENCE, V62, P170, DOI 10.1525/bio.2012.62.2.10; R Core Development Team, 2008, R LANG ENV STAT COMP; Schwartz MD, 2010, INT J CLIMATOL, V30, P1595, DOI 10.1002/joc.2014; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Thoreau H. D., 1854, WALDEN LIFE WOODS; Tryjanowski P, 2006, CLIM RES, V32, P89, DOI 10.3354/cr032089; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wisconsin Initiative on Climate Change Impacts, 2011, WISC CHANG CLIM IMP; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wright SD, 2008, VANISHING PRESENT, P42	44	109	115	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53788	10.1371/journal.pone.0053788	http://dx.doi.org/10.1371/journal.pone.0053788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342001	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700045
J	Kaur, H; Li, JJ; Bay, BH; Yung, LYL				Kaur, Harleen; Li, Jasmine J.; Bay, Boon-Huat; Yung, Lin-Yue Lanry			Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO SELECTION; FACTOR VEGF; COMBINATORIAL SELECTION; VASCULAR-PERMEABILITY; SIGNALING PATHWAYS; FACTOR RECEPTOR-1; BREAST-CANCER; EXPRESSION; RNA	Vascular endothelial growth factor (VEGF) is an angiogenic mitogen involved in promoting tumor angiogenesis inside the body. VEGF is a key protein required for progression of tumor from benign to malignant phenotype. In this study, we investigated the binding affinity of a previously selected 26-mer DNA aptamer sequence (SL2-B) against heparin binding domain (HBD) of VEGF(165) protein. The SL2-B was first chemically modified by introduction of phosphorothioate linkages (PS-linkages). Subsequently, surface plasmon resonance (SPR) spectroscopy and circular dichroism (CD) were used to determine the binding affinity, specificity and to deduce the conformation of PS-modified SL2-B sequence. Finally, antiproliferative activity of the modified SL2-B sequence on Hep G2 cancer cells was investigated. Our results demonstrate a marked enhancement in the biostability of the SL2-B sequence after PS modification. The modified SL2-B sequence also exhibits enhanced antiproliferative activity against Hep G2 cancer cells in hypoxia conditions. In addition, modified SL2-B sequence inhibits the expression of Jagged-1 protein, which is one of the ligands to VEGF linked delta/jagged-notch signaling pathway.	[Kaur, Harleen; Li, Jasmine J.; Yung, Lin-Yue Lanry] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Li, Jasmine J.; Bay, Boon-Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Yung, LYL (corresponding author), Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	cheyly@nus.edu.sg	Kaur, Harleen/AAJ-8789-2020; K, Harleen/T-2613-2019; Yung, Lanry/B-6515-2009	Yung, Lanry/0000-0001-7579-6347	Singapore Ministry of Education [MOE2008-T2-1-046, R279000282112]; NUS	Singapore Ministry of Education(Ministry of Education, Singapore); NUS(National University of Singapore)	This work was supported by research funding from the Singapore Ministry of Education Academic Research Fund Tier 2 grant MOE2008-T2-1-046 and Tier 1 grant R279000282112. The authors also appreciated the doctoral scholarship (for H.K.) from NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL S, 1995, CLIN PHARMACOKINET, V28, P7, DOI 10.2165/00003088-199528010-00002; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Boomer RM, 2005, OLIGONUCLEOTIDES, V15, P183, DOI 10.1089/oli.2005.15.183; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Costa RB, 2010, ANN ONCOL, V21, P2153, DOI 10.1093/annonc/mdq096; DESMIDT PC, 1991, NUCLEIC ACIDS RES, V19, P4695, DOI 10.1093/nar/19.17.4695; EATON BE, 1995, CHEM BIOL, V2, P633, DOI 10.1016/1074-5521(95)90023-3; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Frampton JE, 2010, DRUGS, V70, P1987, DOI 10.2165/11205010-000000000-00000; Gao J, 2007, BIOCHEM BIOPH RES CO, V356, P341, DOI 10.1016/j.bbrc.2007.02.130; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Itakura J, 2000, INT J CANCER, V85, P27; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; [姜昕 JIANG Xin], 2007, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V32, P1031; Kang J, 2008, BIOORG MED CHEM LETT, V18, P1835, DOI 10.1016/j.bmcl.2008.02.023; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031196; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Leighl NB, 2010, J THORAC ONCOL, V5, P1970, DOI 10.1097/JTO.0b013e3181f49c22; Lin Y, 1996, NUCLEIC ACIDS RES, V24, P3407, DOI 10.1093/nar/24.17.3407; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Oswald J, 2007, CANCER LETT, V254, P102, DOI 10.1016/j.canlet.2007.02.016; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Robinson CJ, 2001, J CELL SCI, V114, P853; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Suzuki H, 1999, AM J PHYSIOL-GASTR L, V276, pG92, DOI 10.1152/ajpgi.1999.276.1.G92; Thiviyanathan V, 2007, BIOCHEM SOC T, V35, P50, DOI 10.1042/BST0350050; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wey JS, 2005, CANCER-AM CANCER SOC, V104, P427, DOI 10.1002/cncr.21145; Wong SF, 2005, CLIN THER, V27, P684, DOI 10.1016/j.clinthera.2005.06.003; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	55	32	33	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50964	10.1371/journal.pone.0050964	http://dx.doi.org/10.1371/journal.pone.0050964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341879	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700007
J	Laskar, BA; Bhattacharjee, MJ; Dhar, B; Mahadani, P; Kundu, S; Ghosh, SK				Laskar, Boni A.; Bhattacharjee, Maloyjo J.; Dhar, Bishal; Mahadani, Pradosh; Kundu, Shantanu; Ghosh, Sankar K.			The Species Dilemma of Northeast Indian Mahseer (Actinopterygii: Cyprinidae): DNA Barcoding in Clarifying the Riddle	PLOS ONE			English	Article							FISHES; TOR; DIVERSITY; TELEOSTEI	Background: The taxonomic validity of Northeast Indian endemic Mahseer species, Tor progeneius and Neolissochilus hexastichus, has been argued repeatedly. This is mainly due to disagreements in recognizing the species based on morphological characters. Consequently, both the species have been concealed for many decades. DNA barcoding has become a promising and an independent technique for accurate species level identification. Therefore, utilization of such technique in association with the traditional morphotaxonomic description can resolve the species dilemma of this important group of sport fishes. Methodology/Principal Findings: Altogether, 28 mahseer specimens including paratypes were studied from different locations in Northeast India, and 24 morphometric characters were measured invariably. The Principal Component Analysis with morphometric data revealed five distinct groups of sample that were taxonomically categorized into 4 species, viz., Tor putitora, T. progeneius, Neolissochilus hexagonolepis and N. hexastichus. Analysis with a dataset of 76 DNA barcode sequences of different mahseer species exhibited that the queries of T. putitora and N. hexagonolepis clustered cohesively with the respective conspecific database sequences maintaining 0.8% maximum K2P divergence. The closest congeneric divergence was 3 times higher than the mean conspecific divergence and was considered as barcode gap. The maximum divergence among the samples of T. progeneius and T. putitora was 0.8% that was much below the barcode gap, indicating them being synonymous. The query sequences of N. hexastichus invariably formed a discrete and a congeneric clade with the database sequences and maintained the interspecific divergence that supported its distinct species status. Notably, N. hexastichus was encountered in a single site and seemed to be under threat. Conclusion: This study substantiated the identification of N. hexastichus to be a true species, and tentatively regarded T. progeneius to be a synonym of T. putitora. It would guide the conservationists to initiate priority conservation of N. hexastichus and T. putitora.	[Laskar, Boni A.; Bhattacharjee, Maloyjo J.; Dhar, Bishal; Mahadani, Pradosh; Kundu, Shantanu; Ghosh, Sankar K.] Assam Univ, Dept Biotechnol, Silchar, Assam, India	Assam University	Ghosh, SK (corresponding author), Assam Univ, Dept Biotechnol, Silchar, Assam, India.	drsankarghosh@gmail.com	Kundu, Dr. Shantanu/AAX-1130-2020	Kundu, Dr. Shantanu/0000-0002-5488-4433; Dhar, Bishal/0000-0001-9268-4662	fellowship (DBT-RA) from the Department of Biotechnology, Government of India	fellowship (DBT-RA) from the Department of Biotechnology, Government of India	BAL has received a fellowship (DBT-RA) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2020, CATALOG FISHES; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Avise John C., 1994, pi; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bagra Kenjum, 2009, Check List, V5, P330; Bhattacharjee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049950; Byrkjedal I, 2007, J FISH BIOL, V71, P111, DOI 10.1111/j.1095-8649.2007.01550.x; CLARE EB, 2006, MOL ECOL NOTES, V7, P184; Day F, 1878, FISHES INDIA BEING N, V1-2; Day F, 1878, FISHES INDIA BEING N, VII; Desai VR, 1822, SYNOPSIS BIOL DATA T, V158; Devi RK, 1997, CHECK LIST NATIVE FR; Doi Atsushi, 1997, Japanese Journal of Ichthyology, V44, P1; FAO, 2006, FAO NEWSLETTER; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Hamilton F., 1822, ACCOUNT FISHES FOUND; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hora S. L., 1936, REC INDIAN MUS, V38, P328; Hora SL, 1941, J BOMBAY NATURAL HIS, V12, P526; IUCN, 2012, IUCN RED LIST THREAT; Jayaram KC., 1999, FRESHWATER FISHES IN; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; McClelland J, 1939, INDIAN CYPRINIDAE, V19, P217; McDonald J. A., 1948, CIRCUMVENTING MAHSEE; Menon A. G. K., 1992, J BOMBAY NAT HIST SO, V89, P244; Mohindra Vindhya, 2007, Acta Zoologica Sinica, V53, P725; Molur S, 1998, WORKSH CONS ASS MAN; Nautiyal P, 2006, CURR SCI INDIA, V91, P1604; Nguyen TTT, 2008, FRESHWATER BIOL, V53, P924, DOI 10.1111/j.1365-2427.2007.01948.x; Oo W., 2002, FAO Fisheries Technical Paper, P71; RAINBOTH W J, 1985, Beaufortia, V35, P25; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Roberts TR, 1999, RAFFLES B ZOOL, V47, P225; Sambrook J., 2001, MOL CLONING LAB MANU; Sen T.K., 1982, Records of the Zoological Survey of India Occasional Paper, P1; Singh M, 2009, GENOME, V52, P783, DOI [10.1139/G09-052, 10.1139/g09-052]; Smith Andrew, 2005, FISH AQ TOP RECR FIS; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Talwar P.K., 1991, P1; Talwar P K, 1991, INLAND FISHES INDIA, V2, P1158; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Thomas HS, 1897, ROD INDIA; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yang L, 2010, ZOOL SCR, V39, P527, DOI 10.1111/j.1463-6409.2010.00443.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	50	39	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53704	10.1371/journal.pone.0053704	http://dx.doi.org/10.1371/journal.pone.0053704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341979	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700036
J	Chlystun, M; Campanella, M; Law, AL; Duchen, MR; Fatimathas, L; Levine, TP; Gerke, V; Moss, SE				Chlystun, Marcin; Campanella, Michelangelo; Law, Ah-Lai; Duchen, Michael R.; Fatimathas, Lux; Levine, Tim P.; Gerke, Volker; Moss, Stephen E.			Regulation of Mitochondrial Morphogenesis by Annexin A6	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; CA2+; CALCIUM; DRP1; FISSION; KINASE; VI; ASSOCIATION; BAX; PHOSPHORYLATION	Mitochondrial homeostasis is critical in meeting cellular energy demands, shaping calcium signals and determining susceptibility to apoptosis. Here we report a role for anxA6 in the regulation of mitochondrial morphogenesis, and show that in cells lacking anxA6 mitochondria are fragmented, respiration is impaired and mitochondrial membrane potential is reduced. In fibroblasts from AnxA6(-/-) mice, mitochondrial Ca2+ uptake is reduced and cytosolic Ca2+ transients are elevated. These observations led us to investigate possible interactions between anxA6 and proteins with roles in mitochondrial fusion and fission. We found that anxA6 associates with Drp1 and that mitochondrial fragmentation in AnxA6(-/-) fibroblasts was prevented by the Drp1 inhibitor mdivi-1. In normal cells elevation of intracellular Ca2+ disrupted the interaction between anxA6 and Drp1, displacing anxA6 to the plasma membrane and promoting mitochondrial fission. Our results suggest that anxA6 inhibits Drp1 activity, and that Ca2+-binding to anxA6 relieves this inhibition to permit Drp1-mediated mitochondrial fission.	[Chlystun, Marcin; Law, Ah-Lai; Fatimathas, Lux; Levine, Tim P.; Moss, Stephen E.] UCL, Inst Ophthalmol, Dept Cell Biol, London, England; [Campanella, Michelangelo] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, Mitochondrial Biol Grp, London, England; [Gerke, Volker] Univ Munster, Inst Med Biochem, D-48149 Munster, Germany; [Campanella, Michelangelo; Duchen, Michael R.] UCL, Consortium Mitochondrial Res CfMR, London, England	University of London; University College London; University of London; University of London Royal Veterinary College; University of London; University College London; University of Munster; University of London; University College London	Moss, SE (corresponding author), UCL, Inst Ophthalmol, Dept Cell Biol, London, England.	s.moss@ucl.ac.uk	duchen, michael/A-2116-2009	duchen, michael/0000-0003-2548-4294; Levine, Timothy/0000-0002-7231-0775	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; DFG; Marie Curie Actions; Biotechnology and Biological Sciences Research Council [BB/D018099/1, BB/I013695/1] Funding Source: researchfish; Medical Research Council [MR/K000608/1] Funding Source: researchfish; BBSRC [BB/D018099/1, BB/I013695/1] Funding Source: UKRI; MRC [MR/K000608/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG)); Marie Curie Actions(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust and the DFG. The authors also thank Marie Curie Actions for support to M. Campanella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz J, 1997, BIOL CHEM, V378, P177; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DEMURCIA G, 1995, TRENDS CELL BIOL, V5, P78, DOI 10.1016/S0962-8924(00)88951-5; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Fleet A, 1999, BIOCHEM BIOPH RES CO, V260, P540, DOI 10.1006/bbrc.1999.0915; Francia G, 1996, CANCER RES, V56, P3855; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hanson CJ, 2008, CELL CALCIUM, V44, P324, DOI 10.1016/j.ceca.2008.01.003; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Hawkins TE, 2000, CELL BIOCHEM BIOPHYS, V33, P275, DOI 10.1385/CBB:33:3:275; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nelsestuen GL, 1999, CURR OPIN STRUC BIOL, V9, P433, DOI 10.1016/S0959-440X(99)80060-8; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; SHADLE PJ, 1985, J BIOL CHEM, V260, P6354; Smith DL, 2002, MOL CELL PROTEOMICS, V1, P876, DOI 10.1074/mcp.M200035-MCP200; Song GJ, 2002, FASEB J, V16, P622, DOI 10.1096/fj.01-0892fje; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	52	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53774	10.1371/journal.pone.0053774	http://dx.doi.org/10.1371/journal.pone.0053774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341998	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400080
J	Coffey, CM; Solleveld, PA; Fang, J; Roberts, AK; Hong, SK; Dawid, IB; Laverriere, CE; Glasgow, E				Coffey, Caitrin M.; Solleveld, Patricia A.; Fang, Joyce; Roberts, Antonia K.; Hong, Sung-Kook; Dawid, Igor B.; Laverriere, Caroline E.; Glasgow, Eric			Novel Oxytocin Gene Expression in the Hindbrain Is Induced by Alcohol Exposure: Transgenic Zebrafish Enable Visualization of Sensitive Neurons	PLOS ONE			English	Article							OPITZ-KAVEGGIA-SYNDROME; SPECTRUM DISORDERS; ETHANOL EXPOSURE; LARVAL ZEBRAFISH; BRAIN-STEM; HOPA(12BP) POLYMORPHISM; SEROTONERGIC NEURONS; BEHAVIORAL FEATURES; PRENATAL ETHANOL; AREA POSTREMA	Background: Fetal Alcohol Spectrum Disorders (FASD) are a collection of disorders resulting from fetal ethanol exposure, which causes a wide range of physical, neurological and behavioral deficits including heightened susceptibility for alcoholism and addictive disorders. While a number of mechanisms have been proposed for how ethanol exposure disrupts brain development, with selective groups of neurons undergoing reduced proliferation, dysfunction and death, the induction of a new neurotransmitter phenotype by ethanol exposure has not yet been reported. Principal Findings: The effects of embryonic and larval ethanol exposure on brain development were visually monitored using transgenic zebrafish expressing cell-specific green fluorescent protein (GFP) marker genes. Specific subsets of GFP-expressing neurons were highly sensitive to ethanol exposure, but only during defined developmental windows. In the med12 mutant, which affects the Mediator co-activator complex component Med12, exposure to lower concentrations of ethanol was sufficient to reduce GFP expression in transgenic embryos. In transgenic embryos and larva containing GFP driven by an oxytocin-like (oxtl) promoter, ethanol exposure dramatically up-regulated GFP expression in a small group of hindbrain neurons, while having no effect on expression in the neuroendocrine preoptic area. Conclusions: Alcohol exposure during limited embryonic periods impedes the development of specific, identifiable groups of neurons, and the med12 mutation sensitizes these neurons to the deleterious effects of ethanol. In contrast, ethanol exposure induces oxtl expression in the hindbrain, a finding with profound implications for understanding alcoholism and other addictive disorders.	[Coffey, Caitrin M.; Solleveld, Patricia A.; Fang, Joyce; Roberts, Antonia K.; Laverriere, Caroline E.; Glasgow, Eric] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD USA; [Hong, Sung-Kook] NHGRI, Mol Genet Branch, NIH, Bethesda, MD 20892 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Glasgow, E (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	eg239@georgetown.edu		Glasgow, Eric/0000-0001-7729-3954	National Cancer Institue [P30-CA051008]; National Institute of Child Health and Human Development, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institue(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partially funded by National Cancer Institue grant P30-CA051008, and by the Intramural Research Program of the National Institute of Child Health and Human Development, United States National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Amsterdam A, 2005, DEV DYNAM, V234, P255, DOI 10.1002/dvdy.20541; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Barbier E, 2008, NEUROPHARMACOLOGY, V55, P1199, DOI 10.1016/j.neuropharm.2008.07.030; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Bennett B, 2006, TRENDS GENET, V22, P367, DOI 10.1016/j.tig.2006.05.005; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Bonthius DJ, 2003, DEV BRAIN RES, V140, P15, DOI 10.1016/S0165-3806(02)00549-7; Burd L, 2007, INT J DISABIL HUM DE, V6, P383; Buske C, 2011, NEUROTOXICOL TERATOL, V33, P698, DOI 10.1016/j.ntt.2011.05.009; Caldeira JC, 2004, J NEUROCHEM, V90, P1530, DOI 10.1111/j.1471-4159.2004.02686.x; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Chotro MG, 2007, NEUROSCI BIOBEHAV R, V31, P181, DOI 10.1016/j.neubiorev.2006.06.021; Davis K, 2011, J DEV PHYS DISABIL, V23, P143, DOI 10.1007/s10882-010-9204-2; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eaton JL, 2006, DEV DYNAM, V235, P2071, DOI 10.1002/dvdy.20848; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fitzgerald DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024364; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; GALLO M, 1990, PHARMACOL BIOCHEM BE, V35, P543, DOI 10.1016/0091-3057(90)90287-R; Gohlke JM, 2008, ALCOHOL RES HEALTH, V31, P76; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Graham JM, 2010, AM J MED GENET C, V154C, P477, DOI 10.1002/ajmg.c.30284; Hayes UL, 2005, PHYSIOL BEHAV, V84, P147, DOI 10.1016/j.physbeh.2004.11.001; Heaton MB, 2003, DEV BRAIN RES, V145, P249, DOI 10.1016/j.devbrainres.2003.08.005; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Hong SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019076; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ikonomidou C, 2011, ANTIOXID REDOX SIGN, V14, P1535, DOI 10.1089/ars.2010.3581; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurta A, 2010, DOSE-RESPONSE, V8, P527, DOI 10.2203/dose-response.10-008.Palestis; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lebel C, 2011, NEUROPSYCHOL REV, V21, P102, DOI 10.1007/s11065-011-9163-0; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mattson SN, 2011, NEUROPSYCHOL REV, V21, P81, DOI 10.1007/s11065-011-9167-9; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; McMurray MS, 2008, NEUROTOXICOL TERATOL, V30, P475, DOI 10.1016/j.ntt.2008.07.001; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; Tong M, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/213286; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Philibert RA, 2006, PSYCHIAT GENET, V16, P73, DOI 10.1097/01.ypg.0000194443.81813.f0; Philibert RA, 2007, AM J MED GENET B, V144B, P743, DOI 10.1002/ajmg.b.30489; Picker A, 2002, DEVELOPMENT, V129, P3227; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Sarnyai Z, 2011, ADDICT BIOL, V16, P199, DOI 10.1111/j.1369-1600.2011.00332.x; Scantamburlo G, 2009, ANN ENDOCRINOL-PARIS, V70, P449, DOI 10.1016/j.ando.2009.09.002; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Sorensen HJ, 2011, ALCOHOL CLIN EXP RES, V35, P1315, DOI 10.1111/j.1530-0277.2011.01467.x; Sowell ER, 2001, NEUROLOGY, V57, P235, DOI 10.1212/WNL.57.2.235; Thiele TE, 1996, ALCOHOL CLIN EXP RES, V20, P1023, DOI 10.1111/j.1530-0277.1996.tb01941.x; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Warren KR, 2005, BIRTH DEFECTS RES A, V73, P195, DOI 10.1002/bdra.20125; Westerfield M, 1995, ZEBRAFISH BOOK; Williams SK, 2009, NEUROTOXICOL TERATOL, V31, P291, DOI 10.1016/j.ntt.2009.06.001; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Young KA, 2011, NEUROSCI BIOBEHAV R, V35, P498, DOI 10.1016/j.neubiorev.2010.06.004; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106	91	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53991	10.1371/journal.pone.0053991	http://dx.doi.org/10.1371/journal.pone.0053991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342055	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400108
J	Malli, F; Koutsokera, A; Paraskeva, E; Zakynthinos, E; Papagianni, M; Makris, D; Tsilioni, I; Molyvdas, PA; Gourgoulianis, KI; Daniil, Z				Malli, Foteini; Koutsokera, Angela; Paraskeva, Efrosini; Zakynthinos, Epaminondas; Papagianni, Maria; Makris, Dimosthenes; Tsilioni, Irene; Molyvdas, Paschalis Adam; Gourgoulianis, Konstantinos I.; Daniil, Zoe			Endothelial Progenitor Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis: An Evolving Concept	PLOS ONE			English	Article							ACUTE LUNG INJURY; ARTERIAL-HYPERTENSION; PRESSURE; DISEASE; SURVIVAL; EFFICACY	Background: Idiopathic pulmonary fibrosis (IPF) has been associated with abnormal vascular remodeling. Bone marrow derived endothelial progenitor cells (EPCs) are considered to possess lung tissue repair and vascular remodeling properties. Objectives: The study aimed to assess early EPCs levels and EPCs endogenous vascular endothelial growth factor (VEGF) expression in IPF. In order to examine alterations in the mobilization of EPCs from the bone marrow we measured plasma VEGF. Main Results: Twenty-three patients with IPF and fifteen healthy subjects were included. The number of early EPCs colonies was markedly reduced in IPF patients vs controls (6.00 +/- 6.49 vs 49.68 +/- 16.73, respectively, p<0.001). EPCs were further decreased in patients presenting systolic pulmonary arterial pressure (sPAP)>= 35 mmHg. The number of colonies per well correlated negatively with P(A-a)O2 (r = -0.750, p<0.001). Additionally, VEGF mRNA levels were significantly increased in IPF patients. There were no differences observed in VEGF plasma levels in IPF patients when compared to controls. Conclusions: The current data suggest that inadequate levels of early EPCs may potentially contribute to suppressed repair and recovery of the damaged pulmonary endothelium and thereby may drive the sequence of events in profibrogenic direction. Increased VEGFmRNA levels in the clinical context of IPF may represent a compensatory mechanism to overcome reduced EPCs levels.	[Malli, Foteini; Koutsokera, Angela; Tsilioni, Irene; Gourgoulianis, Konstantinos I.; Daniil, Zoe] Univ Thessaly, Dept Resp Med, Sch Med, Larisa, Greece; [Paraskeva, Efrosini; Papagianni, Maria; Molyvdas, Paschalis Adam] Univ Thessaly, Dept Physiol, Sch Med, Larisa, Greece; [Zakynthinos, Epaminondas; Makris, Dimosthenes] Univ Thessaly, Dept Crit Care Med, Sch Med, Larisa, Greece	University of Thessaly; University of Thessaly; University of Thessaly	Daniil, Z (corresponding author), Univ Thessaly, Dept Resp Med, Sch Med, Larisa, Greece.	zdaniil@med.uth.gr	Papagianni, Maria/AGC-9926-2022; MAKRIS, DEMOSTHENES/J-5953-2015; Koutsokera, Angela/H-8540-2019; Paraskeva, Efrosyni/E-6449-2015; Zakynthinos, Epameinondas/N-9024-2019	MAKRIS, DEMOSTHENES/0000-0003-1951-6421; Koutsokera, Angela/0000-0003-1227-1679; Paraskeva, Efrosyni/0000-0002-1312-0322; 	Hellenic Thoracic Society	Hellenic Thoracic Society	This work was supported by a grant from the Hellenic Thoracic Society to FM and ZD. The funders of the study had no role in study design, data collection, data analysis, decision to publish, data interpretation, or the preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Avouac J, 2008, ARTHRITIS RHEUM-US, V58, P3550, DOI 10.1002/art.23968; Barst R. J., 2004, J AM COLL CARDIOL S, V43, P40, DOI DOI 10.1016/j.jacc.2004.02.032; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Corte TJ, 2009, SARCOIDOSIS VASC DIF, V26, P7; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Fadini GP, 2010, EUR RESPIR J, V35, P418, DOI 10.1183/09031936.00112809; Fadini GP, 2007, SARCOIDOSIS VASC DIF, V24, P85; Fadini GP, 2007, AM J RESP CRIT CARE, V176, P724, DOI 10.1164/ajrccm.176.7.724a; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HIMELMAN RB, 1989, CIRCULATION, V79, P863, DOI 10.1161/01.CIR.79.4.863; Ito H, 1999, CANCER RES, V59, P5875; Joppa P, 2006, CHEST, V130, P326, DOI 10.1378/chest.130.2.326; Lam CF, 2008, ANESTHESIOLOGY, V108, P392, DOI 10.1097/ALN.0b013e318164ca64; Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657; Zammaretti P, 2005, INT J BIOCHEM CELL B, V37, P493, DOI 10.1016/j.biocel.2004.06.018; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	31	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53658	10.1371/journal.pone.0053658	http://dx.doi.org/10.1371/journal.pone.0053658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341966	gold, Green Submitted, Green Published			2022-12-27	WOS:000314759400060
J	Murase, K; Mori, K; Yoshimura, C; Aihara, K; Chihara, Y; Azuma, M; Harada, Y; Toyama, Y; Tanizawa, K; Handa, T; Hitomi, T; Oga, T; Mishima, M; Chin, K				Murase, Kimihiko; Mori, Kiyoshi; Yoshimura, Chikara; Aihara, Kensaku; Chihara, Yuichi; Azuma, Masanori; Harada, Yuka; Toyama, Yoshiro; Tanizawa, Kiminobu; Handa, Tomohiro; Hitomi, Takefumi; Oga, Toru; Mishima, Michiaki; Chin, Kazuo			Association between Plasma Neutrophil Gelatinase Associated Lipocalin Level and Obstructive Sleep Apnea or Nocturnal Intermittent Hypoxia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; NGAL; IDENTIFICATION; OBESITY; EXPRESSION; BIOMARKER; MARKER	Background: Both obstructive sleep apnea (OSA) and a novel lipocalin, neutrophil gelatinase associated lipocalin (Ngal), have been reported to be closely linked with cardiovascular disease and loss of kidney function through chronic inflammation. However, the relationship between OSA and Ngal has never been investigated. Objectives: To evaluate the relationship between Ngal and OSA in clinical practice. Methods: In 102 patients, polysomnography was performed to diagnose OSA and plasma Ngal levels were measured. The correlations between Ngal levels and OSA severity and other clinical variables were evaluated. Of the 46 patients who began treatment with continuous positive airway pressure (CPAP), Ngal levels were reevaluated after three months of treatment in 25 patients. Results: The Ngal level correlated significantly with OSA severity as determined by the apnea hypopnea index (r = 0.24, p = 0.01) and 4% oxygen desaturation index (ODI) (r = 0.26, p = 0.01). Multiple regression analysis showed that the Ngal level was associated with 4% ODI independently of other clinical variables. Compliance was good in 13 of the 25 patients who used CPAP. Although the OSA (4% ODI: 33.1 +/- 16.7 to 1.1 +/- 1.9/h, p<0.01) had significantly improved in those with good compliance, the Ngal levels were not significantly changed (60.5 +/- 18.1 before CPAP vs 64.2 +/- 13.9 ng/ml after CPAP, p = 0.27). Conclusions: Plasma Ngal levels were positively associated with the severity of OSA. However, the contribution rate of OSA to systemic Ngal secretion was small and changes in Ngal levels appeared to be influenced largely by other confounding factors. Therefore, it does not seem reasonable to use the Ngal level as a specific biomarker of OSA in clinical practice.	[Murase, Kimihiko; Aihara, Kensaku; Azuma, Masanori; Harada, Yuka; Toyama, Yoshiro; Tanizawa, Kiminobu; Handa, Tomohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Yoshimura, Chikara; Hitomi, Takefumi; Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Chihara, Yuichi] Red Cross Otsu Hosp, Dept Resp Med, Shiga, Japan	Kyoto University; Kyoto University; Kyoto University	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Tanizawa, Kiminobu/GPC-4728-2022; Mori, Kiyoshi/N-1267-2014; Aihara, Kensaku/AAB-9889-2021; Chihara, Yuichi/AAK-3397-2020	Mori, Kiyoshi/0000-0002-7285-8351; Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology; Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was partly supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Choi KM, 2009, CLIN ENDOCRINOL, V70, P569, DOI 10.1111/j.1365-2265.2008.03374.x; Collen J, 2009, CHEST, V135, P704, DOI 10.1378/chest.08-2182; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Fassett RG, 2012, NEPHROL DIAL TRANSPL, V27, P182, DOI 10.1093/ndt/gfr193; Giaginis C, 2010, CLIN CHEM LAB MED, V48, P1035, DOI 10.1515/CCLM.2010.211; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Iber C., 2007, AASM MANUAL SCORING; Jayaraman A, 2005, BIOTECHNOL BIOENG, V91, P502, DOI 10.1002/bit.20535; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Liu XW, 2011, EUR J ENDOCRINOL, V165, P805, DOI 10.1530/EJE-11-0660; Makino S, 2009, HORM METAB RES, V41, P221, DOI 10.1055/s-0028-1100411; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nakayama-Ashida Y, 2008, SLEEP, V31, P419, DOI 10.1093/sleep/31.3.419; Nena E, 2010, RESPIRATION, V80, P517, DOI 10.1159/000295903; Nicholl DDM, 2012, CHEST, V141, P1422, DOI 10.1378/chest.11-1809; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ronco C, 2007, CRIT CARE, V11, DOI 10.1186/cc6162; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wallenius V, 2011, EXP CLIN ENDOCR DIAB, V119, P75, DOI 10.1055/s-0030-1265212; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	35	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54184	10.1371/journal.pone.0054184	http://dx.doi.org/10.1371/journal.pone.0054184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342100	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400130
J	Gottlieb, A; Muller, HG; Massa, AN; Wanjugi, H; Deal, KR; You, FM; Xu, XY; Gu, YQ; Luo, MC; Anderson, OD; Chan, AP; Rabinowicz, P; Devos, KM; Dvorak, J				Gottlieb, Andrea; Mueller, Hans-Georg; Massa, Alicia N.; Wanjugi, Humphrey; Deal, Karin R.; You, Frank M.; Xu, Xiangyang; Gu, Yong Q.; Luo, Ming-Cheng; Anderson, Olin D.; Chan, Agnes P.; Rabinowicz, Pablo; Devos, Katrien M.; Dvorak, Jan			Insular Organization of Gene Space in Grass Genomes	PLOS ONE			English	Article							ORYZA-SATIVA; EVOLUTION; SEQUENCE; WHEAT; RECOMBINATION; ISLANDS; REGIONS; EXPANSION; LOCUS; ENDS	Wheat and maize genes were hypothesized to be clustered into islands but the hypothesis was not statistically tested. The hypothesis is statistically tested here in four grass species differing in genome size, Brachypodium distachyon, Oryza sativa, Sorghum bicolor, and Aegilops tauschii. Density functions obtained under a model where gene locations follow a homogeneous Poisson process and thus are not clustered are compared with a model-free situation quantified through a non-parametric density estimate. A simple homogeneous Poisson model for gene locations is not rejected for the small O. sativa and B. distachyon genomes, indicating that genes are distributed largely uniformly in those species, but is rejected for the larger S. bicolor and Ae. tauschii genomes, providing evidence for clustering of genes into islands. It is proposed to call the gene islands "gene insulae" to distinguish them from other types of gene clustering that have been proposed. An average S. bicolor and Ae. tauschii insula is estimated to contain 3.7 and 3.9 genes with an average intergenic distance within an insula of 2.1 and 16.5 kb, respectively. Inter-insular distances are greater than 8 and 81 kb and average 15.1 and 205 kb, in S. bicolor and Ae. tauschii, respectively. A greater gene density observed in the distal regions of the Ae. tauschii chromosomes is shown to be primarily caused by shortening of inter-insular distances. The comparison of the four grass genomes suggests that gene locations are largely a function of a homogeneous Poisson process in small genomes. Nonrandom insertions of LTR retroelements during genome expansion creates gene insulae, which become less dense and further apart with the increase in genome size. High concordance in relative lengths of orthologous intergenic distances among the investigated genomes including the maize genome suggests functional constraints on gene distribution in the grass genomes.	[Gottlieb, Andrea; Mueller, Hans-Georg] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Massa, Alicia N.; Xu, Xiangyang; Devos, Katrien M.] Univ Georgia, Dept Plant Biol, Inst Plant Breeding Genet & Genom, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Wanjugi, Humphrey; Gu, Yong Q.; Anderson, Olin D.] ARS, USDA, Western Res Ctr, Albany, CA USA; [Deal, Karin R.; You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Chan, Agnes P.] J Craig Venter Inst, Rockville, MD USA; [Rabinowicz, Pablo] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Rabinowicz, Pablo] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University of California System; University of California Davis; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University of California System; University of California Davis; J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dvorak, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdvorak@ucdavis.edu	Devos, Katrien M/B-1380-2014; Luo, Ming-Cheng/C-5600-2011	Luo, Ming-Cheng/0000-0002-9744-5887	National Science Foundation [DBI-0077766, DBI-0638558]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Plant Genome Research Program Cooperative Agreements DBI-0077766 and DBI-0638558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cox D., 1980, POINT PROCESSES; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Fan J., 1996, LOCAL POLYNOMIAL MOD; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; GILL KS, 1993, CHROMOSOMA, V102, P374, DOI 10.1007/BF00360401; Kendall MG, 1945, BIOMETRIKA, V33, P239, DOI 10.2307/2332303; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kronmiller BA, 2009, PLANT PHYSIOL, V151, P483, DOI 10.1104/pp.109.143370; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Lou XL, 2009, GENE, V437, P71, DOI 10.1016/j.gene.2009.02.012; Luo MC, 2012, P NATL ACAD SC UNPUB; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Nelson W, 2005, GENOME RES, V15, P1284, DOI 10.1101/gr.3869505; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; See DR, 2006, P NATL ACAD SCI USA, V103, P4162, DOI 10.1073/pnas.0508942102; Silverman B.W., 1986, DENSITY ESTIMATION S; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Z, 2011, COMPUT STAT DATA AN, V55, P2234, DOI 10.1016/j.csda.2011.01.007	38	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54101	10.1371/journal.pone.0054101	http://dx.doi.org/10.1371/journal.pone.0054101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326580	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800107
J	Kregel, S; Kiriluk, KJ; Rosen, AM; Cai, Y; Reyes, EE; Otto, KB; Tom, W; Paner, GP; Szmulewitz, RZ; Vander Griend, DJ				Kregel, Steven; Kiriluk, Kyle J.; Rosen, Alex M.; Cai, Yi; Reyes, Edwin E.; Otto, Kristen B.; Tom, Westin; Paner, Gladell P.; Szmulewitz, Russell Z.; Vander Griend, Donald J.			Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							STEM-LIKE CELLS; IN-VITRO; SELF-RENEWAL; NANOG; GROWTH; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; CARCINOMA; MECHANISM	Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a major clinical problem. The aberrant activity of stem cell pathways, and their regulation by the Androgen Receptor (AR), has the potential to provide insight into novel mechanisms and pathways to prevent and treat advanced, castrate-resistant prostate cancers. To this end, we investigated the role of the embryonic stem cell regulator Sox2 [SRY (sex determining region Y)-box 2] in normal and malignant prostate epithelial cells. In the normal prostate, Sox2 is expressed in a portion of basal epithelial cells. Prostate tumors were either Sox2-positive or Sox2-negative, with the percentage of Sox2-positive tumors increasing with Gleason Score and metastases. In the castration-resistant prostate cancer cell line CWR-R1, endogenous expression of Sox2 was repressed by AR signaling, and AR chromatin-IP shows that AR binds the enhancer element within the Sox2 promoter. Likewise, in normal prostate epithelial cells and human embryonic stem cells, increased AR signaling also decreases Sox2 expression. Resistance to the anti-androgen MDV3100 results in a marked increase in Sox2 expression within three prostate cancer cell lines, and in the castration-sensitive LAPC-4 prostate cancer cell line ectopic expression of Sox2 was sufficient to promote castration-resistant tumor formation. Loss of Sox2 expression in the castration-resistant CWR-R1 prostate cancer cell line inhibited cell growth. Up-regulation of Sox2 was not associated with increased CD133 expression but was associated with increased FGF5 (Fibroblast Growth Factor 5) expression. These data propose a model of elevated Sox2 expression due to loss of AR-mediated repression during castration, and consequent castration-resistance via mechanisms not involving induction of canonical embryonic stem cell pathways.	[Kregel, Steven; Vander Griend, Donald J.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Reyes, Edwin E.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Paner, Gladell P.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Szmulewitz, Russell Z.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Kiriluk, Kyle J.; Rosen, Alex M.; Cai, Yi; Otto, Kristen B.; Tom, Westin; Vander Griend, Donald J.] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Vander Griend, DJ (corresponding author), Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA.	prostate@uchicago.edu	Tom, Westin/ABC-9183-2020; Griend, Donald J Vander/H-7532-2019	Griend, Donald J Vander/0000-0003-4421-5698; Tom, Westin/0000-0001-7788-2070	University of Chicago Department of Surgery; Section of Urology; University of Chicago Comprehensive Cancer Center (UCCCC); National Cancer Institute (NCI) SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University [P50 CA090386]; Cancer Research Center of the University of Chicago; American Cancer Society (ACS-IRG) [IRG-58-004]; Cancer Center Support Grant [P30 CA14599]; Brinson Foundation; Alvin Baum Family Fund; University of Chicago Cancer Research Foundation Women's Board; HHMI: Med-into-Grad Fellowship [56006772]; Cancer Biology Training Grant [T32-CA09594]; Immunology Training Grant [AI07090-31]; University Of Chicago Section Of Urology; University of Chicago Comprehensive Cancer Center (wUCCCC); NATIONAL CANCER INSTITUTE [P30CA014599, T32CA009594, P50CA090386] Funding Source: NIH RePORTER	University of Chicago Department of Surgery; Section of Urology; University of Chicago Comprehensive Cancer Center (UCCCC); National Cancer Institute (NCI) SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Cancer Research Center of the University of Chicago; American Cancer Society (ACS-IRG)(American Cancer Society); Cancer Center Support Grant; Brinson Foundation; Alvin Baum Family Fund; University of Chicago Cancer Research Foundation Women's Board; HHMI: Med-into-Grad Fellowship; Cancer Biology Training Grant; Immunology Training Grant; University Of Chicago Section Of Urology; University of Chicago Comprehensive Cancer Center (wUCCCC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was generously provided by: The University of Chicago Department of Surgery, the Section of Urology; the University of Chicago Comprehensive Cancer Center (UCCCC); a Pilot Award from the National Cancer Institute (NCI) P50 CA090386 SPORE in Prostate Cancer at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Cancer Research Center of the University of Chicago; an American Cancer Society Institutional Research Grant (ACS-IRG, #IRG-58-004); a Cancer Center Support Grant (P30 CA14599); The Brinson Foundation; the Alvin Baum Family Fund; and The University of Chicago Cancer Research Foundation Women's Board. S. Kregel is supported by an HHMI: Med-into-Grad Fellowship (56006772) and a Cancer Biology Training Grant (T32-CA09594); E. Reyes is supported by an Immunology Training Grant (AI07090-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support of the University Of Chicago Section Of Urology led by Dr. Arieh Shalhav, and the Director of Urologic Research Dr. Carrie Rinker-Schaeffer. We would also like to acknowledge the support of the University of Chicago Comprehensive Cancer Center (wUCCCC) led by Dr. Michelle Le Beau. We also with to thank expert technical assistance of the Human Tissue Resource Center core facility led by Dr. Mark Lingen, and the assistance of Leslie Martin and Mary Jo Fekete. We also thank the Immunohistochemistry Core Facility run by Terri Li, the Functional Genomics Core facility run by Dr. Pieter W. Faber, and the Clinical Chemistry Lab run by Jerry Yeo and managed by Christine Lee. We also wish to thank Dr. Karen Kaul and Dr. Robin Leikin of the Prostate Cancer SPORE of Northshore University and Northwestern University, respectively. Finally, we wish to thank Dr. John Isaacs at Johns Hopkins for generously providing many of the cancer cell lines used.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; D'Antonio JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011475; Denmeade SR, 2003, PROSTATE, V56, P45, DOI 10.1002/pros.10213; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gao J, 2001, CANCER RES, V61, P5038; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang PZ, 2011, CLIN BIOCHEM, V44, P582, DOI 10.1016/j.clinbiochem.2011.02.012; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Karoubi Golnaz, 2009, Interact Cardiovasc Thorac Surg, V8, P393, DOI 10.1510/icvts.2008.193995; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tepper CG, 2002, CANCER RES, V62, P6606; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ugolkov AV, 2011, PROSTATE, V71, P18, DOI 10.1002/pros.21217; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vander Griend DJ, 2010, PROSTATE, V70, P90, DOI 10.1002/pros.21043; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	66	105	110	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53701	10.1371/journal.pone.0053701	http://dx.doi.org/10.1371/journal.pone.0053701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326489	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800071
J	Simoens, VL; Tervaniemi, M				Simoens, Veerle L.; Tervaniemi, Mari			Auditory Short-Term Memory Activation during Score Reading	PLOS ONE			English	Article							EYE-HAND SPAN; WORKING-MEMORY; IMAGERY; REPRESENTATION; INTERFERENCE; EXPECTANCY; POTENTIALS; PERCEPTION; RESPONSES; COMPONENT	Performing music on the basis of reading a score requires reading ahead of what is being played in order to anticipate the necessary actions to produce the notes. Score reading thus not only involves the decoding of a visual score and the comparison to the auditory feedback, but also short-term storage of the musical information due to the delay of the auditory feedback during reading ahead. This study investigates the mechanisms of encoding of musical information in short-term memory during such a complicated procedure. There were three parts in this study. First, professional musicians participated in an electroencephalographic (EEG) experiment to study the slow wave potentials during a time interval of short-term memory storage in a situation that requires cross-modal translation and short-term storage of visual material to be compared with delayed auditory material, as it is the case in music score reading. This delayed visual-to-auditory matching task was compared with delayed visual-visual and auditory-auditory matching tasks in terms of EEG topography and voltage amplitudes. Second, an additional behavioural experiment was performed to determine which type of distractor would be the most interfering with the score reading-like task. Third, the self-reported strategies of the participants were also analyzed. All three parts of this study point towards the same conclusion according to which during music score reading, the musician most likely first translates the visual score into an auditory cue, probably starting around 700 or 1300 ms, ready for storage and delayed comparison with the auditory feedback.	[Simoens, Veerle L.; Tervaniemi, Mari] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Simoens, Veerle L.; Tervaniemi, Mari] Univ Jyvaskyla, Dept Mus, Finnish Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland; [Tervaniemi, Mari] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; University of Jyvaskyla	Tervaniemi, M (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	veerle.simoens@helsinki.fi	Campailla, Jasmin/AAK-2420-2021	Tervaniemi, Mari/0000-0002-9651-2929	Academy of Finland; Finnish Work Environment Fund [106055]; Signe & Ane Gyllenberg Foundation	Academy of Finland(Academy of Finland); Finnish Work Environment Fund; Signe & Ane Gyllenberg Foundation	This research was funded by the Academy of Finland, Finnish Work Environment Fund [106055] and the Signe & Ane Gyllenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birbaumer N, 1999, NEUROSCIENTIST, V5, P74, DOI 10.1177/107385849900500211; Bittrich K, 2012, BRAIN RES, V1432, P84, DOI 10.1016/j.brainres.2011.11.011; Brodsky W, 2003, PERCEPT PSYCHOPHYS, V65, P602, DOI 10.3758/BF03194586; Brodsky W, 2008, J EXP PSYCHOL HUMAN, V34, P427, DOI 10.1037/0096-1523.34.2.427; BROPHY AL, 1986, BEHAV RES METH INSTR, V18, P285, DOI 10.3758/BF03204400; Caspers H, 1980, Prog Brain Res, V54, P3, DOI 10.1016/S0079-6123(08)61603-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Furneaux S, 1999, P ROY SOC B-BIOL SCI, V266, P2435, DOI 10.1098/rspb.1999.0943; Gilman E, 2003, VIS COGN, V10, P201, DOI [10.1080/713756679, 10.1080/13506280244000104]; Gordon E., 1975, LEARNING THEORY PATT; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Highben Z, 2004, B COUN RES MUSIC ED, P58; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Huijbers W, 2011, NEUROPSYCHOLOGIA, V49, P1730, DOI 10.1016/j.neuropsychologia.2011.02.051; Kalakoski V, 2007, SCAND J PSYCHOL, V48, P87, DOI 10.1111/j.1467-9450.2007.00535.x; Kislyuk DS, 2008, J COGNITIVE NEUROSCI, V20, P2175, DOI 10.1162/jocn.2008.20152; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; LANG W, 1992, ELECTROEN CLIN NEURO, V82, P285, DOI 10.1016/0013-4694(92)90108-T; Larsen A, 2003, PERCEPT PSYCHOPHYS, V65, P568, DOI 10.3758/BF03194583; Lindstrom R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00159; Lloyd-Jones TJ, 2005, TRENDS EXPT PSYCHOL, P111; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; PECHMANN T, 1992, MEM COGNITION, V20, P314, DOI 10.3758/BF03199668; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Ponton CW, 1997, EVOKED POTENTIAL, V104, P143, DOI 10.1016/S0168-5597(97)96104-9; Rockstroh B., 1989, SLOW CORTICAL POTENT; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; RUCHKIN DS, 1990, ELECTROEN CLIN NEURO, V76, P419, DOI 10.1016/0013-4694(90)90096-3; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schon D, 2003, ANN NY ACAD SCI, V999, P193, DOI 10.1196/annals.1284.028; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Schurmann M, 2002, NEUROIMAGE, V16, P434, DOI 10.1006/nimg.2002.1098; SLOBODA JA, 1984, MUSIC PERCEPT, V2, P222; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spironelli C, 2006, BEHAV BRAIN RES, V175, P296, DOI 10.1016/j.bbr.2006.08.038; Tervaniemi M, 2003, MUSIC SCI, V7, P241, DOI 10.1177/102986490300700203; Truitt FE, 1997, VIS COGN, V4, P143, DOI 10.1080/713756756; Verde MF, 2006, PERCEPT PSYCHOPHYS, V68, P643, DOI 10.3758/BF03208765; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Wurtz P, 2009, EXP BRAIN RES, V194, P445, DOI 10.1007/s00221-009-1719-3; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	52	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53691	10.1371/journal.pone.0053691	http://dx.doi.org/10.1371/journal.pone.0053691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326487	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800069
J	Davis, MI; Sasaki, AT; Shen, M; Emerling, BM; Thorne, N; Michael, S; Pragani, R; Boxer, M; Sumita, K; Takeuchi, K; Auld, DS; Li, ZY; Cantley, LC; Simeonov, A				Davis, Mindy I.; Sasaki, Atsuo T.; Shen, Min; Emerling, Brooke M.; Thorne, Natasha; Michael, Sam; Pragani, Rajan; Boxer, Matthew; Sumita, Kazutaka; Takeuchi, Koh; Auld, Douglas S.; Li, Zhuyin; Cantley, Lewis C.; Simeonov, Anton			A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation	PLOS ONE			English	Article							II-BETA; CHEMICAL LIBRARIES; PHOSPHATE KINASE; INHIBITORS; RECEPTOR; PI3K; BIOLUMINESCENT; PHOSPHORYLATION; LUCIFERASE; 3-KINASE	Phosphoinositide kinases regulate diverse cellular functions and are important targets for therapeutic development for diseases, such as diabetes and cancer. Preparation of the lipid substrate is crucial for the development of a robust and miniaturizable lipid kinase assay. Enzymatic assays for phosphoinositide kinases often use lipid substrates prepared from lyophilized lipid preparations by sonication, which result in variability in the liposome size from preparation to preparation. Herein, we report a homogeneous 1536-well luciferase-coupled bioluminescence assay for PI5P4K alpha. The substrate preparation is novel and allows the rapid production of a DMSO-containing substrate solution without the need for lengthy liposome preparation protocols, thus enabling the scale-up of this traditionally difficult type of assay. The Z'-factor value was greater than 0.7 for the PI5P4K alpha assay, indicating its suitability for high-throughput screening applications. Tyrphostin AG-82 had been identified as an inhibitor of PI5P4K alpha by assessing the degree of phospho transfer of gamma-P-32-ATP to PI5P; its inhibitory activity against PI5P4Ka was confirmed in the present miniaturized assay. From a pilot screen of a library of bioactive compounds, another tyrphostin, I-OMe tyrphostin AG-538 (I-OMe-AG-538), was identified as an ATP-competitive inhibitor of PI5P4K alpha with an IC50 of 1 mu M, affirming the suitability of the assay for inhibitor discovery campaigns. This homogeneous assay may apply to other lipid kinases and should help in the identification of leads for this class of enzymes by enabling high-throughput screening efforts.	[Davis, Mindy I.; Shen, Min; Thorne, Natasha; Michael, Sam; Pragani, Rajan; Boxer, Matthew; Auld, Douglas S.; Li, Zhuyin; Simeonov, Anton] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Sasaki, Atsuo T.; Emerling, Brooke M.; Cantley, Lewis C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med,Sch Med, Div Signal Transduct,Dept Syst Biol, Boston, MA 02215 USA; [Sasaki, Atsuo T.; Sumita, Kazutaka] Univ Cincinnati, Coll Med, Dept Internal Med,Neurosci Inst, Div Hematol & Oncol,Brain Tumor Ctr, Cincinnati, OH USA; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan; [Auld, Douglas S.] Novartis Inst Biomed Res, Ctr Prote Chem, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Ohio; University of Cincinnati; National Institute of Advanced Industrial Science & Technology (AIST); Novartis	Simeonov, A (corresponding author), NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA.	asimeono@mail.nih.gov	Takeuchi, Koh/B-4971-2010; Sumita, Kazutaka/AAI-1553-2019; Cantley, Lewis C/D-1800-2014	Takeuchi, Koh/0000-0002-6227-4627; Cantley, Lewis C/0000-0002-1298-7653; Sasaki, Atsuo/0000-0003-2963-4501	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Institutes of Health [GM41890]; Grants-in-Aid for Scientific Research [23790064] Funding Source: KAKEN; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM041890] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and by National Institutes of Health grant GM41890 (to LCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2009, J MED CHEM, V52, P1450, DOI 10.1021/jm8014525; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Blum G, 2000, BIOCHEMISTRY-US, V39, P15705, DOI 10.1021/bi001516y; Bultsma Y, 2010, BIOCHEM J, V430, P223, DOI 10.1042/BJ20100341; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Demian DJ, 2009, J BIOMOL SCREEN, V14, P838, DOI 10.1177/1087057109339205; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Fuchikami K, 2002, J BIOMOL SCREEN, V7, P441, DOI 10.1177/108705702237676; Grainger DL, 2011, PFLUG ARCH EUR J PHY, V462, P723, DOI 10.1007/s00424-011-1008-4; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kouchi Z, 2011, BIOCHEM BIOPH RES CO, V408, P523, DOI 10.1016/j.bbrc.2011.04.045; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; LING LE, 1989, J BIOL CHEM, V264, P5080; Lingaraj T, 2008, J BIOMOL SCREEN, V13, P906, DOI 10.1177/1087057108324498; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; POSNER I, 1994, MOL PHARMACOL, V45, P673; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Strelow J., 2004, ASSAY GUIDANCE MANUA; Tanega C, 2009, ASSAY DRUG DEV TECHN, V7, P606, DOI 10.1089/adt.2009.0230; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vidugiriene J, 2009, ASSAY DRUG DEV TECHN, V7, P585, DOI 10.1089/adt.2009.0223; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222	41	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54127	10.1371/journal.pone.0054127	http://dx.doi.org/10.1371/journal.pone.0054127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326584	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400078
J	Young, WB; Park, JE; Tian, IX; Kempner, J				Young, William B.; Park, Jung E.; Tian, Iris X.; Kempner, Joanna			The Stigma of Migraine	PLOS ONE			English	Article							DISCRIMINATION; EPILEPSY; PEOPLE	Background: People who have a disease often experience stigma, a socially and culturally embedded process through which individuals experience stereotyping, devaluation, and discrimination. Stigma has great impact on quality of life, behavior, and life chances. We do not know whether or not migraine is stigmatizing. Methods: We studied 123 episodic migraine patients, 123 chronic migraine patients, and 62 epilepsy patients in a clinical setting to investigate the extent to which stigma attaches to migraine, using epilepsy as a comparison. We used the stigma scale for chronic illness, a 24-item questionnaire suitable for studying chronic neurologic diseases, and various disease impact measures. Results: Patients with chronic migraine had higher scores (54.0 +/- 20.2) on the stigma scale for chronic illness than either episodic migraine (41.7 +/- 14.8) or epilepsy patients (44.6 +/- 16.3) (p<0.001). Subjects with migraine reported greater inability to work than epilepsy subjects. Stigma correlated most strongly with the mental component score of the short form of the medical outcomes health survey (SF-12), then with ability to work and migraine disability score for chronic and episodic migraine and the Liverpool impact on epilepsy scale for epilepsy. Analysis of covariance showed adjusted scores for the stigma scale for chronic illness were similar for chronic migraine (49.3; 95% confidence interval, 46.2 to 52.4) and epilepsy (46.5; 95% confidence interval, 41.6 to 51.6), and lower for episodic migraine (43.7; 95% confidence interval, 40.9 to 46.6). Ability to work was the strongest predictor of stigma as measured by the stigma scale for chronic illness. Conclusion: In our model, adjusted stigma was similar for chronic migraine and epilepsy, which were greater than for episodic migraine. Stigma correlated most strongly with inability to work, and was greater for chronic migraine than epilepsy or episodic migraine because chronic migraine patients had less ability to work.	[Young, William B.; Park, Jung E.; Tian, Iris X.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Kempner, Joanna] Rutgers State Univ, Dept Sociol, New Brunswick, NJ 08903 USA	Jefferson University; Rutgers State University New Brunswick	Young, WB (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	William.B.Young@jefferson.edu		Kempner, Joanna/0000-0002-0198-8781; Kempner, Joanna/0000-0002-9784-6381				Bandstra NF, 2008, CAN J NEUROL SCI, V35, P436, DOI 10.1017/S0317167100009082; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Finch BK, 2000, J HEALTH SOC BEHAV, V41, P295, DOI 10.2307/2676322; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Jacoby A, 2008, CURR NEUROL NEUROSCI, V8, P339, DOI 10.1007/s11910-008-0052-8; Koller M, 1996, CANCER, V77, P983, DOI 10.1002/(SICI)1097-0142(19960301)77:5<983::AID-CNCR27>3.0.CO;2-Z; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Scambler G., 2004, SOC THEOR HEALTH, V2, P29, DOI [10.1057/palgrave.sth.8700012, DOI 10.1057/PALGRAVE.STH.8700012]; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364	15	65	67	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54074	10.1371/journal.pone.0054074	http://dx.doi.org/10.1371/journal.pone.0054074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342079	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700084
J	Das, S; Shetty, RK; Kumar, A; Shridharan, RN; Tatineni, R; Chi, G; Mukherjee, A; Das, S; Subbarao, SM; Karande, AA				Das, Soma; Shetty, Rohini K.; Kumar, Anuj; Shridharan, Radhika Nagamangalam; Tatineni, Ranjitha; Chi, Giriprakash; Mukherjee, Anirban; Das, Saumitra; Subbarao, Shaila Melkote; Karande, Anjali Anoop			Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; HYPERVARIABLE REGION-1; VIRAL DYNAMICS; BINDING; CD81; PROTEINS; INFECTION; REQUIRES; HORMONE	The envelope protein (E1-E2) of Hepatitis C virus (HCV) is a major component of the viral structure. The glycosylated envelope protein is considered to be important for initiation of infection by binding to cellular receptor(s) and also known as one of the major antigenic targets to host immune response. The present study was aimed at identifying mouse monoclonal antibodies which inhibit binding of virus like particles of HCV to target cells. The first step in this direction was to generate recombinant HCV-like particles (HCV-LPs) specific for genotypes 3a of HCV (prevalent in India) using the genes encoding core, E1 and E2 envelop proteins in a baculovirus expression system. The purified HCV-LPs were characterized by ELISA and electron microscopy and were used to generate monoclonal antibodies (mAbs) in mice. Two monoclonal antibodies (E8G9 and H1H10) specific for the E2 region of envelope protein of HCV genotype 3a, were found to reduce the virus binding to Huh7 cells. However, the mAbs generated against HCV genotype 1b (D2H3, G2C7, E1B11) were not so effective. More importantly, mAb E8G9 showed significant inhibition of the virus entry in HCV JFH1 cell culture system. Finally, the epitopic regions on E2 protein which bind to the mAbs have also been identified. Results suggest a new therapeutic strategy and provide the proof of concept that mAb against HCV-LP could be effective in preventing virus entry into liver cells to block HCV replication.	[Das, Soma; Shridharan, Radhika Nagamangalam; Mukherjee, Anirban; Karande, Anjali Anoop] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Shetty, Rohini K.; Kumar, Anuj; Tatineni, Ranjitha; Chi, Giriprakash; Das, Saumitra; Subbarao, Shaila Melkote] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in	KUMAR, ANUJ/AAB-5238-2019	KUMAR, ANUJ/0000-0002-8101-8012	Department of Biotechnology, Govt. of India; UGC, Govt. of India; CSIR, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); UGC, Govt. of India(University Grants Commission, India); CSIR, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Govt. of India. Dr. Soma Das was the recipient of S K Kothari postdoctoral Fellowship from UGC, Govt. of India. Anuj Kumar Dayal was a recipient of Junior Research Fellowship from CSIR, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Baumert TF, 2000, HEPATOLOGY, V32, P610, DOI 10.1053/jhep.2000.9876; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fukumoto T, 1996, HEPATOLOGY, V24, P1351, DOI 10.1053/jhep.1996.v24.pm0008938160; Gangatirkar P, 2002, HYBRIDOMA HYBRIDOM, V21, P281, DOI 10.1089/153685902760213895; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Haqshenas G, 2007, J GEN VIROL, V88, P895, DOI 10.1099/vir.0.82467-0; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; KARANDE AA, 1995, MOL CELL ENDOCRINOL, V114, P51, DOI 10.1016/0303-7207(95)03641-J; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Major ME, 1997, HEPATOLOGY, V25, P1527, DOI 10.1002/hep.510250637; Mukhopadhya A, 2008, J BIOSCIENCES, V33, P465, DOI 10.1007/s12038-008-0065-0; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rice CM, 1996, FIELDS VIROLOGY, P931; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Triyatni M, 2002, J VIROL, V76, P9335, DOI 10.1128/JVI.76.18.9335-9344.2002; Triyatni M, 2002, VIROLOGY, V298, P124, DOI 10.1006/viro.2002.1463; Wellnitz S, 2002, J VIROL, V76, P1181, DOI 10.1128/JVI.76.3.1181-1193.2002; Xiang JH, 2002, J MED VIROL, V68, P537, DOI 10.1002/jmv.10237; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; ZIBERT A, 1995, VIROLOGY, V208, P653, DOI 10.1006/viro.1995.1196	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53619	10.1371/journal.pone.0053619	http://dx.doi.org/10.1371/journal.pone.0053619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341957	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314707700021
J	Maas, AE; Blanco-Bercial, L; Lawson, GL				Maas, Amy E.; Blanco-Bercial, Leocadio; Lawson, Gareth L.			Reexamination of the Species Assignment of Diacavolinia Pteropods Using DNA Barcoding	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; LIMACINA-HELICINA; OCEAN ACIDIFICATION; MAXIMUM-LIKELIHOOD; METABOLIC-RESPONSE; SOUTHERN-OCEAN; GASTROPODA; MOLLUSCA; IMPACT; ZOOPLANKTON	Thecosome pteropods (Mollusca, Gastropoda) are an ecologically important, diverse, and ubiquitous group of holoplanktonic animals that are the focus of intense research interest due to their external aragonite shell and vulnerability to ocean acidification. Characterizing the response of these animals to low pH and other environmental stressors has been hampered by continued uncertainty in their taxonomic identification. An example of this confusion in species assignment is found in the genus Diacavolinia. All members of this genus were originally indentified as a single species, Cavolinia longirostris, but over the past fifty years the taxonomy has been revisited multiple times; currently the genus comprises 22 different species. This study examines five species of Diacavolinia, including four sampled in the Northeast Atlantic (78 individuals) and one from the Eastern tropical North Pacific (15 individuals). Diacavolina were identified to species based on morphological characteristics according to the current taxonomy, photographed, and then used to determine the sequence of the "DNA barcoding'' region of the cytochrome c oxidase subunit I (COI). Specimens from the Atlantic, despite distinct differences in shell morphology, showed polyphyly and a genetic divergence of <3% (K2P distance) whereas the Pacific and Atlantic samples were more distant (similar to 19%). Comparisons of Diacavolinia spp. with other Cavolinia spp. reveal larger distances (similar to 24%). These results indicate that specimens from the Atlantic comprise a single monophyletic species and suggest possible species-level divergence between Atlantic and Pacific populations. The findings support the maintenance of Diacavolinia as a separate genus, yet emphasize the inadequacy of our current taxonomic understanding of pteropods. They highlight the need for accurate species identifications to support estimates of biodiversity, range extent and natural exposure of these planktonic calcifiers to environmental variability; furthermore, the apparent variation of the pteropods shell may have implications for our understanding of the species' sensitivity to ocean acidification.	[Maas, Amy E.; Lawson, Gareth L.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Blanco-Bercial, Leocadio] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Woods Hole Oceanographic Institution; University of Connecticut	Maas, AE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	amaas@whoi.edu	Blanco-Bercial, Leocadio/N-4061-2019; Blanco-Bercial, Leocadio/G-5441-2013; Maas, Amy/AAC-1181-2022	Blanco-Bercial, Leocadio/0000-0003-0658-7183; Blanco-Bercial, Leocadio/0000-0003-0658-7183; Maas, Amy/0000-0002-3730-2876	National Science Foundation [OCE-0928801]; WHOI Postdoctoral Scholarship; Census of Marine Life/Alfred P. Sloan Foundation; College of Liberal Arts AMP; Sciences, University of Connecticut; Division Of Ocean Sciences [1041068] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); WHOI Postdoctoral Scholarship; Census of Marine Life/Alfred P. Sloan Foundation; College of Liberal Arts AMP; Sciences, University of Connecticut; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under Grant Number OCE-0928801. AEM was funded through the WHOI Postdoctoral Scholarship. Support to LBB was provided by the College of Liberal Arts & Sciences, University of Connecticut; and by the Census of Marine Life/Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babior BM, 2002, ANTIOXID REDOX SIGN, V4, P35, DOI 10.1089/152308602753625834; Bandel K, 1995, MAR BIOL, V124, P225, DOI 10.1007/BF00347127; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bernard KS, 2009, DEEP-SEA RES PT I, V56, P582, DOI 10.1016/j.dsr.2008.11.007; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011362; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; de Blainville H, 1821, DICT SCI NATURELLES, V22, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Eberl R, 2007, AQUAT BIOL, V1, P33, DOI 10.3354/ab00002; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falk-Petersen S, 2001, POLAR BIOL, V24, P163, DOI 10.1007/s003000000190; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOSTER BA, 1987, POLAR BIOL, V8, P49, DOI 10.1007/BF00297164; GILMER RW, 1991, MAR ECOL PROG SER, V77, P125, DOI 10.3354/meps077125; GILMER RW, 1974, J EXP MAR BIOL ECOL, V15, P127, DOI 10.1016/0022-0981(74)90039-2; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Honjo S, 2004, ANTARCT SCI, V16, P501, DOI 10.1017/S0954102004002287; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Karnovsky NJ, 2008, MARINE ECOLOGY PROGR, V357, P99; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klussmann-Kolb A, 2006, J ZOOL SYST EVOL RES, V44, P118, DOI 10.1111/j.1439-0469.2006.00351.x; Koehler Frank, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P44, DOI 10.1002/mmnz.200600025; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Maas AE, MARINE BIOL IN PRESS; Maas AE, 2011, MAR ECOL PROG SER, V441, P129, DOI 10.3354/meps09358; Manno C, 2010, J PLANKTON RES, V32, P145, DOI 10.1093/plankt/fbp108; McGowan JA, 1960, SYSTEMATICS DISTRIBU; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miyamoto H, 2010, DEEP-SEA RES PT II, V57, P2211, DOI 10.1016/j.dsr2.2010.09.023; Newman LJ, 1990, HOLOPLANKTONIC MOLLU; Noji TT, 1997, J PLANKTON RES, V19, P863, DOI 10.1093/plankt/19.7.863; Ott M, 2007, LARGE SCALE MAXIMUM, P1; Pakhomov EA, 2002, MAR ECOL PROG SER, V233, P73, DOI 10.3354/meps233073; Paulmier A, 2011, BIOGEOSCIENCES, V8, P239, DOI 10.5194/bg-8-239-2011; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Seibel BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030464; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tesch JJ, 1946, THECOSOMATOUS PTEROP; Tesch JJ, 1948, THECOSOMATOUS PTEROP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Umbach AL, 2006, BBA-BIOENERGETICS, V1757, P135, DOI 10.1016/j.bbabio.2005.12.005; van der Spoel S., 1970, Basteria, V34, P103; van der Spoel S., 1987, Bulletin Zoologisch Museum Universiteit van Amsterdam, V11, P77; van der Spoel S., 1973, Bulletin Zool Mus Univ Amsterdam, V3, P99; van der Spoel S, 1968, BEAUFORTIA BULL ZOOL, P16; van der Spoel S, 1971, BEAUFORTIA, V19, P1; van der Spoel Siebrecht, 1999, P649; VANDERSPOEL S, 1993, BIJDR DIERKD, V62, P127, DOI 10.1163/26660644-06203001; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	79	20	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53889	10.1371/journal.pone.0053889	http://dx.doi.org/10.1371/journal.pone.0053889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335979	Green Published, gold			2022-12-27	WOS:000314707700037
J	Moayed, F; Mashaghi, A; Tans, SJ				Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.			A Polypeptide-DNA Hybrid with Selective Linking Capability Applied to Single Molecule Nano-Mechanical Measurements Using Optical Tweezers	PLOS ONE			English	Article							STREP-TAG; FORCE SPECTROSCOPY; AFFINITY PEPTIDE; PROTEIN; BIOTIN; STREPTAVIDIN; IMMOBILIZATION; TRANSLOCATION; PURIFICATION; DIGOXIGENIN	Many applications in biosensing, biomaterial engineering and single molecule biophysics require multiple non-covalent linkages between DNA, protein molecules, and surfaces that are specific yet strong. Here, we present a novel method to join proteins and dsDNA molecule at their ends, in an efficient, rapid and specific manner, based on the recently developed linkage between the protein StrepTactin (STN) and the peptide StrepTag II (ST). We introduce a two-step approach, in which we first construct a hybrid between DNA and a tandem of two STs peptides (tST). In a second step, this hybrid is linked to polystyrene bead surfaces and Maltose Binding Protein (MBP) using STN. Furthermore, we show the STN-tST linkage is more stable against forces applied by optical tweezers than the commonly used biotin-Streptavidin (STV) linkage. It can be used in conjunction with Neutravidin (NTV)-biotin linkages to form DNA tethers that can sustain applied forces above 65 pN for tens of minutes in a quarter of the cases. The method is general and can be applied to construct other surface-DNA and protein-DNA hybrids. The reversibility, high mechanical stability and specificity provided by this linking procedure make it highly suitable for single molecule mechanical studies, as well as biosensing and lab on chip applications.	[Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] AMOLF Inst, Amsterdam, Netherlands; [Moayed, Fatemeh; Mashaghi, Alireza; Tans, Sander J.] Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	AMOLF; Delft University of Technology	Mashaghi, A (corresponding author), AMOLF Inst, Amsterdam, Netherlands.	mashaghi@amolf.nl; tans@amolf.nl	Tans, Sander/AAS-2901-2020; Mashaghi, Alireza/Q-8218-2017	Mashaghi, Alireza/0000-0002-2157-1211	Foundation for Fundamental Research on Matter (FOM), part of the Netherlands Organisation for Scientific Research (NWO)	Foundation for Fundamental Research on Matter (FOM), part of the Netherlands Organisation for Scientific Research (NWO)	This work was supported by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Barhoumi A, 2009, CHEM PHYS LETT, V482, P171, DOI 10.1016/j.cplett.2009.09.076; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Cecconi C, 2011, METHODS MOL BIOL, V749, P255, DOI 10.1007/978-1-61779-142-0_18; Chevalier J, 1997, J HISTOCHEM CYTOCHEM, V45, P481, DOI 10.1177/002215549704500401; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fuller DN, 2006, NUCLEIC ACIDS RES, V34, P1; GRAY JI, 1978, J AM OIL CHEM SOC, V55, P539, DOI 10.1007/BF02668066; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Gunnarsson A, 2009, NUCLEIC ACIDS RES, V37, P1; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hout M, 2008, NUCLEIC ACIDS RES, V36, P1; Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059; Kim M, 2012, ANGEW CHEM-GER EDIT, V124, P1939; Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1; Langereis S, 2004, ORG BIOMOL CHEM, V2, P1271, DOI 10.1039/b402917h; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Lin CX, 2007, ANGEW CHEM INT EDIT, V46, P6089, DOI 10.1002/anie.200701767; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Marie Aubin Tam E, 2011, CELL, V145, P257; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Mashaghi A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3658825; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Medintz IL, 2006, CURR OPIN BIOTECH, V17, P17, DOI 10.1016/j.copbio.2006.01.002; Neuert G, 2006, FEBS LETT, V580, P505, DOI 10.1016/j.febslet.2005.12.052; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Tang JL, 2008, NANO LETT, V8, P4312, DOI 10.1021/nl802092c; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; van Mameren J, 2008, NUCLEIC ACIDS RES, V36, P4381, DOI 10.1093/nar/gkn412; Waner MJ, 2004, BIOPHYS J, V87, P2701, DOI 10.1529/biophysj.104.047266; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668	40	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54440	10.1371/journal.pone.0054440	http://dx.doi.org/10.1371/journal.pone.0054440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336001	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700059
J	Tani, Y; Araki, K; Nagai, T; Koida, K; Nakauchi, S; Kitazaki, M				Tani, Yusuke; Araki, Keisuke; Nagai, Takehiro; Koida, Kowa; Nakauchi, Shigeki; Kitazaki, Michiteru			Enhancement of Glossiness Perception by Retinal-Image Motion: Additional Effect of Head-Yoked Motion Parallax	PLOS ONE			English	Article							SURFACE; COLOR; SHAPE; DISPARITY; ILLUMINATION; REFLECTANCE; INFORMATION; STATISTICS; HIGHLIGHTS; CUE	It has been argued that when an observer moves, a contingent retinal-image motion of a stimulus would strengthen the perceived glossiness. This would be attributed to the veridical perception of three-dimensional structure by motion parallax. However, it has not been investigated whether the effect of motion parallax is more than that of retinal-image motion of the stimulus. Using a magnitude estimation method, we examine in this paper whether cross-modal coordination of the stimulus change and the observer's motion (i.e., motion parallax) is essential or the retinal-image motion alone is sufficient for enhancing the perceived glossiness. Our data show that a retinal-image motion simulating motion parallax without head motion strengthened the perceived glossiness but that its effect was weaker than that of motion parallax with head motion. These results suggest the existence of an additional effect of the cross-modal coordination between vision and proprioception on glossiness perception. That is, motion parallax enhances the perception of glossiness, in addition to retinal-image motions of specular surfaces.	[Tani, Yusuke; Araki, Keisuke; Nagai, Takehiro; Koida, Kowa; Nakauchi, Shigeki; Kitazaki, Michiteru] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Tani, Y (corresponding author), Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan.	tani@vpac.cs.tut.ac.jp	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842; Nakauchi, Shigeki/0000-0002-4954-6915; Koida, Kowa/0000-0003-0156-3406; Nagai, Takehiro/0000-0002-1619-9654	 [22135005]; Grants-in-Aid for Scientific Research [22135001] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (for SN, #22135005; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; BECK J, 1981, PERCEPT PSYCHOPHYS, V30, P407, DOI 10.3758/BF03206160; Berzhanskaya J, 2005, PERCEPTION, V34, P565, DOI 10.1068/p5401; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; BRAJE WL, 1994, INVEST OPHTH VIS SCI, V35, P1628; Debevec P., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P189, DOI 10.1145/280814.280864; Doerschner K, 2011, CURR BIOL, V21, P2010, DOI 10.1016/j.cub.2011.10.036; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Gerhard HE, 2010, J VISION, V10, DOI 10.1167/10.9.14; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Hartung B., 2002, JOURNAL, V2, P551, DOI DOI 10.1167/2.7.551; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Hurlbert A., 1991, INVEST OPHTHALMOL  S, V32, P105; Khang BG, 2007, PERCEPTION, V36, P1191, DOI 10.1068/p5807; Kim J, 2012, NAT NEUROSC IN PRESS; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Kitazaki M, 1998, PERCEPTION, V27, P1153, DOI 10.1068/p271153; Kitazaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003177; KOENDERINK JJ, 1980, OPT ACTA, V27, P981, DOI 10.1080/713820338; Le Floch A, 2010, VISION RES, V50, P2048, DOI 10.1016/j.visres.2010.07.007; LEE HC, 1990, IEEE T PATTERN ANAL, V12, P402, DOI 10.1109/34.50626; Marlow P, 2011, J VISION, V11, DOI 10.1167/11.9.16; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; MINGOLLA E, 1986, BIOL CYBERN, V53, P137, DOI 10.1007/BF00342882; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; Nefs HT, 2006, ACTA PSYCHOL, V121, P297, DOI 10.1016/j.actpsy.2005.08.001; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Obein G, 2004, J VISION, V4, P711, DOI 10.1167/4.9.4; Okazawa G, 2012, NEUROIMAGE, V63, P1321, DOI 10.1016/j.neuroimage.2012.07.052; Olkkonen M, 2010, J VISION, V10, DOI 10.1167/10.9.5; Oren M, 1997, INT J COMPUT VISION, V24, P105, DOI 10.1023/A:1007954719939; PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839; Pont SC, 2006, PERCEPTION, V35, P1331, DOI 10.1068/p5440; Richards W., 1988, NATURAL COMPUTATION; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Roth S., 2006, J VISION, V1, P1869, DOI [10.1167/3.9.413, DOI 10.1167/3.9.413]; Roth S., 2006, P IEEE COMP SOC C CO, V2, P1869; Sakano Y, 2010, J VISION, V10, DOI 10.1167/10.9.15; SHAFER SA, 1985, COLOR RES APPL, V10, P210, DOI 10.1002/col.5080100409; SHUTE CCD, 1978, VISION RES, V18, P1467, DOI 10.1016/0042-6989(78)90247-X; Vangorp P, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276473, 10.1145/1239451.1239528]; Wendt G, 2010, J VISION, V10, DOI 10.1167/10.9.7; Wendt G, 2008, J VISION, V8, DOI 10.1167/8.1.14; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13; Xiao B, 2008, VISUAL NEUROSCI, V25, P371, DOI 10.1017/S0952523808080267	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54549	10.1371/journal.pone.0054549	http://dx.doi.org/10.1371/journal.pone.0054549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336006	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700064
J	Costa-da-Silva, AL; Navarrete, FR; Salvador, FS; Karina-Costa, M; Ioshino, RS; Azevedo, DS; Rocha, DR; Romano, CM; Capurro, ML				Costa-da-Silva, Andre Luis; Navarrete, Flavia Rosa; Salvador, Felipe Scassi; Karina-Costa, Maria; Ioshino, Rafaella Sayuri; Azevedo, Diego Soares; Rocha, Desiree Rafaela; Romano, Camila Malta; Capurro, Margareth Lara			Glytube: A Conical Tube and Parafilm M-Based Method as a Simplified Device to Artificially Blood-Feed the Dengue Vector Mosquito, Aedes aegypti	PLOS ONE			English	Article							RHODNIUS-PROLIXUS; SYSTEM; INSECT	Aedes aegypti, the main vector of dengue virus, requires a blood meal to produce eggs. Although live animals are still the main blood source for laboratory colonies, many artificial feeders are available. These feeders are also the best method for experimental oral infection of Ae. aegypti with Dengue viruses. However, most of them are expensive or laborious to construct. Based on principle of Rutledge-type feeder, a conventional conical tube, glycerol and Parafilm-M were used to develop a simple in-house feeder device. The blood feeding efficiency of this apparatus was compared to a live blood source, mice, and no significant differences (p = 0.1189) were observed between artificial-fed (51.3% of engorgement) and mice-fed groups (40.6%). Thus, an easy to assemble and cost-effective artificial feeder, designated "Glytube" was developed in this report. This simple and efficient feeding device can be built with common laboratory materials for research on Ae. aegypti.	[Costa-da-Silva, Andre Luis; Navarrete, Flavia Rosa; Karina-Costa, Maria; Ioshino, Rafaella Sayuri; Azevedo, Diego Soares; Rocha, Desiree Rafaela; Capurro, Margareth Lara] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Salvador, Felipe Scassi; Romano, Camila Malta] Univ Sao Paulo, Virol Lab, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Costa-da-Silva, AL (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	alcosta@icb.usp.br	Capurro, Margareth L/F-8679-2012; Romano, Camila M/C-8185-2013; Capurro, Margareth/M-5286-2019; Salvador, Felipe Scassi/AAU-8431-2021; Romano, Camila/ABC-2883-2020; Costa-da-Silva, Andre Luis/F-7874-2012; Silva, Andre/N-8654-2013; Costa-Da-Silva, André Luis/J-8913-2019; Ioshino, Rafaella Sayuri/P-9814-2016	Capurro, Margareth L/0000-0002-7480-2116; Romano, Camila/0000-0003-4550-1987; Costa-da-Silva, Andre Luis/0000-0002-7615-7376; Costa-Da-Silva, André Luis/0000-0002-7615-7376; Ioshino, Rafaella Sayuri/0000-0002-9225-0140	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/10254-1, 2009/53637-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT [555648/2009-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (#2008/10254-1; #2009/53637-0) - www.fapesp.br, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Departamento de Ciencia e Tecnologia - DECIT (#555648/2009-5) - www.cnpq.br, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES - www.capes.gov.br, Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular - INCT-EM - www.inctem.bioqmed.ufrj.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict M. Q., 2009, METHODS ANOPHELES RE, P288; BENZON GL, 1987, J AM MOSQUITO CONTR, V3, P322; Chiang RG, 2010, ARCH INSECT BIOCHEM, V74, P103, DOI 10.1002/arch.20365; Clements AN., 1992, BIOL MOSQUITOES DEV; COSGROVE JB, 1995, J AM MOSQUITO CONTR, V11, P339; COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434; Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220; Deng L, 2012, TROP BIOMED, V29, P169; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024059; Filipecki Ana Tereza Pinto, 2011, ILAR J, V52, pE8; Gauthier C, 2008, I ANIMAL CARE COMMIT, V14, P157; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; HUEBNER E, 1994, CAN J ZOOL, V72, P2244, DOI 10.1139/z94-299; Jagjiwanram, 2004, INDIAN J ENG MATER S, V11, P125; Pothikasikorn J, 2010, J VECTOR ECOL, V35, P149, DOI 10.1111/j.1948-7134.2010.00041.x; Rampersad J, 2007, J AM MOSQUITO CONTR, V23, P149, DOI 10.2987/8756-971X(2007)23[149:VBBFLF]2.0.CO;2; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Tseng M, 2003, J MED ENTOMOL, V40, P588, DOI 10.1603/0022-2585-40.4.588; Waladde SM, 1996, PARASITOL TODAY, V12, P272, DOI 10.1016/0169-4758(96)10027-2	20	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53816	10.1371/journal.pone.0053816	http://dx.doi.org/10.1371/journal.pone.0053816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342010	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400088
J	Groenewold, NA; Doornbos, B; Zuidersma, M; Vogelzangs, N; Penninx, BWJH; Aleman, A; de Jonge, P				Groenewold, Nynke A.; Doornbos, Bennard; Zuidersma, Marij; Vogelzangs, Nicole; Penninx, Brenda W. J. H.; Aleman, Andre; de Jonge, Peter			Comparing Cognitive and Somatic Symptoms of Depression in Myocardial Infarction Patients and Depressed Patients in Primary and Mental Health Care	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; LATE-ONSET DEPRESSION; LATE-LIFE DEPRESSION; TRIAL MIND-IT; AGE-OF-ONSET; RISK-FACTORS; CARDIOVASCULAR PROGNOSIS; CARDIAC PROGNOSIS; HEART-DISEASE; INVENTORY-II	Depression in myocardial infarction patients is often a first episode with a late age of onset. Two studies that compared depressed myocardial infarction patients to psychiatric patients found similar levels of somatic symptoms, and one study reported lower levels of cognitive/affective symptoms in myocardial infarction patients. We hypothesized that myocardial infarction patients with first depression onset at a late age would experience fewer cognitive/affective symptoms than depressed patients without cardiovascular disease. Combined data from two large multicenter depression studies resulted in a sample of 734 depressed individuals (194 myocardial infarction, 214 primary care, and 326 mental health care patients). A structured clinical interview provided information about depression diagnosis. Summed cognitive/affective and somatic symptom levels were compared between groups using analysis of covariance, with and without adjusting for the effects of recurrence and age of onset. Depressed myocardial infarction and primary care patients reported significantly lower cognitive/affective symptom levels than mental health care patients (F (2,682) = 6.043, p = 0.003). Additional analyses showed that the difference between myocardial infarction and mental health care patients disappeared after adjusting for age of onset but not recurrence of depression. These group differences were also supported by data-driven latent class analyses. There were no significant group differences in somatic symptom levels. Depression after myocardial infarction appears to have a different phenomenology than depression observed in mental health care. Future studies should investigate the etiological factors predictive of symptom dimensions in myocardial infarction and late-onset depression patients.	[Groenewold, Nynke A.; Doornbos, Bennard; Zuidersma, Marij; Penninx, Brenda W. J. H.; de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Groenewold, Nynke A.; Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands; [Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Groenewold, NA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, NL-9713 AV Groningen, Netherlands.	N.A.Groenewold01@umcg.nl	de Jonge, peter/L-6395-2013; Penninx, Brenda WJH/S-7627-2017	de Jonge, peter/0000-0002-0866-6929; Penninx, Brenda WJH/0000-0001-7779-9672; Groenewold, Nynke A./0000-0002-0865-8427	Netherlands Heart Foundation [97.016]; Organon (The Netherlands); Lundbeck (Denmark); Netherlands Organization for Health Research and Development (ZonMw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos); Organon; Lundbeck	Netherlands Heart Foundation(Netherlands Heart Foundation); Organon (The Netherlands)(Netherlands Government); Lundbeck (Denmark)(Lundbeck Corporation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Health Care (IQ Healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos); Organon; Lundbeck(Lundbeck Corporation)	MIND-IT was sponsored by the Netherlands Heart Foundation (97.016). MIND-IT received educational grants from Organon (The Netherlands) and Lundbeck (Denmark). These sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. The infrastructure for the NESDA study (available at www.nesda.nl) is funded, in part, by the Geestkracht program of the Netherlands Organization for Health Research and Development (ZonMw, Grant 10-000-1002) and is supported, in part, by participating universities and mental health care organizations: VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Health Care (IQ Healthcare), Netherlands Institute for Health Services Research (NIVEL), and Netherlands Institute of Mental Health and Addiction (Trimbos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by: Organon, Lundbeck, GGZ inGeest, Arkin, GGZ Rivierduinen, Lentis, GGZ Friesland, and GGZ Drenthe. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alloy LB, 2006, J ABNORM PSYCHOL, V115, P145, DOI 10.1037/0021-843X.115.1.145; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1996, PSYCHOL ASSESS; Bus BAA, 2011, PSYCHOL MED, V41, P1419, DOI 10.1017/S0033291710002151; Corruble E, 2008, ACTA PSYCHIAT SCAND, V118, P389, DOI 10.1111/j.1600-0447.2008.01239.x; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; de Jonge P, 2006, J AM COLL CARDIOL, V48, P2204, DOI 10.1016/j.jacc.2006.06.077; de Jonge P, 2010, NEUROSCI BIOBEHAV R, V35, P84, DOI 10.1016/j.neubiorev.2009.11.025; Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012; Gallagher D, 2010, INT J GERIATR PSYCH, V25, P981, DOI 10.1002/gps.2438; Hankin BL, 2009, J CLIN PSYCHOL, V65, P1327, DOI 10.1002/jclp.20625; Holzapfel N, 2008, J AFFECT DISORDERS, V105, P53, DOI 10.1016/j.jad.2007.04.009; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lux V, 2010, PSYCHOL MED, V40, P1679, DOI 10.1017/S0033291709992157; Martens EJ, 2010, PSYCHOL MED, V40, P807, DOI 10.1017/S0033291709990997; Martens EJ, 2006, J AFFECT DISORDERS, V94, P231, DOI 10.1016/j.jad.2006.04.023; Muthen LK, 2007, MPLUS USERS GUIDE ST, V5; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Rubin DB, 2004, MULTIPLE IMPUTATION; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sneed JR, 2007, INT J GERIATR PSYCH, V22, P663, DOI 10.1002/gps.1727; Sorensen C, 2005, ACTA PSYCHIAT SCAND, V111, P116, DOI 10.1111/j.1600-0447.2004.00430.x; Spijkerman T, 2005, GEN HOSP PSYCHIAT, V27, P411, DOI 10.1016/j.genhosppsych.2005.05.007; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2008, J PSYCHOSOM RES, V65, P115, DOI 10.1016/j.jpsychores.2008.02.027; Thombs BD, 2010, BRIT J PSYCHIAT, V197, P61, DOI 10.1192/bjp.bp.109.076596; van den Brink RHS, 2002, AM HEART J, V144, P219, DOI 10.1067/mhj.2002.123580; van Melle JP, 2006, INT J CARDIOL, V109, P88, DOI 10.1016/j.ijcard.2005.05.053; Zuidersma M, 2011, PSYCHOTHER PSYCHOSOM, V80, P227, DOI 10.1159/000322633	37	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53859	10.1371/journal.pone.0053859	http://dx.doi.org/10.1371/journal.pone.0053859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342019	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400092
J	Willis, KL; Christensen-Dalsgaard, J; Ketten, DR; Carr, CE				Willis, Katie L.; Christensen-Dalsgaard, Jakob; Ketten, Darlene R.; Carr, Catherine E.			Middle Ear Cavity Morphology Is Consistent with an Aquatic Origin for Testudines	PLOS ONE			English	Article							UNDERWATER HEARING; DIAPSID REPTILES; SISTER GROUP; TURTLES EAR; SEA-TURTLE; PHYLOGENY; EVOLUTION; POSITION; SENSITIVITY; POTENTIALS	The position of testudines in vertebrate phylogeny is being re-evaluated. At present, testudine morphological and molecular data conflict when reconstructing phylogenetic relationships. Complicating matters, the ecological niche of stem testudines is ambiguous. To understand how turtles have evolved to hear in different environments, we examined middle ear morphology and scaling in most extant families, as well as some extinct species, using 3-dimensional reconstructions from micro magnetic resonance (MR) and submillimeter computed tomography (CT) scans. All families of testudines exhibited a similar shape of the bony structure of the middle ear cavity, with the tympanic disk located on the rostrolateral edge of the cavity. Sea Turtles have additional soft tissue that fills the middle ear cavity to varying degrees. When the middle ear cavity is modeled as an air-filled sphere of the same volume resonating in an underwater sound field, the calculated resonances for the volumes of the middle ear cavities largely fell within testudine hearing ranges. Although there were some differences in morphology, there were no statistically significant differences in the scaling of the volume of the bony middle ear cavity with head size among groups when categorized by phylogeny and ecology. Because the cavity is predicted to resonate underwater within the testudine hearing range, the data support the hypothesis of an aquatic origin for testudines, and function of the middle ear cavity in underwater sound detection.	[Willis, Katie L.; Carr, Catherine E.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Christensen-Dalsgaard, Jakob] Univ So Denmark, Inst Biol, Odense M, Denmark; [Ketten, Darlene R.] Harvard Univ, Sch Med, Dept Biol, Dept Otol & Laryngol,Woods Hole Oceanog Inst, Woods Hole, MA USA	University System of Maryland; University of Maryland College Park; University of Southern Denmark; Harvard University; Woods Hole Oceanographic Institution	Willis, KL (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	kwillis@umd.edu	Christensen-Dalsgaard, Jakob/H-5299-2019; Christensen-Dalsgaard, Jakob/G-9947-2012	Christensen-Dalsgaard, Jakob/0000-0002-6075-3819	Danish National Science Foundation [09-065990]; Carlsberg Foundation [2009-01-0684]; Velux Foundation (Denmark); ONR [N000140811231]; NIH (National Institutes of Health) [DC00436, P30 DC0466]; NSF [IIS 9874781, 0208675]; Directorate For Geosciences [0948842] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046, F32DC000466, R29DC000436, R01DC000436] Funding Source: NIH RePORTER	Danish National Science Foundation(Danmarks Grundforskningsfond); Carlsberg Foundation(Carlsberg Foundation); Velux Foundation (Denmark); ONR(Office of Naval Research); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by awards from the Danish National Science Foundation 09-065990 and Carlsberg Foundation 2009-01-0684 (JCD), the Velux Foundation (Denmark), ONR N000140811231(DRK) and NIH (National Institutes of Health) DC00436 (CEC), and by NIH P30 DC0466 to the University of Maryland Center for Comparative and Evolutionary Biology of Hearing, by NSF IIS 9874781 and 0208675 to T. Rowe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1938, PROC R SOC SER B-BIO, V125, P435, DOI 10.1098/rspb.1938.0036; Bartol SM, 1999, COPEIA, P836, DOI 10.2307/1447625; Brinkman DB, 2005, DINOSAUR PROVINCIAL; CAMPBELL H W, 1972, Herpetologica, V28, P277; CAMPBELL HOWARD W., 1967, HERPETOLOGICA, V23, P204; Carr AF, 1969, HDB TURTLES TURTLES; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Christensen-Dalsgaard J, 1995, J COMP PHYSIOL A, V176, P1; Christensen-Dalsgaard J, 2008, JARO-J ASSOC RES OTO, V9, P407, DOI 10.1007/s10162-008-0130-2; Christensen-Dalsgaard J, 2008, BRAIN RES BULL, V75, P365, DOI 10.1016/j.brainresbull.2007.10.044; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; Clack JA., 2012, GAINING GROUND ORIGI; Crawford N. G., 2012, BIOL LETT, V8, P1; Evans HM, 1925, P R SOC LOND B-CONTA, V97, P545, DOI 10.1098/rspb.1925.0018; Frazier J, 1981, AMPHIBIA-REPTILIA, V2, P1; Gaffney E.S., 1983, Journal of Vertebrate Paleontology, V3, P25, DOI 10.1080/02724634.1983.10011953; Gaffney E.S., 1972, ILLUSTRATED GLOSSARY, P1; Giles JC, 2009, J ACOUST SOC AM, V126, P434, DOI 10.1121/1.3148209; Guillon JM, 2012, CONTRIB ZOOL, V81, P147, DOI 10.1163/18759866-08103002; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Ketten DR, 1999, ACOUST SOC AM ANN M; KONISHI M, 1970, Z VERGL PHYSIOL, V66, P257, DOI 10.1007/BF00297829; Lee MSY, 2001, CONTRIB ZOOL, V70, P1; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; LOMBARD RE, 1981, J EXP BIOL, V91, P57; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; Mannen H, 1999, MOL PHYLOGENET EVOL, V13, P144, DOI 10.1006/mpev.1999.0640; Mason Mj, 2009, Proc Inst Acoust, V31, P13; Pineiro G, 2012, CR PALEVOL, V11, P379, DOI 10.1016/j.crpv.2012.02.001; PLASSMANN W, 1991, BRAIN BEHAV EVOLUT, V38, P115, DOI 10.1159/000114382; Polgar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021434; Ravicz ME, 1997, J ACOUST SOC AM, V101, P2135, DOI 10.1121/1.418275; RIDGWAY SH, 1969, P NATL ACAD SCI USA, V64, P884, DOI 10.1073/pnas.64.3.884; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Tang YZ, 2012, J COMP NEUROL, V520, P1784, DOI 10.1002/cne.23013; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; van Dijk P. P., 2011, CONSERVATION BIOL FR; Webb JF, 2006, J MORPHOL, V267, P1338, DOI 10.1002/jmor.10480; WEBSTER DOUGLAS B., 1962, PHYSIOL ZOOL, V35, P248; Wever E.., 1978, REPTILE EAR ITS STRU; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P292, DOI 10.1073/pnas.42.5.292; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P213, DOI 10.1073/pnas.42.4.213; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P962, DOI 10.1073/pnas.42.12.962; Willis KL, 2011, SOC NEUR ANN M; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zeddies DG, 2005, J EXP BIOL, V208, P1363, DOI 10.1242/jeb.01534	51	22	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54086	10.1371/journal.pone.0054086	http://dx.doi.org/10.1371/journal.pone.0054086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342082	gold, Green Published			2022-12-27	WOS:000314759400120
J	Tominaga-Wada, R; Nukumizu, Y; Sato, S; Wada, T				Tominaga-Wada, Rumi; Nukumizu, Yuka; Sato, Shusei; Wada, Takuji			Control of Plant Trichome and Root-Hair Development by a Tomato (Solanum lycopersicum) R3 MYB Transcription Factor	PLOS ONE			English	Article							EPIDERMAL-CELL FATE; CONTROLS ENDOREDUPLICATION; SPECIALIZED METABOLITES; BHLH PROTEINS; GENE ENCODES; ARABIDOPSIS; EXPRESSION; CAPRICE; SPECIFY; TT8	In Arabidopsis thaliana the CPC-like MYB transcription factors [CAPRICE (CPC), TRIPTYCHON (TRY), ENHANCER OF TRY AND CPC 1, 2, 3/CPC-LIKE MYB 3 (ETC1, ETC2, ETC3/CPL3), TRICHOMELESS 1, 2/CPC-LIKE MYB 4 (TCL1, TCL2/CPL4)] and the bHLH transcription factors [GLABRA3 (GL3) and ENHANCER OF GLABRA 3 (EGL3)] are central regulators of trichome and root-hair development. We identified TRY and GL3 homologous genes from the tomato genome and named them SlTRY and SlGL3, respectively. Phylogenic analyses revealed a close relationship between the tomato and Arabidopsis genes. Real-time reverse transcription PCR analyses showed that SlTRY and SlGL3 were predominantly expressed in aerial parts of developing tomato. After transformation into Arabidopsis, CPC::SlTRY inhibited trichome formation and enhanced root-hair differentiation by strongly repressing GL2 expression. On the other hand, GL3:: SlGL3 transformation did not show any obvious effect on trichome or non-hair cell differentiation. These results suggest that tomato and Arabidopsis partially use similar transcription factors for epidermal cell differentiation, and that a CPC-like R3 MYB may be a key common regulator of plant trichome and root-hair development.	[Tominaga-Wada, Rumi; Nukumizu, Yuka; Wada, Takuji] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Sato, Shusei] Kazusa DNA Res Inst, Chiba, Japan	University of Miyazaki; Kazusa DNA Research Institute	Tominaga-Wada, R (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	rtominaga@cc.miyazaki-u.ac.jp	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366	Ministry of Education, Culture, Sports, Science and Technology; University of Miyazaki; Japan Society for the Promotion of Science [23570057]; Ministry of Education, Culture, Sports, Science and Technology [23012035]; Grants-in-Aid for Scientific Research [23570057] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by the program "Improvement of Research Environment for Young Researchers" from the Ministry of Education, Culture, Sports, Science and Technology, a grant for Scientific Research on Priority Areas from the University of Miyazaki, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 23570057) and a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (No. 23012035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BAUR R, 1991, OECOLOGIA, V87, P219, DOI 10.1007/BF00325259; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clowes FAL, 2000, NEW PHYTOL, V146, P83, DOI 10.1046/j.1469-8137.2000.00614.x; CORMACK RGH, 1947, AM J BOT, V34, P310, DOI 10.2307/2437142; CUTTER EG, 1972, J CELL SCI, V11, P723; Dolan L, 1996, ANN BOT-LONDON, V77, P547, DOI 10.1006/anbo.1996.0069; Dolan L, 2001, J EXP BOT, V52, P413, DOI 10.1093/jexbot/52.suppl_1.413; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Gan LJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-176; Girardi CL, 2006, POSTHARVEST BIOL TEC, V42, P1, DOI 10.1016/j.postharvbio.2006.06.002; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Hulskamp M, 2000, ADV BOT RES, P37; Ishida T, 2007, PLANT CELL, V19, P2531, DOI 10.1105/tpc.107.052274; Kang JH, 2010, PLANT PHYSIOL, V154, P262, DOI 10.1104/pp.110.160192; Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Leavitt RG, 1904, P BOSTON SOC NATURAL, V31, P273; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2001, DEVELOPMENT, V128, P1539; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckwill L.C., 1943, ABERD U STUD, V120, P1; Marks MD, 2003, EMBO REP, V4, P24, DOI 10.1038/sj.embor.embor705; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Payne CT, 2000, GENETICS, V156, P1349; Pemberton LMS, 2001, ANN BOT-LONDON, V87, P649, DOI 10.1006/anbo.2001.1385; Pires N, 2010, PLANT SIGNAL BEHAV, V5, P911, DOI 10.4161/psb.5.7.12100; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schilmiller A, 2010, PLANT J, V62, P391, DOI 10.1111/j.1365-313X.2010.04154.x; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Szymanski DB, 1998, DEVELOPMENT, V125, P1161; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Tominaga-Wada R, 2012, INT J MOL SCI, V13, P3478, DOI 10.3390/ijms13033478; Tominaga-Wada R, 2011, PLANT SCI, V181, P471, DOI 10.1016/j.plantsci.2011.07.006; Tominaga-Wada R, 2009, PLANT J, V60, P564, DOI 10.1111/j.1365-313X.2009.03976.x; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yoshizumi T, 2006, PLANT CELL, V18, P2452, DOI 10.1105/tpc.106.043869; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao HT, 2012, J BIOL CHEM, V287, P14109, DOI 10.1074/jbc.M111.280735; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; [No title captured]	62	56	63	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54019	10.1371/journal.pone.0054019	http://dx.doi.org/10.1371/journal.pone.0054019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326563	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800102
J	Wayama, M; Ota, S; Matsuura, H; Nango, N; Hirata, A; Kawano, S				Wayama, Marina; Ota, Shuhei; Matsuura, Hazuki; Nango, Nobuhito; Hirata, Aiko; Kawano, Shigeyuki			Three-Dimensional Ultrastructural Study of Oil and Astaxanthin Accumulation during Encystment Green Alga Haematococcus pluvialis	PLOS ONE			English	Article							CHLORELLA-ZOFINGIENSIS; SECONDARY CAROTENOIDS; HIGH-LIGHT; STRESS; BIOSYNTHESIS; VOLVOCALES	Haematococcus pluvialis is a freshwater species of green algae and is well known for its accumulation of the strong antioxidant astaxanthin, which is used in aquaculture, various pharmaceuticals, and cosmetics. High levels of astaxanthin are present in cysts, which rapidly accumulate when the environmental conditions become unfavorable for normal cell growth. It is not understood, however, how accumulation of high levels of astaxanthin, which is soluble in oil, becomes possible during encystment. Here, we performed ultrastructural 3D reconstruction based on over 350 serial sections per cell to visualize the dynamics of astaxanthin accumulation and subcellular changes during the encystment of H. pluvialis. This study showcases the marked changes in subcellular elements, such as chloroplast degeneration, in the transition from green coccoid cells to red cyst cells during encystment. In green coccoid cells, chloroplasts accounted for 41.7% of the total cell volume, whereas the relative volume of astaxanthin was very low (0.2%). In contrast, oil droplets containing astaxanthin predominated in cyst cells (52.2%), in which the total chloroplast volume was markedly decreased (9.7%). Volumetric observations also demonstrated that the relative volumes of the cell wall, starch grains, pyrenoids, mitochondria, the Golgi apparatus, and the nucleus in a cyst cell are smaller than those in green coccid cells. Our data indicated that chloroplasts are degraded, resulting in a net-like morphology, but do not completely disappear, even at the red cyst stage.	[Wayama, Marina; Ota, Shuhei; Matsuura, Hazuki; Hirata, Aiko; Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Ota, Shuhei; Kawano, Shigeyuki] JST CREST, Kashiwa, Chiba, Japan; [Nango, Nobuhito] Ratoc Syst Engn Co Ltd, Tokyo, Japan; [Hirata, Aiko] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kawano, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	kawano@k.u-tokyo.ac.jp	Ota, Shuhei/AAI-1557-2020	Ota, Shuhei/0000-0003-4349-3047	CREST from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24657046, 22370024, 22570084] Funding Source: KAKEN	CREST from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; BAR E, 1995, J PLANT PHYSIOL, V146, P527, DOI 10.1016/S0176-1617(11)82019-5; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111x./; Damiani MC, 2010, BIORESOURCE TECHNOL, V101, P3801, DOI 10.1016/j.biortech.2009.12.136; Collins AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024302; Del Campo JA, 2004, APPL MICROBIOL BIOT, V64, P848, DOI 10.1007/s00253-003-1510-5; FAN L, 1994, J PHYCOL, V30, P829, DOI 10.1111/j.0022-3646.1994.00829.x; Grunewald K, 2001, J BIOL CHEM, V276, P6023, DOI 10.1074/jbc.M006400200; Grunewald K, 2001, J APPL PHYCOL, V13, P89, DOI 10.1023/A:1008183328839; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hagen C, 2002, EUR J PHYCOL, V37, P217, DOI 10.1017/S0967026202003669; Kaczor A, 2011, ANALYST, V136, P1109, DOI 10.1039/c0an00553c; KAKIZONO T, 1992, J FERMENT BIOENG, V74, P403, DOI 10.1016/0922-338X(92)90041-R; Katagiri M, 2012, J CLIN BIOCHEM NUTR, V51, P102, DOI 10.3164/jcbn.D-11-00017; KOBAYASHI M, 1992, J FERMENT BIOENG, V74, P61, DOI 10.1016/0922-338X(92)90271-U; LANG NJ, 1968, J PHYCOL, V4, P12, DOI 10.1111/j.1529-8817.1968.tb04670.x; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Li YT, 2010, J APPL PHYCOL, V22, P253, DOI 10.1007/s10811-009-9453-6; Li YT, 2009, J PHYCOL, V45, P635, DOI 10.1111/j.1529-8817.2009.00689.x; Margalith PZ, 1999, APPL MICROBIOL BIOT, V51, P431, DOI 10.1007/s002530051413; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P291, DOI 10.1016/0003-9861(92)90675-M; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RISE M, 1994, J PLANT PHYSIOL, V144, P287, DOI 10.1016/S0176-1617(11)81189-2; Sarada R, 2002, PROCESS BIOCHEM, V37, P623, DOI 10.1016/S0032-9592(01)00246-1; STOREBAKKEN T, 1987, AQUACULTURE, V65, P279, DOI 10.1016/0044-8486(87)90241-9; TJAHJONO AE, 1994, BIOTECHNOL LETT, V16, P133, DOI 10.1007/BF01021659; Tominaga K, 2012, ACTA BIOCHIM POL, V59, P43; Triki A, 1997, PHYCOLOGIA, V36, P190, DOI 10.2216/i0031-8884-36-3-190.1; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x	30	115	123	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53618	10.1371/journal.pone.0053618	http://dx.doi.org/10.1371/journal.pone.0053618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326471	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800063
J	Lieu, CA; Chinta, SJ; Rane, A; Andersen, JK				Lieu, Christopher A.; Chinta, Shankar J.; Rane, Anand; Andersen, Julie K.			Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							MAO-B; 3-NITROPROPIONIC ACID; BRAIN ASTROCYTES; KNOCKOUT MICE; PC12 CELLS; MPTP; DEFICIENT; NEURONS; NEUROTOXICITY; DEGENERATION	We have previously shown that increases in astrocytic monoamine oxidase-B (MAO-B) expression, mimicking that which occurs with aging and in neurodegenerative disease, in a doxycycline (dox)-inducible transgenic mouse model evokes neuropathological similarities to what is observed in the human parkinsonian brain. Additional behavioral and neuropathological studies could provide further validation for its usage as a model for Parkinson's disease (PD). In the present study, we utilized a battery of behavioral tests to evaluate age-related phenotype in this model. In the open field test, we found that dox-induction impaired motor ability with decreases in movement and ambulatory function as well as diminished stereotypical, repetitive movement episodes in both young and old mice. Older mice also showed decreased motor performance in the pole test when compared to younger mice. Furthermore, dox-induced older mice displayed severe hindlimb clasping and the most significant loss of dopamine (DA) in the striatum when compared to young and non-induced animals. Additionally, increased MAO-B activity significantly correlated with decreased expression of striatal DA. The results of our study further confirms that the dox-inducible astrocytic MAO-B transgenic mouse displays similar age-related behavioral and neuropathological features to other models of PD, and could serve as a useful tool to study PD pathophysiology and for the evaluation of therapeutic interventions.	[Lieu, Christopher A.; Chinta, Shankar J.; Rane, Anand; Andersen, Julie K.] Buck Inst Res Aging, Novato, CA USA	Buck Institute for Research on Aging	Andersen, JK (corresponding author), Buck Inst Res Aging, Novato, CA USA.	jandersen@buckinstitute.org	Rane, Anders/L-2675-2013	Andersen, Julie/0000-0003-1324-4875	PPG [AG025901]; NIH T32 fellowship [AG000266]; NATIONAL INSTITUTE ON AGING [T32AG000266, P01AG025901] Funding Source: NIH RePORTER	PPG; NIH T32 fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was made possible by PPG AG025901 (J.K.A.) and NIH T32 fellowship AG000266 (C.A.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; COHEN G, 1984, EUR J PHARMACOL, V106, P209, DOI 10.1016/0014-2999(84)90700-3; Fernagut PO, 2004, EXP NEUROL, V185, P47, DOI 10.1016/j.expneurol.2003.09.014; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Finberg JPM, 1998, NEUROREPORT, V9, P703; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Guyenet S.J., 2010, J VIS EXP; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Klivenyi P, 2000, J NEUROSCI, V20, P1; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Lee M, 2004, GENES BRAIN BEHAV, V3, P216, DOI 10.1111/j.1601-1848.2004.00074.x; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; Lieu CA, 2010, PARKINSONISM RELAT D, V16, P458, DOI 10.1016/j.parkreldis.2010.04.015; Mahy N., 2000, Neurobiology (Budapest), V8, P47; Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616; SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X; Siddiqui A, 2012, FREE RADIC RES; Siddiqui A, 2011, NEUROBIOL DIS, V43, P527, DOI 10.1016/j.nbd.2010.12.014; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Van Waes V, 2010, EUR J NEUROSCI, V32, P435, DOI 10.1111/j.1460-9568.2010.07294.x; Wei Q, 1996, J NEUROSCI RES, V46, P666; Wei QZ, 1997, J NEUROSCI RES, V50, P618	24	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54200	10.1371/journal.pone.0054200	http://dx.doi.org/10.1371/journal.pone.0054200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326597	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400083
J	Ponjavic-Conte, KD; Hambrook, DA; Pavlovic, S; Tata, MS				Ponjavic-Conte, Karla D.; Hambrook, Dillon A.; Pavlovic, Sebastian; Tata, Matthew S.			Dynamics of Distraction: Competition among Auditory Streams Modulates Gain and Disrupts Inter-Trial Phase Coherence in the Human Electroencephalogram	PLOS ONE			English	Article							TRANSIENT SPATIAL ATTENTION; SELECTIVE ATTENTION; INFORMATIONAL MASKING; NEURONAL SYNCHRONIZATION; BRAIN POTENTIALS; ALPHA-ACTIVITY; VISUAL-SEARCH; OSCILLATIONS; RESPONSES; CORTEX	Auditory distraction is a failure to maintain focus on a stream of sounds. We investigated the neural correlates of distraction in a selective-listening pitch-discrimination task with high (competing speech) or low (white noise) distraction. High-distraction impaired performance and reduced the N1 peak of the auditory Event-Related Potential evoked by probe tones. In a series of simulations, we explored two theories to account for this effect: disruption of sensory gain or a disruption of inter-trial phase consistency. When compared to these simulations, our data were consistent with both effects of distraction. Distraction reduced the gain of the auditory evoked potential and disrupted the inter-trial phase consistency with which the brain responds to stimulus events. Tones at a non-target, unattended frequency were more susceptible to the effects of distraction than tones within an attended frequency band.	[Ponjavic-Conte, Karla D.; Hambrook, Dillon A.; Pavlovic, Sebastian; Tata, Matthew S.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Ponjavic-Conte, KD (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	karla.ponjavic@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	A Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to MST funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 2006, CEREB CORTEX; Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bregman AS, 1990, AUDITORY SCENE ANAL, pxiii; BROADBENT DE, 1952, J EXP PSYCHOL, V44, P51, DOI 10.1037/h0056491; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; DONALD MW, 1982, EXP BRAIN RES, V46, P357; Dowdall JR, 2012, NEUROPSYCHOLOGIA, V50, P2442, DOI 10.1016/j.neuropsychologia.2012.06.015; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; HANSEN JC, 1988, PSYCHOPHYSIOLOGY, V25, P316, DOI 10.1111/j.1469-8986.1988.tb01249.x; HARI R, 1988, EXP BRAIN RES, V71, P87; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hymel M R, 1998, J Am Acad Audiol, V9, P385; Hymel MR, 2000, NEUROSCI LETT, V283, P105, DOI 10.1016/S0304-3940(00)00915-0; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Krumm M P, 1994, J Am Acad Audiol, V5, P127; LEEK MR, 1991, PERCEPT PSYCHOPHYS, V50, P205, DOI 10.3758/BF03206743; Low YF, 2009, PHYSIOL MEAS, V30, P821, DOI 10.1088/0967-3334/30/8/007; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mazaheri A, 2006, P NATL ACAD SCI USA, V103, P2948, DOI 10.1073/pnas.0505785103; Min BK, 2007, INT J PSYCHOPHYSIOL, V65, P58, DOI 10.1016/j.ijpsycho.2007.03.002; Naatanen R., 2018, ATTENTION BRAIN FUNC; Obleser J., 2011, CEREB CORTEX; POLLACK I, 1976, J ACOUST SOC AM, V60, P680, DOI 10.1121/1.381139; Ponjavic-Conte KD, 2012, NEUROREPORT, V23, P240, DOI 10.1097/WNR.0b013e3283505ac6; Salmi J, 2007, EUR J NEUROSCI, V25, P3725, DOI 10.1111/j.1460-9568.2007.05616.x; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Schroger E, 2000, CLIN NEUROPHYSIOL, V111, P1450, DOI 10.1016/S1388-2457(00)00337-0; SCHROGER E, 1993, NEUROREPORT, V4, P588, DOI 10.1097/00001756-199305000-00033; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tata MS, 2005, NEUROPSYCHOLOGIA, V43, P509, DOI 10.1016/j.neuropsychologia.2004.07.019; Tata MS, 2004, PSYCHON B REV, V11, P262, DOI 10.3758/BF03196568; Tata MS, 2002, PERCEPT PSYCHOPHYS, V64, P1028, DOI 10.3758/BF03194754; Tata MS, 2001, NEUROREPORT, V12, P3679, DOI 10.1097/00001756-200112040-00015; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TREISMAN AM, 1964, AM J PSYCHOL, V77, P533, DOI 10.2307/1420765; Watson CS, 2005, ACTA ACUST UNITED AC, V91, P502; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; WOODS DL, 1984, J EXP PSYCHOL HUMAN, V10, P761, DOI 10.1037/0096-1523.10.6.761	57	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53953	10.1371/journal.pone.0053953	http://dx.doi.org/10.1371/journal.pone.0053953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326548	Green Published, gold			2022-12-27	WOS:000313552400064
J	Bublatzky, F; Guerra, PM; Pastor, MC; Schupp, HT; Vila, J				Bublatzky, Florian; Guerra, Pedro M.; Carmen Pastor, M.; Schupp, Harald T.; Vila, Jaime			Additive Effects of Threat-of-Shock and Picture Valence on Startle Reflex Modulation	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; ANTICIPATORY ANXIETY; EMOTION; BRAIN; PERCEPTION; ATTENTION; EXPOSURE; REACTIVITY; PHYSIOLOGY; RESPONSES	The present study examined the effects of sustained anticipatory anxiety on the affective modulation of the eyeblink startle reflex. Towards this end, pleasant, neutral and unpleasant pictures were presented as a continuous stream during alternating threat-of-shock and safety periods, which were cued by colored picture frames. Orbicularis-EMG to auditory startle probes and electrodermal activity were recorded. Previous findings regarding affective picture valence and threat-of-shock modulation were replicated. Of main interest, anticipating aversive events and viewing affective pictures additively modulated defensive activation. Specifically, despite overall potentiated startle blink magnitude in threat-of-shock conditions, the startle reflex remained sensitive to hedonic picture valence. Finally, skin conductance level revealed sustained sympathetic activation throughout the entire experiment during threat-compared to safety-periods. Overall, defensive activation by physical threat appears to operate independently from reflex modulation by picture media. The present data confirms the importance of simultaneously manipulating phasic-fear and sustained-anxiety in studying both normal and abnormal anxiety.	[Bublatzky, Florian] Univ Mannheim, Dept Psychol, Sch Social Sci, D-68131 Mannheim, Germany; [Bublatzky, Florian; Schupp, Harald T.] Univ Konstanz, Dept Psychol, Constance, Germany; [Guerra, Pedro M.; Vila, Jaime] Univ Granada, Dept Personal, Granada, Spain; [Carmen Pastor, M.] Jaume I Univ, Dept Psychol, Castellon de La Plana, Spain	University of Mannheim; University of Konstanz; University of Granada; Universitat Jaume I	Bublatzky, F (corresponding author), Univ Mannheim, Dept Psychol, Sch Social Sci, D-68131 Mannheim, Germany.	f.bublatzky@uni-mannheim.de	Bublatzky, Florian/F-7563-2017; Guerra, Pedro/ABH-1639-2020; Vila, Jaime/F-9719-2010; Pastor, M. Carmen/N-1692-2019; Guerra, Pedro/ABF-1291-2020; Bublatzky, Florian/J-6105-2019; Pastor, M. Carmen/H-7183-2015	Bublatzky, Florian/0000-0002-7726-0682; Guerra, Pedro/0000-0003-0614-629X; Vila, Jaime/0000-0002-1767-8606; Pastor, M. Carmen/0000-0001-9909-3646; Bublatzky, Florian/0000-0002-7726-0682; Pastor, M. Carmen/0000-0001-9909-3646	German Academic Exchange Service (DAAD); State Ministry for Education and Cultural Affairs of Baden-Wuerttemberg (LGFG); DFG [Schu 1074/11-2]; Junta de Andalucia, group [HUM-388]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); State Ministry for Education and Cultural Affairs of Baden-Wuerttemberg (LGFG); DFG(German Research Foundation (DFG)); Junta de Andalucia, group(Junta de Andalucia)	This work was supported in part by scholarships awarded to F. B. by the German Academic Exchange Service (DAAD) and by the State Ministry for Education and Cultural Affairs of Baden-Wuerttemberg (LGFG); a DFG grant Schu 1074/11-2; and the research group: Junta de Andalucia, group: HUM-388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein C, 2004, INT J PSYCHOPHYSIOL, V54, P231, DOI 10.1016/j.ijpsycho.2004.05.009; Balaban MT, 1986, PSYCHOPHYSIOLOGY, V23, P612; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2005, PSYCHOL SCI, V16, P468; Bublatzky F, 2012, SOC COGN AFFECT NEUR, V7, P611, DOI 10.1093/scan/nsr032; Bublatzky F, 2010, PSYCHOPHYSIOLOGY, V47, P687, DOI 10.1111/j.1469-8986.2010.00966.x; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Cook III EW, 2003, VPM REFERENCE MANUAL; Cornwell BR, 2007, NEUROIMAGE, V37, P282, DOI 10.1016/j.neuroimage.2007.04.055; Dichter GS, 2002, INT J PSYCHOPHYSIOL, V43, P191, DOI 10.1016/S0167-8760(01)00170-2; DOCHERTY NM, 1995, BIOL PSYCHIAT, V38, P68, DOI 10.1016/0006-3223(95)00074-Q; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Greenwald MK, 1998, BEHAV NEUROSCI, V112, P1069, DOI 10.1037/0735-7044.112.5.1069; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; GRILLON C, 1993, PSYCHOPHYSIOLOGY, V30, P340, DOI 10.1111/j.1469-8986.1993.tb02055.x; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; HAMM AO, 1993, J ABNORM PSYCHOL, V102, P453, DOI 10.1037/0021-843X.102.3.453; Hasler G, 2007, J NEUROSCI, V27, P6313, DOI 10.1523/JNEUROSCI.5369-06.2007; Junghofer M, 2005, NEUROIMAGE, V25, P520, DOI 10.1016/j.neuroimage.2004.12.011; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lang PJ, 2008, A6 U FLOR; Leite J, 2012, INT J PSYCHOPHYSIOL, V83, P375, DOI 10.1016/j.ijpsycho.2011.12.005; Lipp OV, 2001, J PSYCHOPHYSIOL, V15, P155, DOI 10.1027//0269-8803.15.3.155; Lissek S, 2007, BIOL PSYCHOL, V76, P124, DOI 10.1016/j.biopsycho.2007.07.002; Low A, 2008, PSYCHOL SCI, V19, P865, DOI 10.1111/j.1467-9280.2008.02170.x; Melzig CA, 2009, INT J PSYCHOPHYSIOL, V71, P109, DOI 10.1016/j.ijpsycho.2008.07.013; Nitschke JB, 2002, PSYCHOPHYSIOLOGY, V39, P254, DOI 10.1017/S004857720139217X; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Sabatinelli D, 2001, PSYCHOPHYSIOLOGY, V38, P719, DOI 10.1111/1469-8986.3840719; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Smith JC, 2006, EMOTION, V6, P208, DOI 10.1037/1528-3542.6.2.208; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2	40	33	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54003	10.1371/journal.pone.0054003	http://dx.doi.org/10.1371/journal.pone.0054003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342060	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700074
J	Pando, MA; Coloccini, RS; Reynaga, E; Fermepin, MR; Vaulet, LG; Kochel, TJ; Montano, SM; Avila, MM				Pando, Maria A.; Coloccini, Romina S.; Reynaga, Elena; Rodriguez Fermepin, Marcelo; Gallo Vaulet, Lucia; Kochel, Tadeusz J.; Montano, Silvia M.; Avila, Maria M.			Violence as a Barrier for HIV Prevention among Female Sex Workers in Argentina	PLOS ONE			English	Article							PARTNER VIOLENCE; CONDOM NEGOTIATION; PREVALENCE; RISK; HEALTH; WOMEN; PROSTITUTION; INFECTION; INTIMATE; IMPACT	Background: Violence against female sex workers (FSWs) has been increasingly reported as an important determinant of HIV infection risk. This study explores the frequency of different violent experiences (sexual abuse, rejection, beating and imprisonment) among FSWs in Argentina and its association with condom use and HIV and T. pallidum prevalence. Methods: A convenience sample of 1255 FSWs was included in a cross-sectional study conducted between October 2006 and November 2009. Results: Sexual abuse was reported by 24.1% (219/907) of women. A total of 34.7% (42/1234) reported rejection experiences, 21.9% (267/1215) reported having been beaten and 45.4% (561/1236) stated having been arrested because of their sex work activity. There was a higher frequency of inconsistent condom use with clients among FSWs who had experienced sexual abuse, rejection, and police detention. A higher frequency of HIV and T. pallidum infection was detected among FSWs who reported having been arrested by the police. Conclusion: The study shows for the first time the frequency of different violent situations among FSWs in Argentina. The association between violence against sex workers, condom use and STI prevalence demonstrated here calls for measures to reduce stigma and violence against FSWs. Such violent experiences may increase vulnerability to STI through coerced unprotected sex.	[Pando, Maria A.; Coloccini, Romina S.; Avila, Maria M.] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Pando, Maria A.; Coloccini, Romina S.; Avila, Maria M.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Reynaga, Elena] Asociac Mujeres Meretrices Argentina, AMMAR, Buenos Aires, DF, Argentina; [Rodriguez Fermepin, Marcelo; Gallo Vaulet, Lucia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Inmunol Clin, RA-1113 Buenos Aires, DF, Argentina; [Kochel, Tadeusz J.; Montano, Silvia M.] USN, Med Res Unit 6, Lima, Peru	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pando, MA (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	mpando@fmed.uba.ar	RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262	Global Fund [112]; Work Unit [62787A S17 H B0002]	Global Fund; Work Unit	This work was supported by Global Fund (Sub-project No112) and Work Unit Number 62787A S17 H B0002. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2001, LANCET, V358, P643, DOI 10.1016/S0140-6736(01)05819-6; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Carlson CE, 2012, J INTERPERS VIOLENCE, V27, P1911, DOI 10.1177/0886260511431439; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Pando MD, 2011, REV PANAM SALUD PUBL, V30, P303; Decker MR, 2012, SEX TRANSM INFECT, V88, P278, DOI 10.1136/sextrans-2011-050171; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Decker MR, 2009, INT J GYNECOL OBSTET, V107, P151, DOI 10.1016/j.ijgo.2009.06.002; Farley M, 1998, FEM PSYCHOL, V8, P405, DOI 10.1177/0959353598084002; Frye V, 2011, AIDS BEHAV, V15, P153, DOI 10.1007/s10461-009-9659-2; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Lang DL, 2012, AIDS BEHAV; Ministerio de Salud Presidencia de la Nacion, 2010, B HIV SID ARG; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Pontecorvo C, 2004, MEDICINA-BUENOS AIRE, V64, P492; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T., 2008, BMJ-BRIT MED J, V337/7669, P560; Schacht RL, 2010, ARCH SEX BEHAV, V39, P898, DOI 10.1007/s10508-009-9544-0; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Simic M, 2009, SOCIOL HEALTH ILL, V31, P1, DOI 10.1111/j.1467-9566.2008.01112.x; Swain SN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-357; Swan H, 2012, J INTERPERS VIOLENCE, V27, P775, DOI 10.1177/0886260511423240; UNAIDS, 2002, SEX WORK HIV AIDS; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2007, 3 MIL GLOB CAMP VIOL; World Health Organization, 2005, WHO INF B SER, V3; Zhang C, 2012, AIDS BEHAV, V16, P1020, DOI 10.1007/s10461-011-9968-0	31	55	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54147	10.1371/journal.pone.0054147	http://dx.doi.org/10.1371/journal.pone.0054147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342092	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700090
J	Watanabe, S; Sanuki, R; Ueno, S; Koyasu, T; Hasegawa, T; Furukawa, T				Watanabe, Satoshi; Sanuki, Rikako; Ueno, Shinji; Koyasu, Toshiyuki; Hasegawa, Toshiaki; Furukawa, Takahisa			Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders	PLOS ONE			English	Article							CELL FATE DETERMINATION; CONE-ROD DYSTROPHY; HOMEOBOX GENE; NEURAL RETINA; CRX; TRANSDUCTION; EXPRESSION; MUTATIONS; PROTEIN; MICE	Background: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer into the mammalian retina. This virus is promising not only for gene therapy of retinal diseases, but also for in vivo functional analysis of retinal genes. Previous reports have shown that AAV can infect various cell types in the developing mouse retina. However, AAV tropism in the developing retina has not yet been examined in detail. Methodology/Principal Findings: We subretinally delivered seven AAV serotypes (AAV2/1, 2/2, 2/5, 2/8, 2/9, 2/10, and 2/11) of AAV-CAG-mCherry into P0 mouse retinas, and quantitatively evaluated the tropisms of each serotype by its infecting degree in retinal cells. After subretinal injection of AAV into postnatal day 0 (P0) mouse retinas, various retinal cell types were efficiently transduced with different AAVs. Photoreceptor cells were efficiently transduced with AAV2/5. Retinal cells, except for bipolar and Muller glial cells, were efficiently transduced with AAV2/9. Horizontal and/or ganglion cells were efficiently transduced with AAV2/1, AAV2/2, AAV2/8, AAV2/9 and AAV2/10. To confirm the usefulness of AAV-mediated gene transfer into the P0 mouse retina, we performed AAV-mediated rescue of the Cone-rod homeobox gene knockout (Crx KO) mouse, which exhibits an outer segment formation defect, flat electroretinogram (ERG) responses, and photoreceptor degeneration. We injected an AAV expressing Crx under the control of the Crx 2kb promoter into the neonatal Crx KO retina. We showed that AAV mediated-Crx expression significantly decreased the abnormalities of the Crx KO retina. Conclusion/Significance: In the current study, we report suitable AAV tropisms for delivery into the developing mouse retina. Using AAV2/5 in photoreceptor cells, we demonstrated the possibility of gene replacement for the developmental disorder and subsequent degeneration of retinal photoreceptors caused by the absence of Crx.	[Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] CREST, JST, Suita, Osaka, Japan; [Watanabe, Satoshi; Sanuki, Rikako; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka 565, Japan; [Watanabe, Satoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Ueno, Shinji; Koyasu, Toshiyuki] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Hasegawa, Toshiaki] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Kyoto University; Nagoya University; Osaka University	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp	Ueno, Shinji/M-5063-2014; Sanuki, Rikako/AAV-7143-2021	Sanuki, Rikako/0000-0001-9862-9840; Watanabe, Satoshi/0000-0002-8129-6223	CREST; Japan Science and Technology Agency; Molecular Brain Science; Ministry of Education, Culture, Sports and Technology of Japan [20390087, 24700360]; The Takeda Science Foundation; The Uehara Memorial Foundation; Novartis Foundation [20-10]; The Naito Foundation; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation; Research Foundation for Opto-Science and Technology	CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Molecular Brain Science; Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Takeda Science Foundation(Takeda Science Foundation (TSF)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); The Naito Foundation; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation; Research Foundation for Opto-Science and Technology	This work was supported by CREST and from Japan Science and Technology Agency (http://www.jst.go.jp), a grant for Molecular Brain Science, Grants-in-Aid for Scientific Research on Priority Areas, and Grant-in-Aid for Scientific Research (B) (#20390087), Young Scientists (B) (#24700360) from the Ministry of Education, Culture, Sports and Technology of Japan (http://www.jsps.go.jp/), The Takeda Science Foundation (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (http://www.ueharazaidan.com/), Novartis Foundation (#20-10, http://novartisfound.or.jp/), The Naito Foundation (http://www.naito-f.or.jp/), Senri Life Science Foundation (#S-2144, http://www.senri-life.or.jp/), Kato Memorial Bioscience Foundation (http://www.katokinen.or.jp/), Daiichi-Sankyo Foundation of Life Science; Japanese Retinitis Pigmentosa Society Foundation, and Research Foundation for Opto-Science and Technology (http://www.jrps.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; de Melo J, 2011, J VIS EXP, V52; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Giove TJ, 2010, EXP EYE RES, V91, P652, DOI 10.1016/j.exer.2010.08.011; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mori S, 2004, VIROLOGY, V330, P375, DOI 10.1016/j.virol.2004.10.012; Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Surace EM, 2003, J VIROL, V77, P7957, DOI 10.1128/JVI.77.14.7957-7963.2003; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7	29	37	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54146	10.1371/journal.pone.0054146	http://dx.doi.org/10.1371/journal.pone.0054146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335994	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700052
J	Marchetti, M; Onorati, F; Matteucci, M; Mainardi, L; Piccione, F; Silvoni, S; Priftis, K				Marchetti, Mauro; Onorati, Francesco; Matteucci, Matteo; Mainardi, Luca; Piccione, Francesco; Silvoni, Stefano; Priftis, Konstantinos			Improving the Efficacy of ERP-Based BCIs Using Different Modalities of Covert Visuospatial Attention and a Genetic Algorithm-Based Classifier	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MENTAL PROSTHESIS; COMMUNICATION; SYSTEM	We investigated whether the covert orienting of visuospatial attention can be effectively used in a brain-computer interface guided by event-related potentials. Three visual interfaces were tested: one interface that activated voluntary orienting of visuospatial attention and two interfaces that elicited automatic orienting of visuospatial attention. We used two epoch classification procedures. The online epoch classification was performed via Independent Component Analysis, and then it was followed by fixed features extraction and support vector machines classification. The offline epoch classification was performed by means of a genetic algorithm that permitted us to retrieve the relevant features of the signal, and then to categorise the features with a logistic classifier. The offline classification, but not the online one, allowed us to differentiate between the performances of the interface that required voluntary orienting of visuospatial attention and those that required automatic orienting of visuospatial attention. The offline classification revealed an advantage of the participants in using the "voluntary" interface. This advantage was further supported, for the first time, by neurophysiological data. Moreover, epoch analysis was performed better with the "genetic algorithm classifier" than with the "independent component analysis classifier". We suggest that the combined use of voluntary orienting of visuospatial attention and of a classifier that permits feature extraction ad personam (i.e., genetic algorithm classifier) can lead to a more efficient control of visual BCIs.	[Marchetti, Mauro; Priftis, Konstantinos] Univ Padua, Dept Gen Psychol, Padua, Italy; [Onorati, Francesco] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy; [Matteucci, Matteo; Mainardi, Luca] Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy; [Piccione, Francesco; Silvoni, Stefano] IRCCS San Camillo Hosp, Dept Neurophysiol, Venice, Italy; [Priftis, Konstantinos] IRCCS San Camillo Hosp, Neuropsychol Lab, Venice, Italy	University of Padua; Polytechnic University of Milan; Polytechnic University of Milan; IRCCS Ospedale San Camillo; IRCCS Ospedale San Camillo	Priftis, K (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	konstantinos.priftis@unipd.it	MAINARDI, LUCA/CAG-8179-2022; Onorati, Francesco/U-8336-2019; Onorati, Francesco/J-4279-2018; Priftis, Konstantinos/B-7862-2008; Piccione, Francesco/K-7214-2016	Onorati, Francesco/0000-0002-0879-3557; Priftis, Konstantinos/0000-0002-5215-4621; Piccione, Francesco/0000-0002-0173-903X; Mainardi, Luca/0000-0002-6276-6314; Marchetti, Mauro/0000-0002-8474-2874				Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Beverina F, 2004, PSYCHNOLOGY J, V1, P331; Bianchi L, 2007, IEEE T NEUR SYS REH, V15, P207, DOI 10.1109/TNSRE.2007.897024; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Boostani R, 2007, MED BIOL ENG COMPUT, V45, P403, DOI 10.1007/s11517-007-0169-y; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Citi L, 2004, LAT BREAK GEN EV COM; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; Cover T. M., 1991, ELEMENTS INFORM THEO; Dal Seno Bernardo, 2010, Computational Intelligence & Neuroscience, DOI 10.1155/2010/307254; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Dal Seno B, 2008, IEEE IJCNN, P3145, DOI 10.1109/IJCNN.2008.4634243; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goldberg D. E., 1989, COMPLEX SYST, V3, P493, DOI DOI 10.1007/978-1-4757-3643-4; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Holland J.H., 1975, ADAPTATION NATURAL A; Jung JP, 1998, ADV NEURAL INFORM PR, V10, P894; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Karjalainen PA, 1999, IEEE T BIO-MED ENG, V46, P849, DOI 10.1109/10.771195; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; KUBLER A, 2001, BRAIN COMPUTER COMMU, V127, P358, DOI DOI 10.1037//0033-2909.127.3.358; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li YQ, 2011, INT J HUM-COMPUT INT, V27, P52, DOI 10.1080/10447318.2011.535753; Liu Y, 2011, CLIN NEUROPHYSIOL, V122, P1127, DOI 10.1016/j.clinph.2010.10.049; Luck S.J., 2005, INTRO EVENT RELATED; Marchetti M, 2012, CLIN NEUROPHYSIOL, V123, P774, DOI 10.1016/j.clinph.2011.07.045; Miceli G, 1994, BATTERIA PER ANALISI; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Rastjoo A, 2009, STUD HEALTH TECHNOL, V142, P265, DOI 10.3233/978-1-58603-964-6-265; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.001.2009; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; STONE M, 1974, BIOMETRIKA, V61, P509, DOI 10.1093/biomet/61.3.509; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang T, 2004, CLIN NEUROPHYSIOL, V115, P2744, DOI 10.1016/j.clinph.2004.06.022; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wright R.D, 2008, ORIENTING ATTENTION	59	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53946	10.1371/journal.pone.0053946	http://dx.doi.org/10.1371/journal.pone.0053946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342043	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400103
J	Quignot, N; Bois, FY				Quignot, Nadia; Bois, Frederic Y.			A Computational Model to Predict Rat Ovarian Steroid Secretion from In Vitro Experiments with Endocrine Disruptors	PLOS ONE			English	Article							GRAPHICAL SYSTEMS-MODEL; ESTROGEN-RECEPTOR-ALPHA; PITUITARY-GONADAL AXIS; AROMATASE INHIBITORS; GENE-EXPRESSION; ESTRADIOL; METHOXYCHLOR; STIMULATION; VINCLOZOLIN; CHEMICALS	A finely tuned balance between estrogens and androgens controls reproductive functions, and the last step of steroidogenesis plays a key role in maintaining that balance. Environmental toxicants are a serious health concern, and numerous studies have been devoted to studying the effects of endocrine disrupting chemicals (EDCs). The effects of EDCs on steroidogenic enzymes may influence steroid secretion and thus lead to reproductive toxicity. To predict hormonal balance disruption on the basis of data on aromatase activity and mRNA level modulation obtained in vitro on granulosa cells, we developed a mathematical model for the last gonadal steps of the sex steroid synthesis pathway. The model can simulate the ovarian synthesis and secretion of estrone, estradiol, androstenedione, and testosterone, and their response to endocrine disruption. The model is able to predict ovarian sex steroid concentrations under normal estrous cycle in female rat, and ovarian estradiol concentrations in adult female rats exposed to atrazine, bisphenol A, metabolites of methoxychlor or vinclozolin, and letrozole.	[Quignot, Nadia; Bois, Frederic Y.] Univ Technol Compiegne, Bioengn Dept, Chair Math Modeling Syst Toxicol, Compiegne, France; [Quignot, Nadia; Bois, Frederic Y.] Inst Natl Environm Ind & Risques, Verneuil En Halatte, France	Picardie Universites; Universite de Technologie de Compiegne; Institut National de l'Environnement Industriel et des Risques (INERIS)	Quignot, N (corresponding author), Univ Technol Compiegne, Bioengn Dept, Chair Math Modeling Syst Toxicol, Compiegne, France.	nadia.quignot@utc.fr	Quignot, Nadia/D-1914-2016; Bois, Frédéric/T-1954-2019; Bois, Frederic/E-9241-2012	Bois, Frédéric/0000-0002-4154-0391; Bois, Frederic/0000-0002-4154-0391; Quignot, Nadia/0000-0001-8718-1307	French Ministry of the Environment and Sustainable Development [P189-DYSHORMO]	French Ministry of the Environment and Sustainable Development	This work was supported by a grant [P189-DYSHORMO] to the National Institute of Industrial Environment and Risks from the French Ministry of the Environment and Sustainable Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinola LA, 1996, ENDOCRINOLOGY, V137, P1572, DOI 10.1210/en.137.5.1572; Andersen ME, 2005, REPROD TOXICOL, V19, P327, DOI 10.1016/j.reprotox.2004.12.004; Andersen ME, 1997, J TOXICOL ENV HEALTH, V52, P189, DOI 10.1080/009841097159656; Auvray P, 2002, EUR J BIOCHEM, V269, P1393, DOI 10.1046/j.1432-1033.2002.02779.x; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Bois FY, 2009, BIOINFORMATICS, V25, P1453, DOI 10.1093/bioinformatics/btp162; Breen MS, 2007, ANN BIOMED ENG, V35, P970, DOI 10.1007/s10439-007-9309-7; Breen MS, 2010, ENVIRON HEALTH PERSP, V118, P265, DOI 10.1289/ehp.0901107; Charles GD, 2004, ILAR J, V45, P494, DOI 10.1093/ilar.45.4.494; Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899; EPA, 2007, INT SUMM REP AROM; Fan W, 2007, BIOCHEM BIOPH RES CO, V355, P1012, DOI 10.1016/j.bbrc.2007.02.062; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gaido KW, 2000, MOL PHARMACOL, V58, P852, DOI 10.1124/mol.58.4.852; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gordon A, 2009, REPRODUCTION, V137, P151, DOI 10.1530/REP-08-0318; Harada N, 1999, ENDOCR-RELAT CANCER, V6, P211, DOI 10.1677/erc.0.0060211; HARGROVE JL, 1993, FASEB J, V7, P1163, DOI 10.1096/fasebj.7.12.8375615; HARGROVE JL, 1993, BIOTECHNIQUES, V15, P1096; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Holloway AC, 2008, J APPL TOXICOL, V28, P260, DOI 10.1002/jat.1275; Holme JA, 2002, TOXICOL LETT, V127, P135, DOI 10.1016/S0378-4274(01)00493-3; Ishikura S, 2006, J BIOCHEM, V139, P1053, DOI 10.1093/jb/mvj109; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; KREKELS M D W G, 1990, Steroids, V55, P69, DOI 10.1016/0039-128X(90)90027-9; LEPHART ED, 1992, MOL CELL ENDOCRINOL, V85, P205, DOI 10.1016/0303-7207(92)90259-9; Li ZH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-63; Liebermeister W, 2005, IEE P SYST BIOL, V152, P97, DOI 10.1049/ip-syb:20045033; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Maranghi F, 2012, REPROD TOXICOL, V33, P290, DOI 10.1016/j.reprotox.2012.01.009; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Molina-Molina JM, 2006, TOXICOL APPL PHARM, V216, P44, DOI 10.1016/j.taap.2006.04.005; Odum J, 2002, TOXICOL LETT, V129, P119, DOI 10.1016/S0378-4274(01)00521-5; Odum J, 2001, TOXICOL LETT, V118, P165, DOI 10.1016/S0378-4274(00)00293-9; Petkov PI, 2009, SAR QSAR ENVIRON RES, V20, P657, DOI 10.1080/10629360903438347; Plowchalk DR, 2002, TOXICOL SCI, V69, P60, DOI 10.1093/toxsci/69.1.60; Quignot N, 2012, ANAL BIOANAL CHEM, V403, P1629, DOI 10.1007/s00216-012-5990-y; Quignot N, 2012, REPROD TOXICOL, V33, P339, DOI 10.1016/j.reprotox.2012.01.004; Quignot N, 2012, TOXICOL IN VITRO, V26, P107, DOI 10.1016/j.tiv.2011.11.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RENWICK AGC, 1981, J BIOL CHEM, V256, P1881; Sandhoff TW, 1996, ENDOCRINE, V4, P259, DOI 10.1007/BF02738692; Sinha S, 1998, BREAST CANCER RES TR, V48, P45, DOI 10.1023/A:1005937900788; Soffker M, 2012, CRIT REV TOXICOL, V42, P653, DOI 10.3109/10408444.2012.692114; Steckelbroeck S, 2003, J STEROID BIOCHEM, V86, P79, DOI 10.1016/S0960-0760(03)00251-6; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stokes WS, 2004, ILAR J, V45, P387, DOI 10.1093/ilar.45.4.387; Villeneuve DL, 2007, ENVIRON SCI TECHNOL, V41, P321, DOI 10.1021/es061739x; Villeneuve DL, 2012, MUTAT RES-GEN TOX EN, V746, P151, DOI 10.1016/j.mrgentox.2011.12.016; WANG C, 1981, MOL CELL ENDOCRINOL, V24, P17, DOI 10.1016/0303-7207(81)90075-7; Watanabe KH, 2009, TOXICOL SCI, V109, P180, DOI 10.1093/toxsci/kfp069; Zheng XF, 2008, REPRODUCTION, V136, P447, DOI 10.1530/REP-07-0316	54	10	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53891	10.1371/journal.pone.0053891	http://dx.doi.org/10.1371/journal.pone.0053891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326527	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800083
J	Cheng, Y; Huang, LZ; Li, XX; Zhou, P; Zeng, WT; Zhang, CF				Cheng, Yong; Huang, LvZhen; Li, Xiaoxin; Zhou, Peng; Zeng, Wotan; Zhang, ChunFang			Genetic and Functional Dissection of ARMS2 in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; MESSENGER-RNA EXPRESSION; BEAVER DAM EYE; EXTENDED FAMILIES; CHROMOSOME 10Q26; GENOMEWIDE-SCAN; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; VISUAL IMPAIRMENT; LINKAGE ANALYSIS	Age-related maculopathy susceptibility 2(ARMS2) was suggested to be associated with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) in multiple genetic studies in Caucasians and Japanese. To date, no biological properties have been attributed to the putative protein in nAMD and PCV. The complete genes of ARMS2 and HTRA1 including all exons and the promoter region were assessed using direct sequencing technology in 284 unrelated mainland northern Chinese individuals: 96 nAMD patients, 92 PCV patients and 96 controls. Significant associations with both nAMD and PCV were observed in 2 polymorphisms of ARMS2 and HTRA1 rs11200638, with different genotypic distributions between nAMD and PCV (p<0.001). After adjusting for rs11200638, ARMS2 rs10490924 remained significantly associated with nAMD and PCV (p<0.001). Then we overexpressed wild-type ARMS2 and ARMS2 A69S mutation (rs10490924) in RF/6A cells and RPE cells as in vitro study model. Cell proliferation, attachment, migration and tube formation were analyzed for the first time. Compare with wild-type ARMS2, A69S mutation resulted in a significant increase in proliferation and attachment but inhibited cell migration. Moreover, neither wild-type ARMS2 nor A69S mutation affected tube formation of RF/6A cells. There is a strong and consistent association of the ARMS2/HTRA1 locus with both nAMD and PCV, suggesting the two disorders share, at least partially, similar molecular mechanisms. Neither wild-type ARMS2 nor A69S mutation had direct association with neovascularisation in the pathogenesis of AMD.	[Cheng, Yong; Huang, LvZhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Cheng, Yong; Huang, LvZhen; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Zhou, Peng] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Zeng, Wotan] Chinese Natl Human Genome Ctr, Beijing, Peoples R China; [Zhang, ChunFang] Peking Univ, Peoples Hosp, Dept Clin Epidemiol, Beijing 100871, Peoples R China	Peking University; Fudan University; Peking University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com			National Basic Research Program of China (973 Program) [2011CB510200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Research supported by the National Basic Research Program of China (973 Program; #2011CB510200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Barral S, 2006, INVEST OPHTH VIS SCI, V47, P5453, DOI 10.1167/iovs.06-0655; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Chen Y, 2008, GRAEF ARCH CLIN EXP, V246, P373, DOI 10.1007/s00417-007-0728-9; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Gotoh N, 2008, CLIN EXP OPHTHALMOL, V36, P437, DOI 10.1111/j.1442-9071.2008.01791.x; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Hadley D, 2010, INVEST OPHTH VIS SCI, V51, P2191, DOI 10.1167/iovs.09-3798; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hauswirth WW, 2000, INVEST OPHTH VIS SCI, V41, P2821; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Huang LZ, 2009, MOL VIS, V15, P1057; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kanda A, 2010, MOL VIS, V16, P1317; Kenealy SJ, 2004, MOL VIS, V10, P57; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein ML, 2010, OPHTHALMOLOGY, V117, P1554, DOI 10.1016/j.ophtha.2009.12.012; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Liang XY, 2012, INVEST OPHTH VIS SCI, V53, P3175, DOI 10.1167/iovs.11-8135; Lima LH, 2010, OPHTHALMOLOGY, V117, P1567, DOI 10.1016/j.ophtha.2009.12.018; Liu Ning-pu, 2009, Zhonghua Yan Ke Za Zhi, V45, P393; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Meyers S M, 1994, Trans Am Ophthalmol Soc, V92, P775; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sayen Alexandra, 2011, Rev Prat, V61, P159; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schmidt S, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-18; Scholl HPN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007418; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Shen WY, 2003, J GENE MED, V5, P576, DOI 10.1002/jgm.375; Wang GF, 2010, HUM GENET, V127, P595, DOI 10.1007/s00439-010-0805-8; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi Lawrence A, 2012, Retina, V32 Suppl 1, P1; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang TH, 2009, OPHTHALMIC RES, V41, P36, DOI 10.1159/000163220; Zhou P, 2007, CURR EYE RES, V32, P973, DOI 10.1080/02713680701658323	61	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53665	10.1371/journal.pone.0053665	http://dx.doi.org/10.1371/journal.pone.0053665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326481	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500090
J	Wang, P; Ning, SW; Wang, QH; Li, RH; Ye, JR; Zhao, ZXL; Li, Y; Huang, T; Li, X				Wang, Peng; Ning, Shangwei; Wang, Qianghu; Li, Ronghong; Ye, Jingrun; Zhao, Zuxianglan; Li, Yan; Huang, Teng; Li, Xia			mirTarPri: Improved Prioritization of MicroRNA Targets through Incorporation of Functional Genomics Data	PLOS ONE			English	Article							GENE-EXPRESSION; REGULATORY MODULES; PREDICTION; PROTEIN; IDENTIFICATION; INTERACTOME; MIRNA; TRANSCRIPTOME; TOOL; MAP	MicroRNAs (miRNAs) are a class of small (19-25 nt) non-coding RNAs. This important class of gene regulator downregulates gene expression through sequence-specific binding to the 3'untranslated regions (3'UTRs) of target mRNAs. Several computational target prediction approaches have been developed for predicting miRNA targets. However, the predicted target lists often have high false positive rates. To construct a workable target list for subsequent experimental studies, we need novel approaches to properly rank the candidate targets from traditional methods. We performed a systematic analysis of experimentally validated miRNA targets using functional genomics data, and found significant functional associations between genes that were targeted by the same miRNA. Based on this finding, we developed a miRNA target prioritization method named mirTarPri to rank the predicted target lists from commonly used target prediction methods. Leave-one-out cross validation has proved to be successful in identifying known targets, achieving an AUC score up to 0.84. Validation in high-throughput data proved that mirTarPri was an unbiased method. Applying mirTarPri to prioritize results of six commonly used target prediction methods allowed us to find more positive targets at the top of the prioritized candidate list. In comparison with other methods, mirTarPri had an outstanding performance in gold standard and CLIP data. mirTarPri was a valuable method to improve the efficacy of current miRNA target prediction methods. We have also developed a web-based server for implementing mirTarPri method, which is freely accessible at http://bioinfo.hrbmu.edu.cn/mirTarPri.	[Wang, Peng; Ning, Shangwei; Wang, Qianghu; Li, Ronghong; Ye, Jingrun; Zhao, Zuxianglan; Li, Yan; Huang, Teng; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022; Ye, jingrun/GSJ-2822-2022		National Natural Science Foundation of China [31100948, 61073136, 91129710, 61170154]; National Science Foundation of Heilongjiang Province [D201114, QC2009C23]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31100948, 61073136, 91129710 and 61170154), National Science Foundation of Heilongjiang Province (Grant Nos. D201114, QC2009C23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Artmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Corrada D, 2011, BRIEF BIOINFORM, V12, P588, DOI 10.1093/bib/bbr062; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Enright AJ, 2004, GENOME BIOL, V5; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang J C, 2008, Pac Symp Biocomput, P52; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li X, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr770; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lv SL, 2012, J R SOC INTERFACE, V9, P1063, DOI 10.1098/rsif.2011.0551; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127	63	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53685	10.1371/journal.pone.0053685	http://dx.doi.org/10.1371/journal.pone.0053685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326485	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500092
J	Grimm, JW; Weber, R; Barnes, J; Koerber, J; Dorsey, K; Glueck, E				Grimm, Jeffrey W.; Weber, Rachel; Barnes, Jesse; Koerber, Jon; Dorsey, Kylan; Glueck, Edwin			Brief Exposure to Novel or Enriched Environments Reduces Sucrose Cue-Reactivity and Consumption in Rats after 1 or 30 Days of Forced Abstinence from Self-Administration	PLOS ONE			English	Article							DRUG-ADDICTION; ORBITOFRONTAL CORTEX; COCAINE-SEEKING; FEMALE RATS; REINSTATEMENT; BEHAVIOR; OBESITY; AMPHETAMINE; INCUBATION; ALCOHOL	Environmental enrichment (EE) reduces drug and sucrose cue-reactivity in rats. In a previous study we reported that 1 month of EE (large cage, toys, and social cohorts) significantly reduced sucrose cue-reactivity. In the present study, we examined whether overnight (22 h) EE would be as effective. We also examined whether social enrichment (SE), enrichment alone (SoloEE), or exposure to an alternative environment (AEnv) might account for the EE effect. Rats self-administered 10% sucrose (.2 mL/delivery) in 10 daily 2-h sessions. Sucrose delivery was accompanied by a tone+light cue. Rats were then exposed to enrichment or alternative environment conditions overnight (acute) or for 29 days (chronic). Sucrose cue-reactivity was measured after this period of forced abstinence in a session identical to training, but no sucrose was delivered with the cue. All acute conditions markedly reduced sucrose cue-reactivity after 1 day of forced abstinence compared to single-housed rats in standard vivarium housing (CON). Sucrose consumption was also significantly reduced in all groups but SoloEE in a next-day test. All acute conditions but SE significantly reduced sucrose cue-reactivity when administered just prior to Day 30 of forced abstinence; all reduced sucrose consumption in a next-day test. All chronic conditions except for SE and AEnv significantly reduced sucrose cue-reactivity on the Day 30 test and sucrose consumption in a next day test. For both acute and chronic comparisons, EE manipulations were the most effective at reducing sucrose cue-reactivity and consumption. SoloEE and EE were equally effective at reducing sucrose cue-reactivity and similarly effective at reducing sucrose consumption. This indicates that social interaction is not a necessary condition for reducing sucrose-motivated behaviors. These results may be useful in the development of anti-relapse strategies for drug and food addictions.	[Grimm, Jeffrey W.] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; Western Washington Univ, Program Behav Neurosci, Bellingham, WA 98225 USA	Western Washington University; Western Washington University	Grimm, JW (corresponding author), Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA.	jeff.grimm@wwu.edu			NIH [R15 DA016285-03]; Western Washington University Biomedical Research Activities in Neuroscience Initiative; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA016285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western Washington University Biomedical Research Activities in Neuroscience Initiative; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH Grant R15 DA016285-03 and the Western Washington University Biomedical Research Activities in Neuroscience Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278; Brenes JC, 2008, NEUROSCI LETT, V436, P278, DOI 10.1016/j.neulet.2008.03.045; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Chauvet C, 2012, NEUROPHARMACOLOGY, V63, P635, DOI 10.1016/j.neuropharm.2012.05.014; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; De Alba I, 2004, AM J ADDICTION, V13, P33, DOI 10.1080/10550490490265307; Deehan GA, 2011, BEHAV NEUROSCI, V125, P184, DOI 10.1037/a0022627; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gill MJ, 2011, BEHAV PHARMACOL, V22, P40, DOI 10.1097/FBP.0b013e3283425a86; Gipson CD, 2011, PSYCHOPHARMACOLOGY, V214, P557, DOI 10.1007/s00213-010-2060-z; Grimm J. W., 2012, FOOD ADDICTION, P214; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2011, JOVE-J VIS EXP, DOI 10.3791/3335; Harkness JH, 2010, PSYCHOPHARMACOLOGY, V208, P521, DOI 10.1007/s00213-009-1755-5; Klebaur JE, 2001, EXP CLIN PSYCHOPHARM, V9, P372, DOI 10.1037/1064-1297.9.4.372; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Mar AC, 2011, J NEUROSCI, V31, P6398, DOI 10.1523/JNEUROSCI.6620-10.2011; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Puhl MD, 2012, BEHAV PHARMACOL, V23, P43, DOI 10.1097/FBP.0b013e32834eb060; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P289, DOI 10.1901/jeab.1961.4-289; Shahan TA, 2011, J EXP ANAL BEHAV, V95, P91, DOI 10.1901/jeab.2011.95-91; Smith MA, 2009, BEHAV PHARMACOL, V20, P312, DOI 10.1097/FBP.0b013e32832ec568; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Thiel KJ, 2010, NEUROSCIENCE, V171, P1187, DOI 10.1016/j.neuroscience.2010.10.001; Thiel KJ, 2012, ADDICT BIOL, V17, P365, DOI 10.1111/j.1369-1600.2011.00358.x; Thiel KJ, 2011, PHARMACOL BIOCHEM BE, V97, P595, DOI 10.1016/j.pbb.2010.09.014; Thiel KJ, 2009, INT J NEUROPSYCHOPH, V12, P1151, DOI 10.1017/S1461145709990472; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wood DA, 2006, PHYSIOL BEHAV, V88, P132, DOI 10.1016/j.physbeh.2006.03.024; Wood DA, 2009, BRAIN RES, V1259, P59, DOI 10.1016/j.brainres.2008.12.038; Zlebnik NE, 2010, PSYCHOPHARMACOLOGY, V209, P113, DOI 10.1007/s00213-010-1776-0	37	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54164	10.1371/journal.pone.0054164	http://dx.doi.org/10.1371/journal.pone.0054164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342096	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700092
J	Moore, XL; Michell, D; Lee, S; Skilton, MR; Nair, R; Dixon, JB; Dart, AM; Chin-Dusting, J				Moore, Xiao L.; Michell, Danielle; Lee, Sabrina; Skilton, Michael R.; Nair, Rajesh; Dixon, John B.; Dart, Anthony M.; Chin-Dusting, Jaye			Increased Carotid Intima-Media Thickness and Reduced Distensibility in Human Class III Obesity: Independent and Differential Influences of Adiposity and Blood Pressure on the Vasculature	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; ABDOMINAL OBESITY; RISK; MICROPARTICLES; HEALTHY; IMPACT; ATHEROSCLEROSIS; DYSFUNCTION	Carotid intima-media-thickness (cIMT) and carotid distensibility (distensibility), structural and functional properties of carotid arteries respectively, are early markers, as well as strong predictors of cardiovascular disease (CVD). The characteristic of these two parameters in individuals with BMI>40.0 kg/m(2) (Class III obesity), however, are largely unknown. The present study was designed to document cIMT and distensibility in this population and to relate these to other factors with established association with CVD in obesity. The study included 96 subjects (65 with BMI>40.0 kg/m(2) and 31, age- and gender-matched, with BMI of 18.5 to 30.0 kg/m(2)). cIMT and distensibility were measured by non-invasive high resolution ultrasonography, circulatory CD133(+)/KDR+ angiogenic cells and endothelial microparticles (EMP) by flow cytometry, and plasma levels of adipokines, growth factors and cytokines by Luminex immunoassay kits. The study results demonstrated increased cIMT (0.62 +/- 0.11 mm vs. 0.54 +/- 0.08 mm, P = 0.0002) and reduced distensibility (22.52 +/- 10.79 10(-3) kpa(-1) vs. 29.91 +/- 12.37 10(-3) kpa(-1), P<0.05) in individuals with BMI>40.0 kg/m(2). Both cIMT and distensibility were significantly associated with traditional CVD risk factors, adiposity/adipokines and inflammatory markers but had no association with circulating angiogenic cells. We also demonstrated, for the first time, elevated plasma EMP levels in individuals with BMI>40.0 kg/m(2). In conclusion, cIMT is increased and distensibility reduced in Class III obesity with the changes predominantly related to conventional CVD risk factors present in this condition, demonstrating that both cIMT and distensibility remain as CVD markers in Class III obesity.	[Moore, Xiao L.; Michell, Danielle; Lee, Sabrina; Nair, Rajesh; Dixon, John B.; Dart, Anthony M.; Chin-Dusting, Jaye] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Skilton, Michael R.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Dixon, John B.] Monash Univ, Dept Gen Practise, Obes Res Unit, Clayton, Vic, Australia; [Nair, Rajesh; Dart, Anthony M.] Alfred Hosp, Alfred Heart Ctr, Prahran, Vic 3181, Australia	Baker Heart and Diabetes Institute; University of Sydney; Monash University; Florey Institute of Neuroscience & Mental Health	Dart, AM (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	A.Dart@alfred.org.au	Michell, Danielle/D-9367-2013; Dixon, John B/A-5318-2011; Dart, Anthony/E-7461-2010	Dixon, John B/0000-0001-5391-4082; Dart, Anthony/0000-0003-1360-3778; Lee, Poay Sian Sabrina/0000-0002-4660-514X; Skilton, Michael/0000-0003-2793-2388	National Heart Foundation of Australia [APP1012003]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia	National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Heart Foundation of Australia Project Grant (APP1012003) and in part by the Victorian Government's Operational Infrastructure Support Program. MRS is a National Health and Medical Research Council of Australia (NHMRC) Career Development Fellow. AMD, JCD and JBD are NHMRC Fellows. Funding also provided by National Heart Foundation of Australia: http://www.heartfoundation.org.au/Pages/default.aspx, Victorian Government's Operational Infrastructure Support Program: http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program and National Health and Medical Research Council of Australia: http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows CF, 2011, OBESITY, V19, P1722, DOI 10.1038/oby.2010.347; Blaha MJ, 2009, HYPERTENSION, V54, P1408, DOI 10.1161/HYPERTENSIONAHA.109.138396; Burke GL, 2008, ARCH INTERN MED, V168, P928, DOI 10.1001/archinte.168.9.928; Cheriyath P, 2010, EUR J CARDIOV PREV R, V17, P309, DOI 10.1097/HJR.0b013e32833189b8; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Clement K, 2007, J INTERN MED, V262, P422, DOI 10.1111/j.1365-2796.2007.01851.x; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Elkiran O, 2011, INT J CARDIOL; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Esposito K, 2006, J CLIN ENDOCR METAB, V91, P3676, DOI 10.1210/jc.2006-0851; Feng B, 2010, ATHEROSCLEROSIS, V208, P264, DOI 10.1016/j.atherosclerosis.2009.06.037; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Fonseca Vivian A, 2005, Clin Cornerstone, V7, P61, DOI 10.1016/S1098-3597(05)80069-9; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Harloff A, 2006, STROKE, V37, P2708, DOI 10.1161/01.STR.0000244763.19013.dc; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556; Ketel IJ, 2010, J CLIN ENDOCR METAB, V95, P4566, DOI 10.1210/jc.2010-0868; Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Liang YL, 1998, CLIN SCI, V95, P669, DOI 10.1042/cs0950669; Loehr LR, 2009, CIRC-HEART FAIL, V2, P18, DOI 10.1161/CIRCHEARTFAILURE.108.813782; Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015; Montes M, 2006, J IMMUNOL METHODS, V317, P45, DOI 10.1016/j.jim.2006.09.013; Muller-Ehmsen J, 2008, EUR HEART J, V29, P1560, DOI 10.1093/eurheartj/ehn213; Noon JP, 2008, J CLIN NURS, V17, P2311, DOI 10.1111/j.1365-2702.2007.02155.x; Nozaki T, 2010, EUR J HEART FAIL, V12, P1223, DOI 10.1093/eurjhf/hfq145; Peralta CA, 2010, AM J EPIDEMIOL, V171, P63, DOI 10.1093/aje/kwp319; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Recio-Rodriguez JI, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-3; Rosendorff Clive, 2007, J Clin Hypertens (Greenwich), V9, P790; Rustemeyer P, 2007, J IMMUNOASS IMMUNOCH, V28, P13, DOI 10.1080/15321810601025549; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Skilton MR, 2008, DIABETES OBES METAB, V10, P874, DOI 10.1111/j.1463-1326.2007.00817.x; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Sturm W, 2009, OBESITY, V17, P1783, DOI 10.1038/oby.2009.81; Tentolouris N, 2003, EUR J CLIN INVEST, V33, P1075, DOI 10.1111/j.1365-2362.2003.01279.x; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Zhao BC, 2010, HEPATO-GASTROENTEROL, V57, P1382	40	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53972	10.1371/journal.pone.0053972	http://dx.doi.org/10.1371/journal.pone.0053972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342053	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700070
J	Rifel, J; Svab, I; Selic, P; Pavlic, DR; Nazareth, I; Car, J				Rifel, Janez; Svab, Igor; Selic, Polona; Pavlic, Danica Rotar; Nazareth, Irwin; Car, Josip			Association of Common Mental Disorders and Quality of Life with the Frequency of Attendance in Slovenian Family Medicine Practices: Longitudinal Study	PLOS ONE			English	Article							GENERAL-PRACTICE; ATTENDERS; CARE	Background: Most research on frequent attendance has been cross-sectional and restricted to one year attendance rates. A few longitudinal studies suggest that frequent attendance is self-limiting. Frequent attenders are more likely to have social and psychiatric problems, medically unexplained physical symptoms, chronic somatic diseases (especially diabetes) and are prescribed more psychotropic medication and analgesics. Research Question: To describe the attendance rates in a longitudinal study and to test if depression, panic syndrome, other anxiety syndrome, alcohol misuse and general quality of life are associated with frequent attendance in next two consecutive years. Methods: 1118 consecutive family practice attendees, aged 18 to 75 years from randomly selected family medicine practices were recruited at baseline and followed up at 12 and 24 months. We identified frequent attenders in the top 10 centile within one year. Using a multivariate model, we ascertained if presence of common mental disorders and quality of life assessed at baseline in 2003 predict frequent attendance in 2004 and 2005. Results: 40% of frequent attenders continue to be frequent attenders in the following year and 20% of the frequent attenders were so for the 24 month period. Lower physical scores on the SF-12 questionnaire were strongly associated with future frequent attendance at 12 and 24 months. There was a trend for people with greater than elementary school education to be less likely to become frequent attenders at both 12 and 24 months. For other variables these effects were less consistent. Presence of major depression, panic syndrome, other anxiety syndrome and alcohol misuse were not predictive of frequent attendance in the following two years. Conclusion: Low physical quality of life is strongly predictive of higher frequent attendance and similar finding was observed for people with lower educational level but further confirmatory research is required to establish this association.	[Rifel, Janez; Svab, Igor; Selic, Polona; Pavlic, Danica Rotar; Car, Josip] Univ Ljubljana, Fac Med, Dept Family Med, Ljubljana, Slovenia; [Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England; [Car, Josip] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Global eHlth Unit, London, England	University of Ljubljana; University of London; University College London; Imperial College London	Rifel, J (corresponding author), Univ Ljubljana, Fac Med, Dept Family Med, Ljubljana, Slovenia.	janez.rifel@mf.uni-lj.si	Car, Josip/H-6755-2015; Rifel, Janez/AAE-9511-2020; Selic-Zupancic, Polona/AAJ-8354-2020	Car, Josip/0000-0001-8969-371X; Rifel, Janez/0000-0001-9594-4271; Selic-Zupancic, Polona/0000-0002-5949-0580; Nazareth, Irwin/0000-0003-2146-9628	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was was funded by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOR TF, 1989, ALCOHOL USE DISORDER; Botica MV, 2004, CROAT MED J, V45, P620; Foster A, 2006, FAM PRACT, V23, P444, DOI 10.1093/fampra/cml019; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Kersnik J, 2001, SCAND J PRIM HEALTH, V19, P174; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-6; Neal RD, 1998, BRIT J GEN PRACT, V48, P895; Norton J, 2012, J PSYCHOSOM RES, V72, P413, DOI 10.1016/j.jpsychores.2012.02.010; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Smits FTHM, 2009, BRIT J GEN PRACT, V59, P114, DOI 10.3399/bjgp09X395120; Smits FTM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-21; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Svab I, 1993, Scand J Prim Health Care, V11, P38, DOI 10.3109/02813439308994900; Upton G., 2006, OXFORD DICT STAT; Vedsted P, 2005, PUBLIC HEALTH, V119, P118, DOI 10.1016/j.puhe.2004.03.007; WARD AM, 1994, FAM PRACT, V11, P431, DOI 10.1093/fampra/11.4.431; World Health Organization, 1997, WHO COMP INT DIAGN I	17	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54241	10.1371/journal.pone.0054241	http://dx.doi.org/10.1371/journal.pone.0054241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342107	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700095
J	Engstrom, KS; Hossain, MB; Lauss, M; Ahmed, S; Raqib, R; Vahter, M; Broberg, K				Engstrom, Karin S.; Hossain, Mohammad Bakhtiar; Lauss, Martin; Ahmed, Sultan; Raqib, Rubhana; Vahter, Marie; Broberg, Karin			Efficient Arsenic Metabolism - The AS3MT Haplotype Is Associated with DNA Methylation and Expression of Multiple Genes Around AS3MT	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DRINKING-WATER; IN-UTERO; EXPOSURE; METHYLTRANSFERASE; SOFTWARE; CANCER; MOUSE	Arsenic is a very potent toxicant. One major susceptibility factor for arsenic-related toxicity is the efficiency of arsenic metabolism. The efficiency, in turn, is associated with non-coding single nucleotide polymorphisms (SNPs) in the arsenic methyltransferase AS3MT on chromosome 10q24. However, the mechanism of action for these SNPs is not yet clarified. Here, we assessed the influence of genetic variation in AS3MT on DNA methylation and gene expression within 10q24, in people exposed to arsenic in drinking water. DNA was extracted from peripheral blood from women in the Argentinean Andes (N = 103) and from cord blood from new-borns in Bangladesh (N = 127). AS3MT SNPs were analyzed with Sequenom or Taqman assays. Whole genome epigenetic analysis with Infinium HumanMethylation450 BeadChip was performed on bisulphite-treated DNA. Whole genome gene expression analysis was performed with Illumina DirectHyb HumanHT-12 v4.0 on RNA from peripheral blood. Arsenic exposure was assessed by HPLC-ICPMS. In the Argentinean women, the major AS3MT haplotype, associated with more efficient arsenic metabolism, showed increased methylation of AS3MT (p = 10(-6)) and also differential methylation of several other genes within about 800 kilobasepairs: CNNM2 (p<10(-16)), NT5C2 (p<10(-16)), C10orf26 (p = 10(-8)), USMG5 (p = 10(-5)), TRIM8 (p = 10(-4)), and CALHM2 (p = 0.038) (adjusted for multiple comparisons). Similar, but weaker, associations between AS3MT haplotype and DNA methylation in 10q24 were observed in cord blood (Bangladesh). The haplotype-associated altered CpG methylation was correlated with reduced expression of AS3MT and CNNM2 (r(s) = -0.22 to -0.54), and with increased expression of NT5C2 and USMG5 (r(s) = 0.25 to 0.58). Taking other possibly influential variables into account in multivariable linear models did only to a minor extent alter the strength of the associations. In conclusion, the AS3MT haplotype status strongly predicted DNA methylation and gene expression of AS3MT as well as several genes in 10q24. This raises the possibility that several genes in this region are important for arsenic metabolism.	[Engstrom, Karin S.; Broberg, Karin] Lund Univ, Sect Occupat & Environm Med, Dept Lab Med, Lund, Sweden; [Hossain, Mohammad Bakhtiar; Vahter, Marie; Broberg, Karin] Karolinska Inst, Inst Environm Med, Sect Met & Hlth, S-10401 Stockholm, Sweden; [Hossain, Mohammad Bakhtiar; Ahmed, Sultan; Raqib, Rubhana] Bangladesh ICDDR B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Lauss, Martin] Lund Univ, Dept Oncol, Lund, Sweden	Lund University; Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Lund University	Broberg, K (corresponding author), Lund Univ, Sect Occupat & Environm Med, Dept Lab Med, Lund, Sweden.	karin.broberg_palmgren@med.lu.se	Vahter, Marie/HGB-1674-2022	Raqib, Rubhana/0000-0002-8116-4511; Broberg, Karin/0000-0002-5862-468X	Swedish Council for Working Life and Social Research; Karolinska Institutet; Kungliga fysiografiska sallskapet; EU ["PHIME" FOOD-CT-2006-016253]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Kungliga fysiografiska sallskapet; EU(European Commission)	This research was supported by the Swedish Council for Working Life and Social Research, Karolinska Institutet, and Kungliga fysiografiska sallskapet, and the EU (FP6; "PHIME" FOOD-CT-2006-016253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Caratozzolo MF, 2012, CELL CYCLE, V11, P511, DOI 10.4161/cc.11.3.19008; Chung WH, 2009, INT J ONCOL, V34, P1669, DOI 10.3892/ijo_00000298; Concha G, 1998, ENVIRON HEALTH PERSP, V106, P355, DOI 10.2307/3434042; Concha G, 2006, J HEALTH POPUL NUTR, V24, P317; Concha G, 2010, ENVIRON SCI TECHNOL, V44, P6875, DOI 10.1021/es1010384; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Engstrom KS, 2009, MUTAT RES-FUND MOL M, V667, P4, DOI 10.1016/j.mrfmmm.2008.07.003; Gomez-Rubio P, 2010, J APPL TOXICOL, V30, P260, DOI 10.1002/jat.1492; Hotta K, 2012, J HUM GENET, V57, P46, DOI 10.1038/jhg.2011.127; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans World Health Organization & International Agency for Research on Cancer, 2004, SOM DRINK WAT DIS CO, V84; Kulkarni SS, 2011, J BIOL CHEM, V286, P34567, DOI 10.1074/jbc.M111.268292; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lindberg AL, 2008, TOXICOL APPL PHARM, V230, P9, DOI 10.1016/j.taap.2008.02.001; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; NCBI, 2006, NAT CANC BIOT INF NU; *NCBI, 2006, SNP DAT; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Engstrom KS, 2007, ENVIRON HEALTH PERSP, V115, P599, DOI 10.1289/ehp.9734; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; VAHTER M, 1995, EUR J PHARM-ENVIRON, V293, P455, DOI 10.1016/S0014-2999(95)80104-9; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; Wood TC, 2006, J BIOL CHEM, V281, P7364, DOI 10.1074/jbc.M512227200	42	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53732	10.1371/journal.pone.0053732	http://dx.doi.org/10.1371/journal.pone.0053732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341986	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400072
J	Oteng-Ntim, E; Kopeika, J; Seed, P; Wandiembe, S; Doyle, P				Oteng-Ntim, Eugene; Kopeika, Julia; Seed, Paul; Wandiembe, Symon; Doyle, Pat			Impact of Obesity on Pregnancy Outcome in Different Ethnic Groups: Calculating Population Attributable Fractions	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; RISK-FACTORS; INEQUALITIES; WEIGHT; COHORT; BMI	Objectives: To quantify the proportion of adverse pregnancy outcome attributable to maternal obesity. Design: Cross sectional analysis of routine obstetric dataset. Setting: Guy's and St Thomas's NHS Foundation Trust (GSTFT). Population: 23,668 women who had singleton deliveries at GSTFT between 2004 and 2008. Methods: Logistic regression was used to estimate the association between BMI and outcome in different ethnic groups. Adjusted odds ratios, and the proportions of obese women, were used to calculate population attributable risk fractions (PAFs). Main Outcome Measures: (i) Maternal outcomes: diabetes, type of delivery, post-partum haemorrhage, and preterm delivery. (ii) Perinatal outcomes: macrosomia, low birth weight, admission to neonatal intensive care/special care baby unit, and perinatal death. Results: The prevalence of maternal obesity was 14%. Increasing BMI was independently associated with increasing risk of adverse obstetric and neonatal outcome. At the individual level, the effect of obesity on diabetes was highest in Asian women compared to white women (p for interaction = 0.03). Calculation of population attributable risk fractions demonstrated that one third of diabetes cases and one in six Caesarean sections could be avoided in this population if all obese women were of normal BMI. At the population level, the contribution of obesity to diabetes was highest for Black women (42%), and lowest for oriental women (8%). Seven percent of neonatal macrosomia in all the population, and 13% in Black mothers, were attributable to obesity. Conclusions: Preventing obesity prior to pregnancy will substantially reduce the burden of obstetric and neonatal morbidity in this population. This reduction will be higher in Black women.	[Oteng-Ntim, Eugene; Kopeika, Julia; Seed, Paul; Wandiembe, Symon] St Thomas Hosp, Dept Womens Hlth, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Kings Hlth Partners, London, England; [Oteng-Ntim, Eugene; Doyle, Pat] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Oteng-Ntim, E (corresponding author), St Thomas Hosp, Dept Womens Hlth, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Kings Hlth Partners, London, England.	Eugene.Oteng-Ntim@gstt.nhs.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Kopeika, Julia/0000-0001-8363-388X	Guy's and St Thomas' Charity; National Institute for Health Research [ACF-2009-17-020] Funding Source: researchfish	Guy's and St Thomas' Charity; National Institute for Health Research(National Institute for Health Research (NIHR))	Support of this work was funded by Guy's and St Thomas' Charity. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, DEF DIAGN CLASS DI 1; Carr DB, 2011, HYPERTENS PREGNANCY, V30, P153, DOI 10.3109/10641950903115012; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Djelantik AAAMJ, 2012, BJOG-INT J OBSTET GY, V119, P283, DOI 10.1111/j.1471-0528.2011.03205.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Government Docal. IMD, 2007, ENGL IND DEPR; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hulsey TC, 2005, SOUTH MED J, V98, P411, DOI 10.1097/01.SMJ.0000145283.69631.FC; Knight M, 2008, BJOG-INT J OBSTET GY, V115, P453, DOI 10.1111/j.1471-0528.2007.01622.x; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Lu GC, 2001, AM J OBSTET GYNECOL, V185, P845, DOI 10.1067/mob.2001.117351; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P276, DOI 10.1111/j.1471-0528.2011.03156.x; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Modder J., 2010, CMACE RCOG JOINT GUI, P1; National Institute for Health and Clinical Excellence, 2008, NICE DIAB PREGN GUID; National Institute for Health and Clinical Excellence, 2010, NICE PUBL HLTH GUID, P60; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x	26	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53749	10.1371/journal.pone.0053749	http://dx.doi.org/10.1371/journal.pone.0053749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341993	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314759400077
J	Pan, SC; Tien, KL; Hung, IC; Lin, YJ; Sheng, WH; Wang, MJ; Chang, SC; Kunin, CM; Chen, YC				Pan, Sung-Ching; Tien, Kuei-Lien; Hung, I-Chen; Lin, Yu-Jiun; Sheng, Wang-Huei; Wang, Ming-Jiuh; Chang, Shan-Chwen; Kunin, Calvin M.; Chen, Yee-Chun			Compliance of Health Care Workers with Hand Hygiene Practices: Independent Advantages of Overt and Covert Observers	PLOS ONE			English	Article							IMPROVE COMPLIANCE	Background: Evaluation and feedback of hand hygiene (HH) compliance are important elements of the WHO multimodal strategy for hospital infection control. Overt observation is recommended, but it may be confounded by Hawthorne effect. Covert observation offers the opportunity to decrease observer bias. In this study we conducted a one year hospital-wide HH promotion program that included medical students (MS) as covert observers. Methods: HH compliance for the five WHO indications was determined by trained and validated observers. The overt observers consisted of eleven infection control nurses (ICNs) and two unit HH ambassadors (UAs) in each of 83 wards. The covert observers consisted of nine MS during their rotating clinical clerkships. Feedback was provided to department heads and staff each quarter. Results: Of the 23,333 HH observations 76.0% were by MS, 5.3% by ICNs and 18.7% by UAs. The annual compliance rates were MS 44.1%, ICNs 74.4% and UAs 94.1%; P<0.001. The MS found significantly lower annual compliance rates for 4/5 HH indications compared to ICNs and UAs; P<0.05. The ICNs reported significantly improvement from the first to the fourth quarter; P<0.001. This was associated with feedback from the MS of very poor compliance by nurses during the first quarter. Conclusions: Based on these findings we recommend a two-pronged approach to HH programs. The role of ICNs and UAs is to educate, serve as role models, establish, sustain good HH practices and provide direct feedback. The role of the covert observers is to measure compliance and provide independent feedback.	[Pan, Sung-Ching; Tien, Kuei-Lien; Hung, I-Chen; Lin, Yu-Jiun; Sheng, Wang-Huei; Chang, Shan-Chwen; Chen, Yee-Chun] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Pan, Sung-Ching; Sheng, Wang-Huei; Chen, Yee-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Ming-Jiuh] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wang, Ming-Jiuh] Natl Taiwan Univ Hosp, Dept Hosp Planning, Taipei, Taiwan; [Chang, Shan-Chwen; Chen, Yee-Chun] Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan; [Kunin, Calvin M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Kunin, Calvin M.] Univ Arizona, Tucson, AZ USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University System of Ohio; Ohio State University; University of Arizona	Chen, YC (corresponding author), Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan.	yeechunchen@gmail.com	Chen, Yee-Chun/AGW-7535-2022	Chen, Yee-Chun/0000-0002-1816-9010; PAN, SUNG-CHING/0000-0003-3154-6690; CHANG, SHAN-CHWEN/0000-0001-6505-4139; SHENG, WANG-HUEI/0000-0002-5605-7853	Center for Diseases Control, Department of Health, Taiwan [EU098040]; Department of Health, Taiwan [DOH100-TD-B-111-001]	Center for Diseases Control, Department of Health, Taiwan; Department of Health, Taiwan	The authors are grateful to members of the NTUH Center for Infection Control and Center for Quality Control for their sustained support of the hand hygiene program and the hospital staff for their commitment to improve patient safety and reduce healthcare-associated infections. The authors are indebted to the Center for Diseases Control, Department of Health, Taiwan, for providing financial support for the Center for Excellence for Hand Hygiene (EU098040). Y. C. Chen also received a grant from Department of Health, Taiwan (DOH100-TD-B-111-001). The funding organizations were not involved in designing or conducting the study, the data collection, management, analysis, and interpretation, nor the preparation, and approval of the manuscript.	Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chuang YC, 2010, J HOSP INFECT, V76, P143, DOI 10.1016/j.jhin.2010.05.001; Daniels TL, 2012, J INFECT DIS, V206, P1488, DOI 10.1093/infdis/jis549; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Haas JP, 2007, J HOSP INFECT, V66, P6, DOI 10.1016/j.jhin.2006.11.013; Hornbeck T, 2012, J INFECT DIS, V206, P1549, DOI 10.1093/infdis/jis542; Lin HC, 2010, INFECT CONTROL J, V20, P146; McAteer J, 2008, J HOSP INFECT, V68, P222, DOI 10.1016/j.jhin.2007.12.009; Miyachi H, 2007, AM J INFECT CONTROL, V35, P115, DOI 10.1016/j.ajic.2006.09.003; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Rosenthal T, 2009, ACAD MED, V84, P1705, DOI 10.1097/ACM.0b013e3181bf6988; SETO WH, 1991, AM J INFECT CONTROL, V19, P86, DOI 10.1016/0196-6553(91)90044-D; Son C, 2011, AM J INFECT CONTROL, V39, P716, DOI 10.1016/j.ajic.2010.12.008; van de Mortel T, 2006, AM J INFECT CONTROL, V34, P95, DOI 10.1016/j.ajic.2005.07.006; WHO Training Film, IMPL TOOLK; World Health Organization (WHO), 2009, WHO GUID HAND HYG HL	18	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53746	10.1371/journal.pone.0053746	http://dx.doi.org/10.1371/journal.pone.0053746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341991	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400076
J	Rao, KH; Ghosh, S; Natarajan, K; Datta, A				Rao, Kongara Hanumantha; Ghosh, Swagata; Natarajan, Krishnamurthy; Datta, Asis			N-Acetylglucosamine Kinase, HXK1 Is Involved in Morphogenetic Transition and Metabolic Gene Expression in Candida albicans	PLOS ONE			English	Article							FILAMENTOUS GROWTH; CATABOLIC PATHWAY; GLUCOSE SENSOR; IDENTIFICATION; INDUCTION; HEXOKINASE; EPITHELIUM; VIRULENCE; PROTEINS; PROMOTER	Candida albicans, a common fungal pathogen which diverged from the baker's yeast Saccharomyces cerevisiae has the unique ability to utilise N-acetylglucosamine, an amino sugar and exhibits phenotypic differences. It has acquired intricate regulatory mechanisms at different levels in accordance with its life style. N-acetylglucosamine kinase, a component of the N-acetylglucosamine catabolic cascade is an understudied gene since Saccharomyces cerevisiae lacks it. We report HXK1 to act as both positive and negative regulator of transcription of genes involved in maintaining cellular homeostasis. It is involved in repression of hyphal specific genes in addition to metabolic genes. Its regulation of filamentation and GlcNAc metabolism is independent of the known classical regulators like EFG1, CPH1, RAS1, TPK2 or TUP1. Moreover, Hxk1-GFP is localised to cytoplasm, nucleus and mitochondria in a condition specific manner. By employing two-step affinity purification, we report the interaction of HXK1 with SIR2 under filamentation inducing conditions. Our work highlights a novel regulatory mechanism involved in filamentation repression and attempts to decipher the GlcNAc catabolic regulatory cascade in eukaryotes.	[Rao, Kongara Hanumantha; Ghosh, Swagata; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Express, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Express, New Delhi 110067, India.	nat0200@mail.jnu.ac.in; asis_datta@rediffmail.com		Hanumantha Rao, Kongara/0000-0002-2856-9704	Indian Council of Medical Research (ICMR), Government of India [5/3/3/16/2007-ECD-1]; Department of Biotechnology, Ministry of Science & Technology, Government of India; CSIR	Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by Indian Council of Medical Research (ICMR, project-file number 5/3/3/16/2007-ECD-1), Government of India and Professor of Eminence Scheme of NIPGR, Department of Biotechnology, Ministry of Science & Technology, Government of India. K. H. R and S. G. received financial assistance from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Aususbel FM, 2000, CURRENT PROTOCOLS MO; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; Bhushan D, 2006, J PROTEOME RES, V5, P1711, DOI 10.1021/pr060116f; BISWAS M, 1979, BIOCHIM BIOPHYS ACTA, V585, P535, DOI 10.1016/0304-4165(79)90186-7; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; DELBRUCK S, 1993, MOL MICROBIOL, V10, P859, DOI 10.1111/j.1365-2958.1993.tb00956.x; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; FONZI WA, 1993, GENETICS, V134, P717; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Giusani AD, 2002, GENETICS, V160, P1749; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Guthrie C, 1991, GUIDE YEAST GENETICS; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kaneko A, 2004, YEAST, V21, P1025, DOI 10.1002/yea.1147; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MALATHI K, 1994, J BIOL CHEM, V269, P22945; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mishra PK, 2011, P NATL ACAD SCI USA, V108, P11965, DOI 10.1073/pnas.1109631108; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Reutter, 1997, GLYCOSCIENCES STATUS, P245; Sambrook J., 2001, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004; Singh P, 2001, INFECT IMMUN, V69, P7898, DOI 10.1128/IAI.69.12.7898-7903.2001; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Stevenson John S, 2011, Mol Microbiol, V81, P1078, DOI 10.1111/j.1365-2958.2011.07754.x; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIDOTTO V, 1986, MYCOPATHOLOGIA, V95, P73, DOI 10.1007/BF00437163; Wendland J, 2006, J BASIC MICROB, V46, P513, DOI 10.1002/jobm.200610167; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	57	29	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53638	10.1371/journal.pone.0053638	http://dx.doi.org/10.1371/journal.pone.0053638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341961	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400055
J	Romanelli, P; Fardone, E; Battaglia, G; Brauer-Krisch, E; Prezado, Y; Requardt, H; Le Duc, G; Nemoz, C; Anschel, DJ; Spiga, J; Bravin, A				Romanelli, Pantaleo; Fardone, Erminia; Battaglia, Giuseppe; Braeuer-Krisch, Elke; Prezado, Yolanda; Requardt, Herwig; Le Duc, Geraldine; Nemoz, Christian; Anschel, David J.; Spiga, Jenny; Bravin, Alberto			Synchrotron-Generated Microbeam Sensorimotor Cortex Transections Induce Seizure Control without Disruption of Neurological Functions	PLOS ONE			English	Article							X-RAY MICROBEAMS; MULTIPLE SUBPIAL TRANSECTIONS; RADIATION-THERAPY; IN-VIVO; MICROPLANAR BEAMS; VISUAL-CORTEX; EPILEPTIFORM DISCHARGES; CLINICAL-TRIALS; MOUSE-BRAIN; NEOCORTEX	Synchrotron-generated X-ray microplanar beams (microbeams) are characterized by the ability to deliver extremely high doses of radiation to spatially restricted volumes of tissue. Minimal dose spreading outside the beam path provides an exceptional degree of protection from radio-induced damage to the neurons and glia adjacent to the microscopic slices of tissue irradiated. The preservation of cortical architecture following high-dose microbeam irradiation and the ability to induce non-invasively the equivalent of a surgical cut over the cortex is of great interest for the development of novel experimental models in neurobiology and new treatment avenues for a variety of brain disorders. Microbeams (size 100 mu m/600 mu m, center-to-center distance of 400 mu m/1200 mu m, peak entrance doses of 360-240 Gy/150-100 Gy) delivered to the sensorimotor cortex of six 2-month-old naive rats generated histologically evident cortical transections, without modifying motor behavior and weight gain up to 7 months. Microbeam transections of the sensorimotor cortex dramatically reduced convulsive seizure duration in a further group of 12 rats receiving local infusion of kainic acid. No subsequent neurological deficit was associated with the treatment. These data provide a novel tool to study the functions of the cortex and pave the way for the development of new therapeutic strategies for epilepsy and other neurological diseases.	[Romanelli, Pantaleo] Cyberknife Ctr, Ctr Diagnost Italiano, Milan, Italy; [Romanelli, Pantaleo] AB Med, Lainate, Italy; [Romanelli, Pantaleo; Fardone, Erminia; Braeuer-Krisch, Elke; Prezado, Yolanda; Requardt, Herwig; Le Duc, Geraldine; Nemoz, Christian; Bravin, Alberto] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Battaglia, Giuseppe] Ist Ricovero & Cura Carattere Sci Neuromed, Localita Camerelle, Pozzilli, Italy; [Anschel, David J.] St Charles Hosp, Comprehens Epilepsy Ctr Long Isl, Port Jefferson, NY USA; [Spiga, Jenny] Univ Cagliari, Dept Phys, Monserrato, Italy; [Spiga, Jenny] Ist Nazl Fis Nucl, Monserrato, Italy	European Synchrotron Radiation Facility (ESRF); IRCCS Neuromed; University of Cagliari; Istituto Nazionale di Fisica Nucleare (INFN)	Romanelli, P (corresponding author), Cyberknife Ctr, Ctr Diagnost Italiano, Milan, Italy.	radiosurgery2000@yahoo.com	Battaglia, Giuseppe/A-7709-2010; Fardone, Erminia/ABA-1695-2021; Bravin, Alberto/AAN-6114-2020; Bravin, Alberto/R-8633-2016; prezado, yolanda/O-7376-2014; Brauer-Krisch, Elke/O-6026-2017; prezado, yolanda/B-8455-2009	Battaglia, Giuseppe/0000-0001-7571-3417; Bravin, Alberto/0000-0001-6868-2755; Bravin, Alberto/0000-0001-6868-2755; Spiga, Jenny/0000-0002-6741-8028; Brauer-Krisch, Elke/0000-0003-4587-1160; prezado, yolanda/0000-0001-5957-2327	European Synchrotron Radiation Facility	European Synchrotron Radiation Facility	European Synchrotron Radiation Facility (internal research funds). http://www.esrf.fr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattmann H, 2005, NUCL INSTRUM METH A, V548, P17, DOI 10.1016/j.nima.2005.03.060; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Cullen DE, 1989, UCRL50400 EPDL LAW A, V6; Curtis H J, 1967, Radiat Res Suppl, V7, P250, DOI 10.2307/3583718; Curtis H J, 1967, Radiat Res Suppl, V7, P258, DOI 10.2307/3583719; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2006, P NATL ACAD SCI USA, V103, P9709, DOI 10.1073/pnas.0603567103; Dilmanian FA, 2005, NUCL INSTRUM METH A, V548, P30, DOI 10.1016/j.nima.2005.03.062; Dilmanian FA, 2003, RADIAT RES, V159, P632, DOI 10.1667/0033-7587(2003)159[0632:MECHTE]2.0.CO;2; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Dilmanian FA, 2001, CELL MOL BIOL, V47, P485; Eidelberg G, 1959, ELECTROENCEPHALOGR C, V11, P121; GABBIANI G, 1984, J CELL SCI, V66, P39; Hashizume K, 1998, EPILEPSY RES, V32, P389, DOI 10.1016/S0920-1211(98)00065-5; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Martinez-Rovira I, 2010, PHYS MED BIOL, V55, P4375, DOI 10.1088/0031-9155/55/15/012; Miura M, 2006, BRIT J RADIOL, V79, P71, DOI 10.1259/bjr/50464795; MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231; Morrell F, 1995, BRAIN, V118, P1529, DOI 10.1093/brain/118.6.1529; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Mulligan LP, 2001, EPILEPSIA, V42, P226; Orbach D, 2001, EPILEPSIA, V42, P1316, DOI 10.1111/j.1528-1167.2001.45300.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Prezado Y, 2011, MED PHYS, V38, P5012, DOI 10.1118/1.3608908; Prezado Y, 2009, MED PHYS, V36, P725, DOI 10.1118/1.3070538; REICHENTHAL E, 1977, ELECTROEN CLIN NEURO, V42, P248, DOI 10.1016/0013-4694(77)90031-1; Romanelli P, 2011, NEUROL RES, V33, P825, DOI 10.1179/016164111X13123658647445; Salvat F, 2006, 6222 OECD NUCL EN AG, V6222; Sempau J, 2006, PHYS MED BIOL, V51, P3533, DOI 10.1088/0031-9155/51/14/017; Sempau J, 2001, PHYS MED BIOL, V46, P1163, DOI 10.1088/0031-9155/46/4/318; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2010, J SYNCHROTRON RADIAT, V17, P325, DOI 10.1107/S0909049510006667; Siegbahn EA, 2006, MED PHYS, V33, P3248, DOI 10.1118/1.2229422; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Smilowitz HM, 2006, J NEURO-ONCOL, V78, P135, DOI 10.1007/s11060-005-9094-9; SPERRY RW, 1955, J COMP PHYSIOL PSYCH, V48, P50, DOI 10.1037/h0043456; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; Torres J, 2004, MED PHYS, V31, P296, DOI 10.1118/1.1637970; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P671, DOI 10.1107/S090904951101185X; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; ZEMAN W, 1961, RADIAT RES, V15, P496, DOI 10.2307/3571293; Zhong N, 2003, RADIAT RES, V160, P133, DOI 10.1667/3033	49	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53549	10.1371/journal.pone.0053549	http://dx.doi.org/10.1371/journal.pone.0053549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341950	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400049
J	Abe, K; Hashimoto, Y; Yatsushiro, S; Yamamura, S; Bando, M; Hiroshima, Y; Kido, J; Tanaka, M; Shinohara, Y; Ooie, T; Baba, Y; Kataoka, M				Abe, Kaori; Hashimoto, Yoshiko; Yatsushiro, Shouki; Yamamura, Shohei; Bando, Mika; Hiroshima, Yuka; Kido, Jun-ichi; Tanaka, Masato; Shinohara, Yasuo; Ooie, Toshihiko; Baba, Yoshinobu; Kataoka, Masatoshi			Simultaneous Immunoassay Analysis of Plasma IL-6 and TNF-alpha on a Microchip	PLOS ONE			English	Article							ASSAY SYSTEM; INTEGRATION; SEPARATION; BLOOD	Sandwich enzyme-linked immunosorbant assay (ELISA) using a 96-well plate is frequently employed for clinical diagnosis, but is time-and sample-consuming. To overcome these drawbacks, we performed a sandwich ELISA on a microchip. The microchip was made of cyclic olefin copolymer with 4 straight microchannels. For the construction of the sandwich ELISA for interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha), we used a piezoelectric inkjet printing system for the deposition and fixation of the 1st anti-IL-6 antibody or 1st anti-TNF-alpha antibody on the surface of the each microchannel. After the infusion of 2 mu l of sample to the microchannel and a 20 min incubation, 2 mu l of biotinylated 2nd antibody for either antigen was infused and a 10 min incubation. Then 2 mu l of avidin-horseradish peroxidase was infused; and after a 5 min incubation, the substrate for peroxidase was infused, and the luminescence intensity was measured. Calibration curves were obtained between the concentration and luminescence intensity over the range of 0 to 32 pg/ml (IL-6: R-2 = 0.9994, TNF-alpha: R-2 = 0.9977), and the detection limit for each protein was 0.28 pg/ml and 0.46 pg/ml, respectively. Blood IL-6 and TNF-alpha concentrations of 5 subjects estimated from the microchip data were compared with results obtained by the conventional method, good correlations were observed between the methods according to linear regression analysis (IL-6: R-2 = 0.9954, TNF-alpha: R-2 = 0.9928). The reproducibility of the presented assay for the determination of the blood IL-6 and TNF-alpha concentration was comparable to that obtained with the 96-well plate. Simultaneous detection of blood IL-6 and TNF-alpha was possible by the deposition and fixation of each 1st antibody on the surface of a separate microchannel. This assay enabled us to determine simultaneously blood IL-6 and TNF-alpha with accuracy, satisfactory sensitivity, time saving ability, and low consumption of sample and reagents, and will be applicable to clinic diagnosis.	[Abe, Kaori; Hashimoto, Yoshiko; Yatsushiro, Shouki; Yamamura, Shohei; Tanaka, Masato; Ooie, Toshihiko; Baba, Yoshinobu; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Bando, Mika; Hiroshima, Yuka; Kido, Jun-ichi] Univ Tokushima, Inst Hlth Biosci, Div Med Dent Dynam & Reconstruct, Dept Periodontol & Endodontol Oral & Maxillofacia, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Tokushima University; Nagoya University	Kataoka, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan.	m-kataoka@aist.go.jp	Kataoka, Masatoshi/M-6925-2018; Tanaka, Masato/P-6700-2016; yamamura, shohei/M-8071-2018; Ooie, Toshihiko/J-1498-2018; YATSUSHIRO, shouki/M-8155-2018	Kataoka, Masatoshi/0000-0001-9779-8319; Tanaka, Masato/0000-0002-6164-7786; yamamura, shohei/0000-0002-4971-4560; Ooie, Toshihiko/0000-0001-8725-0691; YATSUSHIRO, shouki/0000-0002-6123-1561	Japan Society for the Promotion of Science (KAKENHI) [23310093]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, Grand-in-Aid for Scientific Research (KAKENHI) 23310093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs C, 2008, BRIT J HAEMATOL, V142, P904, DOI 10.1111/j.1365-2141.2008.07274.x; Christodoulides N, 2002, ANAL CHEM, V74, P3030, DOI 10.1021/ac011150a; Di Serio F, 2006, CLIN CHEM LAB MED, V44, P768, DOI 10.1515/CCLM.2006.125; Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048; Ikami M, 2010, LAB CHIP, V10, P3335, DOI [10.1039/c0lc00241k, 10.1039/c01c00241k]; Maeda E, 2008, ELECTROPHORESIS, V29, P1902, DOI 10.1002/elps.200700688; Maeda E, 2007, ELECTROPHORESIS, V28, P2927, DOI 10.1002/elps.200600795; Mohamadi MR, 2007, ANAL CHEM, V79, P3667, DOI 10.1021/ac0623890; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Ramos AM, 2009, ARQ BRAS CARDIOL, V92, P233, DOI 10.1590/S0066-782X2009000300012; Sato K, 2004, LAB CHIP, V4, P570, DOI 10.1039/b411356j; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Sato K, 2009, LAB CHIP, V8, P1992; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Smith JA, 1995, SHORT PROTOCOLS MOL, P11; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Stewart Thomas N., 2009, Biotechnology Journal, V4, P206, DOI 10.1002/biot.200800234; Tachi T, 2009, ANAL SCI, V25, P149, DOI 10.2116/analsci.25.149; Tachi T, 2009, LAB CHIP, V9, P966, DOI 10.1039/b813640h; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wehmeier M, 2006, CLIN CHEM LAB MED, V44, P888, DOI 10.1515/CCLM.2006.141; Yasukawa T, 2007, BIOSENS BIOELECTRON, V22, P2730, DOI 10.1016/j.bios.2006.11.010; Yatsushiro S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018807	28	17	18	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53620	10.1371/journal.pone.0053620	http://dx.doi.org/10.1371/journal.pone.0053620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326472	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500087
J	Menin, A; Fleith, R; Reck, C; Marlow, M; Fernandes, P; Pilati, C; Bafica, A				Menin, Alvaro; Fleith, Renata; Reck, Carolina; Marlow, Mariel; Fernandes, Paula; Pilati, Celso; Bafica, Andre			Asymptomatic Cattle Naturally Infected with Mycobacterium bovis Present Exacerbated Tissue Pathology and Bacterial Dissemination	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; IMMUNE-RESPONSES; DIAGNOSIS; PATHOGENESIS; PREVALENCE; EXPRESSION; GRANULOMAS; INSIGHTS; LESIONS; TESTS	Rational discovery of novel immunodiagnostic and vaccine candidate antigens to control bovine tuberculosis (bTB) requires knowledge of disease immunopathogenesis. However, there remains a paucity of information on the Mycobacterium bovis-host immune interactions during the natural infection. Analysis of 247 naturally PPD+ M. bovis-infected cattle revealed that 92% (n = 228) of these animals were found to display no clinical signs, but presented severe as well as disseminated bTB-lesions at post-mortem examination. Moreover, dissemination of bTB-lesions positively correlated with both pathology severity score (Spearman r = 0.48; p<0.0001) and viable tissue bacterial loads (Spearman r = 0.58; p = 0.0001). Additionally, granuloma encapsulation negatively correlated with M. bovis growth as well as pathology severity, suggesting that encapsulation is an effective mechanism to control bacterial proliferation during natural infection. Moreover, multinucleated giant cell numbers were found to negatively correlate with bacterial counts (Spearman r = 0.25; p = 0.03) in lung granulomas. In contrast, neutrophil numbers in the granuloma were associated with increased M. bovis proliferation (Spearman r = 0.27; p = 0.021). Together, our findings suggest that encapsulation and multinucleated giant cells control M. bovis viability, whereas neutrophils may serve as a cellular biomarker of bacterial proliferation during natural infection. These data integrate host granuloma responses with mycobacterial dissemination and could provide useful immunopathological-based biomarkers of disease severity in natural infection with M. bovis, an important cattle pathogen.	[Menin, Alvaro; Fleith, Renata; Fernandes, Paula; Bafica, Andre] Univ Fed Santa Catarina, Immunobiol Lab, Florianopolis, SC, Brazil; [Reck, Carolina; Pilati, Celso] Univ Estado Santa Catarina, Lab Histol & Immunohistochem, Lages, SC, Brazil; [Marlow, Mariel] Univ Fed Santa Catarina, Lab Protozool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade do Estado de Santa Catarina; Universidade Federal de Santa Catarina (UFSC)	Menin, A (corresponding author), Univ Fed Santa Catarina, Immunobiol Lab, Florianopolis, SC, Brazil.	amenin@ccb.ufsc.br; andre.bafica@ufsc.br	Bafica, Andre/ABF-5986-2020; Menin, Álvaro/D-9815-2016	Bafica, Andre/0000-0002-5148-600X; Menin, Álvaro/0000-0002-9430-9433; Reck, Carolina/0000-0002-2345-2558; Fleith, Renata Cristina/0000-0003-2874-3642	CAPES (PROCAD); CNPq (INCT/INTEV); National Institutes of Health (GRIP/Fogarty) [394]; Howard Hughes Medical Institute (ECS Program)	CAPES (PROCAD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (INCT/INTEV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (GRIP/Fogarty)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (ECS Program)	This work was funded by CAPES (PROCAD), CNPq (INCT/INTEV), National Institutes of Health 394 (GRIP/Fogarty) and the Howard Hughes Medical Institute (ECS Program). AB is a CNPq 395 scientist scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, VET REC, V161, P782; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Boom WH, 1996, INFECT AGENT DIS, V5, P73; Brotherstone S, 2009, J DAIRY SCI, V93, P1234; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; CORNER LA, 1994, VET MICROBIOL, V40, P53, DOI 10.1016/0378-1135(94)90046-9; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; de Kantor IN, 2008, TUBERCULOSIS, V88, P358, DOI 10.1016/j.tube.2007.11.007; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dean GS, 2005, INFECT IMMUN, V73, P6467, DOI 10.1128/IAI.73.10.6467-6471.2005; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; MAPA-Ministerio da Agricultura Pecuaria e Abastecimento Brasil, 2006, PROGRAMA NACIONAL DE; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Rodriguez JG, 1999, J CLIN MICROBIOL, V37, P2330; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; The World Organization for Animal Health (OIE), 2011, THE MANUAL OF DIAGNO; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; WARDS BJ, 1995, VET MICROBIOL, V43, P227, DOI 10.1016/0378-1135(94)00096-F; Wedlock DN, 1999, INFECT IMMUN, V67, P2172, DOI 10.1128/IAI.67.5.2172-2177.1999; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Whipple DL, 1996, J VET DIAGN INVEST, V8, P351, DOI 10.1177/104063879600800312; Widdison S, 2009, TUBERCULOSIS, V89, P417, DOI 10.1016/j.tube.2009.09.003; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1	53	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53884	10.1371/journal.pone.0053884	http://dx.doi.org/10.1371/journal.pone.0053884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326525	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500100
J	Capps, KA; Flecker, AS				Capps, Krista A.; Flecker, Alexander S.			Invasive Fishes Generate Biogeochemical Hotspots in a Nutrient-Limited System	PLOS ONE			English	Article							CATFISH LORICARIIDAE PTERYGOPLICHTHYS; SUCKERMOUTH ARMORED CATFISH; FOOD WEBS; STOICHIOMETRY; STREAMS; PISCES; LIMITATION; PERIPHYTON; BIOMASS; RECORD	Fishes can play important functional roles in the nutrient dynamics of freshwater systems. Aggregating fishes have the potential to generate areas of increased biogeochemical activity, or hotspots, in streams and rivers. Many of the studies documenting the functional role of fishes in nutrient dynamics have focused on native fish species; however, introduced fishes may restructure nutrient storage and cycling freshwater systems as they can attain high population densities in novel environments. The purpose of this study was to examine the impact of a non-native catfish (Loricariidae: Pterygoplichthys) on nitrogen and phosphorus remineralization and estimate whether large aggregations of these fish generate measurable biogeochemical hotspots within nutrient-limited ecosystems. Loricariids formed large aggregations during daylight hours and dispersed throughout the stream during evening hours to graze benthic habitats. Excretion rates of phosphorus were twice as great during nighttime hours when fishes were actively feeding; however, there was no diel pattern in nitrogen excretion rates. Our results indicate that spatially heterogeneous aggregations of loricariids can significantly elevate dissolved nutrient concentrations via excretion relative to ambient nitrogen and phosphorus concentrations during daylight hours, creating biogeochemical hotspots and potentially altering nutrient dynamics in invaded systems.	[Capps, Krista A.; Flecker, Alexander S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Capps, Krista A.] Univ Maine, Sustainabil Solut Initiat, Orono, ME USA	Cornell University; University of Maine System; University of Maine Orono	Capps, KA (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	krista.capps@maine.edu			National Science Foundation (Doctoral Dissertation Enhancement Program Grant) [183-8371]; Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity [0221658]; Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi; Tinker Field Research Grant; Andrew and Margaret Paul Graduate Fellowship in the Life Sciences; American Cichlid Association Paul V. Loiselle Conservation Fund	National Science Foundation (Doctoral Dissertation Enhancement Program Grant); Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity; Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi; Tinker Field Research Grant; Andrew and Margaret Paul Graduate Fellowship in the Life Sciences; American Cichlid Association Paul V. Loiselle Conservation Fund	This work was funded by the National Science Foundation (Doctoral Dissertation Enhancement Program Grant (183-8371); Integrated Graduate Education and Research in Biogeochemistry and Environmental Biocomplexity (0221658) Small Grant Program), the Fulbright-Hays Doctoral Dissertation Research Abroad Program, Sigma Xi, the Tinker Field Research Grant, the Andrew and Margaret Paul Graduate Fellowship in the Life Sciences, and the American Cichlid Association Paul V. Loiselle Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benstead JP, 2010, FRESHWATER BIOL, V55, P2047, DOI 10.1111/j.1365-2427.2010.02461.x; Bomford M., 2004, RISK ASSESSMENT MODE; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Bunkley-Williams Lucy, 1994, Caribbean Journal of Science, V30, P90; Bunnell DB, 2005, CAN J FISH AQUAT SCI, V62, P15, DOI 10.1139/F04-172; Capps KA, 2012, CHANGES COMMUNITY ST; Capps KA, 2011, AQUAT CONSERV, V21, P528, DOI 10.1002/aqc.1210; Capps KA, 2011, J N AM BENTHOL SOC, V30, P522, DOI 10.1899/10-146.1; Casatti L, 2006, NEOTROP ICHTHYOL, V4, P203, DOI 10.1590/S1679-62252006000200006; Chavez JM, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1109.1.6; Courtenay W.R. Jr, 1986, P675; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; DEVICK WS, 1989, DISTURBANCES FLUCTUA; Evans-White MA, 2006, ECOL LETT, V9, P1186, DOI 10.1111/j.1461-0248.2006.00971.x; Froese R., 2012, FISHBASE; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Hood JM, 2005, OECOLOGIA, V146, P247, DOI 10.1007/s00442-005-0202-5; Hoover J. J., 2004, SUCKERMOUTH CATFISHE; Johnson LT, 2009, J N AM BENTHOL SOC, V28, P694, DOI 10.1899/08-107.1; Kitchell J.F., 1975, Verhandlungen Int Verein Theor Angew Limnol, V19, P2478; Knoll LB, 2009, OIKOS, V118, P1732, DOI 10.1111/j.1600-0706.2009.17367.x; KRAFT CE, 1993, T AM FISH SOC, V122, P749, DOI 10.1577/1548-8659(1993)122<0749:PRBLMA>2.3.CO;2; Liang SH, 2005, ZOOL STUD, V44, P252; Lienart GDH, 2012, SW NATURALI IN PRESS; Liess A, 2006, J N AM BENTHOL SOC, V25, P632, DOI 10.1899/0887-3593(2006)25[632:RONSIG]2.0.CO;2; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McIntyre PB, 2006, LIMNOL OCEANOGR, V51, P1514, DOI 10.4319/lo.2006.51.3.1514; Mendoza R, 2009, TRINATIONAL RISK ASS; Mendoza-Carranza M, 2010, NEOTROP ICHTHYOL, V8, P171, DOI 10.1590/S1679-62252010000100020; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Nico LG, 2010, NEOTROP ICHTHYOL, V8, P893, DOI 10.1590/S1679-62252010005000014; Nico LG, 2001, SOUTHWEST NAT, V46, P98, DOI 10.2307/3672381; Nico LG, 2009, ANSRP B, V9, P1; Ozdilek SY, 2007, SU URUN DERG, V24, P303; Pound KL, 2011, ENVIRON BIOL FISH, V90, P277, DOI 10.1007/s10641-010-9741-7; REDFIELD AC, 1958, AM SCI, V46, P205; Reisinger AJ, 2011, J N AM BENTHOL SOC, V30, P840, DOI 10.1899/10-169.1; Sinha RK, 2010, J APPL ICHTHYOL, V26, P606, DOI 10.1111/j.1439-0426.2010.01474.x; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; WEBER C, 1991, REV SUISSE ZOOL, V98, P637; Zalucki J.M., 1999, BASELINE ENV DATA RE	46	63	67	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54093	10.1371/journal.pone.0054093	http://dx.doi.org/10.1371/journal.pone.0054093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342083	gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700086
J	Fu, KW; Chan, CH				Fu, King-wa; Chan, C. H.			A Study of the Impact of Thirteen Celebrity Suicides on Subsequent Suicide Rates in South Korea from 2005 to 2009	PLOS ONE			English	Article							TIME-TREND ANALYSIS; MEDIA INFLUENCES; HONG-KONG; IDEATION; DEATH	A number of ecological studies have found a pattern of increasing suicide rates after suicides of several Asian entertainment celebrities. However, the finding may be subject to positive outcome bias where cases with no perceived impact may be routinely excluded. In this study, we deploy interrupted time-series analysis using ARIMA transfer function models to investigate systematically the impact of thirteen celebrity suicides on subsequent suicide rates in South Korea. We find that three out of eleven cases were found to be followed by a significant increase in suicide rate, while controlling for seasonality, secular trends, and unemployment rates. Such significant increases could last for nine weeks. Non-significance cases may be attributable to the small amount of media coverage, the "displacement'' effect of preceding case, and the negative connotation of celebrity deaths. We therefore conclude that whether or not the impacts were detected may be largely conditioned by various contextual factors. Current evidence based on ecological studies is insufficient to draw a firm conclusion. Further studies using multiple approaches should be developed.	[Fu, King-wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China; [Chan, C. H.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Fu, KW (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	kwfu@hku.hk	Fu, King-wa/A-2385-2010	Fu, King-wa/0000-0001-8157-5276; Chan, Chee Hon/0000-0002-4112-9383				[Anonymous], 2010, R LANG ENV STAT COMP; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chen YY, 2012, SOC PSYCH PSYCH EPID, V47, P215, DOI 10.1007/s00127-010-0331-y; Cheng ATA, 2007, INT J EPIDEMIOL, V36, P1229, DOI 10.1093/ije/dym196; Coggan C, 1997, SOC SCI MED, V45, P1563, DOI 10.1016/S0277-9536(97)00098-1; Domke D, 1998, INT J PUBLIC OPIN R, V10, P51, DOI 10.1093/ijpor/10.1.51; Etzersdorfer Elmar, 2004, Arch Suicide Res, V8, P137, DOI 10.1080/13811110490270985; Fu KW, 2007, J EPIDEMIOL COMMUN H, V61, P540, DOI 10.1136/jech.2005.045005; Fu KW, 2009, J CLIN PSYCHIAT, V70, P869, DOI 10.4088/JCP.08m04240; Fu KW, 2009, MEDIA PSYCHOL, V12, P26, DOI 10.1080/15213260802669441; Hawton K, 2000, BRIT J PSYCHIAT, V177, P463, DOI 10.1192/bjp.177.5.463; Jeong J, 2012, SOC PSYCH PSYCH EPID, V47, P957, DOI 10.1007/s00127-011-0403-7; JONAS K, 1992, BRIT J SOC PSYCHOL, V31, P295, DOI 10.1111/j.2044-8309.1992.tb00974.x; Markus H., 1985, HDB SOCIAL PSYCHOL, P137; Martin G, 1997, ARCH SUICIDE RES, V3, P187, DOI 10.1080/13811119708258271; McCurry J, 2009, GUARDIAN; Mederkrotenthaler T, 2012, J EPIDEMIOL COMMUNIT; Mesoudi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007252; National Statistical Office of Korea, 2012, KOE STAT INF SERV; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Schmidtke A, 2000, INT HDB SUICIDE ATTE, P675; STACK S, 1987, AM SOCIOL REV, V52, P401, DOI 10.2307/2095359; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Williamson Lucy, 2011, BBC NEWS; World Health Organization, 1992, ICD 10 INT STAT CLAS; Yip PSF, 2006, J AFFECT DISORDERS, V93, P245, DOI 10.1016/j.jad.2006.03.015; Zahl DL, 2004, BEHAV COGN PSYCHOTH, V32, P189, DOI 10.1017/S1352465804001195; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517	31	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53870	10.1371/journal.pone.0053870	http://dx.doi.org/10.1371/journal.pone.0053870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342026	Green Published, gold			2022-12-27	WOS:000313682700058
J	Karsten, M; van Vuuren, BJ; Barnaud, A; Terblanche, JS				Karsten, Minette; van Vuuren, Bettine Jansen; Barnaud, Adeline; Terblanche, John S.			Population Genetics of Ceratitis capitata in South Africa: Implications for Dispersal and Pest Management	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; COMPUTER-PROGRAM; MICROSATELLITE ANALYSIS; DIPTERA; INVASION; FLOW; TEPHRITIDAE; EXPANSION; DIFFERENTIATION; FASCIVENTRIS	The invasive Mediterranean fruit fly (medfly), Ceratitis capitata, is one of the major agricultural and economical pests globally. Understanding invasion risk and mitigation of medfly in agricultural landscapes requires knowledge of its population structure and dispersal patterns. Here, estimates of dispersal ability are provided in medfly from South Africa at three spatial scales using molecular approaches. Individuals were genotyped at 11 polymorphic microsatellite loci and a subset of individuals were also sequenced for the mitochondrial cytochrome oxidase subunit I gene. Our results show that South African medfly populations are generally characterized by high levels of genetic diversity and limited population differentiation at all spatial scales. This suggests high levels of gene flow among sampling locations. However, natural dispersal in C. capitata has been shown to rarely exceed 10 km. Therefore, documented levels of high gene flow in the present study, even between distant populations (> 1600 km), are likely the result of human-mediated dispersal or at least some form of long-distance jump dispersal. These findings may have broad applicability to other global fruit production areas and have significant implications for ongoing pest management practices, such as the sterile insect technique.	[Karsten, Minette] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, Matieland, South Africa; [van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Invas Biol, Auckland Pk, South Africa; [Barnaud, Adeline] IRD, Montpellier, France; [Karsten, Minette; Terblanche, John S.] Univ Stellenbosch, Ctr Invas Biol, Dept Conservat Ecol & Entomol, Matieland, South Africa	Stellenbosch University; University of Johannesburg; Institut de Recherche pour le Developpement (IRD); Stellenbosch University	Terblanche, JS (corresponding author), Univ Stellenbosch, Ctr Invas Biol, Dept Conservat Ecol & Entomol, Matieland, South Africa.	jst@sun.ac.za	Jansen van Vuuren, Bettine/E-6227-2013; Terblanche, John/AAB-4457-2020	Jansen van Vuuren, Bettine/0000-0002-5334-5358; barnaud, adeline/0000-0001-9896-1210; Terblanche, John/0000-0001-9665-9405	Fruitgro Science; NRF-THRIP; NRF Scarce Skills	Fruitgro Science; NRF-THRIP; NRF Scarce Skills	This study was funded by Fruitgro Science (JST), NRF-THRIP (P. Addison) and NRF Scarce Skills. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui A, 2010, INT J AGRIC BIOL, V12, P291; ANNECKE DP, 1982, INSECTS MITES CULTIV; [Anonymous], 1992, FRUIT FLIES EC SIGNI; ARITA L H, 1985, Proceedings of the Hawaiian Entomological Society, V25, P39; Baliraine FN, 2004, MOL ECOL, V13, P683, DOI 10.1046/j.1365-294X.2004.02105.x; Barclay HJ, 2011, INT J AGRON, V2011, DOI 10.1155/2011/409328; Barnes B, 2007, FLA ENTOMOL, V90, P41, DOI 10.1653/0015-4040(2007)90[41:PAQAIT]2.0.CO;2; Barr NB, 2006, MOL PHYLOGENET EVOL, V38, P216, DOI 10.1016/j.ympev.2005.10.013; Bedford E.C.G., 1998, CITRUS PESTS REPUBLI; Belkhir K, 1996, 5000 CNRS UMR U MONT; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonizzoni M, 2002, MOL ECOL, V11, P1915, DOI 10.1046/j.1365-294X.2002.01602.x; Bonizzoni M, 2004, MOL ECOL, V13, P3845, DOI 10.1111/j.1365-294X.2004.02371.x; Bonizzoni M, 2001, MOL ECOL, V10, P2515, DOI 10.1046/j.0962-1083.2001.01376.x; Bonizzoni M, 2000, INSECT MOL BIOL, V9, P251, DOI 10.1046/j.1365-2583.2000.00184.x; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Casey DG, 2001, MOL ECOL NOTES, V1, P120, DOI 10.1046/j.1471-8278.2001.00038.x; Chapuis MP, 2011, P ROY SOC B-BIOL SCI, V278, P3152, DOI 10.1098/rspb.2010.2605; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COYNE JA, 1987, AM NAT, V130, P70, DOI 10.1086/284698; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; De Meyer M, 2000, ZOOL J LINN SOC-LOND, V128, P439, DOI 10.1111/j.1096-3642.2000.tb01523.x; De Meyer M., 2002, P 6 INT FRUIT FLY S; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Duyck PF, 2006, J ANIM ECOL, V75, P518, DOI 10.1111/j.1365-2656.2006.01072.x; Ekesi S, 2007, FIELD GUIDE MANAGEME; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Fu YX, 1997, GENETICS, V147, P915; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; GASPERI G, 1991, HEREDITY, V67, P347, DOI 10.1038/hdy.1991.98; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Hendrichs J, 2007, AREA WIDE CONTROL IN; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kourti A, 2004, B ENTOMOL RES, V94, P449, DOI 10.1079/BER2004324; Lance D, 2005, STERILE INSECT TECHN; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Malacrida AR, 1998, J HERED, V89, P501, DOI 10.1093/jhered/89.6.501; MALACRIDA AR, 1992, HEREDITY, V69, P101, DOI 10.1038/hdy.1992.102; Manrakhan A, 2007, S AFRICAN FRUIT J, V6, P16; MANTEL N, 1967, CANCER RES, V27, P209; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SHARP JL, 1976, P HAWAII ENTOMOL SOC, V22, P335; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stratikopoulos EE, 2008, GENETICA, V133, P147, DOI 10.1007/s10709-007-9195-9; Tolley KA, 2008, DIVERS DISTRIB, V14, P400, DOI 10.1111/j.1472-4642.2007.00428.x; Villablanca FX, 1998, MOL ECOL, V7, P547, DOI 10.1046/j.1365-294x.1998.00351.x; Virgilio M, 2008, MOL PHYLOGENET EVOL, V48, P270, DOI 10.1016/j.ympev.2008.04.018; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429	73	48	48	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54281	10.1371/journal.pone.0054281	http://dx.doi.org/10.1371/journal.pone.0054281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342117	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700101
J	Milner, A; Page, A; LaMontagne, AD				Milner, Allison; Page, Andrew; LaMontagne, Anthony D.			Long-Term Unemployment and Suicide: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PSYCHIATRIC-ILLNESS; MEN; WOMEN; PARASUICIDE; EDINBURGH; BEHAVIOR; DENMARK; LENGTH; HEALTH; IMPACT	Purpose: There have been a number of reviews on the association+ between unemployment and suicide, but none have investigated how this relationship is influenced by duration of unemployment. Method: A systematic review and meta-analysis was conducted of those studies that assessed duration of unemployment as a risk factor for suicide. Studies considered as eligible for inclusion were population-based cohort or case-control designs; population-based ecological designs, or hospital based clinical cohort or case-control designs published in the year 1980 or later. Results: The review identified 16 eligible studies, out of a possible 10,358 articles resulting from a search of four databases: PubMed, Web of Knowledge, Scopus and Proquest. While all 16 studies measured unemployment duration in different ways, a common finding was that longer duration of unemployment was related to greater risk of suicide and suicide attempt. A random effects meta-analysis on a subsample of six cohort studies indicated that the pooled relative risk of suicide in relation to average follow-up time after unemployment was 1.70 (95% CI 1.22 to 2.18). However, results also suggested a possible habituation effect to unemployment over time, with the greatest risk of suicide occurring within five years of unemployment compared to the employed population (RR = 2.50, 95% CI 1.83 to 3.17). Relative risk appeared to decline in studies of those unemployed between 12 and 16 years compared to those currently employed (RR = 1.21, 95% CI 1.10 to 1.33). Conclusion: Findings suggest that long-term unemployment is associated with greater incidence of suicide. Results of the meta-analysis suggest that risk is greatest in the first five years, and persists at a lower but elevated level up to 16 years after unemployment. These findings are limited by the paucity of data on this topic.	[Milner, Allison; LaMontagne, Anthony D.] Univ Melbourne, Melbourne Sch Populat Hlth, VicHlth Ctr Promot Mental Hlth & Community Wellbe, McCaughey Ctr, Melbourne, Vic, Australia; [Page, Andrew] Univ Queensland, Sch Populat Hlth, Discipline Epidemiol & Biostat, Brisbane, Qld, Australia	University of Melbourne; University of Queensland	Milner, A (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, VicHlth Ctr Promot Mental Hlth & Community Wellbe, McCaughey Ctr, Melbourne, Vic, Australia.	allison.milner@unimelb.edu.au	LaMontagne, Anthony Daniel/AAX-3285-2021	LaMontagne, Anthony Daniel/0000-0002-5811-5906; Milner, Allison/0000-0003-4657-0503	National Health and Medical Research Council Capacity Building Grant in Population Health [546248]; Victorian Health Promotion Foundation	National Health and Medical Research Council Capacity Building Grant in Population Health(National Health and Medical Research Council (NHMRC) of Australia); Victorian Health Promotion Foundation	This work was supported by a National Health and Medical Research Council Capacity Building Grant in Population Health (grant number 546248) and McCaughey Centre funding from Victorian Health Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P598, DOI 10.1136/jech.2004.025288; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Classen TJ, 2012, HEALTH ECON, V21, P338, DOI 10.1002/hec.1719; Eliason M, 2009, J HUM RESOUR, V44, P277, DOI 10.1353/jhr.2009.0020; Fergusson DM, 2007, CRISIS, V28, P95, DOI 10.1027/0227-5910.28.2.95; Fergusson DM, 2001, SOC SCI MED, V53, P305, DOI 10.1016/S0277-9536(00)00344-0; Frese M., 1988, CAUSES COPING CONSEQ, P375, DOI DOI 10.1002/SMI.2460050217; Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034; Greenland S., 1998, MODERN EPIDEMIOLOGY, V2, P643; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; JIN RL, 1995, CAN MED ASSOC J, V153, P529; Kulik L, 2001, J EMPLOYMENT COUNS, V38, P15, DOI 10.1002/j.2161-1920.2001.tb00489.x; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lundin A, 2012, PUBLIC HEALTH, V126, P371, DOI 10.1016/j.puhe.2012.01.020; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; Maki N, 2010, FINLAND J EPIDEMIOL, V66, P302; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Morton M J, 1993, Int J Soc Psychiatry, V39, P87, DOI 10.1177/002076409303900202; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; PLATT S, 1990, SOC PSYCH PSYCH EPID, V25, P56; PLATT S, 1984, SOC SCI MED, V19, P93, DOI 10.1016/0277-9536(84)90276-4; PLATT S, 1985, PSYCHOL MED, V15, P113, DOI 10.1017/S0033291700020973; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Qin P, 2005, PREVENTION TREATMENT, P11; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shah A, 2008, PSYCHOL REP, V102, P398, DOI 10.2466/PR0.102.2.398-400; STACK S, 1984, SOCIOL FOCUS, V17, P17, DOI 10.1080/00380237.1984.10570459; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Standish-Barry H M, 1989, Int J Soc Psychiatry, V35, P303, DOI 10.1177/002076408903500402; StataCorp, 2012, STAT REL 12 1; WILSON SH, 1993, PUBLIC HEALTH, V107, P153, DOI 10.1016/S0033-3506(05)80436-6	32	163	163	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e51333	10.1371/journal.pone.0051333	http://dx.doi.org/10.1371/journal.pone.0051333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341881	Green Published, gold			2022-12-27	WOS:000313682700008
J	Agolory, SG; Barbot, O; Averhoff, F; Weiss, D; Wilson, E; Egger, J; Miller, J; Ogbuanu, I; Walton, S; Kahn, E				Agolory, Simon G.; Barbot, Oxiris; Averhoff, Francisco; Weiss, Don; Wilson, Elisha; Egger, Joseph; Miller, Jeffery; Ogbuanu, Ikechukwu; Walton, Sabrina; Kahn, Emily			Implementation of Non-Pharmaceutical Interventions by New York City Public Schools to Prevent 2009 Influenza A	PLOS ONE			English	Article							H1N1 VIRUS-INFECTIONS; PANDEMIC INFLUENZA; ABSENTEEISM; ILLNESS; TRANSMISSION; HOUSEHOLDS; OUTBREAK; CHILDREN	Introduction: Children are important transmitters of influenza in the community and a number of non-pharmaceutical interventions (NPIs), including hand washing and use of hand sanitizer, have been recommended to mitigate the transmission of influenza, but limited information is available regarding schools' ability to implement these NPIs during an influenza outbreak. We evaluated implementation of NPIs during fall 2009 in response to H1N1 pandemic influenza (pH1N1) by New York City (NYC) public schools. Methods: From January 25 through February 9, 2010, an online survey was sent to all the 1,632 NYC public schools and principals were asked to participate in the survey or to designate a school nurse or other school official with knowledge of school policies and characteristics to do so. Results: Of 1,633 schools, 376(23%) accessed and completed the survey. Nearly all respondents (99%) implemented at least two NPIs. Schools that had a Flu Response Team (FRT) as a part of school emergency preparedness plan were more likely to implement the NPI guidelines recommended by NYC public health officials than schools that did not have a FRT. Designation of a room for isolating ill students, for example, was more common in schools with a FRT (72%) than those without (53%) (p < 0.001). Conclusions: Implementing an NPI program in a large school system to mitigate the effects of an influenza outbreak is feasible, but there is potential need for additional resources in some schools to increase capacity and adherence to all recommendations. Public health influenza-preparedness plans should include school preparedness planning and FRTs.	[Agolory, Simon G.; Miller, Jeffery; Ogbuanu, Ikechukwu] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Barbot, Oxiris] Dept Hlth, Baltimore, MD USA; [Averhoff, Francisco; Walton, Sabrina; Kahn, Emily] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Barbot, Oxiris; Weiss, Don; Wilson, Elisha; Egger, Joseph] Dept Hlth & Mental Hyg, New York, NY USA; [Egger, Joseph] SciMetrika LLC, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Agolory, SG (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	sagolory@cdc.gov	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Kahn, Emily/0000-0001-7812-7958	Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention	Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention	This study was funded by the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2010, AM J INFECT CONTROL, V38, P251, DOI 10.1016/j.ajic.2009.12.007; *CDCP, 2009, FLU ACT SURV; Center for Disease Control and Prevention, 2010, UPD CDC EST 2009 H1N; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Centers for Disease Control and Prevention, 2009, CDC GUID STAT LOC PU; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; CHIN T D, 1960, Public Health Rep, V75, P148; COLLINS SD, 1951, PUBLIC HEALTH REP, V66, P1487, DOI 10.2307/4587915; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; GLEZEN WP, 1989, VIRAL INFECTIONS HUM, P419; Hammond B, 2000, AM J INFECT CONTROL, V28, P340, DOI 10.1067/mic.2000.107276; Iuliano AD, 2011, CLIN INFECT DIS, V52, pS161, DOI 10.1093/cid/ciq032; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Meadows E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-50; Mitchell T, 2011, CLIN INFECT DIS, V52, pS138, DOI 10.1093/cid/ciq056; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Munayco CV, 2009, EUROSURVEILLANCE, V2009, P14; Nasrullah M, 2012, INT J INFECT DIS, V16, pE382, DOI 10.1016/j.ijid.2012.01.010; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; New York City Department of Education, SCH DEM ACC SNAPSH; New York City Department of Health and Mental Hygiene, 2010, GUID SCH K 12 RESP I; *NY CIT DEP HLTH M, 2009, ST FRANC PREP UPD SW; Office of Elementary and Secondary Education, TITL 1 A; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	30	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e50916	10.1371/journal.pone.0050916	http://dx.doi.org/10.1371/journal.pone.0050916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341877	gold, Green Published			2022-12-27	WOS:000314707700004
J	Al-Saeedi, FJ; Mathew, PM; Luqmani, YA				Al-Saeedi, Fatma J.; Mathew, Princy M.; Luqmani, Yunus A.			Assessment of Tracer Tc-99m(V)-DMSA Uptake as a Measure of Tumor Cell Proliferation In Vitro	PLOS ONE			English	Article							TC-99M DMSA UPTAKE; DIMERCAPTOSUCCINIC ACID; GROWTH-FACTOR; KINETIC-ANALYSIS; TC-99M-(V)-DMSA UPTAKE; METASTATIC CARCINOMA; MEDULLARY CARCINOMA; CANCER-CELLS; PENTAVALENT; IMATINIB	Purpose: To examine whether Tc-99m(V)-DMSA could be used as a non-invasive measure of cancer cell proliferation. Methods: Human breast cancer MCF-7, MDA-MB-231 and pII, and prostate cancer PC-3 cell lines were grown to 30, 50 and 100% confluency and pulsed with Tc-99m(V)-DMSA in media for 60 min at 37 degrees C. DNA synthesis was analysed by quantification of the S phase using flow cytometry, [methyl-H-3]thymidine incorporation and expression of proliferation markers PCNA and Ki-67 using realtime PCR. One way ANOVA was used to compare groups. Results: In all cell lines rates of Tc-99m(V)-DMSA uptake were inversely related to cell density. This was paralleled by similar trends in S phase proportions, [methyl-H-3]thymidine incorporation and expression of PCNA and Ki-67. Conclusion: Rates of Tc-99m(V)-DMSA uptake into different types of tumour cells correlate well with cell density that is useful as a non-invasive measure of tumour cellular proliferation in vivo.	[Al-Saeedi, Fatma J.; Mathew, Princy M.] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Nucl Med, Hawally, Jabriya, Kuwait; [Luqmani, Yunus A.] Kuwait Univ, Hlth Sci Ctr, Fac Pharm, Dept Pharmaceut Chem, Hawally, Jabriya, Kuwait	Kuwait University; Kuwait University	Al-Saeedi, FJ (corresponding author), Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Nucl Med, Hawally, Jabriya, Kuwait.	fatimas@hsc.edu.kw	AL-Saeedi, Fatma/AAT-8279-2020; Alsaeedi, Fatma/AAD-8211-2021	AL-Saeedi, Fatma/0000-0003-0932-6261; 	Kuwait University Research Sector [MN 03/07];  [GM 01/01];  [GM 01/05]	Kuwait University Research Sector; ; 	The authors would like to acknowledge Research Grant MN 03/07 from Kuwait University Research Sector and for support through Grants GM 01/01 and GM 01/05 funding the Research Core Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2001, CANCER RES, V61, P3599; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al-Saeedi F, 2005, EUR J NUCL MED MOL I, V32, P660, DOI 10.1007/s00259-004-1707-6; Atasever T, 1997, NUKLEARMED, V36, P223; Babbar A, 1991, J Nucl Biol Med, V35, P100; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOWER PJ, 1991, J NUCL MED, V32, P845; Buck AK, 2005, EUR J NUCL MED MOL I, V32, P525, DOI 10.1007/s00259-004-1706-7; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; CLARKE SEM, 1988, J NUCL MED, V29, P33; CONTI PS, 1994, NUCL MED BIOL, V21, P1045, DOI 10.1016/0969-8051(94)90176-7; DAVISON A, 1980, INORG CHEM, V19, P1988, DOI 10.1021/ic50209a031; Denoyer D, 2005, EUR J NUCL MED MOL I, V32, P820, DOI 10.1007/s00259-005-1773-4; Denoyer D, 2004, EUR J NUCL MED MOL I, V31, P77, DOI 10.1007/s00259-003-1334-7; Garnuszek P, 2012, NUCL MED REV, V15, P95, DOI 10.5603/NMR.2012.0003; Glunde K, 2006, MOL PHARMACEUT, V3, P496, DOI 10.1021/mp060067e; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HIGASHI K, 1993, J NUCL MED, V34, P414; Hirano T, 1997, J NUCL MED, V38, P1741; HIRANO T, 1995, J NUCL MED, V36, P202; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; International Atomic Energy Agency, 2008, INT AT EN AG TECHN R; JEGHERS O, 1986, J NUCL MED, V27, P1223; Kakita A, 2004, ATHEROSCLEROSIS, V174, P17, DOI 10.1016/j.atherosclerosis.2003.12.039; KASHYAP R, 1992, CLIN NUCL MED, V17, P119, DOI 10.1097/00003072-199202000-00011; Kilic T, 2000, CANCER RES, V60, P5143; Kirath H, 1998, JPN J OPHTHALMOL, V42, P60, DOI 10.1016/S0021-5155(97)00110-X; KOBAYASHI H, 1995, EUR J NUCL MED, V22, P559, DOI 10.1007/BF00817283; Kothari K, 1999, APPL RADIAT ISOTOPES, V51, P43, DOI 10.1016/S0969-8043(98)00194-8; Ksienski D, 2011, CLIN MED INSIGHTS-ON, V5, P365, DOI 10.4137/CMO.S4259; Lam ASK, 1997, NUCL MED COMMUN, V18, P907, DOI 10.1097/00006231-199710000-00003; LAMKI L, 1984, J NUCL MED, V25, P733; Le Jeune N, 2006, EUR J CANCER, V42, P1004, DOI 10.1016/j.ejca.2006.01.023; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Mankoff DA, 1999, J NUCL MED, V40, P614; Marques FLN, 2007, J LABELLED COMP RA S, V50, pS445; Muzi M, 2005, J NUCL MED, V46, P274; Muzi M, 2006, J NUCL MED, V47, P1612; OHTA H, 1988, NUCL MED COMMUN, V9, P105; OHTA H, 1984, J NUCL MED, V25, P323; OKADA J, 1992, J NUCL MED, V33, P325; Papantoniou V, 2005, BREAST CANCER RES, V7, pR33, DOI 10.1186/bcr948; Papantoniou V, 2002, NUCL MED COMMUN, V23, P461, DOI 10.1097/00006231-200205000-00006; Papantoniou V, 2001, EUR J NUCL MED, V28, P923, DOI 10.1007/s002590100545; Papantoniou V, 1999, EUR J NUCL MED, V26, P977; Papantoniou V, 2012, IMAGING BREAST TECHN, P61; Papantoniou VJ, 2004, BREAST CANCER RES, V6, pR56, DOI 10.1186/bcr751; Park JY, 2007, NUCL MED BIOL, V34, P1029, DOI 10.1016/j.nucmedbio.2007.06.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raymond E, 2008, J CLIN ONCOL, V26, P4659, DOI 10.1200/JCO.2008.16.9235; Saha G.B., 1992, FUNDAMENTALS NUCL PH, V3rd edition; Saha GB, 2004, FUNDAMENTALS NUCL PH; Alexander S, 2007, SEMIN NUCL MED, V37, P429, DOI 10.1053/j.semnuclmed.2007.08.001; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Shields AF, 2006, MOL IMAGING BIOL, V8, P141, DOI 10.1007/s11307-006-0039-2; Shukla J, 2005, PHARMAZIE, V60, P583; Smith TAD, 2006, J NUCL MED, V47, P1525; Tsiouris S, 2007, J NEURO-ONCOL, V85, P291, DOI 10.1007/s11060-007-9410-7; Vesselle H, 2003, J NUCL MED, V44, P1482; WASHBURN LC, 1995, NUCL MED BIOL, V22, P689, DOI 10.1016/0969-8051(94)00145-A; WATKINSON JC, 1989, J NUCL MED, V30, P174; WESTERA G, 1985, INT J APPL RADIAT IS, V36, P311, DOI 10.1016/0020-708X(85)90091-2	62	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54361	10.1371/journal.pone.0054361	http://dx.doi.org/10.1371/journal.pone.0054361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335999	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700057
J	Chang, HY; Shih, MH; Huang, HC; Tsai, SR; Juan, HF; Lee, SC				Chang, Hsin-Yi; Shih, Meng-Her; Huang, Hsuan-Cheng; Tsai, Shang-Ru; Juan, Hsueh-Fen; Lee, Si-Chen			Middle Infrared Radiation Induces G(2)/M Cell Cycle Arrest in A549 Lung Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; OXIDATIVE STRESS; SINGLET OXYGEN; ACTION SPECTRA; HUMAN SKIN; ULTRAVIOLET; INDUCTION; PATHWAY; KINASE; REPAIR	There were studies investigating the effects of broadband infrared radiation (IR) on cancer cell, while the influences of middle-infrared radiation (MIR) are still unknown. In this study, a MIR emitter with emission wavelength band in the 3-5 mu m region was developed to irradiate A549 lung adenocarcinoma cells. It was found that MIR exposure inhibited cell proliferation and induced morphological changes by altering the cellular distribution of cytoskeletal components. Using quantitative PCR, we found that MIR promoted the expression levels of ATM (ataxia telangiectasia mutated), ATR (ataxia-telangiectasia and Rad3-related and Rad3-related), TP53 (tumor protein p53), p21 (CDKN1A, cyclin-dependent kinase inhibitor 1A) and GADD45 (growth arrest and DNA-damage inducible), but decreased the expression levels of cyclin B coding genes, CCNB1 and CCNB2, as well as CDK1 (Cyclin-dependent kinase 1). The reduction of protein expression levels of CDC25C, cyclin B1 and the phosphorylation of CDK1 at Thr-161 altogether suggest G(2)/M arrest occurred in A549 cells by MIR. DNA repair foci formation of DNA double-strand breaks (DSB) marker gamma-H2AX and sensor 53BP1 was induced by MIR treatment, it implies the MIR induced G2/M cell cycle arrest resulted from DSB. This study illustrates a potential role for the use of MIR in lung cancer therapy by initiating DSB and blocking cell cycle progression.	[Chang, Hsin-Yi; Shih, Meng-Her; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Tsai, Shang-Ru; Juan, Hsueh-Fen; Lee, Si-Chen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lee, Si-Chen] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; sclee@cc.ee.ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; JUAN, HSUEH-FEN/0000-0003-4876-3309; Lee, Si-Chen/0000-0002-3788-2030; Chang, Hsin-Yi/0000-0002-2742-0676	National Science Council, Taiwan [NSC 100-2120-M-002-014, NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3, 101R4000]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project	This work was supported by the National Science Council, Taiwan (NSC 100-2120-M-002-014, NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001MY3) and National Taiwan University Cutting-Edge Steering Research Project (10R70602C3 and 101R4000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albro PW, 1997, PHOTOCHEM PHOTOBIOL, V66, P316, DOI 10.1111/j.1751-1097.1997.tb03154.x; [Anonymous], 1980, INFRARED CHARACTERIS; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; Chan TA, 2000, GENE DEV, V14, P1584; Chang CH, 2011, TOXICOL SCI, V119, P84, DOI 10.1093/toxsci/kfq309; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Frank S, 2004, J INVEST DERMATOL, V123, P823, DOI 10.1111/j.0022-202X.2004.23472.x; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Graf A, 2007, MEAS SCI TECHNOL, V18, pR59, DOI 10.1088/0957-0233/18/7/E01; Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576; Harper JV, 2010, DNA REPAIR, V9, P907, DOI 10.1016/j.dnarep.2010.06.002; INOUE S, 1989, INT J BIOMETEOROL, V33, P145, DOI 10.1007/BF01084598; Ishibashi J, 2008, MED ONCOL, V25, P229, DOI 10.1007/s12032-007-9020-4; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; JONES CA, 1987, RADIAT RES, V110, P244, DOI 10.2307/3576902; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; KASPRZAK KS, 1995, CANCER INVEST, V13, P411, DOI 10.3109/07357909509031921; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kim MS, 2006, BRIT J DERMATOL, V155, P1131, DOI 10.1111/j.1365-2133.2006.07510.x; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Lin CC, 2008, ARTERIOSCL THROM VAS, V28, P739, DOI 10.1161/ATVBAHA.107.160085; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Menezes S, 1998, J INVEST DERMATOL, V111, P629, DOI 10.1046/j.1523-1747.1998.00338.x; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; Morris JR, 2010, CANCER RES, V70, P3861, DOI 10.1158/0008-5472.CAN-10-0468; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rau CS, 2011, PHOTOCHEM PHOTOBIOL, V87, P441, DOI 10.1111/j.1751-1097.2010.00853.x; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skovsen E, 2005, J PHYS CHEM B, V109, P8570, DOI 10.1021/jp051163i; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Valencia A, 2006, FREE RADICAL BIO MED, V41, P1704, DOI 10.1016/j.freeradbiomed.2006.09.006; Viteri G, 2003, PHOTOCHEM PHOTOBIOL, V77, P535, DOI 10.1562/0031-8655(2003)077<0535:SOTIBT>2.0.CO;2; WELLS RL, 1984, MUTAT RES, V129, P251, DOI 10.1016/0027-5107(84)90158-1; Yamashita Kikuji, 2010, Journal of Electromagnetic Analysis and Applications, V2, P382, DOI 10.4236/jemaa.2010.26050; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x	57	25	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54117	10.1371/journal.pone.0054117	http://dx.doi.org/10.1371/journal.pone.0054117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335992	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700050
J	Vellanki, RN; Zhang, LL; Volchuk, A				Vellanki, Ravi N.; Zhang, Liling; Volchuk, Allen			OASIS/CREB3L1 Is Induced by Endoplasmic Reticulum Stress in Human Glioma Cell Lines and Contributes to the Unfolded Protein Response, Extracellular Matrix Production and Cell Migration	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTOR; ER STRESS; CREB/ATF-FAMILY; FACTOR OASIS; EXPRESSION; TRANSDUCER; APOPTOSIS; GENES; DEATH	OASIS is a transcription factor similar to ATF6 that is activated by endoplasmic reticulum stress. In this study we investigated the expression of OASIS in human glioma cell lines and the effect of OASIS knock-down on the ER stress response and cell migration. OASIS mRNA was detected in three distinct glioma cell lines (U373, A172 and U87) and expression levels were increased upon treatment with ER stress-inducing compounds in the U373 and U87 lines. OASIS protein, which is glycosylated on Asn-513, was detected in the U373 and U87 glioma lines at low levels in control cells and protein expression was induced by ER stress. Knock-down of OASIS in human glioma cell lines resulted in an attenuated unfolded protein response to ER stress (reduced GRP78/BiP and GRP94 induction) and decreased expression of chondroitin sulfate proteoglycan extracellular matrix proteins, but induction of the collagen gene Col1a1 was unaffected. Cells in which OASIS was knocked-down exhibited altered cell morphology and reduced cell migration. These results suggest that OASIS is important for the ER stress response and maintenance of some extracellular matrix proteins in human glioma cells.	[Vellanki, Ravi N.; Zhang, Liling; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Volchuk, Allen] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Volchuk, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada.	avolchuk@uhnres.utoronto.ca	Vellanki, Ravi/M-8738-2019	Vellanki, Ravi/0000-0002-5081-3187	Banting and Best Diabetes Centre (University of Toronto); CIHR operating grant [MOP 86641]	Banting and Best Diabetes Centre (University of Toronto)(University of Toronto); CIHR operating grant(Canadian Institutes of Health Research (CIHR))	RNV was funded by a post-doctoral fellowship from the Banting and Best Diabetes Centre (University of Toronto). This work was funded by a CIHR operating grant to AV (MOP 86641). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. James Rutka and Dr. Christian Smith (Hospital for Sick Children, Toronto) for providing the human glioma cell lines and comments on the manuscript. RNV was funded by a post-doctoral fellowship from the Banting and Best Diabetes Centre (University of Toronto).	Bailey D, 2007, ANTIOXID REDOX SIGN, V9, P2305, DOI 10.1089/ars.2007.1796; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; BECKMAN G, 1971, HUM HERED, V21, P238, DOI 10.1159/000152408; BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Hikake T, 2003, ANAT EMBRYOL, V206, P373, DOI 10.1007/s00429-003-0311-z; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Johnson GG, 2011, CURR PHARM DESIGN, V17, P284; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lander C, 1997, J NEUROSCI, V17, P1928; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Natori T, 2008, CELL MOL NEUROBIOL, V28, P857, DOI 10.1007/s10571-008-9262-5; Ogaki S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-13; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Correa TCS, 2010, J CELL BIOCHEM, V110, P52, DOI 10.1002/jcb.22472; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vellanki RN, 2010, ENDOCRINOLOGY, V151, P4146, DOI 10.1210/en.2010-0137; Wang DY, 2005, BRAIN PATHOL, V15, P318; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	39	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54060	10.1371/journal.pone.0054060	http://dx.doi.org/10.1371/journal.pone.0054060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335989	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700047
J	Zaccheus, MV; Ali, T; Cloeckaert, A; Zygmunt, MS; Weintraub, A; Iriarte, M; Moriyon, I; Widmalm, G				Zaccheus, Mona V.; Ali, Tara; Cloeckaert, Axel; Zygmunt, Michel S.; Weintraub, Andrej; Iriarte, Maite; Moriyon, Ignacio; Widmalm, Goran			The Epitopic and Structural Characterization of Brucella suis Biovar 2 O-Polysaccharide Demonstrates the Existence of a New M-Negative C-Negative Smooth Brucella Serovar	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODIES; LIPOPOLYSACCHARIDE HETEROGENEITY; A-ANTIGENS; ABORTUS; MICE; NMR; SENSITIVITY; RESONANCE; ZOONOSIS	The brucellae are Gram-negative bacteria that cause an important zoonosis. Studies with the main Brucella species have shown that the O-antigens of the Brucella smooth lipopolysaccharide are alpha-(1 -> 2) and alpha-(1 -> 3)-linked N-formyl-perosamine polysaccharides that carry M, A and C (A = M, A>M and A<M) epitopes relevant in serodiagnosis and typing. We report that, in contrast to the B. suis biovar 1 O-antigen used as a reference or to all described Brucella O-antigens, B. suis biovar 2 O-antigen failed to bind monoclonal antibodies of C (A = M), C (M>A) and M specificities. However, the biovar 2 O-antigen bound monoclonal antibodies to the Brucella A epitope, and to the C/Y epitope shared by brucellae and Yersinia enterocolitica O:9, a bacterium that carries an N-formyl-perosamine O-antigen in exclusively alpha-(1 -> 2)-linkages. By C-13 NMR spectroscopy, B. suis biovar 1 but not B. suis biovar 2 or Y.enterocolitica O:9 polysaccharide showed the signal characteristic of alpha-(1 -> 3)-linked N-formyl-perosamine, indicating that biovar 2 may altogether lack this linkage. Taken together, the NMR spectroscopy and monoclonal antibody analyses strongly suggest a role for alpha-(1 -> 3)-linked N-formyl-perosamine in the C (A = M) and C (M>A) epitopes. Moreover, they indicate that B. suis biovar 2 O-antigen lacks some lipopolysaccharide epitopes previously thought to be present in all smooth brucellae, thus representing a new brucella serovar that is M-negative, C-negative. Serologically and structurally this new serovar is more similar to Y. enterocolitica O:9 than to other brucellae.	[Zaccheus, Mona V.; Ali, Tara; Widmalm, Goran] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden; [Ali, Tara; Weintraub, Andrej] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Cloeckaert, Axel; Zygmunt, Michel S.] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Cloeckaert, Axel; Zygmunt, Michel S.] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France; [Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain; [Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	Stockholm University; Karolinska Institutet; Karolinska University Hospital; INRAE; Universite de Tours; University of Navarra; University of Navarra	Moriyon, I (corresponding author), Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain.	imoriyon@unav.es; gw@organ.su.se	Moriyon, Ignacio/N-4764-2016; IRIARTE, MAITE/L-9460-2014	Moriyon, Ignacio/0000-0002-4288-0195; IRIARTE, MAITE/0000-0002-6726-8920; Zygmunt, Michel/0000-0002-1389-6366; Widmalm, Goran/0000-0001-8303-4481; Weintraub, Andrej/0000-0003-3646-247X	Swedish Research Council; Knut and Alice Wallenberg Foundation; European Commission [QLK2-CT-2002-00918]; Ministerio de Ciencia y Tecnologia of Spain [AGL2008-04514]; Fundacion para la Investigacion Medica Aplicada (FIMA)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion Medica Aplicada (FIMA)	This work was supported by grants from the Swedish Research Council, The Knut and Alice Wallenberg Foundation, the European Commission (Research Contract QLK2-CT-2002-00918), Ministerio de Ciencia y Tecnologia of Spain (AGL2008-04514) and Fundacion para la Investigacion Medica Aplicada (FIMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2005, J VET MED B, V52, P444, DOI 10.1111/j.1439-0450.2005.00898.x; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Baucheron S, 2002, RES MICROBIOL, V153, P277, DOI 10.1016/S0923-2508(02)01317-7; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; BUNDLE DR, 1989, INFECT IMMUN, V57, P2829, DOI 10.1128/IAI.57.9.2829-2836.1989; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Cloeckaert A, 1998, CLIN DIAGN LAB IMMUN, V5, P862, DOI 10.1128/CDLI.5.6.862-870.1998; CLOECKAERT A, 1993, J GEN MICROBIOL, V139, P1551, DOI 10.1099/00221287-139-7-1551; DEBEER T, 1994, FEBS LETT, V348, P1, DOI 10.1016/0014-5793(94)00547-8; DOMKE T, 1991, J MAGN RESON, V95, P174, DOI 10.1016/0022-2364(91)90334-P; DOUGLAS JT, 1988, J CLIN MICROBIOL, V26, P1353, DOI 10.1128/JCM.26.7.1353-1356.1988; FERNANDEZLAGO L, 1982, INFECT IMMUN, V38, P778, DOI 10.1128/IAI.38.2.778-780.1982; Garin-Bastuji B, 2006, P INT SOC CHEM DIS M; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; KENNE L, 1988, J CHEM SOC PERK T 1, P1183, DOI 10.1039/p19880001183; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LIMET J, 1987, ANN INST PASTEUR IMM, V138, P417, DOI 10.1016/S0769-2625(87)80052-1; LIMET JN, 1989, J MED MICROBIOL, V30, P37, DOI 10.1099/00222615-30-1-37; Lipinski T, 2002, EUR J BIOCHEM, V269, P93, DOI 10.1046/j.0014-2956.2001.02638.x; MEIKLE PJ, 1989, INFECT IMMUN, V57, P2820, DOI 10.1128/IAI.57.9.2820-2828.1989; Moreno E, 2002, VET MICROBIOL, V90, P209, DOI 10.1016/S0378-1135(02)00210-9; Nyberg NT, 2005, MAGN RESON CHEM, V43, P971, DOI 10.1002/mrc.1698; Parella T, 1997, J MAGN RESON, V126, P274, DOI 10.1006/jmre.1997.1164; PERRY MB, 1990, ADVANCES IN BRUCELLOSIS RESEARCH, P76; PETERS T, 1990, CAN J CHEM, V68, P979, DOI 10.1139/v90-154; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Soderman P, 1998, J CHEM SOC PERK T 2, P639, DOI 10.1039/a707346a; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Weynants V, 1997, INFECT IMMUN, V65, P1939, DOI 10.1128/IAI.65.5.1939-1943.1997; Weynants V, 1996, CLIN DIAGN LAB IMMUN, V3, P309, DOI 10.1128/CDLI.3.3.309-314.1996; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Zheludkov MM, 2010, BIOL BULL+, V37, P709, DOI 10.1134/S106235901007006X; Zygmunt MS, 2012, CLIN VACCINE IMMUNOL, V19, P1370, DOI 10.1128/CVI.00300-12	36	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53941	10.1371/journal.pone.0053941	http://dx.doi.org/10.1371/journal.pone.0053941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335981	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700039
J	Cho, IH; Kim, DH; Lee, MJ; Bae, J; Lee, KH; Song, WK				Cho, In Ha; Kim, Dae Hwan; Lee, Min-Jung; Bae, Jeomil; Lee, Kun Ho; Song, Woo Keun			SPIN90 Phosphorylation Modulates Spine Structure and Synaptic Function	PLOS ONE			English	Article							DENDRITIC SPINES; MORPHOGENESIS; COMPLEX; PROTEIN; ACTIN; ACTIVATION; PLASTICITY; PSD-95; MECHANISMS; MORPHOLOGY	The correct rearrangement of postsynaptic components in dendritic spines is important for driving changes of spine structure and synaptic function. SPIN90 plays an essential role in many cellular processes including actin polymerization, endocytosis, growth cone formation and dendritic spine morphogenesis. Here, we demonstrate that SPIN90, which is a binding partner of PSD95 and Shank in spines, is targeted to synapses and leads to enhanced synaptic activity in neurons. We show, using in vitro and in vivo kinase assays, that SPIN90 is tyrosine phosphorylated by Src kinase. SPIN90 that was tyrosine-phosphorylated by Src was targeted to dendritic spines in cultured hippocampal neurons. Moreover, a SPIN90 phospho-deficient mutant was unable to accumulate at dendritic spines whereas SPIN90 WT and a phospho-mimicking mutant were localized at spines and bound PSD95 and Shank with increased efficiency. Consistent with these findings, hippocampal neurons that overexpressed SPIN90 WT or a phospho-mimicking mutant had enlarged spine heads, leading to enhanced postsynaptic function in terms of both amplitude and frequency. Together, our findings show that SPIN90 modulates synaptic activity in neurons as a result of its phosphorylation.	[Cho, In Ha; Kim, Dae Hwan; Lee, Min-Jung; Bae, Jeomil; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Ctr, Kwangju, South Korea; [Lee, Kun Ho] Chosun Univ, Dept Marine Life Sci, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Chosun University	Song, WK (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Ctr, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Bio Imaging and Cell Dynamics Research Center [2012-0000761]; Converging Research Center Program [2011K000690]; National Research Foundation [2011-0017009]	Bio Imaging and Cell Dynamics Research Center; Converging Research Center Program; National Research Foundation	This work was supported in part by the Bio Imaging and Cell Dynamics Research Center (2012-0000761) and the Converging Research Center Program (2011K000690) and National Research Foundation (Kun Ho Lee, 2011-0017009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrar S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-39; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; He KW, 2011, J NEUROPHYSIOL, V105, P1897, DOI 10.1152/jn.00913.2010; Hering H, 2003, J NEUROSCI, V23, P11759; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hoe HS, 2009, BIOCHEM BIOPH RES CO, V384, P55, DOI 10.1016/j.bbrc.2009.04.069; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Kim DJ, 2006, J BIOL CHEM, V281, P617, DOI 10.1074/jbc.M504450200; Kim SM, 2011, EXP CELL RES, V317, P2276, DOI 10.1016/j.yexcr.2011.06.018; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Kim Y, 2005, J NEUROSCI, V25, P9515, DOI 10.1523/JNEUROSCI.1643-05.2005; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lee S, 2006, EMBO J, V25, P4983, DOI 10.1038/sj.emboj.7601349; Li D, 2011, J PHYSIOL-LONDON, V589, P4491, DOI 10.1113/jphysiol.2011.215566; Lim CS, 2001, J BIOL CHEM, V276, P12871, DOI 10.1074/jbc.M009411200; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Sokolova IV, 2006, J NEUROPHYSIOL, V95, P2570, DOI 10.1152/jn.00617.2005; Takahashi H, 2003, J NEUROSCI, V23, P6586; Teodorof C, 2009, EXP CELL RES, V315, P2410, DOI 10.1016/j.yexcr.2009.05.010; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	47	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54276	10.1371/journal.pone.0054276	http://dx.doi.org/10.1371/journal.pone.0054276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342115	gold, Green Submitted, Green Published			2022-12-27	WOS:000314759400139
J	Guo, QH; Yang, Y; Mu, YM; Lu, JM; Pan, CY; Dou, JT; Lv, ZH; Ba, JM; Wang, BA; Zou, XM; Yang, LJ; Ouyang, JZ; Yang, GQ; Wang, XL; Du, J; Gu, WJ; Jin, N; Chen, K; Zang, L; Erickson, BJ				Guo, Qinghua; Yang, Yan; Mu, Yiming; Lu, Jvming; Pan, Changyu; Dou, Jingtao; Lv, Zhaohui; Ba, Jianming; Wang, Baoan; Zou, Xiaoman; Yang, Lijuan; Ouyang, Jinzhi; Yang, Guoqing; Wang, Xianling; Du, Jin; Gu, Weijun; Jin, Nan; Chen, Kang; Zang, Li; Erickson, Bradley J.			Pituitary Stalk Interruption Syndrome in Chinese People: Clinical Characteristic Analysis of 55 Cases	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; IDIOPATHIC HYPOPITUITARISM; ECTOPIC NEUROHYPOPHYSIS; CHILDREN; TRANSECTION; DISORDERS; ADULTHOOD; STATURE	Objective: Pituitary stalk interruption syndrome (PSIS) is characterized by the absence of pituitary stalk, pituitary hypoplasia, and ectopic posterior pituitary. Due to the rarity of PSIS, clinical data are limited, especially in Chinese people. Herein, we analyzed the clinical characteristics of patients diagnosed with PSIS from our center over 10 years. Patients and Methods: We retrospectively analyzed the clinical manifestations and laboratory and MRI findings in 55 patients with PSIS. Results: Of the 55 patients with PSIS, 48 (87.3%) were male. The average age was 19.7 +/- 6.7 years and there was no familial case. A history of breech delivery was documented in 40 of 45 patients (88.9%) and 19 of 55 patients (34.5%) had a history of dystocia. Short stature was found in 47 of 55 patients (85.5%) and bone age delayed 7.26 +/- 5.37 years. Secondary sex characteristics were poor or undeveloped in most patients. The prevalence of deficiencies in growth hormone, gonadotropins, corticotropin, and thyrotropin were 100%, 95.8%, 81.8%, 76.3%, respectively. Hyperprolactinemia was found in 36.4% of patients. Three or more pituitary hormone deficiencies were found in 92.7% of the patients. All patients had normal posterior pituitary function and absent pituitary stalk on imaging. The average height of anterior pituitary was 28 mm, documented anterior pituitary hypoplasia. Midline abnormalities were presented in 9.1% of patients. Conclusions: The clinical features of our Chinese PSIS patients seem to be different from other reported patients in regarding to the higher degree of hypopituitarism and lower prevalence of midline defects. In addition, our patients were older at the time of case detection and the bone age was markedly delayed. We also had no cases of familial PSIS.	[Guo, Qinghua; Yang, Yan; Mu, Yiming; Lu, Jvming; Pan, Changyu; Dou, Jingtao; Lv, Zhaohui; Ba, Jianming; Wang, Baoan; Zou, Xiaoman; Yang, Lijuan; Ouyang, Jinzhi; Yang, Guoqing; Wang, Xianling; Du, Jin; Gu, Weijun; Jin, Nan; Chen, Kang; Zang, Li] Chinese Peoples Liberat Army Gen Hosp, Div Endocrinol, Beijing, Peoples R China; [Erickson, Bradley J.] Mayo Clin, Mayo Med Sch, Rochester, MN USA	Chinese People's Liberation Army General Hospital; Mayo Clinic	Mu, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Div Endocrinol, Beijing, Peoples R China.	muyiming@301hospital.com.cn			National Natural Science Foundation of China [81270866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work has been partially supported by the National Natural Science Foundation of China (Project Grant No: 81270866). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abernethy LJ, 1998, EUR J RADIOL, V26, P102, DOI 10.1016/S0720-048X(97)00086-7; Albertsson-Wikland K, 1990, Acta Paediatr Scand Suppl, V370, P115; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; Barbeau C, 1998, ARCH PEDIATRIE, V5, P274, DOI 10.1016/S0929-693X(97)89368-2; Chen S, 1999, J CLIN ENDOCR METAB, V84, P2408, DOI 10.1210/jc.84.7.2408; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; CRAFT WH, 1980, J PEDIATR-US, V96, P397, DOI 10.1016/S0022-3476(80)80680-9; den Ouden DT, 2002, J CLIN ENDOCR METAB, V87, P5430, DOI 10.1210/jc.2002-020672; El Chehadeh-Djebbar S, 2011, EUR J MED GENET, V54, P369, DOI 10.1016/j.ejmg.2011.03.001; Fang XJ, 2007, MED WORLD, V02, P16; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; FUJISAWA I, 1987, RADIOLOGY, V165, P487, DOI 10.1148/radiology.165.2.3659371; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Gudat D., 2008, SCI SYNTHESIS, P155; [郭清华 GUO Qinghua], 2008, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V24, P480; Hamilton J, 1998, AM J NEURORADIOL, V19, P1609; Ioachimescu AG, 2012, PITUITARY, V15, P405, DOI 10.1007/s11102-011-0337-9; Kageyama K, 1998, INTERNAL MED, V37, P472, DOI 10.2169/internalmedicine.37.472; Kornreich L, 1998, AM J NEURORADIOL, V19, P1495; Leger J, 2005, J CLIN ENDOCR METAB, V90, P650, DOI 10.1210/jc.2004-1274; Liu Y, 2004, CHINESE J CLIN NEURO, V17, P456; Marcu M, 2008, BMC ENDOCR DISORD, V11, P7; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Tauber M, 2005, HORM RES, V64, P266, DOI 10.1159/000089425; Vijayanand P, 2007, INDIAN J PEDIATR, V74, P874, DOI 10.1007/s12098-007-0161-4; [王高良 WANG Gao-liang], 2010, [中华儿科杂志, Chinese Journal of Pediatrics], V48, P305; [赵明 Zhao Ming], 2005, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V21, P280; 刘影, 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P324	31	25	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53579	10.1371/journal.pone.0053579	http://dx.doi.org/10.1371/journal.pone.0053579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341953	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400051
J	Serrano, E; Coma, R; Ribes, M; Weitzmann, B; Garcia, M; Ballesteros, E				Serrano, Eduard; Coma, Rafel; Ribes, Marta; Weitzmann, Boris; Garcia, Maria; Ballesteros, Enric			Rapid Northward Spread of a Zooxanthellate Coral Enhanced by Artificial Structures and Sea Warming in the Western Mediterranean	PLOS ONE			English	Article							LONG-TERM DECLINE; CLIMATE-CHANGE; OCULINA-PATAGONICA; CLADOCORA-CAESPITOSA; BIOLOGICAL INVASIONS; ALGAL ASSEMBLAGES; MASS MORTALITY; CATALAN COAST; PHASE-SHIFTS; REEF CORALS	The hermatypic coral Oculina patagonica can drive a compositional shift in shallow water benthic marine communities in the northwestern Mediterranean. Here, we analyze a long-term, large-scale observational dataset to characterize the dynamics of the species' recent northward range shift along the coast of Catalonia and examine the main factors that could have influenced this spread. The variation in the distributional range of Oculina patagonica was examined by monitoring 223 locations including natural and artificial habitats along >400 km of coastline over the last 19 years (1992-2010). Abundance of the species increased from being present in one location in 1992 to occur on 19% of the locations in 2010, and exhibited an acceleration of its spreading over time driven by the join action of neighborhood and long-distance dispersal. However, the pattern of spread diverged between artificial and natural habitats. A short lag phase and a high slope on the exponential phase characterized the temporal pattern of spread on artificial habitats in contrast to that observed on natural ones. Northward expansion has occurred at the fastest rate (22 km year(-1)) reported for a coral species thus far, which is sufficiently fast to cope with certain climate warming predictions. The pattern of spread suggests that this process is mediated by the interplay of (i) the availability of open space provided by artificial habitats, (ii) the seawater temperature increase with the subsequent extension of the growth period, and (iii) the particular biological features of O. patagonica (current high growth rates, early reproduction, and survival to low temperature and in polluted areas). These results are indicative of an ongoing fundamental modification of temperate shallow water assemblages, which is consistent with the predictions indicating that the Mediterranean Sea is one of the most sensitive regions to global change.	[Serrano, Eduard; Coma, Rafel; Weitzmann, Boris; Garcia, Maria; Ballesteros, Enric] CSIC, CEAB, Blanes, Girona, Spain; [Serrano, Eduard; Ribes, Marta] CSIC, ICM, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Serrano, E (corresponding author), CSIC, CEAB, Blanes, Girona, Spain.	eserrano@ceab.csic.es	Serrano, Eduard/B-5269-2019; Coma, Rafel/ABF-2082-2021; Coma, Rafel/J-8987-2012; Ribes, Marta/B-2495-2013	Serrano, Eduard/0000-0001-9082-473X; Coma, Rafel/0000-0001-6107-225X; Coma, Rafel/0000-0001-6107-225X; Ribes, Marta/0000-0001-9747-295X; Garcia, Maria/0000-0002-0108-4424	Spanish Ministry of Science and Innovation [ENCHANGES (CGL2010-18466), GRACCIE (C5D2007-00067)]; European Community [287844]; "Departament de Medi Ambient" from the Generalitat de Catalunya; "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); "Departament de Medi Ambient" from the Generalitat de Catalunya(Generalitat de Catalunya); "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya	Financial support for this work was provided by projects ENCHANGES (CGL2010-18466) and GRACCIE (C5D2007-00067) from the Spanish Ministry of Science and Innovation, as well as European Community's project CoCoNET (FP7 Grant-Agreement: 287844), and "Departament de Medi Ambient" and "Agencia Catalana de l'Aigua (ACA)" from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Armoza-Zvuloni R, 2011, MAR ECOL PROG SER, V426, P149, DOI 10.3354/meps09018; Ballesteros, 1989, SCI MAR, V53, P3; BALLESTEROS E, 1989, Scientia Marina, V53, P357; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; BALLESTEROS E, 1991, OECOL AQUAT, V10, P223; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bertelsen E., 1936, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V100, P237; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; CAMP J, 1980, INVEST PESQ, V44, P199; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Casado-Amezua P, 2011, J HERED, V102, P622, DOI 10.1093/jhered/esr070; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Clark JS, 2003, ECOLOGY, V84, P1979, DOI 10.1890/01-0618; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Connell J.H., 1973, P205; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; Corbacho A, 2011, HIST NATURAL DELS PA, P195; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; EEA, 2006, 62006 EEA OPOCE; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fine M, 2003, MAR BIOL, V142, P989, DOI 10.1007/s00227-002-0982-7; Fine M, 2001, MAR BIOL, V138, P1195; Gacia E, 2007, SCI MAR, V71, P259, DOI 10.3989/scimar.2007.71n2259; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gili JM, 1985, THESIS U AUTONOMA BA; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Glasby TM, 1999, AMBIO, V28, P595; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoeksema BW, 2012, MAR ECOL PROG SER, V445, P209, DOI 10.3354/meps09460; Hughes T, 1999, LIMNOL OCEANOGR, V44, P1583; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lyons DA, 2009, DIVERS DISTRIB, V15, P762, DOI 10.1111/j.1472-4642.2009.00580.x; Marsh L, 1993, P 7 INT COR REEF S G, V2, P1233; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McManus JW, 1998, REEFBASE GLOBAL DATA; Meiners SJ, 2004, ECOL LETT, V7, P121, DOI 10.1111/j.1461-0248.2003.00563.x; Mendez V, 2010, SPRINGER SER SYNERG, P33, DOI 10.1007/978-3-642-11443-4_2; Mihulka S, 2001, J BIOGEOGR, V28, P597, DOI 10.1046/j.1365-2699.2001.00574.x; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Occhipinti-Ambrogi A., 2010, ADV OCEANOGR LIMNOL, V1, P199, DOI [10.1080/19475721003743876, DOI 10.1080/19475721003743876]; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Palacin C, 1998, MAR ECOL-P S Z N I, V19, P163, DOI 10.1111/j.1439-0485.1998.tb00460.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; PYSEK P, 1991, FOLIA GEOBOT PHYTOTX, V26, P439, DOI 10.1007/BF02912779; QUANDT RE, 1958, J AM STAT ASSOC, V53, P873, DOI 10.2307/2281957; QUANDT RE, 1960, J AM STAT ASSOC, V55, P324, DOI 10.2307/2281745; R Core Team, 2021, R LANGUAGE ENV STAT; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Sakai K, 1998, RES POPUL ECOL, V40, P287, DOI 10.1007/BF02763460; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017356; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; SAMMARI C, 1995, DEEP-SEA RES PT I, V42, P893, DOI 10.1016/0967-0637(95)00031-Z; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Sartoretto S., 2008, Aquatic Invasions, V3, P173, DOI 10.3391/ai.2008.3.2.7; Serrano E, 2012, CORAL REEFS, V31, P1199, DOI 10.1007/s00338-012-0939-3; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Shigesada N., 1997, BIOL INVASIONS THEOR; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Uriz MJ, 1987, THESIS U AUTONOMA BA; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Vargas-Yanez M, 2010, J MARINE SYST, V82, P171, DOI 10.1016/j.jmarsys.2010.04.013; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; VERON JEN, 1995, CORALS SPACE TIME BI; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Woodroffe Colin D., 2011, P813; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zabala M., 1986, FAUNA DELS BRIOZOUS; Zar J.H., 2010, BIOSTAT ANAL; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87; Zibrowius H., 1983, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V28, P297; ZIBROWIUS H, 1974, HELGOLAND WISS MEER, V26, P153, DOI 10.1007/BF01611381; Zibrowius H, 1992, MESOGEE, V51, P83	127	37	39	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52739	10.1371/journal.pone.0052739	http://dx.doi.org/10.1371/journal.pone.0052739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341904	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400019
J	Koyanagi, S; Levesque, CM				Koyanagi, Stephanie; Levesque, Celine M.			Characterization of a Streptococcus mutans Intergenic Region Containing a Small Toxic Peptide and Its cis-Encoded Antisense Small RNA Antitoxin	PLOS ONE			English	Article							SOS-INDUCED TOXIN; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; PERSISTER CELLS; STRESS-RESPONSE; FUNCTIONAL-ANALYSIS; SYSTEMS; BACTERIAL; LOCI; FST	Toxin-antitoxin (TA) modules consist of a pair of genes that encode two components: a protein toxin and an antitoxin, which may be in the form of either a labile protein or an antisense small RNA. Here we describe, to the best of our knowledge, the first functional chromosomal type I TA system in streptococci. Our model organism is the oral pathogen Streptococcus mutans. Our results showed that the genome of S. mutans UA159 reference strain harbors a previously unannotated Fst-like toxin (Fst-Sm) and its cis-encoded small RNA antitoxin (srSm) converging towards the end of the toxin gene in IGR176, a small intergenic region of 318 nt. Fst-Sm is a small hydrophobic peptide of 32 amino acid residues with homology to the Fst toxin family. Transcripts of similar to 200 nt and similar to 70 nt specific to fst-Sm mRNA and srSm RNA, respectively, were detected by Northern blot analysis throughout S. mutans growth. The toxin mRNA was considerably more stable than its cognate antitoxin. The half-life of srSm RNA was determined to be similar to 30 min, while fst-Sm mRNA had a half-life of similar to 90 min. Both fst-Sm and srSm RNAs were transcribed across direct tandem repeats providing a region of complementarity for inhibition of toxin translation. Overproduction of Fst-Sm had a toxic effect on E. coli and S. mutans cells which can be neutralized by coexpression of srSm RNA. Deletion of fst-Sm/srSm locus or overexpression of Fst-Sm/srSm had no effect on S. mutans cell growth in liquid medium and no differences in the total biofilm biomass were noted. In contrast, mild-overproduction of Fst-Sm/srSm type I TA system decreases the levels of persister cells tolerant to bacterial cell wall synthesis inhibitors.	[Koyanagi, Stephanie; Levesque, Celine M.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada	University of Toronto	Levesque, CM (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON, Canada.	celine.levesque@dentistry.utoronto.ca			Canadian Institutes of Health Research grant [MOP-93555]; Natural Sciences and Engineering Research Council of Canada grant [RGPIN 355968]; Canada Research Chair	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a Canadian Institutes of Health Research grant MOP-93555 to CML and a Natural Sciences and Engineering Research Council of Canada grant RGPIN 355968 to CML. CML is a recipient of a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Brantl S, 2002, PLASMID, V48, P165, DOI 10.1016/S0147-619X(02)00108-7; Dufour D, 2011, J BACTERIOL, V193, P6552, DOI 10.1128/JB.05968-11; Evguenieva-Hackenberg E, 2011, CURR OPIN MICROBIOL, V14, P587, DOI 10.1016/j.mib.2011.07.025; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; FITZGERALD R J, 1960, J Am Dent Assoc, V61, P9; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Greenfield TJ, 2000, MOL MICROBIOL, V37, P652, DOI 10.1046/j.1365-2958.2000.02035.x; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Kawano M, 2002, MOL MICROBIOL, V45, P333, DOI 10.1046/j.1365-2958.2002.03042.x; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kwong SM, 2010, MICROBIOL-SGM, V156, P975, DOI 10.1099/mic.0.038323-0; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Overbeek R, 2007, CHEM REV, V107, P3431, DOI 10.1021/cr068308h; Patel S, 2006, J BACTERIOL, V188, P5374, DOI 10.1128/JB.00513-06; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Syed MA, 2012, CAN J MICROBIOL, V58, P553, DOI [10.1139/w2012-025, 10.1139/W2012-025]; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Weaver KE, 2003, J BACTERIOL, V185, P2169, DOI 10.1128/JB.185.7.2169-2177.2003; Weaver KE, 1996, MOL MICROBIOL, V20, P53, DOI 10.1111/j.1365-2958.1996.tb02488.x; Weaver KE, 2009, MICROBIOL-SGM, V155, P2930, DOI 10.1099/mic.0.030932-0; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	47	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54291	10.1371/journal.pone.0054291	http://dx.doi.org/10.1371/journal.pone.0054291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326602	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800117
J	Vincenzi, F; Padovan, M; Targa, M; Corciulo, C; Giacuzzo, S; Merighi, S; Gessi, S; Govoni, M; Borea, PA; Varani, K				Vincenzi, Fabrizio; Padovan, Melissa; Targa, Martina; Corciulo, Carmen; Giacuzzo, Sarah; Merighi, Stefania; Gessi, Stefania; Govoni, Marcello; Borea, Pier Andrea; Varani, Katia			A(2A) Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats	PLOS ONE			English	Article							DISEASE-ACTIVITY; INFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; ANIMAL-MODELS; UP-REGULATION; EXPRESSION; INTERLEUKIN-10; CLASSIFICATION; IDENTIFICATION; LYMPHOCYTES	A(2A) adenosine receptors (ARs) play a key role in the inhibition of the inflammatory process. The purpose of this study was to evaluate the modulation of A(2A)ARs in rheumatoid arthritis (RA) patients after different pharmacological treatments and to investigate the effect of A(2A)AR stimulation in a rat model of arthritis. We investigated A(2A)AR density and functionality in RA progression by using a longitudinal study in RA patients before and after methotrexate (MTX), anti-TNF alpha agents or rituximab treatments. A(2A)ARs were analyzed by saturation binding assays in lymphocytes from RA patients throughout the 24-month study timeframe. In an adjuvant-induced arthritis model in rats we showed the efficacy of the A(2A)AR agonist, CGS 21680 in comparison with standard therapies by means of paw volume assessment, radiographic and ultrasonographic imaging. Arthritic-associated pain was investigated in mechanical allodynia and thermal hyperalgesia tests. IL-10 release following A(2A)AR stimulation in lymphocytes from RA patients and in serum from arthritic rats was measured. In lymphocytes obtained from RA patients, the A(2A)AR up-regulation was gradually reduced in function of the treatment time and the stimulation of these receptors mediated a significant increase of IL-10 production. In the same cells, CGS 21680 did not affected cell viability and did not produced cytotoxic effects. The A(2A)AR agonist CGS 21680 was highly effective, as suggested by the marked reduction of clinical signs, in rat adjuvant-induced arthritis and associated pain. This study highlighted that A(2A)AR agonists represent a physiological-like therapeutic alternative for RA treatment as suggested by the anti-inflammatory role of A(2A)ARs in lymphocytes from RA patients. The effectiveness of A(2A)AR stimulation in a rat model of arthritis supported the role of A(2A)AR agonists as potential pharmacological treatment for RA.	[Vincenzi, Fabrizio; Targa, Martina; Corciulo, Carmen; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia] Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy; [Padovan, Melissa; Govoni, Marcello] Univ Ferrara, Dept Clin & Expt Med, Rheumatol Sect, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Varani, K (corresponding author), Univ Ferrara, Dept Clin & Expt Med, Pharmacol Sect, I-44100 Ferrara, Italy.	vrk@unife.it	Gessi, Stefania/AAS-3844-2020; Vincenzi, Fabrizio/E-7925-2013	Govoni, Marcello/0000-0003-0499-5773; Gessi, Stefania/0000-0002-2197-5611; MERIGHI, STEFANIA/0000-0003-0839-6671; Vincenzi, Fabrizio/0000-0002-5027-1699; CORCIULO, CARMEN/0000-0002-1865-3494	Italian Ministry of Education, University and Research [MIUR-2009EE3SWA]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Ministry of Education, University and Research (MIUR-2009EE3SWA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarestani L, 2011, ARTHRITIS RHEUM-US, V63, P1573, DOI 10.1002/art.30303; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Belavic JM, 2010, NURSE PRACT, V36, P10; Bitto A, 2011, ARTHRITIS RHEUM-US, V63, P3364, DOI 10.1002/art.30538; Bush KA, 2002, CLIN EXP IMMUNOL, V127, P423, DOI 10.1046/j.1365-2249.2002.01742.x; Cronstein B, 2010, CLIN EXP RHEUMATOL, V28, pS21; Dorner T, 2010, PHARMACOL THERAPEUT, V125, P464, DOI 10.1016/j.pharmthera.2010.01.001; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Forrest CM, 2005, CLIN EXP RHEUMATOL, V23, P89; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Gao ZG, 2007, EXPERT OPIN EMERG DR, V12, P479, DOI 10.1517/14728214.12.3.479; Gessi S, 2011, EXPERT OPIN INV DRUG, V20, P1591, DOI 10.1517/13543784.2011.627853; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Ishaq M, 2011, MOD RHEUMATOL, V21, P375, DOI 10.1007/s10165-010-0405-4; Joseph A, 2010, J ALLERGY CLIN IMMUN, V125, pS204, DOI 10.1016/j.jaci.2009.10.067; Kaur Shamsherjit, 2011, Inflammopharmacology, V19, P265, DOI 10.1007/s10787-011-0090-8; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; MacKay K, 2003, RHEUMATOLOGY, V42, P149, DOI 10.1093/rheumatology/keg054; Manera C, 2010, CURR TOP MED CHEM, V10, P902, DOI 10.2174/156802610791268765; Mazzon E, 2011, J RHEUMATOL, V38, P2119, DOI 10.3899/jrheum.110111; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Meenagh G, 2008, CLIN EXP RHEUMATOL, V26, P982; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Moore CC, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-141; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Nowak M, 2010, EUR J IMMUNOL, V40, P682, DOI 10.1002/eji.200939897; Ongaro A, 2012, J CELL PHYSIOL, V227, P2461, DOI 10.1002/jcp.22981; Patel HB, 2010, FASEB J, V24, P4835, DOI 10.1096/fj.10-167759; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sakowicz-Burkiewicz M, 2010, J CELL BIOCHEM, V109, P396, DOI 10.1002/jcb.22417; Scott DL, 2012, CLIN PHARMACOL THER, V91, P30, DOI 10.1038/clpt.2011.278; Shaver TS, 2008, J RHEUMATOL, V35, P1015; Shi MQ, 2011, ARTHRITIS RHEUM-US, V63, P434, DOI 10.1002/art.30098; Singh JA, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD008794.PUB2; Soubrier M, 2011, ANN RHEUM DIS, V70, P611, DOI 10.1136/ard.2010.137695; Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002; Varani K, 2010, BRIT J PHARMACOL, V160, P101, DOI 10.1111/j.1476-5381.2010.00667.x; Varani K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3527; Varani K, 2010, AUTOIMMUN REV, V10, P61, DOI 10.1016/j.autrev.2010.07.019; Varani K, 2009, ARTHRITIS RHEUM-US, V60, P2880, DOI 10.1002/art.24794; Vincenzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039317; Wood PB, 2009, CURR PAIN HEADACHE R, V13, P434, DOI 10.1007/s11916-009-0071-4; Wright DE, 2007, J PERIPHER NERV SYST, V12, P250, DOI 10.1111/j.1529-8027.2007.00144.x; Yang T, 2010, PLOS COMPUTATIONAL B, V6, P1; Zhang J, 2011, CYTOKINE, V56, P351, DOI 10.1016/j.cyto.2011.05.022	51	38	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54195	10.1371/journal.pone.0054195	http://dx.doi.org/10.1371/journal.pone.0054195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326596	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800115
J	Nijhuis, THJ; de Boer, SAS; Wahegaonkar, AL; Bishop, AT; Shin, AY; Hovius, SER; Selles, RW				Nijhuis, Tim H. J.; de Boer, Siebe A. S.; Wahegaonkar, Abhijeet L.; Bishop, Allen T.; Shin, Alexander Y.; Hovius, Steven E. R.; Selles, Ruud W.			A New Approach to Assess the Gastrocnemius Muscle Volume in Rodents Using Ultrasound; Comparison with the Gastrocnemius Muscle Index	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; FOOT MUSCLES; RAT; ULTRASONOGRAPHY; PROTOCOLS; ATROPHY; REPAIR; FORCE; GAP	Introduction: The purpose of this study was to determine the reliability and validity of a new non-invasive ultrasound technique to measure gastrocnemius muscle atrophy after nerve denervation in an animal model. Methods: In sixteen rodents an eight mm sciatic nerve gap was created. In the following 8 weeks, each week, two rodents were euthanized and the gastrocnemius muscle was examined using two different ultrasound systems and two investigators. The standardized ultrasound measurement protocol consisted of identifying pre-defined anatomical landmarks: 1) the fibula, 2) the fibular nerve, and 3) the junction between the most distal point of the semitendinosus muscle and gastrocnemius muscle. Consequently, we measured the muscle thickness as the length of the line between the fibula and the junction between the two muscles, perpendicular to the fibular nerve. After the ultrasound recording, the muscle mass was determined. Results: A steep decline of muscle weight of 24% was observed after one week. In the following weeks, the weight further decreased and then remained stable from 6 weeks onwards, resulting in a maximal muscle weight decrease of 82%. The correlation coefficient was >0.96 between muscle diameter and weight using both ultrasound systems. The inter-rater reliability was excellent for both devices on the operated side (ICC of 0.99 for both ultrasound systems) and good for the non-operated site (ICC's: 0.84 & 0.89). The difference between the muscle mass ratio and the muscle thickness ratio was not more than 5% with two outliers of approximately 13%. Discussion: We have developed an innovative, highly reliable technique for quantifying muscle atrophy after nerve injury. This technique allows serial measurements in the same animal over time. This is a significant advantage compared to the conventional technique for quantifying muscle atrophy, which requires sacrificing the animal.	[Nijhuis, Tim H. J.; de Boer, Siebe A. S.; Wahegaonkar, Abhijeet L.; Hovius, Steven E. R.; Selles, Ruud W.] Univ Med Ctr, Erasmus MC, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands; [Bishop, Allen T.; Shin, Alexander Y.] Mayo Clin, Div Hand Surg, Dept Orthopaed Surg, Rochester, MN USA; [Wahegaonkar, Abhijeet L.] Mayo Clin, Microvasc Res Lab, Rochester, MN USA	Erasmus University Rotterdam; Erasmus MC; Mayo Clinic; Mayo Clinic	Nijhuis, THJ (corresponding author), Univ Med Ctr, Erasmus MC, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.	t.nijhuis@erasmusmc.nl	Nijhuis, Tim/AAB-4559-2021; Selles, Ruud/N-9665-2019	Selles, Ruud/0000-0002-2432-6756; Shin, Alexander/0000-0001-9658-8192				Bianchi S, 2008, JOINT BONE SPINE, V75, P643, DOI 10.1016/j.jbspin.2008.07.002; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Costa LM, 2009, INT REV NEUROBIOL, V87, P127, DOI 10.1016/S0074-7742(09)87007-4; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Diao E, 2000, HAND CLIN, V16, P53; Fornage B D, 1993, Radiol Med, V85, P162; FORNAGE BD, 1988, RADIOLOGY, V167, P179, DOI 10.1148/radiology.167.1.3279453; Kuffler DP, 2010, J NEUROSCI METH, V188, P276, DOI 10.1016/j.jneumeth.2010.02.023; Kullmer K, 1998, ARCH ORTHOP TRAUM SU, V117, P228, DOI 10.1007/s004020050234; MILLESI H, 1995, CLIN ORTHOP RELAT R, P76; Morse CI, 2005, J APPL PHYSIOL, V99, P1050, DOI 10.1152/japplphysiol.01186.2004; Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2; Nijhuis THJ, 2011, J NEUROSCI METH, V194, P283, DOI 10.1016/j.jneumeth.2010.10.026; Nijhuis THJ, 2010, MICROSURG, V30, P639, DOI 10.1002/micr.20818; Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5; Severinsen K, 2007, DIABETES CARE, V30, P3053, DOI 10.2337/dc07-0108; Severinsen K, 2007, CLIN NEUROPHYSIOL, V118, P2172, DOI 10.1016/j.clinph.2007.06.019; Shin RH, 2008, MICROSURG, V28, P452, DOI 10.1002/micr.20520; Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799; Stokvis A, 2009, J HAND SURG-EUR VOL, V34E, P766, DOI 10.1177/1753193409102268; Sunderland IRP, 2004, ANN PLAS SURG, V53, P382, DOI 10.1097/01.sap.0000125502.63302.47; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168	23	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54041	10.1371/journal.pone.0054041	http://dx.doi.org/10.1371/journal.pone.0054041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326570	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400070
J	Dai, K; Liao, SH; Zhang, JH; Zhang, XC; Tu, XM				Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Zhang, Xuecheng; Tu, Xiaoming			Structural and Functional Insight into ADF/Cofilin from Trypanosoma brucei	PLOS ONE			English	Article							ACTIN-DEPOLYMERIZING FACTOR; FACTOR HOMOLOGY DOMAIN; PROTEINS; COFILIN; DYNAMICS; BINDING; FILAMENTS; PROGRAM; SYSTEM; SERVER	The ADF/cofilin family has been characterized as a group of actin-binding proteins critical for controlling the assembly of actin within the cells. In this study, the solution structure of the ADF/cofilin from Trypanosoma brucei (TbCof) was determined by NMR spectroscopy. TbCof adopts the conserved ADF/cofilin fold with a central beta-sheet composed of six beta-strands surrounded by five alpha-helices. Isothermal titration calorimetry experiments denoted a submicromolar affinity between TbCof and G-actin, and the affinity between TbCof and ADP-G-actin was five times higher than that between TbCof and ATP-G-actin at low ionic strength. The results obtained from electron microscopy and actin filament sedimentation assays showed that TbCof depolymerized but did not co-sediment with actin filaments and its ability of F-actin depolymerization was pH independent. Similar to actin, TbCof was distributed throughout the cytoplasm. All our data indicate a structurally and functionally conserved ADF/cofilin from Trypanosoma brucei.	[Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University	Tu, XM (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	xmtu@ustc.edu.cn	Liao, Shanhui/N-1628-2018; Tu, Xiaoming/G-5090-2018	Liao, Shanhui/0000-0002-5083-667X; 	National Basic Research Program of China (973 Program) [2009CB918804]; Knowledge Innovation Program of the Chinese Academy of Science [KSCX2-EW-Q-4]; Chinese National Natural Science Foundations [31270780, 30900228]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese National Natural Science Foundations(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program), grant number 2009CB918804, the Knowledge Innovation Program of the Chinese Academy of Science, grant number KSCX2-EW-Q-4, the Chinese National Natural Science Foundations, grant number 31270780, and the Chinese National Natural Science Foundations, grant number 30900228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blondin L, 2002, EUR J BIOCHEM, V269, P4194, DOI 10.1046/j.1432-1033.2002.03101.x; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Dai K, 2011, BIOMOL NMR ASSIGN, V5, P249, DOI 10.1007/s12104-011-9311-8; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Goddard T.D., 2004, SPARKY 3; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Maciver SK, 2002, GENOME BIOL, V3; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pathak PP, 2010, J STRUCT BIOL, V172, P219, DOI 10.1016/j.jsb.2010.07.001; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Schrodinger L., 2002, PYMOL MOL GRAPHICS S; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tammana TVS, 2008, MOL MICROBIOL, V70, P837, DOI 10.1111/j.1365-2958.2008.06448.x; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011	46	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53639	10.1371/journal.pone.0053639	http://dx.doi.org/10.1371/journal.pone.0053639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326476	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500089
J	Panczak, R; Zwahlen, M; Spoerri, A; Tal, K; Killias, M; Egger, M				Panczak, Radoslaw; Zwahlen, Marcel; Spoerri, Adrian; Tal, Kali; Killias, Martin; Egger, Matthias		Swiss Natl Cohort	Incidence and Risk Factors of Homicide-Suicide in Swiss Households: National Cohort Study	PLOS ONE			English	Article							MURDER; EPIDEMIOLOGY; STATES; AVAILABILITY; VIOLENCE	Background: Homicide-suicides are rare but catastrophic events. This study examined the epidemiology of homicide-suicide in Switzerland. Methods: The study identified homicide-suicide events 1991-2008 in persons from the same household in the Swiss National Cohort, which links census and mortality records. The analysis examined the association of the risk of dying in a homicide-suicide event with socio-demographic variables, measured at the individual-level, household composition variables and area-level variables. Proportional hazards regression models were calculated for male perpetrators and female victims. Results are presented as age-adjusted hazard ratios (HR) with 95% confidence intervals (95%CI). Results: The study identified 158 deaths from homicide-suicide events, including 85 murder victims (62 women, 4 men, 19 children and adolescents) and 68 male and 5 female perpetrators. The incidence was 3 events per million households and year. Firearms were the most prominent method for both homicides and suicides. The risk of perpetrating homicide-suicide was higher in divorced than in married men (HR 3.64; 95%CI 1.56-8.49), in foreigners without permanent residency compared to Swiss citizens (HR 3.95; 1.52-10.2), higher in men without religious affiliations than in Catholics (HR 2.23; 1.14-4.36) and higher in crowded households (HR 4.85; 1.72-13.6 comparing >= 2 with <1 persons/room). There was no association with education, occupation or nationality, the number of children, the language region or degree of urbanicity. Associations were similar for female victims. Conclusions: This national longitudinal study shows that living conditions associated with psychological stress and lower levels of social support are associated with homicide-suicide events in Switzerland.	[Panczak, Radoslaw; Zwahlen, Marcel; Spoerri, Adrian; Tal, Kali; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Killias, Martin] Univ Zurich, Inst Criminol, CH-8006 Zurich, Switzerland	University of Bern; University of Zurich	Egger, M (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Panczak, Radoslaw/E-7384-2018	Zwahlen, Marcel/0000-0002-6772-6346; Panczak, Radoslaw/0000-0001-5141-683X; Spoerri, Adrian/0000-0001-5016-9822; Egger, Matthias/0000-0001-7462-5132; Tal, Kali/0000-0003-2454-2560	Swiss National Science Foundation [3347C0-108806]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Swiss National Cohort is funded by the Swiss National Science Foundation (grant No. 3347C0-108806, see www.snf.ch) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2010, EUR PSYCHIAT, V25, P432, DOI 10.1016/j.eurpsy.2010.04.006; Ajdacic-Gross V, 2006, AM J PUBLIC HEALTH, V96, P1752, DOI 10.2105/AJPH.2005.075812; Anacleto AJ, 2009, CAD SAUDE PUBLICA, V25, P800, DOI 10.1590/S0102-311X2009000400011; [Anonymous], 1994, CATECHISM CATHOLIC C; Bopp M, 2009, INT J EPIDEMIOL, V38, P379, DOI 10.1093/ije/dyn042; Bossarte RM, 2006, INJURY PREV, V12, P33, DOI 10.1136/ip.2006.012807; Bridges FS, 2011, FORENSIC SCI INT, V206, P185, DOI 10.1016/j.forsciint.2010.08.003; Bridges FS, 2004, PERCEPT MOTOR SKILL, V98, P594; Carcach C, 1998, AUSTR I CRIMINOLOGY, P1; COID J, 1983, PSYCHOL MED, V13, P855, DOI 10.1017/S0033291700051576; Dawson M, 2005, SUICIDE LIFE-THREAT, V35, P76, DOI 10.1521/suli.35.1.76.59261; Eliason S, 2009, J AM ACAD PSYCHIATRY, V37, P371; Flynn S, 2009, J FORENSIC PSYCHI PS, V20, P306, DOI 10.1080/14789940802364369; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gregory M, 2012, INT J LAW CRIME JUST, V40, P133, DOI 10.1016/j.ijlcj.2011.08.001; Harper DW, 2007, HOMICIDE STUD, V11, P295, DOI 10.1177/1088767907306993; Huss A, 2009, AM J EPIDEMIOL, V169, P167, DOI 10.1093/aje/kwn297; Killias M, 2012, JUVENILE DELINQUENCE; Killias M, 2009, HOMICIDE SUICIDE SWI, P1; Killias M, 2012, HANDBOOK OF EUROPEAN HOMICIDE RESEARCH: PATTERN, EXPLANATIONS, AND COUNTRY STUDIES, P261, DOI 10.1007/978-1-4614-0466-8_16; Large M, 2009, SUICIDE LIFE-THREAT, V39, P294, DOI 10.1521/suli.2009.39.3.294; Large MM, 2010, J FORENSIC LEG MED, V17, P225, DOI 10.1016/j.jflm.2010.02.003; Levin J, 2009, AM BEHAV SCI, V52, P1227, DOI 10.1177/0002764209332543; Liem M, 2011, FORENSIC SCI INT, V207, P70, DOI 10.1016/j.forsciint.2010.09.003; Liem M, 2010, SUICIDE LIFE-THREAT, V40, P133, DOI 10.1521/suli.2010.40.2.133; Liem M, 2010, AGGRESS VIOLENT BEH, V15, P153, DOI 10.1016/j.avb.2009.10.001; Liem M, 2009, HOMICIDE STUD, V13, P99, DOI 10.1177/1088767908330833; Logan J, 2008, AM J EPIDEMIOL, V168, P1056, DOI 10.1093/aje/kwn213; Markwalder N, 2012, HANDBOOK OF EUROPEAN HOMICIDE RESEARCH: PATTERN, EXPLANATIONS, AND COUNTRY STUDIES, P343, DOI 10.1007/978-1-4614-0466-8_22; MARZUK PM, 1992, JAMA-J AM MED ASSOC, V267, P3179, DOI 10.1001/jama.267.23.3179; Mathews S, 2008, B WORLD HEALTH ORGAN, V86, P552, DOI 10.2471/BLT.07.043786; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; Milroy C M, 1998, J Clin Forensic Med, V5, P61, DOI 10.1016/S1353-1131(98)90054-2; MILROY CM, 1995, FORENSIC SCI INT, V71, P117, DOI 10.1016/0379-0738(94)01648-O; PALMER S, 1980, SUICIDE LIFE-THREAT, V10, P106; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Spoerri A, 2010, INT J EPIDEMIOL, V39, P1486, DOI 10.1093/ije/dyq141; Spoerri A, 2010, INT J PUBLIC HEALTH, V55, P239, DOI 10.1007/s00038-010-0160-5	39	15	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53714	10.1371/journal.pone.0053714	http://dx.doi.org/10.1371/journal.pone.0053714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326491	Green Published, gold			2022-12-27	WOS:000313551500094
J	De Araujo, ME; Erhart, G; Buck, K; Muller-Holzner, E; Hubalek, M; Fiegl, H; Campa, D; Canzian, F; Eilber, U; Chang-Claude, J; Coassin, S; Haun, M; Kedenko, L; Paulweber, B; Reitsamer, R; Himmel, I; Flesch-Janys, D; Lamina, C; Kronenberg, F; Huber, LA; Kloss-Brandstatter, A				De Araujo, Mariana E.; Erhart, Gertraud; Buck, Katharina; Mueller-Holzner, Elisabeth; Hubalek, Michael; Fiegl, Heidelinde; Campa, Daniele; Canzian, Federico; Eilber, Ursula; Chang-Claude, Jenny; Coassin, Stefan; Haun, Margot; Kedenko, Lyudmyla; Paulweber, Bernhard; Reitsamer, Roland; Himmel, Irmgard; Flesch-Janys, Dieter; Lamina, Claudia; Kronenberg, Florian; Huber, Lukas A.; Kloss-Brandstaetter, Anita			Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk	PLOS ONE			English	Article							SIGNALING PATHWAY; CROSS-TALK; EXPRESSION; KINASE; PROTEIN; ACTIVATION; RECEPTOR; TARGETS; SURVIVAL; MIR-126	Background: The late endosomal LAMTOR complex serves as a convergence point for both the RAF/MEK/ERK and the PI3K/AKT/mTOR pathways. Interestingly, both of these signalling cascades play a significant role in the aetiology of breast cancer. Our aim was to address the possible role of genetic polymorphisms in LAMTOR2 and LAMTOR3 as genetic risk factors for breast cancer. Methodology/Results: We sequenced the exons and exon-intron boundaries of LAMTOR2 (p14) and LAMTOR3 (MP1) in 50 prospectively collected pairs of cancerous tissue and blood samples from breast cancer patients and compared their genetic variability. We found one single nucleotide polymorphism (SNP) in LAMTOR2 (rs7541) and two SNPs in LAMTOR3 (rs2298735 and rs148972953) in both tumour and blood samples, but no somatic mutations in cancerous tissues. In addition, we genotyped all three SNPs in 296 samples from the Risk Prediction of Breast Cancer Metastasis Study and found evidence of a genetic association between rs148972953 and oestrogen (ER) and progesterone receptor negative status (PR) (ER: OR = 3.60 (1.15-11.28); PR: OR = 4.27 (1.43-12.72)). However, when we additionally genotyped rs148972953 in the MARIE study including 2,715 breast cancer cases and 5,216 controls, we observed neither a difference in genotype frequencies between patients and controls nor was the SNP associated with ER or PR. Finally, all three SNPs were equally frequent in breast cancer samples and female participants (n = 640) of the population-based SAPHIR Study. Conclusions: The identified polymorphisms in LAMTOR2 and LAMTOR3 do not seem to play a relevant role in breast cancer. Our work does not exclude a role of other not yet identified SNPs or that the here annotated polymorphism may in fact play a relevant role in other diseases. Our results underscore the importance of replication in association studies.	[De Araujo, Mariana E.; Huber, Lukas A.] Med Univ Innsbruck, Div Cell Biol, A-6020 Innsbruck, Austria; [Erhart, Gertraud; Coassin, Stefan; Haun, Margot; Lamina, Claudia; Kronenberg, Florian; Kloss-Brandstaetter, Anita] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Buck, Katharina; Eilber, Ursula; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Mueller-Holzner, Elisabeth; Hubalek, Michael; Fiegl, Heidelinde] Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria; [Campa, Daniele; Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Kedenko, Lyudmyla; Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; [Reitsamer, Roland] Paracelsus Med Univ, Breast Ctr Salzburg, Salzburg, Austria; [Himmel, Irmgard] Hosp Meran, Dept Gynecol & Obstet, Meran, Italy; [Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometr & Epidemiol, Hamburg, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Paracelsus Private Medical University; Paracelsus Private Medical University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kloss-Brandstatter, A (corresponding author), Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	anita.kloss@i-med.ac.at	Campa, Daniele/K-1617-2016; Lamina, Claudia/F-7608-2010; Hubalek, Michael/ABD-8041-2021; Coassin, Stefan/J-2611-2018; Huber, Lukas Alfons/AAM-3499-2021; Canzian, Federico/I-2804-2014; Kronenberg, Florian/B-1736-2008; Fiegl, Heidi/K-4445-2017	Campa, Daniele/0000-0003-3220-9944; Lamina, Claudia/0000-0002-5398-5806; Coassin, Stefan/0000-0001-5677-8979; Kronenberg, Florian/0000-0003-2229-1120; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Canzian, Federico/0000-0002-4261-4583; Huber, Lukas Alfons/0000-0003-1116-2120; Fiegl, Heidi/0000-0002-1236-6806; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680	COMET Centre ONCOTYROL; BMVIT; BMWFJ; Tiroler-Zukunftsstiftung; Styrian Business Promotion Agency; Innsbruck Medical University; Verein Sanitatsbetrieb Autonome Provinz-Bozen; Tiroler-Landeskrankenanstalten-GmbH (TILAK); Sequencing & Genotyping Unit of the Innsbruck Medical University; FWF (Austria) [SFB021]	COMET Centre ONCOTYROL; BMVIT; BMWFJ; Tiroler-Zukunftsstiftung; Styrian Business Promotion Agency; Innsbruck Medical University; Verein Sanitatsbetrieb Autonome Provinz-Bozen; Tiroler-Landeskrankenanstalten-GmbH (TILAK); Sequencing & Genotyping Unit of the Innsbruck Medical University; FWF (Austria)(Austrian Science Fund (FWF))	The project was supported by the COMET Centre ONCOTYROL (which is funded by BMVIT, BMWFJ, the Tiroler-Zukunftsstiftung and the Styrian Business Promotion Agency), by the Innsbruck Medical University, by the Verein Sanitatsbetrieb Autonome Provinz-Bozen, by the Tiroler-Landeskrankenanstalten-GmbH (TILAK), and by the Sequencing & Genotyping Unit of the Innsbruck Medical University. Work in the Huber laboratory was supported by the FWF (Austria) funded special research program "cell proliferation and cell death in tumors"-SFB021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; delPeso L, 1997, SCIENCE, V278, P687; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Georges M, 2006, COLD SPRING HARB SYM, V71, P343, DOI 10.1101/sqb.2006.71.056; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Li ZJ, 2011, METHODS MOL BIOL, V676, P185, DOI 10.1007/978-1-60761-863-8_13; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Marina M, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-18; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Murphy LC, 2006, J STEROID BIOCHEM, V102, P139, DOI 10.1016/j.jsbmb.2006.09.021; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Steelman LS, 2008, MOL MED REP, V1, P139; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53768	10.1371/journal.pone.0053768	http://dx.doi.org/10.1371/journal.pone.0053768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341997	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700044
J	Cresswell, K; Coleman, J; Slee, A; Williams, R; Sheikh, A				Cresswell, Kathrin; Coleman, Jamie; Slee, Ann; Williams, Robin; Sheikh, Aziz		ePrescribing Programme Team	Investigating and Learning Lessons from Early Experiences of Implementing ePrescribing Systems into NHS Hospitals: A Questionnaire Study	PLOS ONE			English	Article							CLINICAL DECISION-SUPPORT; PHYSICIAN ORDER ENTRY; PRACTICE COMPUTER-SYSTEMS; INFORMATION-TECHNOLOGY; SAFETY FEATURES; PATIENT SAFETY; RECORD; CHALLENGES; ENGLAND; ALERT	Background: ePrescribing systems have significant potential to improve the safety and efficiency of healthcare, but they need to be carefully selected and implemented to maximise benefits. Implementations in English hospitals are in the early stages and there is a lack of standards guiding the procurement, functional specifications, and expected benefits. We sought to provide an updated overview of the current picture in relation to implementation of ePrescribing systems, explore existing strategies, and identify early lessons learned. Methods: A descriptive questionnaire-based study, which included closed and free text questions and involved both quantitative and qualitative analysis of the data generated. Results: We obtained responses from 85 of 108 NHS staff (78.7% response rate). At least 6% (n = 10) of the 168 English NHS Trusts have already implemented ePrescribing systems, 2% (n = 4) have no plans of implementing, and 34% (n = 55) are planning to implement with intended rapid implementation timelines driven by high expectations surrounding improved safety and efficiency of care. The majority are unclear as to which system to choose, but integration with existing systems and sophisticated decision support functionality are important decisive factors. Participants highlighted the need for increased guidance in relation to implementation strategy, system choice and standards, as well as the need for top-level management support to adequately resource the project. Although some early benefits were reported by hospitals that had already implemented, the hoped for benefits relating to improved efficiency and cost-savings remain elusive due to a lack of system maturity. Conclusions: Whilst few have begun implementation, there is considerable interest in ePrescribing systems with ambitious timelines amongst those hospitals that are planning implementations. In order to ensure maximum chances of realising benefits, there is a need for increased guidance in relation to implementation strategy, system choice and standards, as well as increased financial resources to fund local activities.	[Cresswell, Kathrin] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Coleman, Jamie] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Slee, Ann; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Williams, Robin] Univ Edinburgh, Inst Study Sci Technol & Innovat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Birmingham; University of Edinburgh; University of Edinburgh	Cresswell, K (corresponding author), Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland.	kathrin.beyer@ed.ac.uk	Chuter, Antony/GNO-9976-2022; Sheikh, Aziz/D-2818-2009	Chuter, Antony/0000-0002-0646-5939; Sheikh, Aziz/0000-0001-7022-3056; Avery, Anthony/0000-0001-7591-4438; Slight, Sarah P/0000-0002-0339-846X; Lilford, Richard/0000-0002-0634-984X; Coleman, Jamie/0000-0002-7512-5153	National Institute for Health [RP-PG-1209-10099]; National Institute for Health Research [RP-PG-1209-10099] Funding Source: researchfish	National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This work is funded by the National Institute for Health Research Programme Grants for Applied Research funding scheme (grant number: RP-PG-1209-10099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Anderson NR, 2007, INT J MED INFORM, V76, P821, DOI 10.1016/j.ijmedinf.2006.09.022; Avery AJ, 2007, QUAL SAF HEALTH CARE, V16, P28, DOI 10.1136/qshc.2006.018192; Bates DW, 2010, ARCH INTERN MED, V170, P1583, DOI 10.1001/archinternmed.2010.325; Baysari MT, 2012, J AM MED INFORM ASSN, V19, P1003, DOI 10.1136/amiajnl-2011-000730; Bell D, 2011, ELECT PRESCRIBING UK; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Catwell L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000126; Coiera EW, 2007, MED J AUSTRALIA, V186, P3, DOI 10.5694/j.1326-5377.2007.tb00774.x; Cresswell K, 2012, IHI 12 MIAM FLOR US; Cresswell Kathrin, 2009, Inform Prim Care, V17, P153; Cresswell KM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-15; Cresswell KM, 2011, BMJ QUAL SAF, V20, P625, DOI 10.1136/bmjqs.2010.048934; Crowe Sarah, 2010, JRSM Short Rep, V1, P33, DOI 10.1258/shorts.2010.010040; Fernando B, 2004, BMJ-BRIT MED J, V328, P1171, DOI 10.1136/bmj.328.7449.1171; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3111; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Huckvale C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038497; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2310, DOI 10.1377/hlthaff.2010.1111; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Mair FS, 2007, J TELEMED TELECARE, V13, pS36, DOI 10.1258/135763307781645112; Majeed A, 2003, BRIT MED J, V326, P202, DOI 10.1136/bmj.326.7382.202; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Morris CJ, 2005, QUAL SAF HEALTH CARE, V14, P164, DOI 10.1136/qshc.2004.011866; Morrison Z, 2011, J HEALTHC ENG, V2, P25, DOI 10.1260/2040-2295.2.1.25; NHS Connecting for Health, 2007, EPRESCRIBING FUNCT S, P2007; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pollock N, 2007, SOC STUD SCI, V37, P254, DOI 10.1177/0306312706066022; QSR International Pty Ltd, 2020, NVIVO; Reckmann MH, 2009, J AM MED INFORM ASSN, V16, P613, DOI 10.1197/jamia.M3050; Robertson A, 2010, BMJ-BRIT MED J, V41, pc4564; Robertson A, 2011, J ROY SOC MED, V104, P434, DOI 10.1258/jrsm.2011.11k039; Roughead EE, 1998, MED J AUSTRALIA, V168, P405, DOI 10.5694/j.1326-5377.1998.tb138996.x; Schneeweiss S, 2001, BRIT J CLIN PHARMACO, V52, P196, DOI 10.1046/j.0306-5251.2001.01425.x; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Smith DH, 2006, ARCH INTERN MED, V166, P1098, DOI 10.1001/archinte.166.10.1098; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; Westbrook JI, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001164	42	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53369	10.1371/journal.pone.0053369	http://dx.doi.org/10.1371/journal.pone.0053369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23335961	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314707700015
J	Bomash, I; Roudi, Y; Nirenberg, S				Bomash, Illya; Roudi, Yasser; Nirenberg, Sheila			A Virtual Retina for Studying Population Coding	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; GANGLION-CELLS; RECEPTIVE-FIELDS; MAMMALIAN RETINA; PRIMATE RETINA; VISION; MECHANISM; PATHWAYS; SIGNALS; BRAIN	At every level of the visual system - from retina to cortex - information is encoded in the activity of large populations of cells. The populations are not uniform, but contain many different types of cells, each with its own sensitivities to visual stimuli. Understanding the roles of the cell types and how they work together to form collective representations has been a long-standing goal. This goal, though, has been difficult to advance, and, to a large extent, the reason is data limitation. Large numbers of stimulus/response relationships need to be explored, and obtaining enough data to examine even a fraction of them requires a great deal of experiments and animals. Here we describe a tool for addressing this, specifically, at the level of the retina. The tool is a data-driven model of retinal input/output relationships that is effective on a broad range of stimuli - essentially, a virtual retina. The results show that it is highly reliable: (1) the model cells carry the same amount of information as their real cell counterparts, (2) the quality of the information is the same - that is, the posterior stimulus distributions produced by the model cells closely match those of their real cell counterparts, and (3) the model cells are able to make very reliable predictions about the functions of the different retinal output cell types, as measured using Bayesian decoding (electrophysiology) and optomotor performance (behavior). In sum, we present a new tool for studying population coding and test it experimentally. It provides a way to rapidly probe the actions of different cell classes and develop testable predictions. The overall aim is to build constrained theories about population coding and keep the number of experiments and animals to a minimum.	[Bomash, Illya; Roudi, Yasser; Nirenberg, Sheila] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA	Cornell University	Nirenberg, S (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA.	shn2010@med.cornell.edu		Roudi, Yasser/0000-0002-6989-3420	NIH [R01 EY12978]; Tri-Institutional Training Program in Computational Biology and Medicine, NIH [T32GM083937]; NATIONAL EYE INSTITUTE [R01EY012978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Institutional Training Program in Computational Biology and Medicine, NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 EY12978, the Tri-Institutional Training Program in Computational Biology and Medicine, NIH T32GM083937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Di Lorenzo PM, 2000, PHYSIOL BEHAV, V69, P87, DOI 10.1016/S0031-9384(00)00191-8; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Grinstead C. M., 1997, INTRO PROBABILITY; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Nirenberg S., 2011, International Patent, Patent No. [W02011106783, 2011106783]; Nirenberg S, 2012, P NATL ACAD SCI USA, V109, P15012, DOI 10.1073/pnas.1207035109; Oizumi M, 2010, J NEUROSCI, V30, P4815, DOI 10.1523/JNEUROSCI.4360-09.2010; Pandarinath C, 2010, J NEUROSCI, V30, P10006, DOI 10.1523/JNEUROSCI.5616-09.2010; Pandarinath C, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00002; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; RODIECK RW, 1983, BRAIN BEHAV EVOLUT, V23, P121, DOI 10.1159/000121492; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Smith DV, 2000, PHYSIOL BEHAV, V69, P77, DOI 10.1016/S0031-9384(00)00190-6; Thomas MC, 2006, ELEMENTS INFORM THEO; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497	42	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53363	10.1371/journal.pone.0053363	http://dx.doi.org/10.1371/journal.pone.0053363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341940	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400042
J	Busch, C; Krochmann, J; Drews, U				Busch, Christian; Krochmann, Jelena; Drews, Ulrich			The Chick Embryo as an Experimental System for Melanoma Cell Invasion	PLOS ONE			English	Article							NEURAL CREST; IN-VIVO; MIGRATION; GROWTH; MODEL; METASTASIS; PROGRESSION; PATHWAYS; NOGGIN; CUP	Background: A primary cutaneous melanoma will not kill the patient, but its metastases. Since in vitro studies on melanoma cells in 2-D cultures do often not reflect reality, 3-D models might come closer to the physiological situation in the patient during cancer initiation and progression. Methodology/Principal Findings: Here, we describe the chick embryo model for in vivo studies of melanoma cell migration and invasion. After transplantation of neural crest-derived melanoma cells into the neural tube, the melanoma cells resume neural crest cell migration along the medial and lateral pathways and finally undergo apoptosis in the target areas. Upon transplantation into ectopic areas such as the hindbrain or the optic cup malignant invasion and local tissue destruction occurs. In contrast, melanocytes are not able to spontaneously resume neural crest cell migration. However, malignant invasion can be induced in melanocytes by pre-treatment with the TGF-beta family members bone morphegenetic protein-2 or nodal. Transplantation of MCF7 breast cancer cells yields a different growth pattern in the rhombencephalon than melanoma cells. Conclusions/Significance: The chick embryo model is a feasible, cost-effective in vivo system to study invasion by cancer cells in an embryonic environment. It may be useful to study invasive behavior induced by embryonic oncogenes and for targeted manipulation of melanoma or breast cancer cells aiming at ablation of invasive properties.	[Busch, Christian; Krochmann, Jelena; Drews, Ulrich] Univ Tubingen, Dept Dermatol, Sect Dermatooncol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Busch, C (corresponding author), Univ Tubingen, Dept Dermatol, Sect Dermatooncol, Tubingen, Germany.	Christian.Busch@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 773]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich (SFB) 773 "Understanding and overcoming drug resistance of solid tumors" to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartl K, 1998, ANN ANAT, V180, P43; Busch C, 2008, INT J CANCER, V122, P526, DOI 10.1002/ijc.23139; Busch C, 2007, INT J ONCOL, V31, P1367; CHAMBERS AF, 1982, CANCER RES, V42, P4018; DREWS U, 1988, ANAT EMBRYOL, V178, P529, DOI 10.1007/BF00305040; Eigentler TK, 2011, CANCER-AM CANCER SOC, V117, P1697, DOI 10.1002/cncr.25631; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Krochmann J, 2012, PIGM CELL MELANOMA R, V25, P113, DOI 10.1111/j.1755-148X.2011.00914.x; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Le Douarin NM, 1999, NEURAL CREAST, P469; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; LUYTEN GPM, 1993, BIOCHEM BIOPH RES CO, V192, P22, DOI 10.1006/bbrc.1993.1376; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; NISHIKAWA K, 1987, JPN J CLIN ONCOL, V17, P319; Oppitz M, 2007, MELANOMA RES, V17, P17, DOI 10.1097/CMR.0b013e3280114f49; Rothhammer T, 2005, CANCER RES, V65, P448; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schriek G, 2005, MELANOMA RES, V15, P225, DOI 10.1097/00008390-200508000-00001; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448	26	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53970	10.1371/journal.pone.0053970	http://dx.doi.org/10.1371/journal.pone.0053970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342051	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400107
J	Li, YQ; Yan, JP; Xu, WL; Wang, H; Xia, YJ; Wang, HJ; Zhu, YY; Huang, XJ				Li, Ya-qing; Yan, Jian-ping; Xu, Wu-lin; Wang, Hong; Xia, Ying-jie; Wang, Hui-jun; Zhu, Yue-yan; Huang, Xiao-jun			ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; TNF-ALPHA; LENTIVIRAL VECTORS; MATRIX-METALLOPROTEINASE-9; ACTIVATION; DEGRADATION; EMPHYSEMA; SERUM	The purposes were to study the role of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-alpha/nuclear factor-kappa B (NF-kappa B) signaling in matrix metalloproteinase 9 (MMP9) expression in A549 cells and to investigate the effects of lentivirus-mediated RNAi targeting of the disintegrin and metalloproteinase 17 (ADAM17) gene on LPS-induced MMP9 expression. MMP9 expression induced by LPS in A549 cells was significantly increased in a dose-and time-dependent manner (p < 0.05). Pyrrolidine dithiocarbamate (PDTC) and a TNFR1 blocking peptide (TNFR1BP) significantly inhibited LPS-induced MMP9 expression in A549 cells (p < 0.05). TNFR1BP significantly inhibited LPS-induced TNF-alpha production (p < 0.05). Both PDTC and TNFR1BP significantly inhibited the phosphorylation of I kappa B alpha and expression of phosphorylation p65 protein in response to LPS (p < 0.05), and the level of I kappa B alpha in the cytoplasm was significantly increased (p < 0.05). Lentivirus mediated RNA interference (RNAi) significantly inhibited ADAM17 expression in A549 cells. Lentivirus-mediated RNAi targeting of ADAM17 significantly inhibited TNF-alpha production in the supernatants (p < 0.05), whereas the level of TNF-alpha in the cells was increased (p < 0.05). Lentiviral ADAM17 RNAi inhibited MMP9 expression, I kappa B alpha phosphorylation and the expression of phosphorylation p65 protein in response to LPS (p < 0.05). PDTC significantly inhibited the expression of MMP9 and the phosphorylation of I kappa B alpha, as well as the expression of phosphorylation p65 protein in response to TNF-alpha (p < 0.05). Lentiviral RNAi targeting of ADAM17 down-regulates LPS-induced MMP9 expression in lung epithelial cells via inhibition of TNF-alpha/NF-kappa B signaling.	[Li, Ya-qing; Yan, Jian-ping; Xu, Wu-lin; Wang, Hong; Zhu, Yue-yan; Huang, Xiao-jun] Zhejiang Prov Peoples Hosp, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China; [Xia, Ying-jie; Wang, Hui-jun] Zhejiang Prov Peoples Hosp, Zhejiang Prov Gastroenterol Key Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Xu, WL (corresponding author), Zhejiang Prov Peoples Hosp, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China.	wulinxu@126.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [No_81000016]; Medical Science Foundation of Zhejiang Province [No_2008B007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Foundation of Zhejiang Province	This work was supported by grants from the National Natural Science Foundation of China (No_81000016) and the Medical Science Foundation of Zhejiang Province (No_2008B007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2011, J BIOL CHEM, V286, P20054, DOI 10.1074/jbc.M111.249326; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Bellayr IH, 2009, FUTURE MED CHEM, V1, P1095, DOI 10.4155/FMC.09.83; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Li YQ, 2006, ACTA PHARMACOL SIN, V27, P339, DOI 10.1111/j.1745-7254.2006.00264.x; Maclay JD, 2012, THORAX, V67, P606, DOI 10.1136/thoraxjnl-2011-200949; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ramos C, 2009, INHAL TOXICOL, V21, P119, DOI 10.1080/08958370802419145 ; Schambach A, 2008, CURR GENE THER, V8, P474, DOI 10.2174/156652308786848049; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Takizawa Toshihiro, 2010, Journal of Nippon Medical School, V77, P71; van Gestel Arnoldus J R, 2010, J Thorac Dis, V2, P215, DOI 10.3978/j.issn.2072-1439.2010.02.04.5; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Wright C, 2011, AM J PHYSIOL-LUNG C, V301, pL575, DOI 10.1152/ajplung.00226.2010; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	34	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51701	10.1371/journal.pone.0051701	http://dx.doi.org/10.1371/journal.pone.0051701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341882	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400004
J	Melo, CV; Mele, M; Curcio, M; Comprido, D; Silva, CG; Duarte, CB				Melo, Carlos V.; Mele, Miranda; Curcio, Michele; Comprido, Diogo; Silva, Carla G.; Duarte, Carlos B.			BDNF Regulates the Expression and Distribution of Vesicular Glutamate Transporters in Cultured Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INORGANIC-PHOSPHATE COTRANSPORTER; DISTINCT SIGNALING PATHWAYS; DENDRITIC SPINE FORMATION; FIBROBLAST-GROWTH-FACTOR; OCCURRING CELL-DEATH; PROTEIN-KINASE-II; NEUROTROPHIC FACTOR; TRKB RECEPTORS; QUANTAL SIZE	BDNF is a pro-survival protein involved in neuronal development and synaptic plasticity. BDNF strengthens excitatory synapses and contributes to LTP, presynaptically, through enhancement of glutamate release, and postsynaptically, via phosphorylation of neurotransmitter receptors, modulation of receptor traffic and activation of the translation machinery. We examined whether BDNF upregulated vesicular glutamate receptor (VGLUT) 1 and 2 expression, which would partly account for the increased glutamate release in LTP. Cultured rat hippocampal neurons were incubated with 100 ng/ml BDNF, for different periods of time, and VGLUT gene and protein expression were assessed by real-time PCR and immunoblotting, respectively. At DIV7, exogenous application of BDNF rapidly increased VGLUT2 mRNA and protein levels, in a dose-dependent manner. VGLUT1 expression also increased but only transiently. However, at DIV14, BDNF stably increased VGLUT1 expression, whilst VGLUT2 levels remained low. Transcription inhibition with actinomycin-D or alpha-amanitine, and translation inhibition with emetine or anisomycin, fully blocked BDNF-induced VGLUT upregulation. Fluorescence microscopy imaging showed that BDNF stimulation upregulates the number, integrated density and intensity of VGLUT1 and VGLUT2 puncta in neurites of cultured hippocampal neurons (DIV7), indicating that the neurotrophin also affects the subcellular distribution of the transporter in developing neurons. Increased VGLUT1 somatic signals were also found 3 h after stimulation with BDNF, further suggesting an increased de novo transcription and translation. BDNF regulation of VGLUT expression was specifically mediated by BDNF, as no effect was found upon application of IGF-1 or bFGF, which activate other receptor tyrosine kinases. Moreover, inhibition of TrkB receptors with K252a and PLC gamma signaling with U-73122 precluded BDNF-induced VGLUT upregulation. Hippocampal neurons express both isoforms during embryonic and neonatal development in contrast to adult tissue expressing only VGLUT1. These results suggest that BDNF regulates VGLUT expression during development and its effect on VGLUT1 may contribute to enhance glutamate release in LTP.	[Melo, Carlos V.; Mele, Miranda; Curcio, Michele; Comprido, Diogo; Silva, Carla G.; Duarte, Carlos B.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Curcio, Michele] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Duarte, Carlos B.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; University of Sannio; Universidade de Coimbra	Duarte, CB (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	cbduarte@ci.uc.pt	Mele, Miranda/L-7788-2014; Duarte, Carlos B/K-6358-2013	Mele, Miranda/0000-0002-8627-4883; Duarte, Carlos B/0000-0002-1474-0208; Silva, Carla Sofia Gomes/0000-0002-1265-7531; Vieira Melo, Carlos/0000-0001-5392-1258	FCT (Fundacao para a Ciencia e a Tecnologia); FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal) [PTDC/SAU-NMC/120144/2010, PTDC/SAU-NEU/104297/2008]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal)	FCT (Fundacao para a Ciencia e a Tecnologia) and FEDER (Fundo Europeu de Desenvolvimento Regional, Portugal) (grants PTDC/SAU-NMC/120144/2010 and PTDC/SAU-NEU/104297/2008) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Amaral MD, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/203536; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen GQ, 1999, J NEUROSCI, V19, P7983; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Crozier RA, 1999, LEARN MEMORY, V6, P257; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Dorsey SG, 2002, J NEUROSCI, V22, P2571, DOI 10.1523/JNEUROSCI.22-07-02571.2002; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; GOULD E, 1991, J COMP NEUROL, V304, P408, DOI 10.1002/cne.903040306; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Gruart A, 2007, LEARN MEMORY, V14, P54, DOI 10.1101/lm.428307; He HB, 2012, J NEUROSCI, V32, P15886, DOI 10.1523/JNEUROSCI.4505-11.2012; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hong J, 2002, J NEUROCHEM, V81, P922, DOI 10.1046/j.1471-4159.2002.00882.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IP NY, 1993, J NEUROSCI, V13, P3394; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Katsuki H, 2000, BRAIN RES, V885, P240, DOI 10.1016/S0006-8993(00)02953-X; Kawasaki A, 2006, NEUROSCI RES, V56, P124, DOI 10.1016/j.neures.2006.05.008; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Kwon YK, 1997, MOL CELLS, V7, P320; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li T, 2008, GASTROENTEROLOGY, V134, P1994, DOI 10.1053/j.gastro.2008.02.076; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Mark KA, 2007, J NEUROSCI, V27, P6823, DOI 10.1523/JNEUROSCI.0013-07.2007; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; McCusker RH, 2006, J NEUROIMMUNOL, V179, P186, DOI 10.1016/j.jneuroim.2006.06.014; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira DB, 2006, J NEUROSCI RES, V83, P832, DOI 10.1002/jnr.20784; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Smith RE, 2001, NEUROREPORT, V12, P2885, DOI 10.1097/00001756-200109170-00026; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x; Tordera RM, 2005, J NEUROCHEM, V94, P875, DOI 10.1111/j.1471-4159.2005.03192.x; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Weston MC, 2011, NEURON, V69, P1147, DOI 10.1016/j.neuron.2011.02.002; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yelamanchili SV, 2006, J BIOL CHEM, V281, P15671, DOI 10.1074/jbc.M600378200; Yokota S, 2001, J NEUROCHEM, V77, P618, DOI 10.1046/j.1471-4159.2001.00270.x; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhang GR, 2011, BRAIN RES, V1377, P1, DOI 10.1016/j.brainres.2010.12.040; Zhang GR, 2010, BRAIN RES, V1331, P12, DOI 10.1016/j.brainres.2010.03.053; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	101	48	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53793	10.1371/journal.pone.0053793	http://dx.doi.org/10.1371/journal.pone.0053793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326507	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800075
J	Schachtschneider, KM; Yeoman, CJ; Isaacson, RE; White, BA; Schook, LB; Pieters, M				Schachtschneider, Kyle M.; Yeoman, Carl J.; Isaacson, Richard E.; White, Bryan A.; Schook, Lawrence B.; Pieters, Maria			Modulation of Systemic Immune Responses through Commensal Gastrointestinal Microbiota	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE INFECTION; ACUTE-PHASE PROTEIN; C-REACTIVE PROTEIN; GUT MICROBIOTA; PROINFLAMMATORY CYTOKINES; INTESTINAL MICROBIOTA; EXPRESSION; BACTERIA; DISEASE; HYGIENE	Colonization of the gastrointestinal (GI) tract is initiated during birth and continually seeded from the individual's environment. Gastrointestinal microorganisms play a central role in developing and modulating host immune responses and have been the subject of investigation over the last decades. Animal studies have demonstrated the impact of GI tract microbiota on local gastrointestinal immune responses; however, the full spectrum of action of early gastrointestinal tract stimulation and subsequent modulation of systemic immune responses is poorly understood. This study explored the utility of an oral microbial inoculum as a therapeutic tool to affect porcine systemic immune responses. For this study a litter of 12 pigs was split into two groups. One group of pigs was inoculated with a non-pathogenic oral inoculum (modulated), while another group (control) was not. DNA extracted from nasal swabs and fecal samples collected throughout the study was sequenced to determine the effects of the oral inoculation on GI and respiratory microbial communities. The effects of GI microbial modulation on systemic immune responses were evaluated by experimentally infecting with the pathogen Mycoplasma hyopneumoniae. Coughing levels, pathology, toll-like receptors 2 and 6, and cytokine production were measured throughout the study. Sequencing results show a successful modulation of the GI and respiratory microbiomes through oral inoculation. Delayed type hypersensitivity responses were stronger (p = 0.07), and the average coughing levels and respiratory TNF-alpha variance were significantly lower in the modulated group (p < 0.0001 and p = 0.0153, respectively). The M. hyopneumoniae infection study showed beneficial effects of the oral inoculum on systemic immune responses including antibody production, severity of infection and cytokine levels. These results suggest that an oral microbial inoculation can be used to modulate microbial communities, as well as have a beneficial effect on systemic immune responses as demonstrated with M. hyopneumoniae infection.	[Schachtschneider, Kyle M.; White, Bryan A.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Yeoman, Carl J.; White, Bryan A.; Schook, Lawrence B.; Pieters, Maria] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT USA; [Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; University of Minnesota System; University of Minnesota Twin Cities	Schook, LB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	schook@illinois.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Schook, Lawrence/0000-0002-6580-8364; Schachtschneider, Kyle/0000-0002-7293-8642	USDA [AG 2009-34480-19875, 2008-35205-18769, 538 AG58-5438-7-317l, 2007-35212-18046]	USDA(United States Department of Agriculture (USDA))	This project was conducted with funding from the USDA (AG 2009-34480-19875, 2008-35205-18769, 538 AG58-5438-7-317l, and 2007-35212-18046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandrick M, 2008, CLIN VACCINE IMMUNOL, V15, P540, DOI 10.1128/CVI.00466-07; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Calsamiglia M, 1999, J VET DIAGN INVEST, V11, P246, DOI 10.1177/104063879901100307; Calsamiglia M, 2000, VET MICROBIOL, V76, P299, DOI 10.1016/S0378-1135(00)00245-5; Calus D, 2010, J MICROBIOL METH, V83, P335, DOI 10.1016/j.mimet.2010.09.001; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chao A, 2001, J AM STAT ASSOC, V87, P210; Chen K, 2006, GENE, V384, P62, DOI 10.1016/j.gene.2006.07.009; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fano E, 2005, CAN J VET RES, V69, P223; FELD NC, 1992, VET MICROBIOL, V30, P35, DOI 10.1016/0378-1135(92)90092-8; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hwang MH, 2011, VET RES COMMUN, V35, P21, DOI 10.1007/s11259-010-9447-5; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kirjavainen PV, 1999, ANN MED, V31, P288, DOI 10.3109/07853899908995892; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; MOXON ER, 1979, J INFECT DIS, V140, P471, DOI 10.1093/infdis/140.4.471; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Muneta Y, 2003, J INTERF CYTOK RES, V23, P583, DOI 10.1089/107999003322485080; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parra MD, 2006, J VET MED B, V53, P488, DOI 10.1111/j.1439-0450.2006.01002.x; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TAJIMA M, 1984, AM J VET RES, V45, P1928; Thacker E, 2012, DIS SWINE; Thacker EL, 2006, DIS SWINE, P701; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willing BP, 2010, LIVEST SCI, V133, P82, DOI 10.1016/j.livsci.2010.06.031; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	60	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53969	10.1371/journal.pone.0053969	http://dx.doi.org/10.1371/journal.pone.0053969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326551	gold, Green Published			2022-12-27	WOS:000314705800094
J	Ye, L; Zhang, S; Greder, L; Dutton, J; Keirstead, SA; Lepley, M; Zhang, LY; Kaufman, D; Zhang, JY				Ye, Lei; Zhang, Sophia; Greder, Lucas; Dutton, James; Keirstead, Susan A.; Lepley, Mike; Zhang, Liying; Kaufman, Dan; Zhang, Jianyi			Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGF	PLOS ONE			English	Article							SOMATIC-CELLS; CARDIOMYOCYTE DIFFERENTIATION; FUNCTIONAL CONSEQUENCES; EPIGENETIC MEMORY; TRANSPLANTATION; FIBROBLASTS; INDUCTION	Perhaps one of the most significant achievements in modern science is the discovery of human induced pluripotent stem cells (hiPSCs), which have paved the way for regeneration therapy using patients' own cells. Cardiomyocytes differentiated from hiPSCs (hiPSC-CMs) could be used for modelling patients with heart failure, for testing new drugs, and for cellular therapy in the future. However, the present cardiomyocyte differentiation protocols exhibit variable differentiation efficiency across different hiPSC lines, which inhibit the application of this technology significantly. Here, we demonstrate a novel myocyte differentiation protocol that can yield a significant, high percentage of cardiac myocyte differentiation (>85%) in 2 hiPSC lines, which makes the fabrication of a human cardiac muscle patch possible. The established hiPSCs cell lines being examined include the transgene integrated UCBiPS7 derived from cord blood cells and non-integrated PCBC16iPS from skin fibroblasts. The results indicate that hiPSC-CMs derived from established hiPSC lines respond to adrenergic or acetylcholine stimulation and beat regularly for greater than 60 days. This data also demonstrates that this novel differentiation protocol can efficiently generate hiPSC-CMs from iPSC lines that are derived not only from fibroblasts, but also from blood mononuclear cells.	[Ye, Lei; Zhang, Sophia; Zhang, Liying; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Ye, Lei; Greder, Lucas; Dutton, James; Keirstead, Susan A.; Lepley, Mike; Zhang, Liying; Kaufman, Dan; Zhang, Jianyi] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Dutton, James] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Keirstead, Susan A.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Zhang, Jianyi] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA.	zhang047@umn.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Kaufman, Dan/0000-0002-2003-2494; Ye, Lei/0000-0001-5039-6224; Zhang, Sophia/0000-0002-8717-8084	U.S. Public Health Service [NIH RO1 HL67828, HL95077, HL114120]; National Institutes of Health Grant [UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114120, R01HL095077, R01HL067828, U01HL100407] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. Public Health Service Grants NIH RO1 HL67828, HL95077, HL114120, and National Institutes of Health Grant UO1 HL100407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Chen Y, 2006, AM J PHYSIOL-HEART C, V291, pH1653, DOI 10.1152/ajpheart.00363.2005; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Murry CE, 2002, COLD SPRING HARB SYM, V67, P519, DOI 10.1101/sqb.2002.67.519; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xiong Q, 2012, CIRC RES; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye L, 2007, EXP BIOL MED, V232, P1477, DOI 10.3181/0706-RM-175; Ye L, 2011, BIOMATERIALS, V32, P2424, DOI 10.1016/j.biomaterials.2010.12.008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013; Zhang J, 2012, CIRC RES; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	36	53	53	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53764	10.1371/journal.pone.0053764	http://dx.doi.org/10.1371/journal.pone.0053764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326500	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400042
J	Zhang, JY; Liu, HB; Liu, ZY; Liao, Y; Guo, L; Wang, HL; He, L; Zhang, XD; Xing, QH				Zhang, Junyu; Liu, Hongbin; Liu, Zhiyuan; Liao, Yong; Guo, Luo; Wang, Honglian; He, Lin; Zhang, Xiaodong; Xing, Qinghe			A Functional Alternative Splicing Mutation in AIRE Gene Causes Autoimmune Polyendocrine Syndrome Type 1	PLOS ONE			English	Article							CANDIDIASIS-ECTODERMAL DYSTROPHY; POLYGLANDULAR SYNDROME TYPE-1; REGULATOR GENE; DISEASE; PROTEIN; LOCALIZATION; EXPRESSION; RESOURCE; NONSENSE	Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare autosomal recessive disease defined by the presence of two of the three conditions: mucocutaneous candidiasis, hypoparathyroidism, and Addison's disease. Loss-of-function mutations of the autoimmune regulator (AIRE) gene have been linked to APS-1. Here we report mutational analysis and functional characterization of an AIRE mutation in a consanguineous Chinese family with APS-1. All exons of the AIRE gene and adjacent exon-intron sequences were amplified by PCR and subsequently sequenced. We identified a homozygous missense AIRE mutation c.463G>A (p.Gly155Ser) in two siblings with different clinical features of APS-1. In silico splice-site prediction and minigene analysis were carried out to study the potential pathological consequence. Minigene splicing analysis and subsequent cDNA sequencing revealed that the AIRE mutation potentially compromised the recognition of the splice donor of intron 3, causing alternative pre-mRNA splicing by intron 3 retention. Furthermore, the aberrant AIRE transcript was identified in a heterozygous carrier of the c.463G>A mutation. The aberrant intron 3-retaining transcript generated a truncated protein (p.G155fsX203) containing the first 154 AIRE amino acids and followed by 48 aberrant amino acids. Therefore, our study represents the first functional characterization of the alternatively spliced AIRE mutation that may explain the pathogenetic role in APS-1.	[Zhang, Junyu; Guo, Luo; Wang, Honglian; He, Lin; Xing, Qinghe] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Junyu; Guo, Luo; Wang, Honglian; He, Lin; Xing, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Junyu; Guo, Luo; Wang, Honglian; He, Lin; Xing, Qinghe] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Minist Educ, Shanghai 200030, Peoples R China; [Liu, Hongbin; Liu, Zhiyuan] Chineses Armed Police Forces, Henan Prov Corps Hosp, Zhengzhou, Peoples R China; [Liao, Yong] Chineses Armed Police Forces, Chongqing Municipal Corps Hosp, Chongqing, Peoples R China; [Zhang, Xiaodong] Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore; [Zhang, Xiaodong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Zhang, Xiaodong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA	Fudan University; Fudan University; Shanghai Jiao Tong University; National University of Singapore; National University of Singapore; Duke University	Xing, QH (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China.	qhxing@fudan.edu.cn	Zhang, Junyu/AAF-6658-2019	Zhang, Junyu/0000-0003-0239-6670	973 Program [2011CB504501]; National Natural Science Foundation of China [30971582, 90919049]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Duke-NUS Graduate Medical School Singapore; Ministry of Education of China	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Duke-NUS Graduate Medical School Singapore(National University of Singapore); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the 973 Program (2011CB504501), the National Natural Science Foundation of China (No. 30971582, No. 90919049), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Block Funding from the Duke-NUS Graduate Medical School Singapore, and the third phase of 211 project from Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1996, AM J HUM GENET, V59, P879; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eldershaw SA, 2011, CLIN EXP IMMUNOL, V163, P296, DOI 10.1111/j.1365-2249.2010.04316.x; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Keerthikumar S, 2009, NUCLEIC ACIDS RES, V37, pD863, DOI 10.1093/nar/gkn682; Liu Cai-hong, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P18, DOI 10.3760/cma.j.issn.1003-9406.2010.01.004; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Podkrajsek KT, 2008, EUR J ENDOCRINOL, V159, P633, DOI 10.1530/EJE-08-0328; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; von Schnurbein J, 2008, J PEDIATR ENDOCR MET, V21, P1003; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Zhang X, 2011, MOL PSYCHIATR, V16, P1169, DOI 10.1038/mp.2010.99	30	25	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53981	10.1371/journal.pone.0053981	http://dx.doi.org/10.1371/journal.pone.0053981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23342054	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800077
J	Geczi, G; Horvath, M; Kaszab, T; Alemany, GG				Geczi, Gabor; Horvath, Mark; Kaszab, Timea; Alemany, Gonzalo Garnacho			No Major Differences Found between the Effects of Microwave-Based and Conventional Heat Treatment Methods on Two Different Liquid Foods	PLOS ONE			English	Article							CONTINUOUS-FLOW MICROWAVE; VITAMIN-C CONTENT; QUALITY; STORAGE; B-6	Extension of shelf life and preservation of products are both very important for the food industry. However, just as with other processes, speed and higher manufacturing performance are also beneficial. Although microwave heating is utilized in a number of industrial processes, there are many unanswered questions about its effects on foods. Here we analyze whether the effects of microwave heating with continuous flow are equivalent to those of traditional heat transfer methods. In our study, the effects of heating of liquid foods by conventional and continuous flow microwave heating were studied. Among other properties, we compared the stability of the liquid foods between the two heat treatments. Our goal was to determine whether the continuous flow microwave heating and the conventional heating methods have the same effects on the liquid foods, and, therefore, whether microwave heat treatment can effectively replace conventional heat treatments. We have compared the colour, separation phenomena of the samples treated by different methods. For milk, we also monitored the total viable cell count, for orange juice, vitamin C contents in addition to the taste of the product by sensory analysis. The majority of the results indicate that the circulating coil microwave method used here is equivalent to the conventional heating method based on thermal conduction and convection. However, some results in the analysis of the milk samples show clear differences between heat transfer methods. According to our results, the colour parameters (lightness, red-green and blue-yellow values) of the microwave treated samples differed not only from the untreated control, but also from the traditional heat treated samples. The differences are visually undetectable, however, they become evident through analytical measurement with spectrophotometer. This finding suggests that besides thermal effects, microwave-based food treatment can alter product properties in other ways as well.	[Geczi, Gabor] Szent Istvan Univ, Fac Mech Engn, Inst Environm Engn Syst, Dept Environm Engn, Godollo, Hungary; [Horvath, Mark] Szent Istvan Univ, Fac Agr & Environm Sci, Dept Chem & Biochem, Inst Environm Sci, Godollo, Hungary; [Kaszab, Timea] Corvinus Univ Budapest, Fac Food Sci, Dept Phys & Control, Budapest, Hungary; [Alemany, Gonzalo Garnacho] Univ Vic, Escola Politecn Super, Vic, Spain	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Corvinus University Budapest; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Geczi, G (corresponding author), Szent Istvan Univ, Fac Mech Engn, Inst Environm Engn Syst, Dept Environm Engn, Godollo, Hungary.	geczi.gabor@gek.szie.hu		Geczi, Gabor/0000-0002-0909-7131	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; TAMOP [4.2.1.B-11/2/KMR-2011-0003]; Livestock Performance Testing Ltd. (Godollo, Hungary); Gramex 2000 Kft; Uj Mezo Kft; Livestock Performance Testing Ltd.	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); TAMOP; Livestock Performance Testing Ltd. (Godollo, Hungary); Gramex 2000 Kft; Uj Mezo Kft; Livestock Performance Testing Ltd.	This work was financially supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (http://mta.hu/english/) and by TAMOP 4.2.1.B-11/2/KMR-2011-0003 project (http://szie.hu/uj-lendueletet-ad-kutatasnak-kiemelt-tamop-projekt) as a salary supplement for Gabor Geczi. Furthermore this work was supported with experimental materials (orange juice and milk) by Gramex 2000 Kft. (Veresegyhaza, Hungary, http://www.gramex2000.hu/en/index.html) and Uj Mezo Kft. (Egyhazasdengeleg, Hungary, http://hazitej.net/hazitej/?q= content/el%C3%A9rhet%C5%91s%C3%A9g%C3%BCnk). Last but not least this work was supported by Livestock Performance Testing Ltd. (Godollo, Hungary, http://www.atkft.hu/hu/) for the tests carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; During the course of this study, the authors have received funding from three commercial sources (Gramex 2000 Kft, Uj Mezo Kft and Livestock Performance Testing Ltd.) in the form of access to research materials and/or services without charge. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Albert C., 2008, Acta Agraria Kaposvariensis, V12, P25; Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4; CSAPO J., 2008, ACTA AGRARIA KAPOSVA, V12, P11; de la Hoz A, 2005, CHEM SOC REV, V34, P164, DOI 10.1039/b411438h; Decareau R.V., 1985, MICROWAVES FOOD PROC; FernandezGarcia A, 2001, EUR FOOD RES TECHNOL, V213, P290, DOI 10.1007/s002170100332; George DF, 2008, BIOELECTROMAGNETICS, V29, P324, DOI 10.1002/bem.20382; HADDAD P, 1977, J CHEM EDUC, V54, P192, DOI 10.1021/ed054p192; HAMID M A K, 1969, Journal of Microwave Power, V4, P272; Kaszab T, 2011, ACTA ALIMENT HUNG, V40, P41, DOI 10.1556/AAlim.40.2011.Suppl.5; Kaszab T, 2010, ELELMISZER TUDOMANY, V64, P23; Kingston H.M., 1997, MICROWAVE ENHANCED C, DOI [10.1021/ja9856046, DOI 10.1021/JA9856046]; Lakatos E, 2006, THESIS U W HUNGARY M; Lakatos E, 2010, MAGY ALLATORVOSOK, V132, P728; Martinez N., 2009, ALIMENTACION EQUIPOS, V244, P34; MORRISON DG, 1981, J MARKETING, V45, P111, DOI 10.2307/1251546; NEMENYI M., 2006, J FOOD PHYS, V17-18, P29; Peremanyer M, 2010, ALIMENTACION EQUIPOS, V255, P12; Pirate M, 2010, COLOR CALIBRATION KE; Porcelli M, 1997, FEBS LETT, V402, P102, DOI 10.1016/S0014-5793(96)01505-0; Shaman A, 2007, FOOD CHEM, V103, P444, DOI 10.1016/j.foodchem.2006.08.024; Sieber R, 1996, J DAIRY RES, V63, P169, DOI 10.1017/S0022029900031642; Sierra I, 2001, J FOOD PROTECT, V64, P890, DOI 10.4315/0362-028X-64.6.890; Sierra I, 2000, LAIT, V80, P601, DOI 10.1051/lait:2000147; SMOOT JM, 1980, J AGR FOOD CHEM, V28, P417, DOI 10.1021/jf60228a050; STILLMAN JA, 1993, PERCEPT PSYCHOPHYS, V54, P190, DOI 10.3758/BF03211755; Swain MVL, 2004, INT J FOOD SCI TECH, V39, P623, DOI 10.1111/j.1365-2621.2004.00819.x; Szerencsi A, 2009, NONTHERMAL EFFECT 1, P58; Vadivambal R, 2007, BIOSYST ENG, V98, P1, DOI 10.1016/j.biosystemseng.2007.06.006; VALDERRAMA A. M., 2008, LASALLISTA INVESTIGA, V5, P13; Villamiel M, 1996, Z LEBENSM UNTERS FOR, V202, P15, DOI 10.1007/BF01229677; Watanabe F, 1998, J AGR FOOD CHEM, V46, P206, DOI 10.1021/jf970670x; WAYNE A., 2000, HIDDEN HAZARDS MICRO; Wild M, ARE MICROWAVE OVENS	34	11	11	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53720	10.1371/journal.pone.0053720	http://dx.doi.org/10.1371/journal.pone.0053720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341982	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700037
J	Liu, CM; Hsieh, CL; He, YC; Lo, SJ; Liang, JA; Hsieh, TF; Josson, S; Chung, LWK; Hung, MC; Sung, SY				Liu, Che-Ming; Hsieh, Chia-Ling; He, Yun-Chi; Lo, Sen-Jei; Liang, Ji-An; Hsieh, Teng-Fu; Josson, Sajni; Chung, Leland W. K.; Hung, Mien-Chie; Sung, Shian-Ying			In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression	PLOS ONE			English	Article							MITOXANTRONE PLUS PREDNISONE; IV; DOCETAXEL; SURVIVAL; IMMUNOTHERAPY; RESISTANCE; MARKER; SERUM; DISINTEGRIN; METASTASIS	Cancer cells respond to stress by activating a variety of survival signaling pathways. A disintegrin and metalloproteinase (ADAM) 9 is upregulated during cancer progression and hormone therapy, functioning in part through an increase in reactive oxygen species. Here, we present in vitro and in vivo evidence that therapeutic targeting of ADAM9 gene expression by lentivirus-delivered small hairpin RNA (shRNA) significantly inhibited proliferation of human prostate cancer cell lines and blocked tumor growth in a murine model of prostate cancer bone metastasis. Cell cycle studies confirmed an increase in the G1-phase and decrease in the S-phase population of cancer cells under starvation stress conditions, which correlated with elevated intracellular superoxide levels. Microarray data showed significantly decreased levels of regenerating islet-derived family member 4 (REG4) expression in prostate cancer cells with knockdown of ADAM9 gene expression. This REG4 downregulation also resulted in induction of expression of p21(Cip1/WAF1), which negatively regulates cyclin D1 and blocks the G1/S transition. Our data reveal a novel molecular mechanism of ADAM9 in the regulation of prostate cancer cell proliferation, and suggests a combined modality of ADAM9 shRNA gene therapy and cytotoxic agents for hormone refractory and bone metastatic prostate cancer.	[Liu, Che-Ming; Sung, Shian-Ying] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Liu, Che-Ming; Sung, Shian-Ying] Acad Sinica, Taichung, Taiwan; [Hsieh, Chia-Ling; He, Yun-Chi; Lo, Sen-Jei; Hung, Mien-Chie; Sung, Shian-Ying] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Hsieh, Teng-Fu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsieh, Chia-Ling; Hung, Mien-Chie; Sung, Shian-Ying] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan; [Hsieh, Teng-Fu] Buddhist Tzu Chi Gen Hosp, Div Urol, Taichung Branch, Taichung, Taiwan; [Hsieh, Teng-Fu] Buddhist Tzu Chi Univ, Sch Med, Dept Urol, Hualien, Taiwan; [Josson, Sajni; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Hsieh, Chia-Ling; Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Cedars Sinai Medical Center; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Sung, SY (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	ssung@mail.cmu.edu.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	National Science Council, Taiwan [NSC99-2320-B-039-029-MY3]; National Health Research Institute, Taiwan [NHRI-EX99-9902BI, NHRI-EX100- 9902BI, NHRI-EX101-9902BI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by NSC99-2320-B-039-029-MY3 of National Science Council, Taiwan (http://web1.nsc.gov.tw); NHRI-EX99-9902BI, NHRI-EX100- 9902BI and NHRI-EX101-9902BI of National Health Research Institute, Taiwan (http://www.nhri.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cao DX, 2004, CANCER LETT, V214, P103, DOI 10.1016/j.canlet.2004.03.047; COLEMAN WB, 1995, CLIN CHEM, V41, P644; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Fritzsche FR, 2008, EUR UROL, V54, P1097, DOI 10.1016/j.eururo.2007.11.034; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Hayashi T, 2009, ONCOL REP, V21, P95, DOI 10.3892/or_00000194; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Ip SW, 2008, IN VIVO, V22, P237; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Josson S, 2011, PROSTATE, V71, P232, DOI 10.1002/pros.21237; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Kuo PL, 2012, J BIOL CHEM, V287, P9753, DOI 10.1074/jbc.M111.321190; Mahimkar RM, 2005, BIOCHEM J, V385, P461, DOI 10.1042/BJ20041133; McMurtry CT, 2003, J AM GERIATR SOC, V51, P1136, DOI 10.1046/j.1532-5415.2003.51367.x; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Moon JH, 2012, J SURG ONCOL, V105, P189, DOI 10.1002/jso.22021; NAKAZAKI M, 1983, J CHEM SOC CHEM COMM, P787, DOI 10.1039/c39830000787; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Pen CC, 2012, CHINESE J PHYSIOL, V55, P390, DOI 10.4077/CJP.2012.BAA075; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rafa L, 2010, INT J ONCOL, V36, P689, DOI 10.3892/ijo_00000544; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shigemura K, 2007, PROSTATE, V67, P722, DOI 10.1002/pros.20565; Singh B, 2009, INT J CANCER, V124, P531, DOI 10.1002/ijc.23974; Small EJ, 2007, CLIN CANCER RES, V13, P3883, DOI 10.1158/1078-0432.CCR-06-2937; Smith Matthew R, 2004, Oncology (Williston Park), V18, P21; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vanderlaag K, 2012, INT J CANCER, V130, P1251, DOI 10.1002/ijc.26089; VILLAVICENCIO H, 1993, EUR UROL, V24, P118; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; Zhang YW, 2003, CHINESE MED J-PEKING, V116, P918	48	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53795	10.1371/journal.pone.0053795	http://dx.doi.org/10.1371/journal.pone.0053795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342005	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700047
J	Szpak, P; White, CD; Longstaffe, FJ; Millaire, JF; Sanchez, VFV				Szpak, Paul; White, Christine D.; Longstaffe, Fred J.; Millaire, Jean-Francois; Vasquez Sanchez, Victor F.			Carbon and Nitrogen Isotopic Survey of Northern Peruvian Plants: Baselines for Paleodietary and Paleoecological Studies	PLOS ONE			English	Article							N-15 NATURAL-ABUNDANCE; WATER-USE EFFICIENCY; SYMBIOTIC N-2 FIXATION; VERTEBRATE FOOD-WEB; STABLE-ISOTOPE; BONE-COLLAGEN; MYCORRHIZAL FUNGI; DELTA-C-13 VALUES; DELTA-N-15 VALUES; C-13/C-12 RATIOS	The development of isotopic baselines for comparison with paleodietary data is crucial, but often overlooked. We review the factors affecting the carbon (delta C-13) and nitrogen (delta N-15) isotopic compositions of plants, with a special focus on the carbon and nitrogen isotopic compositions of twelve different species of cultivated plants (n = 91) and 139 wild plant species collected in northern Peru. The cultivated plants were collected from nineteen local markets. The mean delta C-13 value for maize (grain) was -11.8 +/- 60.4%(n = 27). Leguminous cultigens (beans, Andean lupin) were characterized by significantly lower delta N-15 values and significantly higher %N than non-leguminous cultigens. Wild plants from thirteen sites were collected in the Moche River Valley area between sea level and similar to 4,000 meters above sea level (masl). These sites were associated with mean annual precipitation ranging from 0 to 710 mm. Plants growing at low altitude sites receiving low amounts of precipitation were characterized by higher delta N-15 values than plants growing at higher altitudes and receiving higher amounts of precipitation, although this trend dissipated when altitude was >2,000 masl and MAP was >400 mm. For C-3 plants, foliar delta C-13 was positively correlated with altitude and precipitation. This suggests that the influence of altitude may overshadow the influence of water availability on foliar delta C-13 values at this scale.	[Szpak, Paul; White, Christine D.; Millaire, Jean-Francois] Univ Western Ontario, Dept Anthropol, London, ON, Canada; [Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada; [Vasquez Sanchez, Victor F.] Ctr Invest Arqueobiol & Paleoecol Andinas ARQUEOB, Trujillo, Peru	Western University (University of Western Ontario); Western University (University of Western Ontario)	Szpak, P (corresponding author), Univ Western Ontario, Dept Anthropol, London, ON, Canada.	pszpak@uwo.ca	Longstaffe, Fred J/A-6843-2008	Millaire, Jean-Francois/0000-0002-8074-5912	Wenner-Gren Foundation [8333]; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Ontario Research Infrastructure Program	Wenner-Gren Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Infrastructure Program	This research was supported by the Wenner-Gren Foundation (PS, Dissertation Fieldwork Grant #8333), the Social Sciences and Humanities Research Council of Canada, the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation and the Ontario Research Infrastructure Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, RAPID COMMUN MASS SP, V22, P1653, DOI 10.1002/rcm.3501; Ambrose S.H., 2000, BIOGEOCHEMICAL APPRO, P243; AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BADA JL, 1989, GEOCHIM COSMOCHIM AC, V53, P3337, DOI 10.1016/0016-7037(89)90114-2; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Belane AK, 2010, BIOL FERT SOILS, V46, P191, DOI 10.1007/s00374-009-0415-6; Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; BENNER R, 1987, NATURE, V329, P708, DOI 10.1038/329708a0; Beresford-Jones DG, 2009, LAT AM ANTIQ, V20, P303, DOI 10.1017/S1045663500002650; Beron MA, 2009, INT J OSTEOARCHAEOL, V19, P250, DOI 10.1002/oa.1049; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Bosl C, 2006, INT J OSTEOARCHAEOL, V16, P296, DOI 10.1002/oa.834; Broadmeadow M. S. J., 1993, Stable isotopes and plant carbon-water relations., P109; Brush S., 1982, MOUNTAIN RES DEV, V2, DOI [DOI 10.2307/3672931, 10.2307/3672931]; Buchmann N, 1997, OECOLOGIA, V110, P120, DOI 10.1007/s004420050140; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Catenazzi A, 2007, J ARID ENVIRON, V71, P330, DOI 10.1016/j.jaridenv.2007.05.003; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; Choi WJ, 2005, COMMUN SOIL SCI PLAN, V36, P2719, DOI 10.1080/00103620500303913; Choi WJ, 2002, PLANT SOIL, V245, P223, DOI 10.1023/A:1020475017254; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Coetsee C, 2011, AFR J ECOL, V49, P62, DOI 10.1111/j.1365-2028.2010.01236.x; Corbisier TN, 2004, POLAR BIOL, V27, P75, DOI 10.1007/s00300-003-0567-z; Cornelisen CD, 2007, LIMNOL OCEANOGR, V52, P820, DOI 10.4319/lo.2007.52.2.0820; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; CRAWFORD TW, 1982, PLANT PHYSIOL, V70, P1654, DOI 10.1104/pp.70.6.1654; Damesin C, 1997, OECOLOGIA, V111, P26, DOI 10.1007/s004420050204; Damesin C, 2003, PLANT CELL ENVIRON, V26, P207, DOI 10.1046/j.1365-3040.2003.00951.x; DELWICHE CC, 1970, ENVIRON SCI TECHNOL, V4, P929, DOI 10.1021/es60046a004; DELWICHE CC, 1979, BOT GAZ, V140, pS65, DOI 10.1086/337037; DeMera AG, 1997, GLOBAL ECOL BIOGEOGR, V6, P349, DOI 10.2307/2997336; DeNiro M.J., 1988, BAR International Series, P119; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, GEOCHIM COSMOCHIM AC, V49, P97, DOI 10.1016/0016-7037(85)90194-2; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Ehleringer JR, 1999, FORENSIC SCI INT, V106, P27, DOI 10.1016/S0379-0738(99)00139-5; Ehleringer JR, 1998, REV CHIL HIST NAT, V71, P79; EHLERINGER JR, 1986, OECOLOGIA, V70, P520, DOI 10.1007/BF00379898; Ericson J.E., 1989, CHEM PREHISTORIC HUM, P68; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Falabella F, 2007, CHUNGARA, V39, P5, DOI 10.4067/S0717-73562007000100002; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1982, OECOLOGIA, V52, P121, DOI 10.1007/BF00349020; Filgueira R, 2011, CONT SHELF RES, V31, P476, DOI 10.1016/j.csr.2010.10.010; Finucane B, 2006, J ARCHAEOL SCI, V33, P1766, DOI 10.1016/j.jas.2006.03.012; Finucane BC, 2008, AM J PHYS ANTHROPOL, V135, P75, DOI 10.1002/ajpa.20710; Finucane BC, 2007, J ARCHAEOL SCI, V34, P2115, DOI 10.1016/j.jas.2007.02.006; Finucane BC, 2009, CURR ANTHROPOL, V50, P534, DOI 10.1086/599860; Fiorentino G, 2012, RAPID COMMUN MASS SP, V26, P327, DOI 10.1002/rcm.5323; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Frank DA, 2004, BIOGEOCHEMISTRY, V68, P169, DOI 10.1023/B:BIOG.0000025736.19381.91; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Fredriksen S, 2003, MAR ECOL PROG SER, V260, P71, DOI 10.3354/meps260071; FRIEND AD, 1989, FUNCT ECOL, V3, P117, DOI 10.2307/2389682; Gathumbi SM, 2002, SOIL BIOL BIOCHEM, V34, P1059, DOI 10.1016/S0038-0717(02)00038-X; Gil AF, 2009, INT J OSTEOARCHAEOL, V19, P215, DOI 10.1002/oa.1041; Gil A.F., 2006, HIST MAIZE MULTIDISC, P199; Gil AF, 2011, J ARCHAEOL SCI, V38, P1395, DOI 10.1016/j.jas.2011.01.010; Gillies CL, 2012, POLAR BIOL, V35, P813, DOI 10.1007/s00300-011-1126-7; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287, DOI 10.1104/pp.102.4.1287; Gollety C, 2010, J SEA RES, V64, P304, DOI 10.1016/j.seares.2010.04.003; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Grall J, 2006, J EXP MAR BIOL ECOL, V338, P1, DOI 10.1016/j.jembe.2006.06.013; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; Grupe G, 2009, J ARCHAEOL SCI, V36, P2125, DOI 10.1016/j.jas.2009.05.011; GUY RD, 1980, OECOLOGIA, V44, P241, DOI 10.1007/BF00572686; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hobbie EA, 1999, OECOLOGIA, V118, P353, DOI 10.1007/s004420050736; Hobbie EA, 2005, OECOLOGIA, V146, P258, DOI 10.1007/s00442-005-0208-z; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hobbie EA, 2003, NEW PHYTOL, V157, P115, DOI 10.1046/j.1469-8137.2003.00657.x; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HOGBERG P, 1990, NEW PHYTOL, V115, P483, DOI 10.1111/j.1469-8137.1990.tb00474.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; Huiskes AHL, 2006, PLANT ECOL, V182, P79, DOI 10.1007/s11258-005-9032-0; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Isla R, 1998, FIELD CROP RES, V58, P97, DOI 10.1016/S0378-4290(98)00088-4; Izeta AD, 2009, INT J OSTEOARCHAEOL, V19, P204, DOI 10.1002/oa.1066; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kang CK, 2008, MAR BIOL, V153, P1181, DOI 10.1007/s00227-007-0890-y; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Kellner CM, 2008, J ANTHROPOL ARCHAEOL, V27, P226, DOI 10.1016/j.jaa.2007.12.003; Knudson KJ, 2007, J ARCHAEOL SCI, V34, P451, DOI 10.1016/j.jas.2006.07.003; Koepcke H.W., 1961, SYNOKOLOGISCHE STUDI; Koepcke M, 1954, MEMORIAS, V3; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; KOHL DH, 1980, PLANT PHYSIOL, V66, P51, DOI 10.1104/pp.66.1.51; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; KOPCZYNSKA EE, 1995, J PLANKTON RES, V17, P685, DOI 10.1093/plankt/17.4.685; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; LAJTHA K, 1993, OECOLOGIA, V94, P95, DOI 10.1007/BF00317308; LANGE OL, 1988, OECOLOGIA, V75, P494, DOI 10.1007/BF00776410; Latorre C, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001521; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; LEAVITT SW, 1982, NATURE, V298, P742, DOI 10.1038/298742a0; LEDGARD SF, 1985, AUST J PLANT PHYSIOL, V12, P631, DOI 10.1071/PP9850631; Lee YI, 2009, POLAR BIOL, V32, P1607, DOI 10.1007/s00300-009-0659-5; Li CL, 2010, J PLANT NUTR SOIL SC, V173, P946, DOI 10.1002/jpln.200900243; Lightfoot E, 2012, J ARCHAEOL SCI, V39, P656, DOI 10.1016/j.jas.2011.10.026; MARIOTTI A, 1980, PHYSIOL VEG, V18, P163; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Martinez G, 2009, INT J OSTEOARCHAEOL, V19, P281, DOI 10.1002/oa.1057; Masuda S., 1985, ANDEAN ECOLOGY CIVIL, P233; Mayr CC, 2011, MAR ECOL PROG SER, V428, P89, DOI 10.3354/meps09015; MEDINA E, 1991, OECOLOGIA, V87, P369, DOI 10.1007/BF00634593; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Michelsen A, 1996, OECOLOGIA, V105, P53, DOI 10.1007/BF00328791; Miller MJ, 2010, J ARCHAEOL SCI, V37, P317, DOI 10.1016/j.jas.2009.09.043; Miller RJ, 2012, MAR BIOL, V159, P1391, DOI 10.1007/s00227-012-1929-2; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; Murphy BP, 2009, FUNCT ECOL, V23, P1040, DOI 10.1111/j.1365-2435.2009.01576.x; Nadon MO, 2010, AQUAT LIVING RESOUR, V23, P167, DOI 10.1051/alr/2010010; NASHOLM T, 1994, OECOLOGIA, V99, P290, DOI 10.1007/BF00627741; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Oka S., 1984, GEOGR REPORTS TOKYO, V19, P113; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Olsen YS, 2011, MAR ECOL PROG SER, V421, P83, DOI 10.3354/meps08900; ONO M., 1986, TAXONOMIC ECOLOGICAL; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; Ostrom NE, 1997, GEOCHIM COSMOCHIM AC, V61, P2929, DOI 10.1016/S0016-7037(97)00131-2; Panarello H, 2002, RADIOCARBON, V44, P709, DOI 10.1017/S0033822200032161; PEFAUR JE, 1982, VEGETATIO, V49, P163, DOI 10.1007/BF00123840; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Pilbeam DJ, 2010, ANN PLANT REV, V42, P305; Politis GG, 2009, INT J OSTEOARCHAEOL, V19, P266, DOI 10.1002/oa.1053; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Rice SK, 2000, OECOLOGIA, V123, P1, DOI 10.1007/s004420050983; Riera P, 2009, ESTUAR COAST SHELF S, V81, P143, DOI 10.1016/j.ecss.2008.10.018; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; RUNDEL P W, 1991, Aliso, V13, P1; RUNDEL PW, 1979, OECOLOGIA, V44, P91, DOI 10.1007/BF00346404; Rundel PW, 2003, PLANT ECOL, V169, P179, DOI 10.1023/A:1026075721045; Sage R., 2004, PHOTOSYNTHESIS PHYSL, V9, P497; Sandweiss DH, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P93, DOI 10.1007/978-0-387-74907-5_6; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Schaal G, 2012, MAR ECOL-EVOL PERSP, V33, P370, DOI 10.1111/j.1439-0485.2011.00487.x; Schaal G, 2010, J SEA RES, V63, P24, DOI 10.1016/j.seares.2009.09.002; Schaal G, 2009, ESTUAR COAST SHELF S, V85, P565, DOI 10.1016/j.ecss.2009.09.027; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHULZE ED, 1994, OECOLOGIA, V100, P406, DOI 10.1007/BF00317862; Schulze ED, 1996, OECOLOGIA, V106, P352, DOI 10.1007/BF00334563; Schwarcz H, 2006, HIST MAIZE MULTIDISC, P315; Schwarcz HP, 1999, J ARCHAEOL SCI, V26, P629, DOI 10.1006/jasc.1998.0380; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; SHEARER G, 1983, OECOLOGIA, V56, P365, DOI 10.1007/BF00379714; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; SHEARER G, 1978, SOIL SCI SOC AM J, V42, P899, DOI 10.2136/sssaj1978.03615995004200060013x; SHIMADA M, 1985, AM ANTIQUITY, V50, P3, DOI 10.2307/280631; SILFER JA, 1992, CHEM GEOL, V101, P211, DOI 10.1016/0009-2541(92)90003-N; Slovak NM, 2011, INT J OSTEOARCHAEOL, V21, P253, DOI 10.1002/oa.1128; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; SONESSON M, 1992, OECOLOGIA, V92, P23, DOI 10.1007/BF00317258; Sprent JI, 1996, OECOLOGIA, V105, P440, DOI 10.1007/BF00330006; Spriggs AC, 2003, PLANT SOIL, V255, P495, DOI 10.1023/A:1026044831178; STEELE KW, 1983, PLANT PHYSIOL, V72, P1001, DOI 10.1104/pp.72.4.1001; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Syvertsen JP, 1997, J AM SOC HORTIC SCI, V122, P226, DOI 10.21273/JASHS.122.2.226; Szpak P, 2012, J ARCHAEOL SCI, V39, P3721, DOI 10.1016/j.jas.2012.06.035; Szpak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033741; Szpak P, 2012, J ARCHAEOL SCI, V39, P1553, DOI 10.1016/j.jas.2011.12.006; Szpak P, 2011, J ARCHAEOL SCI, V38, P3358, DOI 10.1016/j.jas.2011.07.022; Szpak P, 2010, PALAEOGEOGR PALAEOCL, V286, P88, DOI 10.1016/j.palaeo.2009.12.009; Szpak P, 2009, J ARCHAEOL SCI, V36, P2734, DOI 10.1016/j.jas.2009.08.013; Terwilliger VJ, 1996, PHYTOCHEMISTRY, V43, P1183, DOI 10.1016/S0031-9422(96)00538-9; Tessone A, 2009, INT J OSTEOARCHAEOL, V19, P297, DOI 10.1002/oa.1039; Thornton EK, 2011, INT J OSTEOARCHAEOL, V21, P544, DOI 10.1002/oa.1157; Tieszen Larry, 1992, P 1 WORLD C MUMMY ST, P409; TIESZEN LL, 1993, J ARCHAEOL SCI, V20, P25, DOI 10.1006/jasc.1993.1002; Tomczak PD, 2003, J ANTHROPOL ARCHAEOL, V22, P262, DOI 10.1016/S0278-4165(03)00039-4; TOSI J, 1960, ZONAS VIDA NATURAL P; Towle M.A., 1961, ETHNOBOTANY PRECOLUM; Townsend-Small A, 2005, LIMNOL OCEANOGR, V50, P672, DOI 10.4319/lo.2005.50.2.0672; Troll C, 1968, C GEOGRAPHICUM, P15; Turner BL, 2010, CHUNGARA, V42, P515, DOI 10.4067/S0717-73562010000200012; Tykot RH, 2006, HIST MAIZE MULTIDISC, P187; van Groenigen JW, 2002, SOIL SCI SOC AM J, V66, P489, DOI 10.2136/sssaj2002.0489; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VERANO JW, 1993, INVESTIGATIONS ANCIE, P361; VIRGINIA RA, 1982, OECOLOGIA, V54, P317, DOI 10.1007/BF00380000; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; Vizzini S, 2003, MAR BIOL, V142, P1009, DOI 10.1007/s00227-003-1027-6; VOGEL JC, 1978, OECOLOG PLANTAR, V13, P89; Voigt CC, 2010, BIOTROPICA, V42, P634, DOI 10.1111/j.1744-7429.2010.00703.x; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; Wang WL, 2003, BOT BULL ACAD SINICA, V44, P107; Warinner C, 2013, J ARCHAEOL SCI, V40, P868, DOI 10.1016/j.jas.2012.07.003; Waser NAD, 1998, LIMNOL OCEANOGR, V43, P215, DOI 10.4319/lo.1998.43.2.0215; West M, 1971, CALIFORNIA ANTHR, V1, P47; White CD, 2009, J ARCHAEOL SCI, V36, P1527, DOI 10.1016/j.jas.2009.03.008; WIENCKE C, 1990, MAR ECOL PROG SER, V65, P283, DOI 10.3354/meps065283; Williams JS, 2012, J ARCHAEOL SCI, V39, P41, DOI 10.1016/j.jas.2011.07.013; Winterhalder BP, 1978, GEOEC S HIGHL PER; Wittmer MHOM, 2011, PLANT SOIL, V340, P25, DOI 10.1007/s11104-010-0411-5; Wu JP, 1997, DEEP-SEA RES PT I, V44, P287, DOI 10.1016/S0967-0637(96)00099-4; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; Xu YQ, 2010, J PLANT ECOL-UK, V3, P201, DOI 10.1093/jpe/rtq023; Yacobaccio HD, 2009, INT J OSTEOARCHAEOL, V19, P144, DOI 10.1002/oa.1050; Yakir D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034007; YONEYAMA T, 1993, PLANT SOIL, V153, P295, DOI 10.1007/BF00013003; YONEYAMA T, 1986, PLANT CELL PHYSIOL, V27, P791, DOI 10.1093/oxfordjournals.pcp.a077165; Yoneyama Tadakatsu, 2003, Phytochemistry Reviews, V2, P121, DOI 10.1023/B:PHYT.0000004198.95836.ad; Yun SI, 2006, SOIL BIOL BIOCHEM, V38, P1682, DOI 10.1016/j.soilbio.2005.11.022; ZIMMERMAN JK, 1990, OECOLOGIA, V83, P247, DOI 10.1007/BF00317759	235	99	100	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53763	10.1371/journal.pone.0053763	http://dx.doi.org/10.1371/journal.pone.0053763			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341996	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700043
J	Wittemyer, G; Daballen, D; Douglas-Hamilton, I				Wittemyer, George; Daballen, David; Douglas-Hamilton, Iain			Comparative Demography of an At-Risk African Elephant Population	PLOS ONE			English	Article							SPRINGS-NATIONAL-RESERVES; LOXODONTA-AFRICANA; SOUTH-AFRICA; PARK; DYNAMICS; DENSITY; SAMBURU; REPRODUCTION; VARIABILITY; MORTALITY	Knowledge of population processes across various ecological and management settings offers important insights for species conservation and life history. In regard to its ecological role, charisma and threats from human impacts, African elephants are of high conservation concern and, as a result, are the focus of numerous studies across various contexts. Here, demographic data from an individually based study of 934 African elephants in Samburu, Kenya were summarized, providing detailed inspection of the population processes experienced by the population over a fourteen year period (including the repercussions of recent increases in illegal killing). These data were compared with those from populations inhabiting a spectrum of xeric to mesic ecosystems with variable human impacts. In relation to variability in climate and human impacts (causing up to 50% of recorded deaths among adults), annual mortality in Samburu fluctuated between 1 and 14% and, unrelatedly, natality between 2 and 14% driving annual population increases and decreases. Survivorship in Samburu was significantly lower than other populations with age-specific data even during periods of low illegal killing by humans, resulting in relatively low life expectancy of males (18.9 years) and females (21.8 years). Fecundity (primiparous age and inter-calf interval) were similar to those reported in other human impacted or recovering populations, and significantly greater than that of comparable stable populations. This suggests reproductive effort of African savanna elephants increases in relation to increased mortality (and resulting ecological ramifications) as predicted by life history theory. Further comparison across populations indicated that elongated inter-calf intervals and older ages of reproductive onset were related to age structure and density, and likely influenced by ecological conditions. This study provides detailed empirical data on elephant population dynamics strongly influenced by human impacts (laying the foundation for modeling approaches), supporting predictions of evolutionary theory regarding demographic responses to ecological processes.	[Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Wittemyer, George] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Wittemyer, George; Daballen, David; Douglas-Hamilton, Iain] Save Elephants, Nairobi, Kenya; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Colorado State University; Colorado State University; University of Oxford	Wittemyer, G (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	g.wittemyer@colostate.edu	Wittemyer, George/AFQ-1840-2022		National Science Foundation [OISE-0502340]; Escape Foundation	National Science Foundation(National Science Foundation (NSF)); Escape Foundation	Funding for this study included the National Science Foundation GRFP and IRFP OISE-0502340, Save the Elephants private donors and the Escape Foundation (http://www.escapefoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burnham K. P., 1998, MODEL SELECTION INFE; BUSS IO, 1966, J WILDLIFE MANAGE, V30, P375, DOI 10.2307/3797826; Caughley G., 1977, ANAL VERTEBRATE POPU; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Douglas-Hamilton I., 1987, Oryx, V6, P11; Douglas-Hamilton I, 1972, ECOLOGY BEHAV AFRICN; Douglas-Hamilton I, 2010, LEVELS ILLEGAL KILLI; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Foley CAH, 2010, ORYX, V44, P205, DOI 10.1017/S0030605309990706; Freeman EW, 2009, AFR J ECOL, V47, P192, DOI 10.1111/j.1365-2028.2008.00957.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; HANKS J, 1972, J REPROD FERTIL, V30, P13, DOI 10.1530/jrf.0.0300013; IUCN, 2012, IUCN RED LIST THREAT; Kahindi O, 2010, AFR J ECOL, V48, P972, DOI 10.1111/j.1365-2028.2009.01200.x; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Laws R. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P193; Laws R.M., 1975, ELEPHANTS THEIR HABI; LAWS RM, 1970, OIKOS, V21, P1, DOI 10.2307/3543832; Lindeque M, 1988, POPULATION DYNAMICS; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maisels F, PLOS ONE IN PRESS; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss Cynthia, 1996, P58; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; Rasmussen HB, 2005, AFR J ECOL, V43, P215, DOI 10.1111/j.1365-2028.2005.00571.x; Roff Derek A., 1992; Stearns S.C., 1992, pi; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2007, HORM BEHAV, V51, P346, DOI 10.1016/j.yhbeh.2006.12.013; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2011, CONSERV BIOL, V25, P1002, DOI 10.1111/j.1523-1739.2011.01713.x; Wittemyer G, 2011, NATURE, V476, P282, DOI 10.1038/476282c; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941	56	62	63	1	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53726	10.1371/journal.pone.0053726	http://dx.doi.org/10.1371/journal.pone.0053726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341984	gold, Green Published			2022-12-27	WOS:000313682700039
J	De, G; Yip, WK; Ionita-Laza, I; Laird, N				De, Gourab; Yip, Wai-Ki; Ionita-Laza, Iuliana; Laird, Nan			Rare Variant Analysis for Family-Based Design	PLOS ONE			English	Article							COMBINING DEPENDENT TESTS; ASSOCIATION TESTS; COMMON DISEASES; COMPLEX TRAITS; POPULATIONS; INFORMATION; ARRAY	Genome-wide association studies have been able to identify disease associations with many common variants; however most of the estimated genetic contribution explained by these variants appears to be very modest. Rare variants are thought to have larger effect sizes compared to common SNPs but effects of rare variants cannot be tested in the GWAS setting. Here we propose a novel method to test for association of rare variants obtained by sequencing in family-based samples by collapsing the standard family-based association test (FBAT) statistic over a region of interest. We also propose a suitable weighting scheme so that low frequency SNPs that may be enriched in functional variants can be upweighted compared to common variants. Using simulations we show that the family-based methods perform at par with the population-based methods under no population stratification. By construction, family-based tests are completely robust to population stratification; we show that our proposed methods remain valid even when population stratification is present.	[De, Gourab; Yip, Wai-Ki; Laird, Nan] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY USA	Harvard University; Columbia University	De, G (corresponding author), Harvard Univ, Dept Biostat, Boston, MA 02115 USA.	gde@post.harvard.edu			FBAT (Family Based Association Tests) grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797] Funding Source: NIH RePORTER	FBAT (Family Based Association Tests) grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	FBAT (Family Based Association Tests) grant was used to fund this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Balding DJ, 1995, GENETICA, V2, P3; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Murphy A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000197; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rakovski CS, 2007, GENET EPIDEMIOL, V31, P9, DOI 10.1002/gepi.20186; Saunders IW, 2007, GENOMICS, V90, P291, DOI 10.1016/j.ygeno.2007.05.011; Steen LV, 2005, NAT GENET, V37, P683; WEI LJ, 1985, BIOMETRIKA, V72, P359; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Xu X, 2006, GENET EPIDEMIOL, V30, P620, DOI 10.1002/gepi.20174; Yip Wai-Ki, 2011, BMC Proc, V5 Suppl 9, pS21, DOI 10.1186/1753-6561-5-S9-S21; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449; [No title captured]	30	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e48495	10.1371/journal.pone.0048495	http://dx.doi.org/10.1371/journal.pone.0048495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341868	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700002
J	Fu, SL; Sun, CF; Yang, MY; Fei, YY; Tan, FQ; Yan, BJ; Ren, ZL; Tang, ZX				Fu, Shulan; Sun, Chuanfei; Yang, Manyu; Fei, Yunyan; Tan, Feiqun; Yan, Benju; Ren, Zhenglong; Tang, Zongxiang			Genetic and Epigenetic Variations Induced by Wheat-Rye 2R and 5R Monosomic Addition Lines	PLOS ONE			English	Article							NEWLY SYNTHESIZED AMPHIPLOIDS; RAPID GENOMIC CHANGES; CHROMOSOMES; DNA; TRITICUM; POLYPLOIDIZATION; HETEROCHROMATIN; INTROGRESSION; METHYLATION; CHROMATIN	Background: Monosomic alien addition lines (MAALs) can easily induce structural variation of chromosomes and have been used in crop breeding; however, it is unclear whether MAALs will induce drastic genetic and epigenetic alterations. Methodology/Principal Findings: In the present study, wheat-rye 2R and 5R MAALs together with their selfed progeny and parental common wheat were investigated through amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MSAP) analyses. The MAALs in different generations displayed different genetic variations. Some progeny that only contained 42 wheat chromosomes showed great genetic/epigenetic alterations. Cryptic rye chromatin has introgressed into the wheat genome. However, one of the progeny that contained cryptic rye chromatin did not display outstanding genetic/epigenetic variation. 78 and 49 sequences were cloned from changed AFLP and MSAP bands, respectively. Blastn search indicated that almost half of them showed no significant similarity to known sequences. Retrotransposons were mainly involved in genetic and epigenetic variations. Genetic variations basically affected Gypsy-like retrotransposons, whereas epigenetic alterations affected Copia-like and Gypsy-like retrotransposons equally. Genetic and epigenetic variations seldom affected low-copy coding DNA sequences. Conclusions/Significance: The results in the present study provided direct evidence to illustrate that monosomic wheat-rye addition lines could induce different and drastic genetic/epigenetic variations and these variations might not be caused by introgression of rye chromatins into wheat. Therefore, MAALs may be directly used as an effective means to broaden the genetic diversity of common wheat.	[Fu, Shulan; Sun, Chuanfei; Yang, Manyu; Fei, Yunyan; Tan, Feiqun; Yan, Benju; Ren, Zhenglong; Tang, Zongxiang] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Fu, SL (corresponding author), Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.	fusl@sicau.edu.cn; zhlren@sohu.com			National Natural Science Foundation of China [31000713]; National High Technology Research and Development Program ("863" Program) of China [2011AA100101, 2011AA100103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This study was supported by National Natural Science Foundation of China (No. 31000713) and by the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA100101; 2011AA100103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; APPELS R, 1982, THEOR APPL GENET, V63, P235, DOI 10.1007/BF00304002; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Chen JF, 2004, THEOR APPL GENET, V108, P1343, DOI 10.1007/s00122-003-1546-z; Chevre AM, 1996, PLANT BREEDING, V115, P113, DOI 10.1111/j.1439-0523.1996.tb00884.x; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Katto MC, 2004, GENES GENET SYST, V79, P245, DOI 10.1266/ggs.79.245; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Multani DS, 2003, THEOR APPL GENET, V107, P395, DOI 10.1007/s00122-003-1214-3; REAMONRAMOS SM, 1992, THEOR APPL GENET, V84, P411, DOI 10.1007/BF00229501; Ren ZL, 1997, SCI CHINA SER C, V40, P323, DOI 10.1007/BF02879094; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Singh RJ, 1998, CROP SCI, V38, P1483, DOI 10.2135/cropsci1998.0011183X003800060013x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2012, INT J PLANT SCI, V173, P1, DOI 10.1086/662655; van Heusden AW, 2000, THEOR APPL GENET, V100, P480, DOI 10.1007/s001220050062; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang Y, 2008, CHINESE SCI BULL, V53, P58, DOI 10.1007/s11434-008-0049-3	26	14	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54057	10.1371/journal.pone.0054057	http://dx.doi.org/10.1371/journal.pone.0054057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342073	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400116
J	Young, MH; U'Ren, L; Huang, SX; Mallevaey, T; Scott-Browne, J; Crawford, F; Lantz, O; Hansen, TH; Kappler, J; Marrack, P; Gapin, L				Young, Mary H.; U'Ren, Lance; Huang, Shouxiong; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Lantz, Olivier; Hansen, Ted H.; Kappler, John; Marrack, Philippa; Gapin, Laurent			MAIT Cell Recognition of MR1 on Bacterially Infected and Uninfected Cells	PLOS ONE			English	Article							INVARIANT T-CELLS; MHC-RELATED PROTEIN-1; ANTIGEN PRESENTATION	Mucosal-associated invariant T cells are a unique population of T cells that express a semi-invariant ab TCR and are restricted by the MHC class I-related molecule MR1. MAIT cells recognize uncharacterized ligand(s) presented by MR1 through the cognate interaction between their TCR and MR1. To understand how the MAIT TCR recognizes MR1 at the surface of APCs cultured both with and without bacteria, we undertook extensive mutational analysis of both the MAIT TCR and MR1 molecule. We found differential contribution of particular amino acids to the MAIT TCR-MR1 interaction based upon the presence of bacteria, supporting the hypothesis that the structure of the MR1 molecules with the microbial-derived ligand(s) differs from the one with the endogenous ligand(s). Furthermore, we demonstrate that microbial-derived ligand(s) is resistant to proteinase K digestion and does not extract with common lipids, suggesting an unexpected class of antigen(s) might be recognized by this unique lymphocyte population.	[Young, Mary H.; U'Ren, Lance; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Kappler, John; Marrack, Philippa; Gapin, Laurent] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Young, Mary H.; U'Ren, Lance; Mallevaey, Thierry; Scott-Browne, James; Crawford, Frances; Kappler, John; Marrack, Philippa; Gapin, Laurent] Univ Colorado, Sch Med, Denver, CO USA; [Kappler, John; Marrack, Philippa] Univ Colorado, Howard Hughes Med Inst, Sch Med, Aurora, CO USA; [Kappler, John; Marrack, Philippa] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Kappler, John] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Kappler, John] Univ Colorado, Program Biomol Struct, Sch Med, Aurora, CO USA; [Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Lantz, Olivier] Inst Curie, INSERM, U732, Paris, France; [Huang, Shouxiong; Hansen, Ted H.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Washington University (WUSTL)	Marrack, P (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA.	marrackp@njhealth.org; gapinl@njhealth.org	Mallevaey, Thierry/AAH-4499-2020; Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Huang, Shouxiong/0000-0001-7797-3626; Lantz, olivier/0000-0003-3161-7719	National Institutes of Health (NIH) [AI18785, AI22295, AI046553, AI078246, AI076463, AI092108]; ANR; NIH [T32 AI07405]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R56AI078246, R01AI018785, R37AI018785, R01AI046553, T32AI007405, R21AI076463, R01AI092108, R56AI018785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) (AI18785 and AI22295 to PM and JWK, AI046553 to TH and AI078246, AI076463 and AI092108 to LG) and an ANR grant to OL. JPS-B and MHY were supported by an NIH training grant (T32 AI07405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Chua WJ, 2012, INFECT IMMUN; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Miley MJ, 2003, J IMMUNOL, V170, P6090, DOI 10.4049/jimmunol.170.12.6090; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Shimamura M, 2008, MINI-REV MED CHEM, V8, P285, DOI 10.2174/138955708783744119; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Yamaguchi H, 1997, BIOCHEM BIOPH RES CO, V238, P697, DOI 10.1006/bbrc.1997.7379	21	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53789	10.1371/journal.pone.0053789	http://dx.doi.org/10.1371/journal.pone.0053789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342002	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400083
J	Burke, BJ; Peterson, WT; Beckman, BR; Morgan, C; Daly, EA; Litz, M				Burke, Brian J.; Peterson, William T.; Beckman, Brian R.; Morgan, Cheryl; Daly, Elizabeth A.; Litz, Marisa			Multivariate Models of Adult Pacific Salmon Returns	PLOS ONE			English	Article							COHO ONCORHYNCHUS-KISUTCH; SIZE-SELECTIVE MORTALITY; EARLY MARINE RESIDENCE; SPRING CHINOOK SALMON; COLUMBIA RIVER; INTERANNUAL VARIABILITY; JUVENILE SALMON; OCEAN GROWTH; TSHAWYTSCHA; CALIFORNIA	Most modeling and statistical approaches encourage simplicity, yet ecological processes are often complex, as they are influenced by numerous dynamic environmental and biological factors. Pacific salmon abundance has been highly variable over the last few decades and most forecasting models have proven inadequate, primarily because of a lack of understanding of the processes affecting variability in survival. Better methods and data for predicting the abundance of returning adults are therefore required to effectively manage the species. We combined 31 distinct indicators of the marine environment collected over an 11-year period into a multivariate analysis to summarize and predict adult spring Chinook salmon returns to the Columbia River in 2012. In addition to forecasts, this tool quantifies the strength of the relationship between various ecological indicators and salmon returns, allowing interpretation of ecosystem processes. The relative importance of indicators varied, but a few trends emerged. Adult returns of spring Chinook salmon were best described using indicators of bottom-up ecological processes such as composition and abundance of zooplankton and fish prey as well as measures of individual fish, such as growth and condition. Local indicators of temperature or coastal upwelling did not contribute as much as large-scale indicators of temperature variability, matching the spatial scale over which salmon spend the majority of their ocean residence. Results suggest that effective management of Pacific salmon requires multiple types of data and that no single indicator can represent the complex early-ocean ecology of salmon.	[Burke, Brian J.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Washington, DC USA; [Peterson, William T.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Newport, OR USA; [Beckman, Brian R.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Div, Seattle, WA USA; [Morgan, Cheryl; Daly, Elizabeth A.; Litz, Marisa] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Burke, BJ (corresponding author), Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Washington, DC USA.	brian.burke@noaa.gov			Bonneville Power Administration [1998-014-00]; National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization [NA09NMF4720182]; National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics [NA67RJ0151]	Bonneville Power Administration; National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization; National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics	Funding for this came from Bonneville Power Administration, project #1998-014-00 (http://www.bpa.gov/), National Oceanic and Atmospheric Administration - Comparative Analysis of Marine Ecosystem Organization grant #NA09NMF4720182 (http://cameo.noaa.gov/), and National Oceanic and Atmospheric Administration - Global Ocean Ecosystems Dynamics grant #NA67RJ0151 (http://www.usglobec.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2009, ECOL APPL, V19, P1989, DOI 10.1890/08-0477.1; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Bi HS, 2011, FISH OCEANOGR, V20, P125, DOI 10.1111/j.1365-2419.2011.00573.x; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Brodeur RD, 2005, MAR ECOL PROG SER, V298, P41, DOI 10.3354/meps298041; Brodeur RD, 2007, FISH OCEANOGR, V16, P395, DOI 10.1111/j.1365-2419.2007.00438.x; Burnham K.P., 2010, MODEL SELECTION MULT; Cross AD, 2009, MAR COAST FISH, V1, P57, DOI 10.1577/C08-005.1; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; Daly EA, 2009, T AM FISH SOC, V138, P1420, DOI 10.1577/T08-226.1; Duffy EJ, 2009, FACTORS EARLY MARINE; Emmett RL, 2006, PROG OCEANOGR, V68, P1, DOI 10.1016/j.pocean.2005.08.001; Emmett RL, 2008, T AM FISH SOC, V137, P657, DOI 10.1577/T06-058.1; Ford MJ, 2010, STATUS REV UPDATE PA; Geiger HJ, 1997, RUN FORECASTS HARVES; Haeseker SL, 2008, N AM J FISH MANAGE, V28, P12, DOI 10.1577/M06-287.1; Hare SR, 2004, CLIMATE CHANGE NO FI; Hinke JT, 2005, MAR ECOL PROG SER, V304, P207, DOI 10.3354/meps304207; HOLTBY LB, 1990, CAN J FISH AQUAT SCI, V47, P2181, DOI 10.1139/f90-243; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Hyun SY, 2005, CAN J FISH AQUAT SCI, V62, P1665, DOI 10.1139/F05-071; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Legendre P., 2012, NUMERICAL ECOLOGY; Litz MNC, 2008, ECOLOGY NO SUBPOPULA; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Martin F, 2009, ECOL FRESHW FISH, V18, P406, DOI 10.1111/j.1600-0633.2009.00357.x; Mazur MM, 2006, J FISH BIOL, V69, P151, DOI 10.1111/j.1095-8649.2006.01075.x; McKinnell S, 2012, CAN J FISH AQUAT SCI, V69, P1499, DOI 10.1139/F2012-078; Moss JH, 2005, T AM FISH SOC, V134, P1313, DOI 10.1577/T05-054.1; Nelson G C, 2005, DRIVERS ECOSYSTEM CH; NOAKES D J, 1990, North American Journal of Fisheries Management, V10, P46, DOI 10.1577/1548-8675(1990)010<0046:ACOPFM>2.3.CO;2; ODFW WDFW, 2012, 2012 JOINT STAFF REP; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Peterman RM, 2009, AM FISH S S, V71, P125; PETERMAN RM, 1982, CAN J FISH AQUAT SCI, V39, P1444, DOI 10.1139/f82-195; Peterson WT, 2010, FISH OCEANOGR, V19, P508, DOI 10.1111/j.1365-2419.2010.00560.x; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Peterson WT, 2012, NOAA FISHERIES; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rupp DE, 2012, FISH OCEANOGR, V21, P1, DOI 10.1111/j.1365-2419.2011.00605.x; Scheuerell MD, 2005, FISH OCEANOGR, V14, P448, DOI 10.1111/j.1365-2419.2005.00346.x; Schreck CB, 2006, T AM FISH SOC, V135, P457, DOI 10.1577/T05-184.1; Sih A., 1987, P203; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Trudel M, 2009, T AM FISH SOC, V138, P1369, DOI 10.1577/T08-181.1; Tucker S, 2011, T AM FISH SOC, V140, P1101, DOI 10.1080/00028487.2011.607035; Wang SZ, 2009, N AM J FISH MANAGE, V29, P423, DOI 10.1577/M07-055.1; Weitkamp LA, 2012, US FISHERY B; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wells BK, 2006, FISH OCEANOGR, V15, P67, DOI 10.1111/j.1365-2419.2005.00361.x; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Westad F, 2002, MULTIVARIATE DATA AN; Zhou SJ, 2003, N AM J FISH MANAGE, V23, P48, DOI 10.1577/1548-8675(2003)023<0048:AOANNF>2.0.CO;2	57	75	77	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54134	10.1371/journal.pone.0054134	http://dx.doi.org/10.1371/journal.pone.0054134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326586	Green Published, gold			2022-12-27	WOS:000314705800111
J	Amitani, H; Asakawa, A; Cheng, KC; Amitani, M; Kaimoto, K; Nakano, M; Ushikai, M; Li, YX; Tsai, ML; Li, JB; Terashi, M; Chaolu, H; Kamimura, R; Inui, A				Amitani, Haruka; Asakawa, Akihiro; Cheng, Kaichun; Amitani, Marie; Kaimoto, Kaori; Nakano, Masako; Ushikai, Miharu; Li, Yingxiao; Tsai, Minglun; Li, Jiang-Bo; Terashi, Mutsumi; Chaolu, Huhe; Kamimura, Ryozo; Inui, Akio			Hydrogen Improves Glycemic Control in Type1 Diabetic Animal Model by Promoting Glucose Uptake into Skeletal Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH FACTOR-I; MOLECULAR-HYDROGEN; OXIDATIVE STRESS; N-ACETYLCYSTEINE; INSULIN-RECEPTOR; LEPTIN RECEPTOR; RICH WATER; VITAMIN-C; ANTIOXIDANT	Hydrogen (H-2) acts as a therapeutic antioxidant. However, there are few reports on H-2 function in other capacities in diabetes mellitus (DM). Therefore, in this study, we investigated the role of H-2 in glucose transport by studying cultured mouse C2C12 cells and human hepatoma Hep-G2 cells in vitro, in addition to three types of diabetic mice [Streptozotocin (STZ)-induced type 1 diabetic mice, high-fat diet-induced type 2 diabetic mice, and genetically diabetic db/db mice] in vivo. The results show that H-2 promoted 2-[C-14]-deoxy-D-glucose (2-DG) uptake into C2C12 cells via the translocation of glucose transporter Glut4 through activation of phosphatidylinositol-3-OH kinase (PI3K), protein kinase C (PKC), and AMP-activated protein kinase (AMPK), although it did not stimulate the translocation of Glut2 in Hep G2 cells. H-2 significantly increased skeletal muscle membrane Glut4 expression and markedly improved glycemic control in STZ-induced type 1 diabetic mice after chronic intraperitoneal (i.p.) and oral (p.o.) administration. However, long-term p.o. administration of H-2 had least effect on the obese and non-insulin-dependent type 2 diabetes mouse models. Our study demonstrates that H-2 exerts metabolic effects similar to those of insulin and may be a novel therapeutic alternative to insulin in type 1 diabetes mellitus that can be administered orally.	[Amitani, Haruka; Asakawa, Akihiro; Cheng, Kaichun; Amitani, Marie; Kaimoto, Kaori; Nakano, Masako; Ushikai, Miharu; Li, Yingxiao; Tsai, Minglun; Li, Jiang-Bo; Terashi, Mutsumi; Chaolu, Huhe; Inui, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Kamimura, Ryozo] Kagoshima Univ, Grad Sch Med & Dent Sci, Inst Lab Anim, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Asakawa, A (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan.	asakawa@m2.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is partially funded by the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation of the Japan Society for the Promotion of Science. The authors gratefully acknowledge VANA Co., Ltd. (Yamanashi, Japan) for the generous gift of natural hydrogen water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bak MJ, 2012, INT J MOL SCI, V13, P2314, DOI 10.3390/ijms13022314; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang CJ, 1996, J AUTONOM NERV SYST, V61, P191; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Childs A, 2001, FREE RADICAL BIO MED, V31, P745, DOI 10.1016/S0891-5849(01)00640-2; DeFronzo RA, 1997, DIABETES REV, V5, P177; Delaney CA, 1995, BIOCHEM PHARMACOL, V50, P2015, DOI 10.1016/0006-2952(95)02102-7; Dong J, 2006, ENDOCRINOLOGY, V147, P2634, DOI 10.1210/en.2005-1335; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Frystyk J, 2005, HORM METAB RES, V37, pS44, DOI 10.1055/s-2005-861362; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Galley HF, 1996, FREE RADICAL BIO MED, V20, P139, DOI 10.1016/0891-5849(95)02022-5; GAMMELTOFT S, 1986, BIOCHEM J, V235, P1; Garg Vishvas, 2011, Indian J Endocrinol Metab, V15, pS5, DOI 10.4103/2230-8210.83053; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P312, DOI 10.5056/jnm.2011.17.3.312; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Herbert V, 1996, J NUTR, V126, pS1213, DOI 10.1093/jn/126.suppl_4.1213S; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Ishii S, 2002, ENDOCRINOLOGY, V143, P4934, DOI 10.1210/en.2002-220612; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kelly G S, 1998, Altern Med Rev, V3, P114; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P179, DOI 10.1515/bchm3.1995.376.3.179; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; Murdolo G, 2003, DIABETES, V52, P2923, DOI 10.2337/diabetes.52.12.2923; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; NeuschwanderTetri BA, 1996, BIOCHEM J, V320, P1005, DOI 10.1042/bj3201005; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Oikawa S, 1999, CARCINOGENESIS, V20, P1485, DOI 10.1093/carcin/20.8.1485; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Song MC, 2004, J PHARMACOL EXP THER, V308, P307, DOI 10.1124/jpet.103.056622; Su MH, 2006, FEBS LETT, V580, P4136, DOI 10.1016/j.febslet.2006.06.060; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang AL, 2006, HEPATOL RES, V34, P199, DOI 10.1016/j.hepres.2005.12.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	72	28	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53913	10.1371/journal.pone.0053913	http://dx.doi.org/10.1371/journal.pone.0053913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326534	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400057
J	Cederlund, A; Kai-Larsen, Y; Printz, G; Yoshio, H; Alvelius, G; Lagercrantz, H; Stromberg, R; Jornvall, H; Gudmundsson, GH; Agerberth, B				Cederlund, Andreas; Kai-Larsen, Ylva; Printz, Gordana; Yoshio, Hiroyuki; Alvelius, Gunvor; Lagercrantz, Hugo; Stromberg, Roger; Jornvall, Hans; Gudmundsson, Gudmundur H.; Agerberth, Birgitta			Lactose in Human Breast Milk an Inducer of Innate Immunity with Implications for a Role in Intestinal Homeostasis	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDE LL-37; ANTIMICROBIAL PEPTIDES; IMMUNOLOGICAL COMPONENTS; 1ST LINE; EXPRESSION; INFANTS; DEFENSE; CELLS; OLIGOSACCHARIDES; GROWTH	Postpartum, infants have not yet established a fully functional adaptive immune system and are at risk of acquiring infections. Hence, newborns are dependent on the innate immune system with its antimicrobial peptides (AMPs) and proteins expressed at epithelial surfaces. Several factors in breast milk are known to confer immune protection, but which the decisive factors are and through which manner they work is unknown. Here, we isolated an AMP-inducing factor from human milk and identified it by electrospray mass spectrometry and NMR to be lactose. It induces the gene (CAMP) that encodes the only human cathelicidin LL-37 in colonic epithelial cells in a dose- and time-dependent manner. The induction was suppressed by two different p38 antagonists, indicating an effect via the p38-dependent pathway. Lactose also induced CAMP in the colonic epithelial cell line T84 and in THP-1 monocytes and macrophages. It further exhibited a synergistic effect with butyrate and phenylbutyrate on CAMP induction. Together, these results suggest an additional function of lactose in innate immunity by upregulating gastrointestinal AMPs that may lead to protection of the neonatal gut against pathogens and regulation of the microbiota of the infant.	[Cederlund, Andreas; Kai-Larsen, Ylva; Alvelius, Gunvor; Jornvall, Hans; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Printz, Gordana; Lagercrantz, Hugo] Karolinska Univ Hosp, Dept Woman & Child Hlth, Stockholm, Sweden; [Yoshio, Hiroyuki] St Marianna Univ, Dept Neonatol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Inst Biol, Biomed Ctr, Reykjavik, Iceland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Saint Marianna University; Karolinska Institutet; University of Iceland	Kai-Larsen, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	ylva.kai-larsen@ki.se	Gudmundsson, Gudmundur H/K-9178-2015; Stromberg, Roger/C-2960-2013	Gudmundsson, Gudmundur H/0000-0001-5793-0565; 	Swedish Research Council [11217, 3532]; Swedish Foundation for Strategic Research; Torsten and Ragnar Soderbergs Foundation; Swedish Cancer Society; Karolinska Institutet; Icelandic Centre for Research (RANNIS); University of Iceland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderbergs Foundation; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Icelandic Centre for Research (RANNIS); University of Iceland	The authors are supported by the Swedish Research Council (11217, 3532), the Swedish Foundation for Strategic Research, the Torsten and Ragnar Soderbergs Foundation, the Swedish Cancer Society, Karolinska Institutet, the Icelandic Centre for Research (RANNIS) and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blewett HJH, 2008, ADV FOOD NUTR RES, V54, P45, DOI 10.1016/S1043-4526(07)00002-2; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brown AC, 2011, EXPERT REV GASTROENT, V5, P411, DOI [10.1586/EGH.11.29, 10.1586/egh.11.29]; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Chu H, 2012, SCIENCE; COUNAHAN R, 1976, ARCH DIS CHILD, V51, P517, DOI 10.1136/adc.51.7.517; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Dai DW, 2000, J PEDIATR GASTR NUTR, V30, pS23, DOI 10.1097/00005176-200003002-00005; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Eadala P, 2011, ALIMENT PHARM THER, V34, P735, DOI 10.1111/j.1365-2036.2011.04799.x; Field CJ, 2000, J PEDIATR GASTR NUTR, V31, P291, DOI 10.1097/00005176-200009000-00017; Field CJ, 2005, J NUTR, V135, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Halldorsson S, 2007, IN VITRO CELL DEV-AN, V43, P283, DOI 10.1007/s11626-007-9050-4; Hanson LA, 2002, ADV EXP MED BIOL, V503, P99; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Hawkes JS, 2006, EUR J CLIN NUTR, V60, P254, DOI 10.1038/sj.ejcn.1602310; He T, 2006, J NUTR, V136, P58, DOI 10.1093/jn/136.1.58; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Jiang TA, 1997, J NUTR, V127, P1489, DOI 10.1093/jn/127.8.1489; Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LU X, 1992, CANCER RES, V52, P3718; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Marchini G, 2002, BRIT J DERMATOL, V147, P1127, DOI 10.1046/j.1365-2133.2002.05014.x; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Murakami M, 2005, PEDIATR RES, V57, P10, DOI 10.1203/01.PDR.0000148068.32201.50; Murray IA, 2000, BRIT J NUTR, V83, P241, DOI 10.1017/S0007114500000313; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Quigley MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub2; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; SAINT L, 1984, BRIT J NUTR, V52, P87, DOI 10.1079/BJN19840074; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Schelonka RL, 1998, SEMIN PERINATOL, V22, P2, DOI 10.1016/S0146-0005(98)80003-7; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Stockinger S, 2011, CELL MOL LIFE SCI, V68, P3699, DOI 10.1007/s00018-011-0831-2; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; Vesa TH, 2000, J AM COLL NUTR, V19, p165S, DOI 10.1080/07315724.2000.10718086; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Yoshio H, 2004, SEMIN PERINATOL, V28, P304, DOI 10.1053/j.semperi.2004.08.008	57	57	60	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53876	10.1371/journal.pone.0053876	http://dx.doi.org/10.1371/journal.pone.0053876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326523	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400053
J	Inauen, J; Hossain, MM; Johnston, RB; Mosler, HJ				Inauen, Jennifer; Hossain, Mohammad Mojahidul; Johnston, Richard B.; Mosler, Hans-Joachim			Acceptance and Use of Eight Arsenic-Safe Drinking Water Options in Bangladesh	PLOS ONE			English	Article							MITIGATION; BEHAVIOR; HEALTH; EXPERIENCE; BELIEFS; NORMS	Arsenic contamination of drinking water is a serious public health threat. In Bangladesh, eight major safe water options provide an alternative to contaminated shallow tubewells: piped water supply, deep tubewells, pond sand filters, community arsenic-removal, household arsenic removal, dug wells, well-sharing, and rainwater harvesting. However, it is uncertain how well these options are accepted and used by the at-risk population. Based on the RANAS model (risk, attitudes, norms, ability, and self-regulation) this study aimed to identify the acceptance and use of available safe water options. Cross-sectional face-to-face interviews were used to survey 1,268 households in Bangladesh in November 2009 (n = 872), and December 2010 (n = 396). The questionnaire assessed water consumption, acceptance factors from the RANAS model, and socioeconomic factors. Although all respondents had access to at least one arsenic-safe drinking water option, only 62.1% of participants were currently using these alternatives. The most regularly used options were household arsenic removal filters (92.9%) and piped water supply (85.6%). However, the former result may be positively biased due to high refusal rates of household filter owners. The least used option was household rainwater harvesting (36.6%). Those who reported not using an arsenic-safe source differed in terms of numerous acceptance factors from those who reported using arsenic-safe sources: non-users were characterized by greater vulnerability; showed less preference for the taste and temperature of alternative sources; found collecting safe water quite time-consuming; had lower levels of social norms, self-efficacy, and coping planning; and demonstrated lower levels of commitment to collecting safe water. Acceptance was particularly high for piped water supplies and deep tubewells, whereas dug wells and well-sharing were the least accepted sources. Intervention strategies were derived from the results in order to increase the acceptance and use of each arsenic-safe water option.	[Inauen, Jennifer; Hossain, Mohammad Mojahidul; Mosler, Hans-Joachim] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Syst Anal Integrated Assessment & Modelling, Dubendorf, Switzerland; [Johnston, Richard B.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Water & Sanitat Developing Countries Sandec, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Inauen, J (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Syst Anal Integrated Assessment & Modelling, Dubendorf, Switzerland.	jennifer.inauen@eawag.ch		Inauen, Jennifer/0000-0002-7884-3222	Eawag; Swiss Federal Institute of Aquatic Science and Technology	Eawag; Swiss Federal Institute of Aquatic Science and Technology	This research was funded by Eawag, the Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Armitage CJ, 2005, HEALTH PSYCHOL, V24, P235, DOI 10.1037/0278-6133.24.3.235; DELEON IG, 1995, ENVIRON BEHAV, V27, P233, DOI 10.1177/0013916595272007; DPHE/BGS/MML, 2000, PHAS 2 NAT HYDR SURV; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Flanagan SV, 2012, B WORLD HEALTH ORGAN, V90, P839, DOI 10.2471/BLT.11.101253; Frick J, 2004, PERS INDIV DIFFER, V37, P1597, DOI 10.1016/j.paid.2004.02.015; Government of Bangladesh, 2004, NAT POL ARS MIT; Government of Bangladesh, 2004, IMPL PLAN ARS MIT; Hoffmeyer-Zlotnik J.H.P, 2003, DEV APPL STAT; Hoque BA, 2004, PUBLIC HEALTH, V118, P70, DOI 10.1016/S0033-3506(03)00135-5; Howard G, 2006, J HEALTH POPUL NUTR, V24, P346; Huber AC, 2012, J PUBLIC HEALTH-HEID, V20, P269, DOI 10.1007/s10389-011-0445-z; Huber AC, 2013, INT J ENVIRON HEAL R, V23, P96, DOI 10.1080/09603123.2012.699032; Johnston RB, 2007, J ENVIRON SCI HEAL A, V42, P1889, DOI 10.1080/10934520701567155; Kabir A, 2007, INT J ENVIRON HEAL R, V17, P207, DOI 10.1080/09603120701254904; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mosler HJ, 2012, INT J ENVIRON HEAL R, V22, P431, DOI 10.1080/09603123.2011.650156; Mosler HJ, 2010, J ENVIRON MANAGE, V91, P1316, DOI 10.1016/j.jenvman.2010.02.012; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Orbell S, 2009, HEALTH PSYCHOL, V28, P753, DOI 10.1037/a0016943; Park HS, 2007, HUM COMMUN RES, V33, P194, DOI 10.1111/j.1468-2958.2007.00296.x; Paul BK, 2004, SOC SCI MED, V59, P1741, DOI 10.1016/j.socscimed.2004.01.037; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Severtson DJ, 2006, RISK ANAL, V26, P353, DOI 10.1111/j.1539-6924.2006.00737.x; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Smith JR, 2008, J SOC PSYCHOL, V148, P311, DOI 10.3200/SOCP.148.3.311-334; Trafimow D, 1998, J EXP SOC PSYCHOL, V34, P378, DOI 10.1006/jesp.1998.1356; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238	33	51	51	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53640	10.1371/journal.pone.0053640	http://dx.doi.org/10.1371/journal.pone.0053640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326477	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400033
J	Pereira, G; Wood, L; Foster, S; Haggar, F				Pereira, Gavin; Wood, Lisa; Foster, Sarah; Haggar, Fatima			Access to Alcohol Outlets, Alcohol Consumption and Mental Health	PLOS ONE			English	Article							LIQUOR STORES; DENSITY; AVAILABILITY; DRINKING; VIOLENCE; YOUTH; IMPACTS; TOBACCO; INJURY; HARM	The objective of this study was to investigate residential exposure to alcohol outlets in relation to alcohol consumption and mental health morbidity (anxiety, stress, and depression). This was a cross-sectional study of 6,837 adults obtained from a population representative sample for the period 2006-2009 in Perth, Western Australia. The number of alcohol outlets was ascertained for a 1600 m service area surrounding the residential address. Zero-inflated negative binomial and logistic regression were used to assess associations with total alcohol consumption, harmful alcohol consumption (7-10 drinks containing 10 g of alcohol for men, 5-6 drinks for women) and medically diagnosed and hospital contacts (for anxiety, stress, and depression), respectively. The rate ratio for the number of days of harmful consumption of alcohol per month and the number of standard drinks of alcohol consumed per drinking day was 1.06 (95% CI: 1.02, 1.11) and 1.01 (95% CI: 1.00, 1.03) for each additional liquor store within a 1600 m service area, respectively. The odds ratio of hospital contact for anxiety, stress, or depression was 1.56 (95% CI: 0.98, 2.49) for those with a liquor store within the service area compared to those without. We observed strong evidence for a small association between residential exposure to liquor stores and harmful consumption of alcohol, and some support for a moderate-sized effect on hospital contacts for anxiety, stress, and depression.	[Pereira, Gavin] Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT 06520 USA; [Pereira, Gavin; Wood, Lisa; Foster, Sarah] Univ Western Australia, Sch Populat Hlth, Ctr Built Environm & Hlth, Crawley, WA, Australia; [Haggar, Fatima] Univ Ottawa, Ottawa Hosp, Res Inst, Dept Surg, Ottawa, ON, Canada	Yale University; University of Western Australia; University of Ottawa; Ottawa Hospital Research Institute	Pereira, G (corresponding author), Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT 06520 USA.	gavin.pereira@yale.edu	Wood, Lisa Jane/C-1816-2012; Pereira, Gavin/D-7136-2014; Foster, Sarah/H-9213-2014	Wood, Lisa Jane/0000-0002-9196-8847; Pereira, Gavin/0000-0003-3740-8117; Foster, Sarah/0000-0002-8624-4908	Western Australian Health Promotion Foundation (Healthway) [18922]; Healthway Health Promotion Research Fellowships [20693, 21363]; Healthway [18922] Funding Source: researchfish	Western Australian Health Promotion Foundation (Healthway); Healthway Health Promotion Research Fellowships; Healthway	The research was undertaken as part of a grant funded by the Western Australian Health Promotion Foundation (Healthway) (project grant # 18922). LW and SF are supported by Healthway Health Promotion Research Fellowships (# 20693 and # 21363, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIoHa Welfare, 2008, DRUG STAT SER, V20; [Anonymous], NOT DIR GEN EXPL MAK; Australian Bureau of Statistics, 2006, INF PAP INTR SOC IND; Australian Institute of Health and Welfare, 2010, DRINK PATT AUSTR 200; Berke EM, 2010, AM J PUBLIC HEALTH, V100, P1967, DOI 10.2105/AJPH.2009.170464; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Castaneda R, 1996, J CLIN PSYCHIAT, V57, P207; Chikritzhs T, 2003, AUSTR ALCOHOL INDICA, P200; Chikritzhs T., 2007, PREDICTING ALCOHOL R; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Escobedo LG, 2002, ACCIDENT ANAL PREV, V34, P689, DOI 10.1016/S0001-4575(01)00068-9; Fone D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-428; Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725; Freisthler B, 2005, CHILD ABUSE NEGLECT, V29, P1049, DOI 10.1016/j.chiabu.2004.12.014; Freisthler B, 2004, J STUD ALCOHOL, V65, P586, DOI 10.15288/jsa.2004.65.586; Gorman DM, 2001, J STUD ALCOHOL, V62, P628, DOI 10.15288/jsa.2001.62.628; Gruenewald PJ, 2006, ADDICTION, V101, P666, DOI 10.1111/j.1360-0443.2006.01405.x; Hay GC, 2009, HEALTH PLACE, V15, P1086, DOI 10.1016/j.healthplace.2009.05.008; Kypri K, 2008, ADDICTION, V103, P1131, DOI 10.1111/j.1360-0443.2008.02239.x; LaScala E A, 2001, Prev Sci, V2, P123, DOI 10.1023/A:1011547831475; LaVeist TA, 2000, SOC SCI MED, V51, P613, DOI 10.1016/S0277-9536(00)00004-6; Liang WB, 2011, DRUG ALCOHOL REV, V30, P524, DOI 10.1111/j.1465-3362.2010.00281.x; Livingston M, 2008, ADDICTION, V103, P619, DOI 10.1111/j.1360-0443.2008.02136.x; Livingston M, 2011, DRUG ALCOHOL REV, V30, P515, DOI 10.1111/j.1465-3362.2010.00251.x; National Health Medical Research Council, 2001, AUSTR GUID RED HLTH; Novak SP, 2006, AM J PUBLIC HEALTH, V96, P670, DOI 10.2105/AJPH.2004.061622; Ogneya-Himmelberger Y, 2010, TOB CONTROL, V19, P475, DOI 10.1136/tc.2008.029173; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Romley JA, 2007, J STUD ALCOHOL DRUGS, V68, P48, DOI 10.15288/jsad.2007.68.48; Scribner R, 1999, J STUD ALCOHOL, V60, P310, DOI 10.15288/jsa.1999.60.310; Treno AJ, 2003, ALCOHOL CLIN EXP RES, V27, P835, DOI 10.1097/01.ALC.0000067979.85714.22; Treno AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1467, DOI 10.1097/00000374-200110000-00009; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Weitzman ER, 2003, HEALTH PLACE, V9, P1, DOI 10.1016/S1353-8292(02)00014-X; WHO, 2011, GLOB STRAT RED HARMF; World Health Organization, 2011, GLOB STAT REP ALC HL; Xiao J., 2008, IMPACT ALCOHOL POPUL; Yu D, 2010, PUBLIC HEALTH, V124, P412, DOI 10.1016/j.puhe.2010.03.024; Zhu L, 2004, ALCOHOL ALCOHOLISM, V39, P369, DOI 10.1093/alcalc/agh062	39	44	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53461	10.1371/journal.pone.0053461	http://dx.doi.org/10.1371/journal.pone.0053461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341943	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700026
J	Goncalves, LCP; Tonelli, RR; Bagnaresi, P; Mortara, RA; Ferreira, AG; Bastos, EL				Pires Goncalves, Leticia Christina; Tonelli, Renata Rosito; Bagnaresi, Piero; Mortara, Renato Arruda; Ferreira, Antonio Gilberto; Bastos, Erick Leite			A Nature-Inspired Betalainic Probe for Live-Cell Imaging of Plasmodium-Infected Erythrocytes	PLOS ONE			English	Article							FALCIPARUM; PURIFICATION; PH; PERFORMANCE; PIGMENTS; PK(A)	A model betalainic dye was semisynthesized from betanin, the magenta pigment of the red beet, and was effective for live-cell imaging of Plasmodium-infected red blood cells. This water-soluble fluorescent probe is photostable, excitable in the visible region and cell membrane-permeable, and its photophysical properties are not notably pH-sensitive. Fluorescence imaging microscopy of erythrocytes infected with Plasmodium falciparum, a causative agent of malaria in humans, showed that only the parasite was stained. Z-stacking analysis suggested that the probe accumulates proximal to the nucleus of the parasite. Indicaxanthin, one of the natural fluorescent betalains found in the petals of certain flowers, did not stain the parasite or the red blood cell.	[Pires Goncalves, Leticia Christina] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Tonelli, Renata Rosito] Univ Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Bagnaresi, Piero] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Mortara, Renato Arruda] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunobiol & Parasitol, Sao Paulo, Brazil; [Ferreira, Antonio Gilberto] Univ Fed Sao Carlos, Dept Quim, Sao Paulo, Brazil; [Bastos, Erick Leite] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Carlos; Universidade de Sao Paulo	Bastos, EL (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil.	elbastos@iq.usp.br	Tonelli, Renata R/H-1334-2012; Ferreira, Antonio Gilberto/D-8254-2013; Mortara, Renato A./C-1864-2012; Ferreira, Antonio/GXH-7620-2022; Gonçalves, Letícia/AAB-9283-2021; Bastos, Erick L/F-8746-2012; Goncalves, Letícia C. P./N-1439-2015	Tonelli, Renata R/0000-0002-1685-9042; Ferreira, Antonio Gilberto/0000-0003-2314-216X; Mortara, Renato A./0000-0002-2311-8349; Ferreira, Antonio/0000-0001-5239-8020; Gonçalves, Letícia/0000-0002-1195-9810; Bastos, Erick L/0000-0002-0592-9455; Goncalves, Letícia C. P./0000-0002-1195-9810	Sao Paulo Research Foundation (FAPESP) [07/00684-6, 10/15042-2, 11/23036-5, 07/59407-1]; Coordination for the Improvement of Higher Education Personnel [PNPD 427-10/2009]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Sao Paulo Research Foundation (FAPESP) (07/00684-6, 10/15042-2, 11/23036-5). LCPG was supported by a FAPESP fellowship (07/59407-1) and the Coordination for the Improvement of Higher Education Personnel (PNPD 427-10/2009) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.G.F., E L.B and R.A.M. thank CNPq for productivity fellowships. We also thank B.M. Di Genova and F. Dorr for technical assistance, E. Pinto for granting access to the HPLC/MS facility and M.L.G. Dutra, R.L.O.R. Cunha and F. Quina for their advice.	ALONSO A, 1993, HYPERTENSION, V22, P348, DOI 10.1161/01.HYP.22.3.348; Bartoloni FH, 2013, MONATSH CHEM, V144, P567, DOI 10.1007/s00706-012-0883-5; CHENG SY, 1980, P NATL ACAD SCI-BIOL, V77, P3425, DOI 10.1073/pnas.77.6.3425; Cho S, 2012, TRENDS BIOTECHNOL, V30, P71, DOI 10.1016/j.tibtech.2011.08.004; DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208; Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223; Freitas AA, 2007, J BRAZIL CHEM SOC, V18, P1537, DOI 10.1590/S0103-50532007000800014; Frisch G. W., 2013, GAUSSIAN 09; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gandia-Herrero F, 2006, PHYTOCHEM ANALYSIS, V17, P262, DOI 10.1002/pca.909; Gandia-Herrero F, 2010, PLANTA, V232, P449, DOI 10.1007/s00425-010-1191-0; GIROD PA, 1991, PHYTOCHEMISTRY, V30, P169, DOI 10.1016/0031-9422(91)84119-D; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hanssen E, 2010, INT J PARASITOL, V40, P1127, DOI 10.1016/j.ijpara.2010.04.012; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Hilou A, 2006, J ETHNOPHARMACOL, V103, P236, DOI 10.1016/j.jep.2005.08.006; KAWAMOTO F, 1991, LANCET, V337, P200, DOI 10.1016/0140-6736(91)92159-Y; Keiser J, 2002, ANN TROP MED PARASIT, V96, P643, DOI 10.1179/000349802125001834; Kelly JX, 2007, EXP PARASITOL, V116, P103, DOI 10.1016/j.exppara.2006.12.001; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Klonis N, 2010, BIOCHEMISTRY-US, V49, P6804, DOI 10.1021/bi100567j; Kobayashi N, 2002, THESIS HALLE WITTENB; Kowalski LA, 2000, ENVIRON MOL MUTAGEN, V35, P300, DOI 10.1002/1098-2280(2000)35:4<300::AID-EM4>3.0.CO;2-Z; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Maxmen A, 2012, NATURE, V485, P293, DOI 10.1038/485293a; Pal H, 2003, J CHEM PHYS, V119, P443, DOI 10.1063/1.1578057; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Goncalves LCP, 2012, FOOD CHEM, V131, P231, DOI 10.1016/j.foodchem.2011.08.067; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Sabnis R.W., 2010, HDB BIOL DYES STAINS, P1; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; SCHWARTZ SJ, 1980, J AGR FOOD CHEM, V28, P540, DOI 10.1021/jf60229a032; Stintzing FC, 2005, J AGR FOOD CHEM, V53, P442, DOI 10.1021/jf048751y; Stintzing FC, 2006, HELV CHIM ACTA, V89, P1008, DOI 10.1002/hlca.200690077; Tesoriere L, 2005, J AGR FOOD CHEM, V53, P1266, DOI 10.1021/jf048134+; Tesoriere L, 2013, EUR J NUTR, V52, P1077, DOI 10.1007/s00394-012-0414-5; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006	39	22	22	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53874	10.1371/journal.pone.0053874	http://dx.doi.org/10.1371/journal.pone.0053874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342028	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700060
J	Millers, EKI; Johnson, LA; Birrell, GW; Masci, PP; Lavin, MF; de Jersey, J; Guddat, LW				Millers, Emma-Karin I.; Johnson, Lambro A.; Birrell, Geoff W.; Masci, Paul P.; Lavin, Martin F.; de Jersey, John; Guddat, Luke W.			The structure of Human Microplasmin in Complex with Textilinin-1, an Aprotinin-like Inhibitor from the Australian Brown Snake	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PROTEASE INHIBITOR; RISK; PROTEINS; BINDING; ENZYME; VENOM	Textilinin-1 is a Kunitz-type serine protease inhibitor from Australian brown snake venom. Its ability to potently and specifically inhibit human plasmin (K-i = 0.44 nM) makes it a potential therapeutic drug as a systemic anti-bleeding agent. The crystal structures of the human microplasmin-textilinin-1 and the trypsin-textilinin-1 complexes have been determined to 2.78 angstrom and 1.64 angstrom resolution respectively, and show that textilinin-1 binds to trypsin in a canonical mode but to microplasmin in an atypical mode with the catalytic histidine of microplasmin rotated out of the active site. The space vacated by the histidine side-chain in this complex is partially occupied by a water molecule. In the structure of microplasminogen the chi(1) dihedral angle of the side-chain of the catalytic histidine is rotated by 67 degrees from its "active" position in the catalytic triad, as exemplified by its location when microplasmin is bound to streptokinase. However, when textilinin-1 binds to microplasmin the chi(1) dihedral angle of this amino acid residue changes by -157 degrees (i.e. in the opposite rotation direction compared to microplasminogen). The unusual mode of interaction between textilinin-1 and plasmin explains textilinin-1's selectivity for human plasmin over plasma kallikrein. This difference can be exploited in future drug design efforts.	[Millers, Emma-Karin I.; de Jersey, John; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Johnson, Lambro A.; Masci, Paul P.] Princess Alexandra Hosp, Dept Med, Woolloongabba, Qld 4102, Australia; [Birrell, Geoff W.; Lavin, Martin F.] Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Queensland Canc Fund Res Unit, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Guddat, LW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021; Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769; Johnson, Lambro/0000-0001-9746-7771; Birrell, Geoff/0000-0002-6593-1514; Guddat, Luke/0000-0002-8204-8408	ARC-Linkage grant; Australian Research Council; QRxPharma Pty Ltd	ARC-Linkage grant(Australian Research Council); Australian Research Council(Australian Research Council); QRxPharma Pty Ltd	This work was supported by an ARC-Linkage grant funded by the Australian Research Council and by QRxPharma Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beattie WS, 2011, J CARDIOTHOR VASC AN, V25, P3, DOI 10.1053/j.jvca.2010.11.018; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHASE T, 1970, METHOD ENZYMOL, V19, P20; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dietrich W, 2007, ANN THORAC SURG, V84, P1144, DOI 10.1016/j.athoracsur.2007.05.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Filippovich I, 2002, BRIT J HAEMATOL, V119, P376, DOI 10.1046/j.1365-2141.2002.03878.x; Flight S, 2005, PATHOPHYSIOL HAEMO T, V34, P188, DOI 10.1159/000092421; Flight SM, 2009, BRIT J HAEMATOL, V145, P207, DOI 10.1111/j.1365-2141.2009.07605.x; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gaffney PJ, 2001, ANN NY ACAD SCI, V936, P594; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; KEZDY FJ, 1970, METHOD ENZYMOL, V19, P3; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levy Jerrold H, 2005, Curr Hematol Rep, V4, P368; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Millers EKI, 2009, FEBS J, V276, P3163, DOI 10.1111/j.1742-4658.2009.07034.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheule AM, 2000, ANESTH ANALG, V90, P262, DOI 10.1097/00000539-200002000-00005; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; SIEKMANN J, 1989, BIOL CHEM H-S, V370, P677, DOI 10.1515/bchm3.1989.370.2.677; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243	43	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54104	10.1371/journal.pone.0054104	http://dx.doi.org/10.1371/journal.pone.0054104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335990	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700048
J	Muller, A; Kleinau, G; Piechowski, CL; Muller, TD; Finan, B; Pratzka, J; Gruters, A; Krude, H; Tschop, M; Biebermann, H				Mueller, Anne; Kleinau, Gunnar; Piechowski, Carolin L.; Mueller, Timo D.; Finan, Brian; Pratzka, Juliane; Grueters, Annette; Krude, Heiko; Tschoep, Matthias; Biebermann, Heike			G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED RECEPTOR; TOGGLE SWITCH MODEL; JP05 MESSENGER-RNA; EXTRACELLULAR LOOPS; MOLECULAR-MECHANISM; STRUCTURAL BIOLOGY; CRYSTAL-STRUCTURES; HOMOLOGY MODEL; CYCLIC-AMP; T-CELLS	The G-protein coupled receptor 83 (GPR83) is an orphan G-protein coupled receptor for which the natural ligand(s) and signaling pathway(s) remain to be identified. Previous studies suggest a role of GPR83 in the regulation of thermogenesis and the control of circulating adiponectin. The aim of this study was to gain insights into the molecular underpinnings underlying GPR83 signaling. In particular, we aimed to assess the underlying G-protein activated signaling pathway of GPR83 and how this pathway is affected by mutational activation and zinc(II) challenge. Finally, we assessed the capacity of GPR83 for homodimerization. Our results show for the first time that mouse (m) GPR83 has high basal Gq/11 activity without affecting Gi or Gs signaling. Furthermore, we found that, under physiological conditions, zinc(II) (but not calcium(II) and magnesium(II)) potently activates mGPR83, thus identifying zinc(II) as an endogenous molecule with agonistic capability to activate mGPR83. In line with the observation that zinc(II)-ions activate mGPR83, we identified a cluster of ion-binding sensitive amino acids (e.g. His145, His204, Cys207, Glu217) in an activation sensitive receptor region of mGPR83. The occurrence of a constitutive activating mutant and a zinc(II)-binding residue at the N-terminal part corroborate the importance of this region in mGPR83 signal regulation. Finally, our results indicate that mGPR83 forms homodimers, which extend the current knowledge and molecular facets of GPR83 signaling.	[Mueller, Anne; Kleinau, Gunnar; Piechowski, Carolin L.; Pratzka, Juliane; Grueters, Annette; Krude, Heiko; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Mueller, Timo D.; Finan, Brian; Tschoep, Matthias] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany; [Tschoep, Matthias] Tech Univ Munich, Dept Metab Dis, D-80290 Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Biebermann, H (corresponding author), Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Müller, Timo D./AAZ-4445-2020; Kleinau, Gunnar/GPX-6330-2022; Tschoep, Matthias H/I-5443-2014	Muller, Anne/0000-0002-6256-8860; Biebermann, Heike/0000-0002-2024-7778; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X	Deutsche Forschungsgemeinschaft (DFG) [BI893/5-1, 893/6-2, KL2334/2-1]; Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth [TP1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de): BI893/5-1, 893/6-2, KL2334/2-1 and Graduate College 1208: Hormonal Regulation of Energy Metabolism, Body Weight and Growth (www.endogk.de/en/), TP1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F, 2003, MOL BRAIN RES, V117, P39, DOI 10.1016/S0169-328X(03)00280-8; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barwell J, 2012, BIOCHEM SOC T, V40, P433, DOI 10.1042/BST20110726; BAUGHMAN G, 1991, MOL ENDOCRINOL, V5, P637, DOI 10.1210/mend-5-5-637; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; Biebermann H, 2012, J CLIN ENDOCR METAB, V97, pE228, DOI 10.1210/jc.2011-2106; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Brezillon S, 2001, BRAIN RES, V921, P21, DOI 10.1016/S0006-8993(01)03068-2; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Ciolek J, 2011, EUR J PHARMACOL, V655, P1, DOI 10.1016/j.ejphar.2010.12.042; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; Costanzi S, 2010, CHIM OGGI, V28, P26; Dubins JS, 2012, METABOLISM IN PRESS; Elinder F, 2003, Q REV BIOPHYS, V36, P373, DOI 10.1017/S0033583504003932; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Fowler CB, 2004, BIOCHEMISTRY-US, V43, P8700, DOI 10.1021/bi036067r; Frazer A., 1999, BASIC NEUROCHEMISTRY, P263; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; HARRIGAN MT, 1989, MOL CELL BIOL, V9, P3438, DOI 10.1128/MCB.9.8.3438; Holst B, 2002, J BIOL CHEM, V277, P47662, DOI 10.1074/jbc.M202103200; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kontoyianni M, 2012, CURR MED CHEM, V19, P544, DOI 10.2174/092986712798918824; Lu LF, 2007, MOL CELL BIOL, V27, P8065, DOI 10.1128/MCB.01075-07; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pesini P, 1998, MOL BRAIN RES, V57, P281, DOI 10.1016/S0169-328X(98)00099-0; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Rosenkilde MM, 1998, FEBS LETT, V439, P35, DOI 10.1016/S0014-5793(98)01331-3; Sah R, 2005, NEUROSCIENCE, V133, P281, DOI 10.1016/j.neuroscience.2005.01.066; Sah R, 2007, PEPTIDES, V28, P302, DOI 10.1016/j.peptides.2006.11.013; Schetz JA, 1999, J PHARMACOL EXP THER, V289, P956; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7; Thiel G, 2012, ENDOCRINOLOGY, V153, P4716, DOI 10.1210/en.2012-1343; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wheatley M, 2007, BIOCHEM SOC T, V35, P717, DOI 10.1042/BST0350717; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Winkler F, 2010, J CLIN ENDOCR METAB, V95, P3605, DOI 10.1210/jc.2010-0112; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; XIE XM, 1994, PFLUG ARCH EUR J PHY, V427, P481, DOI 10.1007/BF00374264; Zhao Q, 2012, ACTA PHARMACOL SIN, V33, P324, DOI 10.1038/aps.2011.187	70	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53347	10.1371/journal.pone.0053347	http://dx.doi.org/10.1371/journal.pone.0053347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335960	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700014
J	Pell, C; Menaca, A; Were, F; Afrah, NA; Chatio, S; Manda-Taylor, L; Hamel, MJ; Hodgson, A; Tagbor, H; Kalilani, L; Ouma, P; Pool, R				Pell, Christopher; Menaca, Arantza; Were, Florence; Afrah, Nana A.; Chatio, Samuel; Manda-Taylor, Lucinda; Hamel, Mary J.; Hodgson, Abraham; Tagbor, Harry; Kalilani, Linda; Ouma, Peter; Pool, Robert			Factors Affecting Antenatal Care Attendance: Results from Qualitative Studies in Ghana, Kenya and Malawi	PLOS ONE			English	Article							MATERNAL MORTALITY; PREGNANCY; PERSPECTIVES; STRATEGIES; MALARIA; BIRTH	Background: Antenatal care (ANC) is a key strategy to improve maternal and infant health. However, survey data from sub-Saharan Africa indicate that women often only initiate ANC after the first trimester and do not achieve the recommended number of ANC visits. Drawing on qualitative data, this article comparatively explores the factors that influence ANC attendance across four sub-Saharan African sites in three countries (Ghana, Kenya and Malawi) with varying levels of ANC attendance. Methods: Data were collected as part of a programme of qualitative research investigating the social and cultural context of malaria in pregnancy. A range of methods was employed interviews, focus groups with diverse respondents and observations in local communities and health facilities. Results: Across the sites, women attended ANC at least once. However, their descriptions of ANC were often vague. General ideas about pregnancy care - checking the foetus' position or monitoring its progress - motivated women to attend ANC; as did, especially in Kenya, obtaining the ANC card to avoid reprimands from health workers. Women's timing of ANC initiation was influenced by reproductive concerns and pregnancy uncertainties, particularly during the first trimester, and how ANC services responded to this uncertainty; age, parity and the associated implications for pregnancy disclosure; interactions with healthcare workers, particularly messages about timing of ANC; and the cost of ANC, including charges levied for ANC procedures - in spite of policies of free ANC - combined with ideas about the compulsory nature of follow-up appointments. Conclusion: In these socially and culturally diverse sites, the findings suggest that 'supply' side factors have an important influence on ANC attendance: the design of ANC and particularly how ANC deals with the needs and concerns of women during the first trimester has implications for timing of initiation.	[Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Pell, Christopher; Menaca, Arantza; Pool, Robert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Were, Florence; Ouma, Peter] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Afrah, Nana A.; Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana; [Chatio, Samuel; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Upper East Regi, Ghana; [Manda-Taylor, Lucinda; Kalilani, Linda] Univ Malawi, Coll Med, Blantyre, Malawi; [Tagbor, Harry] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; [Hamel, Mary J.; Ouma, Peter] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA USA	University of Amsterdam; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Kenya Medical Research Institute; Kwame Nkrumah University Science & Technology; Navrongo Health Research Center; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Pell, C (corresponding author), Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands.	c.l.pell@uva.nl	Manda-Taylor, Lucinda/AAK-2116-2021; Tagbor, Harry/B-9312-2018	Manda-Taylor, Lucinda/0000-0001-8149-0897; Tagbor, Harry/0000-0002-9300-665X; Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium; Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Allen DR, 2004, MANAGING MOTHERHOOD; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Bergsjo P, 1997, ACTA OBSTET GYN SCAN, V76, P15, DOI 10.3109/00016349709047779; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Centre National de la Statistique et destudes Etudes Economiques (CNSEE) and ORC Macro, 2006, ENQ DEM SANT CONG 20; Chapman RR, 2003, SOC SCI MED, V57, P355, DOI 10.1016/S0277-9536(02)00363-5; Conrad P, 2012, TROP MED INT HEALTH, V17, P300, DOI 10.1111/j.1365-3156.2011.02923.x; Dowswell T, 2010, COCHRANE DATABASE SY, P10; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Gross K, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-36; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Service GS, 2008, GHAN POP HOUS CENS 2; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; Strauss A, 1997, GROUNDED THEORY PRAC; Wang W, 2011, DHS COMP REPORTS, P85; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2010, IMPAC INT MAN PREG C; World Health Organization, 2007, PROV EFF ANT CAR STA; World Health Organization, 2011, WHO STAT ANT CAR	38	196	197	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53747	10.1371/journal.pone.0053747	http://dx.doi.org/10.1371/journal.pone.0053747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23335973	gold, Green Published, Green Accepted			2022-12-27	WOS:000314707700029
J	Kim, H; Cruz, M; Bourdeau, A; Dumont, DJ				Kim, Harold; Cruz, Maribelle; Bourdeau, Annie; Dumont, Daniel J.			Cell-Cell Interactions Influence Vascular Reprogramming by Prox1 during Embryonic Development	PLOS ONE			English	Article							ARTERIAL ENDOTHELIAL-CELLS; LYMPHATIC VASCULATURE; MOLECULAR-MECHANISMS; NOTCH PATHWAY; COUP-TFII; EXPRESSION; BLOOD; LYMPHANGIOGENESIS; DIFFERENTIATION; HETEROGENEITY	Lymphangiogenesis is a highly regulated process that involves the reprogramming of venous endothelial cells into early lymphatic endothelial cells. This reprogramming not only displays a polarized expression pattern from the cardinal vein, but also demonstrates vascular specificity; early lymphatics only develop from the cardinal vein and not the related dorsal aorta. In our transgenic model of lymphangiogenesis, we demonstrate that Prox1 overexpression has the ability to reprogram venous endothelium but not early arterial endothelial cells in vivo, in spite of the fact that Prox1 expression is forced onto both vascular beds. Our observations suggest that this specificity during embryogenesis may be due to cell-cell interactions between the developing arterial endothelial cells and smooth muscle cells. These conclusions have far reaching implications on how we understand the vascular specificity of lymphangiogenesis.	[Kim, Harold; Cruz, Maribelle; Dumont, Daniel J.] Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada; [Bourdeau, Annie] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dumont, DJ (corresponding author), Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada.	dan.dumont@sri.utoronto.ca			Heart and Stroke Foundation of Canada [T-7097]; Susan G. Komen Foundation USA [PDF0600259]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Susan G. Komen Foundation USA	Funding for this study was provided by the Heart and Stroke Foundation of Canada (T-7097). HK was awarded a Postdoctoral Fellowship from the Susan G. Komen Foundation USA (PDF0600259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kang J, 2010, BLOOD, V116, P140, DOI 10.1182/blood-2009-11-252270; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kawai Yoshiko, 2008, Lymphatic Research and Biology, V6, P15, DOI 10.1089/lrb.2007.1019; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kim H, 2003, CLIN GENET, V64, P282, DOI 10.1034/j.1399-0004.2003.00152.x; Kim HM, 2010, INT IMMUNOPHARMACOL, V10, P72, DOI 10.1016/j.intimp.2009.09.024; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee S, 2009, BLOOD, V113, P1856, DOI 10.1182/blood-2008-03-145789; Miceli-Libby L, 2008, J VASC RES, V45, P1, DOI 10.1159/000109072; Nguyen VPKH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-10; Nguyen VPKH, 2010, PROTEOMICS, V10, P1658, DOI 10.1002/pmic.200900594; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Sarao R, 1998, TRANSGENIC RES, V7, P421, DOI 10.1023/A:1008837410485; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52197	10.1371/journal.pone.0052197	http://dx.doi.org/10.1371/journal.pone.0052197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341894	gold, Green Submitted, Green Published			2022-12-27	WOS:000314759400011
J	Xia, Y; Ju, F; Fang, HHP; Zhang, T				Xia, Yu; Ju, Feng; Fang, Herbert H. P.; Zhang, Tong			Mining of Novel Thermo-Stable Cellulolytic Genes from a Thermophilic Cellulose-Degrading Consortium by Metagenomics	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; HYDROLASES; ALIGNMENT; REVEALS; RUMEN	In this study, metagenomics was applied to characterize the microbial community and to discover carbohydrate-active genes of an enriched thermophilic cellulose-degrading sludge. The 16S analysis showed that the sludge microbiome was dominated by genus of cellulolytic Clostridium and methanogenesis Methanothermobacter. In order to retrieve genes from the metagenome, de novo assembly of the 11,930,760 Illumina 100 bp paired-end reads (totally 1.2 Gb) was carried out. 75% of all reads was utilized in the de novo assembly. 31,499 ORFs (Open Reading Frame) with an average length of 852 bp were predicted from the assembly; and 64% of these ORFs were predicted to present full-length genes. Based on the Hidden Markol Model, 253 of the predicted thermo-stable genes were identified as putatively carbohydrate-active. Among them the relative dominance of GH9 (Glycoside Hydrolase) and corresponding CBM3 (Carbohydrate Binding Module) revealed a cellulosome-based attached metabolism of polysaccharide in the thermophilic sludge. The putative carbohydrate-active genes ranged from 20% to 100% amino acid sequence identity to known proteins in NCBI nr database, with half of them showed less than 50% similarity. In addition, the coverage of the genes (in terms of ORFs) identified in the sludge were developed into three clear trends (112x, 29x and 8x) in which 85% of the high coverage trend (112x) mainly consisted of phylum of Firmicutes while 49.3% of the 29x trend was affiliated to the phylum of Chloroflexi.	[Xia, Yu; Ju, Feng; Fang, Herbert H. P.; Zhang, Tong] Univ Hong Kong, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hkucc.hku.hk	Zhang, Tong/HGC-1090-2022; Ju, Feng/I-8437-2016; 張彤, Tong Zhang/C-6786-2008; XIA, Yu/I-4037-2018; Xia, Yu/AAM-7471-2020	Ju, Feng/0000-0003-4137-5928; XIA, Yu/0000-0003-2842-6639; Xia, Yu/0000-0003-2842-6639; Zhang, Tong/0000-0003-1148-4322	Hong Kong General Research Fund [HKU7125/09E]; University of Hong Kong	Hong Kong General Research Fund; University of Hong Kong(University of Hong Kong)	This work was supported by a grant from the Hong Kong General Research Fund (HKU7125/09E) (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Lin Cai for his technical assistance on primer design. Yu Xia and Feng Ju, wish to thank The University of Hong Kong for the postgraduate studentship.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geng AL, 2012, APPL MICROBIOL BIOT, V96, P951, DOI 10.1007/s00253-012-3873-y; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ilmberger N, 2012, APPL MICROBIOL BIOT, V95, P135, DOI 10.1007/s00253-011-3732-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nealson KH, 2007, ISME J, V1, P185, DOI 10.1038/ismej.2007.43; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rees HC, 2003, EXTREMOPHILES, V7, P415, DOI 10.1007/s00792-003-0339-2; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xia Y, 2012, INT J HYDROGEN ENERG, V37, P13652, DOI 10.1016/j.ijhydene.2012.02.079; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	30	42	43	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53779	10.1371/journal.pone.0053779	http://dx.doi.org/10.1371/journal.pone.0053779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341999	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400081
J	Hartlieb, E; Kempf, B; Partilla, M; Vigh, B; Spindler, V; Waschke, J				Hartlieb, Eva; Kempf, Bettina; Partilla, Miriam; Vigh, Balazs; Spindler, Volker; Waschke, Jens			Desmoglein 2 Is Less Important than Desmoglein 3 for Keratinocyte Cohesion	PLOS ONE			English	Article							PEMPHIGUS-VULGARIS; CELL-ADHESION; DSG2; INHIBITION; EXPRESSION; PHENOTYPE; DESMOSOME; IDENTIFICATION; DISSOCIATION; REGULATOR	Desmosomes provide intercellular adhesive strength required for integrity of epithelial and some non-epithelial tissues. Within the epidermis, the cadherin-type adhesion molecules desmoglein (Dsg) 1-4 and desmocollin (Dsc) 1-3 build the adhesive core of desmosomes. In keratinocytes, several isoforms of these proteins are co-expressed. However, the contribution of specific isoforms to overall cell cohesion is unclear. Therefore, in this study we investigated the roles of Dsg2 and Dsg3, the latter of which is known to be essential for keratinocyte adhesion based on its autoantibody-induced loss of function in the autoimmune blistering skin disease pemphigus vulgaris (PV). The pathogenic PV antibody AK23, targeting the Dsg3 adhesive domain, led to profound loss of cell cohesion in human keratinocytes as revealed by the dispase-based dissociation assays. In contrast, an antibody against Dsg2 had no effect on cell cohesion although the Dsg2 antibody was demonstrated to interfere with Dsg2 transinteraction by single molecule atomic force microscopy and was effective to reduce cell cohesion in intestinal epithelial Caco-2 cells which express Dsg2 as the only Dsg isoform. To substantiate these findings, siRNA-mediated silencing of Dsg2 or Dsg3 was performed in keratinocytes. In contrast to Dsg3-depleted cells, Dsg2 knockdown reduced cell cohesion only under conditions of increased shear. These experiments indicate that specific desmosomal cadherins contribute differently to keratinocyte cohesion and that Dsg2 compared to Dsg3 is less important in this context.	[Hartlieb, Eva; Partilla, Miriam; Vigh, Balazs; Spindler, Volker; Waschke, Jens] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Kempf, Bettina] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Munich; University of Wurzburg	Waschke, J (corresponding author), Univ Munich, Inst Anat & Cell Biol, Munich, Germany.	jens.waschke@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421	Deutsche Forschungsgemeinschaft [SFB487, TP B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft SFB487, TP B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner W, 2003, J CELL SCI, V116, P1001, DOI 10.1242/jcs.00322; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Cirillo N, 2010, EXP CELL RES, V316, P580, DOI 10.1016/j.yexcr.2009.10.005; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Getsios Spiro, 2010, J Invest Dermatol, V130, P1764, DOI 10.1038/jid.2010.111; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Man Tsang S, 2012, EXP CELL RES; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nie ZX, 2011, J BIOL CHEM, V286, P2143, DOI 10.1074/jbc.M110.192245; Pan M, 2011, CLIN EXP DERMATOL, V36, P703, DOI 10.1111/j.1365-2230.2011.04092.x; Schafer S, 1996, DIFFERENTIATION, V60, P99, DOI 10.1046/j.1432-0436.1996.6020099.x; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Tsang SM, 2012, J PATHOL, V227, P81, DOI 10.1002/path.3982; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Wadhawan V, 2012, BIOCH J; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Wu H, 2003, J INVEST DERMATOL, V120, P1152	48	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53739	10.1371/journal.pone.0053739	http://dx.doi.org/10.1371/journal.pone.0053739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326495	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800073
J	Soulet, D; Pare, A; Coste, J; Lacroix, S				Soulet, Denis; Pare, Alexandre; Coste, Julien; Lacroix, Steve			Automated Filtering of Intrinsic Movement Artifacts during Two-Photon Intravital Microscopy	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; MOUSE SPINAL-CORD; IN-VIVO; FUNCTIONAL RECOVERY; MOTION ARTIFACTS; BLOOD-VESSELS; DEGENERATION; REGISTRATION; TISSUES; CELLS	In vivo imaging using two-photon microscopy is an essential tool to explore the dynamic of physiological events deep within biological tissues for short or extended periods of time. The new capabilities offered by this technology (e. g. high tissue penetrance, low toxicity) have opened a whole new era of investigations in modern biomedical research. However, the potential of using this promising technique in tissues of living animals is greatly limited by the intrinsic irregular movements that are caused by cardiac and respiratory cycles and muscular and vascular tone. Here, we show real-time imaging of the brain, spinal cord, sciatic nerve and myenteric plexus of living mice using a new automated program, named Intravital_Microscopy_Toolbox, that removes frames corrupted with motion artifacts from time-lapse videos. Our approach involves generating a dissimilarity score against precalculated reference frames in a specific reference channel, thus allowing the gating of distorted, out-of-focus or translated frames. Since the algorithm detects the uneven peaks of image distortion caused by irregular animal movements, the macro allows a fast and efficient filtering of the image sequence. In addition, extra features have been implemented in the macro, such as XY registration, channel subtraction, extended field of view with maximum intensity projection, noise reduction with average intensity projections, and automated timestamp and scale bar overlay. Thus, the Intravital_Microscopy_Toolbox macro for ImageJ provides convenient tools for biologists who are performing in vivo two-photon imaging in tissues prone to motion artifacts.	[Soulet, Denis; Pare, Alexandre; Coste, Julien; Lacroix, Steve] Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada; [Soulet, Denis] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [Lacroix, Steve] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Soulet, D (corresponding author), Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada.	Denis.Soulet@crchul.ulaval.ca; Steve.Lacroix@crchul.ulaval.ca	Soulet, Denis/P-4940-2019	Soulet, Denis/0000-0002-0937-7061; Lacroix, Steve/0000-0003-0781-6371	Natural Sciences and Engineering Research Council of Canada [298516-2010]; Canadian Foundation for Innovation [24296]; Parkinson Society of Canada [98524]; Multiple Sclerosis Society of Canada [789]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Parkinson Society of Canada; Multiple Sclerosis Society of Canada	Funding provided by Natural Sciences and Engineering Research Council of Canada (Grant awarded to SL, Grant # 298516-2010, http://www.nserc-crsng.gc.ca/index_eng.asp); Canadian Foundation for Innovation (Grant awarded to SL, Grant # 24296, http://www.innovation.ca/en/OurInvestments/Projectsfunded); Parkinson Society of Canada (Grant awarded to DS, Grant # 98524, http://www.parkinson.ca/site/c.kgLNIWODKpF/b.3536153/k.9974/Funded_Research.htm), Multiple Sclerosis Society of Canada (Studentship awarded to AP, Grant # 789, http://mssociety.ca/en/research/researchprojects.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benninger RKP, 2008, REV PHYSIOL BIOCH P, V160, P71, DOI 10.1007/112_2008_801; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dibaj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017910; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Farrar M. J., 2012, NAT METHODS; Faust N, 2000, BLOOD, V96, P719; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Hecker D, 2008, J NEUROSCI METH, V172, P67, DOI 10.1016/j.jneumeth.2008.04.010; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Megens RTA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281672; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Saalfeld S, 2010, BIOINFORMATICS, V26, pi57, DOI 10.1093/bioinformatics/btq219; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	24	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53942	10.1371/journal.pone.0053942	http://dx.doi.org/10.1371/journal.pone.0053942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326545	Green Published, gold			2022-12-27	WOS:000314705800091
J	Hain, JHW; Hampp, JD; McKenney, SA; Albert, JA; Kenney, RD				Hain, James H. W.; Hampp, Joy D.; McKenney, Sheila A.; Albert, Julie A.; Kenney, Robert D.			Swim Speed, Behavior, and Movement of North Atlantic Right Whales (Eubalaena glacialis) in Coastal Waters of Northeastern Florida, USA	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; SEA-SURFACE TEMPERATURE; AUSTRALIS; ENCOUNTERS; OFFSHORE	In a portion of the coastal waters of northeastern Florida, North Atlantic right whales (Eubalaena glacialis) occur close to shore from December through March. These waters are included within the designated critical habitat for right whales. Data on swim speed, behavior, and direction of movement - with photo-identification of individual whales - were gathered by a volunteer sighting network working alongside experienced scientists and supplemented by aerial observations. In seven years (2001-2007), 109 tracking periods or "follows" were conducted on right whales during 600 hours of observation from shore-based observers. The whales were categorized as mother-calf pairs, singles and non-mother-calf pairs, and groups of 3 or more individuals. Sample size and amount of information obtained was largest for mother-calf pairs. Swim speeds varied within and across observation periods, individuals, and categories. One category, singles and non mother-calf pairs, was significantly different from the other two - and had the largest variability and the fastest swim speeds. Median swim speed for all categories was 1.3 km/h (0.7 kn), with examples that suggest swim speeds differ between within-habitat movement and migration-mode travel. Within-habitat right whales often travel back-and-forth in a north-south, along-coast, direction, which may cause an individual to pass by a given point on several occasions, potentially increasing anthropogenic risk exposure (e.g., vessel collision, fishing gear entanglement, harassment). At times, mothers and calves engaged in lengthy stationary periods (up to 7.5 h) that included rest, nursing, and play. These mother-calf interactions have implications for communication, learning, and survival. Overall, these behaviors are relevant to population status, distribution, calving success, correlation to environmental parameters, survey efficacy, and human-impacts mitigation. These observations contribute important parameters to conservation biology, predictive modeling, and management. However, while we often search for predictions, patterns, and means, the message here is also about variability and the behavioral characteristics of individual whales.	[Hain, James H. W.] Associated Scientists Woods Hole, Woods Hole, MA USA; [Hampp, Joy D.; McKenney, Sheila A.] Marineland Right Whale Project, Marineland, FL USA; [Albert, Julie A.] Marine Resources Council, Palm Bay, FL USA; [Kenney, Robert D.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Hain, JHW (corresponding author), Associated Scientists Woods Hole, Woods Hole, MA USA.	jhain@earthlink.net			U.S. Army Corps of Engineers; Harbor Branch Oceanographic Institute at Florida Atlantic University; Protect Florida Whales License Plate Fund; Lastinger Family Foundation; Sea World & Busch Gardens Conservation Fund; Catto Charitable Foundation; Ginn Championship Golf Tournament; Charles R. Bush Charitable Fund; Albert E. and Birdie W. Einstein Fund; Jacoby Development, Inc.; Disney Worldwide Conservation Fund; Canaveral Port Authority; IBM International Foundation; Bank of America Foundation	U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army); Harbor Branch Oceanographic Institute at Florida Atlantic University; Protect Florida Whales License Plate Fund; Lastinger Family Foundation; Sea World & Busch Gardens Conservation Fund; Catto Charitable Foundation; Ginn Championship Golf Tournament; Charles R. Bush Charitable Fund; Albert E. and Birdie W. Einstein Fund; Jacoby Development, Inc.; Disney Worldwide Conservation Fund; Canaveral Port Authority; IBM International Foundation(International Business Machines (IBM)); Bank of America Foundation	Program support was provided by the U.S. Army Corps of Engineers, Harbor Branch Oceanographic Institute at Florida Atlantic University and the Protect Florida Whales License Plate Fund, Lastinger Family Foundation, Sea World & Busch Gardens Conservation Fund, Catto Charitable Foundation, Friends of the GTM Reserve, Georgia Aquarium Research Fund, Ginn Championship Golf Tournament, Charles R. Bush Charitable Fund, Albert E. and Birdie W. Einstein Fund, Jacoby Development, Inc., Disney Worldwide Conservation Fund, Canaveral Port Authority, IBM International Foundation, Bank of America Foundation; and individual donors M. R. Adair, M. J. Haverstick, and H. P. Richter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SEA SURF TEMP IM; Bender CE, 2009, ANIM COGN, V12, P43, DOI 10.1007/s10071-008-0169-9; Best PB, 2000, S AFR J MARINE SCI, V22, P43, DOI 10.2989/025776100784125618; Brown M. W., 2007, URBAN WHALE N ATLANT, P105; Burnell SR, 1997, J ZOOL, V241, P613, DOI 10.1111/j.1469-7998.1997.tb05736.x; Caldwell D. K., 1972, WORLD BOTTLENOSED DO; CALDWELL DAVID K., 1965, J ELESHA MITCHELL SCI SOC, V81, P24; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Colborn K, 1998, PROFESSIONAL MARINER, V35, P24; Garrison Lance P., 2007, P460; Garrison LP, 2007, NMFSSEFSC53 NOAA; Good CP, 2008, THESIS DUKE U CHAPEL; Hain JHW, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P191; Haldiman Jerrold T., 1993, Society for Marine Mammalogy Special Publication, V2, P71; Hamilton Philip K., 2007, P75; Keller CA, 2006, MAR MAMMAL SCI, V22, P426, DOI 10.1111/j.1748-7692.2006.00033.x; KNOWLTON AR, 1994, CAN J ZOOL, V72, P1297, DOI 10.1139/z94-173; Kraus Scott D., 2007, P172; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P231; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Kraus SD, 1984, COASTLINES GEORGIA, V7, P4; KRAUS SD, 1991, INFORM RIGHT WHALES; Layne JN, 1965, BIOL SCI, V9, P132; Lerczak JA, 1998, MAR MAMMAL SCI, V14, P590, DOI 10.1111/j.1748-7692.1998.tb00745.x; Mate BR, 2011, MAR MAMMAL SCI, V27, P455, DOI 10.1111/j.1748-7692.2010.00412.x; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; Mate BR, 1992, 910069 MMS US DEP IN; MOORE JC, 1953, AM MIDL NAT, V49, P117, DOI 10.2307/2422283; NMFS, 2005, REC PLAN N ATL RIGHT; NMFS (National Marine Fisheries Service), 2008, FIN ENV IMP STATEMET; PAYNE R, 1976, NATL GEOGR, V149, P322; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Pryor K, 1986, REPORTS INT WHALING, V8, P89; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Slay CK, 1999, SC51CAWS5 INT WHAL C; Slay CK, 1997, RIGHT WHALE SATELLIT; Slijper E.J., 1962, WHALES; Stegmann PM, 1996, CONT SHELF RES, V16, P843, DOI 10.1016/0278-4343(95)00029-1; TABER S, 1982, ANIM BEHAV, V30, P1072, DOI 10.1016/S0003-3472(82)80197-8; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; Vanderlaan Angelia S. M., 2009, Endangered Species Research, V6, P273, DOI 10.3354/esr00176; Vanderlaan Angelia S. M., 2008, Endangered Species Research, V4, P283, DOI 10.3354/esr00083; Ward-Geiger Leslie I., 2011, Gulf of Mexico Science, V29, P74; Ward-Geiger LI, 2005, COAST MANAGE, V33, P263, DOI 10.1080/08920750590951965; Waring GT, 2010, NMFSNE219 NOAA; Winn HE, 1984, MMC8205 NAT TECHN IN; Witherington B, 2007, FLORIDAS LIVING BEAC; 1994, FED REG, V59, P28793	49	13	13	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54340	10.1371/journal.pone.0054340	http://dx.doi.org/10.1371/journal.pone.0054340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326603	Green Published, gold			2022-12-27	WOS:000313552400086
J	Song, YJ; Xue, YF; Ma, YH				Song, Yajian; Xue, Yanfen; Ma, Yanhe			Global Microarray Analysis of Carbohydrate Use in Alkaliphilic Hemicellulolytic Bacterium Bacillus sp N16-5	PLOS ONE			English	Article							DIFFERENT CARBON-SOURCES; CLOSTRIDIUM-THERMOCELLUM; THERMOTOGA-MARITIMA; ABC TRANSPORTERS; FUEL ETHANOL; CELLULOSOME; EXPRESSION; ENZYMES; BIOMASS; DEGRADATION	The alkaliphilic hemicellulolytic bacterium Bacillus sp. N16-5 has a broad substrate spectrum and exhibits the capacity to utilize complex carbohydrates such as galactomannan, xylan, and pectin. In the monosaccharide mixture, sequential utilization by Bacillus sp. N16-5 was observed. Glucose appeared to be its preferential monosaccharide, followed by fructose, mannose, arabinose, xylose, and galactose. Global transcription profiles of the strain were determined separately for growth on six monosaccharides (glucose, fructose, mannose, galactose, arabinose, and xylose) and four polysaccharides (galactomannan, xylan, pectin, and sodium carboxymethylcellulose) using one-color microarrays. Numerous genes potentially related to polysaccharide degradation, sugar transport, and monosaccharide metabolism were found to respond to a specific substrate. Putative gene clusters for different carbohydrates were identified according to transcriptional patterns and genome annotation. Identification and analysis of these gene clusters contributed to pathway reconstruction for carbohydrate utilization in Bacillus sp. N16-5. Several genes encoding putative sugar transporters were highly expressed during growth on specific sugars, suggesting their functional roles. Two phosphoenolpyruvate-dependent phosphotransferase systems were identified as candidate transporters for mannose and fructose, and a major facilitator superfamily transporter was identified as a candidate transporter for arabinose and xylose. Five carbohydrate uptake transporter 1 family ATP-binding cassette transporters were predicted to participate in the uptake of hemicellulose and pectin degradation products. Collectively, microarray data improved the pathway reconstruction involved in carbohydrate utilization of Bacillus sp. N16-5 and revealed that the organism precisely regulates gene transcription in response to fluctuations in energy resources.	[Song, Yajian; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Song, Yajian; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Natl Engn Lab Ind Enzymes, Beijing, Peoples R China; [Song, Yajian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		Ministry of Sciences and Technology of China [2011CBA00800, 2011AA02A206, 2012AA022100, 2007CB707801]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Sciences and Technology of China (Grant No. 2011CBA00800, 2011AA02A206, 2012AA022100 and 2007CB707801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Ajdic D, 2007, J BACTERIOL, V191, P6415; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Dahl MK, 2002, J MOL MICROB BIOTECH, V4, P315; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Han SO, 2004, J BACTERIOL, V186, P4218, DOI 10.1128/JB.186.13.4218-4227.2004; Inacio JM, 2008, MICROBIOL-SGM, V154, P2719, DOI 10.1099/mic.0.2008/018978-0; Jojima T, 2010, APPL MICROBIOL BIOT, V85, P471, DOI 10.1007/s00253-009-2292-1; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Li G, 2011, SCI CHINA LIFE SCI, V54, P90, DOI 10.1007/s11427-010-4106-1; Li G, 2010, J MICROBIOL BIOTECHN, V20, P670, DOI 10.4014/jmb.0911.11019; Lynd LR, 1996, ANNU REV ENERG ENV, V21, P403, DOI 10.1146/annurev.energy.21.1.403; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; Newcomb M, 2007, P NATL ACAD SCI USA, V104, P3747, DOI 10.1073/pnas.0700087104; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Servinsky MD, 2010, MICROBIOL-SGM, V156, P3478, DOI 10.1099/mic.0.037085-0; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; TEUNISSEN MJ, 1991, ARCH MICROBIOL, V156, P290, DOI 10.1007/BF00263000; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624	40	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54090	10.1371/journal.pone.0054090	http://dx.doi.org/10.1371/journal.pone.0054090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326578	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400077
J	Chen, Z; Zhou, P; Yang, ZQ; Li, Y; Luo, YC; He, Y; Li, NN; Xie, CQ; Lai, C; Fang, XL; Chen, X				Chen, Zhi; Zhou, Peng; Yang, Zhong-Qing; Li, Yang; Luo, Yan-Cheng; He, Yao; Li, Nan-Nan; Xie, Chao-Qun; Lai, Chen; Fang, Xiao-Long; Chen, Xiang			Transperitoneal Mini-Laparoscopic Pyeloplasty and Concomitant Ureteroscopy-Assisted Pyelolithotomy for Ureteropelvic Junction Obstruction Complicated by Renal Caliceal Stones	PLOS ONE			English	Article							ANTEGRADE ENDOPYELOTOMY; MANAGEMENT; NEPHROLITHOTOMY; EXPERIENCE; OUTCOMES; CALCULI; LASER; LONG	Objective: To present our experience of combining transperitoneal mini-laparoscopic pyeloplasty (mini-LP) and concomitant ureteroscopy-assisted pyelolithotomy (U-P) for ureteropelvic junction obstruction (UPJO) complicated by renal caliceal stones in the same session. Methods: Between May 2007 and December 2011, mini-LP and concomitant U-P was performed in nine patients with UPJO and ipsilateral renal caliceal stones. Stone location and burden were preoperatively assessed. After pyelotomy with appropriate length (about 4 mm), a 16-Fr catheter sheath replaced the uppermost or lowermost laparoscopic trocar and was introduced directly into the renal pelvis under the guidance of a guide wire and laparoscopic vision. A 7.5F rigid ureteroscopy passed through the catheter sheath into the plevis. Intracorporeal lithotripsy and/or pressure irrigation via a pump was used for caliceal stone removal. Subsequently, laparoscopic pyeloplasty was performed in a standard fashion. Postoperative imaging was assessed. Results: The calculi sizes ranged from 2 to 11 mm (mean, 7.1 mm) and an average of 3 stones per patient was removed (range, 1 to 6 stones). Complete stone clearance confirmed by postoperative imaging was achieved in all patients. Mean operative time was 210 minutes, and estimated blood loss was 20 mL. Mean hospital stay was 5 days (4-7). Stent was removed after 4-8 weeks. No intraoperative or postoperative complications were noted during a mean follow-up of 18.5 months (range, 6 to 24 months). Conclusions: Mini-LP and concomitant U-P are simple and effective alternatives for the simultaneous management of UPJO complicated by coexisting ipsilateral renal caliceal stones.	[Chen, Zhi; Yang, Zhong-Qing; Li, Yang; Luo, Yan-Cheng; He, Yao; Li, Nan-Nan; Xie, Chao-Qun; Lai, Chen; Fang, Xiao-Long; Chen, Xiang] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Zhou, Peng] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, X (corresponding author), Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China.	cxiang1007@126.com						Agarwal A, 2008, J ENDOUROL, V22, P2251, DOI 10.1089/end.2008.9726; Atug F, 2005, BJU INT, V96, P1365, DOI 10.1111/j.1464-410X.2005.05819.x; Ball Adam J, 2004, JSLS, V8, P223; Berkman DS, 2009, J ENDOUROL, V23, P1409, DOI 10.1089/end.2009.0379; Bernardo NO, 2008, J ENDOUROL, V22, P1893, DOI 10.1089/end.2008.9782; Boylu U, 2012, J LAPAROENDOSC ADV A; Dimarco DS, 2006, J ENDOUROL, V20, P707, DOI 10.1089/end.2006.20.707; Doo CK, 2007, J ENDOUROL, V21, P158, DOI 10.1089/end.2006.0191; El-Nahas AR, 2006, J UROLOGY, V175, P614, DOI 10.1016/S0022-5347(05)00142-4; Gupta M, 1997, J UROLOGY, V157, P1613, DOI 10.1016/S0022-5347(01)64808-0; Inagaki T, 2005, BJU INT, V95, P102, DOI 10.1111/j.1464-410X.2005.05208.x; Jacobs BL, 2012, J ENDOUROL; Micali S, 1997, J UROLOGY, V157, P463, DOI 10.1016/S0022-5347(01)65173-5; Minervini A, 2006, EUR UROL, V49, P536, DOI 10.1016/j.eururo.2005.11.025; Nambirajan T, 2005, J ENDOUROL, V19, P353, DOI 10.1089/end.2005.19.353; Ost MC, 2005, UROLOGY, V66, P47, DOI 10.1016/j.urology.2005.06.115; Ramakumar S, 2002, J UROLOGY, V167, P1378, DOI 10.1016/S0022-5347(05)65305-0; Riachy E, 2012, J UROL; Samarasekera D, 2011, CUAJ-CAN UROL ASSOC, V5, P134, DOI 10.5489/cuaj.11032; Shalhav AL, 1998, J UROLOGY, V160, P685, DOI 10.1016/S0022-5347(01)62755-1; Srivastava A, 2008, UROL INT, V80, P306, DOI 10.1159/000127347; Stein RJ, 2008, J ENDOUROL, V22, P1251, DOI 10.1089/end.2008.0003; Stilling NM, 2009, SCAND J UROL NEPHROL, V43, P68, DOI 10.1080/00365590802473164	23	4	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e55026	10.1371/journal.pone.0055026	http://dx.doi.org/10.1371/journal.pone.0055026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326607	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500113
J	Kurashige, M; Imamura, M; Araki, SI; Suzuki, D; Babazono, T; Uzu, T; Umezono, T; Toyoda, M; Kawai, K; Imanishi, M; Hanaoka, K; Maegawa, H; Uchigata, Y; Hosoya, T; Maeda, S				Kurashige, Mahiro; Imamura, Minako; Araki, Shin-ichi; Suzuki, Daisuke; Babazono, Tetsuya; Uzu, Takashi; Umezono, Tomoya; Toyoda, Masao; Kawai, Koichi; Imanishi, Masahito; Hanaoka, Kazushige; Maegawa, Hiroshi; Uchigata, Yasuko; Hosoya, Tatsuo; Maeda, Shiro			The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes	PLOS ONE			English	Article							CARNOSINASE GENE CNDP1; STAGE RENAL-DISEASE; LEUCINE REPEAT; AFRICAN-AMERICANS; SKELETAL-MUSCLE; ASSOCIATION; CELLS; SCAN; RISK; SEX	Background: Several linkage analyses have mapped a susceptibility locus for diabetic nephropathy to chromosome 18q22-23, and polymorphisms within the carnosine dipeptidase 1 gene (CNDP1), located on 18q22.3, have been shown to be associated with diabetic nephropathy in European subjects with type 2 diabetes. However, the association of this locus with diabetic nephropathy has not been evaluated in the Japanese population. In this study, we examined the association of polymorphisms within the CNDP1/CNDP 2 locus with diabetic nephropathy in Japanese subjects with type 2 diabetes. Methodology/Principal Findings: We genotyped a leucine repeat polymorphism (D18S880) that is within CNDP1 along with 29 single nucleotide polymorphisms (SNPs) in the CNDP1/CNDP2 locus for 2,740 Japanese subjects with type 2 diabetes (1,205 nephropathy cases with overt nephropathy or with end-stage renal disease [ ESRD], and 1,535 controls with normoalbuminuria). The association of each polymorphism with diabetic nephropathy was analysed by performing logistic regression analysis. We did not observe any association between D18S880 and diabetic nephropathy in Japanese subjects with type 2 diabetes. None of the 29 SNPs within the CNDP1/CNDP2 locus were associated with diabetic nephropathy, but a subsequent sex-stratified analysis revealed that 1 SNP in CNDP1 was nominally associated with diabetic nephropathy in women (rs12604675-A; p = 0.005, odds ratio [OR] = 1.76, 95% confidence interval [CI], 1.19-2.61). Rs12604675 was associated with overt proteinuria (p = 0.002, OR = 2.18, 95% CI, 1.32-3.60), but not with ESRD in Japanese women with type 2 diabetes. Conclusions/Significance: Rs12604675-A in CNDP1 may confer susceptibility to overt proteinuria in Japanese women with type 2 diabetes.	[Kurashige, Mahiro; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Kurashige, Mahiro; Hanaoka, Kazushige; Hosoya, Tatsuo] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo, Japan; [Araki, Shin-ichi; Uzu, Takashi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Suzuki, Daisuke; Umezono, Tomoya; Toyoda, Masao] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan; [Babazono, Tetsuya; Uchigata, Yasuko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; [Kawai, Koichi] Kawai Clin, Tsukuba, Ibaraki, Japan; [Imanishi, Masahito] Osaka City Gen Hosp, Dept Internal Med, Osaka, Japan	RIKEN; Jikei University; Shiga University of Medical Science; Tokai University; Tokyo Women's Medical University; Osaka City General Hospital	Maeda, S (corresponding author), RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan.	smaeda@src.riken.jp	Koya, Daisuke/J-3257-2014	Toyoda, Masao/0000-0003-4142-1218; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia TS, 2011, DIABETOLOGIA, V54, P2295, DOI 10.1007/s00125-011-2178-5; Alkhalaf A, 2010, DIABETOLOGIA, V53, P2562, DOI 10.1007/s00125-010-1863-0; Baguet A, 2012, AMINO ACIDS, V43, P13, DOI 10.1007/s00726-011-1197-3; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Chakkera HA, 2011, MOL GENET METAB, V103, P185, DOI 10.1016/j.ymgme.2011.02.010; ERA-EDTA Registry committee, 2012, ERA EDTA REG ANN REP; Freedman BI, 2007, NEPHROL DIAL TRANSPL, V22, P1131, DOI 10.1093/ndt/gfl717; Hobart LJ, 2004, LIFE SCI, V75, P1379, DOI 10.1016/j.lfs.2004.05.002; Hou WC, 2003, J AGR FOOD CHEM, V51, P1706, DOI 10.1021/jf0260242; Iyengar SK, 2007, DIABETES, V56, P1577, DOI 10.2337/db06-1154; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Krolewski AS, 2006, KIDNEY INT, V69, P129, DOI 10.1038/sj.ki.5000023; Maeda Shiro, 2008, Ther Adv Cardiovasc Dis, V2, P363, DOI 10.1177/1753944708094768; McDonough CW, 2009, HUM GENET, V126, P265, DOI 10.1007/s00439-009-0667-0; Mooyaart AL, 2009, DIABETES RES CLIN PR, V85, P272, DOI 10.1016/j.diabres.2009.06.001; Mooyaart AL, 2010, DIABETES, V59, P1555, DOI 10.2337/db09-1377; Mozdzan M, 2005, BASIC CLIN PHARMACOL, V96, P352, DOI 10.1111/j.1742-7843.2005.pto_03.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Penafiel R, 2004, AMINO ACIDS, V26, P53, DOI 10.1007/s00726-003-0034-8; Poon PYK, 2010, CLIN NEPHROL, V74, P343; Riedl E, 2007, DIABETES, V56, P2410, DOI 10.2337/db07-0128; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Vardarli I, 2002, KIDNEY INT, V62, P2176, DOI 10.1046/j.1523-1755.2002.00663.x; Wanic K, 2008, DIABETES, V57, P2547, DOI 10.2337/db07-1303	26	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54064	10.1371/journal.pone.0054064	http://dx.doi.org/10.1371/journal.pone.0054064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342076	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700082
J	Lyng, MB; Laenkholm, AV; Tan, QH; Vach, W; Gravgaard, KH; Knoop, A; Ditzel, HJ				Lyng, Maria B.; Laenkholm, Anne-Vibeke; Tan, Qihua; Vach, Werner; Gravgaard, Karina H.; Knoop, Ann; Ditzel, Henrik J.			Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; CLINICAL-PRACTICE; RECURRENCE; WOMEN; ASSAY; CARCINOMAS; EXPERIENCE; SELECTION; EFFICACY; SUBTYPES	Background: Tamoxifen significantly improves outcome for estrogen receptor-positive (ER+) breast cancer, but the 15-year recurrence rate remains 30%. The aim of this study was to identify gene profiles that accurately predicted the outcome of ER+ breast cancer patients who received adjuvant Tamoxifen mono-therapy. Methodology/Principal Findings: Post-menopausal breast cancer patients diagnosed no later than 2002, being ER+ as defined by >1% IHC staining and having a frozen tumor sample with >50% tumor content were included. Tumor samples from 108 patients treated with adjuvant Tamoxifen were analyzed for the expression of 59 genes using quantitative-PCR. End-point was clinically verified recurrence to distant organs or ipsilateral breast. Gene profiles were identified using a model building procedure based on conditional logistic regression and leave-one-out cross-validation, followed by a non-parametric bootstrap (1000x re-sampling). The optimal profiles were further examined in 5 previously-reported datasets containing similar patient populations that were either treated with Tamoxifen or left untreated (n = 623). Three gene signatures were identified, the strongest being a 2-gene combination of BCL2-CDKN1A, exhibiting an accuracy of 75% for prediction of outcome. Independent examination using 4 previously-reported microarray datasets of Tamoxifen-treated patient samples (n = 503) confirmed the potential of BCL2-CDKN1A. The predictive value was further determined by comparing the ability of the genes to predict recurrence in an additional, previously-published, cohort consisting of Tamoxifen-treated (n = 58, p = 0.015) and untreated patients (n = 62, p = 0.25). Conclusions/Significance: A novel gene expression signature predictive of outcome of Tamoxifen-treated patients was identified. The validation suggests that BCL2-CDKN1A exhibit promising predictive potential.	[Lyng, Maria B.; Gravgaard, Karina H.; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Laenkholm, Anne-Vibeke] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Tan, Qihua] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Tan, Qihua] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Vach, Werner] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany; [Knoop, Ann; Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Knoop, Ann] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Freiburg; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Lyng, MB (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	mlyng@health.sdu.dk; hdtizel@health.sdu.dk	Knoop, Ann Soeegaard/GLR-2775-2022; Tan, Qihua/F-1349-2015; Tan, Qihua/AAG-2582-2019; Vach, Werner/F-2512-2011	Knoop, Ann Soeegaard/0000-0003-2898-1093; Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Vach, Werner/0000-0003-1865-8399; Ditzel, Henrik J./0000-0003-3927-5135; Gravgaard Thomsen, Karina/0000-0002-9593-7239; Laenkholm, Anne-Vibeke/0000-0003-2166-8686	Danish Cancer Society; Danish Cancer Research Foundation; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; Danish Strategic Research Council; Danish Center for Translational Breast Cancer research	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Center for Translational Breast Cancer research	This work was supported by grants from the Danish Cancer Society, the Danish Cancer Research Foundation, A Race Against Breast Cancer, Sino-Danish Breast Cancer Research Centre, The Danish Strategic Research Council and Danish Center for Translational Breast Cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Baum M, 2002, LANCET, V359, P2131; Bertoldo F, 2010, EXPERT OPIN EMERG DR, V15, P323, DOI 10.1517/14728211003631385; Bilal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038575; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Ciocca DR, 2000, ENDOCRINE, V13, P1, DOI 10.1385/ENDO:13:1:1; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daidone MG, 2000, BRIT J CANCER, V82, P270; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Ditzel HJ, 2008, NAT CLIN PRACT ONCOL, V5, P376, DOI 10.1038/ncponc1139; ELSTON CW, 1984, AUST NZ J SURG, V54, P11, DOI 10.1111/j.1445-2197.1984.tb06677.x; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Hajage D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027446; Jankowitz RC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3038; Knoop AS, 2001, J CLIN ONCOL, V19, P3376, DOI 10.1200/JCO.2001.19.14.3376; Larsen MS, 2012, ACTA ONCOL; Linke SP, 2006, CLIN CANCER RES, V12, P1175, DOI 10.1158/1078-0432.CCR-05-1562; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lonning PE, 2007, J STEROID BIOCHEM, V106, P55, DOI 10.1016/j.jsbmb.2007.05.002; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mouridsen HT, 2008, SABCS; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2004, BREAST CANCER RES TR, V88, pS15; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Sturmer T, 2000, J Epidemiol Biostat, V5, P125; Tan Q, 2007, CANCER INFORM, V3, P213; Thomassen M, 2007, CLIN CANCER RES, V13, P5355, DOI 10.1158/1078-0432.CCR-07-0249; van de Velde CJH, 2010, CANCER TREAT REV, V36, P54, DOI 10.1016/j.ctrv.2009.10.003; Vendrell JA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2158; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wong ZW, 2004, BRIT J CANCER, V90, P20, DOI 10.1038/sj.bjc.6601508; YANAGAWA T, 1979, ENVIRON HEALTH PERSP, V32, P143, DOI 10.2307/3429012; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54078	10.1371/journal.pone.0054078	http://dx.doi.org/10.1371/journal.pone.0054078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342080	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700085
J	Efrati, S; Fishlev, G; Bechor, Y; Volkov, O; Bergan, J; Kliakhandler, K; Kamiager, I; Gal, N; Friedman, M; Ben-Jacob, E; Golan, H				Efrati, Shai; Fishlev, Gregori; Bechor, Yair; Volkov, Olga; Bergan, Jacob; Kliakhandler, Kostantin; Kamiager, Izhak; Gal, Nachum; Friedman, Mony; Ben-Jacob, Eshel; Golan, Haim			Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients - Randomized, Prospective Trial	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ISCHEMIC BRAIN-DAMAGE; DEAD-SEA; LOW-ALTITUDE; TISSUE OXYGEN; THERAPY; REHABILITATION; PRESSURE; DISEASE; INJURY	Background: Recovery after stroke correlates with non-active (stunned) brain regions, which may persist for years. The current study aimed to evaluate whether increasing the level of dissolved oxygen by Hyperbaric Oxygen Therapy (HBOT) could activate neuroplasticity in patients with chronic neurologic deficiencies due to stroke. Methods and Findings: A prospective, randomized, controlled trial including 74 patients (15 were excluded). All participants suffered a stroke 6-36 months prior to inclusion and had at least one motor dysfunction. After inclusion, patients were randomly assigned to "treated" or "cross" groups. Brain activity was assessed by SPECT imaging; neurologic functions were evaluated by NIHSS, ADL, and life quality. Patients in the treated group were evaluated twice: at baseline and after 40 HBOT sessions. Patients in the cross group were evaluated three times: at baseline, after a 2-month control period of no treatment, and after subsequent 2-months of 40 HBOT sessions. HBOT protocol: Two months of 40 sessions (5 days/week), 90 minutes each, 100% oxygen at 2 ATA. We found that the neurological functions and life quality of all patients in both groups were significantly improved following the HBOT sessions while no improvement was found during the control period of the patients in the cross group. Results of SPECT imaging were well correlated with clinical improvement. Elevated brain activity was detected mostly in regions of live cells (as confirmed by CT) with low activity (based on SPECT) - regions of noticeable discrepancy between anatomy and physiology. Conclusions: The results indicate that HBOT can lead to significant neurological improvements in post stroke patients even at chronic late stages. The observed clinical improvements imply that neuroplasticity can still be activated long after damage onset in regions where there is a brain SPECT/CT (anatomy/physiology) mismatch.	[Efrati, Shai; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Gal, Nachum; Friedman, Mony] Assaf Harofeh Med Ctr, Inst Hyperbar Med, IL-70300 Zerifin, Israel; [Efrati, Shai; Ben-Jacob, Eshel] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai; Volkov, Olga; Kamiager, Izhak; Golan, Haim] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Volkov, Olga; Golan, Haim] Assaf Harofeh Med Ctr, Inst Nucl Med, IL-70300 Zerifin, Israel; [Kliakhandler, Kostantin; Ben-Jacob, Eshel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Kamiager, Izhak] Assaf Harofeh Med Ctr, Dept Neurol, IL-70300 Zerifin, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Rice University	Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Inst Hyperbar Med, IL-70300 Zerifin, Israel.	efratishai@013.net	Golan, Haim/K-2831-2019		Assaf-Harofeh medical center; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Joseph Hackmey; Division Of Physics [1308264] Funding Source: National Science Foundation	Assaf-Harofeh medical center; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Joseph Hackmey; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The study was supported by the research fund of Assaf-Harofeh medical center, by the Tauber Family Foundation and the Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University and by Joseph Hackmey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abinader EG, 1999, AM J CARDIOL, V83, P250, DOI 10.1016/S0002-9149(98)00829-7; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Austin D, 1998, LANCET, V351, P1815, DOI 10.1016/S0140-6736(05)78781-X; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Culmsee C, 2007, EMBO REP, V8, P129, DOI 10.1038/sj.embor.7400892; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Falk B, 2006, PEDIATR PULM, V41, P234, DOI 10.1002/ppul.20342; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Gabizon I, 2011, ISR MED ASSOC J, V13, P402; Goldbart AD, 2007, ISR MED ASSOC J, V9, P806; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; GOLDING F C, 1960, Br J Ind Med, V17, P167; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Imai K, 2006, NEUROL MED-CHIR, V46, P373, DOI 10.2176/nmc.46.373; James PB, 2001, LANCET, V357, P2052, DOI 10.1016/S0140-6736(00)05137-0; JASZCZAK RJ, 1979, PHYS MED BIOL, V24, P1123, DOI 10.1088/0031-9155/24/6/003; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Kattenstroth JC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00244; KOL S, 1993, ANN THORAC SURG, V55, P401, DOI 10.1016/0003-4975(93)91010-K; Kramer MR, 1998, CHEST, V113, P571, DOI 10.1378/chest.113.3.571; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Mahadeva S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-20; Muth CM, 2003, INT J SPORTS MED, V24, P104, DOI 10.1055/s-2003-38401; Neubauer RA, 1998, NEUROL RES, V20, pS33; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; Sterr A, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/970136; Teasell R, 2009, TOP STROKE REHABIL, V16, pV; Vila JF, 2005, UNDERSEA HYPERBAR M, V32, P341; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zimerman M, 2012, STROKE, V43, P2185, DOI 10.1161/STROKEAHA.111.645382	41	103	112	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53716	10.1371/journal.pone.0053716	http://dx.doi.org/10.1371/journal.pone.0053716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335971	Green Published, gold			2022-12-27	WOS:000314707700027
J	Kouri, VP; Olkkonen, J; Kaivosoja, E; Ainola, M; Juhila, J; Hovatta, I; Konttinen, YT; Mandelin, J				Kouri, Vesa-Petteri; Olkkonen, Juri; Kaivosoja, Emilia; Ainola, Mari; Juhila, Juuso; Hovatta, Iiris; Konttinen, Yrjo T.; Mandelin, Jami			Circadian Timekeeping Is Disturbed in Rheumatoid Arthritis at Molecular Level	PLOS ONE			English	Article							GENE-EXPRESSION; TNF-ALPHA; CLOCK; TRANSCRIPTION; SYSTEM; SYMPTOMS; DISORDER; FATIGUE; IMMUNE; CELLS	Introduction: Patients with rheumatoid arthritis (RA) have disturbances in the hypothalamic-pituitary-adrenal (HPA) axis. These are reflected in altered circadian rhythm of circulating serum cortisol, melatonin and IL-6 levels and in chronic fatigue. We hypothesized that the molecular machinery responsible for the circadian timekeeping is perturbed in RA. The aim of this study was to investigate the expression of circadian clock in RA. Methods: Gene expression of thirteen clock genes was analyzed in the synovial membrane of RA and control osteoarthritis (OA) patients. BMAL1 protein was detected using immunohistochemistry. Cell autonomous clock oscillation was started in RA and OA synovial fibroblasts using serum shock. The effect of pro-inflammatory stimulus on clock gene expression in synovial fibroblasts was studied using IL-6 and TNF-alpha. Results: Gene expression analysis disclosed disconcerted circadian timekeeping and immunohistochemistry revealed strong cytoplasmic localization of BMAL1 in RA patients. Perturbed circadian timekeeping is at least in part inflammation independent and cell autonomous, because RA synovial fibroblasts display altered circadian expression of several clock components, and perturbed circadian production of IL-6 and IL-1 beta after clock resetting. However, inflammatory stimulus disturbs the rhythm in cultured fibroblasts. Throughout the experiments ARNTL2 and NPAS2 appeared to be the most affected clock genes in human immune-inflammatory conditions. Conclusion: We conclude that the molecular machinery controlling the circadian rhythm is disturbed in RA patients.	[Kouri, Vesa-Petteri; Olkkonen, Juri; Kaivosoja, Emilia; Ainola, Mari; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland; [Kouri, Vesa-Petteri] Univ Helsinki, Inst Biomed, Dept Anat, Helsinki, Finland; [Ainola, Mari; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Cent Hosp, Dept Med Invartes Med, Helsinki, Finland; [Juhila, Juuso; Hovatta, Iiris] Univ Helsinki, Haartman Inst, Res Program Mol Neurol, Helsinki, Finland; [Juhila, Juuso; Hovatta, Iiris] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland; [Konttinen, Yrjo T.; Mandelin, Jami] ORTON Fdn, ORTON Orthoped Hosp, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Coxa Hospital for Joint Replacement	Mandelin, J (corresponding author), Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland.	jami.mandelin@helsinki.fi	Kouri, Vesa-Petteri/M-7436-2015; Peltola, Emilia/L-9969-2013; Ainola, Mari-Mia/T-8035-2017; Mandelin, Jami/A-7943-2008; Hovatta, Iiris/D-6871-2012	Kouri, Vesa-Petteri/0000-0001-6256-0642; Peltola, Emilia/0000-0002-8868-9273; Ainola, Mari-Mia/0000-0003-2853-5851; Hovatta, Iiris/0000-0002-5990-7892	Academy of Finland; Finnish Society for Rheumatology; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research; Scandinavian Rheumatology Research Foundation; Paulo Foundation; University of Helsinki; National Graduate School of Musculoskeletal Disorders and Biomaterials; Orion-Farmos Research Fund	Academy of Finland(Academy of Finland); Finnish Society for Rheumatology; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Scandinavian Rheumatology Research Foundation; Paulo Foundation; University of Helsinki; National Graduate School of Musculoskeletal Disorders and Biomaterials; Orion-Farmos Research Fund	This work was supported by the Academy of Finland, Finnish Society for Rheumatology, Finska Lakaresallskapet, ORTON Orthopaedic Hospital of the ORTON Foundation, Danish Council for Strategic Research, Scandinavian Rheumatology Research Foundation, Paulo Foundation, University of Helsinki, National Graduate School of Musculoskeletal Disorders and Biomaterials and Orion-Farmos Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; CHIKANZA IC, 1992, ARTHRITIS RHEUM, V35, P1281, DOI 10.1002/art.1780351107; Cutolo M, 2005, AUTOIMMUN REV, V4, P497, DOI 10.1016/j.autrev.2005.04.019; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DURUM SK, 1985, ANNU REV IMMUNOL, V3, P263; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GUDEWILL S, 1992, EUR ARCH PSY CLIN N, V242, P53, DOI 10.1007/BF02190343; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KOWANKO IC, 1981, BRIT J CLIN PHARMACO, V11, P477, DOI 10.1111/j.1365-2125.1981.tb01153.x; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Repping-Wuts H, 2009, RHEUMATOLOGY, V48, P207, DOI 10.1093/rheumatology/ken399; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; STETSON MH, 1976, SCIENCE, V191, P197, DOI 10.1126/science.942799; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821	30	57	68	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54049	10.1371/journal.pone.0054049	http://dx.doi.org/10.1371/journal.pone.0054049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335987	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700045
J	Pletzer, B; Kronbichler, M; Nuerk, HC; Kerschbaum, H				Pletzer, Belinda; Kronbichler, Martin; Nuerk, Hans-Christoph; Kerschbaum, Hubert			Sex Differences in the Processing of Global vs. Local Stimulus Aspects in a Two-Digit Number Comparison Task - An fMRI Study	PLOS ONE			English	Article							MENSTRUAL-CYCLE; DEFAULT MODE; BRAIN; ACTIVATION; MEMORY; LATERALIZATION	It has been debated for several decades, whether number magnitudes are processed global/holistically (whole number magnitudes) or in a local/decomposed fashion (digit magnitudes). However, while it has been suggested that men attend stronger to the global level, while women attend stronger to the local level, the question has never been studied with regards to sex differences. In two-digit number comparison men should engage a more holistic processing strategy, while women should engage a more decomposed strategy. To test this hypothesis, we employed number comparison stimuli of varying decade crossing and unit-decade compatibility in men (n = 16) and women (n = 16) during their early follicular and mid-luteal cycle phase. In within-decade (WD) items both numbers had the same decade digits. Non-WD items were unit-decade-compatible, if the smaller number contained the smaller unit-digit and incompatible otherwise. In incompatible items the two local features require different responses. Thus, processing of the local level should result in a compatibility effect in RT and recruitment of differential neural networks for compatible and incompatible items. The results support the view of a holistic strategy in men and a decomposed strategy in women. In men RT and BOLD-response did not differ for incompatible compared to compatible items. Women respond slower to incompatible compared to compatible items. They show a BOLD-response compatibility effect in regions of the default mode network during their follicular phase and in prefrontal areas involved in inhibitory control during their luteal phase. Furthermore, lateralization indices interacted with decade crossing and menstrual cycle phase in a way consistent with the hypothesis of progesterone-mediated interhemispheric decoupling.	[Pletzer, Belinda; Kerschbaum, Hubert] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Pletzer, Belinda; Kronbichler, Martin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Pletzer, Belinda; Kronbichler, Martin; Kerschbaum, Hubert] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria; [Pletzer, Belinda] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Kronbichler, Martin] Paracelsus Med Univ, Christian Doppler Clin, Neurosci Inst, Salzburg, Austria; [Kronbichler, Martin] Paracelsus Med Univ, Christian Doppler Clin, Dept Neurol, Salzburg, Austria; [Nuerk, Hans-Christoph] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Kerschbaum, Hubert] Knowledge Media Res Ctr, Tubingen, Germany	Salzburg University; Salzburg University; Salzburg University; University of California System; University of California Irvine; Paracelsus Private Medical University; Paracelsus Private Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien	Pletzer, B (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	Belinda.Pletzer@sbg.ac.at	Pletzer, Belinda/GXV-3186-2022; Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Pletzer, Belinda/0000-0002-7277-0923	DOC fFORTE program of the Austrian Academy of Sciences [22192]	DOC fFORTE program of the Austrian Academy of Sciences	This research was funded by the DOC fFORTE program of the Austrian Academy of Sciences (http://www.oeaw.ac.at) supporting Belinda Pletzer (Nr: 22192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Barkley CL, 2007, BEHAV NEUROSCI, V121, P291, DOI 10.1037/0735-7044.121.2.291; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Cahill L, 2004, LEARN MEMORY, V11, P261, DOI 10.1101/lm.70504; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P81, DOI 10.1016/S1074-7427(02)00019-9; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Colzato LS, 2010, NEUROSCIENCE, V167, P709, DOI 10.1016/j.neuroscience.2010.02.029; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, P ROY SOC B-BIOL SCI, V264, P487, DOI 10.1098/rspb.1997.0070; Forster J, 2010, PSYCHOL INQ, V21, P175, DOI 10.1080/1047840X.2010.487849; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Hatta T, 2009, ARCH SEX BEHAV, V38, P821, DOI 10.1007/s10508-008-9445-7; Hausmann M, 2000, NEUROPSYCHOLOGIA, V38, P1362, DOI 10.1016/S0028-3932(00)00045-2; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Keita L, 2011, LATERALITY, V16, P333, DOI 10.1080/13576501003671603; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Kramer JH, 1996, NEUROPSYCHOLOGY, V10, P402, DOI 10.1037/0894-4105.10.3.402; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lawton CA, 1996, ENVIRON BEHAV, V28, P204, DOI 10.1177/0013916596282003; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Merkley R, 2010, EXP BRAIN RES, V206, P455, DOI 10.1007/s00221-010-2419-8; Muller-Oehring EM, 2007, BRAIN RES, V1142, P189, DOI 10.1016/j.brainres.2007.01.062; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nielsen SE, 2011, NEUROBIOL LEARN MEM, V96, P378, DOI 10.1016/j.nlm.2011.06.013; Nuerk HC, 2001, COGNITION, V82, pB25, DOI 10.1016/S0010-0277(01)00142-1; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Razumnikova O M, 2011, Fiziol Cheloveka, V37, P14; Renteria ME, 2012, TWIN RES HUM GENET, V15, P401, DOI 10.1017/thg.2012.13; Roalf D, 2006, BRAIN COGNITION, V60, P32, DOI 10.1016/j.bandc.2005.09.008; Roberts GMP, 2008, BRAIN RES, V1224, P79, DOI 10.1016/j.brainres.2008.05.061; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Weis S, 2008, J NEUROSCI, V28, P13401, DOI 10.1523/JNEUROSCI.4392-08.2008; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wood G, 2006, NEUROIMAGE, V29, P358, DOI 10.1016/j.neuroimage.2005.07.056; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	46	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53824	10.1371/journal.pone.0053824	http://dx.doi.org/10.1371/journal.pone.0053824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335976	Green Published, gold			2022-12-27	WOS:000314707700033
J	Wakimoto, S; Nakayama-Imaohji, H; Ichimura, M; Morita, H; Hirakawa, H; Hayashi, T; Yasutomo, K; Kuwahara, T				Wakimoto, Shin; Nakayama-Imaohji, Haruyuki; Ichimura, Minoru; Morita, Hidetoshi; Hirakawa, Hideki; Hayashi, Tetsuya; Yasutomo, Koji; Kuwahara, Tomomi			PhoB Regulates the Survival of Bacteroides fragilis in Peritoneal Abscesses	PLOS ONE			English	Article							EXPRESSION PROFILE; GUT MICROBIOME; VIRULENCE; GENES; IDENTIFICATION; DIVERSITY; PHOSPHATE; PATHOGEN; REVEALS; REGULON	In response to phosphate limitation, bacteria employ the Pho regulon, a specific regulatory network for phosphate acquisition. The two-component signal transduction system of PhoRB plays a crucial role in the induction of Pho regulon genes, leading to the adaptation to phosphate starvation. Herein, we identified the PhoRB system in Bacteroides fragilis, a commensal gut bacterium, and evaluated its role in gut colonization and survival in peritoneal abscesses. BF1575 and BF1576 encoded PhoR (sensor histidine kinase) and PhoB (response regulator) in the sequenced B. fragilis strain YCH46, respectively. Transcriptome analysis revealed that deletion of phoB affected the expression of 585 genes (more than 4-fold change) in B. fragilis, which included genes for stress response (chaperons and heat shock proteins), virulence (capsular polysaccharide biosynthesis) and phosphate metabolism. Deletion of phoB reduced the ability of the bacterium to persist in peritoneal abscesses induced by an intra-abdominal challenge of B. fragilis. Furthermore, PhoB was necessary for survival of this anaerobe in peritoneal abscesses but not for in vitro growth in rich media or in intestinal colonization. These results indicate that PhoB plays an important role in the survival of B. fragilis under stressful extraintestinal conditions.	[Wakimoto, Shin; Ichimura, Minoru; Yasutomo, Koji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Immunol & Parasitol, Tokushima 770, Japan; [Nakayama-Imaohji, Haruyuki; Ichimura, Minoru; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, Kagawa, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Kanagawa, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Chiba, Japan; [Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	Tokushima University; Kagawa University; Azabu University; Kazusa DNA Research Institute; University of Miyazaki	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, Kagawa, Japan.	tomomi@med.kagawa-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020		Ministry of Education, Science and Culture of Japan [22790409]; Japan Society for the Promotion of Science [20510187]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported partly by a Grant-in-Aid for Scientific Research for Young Scientists B (no. 22790409) from the Ministry of Education, Science and Culture of Japan and a Grant for Scientific Research C (no. 20510187) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Bertrand N, 2010, INFECT IMMUN, V78, P5324, DOI 10.1128/IAI.00452-10; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V101, P14919; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dubail I, 2000, INFECT IMMUN, V68, P3242, DOI 10.1128/IAI.68.6.3242-3250.2000; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Ichimura M, 2010, APPL ENVIRON MICROB, V76, P3325, DOI 10.1128/AEM.02420-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Kuwahara T, 2002, FEMS MICROBIOL LETT, V207, P193, DOI 10.1016/S0378-1097(01)00584-5; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Marijuan PC, 2010, BIOSYSTEMS, V99, P94, DOI 10.1016/j.biosystems.2009.09.004; Nakayama-Imaohji H, 2009, J BACTERIOL, V191, P6003, DOI 10.1128/JB.00687-09; Patrick S, 2010, MICROBIOL-SGM, V156, P3255, DOI 10.1099/mic.0.042978-0; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Rocha ER, 1997, J BACTERIOL, V179, P7033, DOI 10.1128/jb.179.22.7033-7039.1997; Salyers AA, 1999, METHOD MICROBIOL, V29, P229; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VAREL VH, 1974, APPL MICROBIOL, V28, P251, DOI 10.1128/AEM.28.2.251-257.1974; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wu Licheng R, 2005, Surg Infect (Larchmt), V6, P185, DOI 10.1089/sur.2005.6.185; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999	39	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53829	10.1371/journal.pone.0053829	http://dx.doi.org/10.1371/journal.pone.0053829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23342014	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700034
J	Whelan, A; Mitchell, R; Staudhammer, C; Starr, G				Whelan, Andrew; Mitchell, Robert; Staudhammer, Christina; Starr, Gregory			Cyclic Occurrence of Fire and Its Role in Carbon Dynamics along an Edaphic Moisture Gradient in Longleaf Pine Ecosystems	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; WIREGRASS SAVANNAS; FLUX MEASUREMENTS; PRESCRIBED FIRE; PONDEROSA PINE; GAS-EXCHANGE; FOREST; PRODUCTIVITY; SOIL; DIOXIDE	Fire regulates the structure and function of savanna ecosystems, yet we lack understanding of how cyclic fire affects savanna carbon dynamics. Furthermore, it is largely unknown how predicted changes in climate may impact the interaction between fire and carbon cycling in these ecosystems. This study utilizes a novel combination of prescribed fire, eddy covariance (EC) and statistical techniques to investigate carbon dynamics in frequently burned longleaf pine savannas along a gradient of soil moisture availability (mesic, intermediate and xeric). This research approach allowed us to investigate the complex interactions between carbon exchange and cyclic fire along the ecological amplitude of longleaf pine. Over three years of EC measurement of net ecosystem exchange (NEE) show that the mesic site was a net carbon sink (NEE = -2.48 tonnes C ha 21), while intermediate and xeric sites were net carbon sources (NEE = 1.57 and 1.46 tonnes C ha(-1), respectively), but when carbon losses due to fuel consumption were taken into account, all three sites were carbon sources (10.78, 7.95 and 9.69 tonnes C ha(-1) at the mesic, intermediate and xeric sites, respectively). Nonetheless, rates of NEE returned to pre-fire levels 1-2 months following fire. Consumption of leaf area by prescribed fire was associated with reduction in NEE post-fire, and the system quickly recovered its carbon uptake capacity 30-60 days post fire. While losses due to fire affected carbon balances on short time scales (instantaneous to a few months), drought conditions over the final two years of the study were a more important driver of net carbon loss on yearly to multi-year time scales. However, longer-term observations over greater environmental variability and additional fire cycles would help to more precisely examine interactions between fire and climate and make future predictions about carbon dynamics in these systems.	[Whelan, Andrew; Staudhammer, Christina; Starr, Gregory] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Whelan, Andrew; Mitchell, Robert] Jones Ecol Res Ctr, Newton, GA USA	University of Alabama System; University of Alabama Tuscaloosa	Starr, G (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	gstarr@ua.edu			Joseph W. Jones Ecological Research Station; University of Alabama	Joseph W. Jones Ecological Research Station; University of Alabama	Funding for the project comes from the Joseph W. Jones Ecological Research Station and the University of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington RN, 2006, PLANT CELL ENVIRON, V29, P535, DOI 10.1111/j.1365-3040.2005.01430.x; Addington RN, 2004, TREE PHYSIOL, V24, P561, DOI 10.1093/treephys/24.5.561; ALLEN LH, 1971, AGR METEOROL, V8, P5, DOI 10.1016/0002-1571(71)90091-4; Anderson RC, 1997, AM J BOT, V84, P938, DOI 10.2307/2446284; Aubrey DP, 2012, THESIS U GEORGIA ATH; Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; Beringer J, 2003, INT J WILDLAND FIRE, V12, P333, DOI 10.1071/WF03023; Beringer J, 2007, GLOBAL CHANGE BIOL, V13, P990, DOI 10.1111/j.1365-2486.2007.01334.x; Binford MW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006820; BIRCH H. F., 1958, Plant and Soil, V10, P9, DOI 10.1007/BF01343734; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BOYER WD, 1973, ECOLOGY, V54, P420, DOI 10.2307/1934351; Brooks JR, 1997, TREE PHYSIOL, V17, P1; Campbell Gaylon S., 1998; Campbell JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002236; Carpenter SR, 1998, ECOSYSTEMS, V1, P335, DOI 10.1007/s100219900025; Cernusak LA, 2006, PLANT CELL ENVIRON, V29, P632, DOI 10.1111/j.1365-3040.2005.01442.x; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Christensen N.L., 1981, P C FIR REG EC PROP, P112; Christensen NL, 1981, FIRE REGIMES SE ECOS; Clark KL, 1999, ECOL APPL, V9, P936, DOI 10.1890/1051-0761(1999)009[0936:ECONEO]2.0.CO;2; Clement R., 1999, EDIRE DATA SOFTWARE; Coe MT, 2011, BIOGEOCHEMISTRY, V105, P119, DOI 10.1007/s10533-011-9582-2; de Araujo AC, 2008, ECOL APPL, V18, P1406, DOI 10.1890/06-0982.1; Edwards L, 2012, US DROUGHT MONITOR; Emmerich WE, 2003, AGR FOREST METEOROL, V116, P91, DOI 10.1016/S0168-1923(02)00231-9; Ewers BE, 2001, TREE PHYSIOL, V21, P841, DOI 10.1093/treephys/21.12-13.841; Fesenmyer KA, 2010, ECOLOGY, V91, P662, DOI 10.1890/09-0230.1; Foken T, 2004, AGR FOREST METEOROL, V127, P223, DOI 10.1016/j.agrformet.2004.07.015; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Foken T., 2008, MICROMETEOROLOGY; Ford CR, 2008, CAN J FOREST RES, V38, P2118, DOI 10.1139/X08-061; FROST CC, 1993, P TALL TIMB FIR EC C, V18, P17; Girod CM, 2007, EARTH INTERACT, V11; Goebel P.C., 1997, FIELD GUIDE LANDSCAP; Goebel PC, 2001, J TORREY BOT SOC, V128, P47, DOI 10.2307/3088659; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; HALL DO, 1991, ANN BOT-LONDON, V67, P49, DOI 10.1093/oxfordjournals.aob.a088208; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2007, TREE PHYSIOL, V27, P929, DOI 10.1093/treephys/27.7.929; Jimenez KL, J GEOPHYS RES BIOGEO; Kanniah KD, 2010, PROG PHYS GEOG, V34, P459, DOI 10.1177/0309133310364933; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Kowalski AS, 2008, AGR FOREST METEOROL, V148, P1045, DOI 10.1016/j.agrformet.2008.02.004; Kramer P.J., 1983, WATER RELATIONS PLAN; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; Lavigne MB, 1997, J GEOPHYS RES-ATMOS, V102, P28977, DOI 10.1029/97JD01173; Lavoie M, 2010, NAT AREA J, V30, P82, DOI 10.3375/043.030.0109; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Loescher HW, 2006, J APPL METEOROL CLIM, V45, P1127, DOI 10.1175/JAM2388.1; Massman WJ, 2004, ATMOS ENVIRON, V38, P2323, DOI 10.1016/j.atmosenv.2003.09.079; Mielnick P, 2005, J ARID ENVIRON, V60, P423, DOI 10.1016/j.jaridenv.2004.06.001; Mitchell RJ, 1999, CAN J FOREST RES, V29, P743, DOI 10.1139/cjfr-29-6-743; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moncrieff J. B., 1997, Journal of Hydrology (Amsterdam), V188-189, P589, DOI 10.1016/S0022-1694(96)03194-0; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NCDC, 2011, MONTHL STAT NORM TEM; Noormets A, 2010, GLOBAL CHANGE BIOL, V16, P272, DOI 10.1111/j.1365-2486.2009.01928.x; O'Brien JJ, 2010, FIRE ECOL, V6, P1, DOI 10.4996/fireecology.0602001; Ocheltree TW, 2007, J ATMOS OCEAN TECH, V24, P1389, DOI 10.1175/JTECH2064.1; Ottmar RD, 2007, CAN J FOREST RES, V37, P2383, DOI 10.1139/X07-077; Panek JA, 2001, TREE PHYSIOL, V21, P337, DOI 10.1093/treephys/21.5.337; Powell TL, 2008, GLOBAL CHANGE BIOL, V14, P2523, DOI 10.1111/j.1365-2486.2008.01675.x; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Reichstein M, 2007, DETERMINANTS TERREST; Richardson AD, 2005, AGR FOREST METEOROL, V131, P191, DOI 10.1016/j.agrformet.2005.05.008; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SCHOCH P, 1986, FOREST ECOL MANAG, V14, P13, DOI 10.1016/0378-1127(86)90049-6; Serrano-Ortiz P, 2010, AGR FOREST METEOROL, V150, P321, DOI 10.1016/j.agrformet.2010.01.002; Sheffield MCP, 2003, FOREST ECOL MANAG, V179, P157, DOI 10.1016/S0378-1127(02)00523-6; Starr G, FIRES ROLE IN PRESS; Stephan K, 2012, FOREST ECOL MANAG, V263, P240, DOI 10.1016/j.foreco.2011.09.013; Unger S, 2012, AGR FOREST METEOROL, V154, P9, DOI 10.1016/j.agrformet.2011.10.007; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Van Wagner CE, 2006, FOREST SCI, V52, P704; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; Way AG, 2006, ENVIRON HIST, V11, P500, DOI 10.1093/envhis/11.3.500; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; WERNER PA, 1990, J BIOGEOGR, V17, P343, DOI 10.2307/2845362; Wiedinmyer C, 2010, ENVIRON SCI TECHNOL, V44, P1926, DOI 10.1021/es902455e; Wilson CA, 1999, CAN J FOREST RES, V29, P752, DOI 10.1139/cjfr-29-6-752; Wright JK, MEASURING MODE UNPUB	93	33	33	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54045	10.1371/journal.pone.0054045	http://dx.doi.org/10.1371/journal.pone.0054045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335986	Green Submitted, gold, Green Published			2022-12-27	WOS:000314707700044
J	Ma, GF; Miao, Q; Zeng, XQ; Luo, TC; Ma, LL; Liu, YM; Lian, JJ; Gao, H; Chen, SY				Ma, Gui-Fen; Miao, Qing; Zeng, Xiao-Qing; Luo, Tian-Cheng; Ma, Li-Li; Liu, Yi-Mei; Lian, Jing-Jing; Gao, Hong; Chen, Shi-Yao			Transforming Growth Factor-beta 1 and -beta 2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PANCREATIC DUCTAL ADENOCARCINOMA; TGF-BETA-3 PROTEIN EXPRESSION; REGULATORY T-CELLS; TGF-BETA; SUPPRESSION; ACTIVATION; CARCINOMA; SMAD2; SERUM	Transforming growth factor-beta 1 (TGF-beta 1) and -beta 2 are correlated with poorer prognosis in gastric cancer (GC), which act in both tumor and immune cells. However, their expressions in precancer and tumor-cell interactions with peripheral blood mononuclear cells (PBMCs) remain unclear. Protein levels of TGF-beta 1 and -beta 2 were analyzed by immunohistochemistry and corresponding mRNA levels were determined by quantitative real-time polymerase chain reaction in 93 surgical and biopsy specimens. Serum TGF-beta concentration was detected by enzyme-linked immunosorbent assays. AGS and MKN45 cell lines were directly or indirectly cocultured with PBMCs in vitro. TGF-beta and Smad molecules were detected after cocultures and the growths of GC cells and PBMCs were assessed by cell proliferation assay. The results showed positive staining for TGF-beta 1 was detected in 20% of control samples, 52.3% of precancer, 59.1% of early GC and 66.7% of advanced GC samples, correlated with lesion progression (chi(2) = 9.487, P = 0.002). All tissues were positive for TGF-beta 2. TGF-beta 1 mRNA levels were increased in advanced cancers, while TGF-beta 2 increased earlier. TGF-beta 1 mRNA levels were higher in tumor than in peritumor, which positively correlated with Smad2 and Smad7. Serum TGF-beta levels were significantly higher in patients with early and advanced cancers compared to controls (TGF-beta 1:50.08 +/- 4.38 and 45.76 +/- 5.00 vs. 27.78 +/- 6.11 ng/mL; TGF-beta 2:133.61 +/- 21.90 and 111.34 +/- 15.76 vs. 59.41 +/- 15.42 ng/mL, both P<0.05). The levels of TGF-beta 1 mRNA and cytokine secretion were higher in GC cells after direct coculture compared to indirect culture. TGF-beta 1 was decreased and TGF-beta 2 was increased in PBMCs after cocultures. Moreover, TGF-beta 1 inhibited the viability of PBMCs but not cancer cells. Collectively, neoplastic transformation may be an early event involving the increase of TGF-beta 1 in the general and local environment. TGF-beta 1 production is promoted by the direct interaction between GC cells and PBMCs, which might facilitate cancer development.	[Ma, Gui-Fen; Miao, Qing; Zeng, Xiao-Qing; Luo, Tian-Cheng; Liu, Yi-Mei; Gao, Hong; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Ma, Li-Li; Lian, Jing-Jing; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, SY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	shiyao_chen@163.com			Xinjiang Uygur Autonomous Region Science and Technology Support Project [200991127]	Xinjiang Uygur Autonomous Region Science and Technology Support Project	This work was supported by Xinjiang Uygur Autonomous Region Science and Technology Support Project (No.200991127) (http://www.kjzj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2011, GASTROENTEROLOGY, V141, P1167, DOI 10.1053/j.gastro.2011.07.048; Ananiev J, 2011, WIEN KLIN WOCHENSCHR, V123, P668, DOI 10.1007/s00508-011-0078-9; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Beck C, 2001, MICROSC RES TECHNIQ, V52, P387, DOI 10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W; Bellone G, 2010, INT J ONCOL, V37, P1153, DOI 10.3892/ijo_00000767; Bessler H, 2010, BIOMED PHARMACOTHER, V64, P706, DOI 10.1016/j.biopha.2010.08.006; Coban S, 2007, HEPATO-GASTROENTEROL, V54, P1472; Comerci JT, 1996, CANCER, V77, P1107, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.3.CO;2-A; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hamilton SR, 2000, WHO CLASSIFICATION T; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Lee MS, 2004, INT J ONCOL, V24, P1229; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li X, 2007, CANCER LETT, V253, P144, DOI 10.1016/j.canlet.2007.01.024; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Li ZW, 2006, SCAND J GASTROENTERO, V41, P1007, DOI 10.1080/00365520600554477; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lu XM, 2011, J SURG ONCOL, V104, P571, DOI 10.1002/jso.22005; MABOGUNJE OA, 1978, GUT, V19, P425, DOI 10.1136/gut.19.5.425; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Monteleone G, 2004, GASTROENTEROLOGY, V126, P674, DOI 10.1053/j.gastro.2003.11.048; Naef M, 1997, INT J CANCER, V71, P131; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poggi A, 2006, ARCH IMMUNOL THER EX, V54, P323, DOI 10.1007/s00005-006-0038-7; REINHOLD D, 1994, CYTOKINE, V6, P382, DOI 10.1016/1043-4666(94)90062-0; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Suda A, 2009, INT SURG, V94, P182; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsamandas AC, 2004, STRAHLENTHER ONKOL, V180, P201, DOI 10.1007/s00066-004-1149-x; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vagenas K, 2007, J SURG RES, V139, P182, DOI 10.1016/j.jss.2006.10.005; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yannelli JR, 2009, ONCOL REP, V22, P1459, DOI 10.3892/or_00000588; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722	48	46	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54249	10.1371/journal.pone.0054249	http://dx.doi.org/10.1371/journal.pone.0054249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342108	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400136
J	Socquet-Juglard, D; Kamber, T; Pothier, JF; Christen, D; Gessler, C; Duffy, B; Patocchi, A				Socquet-Juglard, Didier; Kamber, Tim; Pothier, Joel F.; Christen, Danilo; Gessler, Cesare; Duffy, Brion; Patocchi, Andrea			Comparative RNA-Seq Analysis of Early-Infected Peach Leaves by the Invasive Phytopathogen Xanthomonas arboricola pv. pruni	PLOS ONE			English	Article							DISEASE RESISTANCE; EXPRESSION ANALYSIS; LINKAGE MAP; GENE; IDENTIFICATION; PEROXIDASE; METABOLISM; RESPONSES; PROTEINS; SEQUENCE	Xanthomonas arboricola pv. pruni is a quarantine bacterial pathogen that threatens peach production by causing necrotic spots on leaves and fruits, thus with the potential of severely reducing yields. The current understanding of the host plant defense responses to the pathogen is very limited. Using whole transcriptome sequencing, differential gene expression was analyzed at two time points, 2 h and 12 h post inoculation (hpi), by comparing the inoculated samples to their respective controls. On the total of 19,781 known peach genes that were expressed in all time points and conditions, 34 and 263 were differentially expressed at 2 and 12 hpi, respectively. Of those, 82% and 40% were up-regulated, respectively; and 18% and 60% were down-regulated, respectively. The functional annotation based on gene ontology (GO) analysis highlighted that genes involved in metabolic process and response to stress were particularly represented at 2 hpi whereas at 12 hpi cellular and metabolic processes were the categories with the highest number of genes differentially expressed. Of particular interest among the differentially expressed genes identified were several pathogen-associated molecular pattern (PAMP) receptors, disease resistance genes including several RPM1-like and pathogenesis related thaumatin encoding genes. Other genes involved in photosynthesis, in cell wall reorganization, in hormone signaling pathways or encoding cytochrome were also differentially expressed. In addition, novel transcripts were identified, providing another basis for further characterization of plant defense-related genes. Overall, this study gives a first insight of the peach defense mechanisms during the very early stages of infection with a bacterial disease in the case of a compatible interaction.	[Socquet-Juglard, Didier; Kamber, Tim; Pothier, Joel F.; Duffy, Brion; Patocchi, Andrea] Res Stn Agroscope Changins Wadenswil ACW, Wadenswil, Switzerland; [Socquet-Juglard, Didier; Gessler, Cesare] Swiss Fed Inst Technol, IBZ, Zurich, Switzerland; [Christen, Danilo] Conthey Res Ctr, Res Stn Agroscope Changins Wadenswil, Berries Med Plants Greenhouse Crops & Apricots Gr, Conthey, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope	Patocchi, A (corresponding author), Res Stn Agroscope Changins Wadenswil ACW, Wadenswil, Switzerland.	andrea.patocchi@acw.admin.ch	Pothier, Joël F./H-9344-2013	Pothier, Joël F./0000-0002-9604-7780; CHRISTEN, Danilo/0000-0002-6113-549X; Patocchi, Andrea/0000-0002-0919-2702	Swiss Secretariat for Education and Research [SBF COST C08.0124]; European Science Foundation [873]	Swiss Secretariat for Education and Research; European Science Foundation(European Science Foundation (ESF)European Commission)	This project was partially funded by the Swiss Secretariat for Education and Research (SBF COST C08.0124) and was conducted within the European Science Foundation funded research network COST Action 873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aarrouf J, 2008, J PHYTOPATHOL, V156, P338, DOI 10.1111/j.1439-0434.2007.01364.x; Abbott AG, 2002, ACTA HORTIC, P199, DOI 10.17660/ActaHortic.2002.592.28; Adhikari BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034954; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Allison SD, 2004, J CHEM ECOL, V30, P1363, DOI 10.1023/B:JOEC.0000037745.66972.3e; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; [Anonymous], 2006, B OEPP, V36, P129, DOI DOI 10.1111/j.1365-2338.2006.00925.x; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Arus P, 2006, PL BRED RE, V27, P175; Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bazzi C., 1990, INFORM AGRARIO, V46, P71; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Bonghi C, 2010, ACTA HORTIC, V877, P69, DOI 10.17660/ActaHortic.2010.877.3; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Byrne DH, 2012, HANDB PLANT BREED, V8, P505, DOI 10.1007/978-1-4419-0763-9_14; CAMERON RK, 1994, PLANT J, V5, P715, DOI 10.1111/j.1365-313X.1994.00715.x; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dondini L, 2007, TREE GENET GENOMES, V3, P239, DOI 10.1007/s11295-006-0059-8; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Garcin A., 2011, ARBORICULTURE FRUITI, V653, P30; Garcin A, 2005, XANTHOMONAS ARBRES F; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Hajri A, 2012, APPL ENVIRON MICROB, V78, P371, DOI 10.1128/AEM.06119-11; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joobeur T, 1998, THEOR APPL GENET, V97, P1034, DOI 10.1007/s001220050988; Jung S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-76; Khalaf AA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-159; Kim KH, 2011, DNA RES, P1; Kogovsek P, 2010, PLANT PATHOL, V59, P1121, DOI 10.1111/j.1365-3059.2010.02340.x; Kristoffersen P, 2000, PLANTA, V210, P407, DOI 10.1007/PL00008149; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mahmood T, 2009, BIOL PLANTARUM, V53, P285, DOI 10.1007/s10535-009-0052-9; Manganaris GA, 2011, TREE GENET GENOMES, V7, P609, DOI 10.1007/s11295-010-0360-4; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Morant A, 2006, PHYTOCHEMISTRY, V69, P1795; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x; Pasquer F, 2008, PLANT BREEDING, V127, P413, DOI 10.1111/j.1439-0523.2007.01476.x; Pothier JF, 2011, PHYTOPATHOLOGY, V101, pS144; RAJAPAKSE S, 1995, THEOR APPL GENET, V90, P503, DOI 10.1007/BF00221996; Schenk A, 2008, MOL PLANT PATHOL, V9, P227, DOI 10.1111/J.1364-3703.2007.00452.X; Sherif S, 2012, J PLANT PHYSIOL, V169, P731, DOI 10.1016/j.jplph.2012.02.003; Sherif S, 2012, PLANT CELL REP, V31, P697, DOI 10.1007/s00299-011-1188-6; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Socquet-Juglard D, 2013, TREE GENET GENOMES, V9, P409, DOI 10.1007/s11295-012-0562-z; Socquet-Juglard D, 2012, J PLANT PATHOL, V94, pS191; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sosinski B., 2010, 5 INT ROS GEN C NOV, pO46; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wichmann F, 2011, THEOR APPL GENET, V122, P567, DOI 10.1007/s00122-010-1470-y; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang N, 2012, THESIS CLEMSON U; YE XS, 1990, PHYSIOL MOL PLANT P, V36, P523, DOI 10.1016/0885-5765(90)90024-R	74	47	47	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54196	10.1371/journal.pone.0054196	http://dx.doi.org/10.1371/journal.pone.0054196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342103	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400132
J	Tang, SH; Gao, LC; Bi, Q; Xu, GH; Wang, SM; Zhao, GH; Chen, Z; Zheng, XS; Pan, YL; Zhao, LN; Kang, JQ; Yang, GT; Shi, YQ; Wu, KC; Gong, TQ; Fan, DM				Tang, Shanhong; Gao, Liucun; Bi, Qian; Xu, Guanghui; Wang, Simeng; Zhao, Guohong; Chen, Zheng; Zheng, Xiushan; Pan, Yanglin; Zhao, Lina; Kang, Jianqin; Yang, Guitao; Shi, Yongquan; Wu, Kaichun; Gong, Taiqian; Fan, Daiming			SDR9C7 Promotes Lymph Node Metastases in Patients with Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EXPRESSION; PREDICTION; IDENTIFICATION	Background: The major reason for the poor prognosis of esophageal squamous cell carcinoma (ESCC) patients is lymph node (LN) metastases. Methodology/Principal: In the present study, gene expression profiling assay (GEP) was performed to identify the differences in gene expression profiles between primary ESCC tumors that were with LN metastases (N+) and those without LN metastases (N-). Conclusions/Significance: A total of 23 genes were identified as being significantly elevated, and 30 genes were sharply decreased in ESCC tumors that were N+ compared with N-tumors. Among these genes, two transcripts of the short chain dehydrogenase/reductase family 9C, member 7 (SDR9C7) were observed 7 times more frequently in N+ compared with N(-)tumors. Immunohistochemical staining showed that SDR9C7 expression closely correlated with metastasis, and would be a prognostic marker for ESCC patients. To investigate the role of SDR9C7 in the ESCC metastasis, repeated transwell assays were adopted to establish highly and non-invasive ESCC sublines, and western blot showed that SDR9C7 expression was markedly higher in highly invasive cells compared with non-invasive ones. Down-regulation of SDR9C7 dramatically inhibited the metastatic abilities in vitro and in vivo, and repressed the expression of MMP11 in highly invasive cells, indicating that SDR9C7 promotes ESCC metastasis partly through regulation of MMP11, and might be a potential prognostic and therapeutic marker for ESCC patients.	[Tang, Shanhong; Gao, Liucun; Bi, Qian; Xu, Guanghui; Wang, Simeng; Zhao, Guohong; Chen, Zheng; Zheng, Xiushan; Pan, Yanglin; Zhao, Lina; Kang, Jianqin; Yang, Guitao; Shi, Yongquan; Wu, Kaichun; Gong, Taiqian; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gong, Taiqian] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China	Air Force Military Medical University; Army Medical University	Gong, TQ (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China.	gongtq@yahoo.com.cn; fandaim@fmmu.edu.cn	Zhao, Lina/GVR-7716-2022; gao, Liu/AAH-5970-2019; Wang, Simeng/W-8686-2018; Shi, Yongquan/AAE-3954-2020	Gong, Taiqian/0000-0003-4193-7804	China Postdoctoral Science Foundation [20090461447]; National Natural Science Foundations of China [81172288, 81101689]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the China Postdoctoral Science Foundation 20090461447, National Natural Science Foundations of China 81172288, and 81101689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigami T, 2009, J SURG ONCOL, V99, P148, DOI 10.1002/jso.21228; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Chen WG, 2002, GENE, V294, P141, DOI 10.1016/S0378-1119(02)00757-6; Eloubeidi MA, 2002, CANCER-AM CANCER SOC, V95, P1434, DOI 10.1002/cncr.10868; Gong TQ, 2012, CANCER BIOL THER, V13, P606, DOI 10.4161/cbt.19851; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Huang CQ, 2009, ACTA BIOCHIM POL, V56, P279; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kallberg Y, 2006, FEBS J, V273, P1177, DOI 10.1111/j.1742-4658.2006.05153.x; Kim TJ, 2008, CANCER SCI, V99, P31, DOI 10.1111/j.1349-7006.2007.00652.x; Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1; Lagarde SM, 2008, ANN SURG ONCOL, V15, P3459, DOI 10.1245/s10434-008-0165-y; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Moriya Y, 2009, LUNG CANCER, V64, P86, DOI 10.1016/j.lungcan.2008.06.022; Nguyen ST, 2007, CANCER SCI, V98, P740, DOI 10.1111/j.1349-7006.2007.00454.x; Oppermann UCT, 2001, CHEM-BIOL INTERACT, V130, P699, DOI 10.1016/S0009-2797(00)00301-X; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Society for Surgery of the Alimentary Tract, 2007, J Gastrointest Surg, V11, P1216; Tang SH, 2010, CANCER BIOL THER, V9, P88, DOI 10.4161/cbt.9.2.10283; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879	22	12	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52184	10.1371/journal.pone.0052184	http://dx.doi.org/10.1371/journal.pone.0052184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341893	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400010
J	Voskens, CJ; Goldinger, SM; Loquai, C; Robert, C; Kaehler, KC; Berking, C; Bergmann, T; Bockmeyer, CL; Eigentler, T; Fluck, M; Garbe, C; Gutzmer, R; Grabbe, S; Hauschild, A; Hein, RD; Hundorfean, G; Justich, A; Keller, U; Klein, C; Mateus, C; Mohr, P; Paetzold, S; Satzger, I; Schadendorf, D; Schlaeppi, M; Schuler, G; Schuler-Thurner, B; Trefzer, U; Ulrich, J; Vaubel, J; von Moos, R; Weder, P; Wilhelm, T; Goppner, D; Dummer, R; Heinzerling, LM				Voskens, Caroline J.; Goldinger, Simone M.; Loquai, Carmen; Robert, Caroline; Kaehler, Katharina C.; Berking, Carola; Bergmann, Tanja; Bockmeyer, Clemens L.; Eigentler, Thomas; Fluck, Michael; Garbe, Claus; Gutzmer, Ralf; Grabbe, Stephan; Hauschild, Axel; Hein, Ruediger; Hundorfean, Gheorghe; Justich, Armin; Keller, Ullrich; Klein, Christina; Mateus, Christine; Mohr, Peter; Paetzold, Sylvie; Satzger, Imke; Schadendorf, Dirk; Schlaeppi, Marc; Schuler, Gerold; Schuler-Thurner, Beatrice; Trefzer, Uwe; Ulrich, Jens; Vaubel, Julia; von Moos, Roger; Weder, Patrik; Wilhelm, Tabea; Goeppner, Daniela; Dummer, Reinhard; Heinzerling, Lucie M.			The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INDUCED SARCOIDOSIS; CTLA-4 BLOCKADE; AUTOIMMUNITY; HYPOPHYSITIS; REGRESSION; PATIENT; CANCER; SAFETY; TRIAL	Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients. Treatment algorithms for the management of common ipilimumab-induced AEs have lead to a reduction of morbidity, e.g. due to bowel perforations. However, the spectrum of less common AEs is expanding as ipilimumab is increasingly applied. Stringent recognition and management of AEs will reduce drug-induced morbidity and costs, and thus, positively impact the cost-benefit ratio of the drug. To facilitate timely identification and adequate management data on rare AEs were analyzed at 19 skin cancer centers. Methods and Findings: Patient files (n = 752) were screened for rare ipilimumab-associated AEs. A total of 120 AEs, some of which were life-threatening or even fatal, were reported and summarized by organ system describing the most instructive cases in detail. Previously unreported AEs like drug rash with eosinophilia and systemic symptoms (DRESS), granulomatous inflammation of the central nervous system, and aseptic meningitis, were documented. Obstacles included patients delay in reporting symptoms and the differentiation of steroid-induced from ipilimumab-induced AEs under steroid treatment. Importantly, response rate was high in this patient population with tumor regression in 30.9% and a tumor control rate of 61.8% in stage IV melanoma patients despite the fact that some patients received only two of four recommended ipilimumab infusions. This suggests that ipilimumab-induced antitumor responses can have an early onset and that severe autoimmune reactions may reflect overtreatment. Conclusion: The wide spectrum of ipilimumab-induced AEs demands doctor and patient awareness to reduce morbidity and treatment costs and true ipilimumab success is dictated by both objective tumor responses and controlling severe side effects.	[Voskens, Caroline J.; Schuler, Gerold; Schuler-Thurner, Beatrice; Heinzerling, Lucie M.] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [Goldinger, Simone M.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Loquai, Carmen; Garbe, Claus; Klein, Christina] Univ Hosp Mainz, Dept Dermatol, Mainz, Germany; [Robert, Caroline; Mateus, Christine] Inst Gustave Roussy, Dept Dermatol, Villejuif, France; [Kaehler, Katharina C.; Hauschild, Axel] Univ Hosp Kiel, Dept Dermatol, Kiel, Germany; [Berking, Carola] Univ Munich LMU, Dept Dermatol & Allergol, Munich, Germany; [Bergmann, Tanja; Hundorfean, Gheorghe] Univ Hosp Erlangen, Dept Internal Med Gastroenterol Endocrinol & Pneu, Erlangen, Germany; [Bockmeyer, Clemens L.; Gutzmer, Ralf; Satzger, Imke] Hannover Med Sch, Dept Dermatol & Allergy, Dept Pathol, Skin Canc Ctr Hannover, Hannover, Germany; [Eigentler, Thomas; Garbe, Claus] Univ Tubingen Hosp, Dept Dermatol, Tubingen, Germany; [Fluck, Michael] Hosp Hornheide, Dept Dermatol, Munster, Germany; [Hein, Ruediger; Keller, Ullrich] Tech Univ Munich, Dept Dermatol 3, Dept Med, D-80290 Munich, Germany; [Justich, Armin] Univ Hosp Graz, Dept Dermatol, Graz, Austria; [Mohr, Peter] Elbe Kliniken Buxtehude, Dept Dermatol, Buxtehude, Germany; [Paetzold, Sylvie] Univ Hosp Frankfurt, Dept Dermatol, Frankfurt, Germany; [Schadendorf, Dirk; Vaubel, Julia] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Schlaeppi, Marc; Weder, Patrik; Heinzerling, Lucie M.] Cantonal Hosp St Gallen, Dept Oncol Hematol & Dermatol, St Gallen, Switzerland; [Trefzer, Uwe; Wilhelm, Tabea] Univ Hosp Charite Berlin, Dept Dermatol, Berlin, Germany; [Ulrich, Jens] Hosp Quedlinburg, Dept Dermatol, Quedlinburg, Germany; [von Moos, Roger] Cantonal Hosp Graubunden, Dept Dermatol, Chur, Switzerland; [Goeppner, Daniela] Univ Hosp Magdeburg, Dept Dermatol, Magdeburg, Germany	University of Erlangen Nuremberg; University of Zurich; University Zurich Hospital; University Hospital Mainz; UNICANCER; Gustave Roussy; University of Kiel; Schleswig Holstein University Hospital; University of Munich; University of Erlangen Nuremberg; Hannover Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Duisburg Essen; Kantonsspital St. Gallen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kantonsspital Graubunden; University Hospital Magdeburg	Heinzerling, LM (corresponding author), Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany.	lheinzer@post.harvard.edu	Grabe, Stephan/AAJ-4578-2021; Garbe, Claus/ABH-2128-2021; Eigentler, Thomas/K-8570-2015; Loquai, Carmen/AAW-9241-2020; Robert, Caroline/G-6157-2018; von Moos, Roger/AAG-4570-2020; Schadendorf, Dirk/AAE-8206-2019	Grabe, Stephan/0000-0002-6863-8719; Garbe, Claus/0000-0001-8530-780X; Eigentler, Thomas/0000-0003-0019-2770; Robert, Caroline/0000-0002-9493-0238; Bosch-Voskens, Caroline/0000-0001-9398-005X; , lucie/0000-0003-4587-007X				Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Bakacs T, 2012, PHARMACOL RES, V66, P192, DOI 10.1016/j.phrs.2012.03.015; Bashey A, 2009, BLOOD, V113, P1581, DOI 10.1182/blood-2008-07-168468; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Berthod G, 2012, J CLIN ONCOL, V30, pE156, DOI 10.1200/JCO.2011.39.3298; Bhatia S, 2009, J IMMUNOTHER, V32, P203, DOI 10.1097/CJI.0b013e318193a206; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Bompaire F, 2012, INVEST NEW DRUG, V30, P2407, DOI 10.1007/s10637-011-9787-1; Borodic G, 2011, OPHTHAL PLAST RECONS, V27, pE87, DOI 10.1097/IOP.0b013e3181ef72a1; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Chmiel KD, 2011, J CLIN ONCOL, V29, pE237, DOI 10.1200/JCO.2010.32.2206; Delyon J, 2011, NEW ENGL J MED, V365, P1747, DOI 10.1056/NEJMc1110923; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; Eckert A, 2009, DERMATOLOGY, V218, P69, DOI 10.1159/000161122; Fadel F, 2009, NEW ENGL J MED, V361, P211, DOI 10.1056/NEJMc0904283; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Graziani G, 2012, PHARMACOL RES, V65, P9, DOI 10.1016/j.phrs.2011.09.002; Hamnvik OPR, 2011, JNCI-J NATL CANCER I, V103, P1572, DOI 10.1093/jnci/djr373; Harmankaya K, 2011, MED ONCOL, V28, P1140, DOI 10.1007/s12032-010-9606-0; Heinzerling LM, 2010, J IMMUNOTHER, V33, P834, DOI 10.1097/CJI.0b013e3181eef779; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Hunter G, 2009, CAN J NEUROL SCI, V36, P518, DOI 10.1017/S0317167100007939; Kirkwood JM, 2010, CLIN CANCER RES, V16, P1042, DOI 10.1158/1078-0432.CCR-09-2033; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Liu SM, 2012, J IMMUNOL, V188, P155, DOI 10.4049/jimmunol.1102042; Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536; Matsui T, 1999, J IMMUNOL, V162, P4328; Min L, 2011, EUR J ENDOCRINOL, V164, P303, DOI 10.1530/EJE-10-0833; NORDLUND JJ, 1983, J AM ACAD DERMATOL, V9, P689, DOI 10.1016/S0190-9622(83)70182-9; O'Day S, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8554; Phan GQ, 2008, ANN SURG ONCOL, V15, P3014, DOI 10.1245/s10434-008-0104-y; Prieto PA, 2012, CLIN CANCER RES, V18, P2039, DOI 10.1158/1078-0432.CCR-11-1823; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Samaik AA, 2011, CLIN CANCER RES, V17, P896, DOI 10.1158/1078-0432.CCR-10-2463; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Torino F, 2012, ONCOLOGIST, V17, P525, DOI 10.1634/theoncologist.2011-0404; Vogel WV, 2012, J CLIN ONCOL, V30, pE7, DOI 10.1200/JCO.2011.37.9693; Wang HB, 2001, J IMMUNOL, V166, P6430, DOI 10.4049/jimmunol.166.10.6430; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Weber JS, 2011, MELANOMA RES, V21, P530, DOI 10.1097/CMR.0b013e32834d3d88; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Wilgenhof S, 2011, ANN ONCOL, V22, P991, DOI 10.1093/annonc/mdr028; Wilgenhof S, 2012, ANTICANCER RES, V32, P1355; Wolchok Jedd D, 2010, Cancer Immun, V10, P9; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1	49	337	346	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53745	10.1371/journal.pone.0053745	http://dx.doi.org/10.1371/journal.pone.0053745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341990	Green Accepted, Green Published, gold			2022-12-27	WOS:000314759400075
J	Wang, GB; Zhou, Y; Xu, X; Ruan, HH; Wang, JS				Wang, Guobing; Zhou, Yan; Xu, Xia; Ruan, Honghua; Wang, Jiashe			Temperature Sensitivity of Soil Organic Carbon Mineralization along an Elevation Gradient in the Wuyi Mountains, China	PLOS ONE			English	Article							CONIFEROUS FOREST SOILS; RESPIRATION RATE; NITROGEN MINERALIZATION; MATTER DECOMPOSITION; CLIMATE-CHANGE; DEPENDENCE; DYNAMICS; CO2; RESPONSES; POOLS	Soil organic carbon (SOC) actively participates in the global carbon (C) cycle. Despite much research, however, our understanding of the temperature sensitivity of soil organic carbon (SOC) mineralization is still very limited. To investigate the responses of SOC mineralization to temperature, we sampled surface soils (0-10 cm) from evergreen broad-leaf forest (EBF), coniferous forest (CF), sub-alpine dwarf forest (SDF), and alpine meadow (AM) along an elevational gradient in the Wuyi Mountains, China. The soil samples were incubated at 5, 15, 25, and 35 degrees C with constant soil moisture for 360 days. The temperature sensitivity of SOC mineralization (Q(10)) was calculated by comparing the time needed to mineralize the same amount of C at any two adjacent incubation temperatures. Results showed that the rates of SOC mineralization and the cumulative SOC mineralized during the entire incubation significantly increased with increasing incubation temperatures across the four sites. With the increasing extent of SOC being mineralized (increasing incubation time), the Q(10) values increased. Moreover, we found that both the elevational gradient and incubation temperature intervals significantly impacted Q(10) values. Q(10) values of the labile and recalcitrant organic C linearly increased with elevation. For the 5-15, 15-25, and 25-35 degrees C intervals, surprisingly, the overall Q(10) values for the labile C did not decrease as the recalcitrant C did. Generally, our results suggest that subtropical forest soils may release more carbon than expected in a warmer climate.	[Wang, Guobing; Ruan, Honghua] Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Guobing; Ruan, Honghua] Nanjing Forestry Univ, Key Lab Forestry & Ecol Engn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Yan] Nanning Landscape Adm Bur, Nanning, Guangxi, Peoples R China; [Xu, Xia] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Wang, Jiashe] Adm Bur Wuyishan Natl Nat Reserve, Wuyishan, Fujian, Peoples R China	Nanjing Forestry University; Nanjing Forestry University; University of Oklahoma System; University of Oklahoma - Norman	Ruan, HH (corresponding author), Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn			Chinese National Public-warfare Programs [200804006, 201104006]; National Science Foundation of China [31170417]	Chinese National Public-warfare Programs; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese National Public-warfare Programs (No. 200804006 & No. 201104006) and National Science Foundation of China (31170417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison I, 2009, COPENHAGEN DIAGNOSIS; Bekku YS, 2004, ARCT ANTARCT ALP RES, V36, P395, DOI 10.1657/1523-0430(2004)036[0395:SMBRRA]2.0.CO;2; Bekku YS, 2003, APPL SOIL ECOL, V22, P205, DOI 10.1016/S0929-1393(02)00158-0; Bottner P, 2000, SOIL BIOL BIOCHEM, V32, P527, DOI 10.1016/S0038-0717(99)00182-0; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Cote L, 2000, SOIL BIOL BIOCHEM, V32, P1079, DOI 10.1016/S0038-0717(00)00017-1; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; De Neve S, 2000, BIOL FERT SOILS, V30, P544, DOI 10.1007/s003740050034; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; He J. Y., 1994, WUYISHAN RES SERIES; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Hunter MD, 2003, PEDOBIOLOGIA, V47, P231, DOI 10.1078/0031-4056-00187; Hyvonen R, 2002, PLANT SOIL, V242, P33, DOI 10.1023/A:1019677521133; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lange OL, 2005, OECOLOGIA, V142, P11, DOI 10.1007/s00442-004-1697-x; Li JW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001769; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Niklinska M, 1999, BIOGEOCHEMISTRY, V44, P239, DOI 10.1023/A:1006049204600; Niklinska M, 2007, BIOL FERT SOILS, V43, P511, DOI 10.1007/s00374-006-0129-y; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; Reynolds BC, 2001, SOIL BIOL BIOCHEM, V33, P1641, DOI 10.1016/S0038-0717(01)00085-2; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Silver WL, 1998, CLIMATIC CHANGE, V39, P337, DOI 10.1023/A:1005396714941; Simmons JA, 1996, FOREST ECOL MANAG, V84, P81, DOI 10.1016/0378-1127(96)03739-5; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Wu, 2005, ECOL SCI, V25, P243; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Xu X, 2010, SOIL BIOL BIOCHEM, V42, P1811, DOI 10.1016/j.soilbio.2010.06.021; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; [郑成洋 Zheng Chengyang], 2004, [气象学报, Acta Meteorologica Sinica], V62, P251; Zhu BA, 2011, SOIL BIOL BIOCHEM, V43, P866, DOI 10.1016/j.soilbio.2010.12.021	51	60	66	4	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53914	10.1371/journal.pone.0053914	http://dx.doi.org/10.1371/journal.pone.0053914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342038	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400099
J	Cheng, SE; Lee, IT; Lin, CC; Wu, WL; Hsiao, LD; Yang, CM				Cheng, Shin-Ei; Lee, I-Ta; Lin, Chih-Chung; Wu, Wan-Ling; Hsiao, Li-Der; Yang, Chuen-Mao			RETRACTED: ATP Mediates NADPH Oxidase/ROS Generation and COX-2/PGE(2) Expression in A549 Cells: Role of P2 Receptor-Dependent STAT3 Activation (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							PROTEIN-KINASE-C; FACTOR-KAPPA-B; CYCLOOXYGENASE-2 EXPRESSION; TYROSINE PHOSPHORYLATION; AIRWAY INFLAMMATION; OXIDATIVE STRESS; CIGARETTE-SMOKE; TRANSLOCATION; MAPK; TRANSACTIVATION	Background: Up-regulation of cyclooxygenase (COX)-2 and its metabolite prostaglandin E-2 (PGE(2)) are frequently implicated in lung inflammation. Extracellular nucleotides, such as ATP have been shown to act via activation of P2 purinoceptors, leading to COX-2 expression in various inflammatory diseases, such as lung inflammation. However, the mechanisms underlying ATP-induced COX-2 expression and PGE(2) release remain unclear. Principal Findings: Here, we showed that ATP gamma S induced COX-2 expression in A549 cells revealed by western blot and real-time PCR. Pretreatment with the inhibitors of P2 receptor (PPADS and suramin), PKC (Go6983, Go6976, Ro318220, and Rottlerin), ROS (Edaravone), NADPH oxidase [diphenyleneiodonium chloride (DPI) and apocynin], Jak2 (AG490), and STAT3 [cucurbitacin E (CBE)] and transfection with siRNAs of PKC alpha, PKC iota, PKC mu, p47(phox), Jak2, STAT3, and cPLA(2) markedly reduced ATP gamma S-induced COX-2 expression and PGE(2) production. In addition, pretreatment with the inhibitors of P2 receptor attenuated PKCs translocation from the cytosol to the membrane in response to ATP gamma S. Moreover, ATP gamma S-induced ROS generation and p47(phox) translocation was also reduced by pretreatment with the inhibitors of P2 receptor, PKC, and NADPH oxidase. On the other hand, ATP gamma S stimulated Jak2 and STAT3 activation which were inhibited by pretreatment with PPADS, suramin, Go6983, Go6976, Ro318220, GF109203X, Rottlerin, Edaravone, DPI, and apocynin in A549 cells. Significance: Taken together, these results showed that ATP gamma S induced COX-2 expression and PGE(2) production via a P2 receptor/PKC/NADPH oxidase/ROS/Jak2/STAT3/cPLA(2) signaling pathway in A549 cells. Increased understanding of signal transduction mechanisms underlying COX-2 gene regulation will create opportunities for the development of anti-inflammation therapeutic strategies.	[Cheng, Shin-Ei; Lee, I-Ta; Wu, Wan-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Cheng, Shin-Ei; Lee, I-Ta; Wu, Wan-Ling; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Anesthet, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.	chuenmao@mail.cgu.edu.tw			National Science Council, Taiwan [NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2314-B-182-021-MY3, NSC98-2320-B-255-001-MY3]; Ministry of Education, Taiwan [EMRPD1A0831, EMRPD1A0841, EMRPD1B0311, EMRPD1B0321]; Chang Gung Medical Research Foundation, Taiwan [CMRPG391032, CMRPG381523, CMRPD170493, CMRPD180372, CMRPD1B0381, CMRPG3B1091]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2314-B-182-021-MY3, and NSC98-2320-B-255-001-MY3 from National Science Council, Taiwan; EMRPD1A0831, EMRPD1A0841, EMRPD1B0311, and EMRPD1B0321 from Ministry of Education, Taiwan; and CMRPG391032, CMRPG381523, CMRPD170493, CMRPD180372, CMRPD1B0381, and CMRPG3B1091 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; CACCIUTTOLO MA, 1993, FREE RADICAL BIO MED, V14, P267, DOI 10.1016/0891-5849(93)90023-N; Cao W, 2011, J HYPERTENS, V29, P1411, DOI 10.1097/HJH.0b013e32834786f0; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Carey MA, 2003, PROSTAG LEUKOTR ESS, V69, P157, DOI 10.1016/S0952-3278(03)00076-0; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; Esther CR, 2011, SUBCELL BIOCHEM, V55, P75, DOI 10.1007/978-94-007-1217-1_4; FINAN P, 1994, J BIOL CHEM, V269, P13752; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kim EJ, 2008, J CEREBR BLOOD F MET, V28, P1329, DOI 10.1038/jcbfm.2008.26; Kim HS, 2008, FREE RADICAL BIO MED, V45, P950, DOI 10.1016/j.freeradbiomed.2008.06.009; Lagente V, 2008, CLIN EXP PHARMACOL P, V35, P601, DOI 10.1111/j.1440-1681.2007.04848.x; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Li H, 2011, AM J RESP CRIT CARE, V184, P37, DOI 10.1164/rccm.201010-1637OC; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lin CC, 2008, TOXICOL APPL PHARM, V229, P386, DOI 10.1016/j.taap.2008.01.032; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; Lin CC, 2012, J CELL PHYSIOL, V227, P1628, DOI 10.1002/jcp.22880; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Lin CC, 2009, CARDIOVASC RES, V82, P522, DOI 10.1093/cvr/cvp069; Lin RZ, 2011, J CELL PHYSIOL, V226, P1750, DOI 10.1002/jcp.22504; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; Machida T, 2011, EUR J PHARMACOL, V656, P19, DOI 10.1016/j.ejphar.2010.12.044; Mortaz E, 2010, EUR J PHARMACOL, V638, P1, DOI 10.1016/j.ejphar.2010.04.019; Polosa R, 2009, TRENDS PHARMACOL SCI, V30, P528, DOI 10.1016/j.tips.2009.07.005; Qadri SSA, 2002, ANN THORAC SURG, V74, P1648, DOI 10.1016/S0003-4975(02)04022-5; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V494, P7, DOI 10.1016/j.abb.2009.11.002; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Tzeng JI, 2010, PHARMACOL RES, V61, P162, DOI 10.1016/j.phrs.2009.09.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	40	38	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54125	10.1371/journal.pone.0054125	http://dx.doi.org/10.1371/journal.pone.0054125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326583	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800109
J	Kwakkenbos, L; Arthurs, E; van den Hoogen, FHJ; Hudson, M; van Lankveld, WGJM; Baron, M; van den Ende, CHM; Thombs, BD				Kwakkenbos, Linda; Arthurs, Erin; van den Hoogen, Frank H. J.; Hudson, Marie; van Lankveld, Wim G. J. M.; Baron, Murray; van den Ende, Cornelia H. M.; Thombs, Brett D.		Canadian Scleroderma Res Grp	Cross-Language Measurement Equivalence of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis: A Comparison of Canadian and Dutch Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; REPORTED OUTCOMES; RELIABILITY; SCLERODERMA; SYMPTOMS; VALIDITY	Objectives: Increasingly, medical research involves patients who complete outcomes in different languages. This occurs in countries with more than one common language, such as Canada (French/English) or the United States (Spanish/English), as well as in international multi-centre collaborations, which are utilized frequently in rare diseases such as systemic sclerosis (SSc). In order to pool or compare outcomes, instruments should be measurement equivalent (invariant) across cultural or linguistic groups. This study provides an example of how to assess cross-language measurement equivalence by comparing the Center for Epidemiologic Studies Depression (CES-D) scale between English-speaking Canadian and Dutch SSc patients. Methods: The CES-D was completed by 922 English-speaking Canadian and 213 Dutch SSc patients. Confirmatory factor analysis (CFA) was used to assess the factor structure in both samples. The Multiple-Indicator Multiple-Cause (MIMIC) model was utilized to assess the amount of differential item functioning (DIF). Results: A two-factor model (positive and negative affect) showed excellent fit in both samples. Statistically significant, but small-magnitude, DIF was found for 3 of 20 items on the CES-D. The English-speaking Canadian sample endorsed more feeling-related symptoms, whereas the Dutch sample endorsed more somatic/retarded activity symptoms. The overall estimate in depression scores between English and Dutch was not influenced substantively by DIF. Conclusions: CES-D scores from English-speaking Canadian and Dutch SSc patients can be compared and pooled without concern that measurement differences may substantively influence results. The importance of assessing cross-language measurement equivalence in rheumatology studies prior to pooling outcomes obtained in different languages should be emphasized.	[Kwakkenbos, Linda; van den Hoogen, Frank H. J.; van Lankveld, Wim G. J. M.; van den Ende, Cornelia H. M.] Sint Maartensklin Nijmegen, Dept Rheumatol, Nijmegen, Netherlands; [Kwakkenbos, Linda; Arthurs, Erin; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Div Rheumatol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Kwakkenbos, Linda; Arthurs, Erin; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Sint Maartens Clinic; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Kwakkenbos, L (corresponding author), Sint Maartensklin Nijmegen, Dept Rheumatol, Nijmegen, Netherlands.	kwakkenbosL@gmail.com	van den Ende, Cornelia/ABG-7626-2020; Baron, Murray/AAF-9486-2019; van den Ende, Cornelia/G-9559-2011; Pope, Janet/G-3342-2011; Kwakkenbos, Linda/GXH-2756-2022; van den Hoogen, Frank/I-7829-2018	van den Ende, Cornelia/0000-0002-4352-2824; Pope, Janet/0000-0003-1479-5302; Kwakkenbos, Linda/0000-0002-1573-4504; van den Hoogen, Frank/0000-0003-1044-015X; Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Ontario Arthritis Society; Actelion Pharmaceuticals; Pfizer Inc; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Ontario Arthritis Society; Actelion Pharmaceuticals; Pfizer Inc(Pfizer); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	MB is the director of the Canadian Scleroderma Research Group, which receives grant funding from the Canadian Institutes of Health Research, the Scleroderma Society of Canada and its provincial chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, the Ontario Arthritis Society, and educational grants from Actelion Pharmaceuticals and Pfizer Inc. BDT and MH are supported by New Investigator Awards from the Canadian Institutes of Health Research and Etablissement de Jeunes Chercheurs awards from the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Boers M, 1998, J RHEUMATOL, V25, P198; Bouma JR., 1995, METEN SYMPTOMEN DEPR; Bren Linda, 2006, FDA Consum, V40, P26; Buck U, 2010, MUSCULOSKELET CARE, V8, P197, DOI 10.1002/msc.181; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fairclough DL, 2004, STAT METHODS MED RES, V13, P115, DOI 10.1191/0962280204sm357ra; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Her M, 2012, CURR OPIN RHEUMATOL, V24, P327, DOI 10.1097/BOR.0b013e3283521c64; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunt SM, 2004, J EPIDEMIOL COMMUN H, V58, P618, DOI 10.1136/jech.2003.010074; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; Kwakkenbos L, 2012, J PSYCHOSOM RES, V72, P199, DOI 10.1016/j.jpsychores.2011.12.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Martens MP, 2003, ARTHRIT RHEUM-ARTHR, V49, P549, DOI 10.1002/art.11203; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Muller H, 2012, BRIT J DERMATOL, V166, P343, DOI 10.1111/j.1365-2133.2011.10624.x; Muthen LK, 1998, MPLUS USERSGUIDE; Nietert PJ, 2005, J RHEUMATOL, V32, P51; RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Rogler LH, 1999, AM PSYCHOL, V54, P424, DOI 10.1037/0003-066X.54.6.424; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Teresi JA, 2006, MED CARE, V44, pS152, DOI 10.1097/01.mlr.0000245142.74628.ab; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P438, DOI 10.1002/art.23329; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells G, 2008, ANN RHEUM DIS, V67, P260, DOI 10.1136/ard.2007.069690; Zumbo B. D., 2007, LANG ASSESS Q, V4, P223, DOI DOI 10.1080/15434300701375832; Zumbo BD, 1999, HDB THEORY METHODS D	40	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53923	10.1371/journal.pone.0053923	http://dx.doi.org/10.1371/journal.pone.0053923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326538	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800087
J	Laalami, S; Bessieres, P; Rocca, A; Zig, L; Nicolas, P; Putzer, H				Laalami, Soumaya; Bessieres, Philippe; Rocca, Anna; Zig, Lena; Nicolas, Pierre; Putzer, Harald			Bacillus subtilis RNase Y Activity In Vivo Analysed by Tiling Microarrays	PLOS ONE			English	Article							MESSENGER-RNA; OXALATE DECARBOXYLASE; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; SIGMA-FACTOR; EXPRESSION; IDENTIFICATION; INITIATION; PROTEIN; GENES	RNase Y is a key endoribonuclease affecting global mRNA stability in Bacillus subtilis. Its characterization provided the first evidence that endonucleolytic cleavage plays a major role in the mRNA metabolism of this organism. RNase Y shares important functional features with the RNA decay initiating RNase E from Escherichia coli, notably a similar cleavage specificity and a preference for 59 monophosphorylated substrates. We used high-resolution tiling arrays to analyze the effect of RNase Y depletion on RNA abundance covering the entire genome. The data confirm that this endoribonuclease plays a key role in initiating the decay of a large number of mRNAs as well as non coding RNAs. The downstream cleavage products are likely to be degraded by the 59 exonucleolytic activity of RNases J1/J2 as we show for a specific case. Comparison of the data with that of two other recent studies revealed very significant differences. About two thirds of the mRNAs upregulated following RNase Y depletion were different when compared to either one of these studies and only about 10% were in common in all three studies. This highlights that experimental conditions and data analysis play an important role in identifying RNase Y substrates by global transcriptional profiling. Our data confirmed already known RNase Y substrates and due to the precision and reproducibility of the profiles allow an exceptionally detailed view of the turnover of hundreds of new RNA substrates.	[Laalami, Soumaya; Rocca, Anna; Zig, Lena; Putzer, Harald] Univ Paris Diderot, Inst Biol Physicochim, CNRS UPR 9073, Paris, France; [Bessieres, Philippe; Nicolas, Pierre] INRA UR1077, Jouy En Josas, France	UDICE-French Research Universities; Universite Paris Cite; INRAE	Putzer, H (corresponding author), Univ Paris Diderot, Inst Biol Physicochim, CNRS UPR 9073, Paris, France.	putzer@ibpc.fr	Putzer, Harald/GRY-6203-2022		CNRS [UPR 9073]; Univ Paris Diderot; Sorbonne Paris Cite; Agence Nationale de la Recherche ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); Univ Paris Diderot; Sorbonne Paris Cite; Agence Nationale de la Recherche ANR(French National Research Agency (ANR))	This work was supported by funds from the CNRS (UPR 9073), Univ Paris Diderot, Sorbonne Paris Cite and the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) ANR grant RNAJAY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2007, J PROTEOME RES, V6, P897, DOI 10.1021/pr060440a; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bruscella P, 2011, MOL MICROBIOL, V81, P1526, DOI 10.1111/j.1365-2958.2011.07793.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Gaballa A, 2002, J BACTERIOL, V184, P6508, DOI 10.1128/JB.184.23.6508-6514.2002; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Guillouard I, 2002, J BACTERIOL, V184, P4681, DOI 10.1128/JB.184.17.4681-4689.2002; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Laalami Soumaya, 2011, Biomol Concepts, V2, P491, DOI 10.1515/BMC.2011.042; Lehnik-Habrink M, 2011, J BACTERIOL, V193, P5431, DOI 10.1128/JB.05500-11; Lehnik-Habrink M, 2011, MOL MICROBIOL, V81, P1459, DOI 10.1111/j.1365-2958.2011.07777.x; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Naville M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r97; Newman JA, 2012, J MOL BIOL, V416, P121, DOI 10.1016/j.jmb.2011.12.024; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; PUTZER H, 1992, EMBO J, V11, P3117, DOI 10.1002/j.1460-2075.1992.tb05384.x; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P407; Sterk P, 2006, OMICS, V10, P114, DOI 10.1089/omi.2006.10.114; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10	47	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54062	10.1371/journal.pone.0054062	http://dx.doi.org/10.1371/journal.pone.0054062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326572	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400071
J	Opulente, DA; Morales, CM; Carey, LB; Rest, JS				Opulente, Dana A.; Morales, Christopher M.; Carey, Lucas B.; Rest, Joshua S.			Coevolution Trumps Pleiotropy: Carbon Assimilation Traits Are Independent of Metabolic Network Structure in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; DUPLICATION; EVOLUTION; GENOMICS; REVEALS; STRAINS; COPY	Phenotypic traits may be gained and lost together because of pleiotropy, the involvement of common genes and networks, or because of simultaneous selection for multiple traits across environments (multiple-trait coevolution). However, the extent to which network pleiotropy versus environmental coevolution shapes shared responses has not been addressed. To test these alternatives, we took advantage of the fact that the genus Saccharomyces has variation in habitat usage and diversity in the carbon sources that a given strain can metabolize. We examined patterns of gain and loss in carbon utilization traits across 488 strains of Saccharomyces to investigate whether the structure of metabolic pathways or selection pressure from common environments may have caused carbon utilization traits to be gained and lost together. While most carbon sources were gained and lost independently of each other, we found four clusters that exhibit non-random patterns of gain and loss across strains. Contrary to the network pleiotropy hypothesis, we did not find that these patterns are explained by the structure of metabolic pathways or shared enzymes. Consistent with the hypothesis that common environments shape suites of phenotypes, we found that the environment a strain was isolated from partially predicts the carbon sources it can assimilate.	[Opulente, Dana A.; Morales, Christopher M.; Rest, Joshua S.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Carey, Lucas B.] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science	Rest, JS (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	joshua.rest@stonybrook.edu	Carey, Lucas/L-8547-2014	Carey, Lucas/0000-0002-7245-6379; Opulente, Dana/0000-0003-3224-7510; Rest, Joshua/0000-0002-9582-1041	Stony Brook University	Stony Brook University	This work was supported by startup funds from Stony Brook University to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RM, 2010, GENOME BIOL EVOL, V2, P591, DOI 10.1093/gbe/evq043; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Centraalbureau voor Schimmelcultures Fungal Biodiversity Centre, 2012, YEAST STRAIN DAT; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Conner JK, 2002, NATURE, V420, P407, DOI 10.1038/nature01105; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Gerlee P, 2009, J R SOC INTERFACE, V6, P1233, DOI 10.1098/rsif.2008.0514; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Ma M, 2012, BIOENERG RES, V5, P459, DOI 10.1007/s12155-011-9176-9; Marland E, 2004, J MOL EVOL, V59, P806, DOI 10.1007/s00239-004-0068-x; Muller LAH, 2011, FEMS YEAST RES, V11, P587, DOI 10.1111/j.1567-1364.2011.00748.x; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Streisfeld MA, 2009, NEW PHYTOL, V183, P751, DOI 10.1111/j.1469-8137.2009.02929.x; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Vivier MA, 1997, CRIT REV BIOCHEM MOL, V32, P405, DOI 10.3109/10409239709082675; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wong D, 2010, IND BIOTECHNOL, V6, P112; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	25	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54403	10.1371/journal.pone.0054403	http://dx.doi.org/10.1371/journal.pone.0054403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326606	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400088
J	Fulton, CJ; Johansen, JL; Steffensen, JF				Fulton, Christopher J.; Johansen, Jacob L.; Steffensen, John F.			Energetic Extremes in Aquatic Locomotion by Coral Reef Fishes	PLOS ONE			English	Article							DIFFERENT SWIMMING SPEEDS; OXYGEN-CONSUMPTION; PERFORMANCE; COST; TEMPERATURE; PROPULSION; TUNA; JAPONICUS; MACKEREL; SCHOOL	Underwater locomotion is challenging due to the high friction and resistance imposed on a body moving through water and energy lost in the wake during undulatory propulsion. While aquatic organisms have evolved streamlined shapes to overcome such resistance, underwater locomotion has long been considered a costly exercise. Recent evidence for a range of swimming vertebrates, however, has suggested that flapping paired appendages around a rigid body may be an extremely efficient means of aquatic locomotion. Using intermittent flow-through respirometry, we found exceptional energetic performance in the Bluelined wrasse Stethojulis bandanensis, which maintains tuna-like optimum cruising speeds (up to 1 metre s(-1)) while using 40% less energy than expected for their body size. Displaying an exceptional aerobic scope (22-fold above resting), streamlined rigid-body posture, and wing-like fins that generate lift-based thrust, S. bandanensis literally flies underwater to efficiently maintain high optimum swimming speeds. Extreme energetic performance may be key to the colonization of highly variable environments, such as the wave-swept habitats where S. bandanensis and other wing-finned species tend to occur. Challenging preconceived notions of how best to power aquatic locomotion, biomimicry of such lift-based fin movements could yield dramatic reductions in the power needed to propel underwater vehicles at high speed.	[Fulton, Christopher J.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia; [Johansen, Jacob L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Steffensen, John F.] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark	Australian National University; James Cook University; University of Copenhagen	Fulton, CJ (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia.	christopher.fulton@anu.edu.au	Steffensen, John F/F-6778-2010; Johansen, Jacob/F-9189-2011; Fulton, Christopher/A-5971-2008	Steffensen, John F/0000-0002-4477-8039; Fulton, Christopher/0000-0002-1140-1999	Australian Research Council; Danish Agency for Science, Technology and Innovation	Australian Research Council(Australian Research Council); Danish Agency for Science, Technology and Innovation	Funding was provided by the Australian Research Council (to CJF) and the Danish Agency for Science, Technology and Innovation (to JFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; BAUDINETTE RV, 1985, J COMP PHYSIOL B, V155, P373, DOI 10.1007/BF00687481; Bell WH, 1970, J FISH RES BD CAN TE; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; BRETT JR, 1965, J FISH RES BOARD CAN, V22, P1491, DOI 10.1139/f65-128; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Clark TD, 2006, J EXP BIOL, V209, P3940, DOI 10.1242/jeb.02440; DEWAR H, 1994, J EXP BIOL, V192, P13; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; Fitzgibbon QP, 2007, AQUACULTURE, V270, P358, DOI 10.1016/j.aquaculture.2007.04.038; Fulton CJ, 2007, CORAL REEFS, V26, P217, DOI 10.1007/s00338-007-0195-0; Fulton C. J., 2010, FISH LOCOMOTION ECOE, P333; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; GOODING RM, 1981, FISH B-NOAA, V79, P31; GRAHAM JB, 1989, EXP BIOL, V48, P89; Hein AM, 2012, BIOL LETTERS, V8, P266, DOI 10.1098/rsbl.2011.0885; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; KORSMEYER KE, 2001, TUNA PHYSL ECOLOGY E, P35; Long JH, 2006, BIOINSPIR BIOMIM, V1, P20, DOI 10.1088/1748-3182/1/1/003; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Sepulveda C, 2000, J EXP BIOL, V203, P3089; Sepulveda CA, 2003, J EXP BIOL, V206, P2739, DOI 10.1242/jeb.00497; STEFFENSEN JF, 1984, COMP BIOCHEM PHYS A, V79, P437, DOI 10.1016/0300-9629(84)90541-3; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Vogel S., 1994, LIFE MOVING FLUIDS P; Wainwright PC, 2002, ENVIRON BIOL FISH, V65, P47, DOI 10.1023/A:1019671131001; Walker JA, 2002, INTEGR COMP BIOL, V42, P1032, DOI 10.1093/icb/42.5.1032; Walker JA, 2002, J EXP BIOL, V205, P177; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wyneken Jeanette, 1997, P165; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	38	26	26	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54033	10.1371/journal.pone.0054033	http://dx.doi.org/10.1371/journal.pone.0054033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326566	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000313551500108
J	Bjorkenstam, E; Hjern, A; Mittendorfer-Rutz, E; Vinnerljung, B; Hallqvist, J; Ljung, R				Bjorkenstam, Emma; Hjern, Anders; Mittendorfer-Rutz, Ellenor; Vinnerljung, Bo; Hallqvist, Johan; Ljung, Rickard			Multi-Exposure and Clustering of Adverse Childhood Experiences, Socioeconomic Differences and Psychotropic Medication in Young Adults	PLOS ONE			English	Article							RISK-FACTORS; NATIONAL COHORT; MAJOR DEPRESSION; MENTAL-DISORDERS; SOCIAL-CLASS; CHILDREN; HEALTH; MORBIDITY; REGISTER; EPIDEMIOLOGY	Purpose: Stressful childhood experiences have negative long-term health consequences. The present study examines the association between adverse childhood experiences, socioeconomic position, and risk of psychotropic medication in young adulthood. Methods: This register-based cohort study comprises the birth cohorts between 1985 and 1988 in Sweden. We followed 362 663 individuals for use of psychotropic medication from January 2006 until December 2008. Adverse childhood experiences were severe criminality among parents, parental alcohol or drug abuse, social assistance recipiency, parental separation or single household, child welfare intervention before the age of 12, mentally ill or suicidal parents, familial death, and number of changes in place of residency. Estimates of risk of psychotropic medication were calculated as odds ratio (OR) with 95% confidence intervals (CIs) using logistic regression analysis. Results: Adverse childhood experiences were associated with increased risks of psychotropic medication. The OR for more than three adverse childhood experiences and risk of psychotropic medication was for women 2.4 (95% CI 2.3-2.5) and for men 3.1 (95% CI 2.9-3.2). The risk of psychotropic medication increased with a higher rate of adverse childhood experiences, a relationship similar in all socioeconomic groups. Conclusions: Accumulation of adverse childhood experiences increases the risk of psychotropic medication in young adults. Parental educational level is of less importance when adjusting for adverse childhood experiences. The higher risk for future mental health problems among children from lower socioeconomic groups, compared to peers from more advantaged backgrounds, seems to be linked to a higher rate of exposure to adverse childhood experiences.	[Bjorkenstam, Emma; Ljung, Rickard] Karolinska Inst, Div Social Med, Dept Publ Hlth Sci, Stockholm, Sweden; [Bjorkenstam, Emma; Ljung, Rickard] Natl Board Hlth & Welf, Dept Stat Monitoring & Evaluat, Stockholm, Sweden; [Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, S-10691 Stockholm, Sweden; [Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Vinnerljung, Bo] Stockholm Univ, Dept Social Work, S-10691 Stockholm, Sweden; [Hallqvist, Johan] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Ljung, Rickard] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; National Board of Health & Welfare; Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm University; Karolinska Institutet; Uppsala University; Karolinska Institutet	Bjorkenstam, E (corresponding author), Karolinska Inst, Div Social Med, Dept Publ Hlth Sci, Stockholm, Sweden.	emma.bjorkenstam@ki.se	Ljung, Rickard/E-6752-2011	Ljung, Rickard/0000-0002-0654-4530; Hjern, Anders/0000-0002-1645-2058	Gadelius Foundation; Swedish Research Council	Gadelius Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Gadelius Foundation. Dr. Mittendorfer-Rutz is the recipient of the Assistant Professorship grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Anda R.F., HLTH SOCIAL IMPACT G; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2007, AM J PREV MED, V32, P389, DOI 10.1016/j.amepre.2007.01.005; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Dube SR, 2003, PREV MED, V37, P268, DOI 10.1016/S0091-7435(03)00123-3; DUBE SR, 2006, J ADOLESCENT HEALTH, V38, P1; Ebrahim S, 2004, BMJ-BRIT MED J, V328, P861, DOI 10.1136/bmj.38034.702836.55; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Farrington D., 2007, SAVING CHILDREN LIFE; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gilman SE, 2002, INT J EPIDEMIOL, V31, P359, DOI 10.1093/ije/31.2.359; Hjern A, 2004, J EPIDEMIOL COMMUN H, V58, P412, DOI 10.1136/jech.2003.014282; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; LewisHall F, 1996, MT SINAI J MED, V63, P326; Ljung R, 2007, AM J PUBLIC HEALTH, V97, P1927, DOI 10.2105/AJPH.2007.119248; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mark TL, 2010, CNS DRUGS, V24, P319, DOI 10.2165/11533120-000000000-00000; Marks NF, 2007, J FAM ISSUES, V28, P1611, DOI 10.1177/0192513X07302728; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McLaughlin KA, 2011, SOC SCI MED, V73, P1088, DOI 10.1016/j.socscimed.2011.06.011; National Board of Health and Welfare, 2012, PHARM STAT 2011; National Records of Scotland, 2011, CHANG COD CAUS DEATH; Power C, 2008, J EPIDEMIOL COMMUN H, V62, P1030, DOI 10.1136/jech.2007.068817; Reinherz HZ, 2003, AM J PSYCHIAT, V160, P2141, DOI 10.1176/appi.ajp.160.12.2141; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Tracy M, 2008, J PSYCHIATR RES, V42, P1163, DOI 10.1016/j.jpsychires.2008.01.011; Turner HA, 2006, SOC SCI MED, V62, P13, DOI 10.1016/j.socscimed.2005.05.030; Vinnerljung B, 2006, J CHILD PSYCHOL PSYC, V47, P723, DOI 10.1111/j.1469-7610.2005.01530.x; Vinnerljung B, 2007, INT J SOC WELF, V16, P163; Weitoft GR, 2008, PHARMACOEPIDEM DR S, V17, P1020, DOI 10.1002/pds.1635; Weitoft GR, 2003, LANCET, V361, P289, DOI 10.1016/S0140-6736(03)12324-0; Weitoft GR, 2008, SOC SCI MED, V66, P14, DOI 10.1016/j.socscimed.2007.07.031; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Whitfield CL, 2005, CHILD ABUSE NEGLECT, V29, P797, DOI 10.1016/j.chiabu.2005.01.004; WOOD D, 1993, JAMA-J AM MED ASSOC, V270, P1334, DOI 10.1001/jama.270.11.1334	41	56	56	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53551	10.1371/journal.pone.0053551	http://dx.doi.org/10.1371/journal.pone.0053551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341951	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700029
J	Kejnovsky, E; Michalovova, M; Steflova, P; Kejnovska, I; Manzano, S; Hobza, R; Kubat, Z; Kovarik, J; Jamilena, M; Vyskot, B				Kejnovsky, Eduard; Michalovova, Monika; Steflova, Pavlina; Kejnovska, Iva; Manzano, Susana; Hobza, Roman; Kubat, Zdenek; Kovarik, Jan; Jamilena, Manuel; Vyskot, Boris			Expansion of Microsatellites on Evolutionary Young Y Chromosome	PLOS ONE			English	Article							DNA MOTIF D(TG)30; SEX-CHROMOSOMES; DINUCLEOTIDE MICROSATELLITES; HOMOLOGOUS RECOMBINATION; SILENE-LATIFOLIA; REPETITIVE DNA; REPEATS; INTEGRATION; SEQUENCES; ELEMENTS	Sex chromosomes are an ideal system to study processes connected with suppressed recombination. We found evidence of microsatellite expansion, on the relatively young Y chromosome of the dioecious plant sorrel (Rumex acetosa, XY1Y2 system), but no such expansion on the more ancient Y chromosomes of liverwort (Marchantia polymorpha) and human. The most expanding motifs were AC and AAC, which also showed periodicity of array length, indicating the importance of beginnings and ends of arrays. Our data indicate that abundance of microsatellites in genomes depends on the inherent expansion potential of specific motifs, which could be related to their stability and ability to adopt unusual DNA conformations. We also found that the abundance of microsatellites is higher in the neighborhood of transposable elements (TEs) suggesting that microsatellites are probably targets for TE insertions. This evidence suggests that microsatellite expansion is an early event shaping the Y chromosome where this process is not opposed by recombination, while accumulation of TEs and chromosome shrinkage predominate later.	[Kejnovsky, Eduard] Acad Sci Czech Republ, Inst Biophys, Lab Plant Dev Genet, Dept Plant Dev Genet, CS-61265 Brno, Czech Republic; [Kejnovsky, Eduard; Steflova, Pavlina; Kubat, Zdenek] CEITEC Cent European Inst Technol, Lab Genome Dynam, Brno, Czech Republic; [Kejnovska, Iva] Acad Sci Czech Republ, Inst Biophys, Dept CD Spect Nucle Acids, CS-61265 Brno, Czech Republic; [Manzano, Susana; Jamilena, Manuel] Univ Almeria, Escuela Polytecn Super, Dept Biol Aplicada, Almeria, Spain; [Hobza, Roman] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Lab Mol Cytogenet & Cytometry, Olomouc, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Universidad de Almeria; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kejnovsky, E (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Plant Dev Genet, Dept Plant Dev Genet, Kralovopolska 135, CS-61265 Brno, Czech Republic.	kejnovsk@ibp.cz	Jamilena, Manuel/K-3331-2014; Hobza, Roman/G-3119-2014; Vyskot, Boris/H-1962-2014; Hobza, Roman/I-4297-2014; Jamilena, Manuel/ABE-9137-2020; Kejnovsky, Eduard/D-8878-2012; Kubát, Zdeněk/D-9221-2012; Kejnovska, Iva/G-9767-2014; Manzano, Susana/M-1372-2015; Cechova, Monika/AAJ-4459-2020	Jamilena, Manuel/0000-0001-7072-0458; Jamilena, Manuel/0000-0001-7072-0458; Kubát, Zdeněk/0000-0001-8278-9495; Cechova, Monika/0000-0002-7420-2663; Hobza, Roman/0000-0003-3062-2962	Grant Agency of the Czech Republic [P305/10/0930, P501/10/0102, P501/12/2220, P501/12/G090]; Academy of Sciences of the Czech Republic [AV0Z50040702]; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; project OPVK [CZ.1.07/2.3.00/20.0045]; Centre of the Region Hana for Biotechnological and Agricultural Research [ED0007/01/01]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Regional Development Fund(European Commission); project OPVK; Centre of the Region Hana for Biotechnological and Agricultural Research	This work was supported by the Grant Agency of the Czech Republic (grants P305/10/0930 to E.K., P501/10/0102 to B.V., P501/12/2220 to R.H., P501/12/G090 to B.V.), grant No AV0Z50040702 from the Academy of Sciences of the Czech Republic, by the project "CEITEC - Central European Institute of Technology'' (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund, by the project OPVK (CZ.1.07/2.3.00/20.0045) and grant No. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Baller JA, 2011, P NATL ACAD SCI USA, V108, P20351, DOI 10.1073/pnas.1103665108; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Graves JAM, 2002, TRENDS GENET, V18, P259, DOI 10.1016/S0168-9525(02)02666-5; GRAY DM, 1995, METHOD ENZYMOL, V246, P19; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Hrabcova I, 2003, BIOCHEM BIOPH RES CO, V300, P824, DOI 10.1016/S0006-291X(02)02940-6; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kelkar YD, 2011, GENOME RES, V21, P2038, DOI 10.1101/gr.122937.111; Koren Z, 2011, J MOL EVOL, V72, P232, DOI 10.1007/s00239-010-9425-0; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Matula M, 1999, J BIOMOL STRUCT DYN, V17, P275, DOI 10.1080/07391102.1999.10508360; Mayer C, 2006, PHOBOS 3 3 11; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Navajas-Perez R, 2005, MOL BIOL EVOL, V22, P1929, DOI 10.1093/molbev/msi186; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Renciuk D, 2011, BIOPOLYMERS, V95, P174, DOI 10.1002/bip.21555; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Smit A, 1996, REPEATMASKER OPEN 30; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; ULANOVSKY L, 1986, P NATL ACAD SCI USA, V83, P862, DOI 10.1073/pnas.83.4.862; Varela MA, 2008, J MOL EVOL, V66, P575, DOI 10.1007/s00239-008-9107-3; VORLICKOVA M, 1982, NUCLEIC ACIDS RES, V10, P1071, DOI 10.1093/nar/10.3.1071; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; WAHLS WP, 1990, MOL CELL BIOL, V10, P785, DOI 10.1128/MCB.10.2.785; WAHLS WP, 1990, MOL CELL BIOL, V10, P794, DOI 10.1128/MCB.10.2.794; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	50	49	50	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e45519	10.1371/journal.pone.0045519	http://dx.doi.org/10.1371/journal.pone.0045519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341866	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700001
J	Yudowski, GA; Olsen, O; Adesnik, H; Marek, KW; Bredt, DS				Yudowski, Guillermo A.; Olsen, Olav; Adesnik, Hillel; Marek, Kurt W.; Bredt, David S.			Acute Inactivation of PSD-95 Destabilizes AMPA Receptors at Hippocampal Synapses	PLOS ONE			English	Article							STARGAZIN; TRAFFICKING; DOMAIN	Postsynatptic density protein (PSD-95) is a 95 kDa scaffolding protein that assembles signaling complexes at synapses. Over-expression of PSD-95 in primary hippocampal neurons selectively increases synaptic localization of AMPA receptors; however, mice lacking PSD-95 display grossly normal glutamatergic transmission in hippocampus. To further study the scaffolding role of PSD-95 at excitatory synapses, we generated a recombinant PSD-95-4c containing a tetracysteine motif, which specifically binds a fluorescein derivative and allows for acute and permanent inactivation of PSD-95. Interestingly, acute inactivation of PSD-95 in rat hippocampal cultures rapidly reduced surface AMPA receptor immunostaining, but did not affected NMDA or transferrin receptor localization. Acute photoinactivation of PSD-95 in dissociated neurons causes similar to 80% decrease in GluR2 surface staining observed by live-cell microscopy within 15 minutes of PSD-95-4c ablation. These results confirm that PSD-95 stabilizes AMPA receptors at postsynaptic sites and provides insight into the dynamic interplay between PSD-95 and AMPA receptors in live neurons.	[Yudowski, Guillermo A.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Yudowski, Guillermo A.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00936 USA; [Olsen, Olav] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10021 USA; [Adesnik, Hillel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Marek, Kurt W.] NHLBI, NIH, Bethesda, MD 20892 USA; [Bredt, David S.] Johnson & Johnson, Neurosci, San Diego, CA USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; Rockefeller University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johnson & Johnson; Johnson & Johnson USA	Yudowski, GA (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.	Guillermo.yudowski@upr.edu		Yudowski, Guillermo/0000-0001-5989-4131	National Institute of Health (NIH) from National Institute on Drug Abuse (NIDA) [K99/R00, DA023444]; American Recovery & Reinvestment Act (ARRA) [1P30NS069258]; Puerto Rico Science, Technology and Research Trust Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023444, K99DA023444] Funding Source: NIH RePORTER	National Institute of Health (NIH) from National Institute on Drug Abuse (NIDA); American Recovery & Reinvestment Act (ARRA); Puerto Rico Science, Technology and Research Trust Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants from the National Institute of Health (NIH) K99/R00 from National Institute on Drug Abuse (NIDA) DA023444, American Recovery & Reinvestment Act (ARRA) 1P30NS069258 and the Puerto Rico Science, Technology and Research Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Habets RLP, 2011, COLD SPRING HARBOR P; Habets RLP, 2011, COLD SPRING HARBOR P; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Olsen O, 2003, J BIOL CHEM, V278, P6873, DOI 10.1074/jbc.M210165200; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Stein V, 2003, J NEUROSCI, V23, P5503; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624	25	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53965	10.1371/journal.pone.0053965	http://dx.doi.org/10.1371/journal.pone.0053965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342049	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700068
J	Luo, XL; Wu, JH; Li, YB; Nan, ZR; Guo, X; Wang, YX; Zhang, AH; Wang, ZA; Xia, GX; Tian, YC				Luo, Xiaoli; Wu, Jiahe; Li, Yuanbao; Nan, Zhirun; Guo, Xing; Wang, Yixue; Zhang, Anhong; Wang, Zhian; Xia, Guixian; Tian, Yingchuan			Synergistic Effects of GhSOD1 and GhCAT1 Overexpression in Cotton Chloroplasts on Enhancing Tolerance to Methyl Viologen and Salt Stresses	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ASCORBATE PEROXIDASE; HYDROGEN-PEROXIDE; TOBACCO PLANTS; BACTERIAL CATALASE; NICOTIANA-TABACUM; TRANSGENIC PLANTS; OVER-EXPRESSION; ANTIPORTER GENE	In plants, CuZn superoxide dismutase (CuZnSOD, EC l. 15.1.1), ascorbate peroxidase (APX, EC 1.11.1.11), and catalase (CAT, EC l. 11.1.6) are important scavengers of reactive oxygen species (ROS) to protect the cell from damage. In the present study, we isolated three homologous genes (GhSOD1, GhAPX1, and GhCAT1) from Gossypium hirsutum. Overexpressing cassettes containing chimeric GhSOD1, GhAPX1, or GhCAT1 were introduced into cotton plants by Agrobacterium transformation, and overexpressed products of these genes were transported into the chloroplasts by transit peptide, as expected. The five types of transgenic cotton plants that overexpressed GhSOD1, GhAPX1, GhCAT1, GhSOD1 and GhAPX1 stack ( SAT), and GhSOD1 and GhCAT1 stack (SCT) were developed. Analyses in the greenhouse showed that the transgenic plants had higher tolerance to methyl viologen (MV) and salinity than WT plants. Interestingly, SCT plants suffered no damage under stress conditions. Based on analyses of enzyme activities, electrolyte leakage, chlorophyll content, photochemical yield (Fv/Fm), and biomass accumulation under stresses, the SCT plants that simultaneously overexpressed GhSOD1 and GhCAT1 appeared to benefit from synergistic effects of two genes and exhibited the highest tolerance to MV and salt stress among the transgenic lines, while the SAT plants simultaneously overexpressing GhSOD1 and GhAPX1 did not. In addition, transgenic plants overexpressing antioxidant enzymes in their chloroplasts had higher tolerance to salt stress than those expressing the genes in their cytoplasms, although overall enzyme activities were almost the same. Therefore, the synergistic effects of GhSOD1 and GhCAT1 in chloroplasts provide a new strategy for enhancing stress tolerance to avoid yield loss.	[Luo, Xiaoli; Wu, Jiahe; Li, Yuanbao; Nan, Zhirun; Guo, Xing; Wang, Yixue; Xia, Guixian; Tian, Yingchuan] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China; [Luo, Xiaoli; Zhang, Anhong; Wang, Zhian] Shanxi Acad Agr Sci, Inst Cotton Res, Yuncheng, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University	Wu, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China.	wujiahe@im.ac.cn			Special Fund of Agro-Scientific Research in Public Interest [201103026-2]; Sustentation Fund of Chinese Academy of Sciences [Y02B011HH1]	Special Fund of Agro-Scientific Research in Public Interest; Sustentation Fund of Chinese Academy of Sciences	The current research project was supported by Special Fund of Agro-Scientific Research in Public Interest (201103026-2) and by Sustentation Fund of Chinese Academy of Sciences (Y02B011HH1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Allen RD, 1997, FREE RADICAL BIO MED, V23, P473, DOI 10.1016/S0891-5849(97)00107-X; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; [Anonymous], 2000, SAS SYST WIND SOFTW; Aono M, 1995, PLANT CELL PHYSIOL, V36, P1687; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Asencio C, 2003, FASEB J, V17, P1135, DOI 10.1096/fj.02-1022fje; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chabregas SM, 2001, PLANT MOL BIOL, V46, P639, DOI 10.1023/A:1011628510711; Chen HJ, 2012, J PLANT PHYSIOL, V169, P86, DOI 10.1016/j.jplph.2011.08.002; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Iannone MF, 2012, BIOL TRACE ELEM RES, V146, P246, DOI 10.1007/s12011-011-9244-1; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Grover A, 2003, CURR SCI INDIA, V84, P355; GUPTA AS, 1993, P NATL ACAD SCI USA, V90, P1629, DOI 10.1073/pnas.90.4.1629; He CX, 2005, PLANT CELL PHYSIOL, V46, P1848, DOI 10.1093/pcp/pci201; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P1285; Khanna-Chopra R, 2011, BIOCHEM BIOPH RES CO, V412, P522, DOI 10.1016/j.bbrc.2011.06.179; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kitajima S, 2010, BIOSCI BIOTECH BIOCH, V74, P1501, DOI 10.1271/bbb.100218; Kwon SY, 2002, PLANT CELL ENVIRON, V25, P873, DOI 10.1046/j.1365-3040.2002.00870.x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LI TY, 1994, SCI CHINA SER B, V37, P1479; Lin KH, 2010, PLANT CELL REP, V29, P575, DOI 10.1007/s00299-010-0846-4; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohamed EA, 2003, PLANT CELL ENVIRON, V26, P2037, DOI 10.1046/j.0016-8025.2003.01121.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; OGREN WL, 1984, ANNU REV PLANT PHYS, V35, P415, DOI 10.1146/annurev.pp.35.060184.002215; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Payton P, 1997, PHOTOSYNTH RES, V52, P233, DOI 10.1023/A:1005873105596; Payton P, 2001, J EXP BOT, V52, P2345, DOI 10.1093/jexbot/52.365.2345; Pena LB, 2011, J TRACE ELEM MED BIO, V25, P125, DOI 10.1016/j.jtemb.2011.05.001; PITCHER LH, 1991, PLANT PHYSIOL, V97, P452, DOI 10.1104/pp.97.1.452; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Rhoades J. D., 1990, Agronomy, P1089; Sambrook J., 2001, MOL CLONING LAB MANU; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Shikanai T, 1998, FEBS LETT, V428, P47, DOI 10.1016/S0014-5793(98)00483-9; Singh BK, 2010, J GENET, V89, P217, DOI 10.1007/s12041-010-0028-8; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Tang DQ, 2005, J BIOSCIENCE, V30, P101; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; TEPPERMAN JM, 1990, PLANT MOL BIOL, V14, P501, DOI 10.1007/BF00027496; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; VANCAMP W, 1994, BIO-TECHNOL, V12, P165, DOI 10.1038/nbt0294-165; VanCamp W, 1996, PLANT PHYSIOL, V112, P1703, DOI 10.1104/pp.112.4.1703; Wang L, 2003, WATER SALT EVOLUTION, P147; Wang NY, 2007, MOL GENET GENOMICS, V277, P13, DOI 10.1007/s00438-006-0170-4; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wu J, 2005, PLANT BREEDING, V124, P142, DOI 10.1111/j.1439-0523.2004.01056.x; Wu JH, 2011, TRANSGENIC RES, V20, P963, DOI 10.1007/s11248-011-9483-0; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhou SF, 2008, BIOTECHNOL LETT, V30, P369, DOI 10.1007/s10529-007-9548-6	71	39	45	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54002	10.1371/journal.pone.0054002	http://dx.doi.org/10.1371/journal.pone.0054002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335985	Green Submitted, gold, Green Published			2022-12-27	WOS:000314707700043
J	Sullivan, AK; Raben, D; Reekie, J; Rayment, M; Mocroft, A; Esser, S; Leon, A; Begovac, J; Brinkman, K; Zangerle, R; Grzeszczuk, A; Vassilenko, A; Hadziosmanovic, V; Krasnov, M; Sonnerborg, A; Clumeck, N; Gatell, J; Gazzard, B; Monforte, AD; Rockstroh, J; Lundgren, JD				Sullivan, Ann K.; Raben, Dorthe; Reekie, Joanne; Rayment, Michael; Mocroft, Amanda; Esser, Stefan; Leon, Agathe; Begovac, Josip; Brinkman, Kees; Zangerle, Robert; Grzeszczuk, Anna; Vassilenko, Anna; Hadziosmanovic, Vesna; Krasnov, Maksym; Sonnerborg, Anders; Clumeck, Nathan; Gatell, Jose; Gazzard, Brian; Monforte, Antonella d'Arminio; Rockstroh, Juergen; Lundgren, Jens D.			Feasibility and Effectiveness of Indicator ConditionGuided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; UNITED-STATES; INFECTION; CONSEQUENCES; TRANSMISSION; DIAGNOSIS; TIME; CARE; MEN	Improved methods for targeting HIV testing among patients most likely to be infected are required; HIDES I aimed to define the methodology of a European wide study of HIV prevalence in individuals presenting with one of eight indicator conditions/diseases (ID); sexually transmitted infection, lymphoma, cervical or anal cancer/dysplasia, herpes zoster, hepatitis B/C, mononucleosis-like illness, unexplained leukocytopenia/thrombocytopenia and seborrheic dermatitis/exanthema, and to identify those with an HIV prevalence of > 0.1%, a level determined to be cost effective. A staff questionnaire was performed. From October 2009-February 2011, individuals, not known to be HIV positive, presenting with one of the ID were offered an HIV test; additional information was collected on previous HIV testing behaviour and recent medical history. A total of 3588 individuals from 16 centres were included. Sixty-six tested positive for HIV, giving an HIV prevalence of 1.8% [95% CI: 1.42-2.34]; all eight ID exceeded 0.1% prevalence. Of those testing HIV positive, 83% were male, 58% identified as MSM and 9% were injecting drug users. Twenty percent reported previously having potentially HIV-related symptoms and 52% had previously tested HIV negative (median time since last test: 1.58 years); which together with the median CD4 count at diagnosis (400 cell/uL) adds weight to this strategy being effective in diagnosing HIV at an earlier stage. A positive test was more likely for non-white individuals, MSM, injecting drug users and those testing in non-Northern regions. HIDES I describes an effective strategy to detect undiagnosed HIV infection. All eight ID fulfilled the > 0.1% criterion for cost effectiveness. All individuals presenting to any health care setting with one of these ID should be strongly recommended an HIV test. A strategy is being developed in collaboration with ECDC and WHO Europe to guide the implementation of this novel public health initiative across Europe.	[Sullivan, Ann K.; Rayment, Michael; Gazzard, Brian] Chelsea & Westminster NHS Fdn Trust, Directorate Sexual Hlth & HIV Med, London, England; [Raben, Dorthe; Lundgren, Jens D.] Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark; [Reekie, Joanne; Mocroft, Amanda] UCL, Dept Infect Populat Hlth, London, England; [Esser, Stefan] Univ Hosp Essen, Clin Dermatol & Venerol, Essen, Germany; [Leon, Agathe; Gatell, Jose] Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain; [Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Grzeszczuk, Anna] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Vassilenko, Anna] Belorussian State Med Univ, Dept Infect Dis, Minsk, BELARUS; [Hadziosmanovic, Vesna] Univ Sarajevo, Infect Dis Clin, Ctr Clin, Sarajevo 71000, Bosnia & Herceg; [Krasnov, Maksym] Kharkov Reg Clin Infect Dis, Kharkov, Ukraine; [Sonnerborg, Anders] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Clumeck, Nathan] St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium; [Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Infect Dis Unit, Milan, Italy; [Rockstroh, Juergen] Univ Bonn, Dept Med 1, Bonn, Germany; [Lundgren, Jens D.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Imperial College London; University of Copenhagen; University of London; University College London; University of Duisburg Essen; University of Barcelona; Hospital Clinic de Barcelona; Onze Lieve Vrouwe Gasthuis Hospital; Medical University of Innsbruck; Medical University of Bialystok; University of Sarajevo; Karolinska Institutet; Karolinska University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; San Paolo-Polo Universitaria Hospital; University of Milan; University of Bonn; Rigshospitalet; University of Copenhagen	Raben, D (corresponding author), Univ Copenhagen, Copenhagen HIV Programme, Copenhagen, Denmark.	dra@cphiv.dk	Lundgren, Jens/AAE-6876-2019; , Felipe/F-4242-2014; Gatell, Jose M/ABC-3607-2020; Leon, Agathe/K-9851-2015; Begovac, Josip/AAI-5672-2021; Grzeszczuk, Anna/R-7844-2018; Vassilenko, Anna/AAB-4152-2021; Sönnerborg, Anders/W-2011-2019; Mitsura, Viktar/G-2457-2017	, Felipe/0000-0001-7658-5832; Leon, Agathe/0000-0002-1198-5090; Begovac, Josip/0000-0003-2641-4327; Grzeszczuk, Anna/0000-0002-6420-5545; Sönnerborg, Anders/0000-0001-8928-3374; Mitsura, Viktar/0000-0002-0449-5026; Lundgren, Jens/0000-0001-8901-7850; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Anna, Vassilenko/0000-0003-1907-2322	HIV in Europe initiative; Gilead Sciences; Merck; Tibotec; Pfizer; Schering-Plough; Abbott; BoehringerIngelheim; Bristol-Myers Squibb; GlaxoSmithKline; ViiVHealthcare	HIV in Europe initiative; Gilead Sciences(Gilead Sciences); Merck(Merck & Company); Tibotec; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); BoehringerIngelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); ViiVHealthcare	The HIDES study was funded by the HIV in Europe initiative which has received funding from Gilead Sciences, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, BoehringerIngelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiVHealthcare. The operational procedures within the initiative include the following in order to maintain the autonomy of the initiative. The Steering Committee is the governing body and sponsors do not have representation on the Steering Committee. Furthermore, data, records, reports, Intellectual Property Rights and Know How generated as result of the initiative shall be deemed vested in and the property of the Steering Committee, represented by the co-chairs affiliations (AIDS Fonds Netherlands and Copenhagen HIV Programme). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TIM TEST HIV EXP HEA; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; British HIV Association British Association of Sexual Health and HIV British Infection Society, 2008, UK NAT GUID HIV TEST; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; European Centre for Disease Prevention and Control, 2006, HIV PREV EUR ACT NEE; European Centre for Disease Prevention and Control, 2010, ECDC GUID HIV TEST I; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Health Protection Agency, 2011, HIV UK 2011 REP; Lanoy E, 2007, ANTIVIR THER, V12, P89; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Menacio I, 2012, COMP OPT IN VERSUS O; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pinkerton SD, 2008, JAIDS-J ACQ IMM DEF, V47, P354, DOI 10.1097/QAI.0b013e318160d57e; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Sabin CA, 2012, AIDS, V24, P723; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Thornton AC, 2012, SEX TRANSM INFECT, V88, P601, DOI 10.1136/sextrans-2012-050584; UNAIDS, 2011, UNAIDS GLOB REP 2010; Uy J, 2009, J ACQUIRED INFECT DI, V195, P951; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	29	119	119	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52845	10.1371/journal.pone.0052845	http://dx.doi.org/10.1371/journal.pone.0052845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341910	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700009
J	Woods, K; a'Bhaird, NN; Dooley, C; Perez-Morga, D; Nolan, DP				Woods, Katherine; a'Bhaird, Noirin Nic; Dooley, Clodagh; Perez-Morga, David; Nolan, Derek P.			Identification and Characterization of a Stage Specific Membrane Protein Involved in Flagellar Attachment in Trypanosoma brucei	PLOS ONE			English	Article							POLY-N-ACETYLLACTOSAMINE; BLOOD-STREAM FORMS; CELL-DIVISION; CYTOSKELETON; ADHESION; ZONE; CYCLE; GLYCOPROTEIN; ARCHITECTURE; CYTOKINESIS	Flagellar attachment is a visibly striking morphological feature of African trypanosomes but little is known about the requirements for attachment at a molecular level. This study characterizes a previously undescribed membrane protein, FLA3, which plays an essential role in flagellar attachment in Trypanosoma brucei. FLA3 is heavily N-glycosylated, locates to the flagellar attachment zone and appears to be a bloodstream stage specific protein. Ablation of the FLA3 mRNA rapidly led to flagellar detachment and a concomitant failure of cytokinesis in the long slender bloodstream form but had no effect on the procyclic form. Flagellar detachment was obvious shortly after induction of the dsRNA and the newly synthesized flagellum was often completely detached after it emerged from the flagellar pocket. Within 12 h most cells possessed detached flagella alongside the existing attached flagellum. These results suggest that proteins involved in attachment are not shared between the new and old attachment zones. In other respects the detached flagella appear normal, they beat rapidly although directional motion was lost, and they possess an apparently normal axoneme and paraflagellar rod structure. The flagellar attachment zone appeared to be disrupted when FLA3 was depleted. Thus, while flagellar attachment is a constitutive feature of the life cycle of trypanosomes, attachment requires stage specific elements at the protein level.	[Woods, Katherine; a'Bhaird, Noirin Nic; Nolan, Derek P.] Univ Dublin Trinity Coll, Mol Parasitol Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Dooley, Clodagh] Univ Dublin Trinity Coll, Ctr Microscopy & Anal, Dublin 2, Ireland; [Perez-Morga, David] Univ Libre Bruxelles, Mol Parasitol Lab, Gosselies, Belgium	Trinity College Dublin; Trinity College Dublin; Universite Libre de Bruxelles	Nolan, DP (corresponding author), Univ Dublin Trinity Coll, Mol Parasitol Grp, Sch Biochem & Immunol, Dublin 2, Ireland.	denolan@tcd.ie		Nolan, Derek/0000-0002-3742-4304; Perez-Morga, David/0000-0002-7168-1865; Woods, Katherine/0000-0003-3474-3104	Welcome Trust UK [WT061205MF]; Science Foundation Ireland [07/RFP/BICF358]	Welcome Trust UK(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was support by a senior fellowship award to DPN (WT061205MF) from the Welcome Trust UK (www.wellcome.ac.uk/) and a Research Frontiers Programme award (07/RFP/BICF358) from Science Foundation Ireland (www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROOKS AS, 1978, T AM MICROSC SOC, V97, P287, DOI 10.2307/3225982; BRUN R, 1979, ACTA TROP, V36, P289; Carrington M, 1998, MOL BIOCHEM PARASIT, V91, P153, DOI 10.1016/S0166-6851(97)00190-4; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Graham SA, 2011, J BIOL CHEM, V286, P24336, DOI 10.1074/jbc.M111.244772; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; RUIZMORENO L, 1995, EXP PARASITOL, V80, P605, DOI 10.1006/expr.1995.1076; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; VICKERMAN K, 1969, J CELL SCI, V5, P163; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VOORHEIS HP, 1979, BIOCHEM J, V180, P11, DOI 10.1042/bj1800011; WOODS A, 1989, J CELL SCI, V93, P501; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1995, PARASITOLOGY, V111, P77, DOI 10.1017/S0031182000064623; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52846	10.1371/journal.pone.0052846	http://dx.doi.org/10.1371/journal.pone.0052846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335957	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700010
J	Altenhoff, AM; Gil, M; Gonnet, GH; Dessimoz, C				Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe			Inferring Hierarchical Orthologous Groups from Orthologous Gene Pairs	PLOS ONE			English	Article							DATABASE; DUPLICATION; PREDICTION; ALGORITHM; ORTHOMCL; CLUSTERS	Hierarchical orthologous groups are defined as sets of genes that have descended from a single common ancestor within a taxonomic range of interest. Identifying such groups is useful in a wide range of contexts, including inference of gene function, study of gene evolution dynamics and comparative genomics. Hierarchical orthologous groups can be derived from reconciled gene/species trees but, this being a computationally costly procedure, many phylogenomic databases work on the basis of pairwise gene comparisons instead ("graph-based" approach). To our knowledge, there is only one published algorithm for graph-based hierarchical group inference, but both its theoretical justification and performance in practice are as of yet largely uncharacterised. We establish a formal correspondence between the orthology graph and hierarchical orthologous groups. Based on that, we devise GETHOGs ("Graph-based Efficient Technique for Hierarchical Orthologous Groups"), a novel algorithm to infer hierarchical groups directly from the orthology graph, thus without needing gene tree inference nor gene/species tree reconciliation. GETHOGs is shown to correctly reconstruct hierarchical orthologous groups when applied to perfect input, and several extensions with stringency parameters are provided to deal with imperfect input data. We demonstrate its competitiveness using both simulated and empirical data. GETHOGs is implemented as a part of the freely-available OMA standalone package (http://omabrowser.org/standalone). Furthermore, hierarchical groups inferred by GETHOGs ("OMA HOGs") on >1,000 genomes can be interactively queried via the OMA browser (http://omabrowser.org).	[Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe] ETH, Dept Comp Sci, Zurich, Switzerland; [Altenhoff, Adrian M.; Gil, Manuel; Gonnet, Gaston H.; Dessimoz, Christophe] Swiss Inst Bioinformat, Zurich, Switzerland; [Dessimoz, Christophe] EMBL European Bioinformat Inst, Cambridge, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; European Molecular Biology Laboratory (EMBL)	Dessimoz, C (corresponding author), ETH, Dept Comp Sci, Zurich, Switzerland.	cdessimoz@ebi.ac.uk	Dessimoz, Christophe/D-3678-2011; Altenhoff, Adrian Michael/P-5024-2019	Dessimoz, Christophe/0000-0002-2170-853X; Altenhoff, Adrian Michael/0000-0001-7492-1273	ETH Independent Investigators' Research Award; SNSF advanced researcher fellowship [136461]	ETH Independent Investigators' Research Award; SNSF advanced researcher fellowship	This work was supported by an ETH Independent Investigators' Research Award to CD and GHG, and an SNSF advanced researcher fellowship to CD (#136461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Dessimoz C, 2006, NUCLEIC ACIDS RES, V34, P3309, DOI 10.1093/nar/gkl433; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; Karger DR, 1996, J ACM, V43, P601, DOI 10.1145/234533.234534; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Miele V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-116; NEYMAN J, 1971, STAT DECISION THEORY, P1; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; TARJAN RE, 1984, J ACM, V31, P245, DOI 10.1145/62.2160; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Yang ZH, 2000, GENETICS, V155, P431	35	94	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53786	10.1371/journal.pone.0053786	http://dx.doi.org/10.1371/journal.pone.0053786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342000	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400082
J	Cai, L; Ye, L; Tong, AHY; Lok, S; Zhang, T				Cai, Lin; Ye, Lin; Tong, Amy Hin Yan; Lok, Si; Zhang, Tong			Biased Diversity Metrics Revealed by Bacterial 16S Pyrotags Derived from Different Primer Sets	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURES; RARE BIOSPHERE; GUT MICROBIOTA; GENERATION; GENES; AMPLICONS; WRINKLES; DESIGN	In recent years, PCR-based pyrosequencing of 16S rRNA genes has continuously increased our understanding of complex microbial communities in various environments of the Earth. However, there is always concern on the potential biases of diversity determination using different 16S rRNA gene primer sets and covered regions. Here, we first report how bacterial 16S rRNA gene pyrotags derived from a series of different primer sets resulted in the biased diversity metrics. In total, 14 types of pyrotags were obtained from two-end pyrosequencing of 7 amplicon pools generated by 7 primer sets paired by 1 of 4 forward primers (V1F, V3F, V5F, and V7F) and 1 of 4 reverse primers (V2R, V4R, V6R, and V9R), respectively. The results revealed that: i) the activated sludge exhibited a large bacterial diversity that represented a broad range of bacterial populations and served as a good sample in this methodology research; ii) diversity metrics highly depended on the selected primer sets and covered regions; iii) paired pyrotags obtained from two-end pyrosequencing of each short amplicon displayed different diversity metrics; iv) relative abundance analysis indicated the sequencing depth affected the determination of rare bacteria but not abundant bacteria; v) the primer set of V1F and V2R significantly underestimated the diversity of activated sludge; and vi) the primer set of V3F and V4R was highly recommended for future studies due to its advantages over other primer sets. All of these findings highlight the significance of this methodology research and offer a valuable reference for peer researchers working on microbial diversity determination.	[Cai, Lin; Ye, Lin; Zhang, Tong] Univ Hong Kong, Environm Biotechnol Lab, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China; [Tong, Amy Hin Yan; Lok, Si] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Environm Biotechnol Lab, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	Cai, Lin/AAN-8018-2020; Cai, Lin/K-2105-2013; 張彤, Tong Zhang/C-6786-2008; Ye, Lin/F-9709-2013; Zhang, Tong/HGC-1090-2022	Cai, Lin/0000-0001-5993-2011; Ye, Lin/0000-0002-4682-8917; Zhang, Tong/0000-0003-1148-4322	Hong Kong General Research Fund [7198/10E]; HKU Small Project Fund [201109176001]; HKU	Hong Kong General Research Fund; HKU Small Project Fund(University of Hong Kong); HKU(University of Hong Kong)	This study is supported by Hong Kong General Research Fund (7198/10E)and HKU Small Project Fund (201109176001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Lin Cai thanks HKU for the Postdoctoral Fellowship. We thank Ms. Kyana Young from University of Wisconsin-Madison and Mr. Derrick Anderson from HKU for language editing.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; He ZL, 2012, CURR OPIN BIOTECH, V23, P460, DOI 10.1016/j.copbio.2011.12.021; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wagner M, 1998, WATER SCI TECHNOL, V37, P441, DOI 10.1016/S0273-1223(98)00143-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	43	115	118	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53649	10.1371/journal.pone.0053649	http://dx.doi.org/10.1371/journal.pone.0053649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341963	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400057
J	Jin, HJ; Xie, XL; Ye, JM; Li, CG				Jin, Hyou-Ju; Xie, Xiao-Liang; Ye, Ji-Ming; Li, Chun-Guang			TanshinoneIIA and Cryptotanshinone Protect against Hypoxia-Induced Mitochondrial Apoptosis in H9c2 Cells	PLOS ONE			English	Article							PERMEABILITY TRANSITION; ISCHEMIA/REPERFUSION INJURY; CARDIAC MYOCYTES; INDUCED TOXICITY; IIA; MECHANISMS; PATHWAY; EXPRESSION; ISCHEMIA; INHIBITION	Mitochondrial apoptosis pathway is an important target of cardioprotective signalling. Tanshinones, a group of major bioactive compounds isolated from Salvia miltiorrhiza, have been reported with actions against inflammation, oxidative stress, and myocardial ischemia reperfusion injury. However, the actions of these compounds on the chronic hypoxia-related mitochondrial apoptosis pathway have not been investigated. In this study, we examined the effects and molecular mechanisms of two major tanshonones, tanshinone IIA (TIIA) and cryptotanshinone (CT) on hypoxia induced apoptosis in H9c2 cells. Cultured H9c2 cells were treated with TIIA and CT (0.3 and 3 mu M) 2 hr before and during an 8 hr hypoxic period. Chronic hypoxia caused a significant increase in hypoxia inducible factor 1 alpha expression and the cell late apoptosis rate, which was accompanied with an increase in caspase 3 activity, cytochrome c release, mitochondria membrane potential and expression of pro-apoptosis proteins (Bax and Bak). TIIA and CT (0.3 and 3 mu M), in concentrations without affecting the cell viability, significantly inhibited the late apoptosis and the changes of caspase 3 activity, cytochrome c release, and mitochondria membrane potential induced by chronic hypoxia. These compounds also suppressed the overexpression of Bax and reduced the ratio of Bax/Bcl-2. The results indicate that TIIA and CT protect against chronic hypoxia induced cell apoptosis by regulating the mitochondrial apoptosis signaling pathway, involving inhibitions of mitochondria hyperpolarization, cytochrome c release and caspase 3 activity, and balancing anti-and pro-apoptotic proteins in Bcl-2 family proteins.	[Jin, Hyou-Ju; Ye, Ji-Ming; Li, Chun-Guang] RMIT Univ, Sch Hlth Sci, RMIT Hlth Innovat Res Inst, Tradit & Complementary Med Program, Bundoora, Vic, Australia; [Xie, Xiao-Liang] Hebei Acad Agr & Forestry Sci, Med Herb Res Ctr, Shijiazhuang, Peoples R China; [Li, Chun-Guang] Univ Western Sydney, Natl Inst Complementary Med, Ctr Complementary Med Res, Penrith, NSW 1797, Australia	Royal Melbourne Institute of Technology (RMIT); Hebei Academy of Agricultural & Forestry Sciences; Western Sydney University	Li, CG (corresponding author), RMIT Univ, Sch Hlth Sci, RMIT Hlth Innovat Res Inst, Tradit & Complementary Med Program, Bundoora, Vic, Australia.	C.Li@uws.edu.au		Li, Chun Guang/0000-0002-7789-2209; Jin, Hyou-Ju/0000-0003-1735-7551	National Institute of Complementary Medicine; RMIT University, Australia; Hebei Academy of Agriculture and Forestry Sciences, China; RMIT University International Research Scholarship from RMIT University	National Institute of Complementary Medicine; RMIT University, Australia; Hebei Academy of Agriculture and Forestry Sciences, China; RMIT University International Research Scholarship from RMIT University	This work was supported by grants from National Institute of Complementary Medicine, RMIT University, Australia and Hebei Academy of Agriculture and Forestry Sciences, China and Hyou-Ju Jin was supported by a RMIT University International Research Scholarship from RMIT University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen YL, 2012, BIOL PHARM BULL, V35, P164, DOI 10.1248/bpb.35.164; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Ekhterae D, 1999, CIRC RES, V85, pE70; Fischer U, 2005, PHARMACOL REV, V57, P187, DOI 10.1124/pr.57.2.6; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gustafsson AB, 2007, CARDIOVASCULAR RES; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hong H-J, INT J CARDI IN PRESS; Hong HJ, 2012, INT J CARDIOL, V157, P174, DOI 10.1016/j.ijcard.2010.12.012; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Huang SG, 2002, J BIOMOL SCREEN, V7, P383, DOI 10.1177/108705710200700411; Jin YC, 2009, EUR J PHARMACOL, V614, P91, DOI 10.1016/j.ejphar.2009.04.038; Jung F, 2001, BIOCHEM BIOPH RES CO, V286, P419, DOI 10.1006/bbrc.2001.5406; Kim MJ, 2005, EUR J PHARMACOL, V525, P1, DOI 10.1016/j.ejphar.2005.09.043; Lam FFY, 2008, EUR J PHARMACOL, V578, P253, DOI 10.1016/j.ejphar.2007.09.040; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Liu T, 2010, NEUROPHARMACOLOGY, V59, P595, DOI 10.1016/j.neuropharm.2010.08.013; Mahesh R, 2012, PHYTOTHERAPY RES; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200; Meng XF, 2006, ACTA PHARMACOL SIN, V27, P659, DOI 10.1111/j.1745-7254.2006.00324.x; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Rakhit RD, 2000, AM J PHYSIOL-HEART C, V278, pH1211, DOI 10.1152/ajpheart.2000.278.4.H1211; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Ren ZH, 2010, PHYTOMEDICINE, V17, P212, DOI 10.1016/j.phymed.2009.08.010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wu B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004295.pub3; Xu M, 2011, AM J RESP CELL MOL, V45, P1028, DOI 10.1165/rcmb.2011-0113OC; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou Z, 2006, BBA-GEN SUBJECTS, V1760, P1, DOI 10.1016/j.bbagen.2005.09.009	45	58	65	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51720	10.1371/journal.pone.0051720	http://dx.doi.org/10.1371/journal.pone.0051720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341883	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400005
J	Nair, S; Aldrich, AJ; McDonnell, E; Cheng, Q; Aggarwal, A; Patel, P; Williams, MM; Boczkowski, D; Lyerly, HK; Morse, MA; Devi, GR				Nair, Smita; Aldrich, Amy J.; McDonnell, Eoin; Cheng, Qing; Aggarwal, Anshu; Patel, Pujan; Williams, Monique M.; Boczkowski, David; Lyerly, H. Kim; Morse, Michael A.; Devi, Gayathri R.			Immunologic Targeting of FOXP3 in Inflammatory Breast Cancer Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; X-LINKED INHIBITOR; TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; PERIPHERAL-BLOOD; DENDRITIC CELLS; TUMOR-IMMUNITY; LUNG-CANCER; EXPRESSION; APOPTOSIS	The forkhead transcription factor FOXP3 is necessary for induction of regulatory T lymphocytes (Tregs) and their immunosuppressive function. We have previously demonstrated that targeting Tregs by vaccination of mice with murine FOXP3 mRNA-transfected dendritic cells (DCs) elicits FOXP3-specific T cell responses and enhances tumor immunity. It is clear that FOXP3 expression is not restricted to T-cell lineage and herein, using RT-PCR, flow cytometry, and western immunoblot we demonstrate for the first time that FOXP3 is expressed in inflammatory breast cancer (IBC) cells, SUM149 (triple negative, ErbB1-activated) and SUM190 (ErbB2-overexpressing). Importantly, FOXP3-specific T cells generated in vitro using human FOXP3 RNA-transfected DCs as stimulators efficiently lyse SUM149 cells. Interestingly, an isogenic model (rSUM149) derived from SUM149 with an enhanced anti-apoptotic phenotype was resistant to FOXP3-specific T cell mediated lysis. The MHC class I cellular processing mechanism was intact in both cell lines at the protein and transcription levels suggesting that the resistance to cytolysis by rSUM149 cells was not related to MHC class I expression or to the MHC class I antigen processing machinery in these cells. Our data suggest that FOXP3 may be an effective tumor target in IBC cells however increased anti-apoptotic signaling can lead to immune evasion.	[Nair, Smita; Aldrich, Amy J.; McDonnell, Eoin; Cheng, Qing; Aggarwal, Anshu; Patel, Pujan; Williams, Monique M.; Boczkowski, David; Lyerly, H. Kim; Devi, Gayathri R.] Duke Univ Med Ctr, Dept Surg, Durham, NC USA; [Nair, Smita; Lyerly, H. Kim; Morse, Michael A.; Devi, Gayathri R.] Duke Univ Med Ctr, Duke Canc Inst, Durham, NC USA; [Morse, Michael A.] Duke Univ Med Ctr, Dept Med, Durham, NC USA	Duke University; Duke University; Duke University	Devi, GR (corresponding author), Duke Univ Med Ctr, Dept Surg, Durham, NC USA.	gayathri.devi@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020; Nair, Smita/GYR-2993-2022; Nair Jain, Smita/M-2765-2018	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Nair, Smita/0000-0001-5615-7056; Nair Jain, Smita/0000-0002-1542-9913	Department of Defense [W81XWH-07-1-0392, W81XWH-10-1-0339]; Duke SROP training program; Duke Graduate fellowship	Department of Defense(United States Department of Defense); Duke SROP training program; Duke Graduate fellowship	This work was entirely supported by Department of Defense W81XWH-07-1-0392 (GRD) and in part by Department of Defense W81XWH-10-1-0339 (SN), Duke SROP training program (MMW) and Duke Graduate fellowship (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; Aird KM, 2012, BREAST CANCER RES TR, V132, P109, DOI 10.1007/s10549-011-1568-1; Aird KM, 2010, MOL CANCER THER, V9, P1432, DOI 10.1158/1535-7163.MCT-10-0160; Allensworth JL, 2012, MOL CANC THER; Anderson William F, 2005, Breast Dis, V22, P9; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Cheng Q, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3168; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Douglass S, 2012, CANCER METAST REV, V31, P843, DOI 10.1007/s10555-012-9395-3; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Fassnacht M, 2005, CLIN CANCER RES, V11, P5566, DOI 10.1158/1078-0432.CCR-05-0699; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Jazirehi AR, 2010, ANTI-CANCER DRUG, V21, P805, DOI 10.1097/CAD.0b013e32833dad91; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Mansfield AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-231; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Morse MA, 2012, CANCER GENE THER, V19, P30, DOI 10.1038/cgt.2011.63; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Morse MA, 2011, CLIN CANCER RES, V17, P3408, DOI 10.1158/1078-0432.CCR-10-2614; Mosca PJ, 2000, BLOOD, V96, P3499; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Nair S., 2012, CURR PROTOC IMMUNOL, P32; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Nair S, 2007, CANCER RES, V67, P371, DOI 10.1158/0008-5472.CAN-06-2903; Niu JZ, 2011, CANCER IMMUNOL IMMUN, V60, P1109, DOI 10.1007/s00262-011-1025-3; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Perez SA, 2007, CLIN CANCER RES, V13, P2714, DOI 10.1158/1078-0432.CCR-06-2347; Pruitt SK, 2011, EUR J IMMUNOL, V41, P3553, DOI 10.1002/eji.201141383; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seeger JM, 2010, BRIT J CANCER, V102, P1717, DOI 10.1038/sj.bjc.6605704; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Woo EY, 2001, CANCER RES, V61, P4766; Zhang M, 2009, CLIN EXP PHARMACOL P, V36, P304, DOI 10.1111/j.1440-1681.2008.05066.x; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	58	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53150	10.1371/journal.pone.0053150	http://dx.doi.org/10.1371/journal.pone.0053150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341929	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400034
J	Pio, R; Jia, ZY; Baron, VT; Mercola, D				Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T.; Mercola, Dan		UCI NCI SPECS Consortium Strategic	Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR3; LARGE GENE LISTS; UP-REGULATION; CYTOPLASMIC SEQUESTRATION; IONIZING-RADIATION; BREAST-CANCER; CELL-GROWTH; KAPPA-B; NGFI-A; P53	Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS (Strategic Partners for the Evaluation of Predictive Signatures of Prostate Cancer) Affymetrix whole genome gene expression database we report that Egr3 mRNA is significantly over-expressed in prostate cancer compared to normal prostate tissue (5-fold). The Human Protein Atlas (http://www.proteinatlas.org), a database of tissue microarrays labeled with antibodies against over 11,000 human proteins, was utilized to quantify Egr3 protein expression in normal prostate and prostate cancer patients. In agreement with the SPECS data, we found that Egr3 protein is significantly increased in prostate cancer. The SPECS database has the benefit of extensive clinical follow up for the prostate cancer patients. Analysis of Egr3 mRNA expression in relation to the relapse status reveals that Egr3 mRNA expression is increased in tumor cells of non-relapsed samples (n = 63) compared to normal prostate cells, but is significantly lower in relapsed samples (n = 38) compared to non-relapse. The observations were confirmed using an independent data set. A list of genes correlating with this unique expression pattern was determined. These Egr3-correlated genes were enriched with Egr binding sites in their promoters. The gene list contains inflammatory genes such as IL-6, IL-8, IL1 beta and COX-2, which have extensive connections to prostate cancer.	[Pio, Rebecca; Jia, Zhenyu; Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Baron, Veronique T.] San Diego Sci Ctr, Vaccine Res Inst San Diego, San Diego, CA USA	University of California System; University of California Irvine	Mercola, D (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA.	dmercola@uci.edu	mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840; McClelland, Michael/0000-0003-1788-9347	USPHS [U01 CA1148102, U01 CA152738]; University of California of Irvine Faculty Career Development Award; NATIONAL CANCER INSTITUTE [R01CA076173, U01CA152738] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); University of California of Irvine Faculty Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the USPHS grants U01 CA1148102 (NIH/NCI SPECS consortium) and U01 CA152738 (NIH/NCI EDRN), and by the University of California of Irvine Faculty Career Development Award (to Dr. Z. Jia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056; Beckmann AM, 1997, J NEUROCHEM, V69, P2227; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Cullen EM, 2010, MOL IMMUNOL, V47, P1701, DOI 10.1016/j.molimm.2010.03.003; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Eid MA, 1998, CANCER RES, V58, P2461; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hoffmann E, 2008, J BIOL CHEM, V283, P12120, DOI 10.1074/jbc.M800583200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG RP, 1995, CANCER RES, V55, P5054; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEVIN WJ, 1994, CHEST, V106, pS372, DOI 10.1378/chest.106.6.372S; Li S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-73; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; LIU JW, 1991, J BIOL CHEM, V266, P5929; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Plymate SR, 1996, J CLIN ENDOCR METAB, V81, P3709, DOI 10.1210/jc.81.10.3709; Ramana CV, 2009, MOL IMMUNOL, V47, P623, DOI 10.1016/j.molimm.2009.09.001; Recio JA, 2003, CANCER RES, V63, P1576; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Suzuki T, 2007, ENDOCR-RELAT CANCER, V14, P279, DOI 10.1677/ERC-06-0005; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	55	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54096	10.1371/journal.pone.0054096	http://dx.doi.org/10.1371/journal.pone.0054096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342084	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400121
J	Rondelli, T; Berardi, M; Peruzzi, B; Boni, L; Caporale, R; Dolara, P; Notaro, R; Luzzatto, L				Rondelli, Tommaso; Berardi, Margherita; Peruzzi, Benedetta; Boni, Luca; Caporale, Roberto; Dolara, Piero; Notaro, Rosario; Luzzatto, Lucio			The Frequency of Granulocytes with Spontaneous Somatic Mutations: A Wide Distribution in a Normal Human Population	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RED-BLOOD-CELLS; PIG-A; MAMMALIAN-CELLS; CANCER; ASSAY; INDIVIDUALS; PHENOTYPE; PATHWAYS; DISEASE	Germ-line mutation rate has been regarded classically as a fundamental biological parameter, as it affects the prevalence of genetic disorders and the rate of evolution. Somatic mutation rate is also an important biological parameter, as it may influence the development and/or the course of acquired diseases, particularly of cancer. Estimates of this parameter have been previously obtained in few instances from dermal fibroblasts and lymphoblastoid cells. However, the methodology required has been laborious and did not lend itself to the analysis of large numbers of samples. We have previously shown that the X-linked gene PIG-A, since its product is required for glycosyl-phosphatidylinositol-anchored proteins to become surface bound, is a good sentinel gene for studying somatic mutations. We now show that by this approach we can accurately measure the proportion of PIG-A mutant peripheral blood granulocytes, which we call mutant frequency, e. We found that the results are reproducible, with a variation coefficient (CV) of 45%. Repeat samples from 32 subjects also had a CV of 44%, indicating that e is a relatively stable individual characteristic. From a study of 142 normal subjects we found that log e is a normally distributed variable; e variability spans a 80-fold range, from less than 1 x 10(-6) to 37.5 x 10(-6), with a median of 4.9 x 10(-6). Unlike other techniques commonly employed in population studies, such as comet assay, this method can detect any kind of mutation, including point mutation, as long as it causes functional inactivation of PIG-A gene. Since the test is rapid and requires only a small sample of peripheral blood, this methodology will lend itself to investigating genetic factors that underlie the variation in the somatic mutation rate, as well as environmental factors that may affect it. It will be also possible to test whether e is a determinant of the risk of cancer.	[Rondelli, Tommaso; Berardi, Margherita; Peruzzi, Benedetta; Notaro, Rosario] ITT, CRL, Lab Canc Genet & Gene Transfer, Florence, Italy; [Boni, Luca] ITT, CRL, Clin Trials Coordinating Ctr, Florence, Italy; [Caporale, Roberto] Careggi Hosp, Flow Cytometry Unit, Florence, Italy; [Dolara, Piero] Univ Florence, Dept Pharmacol, Florence, Italy; [Luzzatto, Lucio] Ist Toscano Tumori, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Notaro, R (corresponding author), ITT, CRL, Lab Canc Genet & Gene Transfer, Florence, Italy.	rosario.notaro@ittumori.it	Notaro, Rosario/J-7293-2016; Peruzzi, Benedetta/AAC-5178-2022; Boni, Luca/ABI-6243-2020	Notaro, Rosario/0000-0002-9087-9404; Boni, Luca/0000-0003-2217-4047	"Regione Toscana", Bando Salute; Associazione Italiana per la Ricerca sul Cancro - AIRC	"Regione Toscana", Bando Salute(Regione Toscana); Associazione Italiana per la Ricerca sul Cancro - AIRC(Fondazione AIRC per la ricerca sul cancro)	The work reported in this manuscript has been funded in part by: 1) "Regione Toscana", Bando Salute 2009 (RN): http://www.regione.toscana.it; 2) ''Associazione Italiana per la Ricerca sul Cancro - AIRC" (LL): http://www.airc.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; BESSLER M, 1994, HUM MOL GENET, V3, P751, DOI 10.1093/hmg/3.5.751; Bigbee WL, 1998, MUTAT RES-FUND MOL M, V397, P119, DOI 10.1016/S0027-5107(97)00186-3; Bonassi S, 2009, MUTAGENESIS, V24, P295, DOI 10.1093/mutage/gep019; Bryce SM, 2008, ENVIRON MOL MUTAGEN, V49, P256, DOI 10.1002/em.20379; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Dacie JV., 1999, HAEMOLYTIC ANAEMIAS, P139; Dobrovolsky VN, 2011, ENVIRON MOL MUTAGEN, V52, P784, DOI 10.1002/em.20667; Dobrovolsky VN, 2009, MUTAT RES-GEN TOX EN, V673, P21, DOI 10.1016/j.mrgentox.2008.11.006; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Evans HJ, 1996, MUTAT RES-FUND MOL M, V351, P89, DOI 10.1016/0027-5107(95)00201-4; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; HALD A, 1952, STATISTICAL THEORY E, P144; HILLMEN P, 1993, SOMAT CELL MOLEC GEN, V19, P123, DOI 10.1007/BF01233528; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Janeway CA, 2005, IMMUNOBIOLOGY; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Luzzatto L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S12; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; NAFA K, 1995, BLOOD, V86, P4650, DOI 10.1182/blood.V86.12.4650.bloodjournal86124650; Notaro R, 2003, BLOOD PRINCIPLES PRA, P319; Peruzzi B, 2010, MUTAT RES-REV MUTAT, V705, P3, DOI 10.1016/j.mrrev.2009.12.004; Pitozzi V, 2006, FREE RADICAL RES, V40, P1149, DOI 10.1080/10715760600863116; ROSSE WF, 1991, BRIT J HAEMATOL, V79, P99, DOI 10.1111/j.1365-2141.1991.tb08014.x; ROSSMAN TG, 1995, MUTAT RES-FUND MOL M, V328, P21, DOI 10.1016/0027-5107(94)00190-G; Strachan T, 1999, HUMAN MOL GENETICS; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943	31	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54046	10.1371/journal.pone.0054046	http://dx.doi.org/10.1371/journal.pone.0054046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342069	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400114
J	Rosvall, KA				Rosvall, Kimberly A.			Life History Trade-Offs and Behavioral Sensitivity to Testosterone: An Experimental Test When Female Aggression and Maternal Care Co-Occur	PLOS ONE			English	Article							EXPERIMENTALLY-ELEVATED TESTOSTERONE; SEX-ROLE REVERSAL; TREE SWALLOWS; EXOGENOUS TESTOSTERONE; PARENTAL BEHAVIOR; REPRODUCTIVE-PERFORMANCE; TERRITORIAL AGGRESSION; MONOGAMOUS SONGBIRD; PLASMA TESTOSTERONE; SOCIAL MODULATION	Research on male animals suggests that the hormone testosterone plays a central role in mediating the trade-off between mating effort and parental effort. However, the direct links between testosterone, intrasexual aggression and parental care are remarkably mixed across species. Previous attempts to reconcile these patterns suggest that selection favors behavioral insensitivity to testosterone when paternal care is essential to reproductive success and when breeding seasons are especially short. Females also secrete testosterone, though the degree to which similar testosterone-mediated trade-offs occur in females is much less clear. Here, I ask whether testosterone mediates trade-offs between aggression and incubation in females, and whether patterns of female sensitivity to testosterone relate to female life history, as is often the case in males. I experimentally elevated testosterone in free-living, incubating female tree swallows (Tachycineta bicolor), a songbird with a short breeding season during which female incubation and intrasexual aggression are both essential to female reproductive success. Testosterone-treated females showed significantly elevated aggression, reduced incubation temperatures, and reduced hatching success, relative to controls. Thus, prolonged testosterone elevation during incubation was detrimental to reproductive success, but females nonetheless showed behavioral sensitivity to testosterone. These findings suggest that the relative importance of both mating effort and parental effort may be central to understanding patterns of behavioral sensitivity in both sexes.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Rosvall, KA (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	krosvall@indiana.edu	Rosvall, Kimberly/GQB-1395-2022		National Science Foundation [IBN-0710118]; United States National Institutes of Health NRSA [T32HD049336, F32HD068222]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD068222] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	KAR supported by an National Science Foundation doctoral dissertation improvement grant at the time of field components of this study (IBN-0710118) and a United States National Institutes of Health NRSA postdoctoral fellowship during analysis/preparation of the manuscript (T32HD049336 and F32HD068222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; [Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; Ardia DR, 2007, BEHAV ECOL, V18, P259, DOI 10.1093/beheco/arl078; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; Beletsky LD, 1995, CURRENT ORNITHOLOGY; Bishop CA, 1998, J TOXICOL ENV HEAL A, V55, P561, DOI 10.1080/009841098158250; Buntin John D., 1996, Advances in the Study of Behavior, V25, P161; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Clark MM, 1999, J COMP PSYCHOL, V113, P388, DOI 10.1037/0735-7036.113.4.388; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; DESTEVEN D, 1978, IBIS, V120, P516; DUNN PO, 1994, BEHAV ECOL SOCIOBIOL, V35, P273, DOI 10.1007/s002650050098; Eens M, 2000, BEHAV PROCESS, V51, P135, DOI 10.1016/S0376-6357(00)00124-8; Elekonich MM, 2000, ETHOLOGY, V106, P493, DOI 10.1046/j.1439-0310.2000.00555.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fusani L, 2008, GEN COMP ENDOCR, V157, P249, DOI 10.1016/j.ygcen.2008.04.016; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gebhardt-Henrich Sabine, 1998, Oxford Ornithology Series, V8, P324; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Goymann W, 2008, P ROY SOC B-BIOL SCI, V275, P1053, DOI 10.1098/rspb.2007.1707; Goymann W, 2009, GEN COMP ENDOCR, V163, P149, DOI 10.1016/j.ygcen.2008.11.027; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; HUNT K, 1995, AM ZOOL, V35, P274; Hunt KE, 1999, BEHAV ECOL SOCIOBIOL, V45, P360, DOI 10.1007/s002650050572; Hunt KE, 1997, ANIM BEHAV, V54, P1177, DOI 10.1006/anbe.1997.0558; HUSSELL DJT, 1983, J FIELD ORNITHOL, V54, P312; Jawor JM, 2006, HORM BEHAV, V49, P362, DOI 10.1016/j.yhbeh.2005.08.009; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Ketterson ED, 2009, INTEGR COMP BIOL, V49, P365, DOI 10.1093/icb/icp057; Knapp R, 1999, HORM BEHAV, V35, P81, DOI 10.1006/hbeh.1998.1499; KRINER E, 1991, ETHOLOGY, V87, P37; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Langmore NE, 1997, ANIM BEHAV, V53, P881, DOI 10.1006/anbe.1996.0306; LEFFELAAR D, 1985, WILSON BULL, V97, P221; Lombardo MP, 1995, AUK, V112, P973, DOI 10.2307/4089028; Lynn SE, 2005, HORM BEHAV, V47, P170, DOI 10.1016/j.yhbeh.2004.10.004; Lynn SE, 2002, ANIM BEHAV, V63, P795, DOI 10.1006/anbe.2001.1980; Lynn SE, 2008, GEN COMP ENDOCR, V157, P233, DOI 10.1016/j.ygcen.2008.05.009; Lynn SE, 2008, GEN COMP ENDOCR, V156, P181, DOI 10.1016/j.ygcen.2008.01.004; Lynn SE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P699, DOI 10.1086/605915; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; Mank JE, 2007, AM NAT, V169, P142, DOI 10.1086/510103; McCarty JP, 2001, AUK, V118, P176, DOI 10.1642/0004-8038(2001)118[0176:VIGONT]2.0.CO;2; McDonald PG, 2001, HORM BEHAV, V39, P185, DOI 10.1006/hbeh.2001.1644; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; O'Neal DM, 2008, HORM BEHAV, V54, P571, DOI 10.1016/j.yhbeh.2008.05.017; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Robertson R.J., 1992, Birds of North America, V11, P1; Roff DA, 2002, EVOLUTION, V56, P84, DOI 10.1111/j.0014-3820.2002.tb00851.x; Rosvall KA, 2012, P ROY SOC B-BIOL SCI, V279, P3547, DOI 10.1098/rspb.2012.0442; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; Rosvall KA, 2010, BEHAV ECOL, V21, P161, DOI 10.1093/beheco/arp167; Sandell MI, 2007, BEHAV ECOL SOCIOBIOL, V62, P255, DOI 10.1007/s00265-007-0460-9; Sandell MI, 1998, P ROY SOC B-BIOL SCI, V265, P1307, DOI 10.1098/rspb.1998.0434; Schoech SJ, 1998, HORM BEHAV, V34, P1, DOI 10.1006/hbeh.1998.1455; Schwagmeyer PL, 2005, ANIM BEHAV, V69, P481, DOI 10.1016/j.anbehav.2004.04.017; SHUSTER SM, 2003, MG BEH ECOL, pR7; SILVERIN B, 1980, ANIM BEHAV, V28, P906, DOI 10.1016/S0003-3472(80)80152-7; Soma KK, 2008, FRONT NEUROENDOCRIN, V29, P476, DOI 10.1016/j.yfrne.2007.12.003; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Stearns S.C., 1992, pi; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; STUTCHBURY BJ, 1987, AUK, V104, P717, DOI 10.1093/auk/104.4.717; STUTCHBURY BJ, 1987, BEHAV ECOL SOCIOBIOL, V20, P413, DOI 10.1007/BF00302984; STUTCHBURY BJ, 1988, CAN J ZOOL, V66, P827, DOI 10.1139/z88-122; STUTCHBURY BJ, 1985, AUK, V102, P651, DOI 10.1093/auk/102.3.651; Swett MB, 2008, COMP BIOCHEM PHYS A, V151, P226, DOI 10.1016/j.cbpa.2008.06.031; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Van Roo BL, 2004, HORM BEHAV, V46, P678, DOI 10.1016/j.yhbeh.2004.06.011; Veiga JP, 2008, AM NAT, V172, P42, DOI 10.1086/587850; Voigt C, 2007, DEV NEUROBIOL, V67, P1560, DOI 10.1002/dneu.20528; Wang JM, 2011, AUK, V128, P454, DOI 10.1525/auk.2011.10208; Wang JM, 2009, ANIM BEHAV, V78, P601, DOI 10.1016/j.anbehav.2009.05.022; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P417, DOI 10.1016/0016-6480(84)90084-4; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2002, COMP BIOCHEM PHYS B, V132, P275, DOI 10.1016/S1096-4959(01)00540-1; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	99	53	55	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54120	10.1371/journal.pone.0054120	http://dx.doi.org/10.1371/journal.pone.0054120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342089	gold, Green Published			2022-12-27	WOS:000314759400124
J	Shehadah, A; Chen, JL; Kramer, B; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Chopp, M				Shehadah, Amjad; Chen, Jieli; Kramer, Brian; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Chopp, Michael			Efficacy of Single and Multiple Injections of Human Umbilical Tissue-Derived Cells following Experimental Stroke in Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; STEM-CELLS; SYNAPTIC PLASTICITY; GENE-EXPRESSION; RECOVERY; SYNAPTOGENESIS; SYNAPTOPHYSIN	Introduction: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatment of stroke. In this study, we tested the efficacy of hUTC in experimental stroke and whether multiple injections of hUTC provide additional therapeutic benefits as compared to a single injection. Methods: Adult male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo), and randomly selected animals were injected (i.v) with 3 x 10(6) hUTC or with vehicle control (at day: 1, 1&3 or 1&7 after MCAo, n = 8-9/group). A battery of functional outcome tests was performed at days 1, 7, 14, 21, 28, 35, 42, 49, 56 and 63 after MCAo. Rats were sacrificed at 63 days after MCAo and lesion volumes were measured. To investigate the underlying mechanism of hUTC treatment of stroke, Von Willebrand Factor (vWF), and Synaptophysin immunostaining were performed. Results: All hUTC treated groups, single or multiple injections, had better functional recovery compared to control (p<0.01). There was no statistically significant difference between a single and multiple injections of hUTC (p = 0.23) or between different multiple injections groups (p>0.07) in functional outcome. All hUTC treatment groups showed significant increases in Synaptophysin, vascular density and perimeter compared to the control group (p<0.05). There was no statistically significant difference between a single and multiple injections of hUTC or between the two groups of multiple injections in all immunohistochemical measurements (p>0.1). Conclusion: hUTC treatment significantly improves long term functional outcome after stroke and promotes vascular density and synaptic plasticity. At the proscribed doses, multiple injections of hUTC were not superior to single injection therapy in both functional outcome and histological assessments.	[Shehadah, Amjad; Chen, Jieli; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kramer, Brian] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Shehadah, Amjad/0000-0001-8679-3774	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	This work was funded by Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ 08876, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.; The authors declare that one of our co-authors, Brian Kramer PhD, is an employee of Advanced Technologies and Regenerative Medicine, the commercial funder of the study. This affiliation does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors do not have any other declarations related to patents, products in development or marketed products.	Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; BARTH TM, 1990, STROKE, V21, P153; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CABALKA LM, 1990, J COMP NEUROL, V295, P83, DOI 10.1002/cne.902950108; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sun JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024529; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zacharek A, 2009, STROKE, V40, P254, DOI 10.1161/STROKEAHA.108.524116; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	47	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54083	10.1371/journal.pone.0054083	http://dx.doi.org/10.1371/journal.pone.0054083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342081	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400119
J	Wall, JD; Kim, SK; Luca, F; Carbone, L; Mootnick, AR; de Jong, PJ; Di Rienzo, A				Wall, Jeffrey D.; Kim, Sung K.; Luca, Francesca; Carbone, Lucia; Mootnick, Alan R.; de Jong, Pieter J.; Di Rienzo, Anna			Incomplete Lineage Sorting Is Common in Extant Gibbon Genera	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE; HOMINOIDS; EVOLUTION	We sequenced reduced representation libraries by means of Illumina technology to generate over 1.5 Mb of orthologous sequence from a representative of each of the four extant gibbon genera (Nomascus, Hylobates, Symphalangus, and Hoolock). We used these data to assess the evolutionary relationships between the genera by evaluating the likelihoods of all possible bifurcating trees involving the four taxa. Our analyses provide weak support for a tree with Nomascus and Hylobates as sister taxa and with Hoolock and Symphalangus as sister taxa, though bootstrap resampling suggests that other phylogenetic scenarios are also possible. This uncertainty is due to short internal branch lengths and extensive incomplete lineage sorting across taxa. The true phylogenetic relationships among gibbon genera will likely require a more extensive whole-genome sequence analysis.	[Wall, Jeffrey D.; Kim, Sung K.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Wall, Jeffrey D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Luca, Francesca; Di Rienzo, Anna] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Carbone, Lucia] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Mootnick, Alan R.] Gibbon Conservat Ctr, Santa Clarita, CA USA; [de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Chicago; Oregon Health & Science University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Wall, JD (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	wallj@humgen.ucsf.edu	Luca, Francesca/B-4850-2019	Luca, Francesca/0000-0001-8252-9052; Di Rienzo, Anna/0000-0002-8982-9098	National Institutes of Health (NIH) [R01 HG005226, R01 GM079558]; NIH [OD011092]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants R01 HG005226 to JDW and R01 GM079558 to ADR. LC was supported in part by NIH grant OD011092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Geissmann T, 2002, EVOL ANTHROPOL, V11, P28, DOI 10.1002/evan.10047; Groves C.P., 1972, P1; HAIMOFF EH, 1982, FOLIA PRIMATOL, V39, P213, DOI 10.1159/000156079; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Israfil H, 2011, MOL PHYLOGENET EVOL, V58, P447, DOI 10.1016/j.ympev.2010.11.005; Kim SK, 2011, MOL BIOL EVOL, V28, P2211, DOI 10.1093/molbev/msr033; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Meyer TJ, 2012, MOL BIOL EVOL, V29, P3441, DOI 10.1093/molbev/mss149; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZEHR SM, 1999, THESIS HARVARD U	28	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53682	10.1371/journal.pone.0053682	http://dx.doi.org/10.1371/journal.pone.0053682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341974	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400065
J	Walsh, AM; Sweeney, T; Bahar, B; O'Doherty, JV				Walsh, Ann M.; Sweeney, Torres; Bahar, Bojlul; O'Doherty, John V.			Multi-Functional Roles of Chitosan as a Potential Protective Agent against Obesity	PLOS ONE			English	Article							HIGH-FAT DIET; ADIPOSE-TISSUE; GASTROINTESTINAL-TRACT; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PROTEOME ANALYSIS; CHITIN-CHITOSAN; WEIGHT-LOSS; OB/OB MICE; INFLAMMATION	Chitosan, a natural polysaccharide comprising copolymers of glucosamine and N-acetylglucosamine, has been shown to have anti-obesity properties. Two experiments (Exp. 1 and Exp. 2) were performed to determine the role of chitosan on dietary intake, body weight gain, and fat deposition in a pig model, as well as identifying potential mechanisms underlying the anti-obesity effect of chitosan. In Exp. 1, the nutrient digestibility experiment, 16 pigs (n = 4/treatment) were randomly allocated to one of four dietary treatments as follows: 1) basal diet; 2) basal diet plus 300 ppm chitosan; 3) basal diet plus 600 ppm chitosan; 4) basal diet plus 1200 ppm chitosan. The main observation was that crude fat digestibility was lower in the 1200 ppm chitosan group when compared with the control group (P<0.05). In Exp. 2, a total of 80 pigs (n = 20/treatment) were offered identical dietary treatments to that offered to animals in Exp. 1. Blood samples were collected on day 0, day 35 and at the end of the experiment (day 57). Animals offered diets containing 1200 ppm chitosan had a lower daily dietary intake (P<0.001) and body weight gain (P<0.001) from day 35 to 57 when compared with all the other treatment groups. Animals offered diets containing 1200 ppm chitosan had a significantly lower final body weight (P<0.01) when compared with all the other treatment groups. The decreased dietary intake observed in the 1200 ppm chitosan group was associated with increased serum leptin concentrations (P<0.001) and a decrease in serum C-reactive protein (CRP) concentrations (P<0.05). In conclusion, the results of this study highlight novel endocrine mechanisms involving the modulation of serum leptin and CRP concentrations by which chitosan exhibits anti-obesity properties in vivo.	[Walsh, Ann M.; Bahar, Bojlul; O'Doherty, John V.] Univ Coll Dublin, Sch Agr & Food Sci, Lyons Res Farm, Newcastle, Co Dublin, Ireland; [Sweeney, Torres; Bahar, Bojlul] Univ Coll Dublin, Sch Vet Med, Belfield, Co Dublin, Ireland	University College Dublin; University College Dublin	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Lyons Res Farm, Newcastle, Co Dublin, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X	Marine Functional Food Research Consortium (NutraMara); Marine Institute; Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland	Marine Functional Food Research Consortium (NutraMara); Marine Institute; Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland	Funding for this research was provided under the Marine Functional Food Research Consortium (NutraMara) by the Marine Institute and the Department of Agriculture, Fisheries and Food, Agriculture House, Co. Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, OFFICIAL J EUROPEA L, VL257/23; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Bahar B, 2011, BRIT J NUTR, V106, P1142, DOI 10.1017/S0007114511001486; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Candek-Potokar M, 1998, MEAT SCI, V48, P287, DOI 10.1016/S0309-1740(97)00109-5; CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286; CLOSE WH, 1994, PRINCIPLES OF PIG SCIENCE, P123; Coleman RA, 1999, DIABETOLOGIA, V42, P639, DOI 10.1007/s001250051210; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; DEUCHI K, 1995, BIOSCI BIOTECH BIOCH, V59, P781, DOI 10.1271/bbb.59.781; Egras AM, 2011, J OBES, V2011, P297; Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97; Han LK, 1999, INT J OBESITY, V23, P174, DOI 10.1038/sj.ijo.0800806; Heilbronn LK, 2001, ARTERIOSCL THROM VAS, V21, P968, DOI 10.1161/01.ATV.21.6.968; HIRANO S, 1995, J SCI FOOD AGR, V69, P91, DOI 10.1002/jsfa.2740690114; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Latorre MA, 2004, J ANIM SCI, V82, P526; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; MARSHALL S, 1991, FASEB J, V5, P3031, DOI 10.1096/fasebj.5.15.1743436; Mozes S, 2008, FOLIA MICROBIOL, V53, P225, DOI 10.1007/s12223-008-0031-0; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; O'Shea CJ, 2011, J ANIM SCI, V89, P1366, DOI 10.2527/jas.2010-2922; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Rahman MA, 2010, BIOTECHNOL BIOPROC E, V15, P559, DOI 10.1007/s12257-009-3135-8; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; SAS, 2004, SAS US GUID 9 1 2; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9; Tran G., 2004, TABLE COMPOSITION NU, V1st ed.; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013	47	46	46	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53828	10.1371/journal.pone.0053828	http://dx.doi.org/10.1371/journal.pone.0053828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342013	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400090
J	Ford, CE; Jary, E; Ma, SSQ; Nixdorf, S; Heinzelmann-Schwarz, VA; Ward, RL				Ford, Caroline E.; Jary, Eve; Ma, Sean Si Qian; Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.; Ward, Robyn L.			The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; INHIBITS PROLIFERATION; MESENCHYMAL TRANSITION; PATHWAY; CATENIN; EXPRESSION; CONDUCTIN/AXIN2; SURVIVAL; THERAPY; GENE	Aberrant Wnt signalling is implicated in numerous human cancers, and understanding the effects of modulation of pathway members may lead to the development of novel therapeutics. Expression of secreted frizzled related protein 4 (SFRP4), an extracellular modulator of the Wnt signalling pathway, is progressively lost in more aggressive ovarian cancer phenotypes. Here we show that recombinant SFRP4 (rSFRP4) treatment of a serous ovarian cancer cell line results in inhibition of beta-catenin dependent Wnt signalling as measured by TOP/FOP Wnt reporter assay and decreased transcription of Wnt target genes, Axin2, CyclinD1 and Myc. In addition, rSFRP4 treatment significantly increased the ability of ovarian cancer cells to adhere to collagen and fibronectin, and decreased their ability to migrate across an inflicted wound. We conclude that these changes in cell behaviour may be mediated via mesenchymal to epithelial transition (MET), as rSFRP4 treatment also resulted in increased expression of the epithelial marker E-cadherin, and reduced expression of Vimentin and Twist. Combined, these results indicate that modulation of a single upstream gatekeeper of Wnt signalling can have effects on downstream Wnt signalling and ovarian cancer cell behaviour, as mediated through epithelial to mesenchymal plasticity (EMP). This raises the possibility that SFRP4 may be used both diagnostically and therapeutically in epithelial ovarian cancer.	[Ford, Caroline E.; Jary, Eve; Ma, Sean Si Qian; Ward, Robyn L.] Univ New S Wales, Wnt Signalling & Metastasis Grp, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia; [Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.] Univ NSW, Prince Wales Clin Sch, Ovarian Canc Grp, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Nixdorf, Sheri; Heinzelmann-Schwarz, Viola A.] Univ NSW, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Ford, CE (corresponding author), Univ New S Wales, Wnt Signalling & Metastasis Grp, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia.	caroline.ford@unsw.edu.au	Nixdorf, Sheri/F-3269-2013; Ward, Robyn L/I-2313-2013; Ford, Caroline E/A-7850-2010	Ward, Robyn L/0000-0002-6877-8906; Ford, Caroline E/0000-0002-4438-2309; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225	Cure Cancer Australia Foundation [1008633]; National Health and Medical Research Council CJ Martin Fellowship [466005]; Cancer Institute NSW [09/CRF/2-02]; William Maxwell Trust; Royal Australian and New Zealand College of Obstetricians and Gynaecologists	Cure Cancer Australia Foundation; National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; William Maxwell Trust; Royal Australian and New Zealand College of Obstetricians and Gynaecologists	This research was funded in part by grants from the Cure Cancer Australia Foundation (#1008633, CEF), National Health and Medical Research Council CJ Martin Fellowship (#466005, CEF), Cancer Institute NSW (# 09/CRF/2-02, VHS), William Maxwell Trust (VHS) and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (VHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Banerjee S, 2011, EUR J CANCER, V47, pS116, DOI 10.1016/S0959-8049(11)70155-1; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Bolton KL, 2012, J INTERN MED; Bovicelli A, 2011, J CELL PHYSIOL, V226, P2500, DOI 10.1002/jcp.22662; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Hashiguchi Y, 2004, HUM PATHOL, V35, P165, DOI 10.1016/j.humpath.2003.07.018; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Hiss D, 2012, J ONCOL, V2012, DOI 10.1155/2012/737981; Horvath LG, 2007, PROSTATE, V67, P1081, DOI 10.1002/pros.20607; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Jacob F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031885; Jost E, 2009, CANCER LETT, V281, P24, DOI 10.1016/j.canlet.2009.02.002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Karve TM, 2012, FUNCT INTEGR GENOMIC, V12, P63, DOI 10.1007/s10142-011-0251-2; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Schmid S, 2011, INT J GYNECOL CANCER, V21, P975, DOI 10.1097/IGC.0b013e31821caa6f; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Skirnisdottir IA, 2011, INT J GYNECOL CANCER, V21, P236, DOI 10.1097/IGC.0b013e31820986e5; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wu ZQ, 2012, P NATL ACAD SCI US; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177	40	71	79	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54362	10.1371/journal.pone.0054362	http://dx.doi.org/10.1371/journal.pone.0054362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326605	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800118
J	Javadi, AH; Aichelburg, C				Javadi, Amir Homayoun; Aichelburg, Clarisse			Training Enhances the Interference of Numerosity on Duration Judgement	PLOS ONE			English	Article							TIME; NUMBER; SUBTRACTION; MAGNITUDE; SPACE	The interference of magnitudes in different dimensions has been demonstrated previously, but the effect of training in one dimension on judgment of another has yet to be examined. The present study aimed to investigate the effect of training in numerosity judgment on judgment of duration. 32 participants took part in two sessions, 12 days apart, and had to judge which of two successive sets of items was presented longer. Half of the participants (training group) were additionally trained in 11 sessions to judge which one of the two successive sets of items was more numerous. It was found that the participants in the training group became more prone to the interference of numerosity on judging duration after training, when compared to the control group. Thus, being trained to more easily perceive the difference in number of items in the two sets affected the perception of duration. On the 3-month follow up session, no effect was found with 20 participants (n = 10 for each group). These findings indicate that the interference of magnitudes in different dimensions can be modulated by training. We discuss that this modulatory effect might be due to neural changes in shared brain regions between interfering magnitudes and/or is mediated by higher levels of perception.	[Javadi, Amir Homayoun] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Sect Syst Neurosci, D-01062 Dresden, Germany; [Javadi, Amir Homayoun] UCL, Inst Cognit Neurosci, London, England; [Aichelburg, Clarisse] UCL, Div Psychol & Language Sci, London, England	Technische Universitat Dresden; University of London; University College London; University of London; University College London	Javadi, AH (corresponding author), Tech Univ Dresden, Dept Psychiat & Psychotherapy, Sect Syst Neurosci, D-01062 Dresden, Germany.	a.h.javadi@gmail.com	Javadi, Amir-Homayoun/G-8547-2013	Javadi, Amir-Homayoun/0000-0003-0569-6441				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brannon EM, 2005, FUNCTIONAL NEURAL ME, P147; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Butterworth B., 1999, MATH BRAIN; Cappelletti M, 2009, NEUROPSYCHOLOGIA, V47, P2732, DOI 10.1016/j.neuropsychologia.2009.05.024; Carey S, 1998, SCIENCE, V282, P641, DOI 10.1126/science.282.5389.641; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2008, CORTEX, V44, P462, DOI 10.1016/j.cortex.2007.08.011; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Gallistel C. R., 2005, CAMBRIDGE HDB THINKI, P559, DOI [DOI 10.1037/002775, 10.1037/002775]; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; HORNE EP, 1977, J GEN PSYCHOL, V96, P135, DOI 10.1080/00221309.1977.9920807; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Kingdom F, 2009, PALAMEDES MATLAB ROU; Lechelt E, 1971, J GEN PSYCHOL, V84, P121; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; May A, 2011, TRENDS COGNITIVE SCI; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Stavy R., 2000, STUDENTS MISUNDERSTA; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, TRENDS COGN SCI, V7, P335, DOI 10.1016/S1364-6613(03)00166-9; Walsh V, 2005, TRANSCRANIAL MAGNETI; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Wynn K, 1995, MATH COGNITION, V1, P35, DOI DOI 10.1016/S0010-0277(99)00066-9; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54098	10.1371/journal.pone.0054098	http://dx.doi.org/10.1371/journal.pone.0054098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326579	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800106
J	Valdivia, N; Gonzalez, AE; Manzur, T; Broitman, BR				Valdivia, Nelson; Gonzalez, Andres E.; Manzur, Tatiana; Broitman, Bernardo R.			Mesoscale Variation of Mechanisms Contributing to Stability in Rocky Shore Communities	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; BOTTOM-UP; TOP-DOWN; TEMPORAL VARIABILITY; SPECIES INTERACTIONS; ECOSYSTEM FUNCTION; BIOMASS PRODUCTION; BIODIVERSITY LOSS; SPATIAL SCALE; DIVERSITY	Environmental fluctuations can generate asynchronous species' fluctuations and community stability, due to compensatory dynamics of species with different environmental tolerances. We tested this hypothesis in intertidal hard-bottom communities of north-central Chile, where a persistent upwelling centre maintains a mosaic in sea surface temperatures (SST) over 10s of kilometres along the shore. Coastal upwelling implies colder and temporally more stable SST relative to downstream sites. Uni- and multivariate analyses of multiyear timeseries of SST and species abundances showed more asynchronous fluctuations and higher stability in sites characterised by warmer and more variable SST. Nevertheless, these effects were weakened after including data obtained in sites affected by less persistent upwelling centres. Further, dominant species were more stable in sites exposed to high SST variability. The strength of other processes that can influence community stability, chiefly statistical averaging and overyielding, did not vary significantly between SST regimes. Our results provide observational evidence supporting the idea that exogenously driven compensatory dynamics and the stabilising effects of dominant species can determine the stability of ecosystems facing environmental fluctuations.	[Valdivia, Nelson] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Valdivia, Chile; [Gonzalez, Andres E.; Manzur, Tatiana; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Larrondo 1281, Coquimbo, Chile	Universidad Austral de Chile; Universidad Catolica del Norte	Valdivia, N (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Campus Isla Teja, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson A/C-3613-2009; Broitman, Bernardo R/D-6007-2013	Valdivia, Nelson A/0000-0002-5394-2072; Broitman, Bernardo R/0000-0001-6582-3188	Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT) [3100014, 090488, 1120988]; Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile [21110859]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh [AUS0805]	Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh	This study was financially supported by the Fondo Nacional de Desarrollo Cientco y Tecnologico (FONDECYT) through grants # 3100014 (NV), # 1090488 (BRB), and # 1120988 (BRB), by the Consejo Nacional de Ciencia y Tecnologico (CONICYT) through Becas Chile doctoral grant # 21110859 to AEG, and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) through grant # AUS0805 Fortalecimiento de las Ciencias Ecologicas y Evolutivas en la UACh to N.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; Box GE., 1978, STAT EXPT; Broitman BR, 2009, OIKOS, V118, P219, DOI 10.1111/j.1600-0706.2008.17075.x; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2001, FUNCTIONAL CONSEQUEN; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Connolly SR, 2003, ECOLOGY, V84, P2979, DOI 10.1890/02-0347; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Downing AL, 2008, ECOLOGY, V89, P3204, DOI 10.1890/07-1652.1; Elton S. C., 1958, ECOLOGY INVASIONS AN; Espoz C, 2004, REV CHIL HIST NAT, V77, P257; Garreaud RD, 2011, ATMOS CHEM PHYS, V11, P2015, DOI 10.5194/acp-11-2015-2011; Garreaud RD, 2005, MON WEATHER REV, V133, P2246, DOI 10.1175/MWR2972.1; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Hoffmann A., 1997, FLORA MARINA CHILE C; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1978, OECOLOGIA, V34, P17, DOI 10.1007/BF00346238; Munoz RC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009957; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 2008, ECOLOGY, V89, P2005, DOI 10.1890/07-1231.1; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Nybakken J., 2005, MARINE BIOL ECOLOGIC; Oliva D., 1992, GAYANA ZOOLOGIA, V56, P77; Pandit S. N., 2012, OECOLOGIA, V171, P1; Pimm SL, 1991, BALANCE NATURE ECOLO; Polley HW, 2007, OIKOS, V116, P2044, DOI 10.1111/j.2007.0030-1299.16080.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahn DA, 2011, MON WEATHER REV, V139, P3628, DOI 10.1175/MWR-D-11-00059.1; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Rutllant J, 2002, REV CHIL HIST NAT, V75, P217, DOI 10.4067/S0716-078X2002000100020; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Smale DA, 2010, DIVERS DISTRIB, V16, P985, DOI 10.1111/j.1472-4642.2010.00709.x; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Strub P.T., 1998, SEA; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Thibaut LM, 2012, ECOL LETT; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Torres R, 2009, ESTUAR COAST SHELF S, V83, P126, DOI 10.1016/j.ecss.2009.02.030; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Valone TJ, 2008, ECOLOGY, V89, P522, DOI 10.1890/07-0153.1; Vargas CA, 2006, J MAR BIOL ASSOC UK, V86, P1057, DOI 10.1017/S0025315406014032; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060	80	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54159	10.1371/journal.pone.0054159	http://dx.doi.org/10.1371/journal.pone.0054159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326592	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800113
J	Krebs, RM; Boehler, CN; Appelbaum, LG; Woldorff, MG				Krebs, Ruth M.; Boehler, Carsten N.; Appelbaum, Lawrence G.; Woldorff, Marty G.			Reward Associations Reduce Behavioral Interference by Changing the Temporal Dynamics of Conflict Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEDIAL FRONTAL-CORTEX; COGNITIVE CONTROL; STROOP TASK; HUMAN BRAIN; ANTERIOR CINGULATE; PREFRONTAL CORTEX; ACTION SELECTION; MONETARY REWARD; ATTENTION	Associating stimuli with the prospect of reward typically facilitates responses to those stimuli due to an enhancement of attentional and cognitive-control processes. Such reward-induced facilitation might be especially helpful when cognitive-control mechanisms are challenged, as when one must overcome interference from irrelevant inputs. Here, we investigated the neural dynamics of reward effects in a color-naming Stroop task by employing event-related potentials (ERPs). We found that behavioral facilitation in potential-reward trials, as compared to no-reward trials, was paralleled by early ERP modulations likely indexing increased attention to the reward-predictive stimulus. Moreover, reward changed the temporal dynamics of conflict-related ERP components, which may be a consequence of an early access to the various stimulus features and their relationships. Finally, although word meanings referring to potential-reward colors were always task-irrelevant, they caused greater interference compared to words referring to no-reward colors, an effect that was accompanied by a relatively early fronto-central ERP modulation. This latter observation suggests that task-irrelevant reward information can undermine goal-directed behavior at an early processing stage, presumably reflecting priming of a goal-incompatible response. Yet, these detrimental effects of incongruent reward-related words were absent in potential-reward trials, apparently due to the prioritized processing of task-relevant reward information. Taken together, the present data demonstrate that reward associations can influence conflict processing by changing the temporal dynamics of stimulus processing and subsequent cognitive-control mechanisms.	[Krebs, Ruth M.; Boehler, Carsten N.; Appelbaum, Lawrence G.; Woldorff, Marty G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA; [Krebs, Ruth M.; Boehler, Carsten N.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Appelbaum, Lawrence G.; Woldorff, Marty G.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Woldorff, Marty G.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Ghent University; Duke University; Duke University	Krebs, RM (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	ruthmkrebs@gmail.com	Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Woldorff, Marty/0000-0002-2683-4551; Appelbaum, Lawrence/0000-0002-3184-6725	National Institutes of Health [R01-051048, R01-060415]; Research Foundation Flanders [FWO11/PDO/016]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation Flanders(FWO)	This work was supported by National Institutes of Health grants R01-051048 and R01-060415 awarded to M.G.W. (http://grants.nih.gov/grants/oer.htm) and Research Foundation Flanders grant FWO11/PDO/016 awarded to R.M.K. (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Appelbaum LG, 2012, J COGNITIVE NEUROSCI, V24, P1834, DOI 10.1162/jocn_a_00209; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruchmann M, 2010, NEUROIMAGE, V49, P1800, DOI 10.1016/j.neuroimage.2009.09.032; Bunzeck N, 2009, CURR BIOL, V19, P1294, DOI 10.1016/j.cub.2009.06.021; Codispoti M, 2006, NEUROIMAGE, V32, P583, DOI 10.1016/j.neuroimage.2006.04.180; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Goldstein RZ, 2006, INT J PSYCHOPHYSIOL, V62, P272, DOI 10.1016/j.ijpsycho.2006.05.006; Greenham SL, 2000, BIOL PSYCHOL, V55, P79, DOI 10.1016/S0301-0511(00)00070-3; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367, DOI 10.1016/S0168-5597(98)00053-7; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Funes MJ, 2010, J EXP PSYCHOL HUMAN, V36, P147, DOI 10.1037/a0017598; Kanske P, 2011, CEREB CORTEX, V21, P911, DOI 10.1093/cercor/bhq157; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Marini F, 2011, COGN AFFECT BEHAV NE, V11, P627, DOI 10.3758/s13415-011-0057-7; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Murty VP, 2012, J NEUROSCI, V32, P8969, DOI 10.1523/JNEUROSCI.0094-12.2012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Potts GF, 2011, INT J PSYCHOPHYSIOL, V81, P324, DOI 10.1016/j.ijpsycho.2011.07.020; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rutherford HJV, 2010, PSYCHON B REV, V17, P536, DOI 10.3758/PBR.17.4.536; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	55	52	52	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53894	10.1371/journal.pone.0053894	http://dx.doi.org/10.1371/journal.pone.0053894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326530	Green Published, gold			2022-12-27	WOS:000313552400055
J	Bisana, S; Kumar, S; Rismiller, P; Nicol, SC; Lefevre, C; Nicholas, KR; Sharp, JA				Bisana, Swathi; Kumar, Satish; Rismiller, Peggy; Nicol, Stewart C.; Lefevre, Christophe; Nicholas, Kevin R.; Sharp, Julie A.			Identification and Functional Characterization of a Novel Monotreme- Specific Antibacterial Protein Expressed during Lactation	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; O-LINKED POLYLACTOSAMINOGLYCANS; AMINO-ACID-SEQUENCE; TAMMAR WALLABY; HUMAN-MILK; STAPHYLOCOCCUS-EPIDERMIDIS; ALPHA-LACTALBUMIN; MAMMARY-GLAND; EVOLUTION; GLYCOSYLATION	Monotremes are the only oviparous mammals and exhibit a fascinating combination of reptilian and mammalian characters. They represent a component of synapsidal reproduction by laying shelled eggs which are incubated outside the mother's body. This is accompanied by a prototherian lactation process, marking them as representatives of early mammals. The only extant monotremes are the platypus, and the short- and long- beaked echidnas, and their distributions are limited to Australia and New Guinea. Apart for a short weaning period, milk is the sole source of nutrition and protection for the hatchlings which are altricial and immunologically naive. The duration of lactation in these mammals is prolonged relative to the gestational length and period of incubation of eggs. Much of the development of monotreme young occurs in the non-sterile ex-utero environment. Therefore the role of milk in the growth, development and disease protection of the young is of significant interest. By sequencing the cDNA of cells harvested from monotreme milk, we have identified a novel monotreme-specific transcript, and the corresponding gene was designated as the EchAMP. The expression profile of this gene in various tissues revealed that it is highly expressed in milk cells. The peptides corresponding to the EchAMP protein have been identified in a sample of echidna milk In silico analysis indicated putative antimicrobial potential for the cognate protein of EchAMP. This was further confirmed by in vitro assays using a host of bacteria. Interestingly, EchAMP did not display any activity against a commensal gut floral species. These results support the hypothesis of enhancement of survival of the young by antimicrobial bioactives of mammary gland origin and thus emphasize the protective, non- nutritional role of milk in mammals.	[Bisana, Swathi; Lefevre, Christophe; Nicholas, Kevin R.; Sharp, Julie A.] Deakin Univ, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia; [Bisana, Swathi; Kumar, Satish] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Rismiller, Peggy] Univ Adelaide, Adelaide, SA, Australia; [Rismiller, Peggy] Pelican Lagoon Res & Wildlife Ctr, Penneshaw, SA, Australia; [Nicol, Stewart C.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia	Deakin University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Adelaide; University of Tasmania	Bisana, S (corresponding author), Deakin Univ, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia.	swathib@ccmb.res.in		Sharp, Julie/0000-0002-4481-5223	in-house funds of Deakin University, Australia; CSIR- Centre for Cellular and Molecular Biology, India	in-house funds of Deakin University, Australia; CSIR- Centre for Cellular and Molecular Biology, India	This project has been carried out with support from the in-house funds of Deakin University, Australia and CSIR- Centre for Cellular and Molecular Biology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barkema HW, 2009, J DAIRY SCI, V92, P4717, DOI 10.3168/jds.2009-2347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLACKBURN DG, 1989, MAMMAL REV, V19, P1, DOI 10.1111/j.1365-2907.1989.tb00398.x; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Borm AA, 2006, J DAIRY SCI, V89, P2090, DOI 10.3168/jds.S0022-0302(06)72279-2; Bradley AJ, 2001, J CLIN MICROBIOL, V39, P1845, DOI 10.1128/JCM.39.5.1845-1849.2001; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; DeVinney R, 1999, CELL MOL LIFE SCI, V55, P961, DOI 10.1007/s000180050347; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Finlay BB, 1996, ANN NY ACAD SCI, V797, P26, DOI 10.1111/j.1749-6632.1996.tb52946.x; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; GILLIN FD, 1983, SCIENCE, V221, P1290, DOI 10.1126/science.6310751; Gopinath S, 2012, TRENDS MICROBIOL, V20, P320, DOI 10.1016/j.tim.2012.04.004; Griffiths M., 1978, BIOL MONOTREMES; Guss JM, 1997, ACTA CRYSTALLOGR D, V53, P355, DOI 10.1107/S0907444996015831; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HANISCH FG, 1990, GLYCOCONJUGATE J, V7, P525, DOI 10.1007/BF01189075; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HAYSSEN V, 1985, EVOLUTION, V39, P1147, DOI 10.1111/j.1558-5646.1985.tb00454.x; HAYSSEN V, 1993, J DAIRY SCI, V76, P3213, DOI 10.3168/jds.S0022-0302(93)77659-6; HEIKKONEN L, 1986, ANN CLIN RES, V18, P80; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iwamori T, 2010, J VET MED SCI, V72, P621, DOI 10.1292/jvms.08-0331; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kloos W, 1986, BERGYS MANUAL SYSTEM, V2; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Lefevre CM, 2009, REPROD FERT DEVELOP, V21, P1015, DOI 10.1071/RD09083; LINDQUIST S, 1994, BIOTECHNIQUES, V17, P692; Magallon S., 2009, TIMETREE LIFE, P133; Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279; MCORIST S, 1986, J WILDLIFE DIS, V22, P375, DOI 10.7589/0090-3558-22.3.375; Messer M, 1997, COMP BIOCHEM PHYS B, V118, P403, DOI 10.1016/S0305-0491(97)00162-4; Morrow GE, AUSTR J ZOO IN PRESS; Munday BL, 1998, PHILOS T ROY SOC B, V353, P1093, DOI 10.1098/rstb.1998.0268; Nel-Themaat L, 2007, REPROD FERT DEVELOP, V19, P576, DOI 10.1071/RD06153; Nicholas K, 1997, J MAMMARY GLAND BIOL, V2, P299, DOI 10.1023/A:1026392623090; Nicol S, 2003, COMP BIOCHEM PHYS A, V136, P795, DOI 10.1016/S1095-6433(03)00281-2; OEDING P, 1952, ACTA PATHOL MIC SC, V31, P145; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P225, DOI 10.1023/A:1022896515287; Ordonez GR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r81; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; PAAPE MJ, 1966, J DAIRY SCI, V49, P265, DOI 10.3168/jds.S0022-0302(66)87847-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Sambrook J., 2001, MOL CLONING LAB MANU; Sharp JA, 2007, EVOL DEV, V9, P378, DOI 10.1111/j.1525-142X.2007.00175.x; SHAW DC, 1993, BIOCHIM BIOPHYS ACTA, V1161, P177, DOI 10.1016/0167-4838(93)90211-9; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tyndale-Biscoe CH, 1988, DEV MARSUPIAL MODELS; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wanyonyi SS, 2011, COMP BIOCHEM PHYS A, V160, P431, DOI 10.1016/j.cbpa.2011.07.015; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Watt AP, 2012, DEV COMP IMMUNOL, V36, P584, DOI 10.1016/j.dci.2011.10.001; WILLIAMS REO, 1959, BMJ-BRIT MED J, V2, P658, DOI 10.1136/bmj.2.5153.658; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Witte W, 1999, CHEMOTHERAPY, V45, P135, DOI 10.1159/000007174; YADAV M, 1972, J GEN MICROBIOL, V70, P437, DOI 10.1099/00221287-70-3-437; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078	68	15	15	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53686	10.1371/journal.pone.0053686	http://dx.doi.org/10.1371/journal.pone.0053686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326486	Green Published, gold			2022-12-27	WOS:000313551500093
J	Linares, LO; Martinez-Martin, N; Castellanos, FX				Linares, L. Oriana; Martinez-Martin, Nuria; Castellanos, F. Xavier			Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DIAGNOSTIC INTERVIEW SCHEDULE; DISRUPTIVE BEHAVIOR DISORDERS; COMMERCIAL HEALTH PLANS; MEDICAID MANAGED CARE; MENTAL-HEALTH; PSYCHOTROPIC MEDICATION; PSYCHIATRIC-DISORDERS; PSYCHOPHARMACOLOGICAL TREATMENT; DISC-IV	Objectives: The purpose of this study is to examine the use of prescribed psychoactive medications in a prospective cohort of children shortly after they entered foster homes; and to identify demographics, maltreatment history, psychiatric diagnoses including ADHD comorbidity, and level of aggression that contribute to prescribed use of stimulant and atypical antipsychotic medication over time. Methods: The sample included N = 252 children (nested in 95 sibling groups) followed for three years up to 4 yearly waves. Results: Nearly all (89%) met criteria for at least one of eight psychiatric diagnoses and 31% (75/252) used one or more prescribed psychoactive medications. Over half (55%) were diagnosed with Attention Deficit Hyperactivity Disorder (ADHD); of these 38% used stimulants and 36% used atypical antipsychotics. Of the 75 medicated children, 19% received >= 3 different classes of drugs over the course of the study. Stimulants (69%) and atypical antipsychotics (65%) were the most frequently used drugs among medicated children. Adjusted odds ratios (AOR) showed that male gender (AOR = 3.2; 95% CI = 1.5-9.3), African American vs Latino ethnicity (AOR = 5.4; 95% CI = 2.1-14.2), ADHD regardless of Oppositional Defiant (ODD) or Conduct (CD) comorbidity (AOR = 6.0, 95% CI = 1.3-27.5), ODD or CD (AOR = 11.1, 95% CI = 2.1-58.6), and Separation Anxiety (AOR = 2.0, 95% CI = 1.0-4.0) psychiatric disorders were associated with the use of prescribed stimulants; while male gender (AOR = 3.8, 95% CI = 1.5-9.3), African American vs Latino (AOR = 5.1, 95% CI = 1.2-9.2) or Mixed/Other ethnicity (AOR = 3.3, 95% CI = 1.9-13.7), ADHD regardless of ODD or CD comorbidity (AOR = 5.8, 95% CI = 1.2-28.7), ODD or CD (AOR = 13.9, 95% CI = 3.3-58.5), Major Depression/Dysthymia (AOR = 2.8, 95% CI = 1.1-6.7) psychiatric disorders, and history of sexual abuse (AOR = 4.6, 95% CI = 1.3-18.4) were associated with the use of prescribed atypical antipsychotics. Conclusion: The aggressive use of atypical antipsychotics, which has unknown metabolic risks, suggests that the efficacy and safety of such treatment strategies for psychiatrically ill children in foster care should be monitored.	[Linares, L. Oriana] Mt Sinai Sch Med, Adolescent Hlth Ctr, New York, NY USA; [Martinez-Martin, Nuria; Castellanos, F. Xavier] NYU, Sch Med, Ctr Child Study, New York, NY USA; [Castellanos, F. Xavier] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA	Icahn School of Medicine at Mount Sinai; New York University; Nathan Kline Institute for Psychiatric Research	Linares, LO (corresponding author), Mt Sinai Sch Med, Adolescent Hlth Ctr, New York, NY USA.	oriana.linares@mountsinai.org	Castellanos, Francisco Xavier/K-1892-2014	Castellanos, Francisco Xavier/0000-0001-9192-9437; Martinez-Martin, Nuria/0000-0001-9211-0896	United States Office of Abuse and Neglect [9OCA1687]; Centers for Disease Control [R49CE000205]; Alicia Koplowitz Foundation of Madrid Spain; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000205] Funding Source: NIH RePORTER	United States Office of Abuse and Neglect; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Alicia Koplowitz Foundation of Madrid Spain; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by grants from the United States Office of Abuse and Neglect (9OCA1687) and the Centers for Disease Control (R49CE000205) to LOL and by a Fellowship Award from the Alicia Koplowitz Foundation of Madrid Spain to NMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; [Anonymous], 2007, PHYS DESK REFERENCE; Aparasu RR, 2007, CURR MED RES OPIN, V23, P48, DOI 10.1185/030079906X158075; Aparasu RR, 2005, PSYCHIAT SERV, V56, P904, DOI 10.1176/appi.ps.56.8.904; Arizona Department of Health Services, 2006, PSYCH MED CHILDR AD; Armenteros JL, 2007, J AM ACAD CHILD PSY, V46, P558, DOI 10.1097/chi.0b013e3180323354; Bartnett D, 1991, DEV PSYCHOPATHOL, V3, P19; Bellows NM, 2008, HEALTH SERV RES, V43, P582, DOI 10.1111/j.1475-6773.2007.00769.x; Boles M, 2001, J CHILD ADOL PSYCHOP, V11, P43, DOI 10.1089/104454601750143429; Bravo M, 2001, J ABNORM CHILD PSYCH, V29, P433, DOI 10.1023/A:1010499520090; Children's Bureau, 2010, CHILD WELF OUTC 2007; Comer JS, 2010, J AM ACAD CHILD PSY, V49, P1001, DOI 10.1016/j.jaac.2010.07.007; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2008, J AM ACAD CHILD PSY, V47, P9, DOI 10.1097/chi.0b013e31815b5cb1; Correll CU, 2006, J AM ACAD CHILD PSY, V45, P771, DOI 10.1097/01.chi.0000220851.94392.30; DosReis S, 2004, PSYCHIAT SERV, V55, P1041, DOI 10.1176/appi.ps.55.9.1041; Eyberg S.M., 1999, EYBERG CHILD BEHAV I; Findling RL, 2008, J CLIN PSYCHIAT, V69, P9; Froehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857, DOI 10.1001/archpedi.161.9.857; Garland AF, 2001, J AM ACAD CHILD PSY, V40, P409, DOI 10.1097/00004583-200104000-00009; Hardin JW, 2012, GEN ESTIMATING EQUAT; Health and Human Services Commission, 2006, US PSYCH MED TEX FOS; Hurlburt MS, 2004, ARCH GEN PSYCHIAT, V61, P1217, DOI 10.1001/archpsyc.61.12.1217; Ipser J, 2007, PSYCHOPHARMACOLOGY, V191, P127, DOI 10.1007/s00213-006-0537-6; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P797, DOI 10.1097/00004583-199907000-00008; Landon BE, 2008, AM J MANAG CARE, V14, P377; Landon BE, 2007, JAMA-J AM MED ASSOC, V298, P1674, DOI 10.1001/jama.298.14.1674; Leslie LK, 2011, CHILD ABUSE NEGLECT, V35, P333, DOI 10.1016/j.chiabu.2011.01.012; Leslie LK, 2005, J DEV BEHAV PEDIATR, V26, P140, DOI 10.1097/00004703-200504000-00011; Leslie LK, 2003, J AM ACAD CHILD PSY, V42, P1433, DOI 10.1097/00004583-200312000-00010; Linares LO, 2007, J FAM PSYCHOL, V21, P736, DOI 10.1037/0893-3200.21.4.736; Linares LO, 2010, PEDIATRICS, V125, pE489, DOI 10.1542/peds.2009-1285; Linares LO, 2006, AGGRESS VIOLENT BEH, V11, P95, DOI 10.1016/j.avb.2005.07.001; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; National Institute of Mental Health, 2002, MED; Piacentini J, 1999, J ABNORM CHILD PSYCH, V27, P417, DOI 10.1023/A:1021923808118; PIACENTINI JC, 1992, J ABNORM CHILD PSYCH, V20, P51, DOI 10.1007/BF00927116; Raghavan R, 2005, J CHILD ADOL PSYCHOP, V15, P97, DOI 10.1089/cap.2005.15.97; Reich W, 2006, J AM ACAD CHILD PSY, V45, P801, DOI 10.1097/01.chi.0000219833.00979.c3; Rubin D, 2012, CHILD YOUTH SERV REV, V34, P1492, DOI 10.1016/j.childyouth.2012.04.006; Ruths S, 2004, PEDIATR ANN, V33, P318, DOI 10.3928/0090-4481-20040501-10; Safer DJ, 2003, AM J PSYCHIAT, V160, P438, DOI 10.1176/appi.ajp.160.3.438; Schneiderman Janet U, 2003, Contemp Nurse, V14, P123; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shin L, 2008, HARVARD REV PSYCHIAT, V16, P69, DOI 10.1080/10673220802073915; Silver J, 2007, CHILD WELFARE, V86, P35; Staller JA, 2007, PROG NEURO-PSYCHOPH, V31, P131, DOI 10.1016/j.pnpbp.2006.08.009; Staudt Marlys M, 2003, Child Maltreat, V8, P195, DOI 10.1177/1077559503254138; Swann AC, 2003, J CLIN PSYCHIAT, V64, P26; Tang MH, 2008, HEALTH SERV RES, V43, P882, DOI 10.1111/j.1475-6773.2007.00811.x; Tarren-Sweeney M, 2008, CURR OPIN PSYCHIATR, V21, P345, DOI 10.1097/YCO.0b013e32830321fa; Texas Department of State Health Services, 2007, PSYCH MED PAR FOST C; Tremmery S, 2007, EUR CHILD ADOLES PSY, V16, P327, DOI 10.1007/s00787-007-0604-5; US Department of Health and Human Services: Administration for Children and Families' Office of Planning Research and Evaluation, 2005, NAT SURV CHILD AD WE; Zito JM, 1998, J CHILD ADOL PSYCHOP, V8, P99, DOI 10.1089/cap.1998.8.99; Zito JM, 2008, PEDIATRICS, V121, pE157, DOI 10.1542/peds.2007-0212	56	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54152	10.1371/journal.pone.0054152	http://dx.doi.org/10.1371/journal.pone.0054152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326588	gold, Green Published			2022-12-27	WOS:000313551500111
J	Sharma, P; Dube, D; Sinha, M; Yadav, S; Kaur, P; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Sinha, Mau; Yadav, Savita; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Structural Insights into the Dual Strategy of Recognition by Peptidoglycan Recognition Protein, PGRP-S: Structure of the Ternary Complex of PGRP-S with Lipopolysaccharide and Stearic Acid	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INNATE IMMUNITY; ANGSTROM RESOLUTION; BINDING PROTEINS; EXPRESSION; INFECTION; SITE	Peptidoglycan recognition proteins (PGRPs) are part of the innate immune system. The 19 kDa Short PGRP (PGRP-S) is one of the four mammalian PGRPs. The concentration of PGRP-S in camel (CPGRP-S) has been shown to increase considerably during mastitis. The structure of CPGRP-S consists of four protein molecules designated as A, B, C and D forming stable intermolecular contacts, A-B and C-D. The A-B and C-D interfaces are located on the opposite sides of the same monomer leading to the the formation of a linear chain with alternating A-B and C-D contacts. Two ligand binding sites, one at C-D contact and another at A-B contact have been observed. CPGRP-S binds to the components of bacterial cell wall molecules such as lipopolysaccharide (LPS), lipoteichoic acid (LTA), and peptidoglycan (PGN) from both Gram-positive and Gram-negative bacteria. It also binds to fatty acids including mycolic acid of the Mycobacterium tuberculosis (Mtb). Previous structural studies of binary complexes of CPGRP-S with LPS and stearic acid (SA) have shown that LPS binds to CPGRP-S at C-D contact (Site-1) while SA binds to it at the A-B contact (Site-2). The binding studies using surface plasmon resonance showed that LPS and SA bound to CPGRP-S in the presence of each other. The structure determination of the ternary complex showed that LPS and SA bound to CPGRP-S at Site-1 and Site-2 respectively. LPS formed 13 hydrogen bonds and 159 van der Waals contacts (distances <= 4.2 angstrom) while SA formed 56 van der Waals contacts. The ELISA test showed that increased levels of productions of pro-inflammatory cytokines TNF-alpha and IFN-gamma due to LPS and SA decreased considerably upon the addition of CPGRP-S.	[Sharma, Pradeep; Dube, Divya; Sinha, Mau; Yadav, Savita; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160	Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi; Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi; DST for the INSPIRE Faculty; Department of Science and Technology for INSPIRE-Faculty	Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)); Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)Department of Biotechnology (DBT) India); DST for the INSPIRE Faculty; Department of Science and Technology for INSPIRE-Faculty	The authors acknowledge financial support from the Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi. TPS thanks the Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi for the award of Distinguished Biotechnology research professorship to him. PS thanks the DST for the INSPIRE Faculty award to him. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TPS thanks the Department of Biotechnology (DBT), Ministry of science and Technology, New Delhi for the award of Distinguished Biotechnology research professorship to him. PS thanks Department of Science and Technology for INSPIRE-Faculty award to him.	Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sharma P, 2012, ARCH BIOCH IN PRESS; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Sharma P, 2012, J BIOL CHEM, V287, P22153, DOI 10.1074/jbc.M111.321307; Sharma Pradeep, 2012, Int J Biochem Mol Biol, V3, P86; Sharma P, 2011, J BIOL CHEM, V286, P31723, DOI 10.1074/jbc.M111.264374; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WISE EM, 1965, P NATL ACAD SCI USA, V54, P75, DOI 10.1073/pnas.54.1.75; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	27	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53756	10.1371/journal.pone.0053756	http://dx.doi.org/10.1371/journal.pone.0053756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326499	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500095
J	Gear, R; Becerra, L; Upadhyay, J; Bishop, J; Wallin, D; Pendse, G; Levine, J; Borsook, D				Gear, Robert; Becerra, Lino; Upadhyay, Jaymin; Bishop, James; Wallin, Diana; Pendse, Gautam; Levine, Jon; Borsook, David			Pain Facilitation Brain Regions Activated by Nalbuphine Are Revealed by Pharmacological fMRI	PLOS ONE			English	Article							PREFRONTAL CORTICAL PROJECTIONS; ANTERIOR CINGULATE CORTEX; NOXIOUS THERMAL STIMULI; LONGITUDINAL COLUMNS; PERIAQUEDUCTAL GRAY; CEREBRAL ACTIVATION; HEALTHY-VOLUNTEERS; ANALGESIA; HUMANS; NALOXONE	Nalbuphine, an agonist-antagonist kappa-opioid, produces brief analgesia followed by enhanced pain/hyperalgesia in male postsurgical patients. However, it produces profound analgesia without pain enhancement when co-administration with low dose naloxone. To examine the effect of nalbuphine or nalbuphine plus naloxone on activity in brain regions that may explain these differences, we employed pharmacological magnetic resonance imaging (phMRI) in a double blind cross-over study with 13 healthy male volunteers. In separate imaging sessions subjects were administered nalbuphine (5 mg/70 kg) preceded by either saline (Sal-Nalb) or naloxone 0.4 mg (Nalox-Nalb). Blood oxygen level-dependent (BOLD) activation maps followed by contrast and connectivity analyses revealed marked differences. Sal-Nalb produced significantly increased activity in 60 brain regions and decreased activity in 9; in contrast, Nalox-Nalb activated only 14 regions and deactivated only 3. Nalbuphine, like morphine in a previous study, attenuated activity in the inferior orbital cortex, and, like noxious stimulation, increased activity in temporal cortex, insula, pulvinar, caudate, and pons. Co-administration/pretreatment of naloxone selectively blocked activity in pulvinar, pons and posterior insula. Nalbuphine induced functional connectivity between caudate and regions in the frontal, occipital, temporal, insular, middle cingulate cortices, and putamen; naloxone co-admistration reduced all connectivity to non-significant levels, and, like phMRI measures of morphine, increased activation in other areas (e.g., putamen). Naloxone pretreatment to nalbuphine produced changes in brain activity possess characteristics of both analgesia and algesia; naloxone selectively blocks activity in areas associated with algesia. Given these findings, we suggest that nalbuphine interacts with a pain salience system, which can modulate perceived pain intensity.	[Gear, Robert; Levine, Jon] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA; [Becerra, Lino; Upadhyay, Jaymin; Bishop, James; Wallin, Diana; Pendse, Gautam; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Boston, MA USA; [Becerra, Lino; Upadhyay, Jaymin; Bishop, James; Wallin, Diana; Pendse, Gautam; Borsook, David] McLean Hosp, Brain Imaging Ctr, Belmont, MA 02178 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Levine, Jon] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco	Levine, J (corresponding author), Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA.	jon.levine@ucsf.edu	Wallin, Diana/AGP-0651-2022	Wallin, Diana/0000-0003-4244-0314	National Institutes of Health [DE018526]; NINDS [K24]; Louis Herlands Fund for Pain Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Louis Herlands Fund for Pain Research; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant DE018526 (JL); NINDS K24 (DB); and Louis Herlands Fund for Pain Research (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 1998, J COMP NEUROL, V401, P455; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; BERKOWITZ B A, 1976, Clinical Pharmacokinetics, V1, P219, DOI 10.2165/00003088-197601030-00004; BESAG J, 1986, J R STAT SOC B, V48, P259; Borras MC, 2004, J NEUROPHYSIOL, V91, P2723, DOI 10.1152/jn.00249.2003; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Derbyshire SWG, 2002, J PAIN, V3, P401, DOI 10.1054/jpai.2002.126788; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Garavan H, 2010, BRAIN STRUCT FUNCT, V214, P593, DOI 10.1007/s00429-010-0259-8; Gear RW, 2000, J PAIN, V1, P122, DOI 10.1016/S1526-5900(00)90097-X; Gear RW, 2003, NEUROSCI LETT, V351, P5, DOI 10.1016/S0304-3940(03)00939-X; Gear RW, 1999, PAIN, V83, P339, DOI 10.1016/S0304-3959(99)00119-0; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; GORDON NC, 1995, NEUROSCIENCE, V69, P345, DOI 10.1016/0306-4522(95)00335-G; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Leslie RA, 2000, TRENDS PHARMACOL SCI, V21, P314, DOI 10.1016/S0165-6147(00)01507-8; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Oertel BG, 2011, HUM BRAIN MAPP; Pendse G, 2009, ADIS ROBUST PURSUIT, P44; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; Pendse GV, 2010, J MAGN RESON IMAGING, V31, P1445, DOI 10.1002/jmri.22180; Rabiner EA, 2011, MOL PSYCHIATR, V16, P826, DOI 10.1038/mp.2011.29; SCHMIDT WK, 1985, DRUG ALCOHOL DEPEN, V14, P339, DOI 10.1016/0376-8716(85)90066-3; Senapati AK, 2005, J NEUROPHYSIOL, V94, P845, DOI 10.1152/jn.00040.2005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Upadhyay J, 2011, NEUROPSYCHOPHARMACOL; Upadhyay J, 2011, NEUROPSYCHOPHARMACOL, V36, P2659, DOI 10.1038/npp.2011.156; Wanigasekera V, 2011, J NEUROSCI, V31, P2835, DOI 10.1523/JNEUROSCI.5412-10.2011; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Zelaya FO, 2012, MAGN RESON MATER PHY, V25, P163, DOI 10.1007/s10334-011-0293-4; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e50169	10.1371/journal.pone.0050169	http://dx.doi.org/10.1371/journal.pone.0050169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23341872	Green Published, gold, Green Submitted			2022-12-27	WOS:000313429800004
J	Borie, R; Quesnel, C; Phin, S; Debray, MP; Marchal-Somme, J; Tiev, K; Bonay, M; Fabre, A; Soler, P; Dehoux, M; Crestani, B				Borie, Raphael; Quesnel, Christophe; Phin, Sophie; Debray, Marie-Pierre; Marchal-Somme, Joelle; Tiev, Kiet; Bonay, Marcel; Fabre, Aurelie; Soler, Paul; Dehoux, Monique; Crestani, Bruno			Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; LUNG-DISEASE; FIBROBLASTS; CELLS; PROGENITOR	Background: Fibrocytes are circulating precursors for fibroblasts. Blood fibrocytes are increased in patients with idiopathic pulmonary fibrosis (IPF). The aim of this study was to determine whether alveolar fibrocytes are detected in broncho-alveolar lavage (BAL), to identify their prognostic value, and their potential association with culture of fibroblasts from BAL. Methods: We quantified fibrocytes in BAL from 26 patients with IPF, 9 patients with Systemic Sclerosis(SSc)-interstitial lung disease (ILD), and 11 controls. BAL cells were cultured to isolate alveolar fibroblasts. Results: Fibrocytes were detected in BAL in 14/26 IPF (54%) and 5/9 SSc patients (55%), and never in controls. Fibrocytes were in median 2.5% [0.4-19.7] and 3.0% [2.7-3.7] of BAL cells in IPF and SSc-ILD patients respectively. In IPF patients, the number of alveolar fibrocytes was correlated with the number of alveolar macrophages and was associated with a less severe disease but not with a better outcome. Fibroblasts were cultured from BAL in 12/26 IPF (46%), 5/9 SSc-ILD (65%) and never in controls. The detection of BAL fibrocytes did not predict a positive culture of fibroblasts. Conclusion: Fibrocytes were detected in BAL fluid in about half of the patients with IPF and SSc-ILD. Their number was associated with less severe disease in IPF patients and did not associate with the capacity to grow fibroblasts from BAL fluid.	[Borie, Raphael; Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Ctr Competences Malad Rares Pulm, F-75877 Paris, France; [Borie, Raphael; Quesnel, Christophe; Phin, Sophie; Marchal-Somme, Joelle; Bonay, Marcel; Fabre, Aurelie; Soler, Paul; Dehoux, Monique; Crestani, Bruno] Univ Paris 07, INSERM, U700, Fac Bichat, Paris, France; [Quesnel, Christophe] Hop Tenon, AP HP, Serv Anesthesie & Reanimat Chirurg, F-75970 Paris, France; [Debray, Marie-Pierre] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris, France; [Tiev, Kiet] Hop St Antoine, AP HP, Serv Med Interne, F-75571 Paris, France; [Bonay, Marcel] Hop St Antoine, AP HP, Serv Explorat Fonct, F-75571 Paris, France; [Bonay, Marcel; Fabre, Aurelie; Crestani, Bruno] Univ Paris 07, PRES Sorbonne Paris Cite, Paris, France; [Fabre, Aurelie] Hop Bichat Claude Bernard, AP HP, Serv Anatomopathol, F-75877 Paris, France; [Dehoux, Monique] Hop Bichat Claude Bernard, AP HP, Serv Biochim, F-75877 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Crestani, B (corresponding author), Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Ctr Competences Malad Rares Pulm, F-75877 Paris, France.	bruno.crestani@bch.aphp.fr	Bonay, Marcel/ABG-2039-2020	Bonay, Marcel/0000-0003-1446-7456; Borie, Raphael/0000-0002-9906-0024; fabre, aurelie/0000-0001-8176-1386	Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie; Chancellerie des Universites de Paris (legs Poix); Fondation pour la Recherche Medicale; l'association Pierre Enjalran; European Commission [202224]	Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie; Chancellerie des Universites de Paris (legs Poix); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); l'association Pierre Enjalran; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Association des Sclerodermiques de France (ASF), the Groupe Francais de Recherche sur la Sclerodermie, the Chancellerie des Universites de Paris (legs Poix), the Fondation pour la Recherche Medicale, l'association Pierre Enjalran and the European Commission (FP7 grant agreement #202224, European IPF Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Fireman E, 2001, LUNG, V179, P105, DOI 10.1007/s004080000051; Fujiwara A, 2012, RESPIROLOGY, V17, P693, DOI 10.1111/j.1440-1843.2012.02167.x; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Maharaj SS, 2012, PULM PHARMACOL THER, V25, P263, DOI 10.1016/j.pupt.2011.09.002; Mattoli S, 2009, CURR STEM CELL RES T, V4, P266, DOI 10.2174/157488809789649232; Medina A, 2010, MOL CELL BIOCHEM, V344, P11, DOI 10.1007/s11010-010-0524-4; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Quesnel C, 2010, EUR RESPIR J, V35, P1312, DOI 10.1183/09031936.00074709; Quesnel C, 2008, AM J PHYSIOL-LUNG C, V294, pL334, DOI 10.1152/ajplung.00096.2007; Quesnel C, 2012, CRIT CARE MED, V40, P21, DOI 10.1097/CCM.0b013e31822d718b; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200	29	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53736	10.1371/journal.pone.0053736	http://dx.doi.org/10.1371/journal.pone.0053736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341987	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700041
J	Cheng, H; Wang, J; Chu, SS; Yan, HL; Yu, DY				Cheng, Hao; Wang, Jiao; Chu, Shanshan; Yan, Hong-Lang; Yu, Deyue			Diversifying Selection on Flavanone 3-Hydroxylase and Isoflavone Synthase Genes in Cultivated Soybean and Its Wild Progenitors	PLOS ONE			English	Article							BIOSYNTHESIS; RECOMBINATION; ACCUMULATION; EXPRESSION; NUMBER	Soybean isoflavone synthase (IFS) and flavanone 3-hydroxylase (F3H) are two key enzymes catalyzing the biosynthesis of isoflavonoids and flavonoids, both of which play diverse roles in stress responses. However, little is known about the evolutionary pattern of these genes in cultivated soybean and its wild progenitors. Herein, we investigated the nucleotide polymorphisms in Isoflavone synthase (IFS1, IFS2) and Flavanone 3-hydroxylase (F3H2) genes from 33 soybean accessions, including 17 cultivars (Glycine max) and 16 their wild progenitors (Glycine soja). Our data showed that the target genes shared the levels of nucleotide polymorphism with three reference genes involved in plant-microbe interactions, but possessed a much higher nucleotide polymorphism than other reference genes. Moreover, no significant genetic differentiation was found between cultivated soybean and its wild relatives in three target genes, despite of considering bottleneck and founder effect during domestication. These results indicate that IFS and F3H genes could have experienced gene introgressions or diversifying selection events during domestication process. Especially, F3H2 gene appears to evolve under positive selection and enjoy a faster evolutionary rate than IFS1 and IFS2 genes.	[Cheng, Hao; Wang, Jiao; Chu, Shanshan; Yan, Hong-Lang; Yu, Deyue] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yu, DY (corresponding author), Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	dyyu@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB125906, 2009CB118400]; National Natural Science Foundation of China [31000718, 31171573, 31201230]; Jiangsu Provincial Support Program [BE2012328, BK2012768]; Ph.D. Programs Foundation of Ministry of Education of China [20090097120016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Support Program; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported in part by National Basic Research Program of China (973 Program) (2010CB125906, 2009CB118400), National Natural Science Foundation of China (31000718, 31171573, 31201230), Jiangsu Provincial Support Program(BE2012328, BK2012768) and Ph.D. Programs Foundation of Ministry of Education of China (No. 20090097120016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguade M, 2001, MOL BIOL EVOL, V18, P1, DOI 10.1093/oxfordjournals.molbev.a003714; Akashi T, 1999, PLANT PHYSIOL, V121, P821, DOI 10.1104/pp.121.3.821; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Cheng H, 2008, PLANT SCI, V175, P505, DOI 10.1016/j.plantsci.2008.05.020; Cheng H, 2010, MOL BREEDING, V25, P13, DOI 10.1007/s11032-009-9305-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1985, GENETICS, V111, P147; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671; Keim P., 1988, Soybean Genetics Newsletter, V15, P150; Kim HK, 2005, MOL CELLS, V19, P67; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SHEN P, 1986, GENETICS, V112, P441; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang Yusheng, 2002, Yingyong Shengtai Xuebao, V13, P71; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir BS., 1996, GENETIC DATA ANAL; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yu O, 2005, ADV AGRON, V86, P147, DOI 10.1016/S0065-2113(05)86003-1; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; [智海剑 Zhi Haijian], 2005, [大豆科学, Soybean Science], V24, P5	32	8	8	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54154	10.1371/journal.pone.0054154	http://dx.doi.org/10.1371/journal.pone.0054154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342093	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700091
J	Parente, V; Balasso, S; Pompilio, G; Verduci, L; Colombo, GI; Milano, G; Guerrini, U; Squadroni, L; Cotelli, F; Pozzoli, O; Capogrossi, MC				Parente, Valeria; Balasso, Serena; Pompilio, Giulio; Verduci, Lorena; Colombo, Gualtiero I.; Milano, Giuseppina; Guerrini, Uliano; Squadroni, Lidia; Cotelli, Franco; Pozzoli, Ombretta; Capogrossi, Maurizio C.			Hypoxia/Reoxygenation Cardiac Injury and Regeneration in Zebrafish Adult Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CELL-DEATH; RAT-HEART; IN-VIVO; EXPRESSION; HYPOXIA; GENE; ERYTHROPOIETIN; MYOCYTES; RELEASE	Aims: the adult zebrafish heart regenerates spontaneously after injury and has been used to study the mechanisms of cardiac repair. However, no zebrafish model is available that mimics ischemic injury in mammalian heart. We developed and characterized zebrafish cardiac injury induced by hypoxia/reoxygenation (H/R) and the regeneration that followed it. Methods and Results: adult zebrafish were kept either in hypoxic (H) or normoxic control (C) water for 15 min; thereafter fishes were returned to C water. Within 2-6 hours (h) after reoxygenation there was evidence of cardiac oxidative stress by dihydroethidium fluorescence and protein nitrosylation, as well as of inflammation. We used Tg(cmlc2:nucDsRed) transgenic zebrafish to identify myocardial cell nuclei. Cardiomyocyte apoptosis and necrosis were evidenced by TUNEL and Acridine Orange (AO) staining, respectively; 18 h after H/R, 9.9 +/- 2.6% of myocardial cell nuclei were TUNEL+ and 15.0 +/- 2.5% were AO(+). At the 30-day (d) time point myocardial cell death was back to baseline (n = 3 at each time point). We evaluated cardiomyocyte proliferation by Phospho Histone H3 (pHH3) or Proliferating Cell Nuclear Antigen (PCNA) expression. Cardiomyocyte proliferation was apparent 18-24 h after H/R, it achieved its peak 3-7d later, and was back to baseline at 30d. 7d after H/R 17.4 +/- 2.3% of all cardiomyocytes were pHH3(+) and 7.4 +/- 0.6% were PCNA(+) (n = 3 at each time point). Cardiac function was assessed by 2D-echocardiography and Ventricular Diastolic and Systolic Areas were used to compute Fractional Area Change (FAC). FAC decreased from 29.3 +/- 2.0% in normoxia to 16.4 +/- 1.8% at 18 h after H/R; one month later ventricular function was back to baseline (n = 12 at each time point). Conclusions: zebrafish exposed to H/R exhibit evidence of cardiac oxidative stress and inflammation, myocardial cell death and proliferation. The initial decrease in ventricular function is followed by full recovery. This model more closely mimics reperfusion injury in mammals than other cardiac injury models.	[Parente, Valeria; Balasso, Serena; Pompilio, Giulio; Verduci, Lorena; Milano, Giuseppina; Pozzoli, Ombretta] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Rome, Italy; [Parente, Valeria] Ist Nazl Genet Mol, Milan, Italy; [Colombo, Gualtiero I.] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Lab Immunol & Genom Funz, Rome, Italy; [Guerrini, Uliano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Lab Farmacol Trombosi & Aterosclero, Milan, Italy; [Squadroni, Lidia] Osped S Carlo Borromeo, Div Cardiol, Milan, Italy; [Cotelli, Franco] Univ Milan, Dipartimento Biol, Milan, Italy; [Cotelli, Franco] Univ Milan, Dipartimento Biosci, Lab Biol Sviluppo, Milan, Italy; [Capogrossi, Maurizio C.] Ist Ricovero & Cura Carattere Sci, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; University of Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Capogrossi, MC (corresponding author), Ist Ricovero & Cura Carattere Sci, Lab Patol Vascolare, Ist Dermopat Immacolata, Rome, Italy.	capogrossi@idi.it	Pompilio, Giulio/J-6701-2014; Parente, Valeria/H-7817-2016; Colombo, Gualtiero I./B-4737-2010	Pompilio, Giulio/0000-0003-2581-5735; Parente, Valeria/0000-0001-6559-9817; Colombo, Gualtiero I./0000-0002-7348-1939; Milano, Giuseppina/0000-0002-5560-4667	Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico [RC2008-2011]; Italian Ministero della Salute [RF2007-2009]	Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico; Italian Ministero della Salute(Ministry of Health, Italy)	This work was supported by Centro Cardiologico Monzino Istituto di Ricovero e Cura a Carattere Scientifico [RC2008-2011]; and Italian Ministero della Salute [grant RF2007-2009]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Bohuslavova R, 2010, J APPL PHYSIOL, V109, P1195, DOI 10.1152/japplphysiol.00366.2010; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; Bouma W, 2010, AM J PHYSIOL-HEART C, V298, pH1510, DOI 10.1152/ajpheart.01021.2009; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Czibik G, 2009, CARDIOVASC RES, V82, P107, DOI 10.1093/cvr/cvp035; HEARSE DJ, 1973, J MOL CELL CARDIOL, V5, P395, DOI 10.1016/0022-2828(73)90030-8; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Kawata H, 2001, CIRC RES, V88, P696, DOI 10.1161/hh0701.088842; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Laird AS, 2011, METHODS MOL BIOL, V793, P167, DOI 10.1007/978-1-61779-328-8_11; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SILVERMAN HS, 1991, CIRC RES, V69, P196, DOI 10.1161/01.RES.69.1.196; STERN MD, 1985, CIRC RES, V56, P899, DOI 10.1161/01.RES.56.6.899; STERN MD, 1988, P NATL ACAD SCI USA, V85, P6954, DOI 10.1073/pnas.85.18.6954; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Tang YL, 2005, J CARDIOVASC PHARM T, V10, P251, DOI 10.1177/107424840501000405; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	35	50	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53748	10.1371/journal.pone.0053748	http://dx.doi.org/10.1371/journal.pone.0053748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341992	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700042
J	Walmsley, CW; Smits, PD; Quayle, MR; McCurry, MR; Richards, HS; Oldfield, CC; Wroe, S; Clausen, PD; McHenry, CR				Walmsley, Christopher W.; Smits, Peter D.; Quayle, Michelle R.; McCurry, Matthew R.; Richards, Heather S.; Oldfield, Christopher C.; Wroe, Stephen; Clausen, Phillip D.; McHenry, Colin R.			Why the Long Face? The Mechanics of Mandibular Symphysis Proportions in Crocodiles	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; FUNCTIONAL-MORPHOLOGY; FEEDING-BEHAVIOR; MORPHOSPACE OCCUPATION; PREDATORY BEHAVIOR; CRANIAL STRENGTH; BITE FORCE; IN-VIVO; BIOMECHANICS; PERFORMANCE	Background: Crocodilians exhibit a spectrum of rostral shape from long snouted (longirostrine), through to short snouted (brevirostrine) morphologies. The proportional length of the mandibular symphysis correlates consistently with rostral shape, forming as much as 50% of the mandible's length in longirostrine forms, but 10% in brevirostrine crocodilians. Here we analyse the structural consequences of an elongate mandibular symphysis in relation to feeding behaviours. Methods/Principal Findings: Simple beam and high resolution Finite Element (FE) models of seven species of crocodile were analysed under loads simulating biting, shaking and twisting. Using beam theory, we statistically compared multiple hypotheses of which morphological variables should control the biomechanical response. Brevi- and mesorostrine morphologies were found to consistently outperform longirostrine types when subject to equivalent biting, shaking and twisting loads. The best predictors of performance for biting and twisting loads in FE models were overall length and symphyseal length respectively; for shaking loads symphyseal length and a multivariate measurement of shape (PC1 - which is strongly but not exclusively correlated with symphyseal length) were equally good predictors. Linear measurements were better predictors than multivariate measurements of shape in biting and twisting loads. For both biting and shaking loads but not for twisting, simple beam models agree with best performance predictors in FE models. Conclusions/Significance: Combining beam and FE modelling allows a priori hypotheses about the importance of morphological traits on biomechanics to be statistically tested. Short mandibular symphyses perform well under loads used for feeding upon large prey, but elongate symphyses incur high strains under equivalent loads, underlining the structural constraints to prey size in the longirostrine morphotype. The biomechanics of the crocodilian mandible are largely consistent with beam theory and can be predicted from simple morphological measurements, suggesting that crocodilians are a useful model for investigating the palaeobiomechanics of other aquatic tetrapods.	[Walmsley, Christopher W.; Quayle, Michelle R.; McCurry, Matthew R.; McHenry, Colin R.] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Walmsley, Christopher W.; Richards, Heather S.; Oldfield, Christopher C.; Wroe, Stephen; Clausen, Phillip D.; McHenry, Colin R.] Univ Newcastle, Sch Engn, Newcastle, NSW 2300, Australia; [Smits, Peter D.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Smits, Peter D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Wroe, Stephen] Univ New S Wales, Sch Biol Environm & Earth Sci, Sydney, NSW, Australia	Monash University; University of Newcastle; Monash University; University of Chicago; University of New South Wales Sydney	Walmsley, CW (corresponding author), Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	c.w.walmsley@gmail.com	Wroe, Stephen/A-4462-2010; Clausen, Philip/G-7337-2013	Wroe, Stephen/0000-0002-5813-9182; Wroe, Stephen/0000-0002-6365-5915; Clausen, Philip/0000-0003-1186-6419; Smits, Peter D/0000-0003-4074-1447; McCurry, Matthew/0000-0002-2452-1404	Australian Research Council Discovery Project grants [DP0986471, DP0987985]; Monash University; Newcastle University summer vacation scholarship; Directorate For Geosciences [0948842] Funding Source: National Science Foundation	Australian Research Council Discovery Project grants(Australian Research Council); Monash University(Monash University); Newcastle University summer vacation scholarship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Work was funded by Australian Research Council Discovery Project grants DP0986471 (to CRM) and DP0987985 (to SW), Monash University internal funding (to CRM), and a Newcastle University summer vacation scholarship (to CWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrews C. W., 1913, DESCRIPTIVE CATALOGU; Barton K., 2012, MUMIN MULTIMODEL INF; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Clausen P, 2008, J BIOMECH, V41, P3184, DOI 10.1016/j.jbiomech.2008.08.019; CLEUREN J, 1995, BELG J ZOOL, V125, P79; Cruickshank Arthur R. I., 1997, Annals of the South African Museum, V105, P207; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Dryden I., 2009, SHAPES STAT SHAPE AN; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Ellis R., 2003, SEA DRAGONS PREDATOR; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; Iordansky N.N., 1973, P201; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Langston W. Jr., 1973, P263; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; McGowan, 1992, DINOSAURS SPITFIRES; McHenry C.R., 2009, THESIS U NEWCASTLE; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger KA, 2005, ANAT REC PART A, V283A, P331, DOI 10.1002/ar.a.20167; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Mueller-Towe IJ, 2006, THESIS U MAINZ GERMA; O'Keefe ER, 2004, J VERTEBR PALEONTOL, V24, P326; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Owen R., 1881, MONOGRAPH FOSSIL R 3, P83; Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Pierce SE, 2009, PALAEONTOLOGY, V52, P1057, DOI 10.1111/j.1475-4983.2009.00904.x; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Porro LB, 2009, THESIS U CAMBRIDGE; R Development C, 2010, R LANG ENV STAT COMP; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross C. A., 1989, CROCODILES ALLIGATOR; Ross CF, 2004, ANN ANAT, V186, P387, DOI 10.1016/S0940-9602(04)80070-0; Snively E, 2006, ACTA PALAEONTOL POL, V51, P435; Snively Eric, 2010, Kirtlandia, V57, P53; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TAYLOR MA, 1993, PHILOS T ROY SOC B, V341, P399, DOI 10.1098/rstb.1993.0124; TAYLOR MA, 1987, ZOOL J LINN SOC-LOND, V91, P171, DOI 10.1111/j.1096-3642.1987.tb01727.x; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Wiley D.F, 2006, LANDMARK EDITOR 3 0; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	64	75	76	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53873	10.1371/journal.pone.0053873	http://dx.doi.org/10.1371/journal.pone.0053873			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342027	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700059
J	Jiang, JF; Wang, YG; Hu, J; Lei, F; Kheir, MM; Wang, XP; Chai, YS; Yuan, ZY; Lu, X; Xing, DM; Du, F; Du, LJ				Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Kheir, Michael M.; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Feng; Du, Li-Jun			Novel Effect of Berberine on Thermoregulation in Mice Model Induced by Hot and Cold Environmental Stimulation	PLOS ONE			English	Article							HEAT-SHOCK; APOPTOSIS; HSP70; CELLS; THERMOTOLERANCE; RESPONSES; PROMOTER; NEURONS; STRESS; MCF-7	The purpose of this study was to assess the effects of berberine (BBR) on thermoregulation in mice exposed to hot (40 degrees C) and cold (4 degrees C) environmental conditions. Four groups of mice were assembled with three different dosages of BBR (0.2, 0.4, and 0.8 mg/kg) and normal saline (control). In room temperature, our largest dosage of BBR (0.8 mg/kg) can reduce rectal temperatures (Tc) of normal mice. In hot conditions, BBR can antagonize the increasing core body temperature and inhibit the expression of HSP70 and TNF alpha in mice; conversely, in cold conditions, BBR can antagonize the decreasing core body temperature and enhance the expression of TRPM8. This study demonstrates the dual ability of BBR in maintaining thermal balance, which is of great relevance to the regulation of HSP70, TNF alpha and TRPM8.	[Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China; [Jiang, Jing-Fei; Wang, Yu-Gang; Hu, Jun; Lei, Fan; Wang, Xin-Pei; Chai, Yu-Shuang; Yuan, Zhi-Yi; Lu, Xi; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Kheir, Michael M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	Tsinghua University; Tsinghua University; University of Pennsylvania; Pennsylvania Medicine; Tulane University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China.	lijundu@tsinghua.edu.cn	Kheir, Michael/ABA-5760-2021	Kheir, Michael/0000-0001-6469-6746	National Natural Science Foundation of China [30973896, 30801523, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2011ZX09101-002-11, 2012ZX09102-201-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (30973896, 30801523 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2011ZX09101-002-11 and 2012ZX09102-201-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti S, 2012, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbadis.2012.05.011, DOI 10.1016/J.BBADIS.2012.05.011]; Blondin DP, 2010, J APPL PHYSIOL, V109, P654, DOI 10.1152/japplphysiol.00440.2010; Bolcskei K, 2007, EUR J PHARMACOL, V564, P80, DOI 10.1016/j.ejphar.2007.01.097; Cai CQ, 2012, NEUROSCI LETT, V506, P336, DOI 10.1016/j.neulet.2011.11.041; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Clark BJ, 2006, PHYSIOL BEHAV, V87, P805, DOI 10.1016/j.physbeh.2006.01.026; Cok A, 2011, BIOCHIMIE, V93, P1187, DOI 10.1016/j.biochi.2011.04.013; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Fetsch CR, 2006, J THERM BIOL, V31, P40, DOI 10.1016/j.jtherbio.2005.12.001; Flouris AD, 2009, J APPL PHYSIOL, V106, P1264, DOI 10.1152/japplphysiol.91426.2008; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Grosman B, 2011, J APPL PHYSIOL, V111, P938, DOI 10.1152/japplphysiol.00519.2010; Hascoet M, 1997, PHARMACOL BIOCHEM BE, V58, P1131, DOI 10.1016/S0091-3057(97)00093-2; Ho YT, 2009, ANTICANCER RES, V29, P4063; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kim JB, 2010, PHYTOMEDICINE, V17, P436, DOI 10.1016/j.phymed.2009.08.012; Kim JM, 2010, J ETHNOPHARMACOL, V130, P354, DOI 10.1016/j.jep.2010.05.022; Kim SM, 2012, J SURG RES, pe1; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Koishi M, 2001, CLIN CANCER RES, V7, P215; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Leon LR, 2010, AM J PHYSIOL-REG I, V299, pR241, DOI 10.1152/ajpregu.00309.2009; Leon LR, 2008, TOXICOL APPL PHARM, V233, P146, DOI 10.1016/j.taap.2008.01.012; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu ZQ, 1991, CHINESE J PATHOPHYSI, V7, P264; Lu BA, 2010, TOXICOL IN VITRO, V24, P1482, DOI 10.1016/j.tiv.2010.07.017; Marais M, 2011, J THERM BIOL, V36, P116, DOI 10.1016/j.jtherbio.2010.12.004; Mendoza KC, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 3: P-Z, P400; Michel V, 2007, BRAIN RES, V1164, P63, DOI 10.1016/j.brainres.2007.06.011; MILTON AS, 1971, J PHYSIOL-LONDON, V218, P325, DOI 10.1113/jphysiol.1971.sp009620; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Vinkers CH, 2009, PHYSIOL BEHAV, V98, P37, DOI 10.1016/j.physbeh.2009.04.004; Wang Y, 2012, MUTATION RES; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Xia Jianzhong, 2004, J Tradit Chin Med, V24, P208; Yan KQ, 2011, EUR J PHARMACOL, V661, P1, DOI 10.1016/j.ejphar.2011.04.021; Yu L, 1997, CHINESE PHARMACOL B, V13, P223; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023	49	36	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54234	10.1371/journal.pone.0054234	http://dx.doi.org/10.1371/journal.pone.0054234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335996	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700054
J	McCoy, AN; Araujo-Perez, F; Azcarate-Peril, A; Yeh, JJ; Sandler, RS; Keku, TO				McCoy, Amber N.; Araujo-Perez, Felix; Azcarate-Peril, Andrea; Yeh, Jen Jen; Sandler, Robert S.; Keku, Temitope O.			Fusobacterium Is Associated with Colorectal Adenomas	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; COLON-CANCER; NUCLEATUM; CELLS; BACTERIA; BUTYRATE; HEALTH; PH	The human gut microbiota is increasingly recognized as a player in colorectal cancer (CRC). While particular imbalances in the gut microbiota have been linked to colorectal adenomas and cancer, no specific bacterium has been identified as a risk factor. Recent studies have reported a high abundance of Fusobacterium in CRC subjects compared to normal subjects, but this observation has not been reported for adenomas, CRC precursors. We assessed the abundance of Fusobacterium species in the normal rectal mucosa of subjects with (n = 48) and without adenomas (n = 67). We also confirmed previous reports on Fusobacterium and CRC in 10 CRC tumor tissues and 9 matching normal tissues by pyrosequencing. We extracted DNA from rectal mucosal biopsies and measured bacterial levels by quantitative PCR of the 16S ribosomal RNA gene. Local cytokine gene expression was also determined in mucosal biopsies from adenoma cases and controls by quantitative PCR. The mean log abundance of Fusobacterium or cytokine gene expression between cases and controls was compared by t-test. Logistic regression was used to compare tertiles of Fusobacterium abundance. Adenoma subjects had a significantly higher abundance of Fusobacterium species compared to controls (p = 0.01). Compared to the lowest tertile, subjects with high abundance of Fusobacterium were significantly more likely to have adenomas (OR 3.66, 95% CI 1.37-9.74, p-trend 0.005). Cases but not controls had a significant positive correlation between local cytokine gene expression and Fusobacterium abundance. Among cases, the correlation for local TNF-alpha and Fusobacterium was r = 0.33, p = 0.06 while it was 0.44, p = 0.01 for Fusobacterium and IL-10. These results support a link between the abundance of Fusobacterium in colonic mucosa and adenomas and suggest a possible role for mucosal inflammation in this process.	[McCoy, Amber N.; Araujo-Perez, Felix; Sandler, Robert S.; Keku, Temitope O.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Sandler, Robert S.; Keku, Temitope O.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC USA; [Azcarate-Peril, Andrea] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Microbiome Core Facil, Chapel Hill, NC USA; [Azcarate-Peril, Andrea] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Surg, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Keku, TO (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	tokeku@med.unc.edu	Azcarate-Peril, M. Andrea/ABH-5508-2020; Ariel, Pablo/AGJ-4118-2022; Core, UNC Microbiome/AAB-3304-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022; Azcarate-Peril, M. Andrea/AAA-9056-2022	Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M. Andrea/0000-0003-0325-1289	National Institutes of Health [NIH R01 CA04468, R01 CA136887, P50 CA106991, P30 DK034987]; NATIONAL CANCER INSTITUTE [P50CA106991, R01CA136887, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health NIH R01 CA04468, R01 CA136887, P50 CA106991 and P30 DK034987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2011, GUT MICROBES, P2; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Edwards AM, 2006, INFECT IMMUN, V74, P654, DOI 10.1128/IAI.74.1.654-662.2006; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Mutch DM, 2004, PHYSIOL GENOMICS, V19, P22, DOI 10.1152/physiolgenomics.00105.2004; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; NEWMARK HL, 1990, NUTR CANCER, V14, P161, DOI 10.1080/01635589009514091; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Resmer KL, 2011, MOL BIOSYST, V7, P2220, DOI 10.1039/c1mb05105a; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rogler G, 2010, INT J INFLAMMATION, V2010, P1; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanapareddy N, 2012, ISME J, P1; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tanaka Takuji, 2009, J Carcinog, V8, P5; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Walter J, 2011, MICROBIAL ECOLOGY HL, P14; Wang F, 2012, DIGESTIVE DIS SCI; Weiss EI, 2000, ORAL MICROBIOL IMMUN, V15, P371, DOI 10.1034/j.1399-302x.2000.150606.x	48	330	352	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53653	10.1371/journal.pone.0053653	http://dx.doi.org/10.1371/journal.pone.0053653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335968	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700024
J	Albersen, M; Bosma, M; Knoers, NVVAM; de Ruiter, BHB; Diekman, EF; de Ruijter, J; Visser, WF; de Koning, TJ; Verhoeven-Duif, NM				Albersen, Monique; Bosma, Marjolein; Knoers, Nine V. V. A. M.; de Ruiter, Berna H. B.; Diekman, Eugene F.; de Ruijter, Jessica; Visser, Wouter F.; de Koning, Tom J.; Verhoeven-Duif, Nanda M.			The Intestine Plays a Substantial Role in Human Vitamin B6 Metabolism: A Caco-2 Cell Model	PLOS ONE			English	Article							PYRIDOXINE HYDROCHLORIDE; TISSUE DISTRIBUTION; MASS-SPECTROMETRY; TRANSPORT; RAT; PLASMA; MICE; 5'-PHOSPHATE; PYRIDOXAMINE; ABSORPTION	Background: Vitamin B6 is present in various forms (vitamers) in the diet that need to be metabolized to pyridoxal phosphate (PLP), the active cofactor form of vitamin B6. In literature, the liver has been reported to be the major site for this conversion, whereas the exact role of the intestine remains to be elucidated. Objective: To gain insight into the role of the intestine in human vitamin B6 metabolism. Materials and Methods: Expression of the enzymes pyridoxal kinase (PK), pyridox(am)ine phosphate oxidase (PNPO) and PLP-phosphatase was determined in Caco-2 cells and in lysates of human intestine. Vitamin B6 uptake, conversion and excretion were studied in polarized Caco-2 cell monolayers. B6 vitamer concentrations (pyridoxine (PN), pyridoxal (PL), PLP, pyridoxamine (PM), pyridoxamine phosphate (PMP)) and pyridoxic acid (PA) were quantified by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) using stable isotope-labeled internal standards. Results: The enzymatic system involved in vitamin B6 metabolism (PK, PNPO and PLP-phosphatase) is fully expressed in Caco-2 cells as well as in human intestine. We show uptake of PN, PM and PL by Caco-2 cells, conversion of PN and PM into PL and excretion of all three unphosphorylated B6 vitamers. Conclusion: We demonstrate, in a Caco-2 cell model, that the intestine plays a substantial role in human vitamin B6 metabolism.	[Albersen, Monique; Bosma, Marjolein; Knoers, Nine V. V. A. M.; de Ruiter, Berna H. B.; Diekman, Eugene F.; de Ruijter, Jessica; Visser, Wouter F.; de Koning, Tom J.; Verhoeven-Duif, Nanda M.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; [de Koning, Tom J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen	Verhoeven-Duif, NM (corresponding author), Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands.	N.Verhoeven@umcutrecht.nl	De Koning, Tom J/AAE-1323-2020	De Koning, Tom J/0000-0001-5609-1309	Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht	Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht	This research was supported by the Wilhelmina Research Fund, Wilhelmina Children's Hospital, University Medical Center (UMC) Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender D., 2005, HUMAN NUTR, P194; BOOTH CC, 1962, J PHYSIOL-LONDON, V164, P282, DOI 10.1113/jphysiol.1962.sp007021; CHERN CJ, 1975, CLIN CHIM ACTA, V61, P353, DOI 10.1016/0009-8981(75)90425-8; COLOMBINI CE, 1970, BIOCHEMISTRY-US, V9, P533, DOI 10.1021/bi00805a012; CONTRACTOR SF, 1971, BIOCHIM BIOPHYS ACTA, V230, P127, DOI 10.1016/0304-4165(71)90060-2; Footitt E.J., 2012, J INHERIT METAB DIS; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; HAMM MW, 1979, J NUTR, V109, P1552, DOI 10.1093/jn/109.9.1552; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; JOHANSSON S, 1968, BIOCHEMISTRY-US, V7, P2327, DOI 10.1021/bi00846a039; JOHANSSON S, 1974, J BIOL CHEM, V249, P6040; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; LUMENG L, 1980, J CLIN INVEST, V66, P688, DOI 10.1172/JCI109906; LUMENG L, 1974, J LAB CLIN MED, V84, P334; MEHANSHO H, 1979, J NUTR, V109, P1542, DOI 10.1093/jn/109.9.1542; MEHANSHO H, 1980, BIOCHIM BIOPHYS ACTA, V631, P112, DOI 10.1016/0304-4165(80)90059-8; MERRILL AH, 1984, J NUTR, V114, P1664, DOI 10.1093/jn/114.9.1664; MIDDLETON HM, 1977, J NUTR, V107, P126, DOI 10.1093/jn/107.1.126; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Said HM, 2003, AM J PHYSIOL-CELL PH, V285, pC1219, DOI 10.1152/ajpcell.00204.2003; Said ZM, 2008, AM J PHYSIOL-CELL PH, V294, pC1192, DOI 10.1152/ajpcell.00015.2008; SAKURAI T, 1991, J NUTR SCI VITAMINOL, V37, P341, DOI 10.3177/jnsv.37.341; SAKURAI T, 1987, J NUTR SCI VITAMINOL, V33, P11, DOI 10.3177/jnsv.33.11; SAKURAI T, 1988, J NUTR SCI VITAMINOL, V34, P179, DOI 10.3177/jnsv.34.179; SNELL EE, 1945, J AM CHEM SOC, V67, P194, DOI 10.1021/ja01218a013; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018	27	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54113	10.1371/journal.pone.0054113	http://dx.doi.org/10.1371/journal.pone.0054113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342087	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400122
J	Jaramillo, J; Setamou, M; Muchugu, E; Chabi-Olaye, A; Jaramillo, A; Mukabana, J; Maina, J; Gathara, S; Borgemeister, C				Jaramillo, Juliana; Setamou, Mamoudou; Muchugu, Eric; Chabi-Olaye, Adenirin; Jaramillo, Alvaro; Mukabana, Joseph; Maina, Johnson; Gathara, Simon; Borgemeister, Christian			Climate Change or Urbanization? Impacts on a Traditional Coffee Production System in East Africa over the Last 80 Years	PLOS ONE			English	Article							HYPOTHENEMUS-HAMPEI COLEOPTERA; LAND-USE CHANGE; BERRY BORER; SHADE COFFEE; AGROFORESTRY MANAGEMENT; GLOBAL CLIMATE; ARABICA L.; TEMPERATURE; BIODIVERSITY; EMERGENCE	Global environmental changes (GEC) such as climate change (CC) and climate variability have serious impacts in the tropics, particularly in Africa. These are compounded by changes in land use/land cover, which in turn are driven mainly by economic and population growth, and urbanization. These factors create a feedback loop, which affects ecosystems and particularly ecosystem services, for example plant-insect interactions, and by consequence agricultural productivity. We studied effects of GEC at a local level, using a traditional coffee production area in greater Nairobi, Kenya. We chose coffee, the most valuable agricultural commodity worldwide, as it generates income for 100 million people, mainly in the developing world. Using the coffee berry borer, the most serious biotic threat to global coffee production, we show how environmental changes and different production systems (shaded and sun-grown coffee) can affect the crop. We combined detailed entomological assessments with historic climate records (from 1929-2011), and spatial and demographic data, to assess GEC's impact on coffee at a local scale. Additionally, we tested the utility of an adaptation strategy that is simple and easy to implement. Our results show that while interactions between CC and migration/urbanization, with its resultant landscape modifications, create a feedback loop whereby agroecosystems such as coffee are adversely affected, bio-diverse shaded coffee proved far more resilient and productive than coffee grown in monoculture, and was significantly less harmed by its insect pest. Thus, a relatively simple strategy such as shading coffee can tremendously improve resilience of agro-ecosystems, providing small-scale farmers in Africa with an easily implemented tool to safeguard their livelihoods in a changing climate.	[Jaramillo, Juliana] Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany; [Jaramillo, Juliana; Muchugu, Eric; Chabi-Olaye, Adenirin; Borgemeister, Christian] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Jaramillo, Alvaro] Ctr Nacl Invest Cafe Cenicafe, Manizales, Colombia; [Setamou, Mamoudou] Texas A&M Univ, Kingsville Citrus Ctr, Weslaco, TX USA; [Mukabana, Joseph; Maina, Johnson; Gathara, Simon] Kenya Meteorol Dept, Nairobi, Kenya	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE); Texas A&M University System; Texas A&M University Kingsville	Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany.	jjaramillo@icipe.org			German Research Foundation - Deutsche Forschungsgemeinschaft (DFG); Finnish Ministry of Foreign Affairs through the CHIESA project	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Finnish Ministry of Foreign Affairs through the CHIESA project	This research was funded by the German Research Foundation - Deutsche Forschungsgemeinschaft (DFG) and partly supported by the Finnish Ministry of Foreign Affairs through the CHIESA project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; BAKER PS, 1992, B ENTOMOL RES, V82, P145, DOI 10.1017/S000748530005166X; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BARNES C, 1979, AFR ECON HIST, P198, DOI 10.2307/3601565; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Brown O, 2008, IOM INT ORG MIGRATIO; C.R.A, 2011, COUNT FACT SHEETS MA; Cardoso IM, 2003, AGROFOREST SYST, V58, P55, DOI 10.1023/A:1025436908000; Carr MKV, 2001, EXP AGR, V37, P1, DOI 10.1017/S0014479701001090; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Eitzinger A, 2010, CIAT INT CTR TROPICA; EVANS D. E., 1965, Kenya Coffee, V30, P335; Fall S, 2010, INT J CLIMATOL, V30, P1980, DOI 10.1002/joc.1996; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Geromel C, 2008, PLANT PHYSIOL BIOCH, V46, P569, DOI 10.1016/j.plaphy.2008.02.006; Gordon CE, 2009, BASIC APPL ECOL, V10, P246, DOI 10.1016/j.baae.2008.04.004; Greenberg R, 1997, BIOTROPICA, V29, P501, DOI 10.1111/j.1744-7429.1997.tb00044.x; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hope KR, 2009, INT J SUST DEV WORLD, V16, P451, DOI 10.1080/13504500903354424; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kamau M, 2011, NEW REGIONS TAKE COF; Kauth R. J., 1976, LARS S, P41; Kirkpatrick T. W., 1937, Transactions of the Royal Entomological Society of London, V86, P247; Kirkpatrick TW, 1935, E AFR AGR RES STA AM; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Mathieu F, 1998, J AGR FOOD CHEM, V46, P1106, DOI 10.1021/jf970851z; Mathieu F, 1999, J APPL ENTOMOL, V123, P535, DOI 10.1046/j.1439-0418.1999.00400.x; McDonald J, 1937, COFFEE KENYA COLONY; Moore S, 2012, RED TAPE SNAGS KENYA; Muller C, 2011, P NATL ACAD SCI USA, V108, P4313, DOI 10.1073/pnas.1015078108; NOAA, 2012, HIST LA NIN EV 1950; OKE TR, 1981, J CLIMATOL, V1, P237, DOI 10.1002/joc.3370010304; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Rosenthal E, 2011, NY TIMES; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute, 1999, SAS STAT US GUID; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; Staver C, 2001, AGROFOREST SYST, V53, P151, DOI 10.1023/A:1013372403359; Teodoro A, 2009, AGR FOREST ENTOMOL, V125, P120; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; UNPD, 2008, WORLD URB PROSP 2007; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; WALLER J.M, 2007, COFFEE PESTS DIS THE; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Zhou XL, 2011, GEOGR RES-AUST, V49, P23, DOI 10.1111/j.1745-5871.2010.00686.x	64	37	38	4	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51815	10.1371/journal.pone.0051815	http://dx.doi.org/10.1371/journal.pone.0051815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341884	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400006
J	La Rosa, G; Fratini, M; Accardi, L; D'Oro, G; Della Libera, S; Muscillo, M; Di Bonito, P				La Rosa, Giuseppina; Fratini, Marta; Accardi, Luisa; D'Oro, Graziana; Della Libera, Simonetta; Muscillo, Michele; Di Bonito, Paola			Mucosal and Cutaneous Human Papillomaviruses Detected in Raw Sewages	PLOS ONE			English	Article							URBAN SEWAGE; MOLECULAR-DETECTION; TREATMENT PLANTS; ENTERIC VIRUSES; WASTE-WATER; INFECTIONS; PCR; POLYOMAVIRUSES; SURVEILLANCE; NOROVIRUSES	Epitheliotropic viruses can find their way into sewage. The aim of the present study was to investigate the occurrence, distribution, and genetic diversity of Human Papillomaviruses (HPVs) in urban wastewaters. Sewage samples were collected from treatment plants distributed throughout Italy. The DNA extracted from these samples was analyzed by PCR using five PV-specific sets of primers targeting the L1 (GP5/GP6, MY09/MY11, FAP59/64, SKF/SKR) and E1 regions (PM-A/PM-B), according to the protocols previously validated for the detection of mucosal and cutaneous HPV genotypes. PCR products underwent sequencing analysis and the sequences were aligned to reference genomes from the Papillomavirus Episteme database. Phylogenetic analysis was then performed to assess the genetic relationships among the different sequences and between the sequences of the samples and those of the prototype strains. A broad spectrum of sequences related to mucosal and cutaneous HPV types was detected in 81% of the sewage samples analyzed. Surprisingly, sequences related to the anogenital HPV6 and 11 were detected in 19% of the samples, and sequences related to the "high risk" oncogenic HPV16 were identified in two samples. Sequences related to HPV9, HPV20, HPV25, HPV76, HPV80, HPV104, HPV110, HPV111, HPV120 and HPV145 beta Papillomaviruses were detected in 76% of the samples. In addition, similarity searches and phylogenetic analysis of some sequences suggest that they could belong to putative new genotypes of the beta genus. In this study, for the first time, the presence of HPV viruses strongly related to human cancer is reported in sewage samples. Our data increases the knowledge of HPV genomic diversity and suggests that virological analysis of urban sewage can provide key information useful in supporting epidemiological studies.	[La Rosa, Giuseppina; Fratini, Marta; D'Oro, Graziana; Della Libera, Simonetta; Muscillo, Michele] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Accardi, Luisa; Di Bonito, Paola] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	La Rosa, G (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	giuseppina.larosa@iss.it; paola.dibonito@iss.it	Di Bonito, Paola/A-6675-2013; Di Bonito, Paola/AAI-3583-2021; Accardi, Luisa/C-2945-2016; La Rosa, Giuseppina/I-8532-2016	Di Bonito, Paola/0000-0002-4737-374X; Di Bonito, Paola/0000-0002-4737-374X; Accardi, Luisa/0000-0002-5091-9272; La Rosa, Giuseppina/0000-0002-2657-100X; della libera, simonetta/0000-0001-6882-3140; Fratini, Marta/0000-0003-0934-3854	Ministry of Health; joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen"	Ministry of Health; joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen"	This work was partially funded by the Ministry of Health, AIDS projects 2009-2012, and partially supported by the joint Italia-USA project "Assessing the Impact of GIV Norovirus on Human Health: a Molecular Epidemiological Investigation on Environmental and Clinical Samples as a Basis for the Design of Novel Diagnostic Tools for an Emerging Pathogen". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IARC MONOGRAPHS EVAL; Antonsson A, 2012, J MED VIROL, V84, P814, DOI 10.1002/jmv.23257; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bertrand I, 2012, J APPL MICROBIOL, P10; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Bofill-Mas S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-141; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; de Koning M, 2006, J CLIN MICROBIOL, V44, P1792, DOI 10.1128/JCM.44.5.1792-1800.2006; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; Di Bonito P., 2006, INFECT AGENTS CANCER, V1, P1; Ferlay J, 2010, GLOBOCAN 2008 V1 2, V1.2; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Frega A, 2003, CANCER LETT, V194, P21, DOI 10.1016/S0304-3835(03)00048-X; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; Heijnen L, 2011, J WATER HEALTH, V9, P434, DOI 10.2166/wh.2011.019; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iwai M, 2009, APPL ENVIRON MICROB, V75, P1264, DOI 10.1128/AEM.01166-08; Jayaprakash V, 2011, ORAL ONCOL, V47, P1048, DOI 10.1016/j.oraloncology.2011.07.009; Kokkinos PA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-195; La Rosa G, 2010, WATER RES, V44, P1777, DOI 10.1016/j.watres.2009.11.055; La Rosa G, 2010, ANN I SUPER SANITA, V46, P266, DOI 10.4415/ANN_10_03_07; La Rosa G, 2010, APPL ENVIRON MICROB, V76, P5870, DOI 10.1128/AEM.00336-10; MANOS MM, 1989, CANCER CEL, V7, P209; Meleg E, 2008, APPL ENVIRON MICROB, V74, P3394, DOI 10.1128/AEM.02895-07; Meys R, 2010, BRIT J DERMATOL, V162, P6, DOI 10.1111/j.1365-2133.2009.09365.x; Okoh AI, 2010, INT J ENV RES PUB HE, V7, P2620, DOI 10.3390/ijerph7062620; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Pinto RM, 2007, EPIDEMIOL INFECT, V135, P270, DOI 10.1017/S0950268806006753; Reynolds KA, 2012, TAP VIRUSES CANC POT, V54; Sasagawa T, 2012, J MED VIROL, V84, P138, DOI 10.1002/jmv.22195; Sinclair RG, 2008, ADV APPL MICROBIOL, V65, P249, DOI 10.1016/S0065-2164(08)00609-6; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; Syrjanen S., 2000, PAPILLOMAVIRUS INFEC; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x	41	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52391	10.1371/journal.pone.0052391	http://dx.doi.org/10.1371/journal.pone.0052391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341898	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400015
J	Schmiegelow, C; Minja, D; Oesterholt, M; Pehrson, C; Suhrs, HE; Bostrom, S; Lemnge, M; Magistrado, P; Rasch, V; Nielsen, BB; Lusingu, J; Theander, TG				Schmiegelow, Christentze; Minja, Daniel; Oesterholt, Mayke; Pehrson, Caroline; Suhrs, Hannah Elena; Bostrom, Stephanie; Lemnge, Martha; Magistrado, Pamela; Rasch, Vibeke; Nielsen, Birgitte Bruun; Lusingu, John; Theander, Thor G.			Malaria and Fetal Growth Alterations in the 3rd Trimester of Pregnancy: A Longitudinal Ultrasound Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; RAPID DIAGNOSTIC-TESTS; INTRAUTERINE GROWTH; PERINATAL-MORTALITY; SERIAL ULTRASOUND; MATERNAL MALARIA; BLOOD-FLOW; INFECTION; ANEMIA; RETARDATION	Background: Pregnancy associated malaria is associated with decreased birth weight, but in-utero evaluation of fetal growth alterations is rarely performed. The objective of this study was to investigate malaria induced changes in fetal growth during the 3rd trimester using trans-abdominal ultrasound. Methods: An observational study of 876 pregnant women (398 primi- and secundigravidae and 478 multigravidae) was conducted in Tanzania. Fetal growth was monitored with ultrasound and screening for malaria was performed regularly. Birth weight and fetal weight were converted to z-scores, and fetal growth evaluated as fetal weight gain from the 26th week of pregnancy. Results: Malaria infection only affected birth weight and fetal growth among primi- and secundigravid women. Forty-eight of the 398 primi- and secundigravid women had malaria during pregnancy causing a reduction in the newborns z-score of -0.50 (95% CI: -0.86, in -0.13, P = 0.008, multiple linear regression). Fifty-eight percent (28/48) of the primi- and secundigravidae had malaria in the first half of pregnancy, but an effect on fetal growth was observed in the 3rd trimester with an OR of 4.89 for the fetal growth rate belonging to the lowest 25% in the population (95% CI: 2.03-11.79, P<0.001, multiple logistic regression). At an individual level, among the primi- and secundigravidae, 27% experienced alterations of fetal growth immediately after exposure but only for a short interval, 27% only late in pregnancy, 16.2% persistently from exposure until the end of pregnancy, and 29.7% had no alterations of fetal growth. Conclusions: The effect of malaria infections was observed during the 3rd trimester, despite infections occurring much earlier in pregnancy, and different mechanisms might operate leading to different patterns of growth alterations. This study highlights the need for protection against malaria throughout pregnancy and the recognition that observed changes in fetal growth might be a consequence of an infection much earlier in pregnancy.	[Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Suhrs, Hannah Elena; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Minja, Daniel; Lemnge, Martha; Lusingu, John] Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania; [Oesterholt, Mayke] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Pehrson, Caroline] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bostrom, Stephanie] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, DK-5000 Odense, Denmark; [Nielsen, Birgitte Bruun] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark; [Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Suhrs, Hannah Elena; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark	University of Copenhagen; National Institute of Medical Research; Radboud University Nijmegen; University of Copenhagen; Stockholm University; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Copenhagen	Schmiegelow, C (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	chsch@sund.ku.dk	Theander, Thor/F-6714-2015; Rasch, Vibeke/G-9393-2019; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Rasch, Vibeke/0000-0001-6557-0985; Lusingu, John P. A./0000-0002-9407-0602; Pehrson, Caroline/0000-0002-5736-4847; shmiegelow, christentze/0000-0002-9360-9741	European Union Framework 7 (STOPPAM, Tanzania) [200889]; Copenhagen University PhD school; Novo Nordisk Fonden [NNF12OC0002118] Funding Source: researchfish	European Union Framework 7 (STOPPAM, Tanzania); Copenhagen University PhD school; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by European Union Framework 7 (STOPPAM, Tanzania) [contract number 200889] (URL: http://cordis.europa.eu/fp7/capacities/research-sme_en.html) and by the Copenhagen University PhD school (URL: http://healthsciences.ku.dk/phd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; CHANG TC, 1993, OBSTET GYNECOL, V82, P230; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Christensen DL, 2011, INT J GYNECOL OBSTET, V115, pS16, DOI 10.1016/S0020-7292(11)60006-4; Claris O, 2010, SEMIN PERINATOL, V34, P207, DOI 10.1053/j.semperi.2010.02.005; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; de Jong CLD, 1998, ULTRASOUND OBST GYN, V11, P39, DOI 10.1046/j.1469-0705.1998.11010039.x; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Griffin JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-319; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Ishaque S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S3; Kalanda BF, 2006, EPIDEMIOL INFECT, V134, P659, DOI 10.1017/S0950268805005285; Kalanda BF, 2005, ARCH DIS CHILD-FETAL, V90, P161, DOI 10.1136/adc.2004.054650; Kalilani L, 2010, T ROY SOC TROP MED H, V104, P416, DOI 10.1016/j.trstmh.2010.01.013; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Mahajan S, 2008, BRIT J NUTR, V100, P408, DOI 10.1017/S000711450889438X; McGready R, 2011, LANCET INFECT DIS; MEURIS S, 1993, AM J TROP MED HYG, V48, P603, DOI 10.4269/ajtmh.1993.48.603; Minja DTR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-211; Mirghani HM, 2005, J OBSTET GYNAECOL RE, V31, P409, DOI 10.1111/j.1447-0756.2005.00311.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mondry A, 2005, ULTRASOUND OBST GYN, V26, P634, DOI 10.1002/uog.2598; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Nahum GG, 2003, AM J OBSTET GYNECOL, V188, P566, DOI 10.1067/mob.2003.155; Ott WJ, 2006, CLIN OBSTET GYNECOL, V49, P295, DOI 10.1097/00003081-200606000-00011; Ott WJ, 2002, AM J PERINAT, V19, P133, DOI 10.1055/s-2002-25313; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-5; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Schmiegelow C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044773; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Scioscia M, 2008, OBSTET GYNECOL, V111, P57, DOI 10.1097/01.AOG.0000296656.81143.e6; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; Umbers AJ, 2011, TRENDS PARASITOL; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	57	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53794	10.1371/journal.pone.0053794	http://dx.doi.org/10.1371/journal.pone.0053794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326508	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800076
J	Gulde, PE; Christen, L; Brown, SV; Williams, N				Gulde, Paul E.; Christen, Linda; Brown, Silvia V.; Williams, Noreen			Three Distinct Isoforms of ATP Synthase Subunit c Are Expressed in T. brucei and Assembled into the Mitochondrial ATP Synthase Complex	PLOS ONE			English	Article							BLOOD-STREAM FORMS; TRYPANOSOMA-BRUCEI; GENE; RING; F-0; SEQUENCES; PROTEINS	One striking feature of the biology of trypanosomes is the changes in mitochondrial structure and function that occur as these parasites transition from one life cycle stage to another. Our laboratory has been interested in the role the mitochondrial ATP synthase plays in mitochondrial changes through the life cycle. Analysis of the recently completed T. brucei genome suggested that there may be multiple putative genes encoding ATP synthase subunit c. While homologous in their 39 ends, these genes differ in their 59 ends and, if expressed, would result in three distinct proteins. Our analysis showed that all three of the possible transcripts were detected in both procyclic and bloodstream stages, although the c-3 transcript was less abundant than that for c-1 or c-2. The three isoforms of subunit c are produced in both the bloodstream and procyclic stages and their mature protein products possess distinct N-terminal regions of the protein as found within mitochondria. All three isoforms are also incorporated into the assembled ATP synthase complex from procyclic cells. Although multiple subunit c genes have been found in other organisms, they produce identical polypeptides and the finding of significant differences in the mature proteins is unique to T. brucei.	[Williams, Noreen] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Williams, N (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	nw1@buffalo.edu			National Institutes of Health [AI-48845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant AI-48845 to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Brown SV, 2001, MOL BIOCHEM PARASIT, V115, P177, DOI 10.1016/S0166-6851(01)00282-1; Chi TB, 1998, MOL BIOCHEM PARASIT, V92, P29, DOI 10.1016/S0166-6851(97)00222-3; CLAYTON C, 1995, MICROBIOL REV, V59, P325, DOI 10.1128/MMBR.59.3.325-344.1995; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; De Grassi A, 2006, GENE, V371, P224, DOI 10.1016/j.gene.2005.11.022; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; GIRVIN ME, 1993, BIOCHEMISTRY-US, V32, P12167, DOI 10.1021/bi00096a029; Hausler T, 1997, EUR J CELL BIOL, V73, P240; HENSGENS LAM, 1979, P NATL ACAD SCI USA, V76, P1663, DOI 10.1073/pnas.76.4.1663; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthews KR, 1999, PARASITOL TODAY, V15, P76, DOI 10.1016/S0169-4758(98)01381-7; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nolan DP, 1991, SOC T, V18, P735; Pogoryelov D, 2012, P NATL ACAD SCI USA, V109, pE1599, DOI 10.1073/pnas.1120027109; PRIEST JW, 1995, BBA-MOL CELL RES, V1269, P201, DOI 10.1016/0167-4889(95)00154-6; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Vives-Bauza C, 2010, MOL BIOL CELL, V21, P131, DOI 10.1091/mbc.E09-06-0483; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WILLIAMS N, 1994, J BIOENERG BIOMEMBR, V26, P173, DOI 10.1007/BF00763066; WILLIAMS N, 1991, ARCH BIOCHEM BIOPHYS, V288, P509, DOI 10.1016/0003-9861(91)90228-B; WILLIAMS N, 1990, MOL BIOCHEM PARASIT, V43, P125, DOI 10.1016/0166-6851(90)90137-B; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	44	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54039	10.1371/journal.pone.0054039	http://dx.doi.org/10.1371/journal.pone.0054039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326569	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400069
J	Bouhlal, S; Chabanet, C; Issanchou, S; Nicklaus, S				Bouhlal, Sofia; Chabanet, Claire; Issanchou, Sylvie; Nicklaus, Sophie			Salt Content Impacts Food Preferences and Intake among Children	PLOS ONE			English	Article							DIETARY SALT; TASTE; SODIUM; VARIABILITY	Decreasing dietary sodium intake, which can be achieved by reducing salt content in food, is recommended. Salt contributes to the taste of foods and makes them more enjoyable. Whether a food is liked or disliked is an important determinant of food intake, especially among children. However, the role of salt in children's food acceptance has received little attention. The impact of salt content on children's hedonic rating and intake of two foods was investigated in children. Using a within-subject crossover design, we recruited 75 children (8-11 years) to participate in five lunches in their school cafeteria. The target foods were green beans and pasta. The added salt content was 0, 0.6 or 1.2 g/100 g. The children's intake (g) of all lunch items was measured. The children provided their hedonic rating of the food, a preference ranking and a saltiness ranking in the laboratory. Children could rank the foods according to salt content, and they preferred the two saltier options. A food-specific effect of salt content on intake was observed. Compared to the intermediate level (0.6 g salt/100 g), not adding salt decreased green bean intake (-21%; p = 0.002), and increasing the salt content increased pasta intake (+24%; p<0.0001). Structural Equation Modeling was used to model the relative weights of the determinants of intake. It showed that the primary driver of food intake was the child's hunger; the second most important factor was the child's hedonic rating of the food, regardless of its salt content, and the last factor was the child's preference for the particular salt content of the food. In conclusion, salt content has a positive and food-specific effect on intake; it impacted food preferences and intake differently in children. Taking into account children's preferences for salt instead of their intake may lead to excessive added salt.	[Bouhlal, Sofia; Chabanet, Claire; Issanchou, Sylvie; Nicklaus, Sophie] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Bouhlal, Sofia; Chabanet, Claire; Issanchou, Sylvie; Nicklaus, Sophie] INRA, UMR1324, Ctr Sci Gout & Alimentat, Ctr Sci, F-21034 Dijon, France; [Bouhlal, Sofia; Chabanet, Claire; Issanchou, Sylvie; Nicklaus, Sophie] Univ Bourgogne, Ctr Sci Gout & Alimentat, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Nicklaus, S (corresponding author), CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France.	sophie.nicklaus@dijon.inra.fr		Nicklaus, Sophie/0000-0002-0659-2823	PhD grant from the Nutrition, Chemical Food Safety and Consumer Behavior Division of INRA (French National Institute for Agronomical Research, France); Regional Council of Burgundy (France); research grant (Gustolf) from Regional Council of Burgundy (France)	PhD grant from the Nutrition, Chemical Food Safety and Consumer Behavior Division of INRA (French National Institute for Agronomical Research, France); Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte); research grant (Gustolf) from Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte)	This work was supported by a PhD grant from the Nutrition, Chemical Food Safety and Consumer Behavior Division of INRA (French National Institute for Agronomical Research, France) and the Regional Council of Burgundy (France) received by SB; and by a research grant (Gustolf) from Regional Council of Burgundy (France) received by SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SO, 1995, J AM DIET ASSOC, V95, P447, DOI 10.1016/S0002-8223(95)00120-4; [Anonymous], 2004, INTER DISC; *ASTM, 2003, STAND GUID SENS EV P; BELLISLE F, 1988, SCI ALIMENT, V8, P557; BERTINO M, 1986, PHYSIOL BEHAV, V38, P203, DOI 10.1016/0031-9384(86)90155-1; BIRCH LL, 1991, NEW ENGL J MED, V324, P232, DOI 10.1056/NEJM199101243240405; Bouhlal S, 2011, BRIT J NUTR, V105, P645, DOI 10.1017/S0007114510003752; Breslin PAS, 1995, CHEM SENSES, V20, P609, DOI 10.1093/chemse/20.6.609; Busing FMTA, 2005, SCI ULDOP FOSAB, P108; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Eliott P, 2007, SODIUM INTAKES WORLD; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Groupe d'Etude des Marches de Restauration Collective et de Nutrition, 2007, REC TERMS NUTR; Hayes JE, 2010, PHYSIOL BEHAV, V100, P369, DOI 10.1016/j.physbeh.2010.03.017; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; JOOSSENS JV, 1987, AM J CLIN NUTR, V45, P1277, DOI 10.1093/ajcn/45.5.1277; Leshem M, 2009, NEUROSCI BIOBEHAV R, V33, P1, DOI 10.1016/j.neubiorev.2008.07.007; LITTLE TD, 2007, MODELING CONTEXTUAL, P207, DOI DOI 10.1198/TECH.2006.S369; Long J, 1991, CONFIRMATORY FACTOR; LUCAS F, 1987, PHYSIOL BEHAV, V39, P739, DOI 10.1016/0031-9384(87)90259-9; Mannino ML, 2004, INT J BEHAV NUTR PHY, V1, P5, DOI DOI 10.1016/j.jada.2009.02.010; Matsuzuki H, 2008, TOHOKU J EXP MED, V215, P71, DOI 10.1620/tjem.215.71; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Meneton P, 2009, EUR J CLIN NUTR, V63, P1169, DOI 10.1038/ejcn.2009.57; Michael C., 2010, LONGPOWER POWER SAMP; Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Popper R, 2005, J SENS STUD, V20, P75, DOI 10.1111/j.1745-459X.2005.00007.x; Rodriguez G, 2006, NUTR METAB CARDIOVAS, V16, P294, DOI 10.1016/j.numecd.2005.08.005; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; SACN, 2003, SCI ADV COMM NUTR SA, P1; Shepherd R, 1988, Nutr Res Rev, V1, P125, DOI 10.1079/NRR19880011; SHEPHERD R, 1984, APPETITE, V5, P187, DOI 10.1016/S0195-6663(84)80014-8; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391	36	42	42	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53971	10.1371/journal.pone.0053971	http://dx.doi.org/10.1371/journal.pone.0053971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342052	Green Published, gold			2022-12-27	WOS:000313682700069
J	Sung, KC; Choi, JH; Gwon, HC; Choi, SH; Kim, BS; Kwag, HJ; Kim, SH				Sung, Ki-Chul; Choi, Jin-Ho; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk; Kim, Bum-Soo; Kwag, Hyon Joo; Kim, Sun H.			Relationship between Insulin Resistance and Coronary Artery Calcium in Young Men and Women	PLOS ONE			English	Article							RISK-FACTOR LEVELS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; CALCIFICATION; QUANTIFICATION; METAANALYSIS; ASSOCIATION; PROGRESSION; PREVALENCE	Background: The gender disparity in cardiovascular disease (CVD) risk is greatest between young men and women. However, the causes of that are not fully understood. The objective of this study was to evaluate the relationship between insulin resistance and the presence of coronary artery calcium (CAC) to identify risk factors that may predispose young men and women to CVD. Methodology/Principal Findings: Insulin resistance and CVD risk factors were examined in 8682 Korean men and 1829 women aged 30-45 years old. Insulin resistance was estimated using the homeostasis model assessment of insulin resistance (HOMA-IR), and CAC was measured using computed tomography. Women were less likely to be insulin resistant (upper quartile of HOMA-IR, 18% vs. 27%, p<0.001) and had a lower prevalence of CAC (1.6% vs. 6.4%, p<0.001). Even when equally insulin resistant men and women were compared, women continued to have lower prevalence of CAC (3.1% vs. 7.2%, p = 0.004) and a more favorable CVD risk profile. Finally, after adjustment for traditional CVD risk factors, insulin resistance remained an independent predictor of CAC only in men (p = 0.03). Conclusions/Significance: Young women have a lower risk for CVD and a lower CAC prevalence compared with men. This favorable CVD risk profile in women appears to occur regardless of insulin sensitivity. Unlike men, insulin resistance was not a predictor of CAC in women in this cohort. Therefore, insulin resistance has less impact on CVD risk and CAC in young women compared with men, and insulin resistance alone does not explain the gender disparity in CVD risk that is observed at an early age.	[Sung, Ki-Chul; Kim, Bum-Soo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Med, Seoul, South Korea; [Choi, Jin-Ho; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol,Cardiac & Vasc Ctr, Seoul, South Korea; [Kwag, Hyon Joo] Univ Sch Med, Kangbuk Samsung Hosp Sungkyunkwan, Dept Radiol, Seoul, South Korea; [Kim, Sun H.] Stanford Univ, Dept Med, Sch Med, Div Endocrinol, Stanford, CA 94305 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Stanford University	Sung, KC (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Med, Seoul, South Korea.	kcmd.sung@samsung.com		Choi, Seung-Hyuk/0000-0002-0304-6317; Kim, Sun/0000-0003-0895-7491	Samsung Biomedical Research Institute grant [SBRI C-B1-114-1]; NIH Career Development Award [K23 MH079114]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079114] Funding Source: NIH RePORTER	Samsung Biomedical Research Institute grant(Samsung); NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by a Samsung Biomedical Research Institute grant [SBRI C-B1-114-1]. S.H.K. is funded by a NIH Career Development Award [K23 MH079114]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2001, ARTERIOSCL THROM VAS, V21, P2051, DOI 10.1161/hq1201.100257; Cavanaugh-Hussey MW, 2008, PREV MED, V47, P619, DOI 10.1016/j.ypmed.2008.07.012; Chen K, 2008, DIABETES VASC DIS RE, V5, P96, DOI 10.3132/dvdr.2008.016; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colhoun HM, 2000, J AM COLL CARDIOL, V36, P2160, DOI 10.1016/S0735-1097(00)00986-4; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Ho JE, 2005, J WOMENS HEALTH, V14, P117, DOI 10.1089/jwh.2005.14.117; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jeppesen J, 2007, J AM COLL CARDIOL, V49, P2112, DOI 10.1016/j.jacc.2007.01.088; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; Larsson CA, 2005, DIABETES CARE, V28, P2246, DOI 10.2337/diacare.28.9.2246; Lee KK, 2009, AM HEART J, V157, P939, DOI 10.1016/j.ahj.2009.02.006; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Newman AB, 2002, ARTERIOSCL THROM VAS, V22, P424, DOI 10.1161/hq0302.105357; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Reilly MP, 2004, CIRCULATION, V110, P803, DOI 10.1161/01.CIR.0000138740.84883.9C; Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764; Sekikawa A, 2005, INT J EPIDEMIOL, V34, P173, DOI 10.1093/ije/dyh285; Taylor AJ, 2001, AM HEART J, V141, P463, DOI 10.1067/mhj.2001.113069; Wannamethee SG, 2011, DIABETOLOGIA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53316	10.1371/journal.pone.0053316	http://dx.doi.org/10.1371/journal.pone.0053316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341938	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700025
J	Breard, E; Lara, E; Comtet, L; Viarouge, C; Doceul, V; Desprat, A; Vitour, D; Pozzi, N; Cay, AB; De Regge, N; Pourquier, P; Schirrmeier, H; Hoffmann, B; Beer, M; Sailleau, C; Zientara, S				Breard, Emmanuel; Lara, Estelle; Comtet, Loic; Viarouge, Cyril; Doceul, Virginie; Desprat, Alexandra; Vitour, Damien; Pozzi, Nathalie; Cay, Ann Brigitte; De Regge, Nick; Pourquier, Philippe; Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin; Sailleau, Corinne; Zientara, Stephan			Validation of a Commercially Available Indirect Elisa Using a Nucleocapside Recombinant Protein for Detection of Schmallenberg Virus Antibodies	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; G1-GLYCOPROTEIN; EPITOPES; ASSAY	A newly developed Enzym Like Immuno Sorbant Assay (ELISA) based on the recombinant nucleocapsid protein (N) of Schmallenberg virus (SBV) was evaluated and validated for the detection of SBV-specific IgG antibodies in ruminant sera by three European Reference Laboratories. Validation data sets derived from sheep, goat and bovine sera collected in France and Germany (n = 1515) in 2011 and 2012 were categorized according to the results of a virus neutralization test (VNT) or an indirect immuno-flurorescence assay (IFA). The specificity was evaluated with 1364 sera from sheep, goat and bovine collected in France and Belgium before 2009. Overall agreement between VNT and ELISA was 98.9% and 98.3% between VNT and IFA, indicating a very good concordance between the different techniques. Although cross-reactions with other Orthobunyavirus from the Simbu serogroup viruses might occur, it is a highly sensitive, specific and robust ELISA-test validated to detect anti-SBV antibodies. This test can be applied for SBV sero-diagnostics and disease-surveillance studies in ruminant species in Europe.	[Breard, Emmanuel; Lara, Estelle; Viarouge, Cyril; Doceul, Virginie; Desprat, Alexandra; Vitour, Damien; Sailleau, Corinne; Zientara, Stephan] French Agcy Food Environm & Occupat Hlth & Safety, Virol Unit, Maisons Alfort, France; [Comtet, Loic; Pourquier, Philippe] IDVet Soc, Montpellier, France; [Schirrmeier, Horst; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Diagnost Virol Unit, Riems, Germany; [Pozzi, Nathalie] Natl Lab Control Breeding Anim, Maisons Alfort, France; [Cay, Ann Brigitte; De Regge, Nick] Vet & Agrochem Res Ctr, Enzoot & Reemerging Dis Unit, Brussels, Belgium	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Friedrich Loeffler Institute; Ecole Nationale Veterinaire d'Alfort (ENVA)	Breard, E (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Virol Unit, Maisons Alfort, France.	emmanuel.breard@anses.fr	Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021; breard, emmanuel/E-2123-2011	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503; 				Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; Elliott RM, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1; Gonzalez-Scarano F, 1983, Prog Clin Biol Res, V123, P145; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Kim HJ, 2012, J VET MED SCI, V74, P321, DOI 10.1292/jvms.11-0259; KINGSFORD L, 1983, VIROLOGY, V129, P443, DOI 10.1016/0042-6822(83)90182-4; KINGSFORD L, 1990, J GEN VIROL, V71, P523, DOI 10.1099/0022-1317-71-3-523; Loeffen W, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-44; Nakauchi M, 2009, CLIN VACCINE IMMUNOL, V16, P1132, DOI 10.1128/CVI.00163-09; Nicacio CD, 2001, J GEN VIROL, V82, P129, DOI 10.1099/0022-1317-82-1-129; Parsonson I. M., 1982, Viral diseases in South-East Asia and the Western Pacific. Proceedings of an International Seminar, Canberra, Australia, 8-12 February 1982, P644; PEKOSZ A, 1995, J VIROL, V69, P3475, DOI 10.1128/JVI.69.6.3475-3481.1995; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Saijo M, 2002, J CLIN MICROBIOL, V40, P1587, DOI 10.1128/JCM.40.5.1587-1591.2002; Saijo M, 2007, CLIN VACCINE IMMUNOL, V14, P1182, DOI 10.1128/CVI.00101-07; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Yanase T, 2012, ARCH VIROL, V157, P1611, DOI 10.1007/s00705-012-1341-8; Yoshida K, 1998, CLIN DIAGN LAB IMMUN, V5, P192, DOI 10.1128/CDLI.5.2.192-198.1998	20	58	68	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53446	10.1371/journal.pone.0053446	http://dx.doi.org/10.1371/journal.pone.0053446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335964	Green Published, gold			2022-12-27	WOS:000314707700018
J	Kwena, ZA; Camlin, CS; Shisanya, CA; Mwanzo, I; Bukusi, EA				Kwena, Zachary A.; Camlin, Carol S.; Shisanya, Chris A.; Mwanzo, Isaac; Bukusi, Elizabeth A.			Short-Term Mobility and the Risk of HIV Infection among Married Couples in the Fishing Communities along Lake Victoria, Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TANZANIAN COUPLES; DOUBLE-STANDARD; BEHAVIOR; MEN; PREVALENCE; MIGRATION; WOMEN; POPULATION; FISHERFOLK	Objective: Mobility has long been associated with high HIV prevalence. We sought to assess sex differences in the relationship between mobility and risk for HIV infection among married couples in the fishing communities. Methods: We conducted 1090 gender-matched interviews and rapid HIV testing with 545 couples proportionally representing all the different sizes of the fish-landing beaches in Kisumu County. We contacted a random sample of fishermen as our index participants and asked them to enrol in the study together with their spouses. The consenting couples were separated into different private rooms for concurrent interviews and thereafter reunited for couple rapid HIV counselling and testing. In addition to socio-economic and behavioural data, we collected information on overnight travels and divided couples in 4 groups as follows both partners not mobile, both partners mobile, only woman mobile, and only man mobile. Other than descriptive statistics, we used X-2 and U tests to compare groups of variables and multivariate logistic regression to measure association between mobility and HIV infection. Results: We found significant differences in the number of trips women travelled in the preceding month (mean 4.6, SD 7.1) compared to men (mean 3.3, SD 4.9; p<0.01) and when the women did travel, they were more likely to spend more days away from home than their male partners (mean 5.2 [SD 7.2] versus 3.4 SD 5.6; p = 0.01). With an HIV prevalence of 22.7% in women compared to 20.9% among men, mobile women who had non-mobile spouses had 2.1 times the likelihood of HIV infection compared to individuals in couples where both partners were non-mobile. Conclusion: The mobility of fishermen's spouses is associated with HIV infection that is not evident among fishermen themselves. Therefore, interventions in this community could be a combination of sex-specific programming that targets women and combined programming for couples.	[Kwena, Zachary A.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Shisanya, Chris A.] Kenyatta Univ, Dept Geog, Nairobi, Kenya; [Mwanzo, Isaac] Kenyatta Univ, Dept Publ Hlth, Nairobi, Kenya	Kenya Medical Research Institute; University of California System; University of California San Francisco; Kenyatta University; Kenyatta University	Kwena, ZA (corresponding author), Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya.	zkwena@kemri-ucsf.org	Allan, Chrsitopher Shisanya/ABE-7816-2020	Allan, Chrsitopher Shisanya/0000-0002-2137-0372	Consortium for National Health Research (CNHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH093205] Funding Source: NIH RePORTER	Consortium for National Health Research (CNHR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the Consortium for National Health Research (CNHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MG, 2003, J SEX RES, V40, P27, DOI 10.1080/00224490309552164; Allison EH, 2004, FISH FISH, V5, P215, DOI 10.1111/j.1467-2679.2004.00153.x; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2008, RESH EC GEOGR; Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Bloor M, 1998, LANCET, V352, P1664, DOI 10.1016/S0140-6736(98)09414-8; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Chappell L, 2009, MAXIMISING DEV OUTCO; Clark S, 2011, INT PERSPECT SEX R H, V37, P181, DOI 10.1363/3718111; Collinson M., 2006, AFRICA MOVE AFRICAN, P194; Crawford M, 2003, J SEX RES, V40, P13, DOI 10.1080/00224490309552163; Croughs M, 2008, J TRAVEL MED, V15, P6, DOI 10.1111/j.1708-8305.2007.00160.x; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Gupta K, 2010, AIDS BEHAV, V14, P18, DOI 10.1007/s10461-010-9738-4; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; KAIS (Kenya AIDS Indicator Survey), 2009, KEN AIDS IND SURV 20; Katz J, 2000, SEX ROLES, V42, P781, DOI 10.1023/A:1007051131544; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Kwena ZA, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/865903; Lippman SA, 2007, SOC SCI MED, V65, P2464, DOI 10.1016/j.socscimed.2007.07.002; Lyons H, 2011, J SEX RES, V48, P437, DOI 10.1080/00224499.2010.506679; Marks MJ, 2006, SEX ROLES, V54, P19, DOI 10.1007/s11199-006-8866-9; Markussen M., 2002, COPING UNCERTAINTY W; Mercer CH, 2007, SEX TRANSM INFECT, V83, P517, DOI 10.1136/sti.2007.026377; Ministry of Planning and National Development, 2008, KIS E DISTR DEV PLAN; NACC, 2009, KEN AN HIV PREV RESP; NACC and NASCOP, 2009, KEN 2007 HIV AIDS ES; Nagoli J, 2010, AJAR-AFR J AIDS RES, V9, P71, DOI 10.2989/16085906.2010.484575; Nepal B, 2007, J HEALTH POPUL NUTR, V25, P267; Ng'ayo MO, 2008, SEX TRANSM INFECT, V84, P140, DOI 10.1136/sti.2007.028795; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; SMITH TW, 1992, SOC BIOL, V39, P203; Sopheab H, 2006, JAIDS-J ACQ IMM DEF, V41, P81, DOI 10.1097/01.qai.0000174654.25535.f7; Sprecher S, 1998, J SEX RES, V12, P45; Uretsky E, 2008, CULT HEALTH SEX, V10, P801, DOI 10.1080/13691050802380966; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Ward BJ, 2006, J TRAVEL MED, V13, P300, DOI 10.1111/j.1708-8305.2006.00061.x	44	62	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54523	10.1371/journal.pone.0054523	http://dx.doi.org/10.1371/journal.pone.0054523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336005	Green Published, gold			2022-12-27	WOS:000314707700063
J	Masubuchi, Y; Nakagawa, Y; Ma, JH; Sasaki, T; Kitamura, T; Yamamoto, Y; Kurose, H; Kojima, I; Shibata, H				Masubuchi, Yosuke; Nakagawa, Yuko; Ma, Jinhui; Sasaki, Tsutomu; Kitamura, Tadahiro; Yamamoto, Yoritsuna; Kurose, Hitoshi; Kojima, Itaru; Shibata, Hiroshi			A Novel Regulatory Function of Sweet Taste-Sensing Receptor in Adipogenic Differentiation of 3T3-L1 Cells	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; GTP-BINDING PROTEIN; ENTEROENDOCRINE CELLS; SIGNAL-TRANSDUCTION; MAMMALIAN SWEET; RAT ADIPOCYTES; ACTIVATION; ENDOTHELIN-1; EXPRESSION; GUSTDUCIN	Background: Sweet taste receptor is expressed not only in taste buds but also in nongustatory organs such as enteroendocrine cells and pancreatic beta-cells, and may play more extensive physiological roles in energy metabolism. Here we examined the expression and function of the sweet taste receptor in 3T3-L1 cells. Methodology/Principal Findings: In undifferentiated preadipocytes, both T1R2 and T1R3 were expressed very weakly, whereas the expression of T1R3 but not T1R2 was markedly up-regulated upon induction of differentiation (by 83.0 and 3.8-fold, respectively at Day 6). The alpha subunits of Gs (G alpha s) and G14 (G alpha 14) but not gustducin were expressed throughout the differentiation process. The addition of sucralose or saccharin during the first 48 hours of differentiation considerably reduced the expression of peroxisome proliferator activated receptor gamma (PPAR gamma and CCAAT/enhancer-binding protein alpha (C/EBP alpha at Day 2, the expression of aP2 at Day 4 and triglyceride accumulation at Day 6. These anti-adipogenic effects were attenuated by short hairpin RNA-mediated gene-silencing of T1R3. In addition, overexpression of the dominant-negative mutant of Gas but not YM-254890, an inhibitor of G alpha 14, impeded the effects of sweeteners, suggesting a possible coupling of Gs with the putative sweet taste-sensing receptor. In agreement, sucralose and saccharin increased the cyclic AMP concentration in differentiating 3T3-L1 cells and also in HEK293 cells heterologously expressing T1R3. Furthermore, the anti-adipogenic effects of sweeteners were mimicked by Gs activation with cholera toxin but not by adenylate cyclase activation with forskolin, whereas small interfering RNA-mediated knockdown of Gas had the opposite effects. Conclusions: 3T3-L1 cells express a functional sweet taste-sensing receptor presumably as a T1R3 homomer, which mediates the anti-adipogenic signal by a Gs-dependent but cAMP-independent mechanism.	[Masubuchi, Yosuke; Nakagawa, Yuko; Ma, Jinhui; Kojima, Itaru; Shibata, Hiroshi] Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Sasaki, Tsutomu; Kitamura, Tadahiro] Gunma Univ, Metabol Signal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Yamamoto, Yoritsuna] Natl Def Med Coll, Def Med Res Inst, Div Environm Med, Tokorozawa, Saitama 359, Japan; [Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 812, Japan	Gunma University; Gunma University; National Defense Medical College - Japan; Kyushu University	Shibata, H (corresponding author), Gunma Univ, Dept Cell Biol, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	hshibata@gunma-u.ac.jp		Sasaki, Tsutomu/0000-0001-8041-1915	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders" and grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; Bystrova MF, 2010, J CELL SCI, V123, P972, DOI 10.1242/jcs.061879; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2006, CHEM SENSES, V31, P573, DOI 10.1093/chemse/bjj062; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; Delay ER, 2006, CHEM SENSES, V31, P351, DOI 10.1093/chemse/bjj039; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hattori H, 2006, BIOCHEM BIOPH RES CO, V343, P1118, DOI 10.1016/j.bbrc.2006.03.061; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Imamura T, 1999, J BIOL CHEM, V274, P33691, DOI 10.1074/jbc.274.47.33691; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kojima I, 2011, DIABETES METAB J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Lawrence JTR, 2001, MOL CELL BIOL, V21, P5276, DOI 10.1128/MCB.21.15.5276-5285.2001; LEE E, 1992, J BIOL CHEM, V267, P1212; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu XX, 1998, J BIOL CHEM, V273, P11685, DOI 10.1074/jbc.273.19.11685; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034489; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; NAIM M, 1991, COMP BIOCHEM PHYS B, V100, P455, DOI 10.1016/0305-0491(91)90203-P; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nakashima K, 1999, CELL PHYSIOL BIOCHEM, V9, P90, DOI 10.1159/000016305; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; OLANSKY L, 1983, P NATL ACAD SCI-BIOL, V80, P6547, DOI 10.1073/pnas.80.21.6547; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TANAHASHI T, 1991, BIOCHEM BIOPH RES CO, V177, P854, DOI 10.1016/0006-291X(91)91868-D; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Trubey KR, 2006, AM J PHYSIOL-CELL PH, V291, pC237, DOI 10.1152/ajpcell.00303.2005; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang L, 2009, J ENDOCRINOL, V202, P207, DOI 10.1677/JOE-09-0099; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zheng B, 2004, MOL BIOL CELL, V15, p322A, DOI 10.1091/mbc.e04-06-0446	53	70	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54500	10.1371/journal.pone.0054500	http://dx.doi.org/10.1371/journal.pone.0054500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336004	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700062
J	Su, LJ; Chang, CC; Yang, CH; Hsieh, SJ; Wu, YC; Lai, JM; Tseng, TL; Huang, CYF; Hsu, SL				Su, Li-Jen; Chang, Chia-Chuan; Yang, Chih-Hsueh; Hsieh, Shur-Jong; Wu, Yi-Chin; Lai, Jin-Mei; Tseng, Tzu-Ling; Huang, Chi-Ying F.; Hsu, Shih-Lan			Graptopetalum Paraguayense Ameliorates Chemical-Induced Rat Hepatic Fibrosis In Vivo and Inactivates Stellate Cells and Kupffer Cells In Vitro	PLOS ONE			English	Article							LIVER-INJURY; CARBON-TETRACHLORIDE; GENE-EXPRESSION; INTERLEUKIN-10; MECHANISMS; COLLAGEN; DIMETHYLNITROSAMINE; ALCOHOL; HEPATOTOXICITY; SENSITIZATION	Background: Graptopetalum paraguayense (GP) is a folk herbal medicine with hepatoprotective effects that is used in Taiwan. The aim of this study was to evaluate the hepatoprotective and antifibrotic effects of GP on experimental hepatic fibrosis in both dimethylnitrosamine (DMN)- and carbon tetrachloride (CCl4)-induced liver injury rats. Methods: Hepatic fibrosis- induced rats were fed with the methanolic extract of GP (MGP) by oral administration every day. Immunohistochemistry, biochemical assays, and Western blot analysis were performed. The effects of MGP on the expression of fibrotic markers and cytokines in the primary cultured hepatic stellate cells (HSCs) and Kupffer cells, respectively, were evaluated. Results: Oral administration of MGP significantly alleviated DMN- or CCl4-induced liver inflammation and fibrosis. High levels of alanine transaminase, aspartate transaminase, bilirubin, prothrombin activity and mortality rates also decreased in rats treated with MGP. There were significantly decreased hydroxyproline levels in therapeutic rats compared with those of the liver-damaged rats. Collagen I and alpha smooth muscle actin (alpha-SMA) expression were all reduced by incubation with MGP in primary cultured rat HSCs. Furthermore, MGP induced apoptotic cell death in activated HSCs. MGP also suppressed lipopolysaccharide-stimulated rat Kupffer cell activation by decreasing nitric oxide, tumor necrosis factor-alpha and interleukin-6 production, and increasing interleukin-10 expression. Conclusions: The results show that the administration of MGP attenuated toxin-induced hepatic damage and fibrosis in vivo and inhibited HSC and Kupffer cell activation in vitro, suggesting that MGP might be a promising complementary or alternative therapeutic agent for liver inflammation and fibrosis.	[Su, Li-Jen] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Chang, Chia-Chuan] Natl Res Inst Chinese Med, Div Med Chem, Taipei, Taiwan; [Yang, Chih-Hsueh; Hsieh, Shur-Jong; Wu, Yi-Chin; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei Cty, Taiwan; [Tseng, Tzu-Ling] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Biomarker Technol Dev Div, Hsinchu, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Central University; National Research Institute of Chinese Medicine; Taichung Veterans General Hospital; Fu Jen Catholic University; Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw; h2326@vghtc.gov.tw	Chang, Chia-Chuan/A-5518-2009; Lai, Jin-Mei/AAM-4119-2020; Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Chang, Chia-Chuan/0000-0002-1297-9602; Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Su, Li-Jen/0000-0002-8342-9800	National Science Council [NSC100-2627-B-010-005, NSC99-2112-M-008-012, NSC99-2811-M-008-053, NSC101-2320-B-008-001-MY3, NSC99-2627-B-030-001]; National Health Research Institutes [NHRI-EX101-10029BI]; Ministry of Economic Affairs [100-EC-17-A-17-S1-152]; Ministry of Education, Aim for the Top University Plan (National Yang Ming University); Committee on Chinese Medicine and Pharmacy [CCMP-RD-047, CCMP-95-RD-208, 94DOH028]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Economic Affairs; Ministry of Education, Aim for the Top University Plan (National Yang Ming University); Committee on Chinese Medicine and Pharmacy	This research was supported by grants from the National Science Council (NSC100-2627-B-010-005), the National Health Research Institutes (NHRI-EX101-10029BI), Ministry of Economic Affairs (100-EC-17-A-17-S1-152) and the Ministry of Education, Aim for the Top University Plan (National Yang Ming University) to CYH. This work was supported in part by the grants from the Committee on Chinese Medicine and Pharmacy (CCMP-RD-047; CCMP-95-RD-208; 94DOH028) to SLH, the grants from National Science Council (NSC99-2112-M-008-012, NSC99-2811-M-008-053 and NSC101-2320-B-008-001-MY3) to LJS, and (NSC99-2627-B-030-001) to JML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Andres D, 2003, BIOCHEM PHARMACOL, V66, P917, DOI 10.1016/S0006-2952(03)00443-X; ARAI T, 1995, J IMMUNOL, V155, P5743; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Chen SJ, 2008, AM J CHINESE MED, V36, P369, DOI 10.1142/S0192415X08005837; Chen SJ, 2007, FOOD CHEM, V100, P5; Chung YC, 2005, FOOD CHEM, V91, P419, DOI 10.1016/j.foodchem.2004.06.022; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Enomoto N, 1998, GASTROENTEROLOGY, V115, P443, DOI 10.1016/S0016-5085(98)70211-2; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GANDHI CR, 1990, J BIOL CHEM, V265, P18234; GASCONBARRE M, 1989, J HISTOCHEM CYTOCHEM, V37, P377, DOI 10.1177/37.3.2465335; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Huang B, 2010, J ETHNOPHARMACOL, V131, P276, DOI 10.1016/j.jep.2010.06.029; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JEZEQUEL AM, 1987, J HEPATOL, V5, P174, DOI 10.1016/S0168-8278(87)80570-6; Kaplowitz N, 1997, GASTROENTEROLOGY, V113, P1408, DOI 10.1053/gast.1997.v113.agast971131408; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; LASKIN DL, 1990, SEMIN LIVER DIS, V10, P293, DOI 10.1055/s-2008-1040485; LIN JM, 1993, AM J CHINESE MED, V21, P59, DOI 10.1142/S0192415X9300008X; LISSOOS TW, 1992, J PEDIATR GASTR NUTR, V15, P225, DOI 10.1097/00005176-199210000-00001; Louis H, 1997, GASTROENTEROLOGY, V112, P935, DOI 10.1053/gast.1997.v112.pm9041256; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; MAVIER P, 1995, J HEPATOL, V22, P111; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pines M, 1997, J HEPATOL, V27, P391, DOI 10.1016/S0168-8278(97)80186-9; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; ROJKIND M, 1974, ANAL BIOCHEM, V57, P1, DOI 10.1016/0003-2697(74)90043-8; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Su LJ, 2006, GENE EXPRESSION, V13, P107, DOI 10.3727/000000006783991872; Suzuki S, 1996, HEPATOLOGY, V24, P219; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; VANVLASSELAER P, 1994, J CELL BIOL, V124, P569, DOI 10.1083/jcb.124.4.569; WINWOOD PJ, 1993, SEMIN LIVER DIS, V13, P50, DOI 10.1055/s-2007-1007337	42	22	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53988	10.1371/journal.pone.0053988	http://dx.doi.org/10.1371/journal.pone.0053988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335984	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700042
J	Zeng, T; Guo, FF; Zhang, CL; Song, FY; Zhao, XL; Xie, KQ				Zeng, Tao; Guo, Fang-Fang; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin			Roles of Cytochrome P4502E1 Gene Polymorphisms and the Risks of Alcoholic Liver Disease: A Meta-Analysis	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; METABOLIZING ENZYMES; LIPID-PEROXIDATION; EXPOSURE OCCURS; P450IIE1 GENE; CYP2E1 GENE; FATTY LIVER; 2E1 GENE; ETHANOL; CIRRHOSIS	Background: Previous studies investigating the association between cytochrome P4502E1 (CYP2E1) polymorphisms and the risk of alcoholic liver diseases (ALD) have yielded conflicting results. Thus, a meta-analysis was performed to clarify the association between CYP2E1 polymorphisms and the risks of ALD. Methods: A comprehensive literature search was conducted to identify the relevant studies. The fixed or random effect model was selected based on the heterogeneity test among studies. Publication bias was estimated using Begg's funnel plots and Egger's regression test. Results: A total of 27 and 9 studies were finally included for the association between the CYP2E1 Pst I/Rsa I or Dra I polymorphisms and the risks of ALD, respectively. Overall, the combined results showed that homozygous genotype c2c2 was significantly associated with increase risk of ALD in worldwide populations (c2c2 vs. c1c1: OR = 3.12, 95% CI 1.91-5.11) when ALD patients were compared with alcoholics without ALD. Significant associations between CYP2E1 Pst I/Rsa I polymorphism and ALD risk were also observed in Asians (c2c2 vs. c1c1: OR = 4.11, 95% CI 2.32-7.29) and in Caucasians (c2c2/c1c2 vs. c1c1: OR = 1.58, 95% CI 1.04-2.42) when ALD patients were compared with alcoholics without ALD. However, subgroup analysis stratified by ALD types showed that CYP2E1 Pst I/Rsa I polymorphism was not significantly associated with the risks of alcoholic cirrhosis (ALC). No significant association was observed between CYP2E1 Dra I polymorphism and ALD risks. Conclusion: This meta-analysis suggested that CYP2E1 Pst I/Rsa I polymorphism might be not significantly associated with advanced form of ALD (ALC), but might be significantly associated with other form of ALD such as steatosis, hepatisis, fibrosis. Furthermore, CYP2E1 Dra I polymorphism might be not significantly associated with the ALD risks. Since potential confounders could not be ruled out completely, further studies were needed to confirm these results.	[Zeng, Tao; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China; [Guo, Fang-Fang] Shandong Univ, Qilu Hosp, Dept Pharm, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Xie, KQ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn	Zeng, T/CAJ-0684-2022	Zeng, T/0000-0002-1145-2059	National Science Foundation of China [81102153]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by a grant from the National Science Foundation of China (No. 81102153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agundez J, 1996, LIVER, V16, P380; BADGER TM, 1993, BIOCHEM BIOPH RES CO, V190, P780, DOI 10.1006/bbrc.1993.1117; BALL DM, 1995, DRUG ALCOHOL DEPEN, V39, P181, DOI 10.1016/0376-8716(95)01156-2; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; Burim RV, 2004, MUTAGENESIS, V19, P291, DOI 10.1093/mutage/geh034; CARR LG, 1995, ALCOHOL CLIN EXP RES, V19, P182, DOI 10.1111/j.1530-0277.1995.tb01489.x; Carr LG, 1996, ALCOHOL CLIN EXP RES, V20, P43, DOI 10.1111/j.1530-0277.1996.tb01041.x; CARROCCIO A, 1994, BIOCHEM BIOPH RES CO, V203, P727, DOI 10.1006/bbrc.1994.2242; CASTILLO T, 1992, HEPATOLOGY, V16, P992, DOI 10.1002/hep.1840160423; Cederbaum AI, 2010, DIGEST DIS, V28, P802, DOI 10.1159/000324289; Chao YC, 1997, HEPATOLOGY, V25, P112; Cichoz-Lach H, 2006, ALCOHOL CLIN EXP RES, V30, P878, DOI 10.1111/j.1530-0277.2006.00102.x; ELIASSON E, 1988, BIOCHEM BIOPH RES CO, V150, P436, DOI 10.1016/0006-291X(88)90539-6; French SW, 1997, J NUTR, V127, pS907, DOI 10.1093/jn/127.5.907S; Frenzer A, 2002, J GASTROEN HEPATOL, V17, P177, DOI 10.1046/j.1440-1746.2002.02670.x; Garcia-Banuelos J, 2012, ALCOHOL CLIN EXP RES, V36, P425, DOI 10.1111/j.1530-0277.2011.01617.x; Gouillon ZQ, 2000, P SOC EXP BIOL MED, V224, P302, DOI 10.1046/j.1525-1373.2000.22435.x; Gramenzi A, 2006, ALIMENT PHARM THER, V24, P1151, DOI 10.1111/j.1365-2036.2006.03110.x; Grove J, 1998, PHARMACOGENETICS, V8, P335, DOI 10.1097/00008571-199808000-00007; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; INGELMANSUNDBERG M, 1993, ALCOHOL, V10, P447, DOI 10.1016/0741-8329(93)90063-T; Kee Joo Young, 2003, Taehan Kan Hakhoe Chi, V9, P89; Khan AJ, 2010, DRUG ALCOHOL DEPEN, V109, P190, DOI 10.1016/j.drugalcdep.2010.01.010; Khan AJ, 2009, MUTAT RES-FUND MOL M, V664, P55, DOI 10.1016/j.mrfmmm.2009.02.009; Kim Myong Sik, 2004, Korean J Gastroenterol, V43, P355; Le Marchand L, 1999, CANCER EPIDEM BIOMAR, V8, P495; Lee HC, 2001, J KOREAN MED SCI, V16, P745, DOI 10.3346/jkms.2001.16.6.745; Liu Y, 2012, HEPATO-GASTROENTEROL, V59, P204, DOI 10.5754/hge10136; Lorenzo A, 2006, DRUG ALCOHOL DEPEN, V84, P195, DOI 10.1016/j.drugalcdep.2006.03.002; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Lucas D, 1996, ALCOHOL CLIN EXP RES, V20, P1033, DOI 10.1111/j.1530-0277.1996.tb01943.x; LUCAS D, 1995, PHARMACOGENETICS, V5, P298, DOI 10.1097/00008571-199510000-00005; Monzoni A, 2001, MOL MED, V7, P255, DOI 10.1007/BF03401845; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; MORIMOTO M, 1995, J NUTR, V125, P2953; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Parsian A, 1998, ALCOHOL CLIN EXP RES, V22, P888, DOI 10.1097/00000374-199806000-00018; Pirmohamed M, 1995, PHARMACOGENETICS, V5, P351, DOI 10.1097/00008571-199512000-00003; Rodrigo L, 1999, SCAND J GASTROENTERO, V34, P303; RONIS MJJ, 1993, J PHARMACOL EXP THER, V264, P944; Sanchez-Catalan MJ, 2008, ALCOHOL ALCOHOLISM, V43, P401, DOI 10.1093/alcalc/agn012; Savolainen VT, 1997, J HEPATOL, V26, P55, DOI 10.1016/S0168-8278(97)80009-8; Song FJ, 2001, EVAL HEALTH PROF, V24, P126, DOI 10.1177/01632780122034849; STEPHENS EA, 1994, PHARMACOGENETICS, V4, P185, DOI 10.1097/00008571-199408000-00002; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; Tobias A., 1999, STATA TECHNICAL B, V8, P15; TSUTSUMI M, 1994, GASTROENTEROLOGY, V107, P1430, DOI 10.1016/0016-5085(94)90546-0; Vidal F, 2004, J HEPATOL, V41, P744, DOI 10.1016/j.jhep.2003.06.003; Wong NACS, 2000, J CLIN PATHOL-MOL PA, V53, P88, DOI 10.1136/mp.53.2.88; YAMAUCHI M, 1995, HEPATOLOGY, V22, P1136, DOI 10.1016/0270-9139(95)90621-5; Zeng T, 2012, FOOD CHEM TOXICOL, V50, P485, DOI 10.1016/j.fct.2011.11.030; Zeng T, 2009, ARCH TOXICOL, V83, P1075, DOI 10.1007/s00204-009-0457-4; Zhang S, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P338; Zhou WT, 2007, PROGR MODERN BIOMEDI, V7, P1323; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	57	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54188	10.1371/journal.pone.0054188	http://dx.doi.org/10.1371/journal.pone.0054188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335995	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700053
J	Skowronski, DM; Moser, FS; Janjua, NZ; Davoudi, B; English, KM; Purych, D; Petric, M; Pourbohloul, B				Skowronski, Danuta M.; Moser, Flavia S.; Janjua, Naveed Z.; Davoudi, Bahman; English, Krista M.; Purych, Dale; Petric, Martin; Pourbohloul, Babak			H3N2v and Other Influenza Epidemic Risk Based on Age-Specific Estimates of Sero-Protection and Contact Network Interactions	PLOS ONE			English	Article							PANDEMIC H1N1; VIRUS; TRANSMISSION; VACCINATION; PREVALENCE; ANTIBODY; IMMUNE; SURVEILLANCE; STRATEGIES; EMERGENCE	Cases of a novel swine-origin influenza A(H3N2) variant (H3N2v) have recently been identified in the US, primarily among children. We estimated potential epidemic attack rates (ARs) based on age-specific estimates of sero-susceptibility and social interactions. A contact network model previously established for the Greater Vancouver Area (GVA), Canada was used to estimate average epidemic (infection) ARs for the emerging H3N2v and comparator viruses (H1N1pdm09 and an extinguished H3N2 seasonal strain) based on typical influenza characteristics, basic reproduction number (R-0), and effective contacts taking into account age-specific sero-protection rates (SPRs). SPRs were assessed in sera collected from the GVA in 2009 or earlier (pre-H1N1pdm09) and fall 2010 (post-H1N1pdm09, seasonal A/Brisbane/10/2007(H3N2), and H3N2v) by hemagglutination inhibition (HI) assay. SPR was assigned per convention based on proportion with HI antibody titre >= 40 (SPR40). Recognizing that the HI titre >= 40 was established as the 50% sero-protective threshold we also explored for 1/2SPR40, SPR80 and a blended gradient defined as: 1/4SPR20, 1/2SPR40, 3/4SPR80, SPR160. Base case analysis assumed R-0 = 1.40, but we also explored R-0 as high as 1.80. With R-0 = 1.40 and SPR40, simulated ARs were well aligned with field observations for H1N1pdm09 incidence (AR: 32%), sporadic detections without a third epidemic wave post-H1N1pdm09 (negligible AR < 0.1%) as well as A/Brisbane/10/2007(H3N2) seasonal strain extinction and antigenic drift replacement (negligible AR < 0.1%). Simulated AR for the novel swine-origin H3N2v was 6%, highest in children 6-11years (16%). However, with modification to SPR thresholds per above, H3N2v AR >= 20% became possible. At SPR40, H3N2v AR >= 10%, >= 15% or >= 30%, occur if R-0 >= 1.48, >= 1.56 or >= 1.86, respectively. Based on conventional assumptions, the novel swine-origin H3N2v does not currently pose a substantial pandemic threat. If H3N2v epidemics do occur, overall community ARs are unlikely to exceed typical seasonal influenza experience. However risk assessment may change with time and depends crucially upon the validation of epidemiological features of influenza, notably the serologic correlate of protection and R-0.	[Skowronski, Danuta M.; Moser, Flavia S.; Janjua, Naveed Z.; Pourbohloul, Babak] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.; Davoudi, Bahman; English, Krista M.; Pourbohloul, Babak] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Purych, Dale] BC Biomed Labs Ltd, Surrey, BC, Canada; [Petric, Martin] British Columbia Ctr Dis Control, Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Petric, Martin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X	Canadian Institutes of Health Research [PTL-97126]; Michael Smith Foundation for Health Research [CI-SSH-00931(06-1), 20R45696]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Institutes of Health Research (PTL-97126) and the Michael Smith Foundation for Health Research (Grant numbers CI-SSH-00931(06-1) and 20R45696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; ANDERSON R M, 1991; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; BC Centre for Disease Control, BC CDC INFL SURV REP; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; BLACK SC, 2011, AM POETRY REV, V40, P30; Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237; Centers for Disease Control and Prevention, 2012, 1 H3N2 VAR VIR INF R; Centers for Disease Control and Prevention, 2012, INFL A H3N2 VAR VIR; Centers for Disease Control and Prevention, FLUV 2010 2011 INFL; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741; Committee for Proprietary Medicinal Products [CPMP], 1997, CPMPBWP21496, P1; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Lina B, 2011, EUROSURVEILLANCE, V16, P2; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Matrajt L, 2012, EPIDEMICS-NETH, V4, P22, DOI 10.1016/j.epidem.2011.11.003; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; National Advisory Committee on Immunization, 2012, STAT SEAS INFL VACC; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Nicholson KG, 1998, TXB INFLUENZA, P221; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Potter C., 1998, TXB INFLUENZA, P3; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Public Health Agency of Canada, FLUWATCH; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Ross Ted M, 2011, PLoS Curr, V3, pRRN1265, DOI 10.1371/currents.RRN1265; Scholtissek C., 1998, TXB INFLUENZA, P137; Skowronski DM, 2012, EUROSURVEILLANCE, V17, P2; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Van Kerkhove MD, 2013, INFLUENZA O IN PRESS; Waalen K, 2012, EURO SURVEILL, V17; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; World Health Organization, WHO REC COMP INFL VI; World Health Organization, 2011, STAND TERM VAR A H3N; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322; [No title captured]	61	15	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54015	10.1371/journal.pone.0054015	http://dx.doi.org/10.1371/journal.pone.0054015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326561	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800100
J	Wada, S; Chiba, S				Wada, Shinichiro; Chiba, Satoshi			The Dual Protection of a Micro Land Snail against a Micro Predatory Snail	PLOS ONE			English	Article							TRADE-OFFS; SHELL SCULPTURE; EVOLUTION; DEFENSE; SHAPE; SIZE; FORM	Defense against a single predatory attack strategy may best be achieved not by a single trait but by a combination of different traits. We tested this hypothesis experimentally by examining the unique shell traits (the protruded aperture and the denticles within the aperture) of the micro land snail Bensonella plicidens. We artificially altered shell characteristics by removing the denticles and/or cutting the protruded aperture. These snails were offered to the carnivorous micro land snail Indoennea bicolor, which preys on the snails by gaining entry to their shell. B. plicidens exhibited the best defence when both of the traits studied were present; the defensive ability of B. plicidens decreased if either trait was removed and was further reduced if both traits were removed. These results suggest that a combination of different traits provides more effective defence against attack by the predator than either single trait by itself.	[Wada, Shinichiro; Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Tohoku University	Wada, S (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	b0bd3011@s.tohoku.ac.jp		Chiba, Satoshi/0000-0001-9273-0307	Global COE program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [J03]	Global COE program of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	This study was partly supported by the Global COE program J03 of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott RT., 1989, COMPENDIUM LANDSHELL; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Allen John A., 2004, P1, DOI 10.1079/9780851993195.0001; [Anonymous], 2007, LME4 LINEAR MIXED EF; Barker Gary M., 2004, P279, DOI [10.1079/9780851993195.0279, 10.1079/9780851993195.0000]; BERTNESS MD, 1981, J EXP MAR BIOL ECOL, V50, P213, DOI 10.1016/0022-0981(81)90051-4; Boeing WJ, 2006, J PLANKTON RES, V28, P571, DOI 10.1093/plankt/fbi142; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; Brodie ED, 1999, BIOSCIENCE, V49, P557, DOI 10.2307/1313476; Coupland James B., 2004, P85, DOI 10.1079/9780851993195.0085; Cressler CE, 2010, AM NAT, V176, P276, DOI 10.1086/655425; DEMEESTER L, 1995, NATURE, V378, P483; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Donovan DA, 1999, J EXP MAR BIOL ECOL, V236, P235, DOI 10.1016/S0022-0981(98)00200-7; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Gittenberger E, 1996, NETH J ZOOL, V46, P191, DOI 10.1163/156854295X00159; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; Hoso M, 2008, AM NAT, V172, P726, DOI 10.1086/591681; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; Konuma J, 2007, AM NAT, V170, P90, DOI 10.1086/518182; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Lovegrove BG, 2001, EVOLUTION, V55, P1464; Norman MD, 2001, P ROY SOC B-BIOL SCI, V268, P1755, DOI 10.1098/rspb.2001.1708; PALMER AR, 1979, EVOLUTION, V33, P697, DOI 10.1111/j.1558-5646.1979.tb04722.x; Panha S, 2005, MALACOL REV, V37, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; Rundle SD, 2004, ROYAL SOC, V271, P67; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; Schilthuizen Menno, 2004, Journal of Conchology Special Publication, V3, P149; SOLEM A, 1972, Veliger, V15, P81; Sparkes TC, 1996, BEHAV ECOL SOCIOBIOL, V39, P411, DOI 10.1007/s002650050308; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Stuart-Fox DM, 2004, EVOLUTION, V58, P1549; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; TWEEDIE M. W. F., 1961, BULL RAFFLES MUS, V26, P49; Vermeij G.J., 1993, NATURAL HIST SHELLS; VERMEIJ GJ, 1978, AM NAT, V112, P833, DOI 10.1086/283326; VERMEIJ GJ, 1982, MALACOLOGIA, V23, P1; Vermeulen J. J., 1994, Basteria, V58, P75; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Winsor Leigh, 2004, P227, DOI 10.1079/9780851993195.0227; [No title captured]	47	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54123	10.1371/journal.pone.0054123	http://dx.doi.org/10.1371/journal.pone.0054123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326582	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500109
J	Ball, HC; Holmes, RK; Londraville, RL; Thewissen, JGM; Duff, RJ				Ball, Hope C.; Holmes, Robert K.; Londraville, Richard L.; Thewissen, Johannes G. M.; Duff, Robert Joel			Leptin in Whales: Validation and Measurement of mRNA Expression by Absolute Quantitative Real-Time PCR	PLOS ONE			English	Article							REFERENCE GENES; SERUM LEPTIN; HOUSEKEEPING GENES; RT-PCR; QUANTIFICATION; RESISTANCE; MAMMALS; OBESITY; WEIGHT; MASS	Leptin is the primary hormone in mammals that regulates adipose stores. Arctic adapted cetaceans maintain enormous adipose depots, suggesting possible modifications of leptin or receptor function. Determining expression of these genes is the first step to understanding the extreme physiology of these animals, and the uniqueness of these animals presents special challenges in estimating and comparing expression levels of mRNA transcripts. Here, we compare expression of two model genes, leptin and leptin-receptor gene-related product (OB-RGRP), using two quantitative real-time PCR (qPCR) methods: "relative'' and "absolute''. To assess the expression of leptin and OB-RGRP in cetacean tissues, we first examined how relative expression of those genes might differ when normalized to four common endogenous control genes. We performed relative expression qPCR assays measuring the amplification of these two model target genes relative to amplification of 18S ribosomal RNA (18S), ubiquitously expressed transcript (Uxt), ribosomal protein 9 (Rs9) and ribosomal protein 15 (Rs15) endogenous controls. Results demonstrated significant differences in the expression of both genes when different control genes were employed; emphasizing a limitation of relative qPCR assays, especially in studies where differences in physiology and/or a lack of knowledge regarding levels and patterns of expression of common control genes may possibly affect data interpretation. To validate the absolute quantitative qPCR methods, we evaluated the effects of plasmid structure, the purity of the plasmid standard preparation and the influence of type of qPCR "background'' material on qPCR amplification efficiencies and copy number determination of both model genes, in multiple tissues from one male bowhead whale. Results indicate that linear plasmids are more reliable than circular plasmid standards, no significant differences in copy number estimation based upon background material used, and that the use of ethanol precipitated, linearized plasmid preparation produce the most reliable results.	[Ball, Hope C.; Holmes, Robert K.; Londraville, Richard L.; Duff, Robert Joel] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Thewissen, Johannes G. M.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	University of Akron; Northeast Ohio Medical University (NEOMED)	Duff, RJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	rjduff@uakron.edu		Londraville, Richard/0000-0002-9438-7976; Thewissen, J. G. M./0000-0002-0973-4137	Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; National Science Foundation [34284]; NIH [DK079282-01A1]; Division Of Earth Sciences [0745543] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK079282] Funding Source: NIH RePORTER	Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	HCB was supported by a Sigma Xi GIAR and two consecutive Choose Ohio First Scholarships; JGMT was supported by a grant from the National Science Foundation (34284; RLL supported by NIH DK079282-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Concannon P, 2001, AM J PHYSIOL-REG I, V281, pR951, DOI 10.1152/ajpregu.2001.281.3.R951; COSEWIC, 2005, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; Duverger O, 2012, J BIOL CHEM, V287, P12230, DOI 10.1074/jbc.M111.326900; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Florant GL, 2004, J COMP PHYSIOL B, V174, P633, DOI 10.1007/s00360-004-0454-0; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Iverson S., 2002, ENCY MARINE MAMMALS, P107; Izraely S, 2012, INT J CANCER, V131, P1071, DOI 10.1002/ijc.27324; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kakuschke A, 2006, MAR MAMMAL SCI, V22, P985, DOI 10.1111/j.1748-7692.2006.00059.x; Kronfeld-Schor N, 2000, AM J PHYSIOL-REG I, V279, pR1277, DOI 10.1152/ajpregu.2000.279.4.R1277; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Mollenhauer MAM, 2009, AQUAT TOXICOL, V91, P10, DOI 10.1016/j.aquatox.2008.09.013; Morin PA, 2006, MAR MAMMAL SCI, V22, P897, DOI 10.1111/j.1748-7692.2006.00070.x; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Rousseau K, 2003, J NEUROENDOCRINOL, V15, P409, DOI 10.1046/j.1365-2826.2003.01007.x; Rugh DJ, 2002, ENCY MARINE MAMMALS, P129; Satoh T, 2009, BIOCHEM BIOPH RES CO, V389, P673, DOI 10.1016/j.bbrc.2009.09.056; Sitt T, 2008, DEV COMP IMMUNOL, V32, P1253, DOI 10.1016/j.dci.2008.05.001; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Townsend KL, 2008, J COMP PHYSIOL B, V178, P217, DOI 10.1007/s00360-007-0215-y; Yadav P, 2012, LIVEST SCI, V147, P72, DOI 10.1016/j.livsci.2012.04.004; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	8	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54277	10.1371/journal.pone.0054277	http://dx.doi.org/10.1371/journal.pone.0054277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342116	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700100
J	Cibert-Goton, V; Yuan, GL; Battaglia, A; Fredriksson, S; Henkemeyer, M; Sears, T; Gavazzi, I				Cibert-Goton, Vincent; Yuan, Guanglu; Battaglia, Anna; Fredriksson, Sarah; Henkemeyer, Mark; Sears, Thomas; Gavazzi, Isabella			Involvement of EphB1 Receptors Signalling in Models of Inflammatory and Neuropathic Pain	PLOS ONE			English	Article							DORSAL-HORN NEURONS; PERIPHERAL-NERVE INJURY; LONG-TERM POTENTIATION; BONE CANCER PAIN; RAT SPINAL-CORD; NMDA RECEPTOR; SYNAPTIC PLASTICITY; NR2B SUBUNIT; CENTRAL SENSITIZATION; TYROSINE PHOSPHORYLATION	EphB receptors tyrosine kinases and ephrinB ligands were first identified as guidance molecules involved in the establishment of topographical mapping and connectivity in the nervous system during development. Later in development and into adulthood their primary role would switch from guidance to activity-dependent modulation of synaptic efficacy. In sensory systems, they play a role in both the onset of inflammatory and neuropathic pain, and in the establishment of central sensitisation, an NMDA-mediated form of synaptic plasticity thought to underlie most forms of chronic pain. We studied wild type and EphB1 knockout mice in a range of inflammatory and neuropathic pain models to determine 1), whether EphB1 expression is necessary for the onset and/or maintenance of persistent pain, regardless of origin; 2), whether in these models cellular and molecular changes, e.g. phosphorylation of the NR2B subunit of the NMDA receptor, increased c-fos expression or microglial activation, associated with the onset of pain, are affected by the lack of functional EphB1 receptors. Differences in phenotype were examined behaviourally, anatomically, biochemically and electrophysiologically. Our results establish firstly, that functional EphB1 receptors are not essential for the development of normal nociception, thermal or mechanical sensitivity. Secondly, they demonstrate a widespread involvement of EphB1 receptors in chronic pain. NR2B phosphorylation, c-fos expression and microglial activation are all reduced in EphB1 knockout mice. This last finding is intriguing, since microglial activation is supposedly triggered directly by primary afferents, therefore it was not expected to be affected. Interestingly, in some models of long-term pain (days), mechanical and thermal hyperalgesia develop both in wild type and EphB1 knockout mice, but recovery is faster in the latter, indicating that in particular models these receptors are required for the maintenance, rather than the onset of, thermal and mechanical hypersensitivity. This potentially makes them an attractive target for analgesic strategies.	[Cibert-Goton, Vincent; Yuan, Guanglu; Battaglia, Anna; Fredriksson, Sarah; Sears, Thomas; Gavazzi, Isabella] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA	University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gavazzi, I (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Wolfson Wing,Guys Campus, London WC2R 2LS, England.	isabella.gavazzi@kcl.ac.uk		CIBERT-GOTON, Vincent/0000-0002-8483-0284; Henkemeyer, Mark/0000-0002-7525-1061; Gavazzi, Isabella/0000-0002-7728-7682	Wellcome Trust Project [GR071663MA]; Biotechnology and Biological Sciences Research Council Project [C505816]; National Institutes of Health [2R01 MH66332]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C505816/1] Funding Source: researchfish	Wellcome Trust Project(Wellcome Trust); Biotechnology and Biological Sciences Research Council Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Project Grant GR071663MA and Biotechnology and Biological Sciences Research Council Project Grant C505816 to IG and by National Institutes of Health grant 2R01 MH66332 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Battaglia AA, 2003, NAT NEUROSCI, V6, P339, DOI 10.1038/nn1034; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calo L, 2006, J NEUROCHEM, V98, P1, DOI 10.1111/j.1471-4159.2006.03844.x; Cao JL, 2008, PAIN, V139, P617, DOI 10.1016/j.pain.2008.06.023; Caudle RM, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-25; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng HT, 2008, NEUROSCIENCE, V155, P948, DOI 10.1016/j.neuroscience.2008.06.024; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Dong Y, 2011, NEUROSCI LETT, V496, P163, DOI 10.1016/j.neulet.2011.04.008; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; FITZGERALD M, 1994, J COMP NEUROL, V348, P225, DOI 10.1002/cne.903480205; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Graeber MB, 2012, EXP NEUROL, V234, P255, DOI 10.1016/j.expneurol.2012.01.007; Graham BA, 2007, J PHYSIOL-LONDON, V578, P787, DOI 10.1113/jphysiol.2006.123349; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Guo W, 2002, J NEUROSCI, V22, P6208; Han Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-60; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Inturrisi C E, 2005, Minerva Anestesiol, V71, P401; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kobayashi H, 2007, SPINE, V32, P1592, DOI 10.1097/BRS.0b013e318074d46a; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee BH, 1998, EXP BRAIN RES, V120, P432, DOI 10.1007/s002210050416; Liu S, 2011, CANCER RES, V71, P4392, DOI 10.1158/0008-5472.CAN-10-3870; Liu WT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-29; Liu WT, 2009, FASEB J, V23, P90, DOI 10.1096/fj.08-114462; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Matsumura S, 2010, EUR J NEUROSCI, V32, P798, DOI 10.1111/j.1460-9568.2010.07348.x; Orikawa Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-72; Otsubo Y, 2012, PAIN, V153, P2241, DOI 10.1016/j.pain.2012.07.020; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sandkuhler J, 2010, J PAIN, V11, P798, DOI 10.1016/j.jpain.2010.05.002; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Song XJ, 2008, EUR J PAIN, V12, P1031, DOI 10.1016/j.ejpain.2008.01.011; South SM, 2003, J NEUROSCI, V23, P5031; Steffens H, 2001, NEUROSCI RES, V39, P413, DOI 10.1016/S0168-0102(01)00198-5; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Wu Q, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-37; Xu QH, 2011, CURR OPIN ANESTHESIO, V24, P400, DOI 10.1097/ACO.0b013e32834871df; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77; Zhu YF, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-15; Zhuo M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-31	70	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53673	10.1371/journal.pone.0053673	http://dx.doi.org/10.1371/journal.pone.0053673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341972	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700034
J	Di Donato, V; Auer, TO; Duroure, K; Del Bene, F				Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo			Characterization of the Calcium Binding Protein Family in Zebrafish	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHANNEL; GENE; MUTATIONS; EVOLUTION; NUCLEUS; VERSION; MODEL	Calcium Binding Proteins (CaBPs), part of the vast family of EF-Hand- domain containing proteins, modulate intracellular calcium levels. They thereby contribute to a broad spectrum of biological processes - amongst others cell migration, gene expression and neural activity. In this study we identified twelve members of this protein family in zebrafish including one gene (cabp4b) currently not present in the zebrafish genome assembly. To gain insight into their biological functions, we carried out a detailed analysis of the expression patterns of these genes during zebrafish late embryonic and early larval development. We detected specific transcription for most of them in different neuronal cell populations including the neuroretina, the inner ear and the notochord. Our data supports potential roles for CaBPs during neuronal development and function and provides a starting point for genetic studies to examine CaBPs' function in these tissues and organs.	[Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] Inst Curie, Ctr Rech, Paris, France; [Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] CNRS UMR 3215, Paris, France; [Di Donato, Vincenzo; Auer, Thomas O.; Duroure, Karine; Del Bene, Filippo] INSERM U934, Paris, France; [Auer, Thomas O.] Heidelberg Univ, Ctr Organismal Studies Heidelberg, Heidelberg, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg	Del Bene, F (corresponding author), Inst Curie, Ctr Rech, Paris, France.	Filippo.Del-Bene@curie.fr	del bene, filippo/D-1245-2010	del bene, filippo/0000-0001-8551-2846; DUROURE, Karine/0000-0002-5959-569X; Auer, Thomas Oliver/0000-0003-3442-0567; Di Donato, Vincenzo/0000-0002-4080-9301	ATIP/AVENIR program from CNRS/INSERM; EC-IRG reintegration grant; Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates; Boeringer-Ingelheim Fonds Ph.D. fellowship	ATIP/AVENIR program from CNRS/INSERM; EC-IRG reintegration grant; Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates; Boeringer-Ingelheim Fonds Ph.D. fellowship	This work was supported by the ATIP/AVENIR program from CNRS/INSERM and an EC-IRG reintegration grant to FDB. VDD was supported by a Leonardo a scholarship of the Leonardo da Vinci project Unipharma-Graduates. TOA was supported by a Boeringer-Ingelheim Fonds Ph.D. fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Force A, 1999, GENETICS, V151, P1531; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Rieke F, 2008, INVEST OPHTH VIS SCI, V49, P5126, DOI 10.1167/iovs.08-2236; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vihtelic TS, 2005, MOL VIS, V11, P1083; Vitorino M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-14; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westerfield M., ZEBRAFISH BOOK GUIDE; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Wu YQ, 2001, MOL GENET METAB, V72, P343, DOI 10.1006/mgme.2001.3160; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53299	10.1371/journal.pone.0053299	http://dx.doi.org/10.1371/journal.pone.0053299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341937	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700024
J	Donkor, ES; Adegbola, RA; Wren, BW; Antonio, M				Donkor, Eric S.; Adegbola, Richard A.; Wren, Brendan W.; Antonio, Martin			Population Biology of Streptococcus pneumoniae in West Africa: Multilocus Sequence Typing of Serotypes That Exhibit Different Predisposition to Invasive Disease and Carriage	PLOS ONE			English	Article							DAY-CARE-CENTERS; PNEUMOCOCCAL DISEASE; GENETIC RELATEDNESS; RESISTANCE PATTERNS; CHILDREN; MENINGITIS; CLONES; IDENTIFICATION; EPIDEMIOLOGY; OUTBREAK	Background: Little is known about the population biology of Streptococcus pneumoniae in developing countries, although the majority of pneumococcal infections occur in this setting. The aim of the study was to apply MLST to investigate the population biology of S. pneumoniae in West Africa. Methods: Seventy three invasive and carriage S. pneumoniae isolates from three West African countries including The Gambia, Nigeria and Ghana were investigated. The isolates covered seven serotypes (1, 3, 5, 6A, 11, 14, 23F) and were subjected to multilocus sequence typing and antibiotic susceptibility testing. Results: Overall, 50 different sequence types (STs) were identified, of which 38% (29) were novel. The most common ST was a novel clone-ST 4012 (6.5%), and some clones including STs 913, 925, 1737, 2160 and 3310 appeared to be specific to the study region. Two STs including ST 63 and ST 4012 were associated with multiple serotypes indicating a history of serotype switching. ST 63 was associated with serotypes 3 and 23F, while ST 4012 was associated with serotypes 6A and 23. eBURST analyses using the stringent 6/7 identical loci definition grouped the 50 STs into 5 clonal complexes and 65 singletons, expressing a high level of genetic diversity among the isolates. Compared to the other serotypes, serotypes 1 and 5 isolates appeared to be more clonal. Internationally recognized antibiotic resistant clones of S. pneumoniae were generally absent in the population investigated and the only multidrug resistant isolate identified (1/66) belong to the Pneumocococcal Epidemiology Network clone ST 63. Conclusions: The pneumococcal population in West Africa is quite divergent, and serotypes that are common in invasive disease (such as serotypes 1 and 5) are more likely to be clonal than serotypes that are common in carriage.	[Donkor, Eric S.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Antonio, Martin] MRC, Fajara, Gambia; [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium; [Donkor, Eric S.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Ghana	Antonio, M (corresponding author), MRC, Fajara, Gambia.	mantonio@mrc.gm		Donkor, Eric S./0000-0002-9368-0636	Medical Research Council; MRC [MR/K012053/1] Funding Source: UKRI; Medical Research Council [MR/K012053/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Blossom DB, 2007, MICROB DRUG RESIST, V13, P21, DOI 10.1089/mdr.2006.9993; BOWERS EF, 1955, J CLIN PATHOL, V8, P58, DOI 10.1136/jcp.8.1.58; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Donkor ES, 2011, MBIO, V2, DOI 10.1128/mBio.00040-11; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Feil EJ, 2000, GENETICS, V154, P1439; Fraser D, 2001, CLIN INFECT DIS, V33, P421, DOI 10.1086/321874; Hall LMC, 1996, J CLIN MICROBIOL, V34, P853, DOI 10.1128/JCM.34.4.853-859.1996; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Louie M, 1999, J INFECT DIS, V179, P892, DOI 10.1086/314664; Maiden MC, 1988, P NATL ACAD SCI USA, V95, P3140; Marsh R, 2010, J CLIN MICROBIOL, V48, P831, DOI 10.1128/JCM.01701-09; Marsh RL, 2007, VACCINE, V25, P2434, DOI 10.1016/j.vaccine.2006.09.016; Martin DR, 1996, NEW ZEAL MED J, V109, P288; MUFSON MA, 1974, ARCH INTERN MED, V134, P505, DOI 10.1001/archinte.134.3.505; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro S, 2001, LANCET, V357, P1800, DOI 10.1016/S0140-6736(00)04915-1; Overweg K, 2000, J CLIN MICROBIOL, V38, P4548, DOI 10.1128/JCM.38.12.4548-4553.2000; Porat N, 2001, J CLIN MICROBIOL, V39, P1827, DOI 10.1128/JCM.39.5.1827-1832.2001; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08; Spratt BG, 2004, PNEUMOCCOCUS, P119; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Syrogiannopoulos GA, 1997, CLIN INFECT DIS, V25, P188, DOI 10.1086/514526; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	42	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53925	10.1371/journal.pone.0053925	http://dx.doi.org/10.1371/journal.pone.0053925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342041	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000313682700065
J	Summers, DW; Wolfe, KJ; Ren, HY; Cyr, DM				Summers, Daniel W.; Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.			The Type II Hsp40 Sis1 Cooperates with Hsp70 and the E3 Ligase Ubr1 to Promote Degradation of Terminally Misfolded Cytosolic Protein	PLOS ONE			English	Article							QUALITY CONTROL DEGRADATION; TUMOR-SUPPRESSOR COMPLEX; MOLECULAR CHAPERONES; CO-CHAPERONE; SACCHAROMYCES-CEREVISIAE; PRION TOXICITY; IN-VIVO; DNAJ; SPECIFICITY; MECHANISM	Mechanisms for cooperation between the cytosolic Hsp70 system and the ubiquitin proteasome system during protein triage are not clear. Herein, we identify new mechanisms for selection of misfolded cytosolic proteins for degradation via defining functional interactions between specific cytosolic Hsp70/Hsp40 pairs and quality control ubiquitin ligases. These studies revolved around the use of S. cerevisiae to elucidate the degradation pathway of a terminally misfolded reporter protein, short-lived GFP (slGFP). The Type I Hsp40 Ydj1 acts with Hsp70 to suppress slGFP aggregation. In contrast, the Type II Hsp40 Sis1 is required for proteasomal degradation of slGFP. Sis1 and Hsp70 operate sequentially with the quality control E3 ubiquitin ligase Ubr1 to target slGFP for degradation. Compromise of Sis1 or Ubr1 function leads slGFP to accumulate in a Triton X-100-soluble state with slGFP degradation intermediates being concentrated into perinuclear and peripheral puncta. Interestingly, when Sis1 activity is low the slGFP that is concentrated into puncta can be liberated from puncta and subsequently degraded. Conversely, in the absence of Ubr1, slGFP and the puncta that contain slGFP are relatively stable. Ubr1 mediates proteasomal degradation of slGFP that is released from cytosolic protein handling centers. Pathways for proteasomal degradation of misfolded cytosolic proteins involve functional interplay between Type II Hsp40/Hsp70 chaperone pairs, PQC E3 ligases, and storage depots for misfolded proteins.	[Summers, Daniel W.; Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cyr, DM (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	dmcyr@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414; Summers, Daniel/0000-0001-7228-8849	National Institutes of Health [5F31AG032790-02, 5F31NS074777-02, 5R01GM067785-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institutes of Health including 5F31AG032790-02 to DS, 5F31NS074777-02 to KW, and 5R01GM067785-08 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2009, MOL BIOL CELL, V20, P4162, DOI 10.1091/mbc.E09-02-0170; Douglas PM, 2008, P NATL ACAD SCI US; Douglas PM, 2009, PRION, V3; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lewis MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005038; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Summers DW, 2009, J BIOL CHEM, V284, P3628, DOI 10.1074/jbc.M807369200; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584	48	58	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52099	10.1371/journal.pone.0052099	http://dx.doi.org/10.1371/journal.pone.0052099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341891	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700012
J	Wignall, AE; Herberstein, ME				Wignall, Anne E.; Herberstein, Marie E.			The Influence of Vibratory Courtship on Female Mating Behaviour in Orb-Web Spiders (Argiope keyserlingi, Karsch 1878)	PLOS ONE			English	Article							SEXUAL CANNIBALISM; SPERM COMPETITION; ARANEAE; COPULATION; VIBRATIONS; GENITALIA; PATERNITY; SUCCESS; MALES	Web-building spiders are important models for sexual selection. While our understanding of post-copulatory mechanisms including sperm competition and cryptic female choice is considerable, our knowledge of courtship and how it influences male and female mating decisions is still extremely poor. Here, we provide the first comprehensive description of male courtship behaviour and vibrations generated in the web by the orb-web spider, Argiope keyserlingi - a recognised model species. We identified three main elements of male courtship: shudders, abdominal wags and mating thread dances (including both plucks and bounces). The vibrations generated by these behaviours are described in detail. Male shuddering behaviour appears to have a strong influence on female latency to mate acceptance, with males that shudder at high rates without compromising shudder duration being preferred. Shuddering behaviour may also mediate female aggressive behaviour, with males that generate long shudders less likely to be cannibalised after copulation. Male abdominal wagging behaviour, however, appears to have only limited influence on female mating decisions. This study provides avenues for future work that synthesises pre- and post-copulatory mechanisms in web-building spiders to generate an all-encompassing model of how sexual selection operates.	[Wignall, Anne E.; Herberstein, Marie E.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Wignall, AE (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	anne.wignall@mq.edu.au	Herberstein, Marie E./D-2042-2011	Herberstein, Marie E./0000-0001-5071-2952; Wignall, Anne/0000-0002-0152-8312	Australia & Pacific Science Foundation [APSF 11/5]	Australia & Pacific Science Foundation	This study was supported by the Australia & Pacific Science Foundation (APSF 11/5) and a Macquarie University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen JJ, 2004, BEHAV ECOL, V15, P602, DOI 10.1093/beheco/arh062; Barrantes G, 2008, J ARACHNOL, V36, P606, DOI 10.1636/St07-13.1; Barth FG, 1998, SPR HDB AUD, V10, P228; Blumstein DT, 2006, JWATCHER WEBSITE; Eberhard WG, 1998, J ARACHNOL, V26, P342; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Elgar MA, 2003, ANIM BEHAV, V66, P211, DOI 10.1006/anbe.2003.2189; Elgar MA, 2000, P ROY SOC B-BIOL SCI, V267, P2439, DOI 10.1098/rspb.2000.1303; Fromhage L, 2005, BEHAV ECOL, V16, P377, DOI 10.1093/beheco/ari011; Gaskett AC, 2004, BEHAVIOUR, V141, P1197, DOI 10.1163/1568539042729676; Gibson JS, 2012, ANIM BEHAV, V84, P85, DOI 10.1016/j.anbehav.2012.04.010; Herberstein ME, 2012, BEHAV ECOL, V23, P1140, DOI 10.1093/beheco/ars088; Herberstein ME, 2011, BEHAV ECOL, V22, P692, DOI 10.1093/beheco/arr053; Herberstein Marie E., 2011, P1; Herberstein ME, 2005, ETHOLOGY, V111, P1050, DOI 10.1111/j.1439-0310.2005.01114.x; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Herberstein ME, 2011, SPIDER BEHAV FLEXIBI, P1; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; Huber BA, 2004, J MORPHOL, V261, P364, DOI 10.1002/jmor.10255; JACKSON R R, 1985, Journal of Zoology Series B, V1, P175; JACKSON RR, 1992, J ZOOL, V228, P509, DOI 10.1111/j.1469-7998.1992.tb04451.x; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Landolfa MA, 1996, J COMP PHYSIOL A, V179, P493, DOI 10.1007/BF00192316; Maklakov AA, 2003, ANIM BEHAV, V66, P623, DOI 10.1006/anbe.2003.2245; Montgomery TH., 1903, ACAD NAT SCI, V55, P59; Robinson M.H., 1980, Pacific Insects Monograph, V36, P1; ROBINSON MH, 1982, ANNU REV ENTOMOL, V27, P1, DOI 10.1146/annurev.en.27.010182.000245; Schneider JM, 2000, J EVOLUTION BIOL, V13, P939, DOI 10.1046/j.1420-9101.2000.00238.x; Schneider JM, 2008, P ROY SOC LOND B BIO, V276, P3105; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shamble PS, 2009, BEHAV ECOL, V20, P1242, DOI 10.1093/beheco/arp116; Singer F, 2000, BEHAVIOUR, V137, P93, DOI 10.1163/156853900501890; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; Stoltz JA, 2008, BEHAV ECOL SOCIOBIOL, V62, P689, DOI 10.1007/s00265-007-0493-0; Stoltz JA, 2009, ANIM BEHAV, V77, P79, DOI 10.1016/j.anbehav.2008.09.012; SUTER RB, 1984, J ARACHNOL, V12, P37; Uhl Gabriele, 2011, P127; WATSON PJ, 1991, ANIM BEHAV, V41, P343, DOI 10.1016/S0003-3472(05)80486-5; Whitehouse MEA, 1998, J ZOOL, V244, P95, DOI 10.1111/j.1469-7998.1998.tb00011.x; Wignall AE, 2011, P ROY SOC B-BIOL SCI, V278, P1427, DOI 10.1098/rspb.2010.2060; Wilder SM, 2009, ANNU REV ECOL EVOL S, V40, P21, DOI 10.1146/annurev.ecolsys.110308.120238; Wilgers DJ, 2011, CURR ZOOL, V57, P175, DOI 10.1093/czoolo/57.2.175	43	26	26	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53057	10.1371/journal.pone.0053057	http://dx.doi.org/10.1371/journal.pone.0053057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341922	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700019
J	Marinelli, L; Trompetto, C; Mori, L; Vigo, G; Traverso, E; Colombano, F; Abbruzzese, G				Marinelli, Lucio; Trompetto, Carlo; Mori, Laura; Vigo, Gabriele; Traverso, Elisabetta; Colombano, Federica; Abbruzzese, Giovanni			Manual Linear Movements to Assess Spasticity in a Clinical Setting	PLOS ONE			English	Article							BOTULINUM TOXIN; PARKINSONS-DISEASE; STRETCH REFLEXES; LIMB SPASTICITY; RIGIDITY; ASHWORTH	In a clinical setting, where motor-driven systems are not readily available, the major difficulty in the assessment of the stretch reflex lies in the control of passive limb displacement velocity. A potential approach to this problem arises from the use of manual sinusoidal movements (made by continuous alternating flexions and extensions) paced by an external stimulus. Unfortunately, there are conditions in which sinusoidal movements induce interfering phenomena such as the shortening reaction or postactivation depression. In the present paper, a novel manual method to control the velocity of passive linear movements is described and the results obtained from both healthy subjects and spastic patients are reported. This method is based on the synchronisation of movements with tones played by a metronome at different speeds. In a first set of experiments performed in healthy subjects, we demonstrated consistent control of velocity during passive limb movements using this method. Four joints usually examined during muscle tone assessment were tested: wrist, elbow, knee and ankle joints. Following this, we conducted a longitudinal assessment of the stretch reflex amplitude in wrist flexor muscles in patients with spasticity treated with botulinum toxin type A. The evaluators were not only able to vary the movement velocity based on the metronome speed, but also could reproduce the respective speeds two weeks later, despite the changing degree of hypertonia. This method is easy to perform in a clinical setting and hardware requirements are minimal, making it an attractive and robust procedure for the widespread clinical assessment of reflex hypertonia.	[Marinelli, Lucio; Trompetto, Carlo; Mori, Laura; Vigo, Gabriele; Traverso, Elisabetta; Colombano, Federica; Abbruzzese, Giovanni] Univ Genoa, Clin Neurol, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy	University of Genoa	Marinelli, L (corresponding author), Univ Genoa, Clin Neurol, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy.	lucio.marinelli@unige.it	Marinelli, Lucio/K-3141-2012; Mori, Laura/K-2450-2018; Trompetto, Carlo/AAC-3550-2022	Marinelli, Lucio/0000-0003-0620-7654; Mori, Laura/0000-0003-2762-8327; Trompetto, Carlo/0000-0003-3419-0669				Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Delwaide PJ, 2001, FUNCT NEUROL, V16, P147; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Marinelli L, 2010, 6 WORLD C NEUR MED I; MEARA RJ, 1992, BRAIN, V115, P1167, DOI 10.1093/brain/115.4.1167; Miscio G, 2004, J NEUROL, V251, P189, DOI 10.1007/s00415-004-0297-3; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Pandyan AD, 2003, CLIN REHABIL, V17, P290, DOI 10.1191/0269215503cr610oa; Phadke CP, 2012, DISABIL REHABIL, V34, P91, DOI 10.3109/09638288.2011.591882; RACK PMH, 1990, J PHYSIOL-LONDON, V425, pP83; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Sorinola IO, 2009, NEUROREHAB NEURAL RE, V23, P287, DOI 10.1177/1545968308321778; THILMANN AF, 1991, BRAIN, V114, P233; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V76, P459, DOI 10.1136/jnnp.2004.035972; Trompetto C, 2008, EUR J NEUROL, V15, P367, DOI 10.1111/j.1468-1331.2008.02076.x; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53627	10.1371/journal.pone.0053627	http://dx.doi.org/10.1371/journal.pone.0053627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23335966	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700022
J	Costantino, VV; Mansilla, SF; Speroni, J; Amaya, C; Cuello-Carrion, D; Ciocca, DR; Priestap, HA; Barbieri, MA; Gottifredi, V; Lopez, LA				Costantino, Valeria V.; Mansilla, Sabrina F.; Speroni, Juliana; Amaya, Celina; Cuello-Carrion, Dario; Ciocca, Daniel R.; Priestap, Horacio A.; Barbieri, Manuel A.; Gottifredi, Vanesa; Lopez, Luis A.			The Sesquiterpene Lactone Dehydroleucodine Triggers Senescence and Apoptosis in Association with Accumulation of DNA Damage Markers	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; STEM-CELLS; HELA-CELLS; P53; PARTHENOLIDE; PROTEIN; TARGET; PHASE	Sesquiterpene lactones (SLs) are plant-derived compounds that display anti-cancer effects. Some SLs derivatives have a marked killing effect on cancer cells and have therefore reached clinical trials. Little is known regarding the mechanism of action of SLs. We studied the responses of human cancer cells exposed to various concentrations of dehydroleucodine (DhL), a SL of the guaianolide group isolated and purified from Artemisia douglasiana (Besser), a medicinal herb that is commonly used in Argentina. We demonstrate for the first time that treatment of cancer cells with DhL, promotes the accumulation of DNA damage markers such as phosphorylation of ATM and focal organization of gamma H2AX and 53BP1. This accumulation triggers cell senescence or apoptosis depending on the concentration of the DhL delivered to cells. Transient DhL treatment also induces marked accumulation of senescent cells. Our findings help elucidate the mechanism whereby DhL triggers cell cycle arrest and cell death and provide a basis for further exploration of the effects of DhL in in vivo cancer treatment models.	[Costantino, Valeria V.; Amaya, Celina; Lopez, Luis A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol Dr MH Burgos IHEM, Lab Cell Cycle & Cytoskeleton, RA-5500 Mendoza, Argentina; [Cuello-Carrion, Dario; Ciocca, Daniel R.] Inst Med & Biol Expt Cuyo IMBECU CONICET, Mendoza, Argentina; [Mansilla, Sabrina F.; Speroni, Juliana; Gottifredi, Vanesa] Fdn Inst Leloir CONICET, Cell Cycle & Genom Stabil Lab, Buenos Aires, DF, Argentina; [Priestap, Horacio A.; Barbieri, Manuel A.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Barbieri, Manuel A.] Fairchild Trop Bot Garden, Coral Gables, FL USA	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; State University System of Florida; Florida International University	Gottifredi, V (corresponding author), Fdn Inst Leloir CONICET, Cell Cycle & Genom Stabil Lab, Buenos Aires, DF, Argentina.	vgottifredi@leloir.org.ar; llopez@fcm.uncu.edu.ar	Costantino, Valeria/AAN-1960-2020; Gottifredi, Vanesa/AAI-1788-2019; Barbieri, Marco/J-2597-2014	Costantino, Valeria/0000-0001-8723-9505; Gottifredi, Vanesa/0000-0001-9656-5951	Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT); Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina; United States National Institutes of Health [RO3 TW008924, SC1DK084343]; CONICET; ANPCyT; FOGARTY INTERNATIONAL CENTER [R03TW008924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [SC1DK084343] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT)(ANPCyT); Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by funding from the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT) and the Secretaria de Ciencia, Tecnologia y Posgrado, Universidad Nacional de Cuyo of Argentina to LAL and by United States National Institutes of Health grants RO3 TW008924 and SC1DK084343 to V.G. and MAB, respectively. VC and SFM were supported by fellowships from CONICET and ANPCyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly A, 2011, J MOL CELL BIOL, V3, P66, DOI 10.1093/jmcb/mjq055; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Cleaver JE, 2011, CELL CYCLE, V10, P3223, DOI 10.4161/cc.10.19.17448; Crespo-Ortiz MP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/247597; Cruzado M, 2005, CELL MOL BIOL, V51, P525, DOI 10.1170/T659; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; GIORDANO OS, 1990, J NAT PROD, V53, P803, DOI 10.1021/np50070a004; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Green DR, 2000, METHOD ENZYMOL, V322, P15; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Heinrich M, 1998, ANNU REV PHARMACOL, V38, P539, DOI 10.1146/annurev.pharmtox.38.1.539; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Jordan CT, 2006, CANCER CELL, V10, P253, DOI 10.1016/j.ccr.2006.09.010; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Lee YJ, 2006, CARBOHYD RES, V341, P1708, DOI 10.1016/j.carres.2006.03.014; Liao WL, 2009, INVEST OPHTH VIS SCI, V50, P4992, DOI 10.1167/iovs.09-3671; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Lopez ME, 2002, PROTOPLASMA, V219, P82, DOI 10.1007/s007090200008; Losinno AD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095158; Nakase I, 2009, CANCER LETT, V274, P290, DOI 10.1016/j.canlet.2008.09.023; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Polo LM, 2007, EUR J PHARMACOL, V556, P19, DOI 10.1016/j.ejphar.2006.10.049; Priestap HA, 2011, ACTA CRYSTALLOGR E, V67, pO3470, DOI 10.1107/S1600536811048938; ROBLES M, 1995, PLANTA MED, V61, P199, DOI 10.1055/s-2006-958055; Toranzo GS, 2007, ZYGOTE, V15, P183, DOI 10.1017/S0967199407004212; Toranzo GS, 2010, ZYGOTE, V18, P41, DOI 10.1017/S0967199409990086; Sarkar FH, 2008, FRONT BIOSCI-LANDMRK, V13, P2950, DOI 10.2741/2900; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; WOYNAROWSKI JM, 1981, MOL PHARMACOL, V19, P97; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976; Zhou JB, 2008, CELL CYCLE, V7, P1360, DOI 10.4161/cc.7.10.5953	49	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53168	10.1371/journal.pone.0053168	http://dx.doi.org/10.1371/journal.pone.0053168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341930	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400035
J	Holmgaard, DB; Mygind, LH; Titlestad, IL; Madsen, H; Fruekilde, PBN; Pedersen, S; Pedersen, C				Holmgaard, Dennis Back; Mygind, Lone Hagens; Titlestad, Ingrid Louise; Madsen, Hanne; Fruekilde, Palle Bach Nielsen; Pedersen, Stenvang; Pedersen, C.			Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality - Results from a 10-Year Prospective Cohort Study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; 25-HYDROXYVITAMIN D LEVEL; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY; ASSOCIATION; NEUTROPHIL; SUNLIGHT; DECLINE; BURDEN; COPD	Background: Recent studies have found vitamin D (25-OHD) deficiency and insufficiency to be common among patients with COPD. Serum level of 25-OHD seems to correlate to pulmonary function, COPD disease staging, and increased susceptibility to respiratory infections. We wanted to investigate whether vitamin D deficiency or insufficiency was associated with mortality rate in patients suffering from advanced COPD. Methods: 25-OHD serum levels were measured in 462 patients suffering from moderate to very severe COPD. Patients were stratified into three groups according to serum levels of 25-OHD. Outcome measure was mortality in a 10 year follow-up period. Kaplan-Meier curves (KM) were plotted and mortality hazard ratios (HR) were calculated using Cox Proportional Hazard regression (Cox PH). Results: Serum 25-OHD deficiency and insufficiency were prevalent. We were unable to demonstrate any association between baseline serum levels of 25-OHD and mortality rate. We found an association between mortality and age [HR 1.05 (CI 95%: 1.03-1.06)], Charlson score [HR 1.49 (CI 95%: 1.06-2.09)], increasing neutrophil count [HR 1.05 (CI 95%: 1.02-1.09)], severe [HR 1.41 (CI 95%: 1.06-1.86)]/very severe COPD [HR 2.19 (CI 95%: 1.58-3.02)] and a smoking history of more than 40 pack years [HR 1.27 (CI 95%: 1.02-1.70)]. Conclusions: Serum level of 25-OHD does not seem to be associated with mortality rate, suggesting no or only a minor role of 25-OHD in disease progression in patients with moderate to very severe COPD.	[Holmgaard, Dennis Back; Pedersen, Stenvang; Pedersen, C.] Odense Univ Hosp, Dept Infect Dis Q, DK-5000 Odense, Denmark; [Mygind, Lone Hagens] Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark; [Titlestad, Ingrid Louise; Madsen, Hanne] Odense Univ Hosp, Dept Resp Med J, DK-5000 Odense, Denmark; [Madsen, Hanne; Fruekilde, Palle Bach Nielsen] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Holmgaard, DB (corresponding author), Odense Univ Hosp, Dept Infect Dis Q, DK-5000 Odense, Denmark.	Aesklepios@gmail.com		Madsen, Hanne/0000-0002-2915-3161; Titlestad, Ingrid/0000-0001-6418-0088	Research Council of Southern Denmark, Overlaegeradets Legatrad; Danish Lung Association; Danish Council for Independent Research [22-04-0636]	Research Council of Southern Denmark, Overlaegeradets Legatrad; Danish Lung Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The study was supported by the Research Council of Southern Denmark, Overlaegeradets Legatrad, the Danish Lung Association and the Danish Council for Independent Research (grant no. 22-04-0636). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Haroon M, 2011, CLIN RHEUMATOL; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Jordan JG, 2010, SOUTH MED J, V103, P323, DOI 10.1097/SMJ.0b013e3181d394b4; Koli K, 2000, CELL GROWTH DIFFER, V11, P221; KREUTZ M, 1993, BLOOD, V82, P1300, DOI 10.1182/blood.V82.4.1300.1300; Kunisaki KM, 2011, EUR RESPIR J, V37, P238, DOI 10.1183/09031936.00146509; Kunisaki KM, 2011, AM J RESP CRIT CARE; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lash TL, 2011, LUNG, V189, P27, DOI 10.1007/s00408-010-9274-z; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Molfino Nestor A, 2007, Int J Chron Obstruct Pulmon Dis, V2, P117; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nishimura M, 2011, AM J RESP CRIT CARE; Noguera A, 2001, THORAX, V56, P432, DOI 10.1136/thorax.56.6.432; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Sandford AJ, 2001, AM J RESP CRIT CARE, V163, P469, DOI 10.1164/ajrccm.163.2.2006158; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S	38	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53670	10.1371/journal.pone.0053670	http://dx.doi.org/10.1371/journal.pone.0053670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341971	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400064
J	Kim, SH; Xiao, S; Shive, H; Collins, PL; Samal, SK				Kim, Shin-Hee; Xiao, Sa; Shive, Heather; Collins, Peter L.; Samal, Siba K.			Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 4 Confer Increased Replication and Syncytium Formation In Vitro but Not Increased Replication and Pathogenicity in Chickens and Ducks	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; COMPLETE GENOME SEQUENCE; FOREIGN GENE; CLONED CDNA; VIRULENCE; STRAIN; VACCINE; CLEAVABILITY; EXPRESSION; REVEALS	To evaluate the role of the F protein cleavage site in the replication and pathogenicity of avian paramyxoviruses (APMVs), we constructed a reverse genetics system for recovery of infectious recombinant APMV-4 from cloned cDNA. The recovered recombinant APMV-4 resembled the biological virus in growth characteristics in vitro and in pathogenicity in vivo. The F cleavage site sequence of APMV-4 (DIQPRQ down arrow F) contains a single basic amino acid, at the -1 position. Six mutant APMV-4 viruses were recovered in which the F protein cleavage site was mutated to contain increased numbers of basic amino acids or to mimic the naturally occurring cleavage sites of several paramyxoviruses, including neurovirulent and avirulent strains of NDV. The presence of a glutamine residue at the -3 position was found to be important for mutant virus recovery. In addition, cleavage sites containing the furin protease motif conferred increased replication and syncytium formation in vitro. However, analysis of viral pathogenicity in 9-day-old embryonated chicken eggs, 1-day-old and 2-week-old chickens, and 3-week-old ducks showed that none the F protein cleavage site mutations altered the replication, tropism, and pathogenicity of APMV-4, and no significant differences were observed among the parental and mutant APMV-4 viruses in vivo. Although parental and mutant viruses replicated somewhat better in ducks than in chickens, they all were highly restricted and avirulent in both species. These results suggested that the cleavage site sequence of the F protein is not a limiting determinant of APMV-4 pathogenicity in chickens and ducks.	[Kim, Shin-Hee; Xiao, Sa; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Shive, Heather] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			National Institute of Allergy and Infection Diseases (NIAID) [N01A060009]; NIAID, National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infection Diseases (NIAID); NIAID, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infection Diseases (NIAID) contract no N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D.J., 1989, LAB MANUAL ISOLATION; Alexander D.J., 2003, DIS POULTRY, V11th, P88, DOI [10.1080/03079457.2011., DOI 10.1080/03079457.2011]; ALEXANDER DJ, 1982, AVIAN PATHOL, V11, P179, DOI 10.1080/03079458208436091; ALEXANDER DJ, 1982, WORLD POULTRY SCI J, V38, P97, DOI 10.1079/WPS19820008; Beck I, 2003, VACCINE, V21, P1006, DOI 10.1016/S0264-410X(02)00552-2; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Khattar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016776; Kim SH, 2012, PLOS ONE; Kim SH, 2011, J VIROL, V85, P8582, DOI 10.1128/JVI.00652-11; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Kumar S, 2008, VIRUS RES, V137, P189, DOI 10.1016/j.virusres.2008.07.012; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Peter HD, 1965, P NATL ACAD SCI USA, V54, P794, DOI DOI 10.1073/PNAS.54.3.794.PUBMED:5217460; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; SHORTRIDGE KF, 1978, RES VET SCI, V25, P128, DOI 10.1016/S0034-5288(18)33030-3; SHORTRIDGE KF, 1978, J COMP PATHOL, V88, P633, DOI 10.1016/0021-9975(78)90017-8; Stanislawek WL, 2002, ARCH VIROL, V147, P1287, DOI 10.1007/s00705-002-0818-2; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Subbiah M, 2011, J VIROL, V85, P5394, DOI 10.1128/JVI.02696-10; TUREK R, 1984, ACTA VIROL, V28, P156; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Xiao S, 2010, VIRUS RES, V150, P61, DOI 10.1016/j.virusres.2010.02.015; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e50598	10.1371/journal.pone.0050598	http://dx.doi.org/10.1371/journal.pone.0050598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341874	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400002
J	McNaghten, AD; Valverde, EE; Blair, JM; Johnson, CH; Freedman, MS; Sullivan, PS				McNaghten, A. D.; Valverde, Eduardo E.; Blair, Janet M.; Johnson, Christopher H.; Freedman, Mark S.; Sullivan, Patrick S.			Routine HIV Testing among Providers of HIV Care in the United States, 2009	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FOR-DISEASE-CONTROL; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; RECOMMENDATIONS; HEALTH	In 2006, CDC recommended HIV screening as part of routine medical care for all persons aged 13-64 years. We examined adherence to the recommendations among a sample of HIV care providers in the US to determine if known providers of HIV care are offering routine HIV testing in outpatient settings. Data were from the CDC's Medical Monitoring Project Provider Survey, administered to physicians, nurse practitioners and physician assistants from June-September 2009. We assessed bivariate associations between testing behaviors and provider and practice characteristics and used multivariate regression to determine factors associated with offering HIV screening to all patients aged 13-64 years. Sixty percent of providers reported offering HIV screening to all patients 13 to 64 years of age. Being a nurse practitioner (aOR = 5.6, 95% CI = 2.6-11.9) compared to physician, age <39 (aOR = 1.9, 95% CI = 1.0-3.5) or 39-49 (aOR = 2.1, 95% CI = 1.4-3.3) compared with >= 50 years, and black race (aOR = 2.6, 95% CI = 1.2-6.0) compared with white race was associated with offering testing to all patients. Providers with low (aOR = 0.2, 95% CI = 0.1-0.3) or medium (aOR = 0.4, 95% CI = 0.2-0.6) HIV-infected patient loads were less likely to offer HIV testing to all patients compared with providers with high patient loads. Many providers of HIV care are still conducting risk-based rather than routine testing. We found that provider profession, age, race, and HIV-infected patient load were associated with offering HIV testing. Health care providers should use patient encounters as an opportunity to offer routine HIV testing to patients as outlined in CDC's revised recommendations for HIV testing in health care settings.	[McNaghten, A. D.; Valverde, Eduardo E.; Blair, Janet M.; Johnson, Christopher H.; Freedman, Mark S.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	McNaghten, AD (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	a.d.mcnaghten@emory.edu		Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded exclusively by the Centers for Disease Control and Prevention, which conceived the project, developed project-associated materials including data collection instruments, provided oversight of implementation, conducted analytic procedures, and developed this report.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], 1999, Pediatrics, V104, P128; [Anonymous], 1978, MAIL TELEPHONE SURVE; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Bernstein KT, 2008, AIDS PATIENT CARE ST, V22, P649, DOI 10.1089/apc.2007.0261; Bokhour BG, 2009, J GEN INTERN MED, V24, P1109, DOI 10.1007/s11606-009-1078-6; Brown J, 2007, J ACQ IMMUN DEF SYND, V46, P381; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; CDC, 2010, 6 CDC; CDC, 2006, MMWR-MORBID MORTAL W, V55; CDC, 2010, HIV SURV REP 2008, V20; Centers for Disease Control, 2001, Morbidity and Mortality Weekly Report, V50, P59; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1013; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P538; Centers for Disease Control and Prevention (CDC) , 1995, MMWR MORB MORTAL WKL, V44; Centers for Disease Control (CDC), 1987, MMWR Morb Mortal Wkly Rep, V36, P509; Chen Z, 1998, SEX TRANSM DIS, V25, P539, DOI 10.1097/00007435-199811000-00008; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Hanssens C, 2007, CLIN INFECT DIS, V45, pS232, DOI 10.1086/522543; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Herrera J. L., 1993, Morbidity and Mortality Weekly Report, V42, P1; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Mahajan AP, 2009, ANN INTERN MED, V150, P263, DOI 10.7326/0003-4819-150-4-200902170-00007; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; National HIV/AIDS Clinicians' Consultation Center, 2010, COMP 2010 STAT TEST; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Possi PH, 1983, HDB SURVEY RES; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Scott Victor F, 2009, Trans Am Clin Climatol Assoc, V120, P429; Siegel M, 2009, J ACQ IMMUN DEF SYND, V55, P205; The Office of National AIDS Policy, NAT HIV AIDS STRAT U; Valdiserri RO, 2010, J COMMUN HEALTH, V35, P215, DOI 10.1007/s10900-010-9233-x; Walensky R. P., 2004, Morbidity and Mortality Weekly Report, V53, P523; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Weis KE, 2009, AIDS PATIENT CARE ST, V23, P251, DOI 10.1089/apc.2008.0167	49	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e51231	10.1371/journal.pone.0051231	http://dx.doi.org/10.1371/journal.pone.0051231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23341880	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400003
J	Aurit, MD; Peterson, RO; Blanford, JI				Aurit, Mark D.; Peterson, Robert O.; Blanford, Justine I.			A GIS Analysis of the Relationship between Sinkholes, Dry-Well Complaints and Groundwater Pumping for Frost-Freeze Protection of Winter Strawberry Production in Florida	PLOS ONE			English	Article							SPATIAL-ANALYSIS; KARST; USA	Florida is riddled with sinkholes due to its karst topography. Sometimes these sinkholes can cause extensive damage to infrastructure and homes. It has been suggested that agricultural practices, such as sprinkler irrigation methods used to protect crops, can increase the development of sinkholes, particularly when temperatures drop below freezing, causing groundwater levels to drop quickly during groundwater pumping. In the strawberry growing region, Dover/Plant City, Florida, the effects have caused water shortages resulting in dry-wells and ground subsidence through the development of sinkholes that can be costly to maintain and repair. In this study, we look at how frost-freeze events have affected West Central Florida over the past 25 years with detailed comparisons made between two cold-years (with severe frost-freeze events) and a warm year (no frost-freeze events). We analyzed the spatial and temporal correlation between strawberry farming freeze protection practices and the development of sinkholes/dry well complaints, and assessed the economic impact of such events from a water management perspective by evaluating the cost of repairing and drilling new wells and how these compared with using alternative crop-protection methods. We found that the spatial distribution of sinkholes was non-random during both frost-freeze events. A strong correlation between sinkhole occurrence and water extraction and minimum temperatures was found. Furthermore as temperatures fall below 41 degrees F and water levels decrease by more than 20 ft, the number of sinkholes increase greatly (N>10). At this time alternative protection methods such as freeze-cloth are cost prohibitive in comparison to repairing dry wells. In conclusion, the findings from this study are applicable in other agricultural areas and can be used to develop comprehensive water management plans in areas where the abstraction of large quantities of water occur.	[Aurit, Mark D.] Tampa Bay Water, Clearwater, FL USA; [Peterson, Robert O.] SW Florida Water Management Dist, Water Resources Bur, Brooksville, FL USA; [Blanford, Justine I.] Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA; [Blanford, Justine I.] Penn State Univ, Dutton E Educ Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blanford, JI (corresponding author), Penn State Univ, Dept Geog, GeoVISTA Ctr, University Pk, PA 16802 USA.	jib18@psu.edu		Blanford, Justine/0000-0003-0844-9390				[Anonymous], 2009, CRIME MAPPING J RES; Ardaman and Associates I, 2011, GEOT ENG GEM; BECK BF, 1986, ENVIRON GEOL WATER S, V8, P5, DOI 10.1007/BF02525554; BENGTSSON TO, 1989, ENVIRON GEOL WATER S, V14, P43, DOI 10.1007/BF01740584; Boriss H., 2010, AGR MARKETING RES CE; DEP_FL, 2009, FLOR DROUGHT COND FR; Doctor KZ, 2008, 11 MULT C SINKH ENG, P100; Eck J, 2008, SECUR J, P4; EDLING RJ, 1992, AGR FOREST METEOROL, V60, P101, DOI 10.1016/0168-1923(92)90077-H; ESRI, 2010, AV NEAR NEIGHB SPAT; Evens RG, 2000, P ASEV 50 ANN M SEAT, P60; FAN, 2011, SINKH IMC AGR GYPS S; FAO, 2005, REC METH FROST PROT; FGS, 2011, FGS SUBS INC REP; Fleury S, 2009, KARST PROCESSES LAND; Fleury S, 2008, SE GEOGRAPHER, V48, P38; Fraisse CW, 2006, PROC FL STATE HORTIC, V119, P94; Galloway D.L., 1999, LAND SUBSIDENCE US, P23; Galloway DL, 1999, 1182 US GEOL SURV, P175; Hall LE, 1978, SINKHOLE COLLAPSE IN; Ingebritsen S.E., 1999, LAND SUBSIDENCE US, P15; Jackson JL, 2009, CITRUS COLD WEATHER; Jammal SE, 1982, WINTER PARK SINKHOLE, P585; Jammal SE, 2009, WINTER PARK SINKHOLE, P19; Johnson N, 2010, COST PLANT CITY SINK; Knox JW, 1997, AGR WATER MANAGE, V33, P1, DOI 10.1016/S0378-3774(96)01285-1; Newman GH, 2011, CITY TRANSFERS 70000; NOAA, 2011, NNDC CLIM DAT ONL GL; OMAFRA, 2009, FREEZ PROT METH CROP; PANNO SV, 1994, ENVIRON GEOL, V23, P214, DOI 10.1007/BF00771791; Peres NA, 2010, STRAWBERRY PRODUCTIO; Peterson RO, 2012, RESOURCE EVALUATION, P91; Poly-Tex, 2010, ACC; Powell AA, 2000, METHODS FREEZE PROTE, P1; Scheidt J., 2005, ENV GEOSCIENCES, V12, P207, DOI [10.1306/eg.05130404009, DOI 10.1306/EG.05130404009]; Scott, 2011, SPATIAL STAT BEST PR; Scott L.M., 2010, HDB APPL SPATIAL ANA; Sinclair W.C., 1982, SINKHOLE DEV RESULTI, P81; Snyder RL., 2005, FROST PROTECTION FUN, P2; SWFWMD, 2010, DOV PLANT CIT FREEZ; SWFWMD, 2011, DOV PLANT CIT FREEZ; SWFWMD, 2011, STAT EST REG COSTS D; SWFWMD, 2011, SHAP LIB REG; Tampa_Bay_Water, 2011, WATER SUPPLY; Tihansky A.B., 1999, LAND SUBSIDENCE US U, V1182, P121; Unwin D, 2003, GEOGRAPHIC INFORM AN; USDA, 2007, CENS AGR COUNT DAT; USFIFAS, 2005, WAT QUAL QUANT BEST; Waltham T, 2008, Q J ENG GEOL HYDROGE, V41, P291, DOI 10.1144/1470-9236/07-211; Watson Company, 1973, LONG RANG STUD CIT T; Weatherbase, 2011, WEATHERBASE WEATHER; Whitman D, 1999, PHOTOGRAMM ENG REM S, V65, P1169; WILSON WL, 1992, GROUND WATER, V30, P918, DOI 10.1111/j.1745-6584.1992.tb01575.x; Wing MG, 2006, J FOREST, V104, P293; Zektser S, 2005, ENVIRON GEOL, V47, P396, DOI 10.1007/s00254-004-1164-3; Zhang Y, 2010, ENVIRON EARTH SCI, V61, P1135, DOI 10.1007/s12665-009-0433-6	56	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53832	10.1371/journal.pone.0053832	http://dx.doi.org/10.1371/journal.pone.0053832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326518	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800080
J	Lien, YC; Ou, TY; Lin, YT; Kuo, PC; Lin, HJ				Lien, Yi-Chin; Ou, Ting-Yu; Lin, Yu-Tzu; Kuo, Po-Chih; Lin, Han-Jia			Duplication and Diversification of the Spermidine/Spermine N-1-acetyltransferase 1 Genes in Zebrafish	PLOS ONE			English	Article							POLYAMINE ANALOGS; ACETYLTRANSFERASE; IDENTIFICATION; THIALYSINE; EXPRESSION; EVOLUTION; SEQUENCE; BINDS; MICE; UBIQUITINATION	Spermidine/spermine N-1-acetyltransferase 1 (Ssat1) is a key enzyme in the polyamine interconversion pathway, which maintains polyamine homeostasis. In addition, mammalian Ssat1 is also involved in many physiological and pathological events such as hypoxia, cell migration, and carcinogenesis. Using cross-genomic bioinformatic analysis in 10 deuterostomes, we found that ssat1 only exists in vertebrates. Comparing with mammalian, zebrafish, an evolutionarily distant vertebrate, contains 3 homologous ssat1 genes, named ssat1a, ssat1b, and ssat1c. All zebrafish homologues could be transcribed and produce active enzymes. Despite the long history since their evolutionary diversification, some features of human SSAT1 are conserved and subfunctionalized in the zebrafish family of Ssat1 proteins. The polyamine-dependent protein synthesis was only found in Ssat1b and Ssat1c, not in Ssat1a. Further study indicated that both 5' and 3' sequences of ssat1b mediate such kind of translational regulation inside the open reading frame (ORF). The polyamine-dependent protein stabilization was only observed in Ssat1b. The last 70 residues of Ssat1b were crucial for its rapid degradation and polyamine-induced stabilization. It is worth noting that only Ssat1b and Ssat1c, but not the polyamine-insensitive Ssat1a, were able to interact with integrin alpha 9 and Hif-1 alpha. Thus, Ssat1b and Ssat1c might not only be a polyamine metabolic enzyme but also simultaneously respond to polyamine levels and engage in cross-talk with other signaling pathways. Our data revealed some correlations between the sequences and functions of the zebrafish family of Ssat1 proteins, which may provide valuable information for studies of their translational regulatory mechanism, protein stability, and physiological functions.	[Lien, Yi-Chin; Ou, Ting-Yu; Lin, Yu-Tzu; Kuo, Po-Chih; Lin, Han-Jia] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Lin, Han-Jia] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Lin, HJ (corresponding author), Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan.	hanjia@ntou.edu.tw		Lin, Han-Jia/0000-0002-4929-6573	National Science Council (Taipei, Taiwan) [NSC 99-2313-B-019-010-MY3, NSC 100-2627-B-019-005]	National Science Council (Taipei, Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants NSC 99-2313-B-019-010-MY3 and NSC 100-2627-B-019-005 from the National Science Council (Taipei, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Dalo B, 2004, BIOCHEM J, V384, P129, DOI 10.1042/BJ20040789; Agostinelli E, 2010, AMINO ACIDS, V38, P353, DOI 10.1007/s00726-009-0431-8; Agostinelli E, 2012, AMINO ACIDS, V42, P397, DOI 10.1007/s00726-011-1129-2; Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Bai LP, 2011, BIOCHIMIE, V93, P1401, DOI 10.1016/j.biochi.2011.04.014; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Butcher NJ, 2007, J BIOL CHEM, V282, P28530, DOI 10.1074/jbc.M701265200; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; COLEMAN CS, 1995, BIOCHEMISTRY-US, V34, P13423, DOI 10.1021/bi00041a020; Coleman CS, 2004, BIOCHEM J, V384, P139, DOI 10.1042/BJ20040790; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FogelPetrovic M, 1996, BIOCHEMISTRY-US, V35, P14436, DOI 10.1021/bi9612273; Force A, 1999, GENETICS, V151, P1531; Forouhar F, 2005, J BIOL CHEM, V280, P40328, DOI 10.1074/jbc.M505332200; FUKUCHI J, 1994, J BIOL CHEM, V269, P22581; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han LP, 2009, INT J CARDIOL, V132, P142, DOI 10.1016/j.ijcard.2007.07.163; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; Hyvonen MT, 2012, AMINO ACIDS, V42, P485, DOI 10.1007/s00726-011-1027-7; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kim K, 2005, BIOCHEM BIOPH RES CO, V331, P78, DOI 10.1016/j.bbrc.2005.03.121; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Lee SB, 2010, J BIOL CHEM, V285, P15548, DOI 10.1074/jbc.M109.092007; Lin HJ, 2010, ANAL BIOCHEM, V407, P226, DOI 10.1016/j.ab.2010.07.036; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Luersen K, 2005, FEBS LETT, V579, P5347, DOI 10.1016/j.febslet.2005.08.063; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Montemayor EJ, 2008, BIOCHEMISTRY-US, V47, P9145, DOI 10.1021/bi8009357; Niiranen K, 2006, J CELL MOL MED, V10, P933, DOI 10.2755/jcmm010.004.02; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Rao AM, 2000, J NEUROCHEM, V74, P1106; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uimari A, 2012, AMINO ACIDS, V42, P461, DOI 10.1007/s00726-011-1025-9; Vreede J, 2003, J BIOL CHEM, V278, P18434, DOI 10.1074/jbc.M301701200; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wang YL, 1998, J BIOL CHEM, V273, P34623, DOI 10.1074/jbc.273.51.34623; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	58	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54017	10.1371/journal.pone.0054017	http://dx.doi.org/10.1371/journal.pone.0054017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326562	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800101
J	Cano, PM; Seeboth, J; Meurens, F; Cognie, J; Abrami, R; Oswald, IP; Guzylack-Piriou, L				Cano, Patricia M.; Seeboth, Julie; Meurens, Francois; Cognie, Juliette; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence			Deoxynivalenol as a New Factor in the Persistence of Intestinal Inflammatory Diseases: An Emerging Hypothesis through Possible Modulation of Th17-Mediated Response	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; T-CELLS; BARRIER FUNCTION; PROTEIN EXPRESSION; GENE-EXPRESSION; DENDRITIC CELLS; T(H)17 CELLS; TGF-BETA; INDUCTION; ACTIVATION	Background/Aims: Deoxynivalenol (DON) is a mycotoxin produced by Fusarium species which is commonly found in temperate regions worldwide as a natural contaminant of cereals. It is of great concern not only in terms of economic losses but also in terms of animal and public health. The digestive tract is the first and main target of this food contaminant and it represents a major site of immune tolerance. A finely tuned cross-talk between the innate and the adaptive immune systems ensures the homeostatic equilibrium between the mucosal immune system and commensal microorganisms. The aim of this study was to analyze the impact of DON on the intestinal immune response. Methodology: Non-transformed intestinal porcine epithelial cells IPEC-1 and porcine jejunal explants were used to investigate the effect of DON on the intestinal immune response and the modulation of naive T cells differentiation. Transcriptomic proteomic and flow cytometry analysis were performed. Results: DON induced a pro-inflammatory response with a significant increase of expression of mRNA encoding for IL-8, IL-1 alpha and IL-1 beta, TNF-alpha in all used models. Additionally, DON significantly induced the expression of genes involved in the differentiation of Th17 cells (STAT3, IL-17A, IL-6, IL-1 beta) at the expenses of the pathway of regulatory T cells (Treg) (FoxP3, RALDH1). DON also induced genes related to the pathogenic Th17 cells subset such as IL-23A, IL-22 and IL-21 and not genes related to the regulatory Th17 cells (rTh17) such as TGF-beta and IL-10. Conclusion: DON triggered multiple immune modulatory effects which could be associated with an increased susceptibility to intestinal inflammatory diseases.	[Cano, Patricia M.; Seeboth, Julie; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence] INRA, UMR1331, Res Ctr Food Toxicol, Toxalim, F-31931 Toulouse, France; [Cano, Patricia M.; Seeboth, Julie; Abrami, Roberta; Oswald, Isabelle P.; Guzylack-Piriou, Laurence] Univ Toulouse, INPT, UMR1331, Toxalim, Toulouse, France; [Meurens, Francois] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Cognie, Juliette] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Abrami, Roberta] Univ Estadual Londrina, Lab Patol Anim, Londrina, Brazil; [Meurens, Francois] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universidade Estadual de Londrina; University of Saskatchewan	Oswald, IP (corresponding author), INRA, UMR1331, Res Ctr Food Toxicol, Toxalim, F-31931 Toulouse, France.	isabelle.oswald@toulouse.inra.fr; laurence.guzylack@toulouse.inra.fr	OSWALD, Isabelle P/A-8497-2013; Meurens, Francois JMA/J-3829-2019; OSWALD, Isabelle/GPP-1123-2022	OSWALD, Isabelle P/0000-0001-9918-277X; Meurens, Francois JMA/0000-0002-0353-4871; OSWALD, Isabelle/0000-0001-9918-277X; Juliette, Cognie/0000-0003-0908-9833	INRA; ANSES (France); Ministry for Education and Research (France); CAPES-COFECUB (Brazil); EU [FP7-KBBE-KBBE-2008-2B, FP7-KBBE-2007-2A]; INRA-Division of animal health	INRA; ANSES (France); Ministry for Education and Research (France); CAPES-COFECUB (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EU(European Commission); INRA-Division of animal health	Patricia Cano, Julie Seeboth and Roberta Abrami were supported by a doctoral fellowships financed by INRA and ANSES (France), the Ministry for Education and Research (France), CAPES-COFECUB (Brazil) respectively. This study was supported by the EU projects INTERPLAY (FP7-KBBE-KBBE-2008-2B), MycoRed (FP7-KBBE-2007-2A) and by a grant for newly recruited scientist from INRA-Division of animal health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZIED MM, 1991, APPL ENVIRON MICROB, V57, P672, DOI 10.1128/AEM.57.3.672-677.1991; Amuzie CJ, 2009, TOXICOL SCI, V111, P277, DOI 10.1093/toxsci/kfp150; Avantaggiato G, 2004, FOOD CHEM TOXICOL, V42, P817, DOI 10.1016/j.fct.2004.01.004; Bouhet S, 2004, TOXICOL SCI, V77, P165, DOI 10.1093/toxsci/kfh006; Bracarense APFL, 2012, BRIT J NUTR, V107, P1776, DOI 10.1017/S0007114511004946; Bruel T, 2010, DEV COMP IMMUNOL, V34, P562, DOI 10.1016/j.dci.2009.12.017; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; Caprioli F, 2008, J CROHNS COLITIS, V2, P291, DOI 10.1016/j.crohns.2008.05.004; CAST, 2003, COUNCIL AGR SC TECHN, V138, P136; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Delgado-Ortega M, 2011, VET IMMUNOL IMMUNOP, V144, P493, DOI 10.1016/j.vetimm.2011.08.002; Doll S, 2011, PREV VET MED, V102, P132, DOI 10.1016/j.prevetmed.2011.04.008; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gerdts V, 2001, J IMMUNOL METHODS, V256, P19, DOI 10.1016/S0022-1759(01)00429-X; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; GonzalezVallina R, 1996, AM J PHYSIOL-GASTR L, V271, pG249, DOI 10.1152/ajpgi.1996.271.2.G249; Grenier B, 2011, MOL NUTR FOOD RES, V55, P761, DOI 10.1002/mnfr.201000402; Haverson K, 2000, IMMUNOLOGY, V101, P492, DOI 10.1046/j.1365-2567.2000.00128.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser T, 2008, VET IMMUNOL IMMUNOP, V125, P92, DOI 10.1016/j.vetimm.2008.05.007; Kaser T, 2008, VET IMMUNOL IMMUNOP, V122, P153, DOI 10.1016/j.vetimm.2007.08.002; Kaser T, 2012, CYTOKINE, V60, P400, DOI 10.1016/j.cyto.2012.07.007; Kaser T, 2012, VET IMMUNOL IMMUNOP, V148, P136, DOI 10.1016/j.vetimm.2011.05.035; Kaser T, 2011, DEV COMP IMMUNOL, V35, P1166, DOI 10.1016/j.dci.2011.04.006; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kiros TG, 2011, VET IMMUNOL IMMUNOP, V144, P448, DOI 10.1016/j.vetimm.2011.08.021; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Ledger TN, 2004, CLIN DIAGN LAB IMMUN, V11, P691, DOI 10.1128/CDLI.11.4.691-698.2004; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Matricon J, 2010, M S-MED SCI, V26, P405, DOI 10.1051/medsci/2010264405; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Miossec P, 2009, EUR J IMMUNOL, V39, P667, DOI 10.1002/eji.200839088; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Oswald IP, 1998, REV MED VET-TOULOUSE, V149, P585; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Pestka J, 2006, TOXICOL SCI, V92, P445, DOI 10.1093/toxsci/kfl012; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; SCOOP, 2003, COLL OCC DAT FUS TOX; Seeboth J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-35; TRUCKSESS MW, 1995, J AOAC INT, V78, P631; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Wache YJ, 2009, TOXICOLOGY, V262, P239, DOI 10.1016/j.tox.2009.06.014; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Zanello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018573; Zelante T, 2009, MED MYCOL, V47, pS162, DOI 10.1080/13693780802140766; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	71	86	88	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53647	10.1371/journal.pone.0053647	http://dx.doi.org/10.1371/journal.pone.0053647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326479	Green Published, gold			2022-12-27	WOS:000313552400034
J	Sammon, CJ; Snowball, J; McGrogan, A; de Vries, CS				Sammon, Cormac J.; Snowball, Julia; McGrogan, Anita; de Vries, Corinne S.			Evaluating the Hazard of Foetal Death following H1N1 Influenza Vaccination; A Population Based Cohort Study in the UK GPRD	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; PREGNANT-WOMEN; MEDICAL-RECORDS; IMMUNIZATION; SENSITIVITY; INFECTION; OUTCOMES; SAFETY	Background: To evaluate the risk of foetal loss associated with pandemic influenza vaccination in pregnancy. Retrospective cohort study. UK General Practice Research Database Pregnancies ending in delivery or spontaneous foetal death after 21 October 2009 and starting before 01 January 2010. Methodology/Principal Findings: Hazard ratios of foetal death for vaccinated compared to unvaccinated pregnancies were estimated for gestational weeks 9 to 12, 13 to 24 and 25 to 43 using discrete-time survival analysis. Separate models were specified to evaluate whether the potential effect of vaccination on foetal loss might be transient (for similar to 4 weeks post vaccination only) or more permanent (for the duration of the pregnancy). 39,863 pregnancies meeting our inclusion criteria contributed a total of 969,322 gestational weeks during the study period. 9,445 of the women were vaccinated before or during pregnancy. When the potential effect of vaccination was assumed to be transient, the hazard of foetal death during gestational weeks 9 through 12 (HRunadj 0.56; CI95 0.43 to 0.73) and 13 through 24 (HRunadj 0.45; CI95 0.28 to 0.73) was lower in the 4 weeks after vaccination than in other weeks. Where the more permanent exposure definition was specified, vaccinated pregnancies also had a lower hazard of foetal loss than unvaccinated pregnancies in gestational weeks 9 through 12 (HRunadj 0.74; CI95 0.62 to 0.88) and 13 through 24 (HRunadj 0.59; CI95 0.45 to 0.77). There was no difference in the hazard of foetal loss during weeks 25 to 43 in either model. Sensitivity analyses suggest the strong protective associations observed may be due in part to unmeasured confounding. Conclusions/Significance: Influenza vaccination during pregnancy does not appear to increase the risk of foetal death. This study therefore supports the continued recommendation of influenza vaccination of pregnant women.	[Sammon, Cormac J.; Snowball, Julia; McGrogan, Anita; de Vries, Corinne S.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Sammon, CJ (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	cs385@bath.ac.uk	Sammon, Cormac/B-7340-2015	Sammon, Cormac/0000-0002-7921-4858; Snowball, Julia/0000-0002-8454-9046; McGrogan, Anita/0000-0003-3855-9400	University of Bath	University of Bath	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CJS was funded by a University Research Studentship from the University of Bath. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum F, 2010, PANDEMIC H1N1 SWINE; Begum F, 2011, SEASONAL INFLUENZA V; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Bloom-Feshbach K, 2011, J INFECT DIS, V204, P1157, DOI 10.1093/infdis/jir510; Charlton RA, 2010, DRUG SAFETY, V33, P741, DOI 10.2165/11536820-000000000-00000; DEINARD AS, 1981, AM J OBSTET GYNECOL, V140, P240, DOI 10.1016/0002-9378(81)90267-2; Department of Health website, 2012, IMMUNISATION TEA MAR; Department of Health website. PRIMIS+, 2010, INFL A H1N1 V UPT SU; Devine S, 2010, PHARMACOEPIDEM DR S, V19, P45, DOI 10.1002/pds.1862; Ding H, 2011, AM J OBSTET GYNECOL, V204, pS96, DOI 10.1016/j.ajog.2011.03.003; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; General Practice Research Database website, 2011, FACTS FIG; Goldfarb I, 2011, AM J OBSTET GYNECOL, V204, pS112, DOI 10.1016/j.ajog.2011.01.007; Hardy JR, 2004, PHARMACOEPIDEM DR S, V13, P749, DOI 10.1002/pds.935; HEINONEN OP, 1973, INT J EPIDEMIOL, V2, P229, DOI 10.1093/ije/2.3.229; Hoesli IM, 2001, AM J MED GENET, V100, P106, DOI 10.1002/1096-8628(20010422)100:2<106::AID-AJMG1238>3.0.CO;2-L; Lieberman RW, 2011, EMERG INFECT DIS, V17, P107, DOI 10.3201/eid1701.091895; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; MCCLEAN E, 2010, EPIDEMIOLOGICAL REPO; Mereckiene J, 2012, EURO SURVEILL, V17; Moro PL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.047; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Ng S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-230; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Ropero-Alvarez AM, 2012, VACCINE, V30, P916, DOI 10.1016/j.vaccine.2011.11.092; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; SteelFisher GK, 2011, AM J OBSTET GYNECOL, V204, pS116, DOI 10.1016/j.ajog.2011.02.036; SUMAYA CV, 1979, J INFECT DIS, V140, P141, DOI 10.1093/infdis/140.2.141; Tavares F, 2011, VACCINE, V29, P6358, DOI 10.1016/j.vaccine.2011.04.114; van Lier A, 2012, VACCINE; Walker Deborah K., 2011, Morbidity and Mortality Weekly Report, V60, P1078; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Xu RH, 2012, PHARMACOEPIDEM DR S, V21, P844, DOI 10.1002/pds.3301; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6	42	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51734	10.1371/journal.pone.0051734	http://dx.doi.org/10.1371/journal.pone.0051734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23341865	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900116
J	Borel, JC; Burel, B; Tamisier, R; Dias-Domingos, S; Baguet, JP; Levy, P; Pepin, JL				Borel, Jean-Christian; Burel, Benoit; Tamisier, Renaud; Dias-Domingos, Sonia; Baguet, Jean-Philippe; Levy, Patrick; Pepin, Jean-Louis			Comorbidities and Mortality in Hypercapnic Obese under Domiciliary Noninvasive Ventilation	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE SLEEP-APNEA; HYPOVENTILATION SYNDROME; ADULTS; PREVALENCE; PREDICTORS; COMMUNITY; SURVIVAL; OUTCOMES; THERAPY	Background: The higher mortality rate in untreated patients with obesity-associated hypoventilation is a strong rationale for long-term noninvasive ventilation (NIV). The impacts of comorbidities, medications and NIV compliance on survival of these patients remain largely unexplored. Methods: Observational cohort of hypercapnic obese patients initiated on NIV between March 2003 and July 2008. Survival curves were estimated by the Kaplan-Meier method. Anthropometric measurements, pulmonary function, blood gases, nocturnal SpO(2) indices, comorbidities, medications, conditions of NIV initiation and NIV compliance were used as covariates. Univariate and multivariate Cox models allowed to assess predictive factors of mortality. Results: One hundred and seven patients (56% women), in whom NIV was initiated in acute (36%) or chronic conditions, were followed during 43 +/- 14 months. The 1, 2, 3 years survival rates were 99%, 94%, and 89%, respectively. In univariate analysis, death was associated with older age (>61 years), low FEV1 (<66% predicted value), male gender, BMIxtime, concomitant COPD, NIV initiation in acute condition, use of inhaled corticosteroids, beta-blockers, nonthiazide diuretics, angiotensin-converting enzyme inhibitors and combination of cardiovascular drugs (one diuretic and at least one other cardiovascular agent). In multivariate analysis, combination of cardiovascular agents was the only factor independently associated with higher risk of death (HR = 5.3; 95% CI 1.18; 23.9). Female gender was associated with lower risk of death. Conclusion: Cardiovascular comorbidities represent the main factor predicting mortality in patient with obesity-associated hypoventilation treated by NIV. In this population, NIV should be associated with a combination of treatment modalities to reduce cardiovascular risk.	[Borel, Jean-Christian; Tamisier, Renaud; Dias-Domingos, Sonia; Levy, Patrick; Pepin, Jean-Louis] Univ Grenoble 1, Fac Med, INSERM, Lab HP2,U1042, Grenoble, France; [Baguet, Jean-Philippe] CHU Grenoble, Hop A Michallon, Dept Cardiol, F-38043 Grenoble, France; [Borel, Jean-Christian] AGIRadom, Dept Res & Dev, Meylan, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Borel, JC (corresponding author), Univ Grenoble 1, Fac Med, INSERM, Lab HP2,U1042, Grenoble, France.	j.borel@agiradom.com; jpepin@chu-grenoble.fr	Tamisier, Renaud/M-6858-2014; Borel, Jean Christian/AAC-5950-2019; LEVY, Patrick/AAX-2802-2020; Borel, Jean Christian JC/M-7135-2014; Lévy, Patrick/M-6903-2014; PEPIN, Jean-Louis/M-6549-2014; Baguet, Jean-Philippe/M-5536-2014	Tamisier, Renaud/0000-0003-1128-6529; Borel, Jean Christian/0000-0003-4140-6210; LEVY, Patrick/0000-0003-3174-7935; Lévy, Patrick/0000-0003-3632-1327; Pepin, Jean Louis/0000-0003-3832-2358				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Borel JC, 2011, RESPIROLOGY; Borel JC, 2012, CHEST, V141, P692, DOI 10.1378/chest.10-2531; Budweiser S, 2007, J INTERN MED, V261, P375, DOI 10.1111/j.1365-2796.2007.01765.x; Chaouat A, 2001, EUR RESPIR J, V17, P848, DOI 10.1183/09031936.01.17508480; Chaouat A, 1999, EUR RESPIR J, V13, P1091, DOI 10.1034/j.1399-3003.1999.13e25.x; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Heinemann F, 2007, RESP MED, V101, P1229, DOI 10.1016/j.rmed.2006.10.027; Kessler R, 2001, CHEST, V120, P369, DOI 10.1378/chest.120.2.369; Laub M, 2007, RESP MED, V101, P1074, DOI 10.1016/j.rmed.2006.10.007; Lee R, 2011, CURR OPIN PULM MED, V17, P79, DOI 10.1097/MCP.0b013e32834317bb; Machado MCL, 2010, EUR RESPIR J, V35, P132, DOI 10.1183/09031936.00192008; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Mokhlesi B, 2007, SLEEP BREATH, V11, P117, DOI 10.1007/s11325-006-0092-8; Mokhlesi B, 2010, RESP CARE, V55, P1347; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Quint JK, 2007, THORAX, V62, P462, DOI 10.1136/thx.2006.074245; Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Weber MA, 2012, J HYPERTENS, V30, P2213, DOI 10.1097/HJH.0b013e3283582ed6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang YQ, 2012, J HYPERTENS, V30, P2202, DOI 10.1097/HJH.0b013e3283582eec	27	50	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52006	10.1371/journal.pone.0052006	http://dx.doi.org/10.1371/journal.pone.0052006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341888	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700011
J	McCallum, J; Hall, S; Lissone, I; Anderson, J; Huynen, L; Lambert, DM				McCallum, Jonathan; Hall, Samantha; Lissone, Iman; Anderson, Jennifer; Huynen, Leon; Lambert, David M.			Highly Informative Ancient DNA 'Snippets' for New Zealand Moa	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; EVOLUTIONARY HISTORY; SEQUENCES; REMAINS; BIRDS; DECAY	Background: Analysis of ancient DNA has provided invaluable information on past ecologies, ancient populations, and extinct species. We used a short snippet of highly variable mitochondrial control region sequence from New Zealand's moa to characterise a large number of bones previously intractable to DNA analysis as well as bone fragments from swamps to gain information about the haplotype diversity and phylogeography that existed in five moa species. Methodology/Principal Findings: By targeting such 'snippets', we show that moa populations differed substantially in geographic structure that is likely to be related to population mobility and history. We show that populations of Pachyornis geranoides, Dinornis novaezealandiae, and Dinornis robustus were highly structured and some appear to have occupied the same geographic location for hundreds of thousands of years. In contrast, populations of the moa Anomalopteryx didiformis and Euryapteryx curtus were widespread, with specific populations of the latter occupying both the North and South Islands of New Zealand. We further show that for a specific area, in this case a North Island swamp, complete haplotype diversity and even sex can be recovered from collections of small, often discarded, bone fragments. Conclusions/Significance: Short highly variable mitochondrial 'snippets' allow successful typing of environmentally damaged and fragmented skeletal material, and can provide useful information about ancient population diversity and structure without the need to sample valuable, whole bones often held by museums.	[McCallum, Jonathan; Hall, Samantha; Huynen, Leon; Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [McCallum, Jonathan; Hall, Samantha; Huynen, Leon; Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lissone, Iman; Anderson, Jennifer] Massey Univ, Inst Nat Resources, N Shore City, New Zealand	Griffith University; Griffith University; Massey University	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au		Lambert, David/0000-0002-5821-3637	Australian Research Council Discovery [DP110101364]	Australian Research Council Discovery(Australian Research Council)	The work was funded by the Australian Research Council Discovery grant (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Anderson A.J., 1989, PRODIGIOUS BIRDS MOA; Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2000, SCIENCE, V289, P1139; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Gundry RL, 2007, J FORENSIC SCI, V52, P562, DOI 10.1111/j.1556-4029.2007.00425.x; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Huynen L, 2008, J ROY SOC NEW ZEAL, V38, P231, DOI 10.1080/03014220809510557; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Omura Y, 1995, JPN J PHARMACOL, V69, P293, DOI 10.1254/jjp.69.293; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Rawlings LH, 2004, AUST J ZOOL, V52, P215, DOI 10.1071/ZO03030; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Trewick SA, 2001, NEW ZEAL J ZOOL, V28, P291, DOI 10.1080/03014223.2001.9518271; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; WORTHY TH, 2002, LOST WORLD MOA; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027750; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	4	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50732	10.1371/journal.pone.0050732	http://dx.doi.org/10.1371/journal.pone.0050732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341875	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700005
J	Zheng, LX; Hedrick, TL; Mittal, R				Zheng, Lingxiao; Hedrick, Tyson L.; Mittal, Rajat			Time-Varying Wing-Twist Improves Aerodynamic Efficiency of Forward Flight in Butterflies	PLOS ONE			English	Article							IMMERSED BOUNDARY METHOD; INSECT FLIGHT; FLYING BUTTERFLIES; DESERT LOCUST; DEFORMATION; HOVERFLIES; MECHANISMS; KINEMATICS; FORCES; MOTION	Insect wings can undergo significant chordwise (camber) as well as spanwise (twist) deformation during flapping flight but the effect of these deformations is not well understood. The shape and size of butterfly wings leads to particularly large wing deformations, making them an ideal test case for investigation of these effects. Here we use computational models derived from experiments on free-flying butterflies to understand the effect of time-varying twist and camber on the aerodynamic performance of these insects. High-speed videogrammetry is used to capture the wing kinematics, including deformation, of a Painted Lady butterfly (Vanessa cardui) in untethered, forward flight. These experimental results are then analyzed computationally using a high-fidelity, three-dimensional, unsteady Navier-Stokes flow solver. For comparison to this case, a set of non-deforming, flat-plate wing (FPW) models of wing motion are synthesized and subjected to the same analysis along with a wing model that matches the time-varying wing-twist observed for the butterfly, but has no deformation in camber. The simulations show that the observed butterfly wing (OBW) outperforms all the flat-plate wings in terms of usable force production as well as the ratio of lift to power by at least 29% and 46%, respectively. This increase in efficiency of lift production is at least three-fold greater than reported for other insects. Interestingly, we also find that the twist-only-wing (TOW) model recovers much of the performance of the OBW, demonstrating that wing-twist, and not camber is key to forward flight in these insects. The implications of this on the design of flapping wing micro-aerial vehicles are discussed.	[Zheng, Lingxiao; Mittal, Rajat] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Hedrick, Tyson L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Mittal, R (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	mittal@jhu.edu	Hedrick, Tyson/GZH-3140-2022	Hedrick, Tyson/0000-0002-6573-9602; Mittal, Rajat/0000-0002-8107-9499	National Science Foundation (NSF) [0943425, TG-CTS100002, NSF-OCI-108849]; Air-Force Office of Scientific Research [FA9550-10-1-006]	National Science Foundation (NSF)(National Science Foundation (NSF)); Air-Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	RM and LZ acknowledge support from the National Science Foundation (NSF) under Grant No. 0943425. RM and TH also acknowledge support from Air-Force Office of Scientific Research grant FA9550-10-1-006 monitored by Dr. Douglas Smith. Computational time for this research is provided by NSF under Grant Nos. TG-CTS100002 and NSF-OCI-108849. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian RJ, 2000, EXP FLUIDS, V29, P275, DOI 10.1007/s003489900087; Aono H, 2010, 48 AER SCI M INCL NE; BAKER PS, 1981, J COMP PHYSIOL, V141, P233, DOI 10.1007/BF01342669; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Bomphrey RJ, 2002, PHYS FLUIDS, V14, P1079; BRODSKY AK, 1991, J EXP BIOL, V161, P77; CLOUPEAU M, 1979, J EXP BIOL, V80, P1; Combes SA, 2003, J EXP BIOL, V206, P2999, DOI 10.1242/jeb.00502; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Dai H, 2012, J FLUID MECH, V693, P473, DOI 10.1017/jfm.2011.543; Du G, 2010, J EXP BIOL, V213, P2273, DOI 10.1242/jeb.040295; Dudley R., 2000, BIOMECHANICS INSECT; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; ENNOS AR, 1988, J EXP BIOL, V140, P161; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Heathcote S, 2008, J FLUID STRUCT, V24, P183, DOI 10.1016/j.jfluidstructs.2007.08.003; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Lin T, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/044002; Lu Y, 2007, AIAA J, V45, P615, DOI 10.2514/1.22088; Miller LA, 2009, J EXP BIOL, V212, P3076, DOI 10.1242/jeb.028662; Mittal R, 2008, J COMPUT PHYS, V227, P4825, DOI 10.1016/j.jcp.2008.01.028; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Mountcastle AM, 2009, EXP FLUIDS, V46, P873, DOI 10.1007/s00348-008-0607-0; Nakata T, 2012, P ROY SOC B-BIOL SCI, V279, P722, DOI 10.1098/rspb.2011.1023; Seo JH, 2011, J COMPUT PHYS, V230, P7347, DOI 10.1016/j.jcp.2011.06.003; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Sunada S, 2002, JSME INT J B-FLUID T, V45, P836, DOI 10.1299/jsmeb.45.836; Walker SM, 2010, J R SOC INTERFACE, V7, P131, DOI 10.1098/rsif.2009.0120; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; WEISFOGH T, 1952, PHILOS T ROY SOC B, V237, P1, DOI 10.1098/rstb.1952.0011; WOOTTON RJ, 1993, J EXP BIOL, V180, P105; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; ZENG L, 2000, OPT COMMUN, V183, P19, DOI DOI 10.1016/S0030-4018(00)00888-9; Zhang XW, 2012, P I MECH ENG G-J AER, V226, P3, DOI 10.1177/0954410011408763; Zhao L, 2009, OPT COMMUN, V183, P19; Zheng L, 2012, THESIS J HOPKINS U	37	70	71	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53060	10.1371/journal.pone.0053060	http://dx.doi.org/10.1371/journal.pone.0053060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341923	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700020
J	Blomqvist, K; Albrecht, L; Quintana, MD; Angeletti, D; Joannin, N; Chene, A; Moll, K; Wahlgren, M				Blomqvist, Karin; Albrecht, Letusa; del Pilar Quintana, Maria; Angeletti, Davide; Joannin, Nicolas; Chene, Arnaud; Moll, Kirsten; Wahlgren, Mats			A Sequence in Subdomain 2 of DBL1 alpha of Plasmodium falciparum Erythrocyte Membrane Protein 1 Induces Strain Transcending Antibodies	PLOS ONE			English	Article							VARIANT ANTIGENS; INFECTED ERYTHROCYTES; SEVERE MALARIA; HETEROLOGOUS STRAINS; IN-VIVO; SURFACE; BINDING; PFEMP1; ACQUISITION; RECOGNITION	Immunity to severe malaria is the first level of immunity acquired to Plasmodium falciparum. Antibodies to the variant antigen PfEMP1 (P. falciparum erythrocyte membrane protein 1) present at the surface of the parasitized red blood cell (pRBC) confer protection by blocking microvascular sequestration. Here we have generated antibodies to peptide sequences of subdomain 2 of PfEMP1-DBL1 alpha previously identified to be associated with severe or mild malaria. A set of sera generated to the amino acid sequence KLQTLTLHQVREYWWALNRKEVWKA, containing the motif ALNRKE, stained the live pRBC. 50% of parasites tested (7/14) were positive both in flow cytometry and immunofluorescence assays with live pRBCs including both laboratory strains and in vitro adapted clinical isolates. Antibodies that reacted selectively with the sequence REYWWALNRKEVWKA in a 15-mer peptide array of DBL1 alpha-domains were also found to react with the pRBC surface. By utilizing a peptide array to map the binding properties of the elicited anti-DBL1 alpha antibodies, the amino acids WxxNRx were found essential for antibody binding. Complementary experiments using 135 degenerate RDSM peptide sequences obtained from 93 Ugandan patient-isolates showed that antibody binding occurred when the amino acids WxLNRKE/D were present in the peptide. The data suggests that the ALNRKE sequence motif, associated with severe malaria, induces strain-transcending antibodies that react with the pRBC surface.	[Blomqvist, Karin; Albrecht, Letusa; del Pilar Quintana, Maria; Angeletti, Davide; Moll, Kirsten; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [del Pilar Quintana, Maria] Univ Rosario, Fac Ciencias Nat & Matemat, Escuela Med & Ciencias Salud, Bogota, Colombia; [Joannin, Nicolas] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Chene, Arnaud] Inst Pasteur, Paris, France	Karolinska Institutet; Universidad del Rosario; Kyoto University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Chene, Arnaud/O-4397-2017; Angeletti, Davide/H-7350-2019; Albrecht, Letusa/I-1837-2012	Chene, Arnaud/0000-0002-6551-4382; Angeletti, Davide/0000-0002-5256-1972; Albrecht, Letusa/0000-0001-6406-2057; Quintana, Maria del Pilar/0000-0001-6190-3324	Swedish Research Council (VR); The Swedish Academy of Sciences (KVA); The Swedish Academy of Sciences (Soderberg foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); The Swedish Academy of Sciences (KVA); The Swedish Academy of Sciences (Soderberg foundation); Karolinska Institutet-DPA(Karolinska Institutet); EU Network of Excellence EviMalar	This work was supported by Swedish Research Council (VR), The Swedish Academy of Sciences (KVA, Soderberg foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahuja S, 2006, VACCINE, V24, P6140, DOI 10.1016/j.vaccine.2006.05.030; Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2008, METHODS MALARIA RES; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Giha HA, 1999, PARASITOLOGY, V119, P7, DOI 10.1017/S0031182099004485; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Jones TR, 2000, AM J TROP MED HYG, V62, P675, DOI 10.4269/ajtmh.2000.62.675; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; Moll K, 2007, INFECT IMMUN, V75, P211, DOI 10.1128/IAI.00749-06; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams TN, 2003, CYTOM PART A, V56A, P96, DOI 10.1002/cyto.a.10088; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	57	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52679	10.1371/journal.pone.0052679	http://dx.doi.org/10.1371/journal.pone.0052679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335956	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700008
J	Singh, TP; Schon, MP; Wallbrecht, K; Gruber-Wackernagel, A; Wang, XJ; Wolf, P				Singh, Tej Pratap; Schoen, Michael P.; Wallbrecht, Katrin; Gruber-Wackernagel, Alexandra; Wang, Xiao-Jing; Wolf, Peter			Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of Psoriasis	PLOS ONE			English	Article							CHRONIC PLAQUE PSORIASIS; ACTIVATED MAST-CELLS; REGULATORY T-CELLS; TRANSGENIC MICE; TGF-BETA; ALLERGIC INFLAMMATION; PLUS ULTRAVIOLET; SKIN DISORDER; TH17 CELLS; THERAPY	It is thought that a Th1/Th17-weighted immune response plays a predominant role in the pathogenesis of psoriasis. Our findings now indicate a link between IL-9, a Th2 and Th9 cytokine, and Th17 pathway in psoriasis. In K5.hTGF-beta 1 transgenic mice, exhibiting a psoriasis-like phenotype, we found increased IL-9R and IL-9 expression in the skin and intradermal IL-9 injection induced Th17-related inflammation. IL-9 also promoted angiogenesis and VEGF and CD31 overexpression in mice in vivo and increased tube formation of human endothelial cells in vitro. Injecting anti-IL-9 antibody into K5.hTGF-beta 1 transgenic mice not only diminished inflammation (including skin infiltration by T cells, monocytes/macrophages, and mast cells) and angiogenesis but also delayed the psoriasis-like skin phenotype. Notably, injection of anti-psoriatic acting anti-IL17 antibody reduced skin IL-9 mRNA and serum IL-9 protein levels in K5.hTGF-beta 1 transgenic mice and prevented IL-9-induced epidermal hyperplasia and inflammation of the skin of wild type mice. In addition, we observed that IL-9R expression in lesional skin from psoriasis patients was markedly higher than in healthy skin from control subjects. Moreover, IL-9 significantly enhanced IL-17A production by cultured human peripheral blood mononuclear cells or CD4+ T cells, especially in psoriasis patients. Thus, IL-9 may play a role in the development of psoriatic lesions through Th17-associated inflammation and angiogenesis.	[Singh, Tej Pratap; Gruber-Wackernagel, Alexandra; Wolf, Peter] Med Univ Graz, Dept Dermatol, Res Unit Photodermatol, Graz, Austria; [Singh, Tej Pratap] Med Univ Graz, Med Res Ctr, Graz, Austria; [Schoen, Michael P.; Wallbrecht, Katrin] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Otolaryngol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA; [Wang, Xiao-Jing] Univ Colorado Denver, Dept Craniofacial Biol Head & Neck Canc Res, Aurora, CO USA	Medical University of Graz; Medical University of Graz; University of Gottingen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wolf, P (corresponding author), Med Univ Graz, Dept Dermatol, Res Unit Photodermatol, Graz, Austria.	peter.wolf@medunigraz.at		Schon, Michael/0000-0002-0698-4130; Singh, Tej Pratap/0000-0002-0122-1089	Oesterreichische Nationalbank (Anniversary Fund) [11729, 13279]; Austrian Society for Dermatology and Venereology; PhD Program in Molecular Medicine of the Medical University of Graz, Austria; Austrian Society of Dermatology and Venereology; European Union (Angioskin) [LSH-2003-512127]	Oesterreichische Nationalbank (Anniversary Fund); Austrian Society for Dermatology and Venereology; PhD Program in Molecular Medicine of the Medical University of Graz, Austria; Austrian Society of Dermatology and Venereology; European Union (Angioskin)(European Commission)	This work was supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project numbers 11729 and 13279) and the Austrian Society for Dermatology and Venereology. T.P.S. was supported by the PhD Program in Molecular Medicine of the Medical University of Graz, Austria, and by a research grant from the Austrian Society of Dermatology and Venereology. M.P.S. and K.W. were supported by a grant from the European Union (Angioskin, LSH-2003-512127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah SG, 2001, J IMMUNOL, V166, P2768, DOI 10.4049/jimmunol.166.4.2768; Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Asarch A, 2008, J DERMATOL TREAT, V19, P259, DOI 10.1080/09546630802206686; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; Coimbra S, 2010, BRIT J DERMATOL, V163, P1282, DOI 10.1111/j.1365-2133.2010.09992.x; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; Crawshaw AA, 2012, EXPERT OPIN INV DRUG, V21, P33, DOI 10.1517/13543784.2012.636351; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Friberg C, 2006, J INVEST DERMATOL, V126, P998, DOI 10.1038/sj.jid.5700194; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Inzinger M, 2012, ACTA DERM-VENEREOL, V92, P357, DOI 10.2340/00015555-1243; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kearley J, 2010, AM J RESP CRIT CARE; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Matsuzawa S, 2003, J IMMUNOL, V170, P3461, DOI 10.4049/jimmunol.170.7.3461; Nickoloff BJ, 1997, NAT MED, V3, P475, DOI 10.1038/nm0597-475b; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pittelkow MR, 2005, NAT MED, V11, P17, DOI 10.1038/nm0105-17; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Simonetti O, 2006, INT J IMMUNOPATH PH, V19, P751, DOI 10.1177/039463200601900405; Singh TP, 2012, EXP DERMATOL, V21, P228, DOI 10.1111/j.1600-0625.2011.01437.x; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Singh TP, 2010, J IMMUNOL, V184, P7257, DOI 10.4049/jimmunol.0903719; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Zibert JR, 2011, J CLIN INVEST, V121, P410, DOI 10.1172/JCI41295	52	121	137	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e51752	10.1371/journal.pone.0051752	http://dx.doi.org/10.1371/journal.pone.0051752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335955	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700006
J	Spaulding, AB; Radi, D; Macleod, H; Lynfield, R; Larson, M; Hyduke, T; Dehnel, P; DeVries, AS				Spaulding, Alicen B.; Radi, Deborah; Macleod, Heather; Lynfield, Ruth; Larson, Michelle; Hyduke, Terri; Dehnel, Peter; DeVries, Aaron S.			Satisfaction and Public Health Cost of a Statewide Influenza Nurse Triage Line in Response to Pandemic H1N1 Influenza	PLOS ONE			English	Article							CARE	Background: The 2009 H1N1 pandemic strained healthcare systems. There was a need for supportive services, rapid antiviral access, and minimization of unnecessary healthcare contacts particularly face-to-face interactions. In response, the Minnesota Department of Health (MDH) launched a telephone-based nurse triage line (NTL) called the Minnesota FluLine coordinating all major MN healthcare systems with NTLs to form a single toll-free number triage service. Callers were evaluated for symptoms of influenza-like illness (ILI) and were prescribed an antiviral if indicated, using nurse administered protocols. Methods: To determine caller outcomes, associated healthcare seeking, and satisfaction a telephone survey of Minnesota FluLine callers was conducted using a 5% random sample of those who completed the protocol and those who did not. Results: Of 6,122 callers with ILI who began the nurse protocol administered by the contract NTL, 1,221 people were contacted for the survey and 325 agreed to participate; response rate was 26%. Of those who completed the nurse protocol 73% said they would have sought healthcare without the Minnesota FluLine, 89% reported the service was moderately or very helpful, and 91% reported being satisfied or very satisfied. Of those not completing the protocol, 50% reported the service was moderately or very helpful and 50% reported being satisfied or very satisfied. 72% of qualitative responses to open-ended questions were positive regarding the MN FluLine. Cost to MDH for operating the Minnesota FluLine service was $331,226 to service 27,391 callers ($12.09/call). Discussion: The Minnesota FluLine diverted patients with mild ILI symptoms away from acute care visits at low cost and had a high rate of satisfaction among callers. Early intervention likely prevented morbidity and possibly additional cases. NTLs are powerful and flexible tools for pandemic response and should be considered as an important tool for future emergency responses.	[Spaulding, Alicen B.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Spaulding, Alicen B.; Radi, Deborah; Lynfield, Ruth; Larson, Michelle; DeVries, Aaron S.] Minnesota Dept Hlth, St Paul, MN USA; [Macleod, Heather; Hyduke, Terri; Dehnel, Peter] Childrens Phys Network, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD)	DeVries, AS (corresponding author), Minnesota Dept Hlth, St Paul, MN USA.	aaron.devries@state.mn.us		DeVries, Aaron/0000-0001-9211-0722	CDC grant [1H75TP000348-01, 5U01CI000313-05]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000313] Funding Source: NIH RePORTER	CDC grant; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CDC grant # 1H75TP000348-01-Revise providing funding for the MN FluLine program and CDC grant # 5U01CI000313-05 provided funding for the program evaluation presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Azarmina P, 2007, J TELEMED TELECARE, V13, pS3; Bunn F, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004180.PUB2, 10.1002/14651858.CD004180.pub2]; Cariello Francesca P, 2003, J Ambul Care Manage, V26, P124; CDC, 2009, UPD CDC EST 2009 H1N; Clancy Terry, 2009, Am J Disaster Med, V4, P253; Cleary Vivien, 2010, J Bus Contin Emer Plan, V4, P154; Como-Sabetti Kathryn, 2010, Minn Med, V93, P36; Kempe A, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e111; Lilly CM, 2011, JAMA-J AM MED ASSOC, V305, P2175, DOI 10.1001/jama.2011.697; Minnesota Department of Health, 2010, 2009 H1N1 INFL MINN; North F, 2011, J TELEMED TELECARE, V17, P417, DOI 10.1258/jtt.2011.110301; North F, 2010, TELEMED J E-HEALTH, V16, P1012, DOI 10.1089/tmj.2010.0102; Rubin GJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-451; Smith EC, 2009, DISASTER MED PUBLIC, V3, pS154, DOI 10.1097/DMP.0b013e3181be8250; Spaulding AB, 2012, PUBLIC HEALTH REP, V127, P532, DOI 10.1177/003335491212700509; Venn M J, 1996, Eur J Cancer Care (Engl), V5, P38, DOI 10.1111/j.1365-2354.1996.tb00204.x	17	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e50492	10.1371/journal.pone.0050492	http://dx.doi.org/10.1371/journal.pone.0050492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335953	gold, Green Published			2022-12-27	WOS:000314707700003
J	Cope, J; Rank, KC; Gilbert, SP; Rayment, I; Hoenger, A				Cope, Julia; Rank, Katherine C.; Gilbert, Susan P.; Rayment, Ivan; Hoenger, Andreas			Kar3Vik1 Uses a Minus-End Directed Powerstroke for Movement along Microtubules	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; MOTOR-PROTEIN COMPLEX; CRYSTAL-STRUCTURE; DIMERIC KINESIN; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; DRIVES MOTILITY; NCD; DOMAIN; BINDING	We have used cryo-electron microscopy (cryo-EM) and helical averaging to examine the 3-D structure of the heterodimeric kinesin-14 Kar3Vik1 complexed to microtubules at a resolution of 2.5 nm. 3-D maps were obtained at key points in Kar3Vik1's nucleotide hydrolysis cycle to gain insight into the mechanism that this motor uses for retrograde motility. In all states where Kar3Vik1 maintained a strong interaction with the microtubule, we found, as observed by cryo-EM, that the motor bound with one head domain while the second head extended outwards. 3-D reconstructions of Kar3Vik1-microtubule complexes revealed that in the nucleotide-free state, the motor's coiled-coil stalk points toward the plus-end of the microtubule. In the ATP-state, the outer head is shown to undergo a large rotation that reorients the stalk similar to 75 degrees to point toward the microtubule minus-end. To determine which of the two heads binds to tubulin in each nucleotide state, we employed specific Nanogold (R)-labeling of Vik1. The resulting maps confirmed that in the nucleotide-free, ATP and ADP+Pi states, Kar3 maintains contact with the microtubule surface, while Vik1 extends away from the microtubule and tracks with the coiled-coil as it rotates towards the microtubule minus-end. While many previous investigations have focused on the mechanisms of homodimeric kinesins, this work presents the first comprehensive study of the powerstroke of a heterodimeric kinesin. The stalk rotation shown here for Kar3Vik1 is highly reminiscent of that reported for the homodimeric kinesin-14 Ncd, emphasizing the conservation of a mechanism for minus-end directed motility.	[Cope, Julia; Hoenger, Andreas] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Microscopy Cells 3D, Boulder, CO 80309 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Hoenger, A (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Microscopy Cells 3D, Boulder, CO 80309 USA.	hoenger@colorado.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Hoenger, Andreas/0000-0001-9176-6658	NIH/NCRR [P41-RR000592]; NIH [GM086351, GM54141, T32-GM065103, T32-GM07215]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, T32GM065103, T32GM007215, R01GM054141, R01GM086351] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NCRR grant P41-RR000592 to A.H., NIH GM086351 to I.R., NIH GM54141 to S.P.G., NIH Molecular Biophysics Training Grant T32-GM065103 to J.C., and NIH training grant T32-GM07215 to K.C.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Hizlan D, 2006, J STRUCT BIOL, V153, P73, DOI 10.1016/j.jsb.2005.10.007; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Hoenger A, 2000, BIOL CHEM, V381, P1001, DOI 10.1515/BC.2000.123; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HOYT MA, 1993, GENETICS, V135, P35; KIKKAWA M, 1995, NATURE, V376, P274, DOI 10.1038/376274a0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Muto E, 2005, J CELL BIOL, V168, P691, DOI 10.1083/jcb.200409035; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53792	10.1371/journal.pone.0053792	http://dx.doi.org/10.1371/journal.pone.0053792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342004	gold, Green Published			2022-12-27	WOS:000314759400084
J	Corominas, J; Ramayo-Caldas, Y; Puig-Oliveras, A; Perez-Montarelo, D; Noguera, JL; Folch, JM; Ballester, M				Corominas, Jordi; Ramayo-Caldas, Yuliaxis; Puig-Oliveras, Anna; Perez-Montarelo, Dafne; Noguera, Jose L.; Folch, Josep M.; Ballester, Maria			Polymorphism in the ELOVL6 Gene Is Associated with a Major QTL Effect on Fatty Acid Composition in Pigs	PLOS ONE			English	Article							TIME RT-PCR; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; EXPRESSION; ELONGASE; MUSCLE; MEAT; IDENTIFICATION; CARBOHYDRATE; PREDICTION	Background: The ELOVL fatty acid elongase 6 (ELOVL6), the only elongase related to de novo lipogenesis, catalyzes the rate-limiting step in the elongation cycle by controlling the fatty acid balance in mammals. It is located on pig chromosome 8 (SSC8) in a region where a QTL affecting palmitic, and palmitoleic acid composition was previously detected, using an Iberian x Landrace intercross. The main goal of this work was to fine-map the QTL and to evaluate the ELOVL6 gene as a positional candidate gene affecting the percentages of palmitic and palmitoleic fatty acids in pigs. Methodology and Principal Findings: The combination of a haplotype-based approach and single-marker analysis allowed us to identify the main, associated interval for the QTL, in which the ELOVL6 gene was identified and selected as a positional candidate gene. A polymorphism in the promoter region of ELOVL6, ELOVL6: c.-533C > T, was highly associated with the percentage of palmitic and palmitoleic acids in muscle and backfat. Significant differences in ELOVL6 gene expression were observed in backfat when animals were classified by the ELOVL6: c.-533C > T genotype. Accordingly, animals carrying the allele associated with a decrease in ELOVL6 gene expression presented an increase in C16:0 and C16: 1(n-7) fatty acid content and a decrease of elongation activity ratios in muscle and backfat. Furthermore, a SNP genome-wide association study with ELOVL6 relative expression levels in backfat showed the strongest effect on the SSC8 region in which the ELOVL6 gene is located. Finally, different potential genomic regions associated with ELOVL6 gene expression were also identified by GWAS in liver and muscle, suggesting a differential tissue regulation of the ELOVL6 gene. Conclusions and Significance: Our results suggest ELOVL6 as a potential causal gene for the QTL analyzed and, subsequently, for controlling the overall balance of fatty acid composition in pigs.	[Corominas, Jordi; Ramayo-Caldas, Yuliaxis; Puig-Oliveras, Anna; Folch, Josep M.; Ballester, Maria] Ctr Recerca Agrigenom CRAG, Dept Genet Anim, Bellaterra, Spain; [Perez-Montarelo, Dafne] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Noguera, Jose L.] IRTA, Lleida, Spain; [Folch, Josep M.] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); IRTA; Autonomous University of Barcelona	Corominas, J (corresponding author), Ctr Recerca Agrigenom CRAG, Dept Genet Anim, Bellaterra, Spain.	jordi.corominas@uab.cat	Puig Oliveras, Anna/M-5551-2015; Folch, Josep M/I-4738-2015; Corominas Galbany, Jordi/B-6356-2018; Devis, Maria Ballester/AAV-2467-2020; Ballester, Maria/E-7201-2016; Ballester, Maria/H-7277-2013; Caldas, Yuliaxis Ramayo/B-6337-2014	Puig Oliveras, Anna/0000-0003-2551-9012; Folch, Josep M/0000-0003-3689-1303; Corominas Galbany, Jordi/0000-0003-1736-1278; Devis, Maria Ballester/0000-0002-5413-4640; Ballester, Maria/0000-0002-5413-4640; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159	MICINN [AGL2008-04818-C03, AGL2011-29821-CO2]; Innovation Consolider-Ingenio Program (Center for Research in Agrigenomics) [CSD2007-00036]; Spanish Ministerio de Educacion [BES-2009-018223]; Formacion del Profesorado Universitario (FPU) [AP2008-01450]; Universitat Autonoma de Barcelona [458-01-1/2011]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Innovation Consolider-Ingenio Program (Center for Research in Agrigenomics); Spanish Ministerio de Educacion(Spanish Government); Formacion del Profesorado Universitario (FPU)(Spanish Government); Universitat Autonoma de Barcelona	This study has been funded by MICINN projects (AGL2008-04818-C03 and AGL2011-29821-CO2) and the Innovation Consolider-Ingenio 2012 Program (CSD2007-00036, Center for Research in Agrigenomics). J. Corominas was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009-018223), Y. Ramayo by a Formacion del Profesorado Universitario (FPU) PhD grant (AP2008-01450) and A. Puig was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland A, 1997, AM J CLIN NUTR, V65, P1774, DOI 10.1093/ajcn/65.6.1774; BALLARD FJ, 1969, FED PROC, V28, P218; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Clop A, 2003, MAMM GENOME, V14, P650, DOI 10.1007/s00335-002-2210-7; Damcott CM, 2004, METABOLISM, V53, P303, DOI 10.1016/j.metabol.2003.10.010; Drewes T, 1996, MOL CELL BIOL, V16, P925; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Estelle J, 2009, J ANIM BREED GENET, V126, P52, DOI 10.1111/j.1439-0388.2008.00754.x; Estelle J, 2009, ANIM GENET, V40, P813, DOI 10.1111/j.1365-2052.2009.01922.x; Green CD, 2010, J LIPID RES, V51, P1871, DOI 10.1194/jlr.M004747; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jansen GR, 1966, BIOCHEM J, V99, P10; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Lichtenstein AH, 2006, J LIPID RES, V47, P1661, DOI 10.1194/jlr.R600019-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach N, 2006, J ANIM SCI, V84, P3039, DOI 10.2527/jas.2005-632; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; Munoz M, 2012, ANIM GENET, V43, P620, DOI 10.1111/j.1365-2052.2011.02301.x; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Perez-Enciso M, 2002, GENETICS, V161, P1625; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz J, 1998, MEAT SCI, V49, P155, DOI 10.1016/S0309-1740(97)00136-8; Shin JH, 2006, J STAT SOFTWARE, P16; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swierczynski J, 2000, METABOLISM, V49, P594, DOI 10.1016/S0026-0495(00)80033-5; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; Valsta LM, 2005, MEAT SCI, V70, P525, DOI 10.1016/j.meatsci.2004.12.016; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Yang B, 2011, J ANIM BREED GENET, V128, P329, DOI 10.1111/j.1439-0388.2011.00928.x; Yang KX, 2010, J ANIM SCI, V88, P3538, DOI 10.2527/jas.2009-2602	53	41	45	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53687	10.1371/journal.pone.0053687	http://dx.doi.org/10.1371/journal.pone.0053687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341976	Green Published, gold			2022-12-27	WOS:000314759400067
J	Dinari, A; Niazi, A; Afsharifar, AR; Ramezani, A				Dinari, Ali; Niazi, Ali; Afsharifar, Ali Reza; Ramezani, Amin			Identification of Upregulated Genes under Cold Stress in Cold-Tolerant Chickpea Using the cDNA-AFLP Approach	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MESSENGER-RNA; PLANT; ACCLIMATION; PROTEINS; METABOLISM; RESPONSES; DROUGHT	Low temperature injury is one of the most significant causes of crop damage worldwide. Cold acclimatization processes improve the freezing tolerance of plants. To identify genes of potential importance for acclimatzation to the cold and to elucidate the pathways that regulate this process, global transcriptome expression of the chickpea (Cicer arietinum L), a species of legume, was analyzed using the cDNA-AFLP technique. In total, we generated 4800 transcript-derived fragments (TDFs) using cDNA-AFLP in conjunction with 256 primer combinations. We only considered those cDNA fragments that seemed to be up-regulated during cold acclimatization. Of these, 102 TDFs with differential expression patterns were excised from gels and re-amplified by PCR. Fifty-four fragments were then cloned and sequenced. BLAST search of the GenBank non-redundant (nr) sequence database demonstrated that 77 percent of the TDFs belonged to known sequences with putative functions related to metabolism (31), transport (10), signal transduction pathways (15) and transcription factors (21). The last group of expressed transcripts showed homology to genes of unknown function (22). To further analyze and validate our cDNA-AFLP experiments, the expression of 9 TDFs during cold acclimatzatiion was confirmed using real time RT-PCR. The results of this research show that cDNA-AFLP is a powerful technique for investigating the expression pattern of chickpea genes under low-temperature stress. Moreover, our findings will help both to elucidate the molecular basis of low-temperature effects on the chickpea genome and to identify those genes that could increase the cold tolerance of the chickpea plant.	[Dinari, Ali; Niazi, Ali] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Afsharifar, Ali Reza] Shiraz Univ, Coll Agr, Plant Virol Res Ctr, Shiraz, Iran; [Ramezani, Amin] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran	Shiraz University; Shiraz University; Shiraz University of Medical Science	Niazi, A (corresponding author), Shiraz Univ, Inst Biotechnol, Shiraz, Iran.	niazi@shirazu.ac.ir	Ramezani, Amin/AID-2677-2022; Ramezani, Amin/S-1035-2017	Ramezani, Amin/0000-0001-5655-8722; Ramezani, Amin/0000-0001-5655-8722; Niazi, Ali/0000-0002-9902-9422				Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Bachem CWB, 2001, PLANT J, V25, P595, DOI 10.1046/j.1365-313x.2001.00993.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Botton A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-347; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mantri NL, 2010, ENVIRON EXP BOT, V69, P286, DOI 10.1016/j.envexpbot.2010.05.003; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MCKERSIE BD, 1997, ACTIVE OXYGEN FREEZI, P203; Nishizawa-Yokoi A, 2010, PLANT CELL PHYSIOL, V51, P486, DOI 10.1093/pcp/pcq015; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Ravanel S, 1998, BIOCHEM J, V331, P639, DOI 10.1042/bj3310639; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rodriguez M., 2005, BIOTECNOL APL, V22, P1, DOI DOI 10.1007/S00284-005-4515-8; Roudier F, 2002, PLANT PHYSIOL, V130, P538, DOI 10.1104/pp.007468; Sun MM, 2007, J BIOCHEM MOL BIOL, V40, P986; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Viswanathan C, 2002, PHILOS T ROY SOC B, V357, P877, DOI 10.1098/rstb.2002.1076; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wang WX, 2001, ACTA HORTIC, P285; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu T, 2003, CAN J BOT, V81, P1168, DOI [10.1139/b03-115, 10.1139/B03-115]	38	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52757	10.1371/journal.pone.0052757	http://dx.doi.org/10.1371/journal.pone.0052757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341906	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400021
J	Liu, CR; Liu, Z; Li, M; Li, XL; Wong, YS; Ngai, SM; Zheng, WJ; Zhang, YB; Chen, TF				Liu, Chaoran; Liu, Zhong; Li, Meng; Li, Xiaoling; Wong, Yum-Shing; Ngai, Sai-Ming; Zheng, Wenjie; Zhang, Yibo; Chen, Tianfeng			Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; MAMMALIAN THIOREDOXIN; METHYLSELENINIC ACID; CANCER-CELLS; MEDIATED APOPTOSIS; CYCLE ARREST; SELENIUM; MITOCHONDRIA; SUBSTRATE; ERK	Thioredoxin system plays an important role in regulation of intracellular redox balance and various signaling pathways. Thioredoxin reductase (TrxR) is overexpressed in many cancer cells and has been identified as a potential target of anticancer drugs. Auranofin (AF) is potent TrxR inhibitor with novel in vitro and in vivo anticancer activities. Selenocystine (SeC) is a nutritionally available selenoamino acid with selective anticancer effects through induction of apoptosis. In the present study, we demonstrated the synergistic effects and the underlying molecular mechanisms of SeC in combination with AF on MCF-7 human breast cancer cells. The results showed that SeC and AF synergistically inhibited the cancer cell growth through induction of ROS-dependent apoptosis with the involvement of mitochondrial dysfunction. DNA damage-mediated p53 phosphorylation and down-regulation of phosphorylated AKT and ERK also contributed to cell apoptosis. Moreover, we demonstrated the important role of TrxR activity in the synergistic action of SeC and AF. Taken together, our results suggest the strategy to use SeC and AF in combination could be a highly efficient way to achieve anticancer synergism by targeting TrxR.	[Liu, Chaoran; Li, Meng; Li, Xiaoling; Zheng, Wenjie; Zhang, Yibo; Chen, Tianfeng] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Liu, Zhong] Jinan Univ, Guangzhou Jinan Biomed Res & Dev Ctr, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Wong, Yum-Shing; Ngai, Sai-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Jinan University; Jinan University; Chinese University of Hong Kong	Zheng, WJ (corresponding author), Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China.	tzhwj@jnu.edu.cn; tchentf@jnu.edu.cn	Chen, Tianfeng/AAG-6123-2019; meng, li/GVT-2063-2022; Ngai, Sai Ming/S-4898-2018; Liu, Zhong/B-6323-2016	Ngai, Sai Ming/0000-0002-4484-2483; Liu, Zhong/0000-0002-5132-7463	Natural Science Foundation of China; Guangdong Province; Program for New Century Excellent Talents in University; Key Project of Science and Technology Department of Guangdong Province; Fundamental Research Funds for the Central Universities; China Postdoctoral Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Project of Science and Technology Department of Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Foundation of China and Guangdong Province, Program for New Century Excellent Talents in University, Key Project of Science and Technology Department of Guangdong Province, the Fundamental Research Funds for the Central Universities and China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R, 2005, J TRACE ELEM MED BIO, V19, P141, DOI 10.1016/j.jtemb.2005.09.003; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Cai WQ, 2012, FREE RADICAL BIO MED, V52, P257, DOI 10.1016/j.freeradbiomed.2011.10.447; Carvalho H, 2004, J CELL BIOCHEM, V92, P502, DOI 10.1002/jcb.20070; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Chen T, 2008, CELL MOL LIFE SCI, V65, P2763, DOI 10.1007/s00018-008-8329-2; Chen TF, 2008, BIOMED PHARMACOTHER, V62, P77, DOI 10.1016/j.biopha.2007.12.002; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Dvorakova K, 2002, MOL CANCER THER, V1, P185; El-Sayed WM, 2006, TOXICOLOGY, V220, P179, DOI 10.1016/j.tox.2005.12.016; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Green DR, 2008, NATURE, V455, P1047, DOI 10.1038/4551047a; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; Hoffmann FW, 2011, ARCH BIOCHEM BIOPHYS, V512, P38, DOI 10.1016/j.abb.2011.05.007; Hu HB, 2005, CARCINOGENESIS, V26, P1374, DOI 10.1093/carcin/bgi094; Ip C, 2000, CANCER RES, V60, P2882; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jiang C, 2002, MOL CANCER THER, V1, P1059; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Madeja Z, 2005, BIOCHEM PHARMACOL, V69, P1765, DOI 10.1016/j.bcp.2005.02.023; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Rackham O, 2011, FREE RADICAL BIO MED, V50, P689, DOI 10.1016/j.freeradbiomed.2010.12.015; Rigobello MP, 2009, FREE RADICAL BIO MED, V47, P710, DOI 10.1016/j.freeradbiomed.2009.05.027; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; Selenius M, 2008, BIOCHEM PHARMACOL, V75, P2092, DOI 10.1016/j.bcp.2008.02.028; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Shiah HS, 2007, BIOCHEM PHARMACOL, V73, P610, DOI 10.1016/j.bcp.2006.10.019; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Sinha R, 2004, CURR CANCER DRUG TAR, V4, P13, DOI 10.2174/1568009043481614; Snider G, 2010, BIOCHEMISTRY-US, V49, P10329, DOI 10.1021/bi101130t; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tanel A, 2007, CELL SIGNAL, V19, P968, DOI 10.1016/j.cellsig.2006.10.014; Tichy A, 2007, ACTA BIOCHIM POL, V54, P281; Unni E, 2005, BREAST CANCER RES, V7, pR699, DOI 10.1186/bcr1276; van Gurp M, 2003, BIOCHEM BIOPH RES CO, V304, P487, DOI 10.1016/S0006-291X(03)00621-1; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Zhao F, 2006, CANCER LETT, V236, P46, DOI 10.1016/j.canlet.2005.05.010; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhao R, 2009, NUTR CANCER, V61, P397, DOI 10.1080/01635580802582751	53	68	69	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53945	10.1371/journal.pone.0053945	http://dx.doi.org/10.1371/journal.pone.0053945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342042	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400102
J	Marchive, C; Leon, C; Kappel, C; Coutos-Thevenot, P; Corio-Costet, MF; Delrot, S; Lauvergeat, V				Marchive, Chloe; Leon, Celine; Kappel, Christian; Coutos-Thevenot, Pierre; Corio-Costet, Marie-France; Delrot, Serge; Lauvergeat, Virginie			Over-Expression of VvWRKY1 in Grapevines Induces Expression of Jasmonic Acid Pathway-Related Genes and Confers Higher Tolerance to the Downy Mildew	PLOS ONE			English	Article							NECROTROPHIC FUNGAL PATHOGENS; THAUMATIN-LIKE PROTEIN; TRANSCRIPTION FACTOR; VITIS-VINIFERA; BOTRYTIS-CINEREA; PLASMOPARA-VITICOLA; ARABIDOPSIS WRKY33; DEFENSE RESPONSES; EUTYPA-LATA; RESISTANCE	Most WRKY transcription factors activate expression of defence genes in a salicylic acid- and/or jasmonic acid-dependent signalling pathway. We previously identified a WRKY gene, VvWRKY1, which is able to enhance tolerance to fungal pathogens when it is overexpressed in tobacco. The present work analyzes the effects of VvWRKY1 overexpression in grapevine. Microarray analysis showed that genes encoding defence-related proteins were up-regulated in the leaves of transgenic 35S::VvWRKY1 grapevines. Quantitative RT-PCR analysis confirmed that three genes putatively involved in jasmonic acid signalling pathway were overexpressed in the transgenic grapes. The ability of VvWRKY1 to trans-activate the promoters of these genes was demonstrated by transient expression in grape protoplasts. The resistance to the causal agent of downy mildew, Plasmopara viticola, was enhanced in the transgenic plants. These results show that VvWRKY1 can increase resistance of grapevine against the downy mildew through transcriptional reprogramming leading to activation of the jasmonic acid signalling pathway.	[Marchive, Chloe; Leon, Celine; Kappel, Christian; Delrot, Serge; Lauvergeat, Virginie] Univ Bordeaux, ISVV, EGFV, UMR 1287, F-33140 Villenave Dornon, France; [Marchive, Chloe; Leon, Celine; Kappel, Christian; Delrot, Serge; Lauvergeat, Virginie] INRA, ISVV, EGFV, UMR 1287, Villenave Dornon, France; [Coutos-Thevenot, Pierre] Univ Poitiers, CNRS, UMR Ecol & Biol Interact 7267, Equipe Physiol Mol Transport Sucres, Poitiers, France; [Corio-Costet, Marie-France] INRA, UMR SAVE 1065, ISVV, Villenave Dornon, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; INRAE	Lauvergeat, V (corresponding author), Univ Bordeaux, ISVV, EGFV, UMR 1287, F-33140 Villenave Dornon, France.	virginie.lauvergeat@bordeaux.inra.fr	corio-costet, marie-france/AAA-7705-2021	Delrot, Serge/0000-0001-9602-0441; Kappel, Christian/0000-0002-1450-1864; Lauvergeat, Virginie/0000-0002-5950-2051	Conseil Interprofessionnel du Vin de Bordeaux	Conseil Interprofessionnel du Vin de Bordeaux	This work was supported by grants from the "Conseil Interprofessionnel du Vin de Bordeaux" (http://www.bordeaux.com/fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Avanci NC, 2010, GENET MOL RES, V9, P484, DOI 10.4238/vol9-1gmr754; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Blasi P, 2011, THEOR APPL GENET, V123, P43, DOI 10.1007/s00122-011-1565-0; Buhot N, 2004, MOL BIOL CELL, V15, P5047, DOI 10.1091/mbc.E04-07-0575; Camps C, 2010, J EXP BOT, V61, P1719, DOI 10.1093/jxb/erq040; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Corio-Costet MF, 2011, EUR J PLANT PATHOL, V129, P315, DOI 10.1007/s10658-010-9711-0; Coutos-Thevenot P, 2001, J EXP BOT, V52, P901, DOI 10.1093/jexbot/52.358.901; Decendit A, 1996, BIOTECHNOL LETT, V18, P659, DOI 10.1007/BF00130761; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Figueiredo A, 2012, FUNCT INTEGR GENOMIC, V12, P379, DOI 10.1007/s10142-012-0261-8; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hazarika BN, 2006, SCI HORTIC-AMSTERDAM, V108, P105, DOI 10.1016/j.scienta.2006.01.038; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; Hiroyuki K, 2008, PLANT CELL REP, V27, P1521, DOI 10.1007/s00299-008-0536-7; Horstmann V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-13; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Ismail A, 2012, J EXP BOT, V63, P2127, DOI 10.1093/jxb/err426; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Koo SC, 2009, BIOCHEM BIOPH RES CO, V387, P365, DOI 10.1016/j.bbrc.2009.07.026; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Malacarne G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-114; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Marchive C, 2007, J EXP BOT, V58, P1999, DOI 10.1093/jxb/erm062; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Podolyan A, 2010, FUNCT PLANT BIOL, V37, P767, DOI 10.1071/FP09271; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rotter A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-104; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samuelian SK, 2009, PLANT SCI, V177, P211, DOI 10.1016/j.plantsci.2009.05.013; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	45	72	76	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54185	10.1371/journal.pone.0054185	http://dx.doi.org/10.1371/journal.pone.0054185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342101	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400131
J	Trask, JS; George, D; Houghton, P; Kanthaswamy, S; Smith, DG				Trask, Jessica Satkoski; George, Debra; Houghton, Paul; Kanthaswamy, Sree; Smith, David Glenn			Population and Landscape Genetics of an Introduced Species (M-fascicularis) on the Island of Mauritius	PLOS ONE			English	Article							CRAB-EATING MACAQUES; MITOCHONDRIAL-DNA; CYNOMOLGUS MACAQUES; LONGTAIL MACAQUES; NUCLEAR; ORIGIN; DIVERSITY; LIFE	The cynomolgus macaque, Macaca fascicularis, was introduced onto the island of Mauritius in the early 17th century. The species experienced explosive population growth, and currently exists at high population densities. Anecdotes collected from nonhuman primate trappers on the island of Mauritius allege that animals from the northern portion of the island are larger in body size than and superior in condition to their conspecifics in the south. Although previous genetic studies have reported Mauritian cynomolgus macaques to be panmictic, the individuals included in these studies were either from the southern/central or an unknown portion of the island. In this study, we sampled individuals broadly throughout the entire island of Mauritius and used spatial principle component analysis to measure the fine-scale correlation between geographic and genetic distance in this population. A stronger correlation between geographic and genetic distance was found among animals in the north than in those in the southern and central portions of the island. We found no difference in body weight between the two groups, despite anecdotal evidence to the contrary. We hypothesize that the increased genetic structure among populations in the north is related to a reduction in dispersal distance brought about by human habitation and tourist infrastructure, but too recent to have produced true genetic differentiation.	[Trask, Jessica Satkoski; George, Debra; Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Trask, Jessica Satkoski; Kanthaswamy, Sree; Smith, David Glenn] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Houghton, Paul] Primate Prod Inc, Immokalee, FL USA; [Kanthaswamy, Sree] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Trask, JS (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	jasatkoski@ucdavis.edu		Trask, Jessica/0000-0002-9902-8753	NIH [RR05090, RR025871]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR005090, R24RR025871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work has been supported by NIH grants RR05090 and RR025871 to D.G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; ARCHIE JW, 1985, EVOLUTION, V39, P623, DOI 10.1111/j.1558-5646.1985.tb00399.x; Blancher A, 2006, IMMUNOGENETICS, V58, P269, DOI 10.1007/s00251-006-0102-9; Blancher A, 2008, J HERED, V99, P254, DOI 10.1093/jhered/esn003; Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Creager HM, 2011, IMMUNOGENETICS; Education CoBaSSa, 1993, MAUR POP LAND US PRO, P98; Fooden J., 1995, FIELDIANA ZOOLOGY, V81, P1, DOI DOI 10.5962/BHL.TITLE.3456; Fuentes A, 2008, AM J PRIMATOL, V70, P879, DOI 10.1002/ajp.20575; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HOLM S, 1979, SCAND J STAT, V6, P65; Houghton P., 1988, Lab Animal (New York), V17, P36; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanthaswamy S, 2012, AM J PRIMAT IN PRESS; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Kawamoto Y, 2008, J MED PRIMATOL, V37, P45, DOI 10.1111/j.1600-0684.2007.00225.x; KONDO M, 1993, AM J PRIMATOL, V29, P167, DOI 10.1002/ajp.1350290303; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; KURLAND J A, 1973, Primates, V14, P245, DOI 10.1007/BF01730823; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Leuchte N, 2004, TISSUE ANTIGENS, V63, P529, DOI 10.1111/j.0001-2815.2004.0222.x; Lutz W, 1991, POPULATION EC ENV MA; MATSUBAYASHI K, 1992, PRIMATES, V33, P281, DOI 10.1007/BF02382759; MITTERMEIER RA, 1987, PRIMATE CONSERVATION, P109; MURUTHI P, 1991, OECOLOGIA, V87, P467, DOI 10.1007/BF00320408; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pavlin BI, 2009, EMERGING INFECT DIS, V15; Richard AF, 1989, INT J PRIMATOLOGY, V10; Rodman P.S., 1973, P171; Sha JCM, 2009, BIODIVERS CONSERV, V18, P2909, DOI 10.1007/s10531-009-9616-4; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smith DG, 2007, AM J PRIMATOL, V69, P182, DOI 10.1002/ajp.20337; Stevison LS, 2008, J MED PRIMATOL, V37, P311, DOI 10.1111/j.1600-0684.2008.00292.x; SUSSMAN RW, 1986, FOLIA PRIMATOL, V46, P28, DOI 10.1159/000156234; Sussman RW, 2011, MONKEYS EDGE ECOLOGY; TATTERSALL I, 1981, AM J PRIMATOL, V1, P413, DOI 10.1002/ajp.1350010406; Team R. D. C, 2011, R LANG ENV STAT COMP; Tosi AJ, 2006, MOL PHYLOGE IN PRESS; Weir B., 1984, EVOLUTION, V28, P1358, DOI DOI 10.2307/2408641; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	42	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53001	10.1371/journal.pone.0053001	http://dx.doi.org/10.1371/journal.pone.0053001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341917	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400028
J	Yu, YB; Weng, Y; Guo, J; Chen, GD; Yao, K				Yu, Yibo; Weng, Yu; Guo, Jing; Chen, Guangdi; Yao, Ke			Association of Glutathione S transferases Polymorphisms with Glaucoma: A Meta-Analysis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RISK-FACTOR; GENE POLYMORPHISM; PUBLICATION BIAS; GSTM1; GSTT1; GLUTATHIONE-S-TRANSFERASE-M1; POPULATION; DAMAGE; M1	Background: Glutathione S transferase (GST) polymorphisms have been considered risk factors for the development of glaucoma, including primary open angle glaucoma (POAG) and other types of glaucoma. However, the results remain controversial. In this study, we have conducted a meta-analysis to assess the association between polymorphisms of GSTM1, GSTT1 and GSTP1 and glaucoma risk. Methods: Published literature from PubMed and other databases were retrieved. All studies evaluating the association between GSTM1, GSTT1 and GSTP1 polymorphisms and glaucoma risk were included. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random- or fixed-effects model. Results: Twelve studies on GSTM1 (1109 cases and 844 controls), ten studies on GSTT1 (709 cases and 664 controls) and four studies on GSTP1 (543 cases and 511 controls) were included. By pooling all the studies, either GSTM1 or GSTT1 null polymorphism was not associated with a POAG risk, and this negative association maintained in Caucasian. The GSTP1 Ile 105 Val polymorphism was significantly correlated with increased POAG risk among Caucasian in a recessive model (Val/Val vs. Ile/Ile+Ile/Val: OR, 1.62, 95% CI: 1.00-2.61). Interestingly, increased glaucoma risk was associated with the combined GSTM1 and GSTT1 null genotypes (OR, 2.20; 95% CI, 1.47-3.31), and with the combined GSTM1 null and GSTP1 Val genotypes (OR, 1.86; 95% CI, 1.15-3.01). Conclusions: This meta-analysis suggests that combinations of GST polymorphisms are associated with glaucoma risk. Given the limited sample size, the associations between single GST polymorphism and glaucoma risk await further investigation.	[Yu, Yibo; Yao, Ke] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Weng, Yu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Jing; Chen, Guangdi] Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Chen, GD (corresponding author), Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	chenguangdi@gmail.com; xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Zhejiang Key Innovation Team Project of China [2009R50039]; Zhejiang Key Laboratory Fund of China [2011E10006]; National Natural Science Foundation of China [30900273]; Qianjiang Talents Program of Zhejiang Province [2012R10023]; Fundamental Research Funds for the Central Universities [2011QNA7018, 2012QNA7019]; Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau	Zhejiang Key Innovation Team Project of China; Zhejiang Key Laboratory Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Program of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau	This work was supported by the Zhejiang Key Innovation Team Project of China (No. 2009R50039), the Zhejiang Key Laboratory Fund of China (No. 2011E10006), the National Natural Science Foundation of China (No. 30900273), the Qianjiang Talents Program of Zhejiang Province (2012R10023) and the Fundamental Research Funds for the Central Universities (No. 2011QNA7018, 2012QNA7019). Dr. Guangdi Chen was supported by Technology Foundation for Excellent Overseas Chinese Scholar, Zhejiang Province Human Resources and Social Security Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, MOL VIS, V14, P425; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Ginsberg G, 2009, J TOXICOL ENV HEAL B, V12, P389, DOI 10.1080/10937400903158375; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hoiyda A, 2010, J AM SCI, V12, P375; Izzotti A, 2004, EXP EYE RES, V79, P141, DOI 10.1016/j.exer.2004.03.007; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Jansson M, 2003, EXP EYE RES, V77, P239, DOI 10.1016/S0014-4835(03)00109-X; Johansson AS, 1998, J MOL BIOL, V278, P687, DOI 10.1006/jmbi.1998.1708; Josephy PD., 2010, HUM GENOMICS PROTEOM, V2010, P876940, DOI [10.4061/2010/876940, DOI 10.4061/2010/876940]; Juronen E, 2000, EXP EYE RES, V71, P447, DOI 10.1006/exer.2000.0899; Juronen E, 2000, INVEST OPHTH VIS SCI, V41, P2262; Khan MI, 2010, MOL VIS, V16, P2146; Minelli C, 2010, INT J EPIDEMIOL, V39, P539, DOI 10.1093/ije/dyp337; Othman H, 2012, MOL BIOL REP, V39, P3299, DOI 10.1007/s11033-011-1098-2; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramprasath T, 2011, BIOCHEM BIOPH RES CO, V407, P49, DOI 10.1016/j.bbrc.2011.02.097; Rocha AV, 2011, MOL VIS, V17, P1679; Sun L, 2010, INVEST OPHTH VIS SCI, V51, P6381, DOI 10.1167/iovs.10-5815; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Unal M, 2007, BRIT J OPHTHALMOL, V91, P527, DOI 10.1136/bjo.2006.102418; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Worley A, 2011, AUST J PRIM HEALTH, V17, P233, DOI 10.1071/PY10042; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Yildirim O, 2005, GRAEF ARCH CLIN EXP, V243, P327, DOI 10.1007/s00417-004-1013-9; Yilmaz A, 2005, CURR EYE RES, V30, P575, DOI 10.1080/02713680590968123	36	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54037	10.1371/journal.pone.0054037	http://dx.doi.org/10.1371/journal.pone.0054037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342067	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400112
J	Dacevic, M; Isakovic, A; Podolski-Renic, A; Isakovic, AM; Stankovic, T; Milosevic, Z; Rakic, L; Ruzdijic, S; Pesic, M				Dacevic, Mirjana; Isakovic, Aleksandra; Podolski-Renic, Ana; Isakovic, Andelka M.; Stankovic, Tijana; Milosevic, Zorica; Rakic, Ljubisav; Ruzdijic, Sabera; Pesic, Milica			Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POLYMERASE CHAIN-REACTION; LUNG-CARCINOMA; MESSENGER-RNA; GLIOMA-CELLS; IN-VITRO; EXPRESSION; APOPTOSIS; INHIBITION; DIFFERENTIATION	Achieving an effective treatment of cancer is difficult, particularly when resistance to conventional chemotherapy is developed. P-glycoprotein (P-gp) activity governs multi-drug resistance (MDR) development in different cancer cell types. Identification of anti-cancer agents with the potential to kill cancer cells and at the same time inhibit MDR is important to intensify the search for novel therapeutic approaches. We examined the effects of sulfinosine (SF), a quite unexplored purine nucleoside analog, in MDR (P-gp over-expressing) non-small cell lung carcinoma (NSCLC) and glioblastoma cell lines (NCI-H460/R and U87-TxR, respectively). SF showed the same efficacy against MDR cancer cell lines and their sensitive counterparts. However, it was non-toxic for normal human keratinocytes (HaCaT). SF induced caspase-dependent apoptotic cell death and autophagy in MDR cancer cells. After SF application, reactive oxygen species (ROS) were generated and glutathione (GSH) concentration was decreased. The expression of key enzyme for GSH synthesis, gamma Glutamylcysteine-synthetase (cGCS) was decreased as well as the expression of gst-pi mRNA. Consequently, SF significantly decreased the expression of hif-1 alpha, mdr1 and vegf mRNAs even in hypoxic conditions. SF caused the inhibition of P-gp (coded by mdr1) expression and activity. The accumulation of standard chemotherapeutic agent - doxorubicin (DOX) was induced by SF in concentration-and time-dependent manner. The best effect of SF was obtained after 72 h when it attained the effect of known P-gp inhibitors (Dex-verapamil and tariquidar). Accordingly, SF sensitized the resistant cancer cells to DOX in subsequent treatment. Furthermore, SF decreased the experssion of vascular endothelial growth factor (VEGF) on mRNA and protein level and modulated its secretion. In conclusion, the effects on P-gp (implicated in pharmacokinetics and MDR), GSH (implicated in detoxification) and VEGF (implicated in tumor-angiogenesis and progression) qualify SF as multi-potent anti-cancer agent, which use must be considered, in particular for resistant malignancies.	[Dacevic, Mirjana; Isakovic, Aleksandra; Isakovic, Andelka M.] Univ Belgrade, Fac Med, Belgrade, Serbia; [Podolski-Renic, Ana; Stankovic, Tijana; Milosevic, Zorica; Ruzdijic, Sabera; Pesic, Milica] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Rakic, Ljubisav] Serbian Acad Arts & Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade; Serbian Academy of Sciences & Arts	Pesic, M (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevar Despota Stefana 142, Belgrade, Serbia.	vtbvtm@sbb.rs	Pešić, Milica/I-4727-2019; Stanković, Tijana/F-1228-2016	Pešić, Milica/0000-0002-9045-8239; Stanković, Tijana/0000-0001-5623-0612; Isakovic, Andjelka/0000-0001-5270-709X; Podolski-Renic, Ana/0000-0001-7412-3685	Ministry of Education, Science and Technological Development of Serbia [III 41031, III 41025]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	Ministry of Education, Science and Technological Development of Serbia (grant numbers III 41031 and III 41025) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic T, 2008, CANCER BIOL THER, V7, P1024, DOI 10.4161/cbt.7.7.6036; AVERY TL, 1990, CANCER RES, V50, P2625; Bosch S, 1997, ANTICANCER RES, V17, P4595; Bosch TM, 2006, CLIN PHARMACOKINET, V45, P253, DOI 10.2165/00003088-200645030-00003; Chang CY, 2011, J NEURO-ONCOL, V105, P507, DOI 10.1007/s11060-011-0632-3; Dunne G, 2011, INVEST NEW DRUG, V29, P1284, DOI 10.1007/s10637-010-9482-7; Eimer S, 2011, CANCER BIOL THER, V11, P1017, DOI 10.4161/cbt.11.12.15693; Fontanini G, 1997, CLIN CANCER RES, V3, P861; FUJITAKI J M, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P596; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gridelli C, 2003, ONCOGENE, V22, P6629, DOI 10.1038/sj.onc.1206957; Harada H, 1999, CANCER RES, V59, P3783; Hawkins BT, 2010, J NEUROSCI, V30, P1417, DOI 10.1523/JNEUROSCI.5103-09.2010; Horn L, 2009, CLIN LUNG CANCER, V10, pS7, DOI 10.3816/CLC.2009.s.002; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jin WS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-61; Kang WQ, 2005, CARCINOGENESIS, V26, P1129, DOI 10.1093/carcin/bgi045; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; NicAmhlaoibh R, 1999, INT J CANCER, V82, P368, DOI 10.1002/(SICI)1097-0215(19990730)82:3<368::AID-IJC10>3.0.CO;2-E; Nies AT, 2007, CANCER LETT, V254, P11, DOI 10.1016/j.canlet.2006.12.023; Nobili S, 2012, MED RES REV, V32, P1220, DOI 10.1002/med.20239; ODRISCOLL L, 1993, CYTOTECHNOLOGY, V12, P289, DOI 10.1007/BF00744669; Pesic M, 2006, J CHEMOTHERAPY, V18, P66, DOI 10.1179/joc.2006.18.1.66; Pesic M, 2010, INVEST NEW DRUG, V28, P482, DOI 10.1007/s10637-009-9277-x; Pesic M, 2009, INVEST NEW DRUG, V27, P99, DOI 10.1007/s10637-008-9140-5; Podolski-Renic A, 2011, BIOMED PHARMACOTHER, V65, P345, DOI 10.1016/j.biopha.2011.04.015; Presta M, 2002, LEUKEMIA, V16, P1490, DOI 10.1038/sj.leu.2402646; REVANKAR GR, 1990, J MED CHEM, V33, P121, DOI 10.1021/jm00163a020; RILEY T A, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P599; Rudin CM, 2003, CANCER RES, V63, P312; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SOKOLOSKI JA, 1987, CANCER RES, V47, P6283; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Underiner TL, 2004, CURR MED CHEM, V11, P731, DOI 10.2174/0929867043455756; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Walbert T, 2011, J NEURO-ONCOL, V102, P273, DOI 10.1007/s11060-010-0313-7; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Xu Y, 2008, ONCOGENE, V27, P3501, DOI 10.1038/sj.onc.1211023; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	44	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54044	10.1371/journal.pone.0054044	http://dx.doi.org/10.1371/journal.pone.0054044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326571	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800105
J	Zheng, ZG; Guan, HX; Leal, F; Grey, PH; Oppenheimer, DG				Zheng, Zhengui; Guan, Hexin; Leal, Francisca; Grey, Paris H.; Oppenheimer, David G.			Mediator Subunit18 Controls Flowering Time and Floral Organ Identity in Arabidopsis	PLOS ONE			English	Article							RNA-POLYMERASE-II; COMPLEX SUBUNIT PFT1; MEDIATOR COMPLEX; LOCUS-C; TRANSCRIPTIONAL REGULATION; GENETIC INTERACTIONS; AUTONOMOUS PATHWAY; BINDING PROTEINS; PLANT MEDIATOR; HOMEOTIC GENES	Mediator is a conserved multi-protein complex that plays an important role in regulating transcription by mediating interactions between transcriptional activator proteins and RNA polymerase II. Much evidence exists that Mediator plays a constitutive role in the transcription of all genes transcribed by RNA polymerase II. However, evidence is mounting that specific Mediator subunits may control the developmental regulation of specific subsets of RNA polymerase II-dependent genes. Although the Mediator complex has been extensively studied in yeast and mammals, only a few reports on Mediator function in flowering time control of plants, little is known about Mediator function in floral organ identity. Here we show that in Arabidopsis thaliana, MEDIATOR SUBUNIT 18 (MED18) affects flowering time and floral organ formation through FLOWERING LOCUS C (FLC) and AGAMOUS (AG). A MED18 loss-of-function mutant showed a remarkable syndrome of later flowering and altered floral organ number. We show that FLC and AG mRNA levels and AG expression patterns are altered in the mutant. Our results support parallels between the regulation of FLC and AG and demonstrate a developmental role for Mediator in plants.	[Zheng, Zhengui; Guan, Hexin; Leal, Francisca; Grey, Paris H.; Oppenheimer, David G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Zheng, Zhengui] Univ Florida, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Gainesville, FL USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; State University System of Florida; University of Florida	Zheng, ZG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	patrickz@ufl.edu; oppenhe@ufl.edu		Zheng, Zhengui/0000-0003-0997-2976	National Science Foundation [DBI-0115684]; University of Florida	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida)	This work was supported by National Science Foundation grant DBI-0115684 to DGO. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Gillmor CS, 2010, DEVELOPMENT, V137, P113, DOI 10.1242/dev.043174; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Inigo S, 2012, PLANT J, V69, P601, DOI 10.1111/j.1365-313X.2011.04815.x; Ito J, 2011, PLANT CELL PHYSIOL, V52, P539, DOI 10.1093/pcp/pcr013; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Klose C, 2012, PLANT PHYSIOL, V160, P289, DOI 10.1104/pp.112.197319; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEEBENSMACK JH, 2006, DEV GENETICS FLOWER; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; MEYEROWITZ EM, 1991, DEVELOPMENT, P157; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Ni WM, 2004, PLANT PHYSIOL, V134, P1574, DOI 10.1104/pp.103.031971; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Ou B, 2011, MOL PLANT, V4, P546, DOI 10.1093/mp/ssr002; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suzuki E, 2009, P NATL ACAD SCI USA, V106, P3818, DOI 10.1073/pnas.0809819106; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Xu R, 2011, DEVELOPMENT, V138, P4545, DOI 10.1242/dev.071423; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhou Y, 2009, DEV BIOL, V331, P50, DOI 10.1016/j.ydbio.2009.04.023	67	39	41	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53924	10.1371/journal.pone.0053924	http://dx.doi.org/10.1371/journal.pone.0053924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326539	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800088
J	Lyska, D; Engelmann, K; Meierhoff, K; Westhoff, P				Lyska, Dagmar; Engelmann, Kerstin; Meierhoff, Karin; Westhoff, Peter			pAUL: A Gateway-Based Vector System for Adaptive Expression and Flexible Tagging of Proteins in Arabidopsis	PLOS ONE			English	Article							BETA-GLUCURONIDASE; GENE; PURIFICATION; PLANTS; THALIANA; COMPLEX; PROMOTER; IDENTIFICATION; ACCUMULATION; TRANSLATION	Determination of protein function requires tools that allow its detection and/or purification. As generation of specific antibodies often is laborious and insufficient, protein tagging using epitopes that are recognized by commercially available antibodies and matrices appears more promising. Also, proper spatial and temporal expression of tagged proteins is required to prevent falsification of results. We developed a new series of binary Gateway cloning vectors named pAUL1-20 for C- and N-terminal in-frame fusion of proteins to four different tags: a single (i) HA epitope and (ii) Strep-tagIII, (iii) both epitopes combined to a double tag, and (iv) a triple tag consisting of the double tag extended by a Protein A tag possessing a 3C protease cleavage site. Expression can be driven by either the 35 S CaMV promoter or, for C- terminal fusions, promoters from genes encoding the chloroplast biogenesis factors HCF107, HCF136, or HCF173. Fusions of the four promoters to the GUS gene showed that endogenous promoter sequences are functional and drive expression more moderately and consistently throughout different transgenic lines when compared to the 35 S CaMV promoter. By testing complementation of mutations affected in chloroplast biogenesis factors HCF107 and HCF208, we found that the effect of different promoters and tags on protein function strongly depends on the protein itself. Single-step and tandem affinity purification of HCF208 via different tags confirmed the integrity of the cloned tags.	[Lyska, Dagmar; Engelmann, Kerstin; Meierhoff, Karin; Westhoff, Peter] Univ Dusseldorf, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Lyska, D (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	dalyska@lbl.gov			Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1	Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1	The work described here was supported by the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich Transregio TR1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTRAW MJ, 1990, PLANT MOL BIOL, V15, P527, DOI 10.1007/BF00017828; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; Felder S, 2001, PLANT CELL, V13, P2127, DOI 10.1105/tpc.13.9.2127; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Laufs P, 2003, DEVELOPMENT, V130, P785, DOI 10.1242/dev.00295; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Saint-Marcoux D, 2009, J CELL BIOL, V185, P1195, DOI 10.1083/jcb.200812025; Sane AP, 2005, PLANT J, V42, P720, DOI 10.1111/j.1365-313X.2005.02409.x; Sato MH, 1997, BIOTECHNIQUES, V23, P254, DOI 10.2144/97232bm17; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schult K, 2007, PLANT CELL, V19, P1329, DOI 10.1105/tpc.106.042895; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stoppel R, 2012, NUCLEIC ACIDS RES, V40, P8593, DOI 10.1093/nar/gks613; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	37	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53787	10.1371/journal.pone.0053787	http://dx.doi.org/10.1371/journal.pone.0053787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326506	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400046
J	Tichy, H; Kallina, W				Tichy, Harald; Kallina, Wolfgang			The Evaporative Function of Cockroach Hygroreceptors	PLOS ONE			English	Article							STICK INSECT; HUMIDITY; ANTENNA; SENSILLA; MOIST; THERMORECEPTORS; PERIPLANETA; RECEPTOR	Insect hygroreceptors associate as antagonistic pairs of a moist cell and a dry cell together with a cold cell in small cuticular sensilla on the antennae. The mechanisms by which the atmospheric humidity stimulates the hygroreceptive cells remain elusive. Three models for humidity transduction have been proposed in which hygroreceptors operate either as mechanical hygrometers, evaporation detectors or psychrometers. Mechanical hygrometers are assumed to respond to the relative humidity, evaporation detectors to the saturation deficit and psychrometers to the temperature depression (the difference between wet-bulb and dry-bulb temperatures). The models refer to different ways of expressing humidity. This also means, however, that at different temperatures these different types of hygroreceptors indicate very different humidity conditions. The present study tested the adequacy of the three models on the cockroach's moist and dry cells by determining whether the specific predictions about the temperature-dependence of the humidity responses are indeed observed. While in previous studies stimulation consisted of rapid step-like humidity changes, here we changed humidity slowly and continuously up and down in a sinusoidal fashion. The low rates of change made it possible to measure instantaneous humidity values based on UV-absorption and to assign these values to the hygroreceptive sensillum. The moist cell fitted neither the mechanical hygrometer nor the evaporation detector model: the temperature dependence of its humidity responses could not be attributed to relative humidity or to saturation deficit, respectively. The psychrometer model, however, was verified by the close relationships of the moist cell's response with the wet-bulb temperature and the dry cell's response with the dry-bulb temperature. Thus, the hygroreceptors respond to evaporation and the resulting cooling due to the wetness or dryness of the air. The drier the ambient air (absolutely) and the higher the temperature, the greater the evaporative temperature depression and the power to desiccate.	[Tichy, Harald; Kallina, Wolfgang] Univ Vienna, Dept Neurobiol, Fac Life Sci, Vienna, Austria	University of Vienna	Tichy, H (corresponding author), Univ Vienna, Dept Neurobiol, Fac Life Sci, Vienna, Austria.	harald.tichy@univie.ac.at		Harald, Tichy/0000-0003-1582-5139	Austrian Science Fund [P20.197-B17]; Austrian Science Fund (FWF) [P 20196] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (Project P20.197-B17) (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; ALTNER H, 1983, CELL TISSUE RES, V234, P279, DOI 10.1007/BF00213769; Becker D, 1978, ELEKTROPHYSIOLOGISCH, P160; Crank J, 1960, MOISTURE TEXTILES, P106; Diem K, 1968, WISSENSCHAFTLICHE TA; ITOH T, 1984, ZOOL SCI, V1, P533; LOFTUS R, 1976, J COMP PHYSIOL, V111, P153, DOI 10.1007/BF00605530; LOFTUS R, 1987, J COMP PHYSIOL A, V161, P399, DOI 10.1007/BF00603965; Resch R, 1998, APPL PHYS A-MATER, V66, pS607, DOI 10.1007/s003390051209; STEINBRECHT RA, 1991, CELL TISSUE RES, V266, P441, DOI 10.1007/BF00318585; Steinbrecht RA, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P405; TICHY H, 1987, J COMP PHYSIOL A, V160, P43, DOI 10.1007/BF00613440; Tichy H, 2003, J COMP PHYSIOL A, V189, P175, DOI 10.1007/s00359-003-0397-z; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; TICHY H, 1990, J COMP PHYSIOL A, V166, P507, DOI 10.1007/BF00192021; Tichy H, 1996, NATURWISSENSCHAFTEN, V83, P255; Tichy H., 2001, ECOLOGY SENSING, P271, DOI [10.1007/978-3-662-22644-5_14, DOI 10.1007/978-3-662-22644-5_14]; Tichy H, 2007, J NEUROPHYSIOL, V97, P3851, DOI 10.1152/jn.00097.2007; Urquhart A. R., 1960, MOISTURE TEXTILES, P14; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; Yokohari Fumio, 1999, P191	23	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53998	10.1371/journal.pone.0053998	http://dx.doi.org/10.1371/journal.pone.0053998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342058	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700072
J	Wang, B; Xiao, JH; Bian, SN; Niu, LM; Murphy, RW; Huang, DW				Wang, Bo; Xiao, Jin-Hua; Bian, Sheng-Nan; Niu, Li-Ming; Murphy, Robert W.; Huang, Da-Wei			Evolution and Expression Plasticity of Opsin Genes in a Fig Pollinator, Ceratosolen solmsi	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; PCR DATA-ANALYSIS; COLOR-VISION; VISUAL PIGMENTS; LIGHT; DIVERSIFICATION; DUPLICATION; PHYLOGENY; BUTTERFLIES; RECEPTOR	Figs and fig pollinators have co-evolved species-specific systems of mutualism. So far, it was unknown how visual opsin genes of pollinators have evolved in the light conditions inside their host figs. We cloned intact full-length mRNA sequences of four opsin genes from a species of fig pollinator, Ceratosolen solmsi, and tested for selective pressure and expressional plasticity of these genes. Molecular evolutionary analysis indicated that the four opsin genes evolved under different selective constraints. Subsets of codons in the two long wavelength sensitive opsin (LW1, LW2) genes were positively selected in ancestral fig pollinators. The ultraviolet sensitive opsin (UV) gene was under strong purifying selection, whereas a relaxation of selective constrains occurred on several amino acids in the blue opsin. RT-qPCR analysis suggested that female and male fig pollinators had different expression patterns possibly due to their distinct lifestyles and different responses to light within the syconia. Co-evolutionary history with figs might have influenced the evolution and expression plasticity of opsin genes in fig pollinators.	[Wang, Bo; Xiao, Jin-Hua; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Bian, Sheng-Nan; Huang, Da-Wei] Shandong Agr Univ, Plant Protect Coll, Tai An, Shandong, Peoples R China; [Niu, Li-Ming] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Hainan, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Huang, DW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw619@gmail.com		Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [31090253, 31172072, 31210103912]; Major Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-2]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]; Natural Sciences and Engineering Research Council (Canada) [3148]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Innovation Program of Chinese Academy of Sciences; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253, 31172072, 31210103912), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2), a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences and National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004), and by a Natural Sciences and Engineering Research Council (Canada) Discovery Grant (3148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anstett MC, 1997, TRENDS ECOL EVOL, V12, P94, DOI 10.1016/S0169-5347(96)10064-1; Astruc C, 2004, MOL PHYLOGENET EVOL, V31, P880, DOI 10.1016/j.ympev.2003.10.024; Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2002, MOL BIOL EVOL, V19, P983, DOI 10.1093/oxfordjournals.molbev.a004158; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARULLI JP, 1994, J MOL EVOL, V38, P250, DOI 10.1007/BF00176087; Compton SG, 2010, BIOL LETTERS, V6, P838, DOI 10.1098/rsbl.2010.0389; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 2005, CURR BIOL, V15, pR978, DOI 10.1016/j.cub.2005.11.057; Dalal JS, 2003, VISUAL NEUROSCI, V20, P523, DOI 10.1017/S095252380320506X; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henze MJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-163; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kisselev OG, 2005, EXP EYE RES, V81, P366, DOI 10.1016/j.exer.2005.06.018; Koyanagi M, 2008, J MOL EVOL, V66, P130, DOI 10.1007/s00239-008-9065-9; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI [10.1089/152791600459894, DOI 10.1089/152791600459894]; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Maksimovic S, 2009, J EXP BIOL, V212, P3781, DOI 10.1242/jeb.031773; McLeish MJ, 2010, MOL ECOL, V19, P1483, DOI 10.1111/j.1365-294X.2010.04583.x; Mollon JD, 1999, P NATL ACAD SCI USA, V96, P4743, DOI 10.1073/pnas.96.9.4743; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sekharan S, 2011, J AM CHEM SOC, V133, P19052, DOI 10.1021/ja208789h; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Sison-Mangus MP, 2005, INTEGR COMP BIOL, V45, P1073; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SD, 2005, MOL BIOL EVOL, V22, P1165, DOI 10.1093/molbev/msi110; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tierney SM, 2012, P ROY SOC B-BIOL SCI, V279, P794, DOI 10.1098/rspb.2011.1355; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wakakuwa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015015; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yuan FR, 2010, MOL BIOL EVOL, V27, P2392, DOI 10.1093/molbev/msq124; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	60	20	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53907	10.1371/journal.pone.0053907	http://dx.doi.org/10.1371/journal.pone.0053907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342036	Green Published, gold			2022-12-27	WOS:000313682700062
J	Xu, ZQ; Chen, JP; Li, XG; Ge, JC; Pan, JL; Xu, XF				Xu, Zhiqiang; Chen, Jiaping; Li, Xuguang; Ge, Jiachun; Pan, Jianlin; Xu, Xiaofeng			Identification and Characterization of MicroRNAs in Channel Catfish (Ictalurus punctatus) by Using Solexa Sequencing Technology	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; TARGETS; LET-7; MECHANISM; DISCOVERY; CELLS; RNAS	Channel catfish (Ictalurus spp.) is an economically important species in freshwater aquaculture around the world and occupies a prominent position in the aquaculture industry of the United States. MicroRNAs (miRNAs) play important roles in the regulation of almost every biological process in eukaryotes; however, there is little information available concerning miRNAs in channel catfish. In this study, a small-RNA cDNA library was constructed from 10 tissues of channel catfish, and Solexa sequencing technology was used to perform high-throughput sequencing of the library. A total of 14,919,026 raw reads, representing 161,288 unique sequences, were obtained from the small-cDNA library. After comparing the small RNA sequences with the RFam database, 4,542,396 reads that represent 25,538 unique sequences were mapped to the genome sequence of zebrafish to perform distribution analysis and to screen for candidate miRNA genes. Subsequent bioinformatic analysis identified 237 conserved miRNAs and 45 novel miRNAs in the channel catfish. Stem-loop RT-PCR was applied to validate and profile the expression of the novel miRNAs in 10 tissues. Some novel miRNAs, such as ipu-miR-129b, ipu-miR-7562 and ipu-miR-7553, were expressed in all tissues examined. However, some novel miRNAs appear to be tissue specific. Ipu-miR-7575 is predominantly expressed in stomach. Ipu-miR-7147 and ipu-miR-203c are highly expressed in heart, but are relatively weakly expressed in other tissues. Based on sequence complementarity between miRNAs and mRNA targets, potential target sequences for the 45 novel miRNAs were identified by searching for antisense hits in the reference RNA sequences of the channel catfish. These potential target sequences are involved in immune regulation, transcriptional regulation, metabolism and many other biological functions. The discovery of miRNAs in the channel catfish genome by this study contributes to a better understanding of the role miRNAs play in regulating diverse biological processes in fish and vertebrates.	[Xu, Zhiqiang; Xu, Xiaofeng] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Xu, Zhiqiang; Li, Xuguang; Ge, Jiachun; Pan, Jianlin] Freshwater Fisheries Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Chen, Jiaping] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University	Xu, ZQ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	zhiqiangx@163.com; xuxiaofeng@njnu.edu.cn			Natural Science Foundation of Jiangsu Province [BK2011864]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province (BK2011864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Arias CR, 2012, DIS AQUAT ORGAN, V100, P77, DOI 10.3354/dao02492; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barozai MYK, 2012, MOL BIOL REP, V39, P8867, DOI 10.1007/s11033-012-1753-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhardwaj Jyoti, 2010, Journal of Structural and Functional Genomics, V11, P233, DOI 10.1007/s10969-010-9098-3; Bilodeau-Bourgeois L, 2008, FISH SHELLFISH IMMUN, V24, P82, DOI 10.1016/j.fsi.2007.09.001; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; FAO, 2010, YB FISH STAT SUMM TA; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Issabekova A, 2012, BIOINFORMATION, V8, P513, DOI 10.6026/97320630008513; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li SC, 2011, GENOMICS, V98, P453, DOI 10.1016/j.ygeno.2011.08.008; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Lu J, 2010, NUCLEIC ACIDS RES, V39, pD815; Mondol V, 2012, CURR TOP DEV BIOL, V99, P1, DOI 10.1016/B978-0-12-387038-4.00001-X; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pohlenz C, 2012, FISH SHELLFISH IMMUN, V33, P543, DOI 10.1016/j.fsi.2012.06.005; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Saunders HL, 2010, DEV COMP IMMUNOL, V34, P669, DOI 10.1016/j.dci.2010.01.013; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Tani S, 2010, GENE, V449, P41, DOI 10.1016/j.gene.2009.09.005; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wang YG, 2011, SCI TOTAL ENVIRON, V409, P4753, DOI 10.1016/j.scitotenv.2011.07.039; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925	47	69	354	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54174	10.1371/journal.pone.0054174	http://dx.doi.org/10.1371/journal.pone.0054174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342099	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700093
J	Ocklenburg, S; Arning, L; Gerding, WM; Epplen, JT; Gunturkun, O; Beste, C				Ocklenburg, Sebastian; Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.; Guentuerkuen, Onur; Beste, Christian			Cholecystokinin A Receptor (CCKAR) Gene Variation Is Associated with Language Lateralization	PLOS ONE			English	Article							SCHIZOPHRENIC-PATIENTS; HANDEDNESS; DOPAMINE; ASYMMETRY	Schizophrenia is a psychiatric disorder associated with atypical handedness and language lateralization. However, the molecular mechanisms underlying these functional changes are still poorly understood. Therefore, the present study was aimed at investigating whether variation in schizophrenia-related genes modulates individual lateralization patterns. To this end, we genotyped 16 single nucleotide polymorphisms that have previously been linked to schizophrenia on a meta-analysis level in a sample of 444 genetically unrelated healthy participants and examined the association of these polymorphisms with handedness, footedness and language lateralization. We found a significant association of the cholecystokinin-A receptor (CCKAR) gene variation rs1800857 and language lateralization assessed using the dichotic listening task. Individuals carrying the schizophrenia risk allele C of this polymorphism showed a marked reduction of the typical left-hemispheric dominance for language processing. Since the cholecystokinin A receptor is involved in dopamine release in the central nervous system, these findings suggest that genetic variation in this receptor may modulate language lateralization due to its impact on dopaminergic pathways.	[Ocklenburg, Sebastian; Guentuerkuen, Onur; Beste, Christian] Ruhr Univ Bochum, Inst Cognit Neurosci, Bochum, Germany; [Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Ocklenburg, S (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Univ Str 150, Bochum, Germany.	sebastian.ocklenburg@rub.de	Ocklenburg, Sebastian/O-5867-2017	Ocklenburg, Sebastian/0000-0001-5882-3200; Gunturkun, Onur/0000-0003-4173-5233; Epplen, Joerg T./0000-0002-6087-3327	DFG Emmy-Noether grant [BE4045/10-1]; Cutting-Edge Grant from the Ruhr-University of Bochum	DFG Emmy-Noether grant(German Research Foundation (DFG)); Cutting-Edge Grant from the Ruhr-University of Bochum	This research was supported by a DFG Emmy-Noether grant to Christian Beste (BE4045/10-1) and a Cutting-Edge Grant from the Ruhr-University of Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett M, 2002, HANDEDNESS BRAIN ASY; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Collinson SL, 2009, SCHIZOPHR RES, V112, P24, DOI 10.1016/j.schres.2009.03.034; CRAWLEY JN, 1991, TRENDS PHARMACOL SCI, V12, P232, DOI 10.1016/0165-6147(91)90558-A; de la Fuente-Fernandez R, 2000, BEHAV BRAIN RES, V112, P63, DOI 10.1016/S0166-4328(00)00165-0; Di Forti M, 2007, EUR NEUROPSYCHOPHARM, V17, pS101, DOI 10.1016/j.euroneuro.2007.02.005; Dragovic M, 2005, ACTA PSYCHIAT SCAND, V111, P410, DOI 10.1111/j.1600-0447.2005.00519.x; Elias L J, 1998, Laterality, V3, P41, DOI 10.1080/713754287; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Feifel D, 2003, NEUROSCI LETT, V348, P147, DOI 10.1016/S0304-3940(03)00767-5; Gogos JA, 2006, TRENDS PHARMACOL SCI, V27, P226, DOI 10.1016/j.tips.2006.02.005; Hahn C, 2011, BRAIN COGNITION, V76, P300, DOI 10.1016/j.bandc.2011.03.015; HARTLEY LR, 1991, PHYSIOL BEHAV, V50, P881, DOI 10.1016/0031-9384(91)90409-H; HOKFELT T, 1980, NATURE, V285, P476, DOI 10.1038/285476a0; Hugdahl K, 2000, ACTA PSYCHOL, V105, P211, DOI 10.1016/S0001-6918(00)00062-7; Hugdahl Kenneth, 2008, Cogn Neuropsychiatry, V13, P166, DOI 10.1080/13546800801906808; HUPPI K, 1995, GENOMICS, V25, P727, DOI 10.1016/0888-7543(95)80018-H; Josselyn SA, 1996, PSYCHOPHARMACOLOGY, V123, P131, DOI 10.1007/BF02246170; Koefoed P, 2009, ACTA PSYCHIAT SCAND, V120, P281, DOI 10.1111/j.1600-0447.2009.01400.x; Loberg EM, 2004, PSYCHIAT RES, V128, P167, DOI 10.1016/j.psychres.2004.01.011; Loberg EM, 2002, PSYCHIAT RES, V109, P281, DOI 10.1016/S0165-1781(02)00019-7; Lux S, 2008, J ANAT, V212, P235, DOI 10.1111/j.1469-7580.2008.00855.x; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McManus I.C., 2002, RIGHT HAND LEFT HAND; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19, DOI 10.1093/schbul/2.1.19; Nagai T, 2011, BIOL PHARM BULL, V34, P1364, DOI 10.1248/bpb.34.1364; O'Connell G, 2011, BIOCHEM PHARMACOL, V81, P1367, DOI 10.1016/j.bcp.2010.11.009; Ocklenburg S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00005; Ocklenburg S, 2011, BEHAV BRAIN RES, V225, P284, DOI 10.1016/j.bbr.2011.07.042; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Shulkes A, 1997, CLIN EXP PHARMACOL P, V24, P209, DOI 10.1111/j.1440-1681.1997.tb01809.x; Sommer I, 2001, BRIT J PSYCHIAT, V178, P344, DOI 10.1192/bjp.178.4.344; Tanganelli S, 2001, PEPTIDES, V22, P1229, DOI 10.1016/S0196-9781(01)00446-6; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Toirac I, 2007, PSYCHIAT GENET, V17, P47, DOI 10.1097/YPG.0b013e3280298292; Tzourio-Mazoyer N, 2010, CEREB CORTEX, V20, P1476, DOI 10.1093/cercor/bhp209; Wei J, 1999, EUR PSYCHIAT, V14, P67, DOI 10.1016/S0924-9338(99)80719-6; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Zhang XY, 2000, MOL PSYCHIATR, V5, P239, DOI 10.1038/sj.mp.4000677	40	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53643	10.1371/journal.pone.0053643	http://dx.doi.org/10.1371/journal.pone.0053643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341962	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400056
J	Turner, L; Galipeau, J; Garritty, C; Manheimer, E; Wieland, LS; Yazdi, F; Moher, D				Turner, Lucy; Galipeau, James; Garritty, Chantelle; Manheimer, Eric; Wieland, L. Susan; Yazdi, Fatemeh; Moher, David			An Evaluation of Epidemiological and Reporting Characteristics of Complementary and Alternative Medicine (CAM) Systematic Reviews (SRs)	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL QUALITY; CLINICAL-TRIALS; TASK-FORCE; VALIDATION; CHECKLIST; CRITERIA; INDEX; BIAS	Background: Systematic reviews (SRs) are abundant. The optimal reporting of SRs is critical to enable clinicians to use their findings to make informed treatment decisions. Complementary and alternative medicine (CAM) therapies are widely used therefore it is critical that conduct and reporting of systematic research in this field be of high quality. Here, methodological and reporting characteristics of a sample of CAM-related SRs and a sample of control SRs are evaluated and compared. Methods: MEDLINE (R) was searched to identify non-Cochrane SRs indexed from January 2010 to May 2011. Control SRs were retrieved and a search filter was used to identify CAM SRs. Citations were screened and publications that met a pre-specified definition of a SR were included. Pre-designed, standardized data extraction forms were developed to capture reporting and methodological characteristics of the included reviews. Where appropriate, samples were compared descriptively. Results: A total of 349 SRs were identified, of which 174 were CAM-related SRs and 175 were conventional SRs. We compared 131 CAM-related non-Cochrane SRs to the 175 conventional non-Cochrane reviews. Fifty-seven percent (75/131) of CAM SRs specified a primary outcome compared to 21% (37/175) of conventional sample reviews. Reporting of publication bias occurred in less than 5% (6/131) of the CAM sample versus 46% (80/175) of the conventional sample of SRs. Source of funding was frequently and consistently under-reported. Less than 5% (11/306) of all SRs reported public availability of a review protocol. Conclusion: The two samples of reviews exhibited different strengths and weaknesses. In some cases there were consistencies across items which indicate the need for continued improvements in reporting for all SR reports. We advise authors to utilise the PRISMA Statement or other SR guidance when reporting SRs.	[Turner, Lucy; Galipeau, James; Garritty, Chantelle; Yazdi, Fatemeh; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Manheimer, Eric; Wieland, L. Susan] Univ Maryland Sch Med, Ctr Integrat Med, Baltimore, MD USA; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University System of Maryland; University of Maryland Baltimore; University of Ottawa	Turner, L (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	lturner@ohri.ca	Garritty, Chantelle Marie/AAC-4136-2022; Garritty, Chantelle/ABG-7790-2020; Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206; Wieland, Lisa Susan/0000-0003-2157-0603	National Centre for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health [R24 AT001293-04]; National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER	National Centre for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible by grant number R24 AT001293-04 from the National Centre for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCCAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright J, 2001, PHYS THER, V81, P1641; [Anonymous], 2012, AM AC NEUR GUID; [Anonymous], 2012, ENDNOTE CIT SOFTW; [Anonymous], 2008, REFWORKS COS; [Anonymous], 2012, COCHR CENTR REG CONT; [Anonymous], 2012, CRITICAL APPRAISAL S; [Anonymous], 2011, SAS SOFTW VERS 9 1; [Anonymous], 2003, NAT I HLTH CLIN EXC; Barnes PM, 2008, NATL HLTH STAT REPOR, V12, P1, DOI DOI 10.1037/E623942009-001; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Board on Health Services, 2011, FIND WHAT WORKS HLTH; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brozek J, 2008, GRADEPRO VERS 3 2 WI; CHO MK, 1994, JAMA-J AM MED ASSOC, V272, P101, DOI 10.1001/jama.272.2.101; Cox E, 2009, VALUE HEALTH, V12, P1053, DOI 10.1111/j.1524-4733.2009.00601.x; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; DEBACHERE MC, 1995, IFLA J-INT FED LIBR, V21, P94, DOI 10.1177/034003529502100205; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Distiller SR, 2010, EVIDENCE PARTNERS; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Harris P, 2000, COMPLEMENT THER MED, V8, P88, DOI 10.1054/ctim.2000.0353; Harris P, 2000, COMPLEMENT THER MED, V8, P288, DOI 10.1054/ctim.2000.0412; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartling L, 2012, 20 COCHR C AUCKL NZ; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Khan K.S., 2001, UNDERTAKING SYSTEMAT; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Phillips B, 2009, OXFORD CTR EVIDENCE; Phillips Bob, 2009, OXF CTR EV BAS MED L; RevMan 2008 The Cochrane Collaboration, 2008, REVMAN 2008 COCHRANE; Santaguida P, 2012, DEV MCHARM QUAL AS S; Sauerland S, 2005, SURG ENDOSC, V19, P200, DOI 10.1007/s00464-004-9194-1; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stetler CB, 1998, APPL NURS RES, V11, P195, DOI 10.1016/S0897-1897(98)80329-7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tricco AC, 2009, J CLIN EPIDEMIOL, V62, P380, DOI 10.1016/j.jclinepi.2008.08.008; US National Library of Medicine, ABR IND MED AIM COR; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Viswanathan M, 2008, METHODS GUIDE EFFECT; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wells G., 2014, NEWCASTLE OTTAWA SCA; West S, 2002, Evid Rep Technol Assess (Summ), P1; Wieland LS, 2011, ALTERN THER HEALTH M, V17, P50; Zaza S, 2001, AM J PREV MED, V21, P23, DOI 10.1016/S0749-3797(01)00379-8	62	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53536	10.1371/journal.pone.0053536	http://dx.doi.org/10.1371/journal.pone.0053536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23341949	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400048
J	Zhu, WJ; Wei, W; Fu, YP; Cheng, JS; Xie, JT; Li, GQ; Yi, XH; Kang, ZS; Dickman, MB; Jiang, DH				Zhu, Wenjun; Wei, Wei; Fu, Yanping; Cheng, Jiasen; Xie, Jiatao; Li, Guoqing; Yi, Xianhong; Kang, Zhensheng; Dickman, Martin B.; Jiang, Daohong			A Secretory Protein of Necrotrophic Fungus Sclerotinia sclerotiorum That Suppresses Host Resistance	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; INTEGRIN-LIKE PROTEIN; OXALIC-ACID; PLASMA-MEMBRANE; CELL-WALL; ARABIDOPSIS-THALIANA; MAGNAPORTHE-ORYZAE; BOTRYTIS-CINEREA; SALICYLIC-ACID; RECEPTOR	SSITL (SS1G_14133) of Sclerotinia sclerotiorum encodes a protein with 302 amino acid residues including a signal peptide, its secretion property was confirmed with immunolocalization and immunofluorescence techniques. SSITL was classified in the integrin alpha N-terminal domain superfamily, and its 3D structure is similar to those of human integrin alpha 4-subunit and a fungal integrin-like protein. When S. sclerotiorum was inoculated to its host, high expression of SSITL was detected during the initial stages of infection (1.5-3.0 hpi). Targeted silencing of SSITL resulted in a significant reduction in virulence; on the other hand, inoculation of SSITL silenced transformant A10 initiated strong and rapid defense response in Arabidopsis, the highest expressions of defense genes PDF1.2 and PR-1 appeared at 3 hpi which was 9 hr earlier than that time when plants were inoculated with the wild-type strain of S. sclerotiorum. Systemic resistance induced by A10 was detected by analysis of the expression of PDF1.2 and PR-1, and confirmed following inoculation with Botrytis cinerea. A10 induced much larger lesions on Arabidopsis mutant ein2 and jar1, and slightly larger lesions on mutant pad4 and NahG in comparison with the wild-type plants. Furthermore, both transient and constitutive expression of SSITL in Arabidopsis suppressed the expression of PDF1.2 and led to be more susceptible to A10 and the wild-type strain of S. sclerotiorum and B. cinerea. Our results suggested that SSITL is an effector possibly and plays significant role in the suppression of jasmonic/ethylene (JA/ET) signal pathway mediated resistance at the early stage of infection.	[Zhu, Wenjun; Wei, Wei; Li, Guoqing; Jiang, Daohong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Zhu, Wenjun; Wei, Wei; Fu, Yanping; Cheng, Jiasen; Xie, Jiatao; Li, Guoqing; Yi, Xianhong; Jiang, Daohong] Huazhong Agr Univ, Prov Key Lab Plant Pathol Hubei Prov, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China; [Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Dickman, Martin B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA	Huazhong Agricultural University; Huazhong Agricultural University; Northwest A&F University - China; Texas A&M University System; Texas A&M University College Station	Jiang, DH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China.	daohongjiang@mail.hzau.edu.cn	Wei, Wei/L-9201-2019; Abbas, Aqleem/M-9403-2016	Wei, Wei/0000-0001-6295-6903; Abbas, Aqleem/0000-0001-9174-9700; Zhu, Wenjun/0000-0002-9026-7221	Natural Science Foundation of China [31071647]; Special Fund for Agro-scientific Research in the Public Interest [201103016]; earmarked fund for China Agriculture Research System [nycytx-00514]; National ScienceFoundation [0923918]; Binational Agricultural Research & Development Fund [US-4414-11C]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System; National ScienceFoundation(National Science Foundation (NSF)); Binational Agricultural Research & Development Fund	This research was supported by Natural Science Foundation of China (31071647), the Special Fund for Agro-scientific Research in the Public Interest (Grant NO. 201103016) and by the earmarked fund for China Agriculture Research System (nycytx-00514). This study was supported by grants from the National ScienceFoundation (0923918 to MBD) and the Binational Agricultural Research & Development Fund (US-4414-11C to MBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Coppinger P, 2004, PLANT J, V40, P225, DOI 10.1111/j.1365-313X.2004.02203.x; Correa A, 1996, PROTOPLASMA, V194, P91, DOI 10.1007/BF01273171; Dai FM, 2006, J INTEGR PLANT BIOL, V48, P44, DOI 10.1111/j.1744-7909.2006.00181.x-i1; Day B, 2006, PLANT CELL, V18, P2782, DOI 10.1105/tpc.106.044693; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EDWARDS JE, 1986, J IMMUNOL, V137, P3577; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Kikot GE, 2009, J BASIC MICROB, V49, P231, DOI 10.1002/jobm.200800231; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Gale C, 1996, P NATL ACAD SCI USA, V93, P357, DOI 10.1073/pnas.93.1.357; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; Hostetter MK, 1999, FUNGAL GENET BIOL, V28, P135, DOI 10.1006/fgbi.1999.1165; HOSTETTER MK, 1995, BIOCHEM MOL MED, V55, P122, DOI 10.1006/bmme.1995.1042; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KAMINSKYJ SGW, 1995, J CELL SCI, V108, P849; Kang ZhenSheng, 2007, Acta Phytopathologica Sinica, V37, P623; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; LI GQ, 2001, P INT S RAP SCI, P261; Li H, 2008, VIRUS RES, V135, P95, DOI 10.1016/j.virusres.2008.02.011; Li J, 2010, MOL CELL BIOCHEM, V343, P173, DOI 10.1007/s11010-010-0511-9; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MARCIANO P, 1983, PHYSIOL PLANT PATHOL, V22, P339; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MOVAHEDI S, 1990, PHYSIOL MOL PLANT P, V36, P303, DOI 10.1016/0885-5765(90)90061-2; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nagpal P, 1999, GENE, V230, P33, DOI 10.1016/S0378-1119(99)00068-2; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; RIOU C, 1992, APPL ENVIRON MICROB, V58, P578, DOI 10.1128/AEM.58.2.578-583.1992; Rollins JA, 2003, MOL PLANT MICROBE IN, V16, P785, DOI 10.1094/MPMI.2003.16.9.785; SCHINDLER M, 1989, J CELL BIOL, V108, P1955, DOI 10.1083/jcb.108.5.1955; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shlezinger N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002185; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Xu L, 2011, PHYTOPATHOLOGY, V101, P5104; Xu ZY, 2006, J PLANT PATHOL, V88, P89; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034962; Zhang L, 2010, PHYSIOL MOL PLANT P, V75, P71, DOI 10.1016/j.pmpp.2010.09.001	67	102	112	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53901	10.1371/journal.pone.0053901	http://dx.doi.org/10.1371/journal.pone.0053901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342034	gold, Green Published			2022-12-27	WOS:000314759400098
J	Branco, R; Cristovao, A; Morais, PV				Branco, Rita; Cristovao, Armando; Morais, Paula V.			Highly Sensitive, Highly Specific Whole-Cell Bioreporters for the Detection of Chromate in Environmental Samples	PLOS ONE			English	Article							HEAVY-METAL BIOAVAILABILITY; ALCALIGENES-EUTROPHUS; BACTERIAL BIOSENSORS; RESISTANCE; CHROMIUM; STRAIN; SENSORS; GFP; TOXICITY; CADMIUM	Microbial bioreporters offer excellent potentialities for the detection of the bioavailable portion of pollutants in contaminated environments, which currently cannot be easily measured. This paper describes the construction and evaluation of two microbial bioreporters designed to detect the bioavailable chromate in contaminated water samples. The developed bioreporters are based on the expression of gfp under the control of the chr promoter and the chrB regulator gene of TnOtChr determinant from Ochrobactrum tritici 5bvl1. pCHRGFP1 Escherichia coli reporter proved to be specific and sensitive, with minimum detectable concentration of 100 nM chromate and did not react with other heavy metals or chemical compounds analysed. In order to have a bioreporter able to be used under different environmental toxics, O. tritici type strain was also engineered to fluoresce in the presence of micromolar levels of chromate and showed to be as specific as the first reporter. Their applicability on environmental samples (spiked Portuguese river water) was also demonstrated using either freshly grown or cryo-preserved cells, a treatment which constitutes an operational advantage. These reporter strains can provide on-demand usability in the field and in a near future may become a powerful tool in identification of chromate-contaminated sites.	[Branco, Rita; Morais, Paula V.] IMAR, P-3004517 Coimbra, Portugal; [Branco, Rita] Escola Univ Vasco da Gama, Coimbra, Portugal; [Cristovao, Armando] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal; [Cristovao, Armando; Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, P-3000 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), IMAR, P-3004517 Coimbra, Portugal.	pvmorais@ci.uc.pt	Cristóvão, Armando J/N-2612-2013; Branco, Rita/AAQ-4007-2021; Morais, Paula Vasconcelos/C-9756-2014	Cristóvão, Armando J/0000-0002-4090-3269; Branco, Rita/0000-0003-0291-8029; Morais, Paula Vasconcelos/0000-0002-1939-6389	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/MAR/109057/2008]; FCT [SFRH/BPD/48330/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (FCT) under the PTDC/MAR/109057/2008 project. Rita Branco was supported by a grant, SFRH/BPD/48330/2008, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branco R, 2004, CAN J MICROBIOL, V50, P697, DOI [10.1139/w04-048, 10.1139/W04-048]; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1111/j.1574-6976.2001.tb00581.x; Corbisier P, 1999, ANAL CHIM ACTA, V387, P235, DOI 10.1016/S0003-2670(98)00725-9; E.C, 1998, OFFIC J EUR COMMUN L, VL330; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Hansen LH, 2001, MICROBIAL ECOL, V42, P483, DOI 10.1007/s00248-001-0025-9; He ZG, 2009, J HAZARD MATER, V163, P869, DOI 10.1016/j.jhazmat.2008.07.041; Heath Association World, 1993, GUID DRINK WAT QUAL, V1, P45; Hillson NJ, 2007, APPL ENVIRON MICROB, V73, P7615, DOI 10.1128/AEM.01566-07; Ivask A, 2002, SOIL BIOL BIOCHEM, V34, P1439, DOI 10.1016/S0038-0717(02)00088-3; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Liang B, 2010, CURR MICROBIOL, V61, P226, DOI 10.1007/s00284-010-9603-8; Liao VHC, 2006, ENVIRON POLLUT, V142, P17, DOI 10.1016/j.envpol.2005.09.021; Liu XM, 2010, SENSORS-BASEL, V10, P1377, DOI 10.3390/s100201377; Magrisso S, 2008, MICROB BIOTECHNOL, V1, P320, DOI 10.1111/j.1751-7915.2008.00022.x; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morais PV, 2011, BIOMETALS, V24, P401, DOI 10.1007/s10534-011-9446-1; Peitzsch N, 1998, APPL ENVIRON MICROB, V64, P453; Philp J, 2004, HANDB ENVIRON CHEM, V5, P165, DOI 10.1007/b97179; Riether KB, 2001, APPL MICROBIOL BIOT, V57, P712, DOI 10.1007/s00253-001-0852-0; Roberto FF, 2002, TALANTA, V58, P181, DOI 10.1016/S0039-9140(02)00266-7; Rodriguez-Mozaz S, 2006, ANAL BIOANAL CHEM, V386, P1025, DOI 10.1007/s00216-006-0574-3; Ron EZ, 2007, CURR OPIN BIOTECH, V18, P252, DOI 10.1016/j.copbio.2007.05.005; Sambrook J., 2001, MOL CLONING LAB MANU; SELIFONOVA O, 1993, APPL ENVIRON MICROB, V59, P3083, DOI 10.1128/AEM.59.9.3083-3090.1993; Stiner L, 2002, APPL ENVIRON MICROB, V68, P1962, DOI 10.1128/AEM.68.4.1962-1971.2002; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tauriainen S, 1998, BIOSENS BIOELECTRON, V13, P931, DOI 10.1016/S0956-5663(98)00027-X; Tauriainen SM, 2000, WATER RES, V34, P2661, DOI 10.1016/S0043-1354(00)00005-1; Tecon R, 2008, SENSORS-BASEL, V8, P4062, DOI 10.3390/s8074062; Tibazarwa C, 2001, ENVIRON POLLUT, V113, P19, DOI 10.1016/S0269-7491(00)00177-9; Tom-Petersen A, 2001, FEMS MICROBIOL ECOL, V38, P59, DOI 10.1111/j.1574-6941.2001.tb00882.x; Trang PTK, 2005, ENVIRON SCI TECHNOL, V39, P7625, DOI 10.1021/es050992e; U.S. EPA, 2002, NAT PRIM DRINK WAT R; Verma N, 2005, BIOMETALS, V18, P121, DOI 10.1007/s10534-004-5787-3; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6	40	32	33	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54005	10.1371/journal.pone.0054005	http://dx.doi.org/10.1371/journal.pone.0054005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326558	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800097
J	Qi, RF; Zhang, LJ; Zhong, JH; Zhang, ZQ; Ni, L; Jiao, Q; Liao, W; Zheng, G; Lu, GM				Qi, Rongfeng; Zhang, Long Jiang; Zhong, Jianhui; Zhang, Zhiqiang; Ni, Ling; Jiao, Qing; Liao, Wei; Zheng, Gang; Lu, Guangming			Altered Effective Connectivity Network of the Basal Ganglia in Low-Grade Hepatic Encephalopathy: A Resting-State fMRI Study with Granger Causality Analysis	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; TEMPORAL GYRUS; CIRRHOSIS; METABOLISM; IMPAIRMENT; DISEASE; ANATOMY	Background: The basal ganglia often show abnormal metabolism and intracranial hemodynamics in cirrhotic patients with hepatic encephalopathy (HE). Little is known about how the basal ganglia affect other brain system and is affected by other brain regions in HE. The purpose of this study was to investigate whether the effective connectivity network associated with the basal ganglia is disturbed in HE patients by using resting-state functional magnetic resonance imaging (rs-fMRI). Methodology/Principal Findings: Thirty five low-grade HE patients and thirty five age-and gender-matched healthy controls participated in the rs-fMRI scans. The effective connectivity networks associated with the globus pallidus, the primarily affected region within basal ganglia in HE, were characterized by using the Granger causality analysis and compared between HE patients and healthy controls. Pearson correlation analysis was performed between the abnormal effective connectivity and venous blood ammonia levels and neuropsychological performances of all HE patients. Compared with the healthy controls, patients with low-grade HE demonstrated mutually decreased influence between the globus pallidus and the anterior cingulate cortex (ACC), cuneus, bi-directionally increased influence between the globus pallidus and the precuneus, and either decreased or increased influence from and to the globus pallidus in many other frontal, temporal, parietal gyri, and cerebellum. Pearson correlation analyses revealed that the blood ammonia levels in HE patients negatively correlated with effective connectivity from the globus pallidus to ACC, and positively correlated with that from the globus pallidus to precuneus; and the number connectivity test scores in patients negatively correlated with the effective connectivity from the globus pallidus to ACC, and from superior frontal gyrus to globus pallidus. Conclusions/Significance: Low-grade HE patients had disrupted effective connectivity network of basal ganglia. Our findings may help to understand the neurophysiological mechanisms underlying the HE.	[Qi, Rongfeng; Zhang, Long Jiang; Zhang, Zhiqiang; Ni, Ling; Jiao, Qing; Zheng, Gang; Lu, Guangming] Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Nanjing University; Zhejiang University; Hangzhou Normal University; Hangzhou Normal University	Zhang, LJ (corresponding author), Nanjing Univ, Coll Med, Sch Clin, Dept Med Imaging,Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020		Natural Scientific Foundation of China [30700194, 81230032, 30800264, 30971019, 81101039]; Chinese Key Program [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Program	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 30700194 and No. 81230032 for Long Jiang Zhang, Grant No. 30800264 for Zhiqiang Zhang, and Grant No. 30971019 for Qing Jiao, Grant No. 81101039 for Gang Zheng], and Chinese Key Program (Grant No. BWS11J063 and No. 10z026 for Guangming Lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2011, ALIMENT PHARM THER, V33, P739, DOI 10.1111/j.1365-2036.2011.04590.x; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Catafau AM, 2000, J NUCL MED, V41, P405; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Ding L, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3670; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Giewekemeyer K, 2007, J HEPATOL, V46, P1034, DOI 10.1016/j.jhep.2007.01.038; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kappus MR, 2012, CLIN GASTROENTEROL H, V10, P1208, DOI 10.1016/j.cgh.2012.05.026; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McPhail MJW, 2012, CLIN LIVER DIS, V16, P57, DOI 10.1016/j.cld.2011.12.001; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Munoz SJ, 2008, MED CLIN N AM, V92, P795, DOI 10.1016/j.mcna.2008.03.009; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046681; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spahr L, 2002, METAB BRAIN DIS, V17, P399, DOI 10.1023/A:1021974321874; Stephan KE, 2012, NEUROIMAGE, V62, P856, DOI 10.1016/j.neuroimage.2012.01.034; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang LJ, 2012, AJNR AM J NEURORADIO; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang LJ, 2010, HEPATOL RES, V40, P777, DOI 10.1111/j.1872-034X.2010.00681.x	53	16	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53677	10.1371/journal.pone.0053677	http://dx.doi.org/10.1371/journal.pone.0053677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326484	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800068
J	Sims, RE; Wu, HHT; Dale, N				Sims, Robert Edward; Wu, Houdini Ho Tin; Dale, Nicholas			Sleep-Wake Sensitive Mechanisms of Adenosine Release in the Basal Forebrain of Rodents: An In Vitro Study	PLOS ONE			English	Article							ACTIVITY-DEPENDENT RELEASE; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR ADENOSINE; RECOVERY SLEEP; HOMEOSTATIC REGULATION; PROLONGED WAKEFULNESS; CHOLINERGIC NEURONS; RAT HIPPOCAMPUS; A(1) RECEPTOR; MESSENGER-RNA	Adenosine acting in the basal forebrain is a key mediator of sleep homeostasis. Extracellular adenosine concentrations increase during wakefulness, especially during prolonged wakefulness and lead to increased sleep pressure and subsequent rebound sleep. The release of endogenous adenosine during the sleep-wake cycle has mainly been studied in vivo with microdialysis techniques. The biochemical changes that accompany sleep-wake status may be preserved in vitro. We have therefore used adenosine-sensitive biosensors in slices of the basal forebrain (BFB) to study both depolarization-evoked adenosine release and the steady state adenosine tone in rats, mice and hamsters. Adenosine release was evoked by high K+, AMPA, NMDA and mGlu receptor agonists, but not by other transmitters associated with wakefulness such as orexin, histamine or neurotensin. Evoked and basal adenosine release in the BFB in vitro exhibited three key features: the magnitude of each varied systematically with the diurnal time at which the animal was sacrificed; sleep deprivation prior to sacrifice greatly increased both evoked adenosine release and the basal tone; and the enhancement of evoked adenosine release and basal tone resulting from sleep deprivation was reversed by the inducible nitric oxide synthase (iNOS) inhibitor, 1400 W. These data indicate that characteristics of adenosine release recorded in the BFB in vitro reflect those that have been linked in vivo to the homeostatic control of sleep. Our results provide methodologically independent support for a key role for induction of iNOS as a trigger for enhanced adenosine release following sleep deprivation and suggest that this induction may constitute a biochemical memory of this state.	[Sims, Robert Edward; Wu, Houdini Ho Tin; Dale, Nicholas] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sims, RE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.e.sims@warwick.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Sims, Robert/0000-0003-1373-7514	Wellcome Trust [WT087968MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant WT087968MA, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko LO, 2004, NEUROREPORT, V15, P2133, DOI 10.1097/00001756-200409150-00027; ALONSO A, 1994, J NEUROSCI, V14, P5778; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Basheer R, 1999, MOL BRAIN RES, V73, P1, DOI 10.1016/S0169-328X(99)00219-3; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Basheer R, 2001, NEUROREPORT, V12, P1577, DOI 10.1097/00001756-200106130-00013; Bjorness TE, 2009, J NEUROSCI, V29, P1267, DOI 10.1523/JNEUROSCI.2942-08.2009; CULLINAN WE, 1991, J COMP NEUROL, V306, P631, DOI 10.1002/cne.903060408; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; DUNWIDDIE TV, 1982, J PHARMACOL EXP THER, V220, P70; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; FARKAS RH, 1994, P NATL ACAD SCI USA, V91, P2853, DOI 10.1073/pnas.91.7.2853; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; Greco MA, 2000, NEUROREPORT, V11, P437, DOI 10.1097/00001756-200002280-00002; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; HAULICA I, 1973, J NEUROCHEM, V21, P1019, DOI 10.1111/j.1471-4159.1973.tb07549.x; HOFFMAN JC, 1973, AM J PHYSIOL, V224, P245, DOI 10.1152/ajplegacy.1973.224.2.245; Hohmann CF, 1998, INT J DEV NEUROSCI, V16, P645, DOI 10.1016/S0736-5748(98)00075-6; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Kalinchuk AV, 2006, J NEUROCHEM, V99, P483, DOI 10.1111/j.1471-4159.2006.04077.x; Kalinchuk AV, 2006, EUR J NEUROSCI, V24, P1443, DOI 10.1111/j.1460-9568.2006.05019.x; Kalinchuk AV, 2011, J NEUROCHEM, V116, P260, DOI 10.1111/j.1471-4159.2010.07100.x; Khateb A, 1997, NEUROSCIENCE, V81, P47, DOI 10.1016/S0306-4522(97)00167-X; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Madsen P L, 1993, Acta Neurol Scand Suppl, V148, P3; Manns ID, 2000, J NEUROSCI, V20, P1505; MAQUET P, 1992, BRAIN RES, V571, P149, DOI 10.1016/0006-8993(92)90522-B; MCILWAIN H, 1972, J PHYSIOL-LONDON, V221, pP9; McKenna JT, 2007, NEUROSCIENCE, V146, P1462, DOI 10.1016/j.neuroscience.2007.03.009; Minor TR, 2001, BEHAV BRAIN RES, V120, P203, DOI 10.1016/S0166-4328(00)00376-4; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Murillo-Rodriguez E, 2004, NEUROSCIENCE, V123, P361, DOI 10.1016/j.neuroscience.2003.09.015; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Palchykova S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-9; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Porkka-Heiskanen T, 2000, NEUROSCIENCE, V99, P507, DOI 10.1016/S0306-4522(00)00220-7; Porkka-Heiskanen T, 1999, ANN MED, V31, P125, DOI 10.3109/07853899908998788; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Porter JT, 1996, J NEUROSCI, V16, P5073; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Ramesh V, 2004, BEHAV BRAIN RES, V152, P271, DOI 10.1016/j.bbr.2003.10.031; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; SCIOTTI VM, 1993, BRAIN RES, V613, P16, DOI 10.1016/0006-8993(93)90448-V; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Stenberg D, 2003, J SLEEP RES, V12, P283, DOI 10.1046/j.0962-1105.2003.00367.x; Thakkar MM, 2003, J NEUROSCI, V23, P4278; TICHO SR, 1991, PHARMACOL BIOCHEM BE, V40, P33, DOI 10.1016/0091-3057(91)90317-U; van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; VIRUS RM, 1983, NEUROPHARMACOLOGY, V22, P1401, DOI 10.1016/0028-3908(83)90231-9; Wall M, 2008, CURR NEUROPHARMACOL, V6, P329, DOI 10.2174/157015908787386087; Wall MJ, 2007, J PHYSIOL-LONDON, V581, P553, DOI 10.1113/jphysiol.2006.126417; Wigren HK, 2007, NEUROSCIENCE, V147, P811, DOI 10.1016/j.neuroscience.2007.04.046; Xu CQ, 2004, J PHYSIOL-LONDON, V561, P657, DOI 10.1113/jphysiol.2004.071712	70	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53814	10.1371/journal.pone.0053814	http://dx.doi.org/10.1371/journal.pone.0053814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326515	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000314705800078
J	Stotz, GC; Suarez, LH; Gonzales, WL; Gianoli, E				Stotz, Gisela C.; Suarez, Lorena H.; Gonzales, Wilfredo L.; Gianoli, Ernesto			Local Host Adaptation and Use of a Novel Host in the Seed Beetle Megacerus eulophus	PLOS ONE			English	Article							EGG SIZE PLASTICITY; TRADE-OFFS; ECOLOGICAL GENETICS; LARVAL HOST; BEAN WEEVIL; COLEOPTERA; EVOLUTION; FITNESS; BRUCHIDAE; SPECIALIZATION	Spatial variation in host plant availability may lead to specialization in host use and local host adaptation in herbivorous insects, which may involve a cost in performance on other hosts. We studied two geographically separated populations of the seed beetle Megacerus eulophus (Coleoptera: Bruchidae) in central Chile: a population from the host Convolvulus chilensis (in Auco) and a population from C. bonariensis (in Algarrobo). In Auco C. chilensis is the only host plant, while in Algarrobo both C. bonariensis and C. chilensis are available. We tested local adaptation to these native host plants and its influence on the use of another, exotic host plant. We hypothesized that local adaptation would be verified, particularly for the one-host population (Auco), and that the Auco population would be less able to use an alternative, high-quality host. We found evidence of local adaptation in the population from C. chilensis. Thus, when reared on C. chilensis, adults from the C. chilensis population were larger and lived longer than individuals from the C. bonariensis population, while bruchids from the two populations had the same body size and longevity when reared on C. bonariensis. Overall, bruchids from the C. chilensis population showed greater performance traits than those from the C. bonariensis population. There were no differences between the bruchid populations in their ability to use the alternative, exotic host Calystegia sepium, as shown by body size and longevity patterns. Results suggest that differences in local adaptation might be explained by differential host availability in the study populations.	[Stotz, Gisela C.; Suarez, Lorena H.; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gonzales, Wilfredo L.] Univ Peruana Cayetano Heredia, Dept Ciencias Biol & Fisiol, Lima, Peru; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile	Universidad de Concepcion; Universidad Peruana Cayetano Heredia; Universidad de La Serena	Stotz, GC (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	gstotz@udec.cl	Stotz, Gisela/E-2197-2017; Gianoli, Ernesto/A-7984-2015	Stotz, Gisela/0000-0001-8687-7361; Gianoli, Ernesto/0000-0003-4246-8640; GONZALES, WILFREDO/0000-0002-8885-5972				Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; Amarillo-Suarez AR, 2006, OECOLOGIA, V150, P247, DOI 10.1007/s00442-006-0516-y; Ballabeni P, 2003, OIKOS, V101, P70, DOI 10.1034/j.1600-0706.2003.12569.x; Barriga X, 1990, THESIS U CHILE SANTI; Carroll SP, 2001, GENETICA, V112, P257, DOI 10.1023/A:1013354830907; CENTER TD, 1974, ECOLOGY, V55, P1096, DOI 10.2307/1940359; EHRLICH PR, 1988, ECOLOGY, V69, P908, DOI 10.2307/1941244; ERNST WHO, 1992, J INSECT PHYSIOL, V38, P831, DOI 10.1016/0022-1910(92)90093-S; Fox, 1998, MATERNAL EFFECTS ADA; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; FOX CW, 1994, OECOLOGIA, V99, P329, DOI 10.1007/BF00627746; Fox CW, 1996, OECOLOGIA, V107, P541, DOI 10.1007/BF00333946; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Fox CW, 2000, ECOLOGY, V81, P3, DOI 10.2307/177128; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; Friberg M, 2009, OECOLOGIA, V159, P127, DOI 10.1007/s00442-008-1206-8; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Fuentes N., 2012, BIOL INVASIONS, DOI [DOI 10.1007/S10530-012-0334-6, 10.1007/s10530-012-0334-6]; Futuyma D. J., 1998, EVOLUTIONARY BIOL; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GATEHOUSE AMR, 1987, J INSECT PHYSIOL, V33, P843, DOI 10.1016/0022-1910(87)90032-1; Gianoli E, 2007, ENTOMOL EXP APPL, V122, P233, DOI 10.1111/j.1570-7458.2006.00506.x; Gonzalez-Teuber M, 2008, NATURWISSENSCHAFTEN, V95, P609, DOI 10.1007/s00114-008-0361-4; Gonzalez-Teuber M, 2008, J ECOL, V96, P122, DOI 10.1111/j.1365-2745.2007.01321.x; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JANZEN DH, 1977, ECOLOGY, V58, P921, DOI 10.2307/1936229; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kuussaari M, 2000, ECOLOGY, V81, P2177, DOI 10.1890/0012-9658(2000)081[2177:LSALLI]2.0.CO;2; Logarzo GA, 2011, OECOLOGIA, V165, P387, DOI 10.1007/s00442-010-1782-2; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Matthei J, 1995, MANUAL MALEZAS QUE C; MITCHELL R, 1975, ECOLOGY, V56, P696, DOI 10.2307/1935504; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2006, J EVOLUTION BIOL, V19, P929, DOI 10.1111/j.1420-9101.2005.01035.x; ODONELL CA, 1957, B SOC ARGENT BOT, V6, P144; Or K, 2004, J CHEM ECOL, V30, P2297, DOI 10.1023/B:JOEC.0000048790.85830.79; PFAFFENBERGER G S, 1984, Coleopterists Bulletin, V38, P1; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Rova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014628; Savalli UM, 2002, ANN ENTOMOL SOC AM, V95, P724, DOI 10.1603/0013-8746(2002)095[0724:PMIESP]2.0.CO;2; SIEMENS DH, 1990, OECOLOGIA, V82, P408, DOI 10.1007/BF00317490; SORK VL, 1993, AM NAT, V142, P928, DOI 10.1086/285581; Souza AJ, 2011, CROP PROT, V30, P651, DOI 10.1016/j.cropro.2010.12.014; Suarez LH, 2004, REV CHIL HIST NAT, V77, P581; Takakura KI, 2004, ANN ENTOMOL SOC AM, V97, P346, DOI 10.1603/0013-8746(2004)097[0346:VIESWA]2.0.CO;2; Teran AL, 1977, REVISION GENERO MEGA; Teran Arturo L., 1992, Acta Zoologica Lilloana, V42, P19; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1996, ENTOMOL EXP APPL, V80, P133, DOI 10.1007/BF00194742; Vamosi SM, 2005, FUNCT ECOL, V19, P859, DOI 10.1111/j.1365-2435.2005.01029.x; Van Zandt PA, 1998, AM NAT, V152, P595, DOI 10.1086/286192; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225	57	6	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53892	10.1371/journal.pone.0053892	http://dx.doi.org/10.1371/journal.pone.0053892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326528	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800084
J	Koupparis, AM; Kokkinos, V; Kostopoulos, GK				Koupparis, Andreas M.; Kokkinos, Vasileios; Kostopoulos, George K.			Spindle Power Is Not Affected after Spontaneous K-Complexes during Human NREM Sleep	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; EEG; FREQUENCY; MUSCLE; DESYNCHRONIZATION; SYNCHRONIZATION; FLUNITRAZEPAM; AROUSAL	K-complexes and sleep spindles often grouped together characterize the second stage of NREM sleep and interest has been raised on a possible interaction of their underlying mechanisms. The reported inhibition of spindles power for about 15 seconds following evoked K-complexes has implications on their role in arousal. Our objective was to assess this inhibition following spontaneous K-complexes. We used time-frequency analysis of spontaneous K-complexes selected from whole-night EEG recordings of normal subjects. Our results show that spindles are most often observed at the positive phase following the peak of a spontaneous KC (70%). At latencies of 1-3 s following the peak of the K-complex, spindles almost disappear. Compared to long-term effects described for evoked KCs, sleep spindle power is not affected by spontaneous KCs for latencies of 5-15 s. Observation of the recurrence rate of sporadic spindles suggests that the reduction of power at 1-3 s most likely reflects a refractory period of spindles lasting for 1-2 s, rather than an effect of KCs. These results suggest that the mechanisms underlying spontaneous KCs do not affect spindle power as in the case of evoked KCs.	[Koupparis, Andreas M.; Kokkinos, Vasileios; Kostopoulos, George K.] Univ Patras, Sch Med, Dept Physiol, Neurophysiol Unit, Rion, Greece	University of Patras	Kostopoulos, GK (corresponding author), Univ Patras, Sch Med, Dept Physiol, Neurophysiol Unit, Rion, Greece.	gkkostop@med.upatras.gr	Koupparis, Andreas/H-2656-2012; Kokkinos, Vasileios/N-1470-2018	Koupparis, Andreas/0000-0002-0737-2347; Kokkinos, Vasileios/0000-0002-4309-5455	European Commission under the Seventh Framework Programme [ARMOR]; European Union (European Social Fund - ESF); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; European Social Fund	European Commission under the Seventh Framework Programme; European Union (European Social Fund - ESF)(European Social Fund (ESF)); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; European Social Fund(European Social Fund (ESF))	The work was partially funded by the European Commission under the Seventh Framework Programme (FP7/2007-2013) with grant ARMOR, agreement number 287720. Andreas Koupparis has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; Bastien CH, 2000, CAN J EXP PSYCHOL, V54, P255, DOI 10.1037/h0087345; Bonjean M, 2012, J NEUROSCI, V32, P5250, DOI 10.1523/JNEUROSCI.6141-11.2012; Bonjean M, 2011, J NEUROSCI, V31, P9124, DOI 10.1523/JNEUROSCI.0077-11.2011; BONNET MH, 1992, SLEEP, V15, P526; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; CHURCH MW, 1978, ELECTROEN CLIN NEURO, V45, P443, DOI 10.1016/0013-4694(78)90289-4; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Crowley K, 2004, CLIN NEUROPHYSIOL, V115, P471, DOI 10.1016/j.clinph.2003.10.014; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Curcio G, 2003, CLIN NEUROPHYSIOL, V114, P2279, DOI 10.1016/S1388-2457(03)00276-1; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Durka PJ, 2004, IEEE T BIO-MED ENG, V51, P1167, DOI 10.1109/TBME.2004.827341; EHRHART J, 1981, SLEEP, V4, P400; EVANS BM, 1995, J SLEEP RES, V4, P196, DOI 10.1111/j.1365-2869.1995.tb00169.x; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; GAILLARD JM, 1975, INT PHARMACOPSYCHIAT, V10, P199, DOI 10.1159/000468195; Gibbs F., 1950, ATLAS ELECTROENCEPHA, V1; HALASZ P, 1993, PHYSIOL BEHAV, V54, P795, DOI 10.1016/0031-9384(93)90094-V; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; JOHNSON LC, 1976, ELECTROEN CLIN NEURO, V40, P67, DOI 10.1016/0013-4694(76)90180-2; Kokkinos V, 2011, J SLEEP RES, V20, P57, DOI 10.1111/j.1365-2869.2010.00830.x; Kokkinos V, 2009, J NEUROSCI METH, V185, P29, DOI 10.1016/j.jneumeth.2009.09.002; Kostopoulos GK, 2000, CLIN NEUROPHYSIOL, V111, pS27, DOI 10.1016/S1388-2457(00)00399-0; KUBICKI S, 1987, EEG-EMG-Z ELEK ELEKT, V18, P61; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; Loomis AL, 1936, J EXP PSYCHOL, V19, P249, DOI 10.1037/h0062089; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; NAITOH P, 1982, SLEEP, V5, P58, DOI 10.1093/sleep/5.1.58; OKADA H, 1991, NEUROLOGY, V41, P1961, DOI 10.1212/WNL.41.12.1961; Pal I, 1985, SLEEP 84, P232; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rodenbeck R., 2006, SOMNOLOGIE, V10, P159, DOI [DOI 10.1111/J.1439-054X.2006.00101.X, DOI 10.1111/J]; Rossetti AO, 2005, NEUROPHYSIOL CLIN, V35, P19, DOI 10.1016/j.neucli.2004.12.003; ROTH M, 1956, ELECTROEN CLIN NEURO, V8, P385, DOI 10.1016/0013-4694(56)90004-9; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Si Y, 2010, EPILEPSY RES, V92, P219, DOI 10.1016/j.eplepsyres.2010.10.002; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; TAKEUCHI S, 1994, J AUTONOM NERV SYST, V47, P121, DOI 10.1016/0165-1838(94)90073-6; Tank J, 2003, AM J PHYSIOL-REG I, V285, pR208, DOI 10.1152/ajpregu.00013.2003; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; YAMADORI A, 1971, Kobe Journal of Medical Sciences, V17, P97; Zygierewicz J, 2009, ACTA NEUROBIOL EXP, V69, P254	52	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54343	10.1371/journal.pone.0054343	http://dx.doi.org/10.1371/journal.pone.0054343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326604	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400087
J	Honeine, JL; Schieppati, M; Gagey, O; Do, MC				Honeine, Jean-Louis; Schieppati, Marco; Gagey, Olivier; Manh-Cuong Do			The Functional Role of the Triceps Surae Muscle during Human Locomotion	PLOS ONE			English	Article							ANKLE PLANTAR FLEXORS; LOAD RECEPTOR INPUT; FORCE DIRECTION; SOLEUS MUSCLE; STANCE PHASE; WALKING; SUPPORT; BODY; GAIT; INITIATION	Aim: Despite numerous studies addressing the issue, it remains unclear whether the triceps surae muscle group generates forward propulsive force during gait, commonly identified as 'push-off'. In order to challenge the push-off postulate, one must probe the effect of varying the propulsive force while annulling the effect of the progression velocity. This can be obtained by adding a load to the subject while maintaining the same progression velocity. Methods: Ten healthy subjects initiated gait in both unloaded and loaded conditions (about 30% of body weight attached at abdominal level), for two walking velocities, spontaneous and fast. Ground reaction force and EMG activity of soleus and gastrocnemius medialis and lateralis muscles of the stance leg were recorded. Centre of mass velocity and position, centre of pressure position, and disequilibrium torque were calculated. Results: At spontaneous velocity, adding the load increased disequilibrium torque and propulsive force. However, load had no effect on the vertical braking force or amplitude of triceps activity. At fast progression velocity, disequilibrium torque, vertical braking force and triceps EMG increased with respect to spontaneous velocity. Still, adding the load did not further increase braking force or EMG. Conclusions: Triceps surae is not responsible for the generation of propulsive force but is merely supporting the body during walking and restraining it from falling. By controlling the disequilibrium torque, however, triceps can affect the propulsive force through the exchange of potential into kinetic energy.	[Honeine, Jean-Louis; Schieppati, Marco; Gagey, Olivier; Manh-Cuong Do] Univ Paris 11, UFR STAPS, CIAMS Lab, Orsay, France; [Schieppati, Marco] Salvatore Maugeri Fdn IRCCS, CSAM Lab, Pavia, Italy; [Schieppati, Marco] Univ Pavia, I-27100 Pavia, Italy; [Gagey, Olivier] Univ Paris 11, Fac Med, Dept Orthopaed, Le Kremlin Bicetre, France	UDICE-French Research Universities; Universite Paris Saclay; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Honeine, JL (corresponding author), Univ Paris 11, UFR STAPS, CIAMS Lab, Orsay, France.	Jean-Louis.Honeine@u-psud.fr	Schieppati, Marco/O-2138-2019; Schieppati, Marco/K-5171-2016	Schieppati, Marco/0000-0002-0630-0819; Schieppati, Marco/0000-0002-0630-0819	Paris-Sud University; Italian Ministry of University and Research	Paris-Sud University; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The research has been supported in part by a grant "Projet Attractivite" from the Paris-Sud University and by a "PRIN 2007" grant from the Italian Ministry of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Bastiaanse CM, 2000, EXP BRAIN RES, V135, P189, DOI 10.1007/s002210000511; Bogey RA, 2010, J ELECTROMYOGR KINES, V20, P46, DOI 10.1016/j.jelekin.2008.09.013; BRENIERE Y, 1991, J MOTOR BEHAV, V23, P235, DOI 10.1080/00222895.1991.9942034; BRENIERE Y, 1981, J BIOPHYS BIOMEC, V5, P197; CARLSOO S, 1966, ACTA ANAT, V65, P1; CAVAGNA GA, 1986, J PHYSIOL-LONDON, V373, P235, DOI 10.1113/jphysiol.1986.sp016044; Cavagna GA, 2000, J PHYSIOL-LONDON, V528, P657, DOI 10.1111/j.1469-7793.2000.00657.x; Cavagna GA, 2002, J EXP BIOL, V205, P3413; Chastan N, 2010, NEUROSCI LETT, V469, P400, DOI 10.1016/j.neulet.2009.12.038; Chong RKY, 2009, NEUROSCI LETT, V458, P23, DOI 10.1016/j.neulet.2009.04.022; Courtine G, 2006, EXP BRAIN RES, V170, P320, DOI 10.1007/s00221-005-0215-7; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Crenna P, 2001, J PHYSIOL-LONDON, V537, P1059; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; Cronin NJ, 2009, J PHYSIOL-LONDON, V587, P3375, DOI 10.1113/jphysiol.2008.162610; Decker LM, 2012, J NEUROENG REHABIL, V3, P9, DOI [10.1186/1743-0003-9-4, DOI 10.1186/1743-0003-9-4]; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; Franz JR, 2012, GAIT POSTURE, V35, P143, DOI 10.1016/j.gaitpost.2011.08.025; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Gruben KG, 2012, HUM MOVEMENT SCI, V31, P649, DOI 10.1016/j.humov.2011.07.006; Gruben KG, 2012, J BIOMECH, V45, P1661, DOI 10.1016/j.jbiomech.2012.03.018; Holt KG, 2003, J BIOMECH, V36, P465, DOI 10.1016/S0021-9290(02)00457-8; Huang CY, 2009, J ELECTROMYOGR KINES, V19, P492, DOI 10.1016/j.jelekin.2007.07.014; Ivanenko YP, 2011, HUM MOVEMENT SCI, V30, P341, DOI 10.1016/j.humov.2010.04.001; JIAN YC, 1993, GAIT POSTURE, V1, P9, DOI DOI 10.1016/0966-6362(93)90038-3; Jonkers I, 2003, GAIT POSTURE, V17, P264, DOI 10.1016/S0966-6362(02)00102-9; Kepple TM, 1997, GAIT POSTURE, V6, P1, DOI 10.1016/S0966-6362(96)01094-6; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; LEPERS R, 1995, EXP BRAIN RES, V107, P118; Lewek MD, 2011, J BIOMECH, V44, P128, DOI 10.1016/j.jbiomech.2010.08.037; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Mazzaro N, 2005, J NEUROPHYSIOL, V93, P3075, DOI 10.1152/jn.01071.2004; McGowan CP, 2008, J APPL PHYSIOL, V105, P486, DOI 10.1152/japplphysiol.90448.2008; Merletti R, 2000, J ELECTROMYOGR KINES, V10, P283, DOI 10.1016/S1050-6411(00)00019-5; Michel V, 2002, NEUROSCI LETT, V325, P139, DOI 10.1016/S0304-3940(02)00255-0; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; NARDONE A, 1990, EXP BRAIN RES, V80, P323; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; PEDOTTI A, 1977, BIOL CYBERN, V26, P53, DOI 10.1007/BF00363992; PERRY J, 1974, CLIN ORTHOP RELAT R, P18; Sadeghi H, 2001, CLIN BIOMECH, V16, P688, DOI 10.1016/S0268-0033(01)00058-4; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; SIMON SR, 1978, J BONE JOINT SURG AM, V60, P465, DOI 10.2106/00004623-197860040-00006; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Stephens MJ, 1999, EXP BRAIN RES, V124, P363, DOI 10.1007/s002210050633; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P354, DOI 10.2106/00004623-198062030-00005; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011; Zajac FE, 2002, J BIOMECH, V35, P1011, DOI 10.1016/S0021-9290(02)00046-5; Zanetti C, 2007, EUR J APPL PHYSIOL, V100, P331, DOI 10.1007/s00421-007-0434-7	55	54	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52943	10.1371/journal.pone.0052943	http://dx.doi.org/10.1371/journal.pone.0052943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341916	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700017
J	Nov, O; Shapiro, H; Ovadia, H; Tarnovscki, T; Dvir, I; Shemesh, E; Kovsan, J; Shelef, I; Carmi, Y; Voronov, E; Apte, RN; Lewis, E; Haim, Y; Konrad, D; Bashan, N; Rudich, A				Nov, Ori; Shapiro, Hagit; Ovadia, Hilla; Tarnovscki, Tanya; Dvir, Irit; Shemesh, Elad; Kovsan, Julia; Shelef, Ilan; Carmi, Yaron; Voronov, Elena; Apte, Ron N.; Lewis, Eli; Haim, Yulia; Konrad, Daniel; Bashan, Nava; Rudich, Assaf			Interleukin-1 beta Regulates Fat-Liver Crosstalk in Obesity by Auto-Paracrine Modulation of Adipose Tissue Inflammation and Expandability	PLOS ONE			English	Article							INSULIN-RESISTANCE; RECEPTOR ANTAGONIST; PORTAL THEORY; MICE; CELLS; MACROPHAGES; POPULATION; IL-1-BETA; INDUCTION; CYTOKINES	The inflammasome has been recently implicated in obesity-associated dys-metabolism. However, of its products, the specific role of IL-1 beta was clinically demonstrated to mediate only the pancreatic beta-cell demise, and in mice mainly the intra-hepatic manifestations of obesity. Yet, it remains largely unknown if IL-1 beta, a cytokine believed to mainly function locally, could regulate dysfunctional inter-organ crosstalk in obesity. Here we show that High-fat-fed (HFF) mice exhibited a preferential increase of IL-1 beta in portal compared to systemic blood. Moreover, portally-drained mesenteric fat transplantation from IL-1 beta KO donors resulted in lower pyruvate-glucose flux compared to mice receiving wild-type (WT) transplant. These results raised a putative endocrine function for visceral fat-derived IL-1 beta in regulating hepatic gluconeogenic flux. IL-1 beta KO mice on HFF exhibited only a minor or no increase in adipose expression of pro-inflammatory genes (including macrophage M1 markers), Mac2-positive crown-like structures and CD11b-F4/80-double-positive macrophages, all of which were markedly increased in WT-HFF mice. Further consistent with autocrine/paracrine functions of IL-1 beta within adipose tissue, adipose tissue macrophage lipid content was increased in WT-HFF mice, but significantly less in IL-1 beta KO mice. Ex-vivo, adipose explants co-cultured with primary hepatocytes from WT or IL-1-receptor (IL-1RI)-KO mice suggested only a minor direct effect of adipose-derived IL-1 beta on hepatocyte insulin resistance. Importantly, although IL-1 beta KOs gained weight similarly to WT-HFF, they had larger fat depots with similar degree of adipocyte hypertrophy. Furthermore, adipogenesis genes and markers (pparg, cepba, fabp4, glut4) that were decreased by HFF in WT, were paradoxically elevated in IL-1 beta KO-HFF mice. These local alterations in adipose tissue inflammation and expansion correlated with a lower liver size, less hepatic steatosis, and preserved insulin sensitivity. Collectively, we demonstrate that by promoting adipose inflammation and limiting fat tissue expandability, IL-1 beta supports ectopic fat accumulation in hepatocytes and adipose-tissue macrophages, contributing to impaired fat-liver crosstalk in nutritional obesity.	[Nov, Ori; Shapiro, Hagit; Ovadia, Hilla; Tarnovscki, Tanya; Shemesh, Elad; Kovsan, Julia; Lewis, Eli; Haim, Yulia; Bashan, Nava; Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Dvir, Irit] Sapir Acad Coll, Dept Ind Management, Chem & Life Sci Program, Hof Ashkelon, Israel; [Shemesh, Elad; Shelef, Ilan] Ben Gurion Univ Negev, Goldman Med Sch, IL-84105 Beer Sheva, Israel; [Shelef, Ilan] Soroka Acad Med Ctr, Dept Radiol, Beer Sheva, Israel; [Carmi, Yaron; Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Konrad, Daniel] Univ Zurich, Div Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Konrad, Daniel] Univ Zurich, Children Res Ctr, Univ Childrens Hosp, Zurich, Switzerland; [Konrad, Daniel] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of Zurich; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Ben Gurion University	Rudich, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel.	rudich@bgu.ac.il	Shemesh, Elad/O-5039-2019; LEWIS, ELI C/F-1552-2012; Shapiro, Hagit/F-8648-2015	Shemesh, Elad/0000-0003-1162-2991; LEWIS, ELI C/0000-0002-4189-2207; Rudich, Assaf/0000-0002-1366-1444; shelef, ilan/0000-0002-8398-6455; Konrad, Daniel/0000-0001-9067-4356	Israel Science Foundation [1103-09]; Israeli Ministry of Health [3/5067]; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Health; Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education	This study was supported in part by grants from the Israel Science Foundation (1103-09), from the Israeli Ministry of Health (3/5067), and by the Leslie and Susan Gonda (Goldschmid) Center for Diabetes Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Cawood TJ, 2006, EUR J ENDOCRINOL, V155, P395, DOI 10.1530/eje.1.02242; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Ovadia H, 2011, J BIOL CHEM, V286, P30433, DOI 10.1074/jbc.M111.235945; Persson H, 2008, PROTEIN ENG DES SEL, V21, P485, DOI 10.1093/protein/gzn024; Persson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-70; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stienstra R, 2007, J HEPATOL, V46, P869, DOI 10.1016/j.jhep.2006.11.019; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	46	110	111	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53626	10.1371/journal.pone.0053626	http://dx.doi.org/10.1371/journal.pone.0053626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341960	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700032
J	Rohrbaugh, M; Clore, A; Davis, J; Johnson, S; Jones, B; Jones, K; Kim, J; Kithuka, B; Lunsford, K; Mitchell, J; Mott, B; Ramos, E; Tchedou, MR; Acosta, G; Araujo, M; Cushing, S; Duffy, G; Graves, F; Griffin, K; Gurudatta, BV; Jackson, D; Jaimes, D; Jamison, K; Jones, K; Kelley, D; Kilgore, M; Laramore, D; Le, T; Mazhar, B; Mazhar, MM; McCrary, B; Miller, T; Moreland, C; Mullins, A; Munye, E; Okoorie, S; Pittman, E; Roberts, N; Rose, D; Rowland, A; Shagarabi, A; Smith, J; Stallworth, T; Stroud, N; Sung, E; Sung, K; Takenaka, N; Torre, E; Veira, J; Vu, K; Wagstaff, W; Wood, AM; Wu, KR; Yang, JP; Corces, VG				Rohrbaugh, Margaret; Clore, Alyssia; Davis, Julia; Johnson, Sharonta; Jones, Brian; Jones, Keith; Kim, Joanne; Kithuka, Bramwel; Lunsford, Krystal; Mitchell, Joy; Mott, Brian; Ramos, Edward; Tchedou, Maza R.; Acosta, Gilbert; Araujo, Mark; Cushing, Stuart; Duffy, Gabriel; Graves, Felicia; Griffin, Kyler; Gurudatta, B. V.; Jackson, Deaundra; Jaimes, Denis; Jamison, Kendall; Jones, Khali; Kelley, Dhaujee; Kilgore, Marquita; Laramore, Derica; Thuy Le; Mazhar, Bakhtawar; Mazhar, Muhammad M.; McCrary, Britney; Miller, Teanndras; Moreland, Celethia; Mullins, Alex; Munye, Elyas; Okoorie, Sheila; Pittman, Elisha; Roberts, Nikkita; Rose, De'Warren; Rowland, Alex; Shagarabi, Anwar; Smith, Jamela; Stallworth, Tayler; Stroud, Nicole; Sung, Elizabeth; Sung, Kai; Takenaka, Naomi; Torre, Eduardo; Veira, Jarvis; Kim Vu; Wagstaff, William; Wood, Ashley M.; Wu, Karen; Yang, Jingping; Corces, Victor G.			Identification and Characterization of Proteins Involved in Nuclear Organization Using Drosophila GFP Protein Trap Lines	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; GERMLINE STEM-CELLS; CHROMATIN INSULATOR; HISTONE H3; SPERM DECONDENSATION; X-CHROMOSOME; DF31 PROTEIN; MELANOGASTER; NUCLEOPLASMIN; TRANSCRIPTION	Background: Strains from a collection of Drosophila GFP protein trap lines express GFP in the normal tissues where the endogenous protein is present. This collection can be used to screen for proteins distributed in the nucleus in a non-uniform pattern. Methodology/Principal Findings: We analyzed four lines that show peripheral or punctate nuclear staining. One of these lines affects an uncharacterized gene named CG11138. The CG11138 protein shows a punctate distribution in the nuclear periphery similar to that of Drosophila insulator proteins but does not co-localize with known insulators. Interestingly, mutations in Lamin proteins result in alterations in CG11138 localization, suggesting that this protein may be a novel component of the nuclear lamina. A second line affects the Decondensation factor 31 (Df31) gene, which encodes a protein with a unique nuclear distribution that appears to segment the nucleus into four different compartments. The X-chromosome of males is confined to one of these compartments. We also find that Drosophila Nucleoplasmin (dNlp) is present in regions of active transcription. Heat shock leads to loss of dNlp from previously transcribed regions of polytene chromosome without redistribution to the heat shock genes. Analysis of Stonewall (Stwl), a protein previously found to be necessary for the maintenance of germline stem cells, shows that Stwl is present in a punctate pattern in the nucleus that partially overlaps with that of known insulator proteins. Finally we show that Stwl, dNlp, and Df31 form part of a highly interactive network. The properties of other components of this network may help understand the role of these proteins in nuclear biology. Conclusions/Significance: These results establish screening of GFP protein trap alleles as a strategy to identify factors with novel cellular functions. Information gained from the analysis of CG11138 Stwl, dNlp, and Df31 sets the stage for future studies of these proteins.	[Rohrbaugh, Margaret; Kim, Joanne; Kithuka, Bramwel; Mott, Brian; Ramos, Edward; Acosta, Gilbert; Araujo, Mark; Gurudatta, B. V.; Kilgore, Marquita; Laramore, Derica; Sung, Elizabeth; Sung, Kai; Takenaka, Naomi; Torre, Eduardo; Wood, Ashley M.; Wu, Karen; Yang, Jingping; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Clore, Alyssia; Moreland, Celethia; Smith, Jamela; Stallworth, Tayler; Kim Vu] S Atlanta High Sch Hlth & Med Sci, Atlanta, GA USA; [Davis, Julia; Johnson, Sharonta; Jones, Brian; Jones, Keith; Lunsford, Krystal; Mitchell, Joy; Tchedou, Maza R.; Duffy, Gabriel; Jackson, Deaundra; Jones, Khali; Miller, Teanndras; Mullins, Alex; Pittman, Elisha; Roberts, Nikkita; Rose, De'Warren; Rowland, Alex] Carver Sch Hlth Sci & Res, Atlanta, GA USA; [Cushing, Stuart; Okoorie, Sheila] Baltimore Polytech Inst, Baltimore, MD USA; [Graves, Felicia; Jamison, Kendall; Kelley, Dhaujee] Paul Laurence Dunbar High Sch, Baltimore, MD USA; [Griffin, Kyler; Mazhar, Bakhtawar; Mazhar, Muhammad M.; Munye, Elyas; Shagarabi, Anwar; Stroud, Nicole; Veira, Jarvis; Wagstaff, William] N Atlanta High Sch, Atlanta, GA USA; [Jaimes, Denis; Thuy Le] Cross Keys High Sch, Atlanta, GA USA; [McCrary, Britney] Frederick Douglass High Sch, Atlanta, GA USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Wood, Ashley/0000-0002-8713-601X; Corces, Victor/0000-0001-5140-4337	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The RISE program has been supported by a Professor Award from the Howard Hughes Medical Institute to VGC. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2002, DEV GROWTH DIFFER, V44, P97; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Clark KA, 1996, DEVELOPMENT, V122, P937; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; CREVEL G, 1995, EMBO J, V14, P1711, DOI 10.1002/j.1460-2075.1995.tb07160.x; Crevel G, 2001, J CELL SCI, V114, P37; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Guillebault D, 2007, J MOL BIOL, V373, P903, DOI 10.1016/j.jmb.2007.07.049; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; HOOVER KK, 1993, GENETICS, V135, P507; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kimura M, 2008, FEBS LETT, V582, P2833, DOI 10.1016/j.febslet.2008.07.033; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lu ZG, 2005, P NATL ACAD SCI USA, V102, P2778, DOI 10.1073/pnas.0405374102; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; PALMER MJ, 1993, GENETICS, V134, P545; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Ramos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016562; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; Spradling AC, 1999, GENETICS, V153, P135; Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yi X, 2009, MOL BIOL CELL, V20, P983, DOI 10.1091/mbc.E08-06-0639	46	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53091	10.1371/journal.pone.0053091	http://dx.doi.org/10.1371/journal.pone.0053091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341925	Green Published, gold			2022-12-27	WOS:000313682700021
J	Horvat, T; Dezeljin, M; Redzic, I; Barisic, D; Bosnar, MH; Lauc, G; Zoldos, V				Horvat, Tomislav; Dezeljin, Martina; Redzic, Irma; Barisic, Darko; Bosnar, Maja Herak; Lauc, Gordan; Zoldos, Vlatka			Reversibility of Membrane N-Glycome of HeLa Cells upon Treatment with Epigenetic Inhibitors	PLOS ONE			English	Article							HUMAN BREAST-CANCER; DNA METHYLATION; PERICENTRIC HETEROCHROMATIN; MOLECULAR-BASIS; EXPRESSION; ZEBULARINE; GLYCOSYLATION; TRICHOSTATIN; GLYCANS; REACTIVATION	Glycans are essential regulators of protein function and are now in the focus of research in many physiological and pathophysiological processes. There are numerous modes of regulating their biosynthesis, including epigenetic mechanisms implicated in the expression of glyco-genes. Since N-glycans located at the cell membrane define intercellular communication as well as a cellular response to a given environment, we developed a method to preferentially analyze this fraction of glycans. The method is based on incorporation of living cells into polyacrylamide gels, partial denaturation of membrane proteins with 3 M urea and subsequent release of N-glycans with PNGase F followed by HPLC analysis. Using this newly developed method, we revealed multiple effects of epigenetic inhibitors Trichostatin A, sodium butyrate and zebularine on the composition of N-glycans in human cells. The induced changes were found to be reversible after inhibitor removal. Given that many epigenetic inhibitors are currently explored as a therapeutic strategy in treatment of cancer, wherein surface glycans play an important role, the presented work contributes to our understanding of their efficiency in altering the N-glycan profile of cancer cells in culture.	[Horvat, Tomislav; Barisic, Darko; Zoldos, Vlatka] Univ Zagreb, Fac Sci, Zagreb 41000, Croatia; [Dezeljin, Martina; Bosnar, Maja Herak] Rudjer Boskovic Inst, Zagreb, Croatia; [Redzic, Irma; Lauc, Gordan] Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia; [Lauc, Gordan] Genos Ltd, Glycobiol Lab, Zagreb, Croatia; [Lauc, Gordan] Edith Cowan Univ, Perth, WA, Australia	University of Zagreb; Rudjer Boskovic Institute; University of Zagreb; Edith Cowan University	Lauc, G (corresponding author), Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia.	glauc@pharma.hr; vzoldos@biol.pmf.hr	Lauc, Gordan/K-5864-2012; Bosnar, Maja Herak/AAN-6122-2020	Lauc, Gordan/0000-0003-1840-9560; 	Croatian Ministry of Science, Education and Sport [309-0061194-2023, 119-1191196-1224, 098-0982464-2513]; European Commission GlycoBioM [259869]; European Commission HighGlycan [278535]; AUF PSCI Grant (Agence universitaire de la Francophonie)	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); European Commission GlycoBioM; European Commission HighGlycan; AUF PSCI Grant (Agence universitaire de la Francophonie)	This work was supported by the Croatian Ministry of Science, Education and Sport grants #309-0061194-2023 (to GL), #119-1191196-1224 (to VZ) and #098-0982464-2513 (to MHB); by the European Commission GlycoBioM (contract #259869) and HighGlycan (contract #278535) grants and by AUF PSCI Grant (Agence universitaire de la Francophonie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; Chen M, 2012, MOL CANCER THER, V11, P370, DOI 10.1158/1535-7163.MCT-11-0458; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Craig JM, 2003, EMBO J, V22, P2495, DOI 10.1093/emboj/cdg232; Dannenberg LO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-181; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Hellebrekers DMEI, 2006, MOL CANCER THER, V5, P467, DOI 10.1158/1535-7163.MCT-05-0417; Herranz M, 2006, BLOOD, V107, P1174, DOI 10.1182/blood-2005-05-2033; Horvat T, 2012, BBA-GEN SUBJECTS, V1820, P1412, DOI 10.1016/j.bbagen.2011.12.007; Horvat T, 2011, CLIN EPIGENETICS, V2, P425, DOI 10.1007/s13148-011-0039-1; Ide Y, 2006, BIOCHEM BIOPH RES CO, V341, P478, DOI 10.1016/j.bbrc.2005.12.208; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Listinsky JJ, 2011, AM J TRANSL RES, V3, P292; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mariadason JM, 2000, CANCER RES, V60, P4561; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miyoshi E, 2012, BIOMOLECULES, V2, P34, DOI 10.3390/biom2010034; Moriwaki K, 2010, GLYCOCONJUGATE J, V27, P649, DOI 10.1007/s10719-010-9310-5; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Pajak B, 2007, ADV MED SCI-POLAND, V52, P83; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Schraen-Maschke S, 2003, BIOCHIMIE, V85, P219, DOI 10.1016/S0300-9084(03)00018-X; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Serpa J, 2006, CANCER LETT, V242, P191, DOI 10.1016/j.canlet.2005.11.009; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Syrbe U, 2004, BLOOD, V104, P3243, DOI 10.1182/blood-2003-09-3047; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Vanderschaeghe D, 2010, ANAL CHEM, V82, P7408, DOI 10.1021/ac101560a; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wuhrer M, 2007, EXPERT REV PROTEOMIC, V4, P135, DOI 10.1586/14789450.4.2.135; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zoldos V, 2012, EPIGENETICS-US, V7, P164, DOI 10.4161/epi.7.2.18918; Zoldos Vlatka, 2010, Biomol Concepts, V1, P253, DOI 10.1515/bmc.2010.027	61	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54672	10.1371/journal.pone.0054672	http://dx.doi.org/10.1371/journal.pone.0054672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336012	Green Published, gold			2022-12-27	WOS:000314707700070
J	Thuille, N; Wachowicz, K; Hermann-Kleiter, N; Kaminski, S; Fresser, F; Lutz-Nicoladoni, C; Leitges, M; Thome, M; Massoumi, R; Baier, G				Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Kaminski, Sandra; Fresser, Friedrich; Lutz-Nicoladoni, Christina; Leitges, Michael; Thome, Margot; Massoumi, Ramin; Baier, Gottfried			PKC theta/beta and CYLD Are Antagonistic Partners in the NF kappa B and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes	PLOS ONE			English	Article							KINASE-C-THETA; TUMOR-SUPPRESSOR CYLD; DEUBIQUITINATING ENZYME CYLD; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEGATIVE REGULATOR; CELL-ACTIVATION; DEFICIENT MICE; IMMUNOLOGICAL SYNAPSE; IN-VIVO; MALT1	In T cells PKC theta mediates the activation of critical signals downstream of TCR/CD28 stimulation. We investigated the molecular mechanisms by which PKC theta regulates NF kappa B transactivation by examining PKC theta/beta single and double knockout mice and observed a redundant involvement of PKCh and PKC beta in this signaling pathway. Mechanistically, we define a PKC theta-CYLD protein complex and an interaction between the positive PKC theta/beta and the negative CYLD signaling pathways that both converge at the level of TAK1/IKK/I-kB alpha/NF kappa B and NFAT transactivation. In Jurkat leukemic T cells, CYLD is endoproteolytically processed in the initial minutes of stimulation by the paracaspase MALT1 in a PKC-dependent fashion, which is required for robust IL-2 transcription. However, in primary T cells, CYLD processing occurs with different kinetics and an altered dependence on PKC. The formation of a direct PKC theta/CYLD complex appears to regulate the short-term spatial distribution of CYLD, subsequently affecting NF kappa B and NFAT repressional activity of CYLD prior to its MALT1dependent inactivation. Taken together, our study establishes CYLD as a new and critical PKC theta interactor in T cells and reveals that antagonistic PKC theta/beta-CYLD crosstalk is crucial for the adjustment of immune thresholds in primary mouse CD3(+) T cells.	[Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Kaminski, Sandra; Fresser, Friedrich; Lutz-Nicoladoni, Christina; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria; [Leitges, Michael] Biotechnol Ctr Oslo, Oslo, Norway; [Thome, Margot] Univ Lausanne, Dept Biochem, Lausanne, Switzerland; [Massoumi, Ramin] Lund Univ, Dept Lab Med, Malmo, Sweden	Medical University of Innsbruck; University of Lausanne; Lund University	Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria.	Gottfried.Baier@i-med.ac.at	Massoumi, Ramin/AAG-4786-2019; Kleiter, Natascha/I-5101-2018; Kaminski, Sandra/AAM-6134-2021; Thome, Margot/F-8167-2011; Leitges, Michael/AAN-1953-2021	Kleiter, Natascha/0000-0003-4389-9813; Thome, Margot/0000-0002-5656-2139; Baier, Gottfried/0000-0002-2085-8325; Leitges, Michael/0000-0003-4203-6995; Thuille, Nikolaus/0000-0002-2253-3946	FWF Austrian Science Fund [SFB-021, MCBO-DK, P23537, P25044]; Austrian BM:WF; European Community Program SYBILLA [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 23537, P 25044] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian BM:WF; European Community Program SYBILLA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund (SFB-021, MCBO-DK, P23537, and P25044), funds from the Austrian BM:WF and the European Community Program SYBILLA under grant agreement HEALTH-F4-2008-201106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Giannoni F, 2005, J VIROL, V79, P6808, DOI 10.1128/JVI.79.11.6808-6813.2005; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; Gruber T, 2010, IMMUNOL LETT, V132, P6, DOI 10.1016/j.imlet.2010.04.008; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kingeter LM, 2008, J IMMUNOL, V181, P6244, DOI 10.4049/jimmunol.181.9.6244; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Marsland BJ, 2008, TRENDS IMMUNOL, V29, P179, DOI 10.1016/j.it.2008.01.005; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Morley SC, 2008, J IMMUNOL, V181, P4696, DOI 10.4049/jimmunol.181.7.4696; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thuille N, 2004, MOL IMMUNOL, V41, P385, DOI 10.1016/j.molimm.2004.03.007; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	43	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53709	10.1371/journal.pone.0053709	http://dx.doi.org/10.1371/journal.pone.0053709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335970	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700026
J	Xia, CA; Chen, H; Wang, W; Deng, Y; Wen, B; Ruan, L; Tan, WJ				Xia Chuai; Chen, Hong; Wang, Wen; Deng, Yao; Wen, Bo; Ruan, Li; Tan, Wenjie			Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; IMMUNOSTIMULATORY PHOSPHOROTHIOATE OLIGONUCLEOTIDE; SURFACE-ANTIGEN; ANTIBODY-RESPONSES; DIRECT STIMULATION; BACTERIAL-DNA; CPG MOTIFS; T-CELLS; HEALTHY; OLIGODEOXYNUCLEOTIDE	Background: Virus-specific cellular immune responses play a critical role in virus clearance during acute or chronic HBV infection. Currently, the commercially available HBV vaccine is combined with alum adjuvant, which stimulates mainly Th2 immune responses. Therefore, development of new therapeutic HBV vaccine adjuvants and immune strategies that also promote Th1 and CTL responses is urgently needed. Methodology/Principal findings: To improve the immunity induced by the novel HBSS1 HBV vaccine, we evaluated the ability of adjuvants, including alum, CpG and polyriboinosinic polyribocytidylic acid [poly(I:C)], to enhance the response when boosted with the recombinant adenoviral vector vaccine rAdSS1. The immune responses to different adjuvant combinations were assessed in C57BL/6 mice by enzyme-linked immunosorbent assay (ELISA), ELISpot and cytokine release assays. Among the combinations tested, a HBV protein particle vaccine with CpG/alum and poly(I:C)/alum priming combinations accelerated specific seroconversion and produced high antibody (anti-PreS1, anti-S antibody) titres with a Th1 bias. After boosting with recombinant adenoviral vector vaccine rAdSS1, both groups produced a strong multi-antigen (S and PreS1)-specific cellular immune response. HBSS1 immunisation with poly(I:C)/alum priming also generated high-level CD4(+) and CD8(+) T cell responses in terms of Th1 cytokines (IFN-gamma and IL-2). Conclusions: The protein-vaccine HBSS1 with mixed poly(I:C)/alum adjuvant priming, followed by a rAdSS1 vaccine boost, maximises specific antibody and Th1-biased cellular immune responses. This regime might prove useful in the development of HBV therapeutic vaccines. Furthermore, this promising strategy might be applied to vaccines against other persistent infections, such as human immunodeficiency virus and tuberculosis.	[Xia Chuai; Chen, Hong; Wang, Wen; Deng, Yao; Wen, Bo; Ruan, Li; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xia Chuai] Hebei Med Univ, Dept Microbiol, Shijiazhuang, Heibei Province, Peoples R China; [Wen, Bo] Jilin Univ, Coll Life Sci, Changchun 130023, Jinlin Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Jilin University	Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	tanwj28@yahoo.cn			China Mega-projects of Science Research for the RD of New Drugs [2009ZX09102-237]	China Mega-projects of Science Research for the RD of New Drugs	The present study was supported by the China Mega-projects of Science Research for the R&D of New Drugs (No. 2009ZX09102-237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoletti Antonio, 2009, Expert Rev Gastroenterol Hepatol, V3, P561, DOI 10.1586/egh.09.48; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043730; Chen Hong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P74; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Conforti VA, 2008, VACCINE, V26, P907, DOI 10.1016/j.vaccine.2007.12.010; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Davis HL, 1998, J IMMUNOL, V160, P870; Forte G, 2012, J IMMUNOL, V188, P5357, DOI 10.4049/jimmunol.1103811; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guan J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-506; Halperin SA, 2006, VACCINE, V24, P20, DOI 10.1016/j.vaccine.2005.08.095; Halperin SA, 2003, VACCINE, V21, P2461, DOI 10.1016/S0264-410X(03)00045-8; Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lipford GB, 1997, EUR J IMMUNOL, V27, P2340, DOI 10.1002/eji.1830270931; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Michel ML, 2011, J HEPATOL, V54, P1286, DOI 10.1016/j.jhep.2010.12.031; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; SCHIRMBECK R, 1994, J IMMUNOL, V152, P1110; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; [田淑芳 Tian Shufang], 2002, [病毒学报, Chinese Journal of Virology], V18, P312; Verthelyi D, 2004, AIDS, V18, P1003, DOI 10.1097/00002030-200404300-00007; Yuen M F, 2001, Lancet Infect Dis, V1, P232, DOI 10.1016/S1473-3099(01)00118-9; Zhang XC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-78	36	11	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54126	10.1371/journal.pone.0054126	http://dx.doi.org/10.1371/journal.pone.0054126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335993	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700051
J	Noble, MM; van Laake, G; Berumen, ML; Fulton, CJ				Noble, Mae M.; van Laake, Gregoor; Berumen, Michael L.; Fulton, Christopher J.			Community Change within a Caribbean Coral Reef Marine Protected Area following Two Decades of Local Management	PLOS ONE			English	Article							REGION-WIDE DECLINES; GREAT-BARRIER-REEF; PHASE-SHIFTS; RESERVE NETWORKS; FISH POPULATIONS; RESILIENCE; BIOMASS; RECRUITMENT; CONSERVATION; SIZE	Structural change in both the habitat and reef-associated fish assemblages within spatially managed coral reefs can provide key insights into the benefits and limitations of Marine Protected Areas (MPAs). While MPA zoning effects on particular target species are well reported, we are yet to fully resolve the various affects of spatial management on the structure of coral reef communities over decadal time scales. Here, we document mixed affects of MPA zoning on fish density, biomass and species richness over the 21 years since establishment of the Saba Marine Park (SMP). Although we found significantly greater biomass and species richness of reef-associated fishes within shallow habitats (5 meters depth) closed to fishing, this did not hold for deeper (15 m) habitats, and there was a widespread decline (38% decrease) in live hard coral cover and a 68% loss of carnivorous reef fishes across all zones of the SMP from the 1990s to 2008. Given the importance of live coral for the maintenance and replenishment of reef fishes, and the likely role of chronic disturbance in driving coral decline across the region, we explore how local spatial management can help protect coral reef ecosystems within the context of large-scale environmental pressures and disturbances outside the purview of local MPA management.	[Noble, Mae M.; Fulton, Christopher J.] Australian Natl Univ, ARC Ctr Excellence Coral Reef Studies, Res Sch Biol, Canberra, ACT, Australia; [Noble, Mae M.; van Laake, Gregoor] Saba Conservat Fdn, The Bottom, Saba, Netherlands; [Berumen, Michael L.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Berumen, Michael L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Australian National University; King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution	Noble, MM (corresponding author), Australian Natl Univ, ARC Ctr Excellence Coral Reef Studies, Res Sch Biol, Canberra, ACT, Australia.	mae.noble@anu.edu.au	Berumen, Michael L/F-7745-2011; Fulton, Christopher/A-5971-2008	Berumen, Michael L/0000-0003-2463-2742; Fulton, Christopher/0000-0002-1140-1999	Saba Conservation Foundation ((SCF); King Abdullah University of Science and Technology; Australian National University; Australian Research Council	Saba Conservation Foundation ((SCF); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Australian National University(Australian National University); Australian Research Council(Australian Research Council)	Funding was provided by the Saba Conservation Foundation ((SCF), King Abdullah University of Science and Technology, The Australian National University and Australian Research Council. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript. Staff of the SCF were involved in data collection.	Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Bonsack JA, 1988, 215 NOAA NMFSSEFC; Bonsack JA, 1986, 41 NOAA NMFS; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cardoso SC, 2006, MAR BIODIVERS REC, V2, P1; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; FROESE R, 2007, FISHBASE; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; ROBERTS CM, 1995, CONSERV BIOL, V9, P815, DOI 10.1046/j.1523-1739.1995.09040815.x; Roberts CM, 1995, STATUS REEF FISH COR; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; Sea Around Us Project, 2012, GLOB CATCH DAT; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; van Dijken G, 2012, STORM CARIB CARIBBEA; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Wilkinson C, 2008, STATUS CORAL REEFS W; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zeller DC, 1998, CAN J FISH AQUAT SCI, V55, P917, DOI 10.1139/cjfas-55-4-917	66	11	11	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54069	10.1371/journal.pone.0054069	http://dx.doi.org/10.1371/journal.pone.0054069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342078	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400118
J	Paredes, JA; Zhou, XS; Hoglund, S; Karlsson, A				Paredes, Joao A.; Zhou, Xiaoshan; Hoglund, Stefan; Karlsson, Anna			Gene Expression Deregulation in Postnatal Skeletal Muscle of TK2 Deficient Mice Reveals a Lower Pool of Proliferating Myogenic Progenitor Cells	PLOS ONE			English	Article							MITOCHONDRIAL THYMIDINE KINASE; CARDIOMYOCYTE DNA-SYNTHESIS; RETINOBLASTOMA PROTEIN; DEOXYNUCLEOTIDE POOLS; DEPLETION MYOPATHY; MOUSE-TISSUES; STEM-CELLS; DIFFERENTIATION; INHIBITION; MTDNA	Loss of thymidine kinase 2 (TK2) causes a heterogeneous myopathic form of mitochondrial DNA (mtDNA) depletion syndrome (MDS) in humans that predominantly affects skeletal muscle tissue. In mice, TK2 deficiency also affects several tissues in addition to skeletal muscle, including brain, heart, adipose tissue, kidneys and causes death about 3 weeks after birth. We analysed skeletal muscle and heart muscle tissues of Tk2 knockout mice at postnatal development phase and observed that TK2 deficient pups grew slower and their skeletal muscles appeared significantly underdeveloped, whereas heart was close to normal in size. Both tissues showed mtDNA depletion and mitochondria with altered ultrastructure, as revealed by transmission electron microscopy. Gene expression microarray analysis showed a strong down-regulation of genes involved in cell cycle and cell proliferation in both tissues, suggesting a lower pool of undifferentiated proliferating cells. Analysis of isolated primary myoblasts from Tk2 knockout mice showed slow proliferation, less ability to differentiate and signs of premature senescence, even in absence of mtDNA depletion. Our data demonstrate that TK2 deficiency disturbs myogenic progenitor cells function in postnatal skeletal muscle and we propose this as one of the causes of underdeveloped phenotype and myopathic characteristic of the TK2 deficient mice, in addition to the progressive mtDNA depletion, mitochondrial damage and respiratory chain deficiency in post-mitotic differentiated tissue.	[Paredes, Joao A.; Zhou, Xiaoshan; Karlsson, Anna] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden; [Hoglund, Stefan] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University	Paredes, JA (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden.	joao.paredes@ki.se	Karlsson, Anders H/B-5294-2008; Karlsson, Anna/E-7945-2018	Karlsson, Anders H/0000-0003-3466-4502; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society; Swedish Research Council; Karolinska Institute; board of research at the Karolinska Institute; research committee at the Karolinska hospital	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); board of research at the Karolinska Institute(Karolinska Institutet); research committee at the Karolinska hospital	This work was supported by grants from the Swedish Cancer Society (http://www.cancerfonden.se), the Swedish Research Council (http://www.vr.se) and the Karolinska Institute (http://www.ki.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Microarray core facility at Novum, BEA, Bioinformatics and Expression Analysis, which is supported by the board of research at the Karolinska Institute and the research committee at the Karolinska hospital. We would also like to thank Hernan Concha from the Advanced Flow Cytometry Laboratory at Centre for Infectious Diseases, Karolinska Institute, for his help during the flow cytometry analysis performed in this study.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6; Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029; Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043; BERK AJ, 1973, J BIOL CHEM, V248, P2722; BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; Dou QP, 1996, PROG NUCLEIC ACID RE, V53, P197, DOI 10.1016/S0079-6603(08)60145-2; DOU QP, 1994, J BIOL CHEM, V269, P1306; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gurer C, 2005, J VIROL, V79, P5557, DOI 10.1128/JVI.79.9.5557-5567.2005; Hoglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002; Huang DY, 2001, BIOCHEM J, V356, P829, DOI 10.1042/0264-6021:3560829; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001; McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; POULTON J, 1995, J INHERIT METAB DIS, V18, P4, DOI 10.1007/BF00711367; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rumyantsev P P, 1977, Int Rev Cytol, V51, P186; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	62	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53698	10.1371/journal.pone.0053698	http://dx.doi.org/10.1371/journal.pone.0053698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341978	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400069
J	Toutain, J; Prochazkova-Carlotti, M; Cappellen, D; Jarne, A; Chevret, E; Ferrer, J; Idrissi, Y; Pelluard, F; Carles, D; Maugey-Laulon, B; Lacombe, D; Horovitz, J; Merlio, JP; Saura, R				Toutain, Jerome; Prochazkova-Carlotti, Martina; Cappellen, David; Jarne, Ana; Chevret, Edith; Ferrer, Jacky; Idrissi, Yamina; Pelluard, Fanny; Carles, Dominique; Maugey-Laulon, Brigitte; Lacombe, Didier; Horovitz, Jacques; Merlio, Jean-Philippe; Saura, Robert			Reduced Placental Telomere Length during Pregnancies Complicated by Intrauterine Growth Restriction	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; MESENCHYMAL CORE; ABNORMALITIES; EXPRESSION; FISH; PCR	Objectives: Recent studies have shown that telomere length was significantly reduced in placentas collected at delivery from pregnancies complicated by intrauterine growth restriction secondary to placental insufficiency. Placental telomere length measurement during ongoing pregnancies complicated by intrauterine growth restriction has never been reported. This was the main objective of our study. Methods: In our center, late chorionic villus samplings were performed between 18 and 37 weeks of amenorrhea in 24 subjects with severe intrauterine growth restriction (cases) and in 28 subjects with other indications for prenatal diagnosis (controls). Placental insufficiency was assessed by histo-pathological examination. Relative measurement of telomere length was carried out prospectively by quantitative Fluorescent In Situ Hybridization using fluorescent Peptide Nucleic Acid probes on interphase nuclei obtained from long-term cultured villi and with an automated epifluorescent microscope. A quantitative Polymerase Chain Reaction technique was performed to confirm the quantitative Fluorescent In Situ Hybridization results. The number of copies of gene loci encoding the RNA template (hTERC) and the catalytic subunit (hTERT) of the enzyme complex telomerase were also estimated in these placentas by Fluorescent In Situ Hybridization. Results: Mean fluorescence intensity of telomere probes estimated by quantitative Fluorescent In Situ Hybridization was significantly less for cases compared to controls (p < 0.001). This result indicated that mean telomere length was significantly reduced in placentas during pregnancies complicated by intrauterine growth restriction. Reduced telomere length was confirmed by the quantitative Polymerase Chain Reaction technique. No copy number variation of the hTERC and hTERT loci was noticed for cases, or for controls. Conclusion: This study clearly demonstrates a reduction of placental telomere length in ongoing pregnancies (from 18 to 37 weeks of amenorrhea) complicated by severe intrauterine growth restriction secondary to placental insufficiency.	[Toutain, Jerome; Prochazkova-Carlotti, Martina; Cappellen, David; Chevret, Edith; Ferrer, Jacky; Idrissi, Yamina; Pelluard, Fanny; Merlio, Jean-Philippe] Univ Bordeaux Segalen, EA 2406 Histol & Pathol Mol Tumeurs, Bordeaux, France; [Toutain, Jerome; Lacombe, Didier; Saura, Robert] CHU Bordeaux, Serv Genet Med, Bordeaux, France; [Cappellen, David; Merlio, Jean-Philippe] CHU Bordeaux, Serv Biol Tumeurs, Bordeaux, Pessac, France; [Jarne, Ana] Univ Bordeaux Segalen, ISPED, INSERM, U897 Equipe Biostat, Bordeaux, France; [Pelluard, Fanny; Carles, Dominique] CHU Bordeaux, Serv Pathol, Bordeaux, France; [Maugey-Laulon, Brigitte] CHU Bordeaux, Serv Imagerie Antenatale Enfant & Femme, Bordeaux, France; [Lacombe, Didier] Univ Bordeaux Segalen, EA 4576 Malad Rares Genet & Metab, Bordeaux, France; [Horovitz, Jacques] CHU Bordeaux, Serv Gynecol Obstet & Med Foetale, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Toutain, J (corresponding author), Univ Bordeaux Segalen, EA 2406 Histol & Pathol Mol Tumeurs, Bordeaux, France.	jerome.toutain@chu-bordeaux.fr	lacombe, didier/K-7967-2014	Lacombe, Didier/0000-0002-8956-2207; Toutain, Jerome/0000-0003-1236-1551; Prochazkova-Carlotti, Martina/0000-0002-7719-7679				Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Biron-Shental T, 2011, EARLY HUM DEV, V87, P73, DOI 10.1016/j.earlhumdev.2010.08.024; Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036; Brun JL, 2003, PRENATAL DIAG, V23, P295, DOI 10.1002/pd.578; Carles D, 2009, B ACAD NAT MED PARIS, V193, P675, DOI 10.1016/S0001-4079(19)32559-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Ghidini A, 1996, Obstet Gynecol Surv, V51, P376, DOI 10.1097/00006254-199606000-00023; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Izutsu T, 2006, ACTA OBSTET GYN SCAN, V85, P3, DOI 10.1080/00016340500317096; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Militello Mariapia, 2009, J Prenat Med, V3, P6; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; NEWPORT M, 1986, PRENATAL DIAG, V6, P265, DOI 10.1002/pd.1970060406; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Nishi H, 1999, PLACENTA, V20, P317, DOI 10.1053/plac.1998.0386; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; Prochazkova M, 2007, GENE CHROMOSOME CANC, V46, P828, DOI 10.1002/gcc.20469; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Saura R, 2010, PRENATAL DIAG, V30, P387, DOI 10.1002/pd.2476; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sukenik-Halevy R, 2011, CYTOGENET GENOME RES, V135, P12, DOI 10.1159/000329714; Tomas SZ, 2010, EUR J OBSTET GYN R B, V152, P39, DOI 10.1016/j.ejogrb.2010.05.006; Toutain J, 2010, EUR J OBSTET GYN R B, V149, P143, DOI 10.1016/j.ejogrb.2009.12.015; Toutain J, 2011, PRENATAL DIAG, V31, P1111, DOI 10.1002/pd.2776; Toutain J, 2010, PRENATAL DIAG, V30, P1155, DOI 10.1002/pd.2631; Tsatsaris V, 2008, J GYNECOL OBST BIO R, V37, P16, DOI 10.1016/j.jgyn.2007.08.003; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	37	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54013	10.1371/journal.pone.0054013	http://dx.doi.org/10.1371/journal.pone.0054013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326560	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800099
J	Ochoa-Callejero, L; Perez-Martinez, L; Rubio-Mediavilla, S; Oteo, JA; Martinez, A; Blanco, JR				Ochoa-Callejero, Laura; Perez-Martinez, Laura; Rubio-Mediavilla, Susana; Oteo, Jose A.; Martinez, Alfredo; Blanco, Jose R.			Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; CHEMOKINE RECEPTOR 5; CHOLINE-DEFICIENT; LIVER INFLAMMATION; OVAL CELLS; CANCER; MIGRATION; PROMOTES; INJURY; PROLIFERATION	Chronic liver disease may result in a sequential progression through fibrosis, cirrhosis and lead, eventually, to hepatocellular carcinoma (HCC). Hepatic stellate cells (HSC) seem to be responsible for the fibrogenic response through the activation of an autocrine loop involving the chemokine receptor, CCR5. However, the role of CCR5 in HCC remains poorly understood. Since this receptor is also one of the main ports of entry for the human immunodeficiency virus (HIV), several CCR5 inhibitors are being used in the clinic to reduce viral load. We used one of these inhibitors, maraviroc (MVC), in a mouse model of diet-induced HCC to investigate whether this intervention would reduce disease progression. Animals treated with MVC on top of a normal control diet did not present any evidence of toxicity or any morphological change when compared with non-treated mice. Animals treated with MVC presented higher survival, less liver fibrosis, lower levels of liver injury markers and chemokines, less apoptosis, lower proliferation index, and lower tumor burden than their counterparts receiving only the hepatotoxic diet. In addition, MVC inhibits HSC activation markers such as phosphorylation of p38 and ERK, and increases hepatocyte survival. This study suggests that MVC, a well tolerated and clinically characterized drug, may be used as a preventative treatment for HCC. Clinical studies are needed to demonstrate the efficacy of this drug, or other CCR5 inhibitors, in patients with high risk of developing HCC.	[Ochoa-Callejero, Laura; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [Perez-Martinez, Laura; Oteo, Jose A.; Blanco, Jose R.] Ctr Biomed Res La Rioja CIBIR, Infect Dis Area, Logrono, Spain; [Rubio-Mediavilla, Susana] Hosp San Pedro, Pathol Serv, Logrono, Spain		Martinez, A (corresponding author), Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain.	amartinezr@riojasalud.es	Ochoa-Callejero, Laura/K-2560-2012; Oteo, Jose A./AAB-3134-2020; Blanco, Jose-Ramon/L-6768-2018; Perez, Laura/AAC-8394-2020; Martinez, Alfredo/GQH-5998-2022	Ochoa-Callejero, Laura/0000-0001-5366-6613; Oteo, Jose A./0000-0001-7080-6542; Blanco, Jose-Ramon/0000-0002-4268-0150; Martinez, Alfredo/0000-0003-4882-4044; Perez-Martinez, Laura/0000-0002-1384-024X	Fundacion Rioja Salud (FRS)	Fundacion Rioja Salud (FRS)	This study was supported by a grant from Fundacion Rioja Salud (FRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2011, J HEPATOL, V55, P936, DOI 10.1016/j.jhep.2011.04.023; Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010; Davies RA, 2006, CARCINOGENESIS, V27, P1607, DOI 10.1093/carcin/bgi365; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dufour DR, 2000, CLIN CHEM, V46, P2027; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jiang DS, 2011, PRIMARY CARE, V38, P483, DOI 10.1016/j.pop.2011.05.005; Kirk GD, 2006, CARCINOGENESIS, V27, P2070, DOI 10.1093/carcin/bgl060; Knight B, 2005, IMMUNOL CELL BIOL, V83, P364, DOI 10.1111/j.1440-1711.2005.01346.x; Knight B, 2008, GASTROENTEROLOGY, V135, P969, DOI 10.1053/j.gastro.2008.05.077; Lalezari J, 2011, JAIDS-J ACQ IMM DEF, V57, P118, DOI 10.1097/QAI.0b013e318213c2c0; Lee JM, 2010, ONCOLOGY-BASEL, V78, P167, DOI 10.1159/000315246; Lenz JCC, 2010, EXPERT OPIN DRUG MET, V6, P1139, DOI 10.1517/17425255.2010.510833; Lu PR, 2003, AM J PATHOL, V162, P1249, DOI 10.1016/S0002-9440(10)63921-1; Macias J, 2012, EUR J CLIN MICROBIOL, V31, P2083, DOI 10.1007/s10096-012-1546-5; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Moody MD, 2001, BIOTECHNIQUES, V31, P186, DOI 10.2144/01311dd03; NAKAE D, 1992, CANCER RES, V52, P5042; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Parra J, 2011, CLIN DRUG INVEST, V31, P527, DOI 10.2165/11590700-000000000-00000; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Ruddell RG, 2009, HEPATOLOGY, V49, P227, DOI 10.1002/hep.22597; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seeff LB, 2004, GASTROENTEROLOGY, V127, pS1, DOI 10.1053/j.gastro.2004.09.010; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Shin N, 2011, J PHARMACOL EXP THER, V338, P228, DOI 10.1124/jpet.111.179531; SHINOZUKA H, 1978, CANCER RES, V38, P1092; Svegliati-Baroni G, 2008, LIVER INT, V28, P1052, DOI 10.1111/j.1478-3231.2008.01825.x; Tangkijvanich P, 2002, J CELL PHYSIOL, V191, P351, DOI 10.1002/jcp.10112; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Troia-Cancio P, 2011, EXPERT REV ANTI-INFE, V9, P649, DOI [10.1586/eri.11.52, 10.1586/ERI.11.52]; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; Wang P, 2009, LIVER INT, V29, P575, DOI 10.1111/j.1478-3231.2009.01992.x; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yao ZX, 2009, CANCER BIOL THER, V8, P1691, DOI 10.4161/cbt.8.18.9843; Yates MS, 2007, ACTA PHARMACOL SIN, V28, P1331, DOI 10.1111/j.1745-7254.2007.00688.x; Zhang XP, 2010, BIOORG MED CHEM LETT, V20, P4627, DOI 10.1016/j.bmcl.2010.06.003	53	68	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53992	10.1371/journal.pone.0053992	http://dx.doi.org/10.1371/journal.pone.0053992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326556	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500106
J	Saunders, TJ; Tremblay, MS; Despres, JP; Bouchard, C; Tremblay, A; Chaput, JP				Saunders, Travis J.; Tremblay, Mark S.; Despres, Jean-Pierre; Bouchard, Claude; Tremblay, Angelo; Chaput, Jean-Philippe			Sedentary Behaviour, Visceral Fat Accumulation and Cardiometabolic Risk in Adults: A 6-Year Longitudinal Study from the Quebec Family Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; PLASMA-GLUCOSE; BODY-FAT; TIME; OBESITY; HEALTH; LIPOPROTEINS	Background: Sedentary behaviour has recently emerged as a unique risk factor for chronic disease morbidity and mortality. One factor that may explain this relationship is visceral adiposity, which is prospectively associated with increased cardiometabolic risk and mortality. The objective of the present study was to determine whether sedentary behaviour was associated with increased accumulation of visceral fat or other deleterious changes in cardiometabolic risk over a 6-year follow-up period among adult participants in the Quebec Family Study. Methods: The current study included 123 men and 153 women between the ages of 18 and 65. Total sedentary time and physical activity were assessed by self-report questionnaire. Cross-sectional areas of visceral and subcutaneous abdominal adipose tissue were assessed using computed tomography. Cardiometabolic biomarkers including fasting insulin, glucose, blood lipids, HOMA-Insulin Resistance, and oral glucose tolerance were also measured. All variables of interest were collected at both baseline and follow-up. Results: After adjustment for age, sex, baseline BMI, physical activity, energy intake, smoking, education, income and menopausal status, baseline sedentary behaviour was not associated with changes in visceral adiposity or any other marker of cardiometabolic risk. In the longitudinal model which adjusted for all studied covariates, every 15-minute increase in sedentary behaviour from baseline to follow-up was associated with a 0.13 cm increase in waist circumference (95% CI = 0.02, 0.25). However, there was no association between changes in sedentary behaviour and changes in visceral adiposity or other markers of cardiometabolic risk. Conclusion: These results suggest that neither baseline sedentary behaviour nor changes in sedentary behaviour are associated with longitudinal changes in visceral adiposity in adult men and women. With the exception of waist circumference, the present study did not find evidence of a relationship between sedentary behaviour and any marker of cardiometabolic risk in this population.	[Saunders, Travis J.; Tremblay, Mark S.; Chaput, Jean-Philippe] Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada; [Saunders, Travis J.; Tremblay, Mark S.; Chaput, Jean-Philippe] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Tremblay, Mark S.; Chaput, Jean-Philippe] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON K1N 6N5, Canada; [Despres, Jean-Pierre] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Cardiol, Quebec City, PQ, Canada; [Despres, Jean-Pierre; Tremblay, Angelo] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ G1K 7P4, Canada; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Laval University; Laval University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Saunders, TJ (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada.	tsaunders@cheo.on.ca	Bouchard, Claude/AAE-2035-2019; Tremblay, Mark/AAF-2981-2019; Bouchard, Claude/A-7637-2009; Chaput, Jean-Philippe/ABE-6307-2020; Tremblay, Mark/ABI-5477-2020	Bouchard, Claude/0000-0002-0048-491X; Chaput, Jean-Philippe/0000-0002-5607-5736; 	Medical Research Council of Canada; Canadian Institutes for Health Research [PG-11811, MT-13960, GR-15187]; government of Quebec; government of Canada; Canadian Diabetes Association; University of Ottawa; John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance	Medical Research Council of Canada(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); government of Quebec; government of Canada(CGIAR); Canadian Diabetes Association; University of Ottawa; John W. Barton Sr. Chair in Genetics and Nutrition; Canada Research Chair in Environment and Energy Balance(Canada Research Chairs)	The Quebec Family Study was supported over the years by multiple grants from the Medical Research Council of Canada and the Canadian Institutes for Health Research (www.cihr.ca) (PG-11811, MT-13960 and GR-15187) as well as other agencies from the governments of Quebec and Canada. TJS is the recipient of a Doctoral Research Award from the Canadian Diabetes Association and an Excellence Scholarship from the University of Ottawa. JPC holds a Junior Research Chair in Healthy Active Living and Obesity Research from the Children's Hospital of Eastern Ontario Research Institute. JPD is Scientific Director of the International Chair on Cardiometabolic Risk held at Universite Laval. CB is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition. AT is partially funded by the Canada Research Chair in Environment and Energy Balance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Behnke AR, 1974, EVALUATION REGULATIO; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bouchard C, 1996, PROGR OBESITY RES, V7, P33; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chaput JP, 2011, OBES REV, V12, pe12, DOI 10.1111/j.1467-789X.2010.00772.x; Chaput JP, 2007, PHYSIOL BEHAV, V90, P66, DOI 10.1016/j.physbeh.2006.08.030; Chaput JP, 2012, JAMA-J AM MED ASSOC, V307, P2024, DOI 10.1001/jama.2012.3629; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; DESPRES JP, 1991, AM J CLIN NUTR, V54, P471, DOI 10.1093/ajcn/54.3.471; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Goldfield Gary S, 2011, PLoS One, V6, pe26643, DOI 10.1371/journal.pone.0026643; Government of Canada HC, 2005, CAN NUTR FIL; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Henderson M, 2012, DIABETES CARE, V35, P1272, DOI 10.2337/dc11-1785; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lohman T.J., 1988, ANTHROPOMETRIC STAND; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGuire KA, 2012, OBESITY, V20, P576, DOI 10.1038/oby.2011.278; McNeely MJ, 2012, DIABETES CARE, V35, P296, DOI 10.2337/dc11-1193; MENEELY GR, 1949, J CLIN INVEST, V28, P129, DOI 10.1172/JCI102041; OPPERT JM, 1995, METABOLISM, V44, P96, DOI 10.1016/0026-0495(95)90295-3; PERUSSE L, 1989, ARTERIOSCLEROSIS, V9, P308, DOI 10.1161/01.ATV.9.3.308; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Rice T, 1996, DIABETOLOGIA, V39, P1357, DOI 10.1007/s001250050583; Saunders TJ, 2012, BRIT J NUTR, V108, P946, DOI 10.1017/S0007114512002644; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; SJOSTROM L, 1986, AM J PHYSIOL, V250, pE736, DOI 10.1152/ajpendo.1986.250.6.E736; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; TREMBLAY A, 1983, NUTR RES, V3, P819, DOI 10.1016/S0271-5317(83)80035-9; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	39	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54225	10.1371/journal.pone.0054225	http://dx.doi.org/10.1371/journal.pone.0054225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326600	gold, Green Published			2022-12-27	WOS:000313551500112
J	Yuan, HR; Niu, YM; Liu, XL; Yang, FY; Niu, WY; Fu, L				Yuan, Hairui; Niu, Yanmei; Liu, Xiaolei; Yang, Fengying; Niu, Wenyan; Fu, Li			Proteomic Analysis of Skeletal Muscle in Insulin-Resistant Mice: Response to 6-Week Aerobic Exercise	PLOS ONE			English	Article							ACID-BINDING PROTEIN; MITOCHONDRIAL-FUNCTION; METABOLIC SYNDROME; C57BL/6 MICE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; TRANSGENIC MICE; CHAPERONIN; ALPHA; FAT	Aerobic exercise has beneficial effects on both weight control and skeletal muscle insulin sensitivity through a number of specific signaling proteins. To investigate the targets by which exercise exerts its effects on insulin resistance, an approach of proteomic screen was applied to detect the potential different protein expressions from skeletal muscle of insulin-resistant mice after prolonged aerobic exercise training and their sedentary controls. Eighteen C57BL/6 mice were divided into two groups: 6 mice were fed normal chow (NC) and 12 mice were fed high-fat diet (HFD) for 10 weeks to produce an IR model. The model group was then subdivided into HFD sedentary control (HC, n = 6) and HFD exercise groups (HE, n = 6). Mice in HE group underwent 6 weeks of treadmill running. After 6 weeks, mice were sacrificed and skeletal muscle was dissected. Total protein (n = 6, each group) was extracted and followed by citrate synthase, 2D proteome profile analysis and immunoblot. Fifteen protein spots were altered between the NC and HC groups and 23 protein spots were changed between the HC and HE groups significantly. The results provided an array of changes in protein abundance in exercise-trained skeletal muscle and also provided the basis for a new hypothesis regarding the mechanism of exercise ameliorating insulin resistance.	[Yuan, Hairui; Niu, Yanmei; Liu, Xiaolei; Yang, Fengying; Fu, Li] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China; [Niu, Wenyan] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin, Peoples R China; [Fu, Li] Tianjin Med Univ, Sch Basic Med Sci, Dept Physiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Fu, L (corresponding author), Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China.	lifu@tijmu.edu.cn			National Natural Science Foundation of China (NSFC) [30871213, 31100856]; Tianjin Municipal Science and Technology Commission [09JCZDJC17400, 09ZCZDSF04500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission	This work was supported by grants from the National Natural Science Foundation of China (NSFC) 30871213 (to LF), 31100856 (to YMN), Tianjin Municipal Science and Technology Commission 09JCZDJC17400 (to LF) and 09ZCZDSF04500 (to WYN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Boluyt MO, 2006, PROTEOMICS, V6, P3154, DOI 10.1002/pmic.200401356; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Choi KM, 2009, CLIN ENDOCRINOL, V70, P569, DOI 10.1111/j.1365-2265.2008.03374.x; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Fisher G, 2012, J APPL PHYSIOL, V112, P688, DOI 10.1152/japplphysiol.00843.2011; Fu L, 2012, METABOLISM, V61, P146, DOI 10.1016/j.metabol.2011.06.017; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jastrzebski K, 2011, CELL SIGNAL, V23, P1338, DOI 10.1016/j.cellsig.2011.03.016; Kim SY, 2009, PROTEOMICS, V9, P5056, DOI 10.1002/pmic.200800779; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Lapolla A, 2008, J MASS SPECTROM, V43, P74, DOI 10.1002/jms.1274; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Liu XL, 2012, BBA-MOL BASIS DIS, V1822, P1716, DOI 10.1016/j.bbadis.2012.07.008; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Lumini JA, 2008, SPORTS MED, V38, P735, DOI 10.2165/00007256-200838090-00003; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Niu YM, 2010, INT J SPORT NUTR EXE, V20, P370, DOI 10.1123/ijsnem.20.5.370; Park YM, 1998, J CELL PHYSIOL, V174, P27, DOI 10.1002/(SICI)1097-4652(199801)174:1<27::AID-JCP4>3.0.CO;2-I; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Silva LA, 2009, EUR J APPL PHYSIOL, V105, P861, DOI 10.1007/s00421-008-0971-8; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; van der Heijden GJ, 2009, J CLIN ENDOCR METAB, V94, P4292, DOI 10.1210/jc.2009-1379; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503	44	44	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53887	10.1371/journal.pone.0053887	http://dx.doi.org/10.1371/journal.pone.0053887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326526	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500101
J	Bohata, K; Koppelmann, R				Bohata, Karolina; Koppelmann, Rolf			Chaetognatha of the Namibian Upwelling Region: Taxonomy, Distribution and Trophic Position	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; POPULATION-STRUCTURE; SAGITTA-ELEGANS; CARBON ISOTOPES; DIEL MIGRATION; ZOOPLANKTON; SALINITY; NORTH; TEMPERATURE; DELTA-N-15	In October 2010, the vertical distribution, biodiversity and maturity stages of Chaetognatha species were investigated at four stations located off Walvis Bay, Namibia. Seventeen species were detected and classified as pelagic, shallow-mesopelagic, deep-mesopelagic and bathypelagic species based upon the weighted mean depth derived from their average vertical distribution. High abundances of Chaetognatha were found in the upper 100 m at all stations of the Walvis Bay transect with a maximum value of 20837 ind. 1000 m(-3) at the outer shelf station near the surface. The community was dominated by species of the Serratodentata group. Furthermore, the distribution of Chaetognatha did not seem to be influenced by low oxygen concentrations. Stable isotope ratios of carbon and nitrogen in Chaetognatha were determined for seven different areas located off northern Namibia. The values of delta N-15 ranged from 6.05 % to 11.39 %, while the delta C-13 values varied between -23.89 % and -17.03 %. The highest values for delta N-15 were observed at the Walvis Bay shelf break station. The lowest delta C-13 values were found at the Rocky Point offshore station, which was statistically different from all other areas. Stable isotopes of carbon and nitrogen were determined for four taxa (Sagitta minima, Planctonis group, Sagitta enflata, Sagitta decipiens). In this case, the delta N-15 values ranged from 6.17 % to 10.38 %, whereas the delta C-13 values varied from -22.70 % to -21.56 %. The lowest delta N-15 values were found for S. minima. The C- and N-content revealed maximum C-values for S. decipiens and maximum N-values for the Planctonis group. The C:N ratio of Chaetognatha ranged between 5.25 and 6.20. Overall, Chaetognatha are a diverse group in the pelagic food web of the Benguela Upwelling System and act as competitors of fish larvae and jelly fish by preying on copepods.	[Bohata, Karolina; Koppelmann, Rolf] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany	University of Hamburg	Bohata, K (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany.	karolina.bohata@uni-hamburg.de		Koppelmann, Rolf/0000-0002-0561-9617	Federal Ministry of Education and Research, Germany [FKZ 03F0497A]	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF))	Funded by the Federal Ministry of Education and Research, Germany. Grant Number: FKZ 03F0497A (http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Batistic M, 2003, J MAR BIOL ASSOC UK, V83, P1301, DOI 10.1017/S0025315403008713; Besiktepe S, 2000, J PLANKTON RES, V22, P669, DOI 10.1093/plankt/22.4.669; Brasseur P, 1996, DEEP-SEA RES PT I, V43, P159, DOI 10.1016/0967-0637(96)00012-X; Casanova Jean-Paul, 1999, P1353; CHENEY J, 1985, DEEP-SEA RES, V32, P1041, DOI 10.1016/0198-0149(85)90061-5; CONWAY DVP, 1986, MAR BIOL, V93, P377, DOI 10.1007/BF00401105; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DURO A, 1994, J PLANKTON RES, V16, P1149, DOI 10.1093/plankt/16.9.1149; Escribano R, 2000, J MAR BIOL ASSOC UK, V80, P283, DOI 10.1017/S002531549900185X; FEIGENBAUM D, 1979, MAR BIOL, V54, P75, DOI 10.1007/BF00387053; GIBBONS MJ, 1992, S AFR J MARINE SCI, V12, P421; GIBBONS MJ, 1992, J PLANKTON RES, V14, P249, DOI 10.1093/plankt/14.2.249; Giesecke R, 2004, J PLANKTON RES, V26, P475, DOI 10.1093/plankt/fbh039; GORSKY G, 1988, J EXP MAR BIOL ECOL, V124, P133, DOI 10.1016/0022-0981(88)90116-5; GRANT GC, 1991, FISH B-NOAA, V89, P33; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Hart TJ., 1960, BENGUELA CURRENT; Holmes E, 2002, DEEP-SEA RES PT I, V49, P377, DOI 10.1016/S0967-0637(01)00055-3; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; IKEDA T, 1974, Memoirs of the Faculty of Fisheries Hokkaido University, V22, P1; IKEDA T, 1989, MAR BIOL, V100, P261, DOI 10.1007/BF00391967; KEHAYIAS G, 1994, MAR BIOL, V119, P647, DOI 10.1007/BF00354329; Kehayias G, 2008, J NAT HIST, V42, P633, DOI 10.1080/00222930701835597; Kehayias G, 2010, BIOLOGIA, V65, P301, DOI 10.2478/s11756-010-0024-8; Koppelmann R, J MARINE BIOL ASS UK; Kruse S, 2010, MAR ECOL PROG SER, V416, P105, DOI 10.3354/meps08773; Kusum KK, 2011, DEEP-SEA RES PT I, V58, P1163, DOI 10.1016/j.dsr.2011.08.012; Marazzo A, 1996, J PLANKTON RES, V18, P2367, DOI 10.1093/plankt/18.12.2367; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; MCGOWAN JA, 1966, LIMNOL OCEANOGR, V11, P456, DOI 10.4319/lo.1966.11.4.0456; MCLAREN IA, 1968, CAN J ZOOLOG, V46, P1267, DOI 10.1139/z68-175; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Monteiro PMS, 2006, LAR MAR ECOSYST, V14, P71; NELSON G, 1983, PROG OCEANOGR, V12, P333, DOI 10.1016/0079-6611(83)90013-7; OMORI M, 1969, MAR BIOL, V3, P4, DOI 10.1007/BF00355587; PEARRE S, 1982, MAR ECOL PROG SER, V7, P33; PEARRE S JR, 1979, Journal of Plankton Research, V1, P29, DOI 10.1093/plankt/1.1.29; PERRY RI, 1993, CONT SHELF RES, V13, P357, DOI 10.1016/0278-4343(93)90056-4; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; PIERROTBULTS AC, 1988, CHAETOGNATHA KEYS NO; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Redfield A.C., 1934, J JOHNSTONE MEMORIAL, P177; REEVE MR, 1970, MAR BIOL, V6, P357, DOI 10.1007/BF00353669; SAUPE SM, 1989, MAR BIOL, V103, P427, DOI 10.1007/BF00399574; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Shannon C.E., 1949, MATH THEORY INFORM; Shannon LV, 2003, LARGE MARINE ECOSYST; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STUART V, 1991, J MAR RES, V49, P493, DOI 10.1357/002224091784995819; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Zhang WC, 2009, HYDROBIOLOGIA, V636, P257, DOI 10.1007/s10750-009-9955-x; ZO Z, 1973, LIMNOL OCEANOGR, V18, P750, DOI 10.4319/lo.1973.18.5.0750	57	13	16	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53839	10.1371/journal.pone.0053839	http://dx.doi.org/10.1371/journal.pone.0053839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342016	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700049
J	Crame, JA				Crame, J. Alistair			Early Cenozoic Differentiation of Polar Marine Faunas	PLOS ONE			English	Article							TAXONOMIC DIVERSITY GRADIENTS; CLIMATE-CHANGE; LATITUDINAL GRADIENT; BIODIVERSITY; SEA; GASTROPODS; EVOLUTION; PATTERNS; PALEOGEOGRAPHY; SEASONALITY	The widespread assumption that the origin of polar marine faunas is linked to the onset of major global cooling in the Late Eocene - Early Oligocene is being increasingly challenged. The Antarctic fossil record in particular is suggesting that some modern Southern Ocean taxa may have Early Eocene or even Paleocene origins, i.e. well within the Early Cenozoic greenhouse world. A global analysis of one of the largest marine clades at the present day, the Neogastropoda, indicates that not only is there a decrease in the number of species from the tropics to the poles but also a decrease in the evenness of their distribution. A small number of neogastropod families with predominantly generalist trophic strategies at both poles points to the key role of seasonality in structuring the highest latitude marine assemblages. A distinct latitudinal gradient in seasonality is temperature-invariant and would have operated through periods of global warmth such as the Early Cenozoic. To test this concept a second global analysis was undertaken of earliest Cenozoic (Paleocene) neogastropods and this does indeed show a certain degree of faunal differentiation at both poles. The Buccinidae, s.l. is especially well developed at this time, and this is a major generalist taxon at the present day. There is an element of asymmetry associated with this development of Paleocene polar faunas in that those in the south are more strongly differentiated than their northern counterparts; this can in turn be linked to the already substantial isolation of the southern high latitudes. The key role of seasonality in the formation of polar marine faunas has implications for contemporary ecosystem structure and stability.	British Antarctic Survey, NERC, Cambridge, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Crame, JA (corresponding author), British Antarctic Survey, NERC, Cambridge, England.	jacr@bas.ac.uk			Natural Environment Research Council;  [NE/1005803/1]; NERC [NE/I005803/1, NE/I00582X/2] Funding Source: UKRI; Natural Environment Research Council [NE/I00582X/2, NE/I005803/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was received from from the Natural Environment Research Council to the BAS core programme "Evolutionary history of the polar region'' and research grant NE/1005803/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbass HL, 1967, EGYPTIAN GEOL SURV G, V4; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Anderson H.-J., 1975, Geologica Palaeontologica, V9, P141; Anderson HS, 1970, NORSK POL SKRIFT, V153, P89; Archibald SB, 2010, PALEOBIOLOGY, V36, P374, DOI 10.1666/09021.1; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Aronson RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004385; Baceta JI, 2005, PALAEOGEOGR PALAEOCL, V224, P117, DOI 10.1016/j.palaeo.2005.03.033; Bandel Klaus, 1993, Scripta Geologica Special Issue, V2, P7; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; BEU AG, 1990, NZ GEOLOGICAL SURVEY, V58, P518; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P, 2008, MIGHTY NUMBERS PHI 1, VI, P8; BRANDT A, 1992, MAR BIOL, V113, P415, DOI 10.1007/BF00349167; Brandt A, 1999, PALAEONTOLOGY, V42, P663, DOI 10.1111/1475-4983.00090; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Case JA, 2007, 20071047 USGS; Chown SL, 1999, EVOL ECOL RES, V1, P365; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Clarke A., 1989, Geological Society Special Publication, P253; Corliss BH, 2009, DEEP-SEA RES PT I, V56, P835, DOI 10.1016/j.dsr.2008.12.009; Crame J. Alistair, 1996, P119; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Crame JA, 2000, GEOL SOC SPEC PUBL, V177, P347, DOI 10.1144/GSL.SP.2000.177.01.23; Cvancara A. M., 1966, Contributions from the Museum of Paleontology University of Michigan, V20, P277; Dell RK, 1990, B R SOC NZ, V27; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; GLADENKOV YB, 1994, PALAEOGEOGR PALAEOCL, V108, P311, DOI 10.1016/0031-0182(94)90239-9; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; Golikov A. N, 1995, SHELL BEARING GASTRO; H-J Anderson, 1982, GEOL PALAEONT, V15, P161; Harasewych MG, 2004, NAUTILUS, V118, P1; Harper EM, 2003, POLAR BIOL, V26, P208, DOI 10.1007/s00300-002-0455; Harrington GJ, 2011, P ROYAL SOC B, V279, P155, DOI DOI 10.1098/RSPB.2011.1704; Huber M, 2009, NATURE, V457, P669, DOI 10.1038/457669a; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kantor Yu.I., 2005, CATALOGUE MOLLUSCS R; Kiessling W, 2010, SCIENCE, V327, P196, DOI 10.1126/science.1182241; Kiessling W, 2009, ANNU REV ECOL EVOL S, V40, P173, DOI 10.1146/annurev.ecolsys.110308.120251; Kollman HA, 1983, B GRON GEOL UNDERSOG, V146; Krug AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015362; Krug AZ, 2009, ASTROBIOLOGY, V9, P113, DOI 10.1089/ast.2008.0253; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LIPPS JH, 1982, ENV DEEP SEA, V2, P325; Livsic JJ, 1974, NORSK POLARINSTITUTT, V159; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marincovich Jr L, 1990, LATE MESOZOIC CENOZO, VL, P403; Marincovich Jr L, 1993, J PALEONT MEMOIR, V35; MARINCOVICH L, 1991, J PALEONTOL, V65, P242, DOI 10.1017/S0022336000020461; MARINCOVICH L, 1985, GEOLOGY, V13, P770, DOI 10.1130/0091-7613(1985)13<770:ETMFFN>2.0.CO;2; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Montenat C, 2008, GEOSCIENCES, V7-8, P64; Morris Noel, 2000, P149, DOI 10.1017/CBO9780511535505.012; Oleinik AE, 1996, J PALEONTOL, V70, P923, DOI 10.1017/S0022336000038610; Oleinik AE, 2001, PALAEOGEOGR PALAEOCL, V166, P121, DOI 10.1016/S0031-0182(00)00205-4; Perrin Christine, 2002, P587, DOI 10.2110/pec.02.72.0587; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Powell AWB, 1951, DISCOVERY REP, V26, P47, DOI [10.5962/bhl.part.16335, DOI 10.5962/BHL.PART.16335]; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; Rex M.A., 2010, BIOSCIENCE; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rose PJ, 2011, GEOLOGY, V39, P163, DOI 10.1130/G31099.1; Rosenkrantz A., 1970, Meddr dansk. geol. Foren., V19, P406; Sepkoski Jr JJ, 2002, B AM PALEONT, V363; Sessa JA, 2009, GEOLOGY, V37, P115, DOI 10.1130/G25286A.1; SOHL NF, 1987, J PALEONTOL, V61, P1085, DOI 10.1017/S0022336000029486; Stanton TW, 1920, 128A US GEOL SURV; Stilwell JD, 2003, PALAEOGEOGR PALAEOCL, V195, P319, DOI 10.1016/S0031-0182(03)00364-X; Stilwell JD, 1992, ANT RES SER, V55; Stilwell Jeffrey D., 2004, Bulletins of American Paleontology, V367, P1; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; Sun XC, 2006, DEEP-SEA RES PT I, V53, P28, DOI 10.1016/j.dsr.2005.07.003; Tantawy AA, 2001, CRETACEOUS RES, V22, P795, DOI 10.1006/cres.2001.0291; Taylor J.D., 1981, P229; TAYLOR J D, 1980, Palaeontology (Oxford), V23, P375; TAYLOR JD, 1977, J BIOGEOGR, V4, P73, DOI 10.2307/3038130; Thomas E, 1996, GEOLOGY, V24, P355, DOI 10.1130/0091-7613(1996)024<0355:CDSBFT>2.3.CO;2; TITOVA LV, 1994, PALAEOGEOGR PALAEOCL, V108, P319, DOI 10.1016/0031-0182(94)90240-2; Valentine J.W., 1983, Topics in Geobiology, V3, P121; Valentine J. W., 1969, Palaeontology, V12, P684; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij GJ, 2001, MARINE COMMUNITY ECOLOGY, P39; VERMEIJ GJ, 1991, VELIGER, V34, P264; Vonderbank K, 1970, NORSK POL SKRIFT, V153; Watling L., 1989, Geological Society Special Publication, P297; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilson GDF, 1989, DEEP SEA RES 2, V45, P279; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZINSMEISTER WJ, 1982, J PALEONTOL, V56, P84	93	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54139	10.1371/journal.pone.0054139	http://dx.doi.org/10.1371/journal.pone.0054139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342090	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000313682700089
J	Cross, P; St John, FAV; Khan, S; Petroczi, A				Cross, Paul; St John, Freya A. V.; Khan, Saira; Petroczi, Andrea			Innovative Techniques for Estimating Illegal Activities in a Human-Wildlife-Management Conflict	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; RANDOMIZED-RESPONSE; FALSE CONSENSUS; RED GROUSE; TUBERCULOSIS; PREVALENCE; BEHAVIOR; BADGERS; CATTLE; BIAS	Effective management of biological resources is contingent upon stakeholder compliance with rules. With respect to disease management, partial compliance can undermine attempts to control diseases within human and wildlife populations. Estimating non-compliance is notoriously problematic as rule-breakers may be disinclined to admit to transgressions. However, reliable estimates of rule-breaking are critical to policy design. The European badger (Meles meles) is considered an important vector in the transmission and maintenance of bovine tuberculosis (bTB) in cattle herds. Land managers in high bTB prevalence areas of the UK can cull badgers under license. However, badgers are also known to be killed illegally. The extent of illegal badger killing is currently unknown. Herein we report on the application of three innovative techniques (Randomized Response Technique (RRT); projective questioning (PQ); brief implicit association test (BIAT)) for investigating illegal badger killing by livestock farmers across Wales. RRT estimated that 10.4% of farmers killed badgers in the 12 months preceding the study. Projective questioning responses and implicit associations relate to farmers' badger killing behavior reported via RRT. Studies evaluating the efficacy of mammal vector culling and vaccination programs should incorporate estimates of non-compliance. Mitigating the conflict concerning badgers as a vector of bTB requires cross-disciplinary scientific research, departure from deep-rooted positions, and the political will to implement evidence-based management.	[Cross, Paul] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [St John, Freya A. V.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Khan, Saira; Petroczi, Andrea] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Petroczi, Andrea] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	Bangor University; University of Kent; Kingston University; University of Sheffield	Cross, P (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	paul.cross@bangor.ac.uk	Petroczi, Andrea/ABG-9863-2021	Petroczi, Andrea/0000-0002-8365-6173; St. John, Freya/0000-0002-5707-310X	British Academy, Small Research Grant programme [SG100709]	British Academy, Small Research Grant programme	This study benefited from funding from The British Academy, Small Research Grant programme (SG100709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; BERK RA, 1983, AM SOCIOL REV, V48, P386, DOI 10.2307/2095230; Bourne F., 2007, BOVINE TUBERCULOSIS; BUCHMAN TA, 1982, J ACCOUNTING RES, V20, P263, DOI 10.2307/2490775; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conner MT, 2007, PERS SOC PSYCHOL B, V33, P1727, DOI 10.1177/0146167207309194; Cross P, 2010, PREV VET MED, V96, P252, DOI 10.1016/j.prevetmed.2010.05.012; Defra, 2011, BOV TUB EV PLAN 2011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2012, NATURE, V485, P582, DOI 10.1038/485582a; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; HOLE NH, 1969, NATURE, V224, P244, DOI 10.1038/224244a0; Hovardas T, 2011, ENV BEHAV; Hox J, 2004, STRUCT EQU MODELING, V11, P615, DOI 10.1207/s15328007sem1104_6; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones RD, 2005, RISK ANAL, V25, P533, DOI 10.1111/j.1539-6924.2005.00613.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lensvelt-Mulders GJLM, 2005, QUAL QUANT, V39, P253, DOI 10.1007/s11135-004-0432-3; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; Monin B, 2003, PERS SOC PSYCHOL B, V29, P559, DOI 10.1177/0146167203029005001; MUIRHEAD RH, 1974, VET REC, V95, P552, DOI 10.1136/vr.95.24.552; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Ostapczuk M, 2011, DISABIL REHABIL, V33, P399, DOI 10.3109/09638288.2010.492067; Petroczi A, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-20; Petroczi Andrea, 2008, J Occup Med Toxicol, V3, P19, DOI 10.1186/1745-6673-3-19; Proffitt F, 2004, SCIENCE, V303, P1955; R Core Team, 2021, R LANGUAGE ENV STAT; Reid N, 2012, EUR J WILDLIFE RES, V58, P177, DOI 10.1007/s10344-011-0560-8; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Sherman JW, 2008, PSYCHOL REV, V115, P314, DOI 10.1037/0033-295X.115.2.314; SHERMAN SJ, 1983, PERS SOC PSYCHOL B, V9, P197, DOI 10.1177/0146167283092003; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; St John FAV, 2011, P ROY SOC B; St John FAV, 2011, P R SOC EDINB BIOL; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Uvacsek M, 2011, SCAND J MED SCI SPOR, V21, P224, DOI 10.1111/j.1600-0838.2009.01041.x; van den Hout A, 2007, COMPUT STAT DATA AN, V51, P6060, DOI 10.1016/j.csda.2006.12.002; van der Heijden PGM, 2000, SOCIOL METHOD RES, V28, P505, DOI 10.1177/0049124100028004005; Vial F, 2011, BIOL LETT; von Hippel W, 2008, PSYCHOL SCI, V19, P7, DOI 10.1111/j.1467-9280.2008.02037.x; Wilson GJ, 2011, VET MICROBIOL, V151, P43, DOI 10.1016/j.vetmic.2011.02.024; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	62	14	14	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53681	10.1371/journal.pone.0053681	http://dx.doi.org/10.1371/journal.pone.0053681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341973	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700035
J	Dalman, K; Himmelstrand, K; Olson, A; Lind, M; Brandstrom-Durling, M; Stenlid, J				Dalman, Kerstin; Himmelstrand, Kajsa; Olson, Ake; Lind, Marten; Brandstrom-Durling, Mikael; Stenlid, Jan			A Genome-Wide Association Study Identifies Genomic Regions for Virulence in the Non-Model Organism Heterobasidion annosum s.s	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; COMPLEX TRAITS; CALCINEURIN; PATHOGENICITY; INFERENCE; LOCI; RESISTANCE; SOFTWARE	The dense single nucleotide polymorphisms (SNP) panels needed for genome wide association (GWA) studies have hitherto been expensive to establish and use on non-model organisms. To overcome this, we used a next generation sequencing approach to both establish SNPs and to determine genotypes. We conducted a GWA study on a fungal species, analysing the virulence of Heterobasidion annosum s.s., a necrotrophic pathogen, on its hosts Picea abies and Pinus sylvestris. From a set of 33,018 single nucleotide polymorphisms (SNP) in 23 haploid isolates, twelve SNP markers distributed on seven contigs were associated with virulence (P<0.0001). Four of the contigs harbour known virulence genes from other fungal pathogens and the remaining three harbour novel candidate genes. Two contigs link closely to virulence regions recognized previously by QTL mapping in the congeneric hybrid H. irregulare x H. occidentale. Our study demonstrates the efficiency of GWA studies for dissecting important complex traits of small populations of non-model haploid organisms with small genomes.	[Dalman, Kerstin; Himmelstrand, Kajsa; Olson, Ake; Lind, Marten; Brandstrom-Durling, Mikael; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden	Swedish University of Agricultural Sciences	Dalman, K (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala BioCtr, Uppsala, Sweden.	kerstin.dalman@slu.se	Stenlid, Jan/K-5909-2019; Brandström Durling, Mikael/C-1213-2008	Brandström Durling, Mikael/0000-0001-6485-197X; Stenlid, Jan/0000-0002-5344-2094; Lind, Marten/0000-0002-3817-2823	Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS) [229-2007-1097]; Swedish Foundation for Strategic Research (SSF) [RBb08-0011]	Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support from the Swedish Research Council of Environmental, Agricultural and Spatial planning (FORMAS) grant ID 229-2007-1097 (http://www.formas.se/en/) and the Swedish Foundation for Strategic Research (SSF) number RBb08-0011 (http://www.stratresearch.se/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Connelly CF, 2012, GENETICS; Cumagun CJR, 2004, PHYTOPATHOLOGY, V94, P520, DOI 10.1094/PHYTO.2004.94.5.520; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Hall D, 2010, BRIEF FUNCT GENOMICS, V9, P157, DOI 10.1093/bfgp/elp048; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; Hawthorne B, 1997, FUNGAL GENET NEWSL, V44, P24; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Kim JE, 2007, CURR GENET, V51, P99, DOI 10.1007/s00294-006-0110-1; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P93; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lind M, 2005, FUNGAL GENET BIOL, V42, P519, DOI 10.1016/j.fgb.2005.03.005; Lind M, 2007, CURR GENET, V52, P35, DOI 10.1007/s00294-007-0137-y; Lind M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048347; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Muller LAH, 2011, MOL ECOL, V20, P4085, DOI 10.1111/j.1365-294X.2011.05225.x; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Olson A, 2001, NATURE, V411, P438, DOI 10.1038/35078147; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Pandelova I., 2005, FUNGAL GENET NEWSL, V52; Pritchard JK, 2000, GENETICS, V155, P945; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RAO PV, 1992, J BIOL CHEM, V267, P96; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santoyo F, 2008, ENZYME MICROB TECH, V43, P137, DOI 10.1016/j.enzmictec.2007.11.007; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; STENLID J, 1985, CAN J BOT, V63, P2268, DOI 10.1139/b85-322; Sugiura R, 2001, CELL MOL LIFE SCI, V58, P278, DOI 10.1007/PL00000855; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393	54	50	54	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53525	10.1371/journal.pone.0053525	http://dx.doi.org/10.1371/journal.pone.0053525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341945	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000313682700027
J	Gozlan, RE; Burnard, D; Andreou, D; Britton, JR				Gozlan, Rodolphe E.; Burnard, Dean; Andreou, Demetra; Britton, J. Robert			Understanding the Threats Posed by Non-Native Species: Public vs. Conservation Managers	PLOS ONE			English	Article							PSEUDORASBORA-PARVA; BIODIVERSITY; KNOWLEDGE; LADYBIRD; IMPACTS; ECOLOGY	Public perception is a key factor influencing current conservation policy. Therefore, it is important to determine the influence of the public, end-users and scientists on the prioritisation of conservation issues and the direct implications for policy makers. Here, we assessed public attitudes and the perception of conservation managers to five non-native species in the UK, with these supplemented by those of an ecosystem user, freshwater anglers. We found that threat perception was not influenced by the volume of scientific research or by the actual threats posed by the specific non-native species. Media interest also reflected public perception and vice versa. Anglers were most concerned with perceived threats to their recreational activities but their concerns did not correspond to the greatest demonstrated ecological threat. The perception of conservation managers was an amalgamation of public and angler opinions but was mismatched to quantified ecological risks of the species. As this suggests that invasive species management in the UK is vulnerable to a knowledge gap, researchers must consider the intrinsic characteristics of their study species to determine whether raising public perception will be effective. The case study of the topmouth gudgeon Pseudorasbora parva reveals that media pressure and political debate has greater capacity to ignite policy changes and impact studies on non-native species than scientific evidence alone.	[Gozlan, Rodolphe E.; Burnard, Dean; Andreou, Demetra; Britton, J. Robert] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Sci, Poole BH12 5BB, Dorset, England	Bournemouth University	Gozlan, RE (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Sci, Poole BH12 5BB, Dorset, England.	rgozlan@bournemouth.ac.uk	Britton, Robert/AAO-6673-2020; Britton, Robert/B-5040-2009; Andreou, Demetra/AGF-2932-2022	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; 				Andreou D, 2011, DIS AQUAT ORGAN, V95, P145, DOI 10.3354/dao02356; Andreou D, 2011, PARASITOLOGY, V138, P26, DOI 10.1017/S0031182010000983; Andreou D, 2009, J PARASITOL, V95, P1539, DOI 10.1645/GE-2124.1; Andreou D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036998; [Anonymous], 2009, NECR009, P111; Bailey J. P., 2000, Watsonia, V23, P93; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Britton JR, 2006, FISHERIES MANAG ECOL, V13, P329, DOI 10.1111/j.1365-2400.2006.00510.x; Burnard D, 2008, J FISH BIOL, V73, P1, DOI 10.1111/j.1095-8649.2008.01872.x; Copp GH, 2005, J APPL ICHTHYOL, V21, P371, DOI 10.1111/j.1439-0426.2005.00692.x; Copp GH, 2009, RISK ANAL, V29, P457, DOI 10.1111/j.1539-6924.2008.01159.x; Fraser W., 2001, LANDCARE RES SCI SER, V23; Gherardi F, 2011, AQUAT SCI, V73, P185, DOI 10.1007/s00027-011-0181-z; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2002, J FISH BIOL, V61, P298, DOI 10.1006/jfbi.2002.2042; Gozlan R, 2012, NATURE, V485, P446, DOI 10.1038/485446d; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Guan RZ, 1998, AQUACULTURE, V169, P177, DOI 10.1016/S0044-8486(98)00377-9; Harvey GL, 2011, PROG PHYS GEOG, V35, P517, DOI 10.1177/0309133311409092; Jacobson SK, 2012, CONSERV BIOL, V26, P171, DOI 10.1111/j.1523-1739.2011.01750.x; Johnson MJ, 1997, ATTITUDINAL SURVEY V, V3; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Lauber TB, 2011, CONSERV BIOL, V25, P1186, DOI 10.1111/j.1523-1739.2011.01742.x; Lee DP, 2001, ROTENONE IN FISHERIES: ARE THE REWARDS WORTH THE RISKS?, P55; Linklater WL, 2003, CONSERV BIOL, V17, P968, DOI 10.1046/j.1523-1739.2003.01449.x; Loucks CJ, 2001, SCIENCE, V294, P1465, DOI 10.1126/science.1064710; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Majerus M, 2006, ECOL ENTOMOL, V31, P207, DOI 10.1111/j.1365-2311.2006.00734.x; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Middleton A.D., 1930, P ZOOL SOC LOND, V100, P809, DOI DOI 10.1111/J.1096-3642.1930.TB01000.X; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Office for National Statistics, 2011, 2011 CENS POP HOUS E; Paley RK, 2012, PARASITOLOGY, V139, P904, DOI 10.1017/S0031182012000030; Reaser J, 2001, GREAT RESHUFFLING HU; Rotherham ID, 2012, INVASIVE INTRO PLANT; Sapsford R, 1999, SURVEY RES; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Stankovic VM, 2011, BIOL INVASIONS, V13, P1711, DOI 10.1007/s10530-010-9929-y; Stinchcombe J, 2002, CONSERV ECOL, V6; TEAR TH, 1995, CONSERV BIOL, V9, P182, DOI 10.1046/j.1523-1739.1995.09010182.x; Turgeon J, 2011, J EVOLUTION BIOL, V24, P1044, DOI 10.1111/j.1420-9101.2011.02234.x	43	51	54	3	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53200	10.1371/journal.pone.0053200	http://dx.doi.org/10.1371/journal.pone.0053200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341931	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700023
J	Ranasinghe, WKB; Xiao, L; Kovac, S; Chang, M; Michiels, C; Bolton, D; Shulkes, A; Baldwin, GS; Patel, O				Ranasinghe, Weranja K. B.; Xiao, Lin; Kovac, Suzana; Chang, Mike; Michiels, Carine; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel			The Role of Hypoxia-Inducible Factor 1 alpha in Determining the Properties of Castrate-Resistant Prostate Cancers	PLOS ONE			English	Article							HORMONE-REFRACTORY PROSTATE; ENDOTHELIAL GROWTH-FACTOR; FACTOR-I-ALPHA; ANDROGEN RECEPTOR; CELL-LINES; RADICAL PROSTATECTOMY; HIF-1-ALPHA SYNTHESIS; MESSENGER-RNAS; GASTRIC-CANCER; UP-REGULATION	Background: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving androgen deprivation therapy for prostate cancer (PC). Despite numerous studies showing the expression of HIF1 alpha protein under normoxia in PC cell lines, the role of this normoxic HIF1 alpha expression in chemo-resistance and migration has not been investigated previously. As no method is currently available to determine which tumors will progress to CRPC, the role of HIF1 alpha in PC and its potential for predicting the development of CRPC was also investigated. Methods: The effect of HIF1 alpha protein knockdown on chemo-resistance and migration of PC3 cells was assessed by cell counting and Transwell assays, respectively. Translation efficiency of HIF1 alpha mRNA was determined in PC cells using a HIF1 alpha 5'UTR-luciferase construct. Clinical outcomes were correlated following the staining of 100 prostate tumors for HIF1 alpha expression. Results: The CRPC-like cell lines (PC3 and DU145) expressed more HIF1 alpha protein than an androgen sensitive cell line (LNCaP). Migration rate and chemo-resistance were higher in the PC3 cells and both were decreased when HIF1 alpha expression was reduced. Increased translation of HIF1 alpha mRNA may be responsible for HIF1 alpha overexpression in PC3 cells. Patients whose tumors expressed HIF1 alpha had significantly decreased metastasis-free survival and the patients who were on androgen-deprivation therapy had decreased CRPC-free survival on Kaplan-Meier analysis. On multivariate analysis HIF1 alpha was an independent risk factor for progression to metastatic PC (Hazard ratio (HR) 9.8, p = 0.017) and development of CRPC (HR 10.0, p = 0.021) in patients on androgen-deprivation therapy. Notably the tumors which did not express HIF1 alpha did not metastasize or develop CRPC. Conclusions: HIF1 alpha is likely to contribute to metastasis and chemo-resistance of CRPC and targeted reduction of HIF1 alpha may increase the responsiveness of CRPCs to chemotherapy. Expression of HIF1 alpha may be a useful screening tool for development of CRPC.	[Ranasinghe, Weranja K. B.; Xiao, Lin; Kovac, Suzana; Chang, Mike; Bolton, Damien; Shulkes, Arthur; Baldwin, Graham S.; Patel, Oneel] Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia; [Ranasinghe, Weranja K. B.; Bolton, Damien] Univ Melbourne, Austin Hlth, Dept Urol, Heidelberg, Vic, Australia; [Michiels, Carine] Univ Namur, FUNDP, NARILIS NAmur Res Inst LIfe Sci, Lab Biochem & Cellular Biol URBC, Namur, Belgium	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Namur	Patel, O (corresponding author), Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia.	patelo@unimelb.edu.au	Ranasinghe, Weranja/HHS-8150-2022; Ranasinghe, Weranja/AAV-5678-2021	Ranasinghe, Weranja/0000-0002-4006-0388; Xiao, Lin/0000-0001-7258-5333; Baldwin, Graham/0000-0002-0944-8747; Patel, Oneel/0000-0001-5628-7205	National Health and Medical Research Council of Australia [454322, 566555, 628390]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants 454322 (GSB), 566555 (GSB, AS) and 628390 (AS, OP, GSB) from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Beltran H, 2011, EUR UROL, V60, P279, DOI 10.1016/j.eururo.2011.04.038; Berruti A, 2007, J UROLOGY, V178, P838, DOI 10.1016/j.juro.2007.05.018; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Carnell DM, 2006, INT J RADIAT ONCOL, V65, P91, DOI 10.1016/j.ijrobp.2005.11.044; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chau CH, 2005, CANCER BIOL THER, V4, P1222, DOI 10.4161/cbt.4.11.2091; Chen JH, 2004, CELL COMMUN ADHES, V11, P1, DOI 10.1080/15419060490471739; Chlenski A, 2001, PROSTATE, V47, P66; Chun YS, 2003, CANCER RES, V63, P8700; Dai Y, 2011, INT J RADIAT ONCOL, V81, P521, DOI 10.1016/j.ijrobp.2011.04.027; Danila DC, 2011, EUR UROL, V60, P897, DOI 10.1016/j.eururo.2011.07.011; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Du ZX, 2003, CHINESE MED J-PEKING, V116, P1936; Ellem SJ, 2007, NAT REV CANCER, V7, P621, DOI 10.1038/nrc2174; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Figg WD, 2004, WORLD J UROL, V22, P425, DOI 10.1007/s00345-004-0443-7; Foley R, 2009, CANCER BIOL THER, V8, P118, DOI 10.4161/cbt.8.2.7086; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Guan YL, 2010, MOL THER, V18, P188, DOI 10.1038/mt.2009.219; Hao Ping, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P593; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jans J, 2010, UROLOGY, V75, P786, DOI 10.1016/j.urology.2009.08.024; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kosaka T, 2010, PROSTATE, V70, P162, DOI 10.1002/pros.21049; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Lekas A, 2006, ANTICANCER RES, V26, P2989; Liu L, 2007, MOL CELL BIOCHEM, V303, P151, DOI 10.1007/s11010-007-9467-9; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; Mills CN, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-104; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Monsef N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-385; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Pipinikas C, 2008, BIOMARKERS, V13, P680, DOI 10.1080/13547500802591992 ; Platz EA, 2011, CANCER DISCOV, V1, P68, DOI 10.1158/2159-8274.CD-10-0020; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh PP, 2011, CLIN CANCER RES, V17, P4006, DOI 10.1158/1078-0432.CCR-11-0248; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Vergis R, 2008, LANCET ONCOL, V9, P342, DOI 10.1016/S1470-2045(08)70076-7; Wang Liang, 2006, Zhonghua Nan Ke Xue, V12, P57; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yasuda M, 2007, CANCER DETECT PREV, V31, P396, DOI 10.1016/j.cdp.2007.10.007; Yossepowitch O, 2007, EUR UROL, V51, P940, DOI 10.1016/j.eururo.2006.10.045; Zeng LH, 2007, CANCER SCI, V98, P1394, DOI 10.1111/j.1349-7006.2007.00537.x; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang ZW, 2012, MOL CANCER THER, V11, P2410, DOI 10.1158/1535-7163.MCT-12-0157; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 1999, CANCER RES, V59, P5830	63	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54251	10.1371/journal.pone.0054251	http://dx.doi.org/10.1371/journal.pone.0054251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342109	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700096
J	Tamelander, T; Reigstad, M; Olli, K; Slagstad, D; Wassmann, P				Tamelander, Tobias; Reigstad, Marit; Olli, Kalle; Slagstad, Dag; Wassmann, Paul			New Production Regulates Export Stoichiometry in the Ocean	PLOS ONE			English	Article							PARTICULATE ORGANIC-CARBON; NORTH NORWEGIAN SHELF; MARGINAL ICE-ZONE; VERTICAL FLUX; TIME-SERIES; BIOGENIC MATTER; SEASONAL-VARIATION; PARTICLES; SEA; BIOGEOCHEMISTRY	The proportion in which carbon and growth-limiting nutrients are exported from the oceans' productive surface layer to the deep sea is a crucial parameter in models of the biological carbon pump. Based on >400 vertical flux observations of particulate organic carbon (POC) and nitrogen (PON) from the European Arctic Ocean we show the common assumption of constant C:N stoichiometry not to be met. Exported POC: PON ratios exceeded the classical Redfield atomic ratio of 6.625 in the entire region, with the largest deviation in the deep Central Arctic Ocean. In this part the mean exported POC: PON ratio of 9.7 (a:a) implies c. 40% higher carbon export compared to Redfield-based estimates. When spatially integrated, the potential POC export in the European Arctic was 10-30% higher than suggested by calculations based on constant POC: PON ratios. We further demonstrate that the exported POC: PON ratio varies regionally in relation to nitrate-based new production over geographical scales that range from the Arctic to the subtropics, being highest in the least productive oligotrophic Central Arctic Ocean and subtropical gyres. Accounting for variations in export stoichiometry among systems of different productivity will improve the ability of models to resolve regional patterns in carbon export and, hence, the oceans' contribution to the global carbon cycle will be predicted more accurately.	[Tamelander, Tobias; Reigstad, Marit; Wassmann, Paul] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Olli, Kalle] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Slagstad, Dag] SINTEF Fisheries & Aquaculture, Trondheim, Norway	UiT The Arctic University of Tromso; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; SINTEF	Tamelander, T (corresponding author), CSIC, Inst Marine Sci, Barcelona, Catalonia, Spain.	tobtam@gmail.com	Reigstad, Marit/AFL-8306-2022; Olli, Kalle/G-5389-2010; Reigstad, Marit/B-2497-2013	Reigstad, Marit/0000-0002-8592-7192; Olli, Kalle/0000-0002-7943-5714; Reigstad, Marit/0000-0002-8592-7192	Research Council of Norway [184860/S30 MERCLIM]; Tromso forskningsstiftelse through the project CONFLUX	Research Council of Norway(Research Council of Norway); Tromso forskningsstiftelse through the project CONFLUX	This study was financed by the Research Council of Norway (http://www.forskningsradet.no) through the project 184860/S30 MERCLIM (T.T., D.S., P.W.) and by Tromso forskningsstiftelse through the project CONFLUX (M.R., D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado XA, 2002, DEEP-SEA RES PT I, V49, P1725, DOI 10.1016/S0967-0637(02)00094-8; Andreassen I, 1996, MAR ECOL PROG SER, V137, P215, DOI 10.3354/meps137215; Andreassen IJ, 1999, SARSIA, V84, P227, DOI 10.1080/00364827.1999.10420428; Babiker IS, 2004, J OCEANOGR, V60, P553, DOI 10.1023/B:JOCE.0000038348.66907.db; Bauerfeind E, 2005, J MARINE SYST, V56, P151, DOI 10.1016/j.jmarsys.2004.09.007; Bauerfeind E, 1997, J MARINE SYST, V10, P371, DOI 10.1016/S0924-7963(96)00069-3; Bhaskar PV, 2005, FEMS MICROBIOL ECOL, V53, P255, DOI 10.1016/j.femsec.2004.12.013; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Cianca A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003788; Conte MH, 2001, DEEP-SEA RES PT II, V48, P1471, DOI 10.1016/S0967-0645(00)00150-8; Coppola L, 2002, MAR CHEM, V80, P11, DOI 10.1016/S0304-4203(02)00071-3; Duarte CM, 2000, MAR ECOL PROG SER, V206, P87, DOI 10.3354/meps206087; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dutkiewicz S., 2009, GLOBAL BIOGEOCHEM CY, V23; Ellingsen I, 2009, OCEAN DYNAM, V59, P1095, DOI 10.1007/s10236-009-0230-5; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Forest A, 2010, DEEP-SEA RES PT I, V57, P125, DOI 10.1016/j.dsr.2009.10.002; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Hargrave BT, 2002, DEEP-SEA RES PT II, V49, P5227, DOI 10.1016/S0967-0645(02)00187-X; Hegseth EN, 2008, J MARINE SYST, V74, P108, DOI 10.1016/j.jmarsys.2007.11.011; Jakobsson M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P1; Kawakami H, 2007, J OCEANOGR, V63, P967, DOI 10.1007/s10872-007-0081-y; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Meiners K, 2003, MAR ECOL PROG SER, V248, P1, DOI 10.3354/meps248001; Neuer S, 2007, PROG OCEANOGR, V72, P1, DOI 10.1016/j.pocean.2006.08.001; Olli K, 2002, J MARINE SYST, V38, P189, DOI 10.1016/S0924-7963(02)00177-X; Olli K, 2001, PROG OCEANOGR, V51, P443, DOI 10.1016/S0079-6611(01)00079-9; Olli K, 2007, PROG OCEANOGR, V72, P84, DOI 10.1016/j.pocean.2006.08.002; Omta AW, 2009, J SEA RES, V62, P179, DOI 10.1016/j.seares.2009.06.005; OSCHLIES A, 2008, GLOBAL BIOGEOCHEM CY, V22; Reigstad M, 2007, BIOGEOCHEMISTRY, V83, P217, DOI 10.1007/s10533-007-9093-3; Reigstad M, 2008, DEEP-SEA RES PT II, V55, P2308, DOI 10.1016/j.dsr2.2008.05.007; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Schneider B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002184; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; Slagstad D, 1999, SARSIA, V84, P303, DOI 10.1080/00364827.1999.10420434; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Sundfjord A, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003524; Tamelander T, 2012, MAR ECOL PROG SER, V459, P17, DOI 10.3354/meps09733; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; Tremblay JE, 2002, DEEP-SEA RES PT II, V49, P4927, DOI 10.1016/S0967-0645(02)00171-6; Tremblay JE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004547; Wassmann P, 2006, J MARINE SYST, V59, P1, DOI 10.1016/j.jmarsys.2005.05.006; Wong CS, 2002, DEEP-SEA RES PT II, V49, P5717, DOI 10.1016/S0967-0645(02)00211-4	48	20	20	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54027	10.1371/journal.pone.0054027	http://dx.doi.org/10.1371/journal.pone.0054027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342065	Green Published, gold			2022-12-27	WOS:000313682700077
J	Yuan, Y; Wang, KY; Li, DZ; Pan, Y; Lv, YY; Zhao, MX; Gao, JJ				Yuan, Yue; Wang, Kaiyun; Li, Dezhi; Pan, Yu; Lv, Yuanyuan; Zhao, Meixia; Gao, JinJin			Interspecific Interactions between Phragmites australis and Spartina alterniflora along a Tidal Gradient in the Dongtan Wetland, Eastern China	PLOS ONE			English	Article							YANGTZE-RIVER ESTUARY; ENVIRONMENTAL-FACTORS; NUTRIENT LIMITATION; INVASIVE SPARTINA; SALT-MARSHES; COMPETITION; GROWTH; VEGETATION; SALINITY; FACILITATION	The invasive species Spartina alterniora Loisel was introduced to the eastern coast of China in the 1970s and 1980s for the purposes of land reclamation and the prevention of soil erosion. The resulting interspecific competition had an important influence on the distribution of native vegetation, which makes studying the patterns and mechanisms of the interactions between Spartina alterniora Loisel and the native species Phragmites australis (Cav.) Trin ex Steud in this region very important. There have been some researches on the interspecific interactions between P. australis and S. alterniora in the Dongtan wetland of Chongming, east China, most of which has focused on the comparison of their physiological characteristics. In this paper, we conducted a neighbor removal experiment along a tidal gradient to evaluate the relative competitive abilities of the two species by calculating their relative neighbor effect (RNE) index. We also looked at the influence of environmental stress and disturbance on the competitive abilities of the two species by comparing interaction strength (I) among different tidal zones both for P. australis and S. alterniora. Finally, we measured physiological characteristics of the two species to assess the physiological mechanisms behind their different competitive abilities. Both negative and positive interactions were found between P. australis and S. alterniora along the environmental gradient. When the direction of the competitive intensity index for P. australis and S. alterniora was consistent, the competitive or facilitative effect of S. alterniora on P. australis was stronger than that of P. australis on S. alterniora. The interspecific interactions of P. australis and S. alterniora varied with environmental conditions, as well as with the method used, to measure interspecific interactions.	[Yuan, Yue; Wang, Kaiyun; Li, Dezhi] E China Normal Univ, Key Lab Urbanizat & Ecol Restorat, Shanghai 200062, Peoples R China; [Li, Dezhi] E China Normal Univ, Natl Field Observat & Res Stn Tiantong Forest Eco, Ningbo, Zhejiang, Peoples R China; [Yuan, Yue; Li, Dezhi; Pan, Yu; Lv, Yuanyuan; Zhao, Meixia; Gao, JinJin] E China Normal Univ, Dept Environm Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; East China Normal University	Wang, KY (corresponding author), E China Normal Univ, Key Lab Urbanizat & Ecol Restorat, Shanghai 200062, Peoples R China.	1123686641@qq.com; dzli@des.ecnu.edu.cn		Yuan, Yue/0000-0002-2124-8887	National Key Technologies Research and Development Program of China [2006BAC01A14]; project of NSFC [31170387]	National Key Technologies Research and Development Program of China(National Key Technology R&D Program); project of NSFC(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies Research and Development Program of China during the 11th Five-Year Plan Period (No. 2006BAC01A14) and a project of NSFC (No. 31170387). Web site: http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CHIN AGR SCI B; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; Bockelmann AC, 2002, AQUAT BOT, V73, P211, DOI 10.1016/S0304-3770(02)00022-0; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; BUTTERY BR, 1965, J ECOL, V53, P163, DOI 10.2307/2257575; Callaway RM, 2000, AM NAT, V156, P416, DOI 10.1086/303398; Celmmbers RM, 2003, CONSERV BIOL, V26, P398; Chambers RM, 2002, MAR ECOL PROG SER, V239, P83, DOI 10.3354/meps239083; Chen JQ, 2008, J PLANT ECOL, V1, P79, DOI 10.1093/jpe/rtn007; Cheng XL, 2006, SOIL BIOL BIOCHEM, V38, P3380, DOI 10.1016/j.soilbio.2006.05.016; CURTIS JT, 1951, ECOLOGY, V32, P345, DOI 10.2307/1930427; D-r Xiao, 2010, THESIS E CHINA N U; Deng ZF, 2008, ESTUAR COAST SHELF S, V76, P818, DOI 10.1016/j.ecss.2007.08.008; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Franks SJ, 2003, PLANT ECOL, V168, P13, DOI 10.1023/A:1024450623205; Franks SJ, 2003, CAN J BOT, V81, P330, DOI [10.1139/B03-023, 10.1139/b03-023]; G-q Zhao, 2005, ASSESSMENT WETLAND E; Gan XJ, 2009, ESTUAR COAST SHELF S, V83, P211, DOI 10.1016/j.ecss.2009.03.026; Gao Y, 2009, ECOL RES, V24, P1033, DOI 10.1007/s11284-008-0577-y; [高宇 GAO Yu], 2007, [生态学报, Acta Ecologica Sinica], V27, P3752; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Gratton C, 2005, RESTOR ECOL, V13, P358, DOI 10.1111/j.1526-100X.2005.00045.x; Gusewell S, 2005, FUNCT ECOL, V19, P582, DOI 10.1111/j.1365-2435.2005.01002.x; Hastings A, 2006, THEOR POPUL BIOL, V70, P431, DOI 10.1016/j.tpb.2006.05.003; Holomuzki JR, 2010, WETL ECOL MANAG, V18, P219, DOI 10.1007/s11273-009-9161-7; Huckle JM, 2000, J ECOL, V88, P492, DOI 10.1046/j.1365-2745.2000.00464.x; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Kang H, 2009, GUANGXI SCI, V12, P451; Klimes L, 2000, FOLIA GEOBOT, V35, P403, DOI 10.1007/BF02803552; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Levine JM, 2000, ECOLOGY, V81, P3431, DOI 10.1890/0012-9658(2000)081[3431:CIIASP]2.0.CO;2; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; [李富荣 LI Furong], 2007, [生态环境, Ecology and Environment], V16, P1795; [梁霞 LIANG Xia], 2006, [生态学报, Acta Ecologica Sinica], V26, P842; Ma ZJ, 2009, ENVIRON MANAGE, V43, P1187, DOI 10.1007/s00267-008-9247-7; Markham JH, 1996, FUNCT ECOL, V10, P548; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Ngai JT, 2004, J ECOL, V92, P1001, DOI 10.1111/j.0022-0477.2004.00926.x; Quan WM, 2007, MAR ENVIRON RES, V64, P21, DOI 10.1016/j.marenvres.2006.12.005; R-h Peng, 2009, THESIS FUDAN U SHANG; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Saltonstall K, 2007, AQUAT BOT, V86, P331, DOI 10.1016/j.aquabot.2006.12.003; Sammul M, 2000, OECOLOGIA, V125, P18, DOI 10.1007/PL00008887; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Wang C, 2009, EFFECTS ENV VARIATIO; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Wang Q, 2007, J NANJING U, V43, P15; Warren RS, 2001, ESTUARIES, V24, P90, DOI 10.2307/1352816; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Welch Bradley A., 2006, Wetlands Ecology and Management, V14, P511, DOI 10.1007/s11273-006-9004-8; Williams AC, 2001, ECOL RES, V16, P29, DOI 10.1046/j.1440-1703.2001.00368.x; Wilson MV, 2007, J ECOL, V95, P301, DOI 10.1111/j.1365-2745.2007.01215.x; Windham L., 1999, Biological Invasions, V1, P137, DOI 10.1023/A:1010016319074; Windham L, 1999, ESTUARIES, V22, P927, DOI 10.2307/1353072; Xiao DR, 2009, ESTUAR COAST SHELF S, V83, P105, DOI 10.1016/j.ecss.2009.03.024; [肖强 Xiao Qiang], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P373; Yang XG, 2008, PROG NAT SCI-MATER, V18, P901, DOI 10.1016/j.pnsc.2008.01.032; Yuan L, 2008, ACTA ECOLOGICA SINIC, V28, P5724; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zeng DeHui, 2005, Acta Phytoecologica Sinica, V29, P1007; Zhao B, 2009, ECOL INDIC, V9, P346, DOI 10.1016/j.ecolind.2008.05.009; Zhao Cong-Jiao, 2008, Zhiwu Shengtai Xuebao, V32, P392, DOI 10.3773/j.issn.1005-264x.2008.02.017; Zhao YJ, 2010, HYDROBIOLOGIA, V637, P143, DOI 10.1007/s10750-009-9992-5	69	16	16	5	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53843	10.1371/journal.pone.0053843	http://dx.doi.org/10.1371/journal.pone.0053843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342017	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700050
J	Yuzefovych, LV; Musiyenko, SI; Wilson, GL; Rachek, LI				Yuzefovych, Larysa V.; Musiyenko, Sergiy I.; Wilson, Glenn L.; Rachek, Lyudmila I.			Mitochondrial DNA Damage and Dysfunction, and Oxidative Stress Are Associated with Endoplasmic Reticulum Stress, Protein Degradation and Apoptosis in High Fat Diet-Induced Insulin Resistance Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; KINASE ACTIVATION; LIPID-CONTENT; PALMITATE; OBESITY; LIVER; EXPRESSION; AUTOPHAGY; DISEASE; RODENTS	Background: Recent studies showed a link between a high fat diet (HFD)-induced obesity and lipid accumulation in non-adipose tissues, such as skeletal muscle and liver, and insulin resistance (IR). Although the mechanisms responsible for IR in those tissues are different, oxidative stress and mitochondrial dysfunction have been implicated in the disease process. We tested the hypothesis that HFD induced mitochondrial DNA (mtDNA) damage and that this damage is associated with mitochondrial dysfunction, oxidative stress, and induction of markers of endoplasmic reticulum (ER) stress, protein degradation and apoptosis in skeletal muscle and liver in a mouse model of obesity-induced IR. Methodology/Principal Findings: C57BL/6J male mice were fed either a HFD (60% fat) or normal chow (NC) (10% fat) for 16 weeks. We found that HFD-induced IR correlated with increased mtDNA damage, mitochondrial dysfunction and markers of oxidative stress in skeletal muscle and liver. Also, a HFD causes a change in the expression level of DNA repair enzymes in both nuclei and mitochondria in skeletal muscle and liver. Furthermore, a HFD leads to activation of ER stress, protein degradation and apoptosis in skeletal muscle and liver, and significantly reduced the content of two major proteins involved in insulin signaling, Akt and IRS-1 in skeletal muscle, and Akt in liver. Basal p-Akt level was not significantly influenced by HFD feeding in skeletal muscle and liver. Conclusions/Significance: This study provides new evidence that HFD-induced mtDNA damage correlates with mitochondrial dysfunction and increased oxidative stress in skeletal muscle and liver, which is associated with the induction of markers of ER stress, protein degradation and apoptosis.	[Yuzefovych, Larysa V.; Musiyenko, Sergiy I.; Wilson, Glenn L.; Rachek, Lyudmila I.] Univ S Alabama, Dept Neurosci & Cell Biol, Mobile, AL 36688 USA	University of South Alabama	Rachek, LI (corresponding author), Univ S Alabama, Dept Neurosci & Cell Biol, Mobile, AL 36688 USA.	lrachek@jaguar1.usouthal.edu			National Institutes of Health [DK073808]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grants DK073808 (L.I.R.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790; Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Driggers WJ, 1997, NUCLEIC ACIDS RES, V25, P4362, DOI 10.1093/nar/25.21.4362; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Grishko V. I., 2007, FREE RADIC BIOL MED, V38, P755; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Tyrberg Bjorn, 2002, BMC Endocr Disord, V2, P2, DOI 10.1186/1472-6823-2-2; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wang Y, 2008, J NUTR, V138, P1866, DOI 10.1093/jn/138.10.1866; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	35	191	198	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54059	10.1371/journal.pone.0054059	http://dx.doi.org/10.1371/journal.pone.0054059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342074	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700081
J	Bai, LP; Ho, HM; Ma, DL; Yang, H; Fu, WC; Jiang, ZH				Bai, Li-Ping; Ho, Hing-Man; Ma, Dik-Lung; Yang, Hui; Fu, Wai-Chung; Jiang, Zhi-Hong			Aminoglycosylation Can Enhance the G-Quadruplex Binding Activity of Epigallocatechin	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; GREEN TEA; DNA; RECOGNITION; POLYPHENOL; LIGANDS; TARGETS; DESIGN; REGION; EGCG	With the aim of enhancing G-quadruplex binding activity, two new glucosaminosides (16, 18) of penta-methylated epigallocatechin were synthesized by chemical glycosylation. Subsequent ESI-TOF-MS analysis demonstrated that these two glucosaminoside derivatives exhibit much stronger binding activity to human telomeric DNA and RNA G-quadruplexes than their parent structure (i.e., methylated EGC) (14) as well as natural epigallocatechin (EGC, 6). The DNA G-quadruplex binding activity of 16 and 18 is even more potent than strong G-quadruplex binder quercetin, which has a more planar structure. These two synthetic compounds also showed a higher binding strength to human telomeric RNA G-quadruplex than its DNA counterpart. Analysis of the structure-activity relationship revealed that the more basic compound, 16, has a higher binding capacity with DNA and RNA G-quadruplexes than its N-acetyl derivative, 18, suggesting the importance of the basicity of the aminoglycoside for G-quadruplex binding activity. Molecular docking simulation predicted that the aromatic ring of 16 pi-stacks with the aromatic ring of guanine nucleotides, with the glucosamine moiety residing in the groove of G-quadruplex. This research indicates that glycosylation of natural products with aminosugar can significantly enhance their G-quadruplex binding activities, thus is an effective way to generate small molecules targeting G-quadruplexes in nucleic acids. In addition, this is the first report that green tea catechin can bind to nucleic acid G-quadruplex structures.	[Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Peoples R China; [Bai, Li-Ping; Ho, Hing-Man] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Ma, Dik-Lung; Yang, Hui; Fu, Wai-Chung] Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong, Peoples R China	Macau University of Science & Technology; Macau University of Science & Technology; Hong Kong Baptist University; Hong Kong Baptist University	Jiang, ZH (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	zhjiang@must.edu.mo	Fu, Wai-Chung/C-4487-2013; BAI, Li-Ping/O-5691-2016; Fu, Wai Chung/HGC-1135-2022	Fu, Wai-Chung/0000-0002-7181-0057; BAI, Li-Ping/0000-0002-2806-6883; Fu, Wai Chung/0000-0002-7181-0057; Ma, Dik-Lung/0000-0002-9515-340X; Jiang, Zhi-Hong/0000-0002-7956-2481	Macao Foundation [0205, 0199]	Macao Foundation	This work was financially supported by a grant from the Macao Foundation (grant numbers 0205 and 0199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arola A, 2008, CURR TOP MED CHEM, V8, P1405, DOI 10.2174/156802608786141106; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Arya DP, 2003, J AM CHEM SOC, V125, P8070, DOI 10.1021/ja034241t; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bai LP, 2008, CHEMBIOCHEM, V9, P2583, DOI 10.1002/cbic.200800256; Bai LP, 2008, ANAL BIOANAL CHEM, V392, P709, DOI 10.1007/s00216-008-2302-7; Baker ES, 2006, INT J MASS SPECTROM, V253, P225, DOI 10.1016/j.ijms.2006.03.016; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Collie G, 2009, CHEM COMMUN, P7482, DOI 10.1039/b901889a; Collie GW, 2010, J AM CHEM SOC, V132, P9328, DOI 10.1021/ja100345z; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Daniel JM, 2002, INT J MASS SPECTROM, V216, P1, DOI 10.1016/S1387-3806(02)00585-7; Deng SJ, 1999, J ORG CHEM, V64, P7265, DOI 10.1021/jo990603x; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fang MZ, 2003, CANCER RES, V63, P7563; Gabelica V, 1999, J MASS SPECTROM, V34, P1328, DOI 10.1002/(SICI)1096-9888(199912)34:12<1328::AID-JMS889>3.0.CO;2-F; Gunaherath GMKB, 1981, J NAT PRODUCTS, V45, P140; He H, 2012, BIOORG MED CHEM LETT, V22, P1582, DOI 10.1016/j.bmcl.2011.12.143; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Ikeda T, 1997, J NAT PROD, V60, P102, DOI 10.1021/np960556t; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; La Ferla B, 2011, NAT PROD REP, V28, P630, DOI 10.1039/c0np00055h; Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liu LL, 2008, TETRAHEDRON, V64, P5885, DOI 10.1016/j.tet.2008.04.047; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Ma DL, 2008, CHEMMEDCHEM, V3, P881, DOI 10.1002/cmdc.200700342; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phosrithong N, 2010, MED CHEM RES, V19, P817, DOI 10.1007/s00044-009-9233-5; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Schmidt CA, 2010, J NAT PROD, V73, P2035, DOI 10.1021/np100523s; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Shaw NN, 2008, BIOORG MED CHEM LETT, V18, P4142, DOI 10.1016/j.bmcl.2008.05.090; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sun HX, 2006, BIOORG MED CHEM LETT, V16, P3586, DOI 10.1016/j.bmcl.2006.03.087; Tan JH, 2008, MINI-REV MED CHEM, V8, P1163, DOI 10.2174/138955708785909880; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wan KX, 2000, J AM CHEM SOC, V122, P300, DOI 10.1021/ja990684e; Willis B, 2010, BIOCHEMISTRY-US, V49, P452, DOI 10.1021/bi9016796; Wrodnigg TM, 2006, J CARBOHYD CHEM, V25, P33, DOI 10.1080/07328300500495795; Xi Z, 2002, CHEM BIOL, V9, P925, DOI 10.1016/S1074-5521(02)00188-6; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14579, DOI 10.1073/pnas.1001177107; Xue L, 2002, CHEM COMMUN, P70, DOI 10.1039/b108171c; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Xue LA, 2010, BIOCHEMISTRY-US, V49, P5540, DOI 10.1021/bi100071j; Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536; Zhang HY, 2012, MOL BIOSYST, V8, P3208, DOI 10.1039/c2mb25126d	57	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53962	10.1371/journal.pone.0053962	http://dx.doi.org/10.1371/journal.pone.0053962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335983	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700041
J	de Almeida, RA; Fogli, A; Gaillard, M; Scheper, GC; Boesflug-Tanguy, O; Pavitt, GD				de Almeida, Rogerio A.; Fogli, Anne; Gaillard, Marina; Scheper, Gert C.; Boesflug-Tanguy, Odile; Pavitt, Graham D.			A Yeast Purification System for Human Translation Initiation Factors eIF2 and eIF2B epsilon and Their Use in the Diagnosis of CACH/VWM Disease	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; VANISHING WHITE-MATTER; FACTOR 2B COMPLEX; CHILDHOOD ATAXIA; IN-VIVO; MULTIFACTOR COMPLEX; CATALYTIC DOMAIN; NATURAL-HISTORY; EPSILON-SUBUNIT; PHOSPHORYLATION	Recessive inherited mutations in any of five subunits of the general protein synthesis factor eIF2B are responsible for a white mater neurodegenerative disease with a large clinical spectrum. The classical form is called Childhood Ataxia with CNS hypomyelination (CACH) or Vanishing White Matter Leukoencephalopathy (VWM). eIF2B-related disorders affect glial cells, despite the fact that eIF2B is a ubiquitous protein that functions as a guanine-nucleotide exchange factor (GEF) for its partner protein eIF2 in the translation initiation process in all eukaryotic cells. Decreased eIF2B activity measured by a GEF assay in patients' immortalised lymphocytic cells provides a biochemical diagnostic assay but is limited by the availability of eIF2 protein, which is classically purified from a mammalian cell source by column chromatography. Here we describe the generation of a recombinant expression system to produce purified human eIF2 from yeast cells. We demonstrate that human eIF2 can function in yeast cells in place of the equivalent yeast factor. We purify human eIF2 and the C-terminal domain of human eIF2B epsilon using affinity chromatography from engineered yeast cells and find that both function in a GEF assay: the first demonstration that this human eIF2Be domain has GEF function. We show that CACH/VWM mutations within this domain reduce its activity. Finally we demonstrate that the recombinant eIF2 functions similarly to eIF2 purified from rat liver in GEF assays with CACH/VWM eIF2B-mutated patient derived lymphocytic cells.	[de Almeida, Rogerio A.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Fogli, Anne; Gaillard, Marina] INSERM U1103 CNRS 6293, Lab GReD Genet Reprod & Dev, Fac Med, Clermont Ferrand, France; [Fogli, Anne] Univ Clermont, UFR Med, Clermont Ferrand, France; [Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France; [Scheper, Gert C.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Boesflug-Tanguy, Odile] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Boesflug-Tanguy, Odile] Univ Paris Diderot, UMR U676, Paris, France; [Boesflug-Tanguy, Odile] Hop Robert Debre, APHP, Reference Ctr Leukodystrophies, F-75019 Paris, France	University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	graham.pavitt@manchester.ac.uk	Scheper, Gert C/D-7001-2014; Fogli, Anne/AAL-6640-2020; Pavitt, Graham D/A-1363-2010	Fogli, Anne/0000-0002-2651-7441; Pavitt, Graham D/0000-0002-8593-2418	European Leukodystrophy association (ELA) [ELA 2009-034I5]; European Union EU-FP7 Health project Leukotreat [241622]	European Leukodystrophy association (ELA); European Union EU-FP7 Health project Leukotreat	European Leukodystrophy association (ELA) ela-asso.com; grant: ELA 2009-034I5 to GDP, and The European Union EU-FP7 Health project Leukotreat 241622; http://www.leukotreat.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Carter Z, 2010, YEAST, V27, P765, DOI 10.1002/yea.1774; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Elsby R, 2011, J VIROL, V85, P9716, DOI 10.1128/JVI.05146-11; Erickson FL, 1996, EMBO J, V15, P6311, DOI 10.1002/j.1460-2075.1996.tb01021.x; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042688; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; GOSS DJ, 1984, J BIOL CHEM, V259, P7374; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Huyghe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038264; Jennings Martin D, 2010, Small GTPases, V1, P118, DOI 10.4161/sgtp.1.2.13783; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Kaczorowska M, 2006, EUR J PAEDIATR NEURO, V10, P192, DOI 10.1016/j.ejpn.2006.05.008; KIMBALL SR, 1987, J BIOL CHEM, V262, P2220; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Leng XR, 2011, J HUM GENET, V56, P300, DOI 10.1038/jhg.2011.9; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu AR, 2011, HUM MUTAT; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Pronk JC, 2006, MENT RETARD DEV D R, V12, P123, DOI 10.1002/mrdd.20104; Reid PJ, 2012, J BIOL CHEM, V287, P8275, DOI 10.1074/jbc.M111.331645; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Singh CR, 2007, J MOL BIOL, V370, P315, DOI 10.1016/j.jmb.2007.04.034; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; van der Lei HDW, 2010, NEUROLOGY, V75, P1555, DOI 10.1212/WNL.0b013e3181f962ae; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; Wei J, 2010, PROTEIN CELL, V1, P595, DOI 10.1007/s13238-010-0070-6; Williams DD, 2001, J BIOL CHEM, V276, P3733, DOI 10.1074/jbc.M008041200; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234	59	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53958	10.1371/journal.pone.0053958	http://dx.doi.org/10.1371/journal.pone.0053958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335982	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700040
J	Lin, HV; Chen, DL; Shen, Z; Zhu, L; Ouyang, XS; Vongs, A; Kan, YQ; Levorse, JM; Kowalik, EJ; Szeto, DM; Yao, XR; Xiao, JY; Chen, S; Liu, J; Garcia-Calvo, M; Shin, MK; Pinto, S				Lin, Hua V.; Chen, Dunlu; Shen, Zhu; Zhu, Lei; Ouyang, Xuesong; Vongs, Aurawan; Kan, Yanqing; Levorse, John M.; Kowalik, Edward J., Jr.; Szeto, Daphne M.; Yao, Xiaorui; Xiao, Jianying; Chen, Shirley; Liu, Jinqi; Garcia-Calvo, Marga; Shin, Myung K.; Pinto, Shirly			Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release	PLOS ONE			English	Article							FED HIGH-FAT; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; MICE; POTENT; METABOLISM; ABSORPTION; EXPRESSION; STEATOSIS; INTESTINE	Diacylglycerol acyltransferase-1 (DGAT1) is a potential therapeutic target for treatment of obesity and related metabolic diseases. However, the degree of DGAT1 inhibition required for metabolic benefits is unclear. Here we show that partial DGAT1 deficiency in mice suppressed postprandial triglyceridemia, led to elevations in glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) only following meals with very high lipid content, and did not protect from diet-induced obesity. Maximal DGAT1 inhibition led to enhanced GLP-1 and PYY secretion following meals with physiologically relevant lipid content. Finally, combination of DGAT1 inhibition with dipeptidyl-peptidase-4 (DPP-4) inhibition led to further enhancements in active GLP-1 in mice and dogs. The current study suggests that targeting DGAT1 to enhance postprandial gut hormone secretion requires maximal inhibition, and suggests combination with DPP-4i as a potential strategy to develop DGAT1 inhibitors for treatment of metabolic diseases.	[Lin, Hua V.; Chen, Dunlu; Shen, Zhu; Zhu, Lei; Vongs, Aurawan; Kan, Yanqing; Levorse, John M.; Kowalik, Edward J., Jr.; Szeto, Daphne M.; Yao, Xiaorui; Xiao, Jianying; Chen, Shirley; Liu, Jinqi; Garcia-Calvo, Marga; Shin, Myung K.; Pinto, Shirly] Merck Res Labs, Rahway, NJ USA	Merck & Company	Pinto, S (corresponding author), Merck Res Labs, Rahway, NJ USA.	shirly_pinto@merck.com		Lin, Hua/0000-0001-5001-5567				Ables GP, 2012, J LIPID RES; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Bray GA, 2008, J CLIN ENDOCR METAB, V93, pS81, DOI 10.1210/jc.2008-1294; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao J, 2011, J BIOL CHEM; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Donovan MJ, 2007, PHYSIOL BEHAV, V92, P969, DOI 10.1016/j.physbeh.2007.07.003; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Enayetallah AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027009; Haas JT, 2012, J CLIN INVEST; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; KRASPER H, 1970, DIGESTION, V3, P321, DOI 10.1159/000197052; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Liu JGJ, 2012, OBESITY IN PRESS, DOI [10.1002/oby.20193, DOI 10.1002/0BY.20193]; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184; Novartis, 2011, 12 WEEK MULT RAND DO; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Richard CD, 2011, EUR J PHARMACOL, V660, P131, DOI 10.1016/j.ejphar.2010.12.022; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; WILSON MD, 1994, J LIPID RES, V35, P943; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54480	10.1371/journal.pone.0054480	http://dx.doi.org/10.1371/journal.pone.0054480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336002	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700060
J	SanGiovanni, JP; Chen, J; Sapieha, P; Aderman, CM; Stahl, A; Clemons, TE; Chew, EY; Smith, LEH				SanGiovanni, John Paul; Chen, Jing; Sapieha, Przemyslaw; Aderman, Christopher M.; Stahl, Andreas; Clemons, Traci E.; Chew, Emily Y.; Smith, Lois E. H.			DNA Sequence Variants in PPARGC1A, a Gene Encoding a Coactivator of the omega-3 LCPUFA Sensing PPAR-RXR Transcription Complex, Are Associated with NV AMD and AMD-Associated Loci in Genes of Complement and VEGF Signaling Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED-RECEPTOR-GAMMA; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; MESSENGER-RNA; FATTY-ACIDS; POLYMORPHISMS; RISK; EXPRESSION	Background: Increased intake of omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) and use of peroxisome proliferator activator receptor (PPAR)-activating drugs are associated with attenuation of pathologic retinal angiogenesis. omega-3 LCPUFAs are endogenous agonists of PPARs. We postulated that DNA sequence variation in PPAR gamma (PPARG) co-activator 1 alpha (PPARGC1A), a gene encoding a co-activator of the LCPUFA-sensing PPARG-retinoid X receptor (RXR) transcription complex, may influence neovascularization (NV) in age-related macular degeneration (AMD). Methods: We applied exact testing methods to examine distributions of DNA sequence variants in PPARGC1A for association with NV AMD and interaction of AMD-associated loci in genes of complement, lipid metabolism, and VEGF signaling systems. Our sample contained 1858 people from 3 elderly cohorts of western European ancestry. We concurrently investigated retinal gene expression profiles in 17-day-old neonatal mice on a 2% LCPUFA feeding paradigm to identify LCPUFA-regulated genes both associated with pathologic retinal angiogenesis and known to interact with PPARs or PPARGC1A. Results: A DNA coding variant (rs3736265) and a 3'UTR-resident regulatory variant (rs3774923) in PPARGC1A were independently associated with NV AMD (exact P = 0.003, both SNPs). SNP-SNP interactions existed for NV AMD (P<0.005) with rs3736265 and a AMD-associated variant in complement factor B (CFB, rs512559). PPARGC1A influences activation of the AMD-associated complement component 3 (C3) promoter fragment and CFB influences activation and proteolysis of C3. We observed interaction (P <= 0.003) of rs3736265 with a variant in vascular endothelial growth factor A (VEGFA, rs3025033), a key molecule in retinal angiogenesis. Another PPARGC1A coding variant (rs8192678) showed statistical interaction with a SNP in the VEGFA receptor fms-related tyrosine kinase 1 (FLT1, rs10507386; P <= 0.003). C3 expression was down-regulated 2-fold in retinas of omega-3 LCPUFA-fed mice - these animals also showed 70% reduction in retinal NV (P <= 0.001). Conclusion: Ligands and co-activators of the omega-3 LCPUFA sensing PPAR-RXR axis may influence retinal angiogenesis in NV AMD via the complement and VEGF signaling systems. We have linked the co-activator of a lipid-sensing transcription factor (PPARG co-activator 1 alpha, PPARGC1A) to age-related macular degeneration (AMD) and AMD-associated genes.	[SanGiovanni, John Paul; Chew, Emily Y.] NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Chen, Jing; Aderman, Christopher M.; Smith, Lois E. H.] Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Sapieha, Przemyslaw] Univ Montreal, Dept Ophthalmol, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Stahl, Andreas] Univ Eye Hosp Freiburg, Dept Ophthalmol, Freiburg, Germany; [Clemons, Traci E.] EMMES Corp, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal; University of Freiburg; Emmes Corporation	SanGiovanni, JP (corresponding author), NEI, Clin Trials Branch, NIH, Bethesda, MD 20892 USA.	jpsangio@post.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020		National Eye Institute; Research to Prevent Blindness; Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes); Deutsche Forschungsgemeinschaft; Freifrau von Nauendorf Stiftung; Deutsche Ophthalmologische Gesellschaft; National Institutes of Health [NIH-P50-NS40828, NIH-P30-HD18655];  [EY017017]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes)(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Freifrau von Nauendorf Stiftung; Deutsche Ophthalmologische Gesellschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding support for NEI-AMD was provided by the National Eye Institute (JPSG); EY017017 and Research to Prevent Blindness (RPB) Senior Investigator Award (LEHS). Additional support was provided by Children's Hospital Ophthalmology Foundation and Charles H. Hood Foundation (JC), the Canadian Institues of Health Research (Institute of Nutrition, Metabolism and Diabetes) (PS) and the Deutsche Forschungsgemeinschaft, Freifrau von Nauendorf Stiftung and Deutsche Ophthalmologische Gesellschaft (AS). Mouse microarray studies were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by National Institutes of Health NIH-P50-NS40828, and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LN, 2012, GRAEF ARCH CLIN EXP, V250, P185, DOI 10.1007/s00417-011-1807-5; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Brion M, 2011, ACTA OPHTHALMOL, V89, pE12, DOI 10.1111/j.1755-3768.2010.02040.x; Cano MD, 2008, PPAR RES, V2008, DOI 10.1155/2008/821592; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Galan A, 2010, OPHTHALMOLOGY, V117, P1769, DOI 10.1016/j.ophtha.2010.01.030; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hageman G.S., 2008, WEBVISION ORG RETINA; Halapin NA, 2010, NEUROCHEM RES, V35, P1944, DOI 10.1007/s11064-010-0351-8; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Koto T, 2007, INVEST OPHTH VIS SCI, V48, P4328, DOI 10.1167/iovs.06-1148; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Menon G, 2009, EYE, V23, pS1, DOI 10.1038/eye.2009.13; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pershadsingh HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/164273; Prevent Blindness America [PBA], 2017, EC IMPACT VISION PRO; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Qu Y, 2011, OPHTHALMIC RES, V45, P142, DOI 10.1159/000319543; Richardson AJ, 2007, MOL VIS, V13, P2148; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; SanGiovanni JP, 2009, AM J CLIN NUTR, V90, P1601, DOI 10.3945/ajcn.2009.27594; SanGiovanni JP, 2009, ARCH OPHTHALMOL-CHIC, V127, P110, DOI 10.1001/archophthalmol.2008.518; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sheets KG, 2010, MOL VIS, V16, P320; Smailhodzic D, 2012, OPHTHALMOLOGY; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317; Subramanian ML, 2009, AM J OPHTHALMOL, V148, P875, DOI 10.1016/j.ajo.2009.07.009; Takeda AL, 2007, BRIT J OPHTHALMOL, V91, P1177, DOI 10.1136/bjo.2007.118562; Vanden Heuvel JP, 2012, PROG MOL BIOL TRANSL, V108, P75, DOI 10.1016/B978-0-12-398397-8.00004-6; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2; Wang JJ, 2009, AM J EPIDEMIOL, V169, P633, DOI 10.1093/aje/kwn358; Weikel KA, 2012, MOL ASPECTS MED, V33, P318, DOI 10.1016/j.mam.2012.03.005; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070	61	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53155	10.1371/journal.pone.0053155	http://dx.doi.org/10.1371/journal.pone.0053155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335958	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700012
J	Bai, ZY; Zheng, HF; Lin, JY; Wang, GL; Li, JL				Bai, Zhiyi; Zheng, Hanfeng; Lin, Jingyun; Wang, Guiling; Li, Jiale			Comparative Analysis of the Transcriptome in Tissues Secreting Purple and White Nacre in the Pearl Mussel Hyriopsis cumingii	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; COILED-COIL DOMAINS; CALCIUM-CARBONATE; SHELL MATRIX; KEY MACROMOLECULE; RNA-SEQ; PROTEIN; GENES; BONE; IDENTIFICATION	The triangle sail mussel Hyriopsis cumingii (Lea) is the most important mussel species used for commercial freshwater pearl production in China. Mussel color is an important indicator of pearl quality. To identify genes involved in the nacre coloring, we conducted RNA-seq and obtained 541,268 sequences (298 bp average size) and 440,034 sequences (293 bp average size) in secreting purple and white nacre libraries (P-and W-libraries), respectively. The 981,302 Expressed Sequence Tags (ESTs) were assembled into 47,812 contigs and 289,386 singletons. In BLASTP searches of the deduced protein, 22,495 were proteins with functional annotations. Thirty-three genes involved in pearl or shell formation were identified. Digital expression analysis identified a total of 358 differentially expressed genes, and 137 genes in the P-library and 221 genes in the W-library showed significantly higher expression. Furthermore, a set of SSR motifs and SNPs between the two samples was identified from the ESTs, which provided the markers for genetic linkage, QTL analysis and future breeding. These EST sequences provided valuable information to further understand the molecular mechanisms involved in the formation, color determination and evolution of the pearl or shell.	[Bai, Zhiyi; Zheng, Hanfeng; Lin, Jingyun; Wang, Guiling; Li, Jiale] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Zheng, Hanfeng] Chinese Acad Fishery Sci, E China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Aquaculture Div, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.	jlli@shou.edu.cn	li, jia/GVT-7587-2022		National Science and technology support program [2012BAD26B04]; National Natural Science Foundation of China [31001110]; Agricultural Industry Special Project in the Public Interest from Ministry of Agriculture [200903028]; Basic Research Project from Shanghai City Committee of Science and Technology [10JC1406300]; Shanghai Rising-Star Program [12QA1401400]; Doctoral Research Fund from Shanghai Ocean University [B-8812-10-0001-0191]	National Science and technology support program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Industry Special Project in the Public Interest from Ministry of Agriculture; Basic Research Project from Shanghai City Committee of Science and Technology; Shanghai Rising-Star Program; Doctoral Research Fund from Shanghai Ocean University	This study was supported by the National Science and technology support program (2012BAD26B04), the National Natural Science Foundation of China (31001110), the Agricultural Industry Special Project in the Public Interest from Ministry of Agriculture (200903028), the Basic Research Project from Shanghai City Committee of Science and Technology (10JC1406300), Shanghai Rising-Star Program (12QA1401400) and the Doctoral Research Fund from Shanghai Ocean University (B-8812-10-0001-0191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Bai ZY, 2010, J SHELLFISH RES, V29, P527, DOI 10.2983/035.029.0232; Bai ZY, 2009, MAR BIOTECHNOL, V11, P520, DOI 10.1007/s10126-008-9163-0; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Gong NP, 2008, MAR BIOTECHNOL, V10, P457, DOI 10.1007/s10126-008-9081-1; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Ji L, 2012, AQUACULTURE RES; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karampelas S, 2009, EUR J MINERAL, V21, P85, DOI 10.1127/0935-1221/2009/0021-1897; Lallier TE, 2004, J DENT RES, V83, P677, DOI 10.1177/154405910408300904; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li J., 2009, WORLD AQUAC, V40, P60; Li JiaLe, 2011, Journal of Fisheries of China, V35, P1753; Liu Y.Y., 1979, EC FAUNA CHINA FRESH; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Moreau A, 1998, MOL CELL BIOL, V18, P1312, DOI 10.1128/MCB.18.3.1312; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028; Samata Tetsuro, 2004, Thalassas, V20, P25; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Schnorr O, 2003, J INVEST DERMATOL, V120, P1016, DOI 10.1046/j.1523-1747.2003.12139.x; Schrauwen I, 2009, AM J HUM GENET, V84, P328, DOI 10.1016/j.ajhg.2009.01.023; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Seth A, 2000, J BONE MINER RES, V15, P1683, DOI 10.1359/jbmr.2000.15.9.1683; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; Yang M.Y., 2004, J GEMS GEMMOLOGY, P10; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	70	74	84	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53617	10.1371/journal.pone.0053617	http://dx.doi.org/10.1371/journal.pone.0053617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341956	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400053
J	Christopherson, MR; Suen, G; Bramhacharya, S; Jewell, KA; Aylward, FO; Mead, D; Brumm, PJ				Christopherson, Melissa R.; Suen, Garret; Bramhacharya, Shanti; Jewell, Kelsea A.; Aylward, Frank O.; Mead, David; Brumm, Phillip J.			The Genome Sequences of Cellulomonas fimi and "Cellvibrio gilvus" Reveal the Cellulolytic Strategies of Two Facultative Anaerobes, Transfer of "Cellvibrio gilvus" to the Genus Cellulomonas, and Proposal of Cellulomonas gilvus sp nov	PLOS ONE			English	Article							PROTEIN; CELLULASE; ENZYME; PURIFICATION; FLAVIGENA; BACTERIUM; IDENTIFICATION; GROWTH; GENES; CELLOBIOHYDROLASE	Actinobacteria in the genus Cellulomonas are the only known and reported cellulolytic facultative anaerobes. To better understand the cellulolytic strategy employed by these bacteria, we sequenced the genome of the Cellulomonas fimi ATCC 484(T). For comparative purposes, we also sequenced the genome of the aerobic cellulolytic "Cellvibrio gilvus" ATCC 13127(T). An initial analysis of these genomes using phylogenetic and whole-genome comparison revealed that "Cellvibrio gilvus" belongs to the genus Cellulomonas. We thus propose to assign "Cellvibrio gilvus" to the genus Cellulomonas. A comparative genomics analysis between these two Cellulomonas genome sequences and the recently completed genome for Cellulomonas flavigena ATCC 482(T) showed that these cellulomonads do not encode cellulosomes but appear to degrade cellulose by secreting multi-domain glycoside hydrolases. Despite the minimal number of carbohydrate-active enzymes encoded by these genomes, as compared to other known cellulolytic organisms, these bacteria were found to be proficient at degrading and utilizing a diverse set of carbohydrates, including crystalline cellulose. Moreover, they also encode for proteins required for the fermentation of hexose and xylose sugars into products such as ethanol. Finally, we found relatively few significant differences between the predicted carbohydrate-active enzymes encoded by these Cellulomonas genomes, in contrast to previous studies reporting differences in physiological approaches for carbohydrate degradation. Our sequencing and analysis of these genomes sheds light onto the mechanism through which these facultative anaerobes degrade cellulose, suggesting that the sequenced cellulomonads use secreted, multidomain enzymes to degrade cellulose in a way that is distinct from known anaerobic cellulolytic strategies.	[Christopherson, Melissa R.; Suen, Garret; Bramhacharya, Shanti; Jewell, Kelsea A.; Aylward, Frank O.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Aylward, Frank O.; Mead, David; Brumm, Phillip J.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53715 USA; [Mead, David] Lucigen, Middleton, WI USA; [Brumm, Phillip J.] C5 6 Technol, Middleton, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Brumm, PJ (corresponding author), Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53715 USA.	pbrumm@c56technologies.com	Suen, Garret/AAF-2080-2019; Jewell, Kelsea/AGG-9303-2022	Suen, Garret/0000-0002-6170-711X; MEAD, David/0000-0003-1982-9356; Aylward, Frank/0000-0002-1279-4050	DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE BER Early Career Research Program [DE-SC0008104]; Wisconsin Bioenergy Initiative; DOE GLBRC/BACTER; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; GLBRC	DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE BER Early Career Research Program(United States Department of Energy (DOE)); Wisconsin Bioenergy Initiative; DOE GLBRC/BACTER(United States Department of Energy (DOE)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); GLBRC	This work was funded in part by the DOE Great Lakes Bioenergy Research Center (GLBRC) (DOE BER Office of Science DE-FC02-07ER64494) supporting FOA, DM, and PJB. This work was also supported by a DOE BER Early Career Research Program Award DE-SC0008104 and funding from the Wisconsin Bioenergy Initiative to GS. MRC was supported by a DOE GLBRC/BACTER Post-doctoral Research Fellowship. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. All work performed by employees of Lucigen or C5-6 Technologies was performed under and supported by subcontract to the GLBRC. Neither corporation was a funder of the work; no funds of either corporation was used for this research or to support the researchers during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2010, STAND GENOMIC SCI, V3, P15, DOI 10.4056/sigs.1012662; AKHTAR MW, 1988, GENE, V74, P549, DOI 10.1016/0378-1119(88)90188-6; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; BISHOP DHL, 1962, BIOCHEM J, V83, P606, DOI 10.1042/bj0830606; BREUIL C, 1976, CAN J MICROBIOL, V22, P1776, DOI 10.1139/m76-264; Buller C. S., 1990, US patent, Patent No. [4,908,310, 4908310]; CHOI WY, 1978, AUST J BIOL SCI, V31, P553, DOI 10.1071/BI9780553; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; CLEMMER JE, 1986, BIOTECHNOL LETT, V8, P823, DOI 10.1007/BF01020832; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; DERMOUN Z, 1988, J BACTERIOL, V170, P2827, DOI 10.1128/jb.170.6.2827-2831.1988; DIN N, 1990, ARCH MICROBIOL, V153, P129, DOI 10.1007/BF00247809; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ewing RM, 1998, PLANT MOL BIOL, V36, P593, DOI 10.1023/A:1005947306667; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HAGA K, 1991, AGR BIOL CHEM TOKYO, V55, P1959, DOI 10.1080/00021369.1991.10870897; Han C., 2006, P 2006 INT C BIOINF, P141; Hazlewood GP, 1998, BIOCHEM SOC T, V26, P185, DOI 10.1042/bst0260185; Himmel ME, 2010, BIOFUELS-UK, V1, P323, DOI 10.4155/bfs.09.25; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HULCHER FH, 1958, J BACTERIOL, V76, P565, DOI 10.1128/JB.76.6.565-570.1958; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keddie KM, 1974, BERGEYS MANUAL DETER; Kenyon WJ, 2005, ANTON LEEUW INT J G, V87, P143, DOI 10.1007/s10482-004-2346-4; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEINKE A, 1994, MOL MICROBIOL, V12, P413, DOI 10.1111/j.1365-2958.1994.tb01030.x; Mejia-Castillo T, 2008, BIOTECHNOL LETT, V30, P681, DOI 10.1007/s10529-007-9589-x; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Novick RP, 2000, TRENDS MICROBIOL, V8, P148, DOI 10.1016/S0966-842X(00)01741-8; ONEILL GP, 1986, GENE, V44, P331, DOI 10.1016/0378-1119(86)90198-8; OWOLABI JB, 1988, APPL ENVIRON MICROB, V54, P518, DOI 10.1128/AEM.54.2.518-523.1988; Perez-Avalos O, 2008, CURR MICROBIOL, V57, P39, DOI 10.1007/s00284-008-9149-1; Pokusaeva K, 2011, APPL ENVIRON MICROB, V77, P1681, DOI 10.1128/AEM.01786-10; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SAMI AJ, 1990, BIOCHEM SOC T, V18, P651, DOI 10.1042/bst0180651; Santiago-Hernandez A, 2007, J IND MICROBIOL BIOT, V34, P331, DOI 10.1007/s10295-006-0202-4; SCHAFER ML, 1965, J BACTERIOL, V89, P113, DOI 10.1128/JB.89.1.113-116.1965; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Siriwardana LS, 2011, ANTON LEEUW INT J G, V99, P681, DOI 10.1007/s10482-010-9544-z; STACKEBRANDT E, 1979, INT J SYST BACTERIOL, V29, P273, DOI 10.1099/00207713-29-4-273; Stalbrand H, 1998, APPL ENVIRON MICROB, V64, P2374; STOPPOK W, 1982, APPL ENVIRON MICROB, V44, P44, DOI 10.1128/AEM.44.1.44-53.1982; STORVICK WO, 1963, BIOCHEMISTRY-US, V2, P1106, DOI 10.1021/bi00905a034; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tomme P, 1996, J BACTERIOL, V178, P4216, DOI 10.1128/jb.178.14.4216-4223.1996; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; VLADUTTALOR M, 1986, ARCH MICROBIOL, V144, P191, DOI 10.1007/BF00410945; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; WHITTLE DJ, 1982, GENE, V17, P139, DOI 10.1016/0378-1119(82)90066-X; Yi H, 2007, INT J SYST EVOL MICR, V57, P151, DOI 10.1099/ijs.0.64525-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	39	41	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53954	10.1371/journal.pone.0053954	http://dx.doi.org/10.1371/journal.pone.0053954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342046	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400105
J	Gomaa, F; Mitchell, EAD; Lara, E				Gomaa, Fatma; Mitchell, Edward A. D.; Lara, Enrique			Amphitremida (Poche, 1913) Is a New Major, Ubiquitous Labyrinthulomycete Clade	PLOS ONE			English	Article							EUKARYOTES; PHYLOGENY; DIVERSITY; INFERENCE	Micro-eukaryotic diversity is poorly documented at all taxonomic levels and the phylogenetic affiliation of many taxa - including many well-known and common organisms - remains unknown. Among these incertae sedis taxa are Archerella flavum (Loeblich and Tappan, 1961) and Amphitrema wrightianum (Archer, 1869) (Amphitremidae), two filose testate amoebae commonly found in Sphagnum peatlands. To clarify their phylogenetic position, we amplified and sequenced the SSU rRNA gene obtained from four independent DNA extractions of A. flavum and three independent DNA extractions of A. wrightianum. Our molecular data demonstrate that genera Archerella and Amphitrema form a fully supported deep-branching clade within the Labyrinthulomycetes (Stramenopiles), together with Diplophrys sp. (ATCC50360) and several environmental clones obtained from a wide range of environments. This newly described clade we named Amphitremida is diverse genetically, ecologically and physiologically. Our phylogenetic analysis suggests that osmotrophic species evolved most likely from phagotrophic ancestors and that the bothrosome, an organelle that produces cytoplasmic networks used for attachment to the substratum and to absorb nutrients from the environments, appeared lately in labyrithulomycete evolution.	[Gomaa, Fatma; Mitchell, Edward A. D.; Lara, Enrique] Univ Neuchatel, Lab Soil Biol, CH-2000 Neuchatel, Switzerland; [Gomaa, Fatma] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt	University of Neuchatel; Egyptian Knowledge Bank (EKB); Ain Shams University	Gomaa, F (corresponding author), Univ Neuchatel, Lab Soil Biol, CH-2000 Neuchatel, Switzerland.	fatma.gomaa@unine.ch; enrique.lara@unine.ch	Mitchell, Edward AD/B-7259-2013; Lara, Enrique/N-3679-2017	Mitchell, Edward AD/0000-0003-0358-506X; Lara, Enrique/0000-0001-8500-522X; Gomaa, Fatma/0000-0001-5697-7118	Swiss National Fund (SNF) Ambizione [PZ00P2_122042]	Swiss National Fund (SNF) Ambizione	Funding for EL comes from the Swiss National Fund (SNF) Ambizione PZ00P2_122042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson OR, 2012, J ACTA PROT IN PRESS; Barker J, 1868, Q J MICROSC SCI, V8, P123; BONNET L, 1981, PROTISTOLOGICA, V17, P225; Booth RK, 2008, J QUATERNARY SCI, V23, P43, DOI 10.1002/jqs.1114; Charman DJ, 2001, QUATERNARY RES, V55, P223, DOI 10.1006/qres.2000.2190; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; de SAEDELEER HENRI, 1934, MEM MUS ROY HIST NAT BELGIQUE, V60, P1; Dopheide A, 2008, APPL ENVIRON MICROB, V74, P1740, DOI 10.1128/AEM.01438-07; DUBOIS GEORGES, 1943, BULL GEOL SOC GEOL FRANCE, V13, P21; DYKSTRA MJ, 1975, MYCOLOGIA, V67, P873, DOI 10.2307/3758346; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Fahrni JF, 2003, MOL BIOL EVOL, V20, P1881, DOI 10.1093/molbev/msg201; Grant J, 2009, PROTIST, V160, P376, DOI 10.1016/j.protis.2009.01.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lahr DJG, 2012, BIOL J LINN SOC, V107, P469, DOI 10.1111/j.1095-8312.2012.01962.x; Lara E, 2006, J EUKARYOT MICROBIOL, V53, P112, DOI 10.1111/j.1550-7408.2005.00081.x; Lara E, 2008, PROTIST, V159, P165, DOI 10.1016/j.protis.2007.09.003; Lara E, 2011, PROTIST, V162, P14, DOI 10.1016/j.protis.2010.05.003; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Meisterfeld R., 2002, ILLUSTRATED GUIDE PR, P1054; Meisterfeld R, 2002, ILLUSTRATED GUIDE PR, P827; Mitchell EAD, 2008, BIODIVERS CONSERV, V17, P2115, DOI 10.1007/s10531-007-9221-3; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; Nusslin O, 1884, WISSENSEH ZOOLOGIE, V40, P720; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Penard E., 1902, HENRY KUNDIG, DOI DOI 10.1017/CBO9781107415324.004; Penard E, 1903, ARCH PROTISTENKD, P283; PERKINS FO, 1972, ARCH MIKROBIOL, V84, P95, DOI 10.1007/BF00412431; Poche Franz, 1913, Archiv fuer Protistenkunde Jena, V30; PORTER D, 1972, PROTOPLASMA, V74, P427, DOI 10.1007/BF01281960; RAGHUKUMAR S, 1992, MAR BIOL, V113, P165, DOI 10.1007/BF00367650; Raghukumar S, 2011, BOT MAR, V54, P3, DOI 10.1515/BOT.2011.008; Scharer L, 2007, MAR BIOL, V152, P1095, DOI 10.1007/s00227-007-0755-4; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tekle YI, 2009, BIOSCIENCE, V59, P471, DOI 10.1525/bio.2009.59.6.5; TOLONEN K, 1992, ARCH PROTISTENKD, V142, P119, DOI 10.1016/S0003-9365(11)80076-X; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; van Oye P., 1958, HYDROBIOLOGIA, V10, P85, DOI [10.1007/BF00142183, DOI 10.1007/BF00142183]; Wailes GH, 1915, BRIT FRESHWATER EHIZ; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x	47	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53046	10.1371/journal.pone.0053046	http://dx.doi.org/10.1371/journal.pone.0053046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341921	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400030
J	Liu, CF; Xiong, XY; Xu, W; Sun, JM; Wang, LJ; Li, JJ				Liu, Chunfeng; Xiong, Xiaoyu; Xu, Wei; Sun, Jimei; Wang, Lijie; Li, Jiujun			Serotypes and Patterns of Antibiotic Resistance in Strains Causing Invasive Pneumococcal Disease in Children Less than 5 Years of Age	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; CHINESE CHILDREN; 19A	Objective: The serotypes and patterns of antibiotic resistance of Streptococcus pneumoniae (S. pneumoniae) strains that cause invasive pneumococcal disease (IPD) in infants were analyzed to provide guidance for clinical disease prevention and treatment. Methods: The clinical features of confirmed IPD were evaluated in 61 patients, less than 5 years of age, who were admitted to our hospital between January 2009 and December 2011. The serotypes and antibiotic resistance of strains of S. pneumoniae were determined using the capsular swelling method and the E-test. Results: A total of 61 invasive strains were isolated. The serotype distribution of those isolates were 19A (41.0%), 14 (19.7%), 19F (11.5%), 23F (9.8%), 8 (4.9%), 9V (4.9%), 1 (3.3%), and 4, 6B, and 20 (each 1.6%). The percentage of S. pneumoniae strains resistant to erythromycin, clindamycin, and cotrimoxazole were 100%, 86.9%, and 100%, respectively. The percentage of S. pneumoniae strains resistant to penicillin, amoxicillin/clavulanic acid, cefuroxime, ceftriaxone, cefotaxime, cefepime, and meropenem were 42.6%, 18.0%, 82.0%, 18.0%, 13.1%, 13.1%, and 36.1%, respectively. The percentage of multidrug-resistant strains was 95.6%. Strains of all serotypes isolated in this study were highly resistant to erythromycin, cotrimoxazole, and clindamycin. Strains with serotype 19A had the highest rates of resistance. Conclusions: Serotype 19A strains were most frequently isolated from children with IPD treated in our hospital. The strains causing IPD are highly resistant to antibiotics.	[Liu, Chunfeng; Xiong, Xiaoyu; Xu, Wei; Wang, Lijie; Li, Jiujun] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China; [Sun, Jimei] China Med Univ, Shengjing Hosp, Dept Bacteriol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Liu, CF (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China.	zhliu258@hotmail.com			Pfizer China	Pfizer China(Pfizer)	This is a sponsored study funded by Pfizer China. The authors declare that they have no financial interests that may influnce interpretation of the results and the others. The funders had no role in study design, data collection and analysis, decision to publish, or prepareation of the manuscript.	[Anonymous], 1997, MMWR RECOMM REP, V46, P1; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P511; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P1148; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; CLSI, 2010, M100S16 CLSI, P56; Denham BC, 2005, J MED MICROBIOL, V54, P327, DOI 10.1099/jmm.0.45718-0; Gareia-Suarez Mdel M, 2006, JPN J INFECT DIS, V59, P299; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Liu Su-yun, 2010, Zhonghua Er Ke Za Zhi, V48, P95; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Nyasulu P, 2011, PEDIATR INFECT DIS J, V30, P1075, DOI 10.1097/INF.0b013e31822cca05; Roche P, 2007, COMMUN DIS INTELL, V31, P86; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Sun J, 2012, CHIN PEDIAT EMERG ME, V19, P368; [UNICEF WHO], 2008, WEEKLY EPIDEMIOL REC, V83, P1; Weil-Olivier C, 2012, BMC INFECT DIS, V7, P207; WHO Publication, 2012, VACCINE, V30, P4717; Xue L, 2011, CHINESE MED J-PEKING, V124, P1769, DOI 10.3760/cma.j.issn.0366-6999.2011.12.002; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2008, VACCINE, V26, P4425, DOI 10.1016/j.vaccine.2008.06.052; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; [袁红英 YUAN Hongying], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P2127	26	22	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54254	10.1371/journal.pone.0054254	http://dx.doi.org/10.1371/journal.pone.0054254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342111	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400137
J	Sequeira, KM; Tabesh, A; Sainju, RK; DeSantis, SM; Naselaris, T; Joseph, JE; Ahlman, MA; Spicer, KM; Glazier, SS; Edwards, JC; Bonilha, L				Sequeira, Karen M.; Tabesh, Ali; Sainju, Rup K.; DeSantis, Stacia M.; Naselaris, Thomas; Joseph, Jane E.; Ahlman, Mark A.; Spicer, Kenneth M.; Glazier, Steve S.; Edwards, Jonathan C.; Bonilha, Leonardo			Perfusion Network Shift during Seizures in Medial Temporal Lobe Epilepsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ICTAL SPECT; MRI; ATROPHY; PET; HIPPOCAMPUS; AMYGDALA; TUTORIAL; ONSET	Background: Medial temporal lobe epilepsy (MTLE) is associated with limbic atrophy involving the hippocampus, peri-hippocampal and extra-temporal structures. While MTLE is related to static structural limbic compromise, it is unknown whether the limbic system undergoes dynamic regional perfusion network alterations during seizures. In this study, we aimed to investigate state specific (i.e. ictal versus interictal) perfusional limbic networks in patients with MTLE. Methods: We studied clinical information and single photon emission computed tomography (SPECT) images obtained with intravenous infusion of the radioactive tracer Technetium-Tc 99 m Hexamethylpropyleneamine Oxime (Tc-99 m HMPAO) during ictal and interictal state confirmed by video-electroencephalography (VEEG) in 20 patients with unilateral MTLE (12 left and 8 right MTLE). Pair-wise voxel-based analyses were used to define global changes in tracer between states. Regional tracer uptake was calculated and state specific adjacency matrices were constructed based on regional correlation of uptake across subjects. Graph theoretical measures were applied to investigate global and regional state specific network reconfigurations. Results: A significant increase in tracer uptake was observed during the ictal state in the medial temporal region, cerebellum, thalamus, insula and putamen. From network analyses, we observed a relative decreased correlation between the epileptogenic temporal region and remaining cortex during the interictal state, followed by a surge of cross-correlated perfusion in epileptogenic temporal-limbic structures during a seizure, corresponding to local network integration. Conclusions: These results suggest that MTLE is associated with a state specific perfusion and possibly functional organization consisting of a surge of limbic cross-correlated tracer uptake during a seizure, with a relative disconnection of the epileptogenic temporal lobe in the interictal period. This pattern of state specific shift in metabolic networks in MTLE may improve the understanding of epileptogenesis and neuropsychological impairments associated with MTLE.	[Sequeira, Karen M.; Sainju, Rup K.; Naselaris, Thomas; Joseph, Jane E.; Glazier, Steve S.; Edwards, Jonathan C.; Bonilha, Leonardo] Med Univ S Carolina, Comprehens Epilepsy Ctr, Div Neurol, Dept Neurosci, Charleston, SC 29425 USA; [Tabesh, Ali; Ahlman, Mark A.; Spicer, Kenneth M.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [DeSantis, Stacia M.] Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Bonilha, L (corresponding author), Med Univ S Carolina, Comprehens Epilepsy Ctr, Div Neurol, Dept Neurosci, Charleston, SC 29425 USA.	bonilha@musc.edu		Sainju, Rup/0000-0002-8414-1972	South Carolina Clinical & Translational Research (SCTR) Institute through National Institutes of Health [UL1 RR029882, UL1 TR000062]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	South Carolina Clinical & Translational Research (SCTR) Institute through National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported in part by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, through National Institutes of Health Grant Numbers UL1 RR029882 and UL1 TR000062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amorim BJ, 2005, ARQ NEURO-PSIQUIAT, V63, P977, DOI 10.1590/S0004-282X2005000600014; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bernasconi N, 2000, ANN NY ACAD SCI, V911, P495; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bernhardt BC, 2010, NEUROLOGY, V74, P1776, DOI 10.1212/WNL.0b013e3181e0f80a; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonilha L, 2004, ARCH NEUROL-CHICAGO, V61, P1379, DOI 10.1001/archneur.61.9.1379; Bonilha L, 2003, J NEUROL NEUROSUR PS, V74, P1627, DOI 10.1136/jnnp.74.12.1627; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Brown W., 1987, SURGICAL TREATMENT E, P511; CENDES F, 1993, J COMPUT ASSIST TOMO, V17, P206, DOI 10.1097/00004728-199303000-00008; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Jayalakshmi Sita, 2011, Int J Mol Imaging, V2011, P803920, DOI 10.1155/2011/803920; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kramer MA, 2010, J NEUROSCI, V30, P10076, DOI 10.1523/JNEUROSCI.6309-09.2010; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; THEODORE WH, 1989, LANCET, V1, P502; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Paesschen W, 2007, CURR OPIN NEUROL, V20, P194, DOI 10.1097/WCO.0b013e328042baf6; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P67, DOI 10.1001/archneur.1997.00550130049015; WIESER HG, 1994, EUR NEUROL, V34, P58; Won HJ, 1999, AM J NEURORADIOL, V20, P593	40	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53204	10.1371/journal.pone.0053204	http://dx.doi.org/10.1371/journal.pone.0053204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341932	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400036
J	Silva, LCR; Horwath, WR				Silva, Lucas C. R.; Horwath, William R.			Explaining Global Increases in Water Use Efficiency: Why Have We Overestimated Responses to Rising Atmospheric CO2 in Natural Forest Ecosystems?	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; ELEVATED CO2; GROWTH; ENRICHMENT; ASSIMILATION; CHRONOLOGIES; PLANTS; TREES; WHEAT; PINE	Background: The analysis of tree-ring carbon isotope composition (delta C-13) has been widely used to estimate spatio-temporal variations in intrinsic water use efficiency (iWUE) of tree species. Numerous studies have reported widespread increases in iWUE coinciding with rising atmospheric CO2 over the past century. While this could represent a coherent global response, the fact that increases of similar magnitude were observed across biomes with no apparent effect on tree growth raises the question of whether iWUE calculations reflect actual physiological responses to elevated CO2 levels. Methodology/Results: Here we use Monte Carlo simulations to test if an artifact of calculation could explain observed increases in iWUE. We show that highly significant positive relationships between iWUE and CO2 occur even when simulated data (randomized delta C-13 values spanning the observed range) are used in place of actual tree-ring delta C-13 measurements. From simulated data sets we calculated non-physiological changes in iWUE from 1900 to present and across a 4000 m altitudinal range. This generated results strikingly similar to those reported in recent studies encompassing 22 species from tropical, subtropical, temperate, boreal and mediterranean ecosystems. Only 6 of 49 surveyed case studies showed increases in iWUE significantly higher than predicted from random values. Conclusions/Significance: Our results reveal that increases in iWUE estimated from tree-ring delta C-13 occur independently of changes in C-13 discrimination that characterize physiological responses to elevated CO2. Due to a correlation with CO2 concentration, which is used as an independent factor in the iWUE calculation, any tree-ring delta C-13 data set would inevitably generate increasing iWUE over time. Therefore, although consistent, previously reported trends in iWUE do not necessarily reflect a coherent global response to rising atmospheric CO2. We discuss the significance of these findings and suggest ways to distinguish real from artificial responses in future studies.	[Silva, Lucas C. R.; Horwath, William R.] Univ Calif Davis, Biogeochem & Nutrient Cycling Lab, Dept Land Air & Water Resources LAWR, Davis, CA 95616 USA	University of California System; University of California Davis	Horwath, WR (corresponding author), Univ Calif Davis, Biogeochem & Nutrient Cycling Lab, Dept Land Air & Water Resources LAWR, Davis, CA 95616 USA.	wrhorwath@ucdavis.edu	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X; 				Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Anderson W. T., 2005, Dendrochronologia, V23, P1, DOI 10.1016/j.dendro.2005.07.006; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Ewe SML, 1999, FOREST ECOL MANAG, V118, P139, DOI 10.1016/S0378-1127(98)00493-9; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Gedalof Z, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003699; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McCarroll D, 2009, GEOCHIM COSMOCHIM AC, V73, P1539, DOI 10.1016/j.gca.2008.11.041; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; Observatory ML Reports OI Co S, 2011, DATA MANAGE, P4; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Silva LCR, 2013, GLOBAL ECOL BIOGEOGR, V22, P83, DOI 10.1111/j.1466-8238.2012.00783.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x	25	50	55	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53089	10.1371/journal.pone.0053089	http://dx.doi.org/10.1371/journal.pone.0053089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341924	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400031
J	Tsuruyama, T; Nakai, T; Ohmori, R; Ozeki, M; Tamaki, K; Yoshikawa, K				Tsuruyama, Tatsuaki; Nakai, Tonau; Ohmori, Rei; Ozeki, Munetaka; Tamaki, Keiji; Yoshikawa, Kenichi			Dialysis Purification of Integrase-DNA Complexes Provides High-Resolution Atomic Force Microscopy Images: Dimeric Recombinant HIV-1 Integrase Binding and Specific Looping on DNA	PLOS ONE			English	Article								It remains difficult to obtain high-resolution atomic force microscopy images of HIV-1 integrase bound to DNA in a dimeric or tetrameric fashion. We therefore constructed specific target DNAs to assess HIV-1 integrase binding and purified the complex by dialysis prior to analysis. Our resulting atomic force microscopy analyses indicated precise size of binding human immunodeficiency virus type 1 (HIV-1) recombinant integrase in a tetrameric manner, inducing formation of a loop-like or figure-eight-like secondary structure in the target DNA. Our findings regarding the target DNA secondary structure provide new insights into the intermediate states of retroviral integration.	[Tsuruyama, Tatsuaki; Ohmori, Rei; Tamaki, Keiji] Kyoto Univ, Dept Anat Forens Med & Pathol Studies, Grad Sch Med, Kyoto, Japan; [Tsuruyama, Tatsuaki; Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Dept Forens Med & Mol Pathol, Grad Sch Med, Kyoto, Japan; [Tsuruyama, Tatsuaki] Kyoto Univ, Dept Pathol, Grad Sch Med, Kyoto, Japan; [Nakai, Tonau] Tottori Univ, Dept Mech & Aerosp Engn, Grad Sch Engn, Tottori 680, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University; Tottori University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Dept Anat Forens Med & Pathol Studies, Grad Sch Med, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Science and Technology, Japan; Ministry of Health, Welfare, and Labor, Japan	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Science and Technology, Japan, and by a grant from the Ministry of Health, Welfare, and Labor, Japan. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Magen T, 2010, J VIROL, V84, P9210, DOI 10.1128/JVI.01164-10; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Craigie R, 2002, MOBILE DNA, P613; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Ivanov YD, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9809-5; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Kuznetsov VY, 2002, PROTEOMICS, V2, P1699, DOI 10.1002/1615-9861(200212)2:12<1699::AID-PROT1699>3.0.CO;2-R; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Tsuruyama T, 2012, BIOCHEMISTRY-US, P306; Tsuruyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013841; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; YOSHINAGA T, 1995, J VIROL, V69, P3233, DOI 10.1128/JVI.69.5.3233-3236.1995	20	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53572	10.1371/journal.pone.0053572	http://dx.doi.org/10.1371/journal.pone.0053572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341952	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400050
J	Van Dam, NT; Sano, M; Mitsis, EM; Grossman, HT; Gu, XS; Park, Y; Hof, PR; Fan, J				Van Dam, Nicholas T.; Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Gu, Xiaosi; Park, Yunsoo; Hof, Patrick R.; Fan, Jin			Functional Neural Correlates of Attentional Deficits in Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							EXECUTIVE FUNCTION DEFICITS; ALZHEIMERS-DISEASE; SELECTIVE ATTENTION; DIVIDED ATTENTION; VISUOSPATIAL ATTENTION; METABOLIC-CHANGES; OLDER-ADULTS; EARLY-STAGE; DEMENTIA; NETWORKS	Although amnestic mild cognitive impairment (aMCI; often considered a prodromal phase of Alzheimer's disease, AD) is most recognized by its implications for decline in memory function, research suggests that deficits in attention are present early in aMCI and may be predictive of progression to AD. The present study used functional magnetic resonance imaging to examine differences in the brain during the attention network test between 8 individuals with aMCI and 8 neurologically healthy, demographically matched controls. While there were no significant behavioral differences between groups for the alerting and orienting functions, patients with aMCI showed more activity in neural regions typically associated with the networks subserving these functions (e.g., temporoparietal junction and posterior parietal regions, respectively). More importantly, there were both behavioral (i.e., greater conflict effect) and corresponding neural deficits in executive control (e.g., less activation in the prefrontal and anterior cingulate cortices). Although based on a small number of patients, our findings suggest that deficits of attention, especially the executive control of attention, may significantly contribute to the behavioral and cognitive deficits of aMCI.	[Van Dam, Nicholas T.; Fan, Jin] CUNY, Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Van Dam, Nicholas T.; Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Gu, Xiaosi; Park, Yunsoo; Fan, Jin] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Gu, Xiaosi; Hof, Patrick R.; Fan, Jin] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Grossman, Hillel T.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Sano, Mary; Mitsis, Effie M.; Grossman, Hillel T.; Hof, Patrick R.] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; Mt Sinai Memory & Aging Ctr, Mt Sinai Sch Med, New York, NY USA; [Sano, Mary; Mitsis, Effie M.; Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Fan, J (corresponding author), CUNY, Queens Coll, Dept Psychol, Flushing, NY 11367 USA.	jin.fan@qc.cuny.edu	Fan, Jin/L-2055-2019; Van Dam, Nicholas Thomas/G-2799-2010; Gu, Xiaosi/A-7724-2010; Fan, Jin/A-6716-2009	Fan, Jin/0000-0001-9630-8330; Van Dam, Nicholas Thomas/0000-0002-1131-0739; Gu, Xiaosi/0000-0002-9373-987X; Fan, Jin/0000-0001-9630-8330; Park, Yunsoo/0000-0002-2701-2306	National Institute on Aging (of the National Institutes of Health) [P50 AG005138]; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	National Institute on Aging (of the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The present study was funded as a pilot investigation to J.F. by National Institute on Aging (of the National Institutes of Health) grant P50 AG005138 (M.S., Sam Gandy, P.R.H.). Authors J.F., P.R.H., & M.S. conceived the research design. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], [No title captured]; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baddeley AD, 2001, BRAIN, V124, P1492, DOI 10.1093/brain/124.8.1492; Ballard C, 2001, ARCH NEUROL-CHICAGO, V58, P977, DOI 10.1001/archneur.58.6.977; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Berardi AM, 2005, DEV NEUROPSYCHOL, V28, P507, DOI 10.1207/s15326942dn2801_4; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castel AD, 2007, NEUROPSYCHOLOGY, V21, P170, DOI 10.1037/0894-4105.21.2.170; Castel AD, 2009, NEUROPSYCHOLOGY, V23, P297, DOI 10.1037/a0014888; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Collette F, 1999, CORTEX, V35, P57, DOI 10.1016/S0010-9452(08)70785-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Dannhauser TM, 2005, BRAIN, V128, P1418, DOI 10.1093/brain/awh413; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; El Fakhri G, 2003, ARCH NEUROL-CHICAGO, V60, P1066, DOI 10.1001/archneur.60.8.1066; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2004, PSYCHIAT PRAX, V31, pS210, DOI 10.1055/s-2004-828484; Fan JH, 2008, J HYDRO-ENVIRON RES, V2, P3, DOI 10.1016/j.jher.2008.04.001; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Faust ME, 1997, NEUROPSYCHOLOGY, V11, P13, DOI 10.1037/0894-4105.11.1.13; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; Festa EK, 2006, NEUROPSYCHOLOGY, V20, P757, DOI 10.1037/0894-4105.20.6.757; Festa-Martino E, 2004, NEUROPSYCHOLOGY, V18, P258, DOI 10.1037/0894-4105.18.2.258; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster JK, 2001, FRONT BIOSCI-LANDMRK, V6, pD135, DOI 10.2741/Foster; Foster JK, 1999, NEUROPSYCHOLOGY, V13, P223, DOI 10.1037/0894-4105.13.2.223; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Gorus E, 2006, INT PSYCHOGERIATR, V18, P539, DOI 10.1017/S1041610205002723; GRADY CL, 1988, J CLIN EXP NEUROPSYC, V10, P576, DOI 10.1080/01688638808402796; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; HAXBY JV, 1990, ARCH NEUROL-CHICAGO, V47, P753, DOI 10.1001/archneur.1990.00530070043010; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Johannsen P, 1999, NEUROIMAGE, V10, P269, DOI 10.1006/nimg.1999.0475; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; LAFLECHE G, 1995, NEUROPSYCHOLOGY, V9, P313, DOI 10.1037/0894-4105.9.3.313; Levinoff EJ, 2004, NEUROPSYCHOLOGY, V18, P580, DOI 10.1037/0894-4105.18.3.580; Marra C, 2000, DEMENT GERIATR COGN, V11, P212, DOI 10.1159/000017239; MILLER J, 1988, J EXP PSYCHOL HUMAN, V14, P539, DOI 10.1037/0096-1523.14.3.539; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; NEBES RD, 1989, CORTEX, V25, P305, DOI 10.1016/S0010-9452(89)80045-0; OKEN BS, 1994, NEUROLOGY, V44, P657, DOI 10.1212/WNL.44.4.657; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI DOI 10.1037/0894-4105.7.3.242; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Rapp MA, 2005, AM J GERIAT PSYCHIAT, V13, P134, DOI 10.1176/appi.ajgp.13.2.134; Rizzo M, 2000, NEUROLOGY, V54, P1954, DOI 10.1212/WNL.54.10.1954; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Salmon E, 2007, NEUROBIOL AGING; Sano M, 2006, J GERIATR PSYCH NEUR, V19, P155, DOI 10.1177/0891988706291086; Sano M, 2011, ALZ DIS ASSOC DIS, V25, P122, DOI 10.1097/WAD.0b013e3181f883b7; Sebastian MV, 2006, CORTEX, V42, P1015, DOI 10.1016/S0010-9452(08)70207-7; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Simon SS, 2012, NEUROSCI BIOBEHAV R, V36, P1163, DOI 10.1016/j.neubiorev.2012.01.007; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stern Y, 2000, NEUROLOGY, V55, P1291, DOI 10.1212/WNL.55.9.1291; Tales A, 2002, NEUROREPORT, V13, P2557, DOI 10.1097/00001756-200212200-00035; Tales A, 2006, NEUROPSYCHOLOGY, V20, P752, DOI 10.1037/0894-4105.20.6.752; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Woo BKP, 2010, INT J GERIATR PSYCH, V25, P1150, DOI 10.1002/gps.2452; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	88	40	41	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54035	10.1371/journal.pone.0054035	http://dx.doi.org/10.1371/journal.pone.0054035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326568	Green Published, gold			2022-12-27	WOS:000314705800104
J	Dweep, H; Sticht, C; Kharkar, A; Pandey, P; Gretz, N				Dweep, Harsh; Sticht, Carsten; Kharkar, Asawari; Pandey, Priyanka; Gretz, Norbert			Parallel Analysis of mRNA and microRNA Microarray Profiles to Explore Functional Regulatory Patterns in Polycystic Kidney Disease: Using PKD/Mhm Rat Model	PLOS ONE			English	Article							EPITHELIAL-CELLS; SYSTEMS BIOLOGY; GENE-PRODUCT; APOPTOSIS; GROWTH; NEPHRONOPHTHISIS; PROLIFERATION; MICE; PATHOGENESIS; EXPRESSION	Autosomal polycystic kidney disease (ADPKD) is a frequent monogenic renal disease, characterised by fluid-filled cysts that are thought to result from multiple deregulated pathways such as cell proliferation and apoptosis. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of many genes associated with such biological processes and human pathologies. To explore the possible regulatory role of miRNAs in PKD, the PKD/Mhm (cy/+) rat, served as a model to study human ADPKD. A parallel microarray-based approach was conducted to profile the expression changes of mRNAs and miRNAs in PKD/Mhm rats. 1,573 up- and 1,760 down-regulated genes were differentially expressed in PKD/Mhm. These genes are associated with 17 pathways (such as focal adhesion, cell cycle, ECM-receptor interaction, DNA replication and metabolic pathways) and 47 (e.g., cell proliferation, Wnt and Tgf beta signaling) Gene Ontologies. Furthermore, we found the similar expression patterns of deregulated genes between PKD/Mhm (cy/+) rat and human ADPKD, PKD1(L3/L3), PKD1(-/-), Hnf1 alpha-deficient, and Glis2(lacZ/lacZ) models. Additionally, several differentially regulated genes were noted to be target hubs for miRNAs. We also obtained 8 significantly up-regulated miRNAs (rno-miR-199a-5p, -214, -146b, -21, -34a, -132, -31 and -503) in diseased kidneys of PKD/Mhm rats. Additionally, the binding site overrepresentation and pathway enrichment analyses were accomplished on the putative targets of these 8 miRNAs. 7 out of these 8 miRNAs and their possible interactions have not been previously described in ADPKD. We have shown a strong overlap of functional patterns (pathways) between deregulated miRNAs and mRNAs in the PKD/Mhm (cy/+) rat model. Our findings suggest that several miRNAs may be associated in regulating pathways in ADPKD. We further describe novel miRNAs and their possible targets in ADPKD, which will open new avenues to understand the pathogenesis of human ADPKD. Furthermore they could serve as a useful resource for anti-fibrotic therapeutics.	[Dweep, Harsh; Sticht, Carsten; Kharkar, Asawari; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany	Ruprecht Karls University Heidelberg	Gretz, N (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany.	norbert.gretz@medma.uni-heidelberg.de			Research Council through Graduiertenkolleg [886]; German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2) [01GR0450]	Research Council through Graduiertenkolleg(German Research Foundation (DFG)); German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2)	This work was funded by the Research Council through Graduiertenkolleg 886 and by the German Federal Ministry of Research and Education through the National Genome Research Network (NGFN-2, Grant no. 01GR0450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angerstein G, 2012, MOL NEUROBIOL; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastos AP, 2011, BRAZ J MED BIOL RES, V44, P606, DOI [10.1590/S0100-879X2011007500068, 10.1590/S0100-879X2011000700001]; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen Wen-Cheng, 2008, BMC Res Notes, V1, P131, DOI 10.1186/1756-0500-1-131; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Couillard M, 2002, CANCER RES, V62, P2210; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DWEEP H, 2011, J BIOMED INFORM; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felekkis K, 2011, MOL BIOL EVOL, V28, P2421, DOI 10.1093/molbev/msr078; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; GRETZ N, 1995, KIDNEY INT, V48, P496, DOI 10.1038/ki.1995.319; Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46; Ha E, 2010, MOL MED REP, V3, P275, DOI 10.3892/mmr_00000251; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KASPAREITRITTINGHAUSEN J, 1990, TRANSPLANT P, V22, P2582; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanoix J, 1996, ONCOGENE, V13, P1153; Le Roy H L, 1976, Experientia Suppl, V22, P191; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Obermuller N, 2001, AM J PHYSIOL-RENAL, V280, pF540, DOI 10.1152/ajprenal.2001.280.3.F540; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; SCHAFER K, 1994, KIDNEY INT, V46, P134, DOI 10.1038/ki.1994.253; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; TRUDEL M, 1992, CONTRIB NEPHROL, V97, P47; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson PD, 1999, LAB INVEST, V79, P1311; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	62	51	54	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53780	10.1371/journal.pone.0053780	http://dx.doi.org/10.1371/journal.pone.0053780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326503	Green Published, gold			2022-12-27	WOS:000313552400044
J	Maita, C; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Maita, Chinatsu; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Monomer DJ-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of DJ-1 Mutants	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; CYSTEINE-SULFINIC ACID; PROTEIN DJ-1; ANDROGEN RECEPTOR; OXIDATIVE STRESS; ANTIOXIDATIVE STRESS; CELL INJURY; AUTOPHAGY; DYNAMICS; COMPLEX	DJ-1 is a novel oncogene and also a causative gene for familial Parkinson's disease (park7). DJ-1 has multiple functions that include transcriptional regulation, anti-oxidative reaction and chaperone and mitochondrial regulation. Mitochondrial dysfunction is observed in DJ-1-knockout mice and fry, and mitochondrial DJ-1 is more protective against oxidative stress-induced cell death. Although translocation of DJ-1 into mitochondria is enhanced by oxidative stress that leads to oxidation of cysteine 106 (C106) of DJ-1, the characteristics of mitochondrial DJ-1 and the mechanism by which DJ-1 is translocated into mitochondria are poorly understood. In this study, immunostaining, co-immunoprecipitation, cell fractionation and pull-down experiments showed that mutants of glutamine 18 (E18) DJ-1 are localized in mitochondria and do not make homodimers. Likewise, DJ-1 with mutations of two cysteines located in the dimer interface, C46S and C53A, and pathogenic mutants, M26I and L166P DJ-1, were found to be localized in mitochondria and not to make homodimers. Mutant DJ-1 harboring both E18A and C106S, in which C106 is not oxidized, was also localized in mitochondria, indicating that oxidation of C106 is important but not essential for mitochondrial localization of DJ-1. It should be noted that E18A DJ-1 was translocated from mitochondria to the cytoplasm when mitochondrial membrane potential was reduced by treatment of cells with CCCP, an uncoupler of the oxidative phosphorylation system in mitochondria. Furthermore, deletion or substitution of the N-terminal 12 amino acids in DJ-1 resulted in re-localization of E18A, M26I and L166P DJ-1 from mitochondria into the cytoplasm. These findings suggest that a monomer and the N-terminal 12 amino acids are necessary for mitochondrial localization of DJ-1 mutants and that conformation change induced by C106 oxidation or by E18 mutation leads to translocation of DJ-1 into mitochondria.	[Maita, Chinatsu; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Sanae/H-9647-2013; Maita, Hiroshi/D-5495-2012		Ministry of Education, Science, Culture and Sports; National Institute of Biomedical Innovation (NIBIO) in Japan; Grants-in-Aid for Scientific Research [22300119, 24650191] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO) in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Giaime E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040501; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mizuno Y, 1998, J NEUROCHEM, V71, P893; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Ren HG, 2011, J BIOL CHEM, V286, P35308, DOI 10.1074/jbc.M110.207134; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	50	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54087	10.1371/journal.pone.0054087	http://dx.doi.org/10.1371/journal.pone.0054087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326576	Green Published, gold			2022-12-27	WOS:000313552400075
J	Tan, CO; Tamisier, R; Hamner, JW; Taylor, JA				Tan, Can Ozan; Tamisier, Renaud; Hamner, J. W.; Taylor, J. Andrew			Characterizing Sympathetic Neurovascular Transduction in Humans	PLOS ONE			English	Article							FREQUENCY-RESPONSE CHARACTERISTICS; LIMB BLOOD-FLOW; AGE-RELATED-CHANGES; NITRIC-OXIDE; NERVE ACTIVITY; VASCULAR-RESISTANCE; HEMODYNAMIC BALANCE; CONDUCTANCE; ACTIVATION; EXERCISE	Despite its critical role for cardiovascular homeostasis in humans, only a few studies have directly probed the transduction of sympathetic nerve activity to regional vascular responses - sympathetic neurovascular transduction. Those that have variably relied on either vascular resistance or vascular conductance to quantify the responses. However, it remains unclear which approach would better reflect the physiology. We assessed the utility of both of these as well as an alternative approach in 21 healthy men. We recorded arterial pressure (Finapres), peroneal sympathetic nerve activity (microneurography), and popliteal blood flow (Doppler) during isometric handgrip exercise to fatigue. We quantified and compared transduction via the relation of sympathetic activity to resistance and to conductance and via an adaptation of Poiseuille's relation including pressure, sympathetic activity, and flow. The average relationship between sympathetic activity and resistance (or conductance) was good when assessed over 30-second averages (mean R-2 = 0.49 +/- 0.07) but lesser when incorporating beat-by-beat time lags (R-2 = 0.37 +/- 0.06). However, in a third of the subjects, these relations provided relatively weak estimates (R-2<0.33). In contrast, the Poiseuille relation reflected vascular responses more accurately (R-2 = 0.77 +/- 0.03, >0.50 in 20 of 21 individuals), and provided reproducible estimates of transduction. The gain derived from the relation of resistance (but not conductance) was inversely related to transduction (R-2 = 0.37, p<0.05), but with a proportional bias. Thus, vascular resistance and conductance may not always be reliable surrogates for regional sympathetic neurovascular transduction, and assessment from a Poiseuille relation between pressure, sympathetic nerve activity, and flow may provide a better foundation to further explore differences in transduction in humans.	[Tan, Can Ozan; Hamner, J. W.; Taylor, J. Andrew] Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA; [Tan, Can Ozan; Taylor, J. Andrew] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Tamisier, Renaud] Univ Hosp Grenoble, Sleep Lab, Grenoble, France; [Tamisier, Renaud] Univ Hosp Grenoble, EFCR, Dept Rehabil & Physiol, Grenoble, France; [Tamisier, Renaud] Univ Grenoble 1, INSERM, U1042, Lab Hypoxia Pathophysiol HP2, Grenoble, France	Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tan, CO (corresponding author), Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA.	cotan@partners.org	Tamisier, Renaud/M-6858-2014; Hamner, J. W./B-4607-2017; Tan, Can Ozan/E-2598-2016	Tamisier, Renaud/0000-0003-1128-6529; Hamner, J. W./0000-0002-5819-2362; Tan, Can Ozan/0000-0001-9673-9907; Taylor, J Andrew/0000-0003-2802-4330				Agrawal A, 2008, INT J CLIN EXP MED, V1, P305; AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655; ANDO S, 1993, J AUTONOM NERV SYST, V45, P225, DOI 10.1016/0165-1838(93)90054-X; ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berne R., 2001, CARDIOVASCULAR PHYSL; BOUTOUYRIE P, 1994, AM J PHYSIOL-HEART C, V267, pH1368, DOI 10.1152/ajpheart.1994.267.4.H1368; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CELANDER O, 1954, Acta Physiol Scand Suppl, V32, P1; Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076; COX RH, 1976, AM J PHYSIOL, V231, P420, DOI 10.1152/ajplegacy.1976.231.2.420; Crandall CG, 1995, J APPL PHYSIOL, V79, P1946, DOI 10.1152/jappl.1995.79.6.1946; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; Dinenno FA, 2002, CIRCULATION, V106, P1349, DOI 10.1161/01.CIR.0000028819.64790.BE; Dinenno FA, 2001, J PHYSIOL-LONDON, V536, P977, DOI 10.1111/j.1469-7793.2001.00977.x; Dinenno FA, 2001, J PHYSIOL-LONDON, V531, P573, DOI 10.1111/j.1469-7793.2001.0573i.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278; Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947; Fisher R.A., 1958, STAT METHODS RES WOR; Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997; FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725; GABRIEL A, 1992, CLIN PHYSIOL, V12, P229, DOI 10.1111/j.1475-097X.1992.tb00309.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guild SJ, 2001, AM J PHYSIOL-REG I, V281, pR206, DOI 10.1152/ajpregu.2001.281.1.R206; Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; JOYNER MJ, 1992, AM J PHYSIOL, V263, pH1078, DOI 10.1152/ajpheart.1992.263.4.H1078; Kamiya A, 2004, AM J PHYSIOL-REG I, V286, pR151, DOI 10.1152/ajpregu.00685.2002; Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329; KIOWSKI W, 1983, CLIN PHARMACOL THER, V34, P565, DOI 10.1038/clpt.1983.216; LAL SKL, 1995, HYPERTENSION, V26, P307, DOI 10.1161/01.HYP.26.2.307; LANDSBERG L, 1993, INT J OBESITY, V17, pS29; LANDSBERG L, 1990, J NEUROSCI METH, V34, P179, DOI 10.1016/0165-0270(90)90056-L; LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lyons D, 1997, CLIN SCI, V93, P519, DOI 10.1042/cs0930519; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; McCord GR, 2005, J APPL PHYSIOL, V98, P2011, DOI 10.1152/japplphysiol.00888.2004; Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862; NIELSEN H, 1992, AM J PHYSIOL, V263, pH1190, DOI 10.1152/ajpheart.1992.263.4.H1190; NILSSON H, 1985, ACTA PHYSIOL SCAND, V123, P303, DOI 10.1111/j.1748-1716.1985.tb07592.x; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; OLEARY DS, 1991, AM J PHYSIOL, V260, pH632, DOI 10.1152/ajpheart.1991.260.2.H632; Oppenheim A.V., 1998, DISCRETE TIME SIGNAL, V2nd; Parker BA, 2007, AM J PHYSIOL-HEART C, V292, pH1148, DOI 10.1152/ajpheart.00729.2006; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; ROSENBAUM M, 1968, AM J PHYSIOL, V215, P1397, DOI 10.1152/ajplegacy.1968.215.6.1397; Rowell L., 1986, HUMAN CIRCULATION RE; SAITO M, 1990, EUR J APPL PHYSIOL O, V60, P277, DOI 10.1007/BF00379396; Schlager O, 2011, EUR J VASC ENDOVASC, V41, P821, DOI 10.1016/j.ejvs.2011.01.006; SEALS DR, 1989, J APPL PHYSIOL, V67, P1801, DOI 10.1152/jappl.1989.67.5.1801; Seals DR, 2004, AM J PHYSIOL-HEART C, V287, pH1895, DOI 10.1152/ajpheart.00486.2004; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; SEALS DR, 1989, J APPL PHYSIOL, V66, P2472, DOI 10.1152/jappl.1989.66.5.2472; Shoemaker JK, 2000, AM J PHYSIOL-HEART C, V279, pH1215, DOI 10.1152/ajpheart.2000.279.3.H1215; Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x; Smith EG, 2007, J PHYSIOL-LONDON, V582, P63, DOI 10.1113/jphysiol.2007.130591; Stauss HM, 1997, AM J PHYSIOL-HEART C, V273, pH786, DOI 10.1152/ajpheart.1997.273.2.H786; Stauss HM, 1998, AM J PHYSIOL-HEART C, V274, pH1277, DOI 10.1152/ajpheart.1998.274.4.H1277; Studinger P, 2009, J PHYSIOL-LONDON, V587, P2049, DOI 10.1113/jphysiol.2009.170134; SUNDLOF G, 1978, J PHYSIOL-LONDON, V278, P525, DOI 10.1113/jphysiol.1978.sp012322; Tan CO, 2009, IEEE T BIO-MED ENG, V56, P147, DOI 10.1109/TBME.2008.2002138; VALLBO AB, 1967, ELECTROEN CLIN NEURO, V23, P392; Vianna LC, 2012, AM J PHYSL HEART CIR; WALLIN BG, 1988, ANNU REV PHYSIOL, V50, P565, DOI 10.1146/annurev.ph.50.030188.003025; Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970; Wilson TE, 2006, J APPL PHYSIOL, V100, P1043, DOI 10.1152/japplphysiol.00579.2005	70	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53769	10.1371/journal.pone.0053769	http://dx.doi.org/10.1371/journal.pone.0053769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326501	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400043
J	Espina, J; Feijoo, CG; Solis, C; Glavic, A				Espina, Jaime; Feijoo, Carmen G.; Solis, Camila; Glavic, Alvaro			csrnp1a Is Necessary for the Development of Primitive Hematopoiesis Progenitors in Zebrafish	PLOS ONE			English	Article							CELL-DIFFERENTIATION; TRANSGENIC ZEBRAFISH; FATE; ERYTHROPOIESIS; SPECIFICATION; GENE; TIF1-GAMMA; EXPRESSION; SCL/TAL-1; LEUKEMIA	The CSRNP (cystein-serine-rich nuclear protein) transcription factors are conserved from Drosophila to human. Functional studies in mice, through knockout for each of their paralogs, have resulted insufficient to elucidate the function of this family of proteins in vertebrate development. Previously, we described the function of the zebrafish ortholog, Csnrp1/Axud1, showing its essential role in the survival and proliferation of cephalic progenitors. To extend our understanding of this family, we have studied the function of its paralog csrnp1a. Our results show that csrnp1a is expressed from 0 hpf, until larval stages, particularly in cephalic territories and in the intermediate cell mass (ICM). Using morpholinos in wild type and transgenic lines we observed that Csrnp1a knockdown generates a mild reduction in head size and a depletion of blood cells in circulation. This was combined with in situ hybridizations to analyze the expression of different mesodermal and primitive hematopoiesis markers. Morphant embryos have impaired blood formation without disruption of mesoderm specification, angiogenesis or heart development. The reduction of circulating blood cells occurs at the hematopoietic progenitor level, affecting both the erythroid and myeloid lineages. In addition, cell proliferation was also altered in hematopoietic anterior sites, specifically in spi1 expression domain. These and previous observations suggest an important role of Csnrps transcription factors in progenitor biology, both in the neural and hematopoietic linages.	[Espina, Jaime; Glavic, Alvaro] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Espina, Jaime; Feijoo, Carmen G.; Solis, Camila] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile	Universidad de Chile; Universidad Andres Bello	Glavic, A (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	alglavic@uchile.cl	Feijoo, Carmen G/AAF-9003-2019; Glavic, Alvaro/F-5608-2013	Espina, Jaime/0000-0003-4357-7179; Feijoo, Carmen G/0000-0003-1128-403X	FONDAP grant [15090007]; Universidad Nacional Andres Bello grant [DI-07-09/R]; FONDECYT grant [11090102]	FONDAP grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Universidad Nacional Andres Bello grant; FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding was provided by FONDAP grant 15090007 (A.G.), Universidad Nacional Andres Bello grant DI-07-09/R (C.G.F. and A.G.) and FONDECYT grant 11090102 (C.G.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; BIELEK E, 1981, CELL TISSUE RES, V220, P163; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Glavic A, 2009, MECH DEVELOP, V126, P184, DOI 10.1016/j.mod.2008.11.005; Feijoo CG, 2009, MOL CELL NEUROSCI, V40, P328, DOI 10.1016/j.mcn.2008.11.003; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Kawahara A, 2001, CURR BIOL, V11, P1353, DOI 10.1016/S0960-9822(01)00398-0; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Monteiro R, 2011, EMBO J, V30, P1093, DOI 10.1038/emboj.2011.34; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; O'BRIEN B.R.A., 1961, BIOTECH HISTOCHEM, V36, P57; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sarrazin AF, 2006, DEV BIOL, V295, P534, DOI 10.1016/j.ydbio.2006.03.037; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Taneda T, 2011, GENES CELLS, V16, P231, DOI 10.1111/j.1365-2443.2010.01481.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	40	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53858	10.1371/journal.pone.0053858	http://dx.doi.org/10.1371/journal.pone.0053858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326522	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500099
J	Thammanomai, A; Hamakawa, H; Bartolak-Suki, E; Suki, B				Thammanomai, Apiradee; Hamakawa, Hiroshi; Bartolak-Suki, Erzsebet; Suki, Bela			Combined Effects of Ventilation Mode and Positive End-Expiratory Pressure on Mechanics, Gas Exchange and the Epithelium in Mice with Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BIOLOGICALLY VARIABLE VENTILATION; TIDAL VOLUME VENTILATION; RECRUITMENT MANEUVERS; DEEP INFLATION; ARTERIAL OXYGENATION; ALVEOLAR COLLAPSE; PORCINE MODEL; MOUSE LUNG; E-CADHERIN	The accepted protocol to ventilate patients with acute lung injury is to use low tidal volume (V-T) in combination with recruitment maneuvers or positive end-expiratory pressure (PEEP). However, an important aspect of mechanical ventilation has not been considered: the combined effects of PEEP and ventilation modes on the integrity of the epithelium. Additionally, it is implicitly assumed that the best PEEP-V-T combination also protects the epithelium. We aimed to investigate the effects of ventilation mode and PEEP on respiratory mechanics, peak airway pressures and gas exchange as well as on lung surfactant and epithelial cell integrity in mice with acute lung injury. HCl-injured mice were ventilated at PEEPs of 3 and 6 cmH(2)O with conventional ventilation (CV), CV with intermittent large breaths (CVLB) to promote recruitment, and a new mode, variable ventilation, optimized for mice (VVN). Mechanics and gas exchange were measured during ventilation and surfactant protein (SP)-B, proSP-B and E-cadherin levels were determined from lavage and lung homogenate. PEEP had a significant effect on mechanics, gas exchange and the epithelium. The higher PEEP reduced lung collapse and improved mechanics and gas exchange but it also down regulated surfactant release and production and increased epithelial cell injury. While CVLB was better than CV, VVN outperformed CVLB in recruitment, reduced epithelial injury and, via a dynamic mechanotransduction, it also triggered increased release and production of surfactant. For long-term outcome, selection of optimal PEEP and ventilation mode may be based on balancing lung physiology with epithelial injury.	[Thammanomai, Apiradee; Hamakawa, Hiroshi; Bartolak-Suki, Erzsebet; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Suki, B (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	bsuki@bu.edu			National Institutes of Health (NIH) [HL-098976]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health (NIH) HL-098976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Allen G, 2002, J APPL PHYSIOL, V93, P1709, DOI 10.1152/japplphysiol.00473.2002; Allen GB, 2007, AM J PHYSIOL-LUNG C, V292, pL1580, DOI 10.1152/ajplung.00483.2006; Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Arold SP, 2003, AM J PHYSIOL-LUNG C, V285, pL370, DOI 10.1152/ajplung.00036.2003; Arold SP, 2002, AM J RESP CRIT CARE, V165, P366, DOI 10.1164/ajrccm.165.3.2010155; Azeloglu EU, 2008, J APPL PHYSIOL, V105, P652, DOI 10.1152/japplphysiol.00958.2007; Badet M, 2009, RESP CARE, V54, P847, DOI 10.4187/002013209793800448; Black CLB, 2007, CRIT CARE MED, V35, P870, DOI 10.1097/01.CCM.0000257331.42485.94; Bellardine CL, 2006, CRIT CARE MED, V34, P439, DOI 10.1097/01.CCM.0000196208.01682.87; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; BO G, 1977, J APPL PHYSIOL, V42, P476, DOI 10.1152/jappl.1977.42.4.476; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brunner JX, 2009, INTENS CARE MED, V35, P1479, DOI 10.1007/s00134-009-1510-8; Carvalho AR, 2011, J APPL PHYSIOL, V110, P1083, DOI 10.1152/japplphysiol.00804.2010; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Csendes T., 1988, Acta Cybernetica, V8, P361; Funk DJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-22; Gattinoni L, 2005, CURR OPIN CRIT CARE, V11, P69, DOI 10.1097/00075198-200502000-00011; Goto T, 2010, EUR J CARDIO-THORAC, V37, P426, DOI 10.1016/j.ejcts.2009.06.041; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hodgson Carol L, 2011, J Intensive Care Med, V26, P41, DOI 10.1177/0885066610383953; Ito S, 2004, J APPL PHYSIOL, V97, P204, DOI 10.1152/japplphysiol.01246.2003; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Kaczka DW, 2005, ANESTHESIOLOGY, V103, P306, DOI 10.1097/00000542-200508000-00014; Kostic P, 2011, CRIT CARE, V15, DOI 10.1186/cc10236; Krebs J, 2009, CRIT CARE, V13, DOI 10.1186/cc8118; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lefevre GR, 1996, AM J RESP CRIT CARE, V154, P1567, DOI 10.1164/ajrccm.154.5.8912782; LUTCHEN KR, 1993, J APPL PHYSIOL, V75, P478, DOI 10.1152/jappl.1993.75.1.478; Martynowicz MA, 2001, J APPL PHYSIOL, V90, P1744, DOI 10.1152/jappl.2001.90.5.1744; Meade MO, 2008, RESP CARE, V53, P1441; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mergoni M, 2001, J APPL PHYSIOL, V91, P441, DOI 10.1152/jappl.2001.91.1.441; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Mutch WAC, 2000, AM J RESP CRIT CARE, V162, P319, DOI 10.1164/ajrccm.162.1.9903120; Mutch WAC, 2000, CRIT CARE MED, V28, P2457, DOI 10.1097/00003246-200007000-00045; Santiago VR, 2010, CRIT CARE MED, V38, P2207, DOI 10.1097/CCM.0b013e3181f3e076; Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; Thammanomai A, 2008, J APPL PHYSIOL, V104, P1329, DOI 10.1152/japplphysiol.01002.2007; Thammanomai A, 2007, J APPL PHYSIOL, V103, P1551, DOI 10.1152/japplphysiol.00006.2007; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Zhao ZQ, 2010, CRIT CARE, V14, DOI 10.1186/cc8860; 2000, N ENGL J MED, V342, P1301	52	40	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53934	10.1371/journal.pone.0053934	http://dx.doi.org/10.1371/journal.pone.0053934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326543	gold, Green Submitted, Green Published			2022-12-27	WOS:000313551500102
J	Herbert, C; Kubler, A; Vogele, C				Herbert, Cornelia; Kuebler, Andrea; Voegele, Claus			Risk for Eating Disorders Modulates Startle-Responses to Body Words	PLOS ONE			English	Article							ANOREXIA-NERVOSA; BULIMIA-NERVOSA; IMAGE DISTORTION; EXPOSURE; STIMULI; CUES; PREDICTORS; PERCEPTION; AMYGDALA; EMOTION	Body image disturbances are core symptoms of eating disorders (EDs). Recent evidence suggests that changes in body image may occur prior to ED onset and are not restricted to in-vivo exposure (e. g. mirror image), but also evident during presentation of abstract cues such as body shape and weight-related words. In the present study startle modulation, heart rate and subjective evaluations were examined during reading of body words and neutral words in 41 student female volunteers screened for risk of EDs. The aim was to determine if responses to body words are attributable to a general negativity bias regardless of ED risk or if activated, ED relevant negative body schemas facilitate priming of defensive responses. Heart rate and word ratings differed between body words and neutral words in the whole female sample, supporting a general processing bias for body weight and shape-related concepts in young women regardless of ED risk. Startle modulation was specifically related to eating disorder symptoms, as was indicated by significant positive correlations with self-reported body dissatisfaction. These results emphasize the relevance of examining body schema representations as a function of ED risk across different levels of responding. Peripheral-physiological measures such as the startle reflex could possibly be used as predictors of females' risk for developing EDs in the future.	[Herbert, Cornelia; Kuebler, Andrea] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany; [Herbert, Cornelia] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Voegele, Claus] Univ Luxembourg, Res Unit INSIDE, Luxembourg, Luxembourg	University of Wurzburg; German Sport University Cologne; University of Luxembourg	Herbert, C (corresponding author), Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany.	cornelia.herbert@psychologie.uni-wuerzburg.de	Vögele, Claus/I-5682-2013	Kubler, Andrea/0000-0003-4876-0415; Vogele, Claus/0000-0001-8086-0788	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	The study was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIE I, 1989, DEV PSYCHOL, V25, P70, DOI 10.1037/0012-1649.25.1.70; Beato-Fernandez L, 2004, EUR CHILD ADOLES PSY, V13, P287, DOI 10.1007/s00787-004-0407-x; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brewis AA, 2011, SOC SCI MED, V73, P491, DOI 10.1016/j.socscimed.2011.05.048; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Engel Scott G, 2006, Eat Behav, V7, P368, DOI 10.1016/j.eatbeh.2005.12.002; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V79, P113; Gibson L., 2010, OXFORD HDB EATING DI, P180; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Grogan S., 2008, BODY IMAGE UNDERSTAN, V2nd; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hazlett EA, 2007, BIOL PSYCHIAT, V62, P250, DOI 10.1016/j.biopsych.2006.10.028; Herbert C, 2011, COGN AFFECT BEHAV NE, V11, P199, DOI 10.3758/s13415-011-0026-1; Herbert C, 2010, INT J PSYCHOPHYSIOL, V76, P64, DOI 10.1016/j.ijpsycho.2010.02.004; Hilbert A, 2002, J PSYCHOSOM RES, V52, P137, DOI 10.1016/S0022-3999(01)00314-2; Johansson Linda, 2005, Eat Behav, V6, P271, DOI 10.1016/j.eatbeh.2004.11.001; Johnson G, 1987, BULIMIA NERVOSA BIOP; Kenardy J, 2001, EUR EAT DISORD REV, V9, P242, DOI 10.1002/erv.388; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Knost B, 1997, PSYCHOPHYSIOLOGY, V34, P474, DOI 10.1111/j.1469-8986.1997.tb02392.x; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Laux L., 1981, STATE TRAIT ANGSTINV; Lee M, 2004, CLIN PSYCHOL REV, V24, P215, DOI 10.1016/j.cpr.2003.10.004; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Sanchez-Navarro JP, 2006, INT J PSYCHOPHYSIOL, V61, P34, DOI 10.1016/j.ijpsycho.2005.10.023; Seeger G, 2002, NEUROSCI LETT, V326, P25, DOI 10.1016/S0304-3940(02)00312-9; Sepulvea, 2002, PSYCHOL SPAIN, V6, P83; Shirao N, 2005, BRIT J PSYCHIAT, V186, P48, DOI 10.1192/bjp.186.1.48; Shirao N, 2003, BRAIN SCI MENT DISOR, V14, P141; Smeesters D, 2010, J CONSUM RES, V36, P930, DOI 10.1086/648688; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Smeets MAM, 2001, INT J EAT DISORDER, V29, P409, DOI 10.1002/eat.1037; Spresser CD, 2012, BODY IMAGE, V9, P298, DOI 10.1016/j.bodyim.2011.12.005; Stice E, 2011, BEHAV RES THER, V49, P622, DOI 10.1016/j.brat.2011.06.009; Stice E, 2010, J CHILD PSYCHOL PSYC, V51, P518, DOI 10.1111/j.1469-7610.2010.02212.x; Striegel-Moore Ruth H., 1993, P144; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Vila J, 2007, INT J PSYCHOPHYSIOL, V66, P169, DOI 10.1016/j.ijpsycho.2007.07.004; VITOUSEK KB, 1990, COGNITIVE THER RES, V14, P191, DOI 10.1007/BF01176209; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	55	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53667	10.1371/journal.pone.0053667	http://dx.doi.org/10.1371/journal.pone.0053667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341969	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700033
J	Sapkota, Y; Ghosh, S; Lai, R; Coe, BP; Cass, CE; Yasui, Y; Mackey, JR; Damaraju, S				Sapkota, Yadav; Ghosh, Sunita; Lai, Raymond; Coe, Bradley P.; Cass, Carol E.; Yasui, Yutaka; Mackey, John R.; Damaraju, Sambasivarao			Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; NEUTRAL LOSS; UNIPARENTAL DISOMY; SUSCEPTIBILITY; RISK; HETEROZYGOSITY; COMMON; CONSEQUENCES; NUCLEOTIDE	Breast cancer recurrence (BCR) is a common treatment outcome despite curative-intent primary treatment of non-metastatic breast cancer. Currently used prognostic and predictive factors utilize tumor-based markers, and are not optimal determinants of risk of BCR. Germline-based copy number aberrations (CNAs) have not been evaluated as determinants of predisposition to experience BCR. In this study, we accessed germline DNA from 369 female breast cancer subjects who received curative-intent primary treatment following diagnosis. Of these, 155 experienced BCR and 214 did not, after a median duration of follow up after breast cancer diagnosis of 6.35 years (range = 0.60-21.78) and 8.60 years (range = 3.08-13.57), respectively. Whole genome CNA genotyping was performed on the Affymetrix SNP array 6.0 platform. CNAs were identified using the SNP-Fast Adaptive States Segmentation Technique 2 algorithm implemented in Nexus Copy Number 6.0. Six samples were removed due to poor quality scores, leaving 363 samples for further analysis. We identified 18,561 CNAs with >= 1 kb as a predefined cut-off for observed aberrations. Univariate survival analyses (log-rank tests) identified seven CNAs (two copy number gains and five copy neutral-loss of heterozygosities, CN-LOHs) showing significant differences (P < 2.01 x 10(-5)) in recurrence-free survival (RFS) probabilities with and without CNAs. We also observed three additional but distinct CN-LOHs showing significant differences in RFS probabilities (P < 2.86 x 10(-5)) when analyses were restricted to stratified cases (luminal A, n = 208) only. After adjusting for tumor stage and grade in multivariate analyses (Cox proportional hazards models), all the CNAs remained strongly associated with the phenotype of BCR. Of these, we confirmed three CNAs at 17q11.2, 11q13.1 and 6q24.1 in representative samples using independent genotyping platforms. Our results suggest further investigations on the potential use of germline DNA variations as prognostic markers in cancer-associated phenotypes.	[Sapkota, Yadav; Ghosh, Sunita; Lai, Raymond; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao] Cross Canc Inst, Alberta Hlth Serv, Edmonton, AB T6G 1Z2, Canada; [Sapkota, Yadav; Lai, Raymond; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Ghosh, Sunita; Cass, Carol E.; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Coe, Bradley P.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA USA; [Yasui, Yutaka] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	Alberta Health Services (AHS); University of Alberta; University of Alberta; University of Alberta; University of Washington; University of Washington Seattle; University of Alberta	Damaraju, S (corresponding author), Cross Canc Inst, Alberta Hlth Serv, Edmonton, AB T6G 1Z2, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Yasui, Yutaka/E-2564-2015; Sapkota, Yadav/O-2142-2015; Coe, Bradley/A-2878-2009	Yasui, Yutaka/0000-0002-7717-8638; Sapkota, Yadav/0000-0001-5943-9454; Coe, Bradley/0000-0001-8471-4016	Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; CBCF-Prairies/NWT Region; Alberta Cancer Research Institute (ACRI); CBCF operating grants; Alberta Cancer Board (ACB); Canadian Institute of Health Research, Canada	Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; CBCF-Prairies/NWT Region; Alberta Cancer Research Institute (ACRI); CBCF operating grants; Alberta Cancer Board (ACB); Canadian Institute of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	The authors would like to acknowledge Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund, managed by Alberta Innovates-Health Solutions and CBCF-Prairies/NWT Region for funding support to the CBCF Tumor Bank. Funding for this project was provided by Alberta Cancer Research Institute (ACRI), CBCF operating grants and Alberta Cancer Board (ACB) operating grants to SD. BPC is supported by a post-doctoral fellowship from Canadian Institute of Health Research, Canada. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein L, 2011, JNCI-J NATL CANCER I, V103, P451, DOI 10.1093/jnci/djr046; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587; Canadian Cancer Society's Steering Committee, 2011, CAN CANC STAT 2011; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Grube M, 2007, DRUG METAB DISPOS, V35, P30, DOI 10.1124/dmd.106.011411; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; Makishima H, 2011, CLIN CANCER RES, V17, P3913, DOI 10.1158/1078-0432.CCR-10-2900; Martin DN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-257; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Nakajima T, 2008, CYTOGENET GENOME RES, V123, P156, DOI 10.1159/000184703; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Leij F, 2012, SEMIN RADIAT ONCOL, V22, P100, DOI 10.1016/j.semradonc.2011.12.001; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zickler AM, 2012, HUM MUTAT, V33, P372, DOI 10.1002/humu.21644	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53850	10.1371/journal.pone.0053850	http://dx.doi.org/10.1371/journal.pone.0053850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342018	gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700051
J	Schadow, S; Siebert, HC; Lochnit, G; Kordelle, J; Rickert, M; Steinmeyer, J				Schadow, Saskia; Siebert, Hans-Christian; Lochnit, Guenter; Kordelle, Jens; Rickert, Markus; Steinmeyer, Juergen			Collagen Metabolism of Human Osteoarthritic Articular Cartilage as Modulated by Bovine Collagen Hydrolysates	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NITRIC-OXIDE; ADAMTS4 AGGRECANASE-1; DEGRADED COLLAGEN; JOINT DISEASE; II COLLAGEN; CHONDROCYTES; EXPRESSION; FRAGMENTS; MATRIX	Destruction of articular cartilage is a characteristic feature of osteoarthritis (OA). Collagen hydrolysates are mixtures of collagen peptides and have gained huge public attention as nutriceuticals used for prophylaxis of OA. Here, we evaluated for the first time whether different bovine collagen hydrolysate preparations indeed modulate the metabolism of collagen and proteoglycans from human OA cartilage explants and determined the chemical composition of oligopeptides representing collagen fragments. Using biophysical techniques, like MALDI-TOF-MS, AFM, and NMR, the molecular weight distribution and aggregation behavior of collagen hydrolysates from bovine origin (CH-Alpha (R), Peptan (TM) B 5000, Peptan (TM) B 2000) were determined. To investigate the metabolism of human femoral OA cartilage, explants were obtained during knee replacement surgery. Collagen synthesis of explants as modulated by 0-10 mg/ml collagen hydrolysates was determined using a novel dual radiolabeling procedure. Proteoglycans, NO, PGE(2), MMP-1, -3, -13, TIMP-1, collagen type II, and cell viability were determined in explant cultures. Groups of data were analyzed using ANOVA and the Friedman test (n = 5-12). The significance was set to p <= 0.05. We found that collagen hydrolysates obtained from different sources varied with respect to the width of molecular weight distribution, average molecular weight, and aggregation behavior. None of the collagen hydrolysates tested stimulated the biosynthesis of collagen. Peptan (TM) B 5000 elevated NO and PGE(2) levels significantly but had no effect on collagen or proteoglycan loss. All collagen hydrolysates tested proved not to be cytotoxic. Together, our data demonstrate for the first time that various collagen hydrolysates differ with respect to their chemical composition of collagen fragments as well as by their pharmacological efficacy on human chondrocytes. Our study underscores the importance that each collagen hydrolysate preparation should first demonstrate its pharmacological potential both in vitro and in vivo before being used for both regenerative medicine and prophylaxis of OA.	[Schadow, Saskia; Rickert, Markus; Steinmeyer, Juergen] Univ Hosp Giessen & Marburg, Dept Orthoped, Giessen, Germany; [Siebert, Hans-Christian] RI B NT Res Inst Bioinformat & Nanotechnol, Kiel, Germany; [Lochnit, Guenter] Univ Giessen, Dept Biochem, D-35390 Giessen, Germany; [Kordelle, Jens] Agaples Evangel Hosp Mittelhessen, Giessen, Germany	University Hospital of Giessen & Marburg; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Hosp Giessen & Marburg, Dept Orthoped, Giessen, Germany.	Juergen.Steinmeyer@ortho.med.uni-giessen.de	Rickert, Markus/D-8731-2017	Rickert, Markus/0000-0001-7681-9918; Steinmeyer, Juergen/0000-0002-4053-503X	DRB-Foundation	DRB-Foundation	Supported in part by a grant of the DRB-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; BAYLISS MT, 1978, BIOCHEM J, V176, P683, DOI 10.1042/bj1760683; Bello AE, 2006, CURR MED RES OPIN, V22, P2221, DOI 10.1185/030079906X148373; Benito-Ruiz P, 2009, INT J FOOD SCI NUTR, V60, P99, DOI 10.1080/09637480802498820; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Collins DH, 1949, PATHOLOGY ARTICULAR, P76; European Food Safety Authority, 2005, EFSA J, V174, P1; European Food Safety Authority (EFSA), 2011, EFSA J, V9, P2291; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fichter A, 2006, J ORTHOP RES, V24, P63, DOI 10.1002/jor.20001; FUKUDA K, 1995, INFLAMM RES, V44, P434, DOI 10.1007/BF01757700; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Goldring MB, 2004, CLIN ORTHOP RELAT R, pS37, DOI 10.1097/01.blo.0000144484.69656.e4; Goodwin JL, 2008, OSTEOARTHR CARTILAGE, V16, P1263, DOI 10.1016/j.joca.2008.02.011; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Henrotin Y, 2011, OSTEOARTHR CARTILAGE, V19, P1, DOI 10.1016/j.joca.2010.10.017; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Jennings L, 2001, CONNECT TISSUE RES, V42, P71, DOI 10.3109/03008200109014250; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Oesser S, 1999, J NUTR, V129, P1891, DOI 10.1093/jn/129.10.1891; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Oesser S, 2008, OSTEOARTHRITIS CA S4, pS45; Raabe O, 2010, HISTOCHEM CELL BIOL, V134, P545, DOI 10.1007/s00418-010-0760-4; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Sadowski T, 2001, INFLAMM RES, V50, P175, DOI 10.1007/s000110050742; Sadowski T, 2001, J RHEUMATOL, V28, P336; Sauerland K, 2003, OSTEOARTHR CARTILAGE, V11, P343, DOI 10.1016/S1063-4584(03)00007-4; Siebert HC, 2010, PROTEIN CELL, V1, P393, DOI 10.1007/s13238-010-0038-6; StdtzelS Eckert T, 2012, O J PHYS CH IN PRESS; Steinmeyer J, 2006, ADV DRUG DELIVER REV, V58, P168, DOI 10.1016/j.addr.2006.01.007; Steinmeyer J, 2010, J ORTHOP RES, V28, P828, DOI 10.1002/jor.21026; Stotzel S, 2012, CHEMPHYSCHEM, V13, P3117, DOI 10.1002/cphc.201200284; SWITZER BR, 1971, ANAL BIOCHEM, V39, P487, DOI 10.1016/0003-2697(71)90438-6; Vincent TL, 2008, ARTHRITIS RHEUM, V58, P1207, DOI 10.1002/art.23443; Wolf A, 2007, CELL TISSUE RES, V327, P155, DOI 10.1007/s00441-006-0251-z	46	29	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53955	10.1371/journal.pone.0053955	http://dx.doi.org/10.1371/journal.pone.0053955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342047	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700067
J	Tobe, RG; Mori, R; Huang, LH; Xu, LZ; Han, DM; Shibuya, K				Tobe, Ruoyan Gai; Mori, Rintaro; Huang, Lihui; Xu, Lingzhong; Han, Demin; Shibuya, Kenji			Cost-Effectiveness Analysis of a National Neonatal Hearing Screening Program in China: Conditions for the Scale-Up	PLOS ONE			English	Article							EARLY IDENTIFICATION; LANGUAGE; CHILDREN; IMPAIRMENT; INFANTS; INTERVENTION; AGES	Background: In 2009, the Chinese Ministry of Health recommended scale-up of routine neonatal hearing screening - previously performed primarily only in select urban hospitals - throughout the entire country. Methods: A decision analytical model for a simulated population of all live births in China was developed to compare the costs and health effects of five mutually exclusive interventions: 1) universal screening using Otoacoustic Emission (OAE) and Automated Auditory Brainstem Response (AABR); 2) universal OAE; 3) targeted OAE and AABR; 4) targeted OAE; and 5) no screening. Disability-Adjusted Life Years (DALYs) were calculated for health effects. Results and Discussion: Based on the cost-effectiveness and potential health outcomes, the optimal path for scale-up would be to start with targeted OAE and then expand to universal OAE and universal OAE plus AABR. Accessibility of screening, diagnosis, and intervention services significantly affect decision of the options. Conclusion: In conclusion, to achieve cost-effectiveness and best health outcomes of the NHS program, the accessibility of screening, diagnosis, and intervention services should be expanded to reach a larger population. The results are thus expected to be of particular benefit in terms of the 'rolling out' of the national plan.	[Tobe, Ruoyan Gai; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Huang, Lihui; Han, Demin] Beijing Tongren Hosp, Beijing, Peoples R China; [Huang, Lihui; Han, Demin] Minist Educ, Beijing Inst Otolaryngol, Key Lab Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Han, Demin] China WHO Collaborating Ctr Prevent & Rehabil Hea, Beijing, Peoples R China; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan	Shandong University; National Center for Child Health & Development - Japan; Capital Medical University; University of Tokyo	Han, DM (corresponding author), Beijing Tongren Hosp, Beijing, Peoples R China.	handm@trhos.com		Mori, Rintaro/0000-0001-7656-6156; Shibuya, Kenji/0000-0003-2528-7530	11th Five-Year National Plan for Key Technologies RD Programme [2007BAI18B12]; Ministry of Education, China [09YJA880096]; Ministry of Health, Labor, and Welfare, Japan [H22-iryou-shitei-042]; Shandong Province Natural Science Foundation [Y2008C28]	11th Five-Year National Plan for Key Technologies RD Programme; Ministry of Education, China(Ministry of Education, China); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was organized and managed by the Beijing Institute of Otolaryngology, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, China, with a grant from the 11th Five-Year National Plan for Key Technologies R&D Programme (no. 2007BAI18B12) and Research Grant from the Ministry of Education, China (no. 09YJA880096). The Department of Global Health Policy, Graduate School of Medicine, the University of Tokyo provided technical support in terms of study planning and data analysis pursuant to a grant from the Ministry of Health, Labor, and Welfare, Japan (no. H22-iryou-shitei-042). The School of Public Health, Shandong University coordinated the field survey and data collection under a grant from Shandong Province Natural Science Foundation (no. Y2008C28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Nationale d'Accreditation et d'E valuation en Sante, 1999, EV CLIN EC DEP NEON; [Anonymous], 1993, NIH Consens Statement, V11, P1; Chen L, 2009, J CHILD HEALTH CARE, V17, P103; Chen Yinzhong, 2008, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V22, P737; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; Davis A, 1997, HEALTH TECHNOL ASSES, V1, P1; Feng D, 2009, CHIN SPEC J HEAR SPE, V4, P69; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Gaffney M., 2010, Morbidity and Mortality Weekly Report, V59, P220; Grill E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-14; Harrison M, 1996, EAR HEARING, V17, P55, DOI 10.1097/00003446-199602000-00007; Hessel Franz, 2003, Ger Med Sci, V1, pDoc09; [侯峥 Hou Zheng], 2008, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V16, P206; Huang L, 2009, MOD PREV MED, V36, P1844; Huang LH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-97; International Monetary Fund website, GDP DEFL PURCH POW P; Johnson JL, 2005, PEDIATRICS, V116, P663, DOI 10.1542/peds.2004-1688; Kemper AR, 2000, ARCH PEDIAT ADOL MED, V154, P484, DOI 10.1001/archpedi.154.5.484; Kennedy C, 2005, LANCET, V366, P660, DOI 10.1016/S0140-6736(05)67138-3; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Keren R, 2002, PEDIATRICS, V110, P855, DOI 10.1542/peds.110.5.855; Kezirian EJ, 2001, OTOLARYNG HEAD NECK, V124, P359, DOI 10.1067/mhn.2001.113945; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mai F, 2008, MATERN CHILD HLTH CA, V20, P2831; Ministry of Health China, 2009, NAT NEON CONG DIS SC; Ministry of Health China, 2010, FIN REG HOSP; MOELLER MP, 2000, PEDIATRICS, V106, pNIL83; National Bureau of Statistics of China, 2008, CHIN STAT YB; Olusanya BO, 2004, INT J PEDIATR OTORHI, V68, P287, DOI 10.1016/j.ijporl.2003.10.015; Olusanya BO, 2007, LANCET, V369, P1314, DOI 10.1016/S0140-6736(07)60602-3; Pan J, 2006, CHIN J PERINAT MED, V9, P275; Puig T, 2005, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858CD003731.PUB3, 10.1002/14651858.CD003731.pub3]; Sininger YS, 1999, PEDIATR CLIN N AM, V46, P1, DOI 10.1016/S0031-3955(05)70077-8; Smith A., 2000, GLOBAL BURDEN DIS; Sun Z, 2007, J BIRTH HLTH HEREDIT, V15, P82; Tan-Torres T, 2003, WHO GUIDE COST EFFEC; The World Health Organization, 2010, NEWB HEAR SCREEN CUR; Uus K, 2006, PEDIATRICS, V117, pE887, DOI 10.1542/peds.2005-1064; Vohr B, 2008, PEDIATRICS, V122, P535, DOI 10.1542/peds.2007-2028; Vohr BR, 1998, J PEDIATR-US, V133, P353, DOI 10.1016/S0022-3476(98)70268-9; Weichbold V, 2001, PEDIATRICS, V108, P1111, DOI 10.1542/peds.108.5.1111; World Health Organization, 2001, MACR HLTH INV HLTH E; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161; Yoshinaga-Itano C, 2000, J Perinatol, V20, pS132; Yoshinaga-Itano C., 2003, AUDIOL MED, V1, P199; Zhao Peng-jun, 2003, Zhonghua Yi Xue Za Zhi, V83, P285; 许政敏, 2007, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V15, P277; 胡劲涛, 2006, [中华医学杂志, National Medical Journal of China], V86, P2567	49	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e51990	10.1371/journal.pone.0051990	http://dx.doi.org/10.1371/journal.pone.0051990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341887	gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700010
J	Gillespie, JH				Gillespie, J. Hayley			Application of Stable Isotope Analysis to Study Temporal Changes in Foraging Ecology in a Highly Endangered Amphibian	PLOS ONE			English	Article							STREAM; TOO; SALAMANDERS; BACTERIA; CARBON; DIETS; CAVE	Background: Understanding dietary trends for endangered species may be essential to assessing the effects of ecological disturbances such as habitat modification, species introductions or global climate change. Documenting temporal variation in prey selection may also be crucial for understanding population dynamics. However, the rarity, secretive behaviours and obscure microhabitats of some endangered species can make direct foraging observations difficult or impossible. Furthermore, the lethality or invasiveness of some traditional methods of dietary analysis (e. g. gut contents analysis, gastric lavage) makes them inappropriate for such species. Stable isotope analysis facilitates non-lethal, indirect analysis of animal diet that has unrealized potential in the conservation of endangered organisms, particularly amphibians. Methodology/Findings: I determined proportional contributions of aquatic macroinvertebrate prey to the diet of an endangered aquatic salamander Eurycea sosorum over a two-year period using stable isotope analysis of C-13/12 and N-15/14 and the Bayesian stable isotope mixing model SIAR. I calculated Strauss' dietary electivity indices by comparing these proportions with changing relative abundance of potential prey species through time. Stable isotope analyses revealed that a previously unknown prey item (soft-bodied planarian flatworms in the genus Dugesia) made up the majority of E. sosorum diet. Results also demonstrate that E. sosorum is an opportunistic forager capable of diet switching to include a greater proportion of alternative prey when Dugesia populations decline. There is also evidence of intra-population dietary variation. Conclusions/Significance: Effective application of stable isotope analysis can help circumvent two key limitations commonly experienced by researchers of endangered species: the inability to directly observe these species in nature and the invasiveness or lethality of traditional methods of dietary analysis. This study illustrates the feasibility of stable isotope analysis in identifying preferred prey species that can be used to guide conservation management of both wild and captive food sources for endangered species.	Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Gillespie, JH (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	hayleygillespie@utexas.edu			Sigma Xi; Southwestern Association of Naturalists; Barton Springs Salamander Conservation Fund; Zoology Scholarship Endowment for Excellence; Dorothea Bennett Memorial Graduate Fellowship; Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin	Sigma Xi; Southwestern Association of Naturalists; Barton Springs Salamander Conservation Fund; Zoology Scholarship Endowment for Excellence; Dorothea Bennett Memorial Graduate Fellowship; Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin	This work was generously funded by a Sigma Xi Grant-In-Aid of Research (http://www.sigmaxi.org/programs/giar/index.shtml), a Howard McCarley Student Research Award from the Southwestern Association of Naturalists (http://biosurvey.ou.edu/swan/stuaeng.htm#_HOWARD_MCCARLEY), a grant from the Barton Springs Salamander Conservation Fund (administered by the City of Austin and Austin Community Foundation; http://www.austincommunityfoundation.org/?nd = news#Salamander) and grants from the Zoology Scholarship Endowment for Excellence, Dorothea Bennett Memorial Graduate Fellowship and Terrell H. Hamilton Endowed Graduate Fellowship at the University of Texas at Austin (http://www.biosci.utexas.edu/graduate/eeb/current.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; BOGART JP, 1967, THESIS U TEXAS AUSTI; Brey T, 2010, J SEA RES, V64, P334, DOI 10.1016/j.seares.2010.05.002; BRUNE G, 1981, SPRINGS TEXAS, V1; BURTON TM, 1975, COPEIA, P541; CHIPPINDALE PT, 1993, HERPETOLOGICA, V49, P248; Chippindale PT, 2000, HERPETOL MONOGR, V14, P1, DOI 10.2307/1467045; Church MR, 2009, CAN J FISH AQUAT SCI, V66, P1, DOI 10.1139/F08-206; COHN JP, 1994, BIOSCIENCE, V44, P219, DOI 10.2307/1312225; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Deines P, 2007, ENVIRON MICROBIOL, V9, P1126, DOI 10.1111/j.1462-2920.2006.01235.x; Diaz Jr PH, 2010, THESIS TEXAS STATE U; EFFORD IE, 1973, T AM FISH SOC, V102, P33, DOI 10.1577/1548-8659(1973)102<33:ACOTFO>2.0.CO;2; ENGLISH WR, 1987, ENTOMOL NEWS, V98, P171; Fenolio DB, 2006, P ROY SOC B-BIOL SCI, V273, P439, DOI 10.1098/rspb.2005.3341; Fenolio DB, 2005, SOUTHWEST NAT, V50, P385, DOI 10.1894/0038-4909(2005)050[0385:SMPOPF]2.0.CO;2; Finlay JC, 2007, ECOLOGY, V88, P2187, DOI 10.1890/06-0344.1; FRASER DF, 1976, ECOLOGY, V57, P459, DOI 10.2307/1936431; Gerking SD., 2014, FEEDING ECOLOGY FISH; Hart DD, 1998, OECOLOGIA, V114, P263, DOI 10.1007/s004420050445; Hester F.E., 1962, T AM FISH SOC, V91, P420, DOI [10.1577/1548-8659(1962)91[420:AMSFAM]2.0.CO;2, DOI 10.1577/1548-8659(1962)91]; Hubbs C, 1995, COPEIA, P989, DOI 10.2307/1447053; Inger R, 2006, J ANIM ECOL, V75, P1190, DOI 10.1111/j.1365-2656.2006.01142.x; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jardine T D, 2003, CAN MANUSCR REP FISH, P39; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Kamil A. C., 1981, FORAGING BEHAV ECOLO; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Kolasa J, 2010, AQUAT ECOL SER, P143, DOI 10.1016/B978-0-12-374855-3.00006-6; Limbacher & Godfrey Architects, 2008, BART SPRINGS POOL MA; Lowe WH, 2005, BIOSCIENCE, V55, P196, DOI 10.1641/0006-3568(2005)055[0196:MHSTTH]2.0.CO;2; MACAN TT, 1977, BIOL REV, V52, P45, DOI 10.1111/j.1469-185X.1977.tb01345.x; McCue MD, 2008, RAPID COMMUN MASS SP, V22, P2307, DOI 10.1002/rcm.3615; McKechnie AE, 2004, S AFR J SCI, V100, P131; Najera-Hillman E, 2009, NEW ZEAL J ZOOL, V36, P165, DOI 10.1080/03014220909510149; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pilgrim M.A., 2005, THESIS U ARKANSAS US; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Ramos R, 2011, DIVERS DISTRIB, V17, P338, DOI 10.1111/j.1472-4642.2010.00736.x; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Schmidt O, 1999, OECOLOGIA, V118, P9, DOI 10.1007/s004420050697; Singer MC, 2000, ECOL LETT, V3, P159; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; US Fish and Wildlife Service, 2005, BART SPRINGS SAL EUR; Verburg P, 2007, J TROP ECOL, V23, P643, DOI 10.1017/S0266467407004518; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8	49	30	31	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53041	10.1371/journal.pone.0053041	http://dx.doi.org/10.1371/journal.pone.0053041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341920	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700011
J	Fernandez, RM; Mathieu, Y; Luzon-Toro, B; Nunez-Torres, R; Gonzalez-Meneses, A; Antinolo, G; Amiel, J; Borrego, S				Maria Fernandez, Raquel; Mathieu, Yves; Luzon-Toro, Berta; Nunez-Torres, Rocio; Gonzalez-Meneses, Antonio; Antinolo, Guillermo; Amiel, Jeanne; Borrego, Salud			Contributions of PHOX2B in the Pathogenesis of Hirschsprung Disease	PLOS ONE			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; HOMEOBOX GENE PHOX2B; HOMEODOMAIN PROTEINS; GERMLINE MUTATIONS; CANDIDATE GENE; RET; FRAMESHIFT; PHENOTYPE; EXPANSION	Hirschsprung disease (HSCR) is a congenital malformation of the hindgut resulting from a disruption of neural crest cell migration during embryonic development. It has a complex genetic aetiology with several genes involved in its pathogenesis. PHOX2B plays a key function in the development of neural crest derivatives, and heterozygous mutations cause a complex dysautonomia associating HSCR, Congenital Central Hypoventilation Syndrome (CCHS) and neuroblastoma (NB) in various combinations. In order to determine the role of PHOX2B in isolated HSCR, we performed a mutational screening in a cohort of 207 Spanish HSCR patients. Our most relevant finding has been the identification of a de novo and novel deletion (c.393_410del18) in a patient with HSCR. Results of in silico and functional assays support its pathogenic effect related to HSCR. Therefore our results support that PHOX2B loss-of-function is a rare cause of HSCR phenotype.	[Maria Fernandez, Raquel; Luzon-Toro, Berta; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Univ Seville, Dept Genet Reprod & Fetal Med, Inst Biomed Seville, Univ Hosp Virgen del Rocio,Ctr Super Invest Cient, Seville, Spain; [Maria Fernandez, Raquel; Luzon-Toro, Berta; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis, Seville, Spain; [Mathieu, Yves; Amiel, Jeanne] Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France; [Gonzalez-Meneses, Antonio] Univ Hosp Virgen del Rocio, Dept Paediat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Virgen del Rocio University Hospital	Borrego, S (corresponding author), Univ Seville, Dept Genet Reprod & Fetal Med, Inst Biomed Seville, Univ Hosp Virgen del Rocio,Ctr Super Invest Cient, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, GENETICA/P-3384-2015; amiel, jeanne/AGX-1124-2022; LUZON, BERTA/D-4884-2014; amiel, jeanne/H-3501-2017; IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015	amiel, jeanne/0000-0001-5973-4728; Mathieu, Yves/0000-0003-1366-1644; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain [PI1001290]; Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia [CTS-7447]; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche	Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain(Spanish Government); Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain (PI1001290) and Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalucia (CTS-7447), the Fondation pour la Recherche Medicale and the Agence Nationale de la Recherche. The CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Benailly HK, 2003, CLIN GENET, V64, P204, DOI 10.1034/j.1399-0004.2003.00105.x; Bourdeaut F, 2005, CANCER LETT, V228, P51, DOI 10.1016/j.canlet.2005.01.055; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fitze G, 2008, AM J MED GENET A, V146A, P1486, DOI 10.1002/ajmg.a.32300; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2003, GUT, V52, P563, DOI 10.1136/gut.52.4.563; Hung CC, 2007, ELECTROPHORESIS, V28, P894, DOI 10.1002/elps.200600383; Jennings LJ, 2012, PEDIATR PULM, V47, P153, DOI 10.1002/ppul.21527; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Matera I, 2004, J MED GENET, V41, P373, DOI 10.1136/jmg.2003.015412; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Seo H, 2002, J NEUROCHEM, V80, P905, DOI 10.1046/j.0022-3042.2002.00782.x; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Trochet D, 2009, HUM MUTAT, V30, pE421, DOI 10.1002/humu.20923; Weese-Mayer DE, 2003, AM J MED GENET A, V123A, P267, DOI 10.1002/ajmg.a.20527; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; WILSON DS, 1995, CURR BIOL, V5, P32, DOI 10.1016/S0960-9822(95)00010-8	23	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54043	10.1371/journal.pone.0054043	http://dx.doi.org/10.1371/journal.pone.0054043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342068	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400113
J	Perez-Sieira, S; Martinez, G; Porteiro, B; Lopez, M; Vidal, A; Nogueiras, R; Dieguez, C				Perez-Sieira, Sonia; Martinez, Gloria; Porteiro, Begona; Lopez, Miguel; Vidal, Anxo; Nogueiras, Ruben; Dieguez, Carlos			Female Nur77-Deficient Mice Show Increased Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; BROWN ADIPOSE-TISSUE; CELL-DEATH; METABOLISM; NUR77; EXPRESSION; TARGET; NR4A1	Adipose tissue is essential in the regulation of body weight. The key process in fat catabolism and the provision of energy substrate during times of nutrient deprivation or enhanced energy demand is the hydrolysis of triglycerides and the release of fatty acids and glycerol. Nur77 is a member of the NR4A subfamily of nuclear receptors that plays an important metabolic role, modulating hepatic glucose metabolism and lipolysis in muscle. However, its endogenous role on white adipose tissue, as well as the gender dependency of these mechanisms, remains largely unknown. Male and female wild type and Nur77 deficient mice were fed with a high fat diet (45% calories from fat) for 4 months. Mice were analyzed in vivo with the indirect calorimetry system, and tissues were analyzed by real-time PCR and Western blot analysis. Female, but not male Nur77 deficient mice, gained more weight and fat mass when compared to wild type mice fed with high fat diet, which can be explained by decreased energy expenditure. The lack of Nur77 also led to a decreased pHSL/HSL ratio in white adipose tissue and increased expression of CIDEA in brown adipose tissue of female Nur77 deficient mice. Overall, these findings suggest that Nur77 is an important physiological modulator of lipid metabolism in adipose tissue and that there are gender differences in the sensitivity to deletion of the Nur77 signaling. The decreased energy expenditure and the actions of Nur77 on liver, muscle, brown and white adipose tissue contribute to the increased susceptibility to diet-induced obesity in females lacking Nur77.	[Perez-Sieira, Sonia; Martinez, Gloria; Porteiro, Begona; Lopez, Miguel; Vidal, Anxo; Nogueiras, Ruben; Dieguez, Carlos] Inst Invest Sanitarias IDIS, Dept Physiol, Sch Med, CIMUS, Santiago De Compostela, Spain; [Perez-Sieira, Sonia; Porteiro, Begona; Lopez, Miguel; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela	Nogueiras, R (corresponding author), Inst Invest Sanitarias IDIS, Dept Physiol, Sch Med, CIMUS, Santiago De Compostela, Spain.	ruben.nogueiras@usc.es; carlos.dieguez@usc.es	López, Miguel/ABF-4844-2021; Vidal, Anxo/B-5010-2015; , Begoña/AAB-3599-2021; Nogueiras, Ruben/AAS-9427-2021	López, Miguel/0000-0002-7823-1648; Vidal, Anxo/0000-0002-0866-4202; , Begoña/0000-0001-6646-5132; Nogueiras, Ruben/0000-0002-9976-9930; dieguez, carlos/0000-0002-0919-4337	Ministerio de Ciencia e Innovacion [RYC-2008-02219, SAF2009-07049, RyC-2007-00211, BFU2008-02001]; Xunta de Galicia [10PXIB208164PR, 2010/14]; Fondo Investigationes Sanitarias [PS09/01880]; European Community [245009, ERC-2011-StG-OBESITY53-281408]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); European Community(European Commission)	This work has been supported by grants from Ministerio de Ciencia e Innovacion (to RN: RYC-2008-02219; to RN: SAF2009-07049; to ML: RyC-2007-00211; to CD: BFU2008-02001), Xunta de Galicia (to ML: 10PXIB208164PR and to RN: 2010/14); Fondo Investigationes Sanitarias (to ML: PS09/01880), European Union leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 245009 and also ERC-2011-StG-OBESITY53-281408 (to RN). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WS, 2008, INT J OBESITY, V32, P388, DOI 10.1038/sj.ijo.0803763; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Czyzyk TA, 2010, FASEB J, V24, P1151, DOI 10.1096/fj.09-143610; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gonzalez CR, 2009, J PHYSIOL-LONDON, V587, P3741, DOI 10.1113/jphysiol.2009.172510; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kanzleiter T, 2010, DIABETOLOGIA, V53, P1174, DOI 10.1007/s00125-010-1703-2; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Livingstone C, 2002, CLIN SCI, V102, P151, DOI 10.1042/cs1020151; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Veum VL, 2011, INT J OBES LOND; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang SCM, 2011, MOL ENDOCRINOL, V25, P291, DOI 10.1210/me.2010-0231; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	36	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53836	10.1371/journal.pone.0053836	http://dx.doi.org/10.1371/journal.pone.0053836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342015	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400091
J	Schneeberger, K; Czirjak, GA; Voigt, CC				Schneeberger, Karin; Czirjak, Gabor A.; Voigt, Christian C.			Measures of the Constitutive Immune System Are Linked to Diet and Roosting Habits of Neotropical Bats	PLOS ONE			English	Article							BARN SWALLOWS; DISEASE RISK; BLOOD; PARASITISM; EVOLUTION; INFECTION; LEUKOCYTE; COUNTS; MICROORGANISMS; DIVERSITY	Ecological and social factors are central in the emergence and transmission of infectious diseases, thus bearing the potential for shaping a species' immune functions. Although previous studies demonstrated a link between social factors and the cellular immune system for captive mammals, it is yet poorly understood how ecological factors are connected with the different branches of the immune system in wild populations. Here, we tested how variation in aspects of the constitutive cellular and humoral immune system of free ranging bats is associated with two ecological factors that likely influence the putative risk of species to become infected by parasites and pathogens: diet and shelter. We found that white blood cell counts of 24 syntopic Neotropical bat species varied with the species' diet and body mass. Bats that included at least partially vertebrates in their diet exhibited the highest white blood cell counts, followed by phytophagous and insectivorous species, which is in agreement with the assumption that the immune system varies with the pathogen transmission risk of a trophic level. The soluble part of the constitutive immune response, assessed by an in vitro bacterial killing assay, decreased with increasing roost permanence. Our results suggest that the ecology is an important factor in the evolution of the immune system in bats and probably also other mammals.	[Schneeberger, Karin; Czirjak, Gabor A.; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Schneeberger, Karin; Voigt, Christian C.] Free Univ Berlin, Dept Anim Behav, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Schneeberger, K (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	schneeberger@izw-berlin.de	Czirják, Gábor Árpád/F-5440-2011; Schneeberger, Karin/C-9836-2013	Czirják, Gábor Árpád/0000-0001-9488-0069; Schneeberger, Karin/0000-0003-2098-2542	Leibniz Institute for Zoo and Wildlife Research	Leibniz Institute for Zoo and Wildlife Research	This study was supported by funds from the Leibniz Institute for Zoo and Wildlife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; BELL G, 1991, J ANIM ECOL, V60, P1047, DOI 10.2307/5430; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Cichon M, 2001, J EVOLUTION BIOL, V14, P180, DOI 10.1046/j.1420-9101.2001.00243.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Durbin C, 2009, VET CLIN PATH, V38, P157, DOI 10.1111/j.1939-165X.2009.00110.x; Ezenwa VO, 2012, FUNCT ECOL, V26, P123, DOI 10.1111/j.1365-2435.2011.01919.x; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GREENWOOD BM, 1973, T ROY SOC TROP MED H, V67, P846, DOI 10.1016/0035-9203(73)90013-8; Hoffmann FG, 2003, MOL ECOL, V12, P3403, DOI 10.1046/j.1365-294X.2003.02009.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kunz TH, 2006, BAT ECOLOGY; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; LaVal RK, 2002, MURCIELAGOS COSTA RI; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Moller AP, 2009, FUNCT ECOL, V23, P1097, DOI 10.1111/j.1365-2435.2009.01594.x; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Moore MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027430; Moore MS, 2011, THESIS BOSTON U; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; Nunn CL, 2002, EVOLUTION, V56, P177; Nunn CL, 2003, P ROY SOC B-BIOL SCI, V270, P347, DOI 10.1098/rspb.2002.2249; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Price T, 1997, PHILOS T ROY SOC B, V352, P519, DOI 10.1098/rstb.1997.0036; Saino N, 1997, P NATL ACAD SCI USA, V94, P549, DOI 10.1073/pnas.94.2.549; Santos Mery, 2003, Mammalian Species, V722, P1, DOI 10.1644/722; Schinnerl M, 2011, J ZOO WILDLIFE MED, V42, P382, DOI 10.1638/2010-0060.1; Stearns S., 1992, EVOLUTION LIFE HIST; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; TIMM RM, 1998, OCCASIONAL PUBLICATI, V22, P1; Tvedten H, 1988, Vet Clin Pathol, V17, P4, DOI 10.1111/j.1939-165X.1988.tb00477.x; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Walberg J, 2001, SEMIN AVIAN EXOT PET, V10, P72, DOI 10.1053/saep.2001.22051; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Zysling DA, 2009, FUNCT ECOL, V23, P979, DOI 10.1111/j.1365-2435.2009.01572.x	59	47	47	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54023	10.1371/journal.pone.0054023	http://dx.doi.org/10.1371/journal.pone.0054023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342064	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400111
J	Basile, V; Belluti, S; Ferrari, E; Gozzoli, C; Ganassi, S; Quaglino, D; Saladini, M; Imbriano, C				Basile, Valentina; Belluti, Silvia; Ferrari, Erika; Gozzoli, Chiara; Ganassi, Sonia; Quaglino, Daniela; Saladini, Monica; Imbriano, Carol			bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; SIGNALING PATHWAYS; COLORECTAL-CANCER; GENE-EXPRESSION; UP-REGULATION; IN-VITRO; NF-Y; ACTIVATION	Background: The activation of autophagy has been extensively described as a pro-survival strategy, which helps to keep cells alive following deprivation of nutrients/growth factors and other stressful cellular conditions. In addition to cytoprotective effects, autophagy can accompany cell death. Autophagic vacuoles can be observed before or during cell death, but the role of autophagy in the death process is still controversial. A complex interplay between autophagy and apoptosis has come to light, taking into account that numerous genes, such as p53 and Bcl-2 family members, are shared between these two pathways. Methodology/Principal Findings: In this study we showed a potent and irreversible cytotoxic activity of the stable Curcumin derivative bis-DeHydroxyCurcumin (bDHC) on human colon cancer cells, but not on human normal cells. Autophagy is elicited by bDHC before cell death as demonstrated by increased autophagosome formation -measured by electron microscopy, fluorescent LC3 puncta and LC3 lipidation- and autophagic flux -measured by interfering LC3-II turnover. The accumulation of poly-ubiquitinated proteins and ER-stress occurred upstream of autophagy induction and resulted in cell death. Cell cycle and Western blot analyses highlighted the activation of a mitochondrial-dependent apoptosis, which involves caspase 7, 8, 9 and Cytochrome C release. Using pharmacological inhibitions and RNAi experiments, we showed that ER-stress induced autophagy has a major role in triggering bDHC-cell death. Conclusion/Significance: Our findings describe the mechanism through which bDHC promotes tumor selective inhibition of proliferation, providing unequivocal evidence of the role of autophagy in contrasting the proliferation of colon cancer cells.	[Basile, Valentina; Belluti, Silvia; Gozzoli, Chiara; Ganassi, Sonia; Quaglino, Daniela; Imbriano, Carol] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy; [Ferrari, Erika; Saladini, Monica] Univ Modena & Reggio Emilia, Dipartimento Sci Chim & Geol, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Imbriano, C (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Via Campi 213-D, Modena, Italy.	cimbriano@unimo.it	Quaglino, Daniela/A-9381-2010; Saladini, Monica/N-8596-2015; Imbriano, Carol/ABD-8204-2021; BELLUTI, SILVIA/AAU-2625-2020; Ferrari, Erika/F-7742-2012; Basile, Valentina/S-3828-2016; Imbriano, Carol/C-9376-2015	Quaglino, Daniela/0000-0002-4302-5078; Saladini, Monica/0000-0003-2515-8317; Imbriano, Carol/0000-0003-2864-4820; BELLUTI, SILVIA/0000-0003-0846-9359; Ferrari, Erika/0000-0001-7627-2502; Basile, Valentina/0000-0003-3151-1228; Imbriano, Carol/0000-0003-2864-4820; Ganassi, Sonia/0000-0003-2518-7628	Associazione Italiana per la Ricerca sul Cancro-MFAG [6192]; Fondazione Cassa di Risparmio di Vignola	Associazione Italiana per la Ricerca sul Cancro-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Vignola	This work was supported by Associazione Italiana per la Ricerca sul Cancro-MFAG (grant number 6192 to CI) and Fondazione Cassa di Risparmio di Vignola to CI and EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Baliga B, 2003, CELL DEATH DIFFER, V10, P16, DOI 10.1038/sj.cdd.4401166; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Basile V, 2009, BIOCHEM PHARMACOL, V78, P1305, DOI 10.1016/j.bcp.2009.06.105; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bielak-Zmijewska A, 2004, CANCER CHEMOTH PHARM, V53, P179, DOI 10.1007/s00280-003-0705-x; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferrari E, 2011, J MED CHEM, V54, P8066, DOI 10.1021/jm200872q; Fuchs JR, 2009, BIOORG MED CHEM LETT, V19, P2065, DOI 10.1016/j.bmcl.2009.01.104; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He ZY, 2011, CANCER INVEST, V29, P208, DOI 10.3109/07357907.2010.550592; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Jiang ZH, 2010, MOL CANCER THER, V9, P558, DOI 10.1158/1535-7163.MCT-09-0627; Jullig M, 2006, APOPTOSIS, V11, P627, DOI 10.1007/s10495-006-4990-9; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Moragoda L, 2001, ANTICANCER RES, V21, P873; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nardo L, 2012, J PHYS CHEM A, V116, P9321, DOI 10.1021/jp307928a; Ng APP, 2011, MOL CANCER RES, V9, P878, DOI 10.1158/1541-7786.MCR-10-0545; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Paglin S, 2001, CANCER RES, V61, P439; Pallauf K, 2012, AGEING RES REV; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ramachandran C, 2005, ANTICANCER RES, V25, P3293; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Reuter S, 2008, BIOCHEM PHARMACOL, V76, P1340, DOI 10.1016/j.bcp.2008.07.031; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rosati E, 2010, BLOOD, V116, P2713, DOI 10.1182/blood-2010-03-275628; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Verfaillie T, 2010, INT J CELL BIOL, V2010; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Wu SH, 2010, ANTICANCER RES, V30, P2125; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoon MJ, 2010, FREE RADICAL BIO MED, V48, P713, DOI 10.1016/j.freeradbiomed.2009.12.016; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x; Zhuang W, 2011, CANCER SCI, V103, P684	87	48	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53664	10.1371/journal.pone.0053664	http://dx.doi.org/10.1371/journal.pone.0053664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326480	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800067
J	Iriemenam, NC; Pandey, JP; Williamson, J; Blackstock, AJ; Yesupriya, A; Namboodiri, AM; Rocca, KM; van Eijk, AM; Ayisi, J; Oteino, J; Lal, RB; ter Kuile, FO; Steketee, R; Nahlen, B; Slutsker, L; Shi, YP				Iriemenam, Nnaemeka C.; Pandey, Janardan P.; Williamson, John; Blackstock, Anna J.; Yesupriya, Ajay; Namboodiri, Aryan M.; Rocca, Keith M.; van Eijk, Anna Maria; Ayisi, John; Oteino, Juliana; Lal, Renu B.; ter Kuile, Feiko O.; Steketee, Richard; Nahlen, Bernard; Slutsker, Laurence; Shi, Ya Ping			Association between Immunoglobulin GM and KM Genotypes and Placental Malaria in HIV-1 Negative and Positive Women in Western Kenya	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSES; KM ALLOTYPES; HEAVY-CHAIN; PREGNANCY; BURDEN; SUSCEPTIBILITY; PHAGOCYTOSIS	Immunoglobulin (Ig) GM and KM allotypes, genetic markers of gamma and kappa chains, are associated with humoral immune responsiveness. Previous studies have shown the relationships between GM6-carrying haplotypes and susceptibility to malaria infection in children and adults; however, the role of the genetic markers in placental malaria (PM) infection and PM with HIV co-infection during pregnancy has not been investigated. We examined the relationship between the gene polymorphisms of Ig GM6 and KM allotypes and the risk of PM infection in pregnant women with known HIV status. DNA samples from 728 pregnant women were genotyped for GM6 and KM alleles using polymerase chain reaction-restriction fragment length polymorphism method. Individual GM6 and KM genotypes and the combined GM6 and KM genotypes were assessed in relation to PM in HIV-1 negative and positive women, respectively. There was no significant effect of individual GM6 and KM genotypes on the risk of PM infection in HIV-1 negative and positive women. However, the combination of homozygosity for GM6(+) and KM3 was associated with decreased risk of PM (adjusted OR, 0.25; 95% CI, 0.08-0.8; P = 0.019) in HIV-1 negative women while in HIV-1 positive women the combination of GM6(+/-) with either KM1-3 or KM1 was associated with increased risk of PM infection (adjusted OR, 2.10; 95% CI, 1.18-3.73; P = 0.011). Hardy-Weinberg Equilibrium (HWE) tests further showed an overall significant positive F(is) (indication of deficit in heterozygotes) for GM6 while there was no deviation for KM genotype frequency from HWE in the same population. These findings suggest that the combination of homozygous GM6(+) and KM3 may protect against PM in HIV-1 negative women while the HIV-1 positive women with heterozygous GM6(+/-) combined with KM1-3 or KM1 may be more susceptible to PM infection. The deficit in heterozygotes for GM6 further suggests that GM6 could be under selection likely by malaria infection.	[Iriemenam, Nnaemeka C.; Williamson, John; Blackstock, Anna J.; Steketee, Richard; Nahlen, Bernard; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Pandey, Janardan P.; Namboodiri, Aryan M.; Rocca, Keith M.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Blackstock, Anna J.] Vet Affairs Med Ctr, Atlanta Res & Educ Fdn, Decatur, GA 30033 USA; [Yesupriya, Ajay] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Coordinating Ctr Hlth Promot, Atlanta, GA USA; [van Eijk, Anna Maria; Ayisi, John] Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu, Kenya; [Oteino, Juliana] Minist Hlth, New Nyanza Prov Gen Hosp, Kisumu, Kenya; [Lal, Renu B.] Ctr Dis Control & Prevent, Div AIDS STD TB Lab Res, Natl Ctr HIV STD TB Prevent, Atlanta, GA USA; [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England	Centers for Disease Control & Prevention - USA; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; University of Liverpool	Pandey, JP (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	pandeyj@musc.edu; yps0@cdc.gov	Nahlen, Bernard/AAH-2051-2021; van Eijk, Anna Maria/AAQ-9894-2021; Kuile, Feiko ter/ABD-6681-2020	Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	National Office of Public Health Genomics, Centers for Disease Control and Prevention [92129RQ]; American Society for Microbiology (ASM); Centers for Disease Control and Prevention (CDC) (ASM/CDC)	National Office of Public Health Genomics, Centers for Disease Control and Prevention; American Society for Microbiology (ASM); Centers for Disease Control and Prevention (CDC) (ASM/CDC)	This study was supported by intramural funding from The National Office of Public Health Genomics, Centers for Disease Control and Prevention (Project ID# 92129RQ). NCI was supported by the American Society for Microbiology (ASM) and Centers for Disease Control and Prevention (CDC) Postdoctoral Fellowship (ASM/CDC Research Fellowship Program). The funders had no role in study design, data collection, and decision to publish, or preparation of the manuscript except for AY, a statistician, from the National Office of Public Health Genomics, CDC assisting in data analysis.	ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; Alvarez G, 2008, GENET RES, V90, P209, DOI 10.1017/S0016672307009068; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Ayisi JG, 2003, J INFECTION, V46, P164, DOI 10.1053/jinf.2002.1088; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Brouwer KC, 2004, J INFECT DIS, V190, P1192, DOI 10.1086/422850; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Czerwinski M, 1998, J IMMUNOL, V160, P4406; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Giha HA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-306; GRUBB R, 1995, EXP CLIN IMMUNOGENET, V12, P191; Hedrick P.W., 2011, GENETICS POPULATIONS; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Juompan L, 1998, APPL BIOCHEM BIOTECH, V75, P139, DOI 10.1007/BF02787714; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lachance J, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-15; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Migot-Nabias F, 2008, J INFECT DIS, V198, P1892, DOI 10.1086/593210; Migot-Nabias F, 2011, MICROBES INFECT, V13, P771, DOI 10.1016/j.micinf.2011.04.001; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; MOXLEY G, 1992, GENOMICS, V13, P104, DOI 10.1016/0888-7543(92)90208-A; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Pandey JP, 2007, PARASITE IMMUNOL, V29, P267, DOI 10.1111/j.1365-3024.2007.00938.x; Pandey JP, 2006, SCIENCE, V311, P1376; Pandey JP, 2004, J VIROL, V78, P4561, DOI 10.1128/JVI.78.9.4561-4565.2004; PANDEY JP, 1984, J IMMUNOGENET, V11, P159; Pandey JP, 2000, VACCINE, V19, P613, DOI 10.1016/S0264-410X(00)00255-3; Pozzoli U, 2010, TRENDS GENET, V26, P95, DOI 10.1016/j.tig.2009.12.010; STEINBERG AC, 1981, DISTRIBUTION HUMAN I; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Taylor DW, 2004, INFECT IMMUN, V72, P1603, DOI 10.1128/IAI.72.3.1603-1607.2004; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; WACHSMUTH RR, 1987, EXP CLIN IMMUNOGENET, V4, P163; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53948	10.1371/journal.pone.0053948	http://dx.doi.org/10.1371/journal.pone.0053948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326546	Green Published, Green Accepted, gold			2022-12-27	WOS:000314705800092
J	Kanamaru, T; Fujii, H; Aihara, K				Kanamaru, Takashi; Fujii, Hiroshi; Aihara, Kazuyuki			Deformation of Attractor Landscape via Cholinergic Presynaptic Modulations: A Computational Study Using a Phase Neuron Model	PLOS ONE			English	Article							INHIBITORY CONNECTIONS; SYNAPTIC-TRANSMISSION; VISUAL-CORTEX; SENSORY RESPONSES; MEMORY RETRIEVAL; PARIETAL CORTEX; EPISODIC MEMORY; NETWORK MODEL; GABA RELEASE; ACETYLCHOLINE	Corticopetal acetylcholine (ACh) is released transiently from the nucleus basalis of Meynert (NBM) into the cortical layers and is associated with top-down attention. Recent experimental data suggest that this release of ACh disinhibits layer 2/3 pyramidal neurons (PYRs) via muscarinic presynaptic effects on inhibitory synapses. Together with other possible presynaptic cholinergic effects on excitatory synapses, this may result in dynamic and temporal modifications of synapses associated with top-down attention. However, the system-level consequences and cognitive relevance of such disinhibitions are poorly understood. Herein, we propose a theoretical possibility that such transient modifications of connectivity associated with ACh release, in addition to top-down glutamatergic input, may provide a neural mechanism for the temporal reactivation of attractors as neural correlates of memories. With baseline levels of ACh, the brain returns to quasi-attractor states, exhibiting transitive dynamics between several intrinsic internal states. This suggests that top-down attention may cause the attention-induced deformations between two types of attractor landscapes: the quasi-attractor landscape (Q-landscape, present under low-ACh, non-attentional conditions) and the attractor landscape (A-landscape, present under high-ACh, top-down attentional conditions). We present a conceptual computational model based on experimental knowledge of the structure of PYRs and interneurons (INs) in cortical layers 1 and 2/3 and discuss the possible physiological implications of our results.	[Kanamaru, Takashi] Kogakuin Univ, Dept Innovat Mech Engn, Tokyo, Japan; [Fujii, Hiroshi] Kyoto Sangyo Univ, Dept Intelligent Syst, Kyoto 603, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Kogakuin University; Kyoto Sangyo University; University of Tokyo	Kanamaru, T (corresponding author), Kogakuin Univ, Dept Innovat Mech Engn, Tokyo, Japan.	kanamaru@cc.kogakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20700215, 4103, 21120002, 20246026]; Aihara Project; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	The first author (TK) was supported by a Grant-in-Aid for Encouragement of Young Scientists (B) (No. 20700215) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The second author (HF) was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (21120002) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The third author (KA) was supported by a Grant-in-Aid for Scientific Research (A) (No. 20246026) from The Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also partially supported by the Aihara Project, the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST) from the Japan Society for the Promotion of Science (JSPS), initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1997, NEURAL NETWORKS, V10, P83, DOI 10.1016/S0893-6080(96)00061-5; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; AIHARA K, 1986, PHYS LETT A, V116, P313, DOI 10.1016/0375-9601(86)90578-5; Aihara K, 1990, ADV SERIES DYNAMICAL, V8, P143; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Buno W, 2006, J MOL NEUROSCI, V30, P161, DOI 10.1385/JMN:30:1:161; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CHEN LN, 1995, NEURAL NETWORKS, V8, P915, DOI 10.1016/0893-6080(95)00033-V; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Daelli V, 2010, EXP BRAIN RES, V203, P241, DOI 10.1007/s00221-010-2243-1; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Feudel U, 2000, CHAOS, V10, P231, DOI 10.1063/1.166488; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fujii H, 2011, ADV COGNITIVE NEUROD, VII, P79; Fujii H, 2008, LECT NOTES COMPUT SC, V4984, P170; Fujii H, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P249, DOI 10.1007/978-1-4020-8387-7_44; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HAYASHI H, 1982, PHYS LETT A, V88, P435, DOI 10.1016/0375-9601(82)90674-0; Hess G, 1999, EXP BRAIN RES, V127, P279, DOI 10.1007/s002210050797; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; INOUE M, 1991, PHYS LETT A, V158, P373, DOI 10.1016/0375-9601(91)90677-Z; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Izhikevich EM, 1999, IEEE T NEURAL NETWOR, V10, P499, DOI 10.1109/72.761707; Kanamaru T, 2005, NEURAL COMPUT, V17, P1315, DOI 10.1162/0899766053630387; Kanamaru T, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031916; Kanamaru T, 2004, IEEE T NEURAL NETWOR, V15, P1009, DOI 10.1109/TNN.2004.832715; Kanamaru T, 2008, NEURAL COMPUT, V20, P1951, DOI 10.1162/neco.2008.05-07-516; Kanamaru T, 2007, NEURAL NETWORKS, V20, P781, DOI 10.1016/j.neunet.2007.06.002; Kanamaru T, 2006, INT J BIFURCAT CHAOS, V16, P3309, DOI 10.1142/S021812740601680X; Kanamaru T, 2006, NEURAL COMPUT, V18, P1111, DOI 10.1162/neco.2006.18.5.1111; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Klein I, 2000, J COGNITIVE NEUROSCI, V12, P15, DOI 10.1162/089892900564037; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kuczewski N, 2005, J PHYSIOL-LONDON, V566, P907, DOI 10.1113/jphysiol.2005.089987; Kurashige H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024007; Kuroiwa J, 2004, INT J BIFURCAT CHAOS, V14, P1413, DOI 10.1142/S0218127404009867; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Matsumoto G., 1984, J THEOR NEUROBIOL, V3, P1; METHERATE R, 1992, J NEUROSCI, V12, P4701; MILNOR J, 1985, COMMUN MATH PHYS, V99, P177, DOI 10.1007/BF01212280; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NARA S, 1995, INT J BIFURCAT CHAOS, V5, P1205, DOI 10.1142/S0218127495000867; NARA S, 1992, PROG THEOR PHYS, V88, P845, DOI 10.1143/PTP.88.845; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PERRY EK, 1995, BRAIN COGNITION, V28, P240, DOI 10.1006/brcg.1995.1255; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; Ringach DL, 2003, NATURE, V425, P912, DOI 10.1038/425912a; Rodriguez A, 2004, J COGNITIVE NEUROSCI, V16, P856, DOI 10.1162/089892904970690; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Thompson KA, 2005, ABA J, V91, P25; Tokuda I, 1997, NEURAL NETWORKS, V10, P1673, DOI 10.1016/S0893-6080(97)00023-3; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; TSUDA I, 1987, PROG THEOR PHYS, V78, P51, DOI 10.1143/PTP.78.51; TSUDA I, 1992, NEURAL NETWORKS, V5, P313, DOI 10.1016/S0893-6080(05)80029-2; Tsuda I, 1991, WORLD FUTURES, V32, P167, DOI [DOI 10.1080/02604027.1991.9972257, 10.1080/02604027.1991.9972257]; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Turrini P, 2001, NEUROSCIENCE, V105, P277, DOI 10.1016/S0306-4522(01)00172-5; Uchiyama S, 2004, CHAOS, V14, P699, DOI 10.1063/1.1785612; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varona P, 2001, NEURAL NETWORKS, V14, P865, DOI 10.1016/S0893-6080(01)00046-6; Vecera S. P., 2000, BRAIN MIND, V1, P353, DOI [10.1023/A:1011565623996, DOI 10.1023/A:1011565623996, 10.1023/A]; VONDERMALSBURG C, 1981, CORRELATION THEORY B, P81; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	92	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53854	10.1371/journal.pone.0053854	http://dx.doi.org/10.1371/journal.pone.0053854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326520	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800081
J	Roach, JM; Racioppi, L; Jones, CD; Masci, AM				Roach, Jeffrey M.; Racioppi, Luigi; Jones, Corbin D.; Masci, Anna Maria			Phylogeny of Toll-Like Receptor Signaling: Adapting the Innate Response	PLOS ONE			English	Article							DOMAIN-CONTAINING ADAPTERS; DEPENDENT KINASE-IV; DENDRITIC CELLS; GENE FAMILY; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; PROTEIN UNIVERSE; IMMUNE-RESPONSE; EVOLUTION; DATABASE	The Toll-like receptors represent a largely evolutionarily conserved pathogen recognition machinery responsible for recognition of bacterial, fungal, protozoan, and viral pathogen associated microbial patterns and initiation of inflammatory response. Structurally the Toll-like receptors are comprised of an extracellular leucine rich repeat domain and a cytoplasmic Toll/Interleukin 1 receptor domain. Recognition takes place in the extracellular domain where as the cytoplasmic domain triggers a complex signal network required to sustain appropriate immune response. Signal transduction is regulated by the recruitment of different intracellular adaptors. The Toll-like receptors can be grouped depending on the usage of the adaptor, MyD88, into MyD88-dependent and MyD88 independent subsets. Herein, we present a unique phylogenetic analysis of domain regions of these receptors and their cognate signaling adaptor molecules. Although previously unclear from the phylogeny of full length receptors, these analyses indicate a separate evolutionary origin for the MyD88-dependent and MyD88-independent signaling pathway and provide evidence of a common ancestor for the vertebrate and invertebrate orthologs of the adaptor molecule MyD88. Together these observations suggest a very ancient origin of the MyD88-dependent pathway Additionally we show that early duplications gave rise to several adaptor molecule families. In some cases there is also strong pattern of parallel duplication between adaptor molecules and their corresponding TLR. Our results further support the hypothesis that phylogeny of specific domains involved in signaling pathway can shed light on key processes that link innate to adaptive immune response.	[Roach, Jeffrey M.] Univ N Carolina, Ctr Res Comp, Chapel Hill, NC USA; [Racioppi, Luigi] Duke Univ, Dept Med, Durham, NC USA; [Racioppi, Luigi] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Masci, Anna Maria] Duke Univ, Dept Immunol, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Naples Federico II; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Masci, AM (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.	annamaria.masci@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022	racioppi, luigi/0000-0002-9207-6752; Masci, Anna Maria/0000-0003-1940-6740	Research Computing at the University of North Carolina, Chapel Hill	Research Computing at the University of North Carolina, Chapel Hill	We would like to acknowledge the support of Research Computing at the University of North Carolina, Chapel Hill in making use of the Kure computing environment.	ANDERSON KV, 1992, COLD SPRING HARB SYM, V57, P409, DOI 10.1101/SQB.1992.057.01.046; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fornarino S, 2011, MOL BIOL EVOL, V28, P3087, DOI 10.1093/molbev/msr137; Friedman R, 2002, IMMUNOGENETICS, V53, P964, DOI 10.1007/s00251-001-0399-3; Galgani M, 2004, J BIOL CHEM, V279, P32507, DOI 10.1074/jbc.M403355200; Galgani M, 2004, INFECT IMMUN, V72, P4480, DOI 10.1128/IAI.72.8.4480-4485.2004; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hughes AL, 2008, IMMUNOGENETICS, V60, P249, DOI 10.1007/s00251-008-0283-5; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kasamatsu J, 2010, DEV COMP IMMUNOL, V34, P855, DOI 10.1016/j.dci.2010.03.004; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Masci AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-70; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Satake H, 2010, ZOOL SCI, V27, P154, DOI 10.2108/zsj.27.154; SIPPL MJ, 1999, BIOL SEQUENCE ANAL P, V8, P695; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Uematsu Satoshi, 2008, V183, P1; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Wu BJ, 2011, DEV COMP IMMUNOL, V35, P764, DOI 10.1016/j.dci.2011.02.009; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013; Zhang Q, 2010, IMMUNOGENETICS, V62, P263, DOI 10.1007/s00251-010-0428-1; Zhou HJ, 2007, J MOL EVOL, V65, P119, DOI 10.1007/s00239-005-0008-4	56	21	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54156	10.1371/journal.pone.0054156	http://dx.doi.org/10.1371/journal.pone.0054156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326591	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800112
J	Fonovic, UP; Jevnikar, Z; Rojnik, M; Doljak, B; Fonovic, M; Jamnik, P; Kos, J				Fonovic, Ursa Pecar; Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Fonovic, Marko; Jamnik, Polona; Kos, Janko			Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells	PLOS ONE			English	Article							UP-REGULATION; CANCER; MOTILITY; PROLIFERATION; EXPRESSION; COMPLEXES; CARCINOMA; MIGRATION; PROTEASES; ENA/VASP	Cathepsin X has been reported to be a tumor promotion factor in various types of cancer; however, the molecular mechanisms linking its activity with malignant processes are not understood. Here we present profilin 1, a known tumor suppressor, as a target for cathepsin X carboxypeptidase activity in prostate cancer PC-3 cells. Profilin 1 co-localizes strongly with cathepsin X intracellularly in the perinuclear area as well as at the plasma membrane. Selective cleavage of C-terminal amino acids was demonstrated on a synthetic octapeptide representing the profilin C-terminal region, and on recombinant profilin 1. Further, intact profilin 1 binds its poly-L-proline ligand clathrin significantly better than it does the truncated one, as shown using cathepsin X specific inhibitor AMS-36 and immunoprecipitation of the profilin 1/clathrin complex. Moreover, the polymerization of actin, which depends also on the binding of poly-L-proline ligands to profilin 1, was promoted by AMS-36 treatment of cells and by siRNA cathepsin X silencing. Our results demonstrate that increased adhesion, migration and invasiveness of tumor cells depend on the inactivation of the tumor suppressive function of profilin 1 by cathepsin X. The latter is thus designated as a target for development of new antitumor strategies.	[Fonovic, Ursa Pecar; Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Fonovic, Marko] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia; [Fonovic, Marko] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Jamnik, Polona] Biotech Fac, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Kos, J (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	janko.kos@ffa.uni-lj.si	Fonović, Marko/X-9957-2019	Fonovic, Marko/0000-0002-8375-6713	Slovenia Research Agency [P4-0127, J4-0123]	Slovenia Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenia Research Agency grant P4-0127 and J4-0123 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; FINKEL T, 1994, P NATL ACAD SCI USA, V91, P1510, DOI 10.1073/pnas.91.4.1510; Fonovic UP, 2009, ACTA CHIM SLOV, V56, P985; Frohlich E, 2001, CANCER-AM CANCER SOC, V91, P972; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Jevnikar Z, 2009, EUR J IMMUNOL, V39, P3217, DOI 10.1002/eji.200939562; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kos J, 2005, EXP CELL RES, V306, P103, DOI 10.1016/j.yexcr.2004.12.006; Kos J, 2009, CELL ADHES MIGR, V3, P164, DOI 10.4161/cam.3.2.7403; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lwin ZM, 2010, MODERN PATHOL, V23, P1559, DOI 10.1038/modpathol.2010.173; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nagler DK, 2004, PROSTATE, V60, P109, DOI 10.1002/pros.20046; Nascimento FD, 2005, ARCH BIOCHEM BIOPHYS, V436, P323, DOI 10.1016/j.abb.2005.01.013; Obermajer N, 2006, EXP CELL RES, V312, P2515, DOI 10.1016/j.yexcr.2006.04.019; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Puzer L, 2005, BIOL CHEM, V386, P1191, DOI 10.1515/BC.2005.136; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Staudt ND, 2010, HAEMATOL-HEMATOL J, V95, P1452, DOI 10.3324/haematol.2009.018671; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53918	10.1371/journal.pone.0053918	http://dx.doi.org/10.1371/journal.pone.0053918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326535	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400058
J	Gruber, AV; Nisemblat, S; Zizelski, G; Parnas, A; Dzikowski, R; Azem, A; Weiss, C				Gruber, Anna Vitlin; Nisemblat, Shahar; Zizelski, Gal; Parnas, Avital; Dzikowski, Ron; Azem, Abdussalam; Weiss, Celeste			P. falciparum cpn20 Is a Bona Fide Co-Chaperonin That Can Replace GroES in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; ARABIDOPSIS-THALIANA; IN-VIVO; APICOPLAST; MITOCHONDRIAL; CHLOROPLASTS; CPN10; RING; COCHAPERONINS	Human malaria is among the most ubiquitous and destructive tropical, parasitic diseases in the world today. The causative agent, Plasmodium falciparum, contains an unusual, essential organelle known as the apicoplast. Inhibition of this degenerate chloroplast results in second generation death of the parasite and is the mechanism by which antibiotics function in treating malaria. In order to better understand the biochemistry of this organelle, we have cloned a putative, 20 kDa, co-chaperonin protein, Pf-cpn20, which localizes to the apicoplast. Although this protein is homologous to the cpn20 that is found in plant chloroplasts, its ability to function as a co-chaperonin was questioned in the past. In the present study, we carried out a structural analysis of Pf-cpn20 using circular dichroism and analytical ultracentrifugation and then used two different approaches to investigate the ability of this protein to function as a co-chaperonin. In the first approach, we purified recombinant Pf-cpn20 and tested its ability to act as a co-chaperonin for GroEL in vitro, while in the second, we examined the ability of Pf-cpn20 to complement an E. coli depletion of the essential bacterial co-chaperonin GroES. Our results demonstrate that Pf-cpn20 is fully functional as a co-chaperonin in vitro. Moreover, the parasitic co-chaperonin is able to replace GroES in E. coli at both normal and heat-shock temperatures. Thus, Pf-cpn20 functions as a co-chaperonin in chaperonin-mediated protein folding. The ability of the malarial protein to function in E. coli suggests that this simple system can be used as a tool for further analyses of Pf-cpn20 and perhaps other chaperone proteins from P. falciparum.	[Gruber, Anna Vitlin; Nisemblat, Shahar; Zizelski, Gal; Parnas, Avital; Azem, Abdussalam; Weiss, Celeste] Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, Ramat Aviv, Israel; [Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Inst Med Res Israel Canada,Dept Microbiol & Mol G, IL-91010 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Azem, A (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, Ramat Aviv, Israel.	azema@tauex.tau.ac.il	Dzikowski, Ron/HHZ-2430-2022		BARD [US-4443-11]; United States-Israel Binational Research and Development Fund	BARD; United States-Israel Binational Research and Development Fund	This research was supported by Research Grant No. US-4443-11 from BARD, the United States-Israel Binational Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; de Jongh HHJ, 1998, BIOCHEM BIOPH RES CO, V244, P884, DOI 10.1006/bbrc.1998.8360; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fossati G, 2003, J BACTERIOL, V185, P4256, DOI 10.1128/JB.185.14.4256-4267.2003; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Higurashi T, 1999, J MOL BIOL, V291, P703, DOI 10.1006/jmbi.1999.2994; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Kuo WY, 2013, NEW PHYTOL, V197, P99, DOI 10.1111/j.1469-8137.2012.04369.x; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Machaidze Gia, 2006, Journal of Biological Physics and Chemistry, V6, P91, DOI 10.4024/20608.jbpc.06.02; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; Parnas A, 2012, PLOS ONE IN PRESS; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Roberts MM, 1999, ACTA CRYSTALLOGR D, V55, P910, DOI 10.1107/S0907444998018447; ROY H, 1989, PLANT CELL, V1, P1035, DOI 10.1105/tpc.1.11.1035; Sato S, 2005, MOL BIOCHEM PARASIT, V141, P133, DOI 10.1016/j.molbiopara.2005.01.010; Sato S, 2004, MOL BIOCHEM PARASIT, V134, P175, DOI 10.1016/j.molbiopara.2003.11.015; Sato S, 2011, CELL MOL LIFE SCI, V68, P1285, DOI 10.1007/s00018-011-0646-1; Seale JW, 1996, BIOCHEMISTRY-US, V35, P4079, DOI 10.1021/bi953087n; Seale JW, 1997, J PROTEIN CHEM, V16, P661, DOI 10.1023/A:1026350303043; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	52	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53909	10.1371/journal.pone.0053909	http://dx.doi.org/10.1371/journal.pone.0053909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326533	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400056
J	Jafari, P; Braissant, O; Zavadakova, P; Henry, H; Bonafe, L; Ballhausen, D				Jafari, Paris; Braissant, Olivier; Zavadakova, Petra; Henry, Hugues; Bonafe, Luisa; Ballhausen, Diana			Ammonium Accumulation and Cell Death in a Rat 3D Brain Cell Model of Glutaric Aciduria Type I	PLOS ONE			English	Article							COA DEHYDROGENASE-DEFICIENCY; MOUSE MODEL; NEURODEGENERATION; MANAGEMENT; DIAGNOSIS; TRANSPORT; SECONDARY; TOXICITY; CREATINE; ACIDS	Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap. Biochemical hallmarks of this disease are elevated levels of glutarate and 3-hydroxyglutarate in blood and urine. The neuropathology of this disease is still poorly understood, as low lysine diet and carnitine supplementation do not always prevent brain damage, even in early-treated patients. We used a 3D in vitro model of rat organotypic brain cell cultures in aggregates to mimic glutaric aciduria type I by repeated administration of 1 mM glutarate or 3-hydroxyglutarate at two time points representing different developmental stages. Both metabolites were deleterious for the developing brain cells, with 3-hydroxyglutarate being the most toxic metabolite in our model. Astrocytes were the cells most strongly affected by metabolite exposure. In culture medium, we observed an up to 11-fold increase of ammonium in the culture medium with a concomitant decrease of glutamine. We further observed an increase in lactate and a concomitant decrease in glucose. Exposure to 3-hydroxyglutarate led to a significantly increased cell death rate. Thus, we propose a three step model for brain damage in glutaric aciduria type I: (i) 3-OHGA causes the death of astrocytes, (ii) deficiency of the astrocytic enzyme glutamine synthetase leads to intracerebral ammonium accumulation, and (iii) high ammonium triggers secondary death of other brain cells. These unexpected findings need to be further investigated and verified in vivo. They suggest that intracerebral ammonium accumulation might be an important target for the development of more effective treatment strategies to prevent brain damage in patients with glutaric aciduria type I.	[Jafari, Paris; Braissant, Olivier; Zavadakova, Petra; Henry, Hugues; Bonafe, Luisa; Ballhausen, Diana] Univ Lausanne Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ballhausen, D (corresponding author), Univ Lausanne Hosp, Lausanne, Switzerland.	diana.ballhausen@chuv.ch		Ballhausen, Diana/0000-0003-2940-3439	Swiss National Science Foundation [310030-127497]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation (http://www.snf.ch) grant number 310030-127497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AU, 2012, MOL GENETICS METABOL; Beauchamp MH, 2009, J INHERITED METABOLI; Braissant O, 2002, J NEUROSCI, V22, P9810; Braissant O, 2008, EUR J NEUROSCI, V27, P1673, DOI 10.1111/j.1460-9568.2008.06126.x; Cagnon L, 2008, NEUROBIOL DIS, V32, P281, DOI 10.1016/j.nbd.2008.07.012; Cagnon L, 2007, BRAIN RES REV, V56, P183, DOI 10.1016/j.brainresrev.2007.06.026; Cagnon L, 2009, NEUROBIOL DIS, V33, P133, DOI 10.1016/j.nbd.2008.09.025; Ferreira da Costa G, 2005, NEUROCHEM RES, V30, P1123; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hedlund GL, 2006, AM J MED GENET C, V142C, P86, DOI 10.1002/ajmg.c.30088; Hoffmann GF, 1999, J INHERIT METAB DIS, V22, P381, DOI 10.1023/A:1005543904484; HOFFMANN GF, 1993, J INHERIT METAB DIS, V16, P648, DOI 10.1007/BF00711898; Honegger P, 2002, J NEUROCHEM, V81, P1141, DOI 10.1046/j.1471-4159.2002.00888.x; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; Kolker S, 2007, J INHERIT METAB DIS, V30, P5, DOI 10.1007/s10545-006-0451-4; Kolker S, 2011, J INHERIT METAB DIS, V34, P677, DOI 10.1007/s10545-011-9289-5; Koeller DM, 2002, HUM MOL GENET, V11, P347, DOI 10.1093/hmg/11.4.347; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Olivera-Bravo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020831; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Strauss KA, 2003, AM J MED GENET C, V121C, P53, DOI 10.1002/ajmg.c.20008; Ullrich K, 1999, J INHERIT METAB DIS, V22, P392, DOI 10.1023/A:1005595921323; Wick Regula, 2007, J Forensic Leg Med, V14, P42, DOI 10.1016/j.jcfm.2006.01.002; Zinnanti WJ, 2006, BRAIN, V129, P899, DOI 10.1093/brain/awl009	26	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53735	10.1371/journal.pone.0053735	http://dx.doi.org/10.1371/journal.pone.0053735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326493	Green Published, gold			2022-12-27	WOS:000313552400038
J	Yang, YC; Chang, LK				Yang, Ya-Chun; Chang, Li-Kwan			Role of TAF4 in Transcriptional Activation by Rta of Epstein-Barr Virus	PLOS ONE			English	Article							TATA-LESS PROMOTER; IMMEDIATE-EARLY PROTEIN; HUMAN EPITHELIAL-CELLS; TFIID COMPLEX; BRLF1 PROMOTER; FACTOR-R; LATENT MEMBRANE-PROTEIN-1; BMLF1 PROMOTER; LYTIC CYCLE; DNA-BINDING	Epstein-Barr virus (EBV) expresses an immediate-early protein, Rta, to activate the transcription of EBV lytic genes. This protein usually binds to Rta-response elements or interacts with Sp1 or Zta via a mediator protein, MCAF1, to activate transcription. Rta is also known to interact with TBP and TFIIB to activate transcription. This study finds that Rta interacts with TAF4, a component of TFIID complex, in vitro and in vivo, and on the TATA sequence in the BcLF1 promoter. Rta also interacts with TAF4 and Sp1 on Sp1-binding sequences on TATA-less promoters, including those of BNLF1, BALF5, and the human androgen receptor. These interactions are important to the transcriptional activation of these genes by Rta since introducing TAF4 shRNA substantially reduces the ability of Rta to activate these promoters. This investigation reveals how Rta interacts with TFIID to stimulate transcription.	[Yang, Ya-Chun; Chang, Li-Kwan] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Chang, LK (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute of the Republic of China, Taiwan [NHRI-EX101-10030BI]; National Science Council of the Republic of China, Taiwan [NSC-100-2311-B-002-011]	National Health Research Institute of the Republic of China, Taiwan(National Health Research Institutes - Taiwan); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Health Research Institute of the Republic of China, Taiwan (contract number NHRI-EX101-10030BI) and the National Science Council of the Republic of China, Taiwan (contract number NSC-100-2311-B-002-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang MH, 1997, DNA CELL BIOL, V16, P829, DOI 10.1089/dna.1997.16.829; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; Chang PJ, 1998, J GEN VIROL, V79, P2003, DOI 10.1099/0022-1317-79-8-2003; Chang Y, 2004, J VIROL, V78, P13028, DOI 10.1128/JVI.78.23.13028-13036.2004; CHEVALLIERGRECO A, 1989, J VIROL, V63, P615, DOI 10.1128/JVI.63.2.615-623.1989; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; Chiu YF, 2007, J GEN VIROL, V88, P2463, DOI 10.1099/vir.0.82881-0; Chua HH, 2007, J VIROL, V81, P2459, DOI 10.1128/JVI.02289-06; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUSING MR, 1994, NUCLEIC ACIDS RES, V22, P669, DOI 10.1093/nar/22.4.669; FABER PW, 1993, J BIOL CHEM, V268, P9296; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GIOT JF, 1991, NUCLEIC ACIDS RES, V19, P1251, DOI 10.1093/nar/19.6.1251; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; GRUFFAT H, 1992, J VIROL, V66, P46, DOI 10.1128/JVI.66.1.46-52.1992; Gruffat H, 2012, J VIROL, V86, P6023, DOI 10.1128/JVI.00159-12; Heilmann AMF, 2010, J VIROL, V84, P9920, DOI 10.1128/JVI.00573-10; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hinuma Y, 1967, J Virol, V1, P1045; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hsu TY, 2005, J GEN VIROL, V86, P317, DOI 10.1099/vir.0.80556-0; Johannessen M, 2003, J GEN VIROL, V84, P1887, DOI 10.1099/vir.0.19057-0; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee YH, 2008, J GEN VIROL, V89, P2437, DOI 10.1099/vir.0.2008/003897-0; LIEBERMAN P, 1994, MOL CELL BIOL, V14, P8365, DOI 10.1128/MCB.14.12.8365; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Manet Evelyne, 1993, Gene Expression, V3, P49; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Mazzarelli JM, 1997, J VIROL, V71, P7978, DOI 10.1128/JVI.71.10.7978-7983.1997; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Ragoczy T, 2001, J VIROL, V75, P5240, DOI 10.1128/JVI.75.11.5240-5251.2001; Robinson AR, 2011, J VIROL, V85, P8940, DOI 10.1128/JVI.00569-11; SADLER RH, 1995, J VIROL, V69, P4577, DOI 10.1128/JVI.69.7.4577-4581.1995; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Serio TR, 1998, J VIROL, V72, P8338, DOI 10.1128/JVI.72.10.8338-8343.1998; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Tsai CN, 1999, VIROLOGY, V261, P288, DOI 10.1006/viro.1999.9851; Vorobyeva NE, 2009, P NATL ACAD SCI USA, V106, P11049, DOI 10.1073/pnas.0901801106; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	62	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54075	10.1371/journal.pone.0054075	http://dx.doi.org/10.1371/journal.pone.0054075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326574	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400073
J	Ben Ammar, A; Soltanzadeh, P; Bauche, S; Richard, P; Goillot, E; Herbst, R; Gaudon, K; Huze, C; Schaeffer, L; Yamanashi, Y; Higuchi, O; Taly, A; Koenig, J; Leroy, JP; Hentati, F; Najmabadi, H; Kahrizi, K; Ilkhani, M; Fardeau, M; Eymard, B; Hantai, D				Ben Ammar, Asma; Soltanzadeh, Payam; Bauche, Stephanie; Richard, Pascale; Goillot, Evelyne; Herbst, Ruth; Gaudon, Karen; Huze, Caroline; Schaeffer, Laurent; Yamanashi, Yuji; Higuchi, Osamu; Taly, Antoine; Koenig, Jeanine; Leroy, Jean-Paul; Hentati, Faycal; Najmabadi, Hossein; Kahrizi, Kimia; Ilkhani, Manouchehr; Fardeau, Michel; Eymard, Bruno; Hantai, Daniel			A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia	PLOS ONE			English	Article							TYROSINE KINASE MUSK; NICOTINIC ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; CRYSTAL-STRUCTURE; MUSCLE; SYNAPSE; PROTEIN; DOMAIN; DOK-7; MOUSE	Congenital myasthenic syndromes (CMSs) are a heterogeneous group of genetic disorders affecting neuromuscular transmission. The agrin/muscle-specific kinase (MuSK) pathway is critical for proper development and maintenance of the neuromuscular junction (NMJ). We report here an Iranian patient in whom CMS was diagnosed since he presented with congenital and fluctuating bilateral symmetric ptosis, upward gaze palsy and slowly progressive muscle weakness leading to loss of ambulation. Genetic analysis of the patient revealed a homozygous missense mutation c.2503A>G in the coding sequence of MUSK leading to the p.Met835Val substitution. The mutation was inherited from the two parents who were heterozygous according to the notion of consanguinity. Immunocytochemical and electron microscopy studies of biopsied deltoid muscle showed dramatic changes in pre- and post-synaptic elements of the NMJs. These changes induced a process of denervation/reinnervation in native NMJs and the formation, by an adaptive mechanism, of newly formed and ectopic NMJs. Aberrant axonal outgrowth, decreased nerve terminal ramification and nodal axonal sprouting were also noted. In vivo electroporation of the mutated MuSK in a mouse model showed disorganized NMJs and aberrant axonal growth reproducing a phenotype similar to that observed in the patient's biopsy specimen. In vitro experiments showed that the mutation alters agrin-dependent acetylcholine receptor aggregation, causes a constitutive activation of MuSK and a decrease in its agrin- and Dok-7-dependent phosphorylation.	[Ben Ammar, Asma; Soltanzadeh, Payam; Bauche, Stephanie; Koenig, Jeanine; Leroy, Jean-Paul; Eymard, Bruno; Hantai, Daniel] UPMC, Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Inserm,UMRS 975, Paris, France; [Ben Ammar, Asma; Hentati, Faycal] Univ Tunis El Manar, Inst Natl Neurol, Lab Neurobiol Mol & Neuropathol, Tunis, Tunisia; [Bauche, Stephanie] Ecole Prat Hautes Etud, Paris, France; [Richard, Pascale; Gaudon, Karen] Grp Hosp Pitie Salpetriere, APHP, Serv Biochim Metabol, UF Cardiogenet & Myogenet, F-75634 Paris, France; [Goillot, Evelyne; Huze, Caroline; Schaeffer, Laurent] Univ Lyon, INRA,UMR5161, CNRS,IFR128, ENS Lyon,Equipe Differenciat Neuromusculaire, Lyon, France; [Herbst, Ruth] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Yamanashi, Yuji; Higuchi, Osamu] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Genet, Tokyo, Japan; [Taly, Antoine] Univ Strasbourg, CNRS, UMR 7199, Lab Concept & Applicat Mol Bioact, Illkirch Graffenstaden, France; [Najmabadi, Hossein; Kahrizi, Kimia] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Ilkhani, Manouchehr] Shahid Beheshti Univ Med Sci, Dept Neurol, Tehran, Iran; [Fardeau, Michel] Grp Hosp Pitie Salpetriere, Inst Myol, Unite Morphol Neuromusculaire, F-75634 Paris, France; [Eymard, Bruno; Hantai, Daniel] Grp Hosp Pitie Salpetriere, APHP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Tunis-El-Manar; Institut National de Neurologie; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Medical University of Vienna; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Shahid Beheshti University Medical Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hantai, D (corresponding author), UPMC, Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Inserm,UMRS 975, Paris, France.	daniel.hantai@upmc.fr	Soltanzadeh, Payam/B-4816-2008; Taly, Antoine/B-3339-2008; Najmabadi, Hossein/P-8182-2017; Kahrizi, Kimia/D-7989-2017; Soltanzadeh, Payam/GMJ-0554-2022	Taly, Antoine/0000-0001-5109-0091; Soltanzadeh, Payam/0000-0001-5788-8619; Bauche, Stephanie/0000-0002-6926-339X; schaeffer, laurent/0000-0001-6600-503X; Najmabadi, Hossein/0000-0002-6084-7778; Richard, Pascale/0000-0002-2390-3005; Herbst, Ruth/0000-0002-7764-5363; Goillot, Evelyne/0000-0003-0026-4690	Assistance Publique-Hopitaux de Paris [PHRC AOM 1036]; Reseaux Inserm; ANR-Maladies Rares [ANR-07-MRAR-001]; Association Francaise contre les Myopathies (AFM); Comite Mixte Franco-Tunisien pour la Cooperation Universitaire (CMCU Project) [05G0809]; AFM; Contrat hospitalier de recherche translationnelle AP-HP Inserm; Grants-in-Aid for Scientific Research [23249013] Funding Source: KAKEN	Assistance Publique-Hopitaux de Paris; Reseaux Inserm; ANR-Maladies Rares(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Comite Mixte Franco-Tunisien pour la Cooperation Universitaire (CMCU Project); AFM(Association Francaise contre les Myopathies); Contrat hospitalier de recherche translationnelle AP-HP Inserm; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Assistance Publique-Hopitaux de Paris (PHRC AOM 1036), Reseaux Inserm, ANR-Maladies Rares (#ANR-07-MRAR-001), Association Francaise contre les Myopathies (AFM), and Comite Mixte Franco-Tunisien pour la Cooperation Universitaire (CMCU Project #05G0809). A.BA. was the recipient of a doctoral fellowship from the AFM, P.S. of a postdoctoral fellowship from the AFM, and D.H. of a Contrat hospitalier de recherche translationnelle AP-HP Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Bedlack RS, 2005, NEUROLOGY, V64, P1968, DOI 10.1212/01.WNL.0000163988.28892.79; Beeson D, 2008, ANN NY ACAD SCI, V1132, P99, DOI 10.1196/annals.1405.049; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654; CARONI P, 1994, J CELL BIOL, V125, P893, DOI 10.1083/jcb.125.4.893; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Do Thi N A, 1990, Neurochem Int, V17, P573, DOI 10.1016/0197-0186(90)90045-U; DUCLERT A, 1993, P NATL ACAD SCI USA, V90, P3043, DOI 10.1073/pnas.90.7.3043; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2008, ANN NY ACAD SCI, V1132, P104, DOI 10.1196/annals.1405.039; Feng ZH, 2005, NEUROSCIENTIST, V11, P503, DOI 10.1177/1073858405277409; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Hamuro J, 2008, J BIOL CHEM, V283, P5518, DOI 10.1074/jbc.M708607200; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; Hopf C, 1998, J BIOL CHEM, V273, P6467, DOI 10.1074/jbc.273.11.6467; Huze C, 2009, AM J HUM GENET, V85, P155, DOI 10.1016/j.ajhg.2009.06.015; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Jones G, 1999, J NEUROSCI, V19, P3376; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065; Maselli RA, 2010, HUM MOL GENET, V19, P2370, DOI 10.1093/hmg/ddq110; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; Mihaylova V, 2009, NEUROLOGY, V73, P1926, DOI 10.1212/WNL.0b013e3181c3fce9; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Muller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; RICHARD S, 1989, J SUBMICR CYTOL PATH, V21, P461; SOBEL A, 1978, P NATL ACAD SCI USA, V75, P510, DOI 10.1073/pnas.75.1.510; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305; Taly A, 2008, ANN NY ACAD SCI, V1132, P42, DOI 10.1196/annals.1405.008; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Tam SL, 2003, J NEUROCYTOL, V32, P961, DOI 10.1023/B:NEUR.0000020635.41233.0f; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; Vincent A, 2003, LANCET NEUROL, V2, P99, DOI 10.1016/S1474-4422(03)00306-5; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wiesner A, 2006, CELL MOL LIFE SCI, V63, P2818, DOI 10.1007/s00018-006-6081-z; Yamanashi Y, 2012, J BIOCHEM, V151, P353, DOI 10.1093/jb/mvs013; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307; Zong YN, 2012, GENE DEV, V26, P247, DOI 10.1101/gad.180885.111	48	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53826	10.1371/journal.pone.0053826	http://dx.doi.org/10.1371/journal.pone.0053826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326516	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500097
J	Nobel, S; Witte, K				Noebel, Sabine; Witte, Klaudia			Public Information Influences Sperm Transfer to Females in Sailfin Molly Males	PLOS ONE			English	Article							MALE MATE CHOICE; GUPPY POECILIA-RETICULATA; MALE MATING-BEHAVIOR; SEXUAL SELECTION; GEOGRAPHIC-VARIATION; MULTIPLE PATERNITY; COMPETITION GAMES; SOCIAL INFLUENCES; JAPANESE-QUAIL; LATIPINNA COPY	In animals, including humans, the social environment can serve as a public information network in which individuals can gather public information about the quality of potential mates by observing conspecifics during sexual interactions. The observing individual itself is also a part of this information network. When recognized by the observed conspecifics as an audience, his/her presence could influence the sexual interaction between those individuals, because the observer might be considered as a potential mate or competitor. One of the most challenging questions in sexual selection to date is how the use of public information in the context of mate choice is linked to the fitness of individuals. Here, we could show that public information influences mate-choice behaviour in sailfin molly males, Poecilia latipinna, and influences the amount of sperm males transfer to a female partner. In the presence of an audience male, males spent less time with the previously preferred, larger of two females and significantly more time with the previously non-preferred, smaller female. When males could physically interact with a female and were faced with an audience male, three audience females or no audience, males transferred significantly more sperm to a female partner in the presence of an audience male than with female audience or no audience and spent less time courting his female partner. This is the first study showing that public information use turns into fitness investment, which is the crucial factor to understand the role of public information in the dynamic processes in sexual selection.	[Noebel, Sabine; Witte, Klaudia] Univ Siegen, Biol Sect, Res Grp Ecol & Behav Biol, D-57068 Siegen, Germany	Universitat Siegen	Nobel, S (corresponding author), Univ Siegen, Biol Sect, Res Grp Ecol & Behav Biol, D-57068 Siegen, Germany.	noebel@biologie.uni-siegen.de		Nobel, Sabine/0000-0002-1850-8895				Agrawal AF, 2001, BEHAV ECOL SOCIOBIOL, V51, P33, DOI 10.1007/s002650100401; Alonzo SH, 2008, ANIM BEHAV, V75, P1715, DOI 10.1016/j.anbehav.2007.09.031; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Aspbury AS, 2007, BEHAV ECOL, V18, P776, DOI 10.1093/beheco/arm044; Aspbury AS, 2004, P NATL ACAD SCI USA, V101, P15970, DOI 10.1073/pnas.0405653101; Aspbury AS, 2004, ETHOLOGY, V110, P193, DOI 10.1111/j.1439-0310.2003.00963.x; Auld HL, 2009, BEHAV PROCESS, V82, P78, DOI 10.1016/j.beproc.2009.03.004; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Bierbach D, 2011, BEHAV ECOL SOCIOBIOL, V65, P1699, DOI 10.1007/s00265-011-1177-3; Birkhead TR, 1998, SPERM COMPETITION SE; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Bozynski CC, 2003, ANIM BEHAV, V65, P53, DOI 10.1006/anbe.2002.2024; Brennan BJ, 2008, J THEOR BIOL, V253, P561, DOI 10.1016/j.jtbi.2008.04.003; Brooks R, 1998, TRENDS ECOL EVOL, V13, P45, DOI 10.1016/S0169-5347(97)01253-6; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Dugatkin LA, 1998, BEHAV ECOL, V9, P323, DOI 10.1093/beheco/9.4.323; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Dzieweczynski TL, 2004, ANIM BEHAV, V68, P465, DOI 10.1016/j.anbehav.2003.08.024; Earley Ryan L., 2005, P84, DOI 10.1017/CBO9780511610363.007; Eva KW, 2006, CAN MED ASSOC J, V175, P1573, DOI 10.1503/cmaj.061367; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; Evans Jonathan P., 2011, P197; Evans JP, 2003, BEHAV ECOL, V14, P268, DOI 10.1093/beheco/14.2.268; Evans JP, 1999, P ROY SOC B-BIOL SCI, V266, P2083, DOI 10.1098/rspb.1999.0891; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Frommen JG, 2009, EVOL ECOL, V23, P435, DOI 10.1007/s10682-008-9243-7; Fuller RC, 1998, P ROY SOC B-BIOL SCI, V265, P2365, DOI 10.1098/rspb.1998.0585; Galef BG, 2008, ANIM BEHAV, V75, P1117, DOI 10.1016/j.anbehav.2007.08.026; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; GIBSON RM, 1992, TRENDS ECOL EVOL, V7, P229, DOI 10.1016/0169-5347(92)90050-L; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; Girndt A, 2012, ANIM BIOL, V62, P245, DOI 10.1163/157075611X618192; Godin JGJ, 2009, BEHAVIOUR, V146, P1443, DOI 10.1163/156853909X441014; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; Goulet D, 2006, BEHAV ECOL, V17, P998, DOI 10.1093/beheco/arl032; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; Heubel KU, 2008, BEHAVIOUR, V145, P1041, DOI 10.1163/156853908784474533; Hill SE, 2006, BIOL LETT-UK, V2, P203, DOI 10.1098/rsbl.2005.0423; HOGLUND J, 1995, ANIM BEHAV, V49, P1627, DOI 10.1016/0003-3472(95)90085-3; Hoi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032806; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KIRKPATRICK M, 1994, BEHAV ECOL SOCIOBIOL, V34, P443; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; Lichtenberg EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P763, DOI 10.1007/s00265-010-1080-3; LILEY NR, 1995, CAN J ZOOL, V73, P826, DOI 10.1139/z95-097; LOSEY GS, 1986, AM NAT, V128, P653, DOI 10.1086/284595; Loyau A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00768; MAJERUS MEN, 1986, TRENDS ECOL EVOL, V1, P1, DOI 10.1016/0169-5347(86)90056-X; Makowicz AM, 2010, BEHAV PROCESS, V85, P36, DOI 10.1016/j.beproc.2010.06.003; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Marler CA, 1997, EVOLUTION, V51, P1244, DOI 10.1111/j.1558-5646.1997.tb03971.x; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor Peter K., 1996, P409; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Mouterde SC, 2012, ANIM BEHAV, V83, P605, DOI 10.1016/j.anbehav.2011.11.032; Naguib M, 2004, BEHAV ECOL, V15, P1011, DOI 10.1093/beheco/arh108; Nordell SE, 1998, ECOL LETT, V1, P74; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; OLSEN KH, 1993, GEN COMP ENDOCR, V89, P107, DOI 10.1006/gcen.1993.1014; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; PARTRIDGE L, 1983, MATE CHOICE, P227; PARZEFAL.J, 1969, BEHAVIOUR, V33, P1, DOI 10.1163/156853969X00297; Phelps SM, 2007, BEHAV ECOL, V18, P108, DOI 10.1093/beheco/arl063; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Plath M, 2008, CURR BIOL, V18, P1138, DOI 10.1016/j.cub.2008.06.067; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2007, BEHAV ECOL, V18, P680, DOI 10.1093/beheco/arm030; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Pollick AS, 2005, ANIM BEHAV, V70, P1273, DOI 10.1016/j.anbehav.2005.03.007; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Ptacek MB, 1997, EVOLUTION, V51, P1217, DOI 10.1111/j.1558-5646.1997.tb03969.x; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Ritchie MG, 2000, P ROY SOC B-BIOL SCI, V267, P327, DOI 10.1098/rspb.2000.1004; Schaus JM, 2001, BEHAV ECOL, V12, P740, DOI 10.1093/beheco/12.6.740; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; SCHWAGMEYER PL, 1990, NATURE, V348, P62, DOI 10.1038/348062a0; Sirot E, 2001, J EVOLUTION BIOL, V14, P418, DOI 10.1046/j.1420-9101.2001.00284.x; Smith C, 2003, BEHAV ECOL SOCIOBIOL, V53, P206, DOI 10.1007/s00265-002-0576-x; Stohr S, 1998, ANIM BEHAV, V55, P893, DOI 10.1006/anbe.1997.0674; Tobler M, 2005, BIOL LETTERS, V1, P166, DOI 10.1098/rsbl.2005.0305; TRAVIS J, 1990, COPEIA, P722, DOI 10.2307/1446438; Trefry SA, 2009, ETHOLOGY, V115, P928, DOI 10.1111/j.1439-0310.2009.01675.x; Trexler JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P297, DOI 10.1007/s002650050345; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uehara T, 2005, AM NAT, V165, P403, DOI 10.1086/428301; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Vukomanovic J, 2007, ETHOLOGY, V113, P579, DOI 10.1111/j.1439-0310.2007.01343.x; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; Waynforth D, 2007, HUM NATURE-INT BIOS, V18, P264, DOI 10.1007/s12110-007-9004-2; Webster H, 2010, ETHOLOGY, V116, P233, DOI 10.1111/j.1439-0310.2009.01729.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; White DJ, 2000, ANIM BEHAV, V59, P975, DOI 10.1006/anbe.1999.1402; White DJ, 1999, ANIM BEHAV, V57, P1005, DOI 10.1006/anbe.1998.1059; Widemo MS, 2006, BEHAV ECOL, V17, P255, DOI 10.1093/beheco/arj021; Witte K, 1998, BEHAV ECOL, V9, P534, DOI 10.1093/beheco/9.5.534; Witte K, 2003, ANIM BEHAV, V65, P1151, DOI 10.1006/anbe.2003.2160; Witte K, 2003, BEHAV ECOL, V14, P389, DOI 10.1093/beheco/14.3.389; Witte K, 2002, BEHAV ECOL SOCIOBIOL, V52, P194, DOI 10.1007/s00265-002-0503-1; Witte K, 2002, ANIM BEHAV, V63, P943, DOI 10.1006/anbe.2001.1982; Witte K, 2011, FISH COGNITION BEHAV, P81, DOI DOI 10.1002/9781444342536; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	130	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53865	10.1371/journal.pone.0053865	http://dx.doi.org/10.1371/journal.pone.0053865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342021	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700053
J	Xu, L; Freitas, SMA; Yu, FH; Dong, M; Anten, NPR; Werger, MJA				Xu, Liang; Freitas, Sofia M. A.; Yu, Fei-Hai; Dong, Ming; Anten, Niels P. R.; Werger, Marinus J. A.			Effects of Trampling on Morphological and Mechanical Traits of Dryland Shrub Species Do Not Depend on Water Availability	PLOS ONE			English	Article							BEAN-PLANTS; GROWTH; VEGETATION; STRESS; RESISTANCE; THIGMOMORPHOGENESIS; HETEROGENEITY; AVOIDANCE; TOLERANCE; DIVERSITY	In semiarid drylands water shortage and trampling by large herbivores are two factors limiting plant growth and distribution. Trampling can strongly affect plant performance, but little is known about responses of morphological and mechanical traits of woody plants to trampling and their possible interaction with water availability. Seedlings of four shrubs (Caragana intermedia, Cynanchum komarovi, Hedysarum laeve and Hippophae rhamnoides) common in the semiarid Mu Us Sandland were grown at 4% and 10% soil water content and exposed to either simulated trampling or not. Growth, morphological and mechanical traits were measured. Trampling decreased vertical height and increased basal diameter and stem resistance to bending and rupture (as indicated by the increased minimum bend and break force) in all species. Increasing water availability increased biomass, stem length, basal diameter, leaf thickness and rigidity of stems in all species except C. komarovii. However, there were no interactive effects of trampling and water content on any of these traits among species except for minimum bend force and the ratio between stem resistance to rupture and bending. Overall shrub species have a high degree of trampling resistance by morphological and mechanical modifications, and the effects of trampling do not depend on water availability. However, the increasing water availability can also affect trade-off between stem strength and flexibility caused by trampling, which differs among species. Water plays an important role not only in growth but also in trampling adaptation in drylands.	[Xu, Liang; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Liang; Freitas, Sofia M. A.; Anten, Niels P. R.; Werger, Marinus J. A.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Anten, Niels P. R.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Xu, Liang; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Hangzhou Normal University; Utrecht University; Beijing Forestry University; Wageningen University & Research; Chinese Academy of Sciences; Institute of Botany, CAS	Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	dongmingchina@126.com	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	NSFC [31070371, 31261120580]; Hangzhou Normal University; KNAW grant [02CDC015, 99CDC027]	NSFC(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; KNAW grant	This work was supported by NSFC grants (31070371, 31261120580), Innovative R&D Grant of Hangzhou Normal University and KNAW grants (02CDC015 and 99CDC027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Abellan M, 2006, ENVIRON MONIT ASSESS, V120, P93, DOI 10.1007/s10661-005-9051-2; Anten NPR, 2009, AM NAT, V173, P241, DOI 10.1086/595761; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; BIRO RL, 1980, ANN BOT-LONDON, V45, P655, DOI 10.1093/oxfordjournals.aob.a085874; BOWLES JM, 1982, BIOL CONSERV, V24, P273, DOI 10.1016/0006-3207(82)90015-5; Cui H., 1998, FLORA CHINA, V42; Dong X.J., 1997, CHINESE J PLANT ECOL, V21, P208; Dunne T, 2011, J ARID ENVIRON, V75, P58, DOI 10.1016/j.jaridenv.2010.09.001; Fang W-P, 1983, FLORA CHINA, V52; Fu K-J, 1993, FLORA CHINA, V42; Gere JM, 1999, MECH MAT; Goodman AM, 1996, J EXP BOT, V47, P1499, DOI 10.1093/jxb/47.10.1499; Hamberg L, 2010, J ENVIRON MANAGE, V91, P1811, DOI 10.1016/j.jenvman.2010.04.003; Hanke W, 2011, J ARID ENVIRON, V75, P185, DOI 10.1016/j.jaridenv.2010.09.002; [贺斌 HE Bin], 2006, [西北林学院学报, Journal of Northwest Forestry College], V21, P54; Hill R, 2009, J ENVIRON MANAGE, V90, P1305, DOI 10.1016/j.jenvman.2008.07.015; Housman DC, 2007, SOIL BIOL BIOCHEM, V39, P2138, DOI 10.1016/j.soilbio.2007.03.015; Ibanez J, 2007, ECOL MODEL, V205, P277, DOI 10.1016/j.ecolmodel.2007.02.024; JAFFE MJ, 1984, PHYSIOL PLANTARUM, V62, P73, DOI 10.1111/j.1399-3054.1984.tb05925.x; Jiang Y, 1977, FLORA CHINA, V63; Kobayashi T, 1997, J VEG SCI, V8, P873, DOI 10.2307/3237032; Kobayashi T, 1999, PLANT BIOLOGY, V1, P445, DOI 10.1055/s-2007-978538; Kutiel P, 2000, J ARID ENVIRON, V44, P277, DOI 10.1006/jare.1999.0602; LIDDLE M J, 1975, Biological Conservation, V8, P251, DOI 10.1016/0006-3207(75)90002-6; Lin HuiLong, 2008, Acta Prataculturae Sinica, V17, P85; Littlemore James, 2001, Urban Ecosystems, V5, P257, DOI 10.1023/A:1025639828427; Malmivaara-Lamsa Minna, 2008, Urban Ecosystems, V11, P1, DOI 10.1007/s11252-007-0046-3; Meerts P, 1996, OECOLOGIA, V108, P438, DOI 10.1007/BF00333719; Niklas KJ, 1996, ANN BOT-LONDON, V78, P61, DOI 10.1006/anbo.1996.0096; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Puijalon S, 2008, NEW PHYTOL, V177, P907, DOI 10.1111/j.1469-8137.2007.02314.x; Rodgers K, 2003, ENVIRON MANAGE, V31, P377, DOI 10.1007/s00267-002-2831-3; Rusterholz HP, 2009, PERSPECT PLANT ECOL, V11, P17, DOI 10.1016/j.ppees.2008.09.002; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Striker GG, 2011, APPL VEG SCI, V14, P95, DOI 10.1111/j.1654-109X.2010.01093.x; STRUIK GJ, 1965, ECOLOGY, V46, P401, DOI 10.2307/1934873; SUN D, 1993, BIOL CONSERV, V65, P35, DOI 10.1016/0006-3207(93)90194-6; Sun D, 1993, ENVIRON MANAGE, V17, P551; TELEWSKI FW, 1990, CAN J FOREST RES, V20, P1277, DOI 10.1139/x90-170; Wang YH, 2009, PLANT BIOLOGY, V11, P694, DOI 10.1111/j.1438-8677.2008.00168.x; Wang YH, 2008, INT J PLANT SCI, V169, P503, DOI 10.1086/528750; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Zhang C.Y., 2001, ACTA ECOL SIN, V21, P1986; Zhang X., 1994, ACTA ECOL SIN, V18, P1, DOI DOI 10.1111/1365-2745.12089	45	14	17	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53021	10.1371/journal.pone.0053021	http://dx.doi.org/10.1371/journal.pone.0053021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341918	gold, Green Submitted, Green Published			2022-12-27	WOS:000313682700018
J	Xu, M; Jarrell, TA; Wang, Y; Cook, SJ; Hall, DH; Emmons, SW				Xu, Meng; Jarrell, Travis A.; Wang, Yi; Cook, Steven J.; Hall, David H.; Emmons, Scott W.			Computer Assisted Assembly of Connectomes from Electron Micrographs: Application to Caenorhabditis elegans	PLOS ONE			English	Article							NERVOUS-SYSTEM; RECONSTRUCTION; VISUALIZATION; CIRCUIT; NETWORK; NEURONS	A rate-limiting step in determining a connectome, the set of all synaptic connections in a nervous system, is extraction of the relevant information from serial electron micrographs. Here we introduce a software application, Elegance, that speeds acquisition of the minimal dataset necessary, allowing the discovery of new connectomes. We have used Elegance to obtain new connectivity data in the nematode worm Caenorhabditis elegans. We analyze the accuracy that can be obtained, which is limited by unresolvable ambiguities at some locations in electron microscopic images. Elegance is useful for reconstructing connectivity in any region of neuropil of sufficiently small size.	[Xu, Meng; Jarrell, Travis A.; Wang, Yi; Cook, Steven J.; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	scott.emmons@einstein.yu.edu			United States National Institutes of Health (NIH.gov) [R21MH63223]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH063223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health (NIH.gov)(R21MH63223 to SWE) and the G. Harold and Leila Y. Mathers Charitable Foundation (mathersfoundation.org) to SWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; BRENNER S, 1974, GENETICS, V77, P71; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; FIALA JC, 2002, MICROSC ANAL, V52, P5; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HALL DH, 1991, J NEUROSCI, V11, P1; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jeong WK, 2010, IEEE COMPUT GRAPH, V30, P58, DOI 10.1109/MCG.2010.56; Jeong WK, 2009, IEEE T VIS COMPUT GR, V15, P1505, DOI 10.1109/TVCG.2009.178; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	22	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54050	10.1371/journal.pone.0054050	http://dx.doi.org/10.1371/journal.pone.0054050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342070	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700079
J	Moritoh, S; Komatsu, Y; Yamamori, T; Koizumi, A				Moritoh, Satoru; Komatsu, Yusuke; Yamamori, Tetsuo; Koizumi, Amane			Diversity of Retinal Ganglion Cells Identified by Transient GFP Transfection in Organotypic Tissue Culture of Adult Marmoset Monkey Retina	PLOS ONE			English	Article							NEW-WORLD MONKEY; MIDGET-PARVOCELLULAR PATHWAY; CALLITHRIX-JACCHUS; PRIMATE RETINA; SYNAPTIC CONNECTIVITY; SPATIAL DENSITY; BIPOLAR INPUT; IN-VITRO; MORPHOLOGY; MACAQUE	The mammalian retina has more diversity of neurons than scientists had once believed in order to establish complicated vision processing. In the monkey retina, morphological diversity of retinal ganglion cells (RGCs) besides dominant midget and parasol cells has been suggested. However, characteristic subtypes of RGCs in other species such as bistratified direction-selective ganglion cells (DSGC) have not yet been identified. Increasing interest has been shown in the common marmoset (Callithrix jacchus) monkey as a "super-model" of neuroscientific research. Here, we established organotypic tissue culture of the adult marmoset monkey retina with particle-mediated gene transfer of GFP to survey the morphological diversity of RGCs. We successfully incubated adult marmoset monkey retinas for 2 to 4 days ex vivo for transient expression of GFP. We morphologically examined 121 RGCs out of more than 3240 GFP-transfected cells in 5 retinas. Among them, we identified monostratified or broadly stratified ganglion cells (midget, parasol, sparse, recursive, thorny, and broad thorny ganglion cells), and bistratified ganglion cells (recursive, large, and small bistratified ganglion cells [blue-ON/yellow-OFF-like]). By this survey, we also found a candidate for bistratified DSGC whose dendrites were well cofasciculated with ChAT-positive starburst dendrites, costratified with ON and OFF ChAT bands, and had honeycomb-shaped dendritic arbors morphologically similar to those in rabbits. Our genetic engineering method provides a new approach to future investigation for morphological and functional diversity of RGCs in the monkey retina.	[Moritoh, Satoru; Koizumi, Amane] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Komatsu, Yusuke; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Koizumi, Amane] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi, Japan; [Yamamori, Tetsuo] Grad Univ Adv Studies SOKENDAI, Dept Mol Biomech, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan	Koizumi, A (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	amane@nips.ac.jp	Yamamori, Tetsuo/N-6536-2015	Yamamori, Tetsuo/0000-0001-5016-0078; Koizumi, Amane/0000-0003-1177-0185	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by a Grant-in-Aid for Scientific Research (C) (A.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. A part of this study is the result of the project, "Highly Creative Animal Model Development for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2012, VISUAL NEUROSCI, V29, P157, DOI 10.1017/S095252381200017X; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Erikoz B, 2008, VISUAL NEUROSCI, V25, P67, DOI 10.1017/S0952523808080073; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Ghosh KK, 1997, J COMP NEUROL, V379, P211; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Grunert U, 2011, VISUAL NEUROSCI, V28, P39, DOI 10.1017/S095252381000026X; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Ivanova E, 2010, INVEST OPHTH VIS SCI, V51, P5288, DOI 10.1167/iovs.10-5389; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; Jusuf PR, 2006, J COMP NEUROL, V494, P260, DOI 10.1002/cne.20804; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Percival KA, 2011, J COMP NEUROL, V519, P2135, DOI 10.1002/cne.22586; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; RODIECK RW, 1992, J COMP NEUROL, V321, P46, DOI 10.1002/cne.903210106; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Sanes JR, 2011, CEREBRAL PLASTICITY, P35; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Szmajda BA, 2008, J COMP NEUROL, V510, P251, DOI 10.1002/cne.21783; Telkes I, 2008, J COMP NEUROL, V510, P539, DOI 10.1002/cne.21813; TROILO D, 1993, VISION RES, V33, P1301, DOI 10.1016/0042-6989(93)90038-X; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wilder HD, 1996, VISUAL NEUROSCI, V13, P335, DOI 10.1017/S0952523800007586; Yamada ES, 2005, VISUAL NEUROSCI, V22, P383, DOI 10.1017/S095252380522401X; YANG G, 1994, J NEUROSCI, V14, P5267	37	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54667	10.1371/journal.pone.0054667	http://dx.doi.org/10.1371/journal.pone.0054667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336011	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700069
J	Bouuaert, CC; Chalmers, R				Bouuaert, Corentin Claeys; Chalmers, Ronald			Hsmar1 Transposition Is Sensitive to the Topology of the Transposon Donor and the Target	PLOS ONE			English	Article							SLEEPING-BEAUTY; RETROVIRAL INTEGRATION; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; DNA TRANSPOSITION; SITE PREFERENCES; SETMAR PROTEIN; IN-VITRO; EVOLUTION; ELEMENT	Hsmar1 is a member of the Tc1-mariner superfamily of DNA transposons. These elements mobilize within the genome of their host by a cut-and-paste mechanism. We have exploited the in vitro reaction provided by Hsmar1 to investigate the effect of DNA supercoiling on transposon integration. We found that the topology of both the transposon and the target affect integration. Relaxed transposons have an integration defect that can be partially restored in the presence of elevated levels of negatively supercoiled target DNA. Negatively supercoiled DNA is a better target than nicked or positively supercoiled DNA, suggesting that underwinding of the DNA helix promotes target interactions. Like other Tc1-mariner elements, Hsmar1 integrates into 5'-TA dinucleotides. The direct vicinity of the target TA provides little sequence specificity for target interactions. However, transposition within a plasmid substrate was not random and some TA dinucleotides were targeted preferentially. The distribution of intramolecular target sites was not affected by DNA topology.	[Bouuaert, Corentin Claeys; Chalmers, Ronald] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham	Bouuaert, CC (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	claeysbc@mskcc.org	Claeys Bouuaert, Corentin/P-3497-2017	Claeys Bouuaert, Corentin/0000-0001-5801-7313; chalmers, ronald/0000-0002-1395-7173	Wellcome Trust [WT093160]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust [grant number WT093160 to R. C.] (http://www.wellcome.ac.uk). C. C. B. was supported by a BBSRC Doctoral Training Grant (http://www.bbsrc.ac.uk/funding/studentships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson H, 2010, GENETICA, V138, P485, DOI 10.1007/s10709-009-9434-3; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; CASADESUS J, 1989, MOL GEN GENET, V216, P204, DOI 10.1007/BF00334357; Chalmers R., 1999, ORG PROKARYOTIC GENO, P151; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Crenes G, 2010, GENETICA, V138, P509, DOI 10.1007/s10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Geurts AM, 2006, NUCLEIC ACIDS RES, V34, P2803, DOI 10.1093/nar/gkl301; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Ivics Z, 2011, HUM GENE THER, V22, P1043, DOI 10.1089/hum.2011.143; KELLEY MR, 1987, MOL CELL BIOL, V7, P1545, DOI 10.1128/MCB.7.4.1545; Ketting RF, 1997, NUCLEIC ACIDS RES, V25, P4041, DOI 10.1093/nar/25.20.4041; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lampe DJ, 1998, GENETICS, V149, P179; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Liu DX, 2011, NUCLEIC ACIDS RES, V39, P6660, DOI 10.1093/nar/gkr309; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Miskey C, 2006, NEW HUMAN MARINER TR; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; VANLUENEN HGAM, 1994, NUCLEIC ACIDS RES, V22, P262, DOI 10.1093/nar/22.3.262; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53690	10.1371/journal.pone.0053690	http://dx.doi.org/10.1371/journal.pone.0053690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341977	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400068
J	Varcoe, TJ; Boden, MJ; Voultsios, A; Salkeld, MD; Rattanatray, L; Kennaway, DJ				Varcoe, Tamara J.; Boden, Michael J.; Voultsios, Athena; Salkeld, Mark D.; Rattanatray, Leewen; Kennaway, David J.			Characterisation of the Maternal Response to Chronic Phase Shifts during Gestation in the Rat: Implications for Fetal Metabolic Programming	PLOS ONE			English	Article							MODERATE CALORIC RESTRICTION; GLUCOCORTICOID-RECEPTOR; LIGHT EXPOSURE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MELATONIN SECRETION; CIRCADIAN-RHYTHMS; GENE-EXPRESSION; ADULT DISEASE; LEPTIN; CLOCK	Disrupting maternal circadian rhythms through exposure to chronic phase shifts of the photoperiod has lifelong consequences for the metabolic homeostasis of the fetus, such that offspring develop increased adiposity, hyperinsulinaemia and poor glucose and insulin tolerance. In an attempt to determine the mechanisms by which these poor metabolic outcomes arise, we investigated the impact of chronic phase shifts (CPS) on maternal and fetal hormonal, metabolic and circadian rhythms. We assessed weight gain and food consumption of dams exposed to either CPS or control lighting conditions throughout gestation. At day 20, dams were assessed for plasma hormone and metabolite concentrations and glucose and insulin tolerance. Additionally, the expression of a range of circadian and metabolic genes was assessed in maternal, placental and fetal tissue. Control and CPS dams consumed the same amount of food, yet CPS dams gained 70% less weight during the first week of gestation. At day 20, CPS dams had reduced retroperitoneal fat pad weight (-15%), and time-of-day dependent decreases in liver weight, whereas fetal and placental weight was not affected. Melatonin secretion was not altered, yet the timing of corticosterone, leptin, glucose, insulin, free fatty acids, triglycerides and cholesterol concentrations were profoundly disrupted. The expression of gluconeogenic and circadian clock genes in maternal and fetal liver became either arrhythmic or were in antiphase to the controls. These results demonstrate that disruptions of the photoperiod can severely disrupt normal circadian profiles of plasma hormones and metabolites, as well as gene expression in maternal and fetal tissues. Disruptions in the timing of food consumption and the downstream metabolic processes required to utilise that food, may lead to reduced efficiency of growth such that maternal weight gain is reduced during early embryonic development. It is these perturbations that may contribute to the programming of poor metabolic homeostasis in the offspring.	[Varcoe, Tamara J.; Boden, Michael J.; Voultsios, Athena; Salkeld, Mark D.; Rattanatray, Leewen; Kennaway, David J.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Varcoe, TJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	tamara.varcoe@adelaide.edu.au	Kennaway, David J/B-8955-2009; Varcoe, Tamara/H-2785-2014; Boden, Michael/L-9884-2013	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	Australian Government National Health and Medical Research Project Grant [APP1009877]; NHMRC	Australian Government National Health and Medical Research Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Experiments were funded through an Australian Government National Health and Medical Research Project Grant to DJ Kennaway and TJ Varcoe, APP1009877. DJ Kennaway is funded through a NHMRC senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth CJ, 2000, REV REPROD, V5, P18, DOI 10.1530/ror.0.0050018; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bouret SG, 2010, BRAIN RES, V1350, P2, DOI 10.1016/j.brainres.2010.04.011; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; DALLMAN MF, 1992, J NEUROENDOCRINOL, V4, P517, DOI 10.1111/j.1365-2826.1992.tb00200.x; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Ferguson SA, 2012, APPL ERGON, V43, P695, DOI 10.1016/j.apergo.2011.11.003; Ferreira DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038795; Fowden AL, 2012, PLACENTA, V33, pE1, DOI 10.1016/j.placenta.2012.09.005; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; HONMA K, 1992, AM J PHYSIOL, V262, pE948, DOI 10.1152/ajpendo.1992.262.6.E948; ILLNEROVA H, 1978, NEUROSCI LETT, V9, P189, DOI 10.1016/0304-3940(78)90070-8; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kennaway DJ, 2000, J PINEAL RES, V28, P16, DOI 10.1034/j.1600-079x.2000.280103.x; KENNAWAY DJ, 1994, BRAIN RES BULL, V33, P639, DOI 10.1016/0361-9230(94)90227-5; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Matsuda J, 1999, ENDOCRINOLOGY, V140, P5233, DOI 10.1210/en.140.11.5233; Mendez N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042713; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Seckl JR, 1997, STEROIDS, V62, P89, DOI 10.1016/S0039-128X(96)00165-1; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Varcoe TJ, 2008, BRAIN RES, V1209, P19, DOI 10.1016/j.brainres.2008.02.091; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504	36	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53800	10.1371/journal.pone.0053800	http://dx.doi.org/10.1371/journal.pone.0053800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342007	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400085
J	Wong, MCS; Tam, WWS; Cheung, CSK; Tong, ELH; Sek, ACH; John, G; Cheung, NT; Yan, BPY; Yu, CM; Leeder, S; Griffiths, S				Wong, Martin C. S.; Tam, Wilson W. S.; Cheung, Clement S. K.; Tong, Ellen L. H.; Sek, Antonio C. H.; John, George; Cheung, N. T.; Yan, Bryan P. Y.; Yu, C. M.; Leeder, Stephen; Griffiths, Sian			Initial Antihypertensive Prescription and Switching: A 5 Year Cohort Study from 250,851 Patients	PLOS ONE			English	Article							DIAGNOSED HYPERTENSIVE PATIENTS; BLOOD-PRESSURE; UNITED-STATES; RISK-FACTORS; 33 COMMUNITIES; DRUG-THERAPY; URBAN ADULTS; HONG-KONG; DISCONTINUATION; PREVALENCE	Purpose: Adverse effects of antihypertensive therapy incur substantial cost. We evaluated whether any major classes of antihypertensive drugs were significantly associated with switching as a proxy measure of medication side effects in a large Chinese population in Hong Kong. Methods: From a clinical database, all adult patients newly prescribed an antihypertensive mono-therapy in Hong Kong between the years 2001-2003 and 2005 were included. Those who paid only one visit, died or stayed in the cohort for <180 days after the prescription, or prescribed more than one antihypertensive agent were excluded. The factors associated with switching at 180 days were evaluated by multivariate regression analyses. Age, gender, payment status, service type, district of residence, drug class, systolic and diastolic blood pressure levels were predictor variables. Results: From 250,851 subjects, 159,813 patients were eligible. A total of 6,163 (3.9%) switched their medications within 180 days. Patients prescribed thiazide diuretics had the highest switching rate (5.6%), followed by ACEIs (4.5%), CCBs (4.4%) and beta-blockers (3.2%). When compared with ACEIs, patients on thiazide diuretics were significantly more likely to be switchers (adjusted odds ratio [AOR] 1.49, 95% C. I. 1.31-1.69, p<0.001), whilst patients prescribed CCBs and beta-blockers were similarly likely to have switching. Following these patients up for 5 years showed that thiazide had the most marked increase in switching rate. Conclusions: The higher rates of switching among thiazide diuretics in this study might raise a probably greater incidence of their adverse effects in this Chinese population, yet other factors might also influence switching rates. Patients prescribed thiazide diuretics for longer term should be observed for their intolerability.	[Wong, Martin C. S.; Tam, Wilson W. S.; Griffiths, Sian] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Cheung, Clement S. K.; Tong, Ellen L. H.; Sek, Antonio C. H.; Cheung, N. T.] Hosp Author Informat Technol Serv, Hlth Informat Sect, Hong Kong, Hong Kong, Peoples R China; [John, George] Univ Oxford, Oxford, England; [Yan, Bryan P. Y.; Yu, C. M.] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leeder, Stephen] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	Chinese University of Hong Kong; University of Oxford; Chinese University of Hong Kong; University of Sydney	Tam, WWS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wilsontam@cuhk.edu.hk	TAM, Wilson W.S./H-5890-2019; Cheung, Clement Shek Kei/AAP-9969-2021; Wong, Martin/L-4568-2014; Yan, Bryan P/P-5928-2015; Tam, Wilson/K-1664-2019; Yu, Cheuk-man/P-3747-2015	TAM, Wilson W.S./0000-0003-0641-3060; Cheung, Clement Shek Kei/0000-0002-9014-8628; Wong, Martin/0000-0001-7706-9370; 				[Anonymous], 2006, POP CENS; Benetos A, 2003, J HYPERTENS, V21, P1635, DOI 10.1097/00004872-200309000-00011; Billups SJ, 2000, PHARMACOTHERAPY, V20, P941, DOI 10.1592/phco.20.11.941.35266; Brown MJ, 2006, BMJ-BRIT MED J, V332, P833, DOI 10.1136/bmj.332.7545.833; Burke TA, 2006, J HYPERTENS, V24, P1193, DOI 10.1097/01.hjh.0000226211.95936.f5; Caro JJ, 1999, CAN MED ASSOC J, V160, P31; Census and Statistics Department, GOV HONG KONG ADM RE; CHAN L, 2007, HONG KONG PRACTITION, V29, P470; Cheung NT, REALIZING BENEFITS E; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chou CC, 2005, INT J CLIN PRACT, V59, P85, DOI 10.1111/j.1742-1241.2005.00436.x; Corrao G, 2008, J HYPERTENS, V26, P819, DOI 10.1097/HJH.0b013e3282f4edd7; Erkens JA, 2005, PHARMACOEPIDEM DR S, V14, P795, DOI 10.1002/pds.1156; Esposti LD, 2002, CLIN THER, V24, P1347, DOI 10.1016/S0149-2918(02)80039-X; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Flack JM, 1996, EUR HEART J, V17, P16, DOI 10.1093/eurheartj/17.suppl_A.16; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim SJ, 2011, CIRC J, V75, P135, DOI 10.1253/circj.CJ-09-0948; Kokubo Y, 2009, CIRC J, V73, P1381, DOI 10.1253/circj.CJ-09-0336; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; Meng XJ, 2012, CIRC J, V76, P900, DOI 10.1253/circj.CJ-11-1118; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Nicotra Federica, 2009, J Hypertens, V27, P1917, DOI 10.1097/HJH.0b013e32832d4692; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Redon J, 2007, HYPERTENSION, V49, P799, DOI 10.1161/01.HYP.0000259104.60878.43; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; The Hong Kong Government, 2010, HONG KONG REF FRAM H; Tseng CH, 2008, CIRC J, V72, P1419, DOI 10.1253/circj.CJ-08-0009; Vaur L, 1999, AM J HYPERTENS, V12, P374, DOI 10.1016/S0895-7061(00)86963-0; Wong MCS, 2008, J HUM HYPERTENS, V22, P714, DOI 10.1038/jhh.2008.83; Wong MCS, 2010, J HUM HYPERTENS, V24, P669, DOI 10.1038/jhh.2009.109; Wong MCS, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-138; Wong MCS, 2011, HYPERTENS RES, V34, P888, DOI 10.1038/hr.2011.43; Wong MCS, 2009, AM J HYPERTENS, V22, P904, DOI 10.1038/ajh.2009.95; Wong Martin Cs, 2011, Asia Pac Fam Med, V10, P10, DOI 10.1186/1447-056X-10-10	43	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53625	10.1371/journal.pone.0053625	http://dx.doi.org/10.1371/journal.pone.0053625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341959	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400054
J	Zuriaga, E; Munoz-Sanz, JV; Molina, L; Gisbert, AD; Badenes, ML; Romero, C				Zuriaga, Elena; Munoz-Sanz, Juan V.; Molina, Laura; Gisbert, Ana D.; Badenes, Maria L.; Romero, Carlos			An S-Locus Independent Pollen Factor Confers Self-Compatibility in 'Katy' Apricot	PLOS ONE			English	Article							SPECIES SOLANUM-CHACOENSE; CRISTOBALINA SWEET CHERRY; F-BOX GENE; SKP1-LIKE PROTEIN; NICOTIANA-ALATA; PRUNUS-AVIUM; INCOMPATIBILITY ALLELES; RNASE; IDENTIFICATION; HAPLOTYPE	Loss of pollen-S function in Prunus self-compatible cultivars has been mostly associated with deletions or insertions in the S-haplotype-specific F-box (SFB) genes. However, self-compatible pollen-part mutants defective for non-S-locus factors have also been found, for instance, in the apricot (Prunus armeniaca) cv. 'Canino'. In the present study, we report the genetic and molecular analysis of another self-compatible apricot cv. termed 'Katy'. S-genotype of 'Katy' was determined as S1S2 and S-RNase PCR-typing of selfing and outcrossing populations from 'Katy' showed that pollen gametes bearing either the S-1- or the S-2-haplotype were able to overcome self-incompatibility (SI) barriers. Sequence analyses showed no SNP or indel affecting the SFB1 and SFB2 alleles from 'Katy' and, moreover, no evidence of pollen-S duplication was found. As a whole, the obtained results are compatible with the hypothesis that the loss-of-function of a S-locus unlinked factor gametophytically expressed in pollen (M'-locus) leads to SI breakdown in 'Katy'. A mapping strategy based on segregation distortion loci mapped the M'-locus within an interval of 9.4 cM at the distal end of chr.3 corresponding to similar to 1.29 Mb in the peach (Prunus persica) genome. Interestingly, pollen-part mutations (PPMs) causing self-compatibility (SC) in the apricot cvs. 'Canino' and 'Katy' are located within an overlapping region of similar to 273 Kb in chr.3. No evidence is yet available to discern if they affect the same gene or not, but molecular markers seem to indicate that both cultivars are genetically unrelated suggesting that every PPM may have arisen independently. Further research will be necessary to reveal the precise nature of 'Katy' PPM, but fine-mapping already enables SC marker-assisted selection and paves the way for future positional cloning of the underlying gene.	[Zuriaga, Elena; Munoz-Sanz, Juan V.; Molina, Laura; Gisbert, Ana D.; Badenes, Maria L.; Romero, Carlos] Inst Valenciano Invest Agr, Fruit Tree Breeding Dept, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Romero, C (corresponding author), Inst Valenciano Invest Agr, Fruit Tree Breeding Dept, Valencia, Spain.	romero_carsal@gva.es	MUÑOZ-SANZ, JUAN VICENTE/AAJ-7833-2020; Badenes, Maria Luisa/C-6606-2014; Romero, Carlos/G-6868-2015; Zuriaga, Elena/C-6985-2015; Muñoz-Sanz, Juan Vicente/T-5951-2017	MUÑOZ-SANZ, JUAN VICENTE/0000-0002-6752-7398; Badenes, Maria Luisa/0000-0001-9722-6783; Romero, Carlos/0000-0002-5316-8312; Zuriaga, Elena/0000-0001-5497-4941; Muñoz-Sanz, Juan Vicente/0000-0002-6752-7398	Ministerio de Economia y Competitividad [AGL2010-19208]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by grants from the 'Ministerio de Economia y Competitividad', Research project AGL2010-19208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI YJ, 1991, MOL GEN GENET, V230, P353, DOI 10.1007/BF00280291; Alburquerque N, 2002, PLANT BREEDING, V121, P343, DOI 10.1046/j.1439-0523.2002.725292.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bonfield J, 2004, STADEN PACKAGE VERSI; Boskovic R, 1996, EUPHYTICA, V90, P245, DOI 10.1007/BF00023865; Boskovic RI, 2010, J EXP BOT, V61, P755, DOI 10.1093/jxb/erp340; Burgos L, 1998, SEX PLANT REPROD, V11, P153, DOI 10.1007/s004970050133; Cachi AM, 2011, J EXP BOT, V62, P1847, DOI 10.1093/jxb/erq374; Chen G, 2010, J EXP BOT, V61, P2027, DOI 10.1093/jxb/erp381; Doyle J. J., 1987, PHYTOCHEM B, P11; Egea J, 1996, J AM SOC HORTIC SCI, V121, P1002, DOI 10.21273/JASHS.121.6.1002; Feng JR, 2006, MOL BIOL REP, V33, P215, DOI 10.1007/s11033-006-0011-x; Marti AFI, 2009, SEX PLANT REPROD, V22, P179, DOI 10.1007/s00497-009-0102-7; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Golz JF, 1999, GENETICS, V152, P1123; Golz JF, 2001, P NATL ACAD SCI USA, V98, P15372, DOI 10.1073/pnas.261571598; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hauck NR, 2006, GENETICS, V172, P1191, DOI 10.1534/genetics.105.049395; Hosaka K, 1998, EUPHYTICA, V103, P265, DOI 10.1023/A:1018380725160; Hosaka K, 1998, EUPHYTICA, V99, P191, DOI 10.1023/A:1018353613431; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huang J, 2006, PLANT J, V46, P780, DOI 10.1111/j.1365-313X.2006.02735.x; Jung S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-130; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Lai Z, 2002, PLANT MOL BIOL, V50, P29, DOI 10.1023/A:1016050018779; Marchese A, 2007, J EXP BOT, V58, P4347, DOI 10.1093/jxb/erm322; Matsumoto D, 2012, PLANT PHYSIOL, V159, P1252, DOI 10.1104/pp.112.197343; McClure B, 1999, P NATL ACAD SCI USA, V96, P13548, DOI 10.1073/pnas.96.23.13548; McClure BA, 2000, ANN BOT-LONDON, V85, P113, DOI 10.1006/anbo.1999.1061; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2011, ANN BOT-LONDON, V108, P647, DOI 10.1093/aob/mcr179; Movahedi S, 2011, PLANT PHYSIOL, V156, P1316, DOI 10.1104/pp.111.177865; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nettancourt, 2001, INCOMPATIBILITY INCO; Romero C, 2004, PLANT MOL BIOL, V56, P145, DOI 10.1007/s11103-004-2651-3; Russell D, 1998, STONEFRUIT CULTIVAR; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Sonneveld T, 2003, THEOR APPL GENET, V107, P1059, DOI 10.1007/s00122-003-1274-4; Tao R, 1999, J AM SOC HORTIC SCI, V124, P224, DOI 10.21273/JASHS.124.3.224; Tao R, 2007, PLANT MOL BIOL, V63, P109, DOI 10.1007/s11103-006-9076-0; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; THOMPSON RD, 1991, MOL GEN GENET, V226, P283, DOI 10.1007/BF00273614; THOMSON D, 1995, BIOTECHNIQUES, V19, P394; Tsukamoto T, 2003, PLANT PHYSIOL, V131, P1903, DOI 10.1104/pp.102.018069; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vilanova S, 2005, J AM SOC HORTIC SCI, V130, P893, DOI 10.21273/JASHS.130.6.893; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Watari A, 2007, J AM SOC HORTIC SCI, V132, P396, DOI 10.21273/JASHS.132.3.396; Wu J, 2011, SEX PLANT REPROD, V24, P23, DOI 10.1007/s00497-010-0148-6; Wunsch A, 2010, PLANT CELL REP, V29, P715, DOI 10.1007/s00299-010-0857-1; Wunsch A, 2004, SEX PLANT REPROD, V17, P203, DOI 10.1007/s00497-004-0234-8; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, J EXP BOT, V54, P2431, DOI 10.1093/jxb/erg271; Yamane H, 2009, J JPN SOC HORTIC SCI, V78, P137, DOI 10.2503/jjshs1.78.137; Busot GY, 2008, J EXP BOT, V59, P3187, DOI 10.1093/jxb/ern175; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P745, DOI 10.1007/s11295-008-0147-z; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045; Zhu CS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-82; Zuriaga E, 2012, PLANT MOL BIOL, V79, P229, DOI 10.1007/s11103-012-9908-z	69	31	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53947	10.1371/journal.pone.0053947	http://dx.doi.org/10.1371/journal.pone.0053947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342044	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400104
J	Moon, CH; Lee, SJ; Lee, HY; Lee, JC; Cha, H; Cho, WJ; Park, JW; Park, HJ; Seo, J; Lee, YH; Song, HT; Min, YJ				Moon, Chang Hoon; Lee, Seung Ju; Lee, Ho Yong; Lee, Jong Cheol; Cha, HeeJeong; Cho, Wha Ja; Park, Jeong Woo; Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek; Min, Young Joo			KML001 Displays Vascular Disrupting Properties and Irinotecan Combined Antitumor Activities in a Murine Tumor Model	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; TARGETING AGENTS; CANCER; MECHANISMS; APOPTOSIS; NECROSIS; PROSTATE; BINDING	KML001 is sodium metaarsenite, and has shown cytotoxic activity in human tumor cell lines. The anti-cancer mechanism of KML001 involves cancer cell destruction due to DNA damage at the telomeres of cancer cell chromosomes. In this study, we assessed the vascular disrupting properties of KML001 and investigated whether KML001 as VDA is able to increase anti-tumor activity in irinotecan combined treatment. We used a murine model of the CT26 colon carcinoma cell line. CT26 isograft mice treated intraperitoneally with 10 mg/kg KML001 displayed extensive central necrosis of tumor by 24 h. The vascular disrupting effects of KML001 were assessed by dynamic contrast enhanced magnetic resonance imaging. Gadopentetic acid-diethylene triaminepentaacetic acid contrast enhancement was markedly decreased in KML001-treated mice one day after treatment, whereas persistently high signal enhancement was observed in mice injected with saline. Rate constant K-ep value representing capillary permeability was significantly decreased (p<0.05) in mice treated with KML001. Cytoskeletal changes of human umbilical vein endothelial cells (HUVECs) treated with 10 uM KML001 were assessed by immune blotting and confocal imaging. KML001 degraded tubulin protein in HUVECs, which may be related to vascular disrupting properties of KML001. Finally, in the mouse CT26 isograft model, KML001 combined with irinotecan significantly delayed tumor growth as compared to control and irinotecan alone. These results suggest that KML001 is a novel vascular disrupting agent, which exhibits significant vascular shut-down activity and enhances anti-tumor activity in combination with chemotherapy. These data further suggest an avenue for effective combination therapy in treating solid tumors.	[Moon, Chang Hoon; Lee, Seung Ju; Lee, Ho Yong; Cho, Wha Ja; Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea; [Lee, Jong Cheol] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Otorhinolaryngol, Ulsan 680749, South Korea; [Cha, HeeJeong] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 680749, South Korea; [Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Hyun Jin; Seo, Jin; Lee, Young Han; Song, Ho-Taek] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Hematol Oncol,Dept Internal Med, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan; Ulsan University Hospital	Min, YJ (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea.	yjmin@uuh.ulsan.kr	Song, Ho-Taek/K-3807-2014; Lee, Jong Cheol/K-3603-2019	Song, Ho-Taek/0000-0002-6655-2575; Lee, Young Han/0000-0002-5602-391X	Priority Research Center Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029621]; Komipharm International Co., LTD in Korea; Komipharm International Co., LTD.	Priority Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Komipharm International Co., LTD in Korea; Komipharm International Co., LTD.	This work was supported by Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029621) and by grants from the Komipharm International Co., LTD in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (Komipharm International Co., LTD). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bouzin C, 2007, DRUG RESIST UPDATE, V22, P97; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chaplin DJ, 2006, CURR OPIN INVEST DR, V7, P522; Chen GQ, 1996, BLOOD, V88, P1052; Ching LM, 1999, CANCER RES, V59, P3304; Demsar F, 1997, MAGNET RESON MED, V37, P236, DOI 10.1002/mrm.1910370216; Esteve MA, 2007, CURR CANCER DRUG TAR, V7, P713; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Hinnen P, 2007, BRIT J CANCER, V96, P1159, DOI 10.1038/sj.bjc.6603694; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Joseph WR, 1999, CANCER RES, V59, P633; Kanthou C, 2009, INT J EXP PATHOL, V90, P284, DOI 10.1111/j.1365-2613.2009.00651.x; Kleespies A, 2005, NEOPLASIA, V7, P957, DOI 10.1593/neo.05304; Lew YS, 1999, CANCER RES, V59, P6033; Ma MK, 2003, CURR MED CHEM, V10, P41, DOI 10.2174/0929867033368619; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Miller WH, 2002, CANCER RES, V62, P3893; Patterson DA, 2007, CLIN ONCOL-UK, V19, P443, DOI 10.1016/j.clon.2007.03.014; Phatak P, 2008, CLIN CANCER RES, V14, P4593, DOI 10.1158/1078-0432.CCR-07-4572; Seshadri M, 2008, INT J RADIAT ONCOL, V72, P1198, DOI 10.1016/j.ijrobp.2008.07.043; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Uslu R, 2000, CLIN CANCER RES, V6, P4957; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zweifel M, 2009, J CLIN ONCOL, V27; Zweifel M, 2010, EUR J NUCL MED MOL I, V37, pS164, DOI 10.1007/s00259-010-1451-z	27	122	124	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53900	10.1371/journal.pone.0053900	http://dx.doi.org/10.1371/journal.pone.0053900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326531	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800085
J	Koyama-Nasu, R; Takahashi, R; Yanagida, S; Nasu-Nishimura, Y; Oyama, M; Kozuka-Hata, H; Haruta, R; Manabe, E; Hoshino-Okubo, A; Omi, H; Yanaihara, N; Okamoto, A; Tanaka, T; Akiyama, T				Koyama-Nasu, Ryo; Takahashi, Rina; Yanagida, Satoshi; Nasu-Nishimura, Yukiko; Oyama, Masaaki; Kozuka-Hata, Hiroko; Haruta, Ryo; Manabe, Emi; Hoshino-Okubo, Akemi; Omi, Hiroko; Yanaihara, Nozomu; Okamoto, Aikou; Tanaka, Tadao; Akiyama, Tetsu			The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels	PLOS ONE			English	Article							LINES	The pentaspan membrane glycoprotein CD133 (also known as prominin-1) has been widely used as a marker for both cancer and normal stem cells. However, the function of CD133 has not been elucidated. Here we describe a cancer stem cell line established from clear cell carcinoma of the ovary (CCC) and show that CD133 interacts with plakoglobin (also known as c-catenin), a desmosomal linker protein. We further demonstrate that knockdown of CD133 by RNA interference (RNAi) results in the downregulation of desmoglein-2, a desmosomal cadherin, and abrogates cell-cell adhesion and tumorigenicity of CCC stem cells. We speculate that CD133 may be a promising target for cancer chemotherapy.	[Koyama-Nasu, Ryo; Takahashi, Rina; Yanagida, Satoshi; Nasu-Nishimura, Yukiko; Haruta, Ryo; Manabe, Emi; Hoshino-Okubo, Akemi; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan; [Yanagida, Satoshi; Omi, Hiroko; Yanaihara, Nozomu; Okamoto, Aikou; Tanaka, Tadao] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan	University of Tokyo; Jikei University; University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo, Japan.	akiyama@iam.u-tokyo.ac.jp		Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan	Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks); Takeda Science Foundation(Takeda Science Foundation (TSF)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic Signaling Networks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network) and for Scientific Research (C), Takeda Science Foundation and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Kozuka-Hata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043398; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5	16	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53710	10.1371/journal.pone.0053710	http://dx.doi.org/10.1371/journal.pone.0053710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326490	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400036
J	Meng, J; Cui, C; Liu, YC; Jin, ML; Wu, DD; Liu, C; Wang, EH; Yu, BZ				Meng, Jun; Cui, Cheng; Liu, Yanchun; Jin, Minglin; Wu, Didi; Liu, Chao; Wang, Enhua; Yu, Bingzhi			The Role of 14-3-3 epsilon Interaction with Phosphorylated Cdc25B at Its Ser321 in the Release of the Mouse Oocyte from Prophase I Arrest	PLOS ONE			English	Article							PROTEIN-KINASE-A; SUBCELLULAR-LOCALIZATION; MEIOTIC ARREST; MATURATION; RESUMPTION; PKA; 14-3-3-PROTEINS; PHOSPHATASE; MEIOSIS; WEE1B	The protein kinase A (PKA)/Cdc25B pathway plays a critical role in maintaining meiotic arrest in mouse oocytes. However, the molecular mechanism underlying this interchange is not known. In this study, we assessed the role of 14-3-3 epsilon interaction with phosphorylated Cdc25B at its Ser321 as the mouse oocyte is released from prophase I arrest. The 14-3-3 epsilon isoform is a highly conserved protein with various regulatory roles, including maintenance of meiotic arrest. Cdc25B phosphatase is also a key cell cycle regulator. 14-3-3 epsilon binds to Cdc25B-WT, which was abrogated when Ser321 of Cdc25B was mutated to Ala. In addition, we found that 14-3-3 epsilon and Cdc25B were co-localized. Cdc25B was translocated from the cytoplasm to the nucleus shortly before germinal vesicle breakdown (GVBD) during the primary oocyte stage of oogenesis. However, mutation of Ser321 to Ala completely abolished the cytoplasmic localization of Cdc25B. Furthermore, oocytes co-expressing of Cdc25B-WT or Cdc25B-Ser321D and 14-3-3 epsilon were unable to undergo GVBD. In contrast, co-expression of 14-33 epsilon and Cdc25B-Ser321A induced GVBD and allowed the process to continue. Down-regulation of 14-3-3 epsilon caused partial meiotic resumption. Taken together, these data indicate that Ser321 of Cdc25B is the specific binding site for 14-3-3 epsilon binding, and that 14-3-3 epsilon is the significant factor in Cdc25B regulation during meiotic resumption of GV stage.	[Meng, Jun; Cui, Cheng; Liu, Yanchun; Jin, Minglin; Wu, Didi; Liu, Chao; Yu, Bingzhi] China Med Univ, Dept Biochem & Mol Biol, Shenyang, Liaoning Provin, Peoples R China; [Meng, Jun] Inner Mongolia Med Univ, Affiliated Hosp, Ctr Clin Lab, Hohhot, Inner Mongolia, Peoples R China; [Wang, Enhua; Yu, Bingzhi] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Inner Mongolia Medical University; China Medical University	Yu, BZ (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Shenyang, Liaoning Provin, Peoples R China.	ybzbiochem@yeah.net			National Nature Science Foundation of China [30900514, 81070489, 81270654]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China Grant #30900514, #81070489, and #81270654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; D'Angiolella V, 2001, CURR BIOL, V11, P1221, DOI 10.1016/S0960-9822(01)00352-9; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gallicano GI, 1997, MOL REPROD DEV, V46, P587, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;587::AID-MRD16&gt;3.0.CO;2-T; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Margolis SS, 2004, CELL CYCLE, V3, P425; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mils V, 2000, ONCOGENE, V19, P1257, DOI 10.1038/sj.onc.1203419; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; RoseHellekant TA, 1996, MOL REPROD DEV, V44, P241, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;241::AID-MRD14&gt;3.0.CO;2-5; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Schultz R, 2009, CELL CYCLE, V8, P516; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; Uchida S, 2006, J BIOCHEM, V139, P761, DOI 10.1093/jb/mvj079; van Hemert MJ, 2004, J CELL SCI, V117, P1411, DOI 10.1242/jcs.00990; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Xiao JY, 2011, J BIOL CHEM, V286, P10356, DOI 10.1074/jbc.M110.150524; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yu BZ, 2005, DEV DYNAM, V232, P98, DOI 10.1002/dvdy.20205; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799	46	19	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53633	10.1371/journal.pone.0053633	http://dx.doi.org/10.1371/journal.pone.0053633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326474	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400032
J	Daburon, S; Devaud, C; Costet, P; Morello, A; Garrigue-Antar, L; Maillasson, M; Hargous, N; Lapaillerie, D; Bonneu, M; Dechanet-Merville, J; Legembre, P; Capone, M; Moreau, JF; Taupin, JL				Daburon, Sophie; Devaud, Christel; Costet, Pierre; Morello, Aurore; Garrigue-Antar, Laure; Maillasson, Mike; Hargous, Nathalie; Lapaillerie, Delphine; Bonneu, Marc; Dechanet-Merville, Julie; Legembre, Patrick; Capone, Myriam; Moreau, Jean-Francois; Taupin, Jean-Luc			Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; LOW-AFFINITY RECEPTOR; MEDIATED APOPTOSIS; EXPRESSION; ANTIBODY; MICE; GP130; CYTOTOXICITY; ACTIVATION; HEPATITIS	Binding of ligand FasL to its receptor Fas triggers apoptosis via the caspase cascade. FasL itself is homotrimeric, and a productive apoptotic signal requires that FasL be oligomerized beyond the homotrimeric state. We generated a series of FasL chimeras by fusing FasL to domains of the Leukemia Inhibitory Factor receptor gp190 which confer homotypic oligomerization, and analyzed the capacity of these soluble chimeras to trigger cell death. We observed that the most efficient FasL chimera, called pFasL, was also the most polymeric, as it reached the size of a dodecamer. Using a cellular model, we investigated the structure-function relationships of the FasL/Fas interactions for our chimeras, and we demonstrated that the Fas-mediated apoptotic signal did not solely rely on ligand-mediated receptor aggregation, but also required a conformational adaptation of the Fas receptor. When injected into mice, pFasL did not trigger liver injury at a dose which displayed anti-tumor activity in a model of human tumor transplanted to immunodeficient animals, suggesting a potential therapeutic use. Therefore, the optimization of the FasL conformation has to be considered for the development of efficient FasL-derived anti-cancer drugs targeting Fas.	[Daburon, Sophie; Devaud, Christel; Morello, Aurore; Hargous, Nathalie; Dechanet-Merville, Julie; Capone, Myriam; Moreau, Jean-Francois; Taupin, Jean-Luc] Univ Bordeaux 2, CNRS 5164, Unite Mixte Rech, F-33076 Bordeaux, France; [Garrigue-Antar, Laure] Univ Paris Est Creteil, CNRS 7149, Unite Mixte Rech, Creteil, France; [Maillasson, Mike] Univ Nantes, INSERM 892, Unite Mixte Rech, Nantes, France; [Lapaillerie, Delphine; Bonneu, Marc] Univ Bordeaux 2, Ctr Genom Fonctionnelle, F-33076 Bordeaux, France; [Legembre, Patrick] Univ Rennes 1, Inst Rech Sante Environm Travail, Equipe Associe 4427, Rennes, France; [Moreau, Jean-Francois; Taupin, Jean-Luc] Ctr Hosp & Univ Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UDICE-French Research Universities; Universite de Bordeaux; Universite de Rennes; CHU Bordeaux	Taupin, JL (corresponding author), Univ Bordeaux 2, CNRS 5164, Unite Mixte Rech, F-33076 Bordeaux, France.	jean-luc.taupin@chu-bordeaux.fr	Devaud, Christel'/W-8141-2019; legembre, patrick/L-3475-2016; Legembre, Patrick/U-1882-2019; maillasson, mike/K-9627-2015	Devaud, Christel'/0000-0003-3511-3219; legembre, patrick/0000-0001-6649-8049; Legembre, Patrick/0000-0001-6649-8049; Garrigue-Antar, Laure/0000-0001-6331-8882	Association pour la Recherche sur le Cancer [3798]; Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes); MENRT; Conseil Regional d'Aquitaine; CNRS	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes); MENRT; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); CNRS(Centre National de la Recherche Scientifique (CNRS))	Association pour la Recherche sur le Cancer (grant 3798), Ligue Nationale Contre le Cancer (Comites des Landes, de la Dordogne, de la Gironde, des Charentes). C. Devaud was supported by a grant from the MENRT. A. Morello was supported by a grant from the Conseil Regional d'Aquitaine and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2007, CANCER RES, V67, P108, DOI 10.1158/0008-5472.CAN-06-1415; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Chida Y, 2005, GUT, V54, P994, DOI 10.1136/gut.2004.058818; Chodorge M, 2012, CELL DEATH DIFFER; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Descamps D, 2006, HEPATOLOGY, V44, P399, DOI 10.1002/hep.21257; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Krautwald S, 2004, J BIOL CHEM, V279, P44005, DOI 10.1074/jbc.M401327200; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Legembre P, 2003, J IMMUNOL, V171, P5659, DOI 10.4049/jimmunol.171.11.5659; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; Matsuda Y, 2006, INT J ONCOL, V29, P1119; MESSIER TL, 1991, GENE, V99, P291, DOI 10.1016/0378-1119(91)90141-W; Nagata S, 2002, CLIN CANCER RES, V8, P2345; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Taupin JL, 1999, J BIOL CHEM, V274, P14482, DOI 10.1074/jbc.274.20.14482; TAUPIN JL, 1993, SCAND J IMMUNOL, V38, P293, DOI 10.1111/j.1365-3083.1993.tb01728.x; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; TIAN QS, 1995, J EXP MED, V182, P865, DOI 10.1084/jem.182.3.865; Uphoff Cord C, 2005, Methods Mol Biol, V290, P13; Voisin MB, 2002, J BIOL CHEM, V277, P13682, DOI 10.1074/jbc.M111624200; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	35	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54000	10.1371/journal.pone.0054000	http://dx.doi.org/10.1371/journal.pone.0054000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326557	Green Published, gold			2022-12-27	WOS:000313551500107
J	Bichet, C; Scheifler, R; Coeurdassier, M; Julliard, R; Sorci, G; Loiseau, C				Bichet, Coraline; Scheifler, Renaud; Coeurdassier, Michael; Julliard, Romain; Sorci, Gabriele; Loiseau, Claire			Urbanization, Trace Metal Pollution, and Malaria Prevalence in the House Sparrow	PLOS ONE			English	Article							TITS PARUS-MAJOR; HEAVY-METALS; GREAT TITS; CLIMATE-CHANGE; TAENIOPYGIA-GUTTATA; PLASMODIUM-RELICTUM; PASSERINE BIRDS; IMMUNE FUNCTION; AVIAN MALARIA; FEATHERS	Anthropogenic pollution poses a threat for the environment and wildlife. Trace metals (TMs) are known to have negative effects on haematological status, oxidative balance, and reproductive success in birds. These pollutants particularly increase in concentration in industrialized, urbanized and intensive agricultural areas. Pollutants can also interfere with the normal functioning of the immune system and, as such, alter the dynamics of host-parasite interactions. Nevertheless, the impact of pollution on infectious diseases has been largely neglected in natural populations of vertebrates. Here, we used a large spatial scale monitoring of 16 house sparrow (Passer domesticus) populations to identify environmental variables likely to explain variation in TMs (lead, cadmium, zinc) concentrations in the feathers. In five of these populations, we also studied the potential link between TMs, prevalence of infection with one species of avian malaria, Plasmodium relictum, and body condition. Our results show that lead concentration is associated with heavily urbanized habitats and that areas with large woodland coverage have higher cadmium and zinc feather concentrations. Our results suggest that lead concentration in the feathers positively correlates with P. relictum prevalence, and that a complex relationship links TM concentrations, infection status, and body condition. This is one of the first studies showing that environmental pollutants are associated with prevalence of an infectious disease in wildlife. The mechanisms underlying this effect are still unknown even though it is tempting to suggest that lead could interfere with the normal functioning of the immune system, as shown in other species. We suggest that more effort should be devoted to elucidate the link between pollution and the dynamics of infectious diseases.	[Bichet, Coraline; Sorci, Gabriele] Univ Bourgogne, CNRS UMR 6282, Dijon, France; [Scheifler, Renaud; Coeurdassier, Michael] Univ Franche Comte, CNRS UMR 6249, F-25030 Besancon, France; [Julliard, Romain] UMR 7204 MNHN CNRS UPMC, Paris, France; [Loiseau, Claire] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; California State University System; San Francisco State University	Bichet, C (corresponding author), Univ Bourgogne, CNRS UMR 6282, Dijon, France.	coraline.bichet@u-bourgogne.fr	Bichet, Coraline/K-3103-2019; Jurassien, LTER Jurassian Arc Zone atelier Arc/C-1946-2016; Scheifler, Renaud/H-2971-2014	Bichet, Coraline/0000-0003-0255-4966; Scheifler, Renaud/0000-0002-9620-0204; Loiseau, Claire/0000-0002-0407-2904; Sorci, Gabriele/0000-0002-0799-3995	Region Ile de France; Region Bourgogne; Region Franche-Comte; Agence de l'Environnement et de la Maitrise de l'Energie	Region Ile de France(Region Ile-de-France); Region Bourgogne(Region Bourgogne-Franche-Comte); Region Franche-Comte(Region Bourgogne-Franche-Comte); Agence de l'Environnement et de la Maitrise de l'Energie	Financial support was provided by the Region Ile de France to CL, RJ and GS, the Region Bourgogne to GS, and the Region Franche-Comte and the Agence de l'Environnement et de la Maitrise de l'Energie to RS and MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson B, 2000, J INFECT DIS, V182, P420, DOI 10.1086/315726; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Atkinson CT., 1999, FIELD MANUAL WILDLIF, P193; Baos R, 2006, ENVIRON HEALTH PERSP, V114, P1497, DOI 10.1289/ehp.9099; Barbieri E, 2010, WATER ENVIRON RES, V82, P2301, DOI 10.2175/106143009X12465435982935; Bartlett JR, 2003, POULTRY SCI, V82, P1580, DOI 10.1093/ps/82.10.1580; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Biser JA, 2004, J WILDLIFE DIS, V40, P173, DOI 10.7589/0090-3558-40.2.173; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borowska J, 2011, J INSECT PHYSIOL, V57, P760, DOI 10.1016/j.jinsphys.2011.02.012; Bossard M, 2000, CORINE LAND COVER TE, P40; Bouma MJ, 2011, TRENDS PARASITOL, V27, P421, DOI 10.1016/j.pt.2011.07.003; BRIDGER MA, 1983, ARCH ENVIRON CON TOX, V12, P45, DOI 10.1007/BF01055000; BURGER J, 1994, FUND APPL TOXICOL, V23, P553, DOI 10.1006/faat.1994.1140; BURGER J, 1994, J TOXICOL ENV HEALTH, V41, P207, DOI 10.1080/15287399409531837; Burger J., 1993, REV ENV TOXICOL, V5, P203; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camplani A, 1999, P ROY SOC B-BIOL SCI, V266, P1111, DOI 10.1098/rspb.1999.0751; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; CHANDRA RK, 1982, NUTR RES, V2, P721, DOI 10.1016/S0271-5317(82)80116-4; COOK JA, 1975, P SOC EXP BIOL MED, V150, P741, DOI 10.3181/00379727-150-39117; Dauwe T, 2000, ARCH ENVIRON CON TOX, V39, P541, DOI 10.1007/s002440010138; Dauwe T, 2002, ARCH ENVIRON CON TOX, V42, P88; Dauwe T, 2006, ENVIRON POLLUT, V140, P71, DOI 10.1016/j.envpol.2005.06.024; Dauwe T, 2003, ENVIRON POLLUT, V124, P429, DOI 10.1016/S0269-7491(03)00044-7; De Luca-Abbott SB, 2001, ECOTOXICOLOGY, V10, P327, DOI 10.1023/A:1012288811808; DENNEMAN WD, 1993, ENVIRON POLLUT, V82, P301, DOI 10.1016/0269-7491(93)90133-9; Fair JM, 2002, ECOTOXICOLOGY, V11, P199, DOI 10.1023/A:1015474832239; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; GARDNER DE, 1977, B EUR PHYSIOPATH RES, V13, P157; Geens A, 2010, SCI TOTAL ENVIRON, V408, P1174, DOI 10.1016/j.scitotenv.2009.11.029; GRASMAN KA, 1995, ARCH ENVIRON CON TOX, V28, P161, DOI 10.1007/BF00217611; HAHN E, 1993, SCI TOTAL ENVIRON, V140, P259, DOI 10.1016/0048-9697(93)90025-2; Hawley DM, 2009, ECOTOXICOLOGY, V18, P499, DOI 10.1007/s10646-009-0307-4; HILIS DM, 1996, MOL SYSTEMATICS; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Isaksson C, 2009, ENVIRON RES, V109, P46, DOI 10.1016/j.envres.2008.10.006; Jager LP, 1996, J ORNITHOL, V137, P295, DOI 10.1007/BF01651071; Janssens E, 2001, ENVIRON TOXICOL CHEM, V20, P2815, DOI 10.1897/1551-5028(2001)020<2815:HMASIF>2.0.CO;2; Jaspers V, 2004, J ENVIRON MONITOR, V6, P356, DOI 10.1039/b314919f; Kenow KP, 2007, ENVIRON TOXICOL CHEM, V26, P1460, DOI 10.1897/06-442R.1; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; LASCHILOQUERIE A, 1987, IMMUNOPHARM IMMUNOT, V9, P235, DOI 10.3109/08923978709035212; Loiseau C, 2010, P R SOC B, V278, P1264, DOI DOI 10.1098/rspb.2010.1968; Markman S, 2011, J APPL ECOL, V48, P391, DOI 10.1111/j.1365-2664.2010.01931.x; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; Marzluff John M., 2001, P19; Mashima TY, 1998, ECOTOXICOLOGY, V7, P107, DOI 10.1023/A:1008820004249; Nain S, 2011, ECOTOX ENVIRON SAFE, V74, P787, DOI 10.1016/j.ecoenv.2010.10.045; Norte AC, 2009, IBIS, V151, P677, DOI 10.1111/j.1474-919X.2009.00960.x; Orlowski G, 2010, J ORNITHOL, V151, P279, DOI 10.1007/s10336-009-0453-8; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Palinauskas V, 2009, EXP PARASITOL, V123, P134, DOI 10.1016/j.exppara.2009.06.012; Pan C, 2008, B ENVIRON CONTAM TOX, V81, P558, DOI 10.1007/s00128-007-9168-9; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Roux KE, 2007, ARCH ENVIRON CON TOX, V53, P261, DOI 10.1007/s00244-006-0174-4; Scheifler R, 2006, SCI TOTAL ENVIRON, V371, P197, DOI 10.1016/j.scitotenv.2006.09.011; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHERMAN AR, 1992, J NUTR, V122, P604, DOI 10.1093/jn/122.suppl_3.604; Snoeijs T, 2005, ENVIRON POLLUT, V134, P123, DOI 10.1016/j.envpol.2004.07.009; Snoeijs T, 2004, ARCH ENVIRON CON TOX, V46, P399, DOI 10.1007/s00244-003-2195-6; Swaileh KM, 2006, J ENVIRON MONITOR, V8, P209, DOI 10.1039/b510635d; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; USEPA (US Environmental Protection Agency), 1998, EPA600R96084; Valkinas G., 2005, AVIAN MALARIA PARASI; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; WEYERS B, 1988, SCI TOTAL ENVIRON, V77, P61, DOI 10.1016/0048-9697(88)90315-4; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	76	57	59	0	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53866	10.1371/journal.pone.0053866	http://dx.doi.org/10.1371/journal.pone.0053866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342022	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700054
J	del Rey, M; Pericacho, M; Velasco, S; Lumbreras, E; Lopez-Novoa, JM; Hernandez-Rivas, JM; Rodriguez-Barbero, A				del Rey, Monica; Pericacho, Miguel; Velasco, Soraya; Lumbreras, Eva; Lopez-Novoa, Jose Miguel; Hernandez-Rivas, Jesus Maria; Rodriguez-Barbero, Alicia			Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; BONE-MARROW ANGIOGENESIS; MYELODYSPLASTIC SYNDROMES; SOLUBLE ENDOGLIN; GROWTH-FACTOR; ENDOTHELIAL-CELLS; EXPRESSION; LEUKEMIA; CLASSIFICATION; PATHOGENESIS	The functional mechanisms involved in angiogenesis and the potential role of endoglin (ENG), recently described as a new marker for this process, have not been explored in Myelodysplastic Syndromes (MDS). In order to gain insight in MDS angiogenesis a combined analysis in bone marrow (BM) of gene expression levels, angiogenesis-related soluble factors and functional angiogenesis-related studies was carried out. Ninety-seven MDS patients and forty-two normal BM samples were studied. The morphology of the capillary-like structures originated by two endothelial cells lines in the BM environment of patients with refractory cytopenia with multilineage dysplasia (RCMD) was different from those of the remaining MDS. In addition, the BM mononuclear cells from RCMD patients displayed over-expression of VEGF, HIF and FN1 while they showed reduced expression of ENG in contrast to the normal ENG expression of the remaining low-risk MDS and the high expression of ENG in high-risk MDS subtype. Moreover, higher soluble ENG and soluble FLT-1 levels in BM microenvironment were observed in RCMD cases, which distinguished them from other individuals. Therefore, the present study suggests that the patterns of angiogenesis are different between the MDS subtypes. The differences in angiogenesis observed in RCMD patients could be related to ENG abnormalities.	[del Rey, Monica; Lumbreras, Eva; Hernandez-Rivas, Jesus Maria] Univ Salamanca, CSIC, CIC, IBMCC, E-37008 Salamanca, Spain; [del Rey, Monica; Pericacho, Miguel; Lumbreras, Eva; Lopez-Novoa, Jose Miguel; Hernandez-Rivas, Jesus Maria; Rodriguez-Barbero, Alicia] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Pericacho, Miguel; Velasco, Soraya; Lopez-Novoa, Jose Miguel; Rodriguez-Barbero, Alicia] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Hernandez-Rivas, Jesus Maria] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Rodriguez-Barbero, A (corresponding author), Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain.	barberoa@usal.es	Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Lumbreras, Eva/B-4672-2017; Pericacho, Miguel/H-1786-2016; Hernández, Jesus M/B-5459-2017	Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Lumbreras, Eva/0000-0003-0359-6199; Pericacho, Miguel/0000-0003-0226-482X; Hernández, Jesus M/0000-0002-9661-9371; Lopez-Novoa, Jose M./0000-0002-6211-7269	Spanish Fondo de Investigaciones Sanitarias [FIS 09/01543]; Proyectos de Investigacion del [SACYL 355/A/09]; COST Action "EuGESMA'' [BM0801]; Obra Social Banca Civica (Caja Burgos); "Accion Transversal del Cancer''; Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation; Cancer Research Foundation of Salamanca University; Redes de Investigacion RTICC (FIS); Junta de Castilla y Leon [SA052A06, SA029A09]; Ministerio de Ciencia e Innovacion [SAF2010-15881]; "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia; Junta de Castilla y Leon	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Proyectos de Investigacion del; COST Action "EuGESMA''(European Cooperation in Science and Technology (COST)); Obra Social Banca Civica (Caja Burgos); "Accion Transversal del Cancer''(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research Foundation of Salamanca University; Redes de Investigacion RTICC (FIS); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543; Proyectos de Investigacion del SACYL 355/A/09, COST Action "EuGESMA'' (BM0801), Obra Social Banca Civica (Caja Burgos) and by the "Accion Transversal del Cancer'' project, through an agreement between the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation, and the Cancer Research Foundation of Salamanca University and the Redes de Investigacion RTICC (FIS). This work was also supported by grants from the Junta de Castilla y Leon (SA052A06 and SA029A09 to ARB.) and Ministerio de Ciencia e Innovacion (SAF2010-15881 to JMLN). MDR is fully supported by an "Ayuda Predoctoral'' by the Sociedad Espanola de Hematologia y Hemoterapia. The Renal and Cardiovascular Physiology Unit is an Excellence Research Group awarded by Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Aguayo A, 2002, CANCER-AM CANCER SOC, V95, P1923, DOI 10.1002/cncr.10900; Alexandrakis MG, 2005, LEUKEMIA RES, V29, P41, DOI 10.1016/j.leukres.2004.05.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Calabro L, 2003, J CELL PHYSIOL, V194, P171, DOI 10.1002/jcp.10200; Campioni D, 2004, LEUKEMIA RES, V28, P9, DOI 10.1016/S0145-2126(03)00123-1; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cazzola M, 2005, NEW ENGL J MED, V352, P536, DOI 10.1056/NEJMp048266; Della Porta MG, 2008, LEUKEMIA, V22, P530, DOI 10.1038/sj.leu.2405069; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fonsatti Ester, 2004, J Transl Med, V2, P18, DOI 10.1186/1479-5876-2-18; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Keith T, 2007, BRIT J HAEMATOL, V137, P206, DOI 10.1111/j.1365-2141.2007.06539.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Longo V, 2007, LEUKEMIA, V21, P1605, DOI 10.1038/sj.leu.2404790; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Lundberg LG, 2006, LEUKEMIA RES, V30, P247, DOI 10.1016/j.leukres.2005.07.003; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pruneri G, 2002, BRIT J HAEMATOL, V118, P817, DOI 10.1046/j.1365-2141.2002.03654.x; Pruneri G, 1999, BRIT J CANCER, V81, P1398, DOI 10.1038/sj.bjc.6693515; Pruneri G, 2003, BRIT J HAEMATOL, V120, P695, DOI 10.1046/j.1365-2141.2003.04133.x; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Watarai M, 2002, LEUKEMIA, V16, P112, DOI 10.1038/sj.leu.2402326; Wimazal F, 2006, LEUKEMIA LYMPHOMA, V47, P451, DOI 10.1080/10428190500353083	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53624	10.1371/journal.pone.0053624	http://dx.doi.org/10.1371/journal.pone.0053624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341958	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700031
J	Magnusson, M; Sierra, MI; Sasidharan, R; Prashad, SL; Romero, M; Saarikoski, P; Van Handel, B; Huang, A; Li, XM; Mikkola, HKA				Magnusson, Mattias; Sierra, Maria I.; Sasidharan, Rajkumar; Prashad, Sacha L.; Romero, Melissa; Saarikoski, Pamela; Van Handel, Ben; Huang, Andy; Li, Xinmin; Mikkola, Hanna K. A.			Expansion on Stromal Cells Preserves the Undifferentiated State of Human Hematopoietic Stem Cells Despite Compromised Reconstitution Ability	PLOS ONE			English	Article							EX-VIVO EXPANSION; SELF-RENEWAL; BONE-MARROW; IN-VITRO; CORD BLOOD; MAINTENANCE; DIFFERENTIATION; QUIESCENCE; LINE; GENE	Lack of HLA-matched hematopoietic stem cells (HSC) limits the number of patients with life-threatening blood disorders that can be treated by HSC transplantation. So far, insufficient understanding of the regulatory mechanisms governing human HSC has precluded the development of effective protocols for culturing HSC for therapeutic use and molecular studies. We defined a culture system using OP9M2 mesenchymal stem cell (MSC) stroma that protects human hematopoietic stem/progenitor cells (HSPC) from differentiation and apoptosis. In addition, it facilitates a dramatic expansion of multipotent progenitors that retain the immunophenotype (CD34+CD38-CD90+) characteristic of human HSPC and proliferative potential over several weeks in culture. In contrast, transplantable HSC could be maintained, but not significantly expanded, during 2-week culture. Temporal analysis of the transcriptome of the ex vivo expanded CD34+CD38-CD90+ cells documented remarkable stability of most transcriptional regulators known to govern the undifferentiated HSC state. Nevertheless, it revealed dynamic fluctuations in transcriptional programs that associate with HSC behavior and may compromise HSC function, such as dysregulation of PBX1 regulated genetic networks. This culture system serves now as a platform for modeling human multilineage hematopoietic stem/progenitor cell hierarchy and studying the complex regulation of HSC identity and function required for successful ex vivo expansion of transplantable HSC.	[Magnusson, Mattias; Sierra, Maria I.; Sasidharan, Rajkumar; Prashad, Sacha L.; Romero, Melissa; Saarikoski, Pamela; Van Handel, Ben; Huang, Andy; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	hmikkola@mcdb.ucla.edu			CIRM New Faculty Award [RN1-00557-1]; NIH [RO1 (HL097766-01)]; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH Ruth L. Kirschstein National Research Service Award (NRSA) [GM007185, T32 (HL086345)]; Whitcome fellowship; Howard Hughes Medical Institute Gilliam fellowship; Swedish Research Council; Tegger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL086345] Funding Source: NIH RePORTER	CIRM New Faculty Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship; Howard Hughes Medical Institute Gilliam fellowship(Howard Hughes Medical Institute); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tegger Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by CIRM New Faculty Award (RN1-00557-1), NIH RO1 (HL097766-01), and Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA Innovation Award to H.K.A.M. B.V.H. and M.I.S were supported by the NIH Ruth L. Kirschstein National Research Service Award (NRSA, GM007185 and NRSA T32 (HL086345)) and S.L.P. was supported by the Whitcome fellowship and the Howard Hughes Medical Institute Gilliam fellowship. M.M. was supported by the Swedish Research Council and the Tegger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AUSTIN GE, 1994, LEUKEMIA LYMPHOMA, V15, P209, DOI 10.3109/10428199409049717; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cai M, 2012, BLOOD, V120, P335, DOI 10.1182/blood-2012-01-403139; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dorrell C, 2000, BLOOD, V95, P102; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; FUKUDA MN, 1995, GENE DEV, V9, P1199, DOI 10.1101/gad.9.10.1199; Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; ITOH K, 1989, EXP HEMATOL, V17, P145; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakauchi H, 2001, ANN NY ACAD SCI, V938, P18; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nolta JA, 2002, LEUKEMIA, V16, P352, DOI 10.1038/sj.leu.2402371; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Shimakura Y, 2000, STEM CELLS, V18, P183, DOI 10.1634/stemcells.18-3-183; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Stanevsky A, 2009, BLOOD REV, V23, P199, DOI 10.1016/j.blre.2009.02.001; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Teitell MA, 2006, PEDIATR RES, V59, p33R, DOI 10.1203/01.pdr.0000205155.26315.c7; Vanheusden K, 2007, STEM CELLS, V25, P107, DOI 10.1634/stemcells.2006-0256; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	69	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53912	10.1371/journal.pone.0053912	http://dx.doi.org/10.1371/journal.pone.0053912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342037	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700063
J	Nielsen, SE; Shafer, ABA; Boyce, MS; Stenhouse, GB				Nielsen, Scott E.; Shafer, Aaron B. A.; Boyce, Mark S.; Stenhouse, Gordon B.			Does Learning or Instinct Shape Habitat Selection?	PLOS ONE			English	Article							GRIZZLY BEARS; SITE FIDELITY; RELATEDNESS; MORTALITY; ECOSYSTEM; ALBERTA; MODELS; TESTS; DIET	Habitat selection is an important behavioural process widely studied for its population-level effects. Models of habitat selection are, however, often fit without a mechanistic consideration. Here, we investigated whether patterns in habitat selection result from instinct or learning for a population of grizzly bears (Ursus arctos) in Alberta, Canada. We found that habitat selection and relatedness were positively correlated in female bears during the fall season, with a trend in the spring, but not during any season for males. This suggests that habitat selection is a learned behaviour because males do not participate in parental care: a genetically predetermined behaviour (instinct) would have resulted in habitat selection and relatedness correlations for both sexes. Geographic distance and home range overlap among animals did not alter correlations indicating that dispersal and spatial autocorrelation had little effect on the observed trends. These results suggest that habitat selection in grizzly bears are partly learned from their mothers, which could have implications for the translocation of wildlife to novel environments.	[Nielsen, Scott E.; Shafer, Aaron B. A.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Shafer, Aaron B. A.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada; [Stenhouse, Gordon B.] Alberta Sustainable Resource Dev, Fish & Wildlife Div, Hinton, AB, Canada	University of Alberta; University of Alberta	Nielsen, SE (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	scottn@ualberta.ca	Nielsen, Scott/C-2842-2013; Nielsen, Scott/O-7482-2019; Boyce, Mark S/A-2620-2014	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Boyce, Mark S/0000-0001-5811-325X; Shafer, Aaron/0000-0001-7652-225X	Natural Sciences and Engineering Research Council of Canada; Alberta Conservation Association; Foothills Research Institute Grizzly Bear Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Conservation Association; Foothills Research Institute Grizzly Bear Program	The authors thank the Natural Sciences and Engineering Research Council of Canada, the Alberta Conservation Association, and partners from the Foothills Research Institute Grizzly Bear Program for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Boyce MS, 2010, PHILOS T R SOC B, V365, P2213, DOI 10.1098/rstb.2010.0080; Breed M, 2010, NATURE ED KNOWL, V1, P10; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Darwin C, 1859, ORIGIN SPECIES MEANS; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Dukas Reuven, 1998, P129; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Manly B.F.J., 2002, RESOURCE SELECTION A; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E, 1942, SYSTEMATICS ORIGIN S; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; McLoughlin PD, 2005, J ANIM ECOL, V74, P701, DOI 10.1111/j.1365-2656.2005.00967.x; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Morris DW, 2011, P ROY SOC B-BIOL SCI, V278, P2401, DOI 10.1098/rspb.2011.0604; Morris DW, 2008, ISR J ECOL EVOL, V54, P287, DOI 10.1560/IJEE.54.3-4.287; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2003, ECOSCIENCE, V10, P1; Nielson SE, 2002, URSUS, V13, P45; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Ridley M, 1999, GENOME; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Shafer ABA, 2012, ECOLOGY, V93, P1317; TAYLOR CE, 1978, OECOLOGIA, V37, P69, DOI 10.1007/BF00349992; WECKER SC, 1964, SCI AM, V211, P109, DOI 10.1038/scientificamerican1064-109	36	24	26	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53721	10.1371/journal.pone.0053721	http://dx.doi.org/10.1371/journal.pone.0053721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341983	Green Published, gold			2022-12-27	WOS:000313682700038
J	Stulp, G; Buunk, AP; Pollet, TV; Nettle, D; Verhulst, S				Stulp, Gert; Buunk, Abraham P.; Pollet, Thomas V.; Nettle, Daniel; Verhulst, Simon			Are Human Mating Preferences with Respect to Height Reflected in Actual Pairings?	PLOS ONE			English	Article							MATE CHOICE; VARIABLE PREFERENCES; REPRODUCTIVE SUCCESS; SEXUAL-DIMORPHISM; BODY HEIGHT; UNIVERSAL; CONFLICT; WEIGHT; TWINS	Pair formation, acquiring a mate to form a reproductive unit, is a complex process. Mating preferences are a step in this process. However, due to constraining factors such as availability of mates, rival competition, and mutual mate choice, preferred characteristics may not be realised in the actual partner. People value height in their partner and we investigated to what extent preferences for height are realised in actual couples. We used data from the Millennium Cohort Study (UK) and compared the distribution of height difference in actual couples to simulations of random mating to test how established mate preferences map on to actual mating patterns. In line with mate preferences, we found evidence for: (i) assortative mating (r = .18), (ii) the male-taller norm, and, for the first time, (iii) for the male-not-too-tall norm. Couples where the male partner was shorter, or over 25 cm taller than the female partner, occurred at lower frequency in actual couples than expected by chance, but the magnitude of these effects was modest. We also investigated another preference rule, namely that short women (and tall men) prefer large height differences with their partner, whereas tall women (and short men) prefer small height differences. These patterns were also observed in our population, although the strengths of these associations were weaker than previously reported strength of preferences. We conclude that while preferences for partner height generally translate into actual pairing, they do so only modestly.	[Stulp, Gert; Buunk, Abraham P.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Stulp, Gert; Verhulst, Simon] Univ Groningen, Dept Behav Biol, Groningen, Netherlands; [Buunk, Abraham P.] Royal Netherlands Acad Arts & Sci, Amsterdam, Netherlands; [Pollet, Thomas V.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Newcastle University - UK	Stulp, G (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	g.stulp@rug.nl	Verhulst, Simon/B-1613-2009; Pollet, Thomas V/H-3397-2012; Pollet, Thomas/M-6346-2019; Verhulst, Simon/S-3404-2019	Verhulst, Simon/0000-0002-1143-6868; Pollet, Thomas V/0000-0002-4210-935X; Pollet, Thomas/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Stulp, Gert/0000-0003-0173-5554; Nettle, Daniel/0000-0001-9089-2599	consortium of government departments; Wellcome Trust; Royal Netherlands Academy of Arts and Sciences; NWO Veni grant [451.10.032]	consortium of government departments; Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; NWO Veni grant	The Millennium Cohort Study was commissioned by the Economic and Social Research Council (ESRC), whose funding has been supplemented by a consortium of government departments and the Wellcome Trust. This research was supported by a grant to APB from the Royal Netherlands Academy of Arts and Sciences, and an NWO Veni grant to TVP (451.10.032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Courtiol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013010; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; Dex S, 2004, MILLENNIUM COHORT ST; Fink B, 2007, PERS INDIV DIFFER, V43, P2249, DOI 10.1016/j.paid.2007.07.014; GILLIS JS, 1980, PERS SOC PSYCHOL B, V6, P396, DOI 10.1177/014616728063010; Hansen K., 2008, MILLENNIUM COHORT ST; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; MCMANUS IC, 1984, HUM BIOL, V56, P617; Merrill RM, 2009, PREV CHRONIC DIS, V6; Oreffice S, 2010, ECON HUM BIOL, V8, P373, DOI 10.1016/j.ehb.2010.05.001; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; Pawlowski B, 2002, EVOL HUM BEHAV, V23, P139, DOI 10.1016/S1090-5138(01)00092-7; Plewis I., 2007, MILLENNIUM COHORT ST; R Core Team, 2018, R LANG ENV STAT COMP; Riebel Katharina, 2010, Communicative & Integrative Biology, V3, P271; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; RUSBULT CE, 1993, J SOC PERS RELAT, V10, P175, DOI 10.1177/026540759301000202; Salska I, 2008, PERS INDIV DIFFER, V44, P203, DOI 10.1016/j.paid.2007.08.008; Sear R, 2006, HUM NATURE-INT BIOS, V17, P405, DOI 10.1007/s12110-006-1003-1; Sear R, 2010, FRONT COLLECT, P127, DOI 10.1007/978-3-642-12142-5_10; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Silventoinen K, 2004, AM J HUM BIOL, V16, P544, DOI 10.1002/ajhb.20060; Silventoinen K, 2003, AM J HUM BIOL, V15, P620, DOI 10.1002/ajhb.10183; Sorokowski P, 2012, BODY IMAGE, V9, P510, DOI 10.1016/j.bodyim.2012.07.002; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; SPUHLER JN, 1982, SOC BIOL, V29, P53; Stulp G, 2012, BIOL LETTERS, V8, P976, DOI 10.1098/rsbl.2012.0590; Stulp G, 2012, AM J HUM BIOL, V24, P486, DOI 10.1002/ajhb.22252; Stulp G, 2012, BEHAV ECOL SOCIOBIOL, V66, P375, DOI 10.1007/s00265-011-1283-2; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Waynforth D, 1999, EVOL HUM BEHAV, V20, P19, DOI 10.1016/S1090-5138(98)00037-3; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6	41	35	35	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54186	10.1371/journal.pone.0054186	http://dx.doi.org/10.1371/journal.pone.0054186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342102	Green Published, Green Accepted, gold			2022-12-27	WOS:000313682700094
J	Szalinski, CM; Guerriero, CJ; Ruiz, WG; Docter, BE; Rbaibi, Y; Pastor-Soler, NM; Apodaca, G; Puthenveedu, MA; Weisz, OA				Szalinski, Christina M.; Guerriero, Christopher J.; Ruiz, Wily G.; Docter, Brianne E.; Rbaibi, Youssef; Pastor-Soler, Nuria M.; Apodaca, Gerard; Puthenveedu, Manojkumar A.; Weisz, Ora A.			PIP5KI beta Selectively Modulates Apical Endocytosis in Polarized Renal Epithelial Cells	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; CLATHRIN-COATED PITS; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; POLYMERIC IMMUNOGLOBULIN RECEPTOR; LIPID KINASE FAMILY; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; MDCK CELLS; N-WASP; PHOSPHOINOSITIDE METABOLISM	Localized synthesis of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5) P-2] at clathrin coated pits (CCPs) is crucial for the recruitment of adaptors and other components of the internalization machinery, as well as for regulating actin dynamics during endocytosis. PtdIns(4,5) P-2 is synthesized from phosphatidylinositol 4-phosphate by any of three phosphatidylinositol 5-kinase type I (PIP5KI) isoforms (alpha, beta or gamma). PIP5KI beta localizes almost exclusively to the apical surface in polarized mouse cortical collecting duct cells, whereas the other isoforms have a less polarized membrane distribution. We therefore investigated the role of PIP5KI isoforms in endocytosis at the apical and basolateral domains. Endocytosis at the apical surface is known to occur more slowly than at the basolateral surface. Apical endocytosis was selectively stimulated by overexpression of PIP5KI beta whereas the other isoforms had no effect on either apical or basolateral internalization. We found no difference in the affinity for PtdIns(4,5) P-2-containing liposomes of the PtdIns(4,5) P-2 binding domains of epsin and Dab2, consistent with a generic effect of elevated PtdIns(4,5) P-2 on apical endocytosis. Additionally, using apical total internal reflection fluorescence imaging and electron microscopy we found that cells overexpressing PIP5KI beta have fewer apical CCPs but more internalized coated structures than control cells, consistent with enhanced maturation of apical CCPs. Together, our results suggest that synthesis of PtdIns(4,5) P-2 mediated by PIP5KI beta is rate limiting for apical but not basolateral endocytosis in polarized kidney cells. PtdIns(4,5) P-2 may be required to overcome specific structural constraints that limit the efficiency of apical endocytosis.	[Szalinski, Christina M.; Ruiz, Wily G.; Rbaibi, Youssef; Pastor-Soler, Nuria M.; Apodaca, Gerard; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA; [Apodaca, Gerard; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Guerriero, Christopher J.] Univ Pittsburgh, Sch Med, Dept Biol Sci, Pittsburgh, PA USA; [Docter, Brianne E.] Grand Valley State Univ, Allendale, MI 49401 USA; [Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Grand Valley State University; Carnegie Mellon University	Weisz, OA (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA.	weisz@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Puthenveedu, Manojkumar/A-3795-2016	Szalinski, Christina/0000-0002-5991-5606; Puthenveedu, Manojkumar/0000-0002-3177-4231; Guerriero, Christopher/0000-0002-1046-2300	National Institutes of Health (NIH) [R01 DK064613, DA024698, R37DK54425, T32 DK061296]; Core A of the Pittsburgh Center for Kidney Research [P30 DK079307]; Core C of the Pittsburgh Center for Kidney Research [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064613, P30DK079307, R37DK054425, R01DK084184, T32DK061296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024698] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core A of the Pittsburgh Center for Kidney Research; Core C of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01 DK064613 (to OAW), DA024698 (to MAP), R37DK54425 (to GA), and by Cores A and C of the Pittsburgh Center for Kidney Research (P30 DK079307). CMS was supported in part by NIH T32 DK061296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cui SS, 2010, AM J PHYSIOL-RENAL, V298, pF335, DOI 10.1152/ajprenal.00453.2009; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Guerriero CJ, 2006, J BIOL CHEM, V281, P15376, DOI 10.1074/jbc.M601239200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Howard C, 1998, UNBIASED STEREOLOGY; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Hyman T, 2006, MOL BIOL CELL, V17, P427, DOI 10.1091/mbc.E05-05-0420; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; NAIM HY, 1995, J CELL BIOL, V129, P1241, DOI 10.1083/jcb.129.5.1241; Oleinikov AV, 2000, BIOCHEM J, V347, P613, DOI 10.1042/0264-6021:3470613; Oztan Asli, 2008, V440, P157, DOI 10.1007/978-1-59745-178-9_12; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Potter BA, 2006, TRAFFIC, V7, P146, DOI 10.1111/j.1600-0854.2005.00371.x; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Russ J.C., 2000, PRACTICAL STEREOLOGY, V2nd ed.; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Wen PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1500; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	80	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53790	10.1371/journal.pone.0053790	http://dx.doi.org/10.1371/journal.pone.0053790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342003	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000313682700046
J	Becker, A; Allmann, L; Hofstatter, M; Casa, V; Weber, P; Lehmkuhl, A; Herce, HD; Cardoso, MC				Becker, Annette; Allmann, Lena; Hofstaetter, Maria; Casa, Valentina; Weber, Patrick; Lehmkuhl, Anne; Herce, Henry D.; Cardoso, M. Cristina			Direct Homo- and Hetero-Interactions of MeCP2 and MBD2	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; CPG-BINDING PROTEIN-2; DNA METHYLATION; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; MUTATIONS; DIFFERENTIATION; DOMAIN; SITES	Epigenetic marks like methylation of cytosines at CpG dinucleotides are essential for mammalian development and play a major role in the regulation of gene expression and chromatin architecture. The methyl-cytosine binding domain (MBD) protein family recognizes and translates this methylation mark. We have recently shown that the level of MeCP2 and MBD2, two members of the MBD family, increased during differentiation and their ectopic expression induced heterochromatin clustering in vivo. As oligomerization of these MBD proteins could constitute a factor contributing to the chromatin clustering effect, we addressed potential associations among the MBD family performing a series of different interaction assays in vitro as well as in vivo. Using recombinant purified MBDs we found that MeCP2 and MBD2 showed the stronger self and cross association as compared to the other family members. Besides demonstrating that these homo-and hetero-interactions occur in the absence of DNA, we could confirm them in mammalian cells using co-immunoprecipitation analysis. Employing a modified form of the fluorescent two-hybrid protein-protein interaction assay, we could clearly visualize these associations in single cells in vivo. Deletion analysis indicated that the region of MeCP2 comprising amino acids 163-309 as well the first 152 amino acids of MBD2 are the domains responsible for MeCP2 and MBD2 associations. Our results strengthen the possibility that MeCP2 and MBD2 direct interactions could crosslink chromatin fibers and therefore give novel insight into the molecular mechanism of MBD mediated global heterochromatin architecture.	[Becker, Annette; Allmann, Lena; Casa, Valentina; Weber, Patrick; Lehmkuhl, Anne; Herce, Henry D.; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Hofstaetter, Maria] Max Delbruck Ctr Mol Med, Berlin, Germany	Technical University of Darmstadt; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cardoso, MC (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	cardoso@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft [DFG SPP 1356, 1129]; Bundesministerium fur Forschung und Technik BMBF [02S8355]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung und Technik BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by grants of the Deutsche Forschungsgemeinschaft [DFG SPP 1356 and 1129] (URL: www.dfg.de) and the Bundesministerium fur Forschung und Technik BMBF 02S8355] (URL: www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brero A, 2006, CURR TOP MICROBIOL, V301, P21; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks784; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Pichler Garwin, 2012, Methods Mol Biol, V911, P475, DOI 10.1007/978-1-61779-968-6_29; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	36	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53730	10.1371/journal.pone.0053730	http://dx.doi.org/10.1371/journal.pone.0053730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335972	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314707700028
J	Bodvard, K; Jorhov, A; Blomberg, A; Molin, M; Kall, M				Bodvard, Kristofer; Jorhov, Anna; Blomberg, Anders; Molin, Mikael; Kall, Mikael			The Yeast Transcription Factor Crz1 Is Activated by Light in a Ca2+/Calcineurin-Dependent and PKA-Independent Manner	PLOS ONE			English	Article							AFFINITY CAMP-PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; H+/CA2+ EXCHANGE; OXIDATIVE STRESS; CALCIUM INFLUX; HEAT-SHOCK; CA2+; MSN2P	Light in the visible range can be stressful to non-photosynthetic organisms. The yeast Saccharomyces cerevisiae has earlier been reported to respond to blue light via activation of the stress-regulated transcription factor Msn2p. Environmental changes also induce activation of calcineurin, a Ca2+/calmodulin dependent phosphatase, which in turn controls gene transcription by dephosphorylating the transcription factor Crz1p. We investigated the connection between cellular stress caused by blue light and Ca2+ signalling in yeast by monitoring the nuclear localization dynamics of Crz1p, Msn2p and Msn4p. The three proteins exhibit distinctly different stress responses in relation to light exposure. Msn2p, and to a lesser degree Msn4p, oscillate rapidly between the nucleus and the cytoplasm in an apparently stochastic fashion. Crz1p, in contrast, displays a rapid and permanent nuclear localization induced by illumination, which triggers Crz1p-dependent transcription of its target gene CMK2. Moreover, increased extracellular Ca2+ levels stimulates the light-induced responses of all three transcription factors, e. g. Crz1p localizes much quicker to the nucleus and a larger fraction of cells exhibits permanent Msn2p nuclear localization at higher Ca2+ concentration. Studies in mutants lacking Ca2+ transporters indicate that influx of extracellular Ca2+ is crucial for the initial stages of light-induced Crz1p nuclear localization, while mobilization of intracellular Ca2+ stores appears necessary for a sustained response. Importantly, we found that Crz1p nuclear localization is dependent on calcineurin and the carrier protein Nmd5p, while not being affected by increased protein kinase A activity (PKA), which strongly inhibits light-induced nuclear localization of Msn2/4p. We conclude that the two central signalling pathways, cAMP-PKA-Msn2/4 and Ca2+-calcineurin-Crz1, are both activated by blue light illumination.	[Bodvard, Kristofer; Kall, Mikael] Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Bodvard, Kristofer; Jorhov, Anna; Blomberg, Anders; Molin, Mikael] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Bodvard, K (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	kristofer.bodvard@chalmers.se	Käll, Mikael/A-6753-2012	Käll, Mikael/0000-0002-1163-0345; Blomberg, Anders/0000-0002-1260-3920; Molin, Mikael/0000-0002-3903-8503	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The authors acknowledge financial support from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Bodvard K, 2011, BBA-MOL CELL RES, V1813, P358, DOI 10.1016/j.bbamcr.2010.12.004; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Boy-Marcotte E, 2006, MOL GENET GENOMICS, V275, P277, DOI 10.1007/s00438-005-0017-4; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DUNN T, 1994, J BIOL CHEM, V269, P7273; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Fraunhofer-Chalmers Centre for Industrial Mathematics, CELLSTAT COMP SOFTW; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Groppi S, 2011, CELL CALCIUM, V49, P376, DOI 10.1016/j.ceca.2011.03.006; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; KUNO T, 1991, BIOCHEM BIOPH RES CO, V180, P1159, DOI 10.1016/S0006-291X(05)81188-X; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Logg K, 2009, FEMS YEAST RES, V9, P875, DOI 10.1111/j.1567-1364.2009.00536.x; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Park JI, 2005, BIOCHEM BIOPH RES CO, V327, P311, DOI 10.1016/j.bbrc.2004.12.019; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Tsuzi D, 2004, FEBS LETT, V569, P301, DOI 10.1016/j.febslet.2004.05.077; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	61	27	28	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53404	10.1371/journal.pone.0053404	http://dx.doi.org/10.1371/journal.pone.0053404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335962	Green Published, gold			2022-12-27	WOS:000314707700016
J	Imhof, P; Zahran, M				Imhof, Petra; Zahran, Mai			The Effect of a G:T Mispair on the Dynamics of DNA	PLOS ONE			English	Article							UNIQUE TETRANUCLEOTIDE SEQUENCES; IMINO PROTON-EXCHANGE; BASE-PAIR KINETICS; MOLECULAR-DYNAMICS; FREE-ENERGY; B-DNA; NUMERICAL-INTEGRATION; MISMATCH RECOGNITION; POLYMERASE-BETA; REPAIR ENZYMES	Distortions in the DNA sequence such as damages or mispairs are specifically recognized and processed by DNA repair enzymes. A particular challenge for the enzymatic specificity is the recognition of a wrongly-placed native nucleotide such as thymine in T: G mispairs. An important step of substrate binding which is observed in many repair proteins is the flipping of the target base out of the DNA helix into the enzyme's active site. In this work we investigate how much the intrinsic dynamics of mispaired DNA is changed compared to canonical DNA. Our molecular dynamics simulations of DNA with and without T: G mispairs show significant differences in the conformation of paired and mispaired DNA. The wobble pair T: G shows local distortions such as twist, shear and stretch which deviate from canonical B form values. Moreover, the T: G mispair is found to be kinetically less stable, exhibiting two states with respect to base opening: a closed state comparable to the canonical base pairs, and a more open state, indicating a proneness for base flip. In addition, we observe that the thymine base in a T: G mispair is significantly more probable to be flipped than thymine in a T: A pair or cytosine in a C: G pair. Such local deformations and in particular the existence of a second, more-open state can be speculated to help the target-site recognition by repair enzymes.	[Imhof, Petra; Zahran, Mai] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Imhof, P (corresponding author), Free Univ Berlin, Berlin, Germany.	petra.imhof@fu-berlin.de	Imhof, Petra/G-5656-2013; Imhof, Petra/V-2392-2019	Imhof, Petra/0000-0001-9820-4578	German Science Foundation (DFG) [IM141/1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work has been supported by the German Science Foundation (DFG) [IM141/1-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P4925, DOI 10.1093/nar/26.21.4925; Arora K, 2004, BIOPHYS J, V87, P3088, DOI 10.1529/biophysj.104.040915; Banavali NK, 2002, J MOL BIOL, V319, P141, DOI 10.1016/S0022-2836(02)00194-8; Beveridge DL, 2004, BIOPHYS J, V87, P3799, DOI 10.1529/biophysj.104.045252; Bouvier B, 2007, BIOPHYS J, V93, P770, DOI 10.1529/biophysj.106.091751; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cheatham TE, 2004, CURR OPIN STRUC BIOL, V14, P360, DOI 10.1016/j.sbi.2004.05.001; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chipot C, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2138694; Curuksu J, 2008, NUCLEIC ACIDS RES, V36, P2268, DOI 10.1093/nar/gkm1135; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fadda E, 2011, NUCLEIC ACIDS RES, V39, P767, DOI 10.1093/nar/gkq812; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Giudice E, 2003, NUCLEIC ACIDS RES, V31, P1434, DOI 10.1093/nar/gkg239; Gueron M, 1995, METHOD ENZYMOL, V261, P383; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Hagan MF, 2003, P NATL ACAD SCI USA, V100, P13922, DOI 10.1073/pnas.2036378100; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Huang N, 2004, PHILOS T R SOC A, V362, P1439, DOI 10.1098/rsta.2004.1383; Huang N, 2003, P NATL ACAD SCI USA, V100, P68, DOI 10.1073/pnas.0135427100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isaacs RJ, 2004, J AM CHEM SOC, V126, P583, DOI 10.1021/ja037333r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lavery R, 2009, NUCL ACID RES; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; LEROY JL, 1988, J MOL BIOL, V200, P223, DOI 10.1016/0022-2836(88)90236-7; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; MOE JG, 1992, BIOCHEMISTRY-US, V31, P8421, DOI 10.1021/bi00151a005; Nilsson L, 2006, COMPUTATIONAL STUDIE, P73; O'Neil LL, 2008, ORG BIOMOL CHEM, V6, P485, DOI 10.1039/b713318a; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Priyakumar UD, 2006, J CHEM THEORY COMPUT, V2, P187, DOI 10.1021/ct0501957; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Szczepanowski RH, 2008, NUCLEIC ACIDS RES, V36, P6109, DOI 10.1093/nar/gkn622; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 2004, J AM CHEM SOC, V126, P14659, DOI 10.1021/ja0470721; Varnai P, 2002, J AM CHEM SOC, V124, P7272, DOI 10.1021/ja025980x; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yang LJ, 2002, J MOL BIOL, V321, P459, DOI 10.1016/S0022-2836(02)00617-4; Zacharias M, 2006, BIOPHYS J, V91, P882, DOI 10.1529/biophysj.106.083816; Zahran M, 2010, J MOL BIOL, V401, P415, DOI 10.1016/j.jmb.2010.06.026	64	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53305	10.1371/journal.pone.0053305	http://dx.doi.org/10.1371/journal.pone.0053305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335959	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700013
J	Cheung, YTD; Spittal, MJ; Williamson, MK; Tung, SJ; Pirkis, J				Cheung, Yee Tak Derek; Spittal, Matthew J.; Williamson, Michelle Kate; Tung, Sui Jay; Pirkis, Jane			Application of Scan Statistics to Detect Suicide Clusters in Australia	PLOS ONE			English	Article							REMOTE	Background: Suicide clustering occurs when multiple suicide incidents take place in a small area or/and within a short period of time. In spite of the multi-national research attention and particular efforts in preparing guidelines for tackling suicide clusters, the broader picture of epidemiology of suicide clustering remains unclear. This study aimed to develop techniques in using scan statistics to detect clusters, with the detection of suicide clusters in Australia as example. Methods and Findings: Scan statistics was applied to detect clusters among suicides occurring between 2004 and 2008. Manipulation of parameter settings and change of area for scan statistics were performed to remedy shortcomings in existing methods. In total, 243 suicides out of 10,176 (2.4%) were identified as belonging to 15 suicide clusters. These clusters were mainly located in the Northern Territory, the northern part of Western Australia, and the northern part of Queensland. Among the 15 clusters, 4 (26.7%) were detected by both national and state cluster detections, 8 (53.3%) were only detected by the state cluster detection, and 3 (20%) were only detected by the national cluster detection. Conclusions: These findings illustrate that the majority of spatial-temporal clusters of suicide were located in the inland northern areas, with socio-economic deprivation and higher proportions of indigenous people. Discrepancies between national and state/territory cluster detection by scan statistics were due to the contrast of the underlying suicide rates across states/territories. Performing both small-area and large-area analyses, and applying multiple parameter settings may yield the maximum benefits for exploring clusters.	[Cheung, Yee Tak Derek] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Spittal, Matthew J.; Williamson, Michelle Kate; Pirkis, Jane] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Tung, Sui Jay] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Melbourne; University of Hong Kong	Cheung, YTD (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	derekcheung@hku.hk	Cheung, Derek/O-3682-2018; Sui, Tung/A-7076-2011	Cheung, Derek/0000-0002-5850-5349; Sui, Tung/0000-0002-4708-2133; Spittal, Matthew/0000-0002-2841-1536				Australian Bureau of Statistics, 2012, CAUS DEATH 2010; Australian Bureau of Statistics, 2007, SUIC; Caldwell TM, 2004, MED J AUSTRALIA, V181, pS10; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; Cheung YTD, 2012, SOC SCI MED, V75, P1460, DOI 10.1016/j.socscimed.2012.04.008; Exeter DJ, 2007, J EPIDEMIOL COMMUN H, V61, P731, DOI 10.1136/jech.2006.052365; GOULD MS, 1994, INT J EPIDEMIOL, V23, P1185, DOI 10.1093/ije/23.6.1185; Gregorio David I, 2006, Int J Health Geogr, V5, P8, DOI 10.1186/1476-072X-5-8; HANSSENS L, 2008, ABORIGINAL ISLANDER, V0032, P00028; Hanssens L., 2011, ABORIGINAL ISLANDER, V35, P14; Hourani LL, 1999, SUICIDE LIFE-THREAT, V29, P365; Joiner TE, 1999, CURR DIR PSYCHOL SCI, V8, P89, DOI 10.1111/1467-8721.00021; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., 2009, SATSCAN USER GUIDE V; Kulldorff M, 2006, SATSCAN USER GUIDE V, P4; Large MM, 2010, MED J AUSTRALIA, V192, P432, DOI 10.5694/j.1326-5377.2010.tb03580.x; Mazumdar S, 2010, HEALTH PLACE, V16, P539, DOI 10.1016/j.healthplace.2009.12.014; McKenzie N, 2005, BRIT J PSYCHIAT, V187, P476, DOI 10.1192/bjp.187.5.476; Measey MAL, 2006, MED J AUSTRALIA, V185, P315, DOI 10.5694/j.1326-5377.2006.tb00585.x; Qi X, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-86; Qi X, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-106; Spittal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044565; TAIMINEN TJ, 1994, AM J PSYCHIAT, V151, P1087; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Tango T, 2010, STAT BIOL HEALTH, P211, DOI 10.1007/978-1-4419-1572-6_9; Wilson JG, 2010, HEALTH PLACE, V16, P1230, DOI 10.1016/j.healthplace.2010.08.010; Wissow LS, 2001, SOC SCI MED, V53, P1115, DOI 10.1016/S0277-9536(00)00405-6	29	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54168	10.1371/journal.pone.0054168	http://dx.doi.org/10.1371/journal.pone.0054168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23342098	gold, Green Published			2022-12-27	WOS:000314759400129
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Dominguez-Rodriguez, A; Labarta, L; Diaz, C; Sole-Violan, J; Ferreres, J; Borreguero-Leon, JM; Jimenez, A; Morera-Fumero, A				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Dominguez-Rodriguez, Alberto; Labarta, Lorenzo; Diaz, Cesar; Sole-Violan, Jordi; Ferreres, Jose; Maria Borreguero-Leon, Juan; Jimenez, Alejandro; Morera-Fumero, Armando			Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study	PLOS ONE			English	Article							MELATONIN TREATMENT; PROTECTS; CARE	Objective: The oxidant/antioxidant state in septic patients has only been studied in small series. We wished to determine whether malondialdehyde (MDA) serum levels were associated with severity and 30-day mortality in a large series of patients with sepsis. Methods: We performed an observational, prospective, multicenter study in six Spanish Intensive Care Units. Serum levels of MDA were measured in a total of 228 patients (145 survivors and 83 non-survivors) with severe sepsis and 100 healthy controls. Results: Serum levels of MDA were higher in severe septic patients than in healthy controls. Non-surviving septic patients had higher MDA values than survivors. MDA serum levels were associated with severity markers (lactic acid, SOFA, APACHE-II) and coagulation indices. Regression analysis showed that MDA serum levels were associated with 30-day survival (Hazard ratio = 1.05; 95% confidence interval = 1.009-1.091; p = 0.016). Receiver operating characteristic analysis showed that the area under curve of MDA serum levels to predict 30-day survival was 0.62 (95% CI = 0.56-0.69; P = 0.002). The risk of death in septic patients with MDA serum levels above 4.11 nmol/mL was higher than in patients with lower values (Hazard Ratio = 2.43; 95% CI = 1.49-3.94; p<0.001). Conclusions: The novel findings of our study on severe septic patients, to our knowledge the largest series providing data on the oxidative state, are that elevated MDA serum levels probably represent an unbalanced oxidant state and are related with poor prognosis in patients with severe sepsis.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Dept Physiol, Fac Med, Santa Cruz De Tenerife, Spain; [Dominguez-Rodriguez, Alberto] Hosp Univ Canarias, Dept Cardiol, San Cristobal la Laguna, Santa Cruz De T, Spain; [Labarta, Lorenzo] Hosp San Jorge de Huesca, Intens Care Unit, Huesca, Spain; [Diaz, Cesar] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Ferreres, Jose] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Maria Borreguero-Leon, Juan] Hosp Univ Canarias, Dept Lab, San Cristobal la Laguna, Santa Cruz De T, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Morera-Fumero, Armando] Univ La Laguna, Dept Internal Med & Psychiat, Fac Med, San Cristobal la Laguna, Santa Cruz De T, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Hospital Clinic Universitari de Valencia; Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.	lorentemartin@msn.com	Martín, María/HDL-9512-2022; Abreu-Gonzalez, Pedro/AAC-7790-2020; Borreguero León, Juan María/ABQ-2161-2022; Morera-Fumero, Armando/D-2775-2013; Fumero, Armando Morera/M-3394-2019	Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Borreguero León, Juan María/0000-0001-7414-5278; Morera-Fumero, Armando/0000-0002-7663-1154; Fumero, Armando Morera/0000-0002-7663-1154; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos III (Madrid, Spain) [FIS-PI-10-01572, I3SNS-INT-11-063]; Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain)	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain)	Supported, in part, by a grant from Instituto de Salud Carlos III (FIS-PI-10-01572 and I3SNS-INT-11-063) (Madrid, Spain) and Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Andrades Michael Everton, 2009, Front Biosci (Elite Ed), V1, P277; [Anonymous], CRIT CARE MED; Chuang CC, 2006, CRIT CARE, V10, DOI 10.1186/cc4826; Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019; Fulia F, 2001, J PINEAL RES, V31, P343, DOI 10.1034/j.1600-079X.2001.310409.x; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Guerreiro MO, 2010, J TRAUMA, V69, pE102, DOI 10.1097/TA.0b013e3181dbb289; Harrell FE, 2001, REGRESSION MODELING, P53; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Mahreen R, 2010, INT J DIABETES DEV C, V30, P49, DOI 10.4103/0973-3930.60006; Mishra V, 2005, ANN CLIN BIOCHEM, V42, P269, DOI 10.1258/0004563054255461; Moustafa AHA, 2009, EUR J INTERN MED, V20, P703, DOI 10.1016/j.ejim.2009.08.003; OGILVIE AC, 1991, INTENS CARE MED, V17, P40, DOI 10.1007/BF01708408; Paskaloglu K, 2004, LIFE SCI, V74, P1093, DOI 10.1016/j.lfs.2003.07.038; Sahib A S, 2010, Ann Burns Fire Disasters, V23, P199; Sener G, 2005, SURG TODAY, V35, P52, DOI 10.1007/s00595-004-2879-1; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Xing Han-Ying, 2005, Shengli Xuebao, V57, P367	22	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53741	10.1371/journal.pone.0053741	http://dx.doi.org/10.1371/journal.pone.0053741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341989	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400074
J	Xiang, RD; Ghanipoor-Samami, M; Johns, WH; Eindorf, T; Rutley, DL; Kruk, ZA; Fitzsimmons, CJ; Thomsen, DA; Roberts, CT; Burns, BM; Anderson, GI; Greenwood, PL; Hiendleder, S				Xiang, Ruidong; Ghanipoor-Samami, Mani; Johns, William H.; Eindorf, Tanja; Rutley, David L.; Kruk, Zbigniew A.; Fitzsimmons, Carolyn J.; Thomsen, Dana A.; Roberts, Claire T.; Burns, Brian M.; Anderson, Gail I.; Greenwood, Paul L.; Hiendleder, Stefan			Maternal and Paternal Genomes Differentially Affect Myofibre Characteristics and Muscle Weights of Bovine Fetuses at Midgestation	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SKELETAL-MUSCLE; BOS-TAURUS; CARCASS TRAITS; PHENOTYPIC CHARACTERIZATION; RECIPROCAL DIFFERENCES; POLAR OVERDOMINANCE; GENETIC-PARAMETERS; EPIGENETIC CONTROL; EMBRYO-TRANSFER	Postnatal myofibre characteristics and muscle mass are largely determined during fetal development and may be significantly affected by epigenetic parent-of-origin effects. However, data on such effects in prenatal muscle development that could help understand unexplained variation in postnatal muscle traits are lacking. In a bovine model we studied effects of distinct maternal and paternal genomes, fetal sex, and non-genetic maternal effects on fetal myofibre characteristics and muscle mass. Data from 73 fetuses (Day153, 54% term) of four genetic groups with purebred and reciprocal cross Angus and Brahman genetics were analyzed using general linear models. Parental genomes explained the greatest proportion of variation in myofibre size of Musculus semitendinosus (80-96%) and in absolute and relative weights of M. supraspinatus, M. longissimus dorsi, M. quadriceps femoris and M. semimembranosus (82-89% and 56-93%, respectively). Paternal genome in interaction with maternal genome (P<0.05) explained most genetic variation in cross sectional area (CSA) of fast myotubes (68%), while maternal genome alone explained most genetic variation in CSA of fast myofibres (93%, P<0.01). Furthermore, maternal genome independently (M. semimembranosus, 88%, P<0.0001) or in combination (M. supraspinatus, 82%; M. longissimus dorsi, 93%; M. quadriceps femoris, 86%) with nested maternal weight effect (5-6%, P<0.05), was the predominant source of variation for absolute muscle weights. Effects of paternal genome on muscle mass decreased from thoracic to pelvic limb and accounted for all (M. supraspinatus, 97%, P<0.0001) or most (M. longissimus dorsi, 69%, P<0.0001; M. quadriceps femoris, 54%, P<0.001) genetic variation in relative weights. An interaction between maternal and paternal genomes (P<0.01) and effects of maternal weight (P<0.05) on expression of H19, a master regulator of an imprinted gene network, and negative correlations between H19 expression and fetal muscle mass (P<0.001), suggested imprinted genes and miRNA interference as mechanisms for differential effects of maternal and paternal genomes on fetal muscle.	[Xiang, Ruidong; Ghanipoor-Samami, Mani; Eindorf, Tanja; Rutley, David L.; Kruk, Zbigniew A.; Fitzsimmons, Carolyn J.; Thomsen, Dana A.; Anderson, Gail I.; Hiendleder, Stefan] Univ Adelaide, Sch Anim & Vet Sci, JS Davies Nonmendelian Genet Grp, Adelaide, SA 5005, Australia; [Xiang, Ruidong; Ghanipoor-Samami, Mani; Thomsen, Dana A.; Roberts, Claire T.; Hiendleder, Stefan] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Johns, William H.; Greenwood, Paul L.] Univ New England, NSW Dept Primary Ind, Beef Ind Ctr, Armidale, NSW, Australia; [Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Burns, Brian M.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Rockhampton, Qld, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; NSW Department of Primary Industries; University of New England; University of Adelaide; University of Queensland	Hiendleder, S (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, JS Davies Nonmendelian Genet Grp, Roseworthy Campus, Adelaide, SA 5005, Australia.	stefan.hiendleder@adelaide.edu.au	Xiang, Ruidong/A-5773-2015; Xiang, Ruidong/AAF-1071-2020; Greenwood, Paul L/G-9747-2013	Greenwood, Paul L/0000-0002-7719-8233; Roberts, Claire/0000-0002-9250-2192; Xiang, Ruidong/0000-0002-1584-7605	JS Davies Bequest; Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund; China Scholarship Council; University of Adelaide; Iranian Ministry of Science, Research Technology	JS Davies Bequest; Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund(Australian GovernmentDepartment of Agriculture and Water Resources); China Scholarship Council(China Scholarship Council); University of Adelaide; Iranian Ministry of Science, Research Technology	This work was funded by the JS Davies Bequest with support from the Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RX is a recipient of China scholarship and Adelaide University China Fee Scholarship provided by China Scholarship Council and The University of Adelaide. MG-S is recipient of a PhD scholarship from the Iranian Ministry of Science, Research & Technology. SH is a JS Davies Fellow. CTR is a NHMRC Senior Research Fellow (APP1020749). We would like to thank Mick Deland, John Cooper and Struan Research Centre farm staff (SARDI) for animal management, Sarah Truran and David Lines for assistance in fetus collection and Lin Lin for help with figures.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Amen TS, 2007, J ANIM SCI, V85, P365, DOI 10.2527/jas.2005-754; Amen TS, 2007, J ANIM SCI, V85, P373, DOI 10.2527/jas.2005-755; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; ANTHONY RV, 1986, J ANIM SCI, V62, P1375, DOI 10.2527/jas1986.6251375x; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x; Bentzinger C. F., 2012, COLD SPRING HARBOR P, V4; Boysen TJ, 2010, J ANIM SCI, V88, P3167, DOI 10.2527/jas.2009-2565; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Budras K.-D., 2003, BOVINE ANATOMY, V1st; Byrne K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-378; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Canavez FC, 2012, J HERED, V103, P342, DOI 10.1093/jhered/esr153; Carpenter E, 1996, J ANIM SCI, V74, P388; Chang KC, 2007, ANIMAL, V1, P681, DOI 10.1017/S1751731107702070; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cockett N, 2005, GENETICS SELECTION E, V37, P1; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Crist CG, 2009, CELL CYCLE, V8, P3627, DOI 10.4161/cc.8.22.9960; DANIEL PM, 1977, LANCET, V2, P446; DAVIES SM, 1994, CANCER RES, V54, P2560; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Dindot SV, 2004, MAMM GENOME, V15, P966, DOI 10.1007/s00335-004-2407-z; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; DWYER CM, 1994, J ANIM SCI, V72, P911, DOI 10.2527/1994.724911x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Engellandt T, 2002, J ANIM BREED GENET, V119, P154, DOI 10.1046/j.1439-0388.2002.00323.x; FERRELL CL, 1991, J ANIM SCI, V69, P1945, DOI 10.2527/1991.6951945x; FORTIN A, 1987, J AGR SCI, V108, P141, DOI 10.1017/S0021859600064212; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Goodall JJ, 2007, ANIM GENET, V38, P154, DOI 10.1111/j.1365-2052.2007.01576.x; Greenwood PL, 2007, AUST J EXP AGR, V47, P1137, DOI 10.1071/EA06324; Greenwood PL, 2009, J ANIM SCI, V87, P3114, DOI 10.2527/jas.2009-1936; Greenwood PL, 2006, AUST J AGR RES, V57, P1, DOI 10.1071/AR04316; Greenwood PL, 1999, REPROD FERT DEVELOP, V11, P281, DOI 10.1071/RD99054; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Hiendleder S, 2004, BIOL REPROD, V70, P1196, DOI 10.1095/biolreprod.103.023028; Hiendleder S, 2004, REPROD FERT DEVELOP, V17, P204; Jackson SP, 1997, J ANIM SCI, V75, P133; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Larzul C, 1997, J ANIM SCI, V75, P3126; Lee RSF, 2002, GENE, V301, P67, DOI 10.1016/S0378-1119(02)01085-5; Lin WL, 1999, MECH DEVELOP, V82, P195, DOI 10.1016/S0925-4773(99)00009-X; Mannen H, 1998, J ANIM SCI, V76, P36; Mansan Gordo DG, 2012, J ANIMAL SCI; Martyn JK, 2004, ANAT REC PART A, V281A, P1363, DOI 10.1002/ar.a.20140; McLaren RJ, 1999, MAMM GENOME, V10, P588, DOI 10.1007/s003359901050; Merrick D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-65; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NELDER JA, 1994, STAT COMPUT, V4, P221, DOI 10.1007/BF00156745; Neugebauer N, 2010, ANIMAL, V4, P672, DOI 10.1017/S1751731109991625; Neugebauer N, 2010, J ANIM SCI, V88, P523, DOI 10.2527/jas.2009-2026; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nicoll G.B., 1998, P 6 WORLD C GEN APPL, V26, P529, DOI 10.13140/2.1.1379.9684; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Picard B, 1998, HISTOCHEM J, V30, P473, DOI 10.1023/A:1003207922944; PICARD B, 1994, J MUSCLE RES CELL M, V15, P473, DOI 10.1007/BF00122120; Rehfeldt C., 1999, BASIC APPL MYOL, V9, P235; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Relaix F, 2006, CELL MOL LIFE SCI, V63, P1221, DOI 10.1007/s00018-006-6015-9; Reverter A, 2003, AUST J AGR RES, V54, P119, DOI [10.1071/AR02086, 10.1071/AR02088]; Santos VAC, 2007, MEAT SCI, V77, P654, DOI 10.1016/j.meatsci.2007.05.019; Sawitzky M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039711; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810; Seeman E, 1996, AM J PHYSIOL-ENDOC M, V270, pE320, DOI 10.1152/ajpendo.1996.270.2.E320; SEIDEMAN SC, 1986, MEAT SCI, V17, P55, DOI 10.1016/0309-1740(86)90083-5; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Smith T, 2007, J ANIM SCI, V85, P1377, DOI 10.2527/jas.2006-653; Strydom PE, 2010, ANIMAL, V4, P653, DOI 10.1017/S1751731109991479; TOTLAND GK, 1991, ANAT EMBRYOL, V184, P441, DOI 10.1007/BF01236050; UTTARO BE, 1993, J ANIM SCI, V71, P2439, DOI 10.2527/1993.7192439x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WHIPPLE G, 1990, J ANIM SCI, V68, P2716; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561; [No title captured]	92	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53402	10.1371/journal.pone.0053402	http://dx.doi.org/10.1371/journal.pone.0053402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341941	Green Published, gold, Green Accepted			2022-12-27	WOS:000314759400043
J	Zheng, JY; Garg, S; Wang, JR; Loose, DS; Hauer-Jensen, M				Zheng, Junying; Garg, Sarita; Wang, Junru; Loose, David S.; Hauer-Jensen, Martin			Laser Capture Microdissected Mucosa versus Whole Tissue Specimens for Assessment of Radiation-Induced Dynamic Molecular and Pathway Changes in the Small Intestine	PLOS ONE			English	Article							GASTROINTESTINAL-SYNDROME; IONIZING-RADIATION; HAGEMAN-FACTOR; DNA-DAMAGE; ATM; MICE; P53; APOPTOSIS; PROTEIN; PHOSPHORYLATION	Background: The intestinal mucosa is the compartment that sustains the most severe injury in response to radiation and is therefore of primary interest. The use of whole gut extracts for analysis of gene expression may confound important changes in the mucosa. On the other hand, laser capture microdissection (LCM) is hampered by the unstable nature of RNA and by a more complicated collection process. This study assessed, in parallel samples from a validated radiation model, the indications for use of LCM for intestinal gene expression analysis. Methodology/Principal Findings: RNA was extracted from mouse whole intestine and from mucosa by LCM at baseline and 4 h, 24 h, and 3.5 d after total body irradiation and subjected to microarray analysis. Among mucosal genes that were altered >=2-fold, less than 7% were present in the whole gut at 4 and 24 h, and 25% at 3.5 d. As expected, pathway analysis of mucosal LCM samples showed that radiation activated the coagulation system, lymphocyte apoptosis, and tight junction signaling, and caused extensive up-regulation of cell cycle and DNA damage repair pathways. Using similar stringent criteria, regulation of these pathways, with exception of the p53 pathway, was undetectable in the whole gut. Radiation induced a dramatic increase of caspase14 and ectodysplasin A2 receptor (Eda2r), a TNF alpha receptor, in both types of samples. Conclusions/Significance: LCM-isolated mucosal specimens should be used to study cellular injury, cell cycle control, and DNA damage repair pathways. The remarkable increase of caspase14 and Eda2r suggests a novel role for these genes in regulating intestinal radiation injury. Comparative gene expression data from complex tissues should be interpreted with caution.	[Zheng, Junying; Garg, Sarita; Wang, Junru; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Loose, David S.] UTHlth Med Sch, Houston, TX USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Texas System; University of Texas Health Science Center Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Zheng, JY (corresponding author), Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.	jzheng@uams.edu			National Institutes of Health [U19 AI67798, R37 CA71382]; Veterans Administration; NATIONAL CANCER INSTITUTE [R37CA071382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (U19 AI67798 and R37 CA71382 www.nih.gov) and the Veterans Administration (www.va.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABILDGAARD U, 1979, PHYSL INHIBITORS COA, P19; Brosh R, 2010, FEBS LETT, V584, P2473, DOI 10.1016/j.febslet.2010.04.058; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; Garg S, 2010, RADIAT RES, V173, P469, DOI 10.1667/RR1742.1; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; HALE ML, 1984, RADIAT RES, V99, P151, DOI 10.2307/3576453; Hauer-Jensen Martin, 2007, Curr Opin Support Palliat Care, V1, P23, DOI 10.1097/SPC.0b013e3281108014; Keefe Dorothy M K, 2004, Semin Oncol Nurs, V20, P38; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; MANDLE R, 1977, J BIOL CHEM, V252, P6097; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754; NAKAMURA W, 1971, RADIAT RES, V48, P169, DOI 10.2307/3573404; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rau JC, 2011, SEMIN THROMB HEMOST, V37, P339, DOI 10.1055/s-0031-1276582; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; Tanikawa C, 2010, MOL CANCER RES, V8, P855, DOI 10.1158/1541-7786.MCR-09-0484; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X	33	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53711	10.1371/journal.pone.0053711	http://dx.doi.org/10.1371/journal.pone.0053711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341980	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400070
J	Hopfe, M; Deenen, R; Degrandi, D; Kohrer, K; Henrich, B				Hopfe, Miriam; Deenen, Rene; Degrandi, Daniel; Koehrer, Karl; Henrich, Birgit			Host Cell Responses to Persistent Mycoplasmas - Different Stages in Infection of HeLa Cells with Mycoplasma hominis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; INTRACELLULAR LOCATION; IN-VITRO; EXPRESSION; RECEPTOR; PROTEIN; OPPA; ADHERENCE; ADHESION; ATPASE	Mycoplasma hominis is a facultative human pathogen primarily associated with bacterial vaginosis and pelvic inflammatory disease, but it is also able to spread to other sites, leading to arthritis or, in neonates, meningitis. With a minimal set of 537 annotated genes, M. hominis is the second smallest self-replicating mycoplasma and thus an ideal model organism for studying the effects of an infectious agent on its host more closely. M. hominis adherence, colonisation and invasion of HeLa cells were characterised in a time-course study using scanning electron microscopy, confocal microscopy and microarray-based analysis of the HeLa cell transcriptome. At 4 h post infection, cytoadherence of M. hominis to the HeLa cell surface was accompanied by differential regulation of 723 host genes (>2 fold change in expression). Genes associated with immune responses and signal transduction pathways were mainly affected and components involved in cell-cycle regulation, growth and death were highly upregulated. At 48 h post infection, when mycoplasma invasion started, 1588 host genes were differentially expressed and expression of genes for lysosome-specific proteins associated with bacterial lysis was detected. In a chronically infected HeLa cell line (2 weeks), the proportion of intracellular mycoplasmas reached a maximum of 10% and M. hominis-filled protrusions of the host cell membrane were seen by confocal microscopy, suggesting exocytotic dissemination. Of the 1972 regulated host genes, components of the ECM-receptor interaction pathway and phagosome-related integrins were markedly increased. The immune response was quite different to that at the beginning of infection, with a prominent induction of IL1B gene expression, affecting pathways of MAPK signalling, and genes connected with cytokine-cytokine interactions and apoptosis. These data show for the first time the complex, time-dependent reaction of the host directed at mycoplasmal clearance and the counter measures of this pestering pathogen.	[Hopfe, Miriam; Degrandi, Daniel; Henrich, Birgit] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Hopfe, Miriam; Degrandi, Daniel; Henrich, Birgit] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Deenen, Rene; Koehrer, Karl] Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Henrich, B (corresponding author), Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany.	birgit.henrich@uni-duesseldorf.de						Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Axsen WS, 2009, MICROB PATHOGENESIS, V47, P231, DOI 10.1016/j.micpath.2009.08.002; Bengtson SH, 2006, BLOOD, V108, P2055, DOI 10.1182/blood-2006-04-016444; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brechter AB, 2008, BONE, V43, P72, DOI 10.1016/j.bone.2008.02.003; Brumell JH, 2002, CURR BIOL, V12, pR15, DOI 10.1016/S0960-9822(01)00640-6; Butler SE, 2010, PARASITOL RES, V107, P1023, DOI 10.1007/s00436-010-1975-y; Calixto JB, 2000, PAIN, V87, P1, DOI 10.1016/S0304-3959(00)00335-3; Canoz Ozlem, 2002, Pathology & Oncology Research, V8, P262; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Diaz-Garcia FJ, 2006, HUM REPROD, V21, P1591, DOI 10.1093/humrep/del032; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Henrich B, 1999, J BACTERIOL, V181, P4873, DOI 10.1128/JB.181.16.4873-4878.1999; HENRICH B, 1993, INFECT IMMUN, V61, P2945, DOI 10.1128/IAI.61.7.2945-2951.1993; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hopfe M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-185; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; Kaman WE, 2009, MED MICROBIOL IMMUN, V198, P39, DOI 10.1007/s00430-008-0103-4; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang EH, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2797; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kitzerow A, 1999, J MED MICROBIOL, V48, P485, DOI 10.1099/00222615-48-5-485; Lam GY, ADV IMMUNOL, V113, P7; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; MacKenzie CR, 2010, INT J INFECT DIS, V14, pE307, DOI 10.1016/j.ijid.2010.02.2253; Mobius N, 2012, METHODS MOL BIOL, V903, P235, DOI 10.1007/978-1-61779-937-2_15; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; OLSON LD, 1993, J BACTERIOL, V175, P3224, DOI 10.1128/JB.175.10.3224-3227.1993; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poveda JB, 1998, METH MOL B, V104, P105; Rappelli P, 1998, LANCET, V352, P1286, DOI 10.1016/S0140-6736(98)00041-5; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Sato H, 2012, INTERNAL MED, V51, P425, DOI 10.2169/internalmedicine.51.6058; Scott K, 2005, IMMUNOLOGY, V116, P245, DOI 10.1111/j.1365-2567.2005.02218.x; Shin HS, 2011, FEMS IMMUNOL MED MIC, V63, P418, DOI 10.1111/j.1574-695X.2011.00868.x; Targosz A, 2006, J PHYSIOL PHARMACOL, V57, P265; TAYLORROBINSON D, 1991, INT J EXP PATHOL, V72, P705; Vancini RG, 2008, ARCH MICROBIOL, V189, P7, DOI 10.1007/s00203-007-0288-8; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000	52	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54219	10.1371/journal.pone.0054219	http://dx.doi.org/10.1371/journal.pone.0054219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326599	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800116
J	Vera-Ramirez, L; Sanchez-Rovira, P; Ramirez-Tortosa, CL; Quiles, JL; Ramirez-Tortosa, M; Lorente, JA				Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Ramirez-Tortosa, Cesar L.; Quiles, Jose L.; Ramirez-Tortosa, MCarmen; Lorente, Jose A.			Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer Chemoresistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY-GLAND DEVELOPMENT; KEY SIGNALING NODES; STEM-CELLS; HYPOXIA; EXPRESSION; RESISTANCE; THERAPY; CHEMOTHERAPY; PROGRESSION	Background: Distant recurrences after antineoplastic treatment remain a serious problem for breast cancer clinical management, which threats patients' life. Systemic therapy is administered to eradicate cancer cells from the organism, both at the site of the primary tumor and at any other potential location. Despite this intervention, a significant proportion of breast cancer patients relapse even many years after their primary tumor has been successfully treated according to current clinical standards, evidencing the existence of a chemoresistant cell subpopulation originating from the primary tumor. Methods/Findings: To identify key molecules and signaling pathways which drive breast cancer chemoresistance we performed gene expression analysis before and after anthracycline and taxane-based chemotherapy and compared the results between different histopathological response groups (good-, mid- and bad-response), established according to the Miller & Payne grading system. Two cohorts of 33 and 73 breast cancer patients receiving neoadjuvant chemotherapy were recruited for whole-genome expression analysis and validation assay, respectively. Identified genes were subjected to a bioinformatic analysis in order to ascertain the molecular function of the proteins they encode and the signaling in which they participate. High throughput technologies identified 65 gene sequences which were over-expressed in all groups (P <= 0.05 Bonferroni test). Notably we found that, after chemotherapy, a significant proportion of these genes were over-expressed in the good responders group, making their tumors indistinguishable from those of the bad responders in their expression profile (P <= 0.05 Benjamini-Hochgergs method). Conclusions: These data identify a set of key molecular pathways selectively up-regulated in post-chemotherapy cancer cells, which may become appropriate targets for the development of future directed therapies against breast cancer.	[Vera-Ramirez, Laura; Sanchez-Rovira, Pedro] Complejo Hosp Jaen, Dept Oncol, Jaen, Spain; [Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Lorente, Jose A.] Pfizer Univ Granada, GENyO Ctr, Granada, Spain; [Vera-Ramirez, Laura; Sanchez-Rovira, Pedro; Lorente, Jose A.] Andalusian Govt Ctr Genom & Oncol, Granada, Spain; [Ramirez-Tortosa, Cesar L.] Complejo Hosp Jaen, Dept Pathol, Jaen, Spain; [Quiles, Jose L.; Ramirez-Tortosa, MCarmen] Biomed Res Ctr CIBM, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Quiles, Jose L.] Univ Granada, Dept Physiol, Granada, Spain; [Ramirez-Tortosa, MCarmen] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Lorente, Jose A.] Univ Granada, Dept Legal Med, Granada, Spain	Complejo Hospitalario de Jaen; Pfizer; University of Granada; Complejo Hospitalario de Jaen; University of Granada; University of Granada; University of Granada	Vera-Ramirez, L (corresponding author), Complejo Hosp Jaen, Dept Oncol, Jaen, Spain.	laura.vera@genyo.es	Quiles, José L./C-6911-2013; Ramirez, Laura Vera/S-3375-2018; Ramírez-Tortosa, César/F-2055-2016; LORENTE, JOSE A./B-8372-2008	Quiles, José L./0000-0002-9048-9086; Ramirez, Laura Vera/0000-0001-9184-9875; Ramírez-Tortosa, César/0000-0002-3302-707X; LORENTE, JOSE A./0000-0002-9892-7386	Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE) [20072013, CTS-5350]; Ministerio de Sanidad [PN de I+D+i 20062009/ISCIII]; Servicios Sociales e Igualdad (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PI06/90388]	Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Servicios Sociales e Igualdad (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union	Thanks are due to the Consejeria de Economia, Innovacion y Ciencia (CEIC) from the Junta de Andalucia and Fondo Europeo de Desarrollo Regional (FEDER)/Fondo de Cohesion Europeo (FSE) to financial support through the Programa Operativo FEDER/FSE de Andalucia 20072013 and the research project CTS-5350. The authors also acknowledge financial support by the PN de I+D+i 20062009/ISCIII/Ministerio de Sanidad, Servicios Sociales e Igualdad (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union, through the research project PI06/90388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang HR, 2010, CANCER-AM CANCER SOC, V116, P2856, DOI 10.1002/cncr.25120; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Derleth C, 2010, CLIN BREAST CANCER, V10, pE23, DOI 10.3816/CBC.2010.s.004; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Drury S, 2009, DIAGN MOL PATHOL, V18, P103, DOI 10.1097/PDM.0b013e31817c1ae2; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Gazzaniga P, 2010, INT J CANCER, V126, P2437, DOI 10.1002/ijc.24953; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gradilone A, 2011, ANN ONCOL, V22, P86, DOI 10.1093/annonc/mdq323; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kakarala M, 2007, CANCER J, V13, P271, DOI 10.1097/PPO.0b013e318156da4e; Ke X, 2012, CARCINOGENESIS, V33, P1598, DOI 10.1093/carcin/bgs196; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Otto T, 2008, ENDOCRINOLOGY, V149, P2241, DOI 10.1210/en.2007-1238; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; Vera-Ramirez L, 2011, CRIT REV ONCOL HEMAT, V80, P347, DOI 10.1016/j.critrevonc.2011.01.004; Vera-Ramirez L, 2010, CANCER TREAT REV, V36, P477, DOI 10.1016/j.ctrv.2010.02.017; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Walther Z, 2011, CANCER J, V17, P71, DOI 10.1097/PPO.0b013e318212dd6d; Weigelt B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2734; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53983	10.1371/journal.pone.0053983	http://dx.doi.org/10.1371/journal.pone.0053983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326553	Green Submitted, gold, Green Published			2022-12-27	WOS:000313552400066
J	Wilkinson, AV; Swartz, MD; Yu, XY; Spitz, MR; Shete, S				Wilkinson, Anna V.; Swartz, Michael D.; Yu, Xiaoying; Spitz, Margaret R.; Shete, Sanjay			Cigarette Experimentation and the Population Attributable Fraction for Associated Genetic and Non-Genetic Risk Factors	PLOS ONE			English	Article							COGNITIVE SUSCEPTIBILITY; SMOKING; ADOLESCENTS; INITIATION; NICOTINE; EVENTS	Background: We, and others, have shown that experimenting with cigarettes is a function of both non-genetic and genetic factors. In this analysis we ask: how much of the total risk of experimenting with cigarettes, among those who had not experimented with cigarettes when they enrolled in a prospective cohort, is attributable to genetic factors and to non-genetic factors? Methods: Participants (N = 1,118 Mexican origin youth), recruited from a large population-based cohort study in Houston, Texas, provided prospective data on cigarette experimentation over three years. Non-genetic data were elicited twice - baseline and follow-up. Participants were genotyped for 672 functional and tagging variants in the dopamine, serotonin and opioid pathways. Results: In the overall model, the adjusted combined non-genetic PAF was 71.2% and the adjusted combined genetic PAF was 58.5%. Among committed never smokers the adjusted combined non-genetic PAF was 67.0% and the adjusted combined genetic PAF was 53.5%. However, among cognitively susceptible youth, the adjusted combined non-genetic PAF was 52.0% and the adjusted combined genetic PAF was 68.4%. Conclusions: Our results suggest there may be differences in genotypes between youth who think they will try cigarettes in the future compared to their peers who think they will not and underscore the possibility that the relative influence of genetic vs. non-genetic factors on the uptake of smoking may vary between these two groups of youth. Impact: A clearer understanding of the relative role of genetic vs. non- genetic factors in the uptake of smoking may have implications for the design of prevention programs.	[Wilkinson, Anna V.] Univ Texas Sch Publ Hlth, Austin, TX USA; [Swartz, Michael D.; Yu, Xiaoying] Univ Texas Sch Publ Hlth, Houston, TX USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Wilkinson, AV (corresponding author), Univ Texas Sch Publ Hlth, Austin Reg Campus, Austin, TX USA.	Anna.V.Wilkinson@uth.tmc.edu	Swartz, Michael/AEX-2820-2022	Yu, Xiaoying/0000-0003-1659-2365; Swartz, Michael/0000-0003-3953-8775; Wilkinson, Anna/0000-0002-1805-8863	National Cancer Institute grants [CA105203, CA123109, CA126988]; Caroline W. Law Fund for Cancer Prevention; Dan Duncan Family Institute for Risk Assessment and Cancer Prevention; NATIONAL CANCER INSTITUTE [K07CA126988, P30CA016672, R01CA105203, K07CA123109] Funding Source: NIH RePORTER	National Cancer Institute grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Caroline W. Law Fund for Cancer Prevention; Dan Duncan Family Institute for Risk Assessment and Cancer Prevention; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the National Cancer Institute grants [CA105203 to M.R.S., CA123109 to M.D.S., CA126988 to A.V.W.]; funds collected pursuant to the Comprehensive Tobacco Settlement of 1998 and appropriated by the 76th legislature to The University of Texas M.D. Anderson Cancer Center; by the Caroline W. Law Fund for Cancer Prevention, and by the Dan Duncan Family Institute for Risk Assessment and Cancer Prevention. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady AR, 1998, STATA TECHNICAL B, P8; Burt RD, 2000, PREV MED, V30, P115, DOI 10.1006/pmed.1999.0605; Dalton MA, 1999, PREV MED, V29, P460, DOI 10.1006/pmed.1999.0582; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Jackson C, 1998, PREV MED, V27, P129, DOI 10.1006/pmed.1997.0255; Levine Beverly, 2007, Prev Chronic Dis, V4, pA14; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; MURRAY DM, 1987, ADDICT BEHAV, V12, P7, DOI 10.1016/0306-4603(87)90003-7; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Spelman AR, 2009, CANCER EPIDEM BIOMAR, V18, P3459, DOI 10.1158/1055-9965.EPI-09-0765; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wilkinson AV, 2012, CANCER EPIDEM BIOMAR, V21, P228, DOI 10.1158/1055-9965.EPI-11-0456; Wilkinson AV, 2009, CANCER EPIDEM BIOMAR, V18, P3435, DOI 10.1158/1055-9965.EPI-09-0766; Wilkinson AV, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-337; Wilkinson AV, 2005, AM J PUBLIC HEALTH, V95, P1043, DOI 10.2105/AJPH.2004.055319; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53868	10.1371/journal.pone.0053868	http://dx.doi.org/10.1371/journal.pone.0053868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342024	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700056
J	Lenarduzzi, M; Hui, ABY; Alajez, NM; Shi, W; Williams, J; Yue, SJ; O'Sullivan, B; Liu, FF				Lenarduzzi, Michelle; Hui, Angela B. Y.; Alajez, Nehad M.; Shi, Wei; Williams, Justin; Yue, Shijun; O'Sullivan, Brian; Liu, Fei-Fei			MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; SOMATIC MUTATIONS; EXPRESSION; HEAD; CANCER; GENE; IDENTIFICATION; DOMAIN; RAS; ACTIVATION	Despite improvements in therapeutic approaches for head and neck squamous cell carcinomas (HNSCC), clinical outcome has remained disappointing, with 5-year overall survival rates hovering around 40-50%, underscoring an urgent need to better understand the biological bases of this disease. We chose to address this challenge by studying the role of microRNAs (miRNAs) in HNSCC. MiR-193b was identified as an over-expressed miRNA from global miRNA profiling studies previously conducted in our lab, and confirmed in HNSCC cell lines. In vitro knockdown of miR-193b in FaDu cancer cells substantially reduced cell proliferation, migration and invasion, along with suppressed tumour formation in vivo. By integrating in silico prediction algorithms with in vitro experimental mRNA profilings, plus mRNA expression data of clinical specimens, neurofibromin 1 (NF1) was identified to be a target of miR-193b. Concordantly, miR-193b knockdown decreased NF1 transcript and protein levels significantly. Luciferase reporter assays confirmed the direct interaction of miR-193b with NF1. Moreover, p-ERK, a downstream target of NF1 was also suppressed after miR-193b knockdown. FaDu cells treated with a p-ERK inhibitor (U0126) phenocopied the reduced cell proliferation, migration and invasion observed with miR-193b knockdown. Finally, HNSCC patients whose tumours expressed high levels of miR-193b experienced a lower disease-free survival compared to patients with low miR-193b expression. Our findings identified miR-193b as a potentially novel prognostic marker in HNSCC that drives tumour progression via down-regulating NF1, in turn leading to activation of ERK, resulting in proliferation, migration, invasion, and tumour formation.	[Lenarduzzi, Michelle; Hui, Angela B. Y.; Shi, Wei; Williams, Justin; Yue, Shijun; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Lenarduzzi, Michelle; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Alajez, Nehad M.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [O'Sullivan, Brian; Liu, Fei-Fei] Univ Hlth Network, Radiat Med Program, Toronto, ON, Canada; [O'Sullivan, Brian; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; King Saud University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca		Alajez, Nehad/0000-0002-1546-1091; Spence, Tara/0000-0001-7098-4103; O'Sullivan, Brian/0000-0001-8887-843X; Liu, Fei-Fei/0000-0003-4344-6486	Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)	Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Michelle Lenarduzzi is a recipient of a scholarship from the Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR). This scholarship has provided funding to this project. The authors also gratefully acknowledge the philanthropic support from the Wharton Family, Joe's Team, and Gordon Tozer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Boston SR, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-7; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cummings B, 2007, RADIOTHER ONCOL, V85, P7, DOI 10.1016/j.radonc.2007.09.010; Ferlay J, 2008, IARC CANCERBASE; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PEKKOLAHEINO K, 1992, HEAD NECK-J SCI SPEC, V14, P196, DOI 10.1002/hed.2880140306; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; Thiel G, 1995, ANTICANCER RES, V15, P2495; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Unno K, 2009, LEUKEMIA LYMPHOMA, V50, P1865, DOI 10.3109/10428190903221010; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wood PA, 2009, INTEGR CANCER THER, V8, P303, DOI 10.1177/1534735409355292; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298	54	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53765	10.1371/journal.pone.0053765	http://dx.doi.org/10.1371/journal.pone.0053765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335975	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700031
J	Costechareyre, D; Chich, JF; Strub, JM; Rahbe, Y; Condemine, G				Costechareyre, Denis; Chich, Jean-Francois; Strub, Jean-Marc; Rahbe, Yvan; Condemine, Guy			Transcriptome of Dickeya dadantii Infecting Acyrthosiphon pisum Reveals a Strong Defense against Antimicrobial Peptides	PLOS ONE			English	Article							BACTERIUM ERWINIA-CHRYSANTHEMI; ESCHERICHIA-COLI; PEA APHID; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; GLOBAL REGULATOR; SENSOR KINASE; SALMONELLA; EXPRESSION; PATHOGENICITY	The plant pathogenic bacterium Dickeya dadantii has recently been shown to be able to kill the aphid Acyrthosiphon pisum. While the factors required to cause plant disease are now well characterized, those required for insect pathogeny remain mostly unknown. To identify these factors, we analyzed the transcriptome of the bacteria isolated from infected aphids. More than 150 genes were upregulated and 300 downregulated more than 5-fold at 3 days post infection. No homologue to known toxin genes could be identified in the upregulated genes. The upregulated genes reflect the response of the bacteria to the conditions encountered inside aphids. While only a few genes involved in the response to oxidative stress were induced, a strong defense against antimicrobial peptides (AMP) was induced. Expression of a great number of efflux proteins and transporters was increased. Besides the genes involved in LPS modification by addition of 4-aminoarabinose (the arnBCADTEF operon) and phosphoethanolamine (pmrC, eptB) usually induced in Gram negative bacteria in response to AMPs, dltBAC and pbpG genes, which confer Gram positive bacteria resistance to AMPs by adding alanine to teichoic acids, were also induced. Both types of modification confer D. dadantii resistance to the AMP polymyxin. A. pisum harbors symbiotic bacteria and it is thought that it has a very limited immune system to maintain these populations and do not synthesize AMPs. The arnB mutant was less pathogenic to A. pisum, which suggests that, in contrast to what has been supposed, aphids do synthesize AMP.	[Costechareyre, Denis; Rahbe, Yvan; Condemine, Guy] Univ Lyon, Lyon, France; [Costechareyre, Denis; Condemine, Guy] Univ Lyon 1, F-69622 Villeurbanne, France; [Costechareyre, Denis; Condemine, Guy] CNRS, Microbiol Adaptat & Pathogenie UMR5240, Villeurbanne, France; [Costechareyre, Denis; Rahbe, Yvan; Condemine, Guy] INSA Lyon, Villeurbanne, France; [Chich, Jean-Francois] INRA, Sante Vigne & Qualite Vin UMR1131, Colmar, France; [Strub, Jean-Marc] Univ Strasbourg, CNRS, UMR7178, Lab Spectrometrie Masse BioOrgan,IPHC,DSA, Strasbourg, France; [Rahbe, Yvan] INRA, Biol Fonct Insectes & Interact UMR203, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Condemine, G (corresponding author), Univ Lyon, Lyon, France.	guy.condemine@insa-lyon.fr	Rahbe, Yvan/B-9389-2009	Rahbe, Yvan/0000-0002-0074-4443; Condemine, Guy/0000-0002-3256-3815; COSTECHAREYRE, Denis/0000-0002-9258-7421; Strub, Jean-Marc/0000-0001-6224-3428	ANR-Genoplante grant;  [ANR07GPLA002-Aphicibles]	ANR-Genoplante grant(French National Research Agency (ANR)); 	This study was funded by an ANR-Genoplante grant to GC, including a post-doctoral fellowship to DC, coordinated by YR (ANR07GPLA002-Aphicibles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; BARDONNET N, 1991, FEMS MICROBIOL LETT, V84, P97, DOI 10.1016/0378-1097(91)90402-V; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Charles H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029096; Condemine G, 2000, J BACTERIOL, V182, P1340, DOI 10.1128/JB.182.5.1340-1345.2000; Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07; Costechareyre D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030702; Costechareyre D, 2010, ENVIRON MICROBIOL, V12, P3290, DOI 10.1111/j.1462-2920.2010.02305.x; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Llama-Palacios A, 2005, J BACTERIOL, V187, P2157, DOI 10.1128/JB.187.6.2157-2162.2005; Mahajan-Miklos S, 2000, MOL MICROBIOL, V37, P981, DOI 10.1046/j.1365-2958.2000.02056.x; Moule MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001065; Nasser W, 2001, MOL PLANT MICROBE IN, V14, P10, DOI 10.1094/MPMI.2001.14.1.10; Oshima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023242; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pontes MH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002349; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; RESIBOIS A, 1984, VIROLOGY, V137, P102, DOI 10.1016/0042-6822(84)90013-8; Reverchon S, 1997, J BACTERIOL, V179, P3500, DOI 10.1128/jb.179.11.3500-3508.1997; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Rio-Alvarez I, 2012, MOL PLANT MICROBE IN, V25, P523, DOI 10.1094/MPMI-09-11-0247; ROEDER DL, 1985, J BACTERIOL, V164, P51, DOI 10.1128/JB.164.1.51-56.1985; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Shandala T, 2011, J CELL SCI, V124, P2165, DOI 10.1242/jcs.080598; Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulvila J., 2011, J LEUKOCYTE BIOL, V89, P649, DOI [10.1189/jlb.0410195, DOI 10.1189/jlb.0410195]; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; Valecillos AM, 2006, MOL PLANT MICROBE IN, V19, P607, DOI 10.1094/MPMI-19-0607; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	54	20	21	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54118	10.1371/journal.pone.0054118	http://dx.doi.org/10.1371/journal.pone.0054118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342088	Green Published, gold			2022-12-27	WOS:000314759400123
J	Daebeler, A; Gansen, M; Frenzel, P				Daebeler, Anne; Gansen, Martina; Frenzel, Peter			Methyl Fluoride Affects Methanogenesis Rather than Community Composition of Methanogenic Archaea in a Rice Field Soil	PLOS ONE			English	Article							RESTRICTION-FRAGMENT-LENGTH; STABLE-ISOTOPE FRACTIONATION; METHANE OXIDATION; ACETOCLASTIC METHANOGENESIS; CH4 PRODUCTION; MCRA GENES; INHIBITION; CARBON; RHIZOSPHERE; EMISSION	The metabolic pathways of methane formation vary with environmental conditions, but whether this can also be linked to changes in the active archaeal community structure remains uncertain. Here, we show that the suppression of aceticlastic methanogenesis by methyl fluoride (CH3F) caused surprisingly little differences in community composition of active methanogenic archaea from a rice field soil. By measuring the natural abundances of carbon isotopes we found that the effective dose for a 90% inhibition of aceticlastic methanogenesis in anoxic paddy soil incubations was <0.75% CH3F (v/v). The construction of clone libraries as well as t-RFLP analysis revealed that the active community, as indicated by mcrA transcripts (encoding the alpha subunit of methyl-coenzyme M reductase, a key enzyme for methanogenesis), remained stable over a wide range of CH3F concentrations and represented only a subset of the methanogenic community. More precisely, Methanocellaceae were of minor importance, but Methanosarcinaceae dominated the active population, even when CH3F inhibition only allowed for aceticlastic methanogenesis. In addition, we detected mcrA gene fragments of a so far unrecognised phylogenetic cluster. Transcription of this phylotype at methyl fluoride concentrations suppressing aceticlastic methanogenesis suggests that the respective organisms perform hydrogenotrophic methanogenesis. Hence, the application of CH3F combined with transcript analysis is not only a useful tool to measure and assign in situ acetate usage, but also to explore substrate usage by as yet uncultivated methanogens.	[Daebeler, Anne; Gansen, Martina; Frenzel, Peter] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany; [Daebeler, Anne] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Frenzel, P (corresponding author), Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany.	frenzel@mpi-marburg.mpg.de	Daebeler, Anne/AAP-1274-2021; KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; Daebeler, Anne/0000-0001-8026-3297	Deutsche Forschungsgemeinschaft; Riks Laanbroek (NIOO-KNAW)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Riks Laanbroek (NIOO-KNAW)	Work has been carried out at the Max Planck Institute for Terrestrial Microbiology, Marburg, Germany. AD's work on this project was funded by a grant of Deutsche Forschungsgemeinschaft to PF as part of the framework 'Biogeochemistry of paddy soil evolution', and further supported by Riks Laanbroek (NIOO-KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; BANKER BC, 1995, AGR ECOSYST ENVIRON, V53, P243, DOI 10.1016/0167-8809(94)00578-3; Bodelier PLE, 1999, APPL ENVIRON MICROB, V65, P1826; Bodelier PLE, 2000, BIOGEOCHEMISTRY, V51, P225, DOI 10.1023/A:1006438802362; Boeckx P, 1997, SOIL SCI SOC AM J, V61, P1250, DOI 10.2136/sssaj1997.03615995006100040035x; Bukovska P, 2010, J MICROBIOL METH, V82, P223, DOI 10.1016/j.mimet.2010.06.007; Cheng YQ, 2009, GEODERMA, V151, P31, DOI 10.1016/j.geoderma.2009.03.016; Chin KJ, 2004, MICROB ECOL, V47, P59, DOI 10.1007/s00248-003-2014-7; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 1999, FEMS MICROBIOL ECOL, V30, P47, DOI 10.1111/j.1574-6941.1999.tb00634.x; Conrad R, 2000, FEMS MICROBIOL ECOL, V34, P27, DOI 10.1111/j.1574-6941.2000.tb00751.x; Conrad R., 2002, FLOODED SOILS, P1316; Conrad R, 2008, GLOBAL CHANGE BIOL, V14, P657, DOI 10.1111/j.1365-2486.2007.01516.x; Conrad R, 2007, LIMNOL OCEANOGR, V52, P1393, DOI 10.4319/lo.2007.52.4.1393; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; EPP MA, 1993, J GEOPHYS RES-ATMOS, V98, P18413, DOI 10.1029/93JD01667; Frenzel P, 1996, FEMS MICROBIOL ECOL, V21, P25; GELWICKS JT, 1989, ORG GEOCHEM, V14, P441, DOI 10.1016/0146-6380(89)90009-0; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Heilman MA, 2001, BIOGEOCHEMISTRY, V52, P207, DOI 10.1023/A:1006427712846; HENNIGAN AN, 1994, MOL MICROBIOL, V11, P655, DOI 10.1111/j.1365-2958.1994.tb00344.x; Ho A, 2011, ENV MICROBIOL REP, V3, P738, DOI 10.1111/j.1758-2229.2011.00292.x; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; Jerman V, 2009, BIOGEOSCIENCES, V6, P1127, DOI 10.5194/bg-6-1127-2009; Jia ZJ, 2001, PLANT SOIL, V230, P211, DOI 10.1023/A:1010366631538; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; King GM, 1996, APPL ENVIRON MICROB, V62, P4548, DOI 10.1128/AEM.62.12.4548-4555.1996; Kotiaho M, 2010, BIOL FERT SOILS, V46, P567, DOI 10.1007/s00374-010-0461-0; Krause S, 2010, ISME J, V4, P1603, DOI 10.1038/ismej.2010.82; Kruger M, 2005, FEMS MICROBIOL ECOL, V51, P323, DOI 10.1016/j.femsec.2004.09.004; Kruger M, 2002, GLOBAL CHANGE BIOL, V8, P265, DOI 10.1046/j.1365-2486.2002.00476.x; Liu Y, 2010, HDB HYDROCARB LIPID, P595, DOI [10.1007/978-3-540-77587-4, DOI 10.1007/978-3-540-77587-4]; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Ma K, 2012, APPL ENVIRON MICROB, V78, P445, DOI 10.1128/AEM.06934-11; Metje M, 2005, APPL ENVIRON MICROB, V71, P8191, DOI 10.1128/AEM.71.12.8191-8200.2005; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Moosavi SC, 1998, J GEOPHYS RES-ATMOS, V103, P29093, DOI 10.1029/97JD03519; Oksanen J., 2016, R PACKAG; OREMLAND RS, 1988, ADV MICROB ECOL, V10, P285; OREMLAND RS, 1992, APPL ENVIRON MICROB, V58, P2983, DOI 10.1128/AEM.58.9.2983-2992.1992; Penning H, 2006, APPL ENVIRON MICROB, V72, P178, DOI 10.1128/AEM.72.1.178-184.2006; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; Popp TJ, 2000, BIOGEOCHEMISTRY, V51, P259, DOI 10.1023/A:1006452609284; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; Reiche M, 2008, FEMS MICROBIOL ECOL, V65, P88, DOI 10.1111/j.1574-6941.2008.00523.x; Ritz C, 2005, J STAT SOFTW, V12, P1; Roy R, 1997, FEMS MICROBIOL ECOL, V24, P311, DOI 10.1111/j.1574-6941.1997.tb00448.x; Sakai S, 2010, INT J SYST EVOL MICR, V60, P2918, DOI 10.1099/ijs.0.020883-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; vanderGon HACD, 1996, BIOL FERT SOILS, V22, P359, DOI 10.1007/BF00334584; Watanabe T, 2009, SOIL BIOL BIOCHEM, V41, P276, DOI 10.1016/j.soilbio.2008.10.025; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wissing L, 2011, CATENA, V87, P376, DOI 10.1016/j.catena.2011.07.007; Wu LQ, 2009, MICROB ECOL, V58, P819, DOI 10.1007/s00248-009-9554-4	64	18	18	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53656	10.1371/journal.pone.0053656	http://dx.doi.org/10.1371/journal.pone.0053656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341965	Green Published, gold			2022-12-27	WOS:000314759400059
J	Nilsson, RE; Ross, T; Bowman, JP; Britz, ML				Nilsson, Rolf E.; Ross, Tom; Bowman, John P.; Britz, Margaret L.			MudPIT Profiling Reveals a Link between Anaerobic Metabolism and the Alkaline Adaptive Response of Listeria monocytogenes EGD-e	PLOS ONE			English	Article							ESCHERICHIA-COLI; STRINGENT RESPONSE; BACILLUS-SUBTILIS; PH HOMEOSTASIS; STRESS; GROWTH; ACID; IDENTIFICATION; STARVATION; TOLERANCE	Listeria monocytogenes is a foodborne human pathogen capable of causing life-threatening disease in susceptible populations. Previous proteomic analysis we performed demonstrated that different strains of L. monocytogenes initiate a stringent response when subjected to alkaline growth conditions. Here, using multidimensional protein identification technology (MudPIT), we show that in L. monocytogenes EGD-e this response involves an energy shift to anaerobic pathways in response to the extracellular pH environment. Importantly we show that this supports a reduction in relative lag time following an abrupt transition to low oxygen tension culture conditions. This has important implications for the packaging of fresh and ready-to-eat foods under reduced oxygen conditions in environments where potential exists for alkaline adaptation.	[Nilsson, Rolf E.; Ross, Tom; Bowman, John P.; Britz, Margaret L.] Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Sch Agr Sci, Hobart, Tas, Australia	University of Tasmania	Nilsson, RE (corresponding author), Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Sch Agr Sci, Hobart, Tas, Australia.	nilssonr@utas.edu.au	Bowman, John P/C-2414-2014; Britz, Margaret L/J-7632-2014; Bowman, John P./ABF-5108-2020	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Ross, Tom/0000-0001-9916-7772	Food Safety Centre, University of Tasmania; Australian National Food Industry Strategy	Food Safety Centre, University of Tasmania; Australian National Food Industry Strategy	This work was supported by the Food Safety Centre, University of Tasmania and the Australian National Food Industry Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS B, 2004, ESSENTIAL CELL BIOL, P119; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; BARRY AL, 1967, APPL MICROBIOL, V15, P1138, DOI 10.1128/AEM.15.5.1138-1141.1967; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bremer H, 1996, MODULATION CHEM COMP; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Chaturongakul S, 2006, APPL ENVIRON MICROB, V72, P5197, DOI 10.1128/AEM.03058-05; Christensen DP, 1999, APPL ENVIRON MICROB, V65, P2112; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; DANESHVAR MI, 1989, CAN J MICROBIOL, V35, P786, DOI 10.1139/m89-131; Delahunty C, 2005, METHODS, V35, P248, DOI 10.1016/j.ymeth.2004.08.016; Delahunty CM, 2007, BIOTECHNIQUES, V43, P563; Ebersbach T, 2010, INT J FOOD MICROBIOL, V140, P218, DOI 10.1016/j.ijfoodmicro.2010.03.030; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Gardan R, 2003, APPL ENVIRON MICROB, V69, P3137, DOI 10.1128/AEM.69.6.3137-3143.2003; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Giotis ES, 2007, INT J FOOD MICROBIOL, V120, P250, DOI 10.1016/j.ijfoodmicro.2007.08.036; Giotis ES, 2007, APPL ENVIRON MICROB, V73, P997, DOI 10.1128/AEM.00865-06; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hong Y, 2010, BIOTECHNOL BIOENG, V105, P965, DOI 10.1002/bit.22606; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; ITO M, 1983, J BACTERIOL, V153, P310, DOI 10.1128/JB.153.1.310-315.1983; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Lungu B, 2009, ANAEROBE, V15, P7, DOI 10.1016/j.anaerobe.2008.08.001; Lungu B, 2010, FOODBORNE PATHOG DIS, V7, P499, DOI 10.1089/fpd.2009.0408; MARR AG, 1991, MICROBIOL REV, V55, P316, DOI 10.1128/MMBR.55.2.316-333.1991; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06; Nilsson RE, 2012, FOOD MICROBIOL, V30, P187, DOI 10.1016/j.fm.2011.10.004; Nilsson RE, 2011, INT J FOOD MICROBIOL, V150, P14, DOI 10.1016/j.ijfoodmicro.2011.07.012; Ofer A, 2011, J BACTERIOL, V193, P2931, DOI 10.1128/JB.01405-10; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Romick TL, 1996, APPL ENVIRON MICROB, V62, P304, DOI 10.1128/AEM.62.1.304-307.1996; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shabala L, 2002, INT J FOOD MICROBIOL, V75, P89, DOI 10.1016/S0168-1605(01)00740-1; Sleator RD, 2003, APPL ENVIRON MICROB, V69, P1, DOI 10.1128/AEM.69.1.1-9.2003; Sokal R.R., 2012, BIOMETRY; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Tienungoon S, 2000, APPL ENVIRON MICROB, V66, P4979, DOI 10.1128/AEM.66.11.4979-4987.2000; TRIVETT TL, 1971, J BACTERIOL, V107, P770, DOI 10.1128/JB.107.3.770-779.1971; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	49	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54157	10.1371/journal.pone.0054157	http://dx.doi.org/10.1371/journal.pone.0054157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342094	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400126
J	Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, MM; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Capobianchi, MR; Perno, CF				Svicher, Valentina; Cento, Valeria; Rozera, Gabriella; Abbate, Isabella; Santoro, Maria Mercedes; Armenia, Daniele; Fabeni, Lavinia; Bruselles, Alessandro; Latini, Alessandra; Palamara, Guido; Micheli, Valeria; Rizzardini, Giuliano; Gori, Caterina; Forbici, Federica; Ippolito, Giuseppe; Andreoni, Massimo; Antinori, Andrea; Ceccherini-Silberstein, Francesca; Capobianchi, Maria Rosaria; Perno, Carlo Federico			The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing	PLOS ONE			English	Article							CORECEPTOR USAGE; TROPISM; MARAVIROC; LOOP; IMPACT; GP120; TOOLS; 1ST	Objective: The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the likelihood that a V3-sequence is falsely predicted as CXCR4-using. We evaluated the correlation between FPR obtained by V3 population-sequencing and the burden of CXCR4-using variants detected by V3 ultra-deep sequencing (UDPS) and Enhanced-Sensitivity Trofile assay (ESTA). Methods: 54 HIV-1 B-subtype infected-patients (all maraviroc-naive), with viremia >10,000copies/ml, were analyzed. HIV-tropism was assessed by V3 population-sequencing, UDPS (considering variants with >0.5% prevalence), and ESTA. Results: By UDPS, CCR5-using variants were detected in 53/54 patients, irrespective of FPR values, and their intra-patient prevalence progressively increased by increasing the FPR obtained by V3 population-sequencing (rho = 0.75, p = 5.0e-8). Conversely, the intra-patient prevalence of CXCR4-using variants in the 54 patients analyzed progressively decreased by increasing the FPR (rho = -0.61; p = 9.3e-6). Indeed, no CXCR4-using variants were detected in 13/13 patients with FPR>60. They were present in 7/18 (38.8%) patients with FPR 20-60 (intra-patient prevalence range: 2.1%-18.4%), in 5/7 (71.4%) with FPR 10-20, in 4/6 (66.7%) with FPR 5-10, and in 10/10(100%) with FPR<5 (intra-patient prevalence range: 12.1%-98.1%). Conclusions: FPR by V3 population-sequencing can predict the burden of CXCR4-using variants. This information can be used to optimize the management of tropism determination in clinical practice. Due to its low cost and short turnaround time, V3 population-sequencing may represent the most feasible test for HIV-1 tropism determination. More sensitive methodologies (as UDPS) might be useful when V3 population-sequencing provides a FPR >20 (particularly in the range 20-60), allowing a more careful identification of patients harboring CXCR4-using variants.	[Svicher, Valentina; Cento, Valeria; Santoro, Maria Mercedes; Armenia, Daniele; Ceccherini-Silberstein, Francesca; Perno, Carlo Federico] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Rozera, Gabriella; Abbate, Isabella; Fabeni, Lavinia; Bruselles, Alessandro; Gori, Caterina; Forbici, Federica; Ippolito, Giuseppe; Antinori, Andrea; Capobianchi, Maria Rosaria; Perno, Carlo Federico] INMI L Spallanzani, Rome, Italy; [Latini, Alessandra; Palamara, Guido] San Gallicano Hosp, Rome, Italy; [Micheli, Valeria; Rizzardini, Giuliano] L Sacco Hosp Vialba, Milan, Italy; [Andreoni, Massimo] Univ Hosp Tor Vergata, Rome, Italy	University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Milan; Luigi Sacco Hospital; University of Rome Tor Vergata; Policlin Tor Vergata	Ceccherini-Silberstein, F (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.	ceccherini@med.uniroma2.it	latini, alessandra/J-8186-2018; Rozera, Gabriella/B-6874-2017; Abbate, Isabella/K-6434-2016; Micheli, Valeria/G-4927-2018; Antinori, Andrea/K-7125-2016; Andreoni, Masimo/AAL-2214-2020; Di Maio, Velia Chiara/AGH-2628-2022; Armenia, Daniele/K-2009-2016; Bruselles, Alessandro/M-6012-2019; Bruselles, Alessandro/M-7908-2017; Ippolito, Giuseppe/J-7207-2017; perno, carlo federico/O-1544-2016; FABENI, LAVINIA/J-6626-2016; Cento, Valeria/AAF-2607-2020; Ceccherini-Silberstein, Francesca/K-4762-2016; SANTORO, MARIA/K-3250-2018; gori, caterina/B-7836-2017; Forbici, Federica/B-6765-2017; Cento, Valeria/K-6636-2012	Micheli, Valeria/0000-0001-5629-3875; Antinori, Andrea/0000-0003-2121-4684; Armenia, Daniele/0000-0002-3406-7014; Bruselles, Alessandro/0000-0002-1556-4998; Bruselles, Alessandro/0000-0002-1556-4998; FABENI, LAVINIA/0000-0002-2975-8611; SANTORO, MARIA/0000-0002-6228-1114; Rozera, Gabriella/0000-0002-3590-8268; Andreoni, Massimo/0000-0002-3205-9758; SVICHER, VALENTINA/0000-0002-2377-504X; gori, caterina/0000-0002-6042-7570; Forbici, Federica/0000-0002-3954-5679; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Latini, Alessandra/0000-0002-9421-6560; Ippolito, Giuseppe/0000-0002-1076-2979; Cento, Valeria/0000-0002-3272-4252; Capobianchi, Maria Rosaria/0000-0003-3465-0071; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101	CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project [223131]; European Commission Framework 7 Program; Italian National Institute of Health (Programma Nazionale AIDS) [40H41]; Ministry of University and Scientific Research; Current and Finalized Research of the Italian Ministry of Health; AVIRALIA Foundation; Abbott; Boehringer Ingelheim; Bristol Myers Squibb; Gilead; Merck Sharp Dohme; Janssen Cilag; Pfizer; Tibotec; Roche; ViiV	CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project; European Commission Framework 7 Program; Italian National Institute of Health (Programma Nazionale AIDS); Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Current and Finalized Research of the Italian Ministry of Health; AVIRALIA Foundation; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck Sharp Dohme(Merck & Company); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Tibotec; Roche(Roche Holding); ViiV	This work was supported by grants from CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project no. 223131, funded by the European Commission Framework 7 Program, the Italian National Institute of Health (Programma Nazionale AIDS - 40H41), the Ministry of University and Scientific Research, Current and Finalized Research of the Italian Ministry of Health, and AVIRALIA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. C. F. Perno has received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Tibotec, Roche, and ViiV. F. Ceccherini-Silberstein has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Janssen Cilag, and ViiV. V Svicher has received funds for attending symposia, speaking and organizing educational activities from ViiV. The other authors declare that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Abbate I, 2011, J INFECT DIS, V204, P971, DOI 10.1093/infdis/jir427; Abbate I, 2011, AIDS, V25, P611, DOI 10.1097/QAD.0b013e328343489e; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Dimonte S, 2011, RETROVIROL, V12, P8, DOI DOI 10.1186/1742-4690-8-33; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Harrigan R, 2010, REWIEVS ANTIVIRAL TH, V1, P36; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; KOITO A, 1995, VIROLOGY, V206, P878, DOI 10.1006/viro.1995.1010; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; McGovern Rachel A, 2010, J Vis Exp, DOI 10.3791/2531; Nolan KM, 2008, J VIROL, V82, P664, DOI 10.1128/JVI.01793-07; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Svicher V, 2011, ANTIVIR RES, V90, P42, DOI 10.1016/j.antiviral.2011.02.005; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660	28	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53603	10.1371/journal.pone.0053603	http://dx.doi.org/10.1371/journal.pone.0053603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341955	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400052
J	Uusitalo-Seppala, R; Huttunen, R; Aittoniemi, J; Koskinen, P; Leino, A; Vahlberg, T; Rintala, EM				Uusitalo-Seppala, Raija; Huttunen, Reetta; Aittoniemi, Janne; Koskinen, Pertti; Leino, Aila; Vahlberg, Tero; Rintala, Esa M.			Pentraxin 3 (PTX3) Is Associated with Severe Sepsis and Fatal Disease in Emergency Room Patients with Suspected Infection: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN; INNATE IMMUNITY; SEPTIC SHOCK; PROCALCITONIN; MARKER; INFLAMMATION; RECOGNITION; RECEPTOR; CLONING	Background: Early diagnostic and prognostic stratification of patients with suspected infection is a difficult clinical challenge. We studied plasma pentraxin 3 (PTX3) upon admission to the emergency department in patients with suspected infection. Methods: The study comprised 537 emergency room patients with suspected infection: 59 with no systemic inflammatory response syndrome (SIRS) and without bacterial infection (group 1), 67 with bacterial infection without SIRS (group 2), 54 with SIRS without bacterial infection (group 3), 308 with sepsis (SIRS and bacterial infection) without organ failure (group 4) and 49 with severe sepsis (group 5). Plasma PTX3 was measured on admission using a commercial solid-phase enzyme-linked immunosorbent assay (ELISA). Results: The median PTX3 levels in groups 1-5 were 2.6 ng/ml, 4.4 ng/ml, 5.0 ng/ml, 6.1 ng/ml and 16.7 ng/ml, respectively (p<0.001). The median PTX3 concentration was higher in severe sepsis patients compared to others (16.7 vs. 4.9 ng/ml, p<0.001) and in non-survivors (day 28 case fatality) compared to survivors (14.1 vs. 5.1 ng/ml, p<0.001). A high PTX3 level predicted the need for ICU stay (p<0.001) and hypotension (p<0.001). AUC(ROC) in the prediction of severe sepsis was 0.73 (95% CI 0.66-0.81, p<0.001) and 0.69 in case fatality (95% CI 0.58-0.79, p<0.001). PTX3 at a cut-off level for 14.1 ng/ml (optimal cut-off value for severe sepsis) showed 63% sensitivity and 80% specificity. At a cut-off level 7.7 ng/ml (optimal cutoff value for case fatality) showed 70% sensitivity and 63% specificity in predicting case fatality on day 28.In multivariate models, high PTX3 remained an independent predictor of severe sepsis and case fatality after adjusting for potential confounders. Conclusions: A high PTX3 level on hospital admission predicts severe sepsis and case fatality in patients with suspected infection.	[Uusitalo-Seppala, Raija] Satakunta Cent Hosp, Dept Infect Dis, Pori, Finland; [Huttunen, Reetta] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Aittoniemi, Janne] Fimlab Labs, Tampere, Finland; [Koskinen, Pertti; Leino, Aila] Turku Univ, Dept Clin Chem, Turku, Finland; [Koskinen, Pertti; Leino, Aila] Turku Univ Hosp, TYKSLAB, Hosp Dist SW Finland, FIN-20520 Turku, Finland; [Vahlberg, Tero] Turku Univ, Dept Biostat, Turku, Finland; [Rintala, Esa M.] Turku Univ Hosp, Dept Hosp Hyg & Infect Control, FIN-20520 Turku, Finland	Satakunta Central Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; University of Turku; University of Turku	Uusitalo-Seppala, R (corresponding author), Satakunta Cent Hosp, Dept Infect Dis, Pori, Finland.	raija.uusitalo-seppala@satadiag.fi		Rintala, Esa/0000-0002-9289-8043	Research Fund of Satakunta Central Hospital; Tampere University Hospital; Turku University Hospital	Research Fund of Satakunta Central Hospital; Tampere University Hospital; Turku University Hospital	This work was financially supported by the Research Fund of Satakunta Central Hospital and by the Competitive Research Funding of Tampere University Hospital and Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Boyd JC, 1997, SCAND J CLIN LAB INV, V57, P46, DOI 10.1080/00365519709168308; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; de Kruif MD, 2010, J INFECTION, V60, P122, DOI 10.1016/j.jinf.2009.11.010; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlanda C, 2011, CURR PHARM DESIGN, V17, P38, DOI 10.2174/138161211795049750; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017653; Introna M, 1996, Blood, V87, P1862; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; LEE GW, 1993, J IMMUNOL, V150, P1804; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Mauri T, 2010, INTENS CARE MED, V36, P621, DOI 10.1007/s00134-010-1752-5; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Napoleone E, 2004, J LEUKOCYTE BIOL, V76, P203, DOI 10.1189/jlb.1003528; Outinen TK, 2012, EUR J CLIN MICROBIOL, V31, P957, DOI 10.1007/s10096-011-1392-x; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Tang H, 2009, INFECTION, V37, P497, DOI 10.1007/s15010-009-9034-2; Uusitalo-Seppala R, 2012, J INTERN MED, V272, P247, DOI 10.1111/j.1365-2796.2012.02569.x; Uusitalo-Seppala R, 2012, SCAND J INFECT DIS, V44, P697, DOI 10.3109/00365548.2012.677061; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Vanska M, 2011, HAEMATOL-HEMATOL J, V96, P1385, DOI 10.3324/haematol.2011.044925; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zambon M, 2008, J CRIT CARE, V23, P455, DOI 10.1016/j.jcrc.2007.08.003	42	62	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53661	10.1371/journal.pone.0053661	http://dx.doi.org/10.1371/journal.pone.0053661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341967	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400061
J	Wichmann, J; Folke, F; Torp-Pedersen, C; Lippert, F; Ketzel, M; Ellermann, T; Loft, S				Wichmann, Janine; Folke, Fredrik; Torp-Pedersen, Christian; Lippert, Freddy; Ketzel, Matthias; Ellermann, Thomas; Loft, Steffen			Out-of-Hospital Cardiac Arrests and Outdoor Air Pollution Exposure in Copenhagen, Denmark	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSIS; AMERICAN-HEART-ASSOCIATION; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; MYOCARDIAL-INFARCTION; ULTRAFINE PARTICLES; AMBIENT AIR; CARDIOVASCULAR-DISEASE; VASCULAR FUNCTION; DISTRIBUTED LAG	Cardiovascular disease is the number one cause of death globally and air pollution can be a contributing cause. Acute myocardial infarction and cardiac arrest are frequent manifestations of coronary heart disease. The objectives of the study were to investigate the association between 4 657 out-of-hospital cardiac arrests (OHCA) and hourly and daily outdoor levels of PM10, PM2.5, coarse fraction of PM (PM10-2.5), ultrafine particle proxies, NOx, NO2, O-3 and CO in Copenhagen, Denmark, for the period 2000-2010. Susceptible groups by age and sex was also investigated. A case-crossover design was applied. None of the hourly lags of any of the pollutants were significantly associated with OHCA events. The strongest association with OHCA events was observed for the daily lag4 of PM2.5, lag3 of PM10, lag3 of PM10-2.5, lag3 of NOx and lag4 of CO. An IQR increase of PM2.5 and PM10 was associated with a significant increase of 4% (95% CI: 0%; 9%) and 5% (95% CI: 1%; 9%) in OHCA events with 3 days lag, respectively. None of the other daily lags or other pollutants was significantly associated with OHCA events. Adjustment for O-3 slightly increased the association between OHCA and PM2.5 and PM10. No susceptible groups were identified.	[Wichmann, Janine; Loft, Steffen] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark; [Folke, Fredrik; Torp-Pedersen, Christian] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Copenhagen, Denmark; [Lippert, Freddy] Copenhagen Emergency Med Serv, Copenhagen, Denmark; [Ketzel, Matthias; Ellermann, Thomas] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Wichmann, J (corresponding author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark.	stl@sund.ku.dk	Folke, Fredrik/P-3601-2014; Ketzel, Matthias/K-4246-2015; Torp-Pedersen, Christian/E-5931-2013	Ketzel, Matthias/0000-0001-9519-1935; Loft, Steffen/0000-0001-9552-8518; Lippert, Freddy/0000-0002-2356-8809; Folke, Fredrik/0000-0002-2284-7857	Danish Environmental Protection Agency	Danish Environmental Protection Agency	The Danish Environmental Protection Agency funded the air pollution and meteorological measurements as part of the Danish Air Quality Monitoring Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Andersen ZJ, 2007, J EXPO SCI ENV EPID, V17, P625, DOI 10.1038/sj.jes.7500546; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Anderson H. R., 2007, QUANTITATIVE SYSTEMA; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bosson J, 2007, RESP MED, V101, P1140, DOI 10.1016/j.rmed.2006.11.010; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984; Brauner EV, 2009, INHAL TOXICOL, V21, P38, DOI [10.1080/08958370802304735, 10.1080/08958370802304735 ]; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Ellermann T, 2011, 836 AARH U NAT ENV R; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Forastiere F, 2005, AM J RESP CRIT CARE, V172, P1549, DOI 10.1164/rccm.200412-1726OC; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Godleski J J, 2000, Res Rep Health Eff Inst, P5; Goldberg M S, 2000, Res Rep Health Eff Inst, P7; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Horsted TI, 2007, RESUSCITATION, V72, P214, DOI 10.1016/j.resuscitation.2006.06.029; Ibald-Mulli A, 2001, AM J PUBLIC HEALTH, V91, P571, DOI 10.2105/AJPH.91.4.571; Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386; Lee JT, 2000, ENVIRON HEALTH PERSP, V108, P1107, DOI 10.2307/3434821; Levy D, 2001, EPIDEMIOLOGY, V12, P193, DOI 10.1097/00001648-200103000-00011; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Myerburg RJ, 2001, CARDIOVASC RES, V50, P177, DOI 10.1016/S0008-6363(01)00253-X; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Rayner M, 2009, EUR J CARDIOV PREV R, V16, pS43, DOI 10.1097/01.hjr.0000359235.59808.ba; Rich DQ, 2006, ENVIRON HEALTH PERSP, V114, P120, DOI 10.1289/ehp.8371; Rosenthal FS, 2008, ENVIRON HEALTH PERSP, V116, P631, DOI 10.1289/ehp.10757; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Silverman RA, 2010, AM J EPIDEMIOL, V172, P917, DOI 10.1093/aje/kwq217; Sotoodehnia N, 2001, CARDIOVASC RES, V50, P197, DOI 10.1016/S0008-6363(01)00260-7; Spooner PM, 2001, CIRCULATION, V103, P2361; Sullivan J, 2003, AM J EPIDEMIOL, V157, P501, DOI 10.1093/aje/kwg015; Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562; Wahlin P, 2001, ATMOS ENVIRON, V35, P3549, DOI 10.1016/S1352-2310(01)00066-8; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Working group of the Danish Cardiac Arrest Registry, 2005, STAT REP; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	66	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53684	10.1371/journal.pone.0053684	http://dx.doi.org/10.1371/journal.pone.0053684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341975	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400066
J	Dai, BZ; Mao, ZF; Mei, J; Levkoff, S; Wang, HL; Pacheco, M; Wu, B				Dai, Baozhen; Mao, Zongfu; Mei, John; Levkoff, Sue; Wang, Huali; Pacheco, Misty; Wu, Bei			Caregivers in China: Knowledge of Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMER-DISEASE; HIGH-RISK; CARE; DEMENTIA; ONSET; PREVALENCE; DIAGNOSIS; BURDEN	This study aimed to examine the experience and knowledge of mild cognitive impairment (MCI) among Chinese family caregivers of individuals with MCI. The sample was recruited from memory clinics in Zhongnan Hospital in Wuhan, China. In-depth semi-structured interviews were used. Thirteen family members of individuals diagnosed with MCI participated in the study. Data analysis revealed three themes: 1) initial recognition of cognitive decline; 2) experience of the diagnosis of MCI; 3) perception of cognitive decline as a normal part of aging. While family members recognized the serious consequences of memory loss (e. g. getting lost), they would typically not take their family members to see a doctor until something specific triggered their access to the medical care system. The Chinese traditional perception of dementia as part of normal aging may serve to lessen the stigma of individuals with MCI, while the term "laonian chidai" which literally translates to "stupid, demented elderly" may exacerbate the stigma associated with individuals with MCI. It is suggested that family members' worries may be relieved by improving their access to accurate knowledge of the disease, community-based and institutional care services, and culturally appropriately words are needed for MCI.	[Dai, Baozhen] Jiangsu Univ, Sch Management, Zhenjiang, Peoples R China; [Dai, Baozhen] Jiangsu Univ, Res Inst New Rural Dev, Zhenjiang, Peoples R China; [Mao, Zongfu] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Mei, John] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Levkoff, Sue] Univ S Carolina, Coll Social Work, DeSaussure Coll, Columbia, SC 29208 USA; [Wang, Huali] Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Beijing 100871, Peoples R China; [Pacheco, Misty] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Wu, Bei] Duke Univ, Sch Nursing, Durham, NC 27706 USA; [Wu, Bei] Duke Univ, Global Hlth Inst, Durham, NC USA	Jiangsu University; Jiangsu University; Wuhan University; Harvard University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Peking University; University of Hawaii System; University of Hawaii Manoa; Duke University; Duke University	Wu, B (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.	bei.wu@duke.edu	dai, bz/HGC-0467-2022; Wang, Huali/S-9848-2018; Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X	National Institutes of Health Fogarty International Center/National Institute on Aging [1R21AG028180]; Natural Science Foundation of China [71203080, 30500178, 30971044]; Senior Professionals Scientific Research Foundation of Jiangsu University; Ministry of Science and Technology [2007AA02Z421]; NATIONAL INSTITUTE ON AGING [R21AG028180] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Center/National Institute on Aging; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Senior Professionals Scientific Research Foundation of Jiangsu University; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by the National Institutes of Health Fogarty International Center/National Institute on Aging (1R21AG028180), the Natural Science Foundation of China (71203080) and Senior Professionals Scientific Research Foundation of Jiangsu University. The case registry of cognitive impairment at Dementia Care & Research Center of Peking University Institute of Mental Health was supported by research funding from the Natural Science Foundation of China (30500178, 30971044) and the Ministry of Science and Technology (2007AA02Z421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Austrom MG, 2009, CURR ALZHEIMER RES, V6, P392, DOI 10.2174/156720509788929291; Bartlett H, 1997, HEALTH PLACE, V3, P149, DOI 10.1016/S1353-8292(97)00008-7; Bi M, 2010, MED SOC, V23, P79; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blieszner R, 2010, GERONTOLOGIST, V50, P11, DOI 10.1093/geront/gnp068; Bruce JM, 2008, DEMENT GERIATR COGN, V25, P385, DOI 10.1159/000122587; Carpenter BD, 2011, AM J ALZHEIMERS DIS, V26, P121, DOI 10.1177/1533317510394157; Chu LW, 2008, J AM MED DIR ASSOC, V9, P239, DOI 10.1016/j.jamda.2008.01.008; Dai B, 2012, KNOWLEDGE ATTITUDE B; Feldman HH, 2007, LANCET NEUROL, V6, P501, DOI 10.1016/S1474-4422(07)70109-6; Garand L, 2005, INT J GERIATR PSYCH, V20, P512, DOI 10.1002/gps.1318; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gray HL, 2009, AM J GERIAT PSYCHIAT, V17, P925, DOI 10.1097/JGP.0b013e3181ad4f3c; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guo ZB, 2000, RECRUITMENT AND RETENTION IN MINORITY POPULATIONS, P103; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Hinton L, 2000, J Cross Cult Gerontol, V15, P119, DOI 10.1023/A:1006798316654; Hinton WL, 1999, CULT MED PSYCHIAT, V23, P453, DOI 10.1023/A:1005516002792; Huang Juebin, 2005, Current Alzheimer Research, V2, P571, DOI 10.2174/156720505774932223; Jiang RuiHui, 2009, Chinese Journal of Clinical Healthcare, V12, P194; Kleinman A, 1986, SOCIAL ORIGINS DISTR; Kleinman A., 1980, PATIENTS HEALERS CON; Levey A, 2006, CLIN THER, V28, P991, DOI 10.1016/j.clinthera.2006.07.006; Lu YFY, 2009, CURR ALZHEIMER RES, V6, P384, DOI 10.2174/156720509788929309; Mahoney DF, 2005, GERONTOLOGIST, V45, P783, DOI 10.1093/geront/45.6.783; Marcheco B, 2003, GENET TEST, V7, P45, DOI 10.1089/109065703321560930; McIlvane JM, 2008, ALZ DIS ASSOC DIS, V22, P284, DOI 10.1097/WAD.0b013e318169d714; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Peng P, 1998, China Popul Today, V15, P5; Peng P, 1998, CHINA POPUL TODAY, V15, P10; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qiu Chang-jian, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1104; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; SPSS, 2006, SPSS 15 0 WIND REL 1; Strauss A, 1997, GROUNDED THEORY PRAC; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tuokko H, 2005, NEUROCASE, V11, P40, DOI 10.1080/13554790490896802; Werner P, 2001, INT J GERIATR PSYCH, V16, P32, DOI 10.1002/1099-1166(200101)16:1<32::AID-GPS268>3.0.CO;2-2; Wu Bei, 2005, J Aging Soc Policy, V17, P37, DOI 10.1300/J031v17n04_03; Wu B, 2010, AGEING INT, V35, P128, DOI 10.1007/s12126-010-9055-2; Wu B, 2009, J AM MED DIR ASSOC, V10, P472, DOI 10.1016/j.jamda.2009.07.008; Wu B, 2008, J AGING SOC POLICY, V20, P218, DOI 10.1080/08959420801977632; Wu J, 2010, CHINESE J SOCIAL MED, V27, P215; Zhan L, 2004, J GERONTOLOGICAL NUR, V30, P20; Zhang X, 2001, HLTH CHINA, V6, P36; [张振馨 Zhang Zhenxin], 2004, [中国医学科学院学报, Acta Academiae Medicinae Sinicae], V26, P116	49	20	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53928	10.1371/journal.pone.0053928	http://dx.doi.org/10.1371/journal.pone.0053928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086RY	23326541	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800090
J	Davidson, D; Zaytseva, A; Miskolci, V; Castro-Alcaraz, S; Vancurova, I; Patel, H				Davidson, Dennis; Zaytseva, Alla; Miskolci, Veronika; Castro-Alcaraz, Susana; Vancurova, Ivana; Patel, Hardik			Gene Expression Profile of Endotoxin-stimulated Leukocytes of the Term New Born: Control of Cytokine Gene Expression by Interleukin-10	PLOS ONE			English	Article							HYALINE-MEMBRANE DISEASE; INFLAMMATORY RESPONSE SYNDROME; RESPIRATORY-DISTRESS SYNDROME; CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; ANTIINFLAMMATORY RESPONSE; NEWBORN-INFANTS; IL-10; POLYMORPHONUCLEAR	Introduction: Increasing evidence now supports the association between the fetal inflammatory response syndrome (FIRS) with the pathogenesis of preterm labor, intraventricular hemorrhage and bronchopulmonary dysplasia. Polymorphonuclear leukocyte (PMNs) and mononuclear cell (MONOs) infiltration of the placenta is associated with these disorders. The aim of this study was to reveal cell-specific differences in gene expression and cytokine release in response to endotoxin that would elucidate inflammatory control mechanisms in the newly born. Methods: PMNs and MONOs were separately isolated from the same cord blood sample. A genome-wide microarray screened for gene expression and related pathways at 4 h of LPS stimulation (n = 5). RT-qPCR and ELISA were performed for selected cytokines at 4 h and 18 h of LPS stimulation. Results: Compared to PMNs, MONOs had a greater diversity and more robust gene expression that included pro-inflammatory (PI) cytokines, chemokines and growth factors at 4 h. Only MONOs had genes changing expression (all up regulated including interleukin-10) that were clustered in the JAK/STAT pathway. Pre-incubation with IL-10 antibody, for LPS-stimulated MONOs, led to up regulated PI and IL-10 gene expression and release of PI cytokines after 4 h. Discussion: The present study suggests a dominant role of MONO gene expression in control of the fetal inflammatory response syndrome at 4 hrs of LPS stimulation. LPS-stimulated MONOs but not PMNs of the newborn have the ability to inhibit PI cytokine gene expression by latent IL-10 release.	[Davidson, Dennis] Stony Brook Long Isl Childrens Hosp, Div Neonatal Perinatal Med, Stony Brook, NY USA; [Zaytseva, Alla; Miskolci, Veronika; Castro-Alcaraz, Susana; Patel, Hardik] Feinstein Inst Med Res, Manhasset, NY USA; [Vancurova, Ivana] St Johns Univ, Dept Biol, New York, NY USA	Northwell Health; Saint John's University	Davidson, D (corresponding author), Stony Brook Long Isl Childrens Hosp, Div Neonatal Perinatal Med, Stony Brook, NY USA.	dennis.davidson@stonybrookmedicine.edu	Patel, Hardik/L-9000-2013	Patel, Hardik/0000-0003-3819-4691	NICHD [R03-HD048508]; Lilling Family of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048508] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Lilling Family of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded in part by R03-HD048508 (NICHD), http://www.nichd.nih.gov, and by the Lilling Family support of the Neonatal Research Laboratory at The Feinstein Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bayraktar M, 2009, AM J REPROD IMMUNOL, V62, P390, DOI 10.1111/j.1600-0897.2009.00756.x; Beresford MW, 2002, PEDIATR RES, V52, P973, DOI 10.1203/01.PDR.0000036626.67304.65; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Chusid LA, 2010, NEONATOLOGY, V97, P108, DOI 10.1159/000235807; Citarella BV, 2009, PEDIATR RES, V65, P425, DOI 10.1203/PDR.0b013e318199384d; Davidson D, 2007, NEONATOLOGY, V92, P127, DOI 10.1159/000101432; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; JACKSON JC, 1987, AM REV RESPIR DIS, V135, P937, DOI 10.1164/arrd.1987.135.4.937; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Kwong KYC, 1998, CLIN IMMUNOL IMMUNOP, V88, P105, DOI 10.1006/clin.1997.4510; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; McGowan EC, 2009, PEDIATR RES, V66, P455, DOI 10.1203/PDR.0b013e3181b3b0fa; Medzhitov R, 2011, NAT REV IMMUNOL, V11, P693, DOI 10.1038/nri3063; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Munshi UK, 1997, PEDIATR PULM, V24, P331; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Oei J, 2002, ACTA PAEDIATR, V91, P1194; Roberts PC, 2008, BIOTECHNOL ANN REV, V14, P29, DOI 10.1016/S1387-2656(08)00002-1; ROMERO R, 1988, AM J OBSTET GYNECOL, V158, P1044, DOI 10.1016/0002-9378(88)90216-5; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Sorokin Y, 2010, AM J PERINAT, V27, P631, DOI 10.1055/s-0030-1249366; Thornton NL, 2012, NEONATOLOGY, V101, P140, DOI 10.1159/000330567; Viscardi RM, 2012, SEMIN FETAL NEONAT M, V17, P30, DOI 10.1016/j.siny.2011.08.002	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53641	10.1371/journal.pone.0053641	http://dx.doi.org/10.1371/journal.pone.0053641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326478	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800065
J	Fujiwara, K; Nomura, SM				Fujiwara, Kei; Nomura, Shin-ichiro M.			Condensation of an Additive-Free Cell Extract to Mimic the Conditions of Live Cells	PLOS ONE			English	Article							SIZED LIPID VESICLES; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; ARTIFICIAL CELL; GENE-EXPRESSION; DYNAMICS; DNA	The cellular environment differs from that of reconstituted materials mainly because of the presence of highly condensed biomacromolecules. To mimic the environment and conditions in living cells, we developed a method to prepare additive-free, highly concentrated cell extracts. First, we verified the requirement for specific salts and buffers for functional cell-free translation extracts. The S30 fraction of Escherichia coli cell extracts without additives exhibited sufficient cell-free protein production. Next, we established a method to accumulate biological components by gradual evaporation by using a vacuum desiccator. Bovine serum albumin, green fluorescent protein, alkaline phosphatase, and a diluted reconstituted protein expression system were successfully condensed in their active forms using this method. The protein concentration of the prepared cell extract was elevated to 180 mg/mL, which was expected to contain approximately 260 mg/mL macromolecules, without the loss of cell-free protein expression activity. Such a condensed cell extract may be useful for investigating the differences between cells and reconstituted materials and may contribute to the development of methods to synthesize cells from cell extracts in the future.	[Fujiwara, Kei; Nomura, Shin-ichiro M.] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan	Tohoku University	Fujiwara, K (corresponding author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.	fujiwara@molbot.mech.tohoku.ac.jp; nomura@molbot.mech.tohoku.ac.jp	FUJIWARA, KEI/U-8308-2019; FUJIWARA, KEI/G-5467-2010; nomura, Shinichiro/AAD-9593-2019	FUJIWARA, KEI/0000-0001-7308-774X; FUJIWARA, KEI/0000-0001-7308-774X; NOMURA, Shin-ichiro/0000-0002-0346-130X	JST; PRESTO; JSPS KAKENHI [22220001, 23.3718]; Grants-in-Aid for Scientific Research [22220001, 11J03718] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); PRESTO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST, PRESTO, and JSPS KAKENHI (grant numbers 22220001 and 23.3718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Ge XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028707; Hamada T, 2005, BIOPHYS J, V88, p238A; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; Kaneda M, 2009, BIOMATERIALS, V30, P3971, DOI 10.1016/j.biomaterials.2009.04.006; Kato A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00283; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P631, DOI 10.1271/bbb.58.631; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Nomura SM, 2001, CHEMBIOCHEM, V2, P457, DOI 10.1002/1439-7633(20010601)2:6<457::AID-CBIC457>3.0.CO;2-F; Oikawa K, 2005, J BIOL CHEM, V280, P5527, DOI 10.1074/jbc.M412392200; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; SETHI VS, 1970, FEBS LETT, V8, P236, DOI 10.1016/0014-5793(70)80274-5; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Shirokov Vladimir A., 2007, V375, P19; Tsumoto K, 2001, LANGMUIR, V17, P7225, DOI 10.1021/la010887s; Walde P, 2010, BIOESSAYS, V32, P296, DOI 10.1002/bies.200900141; Yu W, 2001, J BIOSCI BIOENG, V92, P590, DOI 10.1263/jbb.92.590; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	30	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54155	10.1371/journal.pone.0054155	http://dx.doi.org/10.1371/journal.pone.0054155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326590	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400080
J	Sundrani, D; Khot, V; Pisal, H; Mehendale, S; Wagh, G; Joshi, A; Joshi, S				Sundrani, Deepali; Khot, Vinita; Pisal, Hemlata; Mehendale, Savita; Wagh, Girija; Joshi, Asmita; Joshi, Sadhana			Gestation Dependant Changes in Angiogenic Factors and Their Associations with Fetal Growth Measures in Normotensive Pregnancy	PLOS ONE			English	Article							HUMAN FETOPLACENTAL VASCULOGENESIS; PHYSIOLOGICAL TRANSFORMATION; FACTOR RECEPTOR-1; TYROSINE KINASE; SPIRAL ARTERIES; PLASMA-LEVELS; HYPOXIA; PREECLAMPSIA; RISK; VEGF	Background: Earlier studies indicate that altered angiogenesis at birth is associated with poor birth outcome in women with preeclampsia. Now, we hypothesize that the progressive gestation dependant changes in markers of angiogenesis will be more useful to predict birth weight early even in a normotensive pregnancy. This study for the first time examines the association of gestation dependant changes in the levels of maternal angiogenic factors in addition to their levels in cord with birth weight. Method: Ninety two pregnant women were followed at three different time points: 16-20 weeks, 26-30 weeks and at delivery during pregnancy. Plasma levels of angiogenic and anti angiogenic factors were determined by commercial enzyme-linked immunosorbent assay (ELISA) kits. Results: Maternal plasma VEGF levels increased (p<0.01) till the second time point and decreased (p<0.05) up to delivery while plasma sFlt-1 levels increased (p<0.01) at delivery. PlGF levels peaked (p<0.01) at second time point and decreased (p<0.01) at delivery. Cord plasma VEGF levels were higher (p<0.01) and sFlt-1 levels were lower (p<0.01) as compared to maternal values at all time points. Maternal plasma VEGF levels at first time point and PlGF levels at delivery were positively (p<0.05 and p<0.01 respectively), while sFlt-1/PlGF ratio at delivery was negatively associated (p<0.05) with birth weight. Conclusion: Levels of pro- and anti-angiogenic factors may be differentially regulated across gestation. Maternal VEGF levels at early gestation (16-20 weeks) may be predictive of birth weight in healthy term pregnancies.	[Sundrani, Deepali; Khot, Vinita; Pisal, Hemlata; Joshi, Asmita; Joshi, Sadhana] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India; [Mehendale, Savita; Wagh, Girija] Bharati Vidyapeeth Univ, Bharati Med Coll & Hosp, Dept Obstet & Gynecol, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Joshi, S (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs, Dept Med Nutr, Pune, Maharashtra, India.	srjoshi62@gmail.com	Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Sundrani, Deepali/0000-0002-2403-5115	Department of Biotechnology Government of India	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India)	The Department of Biotechnology Government of India partly funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; Ali KZ, 2010, J MATERN-FETAL NEO M, V23, P1244, DOI 10.3109/14767050903511560; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Bukhari SA, 2011, MOL BIOL REP, V38, P2703, DOI 10.1007/s11033-010-0413-7; BULTERYS MG, 1990, PEDIATRICS, V86, P535; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim YM, 2002, AM J OBSTET GYNECOL, V187, P1137, DOI 10.1067/mob.2002.127720; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Kulkarni A, 2011, CLIN NUTR, V30, P60, DOI 10.1016/j.clnu.2010.07.007; Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31; Kumar Neeta, 2012, Indian J Public Health, V56, P103, DOI 10.4103/0019-557X.96988; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lygnos MC, 2006, IN VIVO, V20, P157; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Mihailovic M, 2000, BIOL TRACE ELEM RES, V73, P47, DOI 10.1385/BTER:73:1:47; Mijal RS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.001; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Ozkan Y, 2012, ARCH GYNECOL OBSTET, V285, P1319, DOI 10.1007/s00404-011-2150-0; Palm M, 2011, ACTA OBSTET GYN SCAN, V90, P1244, DOI 10.1111/j.1600-0412.2011.01186.x; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Ross B, 2010, AM J HYPERTENS, V23, P1228, DOI 10.1038/ajh.2010.160; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Wills AK, 2010, EARLY HUM DEV, V86, P535, DOI 10.1016/j.earlhumdev.2010.07.002; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	47	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54153	10.1371/journal.pone.0054153	http://dx.doi.org/10.1371/journal.pone.0054153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326589	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400079
J	Wang, GH; Li, CQ; Wang, Y; Chen, GJ				Wang, Guihong; Li, Chaoqun; Wang, Yan; Chen, Guangju			Cooperative Assembly of Co-Smad4 MH1 with R-Smad1/3 MH1 on DNA: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; AMBER FORCE-FIELD; CONTINUUM SOLVENT; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; CELL-MEMBRANE; FREE-ENERGIES; BETA; BINDING; SMAD4	Background: Smads, the homologs of Sma and MAD proteins, play a key role in gene expression regulation in the transforming growth factor-beta (TGF-beta) signaling pathway. Recent experimental studies have revealed that Smad4/R-Smad heterodimers bound on DNA are energetically more favorable than homodimeric R-Smad/R-Smad complexes bound on DNA, which indicates that Smad4 might act as binding vehicle to cooperatively assemble with activated R-Smads on DNA in the nucleus. However, the details of interaction mechanism for cooperative recruitment of Smad4 protein to R-Smad proteins on DNA, and allosteric communication between the Smad4-DNA and R-Smad-DNA interfaces via DNA mediating are not yet clear so far. Methodology: In the present work, we have constructed a series of Smadn+DNA+Smadn (n = 1, 3, 4) models and carried out molecular dynamics simulations, free energy calculations and DNA dynamics analysis for them to study the interaction properties of Smadn (n = 1, 3, 4) with DNA molecule. Results: The results revealed that the binding of Smad4 protein to DNA molecule facilitates energetically the formation of the heteromeric Smad4+DNA+Smad1/3 complex by increasing the affinity of Smad1/3 with DNA molecule. Further investigations through the residue/base motion correlation and DNA dynamics analyses predicted that the binding of Smad4 protein to DNA molecule in the heteromeric Smad4+DNA+Smad1/3 model induces an allosteric communication from the Smad4-DNA interface to Smad1/Smad3-DNA interface via DNA base-pair helical motions, surface conformation changes and new hydrogen bond formations. The present work theoretically explains the mechanism of cooperative recruitment of Smad4 protein to Smad1/3 protein via DNA-mediated indirect readout mode in the nucleus.	[Wang, Guihong; Li, Chaoqun; Wang, Yan; Chen, Guangju] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	wangy@bnu.edu.cn; gjchen@bnu.edu.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210	National Science Foundation of China [20973024, 21073015, 21131003, 21271029]; Major State Basic Research Development Programs [2011CB808500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	The authors acknowledge research support from the National Science Foundation of China (No. 20973024, 21073015, 21131003 and 21271029), the Major State Basic Research Development Programs (grant No. 2011CB808500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulHameed MDM, 2006, J PHYS CHEM B, V110, P26365, DOI 10.1021/jp065207e; Alexandrow MG, 1997, J CELL BIOCHEM, V66, P427, DOI 10.1002/(SICI)1097-4644(19970915)66:4<427::AID-JCB1>3.3.CO;2-Y; [Anonymous], 1999, INTRO COMPUTATIONAL; Baburajendran N, 2011, NUCLEIC ACIDS RES, V39, P8213, DOI 10.1093/nar/gkr500; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Baburajendran N, 2009, ACTA CRYSTALLOGR F, V65, P1105, DOI 10.1107/S1744309109037476; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Hao GF, 2010, J PHYS CHEM B, V114, P9663, DOI 10.1021/jp102546s; Hariharan R, 2008, PROTEINS, V71, P1853, DOI 10.1002/prot.21869; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; Sadiq SK, 2010, PROTEINS, V78, P2873, DOI 10.1002/prot.22806; Kennedy BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022606; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; Koyama M, 1999, MUTAT RES-GENOMICS, V406, P71, DOI 10.1016/S1383-5726(99)00003-5; Kusanagi K, 2001, J BIOL CHEM, V276, P28155, DOI 10.1074/jbc.M103371200; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Makkar P, 2009, J MOL GRAPH MODEL, V27, P803, DOI 10.1016/j.jmgm.2008.12.003; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McQuarrie D. A, 2000, STAT MECH; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Onwuegbusi BA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000177; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schwarte-Waldhoff I, 2000, P NATL ACAD SCI USA, V97, P9624, DOI 10.1073/pnas.97.17.9624; Shankaran H, 2008, PERSPECT, V1, P1; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Strahs D, 2000, J MOL BIOL, V301, P643, DOI 10.1006/jmbi.2000.3863; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Yang B, 2011, J COMPUT CHEM, V32, P416, DOI 10.1002/jcc.21630; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap KL, 2001, METHOD MOL BIOL, V173, P1; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhu XL, 2009, J CHEM INF MODEL, V49, P1936, DOI 10.1021/ci900174d; Zi Z, 2007, PLOS ONE, V2, P1	59	38	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53841	10.1371/journal.pone.0053841	http://dx.doi.org/10.1371/journal.pone.0053841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326519	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400052
J	Sciacqua, A; Marini, MA; Hribal, ML; Perticone, F; Sesti, G				Sciacqua, Angela; Marini, Maria Adelaide; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			Association of Insulin Resistance Indexes to Carotid Intima-Media Thickness	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; GLUCOSE DISPOSAL; ARTERY INTIMA; RISK-FACTOR; SENSITIVITY; PREDICTOR; NONOBESE	Objectives: Accumulating evidence suggests an association between insulin resistance (IR) and cardiovascular diseases The aim of this study was to examine the relationship between indexes of IR and common carotid intima-media thickness (IMT), an indicator of vascular damage. Methods: In 847 non-diabetic Caucasians a 75 g oral glucose tolerance test was performed and surrogate indexes of IR were computed according to published formulas. IMT was measured by ultrasound method. Results: The Stumvoll ISIOGTT index was correlated with IMT more strongly than the other indexes of IR. The IR indexes correlated significantly (P<0.0001) with all cardiovascular risk factors examined. The Stumvoll ISIOGTT index was correlated with waist circumference and high sensitivity C-reactive protein more strongly than the other indexes of IR. The area under the ROC curve (AUC), used to evaluate the accuracy of the IR indexes in identifying individuals with vascular damage defined as IMT >0.9 mm, for the Stumvoll ISIOGTT index was significantly higher (0.710) as compared with the AUCs of Matsuda (0.642) (P = 0.0009), OGIS (0.666) (P = 0.04), HOMA (0.611) (P<0.0001) and Liver IR (0.648) (P = 0.0008) indexes. In a logistic regression model adjusted for age and gender, subjects in the lowest tertile of the Stumvoll ISIOGTT index had the highest risk of having vascular damage (OR 4.95, 95% CI 2.99-8.192) as compared to the corresponding tertiles of the other surrogate indexes. Conclusion: The Stumvoll ISIOGTT index correlated more strongly than other validated surrogates indexes of IR with carotid IMT, and, therefore, it might be a significant indicator of vascular damage.	[Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Marini, Maria Adelaide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy	Magna Graecia University of Catanzaro; University of Rome Tor Vergata	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Sesti, Giorgio/B-1509-2012; Perticone, Francesco/I-4260-2017	Sesti, Giorgio/0000-0002-1618-7688				Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; HAFFNER SM, 1990, METABOLISM, V39, P842, DOI 10.1016/0026-0495(90)90130-5; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Hu G., 2004, DIABETOLOGIA, V47, P1245; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	27	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53968	10.1371/journal.pone.0053968	http://dx.doi.org/10.1371/journal.pone.0053968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326550	Green Published, Green Submitted, gold			2022-12-27	WOS:000313551500104
J	Levkovich, T; Poutahidis, T; Smillie, C; Varian, BJ; Ibrahim, YM; Lakritz, JR; Alm, EJ; Erdman, SE				Levkovich, Tatiana; Poutahidis, Theofilos; Smillie, Christopher; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Alm, Eric J.; Erdman, Susan E.			Probiotic Bacteria Induce a 'Glow of Health'	PLOS ONE			English	Article							GUT MICROBIOTA; IMMUNE-SYSTEM; SKIN INFLAMMATION; HAIR-FOLLICLES; PATHOGENESIS; RESPONSES; RECEPTOR; MODELS; IL-10; CELLS	Radiant skin and hair are universally recognized as indications of good health. However, this 'glow of health' display remains poorly understood. We found that feeding of probiotic bacteria to aged mice induced integumentary changes mimicking peak health and reproductive fitness characteristic of much younger animals. Eating probiotic yogurt triggered epithelial follicular anagen-phase shift with sebocytogenesis resulting in thick lustrous fur due to a bacteria-triggered interleukin-10-dependent mechanism. Aged male animals eating probiotics exhibited increased subcuticular folliculogenesis, when compared with matched controls, yielding luxuriant fur only in probiotic-fed subjects. Female animals displayed probiotic-induced hyperacidity coinciding with shinier hair, a feature that also aligns with fertility in human females. Together these data provide insights into mammalian evolution and novel strategies for integumentary health.	[Levkovich, Tatiana; Poutahidis, Theofilos; Varian, Bernard J.; Ibrahim, Yassin M.; Lakritz, Jessica R.; Alm, Eric J.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos] Aristotle Univ Thessaloniki, Pathol Lab, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Alm, Eric J.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, Div Comparat Med, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869; Smillie, Chris/0000-0002-7606-3433	National Institutes of Health [P30-ES002109, RO1CA108854]; NATIONAL CANCER INSTITUTE [R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to S.E.E and E.J.A) and RO1CA108854 (to S.E.E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico JA, 2004, PHARMACOL BIOCHEM BE, V78, P333, DOI 10.1016/j.pbb.2004.04.006; Arck P, EXP DERMATOL, V19, P401; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Barth JH, 2000, LANCET, V355, P161, DOI 10.1016/S0140-6736(99)00412-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Cavani A, 2012, CHEM IMMUNOL ALLERGY, V96, P39, DOI 10.1159/000331870; Chapat L, 2004, EUR J IMMUNOL, V34, P2520, DOI 10.1002/eji.200425139; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Chinen T, 2012, IMMUNOL REV, V245, P45, DOI 10.1111/j.1600-065X.2011.01083.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dao H, 2007, GENDER MED, V4, P308; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Eurell J.A.C., 2006, DELLMANNS TXB VET HI; Fimmel S, 2007, HORM METAB RES, V39, P149, DOI 10.1055/s-2007-961815; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gueniche A, 2009, EXPT DERMATOLOGY, V19; Gueniche A, 2006, EUR J DERMATOL, V16, P511, DOI 10.1684/ejd.2006.0023; Hacini-Rachinel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004903; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Krutmann J, 2009, J DERMATOL SCI, V54, P1, DOI 10.1016/j.jdermsci.2009.01.002; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McNulty NP, SCI TRANSL MED, V3; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Muscarella F, 1996, ETHOL SOCIOBIOL, V17, P99, DOI 10.1016/0162-3095(95)00130-1; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rebora A, 2004, J AM ACAD DERMATOL, V50, P777, DOI 10.1016/j.jaad.2003.11.073; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; SCHALL R, 1991, BIOMETRIKA, V78, P719; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schneider MR, 2010, INT J BIOCHEM CELL B, V42, P181, DOI 10.1016/j.biocel.2009.11.017; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suh DH, 2002, EUR J DERMATOL, V12, P139; Sundberg JP, 2005, J INVEST DERM SYMP P, V10, P264, DOI 10.1111/j.1087-0024.2005.10126.x; Tango Y, 2001, J COSMET SCI, V52, P237; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; WHEELER PE, 1985, J HUM EVOL, V14, P23, DOI 10.1016/S0047-2484(85)80091-9; Williams S, 2005, SKIN PHARMACOL PHYS, V18, P247, DOI 10.1159/000086671	47	91	102	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53867	10.1371/journal.pone.0053867	http://dx.doi.org/10.1371/journal.pone.0053867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342023	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700055
J	Miyazawa, S				Miyazawa, Sanzo			Prediction of Contact Residue Pairs Based on Co-Substitution between Sites in Protein Structures	PLOS ONE			English	Article							DETECTING COEVOLVING POSITIONS; PACKING DENSITY; DNA-SEQUENCES; MUTATIONS; INFORMATION; ACCURATE; TREES; RECONSTRUCTION; IDENTIFICATION; COEVOLUTION	Residue-residue interactions that fold a protein into a unique three-dimensional structure and make it play a specific function impose structural and functional constraints in varying degrees on each residue site. Selective constraints on residue sites are recorded in amino acid orders in homologous sequences and also in the evolutionary trace of amino acid substitutions. A challenge is to extract direct dependences between residue sites by removing phylogenetic correlations and indirect dependences through other residues within a protein or even through other molecules. Rapid growth of protein families with unknown folds requires an accurate de novo prediction method for protein structure. Recent attempts of disentangling direct from indirect dependences of amino acid types between residue positions in multiple sequence alignments have revealed that inferred residue-residue proximities can be sufficient information to predict a protein fold without the use of known three-dimensional structures. Here, we propose an alternative method of inferring coevolving site pairs from concurrent and compensatory substitutions between sites in each branch of a phylogenetic tree. Substitution probability and physico-chemical changes (volume, charge, hydrogen-bonding capability, and others) accompanied by substitutions at each site in each branch of a phylogenetic tree are estimated with the likelihood of each substitution, and their direct correlations between sites are used to detect concurrent and compensatory substitutions. In order to extract direct dependences between sites, partial correlation coefficients of the characteristic changes along branches between sites, in which linear multiple dependences on feature vectors at other sites are removed, are calculated and used to rank coevolving site pairs. Accuracy of contact prediction based on the present coevolution score is comparable to that achieved by a maximum entropy model of protein sequences for 15 protein families taken from the Pfam release 26.0. Besides, this excellent accuracy indicates that compensatory substitutions are significant in protein evolution.	Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan	Gunma University	Miyazawa, S (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan.	sanzo.miyazawa@gmail.com	Miyazawa, Sanzo/V-5550-2017	Miyazawa, Sanzo/0000-0002-5063-3661				ALTSCHUH D, 1988, PROTEIN ENG, V2, P193, DOI 10.1093/protein/2.3.193; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Dutheil JY, 2012, BRIEF BIOINFORM, V13, P228, DOI 10.1093/bib/bbr048; Edward D, 2000, INTRO GRAPHICAL MODE; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; GO M, 1978, INT J PEPT PROT RES, V12, P237; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulyas-Kovacs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036546; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lie K, 2011, PLOS ONE, V6; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Miyazawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028892; Miyazawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017244; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Romiguier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033852; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sathyapriya R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000584; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Simons KT, 1999, PROTEINS, P171; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stamatakis A, 2012, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTS309:1-3; Tataru P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-465; Taylor WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028265; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Vassura M, 2008, BIOINFORMATICS, V24, P1313, DOI 10.1093/bioinformatics/btn115; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	67	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54252	10.1371/journal.pone.0054252	http://dx.doi.org/10.1371/journal.pone.0054252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342110	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700097
J	Mullally, SL; O'Mara, SM				Mullally, Sinead L.; O'Mara, Shane M.			Suppressing the Encoding of New Information in Memory: A Behavioral Study Derived from Principles of Hippocampal Function	PLOS ONE			English	Article							UNWANTED MEMORIES; WORKING-MEMORY; ASSOCIATIVE RECOGNITION; ITEM RECOGNITION; TASK-SET; SWITCH; DISSOCIATION; RETRIEVAL; DEACTIVATION; CONNECTIVITY	Cognitive processes do not occur in isolation. Interactions between cognitive processes can be observed as a cost in performance following a switch between tasks, a cost that is greatest when the cognitive requirements of the sequential tasks compete. Interestingly, the long-term mnemonic goals associated with specific cognitive tasks can also directly compete. For example, encoding the sequential order in which stimuli are presented in the commonly-utilised 2-Back working memory (WM) tasks is counter-productive to task performance, as this task requires the continual updating of the contents of one's current mental set. Performance of this task consistently results in reduced activity within the medial temporal lobe (MTL), and this response is believed to reflect the inhibitory mnemonic component of the task. Conversely, there are numerous cognitive paradigms in which participants are explicitly instructed to encode incoming information and performance of these tasks reliably increases MTL activity. Here, we explore the behavioural cost of sequentially performing two tasks with conflicting long-term mnemonic goals and contrasting neural profiles within the MTL. We hypothesised that performing the 2-Back WM prior to a hippocampal-dependent memory task would impair performance on the latter task. We found that participants who performed the 2-Back WM task, prior to the encoding of novel verbal/face-name stimuli, recollected significantly fewer of these stimuli, compared to those who had performed a 0-Back control task. Memory processes believed to be independent of the MTL were unaffected. Our results suggest that the inhibition of MTL-dependent mnemonic function persists beyond the cessation of the 2-Back WM task and can alter performance on entirely separate and subsequently performed memory tasks. Furthermore, they indicate that performance of such tasks may induce a temporarily-sustained, virtual lesion of the hippocampus, which could be used as a probe to explore cognitive processes in the absence of hippocampal involvement.	[Mullally, Sinead L.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Mullally, SL (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	s.mullally@ucl.ac.uk; smomara@tcd.ie		Mullally, Sinead/0000-0002-4234-3445; O'Mara, Shane/0000-0001-8087-8531	Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority	Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority	This work was funded under a Programme for Research in Third-Level Institutions - Cycle 3 from the Higher Education Authority (O'Mara/Robertson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; Arbuthnott K, 2000, CAN J EXP PSYCHOL, V54, P33, DOI 10.1037/h0087328; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchner A, 2000, COGNITIVE PSYCHOL, V40, P227, DOI 10.1006/cogp.1999.0731; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; De Jong R, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P357; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Duncan K, 2012, SCIENCE, V337, P485, DOI 10.1126/science.1221936; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Gilbert SJ, 2002, COGNITIVE PSYCHOL, V44, P297, DOI 10.1006/cogp.2001.0770; Giovanello KS, 2003, COGN AFFECT BEHAV NE, V3, P186, DOI 10.3758/CABN.3.3.186; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; KEANE MM, 1995, BRAIN, V118, P1129, DOI 10.1093/brain/118.5.1129; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Levy BJ, 2008, ACTA PSYCHOL, V127, P623, DOI 10.1016/j.actpsy.2007.12.004; Mayes AR, 1998, BEHAV NEUROL, V11, P163; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2000, PSYCHOL RES-PSYCH FO, V63, P250, DOI 10.1007/s004269900005; Mullally SL, 2005, J COGNITIVE NEUROSCI, P103; Nelson HE., 1982, NATL ADULT READING T; Nieuwenhuis S, 2002, PSYCHON B REV, V9, P86, DOI 10.3758/BF03196259; Nyberg L, 1996, J NEUROSCI, V16, P3753; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paz-Alonso PM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.024.2009; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roediger H. L., 1993, HANDB NEUR, P63; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Suzuki WA, 2008, PROG BRAIN RES, V169, P305, DOI 10.1016/S0079-6123(07)00019-2; Thorndike E.L., 1944, TEACHERS WORD BOOK 3; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wais PE, 2008, NEUROPSYCHOLOGIA, V46, P3185, DOI 10.1016/j.neuropsychologia.2008.08.025; WARRINGTON EK, 1974, NEUROPSYCHOLOGIA, V12, P419, DOI 10.1016/0028-3932(74)90072-4; Wu X, 2008, NEUROREPORT, V19, P483, DOI 10.1097/WNR.0b013e3282f6030b; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	67	6	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e50814	10.1371/journal.pone.0050814	http://dx.doi.org/10.1371/journal.pone.0050814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23341876	Green Published, gold			2022-12-27	WOS:000313682700006
J	Hyun, MH; Lee, CH; Kang, MH; Park, BK; Lee, YH				Hyun, Myung-Han; Lee, Chung-Ho; Kang, Min-Hyung; Park, Bong-Kyung; Lee, Young Ho			Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Asthma: A Meta-Analysis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; ASSOCIATION; IL-10; RECEPTOR; INFLAMMATION; CHILDREN; DISEASE; REGION; SENSITIZATION	Objective: The aim of this study was to explore whether the interleukin (IL)-10 polymorphisms and their haplotypes contribute to asthma susceptibility. Methods: MEDLINE, EMBASE and the COCHRANE library databases were utilized to identify available articles. A meta-analysis was conducted on IL-10 -1082 G/A, -819 C/T, -592 C/A polymorphisms, and their haplotypes and asthma. Results: Eleven studies involving 2,215 asthma patients and 2,170 controls were considered in the meta-analysis. The meta-analysis revealed no association between asthma and the IL-10 -1082 G allele [Odds ratio (OR) = 0.87, 95% Confidence interval (CI) = 0.68-1.12, p = 0.28]. However, meta-analysis of the five studies in Hardy-Weinburg equilibrium produced the relationship between the IL-10 -1082 G allele and asthma (OR = 0.71, 95% CI = 0.60-0.83, p, 0.0001). Stratification by ethnicity indicated an association between the IL-10 -1082 G allele and asthma in East Asians (OR = 0.74, 95% CI = 0.57-0.96, p = 0.02), but not in West Asians. Furthermore, stratification by age indicated an association between the IL-10 -1082 G allele and asthma in adults and mixed groups (OR = 0.77, 95% CI = 0.62-0.96, p = 0.02; OR = 0.67, 95% CI = 0.49-0.92, p = 0.01). No association was found between asthma and IL-10 -819 C/T and IL-10 -592 C/A polymorphisms and their haplotypes. Conclusion: The IL-10 -1082 G/A polymorphism confers susceptibility to asthma in East Asians and in adults. However, the IL-10 -819 C/T, -592 C/A polymorphisms and their haplotypes are not associated with asthma.	[Hyun, Myung-Han; Lee, Chung-Ho; Kang, Min-Hyung; Park, Bong-Kyung; Lee, Young Ho] Korea Univ, Coll Med, Seoul 136705, South Korea; [Lee, Young Ho] Korea Univ, Coll Med, Dept Internal Med, Anam Hosp,Div Rheumatol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, YH (corresponding author), Korea Univ, Coll Med, Seoul 136705, South Korea.	lyhcgh@korea.ac.kr		Lee, Young Ho/0000-0003-4213-1909	Korea University	Korea University	This study was supported by a grant from Korea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Arima M, KOREAN J INTERN MED, V26, P8; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Bottema RWB, 2010, J ALLERGY CLIN IMMUN, V126, P338, DOI 10.1016/j.jaci.2010.04.024; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chatterjee R, 2005, CLIN EXP ALLERGY, V35, P914, DOI 10.1111/j.1365-2222.2005.02273.x; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djukanovic R, 2000, J ALLERGY CLIN IMMUN, V105, pS522, DOI 10.1016/S0091-6749(00)90055-1; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskdale J, 1997, TISSUE ANTIGENS, V49, P635, DOI 10.1111/j.1399-0039.1997.tb02812.x; Gruber SG, 2008, EUR J IMMUNOL, V38, P3365, DOI 10.1002/eji.200837718; Guzowski Dorothy, 2005, J Biomol Tech, V16, P154; Hakimizadeh E, 2012, CLIN LAB, V58, P267; Hang LW, 2003, J CLIN LAB ANAL, V17, P168, DOI 10.1002/jcla.10088; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958, DOI 10.1164/ajrccm.158.6.9804011; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Hussein YM, 2011, ANN ALLERG ASTHMA IM, V106, P474, DOI 10.1016/j.anai.2011.02.021; Karjalainen J, 2003, CLIN EXP ALLERGY, V33, P78, DOI 10.1046/j.1365-2222.2003.01577.x; Kim KW, 2011, LUNG, V189, P417, DOI 10.1007/s00408-011-9312-5; KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Lee YH, 2006, RHEUMATOL INT, V27, P157, DOI 10.1007/s00296-006-0175-7; Lee YH, 2012, MOL BIOL REP, V39, P81, DOI 10.1007/s11033-011-0712-7; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mormann M, 2004, GENES IMMUN, V5, P246, DOI 10.1038/sj.gene.6364073; Movahedi M, 2008, J ASTHMA, V45, P790, DOI 10.1080/02770900802207261; Nath SK, 2005, HUM GENET, V118, P225, DOI 10.1007/s00439-005-0044-6; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Park BL, 2004, J HUM GENET, V49, P517, DOI 10.1007/s10038-004-0184-x; Peng WJ, 2012, MOL BIOL REP, V39, P6851, DOI 10.1007/s11033-012-1510-6; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P586; TAGA K, 1992, J IMMUNOL, V148, P1143; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Trajkov D, 2009, IRAN J ALLERGY ASTHM, V8, P31, DOI 08.01/ijaai.3142; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Zedan M, 2008, ALLERGY ASTHMA PROC, V29, P268, DOI 10.2500/aap.2008.29.3123	44	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53758	10.1371/journal.pone.0053758	http://dx.doi.org/10.1371/journal.pone.0053758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335974	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700030
J	Shiryaev, SA; Chernov, AV; Golubkov, VS; Thomsen, ER; Chudin, E; Chee, MS; Kozlov, IA; Strongin, AY; Cieplak, P				Shiryaev, Sergey A.; Chernov, Andrei V.; Golubkov, Vladislav S.; Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.; Strongin, Alex Y.; Cieplak, Piotr			High-Resolution Analysis and Functional Mapping of Cleavage Sites and Substrate Proteins of Furin in the Human Proteome	PLOS ONE			English	Article							INTEGRIN ALPHA(V) SUBUNIT; PROPROTEIN CONVERTASES; ACTIVATION; EXPRESSION; INHIBITORS; RECEPTOR; DATABASE; MT1-MMP; ENZYMES; VIRUSES	Background: There is a growing appreciation of the role of proteolytic processes in human health and disease, but tools for analysis of such processes on a proteome-wide scale are limited. Furin is a ubiquitous proprotein convertase that cleaves after basic residues and transforms secretory proproteins into biologically active proteins. Despite this important role, many furin substrates remain unknown in the human proteome. Methodology/Principal Findings: We devised an approach for proteinase target identification that combines an in silico discovery pipeline with highly multiplexed proteinase activity assays. We performed in silico analysis of the human proteome and identified over 1,050 secretory proteins as potential furin substrates. We then used a multiplexed protease assay to validate these tentative targets. The assay was carried out on over 3,260 overlapping peptides designed to represent P7-P1' and P4-P4' positions of furin cleavage sites in the candidate proteins. The obtained results greatly increased our knowledge of the unique cleavage preferences of furin, revealed the importance of both short-range (P4-P1) and long-range (P7-P6) interactions in defining furin cleavage specificity, demonstrated that the R-X-R/K/X-R down arrow motif alone is insufficient for predicting furin proteolysis of the substrate, and identified similar to 490 potential protein substrates of furin in the human proteome. Conclusions/Significance: The assignment of these substrates to cellular pathways suggests an important role of furin in development, including axonal guidance, cardiogenesis, and maintenance of stem cell pluripotency. The novel approach proposed in this study can be readily applied to other proteinases.	[Shiryaev, Sergey A.; Chernov, Andrei V.; Golubkov, Vladislav S.; Strongin, Alex Y.; Cieplak, Piotr] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Thomsen, Elliot R.; Chudin, Eugene; Chee, Mark S.; Kozlov, Igor A.] Prognosys Biosci Inc, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Cieplak, P (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	strongin@sanfordburnham.org; pcieplak@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017; Chernov, Andrei/I-1623-2019	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418	National Institutes of Health (NIH) [R43GM085884, R01CA83017, R01CA157328, R01GM98835]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835, R43GM085884] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants R43GM085884 (IAK), R01CA83017 and R01CA157328 (AYS), and R01GM98835 (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; [Anonymous], ING PATHW AN IPA SYS; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Becker GL, 2012, J BIOL CHEM, V287, P21992, DOI 10.1074/jbc.M111.332643; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Case D.A., 2022, AMBER 2020; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 1997, J CELL SCI, V110, P2473; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Forneris F, 2012, CURR OPIN STRUCT BIO; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Gawlik K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011305; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kim W, 2012, MOL CELL BI IN PRESS; Kozlov IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037441; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; Rother K, 1998, COMPLEMENT SYSTEM; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040029, 10.1371/journal.pone.0035759]; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sun XW, 2011, J BIOL CHEM, V286, P29063, DOI 10.1074/jbc.M111.242479; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060; Turpeinen H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-618	55	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54290	10.1371/journal.pone.0054290	http://dx.doi.org/10.1371/journal.pone.0054290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335997	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700055
J	Casteran, M; Manckoundia, P; Pozzo, T; Thomas, E				Casteran, Matthieu; Manckoundia, Patrick; Pozzo, Thierry; Thomas, Elizabeth			Alterations with Movement Duration in the Kinematics of a Whole Body Pointing Movement	PLOS ONE			English	Article							MUSCLE ACTIVATION; ARM; SPEED; COORDINATION; AMPLITUDE; SEGMENTS; TRUNK; FALLS	Our aim was to investigate how the organization of a whole body movement is altered when movement duration (MD) is varied. Subjects performed the same whole body pointing movement over long, normal and short MDs. The kinematic trajectories were then analyzed on a normalized time base. A principal components analysis (PCA) revealed that the degree of coordination between the elevation angles of the body did not change with MD. This lack of significant differences in the coordination was interesting given that small spatial and temporal differences were observed in the individual kinematic trajectories. They were revealed by studying the trajectories of the elevation angles, joint markers and center of mass. The elevation angle excursions displayed modifications primarily in their spatial characteristics. These alterations were more marked for the short rather than long duration movements. The temporal characteristics of the elevation angles as measured by the time to peak of angular velocity were not modified in the same fashion hence displaying a dissociation in the tuning of the spatial and temporal aspects of the elevation angles. Modifications in the temporal characteristics of the movement were also studied by examining the velocity profiles of the joint markers. Interestingly, unlike the disordered nature of this variable for the elevation angles, the time to peak velocity was neatly ordered as a function of MD for the joint markers - It arrived first for the short duration movements, followed by those of the normal and finally long duration movements. Despite the modifications observed in the kinematic trajectories, a PCA with the elevation angle excursions at different MDs revealed that two principal components were sufficient to account for nearly all the variance in the data. Our results suggest that although similar, the kinematic trajectories at different MDs are not achieved by a simple time scaling.	[Casteran, Matthieu; Manckoundia, Patrick; Pozzo, Thierry; Thomas, Elizabeth] Univ Bourgogne, INSERM, U1093, UFR STAPS, Dijon, France; [Manckoundia, Patrick] Ctr Hosp Univ, Hop Champmaillot, Serv Med Interne Geriatrie, Dijon, France; [Pozzo, Thierry] Italian Inst Technol, Genoa, Italy; [Pozzo, Thierry] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Istituto Italiano di Tecnologia - IIT; Institut Universitaire de France	Thomas, E (corresponding author), Univ Bourgogne, INSERM, U1093, UFR STAPS, Dijon, France.	Elizabeth.Thomas@u-bourgogne.fr		Pozzo, Thierry/0000-0002-0585-7965; Casteran, Matthieu/0000-0001-8077-0707	Institut National de la Sante et de la Recherche Medicale de France; Conseil Regional de Bourgogne;  [ANR-10-ORAR-006-03]	Institut National de la Sante et de la Recherche Medicale de France; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); 	Matthieu Casteran was supported by a doctoral grant from the Institut National de la Sante et de la Recherche Medicale de France and the Conseil Regional de Bourgogne. Elizabeth Thomas was supported by the ANR-10-ORAR-006-03. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandrov A, 1998, EXP BRAIN RES, V118, P210, DOI 10.1007/s002210050274; ATKESON CG, 1985, J NEUROSCI, V5, P2318; Bernstein N, 1967, COORDINATION REGULAT; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Boulgarides LK, 2003, PHYS THER, V83, P328, DOI 10.1093/ptj/83.4.328; Brooks V.B., 1986, NEURAL BASIS MOTOR C; BUNEO CA, 1994, J NEUROPHYSIOL, V71, P1546, DOI 10.1152/jn.1994.71.4.1546; Chiovetto E, 2010, NEUROSCIENCE, V170, P1223, DOI 10.1016/j.neuroscience.2010.07.006; CORCOS DM, 1989, J NEUROPHYSIOL, V62, P358, DOI 10.1152/jn.1989.62.2.358; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FLANDERS M, 1992, J NEUROPHYSIOL, V67, P931, DOI 10.1152/jn.1992.67.4.931; Gaveau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022045; GOTTLIEB GL, 1989, BEHAV BRAIN SCI, V12, P189, DOI 10.1017/S0140525X00048238; Gottlieb GL, 1996, J NEUROPHYSIOL, V75, P1760, DOI 10.1152/jn.1996.75.4.1760; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Houles M, 2010, CAH ANNEE GERONTOL, V2, P13, DOI 10.1007/s12612-009-0036-6; Jolliffe I.T., 1986, PRINCIPAL COMPONENT; Nishikawa KC, 1999, J NEUROPHYSIOL, V81, P2582, DOI 10.1152/jn.1999.81.5.2582; Paizis C, 2008, BEHAV NEUROSCI, V122, P1361, DOI 10.1037/a0013280; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Pozzo T, 2002, EXP BRAIN RES, V144, P343, DOI 10.1007/s00221-002-1052-6; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Schillings JJ, 1996, J MOTOR BEHAV, V28, P241, DOI 10.1080/00222895.1996.9941749; Schmid M, 2006, NEUROSCIENCE, V139, P909, DOI 10.1016/j.neuroscience.2005.12.060; Schmidt RA, 2005, MOTOR CONTROL LEARNI; SERGIO LE, 1994, EXP BRAIN RES, V97, P551; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; SOECHTING JF, 1981, J NEUROSCI, V1, P710, DOI 10.1523/JNEUROSCI.01-07-00710.1981; Stapley PJ, 1999, EXP BRAIN RES, V129, P134, DOI 10.1007/s002210050944; Thomas JS, 2005, J NEUROPHYSIOL, V93, P352, DOI 10.1152/jn.00582.2004; Thomas JS, 2003, EXP BRAIN RES, V148, P377, DOI 10.1007/s00221-002-1287-2; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Torres EB, 2002, J NEUROPHYSIOL, V88, P2355, DOI 10.1152/jn.00030.2002; Torres EB, 2011, EXP BRAIN RES, V215, P269, DOI 10.1007/s00221-011-2892-8; Torres EB, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-21; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52477	10.1371/journal.pone.0052477	http://dx.doi.org/10.1371/journal.pone.0052477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341899	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400016
J	Gerdts, C; Vohra, D; Ahern, J				Gerdts, Caitlin; Vohra, Divya; Ahern, Jennifer			Measuring Unsafe Abortion-Related Mortality: A Systematic Review of the Existing Methods	PLOS ONE			English	Review							MATERNAL MORTALITY; VERBAL AUTOPSY; SENSITIVITY-ANALYSIS; DEATHS; TRENDS; CARE; MORBIDITY; PREGNANCY; MATLAB; REGISTRATION	Background: The WHO estimates that 13% of maternal mortality is due to unsafe abortion, but challenges with measurement and data quality persist. To our knowledge, no systematic assessment of the validity of studies reporting estimates of abortion-related mortality exists. Study Design: To be included in this study, articles had to meet the following criteria: (1) published between September 1st, 2000-December 1st, 2011; (2) utilized data from a country where abortion is "considered unsafe"; (3) specified and enumerated causes of maternal death including "abortion"; (4) enumerated >= 100 maternal deaths; (5) a quantitative research study; (6) published in a peer-reviewed journal. Results: 7,438 articles were initially identified. Thirty-six studies were ultimately included. Overall, studies rated "Very Good" found the highest estimates of abortion related mortality (median 16%, range 1-27.4%). Studies rated "Very Poor" found the lowest overall proportion of abortion related deaths (median: 2%, range 1.3-9.4%). Conclusions: Improvements in the quality of data collection would facilitate better understanding global abortion-related mortality. Until improved data exist, better reporting of study procedures and standardization of the definition of abortion and abortion-related mortality should be encouraged.	[Gerdts, Caitlin; Ahern, Jennifer] Univ Calif San Francisco, Adv New Stand Reprod Hlth, San Francisco, CA 94143 USA; [Gerdts, Caitlin; Vohra, Divya] Univ Calif Berkeley, Div Epidemiol, Berkeley Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Gerdts, C (corresponding author), Univ Calif San Francisco, Adv New Stand Reprod Hlth, San Francisco, CA 94143 USA.	cgerdts@obgyn.ucsf.edu		Ahern, Jennifer/0000-0002-3853-9760	University of California, Berkeley; Bixby Center for Population, Health, and Sustainability	University of California, Berkeley(University of California System); Bixby Center for Population, Health, and Sustainability	Funding for the doctoral dissertation by Caitlin Gerdts was provided by the University of California, Berkeley, Bixby Center for Population, Health, and Sustainability. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady ES, 2007, J OBSTET GYNAECOL RE, V33, P283, DOI 10.1111/j.1447-0756.2007.00525.x; AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; AbouZahr C, 2006, BR MED B, V67, P1; AbouZahr C, 2011, REPROD HEALTH MATTER, V19, P117, DOI 10.1016/S0968-8080(11)37550-7; Aboyeji AP, 2007, TROP DOCT, V37, P83, DOI 10.1258/004947507780609167; Adler AJ, 2012, INT J GYNECOL OBSTET, V118, pS65, DOI 10.1016/S0020-7292(12)60003-4; Ahman E, 2011, INT J GYNECOL OBSTET, V115, P121, DOI 10.1016/j.ijgo.2011.05.027; Alka P, 2011, J OBSTET GYN INDIA, V61, P280; Almerie MQ, 2011, INT J GYNECOL OBSTET, V112, P70, DOI 10.1016/j.ijgo.2010.08.007; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; Bell JS, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2008.02085.x; Bergsjo P, 2010, ACTA OBSTET GYN SCAN, V89, P789, DOI 10.3109/00016341003801664; Betran AP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-131; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; CATES W, 1982, JAMA-J AM MED ASSOC, V248, P192, DOI 10.1001/jama.248.2.192; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Chhabra S, 2004, J Obstet Gynaecol, V24, P40, DOI 10.1080/01443610310001620279; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Daramola A, 2005, E AFR MED J, V82; Fabamwo Adetokunbo Olusegun, 2009, Afr J Reprod Health, V13, P139; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Garenne M, 1997, AFR J REPROD HLTH, V1; Geelhoed DW, 2003, EUR J OBSTET GYN R B, V107, P135, DOI 10.1016/S0301-2115(02)00224-5; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Granja ACL, 2001, J ADOLESCENT HEALTH, V28, P303, DOI 10.1016/S1054-139X(00)00205-6; Greenland S, 2001, RISK ANAL, V21, P579, DOI 10.1111/0272-4332.214136; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P162, DOI 10.2471/BLT.06.030627; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Iyengar K, 2009, J HEALTH POPUL NUTR, V27, P293; Jafarey SN, 2009, J HEALTH POPUL NUTR, V27, P170; Jain V, 2004, J OBSTET GYNAECOL RE, V30, P197, DOI 10.1111/j.1447-0756.2004.00183.x; Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45; Kao SY, 1997, ACTA OBSTET GYN SCAN, V76, P629, DOI 10.3109/00016349709024602; Kaye DK, 2006, TROP MED INT HEALTH, V11, P90, DOI 10.1111/j.1365-3156.2005.01531.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kullima A, 2010, J OBSTET GYNECOL, V8; Lash TL, 2003, EPIDEMIOLOGY, V14, P451, DOI 10.1097/01.EDE.0000071419.41011.cf; Lema V, 2005, E AFR MED J, V82; Mariaga A, 2009, E AFR MED J, V86; McCaw-Binns A, 2008, INT J GYNECOL OBSTET, V100, P31, DOI 10.1016/j.ijgo.2007.06.054; McCaw-Binns A, 2007, INT J GYNECOL OBSTET, V96, P226, DOI 10.1016/j.ijgo.2006.12.002; Mogobe KD, 2007, REPROD HEALTH MATTER, V15, P163, DOI 10.1016/S0968-8080(07)30330-3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mswia R, 2003, B WORLD HEALTH ORGAN, V81, P87; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27; Oi AF, 2007, SEX HLTH MATTERS, V8, P59; Okonta P I, 2002, J Obstet Gynaecol, V22, P626, DOI 10.1080/0144361021000020394; Oyieke J B O, 2006, East Afr Med J, V83, P4; Panchabhai TS, 2009, J POSTGRAD MED, V55, P8, DOI 10.4103/0022-3859.48434; Phillips CV, 2003, EPIDEMIOLOGY, V14, P459, DOI 10.1097/01.ede.0000072106.65262.ae; Prata N, 2012, REPROD HEALTH MATTER, V20, P196, DOI 10.1016/S0968-8080(12)39606-7; Ramos S, 2007, B WORLD HEALTH ORGAN, V85, P615, DOI 10.2471/BLT.06.032334; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Rasch V, 2009, TROP MED INT HEALTH, V14, P1128, DOI 10.1111/j.1365-3156.2009.02327.x; Rossier C, 2003, STUD FAMILY PLANN, V34, P87, DOI 10.1111/j.1728-4465.2003.00087.x; Say L, 2011, BJOG-INT J OBSTET GY, V118, P15, DOI 10.1111/j.1471-0528.2011.03105.x; Say L, 2008, IPPF MED B, V42; Sedgh G, 2007, INT FAM PLAN PERSPEC, V33, P106, DOI 10.1363/3310607; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Shah I, 2009, J OBSTET GYNAECOL CA, V31, P1149, DOI 10.1016/S1701-2163(16)34376-6; SHAHIDULLAH M, 1995, INT J EPIDEMIOL, V24, P937, DOI 10.1093/ije/24.5.937; Shaw D, 2010, BEST PRACT RES CL OB, V24, P633, DOI 10.1016/j.bpobgyn.2010.02.009; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Sloan NL, 2001, B WORLD HEALTH ORGAN, V79, P805; Supratikto G, 2002, B WORLD HEALTH ORGAN, V80, P228; Ujah I A O, 2005, Afr J Reprod Health, V9, P27; Verma K, 2001, J OBSTET GYNAECOL RE, V27, P183, DOI 10.1111/j.1447-0756.2001.tb01249.x; Walker D, 2004, REPROD HEALTH MATTER, V12, P27, DOI 10.1016/S0968-8080(04)24019-8; WHO, 2010, UNS AB GLOB REG EST; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 1993, ICD 10 INT CLASS DIS; Zakariah AY, 2006, ACTA OBSTET GYN SCAN, V85, P1436, DOI 10.1080/00016340601040902; Zakariah Afisah Yakubu, 2009, Reprod Health, V6, P7, DOI 10.1186/1742-4755-6-7	78	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53346	10.1371/journal.pone.0053346	http://dx.doi.org/10.1371/journal.pone.0053346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341939	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400041
J	Pervin, S; Hewison, M; Braga, M; Tran, L; Chun, R; Karam, A; Chaudhuri, G; Norris, K; Singh, R				Pervin, Shehla; Hewison, Martin; Braga, Melissa; Lac Tran; Chun, Rene; Karam, Amer; Chaudhuri, Gautam; Norris, Keith; Singh, Rajan			Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy	PLOS ONE			English	Article							NITRIC-OXIDE; STEM-CELLS; PROSPECTIVE IDENTIFICATION; EXPRESSION; PATHWAY; BETA; RISK; VDR; DIFFERENTIATION; POLYMORPHISMS	Vitamin D signaling in mammary cancer stem cells (MCSCs), which are implicated in the initiation and progression of breast cancer, is poorly understood. In this study, we examined vitamin D signaling in mammospheres which are enriched in MCSCs from established breast cancer cell lines. Breast cancer cells positive for aldehyde dehydrogenase (ALDH(+)) had increased ability to form mammospheres compared to ALDH(-) cells. These mammospheres expressed MCSC-specific markers and generated transplantable xenografts in nude mice. Vitamin D receptor (VDR) was significantly down-regulated in mammospheres, as well as in ALDH+ breast cancer cells. TN aggressive human breast tumors as well as transplantable xenografts obtained from SKBR3 expressed significantly lower levels of VDR but higher levels of CD44 expression. Snail was up-regulated in mammospheres isolated from breast cancer cells. Inhibition of VDR expression by siRNA led to a significant change in key EMT-specific transcription factors and increased the ability of these cells to form mammospheres. On the other hand, over-expression of VDR led to a down-regulation of Snail but increased expression of E-cad and significantly compromised the ability of cells to form mammospheres. Mammospheres were relatively insensitive to treatment with 1,25-dihydroxyvitamin D (1,25D), the active form of vitamin D, compared to more differentiated cancer cells grown in presence of serum. Treatment of H-Ras transformed HMLEHRas cells with DETA NONOate, a nitric oxide (NO)-donor led to induction of MAP-kinase phosphatase-1 (MKP-1) and dephosphorylation of ERK1/2 in the mammospheres. Combined treatment of these cells with 1,25D and a low-concentration of DETA NONOate led to a significant decrease in the overall size of mammospheres and reduced tumor volume in nude mice. Our findings therefore, suggest that combination therapy using 1,25D with drugs specifically targeting key survival pathways in MCSCs warrant testing in prospective clinical trial for treatment of aggressive breast cancer.	[Pervin, Shehla; Braga, Melissa; Lac Tran; Norris, Keith; Singh, Rajan] Charles R Drew Univ Med & Sci, Dept Internal Med, Los Angeles, CA 90059 USA; [Pervin, Shehla; Karam, Amer; Chaudhuri, Gautam; Singh, Rajan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Hewison, Martin; Chun, Rene] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Pervin, Shehla; Chaudhuri, Gautam; Singh, Rajan] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pervin, S (corresponding author), Charles R Drew Univ Med & Sci, Dept Internal Med, 1621 E 120th St, Los Angeles, CA 90059 USA.	shehlapervin@cdrewu.edu; rajansingh@mednet.ucla.edu	Chun, Rene/A-9415-2010	Chun, Rene/0000-0002-0190-0807; Karam, Amer/0000-0003-1511-5583	National Institutes of Health [SC1 AG033407-01A1, 1SC1 CA165865-01A1]; MSI endowment [5S2MD000103]; NATIONAL CANCER INSTITUTE [SC1CA165865, U54CA143931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [SC1AG033407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSI endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by National Institutes of Health grants SC1 AG033407-01A1 (RS); 1SC1 CA165865-01A1 (SP) and in part by MSI endowment (5S2MD000103, sub award RS) to Charles Drew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2006, ANTICANCER RES, V26, P2557; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Bai SC, 2010, J BONE MINER RES, V25, P830, DOI 10.1359/jbmr.091010; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165; Jeanson NT, 2010, BLOOD, V116, P4126, DOI 10.1182/blood-2010-04-280552; Jensen JD, 2010, CLIN DERMATOL, V28, P644, DOI 10.1016/j.clindermatol.2010.03.026; Larriba MJ, 2010, J STEROID BIOCHEM, V121, P106, DOI 10.1016/j.jsbmb.2010.01.014; Johnson J, 2011, MOL NUTR FOOD RES, V55, P58, DOI 10.1002/mnfr.201000420; Kemmis CM, 2008, J CELL BIOCHEM, V105, P980, DOI 10.1002/jcb.21896; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Krishnan AV, 2010, J STEROID BIOCHEM, V121, P343, DOI 10.1016/j.jsbmb.2010.02.009; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Larriba MJ, 2005, BRIT J CANCER, V92, P985, DOI 10.1038/sj.bjc.6602484; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Narvaez CJ, 2001, STEROIDS, V66, P301, DOI 10.1016/S0039-128X(00)00202-6; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perez-Lopez FR, 2009, REPROD SCI, V16, P7, DOI 10.1177/1933719108327595; Pervin S, 2003, CANCER RES, V63, P8853; Pervin S, 2003, CANCER RES, V63, P5470; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Samuni Y, 2009, FREE RADICAL BIO MED, V47, P419, DOI 10.1016/j.freeradbiomed.2009.05.011; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Swami Srilatha, 2011, Hormones & Cancer, V2, P190, DOI 10.1007/s12672-011-0073-7; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; To K, 2010, CANCER RES, V70; Toner CD, 2010, J AM DIET ASSOC, V110, P1492, DOI 10.1016/j.jada.2010.07.007; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Yin L, 2011, GYNECOL ONCOL, V121, P369, DOI 10.1016/j.ygyno.2011.01.023; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zhang ZT, 2010, J CELL PHYSIOL, V224, P433, DOI 10.1002/jcp.22139	48	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53287	10.1371/journal.pone.0053287	http://dx.doi.org/10.1371/journal.pone.0053287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341935	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400039
J	Psomopoulos, FE; Mitkas, PA; Ouzounis, CA				Psomopoulos, Fotis E.; Mitkas, Pericles A.; Ouzounis, Christos A.			Detection of Genomic Idiosyncrasies Using Fuzzy Phylogenetic Profiles	PLOS ONE			English	Article							COMPUTATIONAL GENOMICS; FUNCTIONAL LINKAGES; DATA ENVIRONMENT; EVOLUTION; SEQUENCE; GENES; PREDICTION; BACTERIAL; PATHWAYS; IDENTIFICATION	Phylogenetic profiles express the presence or absence of genes and their homologs across a number of reference genomes. They have emerged as an elegant representation framework for comparative genomics and have been used for the genome-wide inference and discovery of functionally linked genes or metabolic pathways. As the number of reference genomes grows, there is an acute need for faster and more accurate methods for phylogenetic profile analysis with increased performance in speed and quality. We propose a novel, efficient method for the detection of genomic idiosyncrasies, i.e. sets of genes found in a specific genome with peculiar phylogenetic properties, such as intra-genome correlations or inter-genome relationships. Our algorithm is a four-step process where genome profiles are first defined as fuzzy vectors, then discretized to binary vectors, followed by a de-noising step, and finally a comparison step to generate intra-and inter-genome distances for each gene profile. The method is validated with a carefully selected benchmark set of five reference genomes, using a range of approaches regarding similarity metrics and pre-processing stages for noise reduction. We demonstrate that the fuzzy profile method consistently identifies the actual phylogenetic relationship and origin of the genes under consideration for the majority of the cases, while the detected outliers are found to be particular genes with peculiar phylogenetic patterns. The proposed method provides a time-efficient and highly scalable approach for phylogenetic stratification, with the detected groups of genes being either similar to their own genome profile or different from it, thus revealing atypical evolutionary histories.	[Psomopoulos, Fotis E.; Mitkas, Pericles A.] Aristotle Univ Thessaloniki, Dept Elect & Comp Engn, GR-54006 Thessaloniki, Greece; [Ouzounis, Christos A.] Kings Coll London, Sch Nat & Math Sci, Dept Informat, Ctr Bioinformat, London WC2R 2LS, England	Aristotle University of Thessaloniki; University of London; King's College London	Ouzounis, CA (corresponding author), Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Computat Genom Unit, Thessaloniki, Greece.	ouzounis@certh.gr	Psomopoulos, Fotis/E-9995-2013; Ouzounis, Christos A/G-2302-2010	Psomopoulos, Fotis/0000-0002-0222-4273; Ouzounis, Christos A/0000-0002-0086-8657	FP6 Network of Excellence ENFIN [LSHG-CT-2005-518254]; FP7 Collaborative Project MICROME [222886-2]; European Commission	FP6 Network of Excellence ENFIN; FP7 Collaborative Project MICROME; European Commission(European CommissionEuropean Commission Joint Research Centre)	Parts of this work have been supported by the FP6 Network of Excellence ENFIN (contract # LSHG-CT-2005-518254) and the FP7 Collaborative Project MICROME (grant agreement # 222886-2), both funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Freilich S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-355; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goldovsky L, 2005, BIOINFORMATICS, V21, P3806, DOI 10.1093/bioinformatics/bti579; Gonzalez O, 2008, BIOINFORMATICS, V24, P1257, DOI 10.1093/bioinformatics/btn106; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Janssen P, 2003, BIOINFORMATICS, V19, P1451, DOI 10.1093/bioinformatics/btg161; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Karimpour-Fard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-393; Kastenmuller G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r28; Kunin V, 2005, NUCLEIC ACIDS RES, V33, P616, DOI 10.1093/nar/gki181; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mikkelsen TS, 2005, BIOINFORMATICS, V21, P464, DOI 10.1093/bioinformatics/bti027; Moreno-Hagelsieb G, 2008, PROTEINS, V70, P344, DOI 10.1002/prot.21564; Ouzounis C, 1996, FEBS LETT, V390, P119, DOI 10.1016/0014-5793(96)00631-X; Ouzounis CA, 2006, RES MICROBIOL, V157, P57, DOI 10.1016/j.resmic.2005.06.015; Ouzounis CA, 2003, NAT REV GENET, V4, P508, DOI 10.1038/nrg1113; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Saikolappan S, 2009, J BACTERIOL, V191, P6675, DOI 10.1128/JB.01066-08; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Smith M, 2005, BIOINFORMATICS, V21, P3429, DOI 10.1093/bioinformatics/bti548; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Steimann F, 1997, ARTIF INTELL MED, V11, P1; Sun JC, 2007, BIOCHEM BIOPH RES CO, V353, P985, DOI 10.1016/j.bbrc.2006.12.146; Tamames J, 1997, J MOL EVOL, V44, P66, DOI 10.1007/PL00006122; Tamura M, 2008, BIOINFORMATICS, V24, P1523, DOI 10.1093/bioinformatics/btn210; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52854	10.1371/journal.pone.0052854	http://dx.doi.org/10.1371/journal.pone.0052854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341912	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400023
J	Walzer, C; Kowalczyk, C; Alexander, JM; Baur, B; Bogliani, G; Brun, JJ; Fureder, L; Guth, MO; Haller, R; Holderegger, R; Kohler, Y; Kueffer, C; Righetti, A; Spaar, R; Sutherland, WJ; Ullrich-Schneider, A; Vanpeene-Bruhier, SN; Scheurer, T				Walzer, Chris; Kowalczyk, Christine; Alexander, Jake M.; Baur, Bruno; Bogliani, Giuseppe; Brun, Jean-Jacques; Fuereder, Leopold; Guth, Marie-Odile; Haller, Ruedi; Holderegger, Rolf; Kohler, Yann; Kueffer, Christoph; Righetti, Antonio; Spaar, Reto; Sutherland, William J.; Ullrich-Schneider, Aurelia; Vanpeene-Bruhier, Sylvie N.; Scheurer, Thomas			The 50 Most Important Questions Relating to the Maintenance and Restoration of an Ecological Continuum in the European Alps	PLOS ONE			English	Article							CONSERVATION; SCIENCE; POLICY; IDENTIFICATION; MANAGEMENT; RELEVANT; NEED	The European Alps harbour a unique and species-rich biodiversity, which is increasingly impacted by habitat fragmentation through land-use changes, urbanization and expanding transport infrastructure. In this study, we identified the 50 most important questions relating to the maintenance and restoration of an ecological continuum - the connectedness of ecological processes across many scales including trophic relationship and disturbance processes and hydro-ecological flows in the European Alps. We initiated and implemented a trans-national priority setting exercise, inviting 48 institutions including researchers, conservation practitioners, NGOs, policymakers and administrators from the Alpine region. The exercise was composed of an initial call for pertinent questions, a first online evaluation of the received questions and a final discussion and selection process during a joint workshop. The participating institutions generated 484 initial questions, which were condensed to the 50 most important questions by 16 workshop participants. We suggest new approaches in tackling the issue of an ecological continuum in the Alps by analysing and classifying the characteristics of the resulting questions in a non-prioritized form as well as in a visual conceptualisation of the inter-dependencies among these questions. This priority setting exercise will support research and funding institutions in channelling their capacities and resources towards questions that need to be urgently addressed in order to facilitate significant progress in biodiversity conservation in the European Alps.	[Walzer, Chris; Kowalczyk, Christine] Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria; [Alexander, Jake M.; Kueffer, Christoph] Swiss Fed Inst Technol Zurich, Inst Integrat Biol, Zurich, Switzerland; [Baur, Bruno] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Bogliani, Giuseppe] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Brun, Jean-Jacques] Natl Res Inst Sci & Technol Environm & Agr, Unite Ecosyst Montagnards, St Martin Dheres, France; [Fuereder, Leopold] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Guth, Marie-Odile] Minist Ecol Sustainable Dev & Energy, Paris, France; [Haller, Ruedi] Swiss Natl Pk, Res & Geoinformat, Zernez, Switzerland; [Holderegger, Rolf] Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Biodivers & Conservat Biol, CH-8903 Birmensdorf, Switzerland; [Kohler, Yann] Permanent Secretariat Alpine Convent, Task Force Protected Areas, Chambery, France; [Righetti, Antonio] Partner Innen Umweltfragen, Liebefeld, Switzerland; [Spaar, Reto] Swiss Ornithol Inst, Sempach, Switzerland; [Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Ullrich-Schneider, Aurelia] Int Commiss Protect Alps CIPRA Int, Schaan, Liechtenstein; [Vanpeene-Bruhier, Sylvie N.] Natl Res Inst Sci & Technol Environm & Agr, Aix En Provence, France; [Scheurer, Thomas] Swiss Acad Sci, Bern, Switzerland	University of Veterinary Medicine Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Pavia; INRAE; University of Innsbruck; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Ornithological Institute; University of Cambridge; INRAE	Walzer, C (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria.	chris.walzer@fiwi.at	Kueffer, Christoph/H-6091-2013; Alexander, Jake/P-2580-2014; Sutherland, William/B-1291-2013	Kueffer, Christoph/0000-0001-6701-0703; Alexander, Jake/0000-0003-2226-7913; Bogliani, Giuseppe/0000-0001-9066-6540; Vanpeene, Sylvie/0000-0003-3970-4454; Walzer, Chris/0000-0002-0437-5147; Sutherland, William/0000-0002-6498-0437	"Platform Ecological Network'' of the Alpine Convention; ECONNECT project; EU within the framework of the European Territorial Cooperation Alpine Space Programme; European Regional Development Fund; CCES-GENEREACH project of the ETH domain	"Platform Ecological Network'' of the Alpine Convention; ECONNECT project; EU within the framework of the European Territorial Cooperation Alpine Space Programme; European Regional Development Fund(European Commission); CCES-GENEREACH project of the ETH domain	Funding for this project was provided in part by the "Platform Ecological Network'' of the Alpine Convention (http://www.alpconv.org/en/organization/groups/WGEcologicalNetwork/default.html) and the ECONNECT project funded by the EU within the framework of the European Territorial Cooperation Alpine Space Programme and co-funded by the European Regional Development Fund (www.econnectproject.eu). RH was supported by the CCES-GENEREACH project of the ETH domain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001253; Bennett G., 2004, LINKAGES PRACTICE RE; Bernstein S, 2000, EUR J INT RELAT, V6, P43, DOI 10.1177/1354066100006001003; Braunisch V, 2012, BIOL CONSERV, V153, P201, DOI 10.1016/j.biocon.2012.05.007; Cooke SJ, 2010, J FISH BIOL, V76, P2261, DOI 10.1111/j.1095-8649.2010.02666.x; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fureder L, 2011, ECONNECT POLICY RECO; Hirsch Hadorn G., 2008, HDB TRANSDISCIPLINAR, P19, DOI [DOI 10.1007/978-1-4020-6699-3_2, 10.1007/978-1-4020-6699-3]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kohler Y, 2009, REV GEOGR ALP, V97, DOI 10.4000/rga.808; Lazarus RJ, 2009, CORNELL LAW REV, V94, P77; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Milner-Gulland EJ, 2010, ORYX, V44, P1, DOI 10.1017/S0030605309991001; Morrison S.A., 2006, CONNECTIVITY CONSERV, P536; ProClim/CASS, 1997, VIS SWISS RES RES SU; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Roux DJ, 2006, ECOL SOC, V11; Soule ME, 2006, CONSERV BIOL, P649; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2011, METHODS ECOL EVOL, V2, P238, DOI 10.1111/j.2041-210X.2010.00083.x; Sutherland WJ, 2010, J APPL ECOL, V47, P955, DOI 10.1111/j.1365-2664.2010.01863.x; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Sutherland WJ, 2009, TRENDS ECOL EVOL, V24, P523, DOI 10.1016/j.tree.2009.04.008; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Walzer C, 2011, WEBS LIFE ALPINE BIO; Worboys G.L., 2010, CONNECTIVITY CONSERV; Wuelser G, 2012, SUSTAIN SCI, V7, P81, DOI 10.1007/s11625-011-0143-3	28	16	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53139	10.1371/journal.pone.0053139	http://dx.doi.org/10.1371/journal.pone.0053139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341928	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400033
J	Hart, AW; Mella, S; Mendrychowski, J; van Heyningen, V; Kleinjan, DA				Hart, Alan W.; Mella, Sebastien; Mendrychowski, Jacek; van Heyningen, Veronica; Kleinjan, Dirk A.			The Developmental Regulator Pax6 Is Essential for Maintenance of Islet Cell Function in the Adult Mouse Pancreas	PLOS ONE			English	Article							BETA-CELLS; EARLY-ONSET; GLUCOSE; GENES; MICE; EXPRESSION; GHRELIN; TRANSCRIPTION; PDX1; DIFFERENTIATION	The transcription factor Pax6 is a developmental regulator with a crucial role in development of the eye, brain, and olfactory system. Pax6 is also required for correct development of the endocrine pancreas and specification of hormone producing endocrine cell types. Glucagon-producing cells are almost completely lost in Pax6-null embryos, and insulin-expressing beta and somatostatin-expressing delta cells are reduced. While the developmental role of Pax6 is well-established, investigation of a further role for Pax6 in the maintenance of adult pancreatic function is normally precluded due to neonatal lethality of Pax6-null mice. Here a tamoxifen-inducible ubiquitous Cre transgene was used to inactivate Pax6 at 6 months of age in a conditional mouse model to assess the effect of losing Pax6 function in adulthood. The effect on glucose homeostasis and the expression of key islet cell markers was measured. Homozygous Pax6 deletion mice, but not controls, presented with all the symptoms of classical diabetes leading to severe weight loss requiring termination of the experiment five weeks after first tamoxifen administration. Immunohistochemical analysis of the pancreata revealed almost complete loss of Pax6 and much reduced expression of insulin, glucagon, and somatostatin. Several other markers of islet cell function were also affected. Notably, strong upregulation in the number of ghrelin-expressing endocrine cells was observed. These findings demonstrate that Pax6 is essential for adult maintenance of glucose homeostasis and function of the endocrine pancreas.	[Hart, Alan W.; Mella, Sebastien; Mendrychowski, Jacek; van Heyningen, Veronica; Kleinjan, Dirk A.] Univ Edinburgh, Human Genet Unit, Med Res Council, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh	Kleinjan, DA (corresponding author), Univ Edinburgh, Human Genet Unit, Med Res Council, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland.	Dirk-Jan.Kleinjan@igmm.ed.ac.uk	VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141; Hart, Alan/0000-0001-7463-2535	Medical Research Council UK; EU FP6 [LSHG-CT-2005-512036]; Medical Research Council [MC_PC_U127527199, MC_U127527199] Funding Source: researchfish; MRC [MC_PC_U127527199, MC_U127527199] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP6(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work at the IGMM Human Genetics Unit is supported by core funding from the Medical Research Council UK (http://www.mrc.ac.uk/). SM was supported by an EU FP6 collaborative grant LSHG-CT-2005-512036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlqvist E, 2012, DIABETOLOGIA, V55, P94, DOI 10.1007/s00125-011-2300-8; Andersen FG, 1999, FEBS LETT, V445, P315, DOI 10.1016/S0014-5793(99)00144-1; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Bhatia B, 2011, INVEST OPHTH VIS SCI, V52, P136, DOI 10.1167/iovs.10-5208; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Briggs DI, 2011, CURR DIABETES REV, V7, P201, DOI 10.2174/157339911795843140; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Ding J, 2009, ENDOCRINOLOGY, V150, P2136, DOI 10.1210/en.2008-1006; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Hamasaki A, 2007, BIOCHEM BIOPH RES CO, V353, P40, DOI 10.1016/j.bbrc.2006.11.105; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Nitta Y, 2009, EXP ANIM TOKYO, V58, P105, DOI 10.1538/expanim.58.105; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Ramaesh K, 2005, INT J BIOCHEM CELL B, V37, P547, DOI 10.1016/j.biocel.2004.09.002; Ruige JB, 1999, DIABETOLOGIA, V42, P177, DOI 10.1007/s001250051136; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Steiner DF, 2011, METHODS MOL BIOL, V768, P3, DOI 10.1007/978-1-61779-204-5_1; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Veldhuis Johannes D, 2010, Int J Pept, V2010, DOI 10.1155/2010/879503; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang X, 2003, GENESIS, V35, P22, DOI 10.1002/gene.10160; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	55	56	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54173	10.1371/journal.pone.0054173	http://dx.doi.org/10.1371/journal.pone.0054173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326594	gold, Green Submitted, Green Published			2022-12-27	WOS:000314705800114
J	D'Addio, F; Boenisch, O; Magee, CN; Yeung, MY; Yuan, XL; Mfarrej, B; Vergani, A; Ansari, MJ; Fiorina, P; Najafian, N				D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader			Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOSUPPRESSIVE DRUGS; RABBIT ATG; PHASE-III; IN-VITRO; TOLERANCE; DEPLETION; PROGRESS; BALANCE; VIVO	Background: Despite significant nephrotoxicity, calcineurin inhibitors (CNIs) remain the cornerstone of immunosuppression in solid organ transplantation. We, along with others, have reported tolerogenic properties of anti-thymocyte globulin (ATG, Thymoglobulin (R)), evinced by its ability both to spare Tregs from depletion in vivo and, when administered at low, non-depleting doses, to expand Tregs ex vivo. Clinical trials investigating B7/CD28 blockade (LEA29Y, Belatacept) in kidney transplant recipients have proven that the replacement of toxic CNI use is feasible in selected populations. Methods: Rabbit polyclonal anti-murine thymocyte globulin (mATG) was administered as induction and/or prolonged, low-dose therapy, in combination with CTLA4-Ig, in a stringent, fully MHC-mismatched murine skin transplant model to assess graft survival and mechanisms of action. Results: Prolonged, low-dose mATG, combined with CTLA4-Ig, effectively promotes engraftment in a stringent transplant model. Our data demonstrate that mATG achieves graft acceptance primarily by promoting Tregs, while CTLA4-Ig enhances mATG function by limiting activation of the effector T cell pool in the early stages of treatment, and by inhibiting production of anti-rabbit antibodies in the maintenance phase, thereby promoting regulation of alloreactivity. Conclusion: These data provide the rationale for development of novel, CNI-free clinical protocols in human transplant recipients.	[D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader] Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA 02115 USA; [D'Addio, Francesca; Boenisch, Olaf; Magee, Ciara N.; Yeung, Melissa Y.; Yuan, Xueli; Mfarrej, Bechara; Vergani, Andrea; Ansari, Mohammed Javeed; Fiorina, Paolo; Najafian, Nader] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA USA; [D'Addio, Francesca; Vergani, Andrea; Fiorina, Paolo] Hosp San Raffaele, Transplantat Med Div, I-20132 Milan, Italy; [Ansari, Mohammed Javeed] Northwestern Univ, Feinberg Sch Med, Div Nephrol & Organ Transplantat, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwestern University; Feinberg School of Medicine	Najafian, N (corresponding author), Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, 75 Francis St, Boston, MA 02115 USA.	nnajafian@rics.bwh.harvard.edu	Mfarrej, Bechara/AAE-9616-2021; D'Addio, Francesca/F-3417-2017; Fiorina, Paolo/B-4532-2019	Mfarrej, Bechara/0000-0002-8361-5240; D'Addio, Francesca/0000-0002-0345-0694; Fiorina, Paolo/0000-0002-1093-7724	National Institutes of Health [1KO8AI064335-01A2]; Genzyme; ERA-EDTA Fellowship Grant; SISQT-Biotest Fellowship Grant; NIH Grant [K08 AI080836-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI064335, K08AI080836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme(Sanofi-AventisGenzyme Corporation); ERA-EDTA Fellowship Grant; SISQT-Biotest Fellowship Grant; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health 1KO8AI064335-01A2 and a grant from Genzyme. FD was supported by the ERA-EDTA Fellowship Grant and the SISQT-Biotest Fellowship Grant. MJA was supported by a NIH Grant K08 AI080836-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestard O, 2007, J IMMUNOL, V179, P4901, DOI 10.4049/jimmunol.179.7.4901; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; Boenisch O, 2012, AM J TRANSPLANT, V12, P856, DOI 10.1111/j.1600-6143.2011.03978.x; Broady R, 2009, BLOOD, V114, P5003, DOI 10.1182/blood-2009-04-214437; Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; D'Addio F, 2010, TRANSPLANTATION, V90, P260, DOI 10.1097/TP.0b013e3181e64217; De Serres SA, 2009, CLIN J AM SOC NEPHRO, V4, P1661, DOI 10.2215/CJN.03180509; Durrbach A, 2010, AM J TRANSPLANT, V10, P547, DOI 10.1111/j.1600-6143.2010.03016.x; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; Golshayan D, 2008, DRUGS, V68, P2113, DOI 10.2165/00003495-200868150-00004; Kang SM, 2007, AM J TRANSPLANT, V7, P1457; LaCorcia G, 2009, TRANSPLANTATION, V87, P966, DOI 10.1097/TP.0b013e31819c84b8; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Nador RG, 2010, AM J TRANSPLANT, V10, P262, DOI 10.1111/j.1600-6143.2009.02942.x; Ndejembi MP, 2006, J IMMUNOL, V177, P7698, DOI 10.4049/jimmunol.177.11.7698; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Ruzek MC, 2008, BLOOD, V111, P1726, DOI 10.1182/blood-2007-08-106526; Ruzek MC, 2009, TRANSPLANTATION, V88, P170, DOI 10.1097/TP.0b013e3181abc061; Salama AD, 2003, J AM SOC NEPHROL, V14, P1643, DOI 10.1097/01.ASN.0000057540.98231.C1; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Torrealba JR, 2003, TRANSPLANTATION, V76, P524, DOI 10.1097/01.TP.0000075788.72614.D4; Turka LA, 2009, NAT REV IMMUNOL, V9, P521, DOI 10.1038/nri2568; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2002, AM J TRANSPLANT, V2, P898, DOI 10.1034/j.1600-6143.2002.21005.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zheng XX, 2003, IMMUNOL REV, V196, P75, DOI 10.1046/j.1600-065X.2003.00089.x	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53797	10.1371/journal.pone.0053797	http://dx.doi.org/10.1371/journal.pone.0053797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326509	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400047
J	Dzierma, Y; Nuesken, FG; Fleckenstein, J; Kremp, S; Licht, NP; Ruebe, C				Dzierma, Yvonne; Nuesken, Frank G.; Fleckenstein, Jochen; Kremp, Stephanie; Licht, Norbert P.; Ruebe, Christian			Visualisation of Respiratory Tumour Motion and Co-Moving Isodose Lines in the Context of Respiratory Gating, IMRT and Flattening-Filter-Free Beams	PLOS ONE			English	Article							BREATHING ADAPTED RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; MODULATED RADIATION-THERAPY; INTERNAL TARGET VOLUME; 4-DIMENSIONAL CT SCANS; I LUNG-CANCER; ORGAN MOTION; MULTILEAF COLLIMATOR; DOSIMETRIC IMPACT; MONTE-CARLO	Respiratory motion during percutaneous radiotherapy can be considered based on respiration-correlated computed tomography (4DCT). However, most treatment planning systems perform the dose calculation based on a single primary CT data set, even though cine mode displays may allow for a visualisation of the complete breathing cycle. This might create the mistaken impression that the dose distribution were independent of tumour motion. We present a movie visualisation technique with the aim to direct attention to the fact that the dose distribution migrates to some degree with the tumour and discuss consequences for gated treatment, IMRT plans and flattening-filter-free beams. This is a feasibility test for a visualisation of tumour and isodose motion. Ten respiratory phases are distinguished on the CT, and the dose distribution from a stationary IMRT plan is calculated on each phase, to be integrated into a movie of tumour and dose motion during breathing. For one example patient out of the sample of five lesions, the plan is compared with a gated treatment plan with respect to tumour coverage and lung sparing. The interplay-effect for small segments in the IMRT plan is estimated. While the high dose rate, together with the cone-shaped beam profile, makes the use of flattening-filter-free beams more problematic for conformal and IMRT treatment, it can be the option of choice if gated treatment is preferred. The different effects of respiratory motion, dose build-up and beam properties (segments and flatness) for gated vs. un-gated treatment can best be considered if planning is performed on the full 4DCT data set, which may be an incentive for future developments of treatment planning systems.	[Dzierma, Yvonne; Nuesken, Frank G.; Fleckenstein, Jochen; Kremp, Stephanie; Licht, Norbert P.; Ruebe, Christian] Univ Saarland, Med Ctr, Dept Radiat Oncol, Homburg, Germany	Saarland University	Dzierma, Y (corresponding author), Univ Saarland, Med Ctr, Dept Radiat Oncol, Homburg, Germany.	yvonne.dzierma@uks.eu						Alasti H, 2006, PHYS MED BIOL, V51, P3251, DOI 10.1088/0031-9155/51/12/017; Allen AM, 2004, INT J RADIAT ONCOL, V58, P1251, DOI 10.1016/j.ijrobp.2003.09.081; Balter JM, 1996, INT J RADIAT ONCOL, V36, P167, DOI 10.1016/S0360-3016(96)00275-1; Boda-Heggemann J, 2011, STRAHLENTHERAPIE UND, V5, P284; Bortfeld T, 2002, PHYS MED BIOL, V47, P2203, DOI 10.1088/0031-9155/47/13/302; Brock J, 2011, INT J RADIAT ONCOL, V81, P369, DOI 10.1016/j.ijrobp.2010.05.038; Chen HC, 2009, MED PHYS, V36, P893, DOI 10.1118/1.3070542; Chui CS, 2003, MED PHYS, V30, P1736, DOI 10.1118/1.1578771; Court L, 2011, J APPL CLIN MED PHYS, V12, P28, DOI 10.1120/jacmp.v12i1.3276; Ding CX, 2007, MED PHYS, V34, P3500, DOI 10.1118/1.2760308; Dzierma Y, 2012, MED PHYS, V39, P2595, DOI 10.1118/1.3703835; Flampouri S, 2006, PHYS MED BIOL, V51, P2763, DOI 10.1088/0031-9155/51/11/006; Frazier RC, 2004, INT J RADIAT ONCOL, V58, P1041, DOI 10.1016/j.ijrobp.2003.07.005; Gabrys D, 2011, RADIOTHER ONCOL, V100, P360, DOI 10.1016/j.radonc.2011.09.006; Guckenberger M, 2007, INT J RADIAT ONCOL, V69, P276, DOI 10.1016/j.ijrobp.2007.04.074; Jiang SB, 2003, PHYS MED BIOL, V48, P1773, DOI 10.1088/0031-9155/48/12/307; Keall PJ, 2005, MED PHYS, V32, P942, DOI 10.1118/1.1879152; Korreman SS, 2005, RADIOTHER ONCOL, V76, P311, DOI 10.1016/j.radonc.2005.07.009; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Liu J, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-11; Mancosu P, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-16; McQuaid D, 2011, PHYS MED BIOL, V56, P6935, DOI 10.1088/0031-9155/56/21/011; Muirhead R, 2010, RADIOTHER ONCOL, V95, P172, DOI 10.1016/j.radonc.2010.02.002; Nohadani O, 2010, PHYS MED BIOL, V55, P5189, DOI 10.1088/0031-9155/55/17/019; Peguret N, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-78; Rietzel E, 2005, INT J RADIAT ONCOL, V61, P1535, DOI 10.1016/j.ijrobp.2004.11.037; Rietzel E, 2006, INT J RADIAT ONCOL, V66, P287, DOI 10.1016/j.ijrobp.2006.05.024; Roland T, 2009, PHYS MED BIOL, V54, P5509, DOI 10.1088/0031-9155/54/18/011; ROSS CS, 1990, INT J RADIAT ONCOL, V18, P671, DOI 10.1016/0360-3016(90)90076-V; Saw C B, 2007, Biomed Imaging Interv J, V3, pe40, DOI 10.2349/biij.3.1.e40; Seco J, 2008, MED PHYS, V35, P356, DOI 10.1118/1.2821704; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Stromberg JS, 2000, INT J RADIAT ONCOL, V48, P797, DOI 10.1016/S0360-3016(00)00681-7; Underberg RWM, 2005, INT J RADIAT ONCOL, V62, P554, DOI 10.1016/j.ijrobp.2005.01.032; Underberg RWM, 2004, INT J RADIAT ONCOL, V60, P1283, DOI 10.1016/j.ijrobp.2004.07.665; Vedam S, 2005, MED PHYS, V32, P1607, DOI 10.1118/1.1915017; Webb S, 2008, PHYS MED BIOL, V53, P5177, DOI 10.1088/0031-9155/53/18/022; Webb S, 2006, PHYS MED BIOL, V51, pR403, DOI 10.1088/0031-9155/51/13/R23; Wu JZ, 2008, RADIOTHER ONCOL, V87, P35, DOI 10.1016/j.radonc.2008.02.010; Zhao B, 2009, MED PHYS, V36, P2248, DOI 10.1118/1.3129161	41	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53799	10.1371/journal.pone.0053799	http://dx.doi.org/10.1371/journal.pone.0053799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326510	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400048
J	Sohn, I; Sung, CO				Sohn, Insuk; Sung, Chang Ohk			Predictive Modeling Using a Somatic Mutational Profile in Ovarian High Grade Serous Carcinoma	PLOS ONE			English	Article							CROSS-VALIDATION; BRCA2; SURVIVAL; CHEMOTHERAPY; ACCURACY; OUTCOMES	Purpose: Recent high-throughput sequencing technology has identified numerous somatic mutations across the whole exome in a variety of cancers. In this study, we generate a predictive model employing the whole exome somatic mutational profile of ovarian high-grade serous carcinomas (Ov-HGSCs) obtained from The Cancer Genome Atlas data portal. Methods: A total of 311 patients were included for modeling overall survival (OS) and 259 patients were included for modeling progression free survival (PFS) in an analysis of 509 genes. The model was validated with complete leave-one-out cross-validation involving re-selecting genes for each iteration of the cross-validation procedure. Cross-validated Kaplan-Meier curves were generated. Cross-validated time dependent receiver operating characteristic (ROC) curves were computed and the area under the curve (AUC) values were calculated from the ROC curves to estimate the predictive accuracy of the survival risk models. Results: There was a significant difference in OS between the high-risk group (median, 28.1 months) and the low-risk group (median, 61.5 months) (permutated p-value <0.001). For PFS, there was also a significant difference in PFS between the high-risk group (10.9 months) and the low-risk group (22.3 months) (permutated p-value <0.001). Cross-validated AUC values were 0.807 for the OS and 0.747 for the PFS based on a defined landmark time t = 36 months. In comparisons between a predictive model containing only gene variables and a combined model containing both gene variables and clinical covariates, the predictive model containing gene variables without clinical covariates were effective and high AUC values for both OS and PFS were observed. Conclusions: We designed a predictive model using a somatic mutation profile obtained from high-throughput genomic sequencing data in Ov-HGSC samples that may represent a new strategy for applying high-throughput sequencing data to clinical practice.	[Sohn, Insuk] Samsung Canc Res Inst, Seoul, South Korea; [Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Sung, CO (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	co.sung@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X				Azuaje F, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-5; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Gallagher DJ, 2011, ANN ONCOL, V22, P1127, DOI 10.1093/annonc/mdq577; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hickey JM, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-23; Lacour RA, 2011, GYNECOL ONCOL, V121, P358, DOI 10.1016/j.ygyno.2010.12.354; McConville CM, 1996, AM J HUM GENET, V59, P320; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Sabatier R, 2009, CRIT REV ONCOL HEMAT, V72, P98, DOI 10.1016/j.critrevonc.2009.01.007; Simon RM, 2011, BRIEF BIOINFORM, V12, P203, DOI 10.1093/bib/bbr001; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yuan SSF, 1999, CANCER RES, V59, P3547	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54089	10.1371/journal.pone.0054089	http://dx.doi.org/10.1371/journal.pone.0054089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326577	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400076
J	Rolland-Turner, M; Goretti, E; Bousquenaud, M; Leonard, F; Nicolas, C; Zhang, L; Maskali, F; Marie, PY; Devaux, Y; Wagner, D				Rolland-Turner, Magali; Goretti, Emeline; Bousquenaud, Melanie; Leonard, Frederique; Nicolas, Christelle; Zhang, Lu; Maskali, Fatiha; Marie, Pierre-Yves; Devaux, Yvan; Wagner, Daniel			Adenosine Stimulates the Migration of Human Endothelial Progenitor Cells. Role ofCXCR4 and MicroRNA-150	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE-9 SECRETION; DIFFERENTIAL REGULATION; MYOCARDIAL-INFARCTION; INTERNATIONAL UNION; CARDIAC EXPRESSION; HUMAN MACROPHAGES; VASCULAR INJURY	Background: Administration of endothelial progenitor cells (EPC) represents a promising option to regenerate the heart after myocardial infarction, but is limited because of low recruitment and engraftment in the myocardium. Mobilization and migration of EPC are mainly controlled by stromal cell-derived factor 1 alpha (SDF-1 alpha) and its receptor CXCR4. We hypothesized that adenosine, a cardioprotective molecule, may improve the recruitment of EPC to the heart. Methods: EPC were obtained from peripheral blood mononuclear cells of healthy volunteers. Expression of chemokines and their receptors was evaluated using microarrays, quantitative PCR, and flow cytometry. A Boyden chamber assay was used to assess chemotaxis. Recruitment of EPC to the infarcted heart was evaluated in rats after permanent occlusion of the left anterior descending coronary artery. Results: Microarray analysis revealed that adenosine modulates the expression of several members of the chemokine family in EPC. Among these, CXCR4 was up-regulated by adenosine, and this result was confirmed by quantitative PCR (3-fold increase, P<0.001). CXCR4 expression at the cell surface was also increased. This effect involved the A(2B) receptor. Pretreatment of EPC with adenosine amplified their migration towards recombinant SDF-1 alpha or conditioned medium from cardiac fibroblasts. Both effects were abolished by CXCR4 blocking antibodies. Adenosine also increased CXCR4 under ischemic conditions, and decreased miR-150 expression. Binding of miR-150 to the 3' untranslated region of CXCR4 was verified by luciferase assay. Addition of pre-miR-150 blunted the effect of adenosine on CXCR4. Administration of adenosine to rats after induction of myocardial infarction stimulated EPC recruitment to the heart and enhanced angiogenesis. Conclusion: Adenosine increases the migration of EPC. The mechanism involves A(2B) receptor activation, decreased expression of miR-150 and increased expression of CXCR4. These results suggest that adenosine may be used to enhance the capacity of EPC to revascularize the ischemic heart.	[Rolland-Turner, Magali; Goretti, Emeline; Bousquenaud, Melanie; Leonard, Frederique; Nicolas, Christelle; Zhang, Lu; Devaux, Yvan; Wagner, Daniel] Publ Res Ctr Hlth CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Maskali, Fatiha; Marie, Pierre-Yves] Nancyclotep Expt Imaging Platform, Vandoeuvre Les Nancy, France; [Wagner, Daniel] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Devaux, Y (corresponding author), Publ Res Ctr Hlth CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020; Marie, pierre-yves/AAY-6971-2020	Devaux, Yvan/0000-0002-5321-8543; Bousquenaud, Melanie/0000-0003-0556-0798; Zhang, Lu/0000-0001-7141-6730	Society for Research on Cardiovascular Diseases; Ministry of Culture, Higher Education and Research of Luxembourg; National Fund for Research of Luxembourg [TR-PHF BFR07-132]	Society for Research on Cardiovascular Diseases; Ministry of Culture, Higher Education and Research of Luxembourg; National Fund for Research of Luxembourg	This study was supported by the Society for Research on Cardiovascular Diseases and the Ministry of Culture, Higher Education and Research of Luxembourg. FL is the recipient of a fellowship from the National Fund for Research of Luxembourg (grant # TR-PHF BFR07-132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Azuaje F, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-7; Azuaje FJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-46; Bousquenaud M, 2012, CARDIOVASC RES, V94, P519, DOI 10.1093/cvr/cvs140; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2008, CIRC RES, V102, P942, DOI 10.1161/CIRCRESAHA.107.164376; Devaux Y, 2010, FUNCT INTEGR GENOMIC, V10, P329, DOI 10.1007/s10142-010-0169-0; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goldman S, 1995, J Card Fail, V1, P169, DOI 10.1016/1071-9164(95)90019-5; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Leonard F, 2011, J LEUKOCYTE BIOL, V90, P199, DOI 10.1189/jlb.0910505; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Povsic TJ, 2007, J AM COLL CARDIOL, V50, P2243, DOI 10.1016/j.jacc.2007.08.033; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Richard CL, 2006, INT J CANCER, V119, P2044, DOI 10.1002/ijc.22084; Ryzhov S, 2008, CIRC RES, V102, P356, DOI 10.1161/CIRCRESAHA.107.158147; Siddique A, 2010, J ANGIOGENES RES, V22, P2; Sondergaard CS, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-24; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; Velot E, 2008, CARDIOVASC RES, V80, P246, DOI 10.1093/cvr/cvn201; Wagner DR, 1998, CIRCULATION, V97, P521; Wagner DR, 1999, AM J PHYSIOL-HEART C, V276, pH2141, DOI 10.1152/ajpheart.1999.276.6.H2141; Wagner DR, 1998, CIRC RES, V82, P47; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	42	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e54135	10.1371/journal.pone.0054135	http://dx.doi.org/10.1371/journal.pone.0054135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326587	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500110
J	Chen, L; Zhang, XZ; Zhou, WS; Qiao, Q; Liang, HL; Li, GY; Wang, JH; Cai, F				Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua; Cai, Fei			The Interactive Effects of Cytoskeleton Disruption and Mitochondria Dysfunction Lead to Reproductive Toxicity Induced by Microcystin-LR	PLOS ONE			English	Article							INDUCED APOPTOSIS; IN-VIVO; PERMEABILITY TRANSITION; INTERMEDIATE-FILAMENTS; OXIDATIVE STRESS; DNA-DAMAGE; 3 ORGANS; RAT; LIVER; KIDNEY	The worldwide occurrence of cyanobacterial blooms evokes profound concerns. The presence of microcystins (MCs) in waters and aquatic food increases the risk to human health. Some recent studies have suggested that the gonad is the second most important target organ of MCs, however, the potential toxicity mechanisms are still unclear. For a better understanding of reproductive toxicity of MCs on animals, we conducted the present experimental investigation. Male rats were intraperitoneally injected with MC-LR for 50 d with the doses of 1 and 10 mu g/kg body weight per day. After prolonged exposure to MC-LR, the testes index significantly decreased in 10 mg/kg group. Light microscope observation indicated that the space between the seminiferous tubules was increased. Ultrastructural observation showed some histopathological characteristics, including cytoplasmic shrinkage, cell membrane blebbing, swollen mitochondria and deformed nucleus. Using Q-PCR methods, the transcriptional levels of some cytoskeletal and mitochondrial genes were determined. MC-LR exposure affected the homeostasis of the expression of cytoskeletal genes, causing possible dysfunction of cytoskeleton assembly. In MC-LR treatments, all the 8 mitochondrial genes related with oxidative phosphorylation (OXPHOS) significantly increased. The reactive oxygen species (ROS) level significantly increased in 10 mg/kg group. The mitochondria swelling and DNA damage were also determined in 10 mu g/kg group. Hormone levels of testis significantly changed. The present study verified that both cytoskeleton disruption possibly due to cytoskeletal reorganization or depolymerization and mitochondria dysfunction interact with each other through inducing of reactive oxygen species and oxidative phosphorylation, and jointly result in testis impairment after exposure to MC-LR.	[Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Chen, Liang; Zhang, Xuezhen; Zhou, Wenshan; Qiao, Qin; Liang, Hualei; Li, Guangyu; Wang, Jianghua] Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Cai, Fei] Xianning Univ, Coll Med, Dept Pharmacol, Xianning, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, XZ (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China.	xuezhen@mail.hzau.edu.cn	Chen, Liang/B-4550-2015; Oliver, Brian/E-7939-2010	Chen, Liang/0000-0001-6548-5000; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966	National Natural Science Foundation of China [30800160]; Natural Science Foundation for Distinguished Young Scholars of Hubei Province [2010CDA095]; Fundamental Research Funds for the Central Universities of China [2012MBDX004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Distinguished Young Scholars of Hubei Province; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number. 30800160) and the Natural Science Foundation for Distinguished Young Scholars of Hubei Province (grant number. 2010CDA095), and the study was also supported by the Fundamental Research Funds for the Central Universities of China (grant number. 2012MBDX004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverca E, 2009, TOXICON, V54, P283, DOI 10.1016/j.toxicon.2009.04.014; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Chen J, 2005, TOXICON, V45, P615, DOI 10.1016/j.toxicon.2005.01.003; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Chen T, 2005, MOL CELL PROTEOMICS, V4, P958, DOI 10.1074/mcp.M400185-MCP200; Chen Y, 2011, REPROD TOXICOL, V31, P551, DOI 10.1016/j.reprotox.2011.02.006; Ding WX, 2000, HEPATOLOGY, V32, P547, DOI 10.1053/jhep.2000.16183; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Ding WX, 2002, BIOCHEM BIOPH RES CO, V291, P321, DOI 10.1006/bbrc.2002.6453; Ding WX, 2001, J TOXICOL ENV HEAL A, V64, P507, DOI 10.1080/152873901753215966; Ding WX, 2000, ENVIRON HEALTH PERSP, V108, P605, DOI 10.2307/3434879; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; FALCONER IR, 1992, CHEM-BIOL INTERACT, V81, P181, DOI 10.1016/0009-2797(92)90033-H; Fiorentini C, 1999, FEBS LETT, V453, P124, DOI 10.1016/S0014-5793(99)00706-1; Frangez R, 2003, TOXICON, V41, P999, DOI 10.1016/S0041-0101(03)00072-2; Fu WY, 2009, CHEM RES TOXICOL, V22, P41, DOI 10.1021/tx800396p; Fu WY, 2005, TOXICON, V46, P171, DOI 10.1016/j.toxicon.2005.03.021; Gacsi M, 2009, TOXICOL IN VITRO, V23, P710, DOI 10.1016/j.tiv.2009.02.006; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Hao L, 2010, TOXICON, V55, P1378, DOI 10.1016/j.toxicon.2010.02.015; Hermansky S. J., 1993, Journal of Environmental Pathology Toxicology and Oncology, V12, P101; HOOSER SB, 1991, VET PATHOL, V28, P259, DOI 10.1177/030098589102800401; HOOSER SB, 1990, VET PATHOL, V27, P9, DOI 10.1177/030098589002700102; Hoyal CR, 1998, J TOXICOL ENV HEAL B, V1, P117, DOI 10.1080/10937409809524547; La-Salete R, 2008, J APPL TOXICOL, V28, P55, DOI 10.1002/jat.1251; Lankoff A, 2004, MUTAT RES-GEN TOX EN, V559, P131, DOI 10.1016/j.mrgentox.2004.01.004; Li DS, 2011, ECOTOXICOLOGY, V20, P1018, DOI 10.1007/s10646-011-0693-2; Li GY, 2011, ENVIRON TOXICOL, V26, P111, DOI 10.1002/tox.20532; Li GY, 2011, PROTEOMICS, V11, P2003, DOI 10.1002/pmic.201000442; Li XY, 2001, ENVIRON TOXICOL, V16, P517, DOI 10.1002/tox.10012; Li Y, 2012, ENVIRON TOXICOL PHAR, V33, P318, DOI 10.1016/j.etap.2011.12.015; Li Y, 2008, REPROD TOXICOL, V26, P239, DOI 10.1016/j.reprotox.2008.09.004; Liu Y, 2010, ENVIRON TOXICOL, V25, P9, DOI 10.1002/tox.20467; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun S, 1998, J REPROD FERTIL, V114, P131, DOI 10.1530/jrf.0.1140131; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Majsterek I, 2004, COMP BIOCHEM PHYS C, V139, P175, DOI 10.1016/j.cca.2004.10.007; Mathe C, 2009, AQUAT TOXICOL, V92, P122, DOI 10.1016/j.aquatox.2009.02.005; Meng GM, 2011, TOXICOLOGY, V290, P218, DOI 10.1016/j.tox.2011.09.085; Mikhailov A, 2003, CHEM-BIOL INTERACT, V142, P223, DOI 10.1016/S0009-2797(02)00075-3; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; OHTA T, 1992, CARCINOGENESIS, V13, P2443, DOI 10.1093/carcin/13.12.2443; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Sewer M, 2008, LIPIDS, V43, P1109, DOI 10.1007/s11745-008-3221-2; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Toivola DM, 1997, J CELL SCI, V110, P23; Toivola DM, 1999, TOXICOL IN VITRO, V13, P521, DOI 10.1016/S0887-2333(99)00024-7; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wang GW, 2005, AM J PHYSIOL-HEART C, V288, pH1290, DOI 10.1152/ajpheart.00796.2004; Wang MH, 2010, CHEMOSPHERE, V81, P716, DOI 10.1016/j.chemosphere.2010.07.061; Wang Q, 2008, TOXICON, V52, P721, DOI 10.1016/j.toxicon.2008.08.004; Wang XT, 2012, TOXICON, V59, P205, DOI 10.1016/j.toxicon.2011.12.001; WICKSTROM ML, 1995, TOXICOL PATHOL, V23, P326, DOI 10.1177/019262339502300309; Xiong QA, 2010, J BIOCHEM MOL TOXIC, V24, P361, DOI 10.1002/jbt.20347; Xiong Q, 2009, TOXICON, V54, P1, DOI 10.1016/j.toxicon.2009.01.035; Zegura B, 2003, TOXICON, V41, P41, DOI 10.1016/S0041-0101(02)00207-6; Zegura B, 2004, TOXICOLOGY, V200, P59, DOI 10.1016/j.tox.2004.03.006; Zeviani M, 2005, SCI MED, V10, P154; Zhang H, 2008, FISH PHYSIOL BIOCHEM, V34, P307, DOI 10.1007/s10695-007-9189-7; Zhang H, 2007, ENVIRON TOXICOL, V22, P559, DOI 10.1002/tox.20296; Zhang HZ, 2011, TOHOKU J EXP MED, V224, P235, DOI 10.1620/tjem.224.235; Zhao SJ, 2012, PROTEOMICS, V12, P300, DOI 10.1002/pmic.201100214; Zhao YY, 2008, COMP BIOCHEM PHYS C, V148, P204, DOI 10.1016/j.cbpc.2008.05.008; Zhou Y, 2012, TOXICOL LETT, V212, P48, DOI 10.1016/j.toxlet.2012.05.001	70	130	138	4	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53949	10.1371/journal.pone.0053949	http://dx.doi.org/10.1371/journal.pone.0053949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342045	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700066
J	Denlinger, LC; Kelly, EAB; Dodge, AM; McCartney, JG; Meyer, KC; Cornwell, RD; Jackson, MJ; Evans, MD; Jarjour, NN				Denlinger, Loren C.; Kelly, Elizabeth A. B.; Dodge, Ann M.; McCartney, John G.; Meyer, Keith C.; Cornwell, Richard D.; Jackson, Mary Jo; Evans, Michael D.; Jarjour, Nizar N.			Safety of and Cellular Response to Segmental Bronchoprovocation in Allergic Asthma	PLOS ONE			English	Article							ANTIGEN CHALLENGE; BRONCHOALVEOLAR LAVAGE; AIRWAY INFLAMMATION; BRONCHOSCOPY; IMMEDIATE	Rationale: Despite its incorporation into research studies, the safety aspects of segmental allergen bronchoprovocation and differences in cellular response among different allergens have received limited consideration. Methods: We performed 87 segmental challenges in 77 allergic asthma subjects. Allergen dose was based on each subject's response to whole lung allergen challenge. Bronchoalveolar lavage was performed at 0 and 48 hours. Safety indicators included spirometry, oxygen saturation, heart rate, and symptoms. Results: Among subjects challenged with ragweed, cat dander, or house dust mite, there were no differences in safety indicators. Subjects demonstrated a modest oxygen desaturation and tachycardia during the procedure that returned to normal prior to discharge. We observed a modest reduction in forced vital capacity and forced expiratory volume in one second following bronchoscopy. The most common symptoms following the procedure were cough, sore throat and fatigue. Total bronchoalveolar lavage fluid cell numbers increased from 13 +/- 4 to 106 +/- 108x10(4) per milliliter and eosinophils increased from 1 +/- 2 to 44 +/- 20 percent, with no significant differences among the three allergens. Conclusions: In mild allergic asthma, segmental allergen bronchoprovocation, using individualized doses of aeroallergens, was safe and yielded similar cellular responses.	[Denlinger, Loren C.; Kelly, Elizabeth A. B.; Dodge, Ann M.; McCartney, John G.; Meyer, Keith C.; Cornwell, Richard D.; Jackson, Mary Jo; Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Div, Madison, WI 53706 USA; [Evans, Michael D.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarjour, NN (corresponding author), Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Div, Madison, WI 53706 USA.	nnj@medicine.wisc.edu		Evans, Michael/0000-0001-7449-3993; Kelly, Elizabeth/0000-0001-7335-6698	National Institutes of Health [HL56396, HL088594, K23HL081492, M01RR03186, UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL081492, P50HL056396, P01HL088594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health research grants HL56396, HL088594, K23HL081492, M01RR03186, UL1RR025011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse WW, 2005, AM J RESP CRIT CARE, V172, P807, DOI 10.1164/rccm.200407-966WS; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; GOLDSTEIN RA, 1985, J ALLERGY CLIN IMMUN, V76, P145; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Julius P, 2008, J ALLERGY CLIN IMMUN, V121, P712, DOI 10.1016/j.jaci.2007.08.058; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P883; Kelly EAB, 1997, AM J RESP CRIT CARE, V156, P1421, DOI 10.1164/ajrccm.156.5.9703054; Krug N, 1996, AM J RESP CRIT CARE, V153, P1391, DOI 10.1164/ajrccm.153.4.8616571; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; METZGER WJ, 1985, CHEST, V87, pS16, DOI 10.1378/chest.87.1_Supplement.16S; Moore WC, 2001, J ALLERGY CLIN IMMUN, V108, P908, DOI 10.1067/mai.2001.119413; Moore WC, 2011, J ALLERGY CLIN IMMUN, V128, P328, DOI 10.1016/j.jaci.2011.02.042; Nassenstein C, 2009, J ALLERGY CLIN IMMUN, V123, P270, DOI 10.1016/j.jaci.2008.10.016; Shaver JR, 1997, AM J RESP CRIT CARE, V155, P442, DOI 10.1164/ajrccm.155.2.9032176; Steinbrook R, 2002, NEW ENGL J MED, V346, P716, DOI 10.1056/NEJM200202283460924; Vliagoftis Harissios, 2008, Inflammation & Allergy Drug Targets, V7, P288, DOI 10.2174/187152808786848379	17	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e51963	10.1371/journal.pone.0051963	http://dx.doi.org/10.1371/journal.pone.0051963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341886	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700009
J	Machado, D; Shishido, SM; Queiroz, KCS; Oliveira, DN; Faria, ALC; Catharino, RR; Spek, CA; Ferreira, CV				Machado, Daisy; Shishido, Silvia M.; Queiroz, Karla C. S.; Oliveira, Diogo N.; Faria, Ana L. C.; Catharino, Rodrigo R.; Spek, C. Arnold; Ferreira, Carmen V.			Irradiated Riboflavin Diminishes the Aggressiveness of Melanoma In Vitro and In Vivo	PLOS ONE			English	Article							SONIC HEDGEHOG; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; CELL MOTILITY; CANCER-CELLS; MTOR; INVASION; METASTASIS; GLI1; IDENTIFICATION	Melanoma is one of the most aggressive skin cancers due to its high capacity to metastasize. Treatment of metastatic melanomas is challenging for clinicians, as most therapeutic agents have failed to demonstrate improved survival. Thus, new candidates with antimetastatic activity are much needed. Riboavin (RF) is a component of the vitamin B complex and a potent photosensitizer. Previously, our group showed that the RF photoproducts (iRF) have potential as an antitumoral agent. Hence, we investigated the capacity of iRF on modulating melanoma B16F10 cells aggressiveness in vitro and in vivo. iRF decreases B16F10 cells survival by inhibiting mTOR as well as Src kinase. Moreover, melanoma cell migration was disrupted after treatment with iRF, mainly by inhibition of metalloproteinase (MMP) activity and expression, and by increasing TIMP expression. Interestingly, we observed that the Hedgehog (HH) pathway was inhibited by iRF. Two mediators of HH signaling, GLI1 and PTCH, were downregulated, while SUFU expression (an inhibitor of this cascade) was enhanced. Furthermore, inhibition of HH pathway signaling by cyclopamine and Gant 61 potentiated the antiproliferative action of RF. Accordingly, when a HH ligand was applied, the effect of iRF was almost completely abrogated. Our findings indicate that Hedgehog pathway is involved on the modulation of melanoma cell aggressiveness by iRF. Moreover, iRF treatment decreased pulmonary tumor formation in a murine experimental metastasis model. Research to clarify the molecular action of flavins, in vivo, is currently in progress. Taken together, the present data provides evidence that riboflavin photoproducts may provide potential candidates for improving the efficiency of melanoma treatment.	[Machado, Daisy; Shishido, Silvia M.; Ferreira, Carmen V.] Univ Estadual Campinas, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil; [Queiroz, Karla C. S.; Spek, C. Arnold] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Oliveira, Diogo N.; Faria, Ana L. C.; Catharino, Rodrigo R.] Univ Estadual Campinas, Fac Med Sci, Lab Innovare Biomarkers, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Amsterdam; Academic Medical Center Amsterdam; Universidade Estadual de Campinas	Shishido, SM (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil.	silvia.mika@gmail.com	Spek, Arnold/AAC-5866-2019; Catharino, Rodrigo/G-1487-2013; Machado, Daisy/A-4891-2013; de Oliveira, Diogo Noin/C-3939-2013; Machado, Daisy/ABA-3731-2020; Queiroz, Karla/L-6438-2014; Catharino, Rodrigo/AAH-4333-2021	Spek, Arnold/0000-0002-2149-4068; Catharino, Rodrigo/0000-0001-7219-2644; Machado, Daisy/0000-0002-6435-6159; de Oliveira, Diogo Noin/0000-0002-2725-476X; Machado, Daisy/0000-0002-6435-6159; Catharino, Rodrigo/0000-0001-7219-2644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 09/00144-7, proc. 10/50356-8]; CNPq [proc. 472067/2010-9]; FAPESP; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a PhD scholarship for D. Machado (proc. 09/00144-7) and grant (proc. 10/50356-8) from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). C.V. Ferreira is supported by research fellowships from CNPq. The authors acknowledge financial support by the Brazilian agencies FAPESP, CNPq (proc. 472067/2010-9), and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2004, INT J PHARMACEUT, V280, P199, DOI 10.1016/j.ijpharm.2004.05.020; Anvekar RA, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00034; Bijlsma MF, 2007, CELL SIGNAL, V19, P2596, DOI 10.1016/j.cellsig.2007.08.011; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Bruggemann LW, 2008, THROMB HAEMOSTASIS, V99, P787, DOI 10.1160/TH07-11-0702; Bruggemann LW, 2008, J CELL MOL MED, V12, P2622, DOI 10.1111/j.1582-4934.2008.00316.x; Carpenter RL, 2012, DISCOV MED, V13, P105; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CHASTAIN JL, 1987, J NUTR, V117, P468, DOI 10.1093/jn/117.3.468; Neto AHC, 2010, TOXICOL IN VITRO, V24, P1911, DOI 10.1016/j.tiv.2010.07.026; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chen YH, 2012, J DERMATOL, V39, P339, DOI 10.1111/j.1346-8138.2011.01441.x; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; De Souza AC, 2006, APOPTOSIS, V11, P1761, DOI 10.1007/s10495-006-9549-2; de Souza AP, 2000, DENT MATER, V16, P103, DOI 10.1016/S0109-5641(99)00084-6; Queiroz KCD, 2007, CANCER LETT, V258, P126, DOI 10.1016/j.canlet.2007.08.024; Erve JCL, 2008, RAPID COMMUN MASS SP, V22, P3015, DOI 10.1002/rcm.3702; Eubanks LM, 2005, FEBS LETT, V579, P5361, DOI 10.1016/j.febslet.2005.08.072; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gkika Maria, 2011, International Ophthalmology, V31, P309, DOI 10.1007/s10792-011-9460-x; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Green CL, 2004, SEMIN CANCER BIOL, V14, P63, DOI 10.1016/j.semcancer.2003.11.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Jazirehi AR, 2012, AM J CANCER RES, V2, P178; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kar S, 2012, EXP CELL RES, V318, P1959, DOI 10.1016/j.yexcr.2012.05.015; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Li CM, 2010, INT J ONCOL, V37, P1023, DOI 10.3892/ijo_00000754; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lutzky J, 2010, SEMIN CUTAN MED SURG, V29, P249, DOI 10.1016/j.sder.2010.10.006; Marti RM, 2012, ACTAS DERMO IN PRESS; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; OHKAWA H, 1983, J BIOL CHEM, V258, P5623; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Reddy HL, 2008, TRANSFUS MED REV, V22, P133, DOI 10.1016/j.tmrv.2007.12.003; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Souzaki M, 2011, CANCER SCI, V102, P373, DOI 10.1111/j.1349-7006.2010.01779.x; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30	64	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54269	10.1371/journal.pone.0054269	http://dx.doi.org/10.1371/journal.pone.0054269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342114	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700099
J	Huang, L; Wang, ZB; Jiang, ZZ; Hu, MW; Lin, F; Zhang, QH; Luo, YB; Hou, Y; Zhao, Y; Fan, HY; Schatten, H; Sun, QY				Huang, Lin; Wang, Zhen-Bo; Jiang, Zong-Zhe; Hu, Meng-Wen; Lin, Fei; Zhang, Qing-Hua; Luo, Yi-Bo; Hou, Yi; Zhao, Yong; Fan, Heng-Yu; Schatten, Heide; Sun, Qing-Yuan			Specific Disruption of Tsc1 in Ovarian Granulosa Cells Promotes Ovulation and Causes Progressive Accumulation of Corpora Lutea	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PRIMORDIAL FOLLICLES; MOUSE MODEL; LIFE-SPAN; ACTIVATION; RAPAMYCIN; GROWTH; MTOR; DIFFERENTIATION; EXPRESSION	Tuberous sclerosis complex 1 (Tsc1) is a tumor suppressor negatively regulating mammalian target of rapamycin complex 1 (mTORC1). It is reported that mice lacking Tsc1 gene in oocytes show depletion of primordial follicles, resulting in premature ovarian failure and subsequent infertility. A recent study indicated that deletion of Tsc1 in somatic cells of the reproductive tract caused infertility of female mice. However, it is not known whether specific disruption of Tsc1 in granulosa cells influences the reproductive activity of female mice. To clarify this problem, we mated Tsc1(flox/flox) mice with transgenic mice strain expressing cyp19-cre which exclusively expresses in granulosa cells of the ovary. Our results demonstrated that Tsc1(flox/flox); cyp19-cre mutant mice were fertile, ovulating more oocytes and giving birth to more pups than control Tsc1(flox/flox) mice. Progressive accumulation of corpora lutea occurred in the Tsc1(flox/flox); cyp19-cre mutant mice with advanced age. These phenotypes could be explained by the elevated activity of mTORC1, as indicated by increased phosphorylation of rpS6, a substrate of S6 in the Tsc1(flox/flox); cyp19-cre mutant granulosa cells. In addition, rapamycin, a specific mTORC1 inhibitor, effectively rescued the phenotype caused by increased mTORC1 activity in the Tsc1(cko) ovaries. Our data suggest that conditional knockout of Tsc1 in granulosa cells promotes reproductive activity in mice.	[Huang, Lin; Wang, Zhen-Bo; Jiang, Zong-Zhe; Hu, Meng-Wen; Lin, Fei; Zhang, Qing-Hua; Luo, Yi-Bo; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Huang, Lin; Jiang, Zong-Zhe; Hu, Meng-Wen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou, Zhejiang, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Zhejiang University; University of Missouri System; University of Missouri Columbia	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn		Hu, Mengwen/0000-0002-7480-6432	National Basic Research Program of China [2012CB944404, 2011CB944501]; National Natural Science Foundation of China [30930065]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2012CB944404, 2011CB944501, www.973.gov.cn/English/ReadItem.aspxitemid=487) and National Natural Science Foundation of China (No. 30930065, www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hu MW, 2012, J GENET GENOMICS, V39, P61, DOI 10.1016/j.jgg.2012.01.004; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Tanaka Y, 2012, ENDOCRINOLOGY, V153, P404, DOI 10.1210/en.2011-1191; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; Wayne CM, 2007, MOL ENDOCRINOL, V21, P1940, DOI 10.1210/me.2007-0020; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491; Zhou J, 2009, HUM MOL GENET, V18, P4428, DOI 10.1093/hmg/ddp398	31	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54052	10.1371/journal.pone.0054052	http://dx.doi.org/10.1371/journal.pone.0054052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335988	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700046
J	Milagro, FI; Miranda, J; Portillo, MP; Fernandez-Quintela, A; Campion, J; Martinez, JA				Milagro, Fermin I.; Miranda, Jonatan; Portillo, Maria P.; Fernandez-Quintela, Alfredo; Campion, Javier; Alfredo Martinez, J.			High-Throughput Sequencing of microRNAs in Peripheral Blood Mononuclear Cells: Identification of Potential Weight Loss Biomarkers	PLOS ONE			English	Article							HIGH-FAT DIET; DIFFERENTIAL EXPRESSION; SUBCUTANEOUS ADIPOSE; GENE-EXPRESSION; CANDIDATE GENES; OBESITY; METHYLATION; MIRNAS; TRANSCRIPTOME; ADIPOGENESIS	Introduction: MicroRNAs (miRNAs) are being increasingly studied in relation to energy metabolism and body composition homeostasis. Indeed, the quantitative analysis of miRNAs expression in different adiposity conditions may contribute to understand the intimate mechanisms participating in body weight control and to find new biomarkers with diagnostic or prognostic value in obesity management. Objective: The aim of this study was the search for miRNAs in blood cells whose expression could be used as prognostic biomarkers of weight loss. Methods: Ten Caucasian obese women were selected among the participants in a weight-loss trial that consisted in following an energy-restricted treatment. Weight loss was considered unsuccessful when <5% of initial body weight (non-responders) and successful when >5% (responders). At baseline, total miRNA isolated from peripheral blood mononuclear cells (PBMC) was sequenced with SOLiD v4. The miRNA sequencing data were validated by RT-PCR. Results: Differential baseline expression of several miRNAs was found between responders and non-responders. Two miRNAs were up-regulated in the non-responder group (mir-935 and mir-4772) and three others were down-regulated (mir-223, mir-224 and mir-376b). Both mir-935 and mir-4772 showed relevant associations with the magnitude of weight loss, although the expression of other transcripts (mir-874, mir-199b, mir-766, mir-589 and mir-148b) also correlated with weight loss. Conclusions: This research addresses the use of high-throughput sequencing technologies in the search for miRNA expression biomarkers in obesity, by determining the miRNA transcriptome of PBMC. Basal expression of different miRNAs, particularly mir-935 and mir-4772, could be prognostic biomarkers and may forecast the response to a hypocaloric diet.	[Milagro, Fermin I.; Campion, Javier; Alfredo Martinez, J.] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Miranda, Jonatan; Portillo, Maria P.; Fernandez-Quintela, Alfredo] Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain	University of Navarra; University of Basque Country	Martinez, JA (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain.	jalfmtz@unav.es	Martinez-Gonzalez, Miguel A./AAE-7669-2019; Milagro, Fermin/F-2315-2015; Fernández-Quintela, Alfredo/U-1272-2019; Miranda, Jonatan/L-4511-2014; Portillo, Maria Puy/ABH-2374-2020; Miranda, Jonatan/F-3289-2011; Martinez Hernandez, J Alfredo/K-8709-2014	Milagro, Fermin/0000-0002-3228-9916; Fernández-Quintela, Alfredo/0000-0003-2709-4118; Miranda, Jonatan/0000-0002-5484-2671; Portillo, Maria Puy/0000-0003-0210-6549; Campion, Javier/0000-0002-6522-8271; PORTILLO BAQUEDANO, MARIA PUY/0000-0003-2290-592X; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	Linea Especial LE/97 of the University of Navarra; RETICS; CIBERobn Schemes; Instituto de Salud Carlos III; Government of the Basque Country [IT-386-10, IT-572-13]; University of the Basque Country UPV/EHU (ELDUNANOTEK) [UFI11/32]	Linea Especial LE/97 of the University of Navarra; RETICS; CIBERobn Schemes; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of the Basque Country; University of the Basque Country UPV/EHU (ELDUNANOTEK)	This work has been supported by the Linea Especial LE/97 of the University of Navarra, the RETICS and CIBERobn Schemes funded by Instituto de Salud Carlos III, the Government of the Basque Country (IT-386-10 and IT-572-13) and the University of the Basque Country UPV/EHU (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Ali AS, 2011, OBES REV, V12, P1050, DOI 10.1111/j.1467-789X.2011.00906.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Campion J, 2010, PROG MOL BIOL TRANSL, V94, P291, DOI 10.1016/S1877-1173(10)94011-8; Campion J, 2009, OBESITY, V17, P1293, DOI 10.1038/oby.2008.679; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Cordero P, 2011, J PHYSIOL BIOCHEM, V67, P463, DOI 10.1007/s13105-011-0084-4; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomba A, 2010, MOL GENET METAB, V101, P273, DOI 10.1016/j.ymgme.2010.07.017; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; McGregor RA, 2011, CURR MOL MED, V11, P304; Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964; Milagro FI, 2011, FASEB J, V25, P1378, DOI 10.1096/fj.10-170365; Mutch DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001344; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Park JH, 2011, MOL CELLS, V31, P33, DOI 10.1007/s10059-011-0009-7; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Sarzynski MA, 2011, INT J OBESITY, V35, P676, DOI 10.1038/ijo.2010.166; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Thulasingam S, 2011, MOL CELL BIOCHEM, V352, P181, DOI 10.1007/s11010-011-0752-2; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	55	63	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54319	10.1371/journal.pone.0054319	http://dx.doi.org/10.1371/journal.pone.0054319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335998	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700056
J	Rozhon, W; Husar, S; Kalaivanan, F; Khan, M; Idlhammer, M; Shumilina, D; Lange, T; Hoffmann, T; Schwab, W; Fujioka, S; Poppenberger, B				Rozhon, Wilfried; Husar, Sigrid; Kalaivanan, Florian; Khan, Mamoona; Idlhammer, Markus; Shumilina, Daria; Lange, Theo; Hoffmann, Thomas; Schwab, Wilfried; Fujioka, Shozo; Poppenberger, Brigitte			Genetic Variation in Plant CYP51s Confers Resistance against Voriconazole, a Novel Inhibitor of Brassinosteroid-Dependent Sterol Biosynthesis	PLOS ONE			English	Article							GIBBERELLIN BIOSYNTHESIS; CYTOCHROME-P450 MONOOXYGENASE; SIGNAL-TRANSDUCTION; CELL ELONGATION; DE-ETIOLATION; ARABIDOPSIS; GROWTH; EXPRESSION; TRIAZOLE; 14-ALPHA-DEMETHYLASE	Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant growth by inhibiting sterol-14 alpha-demethylation and thereby interfering with BR production. The plant growth regulatory properties of voriconazole and related triazoles were identified in a screen for compounds with the ability to alter BR homeostasis. Voriconazole suppressed growth of the model plant Arabidopsis thaliana and of a wide range of both monocotyledonous and dicotyledonous plants. We uncover that voriconazole toxicity in plants is a result of a deficiency in BRs that stems from an inhibition of the cytochrome P450 CYP51, which catalyzes a step of BR-dependent sterol biosynthesis. Interestingly, we found that the woodland strawberry Fragaria vesca, a member of the Rosaceae, is naturally voriconazole resistant and that this resistance is conferred by the specific CYP51 variant of F. vesca. The potential of voriconazole as a novel tool for plant research is discussed.	[Rozhon, Wilfried; Khan, Mamoona; Hoffmann, Thomas; Schwab, Wilfried; Poppenberger, Brigitte] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Rozhon, Wilfried; Husar, Sigrid; Kalaivanan, Florian; Khan, Mamoona; Idlhammer, Markus; Shumilina, Daria; Poppenberger, Brigitte] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Lange, Theo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama, Japan	Technical University of Munich; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Braunschweig University of Technology; RIKEN	Poppenberger, B (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Lange, Theo/H-6148-2018; Rozhon, Wilfried/AFK-4445-2022; Rozhon, Wilfried/AAG-3162-2022	Lange, Theo/0000-0003-1294-2647; Rozhon, Wilfried/0000-0003-0659-0593; Rozhon, Wilfried/0000-0003-0659-0593; Khan, Mamoona/0000-0003-3301-9536	Austrian Science Fund FWF [P19948, P22734]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19380069, 23380066]; Higher Education Commission of Pakistan; FWF; Austrian Science Fund (FWF) [P 22734] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (projects P19948 and P22734), by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grant-in-Aid for Scientific Research (B) 19380069 and 23380066 (to S.F.) and by research fellowships to MK (Ph.D. fellowship of the Higher Education Commission of Pakistan) and BP (Hertha-Firnberg fellowship of the FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAMA Y, 1994, BIOCHEM BIOPH RES CO, V201, P1320, DOI 10.1006/bbrc.1994.1848; Asami T, 2003, BIOCHEM J, V369, P71, DOI 10.1042/BJ20020835; Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bishop GJ, 2007, TRENDS PLANT SCI, V12, P377, DOI 10.1016/j.tplants.2007.07.001; Boutte Y, 2009, CURR OPIN PLANT BIOL, V12, P705, DOI 10.1016/j.pbi.2009.09.013; BURDEN RS, 1989, PHYTOCHEMISTRY, V28, P1791, DOI 10.1016/S0031-9422(00)97862-2; Choe S, 2007, J PLANT BIOL, V50, P225, DOI 10.1007/BF03030649; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 2000, CURR BIOL, V10, pR601, DOI 10.1016/S0960-9822(00)00639-4; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Debeljak N, 2003, ARCH BIOCHEM BIOPHYS, V409, P159, DOI 10.1016/S0003-9861(02)00418-6; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fung-Tomc J C, 1997, Expert Opin Investig Drugs, V6, P129, DOI 10.1517/13543784.6.2.129; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GRAUSEM B, 1995, PLANT J, V7, P761, DOI 10.1046/j.1365-313X.1995.07050761.x; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hartwig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036625; Hayashi K, 2000, PHYTOCHEMISTRY, V55, P1, DOI 10.1016/S0031-9422(00)00204-1; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Kim HB, 2005, PLANT PHYSIOL, V138, P2033, DOI 10.1104/pp.105.061598; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Lange T, 2005, PLANT PHYSIOL, V139, P213, DOI 10.1104/pp.105.064162; LENTON JR, 1994, PLANT GROWTH REGUL, V15, P281, DOI 10.1007/BF00029901; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lupetti A, 2003, TRENDS MOL MED, V9, P269, DOI 10.1016/S1471-4914(03)00091-1; McCourt P, 2010, NEW PHYTOL, V185, P15, DOI 10.1111/j.1469-8137.2009.03045.x; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; NAMBARA E, 1991, PLANT PHYSIOL, V97, P736, DOI 10.1104/pp.97.2.736; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh K, 2012, BIOORG MED CHEM LETT, V22, P1625, DOI 10.1016/j.bmcl.2011.12.120; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2011, EMBO J, V30, P1149, DOI 10.1038/emboj.2011.35; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Sanati H, 1997, ANTIMICROB AGENTS CH, V41, P2492, DOI 10.1128/AAC.41.11.2492; Schrick K, 2000, GENE DEV, V14, P1471; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Sekimata K, 2001, PLANTA, V213, P716, DOI 10.1007/s004250100546; Sekimata K, 2008, BIOSCI BIOTECH BIOCH, V72, P7, DOI 10.1271/bbb.70141; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Swain SM, 2005, PLANT CELL PHYSIOL, V46, P284, DOI 10.1093/pcp/pci027; Symons GM, 2008, PLANT SIGNAL BEHAV, V3, P868, DOI 10.4161/psb.3.10.6063; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; TATON M, 1988, PESTIC BIOCHEM PHYS, V30, P178, DOI 10.1016/0048-3575(88)90051-X; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wang JM, 2001, BIOSCI BIOTECH BIOCH, V65, P817, DOI 10.1271/bbb.65.817; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441	65	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53650	10.1371/journal.pone.0053650	http://dx.doi.org/10.1371/journal.pone.0053650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335967	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700023
J	Chatterjee, S; Malhotra, R; Varghese, F; Bukhari, AB; Patil, A; Budrukkar, A; Parmar, V; Gupta, S; De, A				Chatterjee, Sushmita; Malhotra, Renu; Varghese, Frency; Bukhari, Amirali B.; Patil, Asawari; Budrukkar, Ashwini; Parmar, Vani; Gupta, Sudeep; De, Abhijit			Quantitative Immunohistochemical Analysis Reveals Association between Sodium Iodide Symporter and Estrogen Receptor Expression in Breast Cancer	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; IN-SITU HYBRIDIZATION; THYROID-CARCINOMA; GENE; TISSUE; METASTASES; QUANTIFICATION; NIS	Background: Human sodium iodide symporter (hNIS) gene over-expression is under active consideration worldwide as an alternative target molecule for breast cancer (BC) diagnosis and targeted radio-iodine treatment. However, the field demands better stratified analysis of endogenous hNIS expression across major BC subtypes. Therefore, we have analyzed subtype-specific variation of hNIS overexpression in breast tumor tissue samples by immunohistochemistry (IHC) and also report the development of a homogeneous, quantitative analysis method of digital IHC images. Methods: hNIS expression was analyzed from 108 BC tissue samples by IHC. Sub-cellular localization of hNIS protein was analyzed by dual immunofluorescence (IF) staining method using hNIS and HER2 antibodies. An ImageJ based two-step digital analysis method was developed and applied for the bias-free analysis of the images. Results: Staining of the tumor samples show 70% cases are hNIS positive indicating high incidence of hNIS positive cases in BC. More importantly, a subtype specific analysis done for the first time shows that hNIS expression is overly dominated in estrogen receptor (ER) positive cases than the receptor negative cases. Further, 56% of the ER+ve, PgR+ve, HER2-ve and 36% of ER+ve, PgR+ve, HER2+ve cases show highest intensity staining equivalent to the thyroid tissue. A significant positive correlation is also observed between hNIS and estrogen receptor expression (p = 0.0033, CI = 95%) suggesting hNIS mediated targeted radio-iodine therapy procedures may benefit both ER+ve, PgR+ve, HER2-ve as well as HER2+ve cases. Further, in a few cases, hNIS and HER2 protein localization is demonstrated by overlapping membrane co-expression. ImageJ based image analysis method shows over 70% match with manual pathological scoring method. Conclusion: The study indicates a positive link between hNIS and ER expression in BC. The quantitative IHC image analysis method reported here will further help in patient stratification and potentially benefit global clinical assessment where hNIS mediated targeted I-131 radio-ablative therapy is aimed.	[Chatterjee, Sushmita; Malhotra, Renu; Varghese, Frency; Bukhari, Amirali B.; De, Abhijit] Tata Mem Hosp, ACTREC, Funct Mol Imaging Lab, Kharghar, Navi Mumbai, India; [Patil, Asawari] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Budrukkar, Ashwini] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India; [Parmar, Vani] Tata Mem Hosp, Dept Surg, Bombay 400012, Maharashtra, India; [Gupta, Sudeep] Tata Mem Hosp, Dept Med Oncol, Bombay 400012, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	De, A (corresponding author), Tata Mem Hosp, ACTREC, Funct Mol Imaging Lab, Kharghar, Navi Mumbai, India.	ade@actrec.gov.in	Bukhari, Amirali/L-5610-2014; Patil, Asawari/AAW-1878-2020; DE, ABHIJIT/AAR-5631-2021	Bukhari, Amirali/0000-0003-0543-1339; Patil, Asawari/0000-0002-8203-986X; DE, ABHIJIT/0000-0002-5818-0206	TMC-IRG; ICMR	TMC-IRG; ICMR(Indian Council of Medical Research (ICMR))	The clinical study protocol was reviewed and approved by the TMC-ACTREC Institutional Review Board. For all experiments paraffin embedded tissue blocks were used and thus patient consent was not required. Funding support on the study proposals by AD received from TMC-IRG and ICMR are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Beyer SJ, 2009, BREAST CANCER RES TR, V115, P205, DOI 10.1007/s10549-008-0059-5; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; Damle AA, 2011, INDIAN J EXP BIOL, V49, P416; Dwyer RM, 2011, STEM CELLS, V29, P1149, DOI 10.1002/stem.665; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Marsee DK, 2004, CANCER GENE THER, V11, P121, DOI 10.1038/sj.cgt.7700661; Moon DH, 2001, NUCL MED BIOL, V28, P829; Niu G, 2004, J NUCL MED, V45, P445; Oh Hyun Jung, 2005, Cancer Res Treat, V37, P247, DOI 10.4143/crt.2005.37.4.247; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Renier C, 2009, ANN SURG ONCOL, V16, P962, DOI 10.1245/s10434-008-0280-9; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Ryan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016023; Schlumberger M, 1996, J NUCL MED, V37, P598; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Tandon A, 2011, INDIAN J PATHOL MICR, V54, P745, DOI 10.4103/0377-4929.91514; Tawfik OW, 2006, HISTOPATHOLOGY, V48, P258, DOI 10.1111/j.1365-2559.2005.02322.x; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Tazebay UH, 2011, BREAST CANC RECENT A; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Upadhyay G, 2003, BREAST CANCER RES TR, V77, P157, DOI 10.1023/A:1021321409159; Wapnir IL, 2004, CLIN CANCER RES, V10, P4294, DOI 10.1158/1078-0432.CCR-04-0074; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544	28	42	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54055	10.1371/journal.pone.0054055	http://dx.doi.org/10.1371/journal.pone.0054055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342072	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400115
J	Lundberg, K; Albrekt, AS; Nelissen, I; Santegoets, S; de Gruijl, TD; Gibbs, S; Lindstedt, M				Lundberg, Kristina; Albrekt, Ann-Sofie; Nelissen, Inge; Santegoets, Saskia; de Gruijl, Tanja D.; Gibbs, Sue; Lindstedt, Malin			Transcriptional Profiling of Human Dendritic Cell Populations and Models - Unique Profiles of In Vitro Dendritic Cells and Implications on Functionality and Applicability	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; LANGERHANS CELLS; SKIN SENSITIZERS; BONE-MARROW; TNF-ALPHA; GM-CSF; ANTIGEN; BLOOD; DIFFERENTIATION	Background: Dendritic cells (DCs) comprise heterogeneous populations of cells, which act as central orchestrators of the immune response. Applicability of primary DCs is restricted due to their scarcity and therefore DC models are commonly employed in DC-based immunotherapy strategies and in vitro tests assessing DC function. However, the interrelationship between the individual in vitro DC models and their relative resemblance to specific primary DC populations remain elusive. Objective: To describe and assess functionality and applicability of the available in vitro DC models by using a genome-wide transcriptional approach. Methods: Transcriptional profiling was performed with four commonly used in vitro DC models (MUTZ-3-DCs, monocyte-derived DCs, CD34-derived DCs and Langerhans cells (LCs)) and nine primary DC populations (dermal DCs, LCs, blood and tonsillar CD123(+), CD1c(+) and CD141(+) DCs, and blood CD16(+) DCs). Results: Principal Component Analysis showed that transcriptional profiles of each in vitro DC model most closely resembled CD1c(+) and CD141(+) tonsillar myeloid DCs (mDCs) among primary DC populations. Thus, additional differentiation factors may be required to generate model DCs that more closely resemble other primary DC populations. Also, no model DC stood out in terms of primary DC resemblance. Nevertheless, hierarchical clustering showed clusters of differentially expressed genes among individual DC models as well as primary DC populations. Furthermore, model DCs were shown to differentially express immunologically relevant transcripts and transcriptional signatures identified for each model DC included several immune-associated transcripts. Conclusion: The unique transcriptional profiles of in vitro DC models suggest distinct functionality in immune applications. The presented results will aid in the selection of an appropriate DC model for in vitro assays and assist development of DC-based immunotherapy.	[Lundberg, Kristina; Albrekt, Ann-Sofie; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Nelissen, Inge] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium; [Santegoets, Saskia; de Gruijl, Tanja D.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Gibbs, Sue] Vrije Univ Amsterdam Med Ctr, Dept Dermatol, Amsterdam, Netherlands	Lund University; VITO; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Lundberg, K (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	kristina.lundberg@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087; Santegoets, Saskia/0000-0002-2874-4402	Swedish Research Council [2008-743-57748-66]; European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv' [LSHB-CT-2005-018681]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv'	This work was supported by grants from the Swedish Research Council (2008-743-57748-66, http://www.vr.se) and the European Commission as part of the Integrated project 'Novel Testing Strategies for in vitro Assessment of Allergens; Sens-it-iv' (LSHB-CT-2005-018681, http://www.sens-it-iv.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby P, 2007, ALTEX-ALTERN TIEREXP, V24, P3; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Azam P, 2006, TOXICOL APPL PHARM, V212, P14, DOI 10.1016/j.taap.2005.06.018; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; Demeure CE, 2000, J IMMUNOL, V164, P2193, DOI 10.4049/jimmunol.164.4.2193; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014; Hu ZB, 1996, LEUKEMIA, V10, P1025; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 1997, ADV EXP MED BIOL, V417, P363; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lardon F, 1997, IMMUNOLOGY, V91, P553, DOI 10.1046/j.1365-2567.1997.00295.x; Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Nencioni A, 2008, CRIT REV ONCOL HEMAT, V65, P191, DOI 10.1016/j.critrevonc.2007.10.002; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Novak N, 2004, J ALLERGY CLIN IMMUN, V113, P949, DOI 10.1016/j.jaci.2004.02.005; Palucka K, 2011, CURR TOP MICROBIOL, V344, P173, DOI 10.1007/82_2010_48; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Python F, 2009, TOXICOL APPL PHARM, V239, P273, DOI 10.1016/j.taap.2009.06.003; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; REID CDL, 1990, BLOOD, V76, P1139; REID CDL, 1992, J IMMUNOL, V149, P2681; Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rosenzwajg M, 1996, BLOOD, V87, P535, DOI 10.1182/blood.V87.2.535.bloodjournal872535; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P143, DOI 10.1189/jlb.1107750; Schoeters E, 2007, MOL IMMUNOL, V44, P3222, DOI 10.1016/j.molimm.2007.01.031; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Van Gulck E, 2010, CURR HIV RES, V8, P310, DOI 10.2174/157016210791208631; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009	74	77	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52875	10.1371/journal.pone.0052875	http://dx.doi.org/10.1371/journal.pone.0052875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341914	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400026
J	Naeem, A; Amani, S				Naeem, Aabgeena; Amani, Samreen			Deciphering Structural Intermediates and Genotoxic Fibrillar Aggregates of Albumins: A Molecular Mechanism Underlying for Degenerative Diseases	PLOS ONE			English	Article							PARTIALLY FOLDED STATE; HUMAN SERUM-ALBUMIN; 1-ANILINO-8-NAPHTHALENE SULFONATE; PROTEIN AGGREGATION; GLOBULAR-PROTEIN; IN-VITRO; BINDING; ACETONITRILE; SPECTROSCOPY; TRANSITION	The misfolding and aggregation of proteins is involved in some of the most prevalent neurodegenerative disorders. The importance of human serum albumin (HSA) stems from the fact that it is involved in bio-regulatory and transport phenomena. Here the effect of acetonitrile (ACN) on the conformational stability of HSA and by comparison, ovalbumin (OVA) has been evaluated in the presence and absence of NaCl. The results show the presence of significant amount of secondary structure in HSA at 70% ACN and in OVA at 50% ACN, as evident from far-UV Circular Dichroism (CD) and Attenuated Total Reflection Fourier transformed infra red spectroscopy (ATR-FTIR). Tryptophan and 8-Anilino-1-Naphthalene-Sulphonic acid (ANS) fluorescence indicate altered tryptophan environment and high ANS binding suggesting a compact "molten globule"-like conformation with enhanced exposure of hydrophobic surface area. However, in presence of NaCl no intermediate state was observed. Detection of aggregates in HSA and OVA was possible at 90% ACN. Aggregates possess extensive beta-sheet structure as revealed by far-UV CD and ATR-FTIR. These aggregates exhibit increase Thioflavin T (Th T) fluorescence with a red shift of Congo red (CR) absorption spectrum. X-ray diffraction (XRD) and Scanning Electron Microscopy (SEM) analysis confirmed the presence of fibrillar aggregates. Single cell gel electrophoresis (SCGE) assay of these fibrillar aggregates showed the DNA damage resulting in cell necrosis confirming their genotoxic nature. Some proteins not related to any human disease form fibrils in vitro. In the present study ACN gives access to a model system to study the process of aggregation.	[Naeem, Aabgeena; Amani, Samreen] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University	Naeem, A (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	aabgeenanaim@gmail.com			CSIR [37(1365)/09/EMR- II]; UGC-SRF	CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC-SRF(University Grants Commission, India)	The authors are highly thankful for the facilities available at AMU Aligarh. Financial support from CSIR [37(1365)/09/EMR- II] in the form of project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are highly thankful for the facilities available at AMU Aligarh. USIF, AMU has been acknowledged for providing SEM facility. S. A. is the recipient of UGC-SRF.	Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Amani S, 2011, INT J BIOL MACROMOL, V49, P71, DOI 10.1016/j.ijbiomac.2011.03.014; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Daniel FB, 1991, J TOXICOL-CLIN TOXIC, V29, P447; Dzwolak W, 2004, BIOPOLYMERS, V73, P463, DOI 10.1002/bip.10582; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fu XM, 2005, BIOCHEM BIOPH RES CO, V329, P1087, DOI 10.1016/j.bbrc.2005.01.164; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; Iram A, 2013, INT J BIOL MACROMOL, V52, P286, DOI 10.1016/j.ijbiomac.2012.10.023; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; KAYSEN GA, 1990, AM J NEPHROL, V10, P36, DOI 10.1159/000168192; Khan TA, 2012, AMINO ACIDS, V43, P1311, DOI 10.1007/s00726-011-1204-8; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LEE JY, 1992, J BIOL CHEM, V267, P14753; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Marcon G, 2005, J MOL BIOL, V347, P323, DOI 10.1016/j.jmb.2005.01.034; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Matulis D, 1999, BIOPOLYMERS, V49, P451, DOI 10.1002/(SICI)1097-0282(199905)49:6<451::AID-BIP3>3.0.CO;2-6; Meersman F, 2002, BIOPHYS J, V82, P2635, DOI 10.1016/S0006-3495(02)75605-1; MICHAELIS HC, 1991, J TOXICOL-CLIN TOXIC, V29, P447, DOI 10.3109/15563659109025740; Muzammil S, 1999, EUR J BIOCHEM, V266, P26, DOI 10.1046/j.1432-1327.1999.00810.x; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V59, P29, DOI 10.1007/s12013-010-9108-x; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Ollesch J, 2007, APPL SPECTROSC, V61, P1025, DOI 10.1366/000370207782217680; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tatsumi E, 1999, BIOSCI BIOTECH BIOCH, V63, P1285, DOI 10.1271/bbb.63.1285; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Weijers M, 2002, MACROMOLECULES, V35, P4753, DOI 10.1021/ma0120198	50	40	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54061	10.1371/journal.pone.0054061	http://dx.doi.org/10.1371/journal.pone.0054061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342075	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400117
J	Raso-Barnett, L; Banky, B; Barbai, T; Becsagh, P; Timar, J; Raso, E				Raso-Barnett, Livia; Banky, Balazs; Barbai, Tamas; Becsagh, Peter; Timar, Jozsef; Raso, Erzsebet			Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression	PLOS ONE			English	Article							HOMING RECEPTOR CD44; COLORECTAL-CANCER; CELL-LINES; ADHESION MOLECULES; CUTANEOUS MELANOMA; EXPRESSION; VARIANTS; GROWTH; V3; MIGRATION	The role of CD44 in the progression of human melanoma has mostly been characterised by qualitative changes in expression of its individual variable exons. These exons however, may be expressed to form a number of molecules, the alternative splice variants of CD44, which may be structurally and functionally different. Using real-time PCR measurements with variable exon specific primers we have determined that all are expressed in human melanoma. To permit comparison between different tumours we identified a stable CD44 variable exon (CD44v) expression pattern, or CD44 'fingerprint'. This was found to remain unchanged in melanoma cell lines cultured in different matrix environments. To evaluate evolution of this fingerprint during tumour progression we established a scid mouse model, in which the pure expression pattern of metastatic primary tumours, circulating cells and metastases, non-metastatic primary tumours and lung colonies could be studied. Our analyses demonstrated, that although the melanoma CD44 fingerprint is qualitatively stable, quantitative changes are observed suggesting a possible role in tumour progression.	[Raso-Barnett, Livia; Banky, Balazs; Barbai, Tamas; Becsagh, Peter; Timar, Jozsef; Raso, Erzsebet] Semmelweis Univ, Dept Tumour Progress, Inst Pathol 2, H-1085 Budapest, Hungary; [Raso-Barnett, Livia] Guys & St Thomas Hosp, Dept Cellular Pathol, London SE1 9RT, England; [Timar, Jozsef; Raso, Erzsebet] Hungarian Acad Sci, Tumour Progress Res Grp, Budapest, Hungary	Semmelweis University; Guy's & St Thomas' NHS Foundation Trust; Hungarian Academy of Sciences	Raso-Barnett, L (corresponding author), Semmelweis Univ, Dept Tumour Progress, Inst Pathol 2, H-1085 Budapest, Hungary.	rasobarnettlivia@gmail.com	Banky, Balazs/B-9670-2018; BARBAI, TAMÁS/S-5628-2017; Raso, Erzsebet/S-5619-2017	Banky, Balazs/0000-0002-4297-9072; BARBAI, TAMÁS/0000-0002-2374-6097; Raso, Erzsebet/0000-0002-4589-5771	Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) [(TAMOP)-4.2.1./B-09/1/KMR-2010-0001]; Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT) [087-07/2009]; EGT/Norwegian Financial Mechanism [HU0125]	Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme); Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT); EGT/Norwegian Financial Mechanism	This study was supported by grants from Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) (TAMOP)-4.2.1./B-09/1/KMR-2010-0001, Egeszsegugyi Tudomanyos Tanacs (Medical Scientific Board of the Hungarian Ministry of Health) (ETT) 087-07/2009 and EGT/Norwegian Financial Mechanism, HU0125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banky B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-83; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN PD, 1990, CANCER RES, V50, P6184; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Dome B, 2001, VIRCHOWS ARCH, V439, P628; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Haruyama K, 1999, ANTICANCER RES, V19, P4421; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kopp R, 2009, INT J MOL MED, V24, P677, DOI 10.3892/ijmm_00000279; MANTENHORST E, 1995, INT J CANCER, V64, P182, DOI 10.1002/ijc.2910640307; Marhaba R, 2004, J MOL HISTOL, V35, P211; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pacifico MD, 2006, INT J CANCER, V118, P1460, DOI 10.1002/ijc.21504; Poncelet C, 2001, HUM PATHOL, V32, P1190, DOI 10.1053/hupa.2001.28935; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ranuncolo SM, 2002, ONCOL REP, V9, P51; Recio JA, 2003, CANCER RES, V63, P1576; Reeder JA, 1998, CANCER RES, V58, P3719; RODRIGUEZ C, 1995, INT J CANCER, V64, P347, DOI 10.1002/ijc.2910640512; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seiter S, 1996, VIRCHOWS ARCH, V428, P141; Suzuki H, 2002, LUNG CANCER-J IASLC, V38, P137, DOI 10.1016/S0169-5002(02)00176-9; TAKACS J, 1981, ACTA MORPHOL HUNG, V29, P141; Timar J, 2005, ONCOLOGY-BASEL, V69, P185, DOI 10.1159/000088069; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Wang SJ, 2007, HEAD NECK-J SCI SPEC, V29, P550, DOI 10.1002/hed.20544; Wong LS, 1997, BRIT J SURG, V84, P363, DOI 10.1046/j.1365-2168.1997.02582.x; Yamada Y, 2003, ONCOL REP, V10, P1919; Yang K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-16; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003; Zalewski B, 2004, WORLD J GASTROENTERO, V10, P583, DOI 10.3748/wjg.v10.i4.583	37	18	18	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53883	10.1371/journal.pone.0053883	http://dx.doi.org/10.1371/journal.pone.0053883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342032	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000314759400096
J	Sato, Y; Inoue, N; Ishikawa, T; Ishibashi, R; Obata, M; Aoki, H; Atsumi, T; Komaru, A				Sato, Yu; Inoue, Nariaki; Ishikawa, Takashi; Ishibashi, Ryo; Obata, Mayu; Aoki, Hideo; Atsumi, Takashi; Komaru, Akira			Pearl Microstructure and Expression of Shell Matrix Protein Genes MSI31 and MSI60 in the Pearl Sac Epithelium of Pinctada fucata by In Situ Hybridization	PLOS ONE			English	Article							PRISMATIC LAYER; NACREOUS LAYER; OYSTER; CLONING; FAMILY	Expression patterns of the shell matrix protein genes MSI31 and MSI60 in the pearl sac epithelium were examined by in situ hybridization 38 days after implantation, and related to pearl quality. A pearl sac that produced a nacreous pearl showed very weak expression of MSI31 and strong expression of MSI60. A pearl sac, which yielded a prismatic pearl, strongly expressed MSI31 and very weakly expressed MSI60. In a complex pearl, whose surface consisted of a mosaic of both nacreous and prismatic layers, the expression pattern of MSI31 and MSI60 similarly corresponded to the underlying surface structures of the pearl. A nacreous pearl whose pearl sac showed strong MSI31 expression had an entirely nacreous surface composed of a laminar structure with unusual tablet growth at the corresponding site. MSI31 and MSI60 are the major components of the shell matrix proteins of the nacreous and prismatic layers. Clearly, high expression of MSI31 does not always result in prismatic secretion. These observations cannot be explained solely on the basis of the expression patterns of MSI31 and MSI60. We propose that, in addition to the MSI genes that form the prismatic and nacreous layers, upstream from these genes there are regulatory master genes that determine whether a nacreous layer (aragonite) or a prismatic layer (calcite) is formed.	[Sato, Yu; Inoue, Nariaki; Ishikawa, Takashi; Ishibashi, Ryo; Obata, Mayu; Komaru, Akira] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Aoki, Hideo; Atsumi, Takashi] Mie Prefecture Fisheries Res Lab, Shima, Mie, Japan	Mie University	Komaru, A (corresponding author), Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan.	komaru@bio.mie-u.ac.jp			Japanese Government, Ministry of Agriculture, Forestry and Fisheries [22065]	Japanese Government, Ministry of Agriculture, Forestry and Fisheries	This study have been supported by the fund of Japanese Government, Ministry of Agriculture, Forestry and Fisheries during 2012-2015. The title of the fund is "A research program aimed at utilizing advanced technologies in agriculture, forestry and fisheries: MAFF, Japan." The No. of the funding is #22065. The funders had no role in our experiment and study design, data collection and analysis, decision to publish, and preparation of manuscript.	Aoki S, 1957, B NATL PEARL RES LAB, V2, P113; Aoki S, 1966, NIPPON SUISAN GAKK, V32, P1; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Hayashi M, 2007, ZENSHINREN GIJUTU KE, V21, P7; Inoue N, 2011, MAR BIOTECHNOL, V13, P474, DOI 10.1007/s10126-010-9318-7; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Inoue N, 2010, AQUACULTURE, V308, pS68, DOI 10.1016/j.aquaculture.2010.06.036; Kawakami IK, 1952, MEM FS KYUSHU U, V1, P86; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Nakahara H, 1956, B NATL PEARL RES LAB, V1, P10; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Samata Tetsuro, 2004, Thalassas, V20, P25; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Simkiss K., 1989, BIOMINERALIZATION CE, P230; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; WADA K, 1966, NATURE, V211, P1427, DOI 10.1038/2111427a0; WADA K., 1957, BULL JAPANESE SOC SCI FISH, V23, P302; Wada K., 1962, B NATL PEARL RES LAB, V8, P948; Wada K., 1957, B NATL PEARL RES LAB, V3, P167; Wada K, 1999, J GEMMOL SOC JPN, V20, P47; Watabe N, 1954, REP FAC FISH PREF U, V1, P449; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	34	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52372	10.1371/journal.pone.0052372	http://dx.doi.org/10.1371/journal.pone.0052372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341897	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400014
J	Almeida, C; Nagarajan, D; Tian, J; Leal, SW; Wheeler, K; Munley, M; Blackstock, W; Zhao, WL				Almeida, Celine; Nagarajan, Devipriya; Tian, Jian; Leal, Sofia Walder; Wheeler, Kenneth; Munley, Michael; Blackstock, William; Zhao, Weiling			The Role of Alveolar Epithelium in Radiation-Induced Lung Injury	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; HISTONE DEACETYLASE INHIBITORS; INDUCED PULMONARY-FIBROSIS; HEPATIC STELLATE CELLS; THORACIC IRRADIATION; GROWTH-FACTOR; MOUSE LUNG; RAT LUNG; DECREASED EXPRESSION; TGF-BETA	Pneumonitis and fibrosis are major lung complications of irradiating thoracic malignancies. In the current study, we determined the effect of thoracic irradiation on the lungs of FVB/N mice. Survival data showed a dose-dependent increase in morbidity following thoracic irradiation with single (11-13 Gy) and fractionated doses (24-36 Gy) of Cs-137 gamma-rays. Histological examination showed a thickening of vessel walls, accumulation of inflammatory cells, collagen deposition, and regional fibrosis in the lungs 14 weeks after a single 12 Gy dose and a fractionated 30 Gy dose; this damage was also seen 5 months after a fractionated 24 Gy dose. After both single and fractionated doses, i] aquaporin-5 was markedly decreased, ii] E-cadherin was reduced and iii] prosurfactant Protein C (pro-SP-c), the number of pro-SP-c(+) cells and vimentin expression were increased in the lungs. Immunofluorescence analysis revealed co-localization of pro-SP-c and alpha-smooth muscle actin in the alveoli after a single dose of 12 Gy. These data suggest that, i] the FVB/N mouse strain is sensitive to thoracic radiation ii] aquaporin-5, E-cadherin, and pro-SP-c may serve as sensitive indicators of radiation-induced lung injury; and iii] the epithelial-to-mesenchymal transition may play an important role in the development of radiation-induced lung fibrosis.	[Almeida, Celine; Nagarajan, Devipriya; Leal, Sofia Walder; Munley, Michael; Blackstock, William; Zhao, Weiling] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Wheeler, Kenneth] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Almeida, Celine; Nagarajan, Devipriya; Leal, Sofia Walder; Wheeler, Kenneth; Zhao, Weiling] Wake Forest Univ, Wake Forest Sch Med, Brain Tumor Ctr, Winston Salem, NC 27109 USA; [Tian, Jian] Loma Linda Univ, Dept Radiat Med, Radiat Res Labs, Loma Linda, CA 92350 USA; [Tian, Jian] Loma Linda Univ, Med Ctr, Loma Linda, CA USA	Wake Forest University; Wake Forest University; Wake Forest University; Loma Linda University; Loma Linda University	Zhao, WL (corresponding author), Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA.	wzhao@wfubmc.edu	Nagarajan, Devipriya/GNO-9425-2022	Nagarajan, Devipriya/0000-0002-4569-2624				Adamson IY, 1988, AM J PATHOL, V41, P377; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Calveley VL, 2010, RADIAT RES, V173, P602, DOI 10.1667/RR1896.1; Chung YL, 2004, MOL CANCER THER, V3, P317; COGGLE JE, 1987, INT J RADIAT BIOL, V51, P393, DOI 10.1080/09553008714550891; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fleckenstein K, 2007, INT J RADIAT ONCOL, V68, P196, DOI 10.1016/j.ijrobp.2006.12.056; Folkerts G, 1998, TRENDS PHARMACOL SCI, V19, P334, DOI 10.1016/S0165-6147(98)01232-2; Franko AJ, 1996, RADIAT RES, V146, P68, DOI 10.2307/3579397; Franko AJ, 1996, RADIAT RES, V146, P586, DOI 10.2307/3579561; FRANKO AJ, 1994, RADIAT RES, V140, P347, DOI 10.2307/3579112; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; Ghafoori P, 2008, ONCOLOGY-NY, V22, P37; GIRI PGS, 1986, BRIT J CANCER, V53, P324; GIRI PGS, 1985, INT J RADIAT ONCOL, V11, P527, DOI 10.1016/0360-3016(85)90184-1; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hodge S, 2009, AM J TRANSPLANT, V9, P727, DOI 10.1111/j.1600-6143.2009.02558.x; Houchen CW, 2000, AM J PHYSIOL-GASTR L, V279, pG858, DOI 10.1152/ajpgi.2000.279.5.G858; Jackson IL, 2011, RADIAT RES, V175, P510, DOI 10.1667/RR2421.1; Jackson IL, 2010, RADIAT RES, V173, P10, DOI 10.1667/RR1911.1; JOHNSTON CJ, 1995, RADIAT RES, V142, P197, DOI 10.2307/3579029; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6; Kong Feng-Ming, 2008, Cancer Control, V15, P140; Liu DG, 2008, CHINESE MED J-PEKING, V121, P1925, DOI 10.1097/00029330-200810010-00014; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marks L B, 1994, Oncology (Williston Park), V8, P89; Marks LB, 2003, SEMIN RADIAT ONCOL, V13, P333, DOI 10.1016/S1053-4296(03)00034-1; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; MCCORMAC FX, 1995, AM J RESP CRIT CARE, V152, P751, DOI 10.1164/ajrccm.152.2.7633738; Molla M, 2003, INT J RADIAT ONCOL, V57, P264, DOI 10.1016/S0360-3016(03)00523-6; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Nagarajan D, 2012, FREE RADICAL BIO MED, V52, P983, DOI 10.1016/j.freeradbiomed.2011.11.024; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; O'Brien TJ, 2005, CAN J PHYSIOL PHARM, V83, P117, DOI 10.1139/Y05-005; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Park JH, 2004, CLIN CANCER RES, V10, P5271, DOI 10.1158/1078-0432.CCR-03-0709; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Remiszewski SW, 2002, CURR OPIN DRUG DISC, V5, P487; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; SHARPLIN J, 1989, RADIAT RES, V119, P1, DOI 10.2307/3577363; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; STEEL GG, 1979, BRIT J RADIOL, V52, P741, DOI 10.1259/0007-1285-52-621-741; Takayasu H, 2007, J PEDIATR SURG, V42, P415, DOI 10.1016/j.jpedsurg.2006.10.029; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thore CR, 2007, J NEUROPATH EXP NEUR, V66, P337, DOI 10.1097/nen.0b013e3180537147; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; TRAVIS EL, 1980, INT J RADIAT ONCOL, V6, P345, DOI 10.1016/0360-3016(80)90145-5; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; VERKMAN AS, 2000, EXP PHYSL, V85; Williams JP, 2012, RADIAT RES, V177; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yang XB, 2011, AM J RESP CELL MOL, V45, P127, DOI 10.1165/rcmb.2010-0265OC; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187	64	67	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53628	10.1371/journal.pone.0053628	http://dx.doi.org/10.1371/journal.pone.0053628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326473	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800064
J	Wolf, A; Akrap, N; Marg, B; Galliardt, H; Heiligentag, M; Humpert, F; Sauer, M; Kaltschmidt, B; Kaltschmidt, C; Seidel, T				Wolf, Annette; Akrap, Nina; Marg, Berenice; Galliardt, Helena; Heiligentag, Martyna; Humpert, Fabian; Sauer, Markus; Kaltschmidt, Barbara; Kaltschmidt, Christian; Seidel, Thorsten			Elements of Transcriptional Machinery Are Compatible among Plants and Mammals	PLOS ONE			English	Article							NF-KAPPA-B; RNA-BINDING PROTEIN; GENE-EXPRESSION; NUCLEAR-PORE; DNA-BINDING; ALPHA; DYNAMICS; RECEPTOR; ATPASE; SIGNAL	In the present work, the objective has been to analyse the compatibility of plant and human transcriptional machinery. The experiments revealed that nuclear import and export are conserved among plants and mammals. Further it has been shown that transactivation of a human promoter occurs by human transcription factor NF-kappa B in plant cells, demonstrating that the transcriptional machinery is highly conserved in both kingdoms. Functionality was also seen for regulatory elements of NF-kappa B such as its inhibitor I kappa B isoform alpha that negatively regulated the transactivation activity of the p50/RelA heterodimer by interaction with NF-kappa B in plant cells. Nuclear export of RelA could be demonstrated by FRAP-measurements so that RelA shows nucleo-cytoplasmic shuttling as reported for RelA in mammalian cells. The data reveals the high level of compatibility of human transcriptional elements with the plant transcriptional machinery. Thus, Arabidopsis thaliana mesophyll protoplasts might provide a new heterologous expression system for the investigation of the human NF-kappa B signaling pathways. The system successfully enabled the controlled manipulation of NF-kappa B activity. We suggest the plant protoplast system as a tool for reconstitution and analyses of mammalian pathways and for direct observation of responses to e. g. pharmaceuticals. The major advantage of the system is the absence of interference with endogenous factors that affect and crosstalk with the pathway.	[Wolf, Annette; Akrap, Nina; Marg, Berenice; Galliardt, Helena; Heiligentag, Martyna; Humpert, Fabian; Kaltschmidt, Barbara; Seidel, Thorsten] Univ Bielefeld, D-33615 Bielefeld, Germany; [Sauer, Markus] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany; [Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Wurzburg; University of Bielefeld	Seidel, T (corresponding author), Univ Bielefeld, D-33615 Bielefeld, Germany.	thorsten.seidel@uni-bielefeld.de	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219	Deutsche Forschungsgemeinschaft [SFB613/A5]; Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	This work was supported by Deutsche Forschungsgemeinschaft (SFB613/A5) and Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; ERNST MK, 1995, MOL CELL BIOL, V15, P872; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmore TD, 2009, E L S, DOI [1 0 . 1 0 0 2 /9780470015902. a0002332.pub3, DOI 10.1002/9780470015902.A0002332.PUB3]; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lummer M, 2011, TRAFFIC, V12, P693, DOI 10.1111/j.1600-0854.2011.01180.x; Meier I, 2009, CURR OPIN PLANT BIOL, V12, P87, DOI 10.1016/j.pbi.2008.09.001; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Schooley K, 2003, BIOCHEM J, V369, P331, DOI 10.1042/BJ20020253; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; Weil R, 1997, IMMUNOBIOLOGY, V198, P14, DOI 10.1016/S0171-2985(97)80023-X; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Widera D, 2009, ENCY NEUROSCIENCE, P2862; Ziemienowicz A, 2003, PLANT MOL BIOL, V53, P201, DOI 10.1023/B:PLAN.0000009288.46713.1f	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53737	10.1371/journal.pone.0053737	http://dx.doi.org/10.1371/journal.pone.0053737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326494	gold, Green Published, Green Submitted			2022-12-27	WOS:000314705800072
J	Shi, FY; Fan, YN; Zhang, LG; Meng, L; Zhi, HF; Hu, HY; Lin, AX				Shi, Fangyu; Fan, Yannan; Zhang, Laiguang; Meng, Lu; Zhi, Huifang; Hu, Hongyu; Lin, Aixin			The Expression of Pax6 Variants Is Subject to Posttranscriptional Regulation in the Developing Mouse Eyelid	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; PAIRED DOMAIN; PROLIFERATION; GENE; OVEREXPRESSION; DOSAGE; MIGRATION; PROMOTES; MICE; DIFFERENTIATION	Pax6 is a pivotal transcription factor that plays a role during early eye morphogenesis, but its expression and function in eyelid development remain unknown. In this study, the expression patterns of Pax6 mRNA and protein were examined in the developing mouse eyelid at embryonic days 14.5, 15.5, and 16.5. The function of Pax6 in eyelid development was determined by comparing it to that in the eyes-open-at-birth mutant mouse. In the normally developing eyelid, Pax6 and Pax6(5a) mRNA levels were low at E14.5, increased at E15.5, and then declined at E16.5, accompanied by a change in the Pax6/Pax6(5a) ratio. Pax6 protein was mainly located in the mesenchyme and conjunctiva. It was expressed at low levels in the epidermis at E14.5, severely reduced at E15.5, but re-expressed in the keratinocyte cells of the periderm at E16.5. In contrast, Pax6 and the Pax6/Pax6(5a) ratio were considerably higher with strong nuclear expression in the mutant at E15.5. Next, we examined the relationship of Pax6 to epidermal cell proliferation, migration, and the associated signalling pathways. The Pax6 protein in the developing eyelid was negatively correlated with epidermal cell proliferation but not migration, and it is in contrast to the activation of the EGFR-ERK pathway. Our in vivo data suggest that Pax6 expression and the Pax6/Pax6(5a) ratio are at relatively low levels in the eyelid, and acting as a transcription factor, Pax6 is required for the initiation of eyelid formation and for differential development of the keratinised cells in the closed eyelid. The Pax6 protein is likely to be controlled by the EGFR-ERK pathways. An abnormal increase in Pax6 expression and the Pax6/Pax6(5a) ratio due to alteration of the pathway activity could suppress epidermal cell proliferation leading to the eyes-open-at-birth defect. This study offers insight into the function of the Pax6 protein in eyelid development.	[Shi, Fangyu; Fan, Yannan; Zhang, Laiguang; Meng, Lu; Zhi, Huifang; Hu, Hongyu; Lin, Aixin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Hu, HY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huhy2008@cau.edu.cn; linaix@cau.edu.cn			National Natural Science Foundation of China [31071990]; State Key Laboratory of Agrobiotechnology; National Transgenic Major Program [2009ZX08009-152B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agrobiotechnology; National Transgenic Major Program	This work is supported by the National Natural Science Foundation of China (No. 31071990), partly supported by the Project for Extramural Scientists of State Key Laboratory of Agrobiotechnology and by the National Transgenic Major Program (No. 2009ZX08009-152B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7; Davis N, 2009, DEV BIOL, V333, P132, DOI 10.1016/j.ydbio.2009.06.023; de Chevigny A, 2012, NAT NEUROSCI, V15, P1120, DOI 10.1038/nn.3142; Dora N, 2008, DEV DYNAM, V237, P1295, DOI 10.1002/dvdy.21528; Duncan MK, 2000, J CELL SCI, V113, P3173; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FINDLATER GS, 1993, J ANAT, V183, P121; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hislop NR, 2008, DEV BIOL, V321, P263, DOI 10.1016/j.ydbio.2008.06.026; Kao WWY, 2008, OCUL SURF, V6, P9; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Kozmik Z, 2008, BRAIN RES BULL, V75, P335, DOI 10.1016/j.brainresbull.2007.10.046; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Pinson J, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-13; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Symonds D, 2003, ANAT REC PART A, V273A, P681, DOI 10.1002/ar.a.10090; Tao H, 2005, DEVELOPMENT, V132, P3217, DOI 10.1242/dev.01892; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; WEISS LW, 1975, ACTA DERM-VENEREOL, V55, P321; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	41	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53919	10.1371/journal.pone.0053919	http://dx.doi.org/10.1371/journal.pone.0053919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326536	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400059
J	Teixido, N; Casas, E; Cebrian, E; Linares, C; Garrabou, J				Teixido, Nuria; Casas, Edgar; Cebrian, Emma; Linares, Cristina; Garrabou, Joaquim			Impacts on Coralligenous Outcrop Biodiversity of a Dramatic Coastal Storm	PLOS ONE			English	Article							CORAL-REEFS; CLIMATE-CHANGE; MARINE INVERTEBRATE; COMMUNITY STABILITY; MEDITERRANEAN SEA; LIFE-HISTORY; DISTURBANCE; MORTALITY; PATTERNS; ASSEMBLAGES	Extreme events are rare, stochastic perturbations that can cause abrupt and dramatic ecological change within a short period of time relative to the lifespan of organisms. Studies over time provide exceptional opportunities to detect the effects of extreme climatic events and to measure their impacts by quantifying rates of change at population and community levels. In this study, we show how an extreme storm event affected the dynamics of benthic coralligenous outcrops in the NW Mediterranean Sea using data acquired before (2006-2008) and after the impact (2009-2010) at four different sites. Storms of comparable severity have been documented to occur occasionally within periods of 50 years in the Mediterranean Sea. We assessed the effects derived from the storm comparing changes in benthic community composition at sites exposed to and sheltered from this extreme event. The sites analyzed showed different damage from severe to negligible. The most exposed and impacted site experienced a major shift immediately after the storm, represented by changes in the species richness and beta diversity of benthic species. This site also showed higher compositional variability immediately after the storm and over the following year. The loss of cover of benthic species resulted between 22% and 58%. The damage across these species (e.g. calcareous algae, sponges, anthozoans, bryozoans, tunicates) was uneven, and those with fragile forms were the most impacted, showing cover losses up to 50 to 100%. Interestingly, small patches survived after the storm and began to grow slightly during the following year. In contrast, sheltered sites showed no significant changes in all the studied parameters, indicating no variations due to the storm. This study provides new insights into the responses to large and rare extreme events of Mediterranean communities with low dynamics and long-lived species, which are among the most threatened by the effects of global change.	[Teixido, Nuria; Linares, Cristina] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain; [Teixido, Nuria; Casas, Edgar; Garrabou, Joaquim] Inst Marine Sci ICM CSIC, Barcelona, Spain; [Cebrian, Emma] Ctr Adv Studies Blanes CEAB CSIC, Blanes, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Teixido, N (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain.	nteixido@icm.csic.es	Linares, Cristina/A-5244-2018; Cebrian, Emma/J-9640-2012	Linares, Cristina/0000-0003-3855-2743; Cebrian, Emma/0000-0001-7588-0135; Teixido, Nuria/0000-0001-9286-2852	Agence National de la Recherche (Medchange project); Total Foundation (medDIVERSA project); CSIC project [PIEC 200430E599]; Agency for Management of University and Research Grants [2009-BP-263]; Spanish Ministry of Science and Innovation [CTM2009-08045]; Spanish National Research Council	Agence National de la Recherche (Medchange project)(French National Research Agency (ANR)); Total Foundation (medDIVERSA project); CSIC project; Agency for Management of University and Research Grants; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Research Council	This study has been funded by the Agence National de la Recherche (Medchange project) and Total Foundation (medDIVERSA project, http://meddiversa.medrecover.org), as well as the CSIC project (PIEC 200430E599). Support of this work was also provided by the Agency for Management of University and Research Grants (to NT, research contract Beatriu de Pinos 2009-BP-263), the Spanish Ministry of Science and Innovation (to E. Casas, doctoral fellowship linked to Biorock project CTM2009-08045; to CL, research contract Ramon y Cajal), and the Spanish National Research Council (to E. Cebrian, research contract JAE doc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Alvarez-Filip L, 2009, B MAR SCI, V84, P295; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Ansell TJ, 2006, J CLIMATE, V19, P2717, DOI 10.1175/JCLI3775.1; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1994, CHANGE MARINE COMMUN; Cocito S, 1998, MAR BIOL, V131, P73, DOI 10.1007/s002270050298; Coll M, 2010, PLOS ONE, V5; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EDMUNDS PJ, 1991, MAR ECOL PROG SER, V78, P201, DOI 10.3354/meps078201; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 1998, CONSERV BIOL, V12, P302, DOI 10.1046/j.1523-1739.1998.96417.x; GILI JM, 1985, PSZNI MAR ECOL, V6, P219, DOI 10.1111/j.1439-0485.1985.tb00323.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hereu B, 2012, 200430E599 CEABCSIC, P123; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; IPCC, 2007, PHYS SCI BAS CONTR W, V996, P2007; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jimenez J, 2012, ASSESSMENT ECOLOGICA, P31; Kipson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027103; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares C, 2012, MAR ECOL PROG SER, V452, P81, DOI 10.3354/meps09586; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; Mateo MA, 2012, 200430E599 PIEC CTR; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Miriti MN, 2007, ECOLOGY, V88, P32, DOI 10.1890/0012-9658(2007)88[32:EDASOD]2.0.CO;2; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Piazzi L, 2001, MAR ECOL PROG SER, V210, P149, DOI 10.3354/meps210149; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; Stoddart D.R., 1974, P 2 INT COR REEF S, V2, P473; Teixido N, 2007, ECOSYSTEMS, V10, P142, DOI 10.1007/s10021-006-9012-9; Teixido N, 2009, MAR ECOL PROG SER, V375, P113, DOI 10.3354/meps07757; Teixido N, 2011, PLOS ONE, V6; Teixido N, 2011, WORLD C MAR BIOD AB; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Underwood AJ, 1999, J EXP MAR BIOL ECOL, V232, P125, DOI 10.1016/S0022-0981(98)00105-1; Walker SJ, 2008, GLOBAL CHANGE BIOL, V14, P2755, DOI 10.1111/j.1365-2486.2008.01644.x; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	87	67	67	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53742	10.1371/journal.pone.0053742	http://dx.doi.org/10.1371/journal.pone.0053742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326496	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400039
J	Spinnler, R; Gorski, T; Stolz, K; Schuster, S; Garten, A; Beck-Sickinger, AG; Engelse, MA; de Koning, EJP; Korner, A; Kiess, W; Maedler, K				Spinnler, Robert; Gorski, Theresa; Stolz, Katharina; Schuster, Susanne; Garten, Antje; Beck-Sickinger, Annette G.; Engelse, Marten A.; de Koning, Eelco J. P.; Koerner, Antje; Kiess, Wieland; Maedler, Kathrin			The Adipocytokine Nampt and Its Product NMN Have No Effect on Beta-Cell Survival but Potentiate Glucose Stimulated Insulin Secretion	PLOS ONE			English	Article							MONOUNSATURATED FATTY-ACIDS; FACTOR-KAPPA-B; HUMAN ISLETS; ADIPONECTIN RECEPTORS; DIABETES-MELLITUS; LEPTIN; APOPTOSIS; MICE; EXPRESSION; INTERLEUKIN-1	Aims/Hypothesis: Obesity is associated with a dysregulation of beta-cell and adipocyte function. The molecular interactions between adipose tissue and beta-cells are not yet fully elucidated. We investigated, whether or not the adipocytokine Nicotinamide phosphoribosyltransferase (Nampt) and its enzymatic product Nicotinamide mononucleotide (NMN), which has been associated with obesity and type 2 diabetes mellitus (T2DM) directly influence beta-cell survival and function. Methods: The effect of Nampt and NMN on viability of INS-1E cells was assessed by WST-1 assay. Apoptosis was measured by Annexin V/PI and TUNEL assay. Activation of apoptosis signaling pathways was evaluated. Adenylate kinase release was determined to assess cytotoxicity. Chronic and acute effects of the adipocytokine Nampt and its enzymatic product NMN on insulin secretion were assessed by glucose stimulated insulin secretion in human islets. Results: While stimulation of beta-cells with the cytokines IL-1 beta, TNF alpha and IFN-gamma or palmitate significantly decreased viability, Nampt and NMN showed no direct effect on viability in INS-1E cells or in human islets, neither alone nor in the presence of pro-diabetic conditions (elevated glucose concentrations and palmitate or cytokines). At chronic conditions over 3 days of culture, Nampt and its product NMN had no effects on insulin secretion. In contrast, both Nampt and NMN potentiated glucose stimulated insulin secretion acutely during 1 h incubation of human islets. Conclusion/Interpretation: Nampt and NMN neither influenced beta-cell viability nor apoptosis but acutely potentiated glucose stimulated insulin secretion.	[Spinnler, Robert; Gorski, Theresa; Schuster, Susanne; Garten, Antje; Koerner, Antje; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany; [Spinnler, Robert] Univ Leipzig, Med Ctr, IFB Adipos Dis, D-04109 Leipzig, Germany; [Stolz, Katharina; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, D-28359 Bremen, Germany; [Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Engelse, Marten A.; de Koning, Eelco J. P.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [de Koning, Eelco J. P.] Hubrecht Inst, Utrecht, Netherlands	Leipzig University; Leipzig University; University of Bremen; Leipzig University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Schuster, S (corresponding author), Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany.	Susanne.Schuster@medizin.uni-leipzig.de	Maedler, Kathrin/ABE-3022-2021; de Koning, Eelco JP/H-6030-2011; Körner, Antje/B-3988-2015	Maedler, Kathrin/0000-0002-7436-1197; de Koning, Eelco JP/0000-0002-1232-7022; Körner, Antje/0000-0001-6001-0356; Gaul, Susanne/0000-0003-4780-1844; Garten, Antje/0000-0002-5354-287X	Deutsche Forschungsgemeinschaft [KFO 152]; LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); IFB (Integrated Research and Treatment Center AdiposityDiseases); BMBF (Bundesministerium fur Bildung und Forschung); German Diabetes Society (DDG); Kompetenznetz Adipositas-Verbund LARGE [TP01]; Kompetenznetz Diabetes; National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation (JDRF); European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program; European Research Council [ERC 260336]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); IFB (Integrated Research and Treatment Center AdiposityDiseases); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Diabetes Society (DDG); Kompetenznetz Adipositas-Verbund LARGE; Kompetenznetz Diabetes; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program; European Research Council(European Research Council (ERC)European Commission)	The work was supported by Deutsche Forschungsgemeinschaft KFO 152 "Atherobesity'' & Emmy Noether Programm, the LIFE program (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment), the IFB (Integrated Research and Treatment Center AdiposityDiseases), BMBF (Bundesministerium fur Bildung und Forschung), the German Diabetes Society (DDG) and the Kompetenznetz Adipositas-Verbund LARGE (TP01) and Kompetenznetz Diabetes and the European Research Council (ERC 260336). Provision of human islets were supported by the National Center for Research Resources (NCRR), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation (JDRF) and through the European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Cheng Q, 2011, J MOL ENDOCRINOL; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; De Marinis L, 2004, J CLIN ENDOCR METAB, V89, P174, DOI 10.1210/jc.2002-021308; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; El-Mesallamy HO, 2011, METABOLISM, V60, P63, DOI 10.1016/j.metabol.2010.04.008; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Gaton PW, 2011, DIABETOLOGIA; Gu WQ, 2006, ENDOCRINE, V30, P217, DOI 10.1385/ENDO:30:2:217; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kieffer TJ, 1996, BIOCHEM BIOPH RES CO, V224, P522, DOI 10.1006/bbrc.1996.1059; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; PUKEL C, 1988, DIABETES, V37, P133, DOI 10.2337/diabetes.37.1.133; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Retnakaran R, 2008, CLIN ENDOCRINOL, V69, P885, DOI 10.1111/j.1365-2265.2008.03264.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Wang CJ, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/515136; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xiang AH, 2010, DIABETES CARE, V33, P396, DOI 10.2337/dc09-1493; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	48	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54106	10.1371/journal.pone.0054106	http://dx.doi.org/10.1371/journal.pone.0054106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342086	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700088
J	Stes, A; De Maeyer, S; Van Petegem, P				Stes, Ann; De Maeyer, Sven; Van Petegem, Peter			Examining the Cross-Cultural Sensitivity of the Revised Two-Factor Study Process Questionnaire (R-SPQ-2F) and Validation of a Dutch Version	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; SPECIFICITY	The Revised Two-Factor Study Process Questionnaire (R-SPQ-2F) is used to examine students' study approaches in higher education. The questionnaire assumes to measure two factors: a deep and a surface study approach. Analyses into the validity and reliability of the original English R-SPQ-2F yielded positive results. In this study, we examined the degree to which these positive results can also be found for the Dutch version that we developed. By comparing our results with the results of earlier studies in different cultures, we conclude cross-cultural sensitivity is an important point to be borne in mind when using the R-SPQ-2F. Our research supports the validity and reliability of our Dutch version of the R-SPQ-2F.	[Stes, Ann; De Maeyer, Sven; Van Petegem, Peter] Univ Antwerp, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium	University of Antwerp	Stes, A (corresponding author), Univ Antwerp, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium.	ann.stes@ua.ac.be	Van Petegem, Peter/R-5494-2016; De Maeyer, Sven/K-7446-2015	Van Petegem, Peter/0000-0002-4078-7800; De Maeyer, Sven/0000-0003-2888-1631				Becher T, 1989, ACAD TRIBES TERRITOR; Biggs J, 2001, BRIT J EDUC PSYCHOL, V71, P133, DOI 10.1348/000709901158433; Biggs J. B, 1987, STUDENT APPROACHES L; Bollen K. A., 1989, J STAT ASS; Byrne B. M., 2001, STRUCTURAL EQUATION; Fryer LK, 2012, BRIT J EDUC PSYCHOL, V82, P549, DOI 10.1111/j.2044-8279.2011.02045.x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hoyle R. H., 1995, STRUCTURAL EQUATION; Immekus JC, 2010, EDUC PSYCHOL MEAS, V70, P495, DOI 10.1177/0013164409355685; Justicia F, 2008, EUR J PSYCHOL EDUC, V23, P355, DOI 10.1007/BF03173004; Kember D, 1998, BRIT J EDUC PSYCHOL, V68, P395, DOI 10.1111/j.2044-8279.1998.tb01300.x; KEMBER D, 1990, BRIT J EDUC PSYCHOL, V60, P356, DOI 10.1111/j.2044-8279.1990.tb00952.x; Kember D., 1997, STUD EDUC EVAL, V23, P141, DOI 10.1016/S0191-491X(97)00009-6; Kolenikov S, 2012, SOCIOL METHOD RES, V41, P124, DOI 10.1177/0049124112442138; Leung DYP, 2008, J CROSS CULT PSYCHOL, V39, P251, DOI 10.1177/0022022107313905; Lindblom-Ylanne S, 2006, STUD HIGH EDUC, V31, P285, DOI 10.1080/03075070600680539; RICHARDSON JTE, 1994, HIGH EDUC, V27, P449, DOI 10.1007/BF01384904; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Wong NY, 1996, EDUC PSYCHOL, V16, P317, DOI DOI 10.1080/0144341960160308	19	23	24	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54099	10.1371/journal.pone.0054099	http://dx.doi.org/10.1371/journal.pone.0054099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342085	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700087
J	Van den Brom, R; Schimmer, B; Schneeberger, PM; Swart, WA; van der Hoek, W; Vellema, P				Van den Brom, Rene; Schimmer, Barbara; Schneeberger, Peter M.; Swart, Wim A.; van der Hoek, Wim; Vellema, Piet			Seroepidemiological Survey for Coxiella burnetii Antibodies and Associated Risk Factors in Dutch Livestock Veterinarians	PLOS ONE			English	Article							Q-FEVER INFECTION; DAIRY GOAT; OUTBREAK; NETHERLANDS; SEROPREVALENCE; SHEEP; TRANSMISSION; PNEUMONIA; WORKERS; AREA	Since 2007, Q fever has become a major public health problem in the Netherlands and goats were the most likely source of the human outbreaks in 2007, 2008 and 2009. Little was known about the consequences of these outbreaks for those professional care providers directly involved. The aim of this survey was to estimate the seroprevalence of antibodies against C. burnetii among Dutch livestock veterinarians and to determine possible risk factors. Single blood samples from 189 veterinarians, including veterinary students in their final year, were collected at a veterinary conference and a questionnaire was filled in by each participant. The blood samples were screened for IgG antibodies against phase I and phase II antigen of C. burnetii using an indirect immunofluorescent assay, and for IgM antibodies using an ELISA. Antibodies against C. burnetii were detected in 123 (65.1%) out of 189 veterinarians. Independent risk factors associated with seropositivity were number of hours with animal contact per week, number of years graduated as veterinarian, rural or sub urban living area, being a practicing veterinarian, and occupational contact with swine. Livestock veterinarians should be aware of this risk to acquire an infection with C. burnetii. Physicians should consider potential infection with C. burnetii when treating occupational risk groups, bearing in mind that the burden of disease among veterinarians remains uncertain. Vaccination of occupational risk groups should be debated.	[Van den Brom, Rene; Vellema, Piet] Anim Hlth Serv, Dept Small Ruminant Hlth, Deventer, Netherlands; [Schimmer, Barbara; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Swart, Wim A.] Anim Hlth Serv, Dept Diagnost Res & Epidemiol, Deventer, Netherlands	Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis	Van den Brom, R (corresponding author), Anim Hlth Serv, Dept Small Ruminant Hlth, Deventer, Netherlands.	r.vd.brom@gddeventer.com		Vellema, Piet/0000-0001-9381-9063				Abe T, 2001, EUR J EPIDEMIOL, V17, P1029, DOI 10.1023/A:1020018907452; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; DAMOSER J, 1993, BERL MUNCH TIERARZTL, V106, P361; de Rooij MMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032108; Derrick E. H., 1937, MED J AUSTRALIA, V2, P282; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dorko E, 2008, ANN AGR ENV MED, V15, P119; Erognul O, 2006, INT J INFECT DIS, V10, P465, DOI 10.1016/j.ijid.2006.06.005; Gardon J, 2001, J INFECT DIS, V184, P278, DOI 10.1086/322034; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Hatchette TF, 2001, EMERG INFECT DIS, V7, P413; Henning K, 2009, BERL MUNCH TIERARZTL, V122, P13, DOI 10.2376/0005-9366-122-13; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; LANGLEY JM, 1988, NEW ENGL J MED, V319, P354, DOI 10.1056/NEJM198808113190607; Lyytikainen O, 1998, EUR J EPIDEMIOL, V14, P193, DOI 10.1023/A:1007452503863; Marmion B, 2007, MED J AUSTRALIA, V186, P164, DOI 10.5694/j.1326-5377.2007.tb00853.x; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Monno R, 2009, ANN AGR ENV MED, V16, P205; Muskens J, 2007, TIJDSCHR DIERGENEESK, V132, P912; Nebreda T, 2001, ENFERM INFEC MICR CL, V19, P57, DOI 10.1016/S0213-005X(01)72561-X; Oren I, 2005, EUR J CLIN MICROBIOL, V24, P338, DOI 10.1007/s10096-005-1324-8; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; RICHARDUS JH, 1987, EPIDEMIOL INFECT, V98, P211, DOI 10.1017/S0950268800061938; Schimmer B, 2009, EUROSURVEILLANCE, V14, P14; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SOMMAMOREIRA RE, 1987, REV INFECT DIS, V9, P386; Stein A, 1999, CLIN INFECT DIS, V29, P617, DOI 10.1086/598643; Valencia MDS, 2000, EUR J EPIDEMIOL, V16, P469, DOI 10.1023/A:1007605414042; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; van der Hoek W, 2010, NED TIJDSCHR GENEES, V154, pA1845; Van Steenbergen J E, 2007, Ned Tijdschr Geneeskd, V151, P1998; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Wouda W, 2007, TIJDSCHR DIERGENEESK, V132, P908; Zeman D H, 1989, J Vet Diagn Invest, V1, P178	37	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54021	10.1371/journal.pone.0054021	http://dx.doi.org/10.1371/journal.pone.0054021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342063	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700076
J	Martins, MA; Bonaldo, MC; Rudersdorf, RA; Piaskowski, SM; Rakasz, EG; Weisgrau, KL; Furlott, JR; Eernisse, CM; de Santana, MGV; Hidalgo, B; Friedrich, TC; Chiuchiolo, MJ; Parks, CL; Wilson, NA; Allison, DB; Galler, R; Watkins, DI				Martins, Mauricio A.; Bonaldo, Myrna C.; Rudersdorf, Richard A.; Piaskowski, Shari M.; Rakasz, Eva G.; Weisgrau, Kim L.; Furlott, Jessica R.; Eernisse, Christopher M.; Veloso de Santana, Marlon G.; Hidalgo, Bertha; Friedrich, Thomas C.; Chiuchiolo, Maria J.; Parks, Christopher L.; Wilson, Nancy A.; Allison, David B.; Galler, Ricardo; Watkins, David I.			Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I MOLECULE; IMMUNODEFICIENCY-VIRUS; HIV-1 VACCINE; ATTENUATED VACCINE; INNATE IMMUNITY; VIRAL LOAD; EPITOPES; VECTOR; LIVE	An effective vaccine remains the best solution to stop the spread of human immunodeficiency virus (HIV). Cellular immune responses have been repeatedly associated with control of viral replication and thus may be an important element of the immune response that must be evoked by an efficacious vaccine. Recombinant viral vectors can induce potent T-cell responses. Although several viral vectors have been developed to deliver HIV genes, only a few have been advanced for clinical trials. The live-attenuated yellow fever vaccine virus 17D (YF17D) has many properties that make it an attractive vector for AIDS vaccine regimens. YF17D is well tolerated in humans and vaccination induces robust T-cell responses that persist for years. Additionally, methods to manipulate the YF17D genome have been established, enabling the generation of recombinant (r)YF17D vectors carrying genes from unrelated pathogens. Here, we report the generation of seven new rYF17D viruses expressing fragments of simian immunodeficiency virus (SIV)mac239 Gag, Nef, and Vif. Studies in Indian rhesus macaques demonstrated that these live-attenuated vectors replicated in vivo, but only elicited low levels of SIV-specific cellular responses. Boosting with recombinant Adenovirus type-5 (rAd5) vectors resulted in robust expansion of SIV-specific CD8(+) T-cell responses, particularly those targeting Vif. Priming with rYF17D also increased the frequency of CD4(+) cellular responses in rYF17D/ rAd5-immunized macaques compared to animals that received rAd5 only. The effect of the rYF17D prime on the breadth of SIV-specific T-cell responses was limited and we also found evidence that some rYF17D vectors were more effective than others at priming SIV-specific T-cell responses. Together, our data suggest that YF17D - a clinically relevant vaccine vector - can be used to prime AIDS virus-specific T-cell responses in heterologous prime boost regimens. However, it will be important to optimize rYF17D-based vaccine regimens to ensure maximum delivery of all immunogens in a multivalent vaccine.	[Martins, Mauricio A.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Bonaldo, Myrna C.; Veloso de Santana, Marlon G.; Galler, Ricardo] Inst Oswaldo Cruz, FIOCRUZ, Lab Biol Mol Flavivirus, BR-20001 Rio De Janeiro, Brazil; [Rudersdorf, Richard A.; Piaskowski, Shari M.; Rakasz, Eva G.; Weisgrau, Kim L.; Furlott, Jessica R.; Eernisse, Christopher M.; Friedrich, Thomas C.; Wilson, Nancy A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Chiuchiolo, Maria J.; Parks, Christopher L.] Brooklyn Army Terminal, Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, Brooklyn, NY USA; [Wilson, Nancy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Hidalgo, Bertha; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA	University of Miami; Fundacao Oswaldo Cruz; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; International AIDS Vaccine Initiative; University of Wisconsin System; University of Wisconsin Madison; University of Alabama System; University of Alabama Birmingham	Watkins, DI (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	dwatkins@med.miami.edu	Galler, Ricardo/B-3280-2014; Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Rakasz, Eva G/H-9197-2019; Martins, Mauricio/AAU-9226-2020; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Martins, Mauricio/0000-0001-8336-216X; Wilson, Nancy/0000-0002-9472-6026; Friedrich, Thomas/0000-0001-9831-6895; Allison, David/0000-0003-3566-9399; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID) [R01 AI076114, R01 AI049120]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FIOCRUZ in Brazil; National Institute for Vaccine Technology (INCTV/CNPq); NCRR [P51 RR000167]; Research Facilities Improvement Program [RR15459, RR020141]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049120, R01AI076114] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ in Brazil; National Institute for Vaccine Technology (INCTV/CNPq); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease (NIAID) grants R01 AI076114 and R01 AI049120 awarded to DIW. Funding also came from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and FIOCRUZ in Brazil. Part of the work done in FIOCRUZ was supported by the National Institute for Vaccine Technology (INCTV/CNPq). In addition, this work was supported by NCRR grant P51 RR000167 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459 and RR020141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; [Anonymous], 2009, WHO VACC PREV DIS MO; Appaiahgari MB, 2010, EXPERT REV VACCINES, V9, P1371, DOI [10.1586/erv.10.139, 10.1586/ERV.10.139]; Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bonaldo MC, 2006, CELL BIOCHEM BIOPHYS, V44, P313, DOI 10.1385/CBB:44:3:313; Bonaldo MC, 2002, J MOL BIOL, V315, P873, DOI 10.1006/jmbi.2001.5258; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Bonaldo MC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-115; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Cline AN, 2005, J MED PRIMATOL, V34, P303; dos Santos AP, 2005, MEM I OSWALDO CRUZ, V100, P331, DOI 10.1590/S0074-02762005000300021; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HIV/ AIDS JUNPo, 2010, GLOB REP UNAIDS REP; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Peters B, 2005, VACCINE, V23, P5212, DOI 10.1016/j.vaccine.2005.07.086; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2007, ADV EXP MED BIOL, V590, P43; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074; Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002; Weatherall D., 2006, USE NONHUMAN PRIMATE; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11	72	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54434	10.1371/journal.pone.0054434	http://dx.doi.org/10.1371/journal.pone.0054434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336000	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700058
J	Noda, Y; Ida, Y; Tanaka, S; Toyama, T; Roggia, MF; Tamaki, Y; Sugita, N; Mitsuishi, M; Ueta, T				Noda, Yasuo; Ida, Yoshiki; Tanaka, Shinichi; Toyama, Taku; Roggia, Murilo Felix; Tamaki, Yasuhiro; Sugita, Naohiko; Mitsuishi, Mamoru; Ueta, Takashi			Impact of Robotic Assistance on Precision of Vitreoretinal Surgical Procedures	PLOS ONE			English	Article							RETINAL MICROSURGERY; SURGERY; SYSTEM	Purpose: To elucidate the merits of robotic application for vitreoretinal maneuver in comparison to conventional manual performance using an in-vitro eye model constructed for the present study. Methods: Capability to accurately approach the target on the fundus, to stabilize the manipulator tip just above the fundus, and to perceive the contact of the manipulator tip with the fundus were tested. The accuracies were compared between the robotic and manual control, as well as between ophthalmologists and engineering students. Results: In case of manual control, ophthalmologists were superior to engineering students in all the 3 test procedures. Robotic assistance significantly improved accuracy of all the test procedures performed by engineering students. For the ophthalmologists including a specialist of vitreoretinal surgery, robotic assistance enhanced the accuracy in the stabilization of manipulator tip (from 90.9 mu m to 14.9 mu m, P = 0.0006) and the perception of contact with the fundus (from 20.0 mN to 7.84 mN, P = 0.046), while robotic assistance did not improve pointing accuracy. Conclusions: It was confirmed that telerobotic assistance has a potential to significantly improve precision in vitreoretinal procedures in both experienced and inexperienced hands.	[Noda, Yasuo; Toyama, Taku; Roggia, Murilo Felix; Tamaki, Yasuhiro; Ueta, Takashi] Univ Tokyo, Grad Sch Sci, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; [Noda, Yasuo; Toyama, Taku; Roggia, Murilo Felix; Tamaki, Yasuhiro; Ueta, Takashi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan; [Ida, Yoshiki; Tanaka, Shinichi; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Ueta, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan.	ueta-tky@umin.ac.jp		Sugita, Naohiko/0000-0002-1369-0747	Japan Society for the Promotion of Science (JSPS) [18106005]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (S) 18106005, Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourla DH, 2008, RETINA-J RET VIT DIS, V28, P154, DOI 10.1097/IAE.0b013e318068de46; Buchs NC, 2012, SURG ENDOSC, V26, P1116, DOI 10.1007/s00464-011-2008-3; Chandra V, 2010, SURGERY, V147, P830, DOI 10.1016/j.surg.2009.11.002; Choi DY, 2005, P ANN INT IEEE EMBS, P5085, DOI 10.1109/IEMBS.2005.1615620; Das H, 1999, Comput Aided Surg, V4, P15; Douglas RS, 2007, BRIT J OPHTHALMOL, V91, P1, DOI 10.1136/bjo.2006.099796; Fleming I, 2008, LECT NOTES COMPUT SC, V5242, P543, DOI 10.1007/978-3-540-85990-1_65; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; GAGNER M, 1994, LANCET, V343, P596, DOI 10.1016/S0140-6736(94)91546-6; Gupta PK, 1999, LECT NOTES COMPUT SC, V1679, P1218; Ida Y, 2012, INT J COMPUT ASS RAD, V7, P27, DOI 10.1007/s11548-011-0602-4; Iordachita I, 2009, INT J COMPUT ASS RAD, V4, P383, DOI 10.1007/s11548-009-0301-6; Maeso S, 2010, ANN SURG, V252, P254, DOI 10.1097/SLA.0b013e3181e6239e; Modi Paul, 2009, Interact Cardiovasc Thorac Surg, V9, P500, DOI 10.1510/icvts.2009.203182; Nakano T, 2009, INT J COMPUT ASS RAD, V4, P517, DOI 10.1007/s11548-009-0374-2; Ohm T, 1997, P 8 INT C ADV ROB, P5; Riviere CN, 2003, IEEE T ROBOTIC AUTOM, V19, P793, DOI 10.1109/TRA.2003.817506; Singh SPN, 2002, PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P171, DOI 10.1109/NEBC.2002.999520; Thiel DD, 2011, UROLOGY, V77, P1238, DOI 10.1016/j.urology.2010.07.542; Uneri A, 2010, P IEEE RAS-EMBS INT, P814, DOI 10.1109/BIOROB.2010.5625991; Ueta T, 2011, BRIT J OPHTHALMOL, V95, P731, DOI 10.1136/bjo.2010.193391; Ueta T, 2009, OPHTHALMOLOGY, V116, P1538, DOI 10.1016/j.ophtha.2009.03.001	22	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54116	10.1371/journal.pone.0054116	http://dx.doi.org/10.1371/journal.pone.0054116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335991	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700049
J	Fares, RP; Belmeguenai, A; Sanchez, PE; Kouchi, HY; Bodennec, J; Morales, A; Georges, B; Bonnet, C; Bouvard, S; Sloviter, RS; Bezin, L				Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Sloviter, Robert S.; Bezin, Laurent			Standardized Environmental Enrichment Supports Enhanced Brain Plasticity in Healthy Rats and Prevents Cognitive Impairment in Epileptic Rats	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; FACTOR MESSENGER-RNA; HIPPOCAMPAL-NEURONS; HUNTINGTONS-DISEASE; GENE-EXPRESSION; MOUSE MODEL; FACTOR-I; ERYTHROPOIETIN RECEPTOR; SYNAPTIC PLASTICITY	Environmental enrichment of laboratory animals influences brain plasticity, stimulates neurogenesis, increases neurotrophic factor expression, and protects against the effects of brain insult. However, these positive effects are not constantly observed, probably because standardized procedures of environmental enrichment are lacking. Therefore, we engineered an enriched cage (the Marlau (TM) cage), which offers: (1) minimally stressful social interactions; (2) increased voluntary exercise; (3) multiple entertaining activities; (4) cognitive stimulation (maze exploration), and (5) novelty (maze configuration changed three times a week). The maze, which separates food pellet and water bottle compartments, guarantees cognitive stimulation for all animals. Compared to rats raised in groups in conventional cages, rats housed in Marlau (TM) cages exhibited increased cortical thickness, hippocampal neurogenesis and hippocampal levels of transcripts encoding various genes involved in tissue plasticity and remodeling. In addition, rats housed in Marlau (TM) cages exhibited better performances in learning and memory, decreased anxiety-associated behaviors, and better recovery of basal plasma corticosterone level after acute restraint stress. Marlau (TM) cages also insure inter-experiment reproducibility in spatial learning and brain gene expression assays. Finally, housing rats in Marlau (TM) cages after severe status epilepticus at weaning prevents the cognitive impairment observed in rats subjected to the same insult and then housed in conventional cages. By providing a standardized enriched environment for rodents during housing, the Marlau (TM) cage should facilitate the uniformity of environmental enrichment across laboratories.	[Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Univ Lyon, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Lyon Neurosci Res Ctr, INSERM, U1028, Tiger Team, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Lyon Neurosci Res Ctr, CNRS, UMR5292, Tiger Team, Lyon, France; [Fares, Raafat P.; Belmeguenai, Amor; Sanchez, Pascal E.; Kouchi, Hayet Y.; Bodennec, Jacques; Morales, Anne; Georges, Beatrice; Bonnet, Chantal; Bouvard, Sandrine; Bezin, Laurent] Inst EpilepsiEs, IDEE, Lyon, France; [Fares, Raafat P.] IRBA, Bretigny Sur Orge, France; [Sloviter, Robert S.] Morehouse Sch Med, Dept Neurobiol Pharmacol & Toxicol, Atlanta, GA 30310 USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Morehouse School of Medicine	Bezin, L (corresponding author), Univ Lyon, Lyon, France.	laurent.bezin@univ-lyon1.fr		FARES, Raafat/0000-0003-3963-381X	Centre National de la Recherche Scientifique; University Claude Bernard Lyon 1; Institut de Medecine Navale du Service de Sante des Armees [21105]; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Claude Bernard Lyon 1; Institut de Medecine Navale du Service de Sante des Armees; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	P. E. Sanchez was a fellow from the Delegation Generale pour l'Armement, Ministere Francais de la Defense. This study was supported by grants from the Centre National de la Recherche Scientifique, the University Claude Bernard Lyon 1, and the Institut de Medecine Navale du Service de Sante des Armees (grant 21105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Augustsson H, 2003, LAB ANIM-UK, V37, P328, DOI 10.1258/002367703322389898; Auvergne R, 2002, BRAIN RES, V954, P277, DOI 10.1016/S0006-8993(02)03355-3; Baumans V, 2005, ILAR J, V46, P162, DOI 10.1093/ilar.46.2.162; Baumans V, 2004, GENE THER, V11, pS64, DOI 10.1038/sj.gt.3302371; Baumans V, 2006, FELASA WORKING GROUP; Benaroya-Milshtein N, 2007, J IMMUNOTHER, V30, P517, DOI 10.1097/CJI.0b013e31804efc5e; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodennec J, 2000, J LIPID RES, V41, P1524; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burrows EL, 2011, PROG NEURO-PSYCHOPH, V35, P1376, DOI 10.1016/j.pnpbp.2010.12.011; Byts N, 2008, CELL DEATH DIFFERENT; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Carro E, 2000, J NEUROSCI, V20, P2926; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Du X, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.58; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FARES RP, 2012, PROTOCOL EXCHANGE; Faverjon S, 2002, NEUROLOGY, V59, P1356, DOI 10.1212/01.WNL.0000033588.59005.55; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Francia N, 2006, EUR J NEUROSCI, V23, P711, DOI 10.1111/j.1460-9568.2006.04585.x; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Hackler EA, 2007, J PHARMACOL EXP THER, V320, P1023, DOI 10.1124/jpet.106.113357; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Hellemans KGC, 2004, DEV BRAIN RES, V150, P103, DOI 10.1016/j.devbrainres.2004.03.003; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hori E, 2003, HIPPOCAMPUS, V13, P190, DOI 10.1002/hipo.10062; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Koh S, 2005, J CHILD NEUROL, V20, P796, DOI 10.1177/08830738050200100301; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Liu XZ, 2003, J NEUROSCI, V23, P11505; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; MOHAMMED AH, 1993, BEHAV BRAIN RES, V57, P183, DOI 10.1016/0166-4328(93)90134-C; Morales A, 2006, BRAIN RES, V1109, P164, DOI 10.1016/j.brainres.2006.06.075; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Navarro FP, 2008, J NEUROCHEM, V105, P34, DOI 10.1111/j.1471-4159.2007.05116.x; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2011, PROG NEURO-PSYCHOPH, V35, P331, DOI 10.1016/j.pnpbp.2010.10.026; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019; Phillips LJ, 2006, AUST NZ J PSYCHIAT, V40, P725, DOI 10.1080/j.1440-1614.2006.01877.x; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Rutten A, 2002, EUR J NEUROSCI, V16, P501, DOI 10.1046/j.1460-9568.2002.02103.x; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Dellen A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-34; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Violle N, 2009, BEHAV BRAIN RES, V203, P35, DOI 10.1016/j.bbr.2009.04.015; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang CA, 2007, EPILEPSY BEHAV, V11, P303, DOI 10.1016/j.yebeh.2007.06.016; Williams JB, 2009, CANCER PREV RES, V2, P850, DOI 10.1158/1940-6207.CAPR-08-0238; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zhao LR, 2000, NEUROSCIENCE, V97, P177, DOI 10.1016/S0306-4522(00)00023-3	106	87	87	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53888	10.1371/journal.pone.0053888	http://dx.doi.org/10.1371/journal.pone.0053888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342033	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400097
J	Kauppila, E; Vanninen, E; Kaurijoki, S; Karhunen, L; Pietilainen, KH; Rissanen, A; Tiihonen, J; Pesonen, U; Kaprio, J				Kauppila, Esa; Vanninen, Esko; Kaurijoki, Salla; Karhunen, Leila; Pietilainen, Kirsi H.; Rissanen, Aila; Tiihonen, Jari; Pesonen, Ullamari; Kaprio, Jaakko			Influence of Serotonin Transporter Gene Polymorphism (5-HTTLPR Polymorphism) on the Relation between Brain 5-HT Transporter Binding and Heart Rate Corrected Cardiac Repolarization Interval	PLOS ONE			English	Article							PHOTON-EMISSION-TOMOGRAPHY; NOR-BETA-CIT; IN-VIVO; QT INTERVAL; EXPRESSION; SPECT; NEUROTOXICITY; AVAILABILITY; GENOTYPE; REST	Objective: Serotonin transporter gene polymorphism (5-HTTLPR polymorphism) predicts the degree of structural and functional connectivity in the brain, and less consistently the degree of vulnerability for anxiety and depressive disorders. It is less known how 5-HTTLPR polymorphism influences on the coupling between brain and neuronal cardiovascular control. The present study demonstrates the impact of 5-HTTLPR polymorphism on the relations between heart rate (HR) corrected cardiac repolarization interval (QTc interval) and the brain 5-HTT binding. Material and Methods: Thirty healthy young adults (fifteen monozygotic twin pairs) (mean age 26 +/- 1.3 years, 16 females) were imagined with single-photon emission computed tomography (SPECT) using iodine-123 labeled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) nortropane (nor-beta-CIT). Continuous ECG recording was obtained from each participant at supine rest. Signal averaged QTc interval on continuous ECG was calculated and compared with the brain imaging results. Results: In the two groups [l homozygotes (n = 16, 10 females), s carriers (n = 14, 8 female)] HR and the length of QTc interval were not influenced by 5-HTTLPR polymorphism. There were no significant relations between HR and 5-HTT binding in the brain. There were significant associations between QTc interval and nor-beta-CIT binding in the brain in l homozygotes, but not in s carriers (correlations for QTc interval and nor-beta-CIT binding of striatum, thalamus and right temporal region were -0.8--0.9, (p < 0.0005), respectively). Conclusion: The finding of longer QTc interval with less 5-HTT binding availability in major serotonergic binding sites in l homozygotes, but not in s carriers, implicate to differentiated control of QTc interval by 5-HTTLPR polymorphism.	[Kauppila, Esa; Vanninen, Esko] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Kauppila, Esa; Vanninen, Esko] Univ Eastern Finland, Kuopio, Finland; [Kauppila, Esa] N Karelia Cent Hosp, Dept Clin Physiol, Joensuu, Finland; [Kaurijoki, Salla; Karhunen, Leila] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Dept Med, Obes Res Unit,Div Endocrinol, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, FIMM, Inst Mol Med Finland, Helsinki, Finland; [Rissanen, Aila] Helsinki Univ Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tiihonen, Jari] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tiihonen, Jari; Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Pesonen, Ullamari] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Eastern Finland; Karolinska Institutet; Finland National Institute for Health & Welfare; University of Turku; University of Helsinki	Kauppila, E (corresponding author), Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland.	ekauppil@gmail.com	Tiihonen, Jari/G-3078-2012; Kaprio, Jaakko/A-1820-2008	Tiihonen, Jari/0000-0002-0400-6798; Kaprio, Jaakko/0000-0002-3716-2455; Pesonen, Ullamari/0000-0002-9962-212X; Pietilainen, Kirsi/0000-0002-8522-1288	Saastamoinen Foundation, Kuopio, Finland; University of Eastern Finland	Saastamoinen Foundation, Kuopio, Finland; University of Eastern Finland	This work was supported by the Saastamoinen Foundation, Kuopio, Finland; and University of Eastern Finland (previously University of Kuopio) for research periods (6 months). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; Acton PD, 1999, EUR J NUCL MED, V26, P518, DOI 10.1007/s002590050420; Bazett HC, 1920, HEART; de Win MML, 2005, NEUROPSYCHOPHARMACOL, V30, P996, DOI 10.1038/sj.npp.1300683; Egawa H, 2001, REGION ANESTH PAIN M, V26, P539, DOI 10.1053/rapm.2001.25935; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Halldin C, 2003, EUR J NUCL MED MOL I, V30, P1220, DOI 10.1007/s00259-003-1212-3; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Hiltunen J, 1998, EUR J NUCL MED, V25, P19; Hojgaard MV, 2005, BLOOD PRESS MONIT, V10, P19; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Kauppila E, 2009, NUCL MED COMMUNICATI; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Lundberg J, 2005, J NUCL MED, V46, P1505; Magnano AR, 2006, AM J CARDIOL, V97, P1244, DOI 10.1016/j.amjcard.2005.11.046; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Murthy NV, 2010, NEUROIMAGE, V52, P50, DOI 10.1016/j.neuroimage.2010.04.032; Nolan ER, 2008, AUTON NEUROSCI-BASIC, V140, P66, DOI 10.1016/j.autneu.2008.04.004; Parsey RV, 2006, AM J PSYCHIAT, V163, P52, DOI 10.1176/appi.ajp.163.1.52; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Reneman L, 1999, SYNAPSE, V34, P77, DOI 10.1002/(SICI)1098-2396(199910)34:1<77::AID-SYN9>3.0.CO;2-Y; Reneman L, 2002, SYNAPSE, V46, P199, DOI 10.1002/syn.10130; Van Dyck CH, 2004, AM J PSYCHIAT, V161, P525, DOI 10.1176/appi.ajp.161.3.525; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zamotrinsky AV, 2001, AUTON NEUROSCI-BASIC, V88, P109, DOI 10.1016/S1566-0702(01)00227-2	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e50303	10.1371/journal.pone.0050303	http://dx.doi.org/10.1371/journal.pone.0050303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341873	gold, Green Submitted, Green Published			2022-12-27	WOS:000314759400001
J	Le, MT; Lobmeyer, MT; Campbell, M; Cheng, J; Wang, ZY; Turner, ST; Chapman, AB; Boerwinkle, E; Gums, JG; Gong, Y; Johnson, RJ; Johnson, JA				Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Cheng, Jing; Wang, Zhiying; Turner, Stephen T.; Chapman, Arlene B.; Boerwinkle, Eric; Gums, John G.; Gong, Yan; Johnson, Richard J.; Johnson, Julie A.			Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SINGLE-NUCLEOTIDE POLYMORPHISMS; FRUCTOSE-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; CORONARY-HEART-DISEASE; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; ANTIHYPERTENSIVE RESPONSE; HDL METABOLISM	Objective: In the past few decades, consumption of added sugars has increased dramatically. Studies have linked high sugar intake with increased risk for a number of diseases. Importantly, fructose, a component of sugar, has been linked with the development of features of metabolic syndrome. This study determined if single nucleotide polymorphisms in genes involved in fructose transport (solute carrier family 2 facilitated glucose transporter, member 2 (SLC2A2) and solute carrier family 2 facilitated glucose/fructose transporter, member 5 (SLC2A5)) and metabolism (ketohexokinase (KHK)) affect inter-individual variability in metabolic phenotypes, such as increased serum uric acid levels. Materials/Methods: The influence of SLC2A2, SLC2A5, and KHK SNPs on metabolic phenotypes was tested in 237 European Americans and 167 African Americans from the Pharmacogenomic Evaluation and Antihypertensive Responses (PEAR) study. Using baseline untreated fasting data, associations were considered significant if p <= 0.005. These SNPs were then evaluated for potential replication (p <= 0.05) using data from the Genetic Epidemiology of Responses to Antihypertensives (GERA) studies. Results: SLC2A5 rs5438 was associated with an increase in serum uric acid in European American males. However, we were unable to replicate the association in GERA. The minor allele of SLC2A2 rs8192675 showed an association with lower high-density lipoproteins in European Americans (A/A: 51.0 mg/dL, A/G: 47.0 mg/dL, G/G: 41.5 mg/dL, p = 0.0034) in PEAR. The association between rs8192675 and lower high-density lipoproteins was replicated in the combined European American GERA study samples (A/A: 47.6 mg/dL, A/G: 48.6 mg/dL, G/G: 41.9 mg/dL, p = 0.0315). Conclusions: The association between SLC2A2 rs8192675 and high-density lipoproteins suggests the polymorphism may play a role in influencing high-density lipoproteins and thus metabolic risk of cardiovascular disease.	[Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Gums, John G.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA; [Le, MyPhuong T.; Lobmeyer, Maximilian T.; Campbell, Marcus; Gums, John G.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Cheng, Jing] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Wang, Zhiying; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Wang, Zhiying; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Chapman, Arlene B.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Johnson, Richard J.] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic; Emory University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.	johnson@cop.ufl.edu	Turner, Stephen/GXM-4654-2022		National Institutes of Health (Bethesda, MD), Pharmacogenetics Research Network (PEAR) [U01 GM074492]; Pharmacogenetics Research Network (PEAR); CTSA [UL1-RR029890, UL1-RR025008, UL1-RR024150]; Mayo Foundation; institutional National Institutes of Health training grant in the Division of Nephrology, University of Florida [T32-DK007518-23]; National Institutes of Health (Bethesda, MD) [R01HL53330]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150, UL1RR029890, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD), Pharmacogenetics Research Network (PEAR); Pharmacogenetics Research Network (PEAR); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; institutional National Institutes of Health training grant in the Division of Nephrology, University of Florida; National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a grants from the National Institutes of Health (Bethesda, MD), grant #U01 GM074492, funded as part of the Pharmacogenetics Research Network (PEAR) and R01HL53330 (GERA I and II). Additional support for this work includes: CTSA grants UL1-RR029890 (University of Florida), UL1-RR025008 (Emory University), and UL1-RR024150 (Mayo Clinic); and funds from the Mayo Foundation. M. Le was supported by institutional National Institutes of Health training grant (T32-DK007518-23) in the Division of Nephrology, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli K, 2001, TRENDS CARDIOVAS MED, V11, P170, DOI 10.1016/S1050-1738(01)00084-6; Barbalic M, 2009, PHYSIOL GENOMICS, V39, P56, DOI 10.1152/physiolgenomics.00061.2009; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; BOOKSTEIN L, 1990, ARCH INTERN MED, V150, P1653, DOI 10.1001/archinte.150.8.1653; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Brown CM, 2008, INT J OBESITY, V32, pS28, DOI 10.1038/ijo.2008.204; Brown IJ, 2011, HYPERTENSION, V57, P695, DOI 10.1161/HYPERTENSIONAHA.110.165456; Canzanello VJ, 2008, AM J HYPERTENS, V21, P61, DOI 10.1038/ajh.2007.24; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Jalal DI, 2010, J AM SOC NEPHROL, V21, P1543, DOI 10.1681/ASN.2009111111; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Laukkanen O, 2005, DIABETES, V54, P2256, DOI 10.2337/diabetes.54.7.2256; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Madero M, 2011, CURR HYPERTENS REP, V13, P29, DOI 10.1007/s11906-010-0163-x; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Short RA, 2005, SEMIN NEPHROL, V25, P25, DOI 10.1016/j.semnephrol.2004.09.005; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Steinmann B, 2001, METABOLIC MOL BASES, P1489; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Taha D, 2008, J PEDIATR ENDOCR MET, V21, P581; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Turner ST, 2008, HYPERTENSION, V52, P359, DOI 10.1161/HYPERTENSIONAHA.107.104273; United States Department of Agriculture/Economic Research Service, 2000, US PER CAP FOOD CONS; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yamamoto T, 1997, METABOLISM, V46, P544, DOI 10.1016/S0026-0495(97)90192-X; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	55	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52062	10.1371/journal.pone.0052062	http://dx.doi.org/10.1371/journal.pone.0052062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341889	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400008
J	Matsunami, N; Hadley, D; Hensel, CH; Christensen, GB; Kim, C; Frackelton, E; Thomas, K; da Silva, RP; Stevens, J; Baird, L; Otterud, B; Ho, K; Varvil, T; Leppert, T; Lambert, CG; Leppert, M; Hakonarson, H				Matsunami, Nori; Hadley, Dexter; Hensel, Charles H.; Christensen, G. Bryce; Kim, Cecilia; Frackelton, Edward; Thomas, Kelly; da Silva, Renata Pellegrino; Stevens, Jeff; Baird, Lisa; Otterud, Brith; Ho, Karen; Varvil, Tena; Leppert, Tami; Lambert, Christophe G.; Leppert, Mark; Hakonarson, Hakon			Identification of Rare Recurrent Copy Number Variants in High-Risk Autism Families and Their Prevalence in a Large ASD Population	PLOS ONE			English	Article							DE-NOVO; STRUCTURAL VARIATION; SPECTRUM DISORDERS; HIGH-FREQUENCY; GENES; LOCI; NEUREXIN-1-BETA; SCHIZOPHRENIA; DELETIONS; CHILDREN	Structural variation is thought to play a major etiological role in the development of autism spectrum disorders (ASDs), and numerous studies documenting the relevance of copy number variants (CNVs) in ASD have been published since 2006. To determine if large ASD families harbor high-impact CNVs that may have broader impact in the general ASD population, we used the Affymetrix genome-wide human SNP array 6.0 to identify 153 putative autism-specific CNVs present in 55 individuals with ASD from 9 multiplex ASD pedigrees. To evaluate the actual prevalence of these CNVs as well as 185 CNVs reportedly associated with ASD from published studies many of which are insufficiently powered, we designed a custom Illumina array and used it to interrogate these CNVs in 3,000 ASD cases and 6,000 controls. Additional single nucleotide variants (SNVs) on the array identified 25 CNVs that we did not detect in our family studies at the standard SNP array resolution. After molecular validation, our results demonstrated that 15 CNVs identified in high-risk ASD families also were found in two or more ASD cases with odds ratios greater than 2.0, strengthening their support as ASD risk variants. In addition, of the 25 CNVs identified using SNV probes on our custom array, 9 also had odds ratios greater than 2.0, suggesting that these CNVs also are ASD risk variants. Eighteen of the validated CNVs have not been reported previously in individuals with ASD and three have only been observed once. Finally, we confirmed the association of 31 of 185 published ASD-associated CNVs in our dataset with odds ratios greater than 2.0, suggesting they may be of clinical relevance in the evaluation of children with ASDs. Taken together, these data provide strong support for the existence and application of high-impact CNVs in the clinical genetic evaluation of children with ASD.	[Matsunami, Nori; Stevens, Jeff; Baird, Lisa; Otterud, Brith; Varvil, Tena; Leppert, Tami; Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Hadley, Dexter; Kim, Cecilia; Frackelton, Edward; Thomas, Kelly; da Silva, Renata Pellegrino; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hensel, Charles H.; Ho, Karen] Lineagen Inc, Salt Lake City, UT USA; [Christensen, G. Bryce; Lambert, Christophe G.] Golden Helix Inc, Bozeman, MT USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	Romanova, Raisa/O-5724-2018; Lambert, Christophe/AAH-4448-2021; Hadley, Dexter/ABB-7568-2021	Lambert, Christophe/0000-0003-1994-2893; Hadley, Dexter/0000-0003-0990-4674; Leppert, Tami/0000-0002-7893-8619	National Institute of Mental Health [1U24MH081810]; Margaret Q. Landenberger Foundation; Lineagen, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Margaret Q. Landenberger Foundation; Lineagen, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All Utah subjects were ascertained and DNA collected with support from R01 MH 06359 from the National Institute of Mental Health and U19HD035476 from the National Institute of Child Health and Human Development. DNA was processed with support from GCRC M01-RR025764 from the National Center for Research Resources. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Dr. Hakonaron is additionally supported by the Margaret Q. Landenberger Foundation. Additional funding for this study was provided by Lineagen, Inc. Scientific input into study design, data analysis, and preparation of the manuscript were provided by two authors who are Lineagen employees (CHH, KH). The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey A, 1998, HUM MOL GENET, V7, P571; Bergboer JGM, 2012, J INVEST DERMATOL; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Camacho-Garcia RJ, 2012, NEUROBIOL DIS, V47, P135, DOI 10.1016/j.nbd.2012.03.031; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cook EH, 1997, AM J HUM GENET, V60, P928; Davis LK, 2009, J NEURODEV DISORD, V1, P292, DOI 10.1007/s11689-009-9013-z; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hedges DJ, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-2; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; Kang JQ, 2013, J AUTISM DEV DISORD, V43, P68, DOI 10.1007/s10803-012-1543-7; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin Christa Lese, 2007, Curr Psychiatry Rep, V9, P141; Michel M, 2012, DEV NEUROBIOL; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Palferman S, 2001, AM J HUM GENET, V69, P570; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prescott SM, 2008, ANNU REV GENOM HUM G, V9, P347, DOI 10.1146/annurev.genom.9.081307.164441; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punia S, 2010, PHARMACOGENET GENOM, V20, P435, DOI 10.1097/FPC.0b013e32833ad3bb; Qiao Y, 2009, J MED GENET, V46, P680, DOI 10.1136/jmg.2009.066795; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sahoo T, 2011, GENET MED, V13, P868, DOI 10.1097/GIM.0b013e3182217a06; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schaaf CP, 2012, EUR J HUM GENET; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stone TW, 2012, FEBS J, V279, P1386, DOI 10.1111/j.1742-4658.2012.08487.x; Sumioka A, 2003, BIOCHEM J, V374, P261, DOI 10.1042/BJ20030489; Sun J, 2012, PSYCHIAT RES; Swaminathan Shanker, 2011, Int J Alzheimers Dis, V2011, P729478, DOI 10.4061/2011/729478; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vilarino-Guell C, 2010, NEUROGENETICS, V11, P401, DOI 10.1007/s10048-010-0241-x; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wu YW, 2011, HUM GENET, V129, P611, DOI 10.1007/s00439-011-0955-3; Xu L, 2011, BRIT J DERMATOL, V165, P882, DOI 10.1111/j.1365-2133.2011.10485.x; Yalcin O, 2012, SEIZURE-EUR J EPILEP, V21, P79, DOI 10.1016/j.seizure.2011.12.002; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893	72	45	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52239	10.1371/journal.pone.0052239	http://dx.doi.org/10.1371/journal.pone.0052239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341896	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400013
J	Mossalam, M; Soto, J; Lim, CS; Abel, ED				Mossalam, Mohanad; Soto, Jamie; Lim, Carol S.; Abel, E. Dale			Solid Phase Synthesis of Mitochondrial Triphenylphosphonium-Vitamin E Metabolite Using a Lysine Linker for Reversal of Oxidative Stress	PLOS ONE			English	Article							E-LIKE ANTIOXIDANT; TARGETED ANTIOXIDANTS; DIABETIC COMPLICATIONS; ISCHEMIA-REPERFUSION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; CORONARY-DISEASE; ALPHA-TOCOPHEROL; KAPPA-B; APOPTOSIS	Mitochondrial targeting of antioxidants has been an area of interest due to the mitochondria's role in producing and metabolizing reactive oxygen species. Antioxidants, especially vitamin E (alpha-tocopherol), have been conjugated to lipophilic cations to increase their mitochondrial targeting. Synthetic vitamin E analogues have also been produced as an alternative to alpha-tocopherol. In this paper, we investigated the mitochondrial targeting of a vitamin E metabolite, 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC), which is similar in structure to vitamin E analogues. We report a fast and efficient method to conjugate the water-soluble metabolite, alpha-CEHC, to triphenylphosphonium cation via a lysine linker using solid phase synthesis. The efficacy of the final product (MitoCEHC) to lower oxidative stress was tested in bovine aortic endothelial cells. In addition the ability of MitoCEHC to target the mitochondria was examined in type 2 diabetes db/db mice. The results showed mitochondrial accumulation in vivo and oxidative stress decrease in vitro.	[Mossalam, Mohanad; Lim, Carol S.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Soto, Jamie; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Soto, Jamie; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mossalam, M (corresponding author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.	mohanad.mossalam@utah.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health (NIH) [R21-DK073590]; National Cancer Institute of the NIH [R01-CA151847]; NATIONAL CANCER INSTITUTE [R01CA151847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institutes of Health (NIH) award number R21-DK073590 to E. Dale Abel and the National Cancer Institute of the NIH under award number R01-CA151847 to Carol S. Lim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADIE C, 1993, FREE RADICAL BIO MED, V15, P209, DOI 10.1016/0891-5849(93)90061-X; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; AMBROSIUS D, 1989, BIOL CHEM H-S, V370, P217, DOI 10.1515/bchm3.1989.370.1.217; Betancor-Fernandez A, 2002, FREE RADICAL RES, V36, P915, DOI 10.1080/1071576021000005357; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; CABALLERO B, 1993, NUTR REV, V51, P339, DOI 10.1111/j.1753-4887.1993.tb03761.x; Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321; Chen WJ, 2006, BIOORG MED CHEM LETT, V16, P5874, DOI 10.1016/j.bmcl.2006.08.063; Cohn W, 1997, EUR J CLIN NUTR, V51, pS80; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Galeano M, 2001, SURGERY, V129, P467, DOI 10.1067/msy.2001.112072; Han YM, 2011, BIOORG MED CHEM LETT, V21, P747, DOI 10.1016/j.bmcl.2010.11.114; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hughes G, 2005, BIOCHEM J, V389, P83, DOI 10.1042/bj20050078; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; James AM, 2005, MECH AGEING DEV, V126, P982, DOI 10.1016/j.mad.2005.03.026; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; KAGAN VE, 1994, METHOD ENZYMOL, V234, P343; Kang W, 2012, BIOORG MED CHEM LETT, V22, P1187, DOI 10.1016/j.bmcl.2011.11.081; Kelly F J, 1998, J Int Fed Clin Chem, V10, P21; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kritharides L, 2002, ATHEROSCLEROSIS, V164, P211, DOI 10.1016/S0021-9150(02)00011-4; Kuroki T, 2003, J AM SOC NEPHROL, V14, pS216, DOI 10.1097/01.ASN.0000077405.07888.07; Laurent A, 2005, CANCER RES, V65, P948; Liley MJ, 2006, J ORG CHEM, V71, P1322, DOI 10.1021/jo051742j; Mayer-Davis EJ, 2002, DIABETES CARE, V25, P2172, DOI 10.2337/diacare.25.12.2172; Meagher E A, 2003, Prev Cardiol, V6, P85, DOI 10.1111/j.1520-037X.2003.00560.x; Moorthi RV, 2006, CLIN CHIM ACTA, V367, P132, DOI 10.1016/j.cca.2005.12.004; Mossalam M, 2008, J CONTROL RELEASE, V130, P234, DOI 10.1016/j.jconrel.2008.06.009; Mossalam M, 2012, MOL PHARMACEUT, V9, P1449, DOI 10.1021/mp3000259; Mossalam M, 2010, THER DELIV, V1, P169, DOI 10.4155/TDE.10.8; Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Mustacich DJ, 2010, FREE RADICAL BIO MED, V48, P73, DOI 10.1016/j.freeradbiomed.2009.10.024; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Navarro A, 2008, ADV DRUG DELIVER REV, V60, P1534, DOI 10.1016/j.addr.2008.05.002; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; PAOLISSO G, 1993, AM J CLIN NUTR, V57, P650, DOI 10.1093/ajcn/57.5.650; PAOLISSO G, 1994, AM J CLIN NUTR, V59, P1291, DOI 10.1093/ajcn/59.6.1291; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; PARTHASARATHY S, 1992, ANNU REV MED, V43, P219, DOI 10.1146/annurev.me.43.020192.001251; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Radosavac D, 2002, EUR J NUTR, V41, P119, DOI 10.1007/s00394-002-0365-3; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; SCHULTZ M, 1995, AM J CLIN NUTR, V62, P1527, DOI 10.1093/ajcn/62.6.1527S; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Singh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032521; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011	60	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53272	10.1371/journal.pone.0053272	http://dx.doi.org/10.1371/journal.pone.0053272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341934	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400038
J	Schonrogge, K; Begg, T; Stone, GN				Schoenrogge, Karsten; Begg, Tracey; Stone, Graham N.			Native Birds and Alien Insects: Spatial Density Dependence in Songbird Predation of Invading Oak Gallwasps	PLOS ONE			English	Article							ANDRICUS-QUERCUSCALICIS HYMENOPTERA; CLIMATE-CHANGE; PARUS-MAJOR; GALL WASPS; CAMERARIA-HAMADRYADELLA; TROPHIC LEVELS; ENEMY RELEASE; TIT PREDATION; LEAF-MINER; PARASITOIDS	Revealing the interactions between alien species and native communities is central to understanding the ecological consequences of range expansion. Much has been learned through study of the communities developing around invading herbivorous insects. Much less, however, is known about the significance of such aliens for native vertebrate predators for which invaders may represent a novel food source. We quantified spatial patterns in native bird predation of invading gall-inducing Andricus wasps associated with introduced Turkey oak (Quercus cerris) at eight sites across the UK. These gallwasps are available at high density before the emergence of caterpillars that are the principle spring food of native insectivorous birds. Native birds showed positive spatial density dependence in gall attack rates at two sites in southern England, foraging most extensively on trees with highest gall densities. In a subsequent study at one of these sites, positive spatial density dependence persisted through four of five sequential week-long periods of data collection. Both patterns imply that invading galls are a significant resource for at least some native bird populations. Density dependence was strongest in southern UK bird populations that have had longest exposure to the invading gallwasps. We hypothesise that this pattern results from the time taken for native bird populations to learn how to exploit this novel resource.	[Schoenrogge, Karsten; Begg, Tracey] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Begg, Tracey; Stone, Graham N.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	UK Centre for Ecology & Hydrology (UKCEH); University of Edinburgh	Stone, GN (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	graham.stone@ed.ac.uk	Schönrogge, Karsten/E-8818-2010; Schonrogge, Karsten/M-9935-2019	Schönrogge, Karsten/0000-0003-0122-6493; Schonrogge, Karsten/0000-0003-0122-6493; Stone, Graham/0000-0002-2737-696X	UK Natural Environment Research Council [NER/S/A/2003/11227, NE/H000135/1]; NERC [NE/H000135/1, NE/H000038/1] Funding Source: UKRI; Natural Environment Research Council [NE/H000038/1, CEH010021, NE/H000135/1, NER/B/S/2003/00856] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council (http://www.nerc.ac.uk/) through grants NER/S/A/2003/11227 and NE/H000135/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew R.R., 1982, Entomologist's Monthly Magazine, V118, P116; ASKEW RR, 1962, J ANIM ECOL, V31, P439, DOI 10.2307/2045; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; BETTS MM, 1955, J ANIM ECOL, V24, P282, DOI 10.2307/1715; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; COLLINS M, 1983, ECOL ENTOMOL, V8, P133, DOI 10.1111/j.1365-2311.1983.tb00491.x; Conner EF, 1999, OIKOS, V87, P105, DOI 10.2307/3547001; CONNOR EF, 1993, OIKOS, V66, P515, DOI 10.2307/3544947; Crawley MJ, 1988, FUNCT ECOL, V2, P409, DOI 10.2307/2389414; Crawley M. J., 2008, R BOOK; Cronin JT, 2007, ECOLOGY, V88, P2977, DOI 10.1890/07-0253.1; Egan SP, 2007, ECOLOGY, V88, P2868, DOI 10.1890/06-1303.1; Eliason EA, 2000, ENVIRON ENTOMOL, V29, P1199, DOI 10.1603/0046-225X-29.6.1199; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; GIBB JA, 1966, J ANIM ECOL, V35, P43, DOI 10.2307/2688; Gibb JA, 1958, IBIS, V96, P513; Gibbons D. W., 1993, NEW ATLAS BREEDING B; Girardoz S, 2007, J APPL ENTOMOL, V131, P603, DOI 10.1111/j.1439-0418.2007.01146.x; Girardoz S, 2006, AGR FOREST ENTOMOL, V8, P49, DOI 10.1111/j.1461-9555.2006.00281.x; Grabenweger G, 2010, BIOL INVASIONS, V12, P2797, DOI 10.1007/s10530-009-9685-z; Grobler BC, 2008, ECOL ENTOMOL, V33, P453, DOI 10.1111/j.1365-2311.2008.00990.x; HAILS R S, 1990, Entomologist, V109, P165; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; HASSELL MP, 1990, PHILOS T R SOC B, V330, P203, DOI 10.1098/rstb.1990.0193; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; HEADS PA, 1983, OIKOS, V41, P161, DOI 10.2307/3544259; Holmes R.T, 1990, STUD AVIAN BIOL, V13, P6; HOLMES RT, 1988, CAN J ZOOL, V66, P720, DOI 10.1139/z88-107; ITAMIES J, 1977, ANN ZOOL FENN, V14, P235; Ito M, 2005, ACTA OECOL, V27, P17, DOI 10.1016/j.actao.2004.08.005; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Jordan M.J.R., 2005, International Zoo Yearbook, V39, P108; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; McGeoch MA, 2005, OECOLOGIA, V144, P278, DOI 10.1007/s00442-005-0073-9; Naef-Daenzer B, 1999, J ANIM ECOL, V68, P708, DOI 10.1046/j.1365-2656.1999.00318.x; Naef-Daenzer B, 2000, ANIM BEHAV, V59, P989, DOI 10.1006/anbe.1999.1380; Naef-Daenzer L, 2004, ARDEA, V92, P229; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NASH DR, 1995, J ANIM ECOL, V64, P225, DOI 10.2307/5757; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Schonrogge K, 2012, INSECT CONSERV DIVER, V5, P298, DOI 10.1111/j.1752-4598.2011.00161.x; Schonrogge K, 2000, J ANIM ECOL, V69, P841, DOI 10.1046/j.1365-2656.2000.00443.x; Schonrogge K, 1999, OIKOS, V84, P293, DOI 10.2307/3546724; Schonrogge K, 1996, ECOL ENTOMOL, V21, P71, DOI 10.1111/j.1365-2311.1996.tb00268.x; SCHONROGGE K, 1995, OIKOS, V72, P51, DOI 10.2307/3546037; Schonrogge K, 1996, OIKOS, V77, P507, DOI 10.2307/3545940; Schonrogge K, 2000, ECOL ENTOMOL, V25, P208, DOI 10.1046/j.1365-2311.2000.00244.x; Schonrogge K, 1998, P ROY SOC B-BIOL SCI, V265, P1643, DOI 10.1098/rspb.1998.0483; SHERRY DF, 1990, ANIM BEHAV, V40, P987, DOI 10.1016/S0003-3472(05)81004-8; SHERRY DF, 1984, ANIM BEHAV, V32, P937, DOI 10.1016/S0003-3472(84)80185-2; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; STEWART AJA, 2000, ECOLOGICAL CONSEQUEN, P1; STONE GN, 1993, MOL ECOL, V2, P251, DOI 10.1111/j.1365-294X.1993.tb00015.x; Stone GN, 2007, MOL ECOL, V16, P2768, DOI 10.1111/j.1365-294X.2007.03348.x; SUHONEN J, 1992, ORNIS SCAND, V23, P467, DOI 10.2307/3676678; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; TSCHARNTKE T, 1992, ECOLOGY, V73, P1689, DOI 10.2307/1940020; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Veldtman R, 2004, P ROY SOC B-BIOL SCI, V271, P2439, DOI 10.1098/rspb.2004.2905; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Walker P, 2002, DIVERS DISTRIB, V8, P335, DOI 10.1046/j.1472-4642.2002.00159.x; Wernhem C, 2002, MIGRATION ATLAS MOVE	76	8	8	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53959	10.1371/journal.pone.0053959	http://dx.doi.org/10.1371/journal.pone.0053959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342048	gold, Green Published, Green Accepted			2022-12-27	WOS:000314759400106
J	Gassei, K; Orwig, KE				Gassei, Kathrin; Orwig, Kyle E.			SALL4 Expression in Gonocytes and Spermatogonial Clones of Postnatal Mouse Testes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMEOTIC GENE SPALT; UNDIFFERENTIATED SPERMATOGONIA; OKIHIRO-SYNDROME; STEM/PROGENITOR CELLS; DROSOPHILA EMBRYO; KIT EXPRESSION; MURINE HOMOLOG; FATE DECISION; PROTEIN	The spermatogenic lineage is established after birth when gonocytes migrate to the basement membrane of seminiferous tubules and give rise to spermatogonial stem cells (SSC). In adults, SSCs reside within the population of undifferentiated spermatogonia (A(undiff)) that expands clonally from single cells (A(single)) to form pairs (A(paired)) and chains of 4, 8 and 16 A(aligned) spermatogonia. Although stem cell activity is thought to reside in the population of Asingle spermatogonia, new research suggests that clone size alone does not define the stem cell pool. The mechanisms that regulate self-renewal and differentiation fate decisions are poorly understood due to limited availability of experimental tools that distinguish the products of those fate decisions. The pluripotency factor SALL4 (sal-like protein 4) is implicated in stem cell maintenance and patterning in many organs during embryonic development, but expression becomes restricted to the gonads after birth. We analyzed the expression of SALL4 in the mouse testis during the first weeks after birth and in adult seminiferous tubules. In newborn mice, the isoform SALL4B is expressed in quiescent gonocytes at postnatal day 0 (PND0) and SALL4A is upregulated at PND7 when gonocytes have colonized the basement membrane and given rise to spermatogonia. During steady-state spermatogenesis in adult testes, SALL4 expression overlapped substantially with PLZF and LIN28 in Asingle, A(paired) and A(aligned) spermatogonia and therefore appears to be a marker of undifferentiated spermatogonia in mice. In contrast, co-expression of SALL4 with GFR alpha 1 and cKIT identified distinct subpopulations of A(undiff) in all clone sizes that might provide clues about SSC regulation. Collectively, these results indicate that 1) SALL4 isoforms are differentially expressed at the initiation of spermatogenesis, 2) SALL4 is expressed in undifferentiated spermatogonia in adult testes and 3) SALL4 co-staining with GFRa1 and cKIT reveals distinct subpopulations of A(undiff) spermatogonia that merit further investigation.	[Gassei, Kathrin; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Orwig, KE (corresponding author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	orwigke@upmc.edu	Gassei, Kathrin/E-3791-2013	Orwig, Kyle/0000-0002-7952-8419	United States National Institutes of Health [HD055475, HD061289, HD008610]; Lalor Foundation; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055475] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD008610, R21HD061289] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lalor Foundation; Magee-Womens Research Institute and Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by United States National Institutes of Health grants HD055475, HD061289 and HD008610 (KEO), a Lalor Foundation Postdoctoral Fellowship (KG) and Magee-Womens Research Institute and Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Camp E, 2003, DEV GENES EVOL, V213, P35, DOI 10.1007/s00427-002-0284-6; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; De Rooij DG, 2000, J ANDROL, V21, P776; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Grisanti L, 2009, STEM CELLS, V27, P3043, DOI 10.1002/stem.206; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; KLUIN PM, 1981, INT J ANDROL, V4, P475, DOI 10.1111/j.1365-2605.1981.tb00732.x; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; LOK D, 1982, ANAT REC, V203, P83, DOI 10.1002/ar.1092030109; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Sweetman D, 2003, J BIOL CHEM, V278, P6560, DOI 10.1074/jbc.M209066200; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Uez N, 2008, GENESIS, V46, P463, DOI 10.1002/dvg.20421; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; Yamatani H, 2004, J COMP NEUROL, V475, P247, DOI 10.1002/cne.20155; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, ANN NY ACAD SCI, V1120, P47, DOI 10.1196/annals.1411.003; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	47	74	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53976	10.1371/journal.pone.0053976	http://dx.doi.org/10.1371/journal.pone.0053976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326552	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000314705800095
J	Yasuo, M; Mizuno, S; Allegood, J; Kraskauskas, D; Bogaard, HJ; Spiegel, S; Voelkel, NF				Yasuo, Masanori; Mizuno, Shiro; Allegood, Jeremy; Kraskauskas, Donatas; Bogaard, Harm J.; Spiegel, Sarah; Voelkel, Norbert F.			Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; INDUCED APOPTOSIS; CELL APOPTOSIS; CERAMIDE SYNTHASE; UP-REGULATION; LUNG; SPHINGOSINE-1-PHOSPHATE; NEUROBLASTOMA; DIHYDROCERAMIDE	Sphingolipids play a role in the development of emphysema and ceramide levels are increased in experimental models of emphysema; however, the mechanisms of ceramide-related pulmonary emphysema are not fully understood. Here we examine mechanisms of ceramide-induced pulmonary emphysema. Male Sprague-Dawley rats were treated with fenretinide (20 mg/kg BW), a synthetic derivative of retinoic acid that causes the formation of ceramide, and we postulated that the effects of fenretinide could be offset by administering sphingosine 1-phosphate (S1P) (100 mg/kg BW). Lung tissues were analyzed and mean alveolar airspace area, total length of the alveolar perimeter and the number of caspase-3 positive cells were measured. Hypoxia-inducible factor alpha (HIF-1 alpha), vascular endothelial growth factor (VEGF) and other related proteins were analyzed by Western blot analysis. Immunohistochemical analysis of HIF-1 alpha was also performed. Ceramide, dihydroceramide, S1P, and dihydro-S1P were measured by mass spectrometer. Chronic intraperitoneal injection of fenretinide increased the alveolar airspace surface area and increased the number of caspase-3 positive cells in rat lungs. Fenretinide also suppressed HIF-1 alpha and VEGF protein expression in rat lungs. Concomitant injection of S1P prevented the decrease in the expression of HIF-1 alpha, VEGF, histone deacetylase 2 (HDAC2), and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protein expression in the lungs. S1P injection also increased phosphorylated sphingosine kinase 1. Dihydroceramide was significantly increased by fenretinide injection and S1P treatment prevented the increase in dihydroceramide levels in rat lungs. These data support the concept that increased de novo ceramide production causes alveolar septal cell apoptosis and causes emphysema via suppressing HIF-1 alpha. Concomitant treatment with S1P normalizes the ceramide-S1P balance in the rat lungs and increases HIF-1 alpha protein expression via activation of sphingosine kinase 1; as a consequence, S1P salvages fenretinide induced emphysema in rat lungs.	[Yasuo, Masanori; Mizuno, Shiro; Kraskauskas, Donatas; Bogaard, Harm J.; Voelkel, Norbert F.] Virginia Commonwealth Univ, Pulm & Crit Care Med Div, Richmond, VA 23284 USA; [Yasuo, Masanori; Mizuno, Shiro; Kraskauskas, Donatas; Bogaard, Harm J.; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Dis, Richmond, VA USA; [Yasuo, Masanori] Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 390, Japan; [Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Shinshu University; Virginia Commonwealth University	Voelkel, NF (corresponding author), Virginia Commonwealth Univ, Pulm & Crit Care Med Div, Richmond, VA 23284 USA.	nvoelkel@mcvh-vcu.edu		Bogaard, Harm Jan/0000-0001-5371-0346	National Institutes of Health (NIH) Lung Division LTRC [N01-HR-46160-3]; Victoria Johnson Center for obstructive Lung Disease Research	National Institutes of Health (NIH) Lung Division LTRC; Victoria Johnson Center for obstructive Lung Disease Research	This work was supported by the National Institutes of Health (NIH) Lung Division LTRC grant support mechanism (Grant number; N01-HR-46160-3, contact name; Norbert F. Voelkel) and by the Victoria Johnson Center for obstructive Lung Disease Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Baldi S, 2001, AM J RESP CRIT CARE, V164, P585, DOI 10.1164/ajrccm.164.4.2010066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SD, 2005, ANN NY ACAD SCI, V1042, P357, DOI 10.1196/annals.1338.033; Claus RA, 2009, CURR MED CHEM, V16, P1978, DOI 10.2174/092986709788682182; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Erdreich-Epstein A, 2002, J BIOL CHEM, V277, P49531, DOI 10.1074/jbc.M209962200; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Golubkov V, 2005, ANTICANCER RES, V25, P249; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; KIM WD, 1991, AM REV RESPIR DIS, V144, P1385, DOI 10.1164/ajrccm/144.6.1385; Kim WD, 2007, CHEST, V131, P1372, DOI 10.1378/chest.06-2194; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu HB, 2008, PANCREAS, V36, pE10, DOI 10.1097/MPA.0b013e31815f3905; Lovat PE, 2003, CANCER LETT, V197, P157, DOI 10.1016/S0304-3835(03)00098-3; Lovat PE, 2002, CANCER RES, V62, P5158; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Mizuno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030678; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Ruvolo VR, 2010, J SIGNAL TRANSDUCT, V2010, DOI DOI 10.1155/2010/584657; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Villorbina G, 2007, BIOORGAN MED CHEM, V15, P50, DOI 10.1016/j.bmc.2006.10.024; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Voelkel Norbert F, 2011, Pulm Circ, V1, P320, DOI 10.4103/2045-8932.87295; Voelkel NF, 2009, IMMUNOL CELL BIOL, V87, P601, DOI 10.1038/icb.2009.45; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	49	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53927	10.1371/journal.pone.0053927	http://dx.doi.org/10.1371/journal.pone.0053927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326540	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800089
J	Foti, F; Menghini, D; Mandolesi, L; Federico, F; Vicari, S; Petrosini, L				Foti, Francesca; Menghini, Deny; Mandolesi, Laura; Federico, Francesca; Vicari, Stefano; Petrosini, Laura			Learning by Observation: Insights from Williams Syndrome	PLOS ONE			English	Article							NEURAL MECHANISMS; HUMAN IMITATION; MOTOR CONTROL; DOWN-SYNDROME; HAND ACTIONS; CHILDREN; MEMORY; PATTERN; CORTEX; FMRI	Observing another person performing a complex action accelerates the observer's acquisition of the same action and limits the time-consuming process of learning by trial and error. Observational learning makes an interesting and potentially important topic in the developmental domain, especially when disorders are considered. The implications of studies aimed at clarifying whether and how this form of learning is spared by pathology are manifold. We focused on a specific population with learning and intellectual disabilities, the individuals with Williams syndrome. The performance of twenty-eight individuals with Williams syndrome was compared with that of mental age- and gender-matched thirty-two typically developing children on tasks of learning of a visuo-motor sequence by observation or by trial and error. Regardless of the learning modality, acquiring the correct sequence involved three main phases: a detection phase, in which participants discovered the correct sequence and learned how to perform the task; an exercise phase, in which they reproduced the sequence until performance was error-free; an automatization phase, in which by repeating the error-free sequence they became accurate and speedy. Participants with Williams syndrome beneficiated of observational training (in which they observed an actor detecting the visuo-motor sequence) in the detection phase, while they performed worse than typically developing children in the exercise and automatization phases. Thus, by exploiting competencies learned by observation, individuals with Williams syndrome detected the visuo-motor sequence, putting into action the appropriate procedural strategies. Conversely, their impaired performances in the exercise phases appeared linked to impaired spatial working memory, while their deficits in automatization phases to deficits in processes increasing efficiency and speed of the response. Overall, observational experience was advantageous for acquiring competencies, since it primed subjects' interest in the actions to be performed and functioned as a catalyst for executed action.	[Foti, Francesca; Federico, Francesca] Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy; [Foti, Francesca; Mandolesi, Laura; Petrosini, Laura] IRCCS Santa Lucia Fdn, Rome, Italy; [Menghini, Deny; Vicari, Stefano] Childrens Hosp Bambino Gesu, Dept Neurosci, Child Neuropsychiat Unit, Rome, Italy; [Mandolesi, Laura] Univ Naples Parthenope, Sch Movement Sci DiSIST, Naples, Italy; [Petrosini, Laura] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; IRCCS Bambino Gesu; Parthenope University Naples; Sapienza University Rome	Foti, F (corresponding author), Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy.	francesca.foti@uniroma1.it	Menghini, Deny/AAB-4343-2020; Foti, Francesca/AAB-9878-2019; Vicari, Stefano/J-3008-2012; Meijer, Anna/K-5118-2016	Menghini, Deny/0000-0002-3459-2601; MANDOLESI, Laura/0000-0002-3685-7554; Federico, Francesca/0000-0002-3589-4783; FOTI, FRANCESCA IRENE/0000-0002-7094-7078; Vicari, Stefano/0000-0002-5395-2262	Fondation Jerome Lejeune	Fondation Jerome Lejeune	This work was supported by the Fondation Jerome Lejeune to L.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Atkinson J, 2001, DEV MED CHILD NEUROL, V43, P330, DOI 10.1017/S0012162201000615; Atkinson J, 2011, PROG BRAIN RES, V189, P261, DOI 10.1016/B978-0-444-53884-0.00029-4; Avanzino L, 2011, J NEUROSCI, V31, P3423, DOI 10.1523/JNEUROSCI.4893-10.2011; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Beery KE, 2000, ITALIAN ADAPTATION; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Berthoz A, 1996, COGNITIVE BRAIN RES, V3, P101, DOI 10.1016/0926-6410(95)00035-6; Bird G, 2005, J EXP PSYCHOL HUMAN, V31, P262, DOI 10.1037/0096-1523.31.2.262; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chaminade T, 2002, NEUROIMAGE, V15, P318, DOI 10.1006/nimg.2001.0981; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Ersche KD, 2011, BIOL PSYCHIAT, V70, P754, DOI 10.1016/j.biopsych.2011.06.033; Farran EK, 2001, J CHILD PSYCHOL PSYC, V42, P719, DOI 10.1111/1469-7610.00768; Fenstermacher SK, 2007, BEHAV GENET, V37, P639, DOI 10.1007/s10519-007-9160-5; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Foti F, 2011, RES DEV DISABIL, V32, P972, DOI 10.1016/j.ridd.2011.02.001; Foti F, 2011, BEHAV GENET, V41, P445, DOI 10.1007/s10519-011-9471-4; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; HAMMILL D, 1994, TPV TEST PERCEZIONE; Hoffstaedter F, 2012, CEREB CORTE IN PRESS; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Jarrold C, 2004, J AUTISM DEV DISORD, V34, P81, DOI 10.1023/B:JADD.0000018078.82542.ab; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; Jones W, 2002, DEV MED CHILD NEUROL, V44, P688; Klein BP, 1999, DEV NEUROPSYCHOL, V16, P177, DOI 10.1207/S15326942DN1602_3; Kokkinaki T, 2000, J REPROD INFANT PSYC, V18, P173, DOI 10.1080/713683042; Leggio MG, 2000, P NATL ACAD SCI USA, V97, P2320, DOI 10.1073/pnas.040554297; Mandolesi L, 2009, INT J DEV NEUROSCI, V27, P205, DOI 10.1016/j.ijdevneu.2009.01.004; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Menghini D, 2011, NEUROPSYCHOLOGIA, V49, P1996, DOI 10.1016/j.neuropsychologia.2011.03.029; Menghini D, 2011, BEHAV GENET, V41, P394, DOI 10.1007/s10519-010-9419-0; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Metzinger T, 2003, CONSCIOUS COGN, V12, P549, DOI 10.1016/S1053-8100(03)00072-2; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Nadel J, 1998, IMITATION INFANCY; Nadel J., 2002, CAMBRIDGE STUDIES CO, P42, DOI [10.1017/CBO9780511489969.003, DOI 10.1017/CBO9780511489969.003]; Petrosini L, 2007, NEUROSCIENTIST, V13, P335, DOI 10.1177/10738584070130040701; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Roid G. H., 2002, LEITER R LEITER INT; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmitt JE, 2001, DEV MED CHILD NEUROL, V43, P155, DOI 10.1017/S0012162201000305; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sokolov AA, 2010, CEREB CORTEX, V20, P486, DOI 10.1093/cercor/bhp117; Sparaci L, 2012, NEUROPSYCHOLOGIA, V50, P1639, DOI 10.1016/j.neuropsychologia.2012.03.019; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Torriero S, 2007, J COGNITIVE NEUROSCI, V19, P1656, DOI 10.1162/jocn.2007.19.10.1656; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; Van der Werf YD, 2009, P NATL ACAD SCI USA, V106, P18926, DOI 10.1073/pnas.0901320106; Vicari S, 2007, J INTELL DISABIL RES, V51, P932, DOI 10.1111/j.1365-2788.2007.01003.x; Vicari S, 2006, DEV MED CHILD NEUROL, V48, P126, DOI 10.1017/S0012162206000272; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Vicari S, 2001, NEUROPSYCHOLOGIA, V39, P665, DOI 10.1016/S0028-3932(01)00012-4; Vicari S., 2007, PROMEA PROVE MEMORIA; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	80	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53782	10.1371/journal.pone.0053782	http://dx.doi.org/10.1371/journal.pone.0053782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YV	23326504	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400045
J	Wang, X; Chen, N; Zuo, ZT; Xue, R; Jing, L; Yan, Z; Shen, DG; Li, KC				Wang Xing; Chen Nan; Zuo ZhenTao; Xue Rong; Jing Luo; Yan Zhuo; Shen DingGang; Li KunCheng			Probabilistic MRI Brain Anatomical Atlases Based on 1,000 Chinese Subjects	PLOS ONE			English	Article							MNI; DECLINE; HAMMER	Brain atlases are designed to provide a standard reference coordinate system of the brain for neuroscience research. Existing human brain atlases are widely used to provide anatomical references and information regarding structural characteristics of the brain. The majority of them, however, are derived from one paticipant or small samples of the Western population. This poses a limitation for scientific studies on Eastern subjects. In this study, 10 new Chinese brain atlases for different ages and genders were constructed using MR anatomical images based on HAMMER (Hierarchical Attribute Matching Mechanism for Elastic Registration). A total of 1,000 Chinese volunteers ranging from 18 to 70 years old participated in this study. These population-specific brain atlases represent the basic structural characteristics of the Chinese population. They may be utilized for basic neuroscience studies and clinical diagnosis, including evaluation of neurological and neuropsychiatric disorders, in Chinese patients and those from other Eastern countries.	[Wang Xing; Chen Nan; Li KunCheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Zuo ZhenTao; Xue Rong; Jing Luo; Yan Zhuo] Chinese Acad Sci, Inst Biophys, Beijing MRI Ctr Brain Res, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Shen DingGang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Shen DingGang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA	Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xue, R (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing MRI Ctr Brain Res, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	rxue@bcslab.ibp.ac.cn; likuncheng19551@yahoo.com.cn	CHEN, NAN/L-1223-2019; Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698	Ministry of Science and Technology of China [2006AA02z391, 2005CB522800, 2004CB318101]; National Natural Science Foundation of China [30621004]; Knowledge Innovation Program of the Chinese Academy of Sciences; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Ministry of Science and Technology of China grants (2006AA02z391, 2005CB522800, 2004CB318101), National Natural Science Foundation of China grant (30621004), and the Knowledge Innovation Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Bang OY, 2010, CEREBROVASC DIS, V29, P87, DOI 10.1159/000256653; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Brodmann K, 2006, BRODMANNS LOCALIZATI; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Chau W, 2005, NEUROIMAGE, V25, P408, DOI 10.1016/j.neuroimage.2004.12.007; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Haegelen C, 2012, INT J COMPUT ASSIST, V18; Jao T, 2009, IEEE ENG MED BIO, P4779, DOI 10.1109/IEMBS.2009.5334211; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kruggel F, 2006, NEUROIMAGE, V30, P1, DOI 10.1016/j.neuroimage.2005.09.063; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; Liu QM, 2005, THESIS SHANDONG U; Mazoyer B, 2008, HUM BRAIN MAPP, V29, P250, DOI 10.1002/hbm.20473; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morgan KD, 2010, PSYCHOL MED, V40, P1137, DOI 10.1017/S0033291709991565; Moriguchi Y, 2005, NEUROREPORT, V16, P133, DOI 10.1097/00001756-200502080-00012; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Sadikot AF, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00071; Shen D, 2008, HAMMER USERS MANUAL; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shen DG, 2003, NEUROIMAGE, V18, P28, DOI 10.1006/nimg.2002.1301; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Taki Y, 2011, NEUROBIOL AGING, V32, P907, DOI 10.1016/j.neurobiolaging.2009.05.003; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	30	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e50939	10.1371/journal.pone.0050939	http://dx.doi.org/10.1371/journal.pone.0050939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067UP	23341878	Green Published, gold			2022-12-27	WOS:000313320900005
J	Bom, RJM; van der Helm, JJ; van der Loeff, MFS; van Rooijen, MS; Heijman, T; Matser, A; de Vries, HJC; Bruisten, SM				Bom, Reinier J. M.; van der Helm, Jannie J.; van der Loeff, Maarten F. Schim; van Rooijen, Martijn S.; Heijman, Titia; Matser, Amy; de Vries, Henry J. C.; Bruisten, Sylvia M.			Distinct Transmission Networks of Chlamydia trachomatis in Men Who Have Sex with Men and Heterosexual Adults in Amsterdam, The Netherlands	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; MOLECULAR EPIDEMIOLOGY; STRAINS; INFECTIONS; GENOTYPES	Background: Genovar distributions of Chlamydia trachomatis based on ompA typing differ between men who have sex with men (MSM) and heterosexuals. We investigated clonal relationships using a high resolution typing method to characterize C. trachomatis types in these two risk groups. Methods: C. trachomatis positive samples were collected at the STI outpatient clinic in Amsterdam between 2008 and 2010 and genotyped by multilocus sequence typing. Clusters were assigned using minimum spanning trees and these were combined with epidemiological data of the hosts. Results: We typed 526 C. trachomatis positive samples: 270 from MSM and 256 from heterosexuals. Eight clusters, containing 10-128 samples were identified of which 4 consisted of samples from MSM (90%-100%), with genovars D, G, J, and L2b. The other 4 clusters consisted mainly of samples from heterosexuals (87%-100%) with genovars D, E, F, I, and J. Genetic diversity was much lower in the MSM clusters than in heterosexual clusters. Significant differences in number of sexual partners and HIV-serostatus were observed for MSM-associated clusters. Conclusions: C. trachomatis transmission patterns among MSM and heterosexuals were largely distinct. We hypothesize that these differences are due to sexual host behavior, but bacterial factors may play a role as well.	[Bom, Reinier J. M.; van Rooijen, Martijn S.; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van der Helm, Jannie J.; van der Loeff, Maarten F. Schim; van Rooijen, Martijn S.; Heijman, Titia; Matser, Amy] Publ Hlth Serv Amsterdam GGD Amsterdam, Dept Res, Amsterdam, Netherlands; [van der Helm, Jannie J.; van Rooijen, Martijn S.; Heijman, Titia; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam GGD Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim; de Vries, Henry J. C.; Bruisten, Sylvia M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Matser, Amy] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Bruisten, SM (corresponding author), Publ Hlth Serv Amsterdam GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands.	sbruisten@ggd.amsterdam.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Helm, Jannie/0000-0002-4288-9544; Matser, Amy/0000-0003-4291-1905; Heijman, Titia/0000-0002-1944-2007	ZonMW [125010008]; Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands	ZonMW(Netherlands Organization for Health Research and Development); Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands(Netherlands Government)	This work was supported by ZonMW [grant number 125010008] and the Public Health Service of Amsterdam (GGD Amsterdam), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES RC, 1987, J INFECT DIS, V156, P953, DOI 10.1093/infdis/156.6.953; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Choudhury B, 2006, LANCET, V368, P139, DOI 10.1016/S0140-6736(06)69003-X; Christerson L, 2012, J CLIN MICROBIOL, V50, P3548, DOI 10.1128/JCM.01713-12; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Heijman TLJ, 2007, SEX TRANSM DIS, V34, P508, DOI 10.1097/01.olq.0000251209.52901.c3; Hsu MC, 2006, J MED MICROBIOL, V55, P301, DOI 10.1099/jmm.0.46262-0; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Kolader ME, 2006, J CLIN MICROBIOL, V44, P2689, DOI 10.1128/JCM.02311-05; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Machado ACS, 2011, J MED MICROBIOL, V60, P472, DOI 10.1099/jmm.0.026476-0; Martin-Iguacel R, 2010, EUR J CLIN MICROBIOL, V29, P917, DOI 10.1007/s10096-010-0959-2; Mossman D, 2008, SEX TRANSM DIS, V35, P614, DOI 10.1097/OLQ.0b013e31816b1b80; Nieuwenhuis RF, 2004, CLIN INFECT DIS, V39, P996, DOI 10.1086/423966; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; Tjon G, 2007, J MED VIROL, V79, P488, DOI 10.1002/jmv.20821; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Van der Bij AK, 2006, CLIN INFECT DIS, V42, P186, DOI 10.1086/498904; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820	26	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53869	10.1371/journal.pone.0053869	http://dx.doi.org/10.1371/journal.pone.0053869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342025	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700057
J	Bhutia, YD; Hung, SW; Krentz, M; Patel, D; Lovin, D; Manoharan, R; Thomson, JM; Govindarajan, R				Bhutia, Yangzom Doma; Hung, Sau Wai; Krentz, Madeline; Patel, Dimal; Lovin, Dylan; Manoharan, Radhika; Thomson, J. Michael; Govindarajan, Rajgopal			Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE R2; GEMCITABINE CHEMORESISTANCE; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; UP-REGULATION; DNA-DAMAGE; M2 SUBUNIT; RESISTANCE; MICRORNAS; GENE	Overexpression of ribonucleotide reductase subunit M2 (RRM2), involved in deoxyribonucleotide synthesis, drives the chemoresistance of pancreatic cancer to nucleoside analogs (e. g., gemcitabine). While silencing RRM2 by synthetic means has shown promise in reducing chemoresistance, targeting endogenous molecules, especially microRNAs (miRNAs), to advance chemotherapeutic outcomes has been poorly explored. Based on computational predictions, we hypothesized that the let-7 tumor suppressor miRNAs will inhibit RRM2-mediated gemcitabine chemoresistance in pancreatic cancer. Reduced expression of the majority of let-7 miRNAs with an inverse relationship to RRM2 expression was identified in innately gemcitabine-resistant pancreatic cancer cell lines. Direct binding of let-7 miRNAs to the 39 UTR of RRM2 transcripts identified post-transcriptional regulation of RRM2 influencing gemcitabine chemosensitivity. Intriguingly, overexpression of human precursor-let-7 miRNAs led to differential RRM2 expression and chemosensitivity responses in a poorly differentiated pancreatic cancer cell line, MIA PaCa-2. Defective processing of let-7a precursors to mature forms, in part, explained the discrepancies observed with let-7a expressional outcomes. Consistently, the ratios of mature to precursor let-7a were progressively reduced in gemcitabine-sensitive L3.6pl and Capan-1 cell lines induced to acquire gemcitabine resistance. Besides known regulators of let-7 biogenesis (e.g., LIN-28), short hairpin RNA library screening identified several novel RNA binding proteins, including the SET oncoprotein, to differentially impact let-7 biogenesis and chemosensitivity in gemcitabine-sensitive versus - resistant pancreatic cancer cells. Further, LIN-28 and SET knockdown in the cells led to profound reductions in cellular proliferation and colony-formation capacities. Finally, defective processing of let-7a precursors with a positive correlation to RRM2 overexpression was identified in patient-derived pancreatic ductal adenocarcinoma (PDAC) tissues. These data demonstrate an intricate post-transcriptional regulation of RRM2 and chemosensitivity by let-7a and that the manipulation of regulatory proteins involved in let-7a transcription/processing may provide a mechanism for improving chemotherapeutic and/or tumor growth control responses in pancreatic cancer.	[Bhutia, Yangzom Doma; Hung, Sau Wai; Krentz, Madeline; Patel, Dimal; Lovin, Dylan; Manoharan, Radhika; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Thomson, J. Michael] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	University System of Georgia; University of Georgia; Vanderbilt University	Govindarajan, R (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	rgovinda@rx.uga.edu			Georgia Cancer Coalition-Georgia Research Alliance; Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA;  [NCI-5-P50-CA128613-SPORE];  [NCI-1R03CA161832-01]; NATIONAL CANCER INSTITUTE [P50CA128613, R03CA161832] Funding Source: NIH RePORTER	Georgia Cancer Coalition-Georgia Research Alliance; Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI-5-P50-CA128613-SPORE (RG), NCI-1R03CA161832-01 (RG), Georgia Cancer Coalition-Georgia Research Alliance (RG), and by the Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barh D, 2010, CURR ONCOL, V17, P70; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Duxbury MS, 2005, CLIN CANCER RES, V11, P3433, DOI 10.1158/1078-0432.CCR-04-1510; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Giovannetti E, 2011, CRIT REV ONCOL HEMAT, V81; Goan YG, 1999, CANCER RES, V59, P4204; Govindarajan R, 2008, AM J PHYSIOL-GASTR L, V295, pG570, DOI 10.1152/ajpgi.00542.2007; Hung SW, 2012, CANCER LETT, V320, P138, DOI 10.1016/j.canlet.2012.03.007; Itoi T, 2007, J GASTROENTEROL, V42, P389, DOI 10.1007/s00535-007-2017-0; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Juhasz A, 2006, ONCOL REP, V15, P1299; Kuo ML, 2003, CANCER J, V9, P277, DOI 10.1097/00130404-200307000-00010; Kuschak TI, 2002, ONCOGENE, V21, P909, DOI 10.1038/sj.onc.1205145; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu XY, 2004, BIOCHEM PHARMACOL, V67, P1499, DOI 10.1016/j.bcp.2003.12.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Noma B, 2008, INT J ONCOL, V33, P1187, DOI 10.3892/ijo_00000108; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhou B, 2001, CYTOGENET CELL GENET, V95, P34, DOI 10.1159/000057014; Zhou BS, 2003, CANCER RES, V63, P6583	50	62	66	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53436	10.1371/journal.pone.0053436	http://dx.doi.org/10.1371/journal.pone.0053436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335963	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700017
J	Penton, CM; Thomas-Ahner, JM; Johnson, EK; McAllister, C; Montanaro, F				Penton, Christopher M.; Thomas-Ahner, Jennifer M.; Johnson, Eric K.; McAllister, Cynthia; Montanaro, Federica			Muscle Side Population Cells from Dystrophic or Injured Muscle Adopt a Fibro-Adipogenic Fate	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; PROGENITOR CELLS; STEM-CELLS; MDX MICE; DIFFERENTIATION; EXPRESSION; PROLIFERATION; REGENERATION; PURIFICATION	Muscle side population (SP) cells are rare multipotent stem cells that can participate in myogenesis and muscle regeneration upon transplantation. While they have been primarily studied for the development of cell-based therapies for Duchenne muscular dystrophy, little is known regarding their non-muscle lineage choices or whether the dystrophic muscle environment affects their ability to repair muscle. Unfortunately, the study of muscle SP cells has been challenged by their low abundance and the absence of specific SP cell markers. To address these issues, we developed culture conditions for the propagation and spontaneous multi-lineage differentiation of muscle SP cells. Using this approach, we show that SP cells from wild type muscle robustly differentiate into satellite cells and form myotubes without requiring co-culture with myogenic cells. Furthermore, this myogenic activity is associated with SP cells negative for immune (CD45) and vascular (CD31) markers but positive for Pax7, Sca1, and the mesenchymal progenitor marker PDGFR alpha. Additionally, our studies revealed that SP cells isolated from dystrophic or cardiotoxin-injured muscle fail to undergo myogenesis. Instead, these SP cells rapidly expand giving rise to fibroblast and adipocyte progenitors (FAPs) and to their differentiated progeny, fibroblasts and adipocytes. Our findings indicate that muscle damage affects the lineage choices of muscle SP cells, promoting their differentiation along fibro-adipogenic lineages while inhibiting myogenesis. These results have implications for a possible role of muscle SP cells in fibrosis and fat deposition in muscular dystrophy. In addition, our studies provide a useful in vitro system to analyze SP cell biology in both normal and pathological conditions.	[Penton, Christopher M.; Thomas-Ahner, Jennifer M.; Johnson, Eric K.; Montanaro, Federica] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Penton, Christopher M.; Montanaro, Federica] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Thomas-Ahner, Jennifer M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Johnson, Eric K.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [McAllister, Cynthia] Nationwide Childrens Hosp, Res Inst, Morphol Core, Columbus, OH USA; [Montanaro, Federica] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Montanaro, F (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.	montanaf@pediatrics.ohio-state.edu	Montanaro, Federica/GRJ-5139-2022; Thomas-Ahner, Jennifer/I-7598-2013; Thomas-Ahner, Jennifer/M-3955-2015	Montanaro, Federica/0000-0002-3338-0498; Thomas-Ahner, Jennifer/0000-0001-5264-7592	Muscle Group; American Heart Association; Nationwide Children's Hospital; Parent Project Muscular Dystrophy	Muscle Group; American Heart Association(American Heart Association); Nationwide Children's Hospital(Ohio State University); Parent Project Muscular Dystrophy	This work was supported by funds from Nationwide Children's Hospital and Parent Project Muscular Dystrophy to FM, an award from the Muscle Group to CMP, and a fellowship from the American Heart Association and from Nationwide Children's Hospital to EKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2011, CYTOMETRY A; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Bachrach E, 2006, MUSCLE NERVE, V34, P44, DOI 10.1002/mus.20560; Beastrom N, 2011, AM J PATHOL; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Doyle MJ, 2011, J CELL BIOL; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; GUNNING P, 1987, MOL CELL BIOL, V7, P4100, DOI 10.1128/MCB.7.11.4100; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Lapan AD, 2012, HUM MOL GENET; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McKinney-Freeman SL, 2003, EXP HEMATOL, V31, P806, DOI 10.1016/S0301-472X(03)00186-3; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Montanaro F, 1998, J NEUROSCI, V18, P1250; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Rivier F, 2004, J CELL SCI, V117, P1979, DOI 10.1242/jcs.01051; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wang YX, 2011, NAT REV MOL CELL BIO; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	46	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54553	10.1371/journal.pone.0054553	http://dx.doi.org/10.1371/journal.pone.0054553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336007	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700065
J	Weitensteiner, SB; Liebl, J; Krystof, V; Havlicek, L; Gucky, T; Strnad, M; Furst, R; Vollmar, AM; Zahler, S				Weitensteiner, Sabine B.; Liebl, Johanna; Krystof, Vladimir; Havlicek, Libor; Gucky, Tomas; Strnad, Miroslav; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan			Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ENDOTHELIAL-CELL MIGRATION; IN-VITRO; ROSCOVITINE; CANCER; CDK5	Current inhibitors of angiogenesis comprise either therapeutic antibodies (e.g. bevacicumab binding to VEGF-A) or small molecular inhibitors of receptor tyrosin kinases like e.g. sunitinib, which inhibits PDGFR and VEGFR. We have recently identified cyclin-dependent kinase 5 (Cdk5) as novel alternative and pharmacologically accessible target in the context of angiogenesis. In the present work we demonstrate that trisubstituted pyrazolo[4,3-d]pyrimidines constitute a novel class of compounds which potently inhibit angiogenesis. All seven tested compounds inhibited endothelial cell proliferation with IC50 values between 1 and 18 mu M. Interestingly, this seems not to be due to cytotoxicity, since none of them showed acute cytotoxic effects on endothelial cells at a concentration of 10 mu M,. The three most potent compounds (LGR1404, LGR1406 and LGR1407) also inhibited cell migration (by 27, 51 and 31%, resp.), chemotaxis (by 50, 70 and 60% in accumulative distance, resp.), and tube formation (by 25, 60 and 30% of total tube length, resp.) at the non-toxic concentration of 10 mu M. Furthermore, angiogenesis was reduced in vivo in the CAM assay by these three compounds. A kinase selectivity profiling revealed that the compounds prevalently inhibit Cdk2, Cdk5 and Cdk9. The phenotype of the migrating cells (reduced formation of lamellipodia, loss of Rac-1 translocation to the membrane) resembles the previously described effects of silencing of Cdk5 in endothelial cells. We conclude that especially LGR1406 and LGR1407 are highly attractive anti-angiogenic compounds, whose effects seem to largely depend on their Cdk5 inhibiting properties.	[Weitensteiner, Sabine B.; Liebl, Johanna; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Krystof, Vladimir; Gucky, Tomas; Strnad, Miroslav] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Krystof, Vladimir; Gucky, Tomas; Strnad, Miroslav] Inst Expt Bot AS CR, Olomouc, Czech Republic; [Havlicek, Libor] Inst Expt Bot AS CR, Isotope Lab, Prague, Czech Republic; [Gucky, Tomas; Strnad, Miroslav] Palacky Univ, Fac Sci, Dept Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	University of Munich; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc	Zahler, S (corresponding author), Univ Munich, Dept Pharm, Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Havlicek, Libor/H-2171-2014; Krystof, Vladimir/B-9499-2009; Strnad, Miroslav/H-1858-2014	Krystof, Vladimir/0000-0001-5838-2118; Strnad, Miroslav/0000-0002-2806-794X; Zahler, Stefan/0000-0002-5140-7287; Furst, Robert/0000-0002-9926-7578	Czech Science Foundation [P305/12/0783]; Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic) [ED0007/01/01]; German Research Foundation (DFG); German Federal Ministry of Education and Research;  [ZA 186/4-1]	Czech Science Foundation(Grant Agency of the Czech Republic); Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic); German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); 	This work was supported by grants P305/12/0783 (Czech Science Foundation), ED0007/01/01 of Centre of the Region Hana for Biotechnological and Agricultural Research (Ministry of Education, Youth and Sports, Czech Republic), by the German Research Foundation (DFG), grant ZA 186/4-1, and the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Berberich N, 2011, BRIT J PHARMACOL, V163, P1086, DOI 10.1111/j.1476-5381.2011.01309.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Jorda R, 2011, J MED CHEM, V54, P2980, DOI 10.1021/jm200064p; Kerr JS, 1999, ANTICANCER RES, V19, P959; Krystof V, 2011, EUR J MED CHEM, V46, P4289, DOI 10.1016/j.ejmech.2011.06.035; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liebl J, 2011, ANGIOGENESIS, V14, P281, DOI 10.1007/s10456-011-9212-6; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; MEIJER L, 2006, INHIBITORS CYCLIN DE; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rothmeier AS, 2008, FASEB J; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Su SC, 2010, ANN REV CELL DEV BIO; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Zahler S, 2010, ANGIOGENESIS, V13, P239, DOI 10.1007/s10456-010-9181-1	28	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54607	10.1371/journal.pone.0054607	http://dx.doi.org/10.1371/journal.pone.0054607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336010	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700068
J	Blanco-Rivero, J; Sastre, E; Caracuel, L; Granado, M; Balfagon, G				Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Granado, Miriam; Balfagon, Gloria			Breast Feeding Increases Vasoconstriction Induced by Electrical Field Stimulation in Rat Mesenteric Artery. Role of Neuronal Nitric Oxide and ATP	PLOS ONE			English	Article							SENSORY NERVES; RELEASE; GENDER; HYPERTENSION; ENDOTHELIUM; INNERVATION; LACTATION; RESPONSES; VESSELS; ALTERS	Objectives: The aim of this study was to investigate in rat mesenteric artery whether breast feeding (BF) affects the vasomotor response induced by electrical field stimulation (EFS), participation by different innervations in the EFS-induced response and the mechanism/s underlying these possible modifications. Methods: Experiments were performed in female Sprague-Dawley rats (3 months old), divided into three groups: Control (in oestrous phase), mothers after 21 days of BF, and mothers that had recovered their oestral cycle (After BF, in oestrous phase). Vasomotor response to EFS, noradrenaline (NA) and nitric oxide (NO) donor DEA-NO were studied. Neuronal NO synthase (nNOS) and phosphorylated nNOS (P-nNOS) protein expression were analysed and NO, superoxide anion (O-2(center dot-)), NA and ATP releases were also determined. Results: EFS-induced contraction was higher in the BF group, and was recovered after BF. 1 mu mol/L phentolamine decreased the response to EFS similarly in control and BF rats. NA vasoconstriction and release were similar in both experimental groups. ATP release was higher in segments from BF rats. 0.1 mmol/L L-NAME increased the response to EFS in both control and BF rats, but more so in control animals. BF decreased NO release and did not modify O-2(center dot-) production. Vasodilator response to DEA-NO was similar in both groups, while nNOS and P-nNOS expressions were decreased in segments from BF animals. Conclusion: Breast feeding increases EFS-induced contraction in mesenteric arteries, mainly through the decrease of neuronal NO release mediated by decreased nNOS and P-nNOS expression. Sympathetic function is increased through the increased ATP release in BF rats.	[Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Granado, Miriam; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Blanco-Rivero, Javier; Balfagon, Gloria] Inst Invest Sanitaria IdIPaz, Madrid, Spain	Autonomous University of Madrid	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	gloria.balfagon@uam.es	Blanco-Rivero, Javier/J-6118-2014; Granado, Miriam/B-8978-2017; Rivero, Javier Blanco/ABE-8749-2020	Blanco-Rivero, Javier/0000-0001-7232-2314; Granado, Miriam/0000-0001-9178-8822; Rivero, Javier Blanco/0000-0001-7232-2314; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Ciencia e Innovacion [SAF 2009-10374]; Red Cardiovascular del Fondo de Investigaciones Sanitarias [RD06/0014/0011]; FPI-UAM fellowship; Alianza 4 Universidades Program	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Cardiovascular del Fondo de Investigaciones Sanitarias; FPI-UAM fellowship; Alianza 4 Universidades Program	This study was supported by Ministerio de Ciencia e Innovacion (SAF 2009-10374) and Red Cardiovascular del Fondo de Investigaciones Sanitarias (RD06/0014/0011). E. Sastre received a FPI-UAM fellowship. L. Caracuel received a fellowship from Alianza 4 Universidades Program.	Altemus M, 2001, PSYCHOSOM MED, V63, P814, DOI 10.1097/00006842-200109000-00015; ALTURA BM, 1984, FED PROC, V43, P80; Balfagon G, 2004, REGUL PEPTIDES, V120, P253, DOI 10.1016/j.regpep.2004.03.016; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, EXP PHYSIOL, V96, P275, DOI 10.1113/expphysiol.2010.055822; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Calderone V, 2002, J PHARM PHARMACOL, V54, P523, DOI 10.1211/0022357021778808; del Campo L, 2011, EUR J PHARMACOL, V666, P142, DOI 10.1016/j.ejphar.2011.03.056; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; Donald JA, 2005, COMP BIOCHEM PHYS A, V142, P188, DOI 10.1016/j.cbpa.2005.07.015; Ferrer M, 1999, LIFE SCI, V66, P337; Flinsenberg TWH, 2010, AM J PHYSIOL-REG I, V298, pR1217, DOI 10.1152/ajpregu.00839.2009; GREENBERG S, 1974, CAN J PHYSIOL PHARM, V52, P14, DOI 10.1139/y74-003; Hogarth AJ, 2007, J HUM HYPERTENS, V21, P239, DOI 10.1038/sj.jhh.1002132; Hogarth AJ, 2007, CLIN SCI, V112, P353, DOI 10.1042/CS20060288; Iizuka T, 1997, J PEDIATR-US, V131, P839, DOI 10.1016/S0022-3476(97)70030-1; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kowalska Joanna, 2009, Postepy Biochem, V55, P323; Lambert E, 2007, J HYPERTENS, V25, P1411, DOI 10.1097/HJH.0b013e3281053af4; LI YJ, 1992, EUR J PHARMACOL, V210, P23, DOI 10.1016/0014-2999(92)90647-M; Loesch A, 2002, HISTOL HISTOPATHOL, V17, P591, DOI 10.14670/HH-17.591; Marin J, 2000, CLIN SCI, V99, P277, DOI 10.1042/CS20000009; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; McNamara JP, 2001, J DAIRY SCI, V84, P1382, DOI 10.3168/jds.S0022-0302(01)70169-5; Mezzacappa ES, 2005, J PSYCHOSOM RES, V58, P351, DOI 10.1016/j.jpsychores.2004.11.004; Molinari C, 2007, ENDOCRINOLOGY, V148, P4080, DOI 10.1210/en.2006-1577; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Peaker M, 1976, Ciba Found Symp, P87; Sastre E, 2010, REV NEUROLOGIA, V50, P727, DOI 10.33588/rn.5012.2010334; Sun C, 2001, NEUROREPORT, V12, P3497, DOI 10.1097/00001756-200111160-00025; Svennersten-Sjaunja K, 2005, DOMEST ANIM ENDOCRIN, V29, P241, DOI 10.1016/j.domaniend.2005.03.006; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; YU XJ, 1993, EUR J PHARMACOL, V241, P35	34	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53802	10.1371/journal.pone.0053802	http://dx.doi.org/10.1371/journal.pone.0053802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342008	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400086
J	Breitfeld, J; Tonjes, A; Gast, MT; Schleinitz, D; Bluher, M; Stumvoll, M; Kovacs, P; Bottcher, Y				Breitfeld, Jana; Toenjes, Anke; Gast, Marie-Therese; Schleinitz, Dorit; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter; Boettcher, Yvonne			Role of Vaspin in Human Eating Behaviour	PLOS ONE			English	Article							SELF-CONTAINED POPULATION; GENETIC-VARIATION; ASSOCIATION; SORBS	Objective: The adipokine vaspin (visceral adipose tissue derived serine protease inhibitor, serpinA12) follows a meal-related diurnal variation in humans and intracerebroventricular vaspin administration leads to acutely reduced food intake in db/db mice. We therefore hypothesized that vaspin may play a role in human eating behaviour. Materials and Methods: We measured serum vaspin concentrations in 548 subjects from a self-contained population of Sorbs (Germany) who underwent detailed metabolic testing including eating behaviour assessments using the three-factor eating questionnaire. In addition, genetic variation within vaspin was assessed by genotyping 28 single nucleotide polymorphisms (SNPs) in all study subjects. Results: Serum vaspin concentrations correlated positively with restraint, disinhibition and hunger (all P<0.05), although the correlations did not withstand further adjustments for age, gender and BMI (all P>0.05). Independent of observed correlations, genetic variants in vaspin were associated with serum vaspin levels but showed no significant association with any of the eating behaviour phenotypes after accounting for multiple testing (P >= 0.05 after adjusting for age, gender and BMI). Conclusion: Our data suggest that serum vaspin concentrations might modulate human eating behaviour, which does not seem to be affected by common genetic variation in vaspin.	[Breitfeld, Jana; Toenjes, Anke; Gast, Marie-Therese; Schleinitz, Dorit; Blueher, Matthias; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Toenjes, Anke; Boettcher, Yvonne] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Kovacs, P (corresponding author), Univ Leipzig, Dept Med, D-04109 Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Federal Ministry of Education and Research (BMBF); Boehringer Ingelheim Foundation; Integrated Research and Treatment Center IFB Adiposity Diseases [K7-38, K7-39, K7-37, K403]; Deutsche Forschungsgemeinschaft (DFG); Clinical Research Group "Atherobesity" [KFO 152, BL 833/1-1, Stu192/6-1, KO 3512/1-1, KO 3880/1-2]; German Diabetes Association; DDS Foundation; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Integrated Research and Treatment Center IFB Adiposity Diseases; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Clinical Research Group "Atherobesity"(German Research Foundation (DFG)); German Diabetes Association; DDS Foundation; DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (BMBF), Boehringer Ingelheim Foundation (to P. K. and D. S.), Integrated Research and Treatment Center IFB Adiposity Diseases, K7-38, K7-39 (to Y.B.) and K7-37 and K403 (to A. T.), Deutsche Forschungsgemeinschaft (DFG), the Clinical Research Group "Atherobesity" KFO 152 (projects BL 833/1-1 to M. B., and Stu192/6-1 (MS), KO 3512/1-1 to A. K., KO 3880/1-2 to P. K., M. B. and J.B.), from the German Diabetes Association (to D. S. and P. K.), from the DDS Foundation to Y.B., DHFD (Diabetes Hilfs- und Forschungsfonds Deutschland; to M. S., P. K., M. B., A. T.), and LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. IFB Adiposity Diseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Breitfeld J, 2013, INT J OBESITY, V37, P861, DOI 10.1038/ijo.2012.133; Brunetti L, 2011, PEPTIDES, V32, P1866, DOI 10.1016/j.peptides.2011.08.003; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Jeong E, 2010, J CLIN ENDOCR METAB, V95, P1869, DOI 10.1210/jc.2009-1088; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kempf K, 2010, EXP CLIN ENDOCR DIAB, V118, P184, DOI 10.1055/s-2008-1081499; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Pudel V, 1989, FRAGEBOGEN ZUM ESSVE; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045	16	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54140	10.1371/journal.pone.0054140	http://dx.doi.org/10.1371/journal.pone.0054140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342091	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400125
J	Soares, SC; Silva, A; Trost, E; Blom, J; Ramos, R; Carneiro, A; Ali, A; Santos, AR; Pinto, AC; Diniz, C; Barbosa, EGV; Dorella, FA; Aburjaile, F; Rocha, FS; Nascimento, KKF; Guimaraes, LC; Almeida, S; Hassan, SS; Bakhtiar, SM; Pereira, UP; Abreu, VAC; Schneider, MPC; Miyoshi, A; Tauch, A; Azevedo, V				Soares, Siomar C.; Silva, Artur; Trost, Eva; Blom, Jochen; Ramos, Rommel; Carneiro, Adriana; Ali, Amjad; Santos, Anderson R.; Pinto, Anne C.; Diniz, Carlos; Barbosa, Eudes G. V.; Dorella, Fernanda A.; Aburjaile, Flavia; Rocha, Flavia S.; Nascimento, Karina K. F.; Guimaraes, Luis C.; Almeida, Sintia; Hassan, Syed S.; Bakhtiar, Syeda M.; Pereira, Ulisses P.; Abreu, Vinicius A. C.; Schneider, Maria P. C.; Miyoshi, Anderson; Tauch, Andreas; Azevedo, Vasco			The Pan-Genome of the Animal Pathogen Corynebacterium pseudotuberculosis Reveals Differences in Genome Plasticity between the Biovar ovis and equi Strains	PLOS ONE			English	Article							DIPHTHERIA-TOXIN; CASEOUS-LYMPHADENITIS; LIFE-STYLE; PHYLOGENETIC NETWORKS; CLASSICAL DIPHTHERIA; MUSCA-DOMESTICA; PHOSPHOLIPASE-D; UNITED-KINGDOM; C-DIPHTHERIAE; SEQUENCE	Corynebacterium pseudotuberculosis is a facultative intracellular pathogen and the causative agent of several infectious and contagious chronic diseases, including caseous lymphadenitis, ulcerative lymphangitis, mastitis, and edematous skin disease, in a broad spectrum of hosts. In addition, Corynebacterium pseudotuberculosis infections pose a rising worldwide economic problem in ruminants. The complete genome sequences of 15 C. pseudotuberculosis strains isolated from different hosts and countries were comparatively analyzed using a pan-genomic strategy. Phylogenomic, pan-genomic, core genomic, and singleton analyses revealed close relationships among pathogenic corynebacteria, the clonal-like behavior of C. pseudotuberculosis and slow increases in the sizes of pan-genomes. According to extrapolations based on the pan-genomes, core genomes and singletons, the C. pseudotuberculosis biovar ovis shows a more clonal-like behavior than the C. pseudotuberculosis biovar equi. Most of the variable genes of the biovar ovis strains were acquired in a block through horizontal gene transfer and are highly conserved, whereas the biovar equi strains contain great variability, both intra- and inter-biovar, in the 16 detected pathogenicity islands (PAIs). With respect to the gene content of the PAIs, the most interesting finding is the high similarity of the pilus genes in the biovar ovis strains compared with the great variability of these genes in the biovar equi strains. Concluding, the polymerization of complete pilus structures in biovar ovis could be responsible for a remarkable ability of these strains to spread throughout host tissues and penetrate cells to live intracellularly, in contrast with the biovar equi, which rarely attacks visceral organs. Intracellularly, the biovar ovis strains are expected to have less contact with other organisms than the biovar equi strains, thereby explaining the significant clonal-like behavior of the biovar ovis strains.	[Soares, Siomar C.; Ali, Amjad; Santos, Anderson R.; Pinto, Anne C.; Diniz, Carlos; Barbosa, Eudes G. V.; Dorella, Fernanda A.; Aburjaile, Flavia; Rocha, Flavia S.; Nascimento, Karina K. F.; Guimaraes, Luis C.; Almeida, Sintia; Hassan, Syed S.; Bakhtiar, Syeda M.; Abreu, Vinicius A. C.; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Soares, Siomar C.; Trost, Eva; Blom, Jochen; Guimaraes, Luis C.; Tauch, Andreas] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Nordrhein Westf, Germany; [Soares, Siomar C.; Trost, Eva; Guimaraes, Luis C.] Univ Bielefeld, CLIB Grad Cluster Ind Biotechnol, Ctr Biotechnol, D-33615 Bielefeld, Nordrhein Westf, Germany; [Silva, Artur; Ramos, Rommel; Carneiro, Adriana; Schneider, Maria P. C.] Fed Univ Para, Dept Genet, BR-66059 Belem, Para, Brazil; [Pereira, Ulisses P.] Univ Fed Lavras, Dept Vet Med, Lavras, Brazil	Universidade Federal de Minas Gerais; University of Bielefeld; University of Bielefeld; Universidade Federal do Para; Universidade Federal de Lavras	Azevedo, V (corresponding author), Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Abreu, Vinicius AC/G-3694-2014; Pereira, Ulisses/AAM-2055-2020; Ali, Amjad/AAG-4441-2021; Aburjaile, Flavia Figueira/U-3782-2019; Guimarães, Luis/T-7186-2019; de Castro Soares, Siomar/I-2705-2012; Almeida, Sintia/K-1217-2012; Azevedo, Vasco/B-1556-2019; Silva, Artur/E-1474-2014; gomide, anne/H-1997-2019; Pereira, Ulisses/F-5618-2013; Azevedo, Vasco A.C/F-4315-2011; Hassan, Syed Shah/AAQ-5460-2021; Luiz Silva, Artur da Costa da/AAI-3516-2021; Aburjaile, Flavia FFA Figueira/E-4042-2013; Guimarães, Luis/J-5689-2015; de Rocha, Flávia/A-2565-2019; Ramos, Rommel Thiago Juca/L-9329-2013; Folador, Adriana Ribeiro Carneiro/R-2658-2019; Folador, Adriana R.C./H-6410-2016; dos Santos, Anderson Rodrigues/G-3020-2011	Pereira, Ulisses/0000-0003-4868-4459; Ali, Amjad/0000-0002-0486-4661; Aburjaile, Flavia Figueira/0000-0002-1067-1882; de Castro Soares, Siomar/0000-0001-7299-3724; Almeida, Sintia/0000-0003-0270-9059; Azevedo, Vasco/0000-0002-4775-2280; Silva, Artur/0000-0002-4082-1132; gomide, anne/0000-0003-3948-5335; Pereira, Ulisses/0000-0001-7680-1259; Azevedo, Vasco A.C/0000-0002-4775-2280; Hassan, Syed Shah/0000-0003-1251-5215; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Guimarães, Luis/0000-0002-7147-9448; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Folador, Adriana R.C./0000-0003-1522-9871; dos Santos, Anderson Rodrigues/0000-0003-3418-0823; Rocha, Flavia/0000-0002-4520-1389; Trost, Eva/0000-0002-1924-1416	CAPES/DAAD international cooperation [5117119]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [578219/2008-5]; Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG) [APQ-01004-08]; Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA); Rede Paraense de Genomica e Proteomica (RPGP)	CAPES/DAAD international cooperation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Rede Paraense de Genomica e Proteomica (RPGP)	The authors thank the CAPES/DAAD international cooperation for financing an exchange scholarship (http://www.capes.gov.br/cooperacao-internacional) (grant number 5117119) and CLIB - Graduate Cluster Industrial Biotechnology (http://www.graduatecluster.net/), where SCS and LCG are currently participating as guest students.; This work was supported by grants from the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/) (grant number 578219/2008-5), Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG; http://www.fapemig.br/) (grant number APQ-01004-08), Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA; http://www.fapespa.pa.gov.br/), and Rede Paraense de Genomica e Proteomica (RPGP; http://www.genoma.ufpa.br/). The funding agencies had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	ADDO PB, 1983, VET REC, V113, P496, DOI 10.1136/vr.113.21.496; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Aleman M, 1996, J AM VET MED ASSOC, V209, P804; Alves FSF, 1999, VET NOUCIAS UBERLAND, P69; Arsenault J, 2003, PREV VET MED, V59, P67, DOI 10.1016/S0167-5877(03)00060-6; AUGUSTINE JL, 1986, AM J VET RES, V47, P713; AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251; Barakat A A, 1984, Rev Sci Tech, V3, P151, DOI 10.20506/rst.3.1.147; Ben Said M S, 2002, Arch Inst Pasteur Tunis, V79, P51; BIBERSTEIN EL, 1971, VET REC, V89, P691, DOI 10.1136/vr.89.26.691; Billington SJ, 1998, J BACTERIOL, V180, P3233, DOI 10.1128/JB.180.12.3233-3236.1998; Binns SH, 2002, VET REC, V150, P263, DOI 10.1136/vr.150.9.263; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bolt F, 2009, THESIS U WARWICK; Braverman Y, 1999, REV SCI TECH OIE, V18, P681, DOI 10.20506/rst.18.3.1187; BUCK GA, 1985, INFECT IMMUN, V49, P679, DOI 10.1128/IAI.49.3.679-684.1985; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cerdeira LT, 2011, J BACTERIOL, V193, P7025, DOI 10.1128/JB.06293-11; Cerdeira LT, 2011, J BACTERIOL, V193, P6420, DOI 10.1128/JB.06044-11; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Collett MG, 1994, INFECT DIS LIVESTOCK, P1387; Collins MD, 1998, INT J SYST BACTERIOL, V48, P1449, DOI 10.1099/00207713-48-4-1449; Connor KM, 2000, J CLIN MICROBIOL, V38, P2633, DOI 10.1128/JCM.38.7.2633-2637.2000; Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056; Dorella FA, 2009, EXPERT REV VACCINES, V8, P205, DOI 10.1586/14760584.8.2.205; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; GROMAN N, 1984, INFECT IMMUN, V45, P511, DOI 10.1128/IAI.45.2.511-517.1984; Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551; Halachev MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028388; Hall K, 2001, J EQUINE VET SCI, V21, P284, DOI 10.1016/S0737-0806(01)70058-5; Hassan SS, 2012, J BACTERIOL, V194, P5718, DOI 10.1128/JB.01373-12; Hirata R, 2008, BRAZ J MED BIOL RES, V41, P986, DOI 10.1590/S0100-879X2008001100007; Hirata R, 2004, MICROB PATHOGENESIS, V36, P125, DOI 10.1016/j.micpath.2003.10.002; Hodgson ALM, 1999, VACCINE, V17, P802, DOI 10.1016/S0264-410X(98)00264-3; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES D, 1986, BERGEYS MANUAL SYSTE, V2, P1261; Ramos RTJ, 2012, J BACTERIOL, V194, P6620, DOI 10.1128/JB.01616-12; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Kloepper TH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-22; Lehman KB, 1896, ATLAS GRUNDRISS BAKE; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Liu DTL, 2005, BRIT J OPHTHALMOL, V89, P245, DOI 10.1136/bjo.2004.051698; Lopes T, 2012, J BACTERIOL, V194, P3567, DOI 10.1128/JB.00461-12; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; MAXIMESCU P, 1974, J GEN MICROBIOL, V82, P49, DOI 10.1099/00221287-82-1-49; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; McKean SC, 2007, MICROBIOL-SGM, V153, P2203, DOI 10.1099/mic.0.2007/005926-0; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mills AE, 1997, PATHOLOGY, V29, P231, DOI 10.1080/00313029700169944; MUCKLE CA, 1982, CAN J COMP MED, V46, P206; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; Nakao H, 1996, J CLIN MICROBIOL, V34, P1711, DOI 10.1128/JCM.34.7.1711-1716.1996; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Oram DM, 2002, J BACTERIOL, V184, P5723, DOI 10.1128/JB.184.20.5723-5732.2002; PASCUAL C, 1995, INT J SYST BACTERIOL, V45, P724, DOI 10.1099/00207713-45-4-724; Paton MW, 2003, AUST VET J, V81, P91, DOI 10.1111/j.1751-0813.2003.tb11443.x; Paviour S, 2002, CLIN INFECT DIS, V35, P1434, DOI 10.1086/344463; Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185; Pethick FE, 2012, J BACTERIOL, V194, P4736, DOI 10.1128/JB.00918-12; Pethick FE, 2012, J BACTERIOL, V194, P4476, DOI 10.1128/JB.00922-12; Pratt SM, 2005, JAVMA-J AM VET MED A, V227, P441, DOI 10.2460/javma.2005.227.441; Pugh DG, 2002, SHEEP GOAT MED, P207; Radostits OM, 2002, CLIN VET TRATADO DOE; Ramos RTJ, 2013, MICROBIAL B IN PRESS; Ruiz JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018551; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Schroder J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-545; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Sekizuka T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-72; Selim SA, 2001, J VET MED B, V48, P241, DOI 10.1046/j.1439-0450.2001.00451.x; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Sing A, 2005, CLIN INFECT DIS, V40, P325, DOI 10.1086/426687; Soares SC, 2013, J BIOTECHNOL, V167, P135, DOI 10.1016/j.jbiotec.2012.11.003; Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848; SONGER JG, 1988, AM J VET RES, V49, P223; SONGER JG, 1990, INFECT IMMUN, V58, P131, DOI 10.1128/IAI.58.1.131-136.1990; Spier SJ, 2008, EQUINE VET EDUC, V20, P37, DOI 10.2746/095777307X260106; SUTHERLAND SS, 1993, AUST VET J, V70, P454, DOI 10.1111/j.1751-0813.1993.tb00851.x; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009; Tauch A, 2008, J BIOTECHNOL, V136, P22, DOI 10.1016/j.jbiotec.2008.03.004; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Trost E, 2012, J BACTERIOL, V194, P3199, DOI 10.1128/JB.00183-12; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-91; Williamson LH, 2001, VET CLIN N AM-FOOD A, V17, P359, DOI 10.1016/S0749-0720(15)30033-5; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; WONG TP, 1984, INFECT IMMUN, V43, P1114, DOI 10.1128/IAI.43.3.1114-1116.1984; YANAGAWA R, 1976, INFECT IMMUN, V13, P1293, DOI 10.1128/IAI.13.4.1293-1295.1976; Yeruham I, 2004, VET DERMATOL, V15, P315, DOI 10.1111/j.1365-3164.2004.00388.x; Yeruham I, 2003, EPIDEMIOL INFECT, V131, P947, DOI 10.1017/S095026880300894X; Yeruham I, 1996, VET QUART, V18, P87, DOI 10.1080/01652176.1996.9694623; Zasada Aleksandra Anna, 2012, Medycyna Doswiadczalna i Mikrobiologia, V64, P19	108	70	72	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53818	10.1371/journal.pone.0053818	http://dx.doi.org/10.1371/journal.pone.0053818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342011	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400089
J	Yamada, Y; Kawabe, T				Yamada, Yuki; Kawabe, Takahiro			Localizing Non-Retinotopically Moving Objects	PLOS ONE			English	Article							DISTORTS VISUAL SPACE; REPRESENTATIONAL MOMENTUM; PERCEIVED POSITION; MENTAL EXTRAPOLATION; TARGET POSITION; HUMAN-VISION; MOTION; ATTENTION; DISPLAY; MEMORY	How does the brain determine the position of moving objects? It turns out to be rather complex to answer this question when we realize that the brain has to solve the motion correspondence problem in two kinds of reference frames: Retinotopic and non-retinotopic ones. We show that visual objects are mislocalized along a non-retinotopic motion direction. Observers viewed two successive movie frames each consisting of an outlined square and two target elements inside the square. In the non-retinotopic condition the elements as well as the square moved vertically while two bars also centripetally or centrifugally moved. In the retinotopic condition the vertical movement of them was removed from the stimuli. The task of the observers was to judge a relative position of the elements. Consequently, the elements were mislocalized in the direction of both retinotopic and non-retinotopic motion, although the mislocalization was significantly larger in the retinotopic than in the non-retinotopic conditions. The results suggest that non-retinotopic as well as retinotopic motion processing contributes to the determination of perceived positions of moving objects.	[Yamada, Yuki] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan; [Yamada, Yuki] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Kawabe, Takahiro] NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan	Yamaguchi University; Kyushu University; Nippon Telegraph & Telephone Corporation	Yamada, Y (corresponding author), Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan.	yamadayuk@gmail.com	Yamada, Yuki/B-2671-2008	Yamada, Yuki/0000-0003-1431-568X	JSPS KAKENHI [24830054]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 24830054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin M, 2011, VISION RES, V51, P435, DOI 10.1016/j.visres.2010.12.013; Boi M, 2011, CURR BIOL, V21, P1732, DOI 10.1016/j.cub.2011.08.059; Boi M, 2011, J VISION, V11, DOI 10.1167/11.3.7; Boi M, 2009, J VISION, V9, DOI 10.1167/9.13.5; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Grossberg S, 2011, ATTEN PERCEPT PSYCHO, V73, P1147, DOI 10.3758/s13414-011-0095-9; Herzog MH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00119; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johansson G., 1950, CONFIGURATIONS EVENT; Kawabe T, 2011, ATTEN PERCEPT PSYCHO, V73, P1522, DOI 10.3758/s13414-011-0128-4; Kawabe T, 2008, J VISION, V8, DOI 10.1167/8.8.7; Kerzel D, 2005, CURR DIR PSYCHOL SCI, V14, P180, DOI 10.1111/j.0963-7214.2005.00360.x; Kerzel D, 2003, VISION RES, V43, P2623, DOI 10.1016/S0042-6989(03)00466-8; Kerzel D, 2003, COGNITION, V88, P109, DOI 10.1016/S0010-0277(03)00018-0; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Ogmen H, 2006, VISION RES, V46, P3234, DOI 10.1016/j.visres.2006.04.007; Otto TU, 2008, J VISION, V8, DOI 10.1167/8.7.16; PANTLE A, 1976, SCIENCE, V193, P500, DOI 10.1126/science.941023; PETERSIK JT, 1979, VISION RES, V19, P143, DOI 10.1016/0042-6989(79)90044-0; Pratt J, 2008, ACTA PSYCHOL, V127, P137, DOI 10.1016/j.actpsy.2007.03.003; Shim WM, 2004, VISION RES, V44, P2393, DOI 10.1016/j.visres.2004.05.003; Suchow JW, 2011, CURR BIOL, V21, P140, DOI 10.1016/j.cub.2010.12.019; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Ternus J, 1926, PSYCHOL FORSCH, V7, P81, DOI 10.1007/BF02424350; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D, 2006, J EXP PSYCHOL HUMAN, V32, P1380, DOI 10.1037/0096-1523.32.6.1380; Yamada Y, 2011, J VISION, V11, DOI 10.1167/11.6.6	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53815	10.1371/journal.pone.0053815	http://dx.doi.org/10.1371/journal.pone.0053815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342009	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400087
J	Hagarman, JA; Motley, MP; Kristjansdottir, K; Soloway, PD				Hagarman, James A.; Motley, Michael P.; Kristjansdottir, Katla; Soloway, Paul D.			Coordinate Regulation of DNA Methylation and H3K27me3 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; CHROMATIN STATE; PROTEIN EED; HISTONE; GENES; PLURIPOTENT; IMMUNOPRECIPITATION; HYPERMETHYLATION; LYSINE-27; SEQUENCES	Chromatin is separated into functional domains distinguished by combinatorial patterns of post-translational histone modifications and DNA methylation. Recent studies examining multiple histone modifications have found numerous chromatin states with distinct profiles of chromatin marks and functional enrichments. There are data showing coordinate regulation between DNAme and H3K27me3, which are both involved in the establishment and maintenance of epigenetic gene silencing, but the data are conflicting. Multiple studies have presented evidence to support the theory that PRC2 and DNAme cooperate to achieve silencing, or alternatively that H3K27me3 and DNAme act antagonistically. Here we examine the effect loss of either PRC2 or DNA methyltransferase activity has on the placement of the reciprocal mark in mouse ES cells. We find that DNAme is acting globally to antagonize the placement of H3K27me3, in accordance with recently published results. At least 471,011 domains in the mouse genome acquire H3K27me3 when DNAme is diminished. Of these 466,563 have been shown to be fully methylated in wildtype ES cells, indicating the effects of DNAme on H3K27me3 are direct. In a reciprocal experiment, we examine the effect loss of PRC2 has on the placement of DNAme. In contrast to the global antagonism DNAme has on the placement of H3K27me3, loss of H3K27me3 has a modest effect on DNAme, with only 4% of genes undergoing changes in DNAme, including 861 showing increases and 552 showing losses of overall DNAme. We anticipate that integrating genomic datasets where the effect of loss of a particular epigenetic mark has on the placement of other marks will help elucidate the rules governing epigenetic regulation and what role coordinate regulation of epigenetic marks plays in development and disease.	[Hagarman, James A.; Motley, Michael P.; Kristjansdottir, Katla; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Soloway, PD (corresponding author), Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA.	soloway@cornell.edu	Soloway, Paul/T-8243-2019	Motley, Michael/0000-0002-4271-1375; Soloway, Paul/0000-0003-1967-0437	National Institutes of Health (NIH) [CA120870]; Cornell Center for Vertebrate Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120870, R01CA098597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Center for Vertebrate Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health (NIH), CA120870, and the Cornell Center for Vertebrate Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brinkman AB, 2012, GENOME RES; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minard ME, 2009, GENESIS, V47, P559, DOI 10.1002/dvg.20534; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sorensen AL, 2009, METHODS MOL BIOL, V567, P249, DOI 10.1007/978-1-60327-414-2_16; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sugimura K, 2010, EXP CELL RES, V316, P2731, DOI 10.1016/j.yexcr.2010.06.016; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	55	71	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53880	10.1371/journal.pone.0053880	http://dx.doi.org/10.1371/journal.pone.0053880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326524	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800082
J	Takiguchi, M; Dow, LE; Prier, JE; Carmichael, CL; Kile, BT; Turner, SJ; Lowe, SW; Huang, DCS; Dickins, RA				Takiguchi, Megumi; Dow, Lukas E.; Prier, Julia E.; Carmichael, Catherine L.; Kile, Benjamin T.; Turner, Stephen J.; Lowe, Scott W.; Huang, David C. S.; Dickins, Ross A.			Variability of Inducible Expression across the Hematopoietic System of Tetracycline Transactivator Transgenic Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; RNA INTERFERENCE; IN-VIVO; PROMOTER; GENOME; ENHANCER; VECTOR; TUMORIGENESIS; ELEMENT	The tetracycline (tet)-regulated expression system allows for the inducible overexpression of protein-coding genes, or inducible gene knockdown based on expression of short hairpin RNAs (shRNAs). The system is widely used in mice, however it requires robust expression of a tet transactivator protein (tTA or rtTA) in the cell type of interest. Here we used an in vivo tet-regulated fluorescent reporter approach to characterise inducible gene/shRNA expression across a range of hematopoietic cell types of several commonly used transgenic tet transactivator mouse strains. We find that even in strains where the tet transactivator is expressed from a nominally ubiquitous promoter, the efficiency of tet-regulated expression can be highly variable between hematopoietic lineages and between differentiation stages within a lineage. In some cases tet-regulated reporter expression differs markedly between cells within a discrete, immunophenotypically defined population, suggesting mosaic transactivator expression. A recently developed CAG-rtTA3 transgenic mouse displays intense and efficient reporter expression in most blood cell types, establishing this strain as a highly effective tool for probing hematopoietic development and disease. These findings have important implications for interpreting tet-regulated hematopoietic phenotypes in mice, and identify mouse strains that provide optimal tet-regulated expression in particular hematopoietic progenitor cell types and mature blood lineages.	[Takiguchi, Megumi; Dickins, Ross A.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic, Australia; [Takiguchi, Megumi; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Chem Biol Div, Parkville, Vic, Australia; [Carmichael, Catherine L.; Kile, Benjamin T.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia; [Takiguchi, Megumi; Carmichael, Catherine L.; Kile, Benjamin T.; Huang, David C. S.; Dickins, Ross A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Prier, Julia E.; Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Dow, Lukas E.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Dickins, RA (corresponding author), Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic, Australia.	rdickins@wehi.edu.au	Turner, Stephen/GXM-4654-2022; Kile, Benjamin/GNP-3246-2022; Dickins, Ross A/K-2852-2012; Huang, David C. S./C-7586-2013; Kile, Benjamin T/F-6593-2011	Kile, Benjamin/0000-0002-8836-8947; Dickins, Ross A/0000-0003-4112-5304; Huang, David C. S./0000-0002-3101-4873; Kile, Benjamin T/0000-0002-8836-8947; Turner, Stephen/0000-0002-1002-0000; Prier, Julia/0000-0002-2653-6300; Carmichael, Catherine/0000-0002-6751-153X; Dow, Lukas/0000-0001-7048-1418	National Health and Medical Research Council of Australia [575535, 1024599, 509693]; Australian Government National Health and Medical Research Council; Sylvia and Charles Viertel Charitable Foundation; Victorian State Government OIS; Australian Research Council; Victorian Endowment for Science, Knowledge and Innovation (VESKI); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; Victorian State Government OIS; Australian Research Council(Australian Research Council); Victorian Endowment for Science, Knowledge and Innovation (VESKI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (Project grants 575535 and 1024599 and Fellowship 509693 to RAD), Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme, the Sylvia and Charles Viertel Charitable Foundation (Fellowships to BTK and RAD), Victorian State Government OIS grants, Australian Research Council Future Fellowship (awarded to SJT) and the Victorian Endowment for Science, Knowledge and Innovation (VESKI Fellowship to RAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; An DS, 2000, J VIROL, V74, P1286, DOI 10.1128/JVI.74.3.1286-1295.2000; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Heaney JD, 2006, MAMM GENOME, V17, P791, DOI 10.1007/s00335-006-0023-9; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kim WI, 2007, EXP HEMATOL, V35, P1231, DOI 10.1016/j.exphem.2007.04.012; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogilvy S, 1999, BLOOD, V94, P1855; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takiguchi M, 2010, J THROMB HAEMOST, V8, P2751, DOI 10.1111/j.1538-7836.2010.04077.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54009	10.1371/journal.pone.0054009	http://dx.doi.org/10.1371/journal.pone.0054009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326559	Green Published, gold			2022-12-27	WOS:000314705800098
J	Lo Sardo, A; Altamura, S; Pegoraro, S; Maurizio, E; Sgarra, R; Manfioletti, G				Lo Sardo, Alessandra; Altamura, Sandro; Pegoraro, Silvia; Maurizio, Elisa; Sgarra, Riccardo; Manfioletti, Guidalberto			Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)	PLOS ONE			English	Article							INHIBITORY FACTOR MIF; SUBSTRATE-SPECIFICITY; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; P53 ACTIVITY; METHYLATION; BINDING; OLIGOMERIZATION	PRMT6 is a protein arginine methyltransferase that has been implicated in transcriptional regulation, DNA repair, and human immunodeficiency virus pathogenesis. Only few substrates of this enzyme are known and therefore its cellular role is not well understood. To identify in an unbiased manner substrates and potential regulators of PRMT6 we have used a yeast two-hybrid approach. We identified 36 new putative partners for PRMT6 and we validated the interaction in vivo for 7 of them. In addition, using in vitro methylation assay we identified 4 new substrates for PRMT6, extending the involvement of this enzyme to other cellular processes beyond its well-established role in gene expression regulation. Holistic approaches create molecular connections that allow to test functional hypotheses. The assembly of PRMT6 protein network allowed us to formulate functional hypotheses which led to the discovery of new molecular partners for the architectural transcription factor HMGA1a, a known substrate for PRMT6, and to provide evidences for a modulatory role of HMGA1a on the methyltransferase activity of PRMT6.	[Lo Sardo, Alessandra; Altamura, Sandro; Pegoraro, Silvia; Maurizio, Elisa; Sgarra, Riccardo; Manfioletti, Guidalberto] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Trieste	Manfioletti, G (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	manfiole@units.it	Altamura, Sandro/R-1195-2016; Pegoraro, Silvia/G-9217-2018	Pegoraro, Silvia/0000-0002-1819-7417; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601; Altamura, Sandro/0000-0002-6781-1073; Sgarra, Riccardo/0000-0002-4496-2856	AIRC (Associazione Italiana per la Ricerca sul Cancro); Universita degli Studi di Trieste; project "Rete Nazionale Proteomica'' [FIRB 2008-RBRN07BMCT]; FIRC (Fondazione Italiana per la Ricerca sul Cancro)	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Universita degli Studi di Trieste; project "Rete Nazionale Proteomica''; FIRC (Fondazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), Universita degli Studi di Trieste, and project "Rete Nazionale Proteomica'' FIRB 2008-RBRN07BMCT to G.M. E.M. is supported by a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Harrison MJ, 2010, NUCLEIC ACIDS RES, V38, P2201, DOI 10.1093/nar/gkp1203; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Iwasaki H, 2008, BIOCHEM BIOPH RES CO, V372, P314, DOI 10.1016/j.bbrc.2008.05.051; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Malini E, 2011, BIOCHEMISTRY-US, V50, P3462, DOI 10.1021/bi200101f; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Neault M, 2012, NUCL ACIDS RES; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Sgarra R, 2005, PROTEOMICS, V5, P1494, DOI 10.1002/pmic.200401028; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Vallance P, 2001, LANCET, V358, P2096, DOI 10.1016/S0140-6736(01)07229-4; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	42	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53750	10.1371/journal.pone.0053750	http://dx.doi.org/10.1371/journal.pone.0053750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326497	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400040
J	Yang, CM; Lee, H; Jove, V; Deng, JH; Zhang, W; Liu, XL; Forman, S; Dellinger, TH; Wakabayashi, M; Yu, H; Pal, S				Yang, Chunmei; Lee, Heehyoung; Jove, Veronica; Deng, Jiehui; Zhang, Wang; Liu, Xueli; Forman, Stephen; Dellinger, Thanh H.; Wakabayashi, Mark; Yu, Hua; Pal, Sumanta			Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; INTRAEPITHELIAL T-CELLS; ADOPTIVE TRANSFER; IMMUNE-RESPONSES; CARCINOMA; STAGE; EXPRESSION; CISPLATIN; MICE; CTL	Background: Several previous studies have identified a strong association between T-cell infiltration and clinical outcome in ovarian cancer. The role of B-cells remains controversial, however. Methods: Forty-nine paraffin-embedded omental specimens derived from patients with high grade epithelial ovarian cancer were assessed. Immunohistochemical analyses were performed to characterize expression of CD19+B-cells and pSTAT3 as high (>50% positively staining cells [PSCs]) or low (>50% PSCs). The Kaplan-Meier method with log-rank test was used to determine the association between clinicopathologic parameters and overall survival (OS). A multi-variate Cox proportional hazards regression analysis including nature of debulking (primary vs secondary), histology, tumor grade, receipt of prior chemotherapy, B-cell infiltration and pSTAT3 expression was performed. Results: Median OS was 160.6 months in those patients with low B-cell expression vs 47.3 months in those with high B-cell expression (P = 0.0015). Similarly, median OS was improved in those patients with low pSTAT3 expression (160.6 vs 47.9 months, P = 0.02). In a multivariate model to predict survival, only the degree of B-cell infiltration and clinical stage were retained. pSTAT3 expression did not enter the final model, possibly be due to a high positive correlation with B-cell infiltration (r = 0.82, P<0.0001). Conclusions: Increased B-cell infiltration and pSTAT3 expression in omental tissue are associated with poorer survival.	[Yang, Chunmei; Lee, Heehyoung; Jove, Veronica; Deng, Jiehui; Zhang, Wang; Yu, Hua] City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Liu, Xueli] City Hope Comprehens Canc Ctr, Dept Biostat, Duarte, CA USA; [Forman, Stephen] City Hope Comprehens Canc Ctr, Dept Hematol, Duarte, CA USA; [Dellinger, Thanh H.; Wakabayashi, Mark] City Hope Comprehens Canc Ctr, Dept Surg, Duarte, CA USA; [Pal, Sumanta] City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; City of Hope	Yu, H (corresponding author), City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA.	hyu@coh.org; spal@coh.org		YU, Hua/0000-0003-0931-1000; DELLINGER, THANH/0000-0003-1855-1989; Deng, Jiehui/0000-0001-7986-8643	National Institutes of Health [K12 2K12CA001727-16A1, NIH U54 CA163117, NIH R01 CA122976-01, NIH P50 CA107399]; Markel Fund; NATIONAL CANCER INSTITUTE [P50CA107399, K12CA001727, R01CA140692, U54CA163117, R01CA122976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Markel Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Pal's efforts are supported by National Institutes of Health K12 2K12CA001727-16A1. Dr. Yu's efforts are supported by NIH U54 CA163117, NIH R01 CA122976-01, NIH P50 CA107399 and the Markel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SF, 2009, CANCER-AM CANCER SOC, V115, P2891, DOI 10.1002/cncr.24317; AOKI Y, 1991, CANCER RES, V51, P1934; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Barbera-Guillem E, 2000, CANCER IMMUNOL IMMUN, V48, P541, DOI 10.1007/PL00006672; Barnett JC, 2010, GYNECOL ONCOL, V116, P556, DOI 10.1016/j.ygyno.2009.11.020; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Fialova A, 2012, INT J CANC; Fujita K, 1995, CLIN CANCER RES, V1, P501; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; IKARASHI H, 1994, CANCER RES, V54, P190; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah S, 2005, INT J CANCER, V117, P574, DOI 10.1002/ijc.21177; Stumpf M, 2009, BRIT J CANCER, V101, P1513, DOI 10.1038/sj.bjc.6605274; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	30	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54029	10.1371/journal.pone.0054029	http://dx.doi.org/10.1371/journal.pone.0054029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326565	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400067
J	Pan, W; Zhong, Y; Cheng, CF; Liu, BR; Wang, L; Li, AQ; Xiong, LG; Liu, SM				Pan, Wei; Zhong, Yun; Cheng, Chuanfang; Liu, Benrong; Wang, Li; Li, Aiqun; Xiong, Longgen; Liu, Shiming			MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MIR-30; EXPRESSION; BIOMARKER; REVEALS; INHIBITORS; TARGETS; MIRNAS; BLOOD	Dysregulated autophagy may lead to the development of disease. Role of autophagy and the diagnostic potential of microRNAs that regulate the autophagy in cardiac hypertrophy have not been evaluated. A rat model of cardiac hypertrophy was established using transverse abdominal aortic constriction (operation group). Cardiomyocyte autophagy was enhanced in rats from the operation group, compared with those in the sham operation group. Moreover, the operation group showed up-regulation of beclin-1 (an autophagy-related gene), and down-regulation of miR-30 in cardiac tissue. The effects of inhibition and over-expression of the beclin-1 gene on the expression of hypertrophy-related genes and on autophagy were assessed. Angiotensin II-induced myocardial hypertrophy was found to be mediated by over-expression of the beclin-1 gene. A dual luciferase reporter assay confirmed that beclin-1 was a target gene of miR-30a. miR-30a induced alterations in beclin-1 gene expression and autophagy in cardiomyocytes. Treatment of cardiomyocytes with miR-30a mimic attenuated the Angiotensin II-induced up-regulation of hypertrophy-related genes and decreased in the cardiomyocyte surface area. Conversely, treatment with miR-30a inhibitor enhanced the up-regulation of hypertrophy-related genes and increased the surface area of cardiomyocytes induced by Angiotensin II. In addition, circulating miR-30 was elevated in patients with left ventricular hypertrophy, and circulating miR-30 was positively associated with left ventricular wall thickness. Collectively, these above-mentioned results suggest that Angiotensin II induces down-regulation of miR-30 in cardiomyocytes, which in turn promotes myocardial hypertrophy through excessive autophagy. Circulating miR-30 may be an important marker for the diagnosis of left ventricular hypertrophy.	[Pan, Wei; Zhong, Yun; Cheng, Chuanfang; Liu, Benrong; Wang, Li; Li, Aiqun; Xiong, Longgen; Liu, Shiming] Guangzhou Med Univ, Hosp Affiliated 2, Guangzhou Inst Cardiovasc Dis, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, SM (corresponding author), Guangzhou Med Univ, Hosp Affiliated 2, Guangzhou Inst Cardiovasc Dis, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China.	gzliushiming@126.com	Zhong, Yun/HCH-6868-2022		Guangzhou Science and Technology Project [11A72020279]	Guangzhou Science and Technology Project	Funding was supported by Guangzhou Science and Technology Project grants 11A72020279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gradus B, 2011, DEV BIOL, V360, P58, DOI 10.1016/j.ydbio.2011.09.002; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guo R, 2012, AUTOPHAGY, V8, P593, DOI 10.4161/auto.18997; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	39	146	161	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53950	10.1371/journal.pone.0053950	http://dx.doi.org/10.1371/journal.pone.0053950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326547	Green Submitted, gold, Green Published			2022-12-27	WOS:000313551500103
J	Wu, DWL; DiGiacomo, A; Kingstone, A				Wu, David W. -L.; DiGiacomo, Alessandra; Kingstone, Alan			A Sustainable Building Promotes Pro-Environmental Behavior: An Observational Study on Food Disposal	PLOS ONE			English	Article							ADAPTIVE-BEHAVIOR; GREEN; PSYCHOLOGY; CULTURE; HEALTH; IMPACT; USER	In order to develop a more sustainable society, the wider public will need to increase engagement in pro-environmental behaviors. Psychological research on pro-environmental behaviors has thus far focused on identifying individual factors that promote such behavior, designing interventions based on these factors, and evaluating these interventions. Contextual factors that may also influence behavior at an aggregate level have been largely ignored. In the current study, we test a novel hypothesis - whether simply being in a sustainable building can elicit environmentally sustainable behavior. We find support for our hypothesis: people are significantly more likely to correctly choose the proper disposal bin (garbage, compost, recycling) in a building designed with sustainability in mind compared to a building that was not. Questionnaires reveal that these results are not due to self-selection biases. Our study provides empirical support that one's surroundings can have a profound and positive impact on behavior. It also suggests the opportunity for a new line of research that bridges psychology, design, and policy-making in an attempt to understand how the human environment can be designed and used as a subtle yet powerful tool to encourage and achieve aggregate pro-environmental behavior.	[Wu, David W. -L.; DiGiacomo, Alessandra; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Wu, DWL (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	David.wl.wu@gmail.com		Wu, David/0000-0002-6924-6047	National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Work for this paper was supported by a Discovery Grant (to A.K.) from the National Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; BITNER MJ, 1992, J MARKETING, V56, P57, DOI 10.2307/1252042; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Brown Z, 2010, FACILITIES, V28, P225, DOI 10.1108/02632771011023168; Brown ZB, 2009, INTELL BUILD INT, V1, P296, DOI 10.3763/inbi.2009.0034; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cole RJ, 2012, BUILD RES INF, V40, P39, DOI 10.1080/09613218.2011.610608; Duffy S, 2009, ENVIRON BEHAV, V41, P741, DOI 10.1177/0013916508323737; GUAGNANO GA, 1995, ENVIRON BEHAV, V27, P699, DOI 10.1177/0013916595275005; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Hunecke M, 2001, ENVIRON BEHAV, V33, P830, DOI 10.1177/00139160121973269; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Jamieson P., 2003, INT J ACAD DEV, V8, P119, DOI DOI 10.1080/1360144042000277991; Lockton D, 2010, APPL ERGON, V41, P382, DOI 10.1016/j.apergo.2009.09.001; Lockton D, 2008, INT J SUSTAIN ENG, V1, P3, DOI 10.1080/19397030802131068; Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144; Meyers-Levy J, 2010, J CONSUM RES, V37, P1, DOI 10.1086/649028; Osbaldiston R, 2012, ENVIRON BEHAV, V44, P257, DOI 10.1177/0013916511402673; Oskamp S, 2000, AM PSYCHOL, V55, P496, DOI 10.1037/0003-066X.55.5.496; Schmuck P, 2003, EUR PSYCHOL, V8, P66, DOI 10.1027//1016-9040.8.2.66; SCHULTZ PW, 1995, J ENVIRON PSYCHOL, V15, P105, DOI 10.1016/0272-4944(95)90019-5; Shalev I, 2011, PERSPECT PSYCHOL SCI, V6, P488, DOI 10.1177/1745691611416993; Spence A, 2009, ENVIRONMENT, V51, P8, DOI 10.1080/00139150903337217; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	27	30	30	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53856	10.1371/journal.pone.0053856	http://dx.doi.org/10.1371/journal.pone.0053856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	070YR	23326521	Green Published, gold, Green Submitted			2022-12-27	WOS:000313551500098
J	He, L; Jiang, H; Cao, DD; Liu, LH; Hu, SN; Wang, Q				He, Lin; Jiang, Hui; Cao, Dandan; Liu, Lihua; Hu, Songnian; Wang, Qun			Comparative Transcriptome Analysis of the Accessory Sex Gland and Testis from the Chinese Mitten Crab (Eriocheir sinensis)	PLOS ONE			English	Article							PROSTASOME-LIKE PARTICLES; CAUDA EPIDIDYMAL SPERM; EXPRESSION CHARACTERISTICS; PROTEINS; FLUID; SPERMATOZOA; GENES; BULLS; ZINC; CAPACITATION	The accessory sex gland (ASG) is an important component of the male reproductive system, which functions to enhance the fertility of spermatozoa during male reproduction. Certain proteins secreted by the ASG are known to bind to the spermatozoa membrane and affect its function. The ASG gene expression profile in Chinese mitten crab (Eriocheir sinensis) has not been extensively studied, and limited genetic research has been conducted on this species. The advent of high-throughput sequencing technologies enables the generation of genomic resources within a short period of time and at minimal cost. In the present study, we performed de novo transcriptome sequencing to produce a comprehensive transcript dataset for the ASG of E. sinensis using Illumina sequencing technology. This analysis yielded a total of 33,221,284 sequencing reads, including 2.6 Gb of total nucleotides. Reads were assembled into 85,913 contigs (average 218 bp), or 58,567 scaffold sequences (average 292 bp), that identified 37,955 unigenes (average 385 bp). We assembled all unigenes and compared them with the published testis transcriptome from E. sinensis. In order to identify which genes may be involved in ASG function, as it pertains to modification of spermatozoa, we compared the ASG and testis transcriptome of E. sinensis. Our analysis identified specific genes with both higher and lower tissue expression levels in the two tissues, and the functions of these genes were analyzed to elucidate their potential roles during maturation of spermatozoa. Availability of detailed transcriptome data from ASG and testis in E. sinensis can assist our understanding of the molecular mechanisms involved with spermatozoa conservation, transport, maturation and capacitation and potentially acrosome activation.	[He, Lin; Jiang, Hui; Liu, Lihua; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Cao, Dandan; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	East China Normal University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qun_300@hotmail.com	Wang, Qun/I-7778-2013; Hu, Songnian/C-6509-2013	Wang, Qun/0000-0001-7929-7692; Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [31172393, 31201974]; Science and Technology Commission of Shanghai Municipality [12ZR1408900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by grants from National Natural Science Foundation of China (No. 31172393 and No. 31201974) and the Science and Technology Commission of Shanghai Municipality (No. 12ZR1408900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Awda BJ, 2010, BIOL REPROD, V83, P750, DOI 10.1095/biolreprod.109.082008; Bal W, 2001, MOL CELL BIOCHEM, V222, P97, DOI 10.1023/A:1017971525105; Bench G, 2000, MOL REPROD DEV, V56, P512, DOI 10.1002/1098-2795(200008)56:4&lt;512::AID-MRD9&gt;3.0.CO;2-M; BJORNDAHL L, 1990, INT J ANDROL, V13, P232, DOI 10.1111/j.1365-2605.1990.tb00981.x; Blobel CP, 2000, REV REPROD, V5, P75, DOI 10.1530/revreprod/5.2.75; BLOBEL CP, 1990, J CELL BIOL, V111, P69, DOI 10.1083/jcb.111.1.69; Caballero Julieta, 2010, Vet Med Int, V2011, P757194, DOI 10.4061/2011/757194; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cheah YunSang, 2011, Advances in Bioscience and Biotechnology, V2, P182, DOI 10.4236/abb.2011.24029; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; DIESEL R, 1989, J CRUSTACEAN BIOL, V9, P266, DOI 10.2307/1548506; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eickhoff R, 2006, CELLS TISSUES ORGANS, V182, P22, DOI 10.1159/000091715; Elzanaty S, 2002, HUM REPROD, V17, P2904, DOI 10.1093/humrep/17.11.2904; Fabrega A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-96; Frenette G, 2004, MOL REPROD DEV, V69, P448, DOI 10.1002/mrd.20170; Frenette G, 2002, BIOL REPROD, V67, P308, DOI 10.1095/biolreprod67.1.308; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Gadella BM, 2004, ANIM REPROD SCI, V82-3, P307, DOI 10.1016/j.anireprosci.2004.04.030; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Girouard J, 2009, BIOL REPROD, V80, P965, DOI 10.1095/biolreprod.108.073551; GMACHL M, 1993, FEBS LETT, V336, P545, DOI 10.1016/0014-5793(93)80873-S; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; HENAULT MA, 1995, BIOL REPROD, V52, P390, DOI 10.1095/biolreprod52.2.390; Herborg LM, 2006, J EXP MAR BIOL ECOL, V329, P1, DOI 10.1016/j.jembe.2005.08.001; Hou XL, 2010, J CRUSTACEAN BIOL, V30, P435, DOI 10.1651/09-3177.1; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim E, 2010, ANIM REPROD SCI, V117, P155, DOI 10.1016/j.anireprosci.2009.04.002; Legare C, 1999, MOL REPROD DEV, V52, P225, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;225::AID-MRD14&gt;3.0.CO;2-M; Li Z, 2010, MICRON, V41, P39, DOI 10.1016/j.micron.2009.08.001; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lum L, 1997, DEV BIOL, V191, P131, DOI 10.1006/dbio.1997.8609; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moura AA, 2006, J ANDROL, V27, P201, DOI 10.2164/jandrol.05089; Moura AA, 2007, ANIM REPROD SCI, V98, P169, DOI 10.1016/j.anireprosci.2006.03.012; Moura AA, 2007, MOL REPROD DEV, V74, P214, DOI 10.1002/mrd.20590; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nixon B, 2010, J CELL PHYSIOL, V224, P71, DOI 10.1002/jcp.22090; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; PATEL S M, 1988, Acta Europaea Fertilitatis, V19, P329; Qiu GF, 2008, ANIM REPROD SCI, V105, P209, DOI 10.1016/j.anireprosci.2007.03.005; Robert M, 1996, BIOL REPROD, V55, P813, DOI 10.1095/biolreprod55.4.813; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Sostaric E, 2008, ANIM REPROD SCI, V107, P237, DOI 10.1016/j.anireprosci.2008.04.011; Sostaric E, 2008, MOL REPROD DEV, V75, P60, DOI 10.1002/mrd.20766; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Suzuki K, 2003, CELL MOL BIOL, V49, P653; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang Q, 2012, GENE, V501, P135, DOI 10.1016/j.gene.2012.04.016; Wang Q, 2012, MOL BIOL REP, V39, P6683, DOI 10.1007/s11033-012-1474-6; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao YM, 2012, P NATL ACAD SCI USA, V109, P1542, DOI 10.1073/pnas.1109912109; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	61	63	63	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53915	10.1371/journal.pone.0053915	http://dx.doi.org/10.1371/journal.pone.0053915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342039	gold, Green Published, Green Submitted			2022-12-27	WOS:000313682700064
J	Beiroa, D; Romero-Pico, A; Langa, C; Bernabeu, C; Lopez, M; Lopez-Novoa, JM; Nogueiras, R; Dieguez, C				Beiroa, Daniel; Romero-Pico, Amparo; Langa, Carmen; Bernabeu, Carmelo; Lopez, Miguel; Lopez-Novoa, Jose M.; Nogueiras, Ruben; Dieguez, Carlos			Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet	PLOS ONE			English	Article							BETA RECEPTOR; ANGIOGENESIS; OBESITY; INFLAMMATION; EXPRESSION; HYPERTENSION; DIAGNOSIS; PROTEIN; SYSTEM; CD105	Endoglin is a transmembrane auxiliary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored. Endoglin deficient mice die during midgestation due to cardiovascular defects. Here we report for first time that heterozygous endoglin deficiency in mice decreases high fat diet-induced hepatic triglyceride content and insulin levels. Importantly, these effects are independent of changes in body weight or adiposity. At molecular level, we failed to detect relevant changes in the insulin signalling pathway at basal levels in liver, muscle or adipose tissues that could explain the insulin-dependent effect. However, we found decreased triglyceride content in the liver of endoglin heterozygous mice fed a high fat diet in comparison to their wild type littermates. Overall, our findings indicate that endoglin is a potentially important physiological mediator of insulin levels and hepatic lipid metabolism.	[Beiroa, Daniel; Romero-Pico, Amparo; Lopez, Miguel; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Inst Invest Sanitarias IDIS, Dept Physiol,Sch Med,CIMUS, Santiago De Compostela, A Coruna, Spain; [Langa, Carmen; Bernabeu, Carmelo] CSIC, Ctr Invest Biol, Madrid, Spain; [Langa, Carmen; Bernabeu, Carmelo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Lopez-Novoa, Jose M.] Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Physiopathol Unit, E-37008 Salamanca, Spain; [Lopez-Novoa, Jose M.] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Nogueiras, R (corresponding author), Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Inst Invest Sanitarias IDIS, Dept Physiol,Sch Med,CIMUS, Santiago De Compostela, A Coruna, Spain.	ruben.nogueiras@usc.es; carlos.dieguez@usc.es	Bernabeu, Carmelo/P-4662-2019; Nogueiras, Ruben/AAS-9427-2021; Beiroa, Daniel/AAB-8662-2020; Lopez-Novoa, Jose M/A-3672-2008; López, Miguel/ABF-4844-2021; Bernabeu, Carmelo/L-3226-2014	Bernabeu, Carmelo/0000-0002-1563-6162; Nogueiras, Ruben/0000-0002-9976-9930; Beiroa, Daniel/0000-0003-1862-1668; López, Miguel/0000-0002-7823-1648; Bernabeu, Carmelo/0000-0002-1563-6162; Romero-Pico, Amparo/0000-0001-5104-6998; Lopez-Novoa, Jose M./0000-0002-6211-7269; dieguez, carlos/0000-0002-0919-4337	Ministerio de Educacion y Ciencia [BFU2011, RyC-2007-00211, RYC- 2008-02219, SAF2009-07049, RYC-2009-04972, SAF2010-15881, SAF2010-19347, SAF2010-61827]; Xunta de Galicia [10PXIB208164PR, 2010/14]; Junta de Castilla y Leon (Excellence Group) [GR100]; Fondo Investigationes Sanitarias [PS09/01880]; Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN); FEDER; European Community [245009, ERC-2011-StG-OBESITY53-281408]	Ministerio de Educacion y Ciencia(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Junta de Castilla y Leon (Excellence Group)(Junta de Castilla y Leon); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN); FEDER(European Commission); European Community(European Commission)	This work has been supported by grants from Ministerio de Educacion y Ciencia (CD: BFU2011; ML: RyC-2007-00211; RN: RYC- 2008-02219 and SAF2009-07049; GS: RYC-2009-04972, SAF2010-15881 and SAF2010-19347; JML-N: SAF2010-15881; CB: SAF2010-61827), Xunta de Galicia (ML: 10PXIB208164PR and RN: 2010/14), Junta de Castilla y Leon (Excellence Group GR100) Fondo Investigationes Sanitarias (ML: PS09/01880), Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), CIBER de Enfermedades Raras (CIBERER) and Red de Investigacion Cooperativa en Enfermedades Renales (REDinREN). CIBERobn, CIBERER and RETIC REDinREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreements (CD, ML and RN: FP7/2007-2013: no 245009: NeuroFAST, and RN: ERC-2011-StG-OBESITY53-281408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cudmore MJ, 2012, EUR HEART J, V33, P1150, DOI 10.1093/eurheartj/ehr065; Czyzyk TA, 2010, FASEB J, V24, P1151, DOI 10.1096/fj.09-143610; Fernandez-L A, 2007, THROMB HAEMOSTASIS, V97, P254, DOI 10.1160/TH06-07-0373; Fornoni A, 2005, CURR HYPERTENS REP, V7, P88, DOI 10.1007/s11906-005-0080-6; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Gonzalez CR, 2009, J PHYSIOL-LONDON, V587, P3741, DOI 10.1113/jphysiol.2009.172510; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Mahmoud M, 2011, BIOCHEM SOC T, V39, P1659, DOI 10.1042/BST20110664; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nishi Y, 2011, BIOCHEM J, V435, P421, DOI 10.1042/BJ20101708; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54591	10.1371/journal.pone.0054591	http://dx.doi.org/10.1371/journal.pone.0054591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23336009	Green Submitted, Green Published, gold			2022-12-27	WOS:000314707700067
J	Zeng, Y; Wang, HX; Guo, SB; Yang, H; Zeng, XJ; Fang, Q; Tang, CS; Du, J; Li, HH				Zeng, Yong; Wang, Hong-Xia; Guo, Shu-Bin; Yang, Hui; Zeng, Xiang-Jun; Fang, Quan; Tang, Chao-Shu; Du, Jie; Li, Hui-Hua			Transcriptional Effects of E3 Ligase Atrogin-1/MAFbx on Apoptosis, Hypertrophy and Inflammation in Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							SKELETAL-MUSCLE ATROPHY; DEPENDENT CARDIAC-HYPERTROPHY; ACETYL-COA TRANSPORTER; UBIQUITIN LIGASE; HEART-FAILURE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; MYOCARDIAL EXPRESSION; SIGNALING PATHWAYS; EP3 RECEPTORS	Atrogin-1/MAFbx is an ubiquitin E3 ligase that regulates myocardial structure and function through the ubiquitin-dependent protein modification. However, little is known about the effect of atrogin-1 activation on the gene expression changes in cardiomyocytes. Neonatal rat cardiomyocytes were infected with adenovirus atrogin-1 (Ad-atrogin-1) or GFP control (Ad-GFP) for 24 hours. The gene expression profiles were compared with microarray analysis. 314 genes were identified as differentially expressed by overexpression of atrogin-1, of which 222 were up-regulated and 92 were down-regulated. Atrogin-1 overexpression significantly modulated the expression of genes in 30 main functional categories, most genes clustered around the regulation of cell death, proliferation, inflammation, metabolism and cardiomyoctye structure and function. Moreover, overexpression of atrogin-1 significantly inhibited cardiomyocyte survival, hypertrophy and inflammation under basal condition or in response to lipopolysaccharide (LPS). In contrast, knockdown of atrogin-1 by siRNA had opposite effects. The mechanisms underlying these effects were associated with inhibition of MAPK (ERK1/2, JNK1/2 and p38) and NF-kappa B signaling pathways. In conclusion, the present microarray analysis reveals previously unappreciated atrogin-1 regulation of genes that could contribute to the effects of atrogin-1 on cardiomyocyte survival, hypertrophy and inflammation in response to endotoxin, and may provide novel insight into how atrogin-1 modulates the programming of cardiac muscle gene expression.	[Zeng, Yong; Fang, Quan] Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Hong-Xia; Yang, Hui; Zeng, Xiang-Jun; Tang, Chao-Shu; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Guo, Shu-Bin] Peking Union Med Hosp, Dept Emergency Med, Beijing, Peoples R China; [Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Lab Vas, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Zeng, Y (corresponding author), Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China.	zengyong1999@yahoo.com; hhli1935@yahoo.cn			China Natural Science Foundation [81025001, 30971097, 30888004]; Beijing High-Level Talents Program [PHR20110507]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing High-Level Talents Program	This study was supported by grants from the China Natural Science Foundation (81025001, 30971097 and 30888004), the Beijing High-Level Talents Program (PHR20110507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2007, CARDIOVASC RES, V73, P120, DOI 10.1016/j.cardiores.2006.10.026; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Ancey C, 2002, CYTOKINE, V18, P199, DOI 10.1006/cyto.2002.1033; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Baba Y, 2010, CANCER EPIDEM BIOMAR, V19, P822, DOI 10.1158/1055-9965.EPI-09-1154; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen W, 2010, HEART FAIL REV, V15, P415, DOI 10.1007/s10741-010-9161-y; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng LL, 2000, IMMUNOL RES, V21, P203, DOI 10.1385/IR:21:2-3:203; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; Galasso G, 2010, EUR J HEART FAIL, V12, P1290, DOI 10.1093/eurjhf/hfq102; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin BW, 2007, J CELL BIOCHEM, V100, P960, DOI 10.1002/jcb.21060; Kanamori A, 1997, P NATL ACAD SCI USA, V94, P2897, DOI 10.1073/pnas.94.7.2897; Kovacic JC, 2007, J MOL CELL CARDIOL, V42, P19, DOI 10.1016/j.yjmcc.2006.10.001; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li JJ, 2011, CELL PHYSIOL BIOCHEM, V27, P463, DOI 10.1159/000329967; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loureiro B, 2011, AM J REPROD IMMUNOL; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Michel MC, 2001, N-S ARCH PHARMACOL, V363, P245, DOI 10.1007/s002100000363; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Nakayama T, 2010, INT ANGIOL, V29, P33; Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sun HP, 2008, CELL SIGNAL, V20, P1952, DOI 10.1016/j.cellsig.2008.07.003; Suzuki J, 2007, J AM COLL CARDIOL, V49, P491, DOI 10.1016/j.jacc.2006.10.043; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tsuchiya H, 2008, J BIOL CHEM, V283, P11064, DOI 10.1074/jbc.M801359200; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Willis MS, 2010, CIRC RES, V106, P463, DOI 10.1161/CIRCRESAHA.109.208801; Wu LY, 2003, INVEST OPHTH VIS SCI, V44, P2404, DOI 10.1167/iovs.02-0317; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yamamoto Y, 2008, CARDIOVASC RES, V79, P89, DOI 10.1093/cvr/cvn076; Yang D, 2010, CELL PHYSIOL BIOCHEM, V25, P605, DOI 10.1159/000315079; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021104	68	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53831	10.1371/journal.pone.0053831	http://dx.doi.org/10.1371/journal.pone.0053831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335977	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700035
J	Zhivov, A; Winter, K; Hovakimyan, M; Peschel, S; Harder, V; Schober, HC; Kundt, G; Baltrusch, S; Guthoff, RF; Stachs, O				Zhivov, Andrey; Winter, Karsten; Hovakimyan, Marine; Peschel, Sabine; Harder, Volker; Schober, Hans-Christof; Kundt, Guenther; Baltrusch, Simone; Guthoff, Rudolf F.; Stachs, Oliver			Imaging and Quantification of Subbasal Nerve Plexus in Healthy Volunteers and Diabetic Patients with or without Retinopathy	PLOS ONE			English	Article							VIVO CONFOCAL MICROSCOPY; CORNEAL NERVES; PERIPHERAL NEUROPATHY; FIBER DAMAGE; SENSITIVITY; POPULATION; PREVALENCE; PERCEPTION; MORPHOLOGY; SEVERITY	Background: The alterations of subbasal nerve plexus (SBP) innervation and corneal sensation were estimated non-invasively and compared with the values in healthy volunteers. Additionally, this study addressed the relation of SBP changes to the retinal status, glycemic control and diabetes duration. Methodology/Principal Findings: Eighteen eyes of diabetic patients with peripheral diabetic neuropathy aged 68.8 +/- 8.8 years and twenty eyes of healthy volunteers aged 66.3 +/- 13.3 yrs. were investigated with in vivo confocal laser-scanning microscopy (CLSM). An adapted algorithm for image analysis was used to quantify the morphological and topological properties of SBP. These properties were correlated to incidence of diabetic retinopathy (DR) and corneal sensation (Cochet-Bonnet esthesiometer). The developed algorithm allows a fully automated analysis of pre-segmented SBP structures. Altogether, 10 parameters were analysed, and all of them revealed significant differences between diabetic patients and healthy volunteers. The nerve fibre density, total fibre length and nerve branches were found to be significantly lower in patients with diabetes than those of control subjects (nerve fibre density 0.006 +/- 0.002 vs. 0.020 +/- 0.007 mm/mm(2); total fibre length 6223 +/- 2419 vs. 19961 +/- 6553 mu m; nerve branches 25.3 +/- 28.6 vs. 141.9 +/- 85.7 in healthy volunteers). Also the corneal sensation was significantly lower in diabetic group when compared to controls (43 +/- 11 vs. 59 +/- 18 mm). There was found no difference in SBP morphology or corneal sensation in the subgroups with (DR) or without (NDR) diabetic retinopathy. Conclusions/Significance: SBP parameters were significantly reduced in diabetic patients, compared to control group. Interestingly, the SBP impairment could be shown even in the diabetic patients without DR. Although automatic adapted image analysis simplifies the evaluation of in vivo CLSM data, image acquisition and quantitative analysis should be optimised for the everyday clinical practice.	[Zhivov, Andrey; Hovakimyan, Marine; Peschel, Sabine; Guthoff, Rudolf F.; Stachs, Oliver] Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany; [Winter, Karsten] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Harder, Volker; Schober, Hans-Christof] Klinikum Sudstadt, Clin Internal Med 1, Rostock, Germany; [Kundt, Guenther] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany	University of Rostock; Leipzig University; University of Rostock; University of Rostock	Zhivov, A (corresponding author), Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany.	andyzhyvov@yahoo.com			DFG (Deutsche Forschungsgemeinschaft) [Transregio 37]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was generously supported by the DFG (Deutsche Forschungsgemeinschaft) (Transregio 37, Micro- and Nanosystems in Medicine - Reconstruction of Biological Functions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P1251, DOI 10.1136/bjo.2009.178244; Allgeier S, 2011, INVEST OPHTH VIS SCI, V52, P5022, DOI 10.1167/iovs.10-6065; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barr ELM, 2006, DIABETES CARE, V29, P1114, DOI 10.2337/dc05-2464; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Chang PY, 2006, AM J OPHTHALMOL, V142, P488, DOI 10.1016/j.ajo.2006.04.033; Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133; Dabbah M. A., 2011, MED IMAGE ANAL; De Cilla S, 2009, INVEST OPHTH VIS SCI, V50, P5155, DOI 10.1167/iovs.09-3384; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Heintz E, 2010, DIABETOLOGIA, V53, P2147, DOI 10.1007/s00125-010-1836-3; Holmes TJ, 2010, INVEST OPHTH VIS SCI, V51, P4480, DOI 10.1167/iovs.09-4108; Hossain P, 2005, LANCET, V366, P1340, DOI 10.1016/S0140-6736(05)67546-0; Kallinikos P, 2004, INVEST OPHTH VIS SCI, V45, P418, DOI 10.1167/iovs.03-0637; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; Labbe A, 2012, INVEST OPHTH VIS SCI, V53, P4926, DOI 10.1167/iovs.11-8708; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Li J Y, 1995, J Tongji Med Univ, V15, P38; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; MARFURT CF, 1995, INVEST OPHTH VIS SCI, V36, P1100; Mehra S, 2007, DIABETES CARE, V30, P2608, DOI 10.2337/dc07-0870; Messmer EM, 2010, GRAEF ARCH CLIN EXP, V248, P1307, DOI 10.1007/s00417-010-1396-8; Midena E, 2006, J REFRACT SURG, V22, pS1047, DOI 10.3928/1081-597X-20061102-08; Mimura T, 2004, DIABETIC MED, V21, P559, DOI 10.1111/j.1464-5491.2004.01204.x; Mocan MC, 2006, CORNEA, V25, P769, DOI 10.1097/01.ico.0000224640.58848.54; NIELSEN NV, 1979, ACTA NEUROL SCAND, V59, P15; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Patel DV, 2009, BRIT J OPHTHALMOL, V93, P853, DOI 10.1136/bjo.2008.150615; Patel DV, 2009, CORNEA, V28, P735, DOI 10.1097/ICO.0b013e318193e0e3; Patel DV, 2005, INVEST OPHTH VIS SCI, V46, P4485, DOI 10.1167/iovs.05-0794; PIRART J, 1978, NOUV PRESSE MED, V7, P4031; Rosenberg ME, 2000, INVEST OPHTH VIS SCI, V41, P2915; Scarpa F, 2008, INVEST OPHTH VIS SCI, V49, P4801, DOI 10.1167/iovs.08-2061; Shahidi AM, 2010, CLIN EXP OPTOM, V93, P309, DOI 10.1111/j.1444-0938.2010.00491.x; Stachs O, 2010, J REFRACT SURG, V26, P159, DOI 10.3928/1081597X-20100224-01; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; VINIK AI, 1995, MUSCLE NERVE, V18, P574, DOI 10.1002/mus.880180603; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889; Winter Karsten, 2010, Biomedizinische Technik, V55, P252, DOI 10.1515/BMT.2010.562; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035; Zhivov A, 2009, BRIT J OPHTHALMOL, V93, P667, DOI 10.1136/bjo.2008.137430; Zhivov A, 2010, BRIT J OPHTHALMOL, V94, P1133, DOI 10.1136/bjo.2009.175489; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	50	76	80	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e52157	10.1371/journal.pone.0052157	http://dx.doi.org/10.1371/journal.pone.0052157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341892	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700007
J	Berniker, M; O'Brien, MK; Kording, KP; Ahmed, AA				Berniker, Max; O'Brien, Megan K.; Kording, Konrad P.; Ahmed, Alaa A.			An Examination of the Generalizability of Motor Costs	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; ENERGY-COST; ADAPTATION; MECHANISMS; ERROR	Most approaches to understanding human motor control assume that people maximize their rewards while minimizing their motor efforts. This tradeoff between potential rewards and a sense of effort is quantified with a cost function. While the rewards can change across tasks, our sense of effort is assumed to remain constant and characterize how the nervous system organizes motor control. As such, when a proposed cost function compares well with data it is argued to be the underlying cause of a motor behavior, and not simply a fit to the data. Implicit in this proposition is the assumption that this cost function can then predict new motor behaviors. Here we examined this idea and asked whether an inferred cost function in one setting could explain subject's behavior in settings that differed dynamically but had identical rewards. We found that the pattern of behavior observed across settings was similar to our predictions of optimal behavior. However, we could not conclude that this behavior was consistent with a conserved sense of effort. These results suggest that the standard forms for quantifying cost may not be sufficient to accurately examine whether or not human motor behavior abides by optimality principles.	[Berniker, Max; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Berniker, Max; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [O'Brien, Megan K.; Ahmed, Alaa A.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Ahmed, Alaa A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	Northwestern University; Shirley Ryan AbilityLab; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Berniker, M (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	mbernike@northwestern.edu	Kording, Konrad P/A-1233-2007; , Alaa/GVR-7153-2022	Kording, Konrad P/0000-0001-8408-4499; OBRIEN, MEGAN/0000-0001-8069-365X	NIH [1R01NS063399]; DARPA Young Faculty Award [D12AP00253]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA Young Faculty Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant 1R01NS063399 and the DARPA Young Faculty Award D12AP00253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; Berniker M, 2009, P NATL ACAD SCI; Berniker M, 2011, P AMER CONTR CONF, P618; Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Bryson A.E., 2018, APPL OPTIMAL CONTROL, P90, DOI 10.1201/9781315137667-3; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CHOW C K, 1971, Mathematical Biosciences, V10, P239, DOI 10.1016/0025-5564(71)90062-9; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Farahat WA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000795; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1987, EXERCISE SPORT SCI R, V15, P153; HOGAN N, 1984, J NEUROSCI, V4, P2745; Huang HJ, 2012, J NEUROSCI, V32, P2182, DOI 10.1523/JNEUROSCI.4003-11.2012; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Mitrovic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013601; Nagengast AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000419; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; Schaal S, 2005, CURR OPIN NEUROBIOL, V15, P675, DOI 10.1016/j.conb.2005.10.009; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Sherback M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000708; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	34	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53759	10.1371/journal.pone.0053759	http://dx.doi.org/10.1371/journal.pone.0053759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341994	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400078
J	Deng, FY; Lei, SF; Zhang, YH; Zhang, ZL; Guo, YF				Deng, Fei-Yan; Lei, Shu-Feng; Zhang, Yong-Hong; Zhang, Zeng-Li; Guo, Yu-Fan			Functional Relevance for Associations between Genetic Variants and Systemic Lupus Erythematosus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INCREASED RISK; IRF5 GENE; POPULATION; EXPRESSION; SUSCEPTIBILITY; AGGREGATION; HAPLOTYPE; CHINESE; ITGAM	Systemic lupus erythematosus (SLE) is a serious prototype autoimmune disease characterized by chronic inflammation, auto-antibody production and multi-organ damage. Recent association studies have identified a long list of loci that were associated with SLE with relatively high statistical power. However, most of them only established the statistical associations of genetic markers and SLE at the DNA level without supporting evidence of functional relevance. Here, using publically available datasets, we performed integrative analyses (gene relationship across implicated loci analysis, differential gene expression analysis and functional annotation clustering analysis) and combined with expression quantitative trait loci (eQTLs) results to dissect functional mechanisms underlying the associations for SLE. We found that 14 SNPs, which were significantly associated with SLE in previous studies, have cis-regulation effects on four eQTL genes (HLA-DQA1, HLA-DQB1, HLA-DQB2, and IRF5) that were also differentially expressed in SLE-related cell groups. The functional evidence, taken together, suggested the functional mechanisms underlying the associations of 14 SNPs and SLE. The study may serve as an example of mining publically available datasets and results in validation of significant disease-association results. Utilization of public data resources for integrative analyses may provide novel insights into the molecular genetic mechanisms underlying human diseases.	[Deng, Fei-Yan; Lei, Shu-Feng; Zhang, Yong-Hong; Zhang, Zeng-Li] Soochow Univ, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Lei, Shu-Feng; Zhang, Yong-Hong] Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Guo, Yu-Fan] Soochow Univ, Dept Rheumatol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Lei, SF (corresponding author), Soochow Univ, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.	leisf@suda.edu.cn			Natural Science Foundation of China (NSFC) [31271336, 31071097]; NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal [30811120436]; Soochow University [Q41390112]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal(Canadian Institutes of Health Research (CIHR)); Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (NSFC) (31271336, 31071097), NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), Startup Fund from Soochow University (Q41390112), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1976, MEDICINE, V55, P313, DOI 10.1097/00005792-197607000-00003; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jimenez S, 2003, CLIN REV ALLERG IMMU, V25, P3, DOI 10.1385/CRIAI:25:1:3; Kawasaki A, 2008, ARTHRITIS RHEUM-US, V58, P826, DOI 10.1002/art.23216; Kelly JA, 2008, GENES IMMUN, V9, P187, DOI 10.1038/gene.2008.4; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lofgren SE, 2010, J RHEUMATOL, V37, P574, DOI 10.3899/jrheum.090440; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; RAMOSNIEMBRO F, 1978, J RHEUMATOL, V5, P433; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sestak AL, 1999, J RHEUMATOL, V26, P1495; Shin HD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2152; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Siu HO, 2008, J RHEUMATOL, V35, P360; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Yang J, 2011, HUM MOL GENET, V20, P601, DOI 10.1093/hmg/ddq474; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	34	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53037	10.1371/journal.pone.0053037	http://dx.doi.org/10.1371/journal.pone.0053037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341919	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400029
J	Hachinohe, M; Yamane, M; Akazawa, D; Ohsawa, K; Ohno, M; Terashita, Y; Masumoto, H				Hachinohe, Mayumi; Yamane, Midori; Akazawa, Daiki; Ohsawa, Kazuhiro; Ohno, Mayumi; Terashita, Yuzu; Masumoto, Hiroshi			A Reduction in Age-Enhanced Gluconeogenesis Extends Lifespan	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENES; YEAST SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION EXTENDS; GENOME STABILITY; BUDDING YEAST; MOTHER CELLS; ACETYLATION; LONGEVITY; EXTENSION; LYSINE-56	The regulation of energy metabolism, such as calorie restriction (CR), is a major determinant of cellular longevity. Although augmented gluconeogenesis is known to occur in aged yeast cells, the role of enhanced gluconeogenesis in aged cells remains undefined. Here, we show that age-enhanced gluconeogenesis is suppressed by the deletion of the tdh2 gene, which encodes glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a protein that is involved in both glycolysis and gluconeogenesis in yeast cells. The deletion of TDH2 restores the chronological lifespan of cells with deletions of both the HST3 and HST4 genes, which encode yeast sirtuins, and represses the activation of gluconeogenesis. Furthermore, the tdh2 gene deletion can extend the replicative lifespan in a CR pathway-dependent manner. These findings demonstrate that the repression of enhanced gluconeogenesis effectively extends the cellular lifespan.	[Hachinohe, Mayumi] Natl Agr & Food Res Org NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Yamane, Midori; Akazawa, Daiki; Ohsawa, Kazuhiro; Ohno, Mayumi; Terashita, Yuzu; Masumoto, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; University of Tsukuba	Masumoto, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hiroshi.masumoto.ff@u-tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Japan Science and Technology (JST) [23131502]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology (JST)(Japan Science & Technology Agency (JST))	This work was supported by Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government and Japan Science and Technology (JST) (Grant number: 23131502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CUPP JR, 1992, J BIOL CHEM, V267, P16417; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dilova I, 2007, CELL MOL LIFE SCI, V64, P752, DOI 10.1007/s00018-007-6381-y; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; GUNJA-SMITH Z, 1977, Journal of Bacteriology, V130, P818; Hachinohe M, 2011, GENES CELLS, V16, P467, DOI 10.1111/j.1365-2443.2011.01493.x; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; Jazwinski SM, 2000, ACTA BIOCHIM POL, V47, P269, DOI 10.18388/abp.2000_4007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; MCALISTER L, 1985, J BIOL CHEM, V260, P5013; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; RINE J, 1987, GENETICS, V116, P9; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; SUN JY, 1994, J BIOL CHEM, V269, P18638; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WEINDRUCH W, 1998, RETARDATION AGING DI; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	63	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54011	10.1371/journal.pone.0054011	http://dx.doi.org/10.1371/journal.pone.0054011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342062	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400110
J	Schaap-Oziemlak, AM; Schouteden, S; Khurana, S; Verfaillie, CM				Schaap-Oziemlak, Aneta M.; Schouteden, Sarah; Khurana, Satish; Verfaillie, Catherine M.			Wnt5a Does Not Support Hematopoiesis in Stroma-Free, Serum-Free Cultures	PLOS ONE			English	Article							STEM-CELL; BETA-CATENIN; LONG-TERM; PATHWAY	Previously we reported that Wnt5a is highly expressed in the murine urogenital ridge-derived UG26-1B6 cells but not embryonic liver-derived EL08-1D2 cells. Mouse long-term repopulating hematopoietic stem cells (LTR-HSC) were maintained in non-contact UG26-1B6 cultures but not EL08-1D2 non-contact cultures, unless Wnt5a was also added to the cultures, suggesting a role for Wnt5a in the in vitro maintenance of LTR-HSC. Here, we investigated if the effect of Wnt5a on adult LTR-HSC activity is HSC-autonomous. To test the effect of Wnt5a on maintenance of LTR-HSC, we performed limiting dilution competitive transplantation assays of murine Lin-Sca1(+) c-kit(+) (LSK) cells cultured for 5 days with TPO and SCF with and without Wnt5a. The effect of Wnt5a on the generation of colony forming units (CFU) and the homing ability of LSK progeny was also tested. No effects were found of Wnt5a on total cell expansion, the number of CFU, or homing ability of day 5 LSK progeny. Furthermore, addition of Wnt5a did not improve, but may have impeded maintenance of LTR-HSC. In conclusion, our data indicate that Wnt5a does not enhance the maintenance and expansion of adult murine LTR-HSCs or committed progenitors cultured in vitro in serum-and stroma-free conditions.	[Schaap-Oziemlak, Aneta M.; Schouteden, Sarah; Khurana, Satish; Verfaillie, Catherine M.] Katholieke Univ Leuven, Interdept Stamcelinst, Louvain, Belgium	KU Leuven	Schaap-Oziemlak, AM (corresponding author), Katholieke Univ Leuven, Interdept Stamcelinst, Louvain, Belgium.	anetaoz@hotmail.com	Verfaillie, Catherine/H-5148-2013; Khurana, Satish/H-9090-2016	Verfaillie, Catherine/0000-0001-7564-4079; Khurana, Satish/0000-0001-5176-1510	FWO [G085111N]; Odysseus; CoE; K.U.Leuven [GOA/11/012]; Vanwayenberghe fund;  [NIH-PO1-CA-65493-06]; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER	FWO(FWO); Odysseus; CoE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); K.U.Leuven(KU Leuven); Vanwayenberghe fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by FWO funding (G085111N), NIH-PO1-CA-65493-06, Odysseus funding, CoE and GOA/11/012 funding from K.U.Leuven, and the Vanwayenberghe fund to CM Verfaillie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Buckley SM, 2011, EXP HEMATOL, V39, P114, DOI 10.1016/j.exphem.2010.09.010; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Szilvassy SJ, 1999, BLOOD, V93, P1557, DOI 10.1182/blood.V93.5.1557; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53669	10.1371/journal.pone.0053669	http://dx.doi.org/10.1371/journal.pone.0053669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341970	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400063
J	Liman, R; Facey, PD; van Keulen, G; Dyson, PJ; Del Sol, R				Liman, Recep; Facey, Paul D.; van Keulen, Geertje; Dyson, Paul J.; Del Sol, Ricardo			A Laterally Acquired Galactose Oxidase-Like Gene Is Required for Aerial Development during Osmotic Stress in Streptomyces coelicolor	PLOS ONE			English	Article							KELCH-REPEAT SUPERFAMILY; MYCELIUM FORMATION; ESCHERICHIA-COLI; GLYOXAL OXIDASE; TRANSFER-RNA; PROTEINS; PRODUCT; GROWTH	Phylogenetic reconstruction revealed that most Actinobacterial orthologs of S. coelicolor SCO2837, encoding a metal-dependent galactose oxidase-like protein, are found within Streptomyces and were probably acquired by horizontal gene transfer from fungi. Disruption of SCO2837 (glxA) caused a conditional bld phenotype that could not be reversed by extracellular complementation. Studies aimed at characterising the regulation of expression of glxA showed that it is not a target for other bld genes. We provide evidence that glxA is required for osmotic adaptation, although independently from the known osmotic stress response element SigB. glxA has been predicted to be part of an operon with the transcription unit comprising the upstream cslA gene and glxA. However, both phenotypic and expression studies indicate that it is also expressed from an independent promoter region internal to cslA. GlxA displays an in situ localisation pattern similar to that one observed for CslA at hyphal tips, but localisation of the former is independent of the latter. The functional role of GlxA in relation to CslA is discussed.	[Liman, Recep] Usak Univ, Dept Genet, Fac Sci, Usak, Turkey; [Facey, Paul D.; van Keulen, Geertje; Dyson, Paul J.; Del Sol, Ricardo] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales	Usak University; Swansea University	Del Sol, R (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Singleton Pk, Swansea, W Glam, Wales.	e.r.abascal@swansea.ac.uk	Facey, Paul/AAK-3265-2021; Dyson, Paul/S-7312-2019; liman, recep/J-3338-2012; Del Sol, Ricardo/L-3171-2015; Liman, Recep/AAO-9652-2020	Del Sol, Ricardo/0000-0003-0015-3843; Liman, Recep/0000-0002-7944-4952; Dyson, Paul/0000-0002-0558-2666; Facey, Paul/0000-0002-3229-0255	Biotechnology and Biological Sciences Research Council [BB/E019242/1] Funding Source: Medline; BBSRC [BB/E019242/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARON AJ, 1994, J BIOL CHEM, V269, P25095; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; CHAMPNESS WC, 1988, J BACTERIOL, V170, P1168, DOI 10.1128/jb.170.3.1168-1174.1988; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Fernandez-Martinez LT, 2011, ANTON LEEUW INT J G, V99, P515, DOI 10.1007/s10482-010-9518-1; Fernandez-Martinez L, 2009, MOL MICROBIOL, V71, P1250, DOI 10.1111/j.1365-2958.2009.06599.x; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Kanhere A, 2005, NUCLEIC ACIDS RES, V33, P3165, DOI 10.1093/nar/gki627; Kelemen GH, 1998, CURR OPIN MICROBIOL, V1, P656, DOI 10.1016/S1369-5274(98)80111-2; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim DW, 2005, J BACTERIOL, V187, P2957, DOI 10.1128/JB.187.9.2957-2966.2005; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWLOR EJ, 1987, GENE DEV, V1, P1305, DOI 10.1101/gad.1.10.1305; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; MERRICK MJ, 1976, J GEN MICROBIOL, V96, P299, DOI 10.1099/00221287-96-2-299; Mistry BV, 2008, J BACTERIOL, V190, P5555, DOI 10.1128/JB.00398-08; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Rangannan V, 2010, BIOINFORMATICS, V26, P3043, DOI 10.1093/bioinformatics/btq577; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Silakowski B, 1998, J BACTERIOL, V180, P1241, DOI 10.1128/JB.180.5.1241-1247.1998; Spadiut O, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-68; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; Whittaker MM, 2006, ARCH BIOCHEM BIOPHYS, V452, P108, DOI 10.1016/j.abb.2006.06.020; WILLEY J, 1993, GENE DEV, V7, P895, DOI 10.1101/gad.7.5.895; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	42	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54112	10.1371/journal.pone.0054112	http://dx.doi.org/10.1371/journal.pone.0054112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326581	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800108
J	Du, WL; Wang, J; Pang, YH; Li, YL; Chen, XH; Zhao, JX; Yang, QH; Wu, J				Du, Wanli; Wang, Jing; Pang, Yuhui; Li, Yanli; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun			Isolation and Characterization of a Psathyrostachys huashanica Keng 6Ns Chromosome Addition in Common Wheat	PLOS ONE			English	Article							MARKERS; GENE; IDENTIFICATION; INTROGRESSION; RESISTANCE; LOCATION	The development of alien addition lines is important for transferring useful genes from exotic species into common wheat. A hybrid of common wheat cv. 7182 (2n = 6x = 42, AABBDD) and Psathyrostachys huashanica Keng (2n = 2x = 14, NsNs) via embryo culture produced the novel intergeneric disomic addition line 59-11. The seed morphology of 59-11 resembled the parent 7182 and it exhibited extreme agronomic characteristics, i.e., twin stable spikelets, fertile florets, and multi-kernel clusters. Furthermore, 59-11 produced plump kernels with a high seed-setting percentage during the advanced maturation stage. The line was screened based on genomic in situ hybridization, EST-SSR, EST-STS, and gliadin to identify P. huashanica chromatin in the wheat background. The chromosome number and configuration of 59-11 was 2n = 44 = 22 II and we confirmed the 6Ns disomic chromosome additions based on A-PAGE analysis and molecular markers. The results suggested that the production of twin spikelets and multiple kernels per spike in the wheat-P. huashanica addition line was related to homologous group 6 in the wheat chromosome. This is the first report of the introduction of improved spike traits into common wheat from the alien species P. huashanica and it opens up the possibility of increasing the wheat yield based on this enlarged gene pool.	[Du, Wanli; Wang, Jing; Pang, Yuhui; Li, Yanli; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun] NW A& F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, J (corresponding author), NW A& F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China.	wjnwsu@yahoo.com.cn			Ministry of Science and Technology of the People's Repubilc of China [2011AA10010203]; Northwest AF University [Z109021002, A212020716]	Ministry of Science and Technology of the People's Repubilc of China; Northwest AF University	The funds of the Ministry of Science and Technology of the People's Repubilc of China (No. 2011AA10010203) and Northwest A&F University (No. Z109021002, A212020716), which only provide funds for purchases equipments and reagents. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEN C, 1991, NORD J BOT, V11, P3, DOI 10.1111/j.1756-1051.1991.tb01790.x; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Chen SY., 1996, ACTA GENET SIN, V23, P447; Cherif-Mouaki S, 2011, EUPHYTICA, V178, P63, DOI 10.1007/s10681-010-0268-y; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Dobrovolskaya O, 2009, THEOR APPL GENET, V119, P867, DOI 10.1007/s00122-009-1095-1; Guo ZF, 2010, GENES GENOM, V32, P259, DOI 10.1007/s13258-010-0005-x; Hu LJ, 2011, EUPHYTICA, V177, P169, DOI 10.1007/s10681-010-0216-x; Hu LJ, 2012, GENES GENOMICS, DOI 101007/s13258-011-0153-7; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Kang HY, 2009, PLANT BREEDING, V128, P36, DOI 10.1111/j.1439-0523.2008.01542.x; Kang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021802; Kishii M, 2010, GENES GENET SYST, V85, P281, DOI 10.1266/ggs.85.281; Kuo P. C., 1987, FLORA REIPUBLICAE PO, P51; Lin ZS, 2007, EUPHYTICA, V158, P109, DOI 10.1007/s10681-007-9435-1; Lu BR, 1995, CHINESE BIODIVERSITY, V3, P63; Nakazawa D, 2011, EUPHYTICA, V181, P197, DOI 10.1007/s10681-011-0393-2; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rossini L, 2006, THEOR APPL GENET, V112, P1073, DOI 10.1007/s00122-006-0209-2; Vaccino P, 2010, CROP SCI, V50, P528, DOI 10.2135/cropsci2009.04.0179; Walling JG, 2005, METHOD ENZYMOL, V395, P443, DOI 10.1016/S0076-6879(05)95024-6; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Wang Y, 2011, AFR J BIOTECHNOL, V10, P2201; Wang Y, 2011, BIOTECHNOL LETT, V33, P1233, DOI 10.1007/s10529-011-0537-4; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yang ZJ, 2006, EUPHYTICA, V149, P11, DOI 10.1007/s10681-005-9010-6; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zheng Y. L., 1993, Wheat Information Service, P25; Zhuang LF, 2011, MOL BREEDING, V27, P455, DOI 10.1007/s11032-010-9443-z; 魏育明, 1999, [四川农业大学学报, Journal of Sichuan Agricultural University], V17, P136	34	34	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53921	10.1371/journal.pone.0053921	http://dx.doi.org/10.1371/journal.pone.0053921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326537	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400060
J	Ta, LE; Schmelzer, JD; Bieber, AJ; Loprinzi, CL; Sieck, GC; Brederson, JD; Low, PA; Windebank, AJ				Ta, Lauren E.; Schmelzer, James D.; Bieber, Allan J.; Loprinzi, Charles L.; Sieck, Gary C.; Brederson, Jill D.; Low, Philip A.; Windebank, Anthony J.			A Novel and Selective Poly (ADP-Ribose) Polymerase Inhibitor Ameliorates Chemotherapy-Induced Painful Neuropathy	PLOS ONE			English	Article							ROOT GANGLION NEURONS; INDUCED PERIPHERAL NEUROPATHY; ADVANCED COLORECTAL-CANCER; OXIDATIVE STRESS; NERVOUS-SYSTEM; DNA-DAMAGE; PHASE-I; OXALIPLATIN; CISPLATIN; POLY(ADP-RIBOSE)	Background: Chemotherapy-induced neuropathy is the principle dose limiting factor requiring discontinuation of many chemotherapeutic agents, including cisplatin and oxaliplatin. About 30 to 40% of patients receiving chemotherapy develop pain and sensory changes. Given that poly (ADP-ribose) polymerase (PARP) inhibition has been shown to provide neuroprotection, the current study was developed to test whether the novel PARP inhibitor compound 4a (analog of ABT-888) would attenuate pain in cisplatin and oxaliplatin-induced neuropathy in mice. Results: An established chemotherapy-induced painful neuropathy model of two weekly cycles of 10 intraperitoneal (i.p.) injections separated by 5 days rest was used to examine the therapeutic potential of the PARP inhibitor compound 4a. Behavioral testing using von Frey, paw radiant heat, cold plate, and exploratory behaviors were taken at baseline, and followed by testing at 3, 6, and 8 weeks from the beginning of drug treatment. Conclusion: Cisplatin-treated mice developed heat hyperalgesia and mechanical allodynia while oxaliplatin-treated mice exhibited cold hyperalgesia and mechanical allodynia. Co-administration of 50 mg/kg or 25 mg/kg compound 4a with platinum regimen, attenuated cisplatin-induced heat hyperalgesia and mechanical allodynia in a dose dependent manner. Similarly, co-administration of 50 mg/kg compound 4a attenuated oxaliplatin-induced cold hyperalgesia and mechanical allodynia. These data indicate that administration of a novel PARP inhibitor may have important applications as a therapeutic agent for human chemotherapy-induced painful neuropathy.	[Ta, Lauren E.; Schmelzer, James D.; Bieber, Allan J.; Low, Philip A.; Windebank, Anthony J.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Ta, Lauren E.; Bieber, Allan J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Dept Neurosci, Rochester, MN USA; [Ta, Lauren E.; Bieber, Allan J.; Windebank, Anthony J.] Mayo Clin, Coll Med, Program Mol Neurosci, Rochester, MN USA; [Loprinzi, Charles L.] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA; [Sieck, Gary C.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Brederson, Jill D.] Abbott Labs, Abbott Pk, IL 60064 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Abbott Laboratories	Ta, LE (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	ta.lauren@mayo.edu		sieck, gary/0000-0003-3040-9424	National Institutes of Health [NIDCR-DE020868, NCI- CA37404]; American Cancer Society-Institutional Research; Abbott Laboratories; NATIONAL CANCER INSTITUTE [U10CA037404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE020868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research(American Cancer Society); Abbott Laboratories(Abbott Laboratories); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants: NIDCR-DE020868 (L.E.T.), NCI- CA37404 (C.L.L. and L.E.T.), American Cancer Society-Institutional Research Grant New Investigator Award (L.E.T.); an unrestricted research grant from Abbott Laboratories (L.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L.E.T. receives research funding support from Abbott Laboratories. J.D.B. is an employee of Abbott Laboratories. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114; Authier N, 2003, EXP NEUROL, V182, P12, DOI 10.1016/S0014-4886(03)00003-7; Barajon I, 1996, EXP NEUROL, V138, P93, DOI 10.1006/exnr.1996.0050; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; Cata JP, 2008, BRAIN RES, V1230, P91, DOI 10.1016/j.brainres.2008.07.022; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Drel VR, 2009, INVEST OPHTH VIS SCI, V50, P1778, DOI 10.1167/iovs.08-2191; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Furuta T, 2002, CANCER RES, V62, P4899; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HIGBY DJ, 1974, CANCER, V33, P1219, DOI 10.1002/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO;2-U; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Loprinzi Charles L, 2007, J Support Oncol, V5, P119; LOPRINZI CL, 2007, J SUPPORT ONCOL, V5, P128; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; OZOLS RF, 1985, J CLIN ONCOL, V3, P1445, DOI 10.1200/JCO.1985.3.11.1445; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Tortora G, 2002, ANN ONCOL, V13, P392, DOI 10.1093/annonc/mdf030; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Verdu E, 1999, MUSCLE NERVE, V22, P329, DOI 10.1002/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	54	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54161	10.1371/journal.pone.0054161	http://dx.doi.org/10.1371/journal.pone.0054161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326593	gold, Green Submitted, Green Published			2022-12-27	WOS:000313552400081
J	Zhang, W; Johnston, JA; Ross, MA; Sanniec, K; Gleason, EA; Dueck, AC; Santello, M				Zhang, Wei; Johnston, Jamie A.; Ross, Mark A.; Sanniec, Kyle; Gleason, Elizabeth A.; Dueck, Amylou C.; Santello, Marco			Effects of Carpal Tunnel Syndrome on Dexterous Manipulation Are Grip Type-Dependent	PLOS ONE			English	Article							PRECISION GRIP; MEDIAN NERVE; SENSORIMOTOR MEMORY; COMPRESSION; OBJECTS; FORCE; POSITIONS	Carpal tunnel syndrome (CTS) impairs sensation of a subset of digits. Although the effects of CTS on manipulation performed with CTS-affected digits have been studied using precision grip tasks, the extent to which CTS affects multi-digit force coordination has only recently been studied. Whole-hand manipulation studies have shown that CTS patients retain the ability to modulate multi-digit forces to object mass, mass distribution, and texture. However, CTS results in sensorimotor deficits relative to healthy controls, including significantly larger grip force and lower ability to balance the torques generated by the digits. Here we investigated the effects of CTS on multi-digit force modulation to object weight when manipulating an object with a variable number of fingers. We hypothesized that CTS patients would be able to modulate digit forces to object weight. However, as different grip types involve the exclusive use of CTS-affected digits ('uniform' grips) or a combination of CTS-affected and non-affected digits ('mixed' grips), we addressed the question of whether 'mixed' grips would reduce or worsen CTS-induced force coordination deficits. The former scenario would be due to adding digits with intact tactile feedback, whereas the latter scenario might occur due to a potentially greater challenge for the central nervous system of integrating 'noisy' and intact tactile feedback. CTS patients learned multi-digit force modulation to object weight regardless of grip type. Although controls exerted the same total grip force across all grip types, patients exerted significantly larger grip force than controls but only for manipulations with four and five digits. Importantly, this effect was due to CTS patients' inability to change the finger force distribution when adding the ring and little fingers. These findings suggest that CTS primarily challenges sensorimotor integration processes for dexterous manipulation underlying the coordination of CTS-affected and non-affected digits.	[Zhang, Wei; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Zhang, Wei] CUNY Coll Staten Isl, Dept Phys Therapy, Staten Isl, NY USA; [Johnston, Jamie A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Johnston, Jamie A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Ross, Mark A.; Sanniec, Kyle; Gleason, Elizabeth A.; Dueck, Amylou C.] Mayo Clin Hosp, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Calgary; University of Calgary; Mayo Clinic; Mayo Clinic Phoenix	Santello, M (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	marco.santello@asu.edu	zhang, wei/AAV-9554-2021	zhang, wei/0000-0002-2341-0876	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH) [1R01 HD057152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057152] Funding Source: NIH RePORTER	National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by grant number 1R01 HD057152 from the National Institute of Child and Health Development (NICHD) at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi M, 2012, CLIN NEUROPHYSIOL, V123, P2281, DOI 10.1016/j.clinph.2012.04.013; Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Cole KJ, 2003, EXP BRAIN RES, V148, P150, DOI 10.1007/s00221-002-1283-6; Dun S, 2007, J ELECTROMYOGR KINES, V17, P348, DOI 10.1016/j.jelekin.2006.02.002; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Jaberzadeh S, 2006, MANUAL THER, V11, P22, DOI 10.1016/j.math.2005.02.007; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Napadow V, 2006, NEUROIMAGE, V31, P520, DOI 10.1016/j.neuroimage.2005.12.017; Nowak DA, 2003, CLIN NEUROPHYSIOL, V114, P472, DOI 10.1016/S1388-2457(02)00386-3; Papanicolaou GD, 2001, J HAND SURG-AM, V26A, P460, DOI 10.1053/jhsu.2001.24972; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Thonnard JL, 1999, EXP BRAIN RES, V128, P61, DOI 10.1007/s002210050817; Tinazzi M, 1998, BRAIN, V121, P1785, DOI 10.1093/brain/121.9.1785; Zhang W, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-83; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53751	10.1371/journal.pone.0053751	http://dx.doi.org/10.1371/journal.pone.0053751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326498	Green Published, gold			2022-12-27	WOS:000313552400041
J	Mochida, K; Hasegawa, A; Li, MW; Fray, MD; Kito, S; Vallelunga, JM; Lloyd, KCK; Yoshiki, A; Obata, Y; Ogura, A				Mochida, Keiji; Hasegawa, Ayumi; Li, Ming-Wen; Fray, Martin D.; Kito, Seiji; Vallelunga, Jadine M.; Lloyd, K. C. Kent; Yoshiki, Atsushi; Obata, Yuichi; Ogura, Atsuo			High Osmolality Vitrification: A New Method for the Simple and Temperature-Permissive Cryopreservation of Mouse Embryos	PLOS ONE			English	Article							FERTILIZATION; INVITRO; BLASTOCYSTS; SURVIVAL; BIRTH	Procedures for cryopreserving embryos vary considerably, each having its specific advantages and disadvantages in terms of technical feasibility, embryo survival yield, temperature permissibility and species-or strain-dependent applicability. Here we report a high osmolality vitrification (HOV) method that is advantageous in these respects. Cryopreservation by vitrification is generally very simple, but, unlike slow freezing, embryos should be kept at a supercooling temperature (below -130 degrees C) to avoid cryodamage. We overcame this problem by using an HOV solution containing 42.5% (v/v) ethylene glycol, 17.3% (w/v) Ficoll and 1.0 M sucrose. This solution is more viscous than other cryopreservation solutions, but easy handling of embryos was assured by employing a less viscous equilibration solution before vitrification. Most (>80%) embryos cryopreserved in this solution survived at -80 degrees C for at least 30 days. Normal mice were recovered even after intercontinental transportation in a conventional dry-ice package for 2-3 days, indicating that special containers such as dry shippers with liquid nitrogen vapor are unnecessary. The HOV solution could also be employed for long-term storage in liquid nitrogen, as with other conventional cryoprotectants. Finally, we confirmed that this new vitrification method could be applied successfully to embryos of all six strains of mice we have tested so far. Thus, our HOV method provides an efficient and reliable strategy for the routine cryopreservation of mouse embryos in animal facilities and biomedical laboratories, and for easy and cheap transportation.	[Mochida, Keiji; Hasegawa, Ayumi; Yoshiki, Atsushi; Obata, Yuichi; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Li, Ming-Wen; Vallelunga, Jadine M.; Lloyd, K. C. Kent] Univ Calif Davis, Sch Vet Med, Mouse Biol Program, Davis, CA 95616 USA; [Fray, Martin D.] Harwell Sci & Innovat Ctr, Med Res Council, Mary Lyon Ctr, Oxford, England; [Kito, Seiji] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan	RIKEN; University of California System; University of California Davis; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); National Institutes for Quantum Science & Technology; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Obata, Yuichi/A-5300-2016; Yoshiki, Atsushi/O-6162-2019; Ogura, Atsuo/J-3916-2014	Obata, Yuichi/0000-0003-1839-4709; Yoshiki, Atsushi/0000-0002-9450-5151; Ogura, Atsuo/0000-0003-0447-1988	Fundamental Technologies Upgrading Program; National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT Japan; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210, U42OD011175] Funding Source: NIH RePORTER	Fundamental Technologies Upgrading Program; National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Fundamental Technologies Upgrading Program, the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan and a Grant-in-Aid from the MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Han MS, 2003, THERIOGENOLOGY, V59, P1851, DOI 10.1016/S0093-691X(02)01227-X; Hasegawa A, 2012, J REPROD DEVELOP, V58, P156, DOI 10.1262/jrd.11-097N; HOCHI S, 1994, THERIOGENOLOGY, V42, P483, DOI 10.1016/0093-691X(94)90686-D; Jin B, 2010, BIOL REPROD, V82, P444, DOI 10.1095/biolreprod.109.077685; KASAI M, 1992, BIOL REPROD, V46, P1042, DOI 10.1095/biolreprod46.6.1042; KASAI M, 1990, J REPROD FERTIL, V89, P91, DOI 10.1530/jrf.0.0890091; Martinez AG, 1998, THERIOGENOLOGY, V49, P1039, DOI 10.1016/S0093-691X(98)00052-1; Mochida K, 2005, THERIOGENOLOGY, V64, P135, DOI 10.1016/j.theriogenology.2004.11.013; Mochida K, 2005, MOL REPROD DEV, V70, P464, DOI 10.1002/mrd.20226; Mochida K., 2010, J MAMMALIAN OVA RES, V27, P87, DOI [10.1274/jmor.27.87, DOI 10.1274/JMOR.27.87]; Mochida K, 2001, REPROD BIOTECHNOLOGY, P279; Mochida K, 2011, J VIS EXP, V57; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; QUINN P, 1985, FERTIL STERIL, V44, P493; TACHIKAWA S, 1993, MOL REPROD DEV, V34, P266, DOI 10.1002/mrd.1080340306; VALDEZ CA, 1992, J REPROD FERTIL, V96, P793, DOI 10.1530/jrf.0.0960793; WHITTINGHAM DG, 1974, GENETICS, V78, P395; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zhou GB, 2005, ANIM BIOTECHNOL, V16, P153, DOI 10.1080/10495390500263831	21	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e49316	10.1371/journal.pone.0049316	http://dx.doi.org/10.1371/journal.pone.0049316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341870	Green Published, gold, Green Submitted			2022-12-27	WOS:000313682700003
J	Moore, JE; Barlow, JP				Moore, Jeffrey E.; Barlow, Jay P.			Declining Abundance of Beaked Whales ( Family Ziphiidae) in the California Current Large Marine Ecosystem	PLOS ONE			English	Article							LINE-TRANSECT SURVEYS; POPULATION-DENSITY; BERARDIUS-BAIRDII; NORTH PACIFIC; CETACEANS; TRENDS; BYCATCH; OXYGEN; NOISE; SEA	Beaked whales are among the most diverse yet least understood groups of marine mammals. A diverse set of mostly anthropogenic threats necessitates improvement in our ability to assess population status for this cryptic group. The Southwest Fisheries Science Center (NOAA) conducted six ship line-transect cetacean abundance surveys in the California Current off the contiguous western United States between 1991 and 2008. We used a Bayesian hidden-process modeling approach to estimate abundance and population trends of beaked whales using sightings data from these surveys. We also compiled records of beaked whale stranding events (3 genera, at least 8 species) on adjacent beaches from 1900 to 2012, to help assess population status of beaked whales in the northern part of the California Current. Bayesian posterior summaries for trend parameters provide strong evidence of declining beaked whale abundance in the study area. The probability of negative trend for Cuvier's beaked whale (Ziphius cavirostris) during 1991-2008 was 0.84, with 1991 and 2008 estimates of 10771 (CV = 0.51) and approximate to 7550 (CV = 0.55), respectively. The probability of decline for Mesoplodon spp. (pooled across species) was 0.96, with 1991 and 2008 estimates of 2206 (CV = 0.46) and 811 (CV = 0.65). The mean posterior estimates for average rate of decline were 2.9% and 7.0% per year. There was no evidence of abundance trend for Baird's beaked whale (Berardius bairdii), for which annual abundance estimates in the survey area ranged from approximate to 900 to 1300 (CV approximate to 1.3). Stranding data were consistent with the survey results. Causes of apparent declines are unknown. Direct impacts of fisheries (bycatch) can be ruled out, but impacts of anthropogenic sound (e.g., naval active sonar) and ecosystem change are plausible hypotheses that merit investigation.	[Moore, Jeffrey E.; Barlow, Jay P.] NOAA, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Moore, JE (corresponding author), NOAA, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA.	jeff.e.moore@noaa.gov	Barlow, Jay/D-3565-2019	Barlow, Jay/0000-0001-7862-855X	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Research was supported by the National Oceanic and Atmospheric Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Antonelis George A., 1994, P211; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baker CS, 2006, ANIM CONSERV, V9, P474, DOI 10.1111/j.1469-1795.2006.00062.x; Barlow J, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P209; Barlow J, 2010, NOAATMNMFSSWFSC456; Barlow J, 2007, FISH B-NOAA, V105, P509; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Buckland S.T., 2001, pi; Carretta J V, 2003, MAR FISH REV, V66, P21; Carretta JV, 2008, MAR MAMMAL SCI, V24, P956, DOI 10.1111/j.1748-7692.2008.00218.x; Carretta James V., 2011, Bulletin Southern California Academy of Sciences, V110, P152; Carretta JV, 2011, NMFSSWFSC488 NOAA US; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Claridge DE, 2012, 2012 MARINE MAMMALS; Committee on Taxonomy, 2012, LIST MAR MAMM SPEC S; Condit R, 2012, MARINE MAMM IN PRESS; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Dalebout ML, 2002, MAR MAMMAL SCI, V18, P577, DOI 10.1111/j.1748-7692.2002.tb01061.x; Danil Kerri, 2010, Journal of Cetacean Research and Management, V11, P163; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Faerber MM, 2010, MAR MAMMAL SCI, V26, P602, DOI 10.1111/j.1748-7692.2010.00370.x; Falcone EA, 2009, MAR BIOL, V156, P2631, DOI 10.1007/s00227-009-1289-8; Fernandez A, 2004, NATURE, V428, DOI 10.1038/nature02528; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Fiscus CH, 1989, 83 NOAA NMFS US DEP; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hooker SK, 2012, P ROY SOC B-BIOL SCI, V279, P1041, DOI 10.1098/rspb.2011.2088; *IWC, 2012, REP SCI COMM; IWC (International Whaling Commisssion), 2012, J CETACEAN RES MANAG, V13, P263; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; Julian F, 1998, FISH B-NOAA, V96, P271; Keller AA, 2012, FISH B-NOAA, V110, P205; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kinzey D., 2000, LJ0008 NOAA SWFSC; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P211; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P271; Marques FFC, 2004, ADV DISTANCE SAMPLIN; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; MEAD JG, 1981, J MAMMAL, V62, P430, DOI 10.2307/1380733; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Moretti D, 2006, P OC 2006 MTS IEEE C; Norman S. A., 2004, Journal of Cetacean Research and Management, V6, P87; Northridge S, 1996, ESTIMATION CET UNPUB; Ohizumi H, 2003, FISHERIES SCI, V69, P11, DOI 10.1046/j.1444-2906.2003.00582.x; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Perrin WF, 2011, MAR MAMMAL SCI, V27, P769, DOI 10.1111/j.1748-7692.2010.00442.x; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pierce SD, 2012, J PHYS OCEANOGR, V42, P495, DOI 10.1175/JPO-D-11-0170.1; Pitman R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P721; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Spiegelhalter D., 2007, WINBUGS USER MANUAL; Stewart Brent S., 1994, P29; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Thompson WL, 2004, SAMPLING RARE ELUSIV; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Walker WA, 2002, MAR MAMMAL SCI, V18, P902, DOI 10.1111/j.1748-7692.2002.tb01081.x; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Wright A.J., 2007, INTERJ COMP PSYCHO, V20, P274, DOI DOI 10.5070/P4202009994; Wright AJ, 2011, MAR POLLUT BULL, V63, P5, DOI 10.1016/j.marpolbul.2009.11.024; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	43	45	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52770	10.1371/journal.pone.0052770	http://dx.doi.org/10.1371/journal.pone.0052770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341907	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700014
J	Pineda, B; Garcia-Perez, MA; Cano, A; Lluch, A; Eroles, P				Pineda, Begona; Angel Garcia-Perez, Miguel; Cano, Antonio; Lluch, Ana; Eroles, Pilar			Associations between Aromatase CYP19 rs10046 Polymorphism and Breast Cancer Risk: From a Case-Control to a Meta-Analysis of 20,098 Subjects	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISMS; SITE POLYMORPHISM; ESTROGEN-LEVELS; PATHWAY; VARIANTS; JAPANESE; BRCA1	Lifetime exposure to estrogen is a factor that plays an important role in the pathogenesis and progression of breast cancer. Genetic variants in genes of the biosynthesis and metabolism of estrogen have been associated with breast cancer risk. Among them, the CYP19 gene encodes for aromatase, the enzyme that catalyzes the conversion of androgens to estrogens. The rs10046 polymorphism on the CYP19 gene has been related to levels of circulating estradiol and to the estradiol/testosterone ratio. To date, epidemiological studies of rs10046 have been performed in different populations with contradictory results. In the present study, we have conducted a case-control analysis (522 cases and 1221 controls) in a Spanish population. Furthermore, we have performed a meta-analysis including 20,098 subjects (7,998 cases and 12,100 controls) to summarize the data available for rs10046 and breast cancer risk. An odds ratio (OR) with a 95% confidence interval (CI) was applied to assess the association. The results of our case-control study show an association between the carriers of at least one C allele (dominant model) and breast cancer risk (OR = 1.29, 95% CI 1.01-1.66, p-value = 0.038). The meta-analysis shows no significant association with breast cancer risk in any of the genetic models tested. The analysis by ethnic subgroups also failed to produce associations. The evaluation of heterogeneity, influence analysis, and publication bias confirms the reliability of the analysis. We can conclude that the rs10046 polymorphism on CYP19 by itself does not constitute breast cancer risk. We cannot, however, reject the possibility that it could contribute (interact), together with other genetic variants, to modify the circulating levels of estradiol.	[Pineda, Begona; Angel Garcia-Perez, Miguel; Cano, Antonio; Lluch, Ana; Eroles, Pilar] Inst Hlth Res INCLIVA, Valencia, Spain; [Angel Garcia-Perez, Miguel] Univ Valencia, Dept Genet, Valencia, Spain; [Cano, Antonio] Univ Valencia, Dept Pediat Obstet & Gynecol, Valencia, Spain; [Lluch, Ana] Univ Hosp Valencia, Dept Haematol & Med Oncol, Valencia, Spain	University of Valencia; University of Valencia	Eroles, P (corresponding author), Inst Hlth Res INCLIVA, Valencia, Spain.	pilar.eroles@uv.es	Lluch, Ana/R-5493-2019; Garcia Perez, Miguel Angel/S-8090-2018	Lluch, Ana/0000-0003-2766-407X; Garcia Perez, Miguel Angel/0000-0002-0626-7502; Eroles, Pilar/0000-0003-2708-6206	Ministerio de Ciencia y Tecnologia- Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PS09/01700]; RTICC [RD06/0020/0080]; Conselleria de Sanidad Valenciana [GE-004/09]; Miguel Servet program (Instituto Salud Carlos III) [FIS03/0090]; Ministerio de Ciencia e Innovacion [JCI-2011-11435];  [PS09/0184];  [PS09/01687]	Ministerio de Ciencia y Tecnologia- Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; RTICC(Instituto de Salud Carlos III); Conselleria de Sanidad Valenciana; Miguel Servet program (Instituto Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ; 	This work has been supported by grants PS09/01700 (Ministerio de Ciencia y Tecnologia- Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III) and RD06/0020/0080 (RTICC) to ALL, by grant GE-004/09 (Conselleria de Sanidad Valenciana) to PE, by grant PS09/0184 to MAG and by grant PS09/01687 to AC. PE is supported by the Miguel Servet program (Instituto Salud Carlos III, FIS03/0090), and BP has been hired under the Juan de la Cierva program (ref. JCI-2011-11435, Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen XW, 2006, HUM MUTAT, V27, P427, DOI 10.1002/humu.20319; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Darabi H, 2011, BREAST CANCER RES TR, V127, P503, DOI 10.1007/s10549-010-1218-z; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dumas I, 2011, ANTICANCER RES, V31, P4369; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Fasching PA, 2008, BREAST CANCER RES TR, V112, P89, DOI 10.1007/s10549-007-9822-2; Garcia-Casado Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-36; Gennari L, 2004, J CLIN ENDOCR METAB, V89, P2803, DOI 10.1210/jc.2003-031342; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Gleser LJ, 1996, STAT MED, V15, P2493, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2493::AID-SIM381>3.0.CO;2-C; Haiman CA, 2000, INT J CANCER, V87, P204, DOI 10.1002/1097-0215(20000715)87:2<204::AID-IJC8>3.3.CO;2-V; Haiman CA, 2002, CANCER EPIDEM BIOMAR, V11, P215; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Iwasaki M, 2010, NUTR CANCER, V62, P466, DOI 10.1080/01635580903441279; JENG GT, 1995, JAMA-J AM MED ASSOC, V274, P830, DOI 10.1001/jama.274.10.830; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; Kristensen VN, 2000, ONCOGENE, V19, P1329, DOI 10.1038/sj.onc.1203425; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lian K, 2005, ARTHRITIS RHEUM-US, V52, P1431, DOI 10.1002/art.21011; Long JR, 2006, CANCER EPIDEM BIOMAR, V15, P2115, DOI 10.1158/1055-9965.EPI-06-0464; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin AM, 2000, JNCI-J NATL CANCER I, V92, P1126, DOI 10.1093/jnci/92.14.1126; Olson JE, 2007, BREAST CANCER RES TR, V102, P237, DOI 10.1007/s10549-006-9324-7; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Pedraza AM, 2012, BREAST CANC RES TREA; Ralph DA, 2007, CANCER, V109, P1940, DOI 10.1002/cncr.22634; Raskin L, 2009, CANCER EPIDEM BIOMAR, V18, P1617, DOI 10.1158/1055-9965.EPI-09-0060; Rodrigues P, 2012, BREAST CANC RES TREA; Skorupski P, 2006, AM J OBSTET GYNECOL, V194, P346, DOI 10.1016/j.ajog.2005.07.034; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Song M, 2011, MOL CARCINOGEN, V50, P280, DOI 10.1002/mc.20639; Tworoger SS, 2004, CANCER EPIDEM BIOMAR, V13, P94, DOI 10.1158/1055-9965.EPI-03-0026; Yoshimoto N, 2011, CANCER SCI, V102, P2065, DOI 10.1111/j.1349-7006.2011.02047.x; Zhang LN, 2009, BREAST CANCER RES TR, V114, P327, DOI 10.1007/s10549-008-9998-0	44	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53902	10.1371/journal.pone.0053902	http://dx.doi.org/10.1371/journal.pone.0053902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342035	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700061
J	Van Lier, J; Revlin, R; De Neys, W				Van Lier, Jens; Revlin, Russell; De Neys, Wim			Detecting Cheaters without Thinking: Testing the Automaticity of the Cheater Detection Module	PLOS ONE			English	Article							SOCIAL-EXCHANGE; SELECTION TASK; EVOLUTIONARY PSYCHOLOGY; COGNITIVE REFLECTION; WORKING-MEMORY; 2 SYSTEMS; HYPOTHESIS; INTELLIGENCE; HEURISTICS; MODULARITY	Evolutionary psychologists have suggested that our brain is composed of evolved mechanisms. One extensively studied mechanism is the cheater detection module. This module would make people very good at detecting cheaters in a social exchange. A vast amount of research has illustrated performance facilitation on social contract selection tasks. This facilitation is attributed to the alleged automatic and isolated operation of the module (i.e., independent of general cognitive capacity). This study, using the selection task, tested the critical automaticity assumption in three experiments. Experiments 1 and 2 established that performance on social contract versions did not depend on cognitive capacity or age. Experiment 3 showed that experimentally burdening cognitive resources with a secondary task had no impact on performance on the social contract version. However, in all experiments, performance on a non-social contract version did depend on available cognitive capacity. Overall, findings validate the automatic and effortless nature of social exchange reasoning.	[Van Lier, Jens] Univ Louvain, Dept Psychol, Res Fdn Flanders FWO, Louvain, Belgium; [Revlin, Russell] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [De Neys, Wim] Paris Descartes Univ, CNRS, LaPsyDE CNRS Unit 3521, Paris, France	University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Van Lier, J (corresponding author), Univ Louvain, Dept Psychol, Res Fdn Flanders FWO, Louvain, Belgium.	jens.vanlier@ppw.kuleuven.be			KU Leuven Center of Excellence on Generalization Research [GRIP*TT;PF/10/005]	KU Leuven Center of Excellence on Generalization Research	Writing of this manuscript was partly supported by KU Leuven Center of Excellence on Generalization Research (GRIP*TT;PF/10/005). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Barrett HC, 2006, J PERS SOC PSYCHOL, V91, P513, DOI 10.1037/0022-3514.91.3.513; BETHELLFOX CE, 1988, J EXP PSYCHOL HUMAN, V14, P12, DOI 10.1037/0096-1523.14.1.12; Carlisle E, 2005, THINK REASONING, V11, P97, DOI 10.1080/13546780442000079; COSMIDES L, 1994, AM ECON REV, V84, P327; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cosmides L., 2008, MORAL PSYCHOL EVOLUT, V1, P53; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; De Neys W, 2006, Q J EXP PSYCHOL, V59, P1070, DOI 10.1080/02724980543000123; de Neys W, 2006, PSYCHOL SCI, V17, P428, DOI 10.1111/j.1467-9280.2006.01723.x; De Neys W, 2007, EXP PSYCHOL, V54, P128, DOI 10.1027/1618-3169.54.2.128; De Neys W, 2006, EXP PSYCHOL, V53, P123, DOI 10.1027/1618-3169.53.1.123; Ermer E, 2006, SOC NEUROSCI-UK, V1, P196, DOI 10.1080/17470910600989771; Evans J.S.B.T., 1993, HUMAN REASONING PSYC; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Harris PL, 2001, MEM COGNITION, V29, P757, DOI 10.3758/BF03200478; Just MA, 1996, PSYCHOL REV, V103, P773, DOI 10.1037/0033-295X.103.4.773; Kaufman SB, 2011, INTELLIGENCE, V39, P311, DOI 10.1016/j.intell.2011.05.002; Kurzban R., 2010, WHY EVERYONE ELSE IS, DOI DOI 10.1515/9781400835997; Liberman N, 1996, COGNITION, V58, P127, DOI 10.1016/0010-0277(95)00677-X; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Over DE, 2003, CURR ISS THINK REASO, P1; POLLARD P, 1987, AM J PSYCHOL, V100, P41, DOI 10.2307/1422641; Samuels R, 1998, BRIT J PHILOS SCI, V49, P575, DOI 10.1093/bjps/49.4.575; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Sperber D, 2002, COGNITION, V85, P277, DOI 10.1016/S0010-0277(02)00125-7; Sperber D, 2000, MATE MENTALITY EVALU; Stanovich K., 1998, THINK REASONING, V4, P193, DOI DOI 10.1080/135467898394139; Stone VE, 2002, P NATL ACAD SCI USA, V99, P11531, DOI 10.1073/pnas.122352699; Sugiyama LS, 2002, P NATL ACAD SCI USA, V99, P11537, DOI 10.1073/pnas.122352999; Tentori K., 2008, MIND SOC, V7, P167, DOI DOI 10.1007/S11299-007-0045-3; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; Wason P. C., 1966, NEW HORIZONS PSYCHOL, VI, P106; Yamagishi T, 2003, EVOL HUM BEHAV, V24, P290, DOI 10.1016/S1090-5138(03)00035-7; [No title captured]	42	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53827	10.1371/journal.pone.0053827	http://dx.doi.org/10.1371/journal.pone.0053827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	072OV	23342012	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700048
J	Tian, C; Ye, XL; Zhang, R; Long, J; Ren, WY; Ding, SB; Liao, D; Jin, X; Wu, HM; Xu, SQ; Ying, CJ				Tian, Chong; Ye, Xiaolei; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Wu, Hongmei; Xu, Shunqin; Ying, Chenjiang			Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats via erk1/2-PPAR gamma-Adiponectin Pathway	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; COMPLEMENT-RELATED PROTEIN; MESSENGER-RNA EXPRESSION; PPAR-GAMMA; INSULIN SENSITIVITY; METABOLIC SYNDROME; ADIPONECTIN LEVELS; HORMONE ADIPONECTIN; GENE-EXPRESSION; DOWN-REGULATION	Objective: Hypoadiponectinemia contributes to the development of obesity and related disorders such as diabetes, hyperlipidemia, and cardiovascular diseases. In this study we investigated the effects of green tea polyphenols (GTPs) on adiponectin levels and fat deposits in high fat (HF) fed rats, the mechanism of signaling pathway was explored as well. Methods and Results: Male Wistar rats were fed with high-fat diet. GTPs (0.8, 1.6, 3.2 g/L) were administered via drinking water. Serum adiponectin and insulin were measured by ELISA, mRNA levels of adiponectin and PPAR gamma in visceral adipose tissue (VAT) were determined by Real-time PCR, protein levels of PPAR gamma, phospho (p) -PPAR gamma, extracellular signal regulated kinase (erk) 1/2 and p-erk1/2 in VAT were determined by western blot. GTPs treatment attenuated the VAT accumulation, hypoadiponectinemia and the decreased mRNA level of adiponectin in VAT induced by HF. Decreased expression and increased phosphorylation of PPAR gamma (the master regulator of adiponectin), and increased activation of erk1/2 were observed in HF group, and these effects could be alleviated by GTPs treatment. To explore the underlying mechanism, VAT was cultured in DMEM with high glucose to mimic the hyperglycemia condition in vitro. Similar to the results of in vivo study, decreased adiponectin levels, decreased expression and increased phosphorylation of PPAR gamma, and elevated erk1/2 phosphorylation in cultured VAT were observed. These effects could be ameliorated by co-treatment with GTPs or PD98059 (a selective inhibitor of erk1/2). Conclusion: GTPs reduced fat deposit, ameliorated hypoadiponectinemia in HF-fed rats, and relieved high glucose-induced adiponectin decrease in VAT in vitro. The signaling pathway analysis indicated that PPAR gamma regulation mediated via erk1/2 pathway was involved.	[Tian, Chong; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Ying, Chenjiang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tian, Chong; Zhang, Rui; Long, Jia; Ren, Weiye; Ding, Shibin; Liao, Dan; Jin, Xin; Xu, Shunqin; Ying, Chenjiang] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Minist Educ, Tongji Med Coll,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Ye, Xiaolei; Wu, Hongmei] WenZhou Med Coll, Dept Publ Hlth, Wenzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wenzhou Medical University	Ying, CJ (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China.	yingchenjiang@yahoo.com	Ying, Chen Jiang/H-7708-2019; Tian, Chong/C-2872-2013; Ying, Chen/GRX-5695-2022; Tian, Chong/AAE-7514-2022	Ying, Chen Jiang/0000-0003-4813-5951; Tian, Chong/0000-0002-3231-9409	National Basic Research Program of China (973 Program) [2012CB722401]; National Natural Science Foundation of China [30972473, 81030051, 81172674, 81273060]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program)(Project No. 2012CB722401; http://www.973.gov.cn/Default_3.aspx), National Natural Science Foundation of China (Grant No. 30972473, 81030051,81172674, 81273060; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; DeClercq V, 2011, METABOLIC SYNDROME U, P73; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gayet C, 2007, BRIT J NUTR, V98, P497, DOI 10.1017/S000711450772514X; Gonzalez-Sanchez JL, 2005, OBES RES, V13, P807, DOI 10.1038/oby.2005.91; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kaplan JM, 2010, MOL MED, V16, P491, DOI 10.2119/molmed.2010.00063; Kasim-Karakas SE, 2006, AM J CLIN NUTR, V83, P774, DOI 10.1093/ajcn/83.4.774; Kriketos AD, 2004, DIABETES CARE, V27, P629, DOI 10.2337/diacare.27.2.629; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Kursawe R, 2010, OBESITY, V18, P1911, DOI 10.1038/oby.2010.23; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Milan G, 2002, OBES RES, V10, P1095, DOI 10.1038/oby.2002.149; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Oberthuer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038481; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Panagopoulou P, 2009, J PEDIATR ENDOCR MET, V22, P955; Park KS, 1997, DIABETES, V46, P1230, DOI 10.2337/diabetes.46.7.1230; Pories WJ, 2008, J CLIN ENDOCR METAB, V93, pS89, DOI 10.1210/jc.2008-1641; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Qi L, 2005, DIABETES CARE, V28, P1022, DOI 10.2337/diacare.28.5.1022; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Renaldi Olly, 2009, Acta Med Indones, V41, P20; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386; Sharabi Y, 2007, AM J HYPERTENS, V20, P206, DOI 10.1016/j.amjhyper.2006.08.002; Shiniada M, 2007, BIOSCI BIOTECH BIOCH, V71, P2079, DOI 10.1271/bbb.70174; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yamane T, 2011, MOL NUTR FOOD RES, V55, pS186, DOI 10.1002/mnfr.201100144; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zeng Q, 2007, J ATHEROSCLER THROMB, V14, P261, DOI 10.5551/jat.E498	64	76	82	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53796	10.1371/journal.pone.0053796	http://dx.doi.org/10.1371/journal.pone.0053796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23342006	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700032
J	Makhluf, H; Buck, MD; King, K; Perry, ST; Henn, MR; Shresta, S				Makhluf, Huda; Buck, Michael D.; King, Kevin; Perry, Stuart T.; Henn, Matthew R.; Shresta, Sujan			Tracking the Evolution of Dengue Virus Strains D2S10 and D2S20 by 454 Pyrosequencing	PLOS ONE			English	Article							IN-VIVO; DISEASE; MICE; RNA	Dengue virus is the most prevalent mosquito-borne virus worldwide. In this study, we used pyrosequencing to analyze the whole viral genome of two mouse-adapted strains, D2S10 and D2S20, that induce a dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)-like lethal disease in mice lacking the type I and/or type II interferon receptors. Previous experiments with D2S10 indicated that N124D and K128E mutations in the envelope protein were responsible for the severe disease induced in mice compared to its parental strain PL046. Here we demonstrate that D2S20 is more virulent than D2S10 and captured the presence of five key amino acid mutations - T70I, N83D, and K122I in envelope (E), and A62T in nonstructural protein 2A (NS2A) and G605V in nonstructural protein 5 (NS5) - that may account for this. These findings set the foundation for further dissection of the viral determinants responsible for dengue disease manifestations in mouse models.	[Makhluf, Huda; Buck, Michael D.; King, Kevin; Perry, Stuart T.; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Makhluf, Huda] Natl Univ, Dept Math & Nat Sci, La Jolla, CA USA; [Henn, Matthew R.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	La Jolla Institute for Immunology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.	sujan@liai.org		Buck, Michael/0000-0002-9611-1199	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense [U54AI057517]; NIH [HHSN272200900042C, HHSN272200900018C]	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services, under grant no. U54AI057517 from the Southeastern Regional Center of Excellence for Emerging Infectious and Biodefense (SS) and NIH Contracts HHSN272200900042C (SS) and HHSN272200900018C (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P., 2012, J VIROL IN PRESS; Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06; Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; World Health Organization, 2009, DENG GUID DIAGN TREA, P147, DOI DOI 10.7705/BIOMEDICA.V37I4.3370; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	14	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54220	10.1371/journal.pone.0054220	http://dx.doi.org/10.1371/journal.pone.0054220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342105	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400134
J	Rada, B; Jendrysik, MA; Pang, L; Hayes, CP; Yoo, DG; Park, JJ; Moskowitz, SM; Malech, HL; Leto, TL				Rada, Balazs; Jendrysik, Meghan A.; Pang, Lan; Hayes, Craig P.; Yoo, Dae-goon; Park, Jonathan J.; Moskowitz, Samuel M.; Malech, Harry L.; Leto, Thomas L.			Pyocyanin-Enhanced Neutrophil Extracellular Trap Formation Requires the NADPH Oxidase	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; DUAL OXIDASE; INFECTION; SPUTUM; DECONDENSATION; ACTIVATION; MECHANISM; AUTOPHAGY	Beyond intracellular killing, a novel neutrophil-based antimicrobial mechanism has been recently discovered: entrapment and killing by neutrophil extracellular traps (NETs). NETs consist of extruded nuclear DNA webs decorated with granule proteins. Although NET formation is an important innate immune mechanism, uncontrolled NET release damages host tissues and has been linked to several diseases including cystic fibrosis (CF). The major CF airway pathogen Pseudomonas aeruginosa establishes chronic infection. Pseudomonas imbedded within biofilms is protected against the immune system, but maintains chronic inflammation that worsens disease symptoms. Aberrant NET release from recruited neutrophils was found in CF, but the underlying mechanisms remain unclear. One of the most important Pseudomonas virulence factors is pyocyanin, a redox-active pigment that has been associated with diminished lung function in CF. Here we show that pyocyanin promotes NET formation in a time-and dose-dependent manner. Most CF Pseudomonas clinical isolates tested produce pyocyanin in vitro. Pyocyanin-derived reactive oxygen species are required for its NET release. Inhibitor experiments demonstrated involvement of Jun N-terminal Kinase (JNK) and phosphatidylinositol 3-Kinase (PI3K) in pyocyanin-induced NET formation. Pyocyanin-induced NETs also require the NADPH oxidase because NET release in chronic granulomatous disease neutrophils was greatly reduced. Comparison of neutrophils from gp91phox- and p47phox-deficient patients revealed that pyocyanin-triggered NET formation is proportional to their residual superoxide production. Our studies identify pyocyanin as the first secreted bacterial toxin that enhances NET formation. The involvement of NADPH oxidase in pyocyanin-induced NET formation represents a novel mechanism of pyocyanin toxicity.	[Rada, Balazs; Jendrysik, Meghan A.; Park, Jonathan J.; Malech, Harry L.; Leto, Thomas L.] NIAID, Lab Host Def, NIH, Rockville, MD USA; [Rada, Balazs; Pang, Lan; Hayes, Craig P.; Yoo, Dae-goon] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Moskowitz, Samuel M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Moskowitz, Samuel M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Georgia; University of Georgia; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rada, B (corresponding author), NIAID, Lab Host Def, NIH, Rockville, MD USA.	radab@uga.edu; tleto@niaid.nih.gov		Malech, Harry/0000-0001-5874-5775; Park, Jonathan/0000-0001-5887-3953	National Institutes of Health, National Institute of Allergy and Infectious Diseases [ZO1-AI-000614]; Public Health Service from the National Heart Lung and Blood Institute [K08HL067903]; Public Health Service from the National Institute of Allergy and Infectious Diseases [R01AI067653]; CF Foundation [MOSKOW01A0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, ZIAAI000988, R01AI067653, ZIAAI000645, Z01AI000614] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service from the National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CF Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds to TLL from the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (ZO1-AI-000614), by Public Health Service grants K08HL067903 to SMM from the National Heart Lung and Blood Institute and R01AI067653 to SMM from the National Institute of Allergy and Infectious Diseases and by grant MOSKOW01A0 to SMM from the CF Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Carlsson A, 2003, CLIN EXP RHEUMATOL, V21, pS95; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang J, 2009, AUTOPHAGY, V5, P887, DOI 10.4161/auto.9125; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Kim JS, 2006, CHEST, V129, P1148, DOI 10.1378/chest.129.5.1148; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MULLER PK, 1989, INFECT IMMUN, V57, P2591; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2009, IMMUNOL RES, V43, P198, DOI 10.1007/s12026-008-8071-8; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Ueyama T, 2011, J BIOL CHEM, V286, P40693, DOI 10.1074/jbc.M111.237289; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637	48	76	80	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54205	10.1371/journal.pone.0054205	http://dx.doi.org/10.1371/journal.pone.0054205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342104	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400133
J	Reinecke, D; Schwede, F; Genieser, HG; Seifert, R				Reinecke, Daniel; Schwede, Frank; Genieser, Hans-Gottfried; Seifert, Roland			Analysis of Substrate Specificity and Kinetics of Cyclic Nucleotide Phosphodiesterases with N '-Methylanthraniloyl-Substituted Purine and Pyrimidine 3 ',5 '-Cyclic Nucleotides by Fluorescence Spectrometry	PLOS ONE			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; ADENYLYL-CYCLASE; PROTEIN-KINASES; EDEMA FACTOR; CGMP; PURIFICATION; CMP; CALMODULIN; BINDING; IDENTIFICATION	As second messengers, the cyclic purine nucleotides adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) play an essential role in intracellular signaling. Recent data suggest that the cyclic pyrimidine nucleotides cytidine 3',5'-cyclic monophosphate (cCMP) and uridine 3',5'-cyclic monophosphate (cUMP) also act as second messengers. Hydrolysis by phosphodiesterases (PDEs) is the most important degradation mechanism for cAMP and cGMP. Elimination of cUMP and cCMP is not completely understood, though. We have shown that human PDEs hydrolyze not only cAMP and cGMP but also cyclic pyrimidine nucleotides, indicating that these enzymes may be important for termination of cCMP- and cUMP effects as well. However, these findings were acquired using a rather expensive HPLC/mass spectrometry assay, the technical requirements of which are available only to few laboratories. N'-Methylanthraniloyl-(MANT-) labeled nucleotides are endogenously fluorescent and suitable tools to study diverse protein/nucleotide interactions. In the present study, we report the synthesis of new MANT-substituted cyclic purine-and pyrimidine nucleotides that are appropriate to analyze substrate specificity and kinetics of PDEs with more moderate technical requirements. MANT-labeled nucleoside 3',5'-cyclic monophosphates (MANT-cNMPs) are shown to be substrates of various human PDEs and to undergo a significant change in fluorescence upon cleavage, thus allowing direct, quantitative and continuous determination of hydrolysis via fluorescence detection. As substrates of several PDEs, MANT-cNMPs show similar kinetics to native nucleotides, with some exceptions. Finally, they are shown to be also appropriate tools for PDE inhibitor studies.	[Reinecke, Daniel; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Schwede, Frank; Genieser, Hans-Gottfried] Biolog Life Sci Inst, Bremen, Germany	Hannover Medical School	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Seifert, Roland/G-3189-2013	Genieser, Hans-Gottfried/0000-0002-4904-5790	Deutsche Forschungsgemeinschaft [529/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant 529/5-2 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Beste K, 2012, N-S ARCH PHARMACOL, V385, P10; Beste KY, 2013, BIOL CHEM, V394, P261, DOI 10.1515/hsz-2012-0282; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; BLOCH A, 1974, BIOCHEM BIOPH RES CO, V59, P955, DOI 10.1016/S0006-291X(74)80072-0; Borgognone A., 2012, THROMB HAEMOSTASIS, P108; Burhenne H., 2011, NAUNYN SCHMIEDEBERGS, V383; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; CHAUDHRY PS, 1988, ARCH BIOCHEM BIOPHYS, V262, P439, DOI 10.1016/0003-9861(88)90395-5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Ding S, 2008, RAPID COMMUN MASS SP, V22, P4129, DOI 10.1002/rcm.3834; ERVENS J, 1991, BIOCHEM BIOPH RES CO, V174, P258, DOI 10.1016/0006-291X(91)90514-8; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Geduhn J, 2011, J PHARMACOL EXP THER, V336, P104, DOI 10.1124/jpet.110.174219; Goettle M, 2007, MOL PHARMACOL, V72, P526, DOI 10.1124/mol.107.034413; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hammerschmidt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039848; HARDMAN JG, 1965, J BIOL CHEM, V240, P3704; HELFMAN DM, 1984, ADV CYCLIC NUCL PROT, V16, P403; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HIRATSUKA T, 1982, J BIOL CHEM, V257, P13354; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; JOHNSON JD, 1987, ANAL BIOCHEM, V162, P291, DOI 10.1016/0003-2697(87)90039-X; KINCAID RL, 1985, J BIOL CHEM, V260, P9009; KLOTZ U, 1971, N-S ARCH PHARMAKOL, V269, P117, DOI 10.1007/BF01422021; Kots Alexander Y., 2009, V191, P1, DOI 10.1007/978-3-540-68964-5_1; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; NEWTON RP, 1986, BIOCHEM J, V236, P431, DOI 10.1042/bj2360431; Newton RP, 1999, RAPID COMMUN MASS SP, V13, P574, DOI 10.1002/(SICI)1097-0231(19990415)13:7<574::AID-RCM526>3.3.CO;2-I; Pinto C, 2011, BIOCHEM PHARMACOL, V82, P358, DOI 10.1016/j.bcp.2011.05.010; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Reinecke D, 2011, FEBS LETT, V585, P3259, DOI 10.1016/j.febslet.2011.09.004; Ren JH, 1996, NUCLEIC ACIDS RES, V24, P3629, DOI 10.1093/nar/24.18.3629; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; Sager G, 2004, NEUROCHEM INT, V45, P865, DOI 10.1016/j.neuint.2004.03.017; Sharma IM, 2012, BIOCHEMISTRY-US, V51, P5443, DOI 10.1021/bi3003617; Sullivan SM, 2000, J BACTERIOL, V182, P3460, DOI 10.1128/JB.182.12.3460-3466.2000; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	49	10	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54158	10.1371/journal.pone.0054158	http://dx.doi.org/10.1371/journal.pone.0054158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342095	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400127
J	Wang, B; Zhang, Q; Zhu, BL; Cui, ZL; Zhou, J				Wang, Biao; Zhang, Qi; Zhu, Bili; Cui, Zhonglin; Zhou, Jie			Protective Effect of Gadolinium Chloride on Early Warm Ischemia/Reperfusion Injury in Rat Bile Duct during Liver Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RISK-FACTORS; HEPATIC ISCHEMIA; KUPFFER CELLS; FAS RECEPTOR; TNF-ALPHA; BILIARY; APOPTOSIS; GDCL3; COMPLICATIONS	Background: Activation of Kupffer cell (KC) is acknowledged as a key event in the initiation and perpetuation of bile duct warm ischemia/reperfusion injury. The inhibitory effect of gadolinium chloride (GdCl3) on KC activation shows potential as a protective intervention in liver injury, but there is less research with regard to bile duct injury. Methods: Sixty-five male Sprague-Dawley rats (200-250 g) were randomly divided into three experimental groups: a sham group (n = 15), a control group (n = 25), and a GdCl3 group (n = 25). Specimen was collected at 0.5, 2, 6, 12 and 24 h after operation. Alanine aminotransferase (ALT), alkaline phosphatase (ALP) and total bilirubin (TBIL) of serum were measured. Tumor necrosis factor-alpha (TNF-alpha), Capase-3 activity and soluble Fas (sFas) were detected. The pathologic changes of bile duct were observed. Immunochemistry for bile duct Fas was performed. Apoptosis of bile duct cells was evaluated by the terminal UDP nick end labeling assay. Results: GdCl3 significantly decreased the levels of ALT, ALP and TBIL at 2, 6, 12, and 24 h, and increased serum sFas at 2, 6 and 12 h (P < 0.05). TNF-alpha was lower in the GdCl3 group than in the control group at 2, 6, 12 and 24 h (P < 0.05). Preadministration of GdCl3 significantly reduced the Caspase-3 activity and bile duct cell apoptosis at 2, 6, 12 and 24 h. After operation for 2, 6 and 12 h, the expression of Fas protein was lower in the GdCl3 group than in the control group (P < 0.05). Conclusions: GdCl3 plays an important role in suppressing bile duct cell apoptosis, including decreasing ALT, ALP, TBIL and TNF-alpha; suppressing Fas-FasL-Caspase signal transduction during transplantation.	[Wang, Biao; Cui, Zhonglin; Zhou, Jie] So Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Bili] So Med Univ, Nanfang Hosp, Huiqiao Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Southern Medical University - China	Zhou, J (corresponding author), So Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.	zhoujiejacky@126.com						Ban D, 2009, J SURG RES, V153, P310, DOI 10.1016/j.jss.2008.02.064; Cag M, 2010, TRANSPL P, V42, P3630, DOI 10.1016/j.transproceed.2010.08.061; Cardinal H, 2010, AM J CARDIOL, V105, P797, DOI 10.1016/j.amjcard.2009.10.061; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Giakoustidis D, 2006, SURG TODAY, V36, P450, DOI 10.1007/s00595-005-3162-9; Guichelaar MMJ, 2003, AM J TRANSPLANT, V3, P885, DOI 10.1034/j.1600-6143.2003.00165.x; Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x; Henrich D, 2008, MICROCIRCULATION, V15, P427, DOI 10.1080/10739680701675213; Iwata M, 2003, HEPATOL RES, V25, P329, DOI 10.1016/S1386-6346(02)00273-5; Lee CM, 2004, INT J BIOCHEM CELL B, V36, P481, DOI 10.1016/j.biocel.2003.08.004; Li JY, 2009, HEPATOB PANCREAT DIS, V8, P518; LIU P, 1995, SHOCK, V3, P56, DOI 10.1097/00024382-199503010-00010; Monbaliu D, 2009, ANN SURG, V250, P808, DOI 10.1097/SLA.0b013e3181bdd787; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Ohkohchi N, 2001, TRANSPLANT P, V33, P3728, DOI 10.1016/S0041-1345(01)02522-2; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Rentsch M, 2005, TRANSPLANT INT, V18, P1079, DOI 10.1111/j.1432-2277.2005.00185.x; Schneider L, 2010, PANCREAS, V39, P502, DOI 10.1097/MPA.0b013e3181bd6470; Singhal A, 2010, TRANSPL INT, V23, P245, DOI 10.1111/j.1432-2277.2009.01037.x; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Wang MF, 2011, HEPATOB PANCREAT DIS, V10, P374, DOI 10.1016/S1499-3872(11)60063-5; Wang XD, 2007, FREE RADICAL BIO MED, V42, P971, DOI 10.1016/j.freeradbiomed.2006.12.023; Zhao HF, 2009, HEPATOB PANCREAT DIS, V8, P247	27	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52743	10.1371/journal.pone.0052743	http://dx.doi.org/10.1371/journal.pone.0052743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341905	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400020
J	Wang, Z; Yuan, LJ; Cao, TS; Yang, Y; Duan, YY; Xing, CY				Wang, Zhen; Yuan, Li-jun; Cao, Tie-sheng; Yang, Yong; Duan, Yun-you; Xing, Chang-yang			Simultaneous Beat-by-Beat Investigation of the Effects of the Valsalva Maneuver on Left and Right Ventricular Filling and the Possible Mechanism	PLOS ONE			English	Article							SEPTAL DISPLACEMENT; STROKE VOLUME; PRESSURE; FLOW; ECHOCARDIOGRAPHY; PERFORMANCE; RESPIRATION	Although the influence of the Valsalva maneuver on the heart and circulatory system has been investigated, the mechanism of intrathoracic pressure influencing cardiovascular function is unclear. To test our hypothesis that the interaction between the anatomy-determined partially-intrathoracic system and the fully-intrathoracic system might explain those issues and help to disclose the mechanism, we used the Hitachi dual pulse wave Doppler echocardiographic apparatus to investigate simultaneously the beat-by-beat influence of 40-mmHg Valsalva maneuver on left and right cardiac ventricular filling in 30 male adult volunteers. The mitral and tricuspid blood inflow velocity spectra during the Valsalva maneuver were recorded simultaneously. The peak velocity (PV), velocity-time integral (VTI) and inflow volume (IV) of each cycle were measured or calculated. The PV, VTI and IV of the left heart remained unchanged at the first beat after the Valsalva maneuver onset (compared with those at rest, p>0.1) and then decreased gradually to the lowest at the 11 +/- 1.2th beat (range, 9th to 12th beat). Simultaneously, the PV, VTI and IV of the right heart decreased significantly (p<0.05) at the first cycle, decreased rapidly to the lowest at the 6 +/- 0.8th beat (range, 4th to 7th beat) and then increased gradually to the 9 +/- 1.3th beat (range, 8th to 10th beat). These results suggest that the left heart and right heart have different physiological responses to the Valsalva maneuver. These could be explained by our hypothesis, the interaction between the partially-intrathoracic system and the fully-intrathoracic system, which might help to disclose the mechanism of how intrathoracic pressure influences the heart and circulatory system.	[Wang, Zhen; Yuan, Li-jun; Cao, Tie-sheng; Yang, Yong; Duan, Yun-you; Xing, Chang-yang] Fourth Mil Med Univ, Dept Ultrasound Diagnost, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Cao, TS (corresponding author), Fourth Mil Med Univ, Dept Ultrasound Diagnost, Tangdu Hosp, Xian 710032, Peoples R China.	caots4335@yahoo.cn	Xing, Changyang/AAE-2899-2019	Xing, Changyang/0000-0003-1605-8285	National Natural Science Foundation of China (NSFC) [81171348]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Grant 81171348 from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005550; BRINKER JA, 1980, CIRCULATION, V61, P626, DOI 10.1161/01.CIR.61.3.626; BROOKER JZ, 1974, BRIT HEART J, V36, P713; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; Cannesson M, 2011, J CLIN MONIT COMPUT, V25, P45, DOI 10.1007/s10877-010-9229-1; GINDEA AJ, 1990, AM J CARDIOL, V65, P1387, DOI 10.1016/0002-9149(90)91333-2; GREENFIELD JC, 1967, CIRCULATION, V35, P653, DOI 10.1161/01.CIR.35.4.653; GUZMAN PA, 1981, BRIT HEART J, V46, P657; Hamilton WF, 1944, AM J PHYSIOL, V141, P0042, DOI 10.1152/ajplegacy.1944.141.1.42; LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425; LITTLE WC, 1985, CIRCULATION, V71, P227, DOI 10.1161/01.CIR.71.2.227; MCKAY RG, 1984, CIRCULATION, V69, P703, DOI 10.1161/01.CIR.69.4.703; Garcia MIM, 2009, INTENS CARE MED, V35, P77, DOI 10.1007/s00134-008-1295-1; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; PARISI AF, 1976, CIRCULATION, V54, P921, DOI 10.1161/01.CIR.54.6.921; PINSKY MR, 1983, J APPL PHYSIOL, V54, P950, DOI 10.1152/jappl.1983.54.4.950; PORTH CJM, 1984, HEART LUNG, V13, P507; ROBERTSON D, 1977, CIRCULATION, V55, P596, DOI 10.1161/01.CIR.55.4.596; ROBOTHAM JL, 1978, J APPL PHYSIOL, V44, P703, DOI 10.1152/jappl.1978.44.5.703; Sharpey-Schafer EP, 1965, HDB PHYSL; SHARPEYSCHAFER EP, 1955, BRIT MED J, V1, P693, DOI 10.1136/bmj.1.4915.693; Silber HA, 2012, AM J PHYSIOL-HEART C, V302, pH2043, DOI 10.1152/ajpheart.00609.2011; Stewart JM, 2004, AM J PHYSIOL-HEART C, V287, pH798, DOI 10.1152/ajpheart.01174.2003; Yuan LJ, 2004, ECHOCARDIOGR-J CARD, V21, P391, DOI 10.1111/j.0742-2822.2004.03086.x	24	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53917	10.1371/journal.pone.0053917	http://dx.doi.org/10.1371/journal.pone.0053917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342040	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400100
J	Zhou, XQ; Chen, CR; Wang, YF; Smaill, S; Clinton, P				Zhou, Xiaoqi; Chen, Chengrong; Wang, Yanfen; Smaill, Simeon; Clinton, Peter			Warming Rather Than Increased Precipitation Increases Soil Recalcitrant Organic Carbon in a Semiarid Grassland after 6 Years of Treatments	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; NITROGEN POOLS; CLIMATE-CHANGE; LABILE; MATTER; FLUXES; MINERALIZATION; DECOMPOSITION; RESPIRATION; RESPONSES	Improved understanding of changes in soil recalcitrant organic carbon (C) in response to global warming is critical for predicting changes in soil organic C (SOC) storage. Here, we took advantage of a long-term field experiment with increased temperature and precipitation to investigate the effects of warming, increased precipitation and their interactions on SOC fraction in a semiarid Inner Mongolian grassland of northern China since April 2005. We quantified labile SOC, recalcitrant SOC and stable SOC at 0-10 and 10-20 cm depths. Results showed that neither warming nor increased precipitation affected total SOC and stable SOC at either depth. Increased precipitation significantly increased labile SOC at the 0-10 cm depth. Warming decreased labile SOC (P = 0.038) and marginally but significantly increased recalcitrant SOC at the 10-20 cm depth (P = 0.082). In addition, there were significant interactive effects of warming and increased precipitation on labile SOC and recalcitrant SOC at the 0-10 cm depth (both P<0.05), indicating that that results from single factor experiments should be treated with caution because of multi-factor interactions. Given that the absolute increase of SOC in the recalcitrant SOC pool was much greater than the decrease in labile SOC, and that the mean residence time of recalcitrant SOC is much greater, our results suggest that soil C storage at 10-20 cm depth may increase with increasing temperature in this semiarid grassland.	[Zhou, Xiaoqi; Wang, Yanfen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhou, Xiaoqi; Smaill, Simeon; Clinton, Peter] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [Zhou, Xiaoqi; Chen, Chengrong] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Griffith University	Zhou, XQ (corresponding author), Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.	zhou318@yahoo.com.cn; yfwang@gucas.ac.cn	Clinton, Peter W/D-1448-2010; chen, chengrong/K-8188-2019; Wang, Yanfen/C-6889-2013; Wang, Yuesi/AAF-3317-2019; Chen, Chengrong/B-3814-2009	chen, chengrong/0000-0001-6377-4001; Chen, Chengrong/0000-0001-6377-4001; Zhou, Xiaoqi/0000-0002-9229-1743; wang, yan fen/0000-0001-5666-9289; Smaill, Simeon/0000-0001-6242-4931; Clinton, Peter/0000-0002-8921-4835	Institute of Botany, Chinese Academy of Sciences; Chinese Academy of Sciences [2010-Biols-CAS-0103]; Chinese Academy of Agriculture [2012BAC19B04]; National Natural Science Foundation of China [30925009]; Griffith University; Postdoctoral Fellowship at Scion, New Zealand	Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Griffith University(Griffith University); Postdoctoral Fellowship at Scion, New Zealand	This study was conducted as part of a comprehensive research project (Global Change Multi-factor Experiment - Duolun) sponsored by Institute of Botany, Chinese Academy of Sciences. This research was supported jointly by Chinese Academy of Sciences (No. 2010-Biols-CAS-0103), Chinese Academy of Agriculture (No. 2012BAC19B04), National Natural Science Foundation of China (30925009), Griffith University and Postdoctoral Fellowship at Scion, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; [Anonymous], 2007, IPCC WORK GROUP 1 CL; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Collins HP, 2000, SOIL BIOL BIOCHEM, V32, P157, DOI 10.1016/S0038-0717(99)00136-4; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fissore C, 2008, GLOBAL CHANGE BIOL, V14, P193, DOI 10.1111/j.1365-2486.2007.01478.x; Fissore C, 2009, GLOBAL CHANGE BIOL, V15, P2295, DOI 10.1111/j.1365-2486.2009.01903.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Karhu K, 2010, ECOLOGY, V91, P370, DOI 10.1890/09-0478.1; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Niinisto SM, 2004, GLOBAL CHANGE BIOL, V10, P1363, DOI 10.1111/j.1365-2486.2004.00799.x; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Rey A, 2006, GLOBAL CHANGE BIOL, V12, P1894, DOI 10.1111/j.1365-2486.2006.01230.x; Rovira P, 2007, SOIL BIOL BIOCHEM, V39, P202, DOI 10.1016/j.soilbio.2006.07.021; Smith P, 2010, NATURE, V464, P499, DOI 10.1038/464499a; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033217; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhou XQ, 2012, BIOL FERT SOILS, V48, P859, DOI 10.1007/s00374-012-0686-1; Zhou XQ, 2012, APPL SOIL ECOL, V53, P49, DOI 10.1016/j.apsoil.2011.11.002; Zhou XQ, 2011, J SOIL SEDIMENT, V11, P762, DOI 10.1007/s11368-011-0353-4	33	13	14	25	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53761	10.1371/journal.pone.0053761	http://dx.doi.org/10.1371/journal.pone.0053761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341995	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400079
J	Balint, M; Tiffin, P; Hallstrom, B; O'Hara, RB; Olson, MS; Fankhauser, JD; Piepenbring, M; Schmitt, I				Balint, Miklos; Tiffin, Peter; Hallstroem, Bjoern; O'Hara, Robert B.; Olson, Matthew S.; Fankhauser, Johnathon D.; Piepenbring, Meike; Schmitt, Imke			Host Genotype Shapes the Foliar Fungal Microbiome of Balsam Poplar (Populus balsamifera)	PLOS ONE			English	Article							ENDOPHYTIC FUNGI; DIVERSITY; COMMUNITIES; ENVIRONMENT; GENERATION; SEQUENCES; DISTANCE; LEAVES; GROWTH; RANGE	Foliar fungal communities of plants are diverse and ubiquitous. In grasses endophytes may increase host fitness; in trees, their ecological roles are poorly understood. We investigated whether the genotype of the host tree influences community structure of foliar fungi. We sampled leaves from genotyped balsam poplars from across the species' range, and applied 454 amplicon sequencing to characterize foliar fungal communities. At the time of the sampling the poplars had been growing in a common garden for two years. We found diverse fungal communities associated with the poplar leaves. Linear discriminant analysis and generalized linear models showed that host genotypes had a structuring effect on the composition of foliar fungal communities. The observed patterns may be explained by a filtering mechanism which allows the trees to selectively recruit fungal strains from the environment. Alternatively, host genotype-specific fungal communities may be present in the tree systemically, and persist in the host even after two clonal reproductions. Both scenarios are consistent with host tree adaptation to specific foliar fungal communities and suggest that there is a functional basis for the strong biotic interaction.	[Balint, Miklos; Hallstroem, Bjoern; O'Hara, Robert B.; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany; [Balint, Miklos] Univ Babes Bolyai, Ctr Mol Biol, R-3400 Cluj Napoca, Romania; [Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Olson, Matthew S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Olson, Matthew S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Fankhauser, Johnathon D.] Univ Minnesota, St Paul, MN 55108 USA; [Piepenbring, Meike; Schmitt, Imke] Goethe Univ Frankfurt, Inst Okol Evolut & Diversitat, D-60054 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Babes Bolyai University from Cluj; University of Minnesota System; University of Minnesota Twin Cities; Texas Tech University System; Texas Tech University; University of Alaska System; University of Alaska Fairbanks; University of Minnesota System; University of Minnesota Twin Cities; Goethe University Frankfurt	Balint, M (corresponding author), Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany.	mbalint@senckenberg.de; ischmitt@senckenberg.de	rolshausen, philippe/F-7999-2011; O'Hara, Bob/A-7499-2008; Olson, Matthew S./ABI-7695-2020	O'Hara, Bob/0000-0001-9737-3724; Tiffin, Peter/0000-0003-1975-610X	Hesse's Ministry of Higher Education, Research, and the Arts; US National Science Foundation [DBI-0701911, 1137001]; Alaska EPSCoR (NSF) [EPS-0701898]; Alaska EPSCoR (state of Alaska)	Hesse's Ministry of Higher Education, Research, and the Arts; US National Science Foundation(National Science Foundation (NSF)); Alaska EPSCoR (NSF); Alaska EPSCoR (state of Alaska)	This study was funded by the research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of Hesse's Ministry of Higher Education, Research, and the Arts, a US National Science Foundation Plant Genome Research Program grant (DBI-0701911 and 1137001) and a grant from Alaska EPSCoR (NSF award #EPS-0701898 and the state of Alaska). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aly AH, 2008, PHYTOCHEMISTRY, V69, P1716, DOI 10.1016/j.phytochem.2008.02.013; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bakker MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044357; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Cannon PF, 2007, FUNGAL FAMILIES WORL; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Crawford KM, 2010, OECOLOGIA, V164, P431, DOI 10.1007/s00442-010-1685-2; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Elamo P, 1999, OECOLOGIA, V118, P151, DOI 10.1007/s004420050713; FONSECA A, 1992, SYST APPL MICROBIOL, V15, P47, DOI 10.1016/S0723-2020(11)80137-2; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grotan V, 2008, POILOG POISSON LOGNO; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; IQBAL SH, 1995, CAN J BOT, V73, P538, DOI 10.1139/b95-055; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Keller SR, 2010, MOL ECOL, V19, P1212, DOI 10.1111/j.1365-294X.2010.04546.x; Khan AL, 2011, PHYSIOL PLANTARUM, V143, P329, DOI 10.1111/j.1399-3054.2011.01508.x; Leuchtmann Adrian, 1992, Natural Toxins, V1, P150, DOI 10.1002/nt.2620010303; Linderman RG, 2004, SCI HORTIC-AMSTERDAM, V99, P67, DOI 10.1016/S0304-4238(03)00081-5; Little E. L. Jr., 1971, MISCELLANEOUS PUBLIC, V1146; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Newcombe G, 2003, MYCOL RES, V107, P108, DOI 10.1017/S0953756202007086; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Oksanen J., 2016, R PACKAG; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Pan JJ, 2009, MICROB ECOL, V58, P668, DOI 10.1007/s00248-009-9543-7; Photita W, 2004, FUNGAL DIVERS, V16, P131; Piepenbring M, 2011, ECOTROPICA, V17, P27; Pompanon F, 2011, BIOFUTUR, P30; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Prillinger H, MOL CHARACTERISATION; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Reiher A, 2011, THESIS LEIPZIG U; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez R.J., 2012, BIOCOMPLEXITY PLANT, V6, P155, DOI [10.1002/9781118314364.ch7, DOI 10.1002/9781118314364.CH7]; Russell DJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-601; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Saunders M, 2008, APPL ENVIRON MICROB, V74, P136, DOI 10.1128/AEM.01538-07; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert K., 2003, SCHLECHTENDALIA, V9, P1; Shepherd R.W., 2012, BIOCOMPLEXITY PLANT, P131; Soolanayakanahally RY, 2009, PLANT CELL ENVIRON, V32, P1821, DOI 10.1111/j.1365-3040.2009.02042.x; Suryanarayanan TS, 2006, J BASIC MICROB, V46, P305, DOI 10.1002/jobm.200510126; SUTTON BC, 1969, CAN J BOTANY, V47, P2095, DOI 10.1139/b69-303; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; TODD D, 1988, CAN J FOREST RES, V18, P601, DOI 10.1139/x88-087; Upson R, 2009, MYCORRHIZA, V20, P1, DOI 10.1007/s00572-009-0260-3; Vaz ABM, 2009, CAN J MICROBIOL, V55, P1381, DOI 10.1139/W09-101; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Webster J., 2007, INTRO FUNGI, V3rd; White IR, 2007, AUST J BOT, V55, P178, DOI 10.1071/BT06125; White T.J., 1990, PCR PROTOCOLS, P315, DOI 10.1016/B978-0-12-372180-8.50042-1; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919	70	135	136	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53987	10.1371/journal.pone.0053987	http://dx.doi.org/10.1371/journal.pone.0053987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326555	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800096
J	Barton, PS; Cunningham, SA; Macdonald, BCT; McIntyre, S; Lindenmayer, DB; Manning, AD				Barton, Philip S.; Cunningham, Saul A.; Macdonald, Ben C. T.; McIntyre, Sue; Lindenmayer, David B.; Manning, Adrian D.			Species Traits Predict Assemblage Dynamics at Ephemeral Resource Patches Created by Carrion	PLOS ONE			English	Article							ARTHROPOD ASSEMBLAGES; CARCASSES; VEGETATION; DIVERSITY; NITROGEN; SOIL; DECOMPOSITION; SUCCESSION; DISPERSION; BIOMASS	Carrion is an ephemeral and spatially patchy resource that supports a diverse subset of species linked to nutrient cycling and the decomposition process. A number of studies have separately documented changes in the diversity of plants, arthropods and vertebrates at individual carcasses, but there are few studies that have examined how functional traits of different groups of organisms underpin their responses to carrion patches. We used a carrion addition experiment to compare changes in composition and functional traits of insect and plant assemblages at carcasses compared with control sites. We found that significant changes in insect assemblage evenness and heterogeneity was associated with species' dispersal traits, and that plant assemblage responses to subsequent soil nitrogen changes was most apparent among graminoids and exotic species. Beetles at carcasses were twice as large as their counterparts at control sites during the first week of carrion decomposition, and also had higher wing loadings. Plants with high specific leaf area responded faster to the carcass addition, and twice as many species recolonised the centre of carcasses in exotic-dominated grassland compared with carcasses in native-dominated grassland. These results provide an example of how traits of opportunist species enable them to exploit patchy and dynamic resources. This increases our understanding of how carcasses can drive biodiversity dynamics, and has implications for the way carrion might be managed in ecosystems, such as appropriate consideration of spatial and temporal continuity in carrion resources to promote heterogeneity in nutrient cycling and species diversity within landscapes.	[Barton, Philip S.; Lindenmayer, David B.; Manning, Adrian D.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Barton, Philip S.; Lindenmayer, David B.] Australian Natl Univ, Australian Res Council, Ctr Excellence Environm Decis, Canberra, ACT, Australia; [Barton, Philip S.; Lindenmayer, David B.] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Cunningham, Saul A.; McIntyre, Sue] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Macdonald, Ben C. T.] CSIRO, Land & Water, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barton, PS (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	philip.barton@anu.edu.au	Macdonald, Ben/G-1078-2012; Cunningham, Saul A/B-9947-2009; Lindenmayer, David B/P-7183-2017; Barton, Philip S/A-6400-2010; McIntyre, Sue/F-1885-2010; Manning, Adrian/AAG-2949-2019; Manning, Adrian/AAX-7288-2021	Macdonald, Ben/0000-0001-8105-0779; Cunningham, Saul A/0000-0003-0703-6893; Lindenmayer, David B/0000-0002-4766-4088; Barton, Philip S/0000-0002-8377-2211; McIntyre, Sue/0000-0002-0399-750X; Manning, Adrian/0000-0003-0989-9203	Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council) [LP0561817, LP110100126]	Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council)(Australian Research Council)	This research was supported by the Mulligans Flat - Goorooyarroo Woodland Experiment (Australian Research Council Linkage Grants LP0561817 and LP110100126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen A. N, 1991, ANTS SO AUSTR GUIDE; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2004, PERMDISP FORTRAN COM; Archer MS, 2003, AUST J ZOOL, V51, P569, DOI 10.1071/ZO03053; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Barton PS, 2011, BIOL J LINN SOC, V102, P301, DOI 10.1111/j.1095-8312.2010.01580.x; Barton PS, 2012, OECOLOGIA, DOI [10.1007/s00442-00012-02460-00443., DOI 10.1007/S00442-00012-02460-00443]; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Bornemissza G. F., 1957, Australian Journal of Zoology, V5, P1; BRAACK L E O, 1981, Koedoe, P33; BRAACK LEO, 1987, OECOLOGIA, V72, P402, DOI 10.1007/BF00377571; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Bump JK, 2009, ECOSYSTEMS, V12, P996, DOI 10.1007/s10021-009-9274-0; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Danell K, 2002, ARCTIC, V55, P389; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dudley R., 2000, BIOMECHANICS INSECT; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Finn JA, 2001, OIKOS, V92, P363, DOI 10.1034/j.1600-0706.2001.920219.x; Freilich JE, 2003, BIOSCIENCE, V53, P759, DOI 10.1641/0006-3568(2003)053[0759:EEORAS]2.0.CO;2; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Giller P.S., 1987, ORG COMMUNITIES PRES, P253; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hodar JA, 1996, ACTA OECOL, V17, P421; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Khan SA, 2001, SOIL SCI SOC AM J, V65, P1751, DOI 10.2136/sssaj2001.1751; Lawrence J.F., 1991, P543; Loomis RS, 1997, P NATL ACAD SCI USA, V94, P13378, DOI 10.1073/pnas.94.25.13378; Manning A.D., 2011, Australian Zoologist, V35, P633; Marini L, 2012, INSECT CONSERV DIVER, V5, P37, DOI 10.1111/j.1752-4598.2011.00152.x; McIntyre S, 2008, AGR ECOSYST ENVIRON, V128, P251, DOI 10.1016/j.agee.2008.06.015; McIntyre S., 2010, Cunninghamia, V11, P319; McIntyre S, 2011, BIOL CONSERV, V144, P1781, DOI 10.1016/j.biocon.2011.03.023; Melis C, 2007, ECOL RES, V22, P807, DOI 10.1007/s11284-006-0321-4; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PIELOU E C, 1969, P286; PUTMAN RJ, 1977, J ANIM ECOL, V46, P853, DOI 10.2307/3645; Rayment G.E., 2011, SOIL CHEM METHODS AU; Sarty M, 2006, OECOLOGIA, V149, P465, DOI 10.1007/s00442-006-0453-9; SCHOENLY K, 1991, J AGR ENTOMOL, V8, P227; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; SCHOENLY K, 1983, J ARID ENVIRON, V6, P253, DOI 10.1016/S0140-1963(18)31510-6; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Sikes DS, 1998, YELLOWSTONE SCI, V6, P10; Smith KE, 1997, ECOL ENTOMOL, V22, P468, DOI 10.1046/j.1365-2311.1997.00093.x; Smith RJ, 2001, ECOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-2311.2001.00307.x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114	59	31	33	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53961	10.1371/journal.pone.0053961	http://dx.doi.org/10.1371/journal.pone.0053961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326549	Green Published, gold			2022-12-27	WOS:000314705800093
J	Henn, D; Bandner-Risch, D; Perttunen, H; Schmied, W; Porras, C; Ceballos, F; Rodriguez-Losada, N; Schafers, HJ				Henn, Dominic; Bandner-Risch, Doris; Perttunen, Hilja; Schmied, Wolfram; Porras, Carlos; Ceballos, Francisco; Rodriguez-Losada, Noela; Schaefers, Hans-Joachim			Identification of Reference Genes for Quantitative RT-PCR in Ascending Aortic Aneurysms	PLOS ONE			English	Article							MARFAN-SYNDROME; BETA-ACTIN; HOUSEKEEPING GENES; ROOT DILATATION; RIBOSOMAL-RNA; EXPRESSION; VALVES; GAPDH; SELECTION; DISEASE	Hypertension and congenital aortic valve malformations are frequent causes of ascending aortic aneurysms. The molecular mechanisms of aneurysm formation under these circumstances are not well understood. Reference genes for gene activity studies in aortic tissue that are not influenced by aortic valve morphology and its hemodynamic consequences, aortic dilatation, hypertension, or antihypertensive medication are not available so far. This study determines genes in ascending aortic tissue that are independent of these parameters. Tissue specimens from dilated and undilated ascending aortas were obtained from 60 patients (age <= 70 years) with different morphologies of the aortic valve (tricuspid undilated n = 24, dilated n = 11; bicuspid undilated n = 6, dilated n = 15; unicuspid dilated n = 4). Of the studied individuals, 36 had hypertension, and 31 received ACE inhibitors or AT1 receptor antagonists. The specimens were obtained intraoperatively from the wall of the ascending aorta. We analyzed the expression levels of 32 candidate reference genes by quantitative RTPCR (RT-qPCR). Differential expression levels were assessed by parametric statistics. The expression analysis of these 32 genes by RT-qPCR showed that EIF2B1, ELF1, and PPIA remained constant in their expression levels in the different specimen groups, thus being insensitive to aortic valve morphology, aortic dilatation, hypertension, and medication with ACE inhibitors or AT1 receptor antagonists. Unlike many other commonly used reference genes, the genes EIF2B1, ELF1, and PPIA are neither confounded by aortic comorbidities nor by antihypertensive medication and therefore are most suitable for gene expression analysis of ascending aortic tissue.	[Henn, Dominic; Bandner-Risch, Doris; Perttunen, Hilja; Schmied, Wolfram; Schaefers, Hans-Joachim] Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany; [Porras, Carlos] Hosp Virgen de la Victoria Malaga, Dept Cardiac Surg, Malaga, Spain; [Ceballos, Francisco] Univ Santiago de Compostela, Fac Biol, Dept Genet, Santiago De Compostela, Spain; [Rodriguez-Losada, Noela] Carlos Haya Univ Hosp, Fdn IMABIS, Malaga, Spain	Universitatsklinikum des Saarlandes; Universidade de Santiago de Compostela; FIMABIS	Henn, D (corresponding author), Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany.	s9dohenn@stud.uni-saarland.de	Ceballos, Francisco C./C-6116-2011; Ceballos, Francisco/ABG-3183-2020; Henn, Dominic/U-3564-2019; losada, noela rodriguez/O-4739-2015	Ceballos, Francisco C./0000-0001-7113-7387; losada, noela rodriguez/0000-0003-3629-4883; Henn, Dominic/0000-0003-4775-0151; Porras, Carlos/0000-0002-8975-716X				Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Aicher D, 2007, ANN THORAC SURG, V83, P1290, DOI 10.1016/j.athoracsur.2006.11.086; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bruce KD, 2012, LIVER INT, V32, P1315, DOI 10.1111/j.1478-3231.2012.02813.x; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Fealey ME, 2012, CARDIOVASC PATHOL, V21, P324, DOI 10.1016/j.carpath.2011.11.004; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Hashemi A, 2012, BIOCHEM BIOPH RES CO, V426, P649, DOI 10.1016/j.bbrc.2012.09.009; Ikonomidis JS, 2007, J THORAC CARDIOV SUR, V133, P1028, DOI 10.1016/j.jtcvs.2006.10.083; Ince H, 2007, NAT CLIN PRACT CARD, V4, P418, DOI 10.1038/ncpcardio0937; Karakaya O, 2006, AM J HYPERTENS, V19, P361, DOI 10.1016/j.amjhyper.2005.08.013; Mane PV, 2008, J BIOMOL TECH, V19, P342; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Sokal R. R., 1994, BIOMETRY PRINCIPLES, P272; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Thanassoulis G, 2008, NAT CLIN PRACT CARD, V5, P821, DOI 10.1038/ncpcardio1369; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergara C, 2012, ARTIF ORGANS, V36, P368, DOI 10.1111/j.1525-1594.2011.01356.x; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	24	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e54132	10.1371/journal.pone.0054132	http://dx.doi.org/10.1371/journal.pone.0054132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326585	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800110
J	Clauset, A				Clauset, Aaron			How Large Should Whales Be?	PLOS ONE			English	Article							BODY-SIZE; METABOLIC-RATE; COPES RULE; MASS; EXTINCTION; EVOLUTION; DISTRIBUTIONS; DYNAMICS; PATTERNS; MAMMALS	The evolution and distribution of species body sizes for terrestrial mammals is well-explained by a macroevolutionary tradeoff between short-term selective advantages and long-term extinction risks from increased species body size, unfolding above the 2 g minimum size induced by thermoregulation in air. Here, we consider whether this same tradeoff, formalized as a constrained convection-reaction-diffusion system, can also explain the sizes of fully aquatic mammals, which have not previously been considered. By replacing the terrestrial minimum with a pelagic one, at roughly 7000 g, the terrestrial mammal tradeoff model accurately predicts, with no tunable parameters, the observed body masses of all extant cetacean species, including the 175,000,000 g Blue Whale. This strong agreement between theory and data suggests that a universal macroevolutionary tradeoff governs body size evolution for all mammals, regardless of their habitat. The dramatic sizes of cetaceans can thus be attributed mainly to the increased convective heat loss is water, which shifts the species size distribution upward and pushes its right tail into ranges inaccessible to terrestrial mammals. Under this macroevolutionary tradeoff, the largest expected species occurs where the rate at which smaller-bodied species move up into large-bodied niches approximately equals the rate at which extinction removes them.	[Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute	Clauset, A (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	aaron.clauset@colorado.edu		CLAUSET, AARON/0000-0002-3529-8746	Santa Fe Institute	Santa Fe Institute	This work was supported by the Santa Fe Institute. http://www.santafe.edu. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn BK, 1999, AM J PHYS, V67, P920, DOI 10.1119/1.19150; Ahlborn BK, 2000, J NON-EQUIL THERMODY, V25, P87, DOI 10.1515/JNETDY.2000.006; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Alroy J, 2000, PALEOBIOLOGY, V26, P319, DOI 10.1666/0094-8373(2000)026<0319:UTDOTW>2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Berg, 2018, RANDOM WALKS BIOL; Best Robin C., 1993, Mammalian Species, V426, P1; Borsa P, 2006, CR BIOL, V329, P277, DOI 10.1016/j.crvi.2006.01.004; Brown J. H., 1995, MACROECOLOGY; Brown JH, 1996, AM NAT, V147, P1092, DOI 10.1086/285895; Clapham Phillip J., 1999, Mammalian Species, V604, P1; Clauset A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038103; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Clauset A, 2009, AM NAT, V173, P256, DOI 10.1086/595760; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; Culik BM, 2004, MARINE MAMMAL ACTION, V177; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; DOWNHOWER JF, 1988, NATURE, V335, P675, DOI 10.1038/335675b0; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Jefferson T. A., 1994, HDB MARINE MAMMALS, V5, P335; Jefferson Thomas A., 1997, Mammalian Species, V553, P1; Jefferson Thomas A., 1993, Mammalian Species, V425, P1; Jefferson Thomas A., 2003, Mammalian Species, V726, P1, DOI 10.1644/726; Jefferson Thomas A., 1994, Mammalian Species, V470, P1; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jefferson Thomas A., 2004, Mammalian Species, P1; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Krapivsky P., 2010, KINETIC VIEW STAT PH; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Long C. A., 1968, Transactions of the Kansas Academy of Science, V71, P201, DOI 10.2307/3627372; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Mead JG, 1982, SMITHSONIAN CONTRIBU; NAGORSEN D, 1985, Mammalian Species, P1, DOI 10.2307/3503937; Newcomer Michael W., 1996, Mammalian Species, V531, P1; PEARSON OP, 1948, SCIENCE, V108, P44, DOI 10.1126/science.108.2793.44; Perrin WF, 2004, NOMTMNMFSSWFSC364 NO; Perrin William F., 2001, Mammalian Species, V683, P1, DOI 10.1644/1545-1410(2001)683<0001:SA>2.0.CO;2; Perrin William F., 2002, Mammalian Species, V702, P1, DOI 10.1644/1545-1410(2002)702<0001:SF>2.0.CO;2; Perrin William F., 1998, Mammalian Species, V599, P1; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; RAUP DM, 1977, AM SCI, V65, P50; REEVES R R, 1980, Mammalian Species, P1, DOI 10.2307/3503952; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Stacey Pam J., 1999, Mammalian Species, V616, P1; Stacey Pam J., 1994, Mammalian Species, V456, P1; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; STEWART B E, 1989, Mammalian Species, P1, DOI 10.2307/3504210; Uhen MD, 1998, EVOLUTION TERTIARY M, V2, P566; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Van Waerebeek Koen, 2004, Aquatic Mammals, V30, P56, DOI 10.1578/AM.30.1.2004.56; Webber MA., 1993, FAO SPECIES IDENTIFI; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	63	23	23	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53967	10.1371/journal.pone.0053967	http://dx.doi.org/10.1371/journal.pone.0053967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23342050	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400065
J	Jauch-Chara, K; Schmid, SM; Hallschmid, M; Oltmanns, KM; Schultes, B				Jauch-Chara, Kamila; Schmid, Sebastian M.; Hallschmid, Manfred; Oltmanns, Kerstin M.; Schultes, Bernd			Pituitary-Gonadal and Pituitary-Thyroid Axis Hormone Concentrations before and during a Hypoglycemic Clamp after Sleep Deprivation in Healthy Men	PLOS ONE			English	Article							BRAIN ENERGY-METABOLISM; TESTOSTERONE; SECRETION; GLYCOGEN; PROLACTIN; INSULIN; HUMANS; PHASE; LH	Total sleep deprivation (TSD) exerts strong modulatory effects on the secretory activity of endocrine systems that might be related to TSD-induced challenges of cerebral glucose metabolism. Here, we investigate whether TSD affects the course of male pituitary-gonadal and pituitary-thyroid axis related hormones during a subsequent 240-min hypoglycemic clamp. Ten healthy men were tested on 2 different conditions, TSD and 7-hour regular sleep. Circulating concentrations of total testosterone, prolactin (PRL), thyroid stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxin (fT4) were measured during baseline and a subsequent hypoglycemic clamp taking place in the morning. Basal, i.e. at 07:00 am measured, concentrations of total testosterone (P = 0.05) and PRL (P<0.01) were lower while the values of TSH (P = 0.02), fT3 (P = 0.08), and fT4 (P = 0.04) were higher after TSD as compared to regular sleep. During the subsequent hypoglycemic clamp (all measurements from baseline to the end of the clamp analyzed) total testosterone concentrations in the regular sleep (P<0.01) but not in the TSD condition (P = 0.61) decreased, while PRL levels increased (P = 0.05) irrespectively of the experimental condition (P = 0.31). TSH concentrations decreased during hypoglycemia (P<0.01), with this decrease being more pronounced after TSD (P = 0.04). However, at the end of the hypoglycemic clamp concentrations all of the above mentioned hormones did not differ between the two sleep conditions. Our data indicate a profound influence of TSD on male pituitary-gonadal and pituitary-thyroid axis hormones characterized by reduced basal testosterone and PRL levels and increased TSH levels. However, since concentrations of these hormones measured at the end of the 240-min hypoglycemic clamp were not affected by TSD it can be speculated that the influence of TSD on the two endocrine axes is rather short lived or does not interact in an additive manner with their responses to hypoglycemia.	[Jauch-Chara, Kamila; Oltmanns, Kerstin M.] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Schmid, Sebastian M.; Schultes, Bernd] Univ Lubeck, Dept Internal Med 1, Lubeck, Germany; [Hallschmid, Manfred] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany; [Schultes, Bernd] eSwiss Med & Surg Ctr, Interdisciplinary Obes Ctr, St Gallen, Switzerland	University of Lubeck; University of Lubeck; University of Lubeck	Jauch-Chara, K (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	kamila.jauchchara@psychiatrie.uk-sh.de	Schmid, Sebastian M/E-5354-2015	Meyhofer, Sebastian/0000-0003-2034-5922	German Research Foundation (DFG) [SFB 654]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG; SFB 654). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1980, SLEEP, V3, P23, DOI 10.1093/sleep/3.1.23; ALLAN JS, 1994, J CLIN ENDOCR METAB, V79, P508, DOI 10.1210/jc.79.2.508; AMIEL S, 1993, NEW ENGL J MED, V329, P876, DOI 10.1056/NEJM199309163291211; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Bischof MG, 2004, DIABETOLOGIA, V47, P648, DOI 10.1007/s00125-004-1362-2; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; BRABANT G, 1992, TRENDS ENDOCRIN MET, V3, P183, DOI 10.1016/1043-2760(92)90169-2; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Carnegie Christina, 2004, Rev Urol, V6 Suppl 6, pS3; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Gruetter R, 2003, J NEUROSCI RES, V74, P179, DOI 10.1002/jnr.10785; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Leproult R, 2011, JAMA-J AM MED ASSOC, V305, P2173, DOI 10.1001/jama.2011.710; Martins RCS, 2010, SLEEP, V33, P243, DOI 10.1093/sleep/33.2.243; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; Oltmanns KM, 2005, CLIN ENDOCRINOL, V62, P217, DOI 10.1111/j.1365-2265.2005.02203.x; Oltmanns KM, 2001, J CLIN ENDOCR METAB, V86, P4913, DOI 10.1210/jc.86.10.4913; Sanford LM, 2010, REPRODUCTION, V139, P197, DOI 10.1530/REP-09-0180; Schmid SM, 2007, J CLIN ENDOCR METAB, V92, P3044, DOI 10.1210/jc.2006-2788; Schmid SM, 2012, CLIN ENDOCRINOL, V77, P749, DOI 10.1111/j.1365-2265.2012.04419.x; Schoeller EL, 2012, CELL TISSUE RES; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; STRASSMAN RJ, 1991, ACTA ENDOCRINOL-COP, V124, P646, DOI 10.1530/acta.0.1240646; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; TRESGUERRES JAF, 1985, J ENDOCRINOL, V105, P423, DOI 10.1677/joe.0.1050423; VANCAUTER E, 1994, AM J PHYSIOL, V266, pE953, DOI 10.1152/ajpendo.1994.266.6.E953; WEEKE J, 1978, ACTA ENDOCRINOL-COP, V89, P659, DOI 10.1530/acta.0.0890659; WEINSTEIN D, 1981, FEBS LETT, V126, P29, DOI 10.1016/0014-5793(81)81025-3	33	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54209	10.1371/journal.pone.0054209	http://dx.doi.org/10.1371/journal.pone.0054209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326598	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400084
J	McFarland, KP; Rimmer, CC; Goetz, JE; Aubry, Y; Wunderle, JM; Sutton, A; Townsend, JM; Sosa, AL; Kirkconnell, A				McFarland, Kent P.; Rimmer, Christopher C.; Goetz, James E.; Aubry, Yves; Wunderle, Joseph M., Jr.; Sutton, Anne; Townsend, Jason M.; Llanes Sosa, Alejandro; Kirkconnell, Arturo			A Winter Distribution Model for Bicknell's Thrush (Catharus bicknelli), a Conservation Tool for a Threatened Migratory Songbird	PLOS ONE			English	Article							MAXIMUM-ENTROPY; CLIMATE-CHANGE; NORTH-AMERICA; PASSERINES; BEHAVIOR; REGION; AREAS	Conservation planning and implementation require identifying pertinent habitats and locations where protection and management may improve viability of targeted species. The winter range of Bicknell's Thrush (Catharus bicknelli), a threatened Nearctic-Neotropical migratory songbird, is restricted to the Greater Antilles. We analyzed winter records from the mid-1970s to 2009 to quantitatively evaluate winter distribution and habitat selection. Additionally, we conducted targeted surveys in Jamaica (n = 433), Cuba (n = 363), Dominican Republic (n = 1,000), Haiti (n = 131) and Puerto Rico (n = 242) yielding 179 sites with thrush presence. We modeled Bicknell's Thrush winter habitat selection and distribution in the Greater Antilles in Maxent version 3.3.1. using environmental predictors represented in 30 arc second study area rasters. These included nine landform, land cover and climatic variables that were thought a priori to have potentially high predictive power. We used the average training gain from ten model runs to select the best subset of predictors. Total winter precipitation, aspect and land cover, particularly broadleaf forests, emerged as important variables. A five-variable model that contained land cover, winter precipitation, aspect, slope, and elevation was the most parsimonious and not significantly different than the models with more variables. We used the best fitting model to depict potential winter habitat. Using the 10 percentile threshold (>0.25), we estimated winter habitat to cover 33,170 km 2, nearly 10% of the study area. The Dominican Republic contained half of all potential habitat (51%), followed by Cuba (15.1%), Jamaica (13.5%), Haiti (10.6%), and Puerto Rico (9.9%). Nearly one-third of the range was found to be in protected areas. By providing the first detailed predictive map of Bicknell's Thrush winter distribution, our study provides a useful tool to prioritize and direct conservation planning for this and other wet, broadleaf forest specialists in the Greater Antilles.	[McFarland, Kent P.; Rimmer, Christopher C.] Vermont Ctr Ecostudies, Norwich, VT USA; [Goetz, James E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Aubry, Yves] Environm Canada, Canadian Wildlife Serv, Ste Foy, PQ, Canada; [Wunderle, Joseph M., Jr.] USDA Forest Serv, Int Inst Trop Forestry, Sabana Field Res Stn, Luquillo, PR USA; [Townsend, Jason M.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Llanes Sosa, Alejandro] Inst Ecol & Sistemat, Havana, Cuba; [Kirkconnell, Arturo] Museo Nacl Hist Nat Cuba, Havana, Cuba	Cornell University; Environment & Climate Change Canada; Canadian Wildlife Service; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	McFarland, KP (corresponding author), Vermont Ctr Ecostudies, Norwich, VT USA.	kmcfarland@vtecostudies.org		McFarland, Kent/0000-0001-7809-5503; Goetz, James/0000-0003-2741-6869	Carolyn Foundation; Charles Blake Fund of the Nuttall Ornithological Club; Conservation and Research Foundation; National Fish and Wildlife Foundation; National Geographic Society Committee for Research and Exploration; Nature Conservancy; Stewart Foundation; Thomas Marshall Foundation; United States Fish and Wildlife Service; United States Department of Agriculture Forest Service Office of International Programs; Wildlife Conservation Society; Vermont Center for Ecostudies; Vermont Institute of Natural Science; Environment Canada; Latin-America Program	Carolyn Foundation; Charles Blake Fund of the Nuttall Ornithological Club; Conservation and Research Foundation; National Fish and Wildlife Foundation; National Geographic Society Committee for Research and Exploration(National Geographic Society); Nature Conservancy; Stewart Foundation; Thomas Marshall Foundation; United States Fish and Wildlife Service(US Fish & Wildlife Service); United States Department of Agriculture Forest Service Office of International Programs; Wildlife Conservation Society; Vermont Center for Ecostudies; Vermont Institute of Natural Science; Environment Canada(CGIAR); Latin-America Program	The authors gratefully acknowledge funding support over the many years of this study from the Carolyn Foundation, the Charles Blake Fund of the Nuttall Ornithological Club, the Conservation and Research Foundation, the National Fish and Wildlife Foundation, the National Geographic Society Committee for Research and Exploration, The Nature Conservancy, the Stewart Foundation, the Thomas Marshall Foundation, the United States Fish and Wildlife Service, the United States Department of Agriculture Forest Service Office of International Programs, and the Wildlife Conservation Society. Additional funding was provided by friends of the Vermont Center for Ecostudies and the Vermont Institute of Natural Science. Field work in Cuba was financially supported by Environment Canada and its Latin-America Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles ME, 2007, INT J CLIMATOL, V27, P555, DOI 10.1002/joc.1416; Atwood JL, 1996, WILSON BULL, V108, P650; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bicheron P., 2008, GLOBCOVER PRODUCTS D; BirdLife International, 2000, THREAT BIRDS WORLD; Chisholm SE, 2008, CAN J ZOOL, V86, P217, DOI 10.1139/Z07-131; Connolly V, 2002, WILSON BULL, V114, P333, DOI 10.1676/0043-5643(2002)114[0333:HUBTBT]2.0.CO;2; COSEWIC, 2009, UNSOLICITED UP UNPUB; *FAO, 1991, FOR RES ASS 1990; Frey S., 2011, ECOGRAPHY, V34, P1; Gardiner R, 2006, THESIS MOUNT ALLISON; Garrido O.H., 1975, CATALOGO AVES CUBA; Graveland J, 1996, OECOLOGIA, V105, P351, DOI 10.1007/BF00328738; Hames RS, 2002, P NATL ACAD SCI USA, V99, P11235, DOI 10.1073/pnas.172700199; Hart JA, 2010, CONSERVATION ACTION; Helmer EH, 2002, CARIBB J SCI, V38, P165; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson AH, 1992, ECOLOGY DECLINE RED, P387; Lambert JD, 2005, WILSON BULL, V117, P1, DOI 10.1676/04-013; Lambert JD, 2008, NORTHEAST NAT, V15; LATTA S., 2006, BIRDS DOMINICAN REPU; Latta SC, 2005, ANIM CONSERV, V8, P69, DOI 10.1017/S136794300400188X; Martin PH, 2007, J BIOGEOGR, V34, P1792, DOI 10.1111/j.1365-2699.2007.01726.x; Ottenwalder JA, 2000, MEDIO AMBIENTE SOSTE, P65; Pashley D.N., 2000, PARTNERS FLIGHT CONS; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; RICH TD, 2004, PARTNERS FLIGHT N AM; Rimmer C. C., 2005, J CARIBBEAN ORNITHOL, V18, P86; Rimmer C. C., 2004, EVALUATING USE VERMO; Rimmer CC, 2005, ECOTOXICOLOGY, V14, P223, DOI 10.1007/s10646-004-6270-1; RIMMER CC, 2001, BIRDS N AM, V592; Rodenhouse NL, 2008, MITIG ADAPT STRAT GL, V13, P517, DOI 10.1007/s11027-007-9126-1; Rompre Ghislain, 2000, Cotinga, V13, P66; Sherman RE, 2005, J TORREY BOT SOC, V132, P293, DOI 10.3159/1095-5674(2005)132[293:VRIFEO]2.0.CO;2; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Strong A. M., 2009, MOUNTAIN RESORTS ECO, P99; Townsend JM, 2010, AUK, V127, P514, DOI 10.1525/auk.2010.09160; Townsend JM, 2009, CONDOR, V111, P565, DOI 10.1525/cond.2009.090062; WALLACE GEORGE J., 1939, PROC BOSTON SOC NAT HIST, V41, P211; Wells J. V., 2007, BIRDERS CONSERVATION; WETMORE A, 1931, US NATL MUSEUM B, V155; Whittam B, 2010, HIGH ELEVATION LANDB; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	44	23	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53986	10.1371/journal.pone.0053986	http://dx.doi.org/10.1371/journal.pone.0053986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326554	Green Published, gold			2022-12-27	WOS:000313551500105
J	Ammirante, P; Russo, FA; Good, A; Fels, DI				Ammirante, Paolo; Russo, Frank A.; Good, Arla; Fels, Deborah I.			Feeling Voices	PLOS ONE			English	Article							GLOTTAL CHARACTERISTICS; SUMMATION; SPEAKERS	Two experiments investigated deaf individuals' ability to discriminate between same-sex talkers based on vibrotactile stimulation alone. Nineteen participants made same/different judgments on pairs of utterances presented to the lower back through voice coils embedded in a conforming chair. Discrimination of stimuli matched for F0, duration, and perceived magnitude was successful for pairs of spoken sentences in Experiment 1 (median percent correct = 83%) and pairs of vowel utterances in Experiment 2 (median percent correct = 75%). Greater difference in spectral tilt between "different" pairs strongly predicted their discriminability in both experiments. The current findings support the hypothesis that discrimination of complex vibrotactile stimuli involves the cortical integration of spectral information filtered through frequency-tuned skin receptors.	[Ammirante, Paolo; Russo, Frank A.; Good, Arla] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Fels, Deborah I.] Ryerson Univ, Ctr Learning Technol, Toronto, ON, Canada	Toronto Metropolitan University; Toronto Metropolitan University	Russo, FA (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	russo@ryerson.ca	Russo, Frank A./H-3748-2019	Russo, Frank A./0000-0002-2939-6358	Natural Sciences and Engineering Research Council of Canada [341583-07),]; Network of Centres of Excellence [: G-NI-10-Ry-01]; Graphics, Animation and New Media (GRAND) Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Network of Centres of Excellence; Graphics, Animation and New Media (GRAND) Canada	This research was supported by a Discovery grant awarded to the second author from the Natural Sciences and Engineering Research Council of Canada (Reference #: 341583-07), and Graphics, Animation and New Media (GRAND) Canada, a federally funded Network of Centres of Excellence (Reference #: G-NI-10-Ry-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, PROFILE ANAL AUDITOR; Birnbaum D.M., 2007, P INT COMP MUS C COP, P397; Boersma P., 2010, PRAAT DOING PHONETIC; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BROOKS PL, 1985, J ACOUST SOC AM, V77, P1576, DOI 10.1121/1.392000; Brooks PL, 1985, J REHABIL ENG, V22, P119; Brooks PL, 1985, J REHABIL ENG, V22, P129; Chasin M., 2009, HEARING LOSS MUSICIA; DiCanio CT, 2009, J INT PHON ASSOC, V39, P162, DOI 10.1017/S0025100309003879; Gault RH, 1924, J ABNORMAL PSYCHOL S, V19, DOI DOI 10.1037/H0065752; Gordon M, 2001, J PHONETICS, V29, P383, DOI 10.1006/jpho.2001.0147; Hanson HM, 1997, J ACOUST SOC AM, V101, P466, DOI 10.1121/1.417991; Hanson HM, 1999, J ACOUST SOC AM, V106, P1064, DOI 10.1121/1.427116; Karam M, 2009, IEEE T HAPTICS, V2, P160, DOI 10.1109/ToH.2009.32; Kramer SE, 2008, INT J AUDIOL, V47, pS124, DOI 10.1080/14992020802310887; Macmillan NA, 2005, DETECTION THEORY USE; MARKS LE, 1979, SENS PROCESS, V3, P188; Price E., 2008, ACM INT C P SERIES G, V322, P267; REED CM, 1985, J ACOUST SOC AM, V77, P247, DOI 10.1121/1.392266; Russo FA, 2012, J EXP PSYCHOL HUMAN, V38, P822, DOI 10.1037/a0029046; VERRILLO RT, 1975, PERCEPT PSYCHOPHYS, V18, P128, DOI 10.3758/BF03204100; Vy QV, 2009, LECT NOTES COMPUT SC, V5727, P916, DOI 10.1007/978-3-642-03658-3_110	22	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53585	10.1371/journal.pone.0053585	http://dx.doi.org/10.1371/journal.pone.0053585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341954	Green Published, Green Submitted, gold			2022-12-27	WOS:000313682700030
J	Keskin, F; Suhre, A; Kose, K; Ersahin, T; Cetin, AE; Cetin-Atalay, R				Keskin, Furkan; Suhre, Alexander; Kose, Kivanc; Ersahin, Tulin; Cetin, A. Enis; Cetin-Atalay, Rengul			Image Classification of Human Carcinoma Cells Using Complex Wavelet-Based Covariance Descriptors	PLOS ONE			English	Article							SEGMENTATION	Cancer cell lines are widely used for research purposes in laboratories all over the world. Computer-assisted classification of cancer cells can alleviate the burden of manual labeling and help cancer research. In this paper, we present a novel computerized method for cancer cell line image classification. The aim is to automatically classify 14 different classes of cell lines including 7 classes of breast and 7 classes of liver cancer cells. Microscopic images containing irregular carcinoma cell patterns are represented by subwindows which correspond to foreground pixels. For each subwindow, a covariance descriptor utilizing the dual-tree complex wavelet transform (DT-CWT) coefficients and several morphological attributes are computed. Directionally selective DT-CWT feature parameters are preferred primarily because of their ability to characterize edges at multiple orientations which is the characteristic feature of carcinoma cell line images. A Support Vector Machine (SVM) classifier with radial basis function (RBF) kernel is employed for final classification. Over a dataset of 840 images, we achieve an accuracy above 98%, which outperforms the classical covariance-based methods. The proposed system can be used as a reliable decision maker for laboratory studies. Our tool provides an automated, time-and cost-efficient analysis of cancer cell morphology to classify different cancer cell lines using image-processing techniques, which can be used as an alternative to the costly short tandem repeat (STR) analysis. The data set used in this manuscript is available as supplementary material through http://signal.ee.bilkent.edu.tr/cancerCellLineClassificationSampleImages.html.	[Keskin, Furkan; Suhre, Alexander; Kose, Kivanc; Cetin, A. Enis] Bilkent Univ, Dept Elect & Elect Engn, TR-06533 Ankara, Turkey; [Ersahin, Tulin; Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University	Cetin-Atalay, R (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.	rengul@bilkent.edu.tr	Cetin-Atalay, Rengul/F-5780-2013; Cetin-Atalay, Rengul/O-9826-2014; Ersahin, Tulin/M-5721-2013; Kose, Kivanc/AAG-8130-2019	Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Ersahin, Tulin/0000-0002-7474-7890; Kose, Kivanc/0000-0003-3185-2639; Keskin, Musa Furkan/0000-0002-7718-8377	European Union [PIRSES-GA-2009-247091]	European Union(European Commission)	This study was funded by the Seventh Framework program of the European Union under grant agreement number PIRSES-GA-2009-247091 "MIRACLE-Microscopic Image Processing, Analysis, Classification and Modelling Environment''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydogan DB, 2008, COMP MED SY, P614, DOI 10.1109/CBMS.2008.46; Bouzahzah B, 1984, IN VITRO, V20, P493; Buontempo F, 2011, INVEST NEW DRUG, V29, P1303, DOI 10.1007/s10637-010-9486-3; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chabrier S, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/96306; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen GY, 2006, IEEE IMAGE PROC, P2645, DOI 10.1109/ICIP.2006.313053; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Doyle S, 2007, I S BIOMED IMAGING, P1284, DOI 10.1109/ISBI.2007.357094; Dundar M. M., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2732, DOI 10.1109/ICPR.2010.669; Habiboglu YH, 2011, EUR SIGNAL PR CONF, P894; Habiboglu YH, 2011, INT CONF ACOUST SPEE, P1817; He L, 1985, J CELL PHYSL, V165, P459; Kilic N, 2010, J MED SYST, V34, P101, DOI 10.1007/s10916-008-9221-1; Kingsbury N, 1999, PHILOS T R SOC A, V357, P2543, DOI 10.1098/rsta.1999.0447; Kwitt Roland, 2007, 2007 11th IEEE International Conference on Computer Vision, P1, DOI 10.1109/ICCV.2007.4409170; Kwitt R, 2010, P IEEE COMP SOC C CO, P103, DOI [10.1109/CVPRW.2010.5543146, DOI 10.1109/CVPRW.2010.5543146]; Lebrun G, 2007, CELL MOL BIOL, V53, P51, DOI 10.1170/T787; Loo P, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P29, DOI 10.1109/ICIP.2000.899275; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maree R, 2005, PROC CVPR IEEE, P34; NAZIF AM, 1984, IEEE T PATTERN ANAL, V6, P555, DOI 10.1109/TPAMI.1984.4767570; Oefinger P, 1981, J GEN VIROL, V53; Raza SH, 2010, IEEE ENG MED BIO, P6749, DOI 10.1109/IEMBS.2010.5626009; Sayan B, 2009, HYBRIDOMA, V28, P1, DOI 10.1089/hyb.2008.0058; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Selesnick IW, 2003, PROC SPIE, V5207, P607, DOI 10.1117/12.504896; Selesnick IW, 2001, IEEE SIGNAL PROC LET, V8, P170, DOI 10.1109/97.923042; Steuer R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002218; Suhre A, 2011, EUR SIGNAL PR CONF, P1005; Thamarai M., 2010, Proceedings of the 2nd International Conference on Machine Learning and Computing (ICMLC 2010), P174, DOI 10.1109/ICMLC.2010.39; Tuna H, 2009, IEEE SIGNAL PROC LET, V16, P751, DOI 10.1109/LSP.2009.2024589; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Tuzel O, 2006, LECT NOTES COMPUT SC, V3952, P589; Vilela M, 2010, PLOS COMPUT BIOL, V6	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e52807	10.1371/journal.pone.0052807	http://dx.doi.org/10.1371/journal.pone.0052807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341908	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700015
J	Otalora-Luna, F; Lapointe, SL; Dickens, JC				Otalora-Luna, Fernando; Lapointe, Stephen L.; Dickens, Joseph C.			Olfactory Cues Are Subordinate to Visual Stimuli in a Neotropical Generalist Weevil	PLOS ONE			English	Article							DIAPREPES-ABBREVIATUS COLEOPTERA; COLORADO-POTATO-BEETLE; AGGREGATION PHEROMONE; MANDUCA-SEXTA; BUMBLE-BEES; CURCULIONIDAE; BEHAVIOR; INSECTS; ORIENTATION; FIELD	The tropical root weevil Diaprepes abbreviatus is a major pest of multiple crops in the Caribbean Islands and has become a serious constraint to citrus production in the United States. Recent work has identified host and conspecific volatiles that mediate host- and mate-finding by D. abbreviatus. The interaction of light, color, and odors has not been studied in this species. The responses of male and female D. abbreviatus to narrow bandwidths of visible light emitted by LEDs offered alone and in combination with olfactory stimuli were studied in a specially-designed multiple choice arena combined with a locomotion compensator. Weevils were more attracted to wavelengths close to green and yellow compared with blue or ultraviolet, but preferred red and darkness over green. Additionally, dim green light was preferred over brighter green. Adult weevils were also attracted to the odor of its citrus host + conspecifics. However, the attractiveness of citrus + conspecific odors disappeared in the presence of a green light. Photic stimulation induced males but not females to increase their speed. In the presence of light emitted by LEDs, turning speed decreased and path straightness increased, indicating that weevils tended to walk less tortuously. Diaprepes abbreviatus showed a hierarchy between chemo- and photo-taxis in the series of experiments presented herein, where the presence of the green light abolished upwind anemotaxis elicited by the pheromone + host plant odor. Insight into the strong responses to visual stimuli of chemically stimulated insects may be provided when the amount of information supplied by vision and olfaction is compared, as the information transmission capacity of compound eyes is estimated to be several orders of magnitude higher compared with the olfactory system. Subordination of olfactory responses by photic stimuli should be considered in the design of strategies aimed at management of such insects.	[Otalora-Luna, Fernando] IVIC, Ctr Multidisciplinario Ciencias, Lab Ecol Sensorial, Parroquia Jaji, Edo Merida, Venezuela; [Lapointe, Stephen L.] Agr Res Serv, USDA, US Hort Res Lab, Ft Pierce, FL USA; [Otalora-Luna, Fernando; Dickens, Joseph C.] Agr Res Serv, USDA, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Otalora-Luna, F (corresponding author), IVIC, Ctr Multidisciplinario Ciencias, Lab Ecol Sensorial, Parroquia Jaji, Edo Merida, Venezuela.	fotalora@ivic.gob.ve	Luna, Fernando Otálora/R-9992-2019; Dickens, Dick/AGY-7295-2022	Luna, Fernando Otálora/0000-0002-5313-2184; 				Adair RC, 1998, FLA ENTOMOL, V81, P225, DOI 10.2307/3496091; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Batschelet E, 1981, CIRCULAR STAT BIOL; BEAVERS JB, 1982, ENVIRON ENTOMOL, V11, P436, DOI 10.1093/ee/11.2.436; BEAVERS JB, 1979, FLA ENTOMOL, V62, P136, DOI 10.2307/3494091; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; Bouyssy A, 1987, PHYS SCI VIE PHYS SE, V1, P129; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Dickens JC, 2006, J APPL ENTOMOL, V130, P26, DOI 10.1111/j.1439-0418.2005.01014.x; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; GRAHAM K, 1959, NATURE, V184, P283, DOI 10.1038/184283b0; Hammock JA, 2007, ARTHROPOD-PLANT INTE, V1, P27, DOI 10.1007/s11829-007-9005-4; Harari AR, 1997, J CHEM ECOL, V23, P857, DOI 10.1023/B:JOEC.0000006416.96240.aa; Hausmann C, 2004, ENVIRON ENTOMOL, V33, P1410, DOI 10.1603/0046-225X-33.5.1410; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JONES IF, 1984, J ECON ENTOMOL, V77, P334, DOI 10.1093/jee/77.2.334; KITCHING RL, 1982, RES POPUL ECOL, V24, P224, DOI 10.1007/BF02515573; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Lapointe SL, 1999, FLA ENTOMOL, V82, P291, DOI 10.2307/3496582; Lapointe SL., 2004, MANEJO INTEGRADO PLA, V71, P106; Lapointe SL, 2007, ENVIRON ENTOMOL, V36, P73, DOI 10.1603/0046-225X(2007)36[73:EOLTOM]2.0.CO;2; Lapointe SL, 2012, J CHEM ECOL, V38, P408, DOI 10.1007/s10886-012-0096-8; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2009, J ECON ENTOMOL, V102, P992, DOI 10.1603/029.102.0318; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Otalora-Luna F, 2004, J COMP PHYSIOL A, V190, P847, DOI 10.1007/s00359-004-0540-5; Otalora-Luna F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020990; Otalora-Luna F, 2009, ARTHROPOD-PLANT INTE, V3, P63, DOI 10.1007/s11829-009-9058-7; Patt JM, 2007, ENVIRON ENTOMOL, V36, P142, DOI 10.1603/0046-225X(2007)36[142:OAVSAH]2.0.CO;2; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Roderick GK, 2003, ANN ENTOMOL SOC AM, V96, P631, DOI 10.1603/0013-8746(2003)096[0631:SPICPB]2.0.CO;2; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; SCHROEDER WJ, 1981, ENVIRON ENTOMOL, V10, P898, DOI 10.1093/ee/10.6.898; SHOREY H. H., 1965, ANN ENTOMOL SOC AMER, V58, P833, DOI 10.1093/aesa/58.6.833; Simpson SE, 1996, ENVIRON ENTOMOL, V25, P333, DOI 10.1093/ee/25.2.333; Sokal RR, 1995, BIOMETRY; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; TURRELL F. M., 1961, BOT GAZ, V123, P10, DOI 10.1086/336123	47	19	19	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e53120	10.1371/journal.pone.0053120	http://dx.doi.org/10.1371/journal.pone.0053120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23341926	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700022
J	Yoshimoto, M; Yoder, MC; Guevara, P; Adkins, B				Yoshimoto, Momoko; Yoder, Mervin C.; Guevara, Patricia; Adkins, Becky			The Murine Th2 Locus Undergoes Epigenetic Modification in the Thymus during Fetal and Postnatal Ontogeny	PLOS ONE			English	Article							LYMPHOCYTE PRECURSOR CELLS; DISTAL REGULATORY ELEMENTS; HEMATOPOIETIC STEM-CELLS; PRIMORDIAL GERM-CELLS; T-CELLS; DNA METHYLATION; IL-4 GENE; LINEAGE COMMITMENT; CYCLIC RENEWAL; IMMUNE-SYSTEM	Epigenetic modifications play a central role in the differentiation and function of immune cells in adult animals. Developmentally regulated epigenetic patterns also appear to contribute to the ontogeny of the immune system. We show here that the epigenetic profile of the T-helper (Th) 2 locus undergoes changes in T lineage cells beginning in mid-gestation and extending throughout the first week of life. In particular, regulatory regions of the Th2 locus are largely methylated at CpG residues among fetal liver common lymphoid progenitor cells. The locus subsequently becomes highly hypomethylated among the downstream progeny of these cells within the fetal thymus. This hypomethylated state is preserved until birth when the locus becomes rapidly re-methylated, achieving adult-like status by 3-6 days post birth. Notably, the capacity for rapid, high level Th2 cytokine production is lost in parallel with this re-methylation. In vitro organ culture and in vivo transplantation experiments indicate that signals from the adult environment are required to achieve the postnatal methylated state. Together, these findings indicate that the Th2 bias of neonates may be conferred, in part, by an epigenetic profile inherited from fetal life. However, the fetal program is rapidly terminated post birth by the development of signals leading to the acquisition of adult-like epigenetic patterns.	[Yoshimoto, Momoko; Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Guevara, Patricia; Adkins, Becky] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	Indiana University System; Indiana University Bloomington; University of Miami	Adkins, B (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	radkins@med.miami.edu	Yoshimoto, Momoko/N-4238-2014; Yoshimoto, Momoko/AFP-3523-2022	Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Yoder, Mervin/0000-0003-4354-7631	National Institute of Allergy and Infectious Diseases [AI044923, AI080759]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044923, R01AI080759, R56AI044923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases AI044923 (B.A) and AI080759 (M.C.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS B, 1994, J IMMUNOL, V153, P5359; Adkins B, 2003, J IMMUNOL, V171, P5157, DOI 10.4049/jimmunol.171.10.5157; Adkins B, 2006, Haematol Rep, V2, P9; Adkins B, 2000, Int Rev Immunol, V19, P157, DOI 10.3109/08830180009088503; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Aoki K, 2009, J IMMUNOL, V182, P7698, DOI 10.4049/jimmunol.0801643; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; CALVERT JE, 1983, J IMMUNOL, V131, P1693; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; Fadel S, 2000, Int Rev Immunol, V19, P173, DOI 10.3109/08830180009088504; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammond K, 1998, INT IMMUNOL, V10, P1491, DOI 10.1093/intimm/10.10.1491; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; JOTEREAU FV, 1982, J IMMUNOL, V129, P1869; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Martino D., 2012, GENES IMMUN; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prescott SL, 1998, J IMMUNOL, V160, P4730; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Ribeiro-do-Couto LM, 2001, EUR J IMMUNOL, V31, P3394, DOI 10.1002/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Siegrist C A, 2000, Int Rev Immunol, V19, P195, DOI 10.3109/08830180009088505; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Upham JW, 2006, INFECT IMMUN, V74, P1106, DOI 10.1128/IAI.74.2.1106-1112.2006; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e51587	10.1371/journal.pone.0051587	http://dx.doi.org/10.1371/journal.pone.0051587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335954	Green Published, gold, Green Submitted			2022-12-27	WOS:000314707700005
J	Caignard, G; Lucas-Hourani, M; Dhondt, KP; Labernardiere, JL; Petit, T; Jacob, Y; Horvat, B; Tangy, F; Vidalain, PO				Caignard, Gregory; Lucas-Hourani, Marianne; Dhondt, Kevin P.; Labernardiere, Jean-Louis; Petit, Thierry; Jacob, Yves; Horvat, Branka; Tangy, Frederic; Vidalain, Pierre-Olivier			The V Protein of Tioman Virus Is Incapable of Blocking Type I Interferon Signaling in Human Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEXES; AMINO-ACID SUBSTITUTION; BINDING-PROTEIN; HUMAN INFECTION; RNA HELICASE; NIPAH-VIRUS; DNA-BINDING; RIG-I; PARAMYXOVIRUS; STAT1	The capacity of a virus to cross species barriers is determined by the development of bona fide interactions with cellular components of new hosts, and in particular its ability to block IFN-alpha/beta antiviral signaling. Tioman virus (TioV), a close relative of mumps virus (MuV), has been isolated in giant fruit bats in Southeast Asia. Nipah and Hendra viruses, which are present in the same bat colonies, are highly pathogenic in human. Despite serological evidences of close contacts between TioV and human populations, whether TioV is associated to some human pathology remains undetermined. Here we show that in contrast to the V protein of MuV, the V protein of TioV (TioV-V) hardly interacts with human STAT2, does not degrade STAT1, and cannot block IFN-alpha/beta signaling in human cells. In contrast, TioV-V properly binds to human STAT3 and MDA5, and thus interferes with IL-6 signaling and IFN-beta promoter induction in human cells. Because STAT2 binding was previously identified as a host restriction factor for some Paramyxoviridae, we established STAT2 sequence from giant fruit bats, and binding to TioV-V was tested. Surprisingly, TioV-V interaction with STAT2 from giant fruit bats is also extremely weak and barely detectable. Altogether, our observations question the capacity of TioV to appropriately control IFN-alpha/beta signaling in both human and giant fruit bats that are considered as its natural host.	[Caignard, Gregory; Lucas-Hourani, Marianne; Labernardiere, Jean-Louis; Tangy, Frederic; Vidalain, Pierre-Olivier] Inst Pasteur, Unite Genom Virale & Vaccinat, CNRS, URA 3015,Virol Dept, Paris, France; [Dhondt, Kevin P.; Horvat, Branka] Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Horvat, Branka] Univ Lyon 1, F-69365 Lyon, France; [Petit, Thierry] Zoo Palmyre, Les Mathes, France; [Jacob, Yves] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Dept Virol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tangy, F (corresponding author), Inst Pasteur, Unite Genom Virale & Vaccinat, CNRS, URA 3015,Virol Dept, Paris, France.	ftangy@pasteur.fr; vidalain@pasteur.fr	Labernardière, Jean-Louis/AAT-2605-2020; Vidalain, Pierre-Olivier/F-9778-2019; Horvat, Branka/M-3504-2014	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Horvat, Branka/0000-0003-0578-7765; Dhondt, Kevin P./0000-0001-8729-4213; Caignard, Gregory/0000-0001-7021-0749; Jacob, Yves/0000-0001-9125-2374	Fondation Recherche Medicale; Institut Carnot Pasteur-MI; DGA-INSERM; INSERM; Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME)	Fondation Recherche Medicale; Institut Carnot Pasteur-MI; DGA-INSERM; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME)(French National Research Agency (ANR))	GC is supported by Fondation Recherche Medicale and Institut Carnot Pasteur-MI and KD is supported by DGA-INSERM. Work in BSL4 was supported by grants from INSERM and Agence Nationale de Recherche, Microbiologie, Immunologie et Maladies Emergentes (ANR MIME) to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Brussow H, 2009, ENVIRON MICROBIOL, V11, P2778, DOI 10.1111/j.1462-2920.2009.01962.x; Caignard G, 2009, VIROLOGY, V383, P112, DOI 10.1016/j.virol.2008.10.014; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Capraro GA, 2008, VIROLOGY, V376, P416, DOI 10.1016/j.virol.2008.03.034; Chant K, 1998, EMERG INFECT DIS, V4, P273, DOI 10.3201/eid0402.980215; Chatziandreou N, 2002, VIROLOGY, V293, P234, DOI 10.1006/viro.2001.1302; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Karron RA., 2007, FIELDS VIROLOGY, V5, P1497; Kraus TA, 2008, VIROLOGY, V371, P196, DOI 10.1016/j.virol.2007.10.001; Kubota T, 2001, BIOCHEM BIOPH RES CO, V283, P255, DOI 10.1006/bbrc.2001.4764; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Nishio M, 2005, J VIROL, V79, P14756, DOI 10.1128/JVI.79.23.14756-14768.2005; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Parisien JP, 2002, J VIROL, V76, P6435, DOI 10.1128/JVI.76.13.6435-6441.2002; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; Puri M, 2009, J VIROL, V83, P6347, DOI 10.1128/JVI.00596-09; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Schaap-Nutt A, 2011, J VIROL, V85, P4007, DOI 10.1128/JVI.02542-10; Schaap-Nutt A, 2010, VIROLOGY, V406, P65, DOI 10.1016/j.virol.2010.07.011; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Ulane CM, 2005, J VIROL, V79, P10180, DOI 10.1128/JVI.79.16.10180-10189.2005; Ulane CM, 2003, J VIROL, V77, P6385, DOI 10.1128/JVI.77.11.6385-6393.2003; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Wansley EK, 2002, J VIROL, V76, P10109, DOI 10.1128/JVI.76.20.10109-10121.2002; Wild TF, 2009, PATHOL BIOL, V57, P188, DOI 10.1016/j.patbio.2008.04.006; Yaiw KC, 2008, ARCH VIROL, V153, P865, DOI 10.1007/s00705-008-0059-0; Yaiw KC, 2007, J INFECT DIS, V196, P884, DOI 10.1086/520817; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240; Young DF, 2001, J VIROL, V75, P3363, DOI 10.1128/JVI.75.7.3363-3370.2001; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	59	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53881	10.1371/journal.pone.0053881	http://dx.doi.org/10.1371/journal.pone.0053881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342031	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400095
J	Calmon, MF; Mota, MTD; Babeto, E; Candido, NM; Girol, AP; Mendiburu, CF; Bonilha, JL; Silvestre, RVD; Rosa, BM; Thome, JA; Medeiros, GHA; Soares, FA; Guimaraes, GC; de Arruda, JGF; Oliani, SM; Villa, LL; Vassallo, J; Rahal, P				Calmon, Marilia Freitas; de Oliveira Mota, Manlio Tasso; Babeto, Erica; Candido, Natalia Maria; Girol, Ana Paula; Mendiburu, Carlos Fabian; Bonilha, Jane Lopes; Duarte Silvestre, Rodrigo Vellasco; Rosa, Bruno Miziara; Thome, Jorge Alberto; Americo Medeiros, Gustavo Hernandez; Soares, Fernando Augusto; Guimaraes, Gustavo Cardoso; Ferraz de Arruda, Jose Germano; Oliani, Sonia Maria; Villa, Luisa Lina; Vassallo, Jose; Rahal, Paula			Overexpression of ANXA1 in Penile Carcinomas Positive for High-Risk HPVs	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS; ANNEXIN-I; INTRAEPITHELIAL NEOPLASIA; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; PROTEIN; A1; P16(INK4A); TUMOR	The incidence of penile cancer varies between populations but is rare in developed nations. Penile cancer is associated with a number of established risk factors and associated diseases including phimosis with chronic inflammation, human papillomavirus (HPV) infection, poor hygiene and smoking. The objective of this study was to identify genes related to this type of cancer. The detection of HPV was analyzed in 47 penile squamous cell carcinoma samples. HPV DNA was detected in 48.9% of penile squamous cell carcinoma cases. High-risk HPV were present in 42.5% of cases and low-risk HPV were detected in 10.6% of penile squamous cell carcinomas. The RaSH approach identified differential expression of Annexin A1 (ANXA1), p16, RPL6, PBEF1 and KIAA1033 in high-risk HPV positive penile carcinoma; ANXA1 and p16 were overexpressed in penile squamous cells positive for high-risk HPVs compared to normal penile samples by qPCR. ANXA1 and p16 proteins were significantly more expressed in the cells from high-risk HPV-positive penile carcinoma as compared to HPV-negative tumors (p<0.0001) independently of the subtype of the carcinoma. Overexpression of ANXA1 might be mediated by HPV E6 in penile squamous cell carcinoma of patients with high-risk HPVs, suggesting that this gene plays an important role in penile cancer.	[Calmon, Marilia Freitas; de Oliveira Mota, Manlio Tasso; Babeto, Erica; Candido, Natalia Maria; Girol, Ana Paula; Oliani, Sonia Maria; Rahal, Paula] Sao Paulo State Univ, Sao Paulo, Brazil; [Mendiburu, Carlos Fabian; Rosa, Bruno Miziara; Thome, Jorge Alberto] Inst Anat Pathol & Cytopathol, Sao Paulo, Brazil; [Bonilha, Jane Lopes; Ferraz de Arruda, Jose Germano] Coll Med Rio Preto, Sao Paulo, Brazil; [Duarte Silvestre, Rodrigo Vellasco] Univ Hosp Joao de Berros Barreto, Belem, Para, Brazil; [Americo Medeiros, Gustavo Hernandez; Soares, Fernando Augusto; Guimaraes, Gustavo Cardoso; Vassallo, Jose] Hosp AC Camargo Fund Antonio Prudente, Sao Paulo, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Sch Med, Dept Radiol & Basic Oncol, Sao Paulo, Brazil; [Villa, Luisa Lina] Coll Med Sci Santa Casa Sao Paulo, Sao Paulo, Brazil	Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Sao Paulo	Rahal, P (corresponding author), Sao Paulo State Univ, Sao Paulo, Brazil.	rahalp@yahoo.com.br	de Oliveira Mota, Mânlio Tasso/E-2619-2013; Candido, Natalia M./H-5703-2013; Papilomavirus, Inct/I-2406-2013; Rahal, Paula/D-3871-2012; GUIMARAES, GUSTAVO CARDOSO/H-3595-2012; Calmon, Marilia Freitas/H-3150-2012; VASSALLO, JOSE/AAP-4600-2021; USP, Oncologia/F-9053-2014; Girol, Ana P/O-1716-2013; Oliani, Sonia Maria/E-3476-2012; VILLA, LUISA/AAH-4761-2019	de Oliveira Mota, Mânlio Tasso/0000-0003-0236-5356; Rahal, Paula/0000-0001-5693-6148; GUIMARAES, GUSTAVO CARDOSO/0000-0002-1317-2114; Calmon, Marilia Freitas/0000-0001-5203-0103; VASSALLO, JOSE/0000-0002-2192-4865; Girol, Ana P/0000-0002-8760-8945; Oliani, Sonia Maria/0000-0003-0918-2130; VILLA, LUISA/0000-0003-4074-2335; Soares, Fernando/0000-0002-1212-9093; Soares, Fernando Augusto/0000-0003-1647-7842	FAPESP [2009/11203-4, 2009/52088-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Source of funding: FAPESP. Grant numbers: 2009/11203-4 and 2009/52088-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Armed Forces Institute of Pathology (U.S.) National Research Council (U.S.)], ATLAS TUMOR PATHOLOG; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029; Begum S, 2007, CLIN CANCER RES, V13, P1186, DOI 10.1158/1078-0432.CCR-06-1690; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Cubilla AL, 2011, AM J SURG PATHOL, V35, P253, DOI 10.1097/PAS.0b013e318203cdba; de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Edge SB, 2010, AJCC CANC STAGING MA; Favorito LA, 2008, INT BRAZ J UROL, V34, P587, DOI 10.1590/S1677-55382008000500007; Ferrandiz-Pulido C, 2012, J AM ACAD DERMATOL; Ferreux E, 2003, J PATHOL, V201, P109, DOI 10.1002/path.1394; Fregonesi PAG, 2003, J HISTOCHEM CYTOCHEM, V51, P1291; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hippo Y, 2001, CANCER RES, V61, P889; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; JOHNSON MD, 1989, HUM PATHOL, V20, P772, DOI 10.1016/0046-8177(89)90071-3; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kang JS, 2002, CLIN CANCER RES, V8, P117; Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nam EJ, 2007, GYNECOL ONCOL, V104, P207, DOI 10.1016/j.ygyno.2006.07.043; Nam Eun Ji, 2008, J Gynecol Oncol, V19, P162, DOI 10.3802/jgo.2008.19.3.162; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Protzel C, 2011, WORLD J UROL, V29, P393, DOI 10.1007/s00345-010-0575-x; Prowse DM, 2008, BRIT J DERMATOL, V158, P261, DOI 10.1111/j.1365-2133.2007.08305.x; Raiol T, 2011, INTERVIROLOGY, V54, P146, DOI 10.1159/000320199; Rodrigo JP, 2005, AM J RHINOL, V19, P483, DOI 10.1177/194589240501900511; Senba M, 2009, ACTA VIROL, V53, P43, DOI 10.4149/av_2009_01_43; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Tewari M, 2007, ASIAN J SURG, V30, P126, DOI 10.1016/S1015-9584(09)60145-7; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106	56	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53260	10.1371/journal.pone.0053260	http://dx.doi.org/10.1371/journal.pone.0053260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341933	Green Submitted, gold, Green Published			2022-12-27	WOS:000314759400037
J	Livingston, DP; Henson, CA; Tuong, TD; Wise, ML; Tallury, SP; Duke, SH				Livingston, David P., III; Henson, Cynthia A.; Tuong, Tan D.; Wise, Mitchell L.; Tallury, Shyamalrau P.; Duke, Stanley H.			Histological Analysis and 3D Reconstruction of Winter Cereal Crowns Recovering from Freezing: A Unique Response in Oat (Avena sativa L.)	PLOS ONE			English	Article							LOW-TEMPERATURE; INJURY; TOLERANCE; BARLEY; GENES; PLANT; ACCLIMATION; ARABIDOPSIS; MICROSCOPY; TRANSPORT	The crown is the below ground portion of the stem of a grass which contains meristematic cells that give rise to new shoots and roots following winter. To better understand mechanisms of survival from freezing, a histological analysis was performed on rye, wheat, barley and oat plants that had been frozen, thawed and allowed to resume growth under controlled conditions. Extensive tissue disruption and abnormal cell structure was noticed in the center of the crown of all 4 species with relatively normal cells on the outside edge of the crown. A unique visual response was found in oat in the shape of a ring of cells that stained red with Safranin. A tetrazolium analysis indicated that tissues immediately inside this ring were dead and those outside were alive. Fluorescence microscopy revealed that the barrier fluoresced with excitation between 405 and 445 nm. Three dimensional reconstruction of a cross sectional series of images indicated that the red staining cells took on a somewhat spherical shape with regions of no staining where roots entered the crown. Characterizing changes in plants recovering from freezing will help determine the genetic basis for mechanisms involved in this important aspect of winter hardiness.	[Livingston, David P., III; Tuong, Tan D.] ARS, USDA, Raleigh, NC USA; [Livingston, David P., III; Tuong, Tan D.; Tallury, Shyamalrau P.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Henson, Cynthia A.; Wise, Mitchell L.] ARS, USDA, Cereal Crops Res Unit, Madison, WI USA; [Henson, Cynthia A.; Wise, Mitchell L.; Duke, Stanley H.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Livingston, DP (corresponding author), ARS, USDA, Raleigh, NC USA.	dpl@ncsu.edu			USDA	USDA(United States Department of Agriculture (USDA))	The study was supported by USDA in-house funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1991, PLANTA, V184, P123, DOI 10.1007/BF00208245; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; Briggs DE, 2009, J I BREWING, V115, P41, DOI 10.1002/j.2050-0416.2009.tb00343.x; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; CATTIVELLI L, 1990, PLANT PHYSIOL, V93, P1504, DOI 10.1104/pp.93.4.1504; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; EAGLES CF, 1993, NEW PHYTOL, V123, P477, DOI 10.1111/j.1469-8137.1993.tb03759.x; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hannah MA, 2006, PLOS GENET, V1, P79; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Johansen DA., 1940, PLANT MICROTECHNIQUE, P49; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Krishnamurthy KV, 1999, METHODS CELL WALL CY, P40; Livingston DP, 2010, J MICROSC-OXFORD, V240, P122, DOI 10.1111/j.1365-2818.2010.03393.x; Livingston DP, 2009, CROP SCI, V49, P1837, DOI 10.2135/cropsci2009.02.0077; Livingston DP, 2006, CAN J BOT, V84, P199, DOI 10.1139/B05-147; Livingston DP, 2005, CROP SCI, V45, P1545, DOI 10.2135/cropsci2004.0579; Livingston DP, 1996, CROP SCI, V36, P1568, DOI 10.2135/cropsci1996.0011183X003600060027x; MARSHALL D, 1988, PHYTOPATHOLOGY, V78, P952, DOI 10.1094/Phyto-78-952; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; OLIEN CR, 1981, CRYOBIOLOGY, V18, P404, DOI 10.1016/0011-2240(81)90114-0; OLIEN CR, 1976, CROP SCI, V16, P201, DOI 10.2135/cropsci1976.0011183X001600020009x; PALTA JP, 1993, ADVANCES IN PLANT COLD HARDINESS, P143; PALTA JP, 1980, PHYSIOL PLANTARUM, V50, P169, DOI 10.1111/j.1399-3054.1980.tb04446.x; PALTA JP, 1977, PLANT PHYSIOL, V60, P393, DOI 10.1104/pp.60.3.393; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Pearce RS, 1998, PLANT PHYSIOL, V117, P787, DOI 10.1104/pp.117.3.787; PETERS J, 2000, CONTRIBUTION AOSA, V29; Ruzin S. E., 1999, PLANT MICROTECHNIQUE, P87; SHANDS HL, 1961, OATS OAT IMPROVEMENT, P465; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; TANINO KK, 1985, CAN J BOT, V63, P432, DOI 10.1139/b85-053; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; ZAMECNIK J, 1994, PLANT SOIL, V167, P149, DOI 10.1007/BF01587610	36	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53468	10.1371/journal.pone.0053468	http://dx.doi.org/10.1371/journal.pone.0053468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341944	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400046
J	Villamon, E; Berbegall, AP; Piqueras, M; Tadeo, I; Castel, V; Djos, A; Martinsson, T; Navarro, S; Noguera, R				Villamon, Eva; Berbegall, Ana P.; Piqueras, Marta; Tadeo, Irene; Castel, Victoria; Djos, Anna; Martinsson, Tommy; Navarro, Samuel; Noguera, Rosa			Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion	PLOS ONE			English	Article							IMPROVED SURVIVAL PROBABILITY; CHROMOSOME INSTABILITY; RISK; TUMORS; GAIN; DDX1; EXPRESSION; CLASSIFICATION; IDENTIFICATION; ACCUMULATION	Background/Aim: Genetic analysis in neuroblastoma has identified the profound influence of MYCN amplification and 11q deletion in patients' prognosis. These two features of high-risk neuroblastoma usually occur as mutually exclusive genetic markers, although in rare cases both are present in the same tumor. The purpose of this study was to characterize the genetic profile of these uncommon neuroblastomas harboring both these high-risk features. Methods: We selected 18 neuroblastomas with MNA plus 11q loss detected by FISH. Chromosomal aberrations were analyzed using Multiplex Ligation-dependent Probe Amplification and Single Nucleotide Polymorphism array techniques. Results and Conclusion: This group of tumors has approximately the same high frequency of aberrations as found earlier for 11q deleted tumors. In some cases, DNA instability generates genetic heterogeneity, and must be taken into account in routine genetic diagnosis.	[Villamon, Eva; Berbegall, Ana P.; Piqueras, Marta; Navarro, Samuel; Noguera, Rosa] Univ Valencia, Dept Pathol, Sch Med, Valencia, Spain; [Tadeo, Irene] Hosp Clin Univ Valencia, Res Fdn, Valencia, Spain; [Castel, Victoria] Hosp Univ La Fe, Pediat Oncol Unit, Valencia, Spain; [Djos, Anna; Martinsson, Tommy] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Genet, Sahlgrenska Acad, Gothenburg, Sweden	University of Valencia; Hospital Clinic Universitari de Valencia; Hospital Universitari i Politecnic La Fe; Sahlgrenska University Hospital; University of Gothenburg	Noguera, R (corresponding author), Univ Valencia, Dept Pathol, Sch Med, Valencia, Spain.	rosa.noguera@uv.es	Villamon, Eva/A-6574-2016; Berbegall, Ana/AAB-2258-2020; Navarro, Samuel/AAD-2021-2020; Piqueras, Marta/ABH-1866-2020; Martinsson, Tommy/J-4140-2013; Tadeo, Irene/M-1639-2016	Berbegall, Ana/0000-0002-8798-3286; Navarro, Samuel/0000-0001-5016-5653; Piqueras, Marta/0000-0002-3748-7444; Martinsson, Tommy/0000-0002-9403-3123; Tadeo, Irene/0000-0003-3690-5007; Djos, Anna/0000-0002-5250-2163; Villamon, Eva/0000-0003-0636-3358; Castel, Victoria/0000-0002-3792-0615	ISCIII ERDF [RD06/0020/0102, PI10/0015]; FAECC [396/2009]; Swedish Cancer Society [09/1217]; Children's Cancer Foundation [08/098]	ISCIII ERDF; FAECC; Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation	This study was supported by the grants: RD06/0020/0102 and PI10/0015 (ISCIII & ERDF); 396/2009 (FAECC); 09/1217 (Swedish Cancer Society); and 08/098 (Children's Cancer Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Ambros IM, 2011, CLIN CANCER RES, V17, P792, DOI 10.1158/1078-0432.CCR-10-0830; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Ambros PF, 2001, MED PEDIATR ONCOL, V36, P1; Ando K, 2008, INT J CANCER, V123, P2087, DOI 10.1002/ijc.23776; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Coco S, 2012, INT J CANCER, V131, P1591, DOI 10.1002/ijc.27432; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; De Preter K, 2005, J CLIN ONCOL, V23, P3167, DOI 10.1200/JCO.2005.05.346; Defferrari R, 2007, CANCER LETT, V256, P56, DOI 10.1016/j.canlet.2007.05.010; Fieuw A, 2012, INT J CANCER, V130, P2599, DOI 10.1002/ijc.26317; Fischer M, 2010, ONCOGENE, V29, P865, DOI 10.1038/onc.2009.390; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Gagos S, 2005, INT J BIOCHEM CELL B, V37, P1014, DOI 10.1016/j.biocel.2005.01.003; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hoebeeck J, 2007, INT J CANCER, V120, P533, DOI 10.1002/ijc.22326; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jeison M, 2010, AM J PATHOL, V176, P2616, DOI 10.2353/ajpath.2010.090624; Kaneko S, 2007, J CANCER RES CLIN, V133, P185, DOI 10.1007/s00432-006-0156-y; Kerbl R, 2002, MED PEDIATR ONCOL, V38, P109, DOI 10.1002/mpo.1281.abs; Kryh H, 2011, INT J ONCOL, V39, P1063, DOI 10.3892/ijo.2011.1120; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McArdle L, 2004, CARCINOGENESIS, V25, P1599, DOI 10.1093/carcin/bgh173; Melegh Z, 2005, VIRCHOWS ARCH, V446, P517, DOI 10.1007/s00428-005-1204-8; Michels E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-173; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morales La Madrid A, 2012, PEDIAT BLOOD CANC; Noguera R, 2003, CANCER GENET CYTOGEN, V140, P157, DOI 10.1016/S0165-4608(02)00677-5; Piqueras M, 2011, BRIT J CANCER, V105, P89, DOI 10.1038/bjc.2011.188; Piqueras M, 2011, HISTOPATHOLOGY, V59, P22, DOI 10.1111/j.1365-2559.2011.03899.x; Schleiermacher G, 2011, BRIT J CANCER, V105, P1940, DOI 10.1038/bjc.2011.472; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; Spitz R, 2006, CLIN CANCER RES, V12, P3368, DOI 10.1158/1078-0432.CCR-05-2495; Stigliani S, 2012, NEOPLASIA, V14, P823, DOI 10.1593/neo.121114; Theissen J, 2009, CLIN CANCER RES, V15, P2085, DOI 10.1158/1078-0432.CCR-08-1648; Thompson PM, 2001, CANCER RES, V61, P679; de Souza DRV, 2011, PEDIATR BLOOD CANCER, V56, P749, DOI 10.1002/pbc.22823; Vandesompele J, 2008, INT J CANCER, V122, P1177, DOI 10.1002/ijc.23156; Villamon E, 2011, HISTOL HISTOPATHOL, V26, P343, DOI 10.14670/HH-26.343; Weber A, 2004, J CLIN ONCOL, V22, P2681, DOI 10.1200/JCO.2004.07.192; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	51	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53740	10.1371/journal.pone.0053740	http://dx.doi.org/10.1371/journal.pone.0053740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341988	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400073
J	Wang, MH; Wang, QS; Pan, YC				Wang, Minghui; Wang, Qishan; Pan, Yuchun			From QTL to QTN: Candidate Gene Set Approach and a Case Study in Porcine IGF1-FoxO Pathway	PLOS ONE			English	Article							GENOME ASSOCIATION; TOOL SET; GROWTH; PREDICTION; INSIGHTS; DISEASE; TRAITS; SNPS	Unraveling the genetic background of economic traits is a major goal in modern animal genetics and breeding. Both candidate gene analysis and QTL mapping have previously been used for identifying genes and chromosome regions related to studied traits. However, most of these studies may be limited in their ability to fully consider how multiple genetic factors may influence a particular phenotype of interest. If possible, taking advantage of the combined effect of multiple genetic factors is expected to be more powerful than analyzing single sites, as the joint action of multiple loci within a gene or across multiple genes acting in the same gene set will likely have a greater influence on phenotypic variation. Thus, we proposed a pipeline of gene set analysis that utilized information from multiple loci to improve statistical power. We assessed the performance of this approach by both simulated and a real IGF1-FoxO pathway data set. The results showed that our new method can identify the association between genetic variation and phenotypic variation with higher statistical power and unravel the mechanisms of complex traits in a point of gene set. Additionally, the proposed pipeline is flexible to be extended to model complex genetic structures that include the interactions between different gene sets and between gene sets and environments.	[Wang, Minghui; Wang, Qishan; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Wang, Minghui; Wang, Qishan; Pan, Yuchun] Shanghai Key Lab Anim Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Pan, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	panyuchun1963@yahoo.com.cn	Wang, Minghui/G-4939-2015		National Natural Science Foundation of China [31072003, 31000992, 31272414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant Nos. 31072003, 31000992, and 31272414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gilmour AR, 2009, ASREML USER GUIDE RE; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; John JMM, 2011, EUR J HUM GENET, V19, P696, DOI 10.1038/ejhg.2011.17; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liang Yulan, 2006, Functional & Integrative Genomics, V6, P1, DOI 10.1007/s10142-005-0006-z; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ron M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-183; Rothschild MF, 1997, PROBE, V8, P13; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Short TH, 1997, J ANIM SCI, V75, P3138; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang MH, 2011, MAMM GENOME, V22, P272, DOI 10.1007/s00335-011-9322-x; Wang QS, 2012, ANIM SCI J, V83, P279, DOI 10.1111/j.1740-0929.2011.00952.x; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Williamson DL, 2010, J GERONTOL A-BIOL, V65, P335, DOI 10.1093/gerona/glq005; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53452	10.1371/journal.pone.0053452	http://dx.doi.org/10.1371/journal.pone.0053452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341942	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400045
J	Wang, QP; Cao, XZ; Wang, XD; Gu, J; Wen, LM; Mao, LM; Shan, PN; Tang, AG				Wang, Qing-ping; Cao, Xiao-zhi; Wang, Xue-dong; Gu, Juan; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan; Tang, Ai-guo			Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ACUTE HEART-FAILURE; OBSTRUCTIVE PULMONARY-DISEASE; DIAGNOSTIC-ACCURACY; GENERAL-POPULATION; DYSPNEIC SUBJECTS; ELDERLY-PATIENTS; DYSFUNCTION; BNP; ASSOCIATION	Background: NT-proBNP has been widely regarded as a useful tool for diagnosis or exclusion of heart failure (HF) in many settings. However, in patients with acute exacerbation of chronic bronchitis (AECB), its roles have not been well described. The objective of this study was to evaluate the diagnostic performance of NT-proBNP for identifying left ventricular (LV) failure in such patients. Methods and Results: 311 AECB patients and 102 stable chronic bronchitis patients with no history of HF were enrolled. Plasma NT-proBNP concentrations were measured using Roche Elecsys. The European Society of Cardiology (ESC) diagnostic principles were adopted to identify HF and the diagnostic performance of NT-proBNP was evaluated by ROC. Our results showed, the median NT-proBNP level in patients with LV failure [4828.4 (2044.4-9203.6) ng/L] was significantly higher than that in those without LV failure [519.2 (179.1-1409.8) ng/L, p < 0.001] and stable controls [207.5 (186.5-318.2) ng/L, p < 0.001]. LV failure, renal function, atrial fibrillation and systolic pulmonary artery pressure were independent predictors of NT-proBNP levels (all p < 0.05). The area under ROC curve (AUC) of NT-proBNP for identifying LV failure was 0.884, significantly superior to clinical judgment alone (AUC 0.835, p = 0.0294). At the optimal cutoff value of 935.0 ng/L, NT-proBNP yielded sensitivity 94.4%, specificity 68.2%, accuracy 74.3% and negative predictive value 97.6%. Adding the results of NT-proBNP to those of clinical judgment improved the diagnostic accuracy for LV failure. Conclusion: As a tool for diagnosis or exclusion of HF, NT-proBNP can help physicians identify LV failure in patients with AECB.	[Wang, Qing-ping; Wang, Xue-dong; Gu, Juan] Nanjing Med Univ, Affiliated Hosp, Peoples Hosp Wuxi 5, Dept Clin Lab, Wuxi, Jiangsu, Peoples R China; [Wang, Qing-ping; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan] China Med Univ, Shaoxing Hosp, Dept Clin Lab, Shaoxing Cty, Zhejiang, Peoples R China; [Wang, Qing-ping; Wen, Li-min; Mao, Li-ming; Shan, Ping-nan] Cent Hosp Shaoxing Cty, Shaoxing Cty, Zhejiang, Peoples R China; [Cao, Xiao-zhi] PLA, Nanjing Command, Fuzhou Gen Hosp, Dept Caroliol, Fuzhou, Fujian, Peoples R China; [Tang, Ai-guo] Cent South Univ, XiangYa Hosp 2, Dept Clin Lab, Changsha, Hunan, Peoples R China	Nanjing Medical University; Central South University	Wang, XD (corresponding author), Nanjing Med Univ, Affiliated Hosp, Peoples Hosp Wuxi 5, Dept Clin Lab, Wuxi, Jiangsu, Peoples R China.	wxd729@126.com	Qingping, Wang/K-2645-2019	Wang, Qing-ping/0000-0002-7239-9693	Medical Research Foundation of the Wuxi Municipal Health Bureau [ML201203]; Scientific Technology Development Foundation of Nanjing Medical University [2012NJMU071]	Medical Research Foundation of the Wuxi Municipal Health Bureau; Scientific Technology Development Foundation of Nanjing Medical University	This research was supported by the Medical Research Foundation of the Wuxi Municipal Health Bureau (Grant No. ML201203) and supported by the Scientific Technology Development Foundation of Nanjing Medical University (Grant No. 2012NJMU071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2008, CURR OPIN CRIT CARE, V14, P340, DOI 10.1097/MCC.0b013e3282faa304; Abroug F, 2006, AM J RESP CRIT CARE, V174, P990, DOI 10.1164/rccm.200603-380OC; Albertson TE, 2010, J AM GERIATR SOC, V58, P570, DOI 10.1111/j.1532-5415.2010.02741.x; Balter M, 1997, INT J ANTIMICROB AG, V9, P83, DOI 10.1016/S0924-8579(97)00034-4; Balter Meyer S, 2003, Can Respir J, V10, P248; Bayes-Genis A, 2004, EUR J HEART FAIL, V6, P301, DOI 10.1016/j.ejheart.2003.12.013; Clerico A, 2004, CLIN CHEM, V50, P33, DOI 10.1373/clinchem.2003.024760; Clerico A, 2007, CLIN CHEM, V53, P813, DOI 10.1373/clinchem.2006.075713; Clerico A, 2011, AM J PHYSIOL-HEART C, V301, pH12, DOI 10.1152/ajpheart.00226.2011; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Donner CF, 2006, PULM PHARMACOL THER, V19, P4, DOI 10.1016/j.pupt.2005.10.011; Epshteyn V, 2003, DIABETES CARE, V26, P2081, DOI 10.2337/diacare.26.7.2081; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Gariani K, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13298; Goetze JP, 2006, EUR HEART J, V27, P3004, DOI 10.1093/eurheartj/ehl406; Hayes D, 2007, DRUG AGING, V24, P555, DOI 10.2165/00002512-200724070-00004; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Inoue Y, 2009, INTERNAL MED, V48, P503, DOI 10.2169/internalmedicine.48.1701; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Krauser DG, 2006, J CARD FAIL, V12, P452, DOI 10.1016/j.cardfail.2006.04.005; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Luchner A, 2005, HYPERTENSION, V46, P118, DOI 10.1161/01.HYP.0000170140.36633.8f; McCullough PA, 2003, ACAD EMERG MED, V10, P198, DOI 10.1197/aemj.10.3.198; Mogelvang R, 2007, J AM COLL CARDIOL, V50, P1694, DOI 10.1016/j.jacc.2007.07.073; Morello A, 2007, AM HEART J, V153, P90, DOI 10.1016/j.ahj.2006.10.005; Nagaya N, 2000, CIRCULATION, V102, P865; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; Shelton RJ, 2006, EUR HEART J, V27, P2353, DOI 10.1093/eurheartj/ehl233; Sirithunyanont Chirasak, 2003, J Med Assoc Thai, V86 Suppl 1, pS87; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Sykes Annemarie, 2007, Proc Am Thorac Soc, V4, P642, DOI 10.1513/pats.200707-101TH; Tsang KWT, 2001, CHEMOTHERAPY, V47, P28, DOI 10.1159/000049178; Tung RH, 2006, ANN EMERG MED, V48, P66, DOI 10.1016/j.annemergmed.2005.12.022; Vassaux C, 2008, EUR RESPIR J, V32, P1275, DOI 10.1183/09031936.00151707; Villacorta H, 2002, ARQ BRAS CARDIOL, V79, P564; Villacorta Humberto, 2002, Arq. Bras. Cardiol., V79, P569, DOI 10.1590/S0066-782X2002001500002; Wang QP, 2009, ANN CLIN BIOCHEM, V46, P495, DOI 10.1258/acb.2009.009065; Zaninotto M, 2005, CLIN BIOCHEM, V38, P1041, DOI 10.1016/j.clinbiochem.2005.07.010	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52553	10.1371/journal.pone.0052553	http://dx.doi.org/10.1371/journal.pone.0052553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341901	Green Submitted, Green Published, gold			2022-12-27	WOS:000314759400018
J	Liu, L; Cao, YY; Cui, GL; Li, ZZ; Sun, J; Zhang, LN; Chen, C; Wang, Y; Wang, PH; Ding, H; Wang, DW				Liu, Lei; Cao, Yanyan; Cui, Guanglin; Li, Zongzhe; Sun, Jing; Zhang, Lina; Chen, Chen; Wang, Yan; Wang, Peihua; Ding, Hu; Wang, Dao Wen			Association Analysis of Polymorphisms in ROCK2 with Cardiovascular Disease in a Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; VASCULAR SMOOTH-MUSCLE; ESSENTIAL-HYPERTENSION SUSCEPTIBILITY; RHO-KINASE INHIBITOR; NITRIC-OXIDE; HAN CHINESE; CELL; PATHOPHYSIOLOGY; INVOLVEMENT; ACTIVATION	Background: Rho-kinase (ROCK) has been shown to play an important role in cardiovascular disease such as coronary artery disease (CAD) and hypertension. Recently, common variants of ROCK2 have been reported to influence blood pressure, but the relationship between common ROCK2 variants and cardiovascular disease has not been extensively studied in the Chinese population. Methods: To derive a more precise estimation of their relationship, we screened for the common variants by direct sequencing of all exons of ROCK2, and then we performed genetic association analyses in a CAD case-control study, including a total of 1344 cases and 1267 ethnically and geographically matched controls. Results: Unconditional logistic regression showed that no significant association between common variants in the coding region of ROCK2 and CAD was observed in our study (for rs978906, OR = 0.92, 95% CI 0.72-1.20 and P = 0.63; for rs2230774, OR = 0.90, 95% CI 0.70-1.16 and P = 0.47; for rs56304104, OR = 0.97, 95% CI 0.70-1.31 and P = 0.83; respectively). Conclusions: The relationship between the ROCK2 polymorphisms and cardiovascular disease risk cannot be entirely discounted and warrants further evaluation in a large population.	[Liu, Lei; Cao, Yanyan; Cui, Guanglin; Li, Zongzhe; Sun, Jing; Zhang, Lina; Chen, Chen; Wang, Yan; Wang, Peihua; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China.	huding@tjh.tjmu.edu.cn; dwwang@tjh.tjmu.edu.cn	Wei, Qin/AAF-3325-2019; Zhang, Li/GWM-7501-2022; Chen, Chen/B-2080-2014	Wang, Dao Wen/0000-0002-9774-3980; ding, hu/0000-0002-1814-1552	National '973' Project [2012CB518004, 2012CB517801]; National Nature Science Foundation of China [30930039, 81100066]	National '973' Project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National '973' Project (2012CB518004, 2012CB517801), and National Nature Science Foundation of China (30930039, 81100066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Ding H, 2011, ATHEROSCLEROSIS, V216, P381, DOI 10.1016/j.atherosclerosis.2011.02.005; Ding H, 2010, PHARMACOGENET GENOM, V20, P187, DOI 10.1097/FPC.0b013e328336eefe; Dong Ming, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P322; Guerin P, 2005, J VASC RES, V42, P21, DOI 10.1159/000082873; Inokuchi K, 2004, J CARDIOVASC PHARM, V44, P275, DOI 10.1097/01.fjc.0000134775.76636.3f; Kandabashi T, 2002, ARTERIOSCL THROM VAS, V22, P243, DOI 10.1161/hq0202.104274; Kuo TY, 2012, AM J HYPERTENS, V25, P804, DOI 10.1038/ajh.2012.44; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Montorsi P, 2006, EUR HEART J, V27, P2632, DOI 10.1093/eurheartj/ehl142; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Rankinen T, 2008, HYPERTENS RES, V31, P1651, DOI 10.1291/hypres.31.1651; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Seasholtz TM, 2006, HYPERTENSION, V47, P937, DOI 10.1161/01.HYP.0000217364.45622.f0; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Xu YJ, 2011, PHARMACOGENET GENOM, V21, P489, DOI 10.1097/FPC.0b013e3283485eb2; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431; Zhao Q, 2008, PHARMACOGENET GENOM, V18, P459, DOI 10.1097/FPC.0b013e3282f97fb2; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	42	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53905	10.1371/journal.pone.0053905	http://dx.doi.org/10.1371/journal.pone.0053905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326532	Green Published, gold, Green Submitted			2022-12-27	WOS:000314705800086
J	Tulinski, P; Fluit, AC; van Putten, JPM; de Bruin, A; Glorieux, S; Wagenaar, JA; Duim, B				Tulinski, Pawel; Fluit, Ad C.; van Putten, Jos P. M.; de Bruin, Alain; Glorieux, Sarah; Wagenaar, Jaap A.; Duim, Birgitta			An Ex Vivo Porcine Nasal Mucosa Explants Model to Study MRSA Colonization	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; ADHERENCE; BACTERIAL; CARRIAGE; CULTURE	Staphylococcus aureus is an opportunistic pathogen able to colonize the upper respiratory tract and skin surfaces in mammals. Methicillin-resistant S. aureus ST398 is prevalent in pigs in Europe and North America. However, the mechanism of successful pig colonization by MRSA ST398 is poorly understood. To study MRSA colonization in pigs, an ex vivo model consisting of porcine nasal mucosa explants cultured at an air-liquid interface was evaluated. In cultured mucosa explants from the surfaces of the ventral turbinates and septum of the pig nose no changes in cell morphology and viability were observed up to 72 h. MRSA colonization on the explants was evaluated followed for three MRSA ST398 isolates for 180 minutes. The explants were incubated with 3x10(8) CFU/ml in PBS for 2 h to allow bacteria to adhere to the explants surface. Next the explants were washed and in the first 30 minutes post adhering time, a decline in the number of CFU was observed for all MRSA. Subsequently, the isolates showed either: bacterial growth, no growth, or a further reduction in bacterial numbers. The MRSA were either localized as clusters between the cilia or as single bacteria on the cilia surface. No morphological changes in the epithelium layer were observed during the incubation with MRSA. We conclude that porcine nasal mucosa explants are a valuable ex vivo model to unravel the interaction of MRSA with nasal tissue.	[Tulinski, Pawel; van Putten, Jos P. M.; Wagenaar, Jaap A.; Duim, Birgitta] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Glorieux, Sarah] Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Ghent University; Wageningen University & Research	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	b.duim@uu.nl	de Bruin, Alain/AAL-9195-2020; Tulinski, Pawel/P-8365-2014	Tulinski, Pawel/0000-0002-5033-5859; de Bruin, Alain/0000-0001-8579-2649; van Putten, Jos/0000-0002-4126-8172	European Union [222718]	European Union(European Commission)	The work was supported by European Union Framework 7 Programme HEALTH project CONCORD (CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions), grant number 222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Crombe F, 2012, APPL ENVIRON MICROB, V78, P1631, DOI 10.1128/AEM.07356-11; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Glorieux S, 2007, J VIROL METHODS, V142, P105, DOI 10.1016/j.jviromet.2007.01.018; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gonzalez-Zorn B, 2005, INFECT IMMUN, V73, P1847, DOI 10.1128/IAI.73.3.1847-1851.2005; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Jackson AD, 1996, AM J RESP CRIT CARE, V153, P1130, DOI 10.1164/ajrccm.153.3.8630556; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kokai-Kun John F., 2008, V431, P241; MartineauDoize B, 1996, ANAT REC, V246, P169, DOI 10.1002/(SICI)1097-0185(199610)246:2<169::AID-AR3>3.0.CO;2-X; Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WYATT JE, 1990, J APPL BACTERIOL, V69, P834	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53783	10.1371/journal.pone.0053783	http://dx.doi.org/10.1371/journal.pone.0053783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23326505	Green Published, Green Submitted, gold			2022-12-27	WOS:000314705800074
J	Greenwood, TA; Kelsoe, JR				Greenwood, Tiffany A.; Kelsoe, John R.		Bipolar Genome Study BiGS Consorti	Genome-Wide Association Study of Irritable vs. Elated Mania Suggests Genetic Differences between Clinical Subtypes of Bipolar Disorder	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; LINKAGE; DATABASE; SAMPLE	The use of clinical features to define subtypes of a disorder may aid in gene identification for complex diseases. In particular, clinical subtypes of mania may distinguish phenotypic subgroups of bipolar subjects that may also differ genetically. To assess this possibility, we performed a genome-wide association study using genotype data from the Bipolar Genome Study (BiGS) and subjects that were categorized as having either irritable or elated mania during their most severe episode. A bipolar case-only analysis in the GAIN bipolar sample identified several genomic regions that differed between irritable and elated subjects, the most significant of which was for 33 SNPs on chromosome 13q31 (peak p = 2x10(-7)). This broad peak is in a relative gene desert over an unknown EST and between the SLITRK1 and SLITRK6 genes. Evidence for association to this region came predominantly from subjects in the sample that were originally collected as part of a family-based bipolar linkage study, rather than those collected as bipolar singletons. We then genotyped an additional sample of bipolar singleton cases and controls, and the analysis of irritable vs. elated mania in this new sample did not replicate our previous findings. However, this lack of replication is likely due to the presence of significant differences in terms of clinical comorbity that were identified between these singleton bipolar cases and those that were selected from families segregating the disorder. Despite these clinical differences, analysis of the combined sample provided continued support for 13q31 and other regions from our initial analysis. Though genome-wide significance was not achieved, our results suggest that irritable mania results from a distinct set of genes, including a region on chromosome 13q31.	[Greenwood, Tiffany A.; Kelsoe, John R.] Univ San Diego, Dept Psychiat, La Jolla, CA USA; [Kelsoe, John R.] San Diego Vet Adm Healthcare Syst, San Diego, CA USA	University of San Diego	Kelsoe, JR (corresponding author), Univ San Diego, Dept Psychiat, La Jolla, CA USA.	jkelsoe@ucsd.edu	Mahon, Pamela Belmonte/O-9806-2018; McMahon, Francis J/A-7290-2009; Zhang, Peng/N-2920-2014; Greenwood, Tiffany/F-6356-2012; Lawson, William/O-9758-2017	Mahon, Pamela Belmonte/0000-0002-3947-441X; McMahon, Francis J/0000-0002-9469-305X; Zhang, Peng/0000-0003-1182-1392; Greenwood, Tiffany/0000-0002-6080-6503; Lawson, William/0000-0002-9324-7090; Nurnberger, John/0000-0002-7674-1767; Edenberg, Howard/0000-0003-0344-9690; coryell, william/0000-0003-3989-7276; Nievergelt, Caroline/0000-0001-5766-8923; Schork, Nicholas/0000-0003-0920-5013; Bloss, Cinnamon/0000-0003-1315-8387	National Institute of Mental Health (NIMH); National Human Genome Research Institute (NHGRI) [MH078151, MH081804, MH059567, K01-MH087889]; Genetic Association Information Network (GAIN); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059545, R01MH059567, R01MH060879, U01MH046280, R01MH059587, K01MH087889, R01MH060870, R01MH059565, R01MH059588, R01MH059534, R01MH059548, R01MH067257, R01MH059556, R01MH059586, R01MH081804, R01MH059553, R01MH078151, R01MH059571, R01MH059566, U01MH046274, R01MH059535, Z01MH002810, R01MH061675, U01MH046282, R01MH060068, R01MH059533] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Genetic Association Information Network (GAIN); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health (NIMH; www.nimh.nih.org) and National Human Genome Research Institute (NHGRI; www.genome.gov) to JRK (MH078151, MH081804, and MH059567 supplement) and TAG (K01-MH087889) and by the Genetic Association Information Network (GAIN; www.genome.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cassidy F, 1998, ARCH GEN PSYCHIAT, V55, P27, DOI 10.1001/archpsyc.55.1.27; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Greenwood TA, 2012, BIOL PSYCHIAT, V72, P303, DOI 10.1016/j.biopsych.2012.01.018; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Potash JB, 2007, AM J PSYCHIAT, V164, P1229, DOI 10.1176/appi.ajp.2007.06122045; Potash JB, 2003, AM J PSYCHIAT, V160, P680, DOI 10.1176/appi.ajp.160.4.680; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Sato T, 2002, AM J PSYCHIAT, V159, P968, DOI 10.1176/appi.ajp.159.6.968; Saunders EH, 2008, AM J MED GENET B, V147B, P18, DOI 10.1002/ajmg.b.30558; Shaw SH, 2003, MOL PSYCHIATR, V8, P558, DOI 10.1038/sj.mp.4001267; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Swann AC, 2002, NEUROPSYCHOPHARMACOL, V26, P530, DOI 10.1016/S0893-133X(01)00390-6; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Tsuang MT, 1990, THE GENETICS OF MOOD; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	29	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53804	10.1371/journal.pone.0053804	http://dx.doi.org/10.1371/journal.pone.0053804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326512	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400050
J	Kovach, RP; Joyce, JE; Echave, JD; Lindberg, MS; Tallmon, DA				Kovach, Ryan P.; Joyce, John E.; Echave, Jesse D.; Lindberg, Mark S.; Tallmon, David A.			Earlier Migration Timing, Decreasing Phenotypic Variation, and Biocomplexity in Multiple Salmonid Species	PLOS ONE			English	Article							ECO-EVOLUTIONARY DYNAMICS; CLIMATE-CHANGE; SOCKEYE-SALMON; PACIFIC SALMON; LIFE-HISTORY; PINK SALMON; ECOLOGICAL CONSEQUENCES; ONCORHYNCHUS-NERKA; MARINE SURVIVAL; FRASER-RIVER	Climate-induced phenological shifts can influence population, evolutionary, and ecological dynamics, but our understanding of these phenomena is hampered by a lack of long-term demographic data. We use a multi-decade census of 5 salmonid species representing 14 life histories in a warming Alaskan stream to address the following key questions about climate change and phenology: How consistent are temporal patterns and drivers of phenology for similar species and alternative life histories? Are shifts in phenology associated with changes in phenotypic variation? How do phenological changes influence the availability of resource subsidies? For most salmonid species, life stages, and life histories, freshwater temperature influences migration timing-migration events are occurring earlier in time (mean = 1.7 days earlier per decade over the 3-5 decades), and the number of days over which migration events occur is decreasing (mean = 1.5 days per decade). Temporal trends in migration timing were not correlated with changes in intra-annual phenotypic variation, suggesting that these components of the phenotypic distribution have responded to environmental change independently. Despite commonalities across species and life histories, there was important biocomplexity in the form of disparate shifts in migration timing and variation in the environmental factors influencing migration timing for alternative life history strategies in the same population. Overall, adult populations have been stable during these phenotypic and environmental changes (lambda approximate to 1.0), but the temporal availability of salmon as a resource in freshwater has decreased by nearly 30 days since 1971 due to changes in the median date of migration timing and decreases in intra-annual variation in migration timing. These novel observations advance our understanding of phenological change in response to climate warming, and indicate that climate change has influenced the ecology of salmon populations, which will have important consequences for the numerous species that depend on this resource.	[Kovach, Ryan P.; Lindberg, Mark S.; Tallmon, David A.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Joyce, John E.; Echave, Jesse D.] Natl Ocean & Atmospher Adm, Alaska Fisheries Sci Ctr, Auke Bay Labs, Juneau, AK USA; [Tallmon, David A.] Univ Alaska SE, Biol & Marine Biol Program, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Southeastern	Kovach, RP (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA.	rpkovach@alaska.edu			Alaska EPSCoR; Institute of Arctic Biology; Direct For Biological Sciences [0960285] Funding Source: National Science Foundation	Alaska EPSCoR; Institute of Arctic Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	An Alaska EPSCoR Graduate Research Fellowship and Institute of Arctic Biology Summer Research Fellowship supported R.P.K. This research was prepared by R.P.K. and D.A.T. under North Pacific Research Board (http://www.nprb.org/) project 1110 and award 45965 from the National Oceanic and Atmospheric Administration, U.S. Department of Commerce, administered by the Alaska Department of Fish and Game (http://www.akssf.org/akssf_org/home.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BenDavid M, 1997, CAN J ZOOL, V75, P376, DOI 10.1139/z97-047; Brodeur Richard D., 2003, North Pacific Anadromous Fish Commission Bulletin, V3, P89; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carlson SM, 2011, HEREDITY, V106, P438, DOI 10.1038/hdy.2010.163; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Carlson SM, 2007, ECOLOGY, V88, P2620, DOI 10.1890/06-1171.1; Carlson SM, 2011, CAN J FISH AQUAT SCI, V68, P1579, DOI 10.1139/F2011-084; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Dickerson BR, 2005, ECOLOGY, V86, P347, DOI 10.1890/03-625; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duffy EJ, 2008, T AM FISH SOC, V137, P165, DOI 10.1577/T07-049.1; Dunham J, 2008, FISHERIES, V33, P537, DOI 10.1577/1548-8446-33.11.537; Ezard THG, 2009, PHILOS T R SOC B, V364, P1491, DOI 10.1098/rstb.2009.0006; Fukushima M, 1998, T AM FISH SOC, V127, P253, DOI 10.1577/1548-8659(1998)127<0253:SHSOSS>2.0.CO;2; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Jones JD, 1997, SEA-RUN CUTTHROAT TROUT, P27; Juanes F, 2004, CAN J FISH AQUAT SCI, V61, P2392, DOI 10.1139/f04-207; Kennedy RJ, 2010, J FISH BIOL, V76, P1786, DOI 10.1111/j.1095-8649.2010.02617.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Lisi PJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00173.1; Malick MJ, 2009, T AM FISH SOC, V138, P846, DOI 10.1577/T08-177.1; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Mcphee MV, 2012, CURR ZOOL, V58, P21, DOI 10.1093/czoolo/58.1.21; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Moore JW, 2010, P ROY SOC B-BIOL SCI, V277, P1695, DOI 10.1098/rspb.2009.2342; Mundy PR, 2011, ICES J MAR SCI, V68, P1155, DOI 10.1093/icesjms/fsr080; Olsen EM, 2009, ECOL LETT, V12, P622, DOI 10.1111/j.1461-0248.2009.01311.x; Pachauri RK, 2007, CLIM CHANG 2007 SYNT; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Quinn TP, 2007, ECOL APPL, V17, P731, DOI 10.1890/06-0771; Quinn Thomas P., 2005, P1; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; Reed TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020380; Rich HB, 2009, CAN J FISH AQUAT SCI, V66, P238, DOI 10.1139/F08-210; Robards MD, 2002, T AM FISH SOC, V131, P523, DOI 10.1577/1548-8659(2002)131<0523:TMTOAS>2.0.CO;2; Roper BB, 1999, CAN J FISH AQUAT SCI, V56, P939, DOI 10.1139/cjfas-56-6-939; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schindler DE, 2005, ECOLOGY, V86, P198, DOI 10.1890/03-0408; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Shaul L, 2011, SPECIAL PUBLICATION, V11-23; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; TAYLOR SG, 1980, T AM FISH SOC, V109, P79, DOI 10.1577/1548-8659(1980)109<79:MSOPSF>2.0.CO;2; Taylor SG, 2008, GLOBAL CHANGE BIOL, V14, P229, DOI 10.1111/j.1365-2486.2007.01494.x; Thomson RE, 2011, FISH OCEANOGR, V20, P47, DOI 10.1111/j.1365-2419.2010.00565.x; Todd BD, 2011, P ROY SOC B-BIOL SCI, V278, P2191, DOI 10.1098/rspb.2010.1768; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Williams JG, 2008, EVOL APPL, V1, P271, DOI 10.1111/j.1752-4571.2008.00027.x; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719	76	77	81	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53807	10.1371/journal.pone.0053807	http://dx.doi.org/10.1371/journal.pone.0053807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326513	Green Published, Green Submitted, gold			2022-12-27	WOS:000313552400051
J	Volberg, G; Wutz, A; Greenlee, MW				Volberg, Gregor; Wutz, Andreas; Greenlee, Mark W.			Top-Down Control in Contour Grouping	PLOS ONE			English	Article							EEG ALPHA OSCILLATIONS; PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; ELECTROPHYSIOLOGICAL CORRELATE; THETA OSCILLATIONS; GLOBAL SHAPES; INTEGRATION; MECHANISMS; SYNCHRONIZATION; ORGANIZATION	Human observers tend to group oriented line segments into full contours if they follow the Gestalt rule of 'good continuation'. It is commonly assumed that contour grouping emerges automatically in early visual cortex. In contrast, recent work in animal models suggests that contour grouping requires learning and thus involves top-down control from higher brain structures. Here we explore mechanisms of top-down control in perceptual grouping by investigating synchronicity within EEG oscillations. Human participants saw two micro-Gabor arrays in a random order, with the task to indicate whether the first (S1) or the second stimulus (S2) contained a contour of collinearly aligned elements. Contour compared to non-contour S1 produced a larger posterior post-stimulus beta power (15-21 Hz). Contour S2 was associated with a pre-stimulus decrease in posterior alpha power (11-12 Hz) and in fronto-posterior theta (4-5 Hz) phase couplings, but not with a post-stimulus increase in beta power. The results indicate that subjects used prior knowledge from S1 processing for S2 contour grouping. Expanding previous work on theta oscillations, we propose that long-range theta synchrony shapes neural responses to perceptual groupings regulating lateral inhibition in early visual cortex.	[Volberg, Gregor; Wutz, Andreas; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Wutz, Andreas] Univ Trento, Ctr Cognit & Brain Sci, Rovereto, Italy	University of Regensburg; University of Trento	Volberg, G (corresponding author), Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany.	gregor.volberg@psychologie.uni-regensburg.de	Wutz, Andreas/AAH-6931-2020; Greenlee, Mark/M-6414-2018; Wutz, Andreas/E-9125-2019	Wutz, Andreas/0000-0003-2807-0863; Greenlee, Mark/0000-0003-2305-9286; Volberg, Gregor/0000-0002-4427-2409				Achtman RL, 2003, J VISION, V3, P616, DOI 10.1167/3.10.4; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Banerjee S, 2011, J NEUROSCI, V31, P9923, DOI 10.1523/JNEUROSCI.4660-10.2011; Beaudot WHA, 2003, VISUAL NEUROSCI, V20, P51, DOI 10.1017/S0952523803201061; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DILOLLO V, 1980, J EXP PSYCHOL GEN, V109, P75, DOI 10.1037/0096-3445.109.1.75; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Donkers Franc C L, 2011, Front Psychiatry, V2, P51, DOI 10.3389/fpsyt.2011.00051; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Flevaris AV, 2011, J VISION, V11, DOI 10.1167/11.7.11; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Hanslmayr S, 2011, J NEUROSCI, V31, P15674, DOI 10.1523/JNEUROSCI.3140-11.2011; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jirmann KU, 2009, EXP BRAIN RES, V192, P369, DOI 10.1007/s00221-008-1583-6; Kamarajan C, 2012, HUM BRAIN MAPP, V33, P1019, DOI 10.1002/hbm.21267; Kayser J., 2009, CURRENT SOURCE DENSI; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Mao R, 2012, CEREB CORTEX, V22, P493, DOI 10.1093/cercor/bhr057; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathes B, 2007, PSYCHOPHYSIOLOGY, V44, P305, DOI 10.1111/j.1469-8986.2007.00501.x; Mathes B, 2006, BRAIN RES, V1114, P98, DOI 10.1016/j.brainres.2006.07.068; May ES, 2012, NEUROIMAGE, V62, P1965, DOI 10.1016/j.neuroimage.2012.05.071; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Norman KA, 2006, NEURAL COMPUT, V18, P1577, DOI 10.1162/neco.2006.18.7.1577; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Sander MC, 2012, NEUROIMAGE, V59, P646, DOI 10.1016/j.neuroimage.2011.06.092; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; Tanskanen T, 2008, J VISION, V8, DOI 10.1167/8.7.15; Tarokh L, 2009, BEHAV BRAIN RES, V196, P55, DOI 10.1016/j.bbr.2008.07.026; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Volberg G, 2009, HUM BRAIN MAPP, V30, P2173, DOI 10.1002/hbm.20659; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Watt R, 2008, J VISION, V8, DOI 10.1167/8.7.23; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Worden MS, 2000, J NEUROSCI, V20; Yeshurun Y, 2008, VISION RES, V48, P1837, DOI 10.1016/j.visres.2008.05.008; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010	58	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54085	10.1371/journal.pone.0054085	http://dx.doi.org/10.1371/journal.pone.0054085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326575	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400074
J	Yang, FY; Chiu, WH				Yang, Feng-Yi; Chiu, Wei-Hsiu			Focused Ultrasound-Modulated Glomerular Ultrafiltration Assessed by Functional Changes in Renal Arteries	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PERMEABILITY; TUMOR	This study demonstrates the feasibility of using focused ultrasound (FUS) to modulate glomerular ultrafiltration by renal artery sonication and determine if protein-creatinine ratios are estimated through vascular parameters. All animal experiments were approved by our Animal Care and Use Committee. The renal arteries of Sprague-Dawley rats were surgically exposed and sonicated at various acoustic power levels using a FUS transducer with a resonant frequency of 1 MHz. The mean peak systolic velocity (PSV) of the blood flow was measured by Doppler ultrasound imaging. Urinary protein-creatinine ratios were calculated during the experiments. Histological examination of renal arteries and whole kidneys was performed. The PSV, pulsatility index, and resistance index of blood flow significantly increased in the arteries after FUS sonication without microbubbles (p<0.05). The change in normalized protein-creatinine ratios significantly increased with increasing acoustic power, but such was not observed when microbubbles were administered. Furthermore, no histological changes were observed in the hematoxylin-and eosin-stained sections. Glomerular ultrafiltration is regulated temporarily by renal artery sonication without microbubbles. Monitoring vascular parameters are useful in estimating the normalized change in protein-creatinine ratios.	[Yang, Feng-Yi; Chiu, Wei-Hsiu] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Yang, FY (corresponding author), Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw			National Science Council of Taiwan [NSC 101-2320-B-010-036-MY3, NSC 100-2321-B-010-010, NSC 99-2321-B-010-017]; Cheng Hsin General Hospital Foundation [100F117CY25, 101F195CY18]; Veterans General Hospitals University [VGHUST100-G1-3-3]; Yen Tjing Ling Medical Foundation [CI-100-17]; Department of Health of Taiwan [DOH101-TD-PB-111-TM012]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Veterans General Hospitals University; Yen Tjing Ling Medical Foundation; Department of Health of Taiwan	This study was supported by grants from the National Science Council of Taiwan (no. NSC 101-2320-B-010-036-MY3, NSC 100-2321-B-010-010 and NSC 99-2321-B-010-017), Cheng Hsin General Hospital Foundation (no. 100F117CY25 and 101F195CY18), Veterans General Hospitals University System of Taiwan Joint Research Program (#VGHUST100-G1-3-3), Yen Tjing Ling Medical Foundation (grant CI-100-17), Department of Health of Taiwan (DOH101-TD-PB-111-TM012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Fischer K, 2009, RADIOLOGY, V253, P697, DOI 10.1148/radiol.2532082100; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Ishikawa T, 2003, ULTRASOUND MED BIOL, V29, P1471, DOI 10.1016/S0301-5629(03)00951-7; Khaibullina A, 2008, J NUCL MED, V49, P295, DOI 10.2967/jnumed.107.046888; LEGARTH J, 1990, J ULTRAS MED, V9, P449; Mcdannold N, 2008, ULTRASOUND MED BIOL, V34, P930, DOI 10.1016/j.ultrasmedbio.2007.11.009; Meairs S, 2009, MED BIOL ENG COMPUT, V47, P839, DOI 10.1007/s11517-009-0468-6; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Unger EC, 2004, ADV DRUG DELIVER REV, V56, P1291, DOI 10.1016/j.addr.2003.12.006; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2012, MED ENG PHYS, V34, P313, DOI 10.1016/j.medengphy.2011.07.021; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2012, INT J NANOMED, V7, P723, DOI 10.2147/IJN.S28503; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2010, IEEE T ULTRASON FERR, V57, P1594, DOI 10.1109/TUFFC.2010.1589; Yang FY, 2009, J ACOUST SOC AM, V126, P3344, DOI 10.1121/1.3242376; Yang FY, 2009, IEEE T ULTRASON FERR, V56, P2643, DOI 10.1109/TUFFC.2009.1355; Yang FY, 2012, J CONTROL RELEASE; Zderic V, 2006, ULTRASONICS, V45, P113, DOI 10.1016/j.ultras.2006.07.018	24	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e54034	10.1371/journal.pone.0054034	http://dx.doi.org/10.1371/journal.pone.0054034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326567	Green Submitted, gold, Green Published			2022-12-27	WOS:000313552400068
J	Vander Wal, E; van Beest, FM; Brook, RK				Vander Wal, Eric; van Beest, Floris M.; Brook, Ryan K.			Density-Dependent Effects on Group Size Are Sex-Specific in a Gregarious Ungulate	PLOS ONE			English	Article							MOUNTAIN-NATIONAL-PARK; TEMPORAL VARIATION; PREDATION RISK; HERD SIZE; ELK; POPULATION; SEGREGATION; BEHAVIOR; DEER; RED	Density dependence can have marked effects on social behaviors such as group size. We tested whether changes in population density of a large herbivore (elk, Cervus canadensis) affected sex-specific group size and whether the response was density- or frequency-dependent. We quantified the probability and strength of changes in group sizes and dispersion as population density changed for each sex. We used group size data from a population of elk in Manitoba, Canada, that was experimentally reduced from 1.20 to 0.67 elk/km(2) between 2002 and 2009. Our results indicated that functional responses of group size to population density are sex-specific. Females showed a positive density-dependent response in group size at population densities >= 0.70 elk/km(2) and we found evidence for a minimum group size at population density <= 0.70 elk/km(2). Changes in male group size were also density-dependent; however, the strength of the relationship was lower than for females. Density dependence in male group size was predominantly a result of fusion of solitary males into larger groups, rather than fusion among existing groups. Our study revealed that density affects group size of a large herbivore differently between males and females, which has important implications for the benefits e.g., alleviating predation risk, and costs of social behaviors e. g., competition for resources and mates, and intra-specific pathogen transmission.	[Vander Wal, Eric; van Beest, Floris M.; Brook, Ryan K.] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [Vander Wal, Eric] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Saskatchewan; University of Sherbrooke	Vander Wal, E (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada.	eric.vander.wal@usherbrooke.ca	van Beest, Floris M./C-6745-2019	van Beest, Floris M./0000-0002-5701-4927	Parks Canada Agency; PrioNet Canada; National Science and Engineering Research Council of Canada; Manitoba Conservation; Manitoba Agriculture, Food and Rural Initiatives; Canadian Food Inspection Agency; University of Manitoba; University of Saskatchewan; Riding Mountain Biosphere Reserve; Louisiana Pacific; Nature Conservancy of Canada; Rocky Mountain Elk Foundation; Manitoba Wildlife Federation; Eastlands Wildlife Association; Westlake Wildlife Association; Earth Rhythms Inc.; Seven Oaks Game and Fish; Global Precision Inc.	Parks Canada Agency; PrioNet Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Conservation; Manitoba Agriculture, Food and Rural Initiatives; Canadian Food Inspection Agency; University of Manitoba; University of Saskatchewan; Riding Mountain Biosphere Reserve; Louisiana Pacific; Nature Conservancy of Canada; Rocky Mountain Elk Foundation; Manitoba Wildlife Federation; Eastlands Wildlife Association; Westlake Wildlife Association; Earth Rhythms Inc.; Seven Oaks Game and Fish; Global Precision Inc.	Funding was provided primarily by Parks Canada Agency and PrioNet Canada. Additional financial support was obtained from the National Science and Engineering Research Council of Canada grants to S. McLauchlin and F. Messier, Manitoba Conservation, Manitoba Agriculture, Food and Rural Initiatives, the Canadian Food Inspection Agency, University of Manitoba, University of Saskatchewan, Riding Mountain Biosphere Reserve, Louisiana Pacific, Nature Conservancy of Canada, Rocky Mountain Elk Foundation, Manitoba Wildlife Federation, Eastlands Wildlife Association, Westlake Wildlife Association, Earth Rhythms Inc., Seven Oaks Game and Fish, and Global Precision Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from the following commercial sources: Louisiana Pacific, Earth Rhythms Inc., Seven Oaks Game and Fish, and Global Precision Inc.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALBON SD, 1992, J ANIM ECOL, V61, P131, DOI 10.2307/5516; BARRETTE C, 1991, MAMMALIA, V55, P207, DOI 10.1515/mamm.1991.55.2.207; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bateman AW, 2011, J ANIMAL ECOLOGY; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Blank D, 2012, EUROPEAN J WILDLIFE; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Borkowski J, 2000, CAN J ZOOL, V78, P1369, DOI 10.1139/cjz-78-8-1369; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; Brook R. K., 2008, ELK AGR CONFLICTS GR; Brook RK, 2009, PREV VET MED, V91, P197, DOI 10.1016/j.prevetmed.2009.05.021; Brook Ryan K., 2009, Human-Wildlife Conflicts, V3, P72; Caners RT, 2003, COMMUNITY ECOL, V4, P185, DOI 10.1556/ComEc.4.2003.2.6; CARBYN LN, 1983, J WILDLIFE MANAGE, V47, P963, DOI 10.2307/3808155; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GEIST V, 1986, CAN J ZOOL, V64, P380, DOI 10.1139/z86-059; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Jackson AL, 2006, P R SOC B, V273, P1055, DOI 10.1098/rspb.2005.3421; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JOHNSON CN, 1983, AUST WILDLIFE RES, V10, P25; Krause J, 2002, LIVING GROUPS; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Mathews F, 2009, ADV PARASIT, V68, P185, DOI 10.1016/S0065-308X(08)00608-8; Millspaugh JJ, 2004, WILDLIFE SOC B, V32, P506, DOI 10.2193/0091-7648(2004)32[506:HOOCEI]2.0.CO;2; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763; MORI H, 1965, PROG THEOR PHYS, V33, P423, DOI 10.1143/PTP.33.423; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pepin D, 2008, ANIM BEHAV, V75, P361, DOI 10.1016/j.anbehav.2006.09.030; Proffitt KM, 2012, J WILDLIFE MANAGE, V76, P847, DOI 10.1002/jwmg.310; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richardson KE, 2007, CAN J ZOOL, V85, P759, DOI 10.1139/Z07-057; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; ROUNDS RC, 1981, J WILDLIFE MANAGE, V45, P187, DOI 10.2307/3807886; Rowcliffe JM, 2004, J ANIM ECOL, V73, P97, DOI 10.1111/j.1365-2656.2004.00783.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Seno H, 2006, J MATH BIOL, V52, P70, DOI 10.1007/s00285-005-0341-7; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Vander Wal E, 2012, ECOLOGY, V93, P206, DOI 10.1890/11-0020.1; Vander Wal E, 2011, SEX FRIENDS DIS SOCI; Vander Wal E, SOCIAL INTERAC UNPUB; Vander Wal E, 2011, J WILDLIFE MANAGE, V75, P1521, DOI 10.1002/jwmg.208; Walker D, 2001, THESIS U MANITOBA WI; Weckerly F, 2004, AM MIDL NAT, V152, P386, DOI 10.1674/0003-0031(2004)152[0386:REDASS]2.0.CO;2; Weckerly FW, 2001, J MAMMAL, V82, P414, DOI 10.1644/1545-1542(2001)082&lt;0414:ALMREL&gt;2.0.CO;2; White G.C., 1990, ANAL WILDLIFE RADIO; White PJ, 2012, AM MIDL NAT, V167, P174, DOI 10.1674/0003-0031-167.1.174; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153; Zuur Alain F., 2009, P1	68	29	29	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53777	10.1371/journal.pone.0053777	http://dx.doi.org/10.1371/journal.pone.0053777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326502	gold, Green Published, Green Submitted			2022-12-27	WOS:000313551500096
J	Adhikari, D; Risal, S; Liu, K; Shen, Y				Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan			Pharmacological Inhibition of mTORC1 Prevents Over-Activation of the Primordial Follicle Pool in Response to Elevated PI3K Signaling	PLOS ONE			English	Article							OVARIAN TOXICITY; MOUSE OVARY; OOCYTES; CHEMOTHERAPY; OVOTOXICITY; SURVIVAL; PATHWAY; GROWTH	The majority of ovarian primordial follicles must be preserved in a quiescent state to allow for the regular production of gametes over the female reproductive lifespan. However, the molecular mechanism that maintains the long quiescence of primordial follicles is poorly understood. Under certain pathological conditions, the entire pool of primordial follicles matures simultaneously leading to an accelerated loss of primordial follicles and to premature ovarian failure (POF). We have previously shown that loss of Pten (phosphatase and tensin homolog deleted on chromosome ten) in mouse oocytes leads to premature activation of the entire pool of primordial follicles, subsequent follicular depletion in early adulthood, and the onset of POF. Lack of PTEN leads to increased phosphatidylinositol 3-kinase (PI3K)-Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling in the oocytes. To study the functional and pathological roles of elevated mTORC1 signaling in the oocytes, we treated the Pten-mutant mice with the specific mTORC1 inhibitor rapamycin. When administered to Pten-deficient mice prior to the activation of the primordial follicles, rapamycin effectively prevented global follicular activation and preserved the ovarian reserve. These results provide a rationale for exploring the possible use of rapamycin as a drug for the preservation of the primordial follicle pool, and the possible prevention of POF.	[Adhikari, Deepak; Risal, Sanjiv; Liu, Kui; Shen, Yan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Adhikari, D (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	deepak.adhikari@medchem.umu.se; yan.shen@vgregion.se	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609				Adhikari D, 2010, CELL CYCLE, V9, P1673, DOI 10.4161/cc.9.9.11626; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Ben-Aharon I, 2012, REPRODUCTION, V144, P153, DOI 10.1530/REP-12-0121; Braun M, 2012, NEW ENGL J MED, V366, P1062, DOI 10.1056/NEJMc1113145; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Jagarlamudi K, 2010, MOL CELL ENDOCRINOL, V315, P1, DOI 10.1016/j.mce.2009.07.016; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	28	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53810	10.1371/journal.pone.0053810	http://dx.doi.org/10.1371/journal.pone.0053810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24124466	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800077
J	Seo, EH; Lee, DY; Lee, JM; Park, JS; Sohn, BK; Lee, DS; Choe, YM; Woo, JI				Seo, Eun Hyun; Lee, Dong Young; Lee, Jong-Min; Park, Jun-Sung; Sohn, Bo Kyung; Lee, Dong Soo; Choe, Young Min; Woo, Jong Inn			Whole-brain Functional Networks in Cognitively Normal, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; NEUROPSYCHOLOGICAL ASSESSMENT; TOPOLOGICAL PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; BLOOD-FLOW; CONNECTIVITY; DEMENTIA	The conceptual significance of understanding functional brain alterations and cognitive deficits associated with Alzheimer's disease (AD) process has been widely established. However, the whole-brain functional networks of AD and its prodromal stage, mild cognitive impairment (MCI), are not well clarified yet. In this study, we compared the characteristics of the whole-brain functional networks among cognitively normal (CN), MCI, and AD individuals by applying graph theoretical analyses to [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) data. Ninety-four CN elderly, 183 with MCI, and 216 with AD underwent clinical evaluation and FDG-PET scan. The overall small-world property as seen in the CN whole-brain network was preserved in MCI and AD. In contrast, individual parameters of the network were altered with the following patterns of changes: local clustering of networks was lower in both MCI and AD compared to CN, while path length was not different among the three groups. Then, MCI had a lower level of local clustering than AD. Subgroup analyses for AD also revealed that very mild AD had lower local clustering and shorter path length compared to mild AD. Regarding the local properties of the whole-brain networks, MCI and AD had significantly decreased normalized betweenness centrality in several hubs regionally associated with the default mode network compared to CN. Our results suggest that the functional integration in whole-brain network progressively declines due to the AD process. On the other hand, functional relatedness between neighboring brain regions may not gradually decrease, but be the most severely altered in MCI stage and gradually re-increase in clinical AD stages.	[Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Woo, Jong Inn] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Jong-Min; Park, Jun-Sung] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Dong Soo] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Seoul National University Hospital	Lee, DS (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea.	selfpsy@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	Seoul National University Hospital [2011-0564]; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092145]; Korea government (MEST) [2011-0028333]	Seoul National University Hospital; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Seoul National University Hospital (Grant No. 2011-0564), a grant from the Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No. A092145), and a grant from the Korea government (MEST) (Grant No. 2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Golob EJ, 2001, NEUROBIOL AGING, V22, P755, DOI 10.1016/S0197-4580(01)00244-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Ishii K, 2003, J NEUROL SCI, V215, P71, DOI 10.1016/S0022-510X(03)00206-5; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vecchio Fabrizio, 2011, Int J Alzheimers Dis, V2011, P214580, DOI 10.4061/2011/214580; Wada Y, 1998, ALZ DIS ASSOC DIS, V12, P175, DOI 10.1097/00002093-199809000-00009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yun JY, 2011, DEMENT GER COGN D EX, V1, P190, DOI 10.1159/000329517; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	73	109	111	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53922	10.1371/journal.pone.0053922	http://dx.doi.org/10.1371/journal.pone.0053922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	24098810	gold, Green Published, Green Submitted			2022-12-27	WOS:000314707700038
J	Holliday, EG; Magee, CA; Kritharides, L; Banks, E; Attia, J				Holliday, Elizabeth G.; Magee, Christopher A.; Kritharides, Leonard; Banks, Emily; Attia, John			Short Sleep Duration Is Associated with Risk of Future Diabetes but Not Cardiovascular Disease: a Prospective Study and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; LEPTIN LEVELS; MORTALITY; QUALITY; POPULATION; MEN; COMPLAINTS; QUANTITY; WORKERS	Epidemiologic studies have observed association between short sleep duration and both cardiovascular disease (CVD) and type 2 diabetes, although these results may reflect confounding by pre-existing illness. This study aimed to determine whether short sleep duration predicts future CVD or type 2 diabetes after accounting for baseline health. Baseline data for 241,949 adults were collected through the 45 and Up Study, an Australian prospective cohort study, with health outcomes identified via electronic database linkage. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals. Compared to 7h sleep, <6h sleep was associated with incident CVD in participants reporting ill-health at baseline (HR=1.38 [95% CI: 1.12-1.70]), but not after excluding those with baseline illness and adjusting for baseline health status (1.03 [0.88-1.21]). In contrast, the risk of incident type 2 diabetes was significantly increased in those with <6h versus 7h sleep, even after excluding those with baseline illness and adjusting for baseline health (HR=1.29 [1.08-1.53], P=0.004). This suggests the association is valid and does not simply reflect confounding or reverse causation. Meta-analysis of ten prospective studies including 447,124 participants also confirmed an association between short sleep and incident diabetes (1.33 [1.20-1.48]). Obtaining less than 6 hours of sleep each night (compared to 7 hours) may increase type 2 diabetes risk by approximately 30%.	[Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Magee, Christopher A.] Univ Wollongong, Ctr Hlth Initiat, Wollongong, NSW, Australia; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia; [Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Wollongong; Concord Repatriation General Hospital; University of Sydney; Australian National University; University of Sydney	Holliday, EG (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	Liz.Holliday@newcastle.edu.au	Smith, Albert Vernon/K-5150-2015; Scott, Rodney J/B-2827-2013; Liew, Gerald/AAB-6870-2022; Hewitt, Alex W/D-1936-2013; Brown, Matthew A/E-5749-2010; Jonasson, Fridbert/ABA-9889-2021; Kritharides, Leonard/AAQ-2720-2020; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Jankowski, Janusz/H-2706-2012; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Bellenguez, Céline/X-4004-2019; Tai, E Shyong/J-9831-2013; Belllenguez, Céline/Y-3183-2018; Attia, John R/F-5376-2013; Sim, Xueling/AAZ-6652-2020; Klaver, Caroline C.W./A-2013-2016; Cheng, Ching-Yu/K-7017-2013; Wang, Jie Jin/P-1499-2014; Rotter, Jerome/AAY-6598-2021; Cheng, Ching-Yu/Y-2229-2019; Aspelund, Thor/K-7022-2019; Blackwell, Jenefer M/H-3015-2015	Smith, Albert Vernon/0000-0003-1942-5845; Scott, Rodney J/0000-0001-7724-3404; Hewitt, Alex W/0000-0002-5123-5999; Brown, Matthew A/0000-0003-0538-8211; Wong, Tien Yin/0000-0002-8448-1264; Jankowski, Janusz/0000-0003-2130-9181; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Bellenguez, Céline/0000-0002-1240-7874; Belllenguez, Céline/0000-0002-1240-7874; Attia, John R/0000-0001-9800-1308; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Aspelund, Thor/0000-0002-7998-5433; Van Duijn, Cornelia/0000-0002-2374-9204; Klein, Ronald/0000-0002-4428-6237; Tai, E Shyong/0000-0003-2929-8966; Banks, Emily/0000-0002-4617-1302; Magee, Christopher/0000-0002-0465-6328; /0000-0001-6694-3587; Inouye, Michael/0000-0001-9413-6520; Klaver, Caroline/0000-0002-2355-5258; Plomin, Robert/0000-0002-0756-3629; Baird, Paul/0000-0002-1305-3502; Gillman, Matthew S./0000-0002-2340-6930; Cotch, Mary Frances/0000-0002-2046-4350	The Sax Institute; Cancer Council New South Wales; National Heart Foundation of Australia (New South Wales Division); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; Australian Red Cross Blood Service; Uniting Care Ageing; Australian National Health and Medical Research Council; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC085084, N01HC045133, N01HC085082, N01HC085080, N01HC035129, N01HC085081, N01HC055222, N01HC015103, N01HC085085, N01HC085086, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000426, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL080295, U01HL080295, R01HL105756, R01HL086694, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, R01AG015928, ZIAAG007380, R56AG020098, R01AG020098, R56AG023629, R01AG023629, ZIAAG007270, R01AG027058] Funding Source: NIH RePORTER	The Sax Institute(University of Sydney); Cancer Council New South Wales(Cancer Council New South Wales); National Heart Foundation of Australia (New South Wales Division)(National Heart Foundation of Australia); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; Australian Red Cross Blood Service; Uniting Care Ageing; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Sax Institute; Cancer Council New South Wales; the National Heart Foundation of Australia (New South Wales Division); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; the Australian Red Cross Blood Service; Uniting Care Ageing; the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Banks Emily, 2009, Aust New Zealand Health Policy, V6, P16, DOI 10.1186/1743-8462-6-16; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Ghanaat F, 2005, METABOLISM, V54, P604, DOI 10.1016/j.metabol.2004.12.003; Hayashino Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-129; HAYS RD, 1995, RAND USERS MANUAL ME; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hosmer D, 2008, APPL SURVIVAL ANAL R, P132; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Johansson I, 2010, EUR J CARDIOVASC NUR, V9, P175, DOI 10.1016/j.ejcnurse.2009.12.003; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Meisinger C, 2007, SLEEP, V30, P1121, DOI 10.1093/sleep/30.9.1121; *NAT CTR CLASS HLT, 2007, ICD10AM NAT CTR CLAS; Olafiranye O, 2012, SLEEP MED, V13, P728, DOI 10.1016/j.sleep.2012.01.015; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281; Shankar A, 2011, SLEEP, V34, P1173, DOI 10.5665/SLEEP.1232; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Suzuki E, 2009, PREV MED, V49, P135, DOI 10.1016/j.ypmed.2009.06.016; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; *WHO, 2008, ACT PLAN GLOB STRAT, P2008; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	40	193	198	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82305	10.1371/journal.pone.0082305	http://dx.doi.org/10.1371/journal.pone.0082305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282622	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500126
J	Zhu, Y; Pires, KMP; Whitehead, KJ; Olsen, CD; Wayment, B; Zhang, YC; Bugger, H; Ilkun, O; Litwin, SE; Thomas, G; Kozma, SC; Abel, ED				Zhu, Yi; Pires, Karla M. P.; Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Litwin, Sheldon E.; Thomas, George; Kozma, Sara C.; Abel, E. Dale			Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMALIAN TARGET; CARDIAC-FUNCTION; IN-VIVO; COMPLEX; MOUSE; MUSCLE; RICTOR; PHOSPHORYLATION; PROLIFERATION	Mechanistic target of rapamycin (Mtor) is required for embryonic inner cell mass proliferation during early development. However, Mtor expression levels are very low in the mouse heart during embryogenesis. To determine if Mtor plays a role during mouse cardiac development, cardiomyocyte specific Mtor deletion was achieved using alpha myosin heavy chain (alpha-MHC) driven Cre recombinase. Initial mosaic expression of Cre between embryonic day (E) 10.5 and E11.5 eliminated a subset of cardiomyocytes with high Cre activity by apoptosis and reduced overall cardiac proliferative capacity. The remaining cardiomyocytes proliferated and expanded normally. However loss of 50% of cardiomyocytes defined a threshold that impairs the ability of the embryonic heart to sustain the embryo's circulatory requirements. As a result 92% of embryos with cardiomyocyte Mtor deficiency died by the end of gestation. Thus Mtor is required for survival and proliferation of cardiomyocytes in the developing heart.	[Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Zhu, Yi; Pires, Karla M. P.; Zhang, Yi Cheng; Bugger, Heiko; Ilkun, Olesya; Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Zhu, Yi; Abel, E. Dale] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Whitehead, Kevin J.; Olsen, Curtis D.; Wayment, Benjamin; Litwin, Sheldon E.] Univ Utah, Sch Med, Div Cardiol, Salt Lake City, UT USA; [Pires, Karla M. P.] Univ Estado Rio De Janeiro, Lab Morphometry & Cardiovasc Morphol, Inst Biol, Biomed Ctr, Rio De Janeiro, Brazil; [Thomas, George; Kozma, Sara C.] Univ Cincinnati, Coll Med, Dept Internal Med, Metab Dis Inst,Div Hematol Oncol, Cincinnati, OH USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Universidade do Estado do Rio de Janeiro; University System of Ohio; University of Cincinnati	Abel, ED (corresponding author), Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA.	dale.abel@hmbg.utah.edu	Thomas, George/K-9235-2014; Bugger, Heiko/ABA-4180-2021	Thomas, George/0000-0003-3518-8149; Zhang, Yi/0000-0003-2228-0341; Slakeski, Nada/0000-0001-9776-6018; Abel, E. Dale/0000-0001-5290-0738; Reynolds, Eric/0000-0002-6618-4856; Dashper, Stuart/0000-0003-0106-8691; Bugger, Heiko/0000-0002-3524-0405	 [U01HL087947];  [R01DK092065]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947, U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317, R01DK092065] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EDA was funded by U01HL087947, R01DK092065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunkaynak ME, 2011, ANAT HISTOL EMBRYOL, V40, P402, DOI 10.1111/j.1439-0264.2011.01085.x; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	28	88	90	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54221	10.1371/journal.pone.0054221	http://dx.doi.org/10.1371/journal.pone.0054221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342106	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400135
J	Shi, JR; Jiang, BB; Qiu, YL; Guan, J; Jain, M; Cao, X; Bauer, M; Su, LH; Burkly, LC; Leone, TC; Kelly, DP; Liao, RL				Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Su, Lihe; Burkly, Linda C.; Leone, Teresa C.; Kelly, Daniel P.; Liao, Ronglih			PGC1 alpha Plays a Critical Role in TWEAK-Induced Cardiac Dysfunction	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MULTIFUNCTIONAL CYTOKINE; PGC-1 COACTIVATORS; WEAK INDUCER; RECEPTOR; PGC-1-ALPHA; METABOLISM; APOPTOSIS; BINDS; FN14	Background: Inflammatory cytokines play an important role in the pathogenesis of heart failure. We have recently found the cytokine TWEAK (tumor necrosis factor (TNF)-like weak inducer of apoptosis), a member of the TNF superfamily, to be increased in patients with cardiomyopathy and result in the development of heart failure when overexpressed in mice. The molecular mechanisms underlying TWEAK-induced cardiac pathology, however, remain unknown. Methodology and Critical Finding: Using mouse models of elevated circulating TWEAK levels, established through intravenous injection of adenovirus expressing TWEAK or recombinant TWEAK protein, we find that TWEAK induces a progressive dilated cardiomyopathy with impaired contractile function in mice. Moreover, TWEAK treatment is associated with decreased expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and genes required for mitochondrial oxidative phosphorylation, which precede the onset of cardiac dysfunction. TWEAK-induced downregulation of PGC1 alpha requires expression of its cell surface receptor, fibroblast growth factor-inducible 14 (Fn14). We further find that TWEAK downregulates PGC1 alpha gene expression via the TNF receptor-associated factor 2 (TRAF2) and NFkB signaling pathways. Maintaining PGC1 alpha levels through adenoviral-mediated gene expression is sufficient to protect against TWEAK-induced cardiomyocyte dysfunction. Conclusion: Collectively, our data suggest that TWEAK induces cardiac dysfunction via downregulation of PGC1 alpha, through FN14-TRAF2-NF kappa B-dependent signaling. Selective targeting of the FN14-TRAF2-NF kappa B-dependent signaling pathway or augmenting PGC1 alpha levels may serve as novel therapeutic strategies for cardiomyopathy and heart failure.	[Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Su, Lihe] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Biogen; Biogen; Sanford Burnham Prebys Medical Discovery Institute	Liao, RL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA.	rliao@rics.bwh.harvard.edu	Qiu, Yiling/C-7138-2013; Kelly, Daniel/ABG-2056-2021	Liao, Ronglih/0000-0002-9598-9020; Bai, Chunxue/0000-0001-5798-3130	National Institute of Health [HL099073, HL086967, HL093147, R01HL058493, R01HL101189, R01DK045416, K08 HL107451]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189, R01HL058493, R01HL086967, K08HL107451, R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institute of Health research grants HL099073 HL086967 and HL093147 (R.L.), R01HL058493, R01HL101189, and R01DK045416 (D.P.K.) grants. M.J. is the recipient of NIH mentored award (K08 HL107451). J.S. and M.B. were supported by a postdoctoral fellowship from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liao Ronglih, 2007, V139, P251; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schilling J, 2011, J MOL CELL CARDIOL, V51, P578, DOI 10.1016/j.yjmcc.2010.09.021; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weinberg JM, 2011, KIDNEY INT, V79, P151, DOI 10.1038/ki.2010.435; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2006, DRUG NEWS PERSPECT, V19, P589, DOI 10.1358/dnp.2006.19.10.1068005	35	43	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54054	10.1371/journal.pone.0054054	http://dx.doi.org/10.1371/journal.pone.0054054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342071	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700080
J	Iyer, S; Killingback, T; Sundaram, B; Wang, Z				Iyer, Swami; Killingback, Timothy; Sundaram, Bala; Wang, Zhen			Attack Robustness and Centrality of Complex Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ERROR; TOLERANCE	Many complex systems can be described by networks, in which the constituent components are represented by vertices and the connections between the components are represented by edges between the corresponding vertices. A fundamental issue concerning complex networked systems is the robustness of the overall system to the failure of its constituent parts. Since the degree to which a networked system continues to function, as its component parts are degraded, typically depends on the integrity of the underlying network, the question of system robustness can be addressed by analyzing how the network structure changes as vertices are removed. Previous work has considered how the structure of complex networks change as vertices are removed uniformly at random, in decreasing order of their degree, or in decreasing order of their betweenness centrality. Here we extend these studies by investigating the effect on network structure of targeting vertices for removal based on a wider range of non-local measures of potential importance than simply degree or betweenness. We consider the effect of such targeted vertex removal on model networks with different degree distributions, clustering coefficients and assortativity coefficients, and for a variety of empirical networks.	[Iyer, Swami] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA; [Sundaram, Bala; Wang, Zhen] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Harbor Campus, Boston, MA 02125 USA.	timothy.killingback@umb.edu	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BEAUCHAMP MA, 1965, BEHAV SCI, V10, P161, DOI 10.1002/bs.3830100205; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Dym H, 2007, LINEAR ALGEBRA ACTIO, V78; Faust K, 2000, SOCIAL NETWORK ANAL; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Newman M, 2008, MATH NETWORKS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; STAUFFER D, 1994, INTRO PERCOLATION TH; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	37	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2013	8	4							e59613	10.1371/journal.pone.0059613	http://dx.doi.org/10.1371/journal.pone.0059613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	127RY	23341946	Green Submitted, Green Published, gold			2022-12-27	WOS:000317717300025
J	Cao, Y; Zhou, XX; Huang, XY; Li, QL; Gao, LL; Jiang, LJ; Huang, M; Zhou, JF				Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng			Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis	PLOS ONE			English	Article							CELLS; TARGETS; ESCAPE	Background: T cell immunoglobulin mucin-3 (Tim-3) has been identified as a negative regulator of anti-tumor immunity. Recent studies highlight the important role of Tim-3 in the CD8(+) T cell exhaustion that takes place in both human and animal cancer models. However, the nature of Tim-3 expression in the tumor cell and the mechanism by which it inhibits anti-tumor immunity are unclear. This present study aims to determine Tim-3 is expressed in cervical cancer cells and to evaluate the role of Tim-3 in cervical cancer progression. Methodology: A total of 85 cervical tissue specimens including 43 human cervical cancer, 22 cervical intraepithelial neoplasia (CIN) and 20 chronic cervicitis were involved. Tim-3 expression in tumor cells was detected and was found to correlate with clinicopathological parameters. Meanwhile, expression of Tim-3 was assessed by RT-PCR, Western Blot and confocal microscopy in cervical cancer cell lines, HeLa and SiHa. The migration and invasion potential of Hela cells was evaluated after inhibiting Tim-3 expression by ADV-antisense Tim-3. Conclusions: We found that Tim-3 was expressed at a higher level in the clinical cervical cancer cells compared to the CIN and chronic cervicitis controls. We supported this finding by confirming the presence of Tim-3 mRNA and protein in the cervical cell lines. Tim-3 expression in tumor cells correlated with clinicopathological parameters. Patients with high expression of Tim-3 had a significant metastatic potential, advanced cancer grades and shorter overall survival than those with lower expression. Multivariate analysis showed that Tim-3 expression was an independent factor for predicting the prognosis of cervical cancer. Significantly, down-regulating the expression of Tim-3 protein inhibited migration and invasion of Hela cells. Our study suggests that the expression of Tim-3 in tumor cells may be an independent prognostic factor for patients with cervical cancer. Moreover, Tim-3 expression may promote metastatic potential in cervical cancers.	[Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Huang, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China.	huangmei@medmail.com.cn	Cao, Yang/HGD-6463-2022	Yu, Shiqiang/0000-0003-3519-0943	National Science Foundation of China [81001049]; National Science Fund for Distinguished Young Scholars of China [81025011]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This article was supported by National Science Foundation of China (No. 81001049) and National Science Fund for Distinguished Young Scholars of China (No. 81025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2012, NAT REV CANCER, V12, P453; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Ibrahim R, 2006, CANCER-AM CANCER SOC, V106, P1065, DOI 10.1002/cncr.21697; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; No JH, 2011, MOL CARCINOGEN, V50, P244, DOI 10.1002/mc.20657; Norde WJ, 2012, BLOOD, V120, P728, DOI 10.1182/blood-2012-02-412510; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Zhou JF, 2005, CLIN CANCER RES, V11, P8431, DOI 10.1158/1078-0432.CCR-05-1085; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425	19	106	126	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53834	10.1371/journal.pone.0053834	http://dx.doi.org/10.1371/journal.pone.0053834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335978	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700036
J	Chen, H; Wu, N; Wang, YF; Zhu, D; Zhu, QA; Yang, G; Gao, YH; Fang, XQ; Wang, X; Peng, CH				Chen, Huai; Wu, Ning; Wang, Yanfen; Zhu, Dan; Zhu, Qiu'an; Yang, Gang; Gao, Yongheng; Fang, Xiuqin; Wang, Xu; Peng, Changhui			Inter-Annual Variations of Methane Emission from an Open Fen on the Qinghai-Tibetan Plateau: A Three-Year Study	PLOS ONE			English	Article							NITROUS-OXIDE; EXPERIMENTAL DROUGHT; CARBON-DIOXIDE; SOIL EMISSIONS; ALPINE WETLAND; NITRIC-OXIDE; RICE FIELDS; FLUXES; CLIMATE; CHINA	The study aimed to understand the inter-annual variations of methane (CH4) emissions from an open fen on the Qinghai-Tibetan Plateau (QTP) from 2005 to 2007. The weighted mean CH4 emission rate was 8.37 +/- 11.32 mg CH4 m(-2) h(-1) during the summers from 2005 to 2007, falling in the range of CH4 fluxes reported by other studies, with significant inter-annual and spatial variations. The CH4 emissions of the year of 2006 (2.11 +/- 3.48 mg CH4 m(-2) h(-1)) were 82% lower than the mean value of the years 2005 and 2007 (13.91 +/- 17.80 mg CH4 m(-2) h(-1) and 9.44 +/- 14.32 mg CH4 m(-2) h(-1), respectively), responding to the inter-annual changes of standing water depths during the growing season of the three years. Significant drawdown of standing water depth is believed to cause such significant reduction in CH4 emissions from wetlands in the year 2006, probably through changing the methanogen composition and decreasing its community size as well as activating methanotrophs to enhance CH4 oxidation. Our results are helpful to understand the inter-annual variations of CH4 emission and provide a more reasonable regional budget of CH4 emission from wetlands on the QTP and even for world-wide natural wetlands under climate change.	[Chen, Huai; Wu, Ning; Zhu, Dan] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Chen, Huai; Zhu, Qiu'an; Yang, Gang; Peng, Changhui] NW A&F Univ, Lab Ecol Forecasting & Global Change, Coll Forestry, Yangling, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yongheng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Fang, Xiuqin; Peng, Changhui] Univ Quebec Montreal, Inst Environm Sci, Montreal, PQ, Canada; [Wang, Xu] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University of Quebec; University of Quebec Montreal; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF	Chen, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	chenhuai81@gmail.com; wuning@cib.ac.cn	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X	National Natural Science Foundation of China [31100348]; Natural Science Foundation Project of CQ CSTC [2009BB7182]; Natural Sciences and Engineering Research Council of Canada (NSERC); China QianRen programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); China QianRen programme	This study was supported by the National Natural Science Foundation of China (No. 31100348), Natural Science Foundation Project of CQ CSTC (2009BB7182), Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant, and the China QianRen programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Chen H, 2009, SCI TOTAL ENVIRON, V407, P1097, DOI 10.1016/j.scitotenv.2008.10.038; Chen H, 2010, ENVIRON MONIT ASSESS, V164, P21, DOI 10.1007/s10661-009-0871-3; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Dowrick DJ, 2006, GEODERMA, V132, P384, DOI 10.1016/j.geoderma.2005.06.003; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Freeman C, 2002, SOIL BIOL BIOCHEM, V34, P61, DOI 10.1016/S0038-0717(01)00154-7; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2011, ATMOS ENVIRON, V45, P5632, DOI 10.1016/j.atmosenv.2011.03.010; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Knorr KH, 2009, SOIL BIOL BIOCHEM, V41, P1187, DOI 10.1016/j.soilbio.2009.02.030; Li L, 2010, ARCT ANTARCT ALP RES, V42, P449, DOI 10.1657/1938-4246-42.4.449; Middelburg JJ, 2002, BIOGEOCHEMISTRY, V59, P95, DOI 10.1023/A:1015515130419; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Ringeval B, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003354; SHANNON RD, 1994, BIOGEOCHEMISTRY, V27, P35, DOI 10.1007/BF00002570; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Tian JQ, 2012, EUROPEAN J SOIL BIOL, DOI [10.1016/j.ej-sobi.2012.1007.1003, DOI 10.1016/J.EJSOBI.2012.1007.1003]; [王德宣 Wang Dexuan], 2002, [地球科学进展, Advance in Earth Sciences], V17, P877; Wang MH, 1987, SCI GEOGRAPHICA SINI, V18, P145; Wu N, 1997, ERDE, V128, P67; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Xu BQ, 2001, SCI CHINA SER D, V44, P689, DOI 10.1007/BF02907198; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yan XY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003182; Zhang Y, 2011, ENVIRON MONIT ASSESS, V180, P189, DOI 10.1007/s10661-010-1781-0	42	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53878	10.1371/journal.pone.0053878	http://dx.doi.org/10.1371/journal.pone.0053878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342029	gold, Green Published			2022-12-27	WOS:000314759400093
J	Zhang, WW; Li, ZZ				Zhang, Weiwei; Li, Zhenzhong			The Effects of Target Skeletal Muscle Cells on Dorsal Root Ganglion Neuronal Outgrowth and Migration In Vitro	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; PRIMARY SENSORY NEURONS; GAP-43 MESSENGER-RNA; SPINAL-CORD; NEUROMUSCULAR-JUNCTION; NMDA RECEPTOR; EXPRESSION; RAT; INJURY; PHOSPHORYLATION	Targets of neuronal innervations play a vital role in regulating the survival and differentiation of innervating neurotrophin-responsive neurons. During development, neurons extend axons to their targets, and then their survival become dependent on the trophic substances secreted by their target cells. Sensory endings were present on myoblasts, myotubes, and myofibers in all intrafusal bundles regardless of age. The interdependence of sensory neurons and skeletal muscle (SKM) cells during both embryonic development and the maintenance of the mature functional state has not been fully understood. In the present study, neuromuscular cocultures of organotypic dorsal root ganglion (DRG) explants and dissociate SKM cells were established. Using this culture system, the morphological relationship between DRG neurons and SKM cells, neurites growth and neuronal migration were investigated. The migrating neurons were determined by fluorescent labeling of microtubule-associated protein-2 (MAP-2) and neurofilament 200 (NF-200) or growth-associated protein 43 (GAP-43). The expression of NF-200 and GAP-43 and their mRNAs was evaluated by Western blot assay and real time-PCR analysis. The results reveal that DRG explants showed more dense neurites outgrowth in neuromuscular cocultures as compared with that in the culture of DRG explants alone. The number of total migrating neurons (the MAP-2-expressing neurons) and the percentage NF-200-immunoreactive (IR) and GAP-43-IR neurons increased significantly in the presence of SKM cells. The levels of NF-200 and GAP-43 and their mRNAs increased significantly in neuromuscular cocultures as compared with that in the culture of DRG explants alone. These results suggested that target SKM cells play an important role in regulating neuronal protein synthesis, promoting neuritis outgrowth and neuronal migration of DRG explants in vitro. These results not only provide new clues for a better understanding of the association of SKM cells with DRG sensory neurons during development, they may also have implications for axonal regeneration after nerve injury.	[Zhang, Weiwei; Li, Zhenzhong] Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China	Shandong University	Li, ZZ (corresponding author), Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China.	zli@sdu.edu.cn			National Natural Science Foundation of China [30973051]; Natural Science Foundation of Shandong Province of China [ZR2010HM027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (No. 30973051) and the Natural Science Foundation of Shandong Province of China (ZR2010HM027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER L, 1993, J CELL BIOL, V123, P417, DOI 10.1083/jcb.123.2.417; Albright MJ, 2007, J NEUROPHYSIOL, V98, P1610, DOI 10.1152/jn.00219.2007; Anand U, 2008, J NEURO-ONCOL, V89, P1, DOI 10.1007/s11060-008-9585-6; Anderson KD, 2003, EXP NEUROL, V183, P100, DOI 10.1016/S0014-4886(03)00103-1; Baird DH, 1996, J NEUROSCI, V16, P2642; Bergman E, 1999, BRAIN RES, V832, P63, DOI 10.1016/S0006-8993(99)01469-9; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Daniels MP, 2000, MICROSC RES TECHNIQ, V49, P26, DOI 10.1002/(SICI)1097-0029(20000401)49:1<26::AID-JEMT4>3.0.CO;2-8; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Di Stefano G, 2001, J HISTOCHEM CYTOCHEM, V49, P1065, DOI 10.1177/002215540104900818; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; Ettorre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031451; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Hall AK, 1997, J NEUROSCI, V17, P2775; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kato N, 2003, NEUROSCI RES, V45, P297, DOI 10.1016/S0168-0102(02)00234-1; Kato N, 2001, J Orthop Sci, V6, P419, DOI 10.1007/s007760170008; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Keswani SC, 2004, J NEUROSCI METH, V136, P193, DOI 10.1016/j.jneumeth.2004.01.004; Liu YL, 2003, ADV ANAT PATHOL, V10, P101, DOI 10.1097/00125480-200303000-00005; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu JJ, 2001, NEUROSCI RES, V41, P355, DOI 10.1016/S0168-0102(01)00293-0; Manzini MC, 2006, J NEUROSCI, V26, P6040, DOI 10.1523/JNEUROSCI.4815-05.2006; Mars T, 2001, PFLUG ARCH EUR J PHY, V442, pR177, DOI 10.1007/s004240100015; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; Mechsner S, 2007, FERTIL STERIL, V88, P581, DOI 10.1016/j.fertnstert.2006.12.087; Murata R, 2006, AUTON NEUROSCI-BASIC, V128, P96, DOI 10.1016/j.autneu.2006.04.003; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Silver L, 2005, DNA CELL BIOL, V24, P438, DOI 10.1089/dna.2005.24.438; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Tanaka H, 2000, J MUSCLE RES CELL M, V21, P507, DOI 10.1023/A:1026561120566; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Tsai SY, 2007, J NEUROSCI RES, V85, P321, DOI 10.1002/jnr.21119; Tsai SY, 2002, NEUROSCIENCE, V114, P55, DOI 10.1016/S0306-4522(02)00261-0; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049; VALMIER J, 1993, MUSCLE NERVE, V16, P397, DOI 10.1002/mus.880160409; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang LH, 2009, ANAT REC, V292, P107, DOI 10.1002/ar.20777; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037; Zhao CN, 2004, J NEUROTRAUM, V21, P1468, DOI 10.1089/neu.2004.21.1468	52	92	105	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e52849	10.1371/journal.pone.0052849	http://dx.doi.org/10.1371/journal.pone.0052849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23405095	Green Published, Green Submitted, gold			2022-12-27	WOS:000314759400022
J	Adhikari, BN; Hamilton, JP; Zerillo, MM; Tisserat, N; Levesque, CA; Buell, CR				Adhikari, Bishwo N.; Hamilton, John P.; Zerillo, Marcelo M.; Tisserat, Ned; Levesque, C. Andre; Buell, C. Robin			Comparative Genomics Reveals Insight into Virulence Strategies of Plant Pathogenic Oomycetes	PLOS ONE			English	Article							PYTHIUM-OLIGANDRUM; BIOLOGICAL-CONTROL; EFFECTOR PROTEINS; PHYLOGENETIC-RELATIONSHIPS; PHYTOPHTHORA-INFESTANS; MOLECULAR PHYLOGENY; EVOLUTION; SEQUENCE; DISEASE; WHEAT	The kingdom Stramenopile includes diatoms, brown algae, and oomycetes. Plant pathogenic oomycetes, including Phytophthora, Pythium and downy mildew species, cause devastating diseases on a wide range of host species and have a significant impact on agriculture. Here, we report comparative analyses on the genomes of thirteen straminipilous species, including eleven plant pathogenic oomycetes, to explore common features linked to their pathogenic lifestyle. We report the sequencing, assembly, and annotation of six Pythium genomes and comparison with other stramenopiles including photosynthetic diatoms, and other plant pathogenic oomycetes such as Phytophthora species, Hyaloperonospora arabidopsidis, and Pythium ultimum var. ultimum. Novel features of the oomycete genomes include an expansion of genes encoding secreted effectors and plant cell wall degrading enzymes in Phytophthora species and an over-representation of genes involved in proteolytic degradation and signal transduction in Pythium species. A complete lack of classical RxLR effectors was observed in the seven surveyed Pythium genomes along with an overall reduction of pathogenesis-related gene families in H. arabidopsidis. Comparative analyses revealed fewer genes encoding enzymes involved in carbohydrate metabolism in Pythium species and H. arabidopsidis as compared to Phytophthora species, suggesting variation in virulence mechanisms within plant pathogenic oomycete species. Shared features between the oomycetes and diatoms revealed common mechanisms of intracellular signaling and transportation. Our analyses demonstrate the value of comparative genome analyses for exploring the evolution of pathogenesis and survival mechanisms in the oomycetes. The comparative analyses of seven Pythium species with the closely related oomycetes, Phytophthora species and H. arabidopsidis, and distantly related diatoms provide insight into genes that underlie virulence.	[Adhikari, Bishwo N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Levesque, C. Andre] Agr & Agri Food Canada, Ottawa, ON, Canada; [Levesque, C. Andre] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Michigan State University; Colorado State University; Agriculture & Agri Food Canada; Carleton University	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Risal, Sanjiv/P-5758-2019; Hamilton, John P/G-1379-2016; zerillo, marcelo/M-4159-2016; Risal, Sanjiv/K-9883-2017; Adhikari, Deepak/H-6176-2013; zerillo, marcelo M/AAE-1735-2022	Risal, Sanjiv/0000-0003-1723-5431; Hamilton, John P/0000-0002-8682-5526; zerillo, marcelo/0000-0001-9671-2894; Risal, Sanjiv/0000-0003-1723-5431; Adhikari, Deepak/0000-0003-0656-9858; Buell, C Robin/0000-0002-6727-4677; Adhikari, Deepak/0000-0002-3404-8753; Adhikari, Bishwo/0000-0003-4840-9609	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program [2007-35600-17774, 2007-35600-18886]	United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program	Funding for the work was provided by the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Sequencing Program to CRB and NT (2007-35600-17774 and 2007-35600-18886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bouwmeester K, 2009, ANNU PLANT REV, V34, P102, DOI 10.1111/b.9781405175326.2009.00005.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley A, 2007, REF USER SERV Q, V47, P133; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P173, DOI 10.1146/annurev.py.30.090192.001133; Bridge PD, 2008, PLANT PATHOL, V57, P1066, DOI 10.1111/j.1365-3059.2008.01868.x; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra John A, 2010, Genome Biol, V11, P306, DOI 10.1186/gb-2010-11-6-306; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RJ, 1987, PHYTOPATHOLOGY, V77, P1192, DOI 10.1094/Phyto-77-1192; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dick MW, 2001, STRAMINIPILOUS FUNGI; Dieguez-Uribeondo J, 2009, FUNGAL GENET BIOL, V46, P365, DOI 10.1016/j.fgb.2009.02.004; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; GOLD SE, 1985, PHYTOPATHOLOGY, V75, P333, DOI 10.1094/Phyto-75-333; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Harvey P., 2008, Outlooks on Pest Management, V19, P127, DOI 10.1564/19jun09; Harvey PR, 2000, PLANT PATHOL, V49, P619, DOI 10.1046/j.1365-3059.2000.00493.x; Harvey PR, 2001, MYCOL RES, V105, P85, DOI 10.1017/S0953756200002902; Horner NR, 2012, FUNGAL BIOL-UK, V116, P24, DOI 10.1016/j.funbio.2011.09.004; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwayama S, 1933, NEW SNOW ROT DIS CER; Kale SD, 2012, NEW PHYTOL, V193, P874, DOI 10.1111/j.1469-8137.2011.03968.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koike S.T., 2006, VEGETABLE DIS COLOR; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P430, DOI 10.1094/Phyto-85-430; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin F.N., 2009, OOMYCETE GENETICS GE, P574; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5; MARTIN FN, 1987, PHYTOPATHOLOGY, V77, P1013, DOI 10.1094/Phyto-77-1013; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Mendoza L, 1996, J MYCOL MED, V6, P151; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mulder Nicola, 2007, V396, P59; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Paulitz TC, 2003, PHYTOPATHOLOGY, V93, P867, DOI 10.1094/PHYTO.2003.93.7.867; Quinn E, 2012, RESOLVING PYTHIUM UL; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUNDERS GA, 1988, J INVERTEBR PATHOL, V52, P360, DOI 10.1016/0022-2011(88)90148-6; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Snowdon A. L., 1990, COLOUR ATLAS POSTHAR, V1; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P1210, DOI 10.1016/j.funbio.2011.08.006; Spies CFJ, 2011, FUNGAL BIOL-UK, V115, P157, DOI 10.1016/j.funbio.2010.11.005; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; SUMNER DR, 1990, PLANT DIS, V74, P704, DOI 10.1094/PD-74-0704; TAKAHASHI M, 1977, T MYCOL SOC JPN, V18, P279; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2011, EFFECTORS PLANT MICR, P101; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Vawdrey LL, 2005, AUSTRALAS PLANT PATH, V34, P127, DOI 10.1071/AP04093; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng HC, 2005, MYCOPATHOLOGIA, V159, P601, DOI 10.1007/s11046-005-5258-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	107	155	159	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e75072	10.1371/journal.pone.0075072	http://dx.doi.org/10.1371/journal.pone.0075072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24124466	Green Published, gold, Green Submitted			2022-12-27	WOS:000325489100023
J	Zhu, LH; Zhao, XC; Lai, LM; Wang, JJ; Jiang, LH; Ding, JZ; Liu, NX; Yu, YJ; Li, JS; Xiao, NW; Zheng, YR; Rimmington, GM				Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen; Zheng, Yuanrun; Rimmington, Glyn M.			Soil TPH Concentration Estimation Using Vegetation Indices in an Oil Polluted Area of Eastern China	PLOS ONE			English	Article							RED-EDGE; REFLECTANCE; LEAF; RESPONSES; FOREST; PREDICTION; PETROLEUM; RATIOS; RADAR; METAL	Assessing oil pollution using traditional field-based methods over large areas is difficult and expensive. Remote sensing technologies with good spatial and temporal coverage might provide an alternative for monitoring oil pollution by recording the spectral signals of plants growing in polluted soils. Total petroleum hydrocarbon concentrations of soils and the hyperspectral canopy reflectance were measured in wetlands dominated by reeds (Phragmites australis) around oil wells that have been producing oil for approximately 10 years in the Yellow River Delta, eastern China to evaluate the potential of vegetation indices and red edge parameters to estimate soil oil pollution. The detrimental effect of oil pollution on reed communities was confirmed by the evidence that the aboveground biomass decreased from 1076.5 g m(-2) to 5.3 g m(-2) with increasing total petroleum hydrocarbon concentrations ranging from 9.45 mg kg(-1) to 652 mg kg(-1). The modified chlorophyll absorption ratio index (MCARI) best estimated soil TPH concentration among 20 vegetation indices. The linear model involving MCARI had the highest coefficient of determination (R-2 = 0.73) and accuracy of prediction (RMSE = 104.2 mg kg(-1)). For other vegetation indices and red edge parameters, the R-2 and RMSE values ranged from 0.64 to 0.71 and from 120.2 mg kg(-1) to 106.8 mg kg(-1) respectively. The traditional broadband normalized difference vegetation index (NDVI), one of the broadband multispectral vegetation indices (BMVIs), produced a prediction (R-2 = 0.70 and RMSE = 110.1 mg kg(-1)) similar to that of MCARI. These results corroborated the potential of remote sensing for assessing soil oil pollution in large areas. Traditional BMVIs are still of great value in monitoring soil oil pollution when hyperspectral data are unavailable.	[Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Zheng, Yuanrun] Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Linhai; Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Research Academy of Environmental Sciences; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	Ding, Jinzhi/AAE-3421-2019; liming, lai/HGB-0743-2022; Xiao, Nengwen/ACW-1426-2022; Zhu, Linhai/B-8551-2011	Ding, Jinzhi/0000-0003-3664-2702; Zhu, Linhai/0000-0001-7064-9022; Xiao, NengWen/0000-0002-7482-135X	National Key Technology R&D Program of China [2008BAC43B01]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (2008BAC43B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Bannari A., 1995, REMOTE SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Baret F., 1989, P 12 CAN S REM SENS, V3, P1355; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Chaineau CH, 2003, WATER AIR SOIL POLL, V144, P419, DOI 10.1023/A:1022935600698; [陈建 CHEN Jian], 2011, [地理科学进展, Progress in Geography], V30, P585; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Clevers JGPW, 2004, INT J REMOTE SENS, V25, P3883, DOI 10.1080/01431160310001654473; COLWELL J E, 1974, Remote Sensing of Environment, V3, P175, DOI 10.1016/0034-4257(74)90003-0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Guyot G., 1988, J CHEM INF MODEL, P279; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Ji GD, 2004, ENVIRON INT, V30, P509, DOI 10.1016/j.envint.2003.10.003; Ji GD, 2007, ECOL ENG, V29, P272, DOI 10.1016/j.ecoleng.2006.04.002; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; Kooistra L, 2004, ENVIRON POLLUT, V127, P281, DOI 10.1016/S0269-7491(03)00266-5; Kooistra L, 2003, INT J REMOTE SENS, V24, P4995, DOI 10.1080/0143116031000080769; [刘五星 LIU Wuxing], 2007, [土壤, Soils], V39, P247; MAJOR DJ, 1990, INT J REMOTE SENS, V11, P727, DOI 10.1080/01431169008955053; Mason DC, 2012, IEEE T GEOSCI REMOTE, V50, P3041, DOI 10.1109/TGRS.2011.2178030; MILLER JR, 1990, INT J REMOTE SENS, V11, P1755, DOI 10.1080/01431169008955128; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Osuji LC, 2004, CHEM BIODIVERS, V1, P1569, DOI 10.1002/cbdv.200490117; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Pu RL, 2003, IEEE T GEOSCI REMOTE, V41, P916, DOI 10.1109/TGRS.2003.813555; Qiu GY, 1998, J HYDROL, V210, P93, DOI 10.1016/S0022-1694(98)00174-7; Ren L., 2000, AGROENVIRONMENTAL PR, V19, P360; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rosso PH, 2005, ENVIRON POLLUT, V137, P241, DOI 10.1016/j.envpol.2005.02.025; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; SHIELDS PG, 1993, CANCER RES, V53, P3486; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; WOOLLEY JT, 1971, PLANT PHYSIOL, V47, P656, DOI 10.1104/pp.47.5.656; 许学工, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P111	51	91	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54028	10.1371/journal.pone.0054028	http://dx.doi.org/10.1371/journal.pone.0054028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342066	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700078
J	Holliday, EG; Smith, AV; Cornes, BK; Buitendijk, GHS; Jensen, RA; Sim, XL; Aspelund, T; Aung, T; Baird, PN; Boerwinkle, E; Cheng, CY; van Duijn, CM; Eiriksdottir, G; Gudnason, V; Harris, T; Hewitt, AW; Inouye, M; Jonasson, F; Klein, BEK; Launer, L; Li, XH; Liew, G; Lumley, T; McElduff, P; McKnight, B; Mitchell, P; Psaty, BM; Rochtchina, E; Rotter, JI; Scott, RJ; Tay, WT; Taylor, K; Teo, YY; Uitterlinden, AG; Viswanathan, A; Xie, S; Vingerling, JR; Klaver, CCW; Tai, ES; Siscovick, D; Klein, R; Cotch, MF; Wong, TY; Attia, J; Wang, JJ				Holliday, Elizabeth G.; Smith, Albert V.; Cornes, Belinda K.; Buitendijk, Gabrielle H. S.; Jensen, Richard A.; Sim, Xueling; Aspelund, Thor; Aung, Tin; Baird, Paul N.; Boerwinkle, Eric; Cheng, Ching Yu; van Duijn, Cornelia M.; Eiriksdottir, Gudny; Gudnason, Vilmundur; Harris, Tamara; Hewitt, Alex W.; Inouye, Michael; Jonasson, Fridbert; Klein, Barbara E. K.; Launer, Lenore; Li, Xiaohui; Liew, Gerald; Lumley, Thomas; McElduff, Patrick; McKnight, Barbara; Mitchell, Paul; Psaty, Bruce M.; Rochtchina, Elena; Rotter, Jerome I.; Scott, Rodney J.; Tay, Wanting; Taylor, Kent; Teo, Yik Ying; Uitterlinden, Andre G.; Viswanathan, Ananth; Xie, Sophia; Vingerling, Johannes R.; Klaver, Caroline C. W.; Tai, E. Shyong; Siscovick, David; Klein, Ronald; Cotch, Mary Frances; Wong, Tien Y.; Attia, John; Wang, Jie Jin		Wellcome Trust Case Control Consor	Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; SKIN PIGMENTATION; IDENTIFIES 3; RISK; PROGRESSION; POPULATION; EYE; VARIANTS	Genetic factors explain a majority of risk variance for age-related macular degeneration (AMD). While genome-wide association studies (GWAS) for late AMD implicate genes in complement, inflammatory and lipid pathways, the genetic architecture of early AMD has been relatively under studied. We conducted a GWAS meta-analysis of early AMD, including 4,089 individuals with prevalent signs of early AMD (soft drusen and/or retinal pigment epithelial changes) and 20,453 individuals without these signs. For various published late AMD risk loci, we also compared effect sizes between early and late AMD using an additional 484 individuals with prevalent late AMD. GWAS meta-analysis confirmed previously reported association of variants at the complement factor H (CFH) (peak P = 1.5x10(-31)) and age-related maculopathy susceptibility 2 (ARMS2) (P = 4.3x10(-24)) loci, and suggested Apolipoprotein E (ApoE) polymorphisms (rs2075650; P = 1.1x10(-6)) associated with early AMD. Other possible loci that did not reach GWAS significance included variants in the zinc finger protein gene GLI3 (rs2049622; P = 8.9x10(-6)) and upstream of GLI2 (rs6721654; P = 6.5x10(-6)), encoding retinal Sonic hedgehog signalling regulators, and in the tyrosinase (TYR) gene (rs621313; P = 3.5x10(-6)), involved in melanin biosynthesis. For a range of published, late AMD risk loci, estimated effect sizes were significantly lower for early than late AMD. This study confirms the involvement of multiple established AMD risk variants in early AMD, but suggests weaker genetic effects on the risk of early AMD relative to late AMD. Several biological processes were suggested to be potentially specific for early AMD, including pathways regulating RPE cell melanin content and signalling pathways potentially involved in retinal regeneration, generating hypotheses for further investigation.	[Holliday, Elizabeth G.; McElduff, Patrick; Attia, John] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Holliday, Elizabeth G.; McElduff, Patrick; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur; Wellcome Trust Case Control Consor] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur; Jonasson, Fridbert] Univ Iceland, Fac Med, Reykjavik, Iceland; [Cornes, Belinda K.; Aung, Tin; Cheng, Ching Yu; Tay, Wanting; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Buitendijk, Gabrielle H. S.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jensen, Richard A.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Psaty, Bruce M.; Siscovick, David] Univ Washington, Dept Med, Seattle, WA USA; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Sim, Xueling] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Baird, Paul N.; Hewitt, Alex W.; Xie, Sophia; Wong, Tien Y.; Wang, Jie Jin] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Human Genome Sequencing Ctr, Houston, TX USA; [Cheng, Ching Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheng, Ching Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cheng, Ching Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore; [Harris, Tamara; Launer, Lenore] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Inouye, Michael] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Jonasson, Fridbert] Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Li, Xiaohui; Rotter, Jerome I.; Taylor, Kent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Liew, Gerald; Mitchell, Paul; Rochtchina, Elena; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Liew, Gerald; Mitchell, Paul; Rochtchina, Elena; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Scott, Rodney J.] Hunter Area Pathol Serv, Newcastle, NSW, Australia; [Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Viswanathan, Ananth] Moorfields Eye Hosp, London, England; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Attia, John] John Hunter Hosp, Dept Med, Newcastle, NSW, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; Icelandic Heart Association; University of Iceland; National University of Singapore; Singapore National Eye Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; University of Michigan System; University of Michigan; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Melbourne; Landspitali National University Hospital; University of Wisconsin System; University of Wisconsin Madison; Cedars Sinai Medical Center; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Auckland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle	Holliday, EG (corresponding author), Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	Liz.Holliday@newcastle.edu.au	Smith, Albert Vernon/K-5150-2015; Scott, Rodney J/B-2827-2013; Liew, Gerald/AAB-6870-2022; Hewitt, Alex W/D-1936-2013; Brown, Matthew A/E-5749-2010; Jonasson, Fridbert/ABA-9889-2021; Kritharides, Leonard/AAQ-2720-2020; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Jankowski, Janusz/H-2706-2012; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Bellenguez, Céline/X-4004-2019; Tai, E Shyong/J-9831-2013; Belllenguez, Céline/Y-3183-2018; Attia, John R/F-5376-2013; Sim, Xueling/AAZ-6652-2020; Klaver, Caroline C.W./A-2013-2016; Cheng, Ching-Yu/K-7017-2013; Wang, Jie Jin/P-1499-2014; Rotter, Jerome/AAY-6598-2021; Cheng, Ching-Yu/Y-2229-2019; Aspelund, Thor/K-7022-2019; Blackwell, Jenefer M/H-3015-2015	Smith, Albert Vernon/0000-0003-1942-5845; Scott, Rodney J/0000-0001-7724-3404; Hewitt, Alex W/0000-0002-5123-5999; Brown, Matthew A/0000-0003-0538-8211; Wong, Tien Yin/0000-0002-8448-1264; Jankowski, Janusz/0000-0003-2130-9181; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Bellenguez, Céline/0000-0002-1240-7874; Belllenguez, Céline/0000-0002-1240-7874; Attia, John R/0000-0001-9800-1308; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Aspelund, Thor/0000-0002-7998-5433; Van Duijn, Cornelia/0000-0002-2374-9204; Klein, Ronald/0000-0002-4428-6237; Tai, E Shyong/0000-0003-2929-8966; Banks, Emily/0000-0002-4617-1302; Magee, Christopher/0000-0002-0465-6328; /0000-0001-6694-3587; Inouye, Michael/0000-0001-9413-6520; Klaver, Caroline/0000-0002-2355-5258; Plomin, Robert/0000-0002-0756-3629; Baird, Paul/0000-0002-1305-3502; Gillman, Matthew S./0000-0002-2340-6930; Cotch, Mary Frances/0000-0002-2046-4350	National Institutes of Health (NIH) [N01-AG-12100, HHSN268200625226C, UL1RR025005]; NIA; NEI Intramural Research Programs at the National Institutes of Health [ZIAAG007380, ZIAEY000401]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103]; National Human Genome Research Institute [U01HG004402]; NIH Roadmap for Medical Research; Australian National Health & Medical Research Council (NHMRC) [974159, 991407, 211069, 457349, 512423, 475604,529912, 590204]; Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye [529923]; Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2 [085475/B/08/Z, 085475/08/Z]; NHMRC [631096, APP1028444, 358702, 632909]; National Center of Advancing Translational Technologies CTSI [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Netherlands Organization of Scientific Research NWO [175.010.2005.011]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Lijf en Leven, Netherlands; Krimpen a/d Lek, Netherlands; MD Fonds, Utrecht, Netherlands; Oogfonds Nederland, Utrecht, Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam, Netherlands; Swart van Essen, Rotterdam, Netherlands; Netherlands Organisation for Scientific Research (NWO), Netherlands; Bevordering van Volkskracht, Rotterdam, Netherlands; Blindenhulp, The Hague, Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam, Netherlands; OOG, The Hague, Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn, Netherlands; Blinden-Penning, Amsterdam, Netherlands; Blindenhulp, 's Gravenzande, Netherlands; Henkes Stichting, Rotterdam, Netherlands; Topcon Europe BV, Netherlands; Capelle aan de IJssel, Netherlands; Medical Workshop BV, Groningen, Netherlands; Heidelberg Engineering, Dossenheim, Germany; Biomedical Research Council of Singapore [BMRC 08/1/35/19/550]; National Medical Research Council of Singapore [NMRC/STaR/0003/2008, CG/SERI/2010]; American Health Assistance Foundation, USA; National Medical Research Council [CG/SERI/2010, 0796/2003,, IRG07nov013, IRG09nov014, STaR/0003/2008]; Biomedical Research Council of Singapore, Singapore [09/1/35/19/616]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC085084, N01HC045133, N01HC085082, N01HC085080, N01HC035129, N01HC085081, N01HC055222, N01HC015103, N01HC085085, N01HC085086, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000426, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL080295, U01HL080295, R01HL105756, R01HL086694, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, R01AG015928, ZIAAG007380, R56AG020098, R01AG020098, R56AG023629, R01AG023629, ZIAAG007270, R01AG027058] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI Intramural Research Programs at the National Institutes of Health; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye(German Research Foundation (DFG)); Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Center of Advancing Translational Technologies CTSI; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Lijf en Leven, Netherlands; Krimpen a/d Lek, Netherlands; MD Fonds, Utrecht, Netherlands; Oogfonds Nederland, Utrecht, Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam, Netherlands(Netherlands Government); Swart van Essen, Rotterdam, Netherlands; Netherlands Organisation for Scientific Research (NWO), Netherlands; Bevordering van Volkskracht, Rotterdam, Netherlands; Blindenhulp, The Hague, Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam, Netherlands; OOG, The Hague, Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn, Netherlands; Blinden-Penning, Amsterdam, Netherlands; Blindenhulp, 's Gravenzande, Netherlands(Netherlands Government); Henkes Stichting, Rotterdam, Netherlands; Topcon Europe BV, Netherlands(Netherlands Government); Capelle aan de IJssel, Netherlands(Netherlands Government); Medical Workshop BV, Groningen, Netherlands; Heidelberg Engineering, Dossenheim, Germany; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); American Health Assistance Foundation, USA; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore, Singapore(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Age, Gene/Environment Susceptibility-Reykjavik Study has been funded by National Institutes of Health (NIH) contract N01-AG-12100, the NIA and NEI Intramural Research Programs at the National Institutes of Health (ZIAAG007380 and ZIAEY000401), Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Blue Mountains Eye Study was supported by the Australian National Health & Medical Research Council (NHMRC) project grants (IDs 974159, 991407, 211069 and 457349) and Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye (ID 529923). The Blue Mountains Eye Study GWAS and genotyping costs were supported by Australian NHMRC project grants (IDs 512423, 475604,529912 and 590204), and the Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2 (grant IDs 085475/B/08/Z and 085475/08/Z). EGH (631096), PNB (APP1028444) and JJW (358702 and 632909) are supported by the NHMRC fellowship scheme. This CHS research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C and NHLBI grants HL080295, HL087652, HL105756 with additional contribution from NINDS. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the NIA. See also http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center of Advancing Translational Technologies CTSI grant UL1TR000124 and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center and Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The GWA database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011). The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ophthalmologic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht.; Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, 's Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; all in the Netherlands; Heidelberg Engineering, Dossenheim, Germany. The Singapore Indian Eye Study (SINDI) was funded by grants from Biomedical Research Council of Singapore (BMRC 08/1/35/19/550), National Medical Research Council of Singapore (NMRC/STaR/0003/2008 and CG/SERI/2010), and American Health Assistance Foundation, USA. The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The Singapore Malay Eye Study (SiMES) is funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and Biomedical Research Council of Singapore (grants 09/1/35/19/616), Singapore and the American Health Assistance Foundation, USA. The Singapore Tissue Network and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Evans J, 2008, EYE, V22, P751, DOI 10.1038/eye.2008.100; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kinnunen K, 2011, ACTA OPHTHALMOL; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Ma L, 2012, BRIT J NUTR, V107, P350, DOI 10.1017/S0007114511004260; Memoli S, 1997, BBA-LIPID LIPID MET, V1346, P61, DOI 10.1016/S0005-2760(97)00018-0; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Raymond P A, 1997, Adv Neurol, V72, P171; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Sallo FB, 2009, CURR EYE RES, V34, P238, DOI 10.1080/02713680802714058; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Sundelin SP, 2001, FREE RADICAL BIO MED, V30, P74, DOI 10.1016/S0891-5849(00)00444-5; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; WEITER JJ, 1985, AM J OPHTHALMOL, V99, P185, DOI 10.1016/0002-9394(85)90230-2; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zareparsi S, 2004, INVEST OPHTH VIS SCI, V45, P1306, DOI 10.1167/iovs.03-1253; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	67	193	198	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53830	10.1371/journal.pone.0053830	http://dx.doi.org/10.1371/journal.pone.0053830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24282622	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800079
J	Cheng, HL; Furnham, A				Cheng, Helen; Furnham, Adrian			Correlates of Adult Binge Drinking: Evidence from a British Cohort	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; ALCOHOL-CONSUMPTION; PERSONALITY; INTELLIGENCE; CHILDHOOD; ANXIETY	Objective: To investigate whether parental social class and cognitive ability in childhood, as well as social and psychological factors, particularly personality traits, are independently associated with binge drinking in 50 year old adults assessed in a longitudinal birth cohort study. Method: 17,415 babies born in Great Britain in 1958 and followed up at 11, 33, and 50 years of age. Their binge drinking alcohol abuse at aged 50 was the outcome measure. Results: 6,478 participants with data on parental social class, childhood cognitive ability, educational qualifications at age 33, personality traits, psychological distress, occupational levels, and alcohol consumption (all measured at age 50) were included in the study. Using logistic regression analyses, results showed that parental social class, childhood intelligence, educational qualifications, occupational levels, personality traits (Extraversion and Disagreeableness), as well as psychological distress, were all significantly and independently associated with adult excessive alcohol use. Men tended to binge drink more than women (22% in men and 9.8% in women). Conclusion: Both social and psychological factors influence adult excessive alcohol consumption. Personality traits play a more important role than previously understood. There appears to be a distinction between the frequency and dose level of alcohol consumption.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England; [Furnham, Adrian] BI Norwegian Business Sch, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X				Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Chambless DL, 1987, J ANXIETY DIORD, V1, P29; Ciarrochi J, 2012, INTELLIGENCE, V40, P317, DOI 10.1016/j.intell.2012.03.003; Cook M, 1998, PERS INDIV DIFFER, V24, P641, DOI 10.1016/S0191-8869(97)00214-6; Davie R, 1972, BIRTH 7; Douglas James W.B, 1964, HOME SCH; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; Furnham A, 2003, BINGE DRINKING; Furnham A., 2008, PERSONALITY INTELLIG; George SM, 2010, PERS INDIV DIFFER, V49, P204, DOI 10.1016/j.paid.2010.03.036; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Gratzer D, 2004, J AFFECT DISORDERS, V79, P209, DOI 10.1016/S0165-0327(02)00355-5; Gunn RL, 2013, ADDICT BEHAV, V38, P2352, DOI 10.1016/j.addbeh.2013.02.009; Kanazawa S, 2012, INTELLIGENCE PARADOX; Kanazawa S, 2010, REV GEN PSYCHOL, V14, P382, DOI 10.1037/a0021526; Leete R, 1977, POPULATION TRENDS, V8, P1; Leino J, 2011, SCAND J PUBLIC HEALT, V39, P749, DOI 10.1177/1403494811421056; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; MARSH C, 1986, KEY VARIABLES SOCIAL; MARTIN NG, 1989, BEHAV GENET, V19, P97, DOI 10.1007/BF01065886; Plewis I, 2004, NATL CHILD DEV STUDY; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutter M, 1976, CYCLES DISADVANTAGE; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Wilkinson R., 2003, Social determinants of health: the solid facts	32	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78838	10.1371/journal.pone.0078838	http://dx.doi.org/10.1371/journal.pone.0078838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	23342029	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700054
J	Cheng, YC; Hsieh, FY; Chiang, MC; Scotting, PJ; Shih, HY; Lin, SJ; Wu, HL; Lee, HT				Cheng, Yi-Chuan; Hsieh, Fu-Yu; Chiang, Ming-Chang; Scotting, Paul J.; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting			Akt1 Mediates Neuronal Differentiation in Zebrafish via a Reciprocal Interaction with Notch Signaling	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; IN-VITRO; NERVOUS-SYSTEM; MOLECULAR-CLONING; CELLS; NEUROGENESIS; ACTIVATION; MICE; TRANSCRIPTION; LEUKEMIA	Akt1 is well known for its role in regulating cell proliferation, differentiation, and apoptosis and is implicated in tumors and several neurological disorders. However, the role of Akt1 in neural development has not been well defined. We have isolated zebrafish akt1 and shown that this gene is primarily transcribed in the developing nervous system, and its spatiotemporal expression pattern suggests a role in neural differentiation. Injection of akt1 morpholinos resulted in loss of neuronal precursors with a concomitant increase in post-mitotic neurons, indicating that knockdown of Akt1 is sufficient to cause premature differentiation of neurons. A similar phenotype was observed in embryos deficient for Notch signaling. Both the ligand (deltaA) and the downstream target of Notch (her8a) were downregulated in akt1 morphants, indicating that Akt1 is required for Delta-Notch signaling. Furthermore, akt1 expression was downregulated in Delta-Notch signaling-deficient embryos and could be induced by constitutive activation of Notch signaling. In addition, knockdown of Akt1 was able to nullify the inhibition of neuronal differentiation caused by constitutive activation of Notch signaling. Taken together, these results provide in vivo evidence that Akt1 interacts with Notch signaling reciprocally and provide an explanation of why Akt1 is essential for the inhibition of neuronal differentiation.	[Cheng, Yi-Chuan; Hsieh, Fu-Yu; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chiang, Ming-Chang] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan; [Scotting, Paul J.] Univ Nottingham, Ctr Genet & Genom, Childrens Brain Tumour Res Ctr, Queens Med Ctr, Nottingham NG7 2RD, England	Chang Gung University; Fu Jen Catholic University; University of Nottingham	Cheng, YC (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	yccheng@mail.cgu.edu.tw	Lin, Sheng-Jia/AGC-3315-2022	Lin, Sheng-Jia/0000-0002-7559-6529; ozturk, nail can/0000-0001-9459-2120; Shih, Hung-Yu/0000-0002-3490-1750	Chang Gung Memorial Hospital [CMRPD170513]; National Science Council of Taiwan [96-2745-B-182-003-URD]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPD170513) and the National Science Council of Taiwan (96-2745-B-182-003-URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bang OS, 2001, J CELL SCI, V114, P81; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chung PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019394; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Namikawa K, 2000, J NEUROSCI, V20, P2875; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu QL, 1995, DEVELOPMENT, V121, P4005; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	59	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54262	10.1371/journal.pone.0054262	http://dx.doi.org/10.1371/journal.pone.0054262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23544149	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400138
J	Meng, Q; Kang, J				Meng, Qi; Kang, Jian			Influence of Social and Behavioural Characteristics of Users on Their Evaluation of Subjective Loudness and Acoustic Comfort in Shopping Malls	PLOS ONE			English	Article							RECTANGULAR LONG ENCLOSURES; SPEECH-INTELLIGIBILITY; MULTIPLE LOUDSPEAKERS; REVERBERATION; SOUNDSCAPES; ENVIRONMENT	A large-scale subjective survey was conducted in six shopping malls in Harbin City, China, to determine the influence of social and behavioural characteristics of users on their evaluation of subjective loudness and acoustic comfort. The analysis of social characteristics shows that evaluation of subjective loudness is influenced by income and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Meanwhile, evaluation of acoustic comfort evaluation is influenced by income, education level, and occupation, with correlation coefficients or contingency coefficients of 0.10 to 0.60 (p<0.05 or p<0.01). The effect of gender and age on evaluation of subjective loudness and acoustic comfort is statistically insignificant. The effects of occupation are mainly caused by the differences in income and education level, in which the effects of income are greater than that of education level. In terms of behavioural characteristics, evaluation of subjective loudness is influenced by the reason for visit, frequency of visit, and length of stay, with correlation coefficients or contingency coefficients of 0.10 to 0.40 (p<0.05 or p<0.01). Evaluation of acoustic comfort is influenced by the reason for visit to the site, the frequency of visit, length of stay, and also season of visit, with correlation coefficients of 0.10 to 0.30 (p<0.05 or p<0.01). In particular, users who are waiting for someone show lower evaluation of acoustic comfort, whereas users who go to shopping malls more than once a month show higher evaluation of acoustic comfort. On the contrary, the influence of the period of visit and the accompanying persons are found insignificant.	[Meng, Qi; Kang, Jian] Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China; [Kang, Jian] Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England	Harbin Institute of Technology; University of Sheffield	Meng, Q (corresponding author), Harbin Inst Technol, Sch Architecture, Harbin 150006, Peoples R China.	mengq@hit.edu.cn; j.kang@sheffield.ac.uk	Yue, Shanchao/D-1846-2009	Yue, Shanchao/0000-0001-8724-2974; Meng, Qingfeng/0000-0003-0047-3089; Kang, Jian/0000-0001-8995-5636	China Natural Science Foundation [50928801]; PR China Ministry of Education Foundation for PhD Bases [20112302110045]; Harbin Technological Innovation Fund [2012RFXXS046]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PR China Ministry of Education Foundation for PhD Bases; Harbin Technological Innovation Fund	The work was supported by the China Natural Science Foundation (No. 50928801), the PR China Ministry of Education Foundation for PhD Bases (20112302110045) and the Harbin Technological Innovation Fund (2012RFXXS046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni D, 1993, P 6 C NOIS PUBL HLTH; Brown AL, 2010, NOISE CONTROL ENG J, V58, P493, DOI 10.3397/1.3484178; Bull Michael, 2000, SOUNDING OUT CITY PE; Chen B., 2004, ARCHIT SCI REV, V47, P107, DOI [10.1080/00038628.2004.9697033, DOI 10.1080/00038628.2004.9697033]; COSMAS SC, 1982, J CONSUM RES, V8, P453, DOI 10.1086/208886; Croome D. J., 1977, NOISE BUILDING PEOPL; Della Crociata S, 2013, BUILD ENVIRON, V59, P369, DOI 10.1016/j.buildenv.2012.09.002; Della Crociata S, 2012, BUILD ENVIRON, V47, P288, DOI 10.1016/j.buildenv.2011.07.011; Deng SC, 1994, CHINESE PUBLIC HLTH, V2, P93; Ellermeier W, 2001, J ACOUST SOC AM, V109, P1464, DOI 10.1121/1.1350402; FIELDS JM, 1993, J ACOUST SOC AM, V93, P2753, DOI 10.1121/1.405851; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2008, GB30962008 GEN ADM Q; Harbin Statistical Bureau, 2011, STAT YB HARB 2011; Harbin Statistical Bureau, 2012, STAT YB HARB 2012; Huang L, 2012, BUILD ENVIRON, V49, P304, DOI 10.1016/j.buildenv.2011.07.022; Jin H, 2009, P INT OTT CAN; Job RFS, 1999, P INT FORT LAUD US; Kang J, 1997, APPL ACOUST, V51, P169, DOI 10.1016/S0003-682X(96)00062-X; Kang J, 1996, ACUSTICA, V82, P509; Kang J, 1998, ACUSTICA, V84, P689; Kang J, 2002, ACTA ACUST UNITED AC, V88, P77; Kang J, 1998, J ACOUST SOC AM, V103, P1213, DOI 10.1121/1.421253; Kang J, 1996, APPL ACOUST, V47, P129, DOI 10.1016/0003-682X(95)00037-A; Kang J, 2010, BUILD ENVIRON, V45, P150, DOI 10.1016/j.buildenv.2009.05.014; Kang J, 1996, J ACOUST SOC AM, V99, P985, DOI 10.1121/1.414627; Kang J, 1996, BUILD ENVIRON, V31, P245, DOI 10.1016/0360-1323(95)00046-1; Kang J., 2006, URBAN SOUND ENV; Kang J, 2012, SCI TOTAL ENVIRON, V435, P80, DOI 10.1016/j.scitotenv.2012.06.105; Karlsson Henrik, 2000, J ACOUSTIC ECOLOGY, V1, P10; Li LS, 2006, DESIGN INVESTIGATION; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Liu SZ, 2011, INT J VENT, V10, P251; Mao Dong-xing, 2009, Technical Acoustics, V28, P693, DOI 10.3969/j.issn1000-3630.2009.06.002; Mehrabian A., 1976, PUBLIC PLACES PRIVAT; Meng Q., 2010, THESIS HARBIN I TECH; Meng Q., 2011, J HARBIN I TECHNO S2, V18, P231; Meng Q., 2010, HUAZHONG ARCHITECTUR, V28, P90; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; Ministry of Environmental Protection of the People's Republic of China, 2008, GB223372008 MIN ENV; Nilsson ME, 2006, ACTA ACUST UNITED AC, V92, P857; Pallant J., 2005, SPSS SURVIVAL GUIDE; Reingold DA, 1999, ECON DEV Q, V13, P23; Schulte-Fortkamp B, 1999, P INT FORT LAUD FL U; Song F, 2011, THESIS HARBIN I TECH; SOUTHWORTH M, 1969, ENVIRON BEHAV, V1, P49; Szeremeta B, 2009, SCI TOTAL ENVIRON, V407, P6143, DOI 10.1016/j.scitotenv.2009.08.039; Tang ZZ, 2009, P EUR 2009 ED SCOTL; Tang ZZ, 2011, J HARBIN I TECHNO S2, V18, P354; Wayne WD, 1979, BUSINESS STAT BASIC; Woolley Helen., 2003, URBAN OPEN SPACES; Yang W, 2005, APPL ACOUST, V66, P211, DOI 10.1016/j.apacoust.2004.07.011; Yang W, 2000, THESIS U SHEFFIELD S; Yang W, 2005, J URBAN DES, V10, P61, DOI 10.1080/13574800500062395; Yu L, 2008, J ACOUST SOC AM, V123, P772, DOI 10.1121/1.2821955; Yu L, 2010, APPL ACOUST, V71, P622, DOI 10.1016/j.apacoust.2010.02.005; Yu L, 2009, J ACOUST SOC AM, V126, P1163, DOI 10.1121/1.3183377; Zhang M, 2007, ENVIRON PLANN B, V34, P68, DOI 10.1068/b31162; Zhang M, 2009, INT J ENVIRON POLLUT, V39, P187, DOI 10.1504/IJEP.2009.027151; Zhao MD, 2009, E MOSCOW HARBIN CITY; Zimmer K, 1999, J ENVIRON PSYCHOL, V19, P295, DOI 10.1006/jevp.1999.0133	60	56	58	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e54497	10.1371/journal.pone.0054497	http://dx.doi.org/10.1371/journal.pone.0054497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	23336003	Green Accepted, Green Published, gold			2022-12-27	WOS:000314707700061
J	Yang, JK; Liu, LY; Dai, JH; Li, Q				Yang, Jiang-Ke; Liu, Li-Ying; Dai, Jiang-Hong; Li, Qin			de novo Design and Synthesis of Candida antarctica Lipase B Gene and alpha-Factor Leads to High-Level Expression in Pichia pastoris	PLOS ONE			English	Article							WHOLE-CELL BIOCATALYST; CODON OPTIMIZATION; ESCHERICHIA-COLI; PROTEIN	Candida antarctica lipase B (CALB) is one of the most widely used and studied enzymes in the world. In order to achieve the high-level expression of CALB in Pichia, we optimized the codons of CALB gene and alpha-factor by using a de novo design and synthesis strategy. Through comparative analysis of a series of recombinants with different expression components, we found that the methanol-inducible expression recombinant carrying the codon-optimized alpha-factor and mature CALB gene (pPIC9K alpha M-CalBM) has the highest lipase production capacity. After fermentation parameters optimization, the lipase activity and protein content of the recombinant pPIC9K alpha M-CalBM reached 6,100 U/mL and 3.0 g/L, respectively, in a 5-L fermentor. We believe this strategy could be of special interest due to its capacity to improve the expression level of target gene, and the Pichia transformants carrying the codon-optimized gene had great potential for the industrial-scale production of CALB lipase.	[Yang, Jiang-Ke; Dai, Jiang-Hong; Li, Qin] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Li-Ying] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Hubei, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China.	jiangke.yang@gmail.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education [212118]	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education(Ministry of Education, China)	This work was financially supported by Human Recourse Foundation of Wuhan Polytechnic University and the Key Project of Chinese Ministry of Education (No. 212118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2011, BIOTECHNOL PROGR, V27, P1257, DOI 10.1002/btpr.663; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; Andrade LH, 2009, ORG LETT, V11, P3052, DOI 10.1021/ol901091f; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; Budisa N, 2010, MOL BIOSYST, V6, P1630, DOI 10.1039/c002256j; Chang SW, 2011, J AGR FOOD CHEM, V59, P6710, DOI 10.1021/jf200537w; Benaiges MD, 2010, BIOTECHNOL PROGR, V26, P1252, DOI 10.1002/btpr.444; Fernandez L, 2006, PROTEIN EXPRES PURIF, V49, P256, DOI 10.1016/j.pep.2006.06.015; HOEGH I, 1995, CAN J BOT, V73, pS869; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2002, BIOPROC BIOSYST ENG, V24, P385, DOI 10.1007/s00449-001-0274-5; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kittl R, 2012, BIOENGINEERED, V3, P232, DOI 10.4161/bioe.20037; Ko MJ, 2012, BIOPROC BIOSYST ENG, V35, P69, DOI 10.1007/s00449-011-0604-1; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; Kruger N J, 1994, Methods Mol Biol, V32, P9; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; PATKAR SA, 1993, INDIAN J CHEM B, V32, P76; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rotticci-Mulder JC, 2001, PROTEIN EXPRES PURIF, V21, P386, DOI 10.1006/prep.2000.1387; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Shu ZY, 2009, BIOTECHNOL PROGR, V25, P409, DOI 10.1002/btpr.147; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Surribas A, 2007, J BIOTECHNOL, V130, P291, DOI 10.1016/j.jbiotec.2007.04.009; Tamalampudi S, 2007, APPL MICROBIOL BIOT, V75, P387, DOI 10.1007/s00253-006-0814-7; Tanino T, 2009, APPL MICROBIOL BIOT, V82, P59, DOI 10.1007/s00253-008-1764-z; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Yang JK, 2007, J MOL CATAL B-ENZYM, V45, P91, DOI 10.1016/j.molcatb.2006.12.007; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Yang JK, 2009, APPL BIOCHEM BIOTECH, V159, P355, DOI 10.1007/s12010-008-8419-5; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	36	76	82	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53939	10.1371/journal.pone.0053939	http://dx.doi.org/10.1371/journal.pone.0053939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326544	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400063
J	Wu, JY; Chen, CH; Wang, CZ; Ho, ML; Yeh, ML; Wang, YH				Wu, Jyun-Yi; Chen, Chia-Hsin; Wang, Chau-Zen; Ho, Mei-Ling; Yeh, Ming-Long; Wang, Yan-Hsiung			Low-Power Laser Irradiation Suppresses Inflammatory Response of Human Adipose-Derived Stem Cells by Modulating Intracellular Cyclic AMP Level and NF-kappa B Activity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; THERAPY LLLT; SIGNALING PATHWAY; RAT; NM; FIBROBLASTS; MECHANISMS; PROTEIN; MUSCLE	Mesenchymal stem cell (MSC)-based tissue regeneration is a promising therapeutic strategy for treating damaged tissues. However, the inflammatory microenvironment that exists at a local injury site might restrict reconstruction. Low-power laser irradiation (LPLI) has been widely applied to retard the inflammatory reaction. The purpose of this study was to investigate the anti-inflammatory effect of LPLI on human adipose-derived stem cells (hADSCs) in an inflammatory environment. We showed that the hADSCs expressed Toll-like Receptors (TLR) 1, TLR2, TLR3, TLR4, and TLR6 and that lipopolysaccharide (LPS) significantly induced the production of pro-inflammatory cytokines (Cyclooxygenase-2 (Cox-2), Interleukin-1b (IL-1b), Interleukin-6 (IL-6), and Interleukin-8 (IL-8)). LPLI markedly inhibited LPS-induced, pro-inflammatory cytokine expression at an optimal dose of 8 J/cm(2). The inhibitory effect triggered by LPLI might occur through an increase in the intracellular level of cyclic AMP (cAMP), which acts to down-regulate nuclear factor kappa B (NF-kappa B) transcriptional activity. These data collectively provide insight for further investigations of the potential application of anti-inflammatory treatment followed by stem cell therapy.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; yhwang@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Health Research Institutes [NHRI-EX101-9914EC]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-99-013]; Kaohsiung Medical University of Taiwan [KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University of Taiwan	This study was supported by a grant from the National Health Research Institutes (NHRI-EX101-9914EC), a grant from the Kaohsiung Municipal Ta-Tung Hospital (KMTTH-99-013), and a grant from the Kaohsiung Medical University (KMU-Q099018) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2008, INFLAMMATION, V31, P189, DOI 10.1007/s10753-008-9064-4; Aimbire F, 2008, INT IMMUNOPHARMACOL, V8, P603, DOI 10.1016/j.intimp.2007.12.007; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Correa F, 2007, PHOTOMED LASER SURG, V25, P245, DOI 10.1089/pho.2007.2079; Crisostomo PR, 2007, SHOCK, V28, P375, DOI 10.1097/shk.0b013e318058a817; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; KARU TI, 1985, DOKL AKAD NAUK SSSR+, V281, P1242; Lombardo E, 2009, TISSUE ENG PT A, V15, P1579, DOI 10.1089/ten.tea.2008.0340; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Xiong Fang, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P449; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zungu IL, 2009, PHOTOCHEM PHOTOBIOL, V85, P987, DOI 10.1111/j.1751-1097.2008.00523.x	33	54	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54067	10.1371/journal.pone.0054067	http://dx.doi.org/10.1371/journal.pone.0054067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23825677	Green Published, gold			2022-12-27	WOS:000313682700083
J	Iyer, SV; Dange, PP; Alam, H; Sawant, SS; Ingle, AD; Borges, AM; Shirsat, NV; Dalal, SN; Vaidya, MM				Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Borges, Anita M.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.			Understanding the Role of Keratins 8 and 18 in Neoplastic Potential of Breast Cancer Derived Cell Lines	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; CYTOKERATIN EXPRESSION; E-CADHERIN; DIFFERENTIATION; GENE; CARCINOMAS; VIMENTIN; INTEGRIN; INVASION	Background: Breast cancer is a complex disease which cannot be defined merely by clinical parameters like lymph node involvement and histological grade, or by routinely used biomarkers like estrogen receptor (ER), progesterone receptor (PGR) and epidermal growth factor receptor 2 (HER2) in diagnosis and prognosis. Breast cancer originates from the epithelial cells. Keratins (K) are cytoplasmic intermediate filament proteins of epithelial cells and changes in the expression pattern of keratins have been seen during malignant transformation in the breast. Expression of the K8/18 pair is seen in the luminal cells of the breast epithelium, and its role in prognostication of breast cancer is not well understood. Methodology/Principal Findings: In this study, we have modulated K8 expression to understand the role of the K8/18 pair in three different breast epithelium derived cell lines: non-transformed MCF10A, transformed but poorly invasive MDA MB 468 and highly invasive MDA MB 435. The up-regulation of K8 in the invasive MDA MB 435 cell line resulted in a significant decrease in proliferation, motility, in-vitro invasion, tumor volume and lung metastasis. The down-regulation of K8 in MDA MB 468 resulted in a significant increase in transformation potential, motility and invasion in-vitro, while MCF10A did not show any changes in cell transformation assays. Conclusions/Significance: These results indicate the role of K8/18 in modulating invasion in breast cancer - its presence correlating with less invasive phenotype and absence correlating with highly invasive, dedifferentiated phenotype. These data may have important implications for prognostication of breast cancer.	[Iyer, Sapna V.; Dange, Prerana P.; Alam, Hunain; Sawant, Sharada S.; Ingle, Arvind D.; Shirsat, Neelam V.; Dalal, Sorab N.; Vaidya, Milind M.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India; [Borges, Anita M.] SL Raheja Hosp, Asian Inst Oncol, Dept Histopathol, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Vaidya, MM (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumbai, India.	mvaidya@actrec.gov.in	Sundaram, Bala/A-6532-2010; Alam, Hunain/H-2984-2019	Sundaram, Bala/0000-0002-1728-704X; Alam, Hunain/0000-0002-6183-3677	Department of Biotechnology (DBT)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by grants from Department of Biotechnology (DBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; BAUMAN PA, 1994, P NATL ACAD SCI USA, V91, P5311, DOI 10.1073/pnas.91.12.5311; BLOBEL GA, 1984, VIRCHOWS ARCH B, V45, P407, DOI 10.1007/BF02889883; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CASANOVA L, 1995, J CELL SCI, V108, P811; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; Cortes Gutierrez Elva I, 2005, Ginecol Obstet Mex, V73, P111; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Galvin S, 1989, Adv Dermatol, V4, P277; Gonzalez A, 2012, APPL MICROBIOL BIOTE; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HEYDEN A, 1992, J ORAL PATHOL MED, V21, P7, DOI 10.1111/j.1600-0714.1992.tb00960.x; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; MOLL R, 1987, ACTA HISTOCHEM, P37; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; OUHAYOUN JP, 1985, DIFFERENTIATION, V30, P123; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Ramesh S, 1999, BRIT J CANCER, V81, P1392, DOI 10.1038/sj.bjc.6693437; Ranganathan K, 2006, J ORAL PATHOL MED, V35, P25, DOI 10.1111/j.1600-0714.2005.00366.x; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Sawaf M H, 1991, J Biol Buccale, V19, P187; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Schaller G, 1999, Zentralbl Gynakol, V121, P126; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Singhai R, 2011, N AM J MED SCI, V3, P227, DOI 10.4297/najms.2011.3227; SOULE HD, 1990, CANCER RES, V50, P6075; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vaidya MM, 1998, ORAL ONCOL, V34, P261, DOI 10.1016/S1368-8375(97)00095-X; VAIDYA MM, 1989, J ORAL PATHOL MED, V18, P282, DOI 10.1111/j.1600-0714.1989.tb00398.x; VANMUIJEN GNP, 1987, EXP CELL RES, V171, P331, DOI 10.1016/0014-4827(87)90166-2; Woelfle U, 2004, CLIN CANCER RES, V10, P2670, DOI 10.1158/1078-0432.CCR-03-0114; Xiang RH, 2002, CANCER RES, V62, P2637	60	287	296	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53532	10.1371/journal.pone.0053532	http://dx.doi.org/10.1371/journal.pone.0053532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23341946	gold, Green Submitted, Green Published			2022-12-27	WOS:000314707700020
J	Chen, SR; Zou, LY; Li, L; Wu, T				Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie			The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; FREE-RADICALS; LIPID-PEROXIDATION; MONOAMINE-OXIDASE; REACTIVE OXYGEN; HEPATITIS-C; MOUSE-LIVER; DNA-DAMAGE; RAT-LIVER	This study was designed to investigate the potentially protective effects of glycyrrhetinic acid (GA) and the role of transcription factor nuclear factor-erythroid 2(NF-E2)-related factor 2 (Nrf2) signaling in the regulation of Carbon Tetrachloride (CCl4)-induced chronic liver fibrosis in mice. The potentially protective effects of GA on CCl4-induced chronic liver fibrosis in mice were depicted histologically and biochemically. Firstly, histopathological changes including regenerative nodules, inflammatory cell infiltration and fibrosis were induced by CCl4. Then, CCl4 administration caused a marked increase in the levels of serum aminotransferases (GOT, GPT), serum monoamine oxidase (MAO) and lipid peroxidation (MDA) as well as MAO in the mice liver homogenates. Also, decreased nuclear Nrf2 expression, mRNA levels of its target genes such as superoxide dismutase 3 (SOD3), catalase (CAT), glutathione peroxidase 2 (GPX2), and activity of cellular antioxidant enzymes were found after CCl4 exposure. All of these phenotypes were markedly reversed by the treatment of the mice with GA. In addition, GA exhibited the antioxidant effects in vitro by on FeCl2-ascorbate induced lipid peroxidation in mouse liver homogenates, and on DPPH scavenging activity. Taken together, these results suggested that GA can protect the liver from oxidative stress in mice, presumably through activating the nuclear translocation of Nrf2, enhancing the expression of its target genes and increasing the activity of the antioxidant enzymes. Therefore, GA may be an effective hepatoprotective agent and viable candidate for treating liver fibrosis and other oxidative stress-related diseases.	[Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie] Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China	Guangdong Medical University	Wu, T (corresponding author), Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China.	wutie2@163.com			GuangDong foundation for basic research [2010B06050]	GuangDong foundation for basic research	This work was supported by the GuangDong foundation for basic research (grant 2010B06050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436; Aslan M, 2004, CURR ALZHEIMER RES, V1, P111, DOI 10.2174/1567205043332162; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1; Brautbar N, 2002, INT J HYG ENVIR HEAL, V205, P479, DOI 10.1078/1438-4639-00175; BRENT JA, 1993, J TOXICOL-CLIN TOXIC, V31, P173, DOI 10.3109/15563659309000384; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen J, 2011, SHANDONG MED J, V51, P12; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; CHU FF, 1993, J BIOL CHEM, V268, P2571; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fan J, 1997, Zhonghua Nei Ke Za Zhi, V36, P808; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; Friedman SL, 2003, SCHIFFS DIS LIVER, P409; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Gong XL, 2008, STRAIT PHARM J, V20, P4; GRESSNER AM, 1982, J CLIN CHEM CLIN BIO, V20, P509; Guyton A.C., 2006, TXB MED PHYSL, P859; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hare MLC, 1928, BIOCHEM J, V22, P968, DOI 10.1042/bj0220968; He SX, 2006, WORLD J GASTROENTERO, V12, P3924, DOI 10.3748/wjg.v12.i24.3924; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jia N, 2007, TOXICOLOGY, V237, P1, DOI 10.1016/j.tox.2007.04.015; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Jin M, 2009, MED RECAPIT, V15, P1712; JU HS, 1990, ACTA PHARM SINIC, V11, P466; [阚周密 KAN Zhoumi], 2007, [天津医药, Tianjin Medical Journal], V35, P361; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; KARLSSON K, 1988, BIOCHEM J, V255, P223; KARLSSON K, 1994, LAB INVEST, V70, P705; Kim HJ, 2008, FOOD CHEM TOXICOL, V46, P3407, DOI 10.1016/j.fct.2008.08.012; Kim HK, 2009, FOOD SCI BIOTECHNOL, V18, P1186; Kobashi K, 1984, Patent No. [JP: 5914799, 5914799]; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Li CY, 2006, J FOOD SCI BIOTECHNO, V25, P1673; Li L, 2011, EXP TOXICOL PATHOL, V4, P1; Luo Ye, 2008, Practical Pharmacy and Clinical Remedies, V11, P182; Makino T, 2008, DRUG METAB DISPOS, V36, P1438, DOI 10.1124/dmd.108.021089; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Mizrahi Meir, 2008, Harefuah, V147, P381; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Moro T, 2008, LIFE SCI, V83, P531, DOI 10.1016/j.lfs.2008.07.023; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; NANJI AA, 1995, J LIPID RES, V36, P736; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Recknagel R.O., 2020, HEPATOTOXICOLOGY, P401; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; [任明 Ren Ming], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P2222; Sikorska K, 2011, HEPATOB PANCREAT DIS, V10, P270, DOI 10.1016/S1499-3872(11)60045-3; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; SLATER TF, 1984, BIOCHEM J, V222, P1; Slotkin TA, 1999, BRAIN RES BULL, V50, P373, DOI 10.1016/S0361-9230(99)00110-0; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810; TSUKAMOTO H, 1995, J GASTROEN HEPATOL, V10, pS50, DOI 10.1111/j.1440-1746.1995.tb01798.x; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Wang JY, 2001, WORLD J GASTROENTERO, V7, P115; Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang YS, 2008, FOOD CHEM TOXICOL, V46, P380, DOI 10.1016/j.fct.2007.08.016; Zhang Qi-sheng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P664; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8	82	187	196	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53662	10.1371/journal.pone.0053662	http://dx.doi.org/10.1371/journal.pone.0053662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341968	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400062
J	Wu, DM; Kraut, JA; Abraham, WM				Wu, Dongmei; Kraut, Jeffrey A.; Abraham, William M.			Sabiporide Improves Cardiovascular Function, Decreases the Inflammatory Response and Reduces Mortality in Acute Metabolic Acidosis in Pigs	PLOS ONE			English	Article							EXTRACELLULAR ACIDOSIS; EXCHANGE INHIBITION; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; MECHANISMS; CONTRACTILITY; MYOCARDIUM; ACTIVATION; MANAGEMENT; DIAGNOSIS	Introduction: Acute metabolic acidosis impairs cardiovascular function and increases the mortality of critically ill patients. However, the precise mechanism(s) underlying these effects remain unclear. We hypothesized that targeting pH-regulatory protein, Na+/H+ exchanger (NHE1) could be a novel approach for the treatment of acute metabolic acidosis. The aim of the present study was to examine the impact of a novel NHE1 inhibitor, sabiporide, on cardiovascular function, blood oxygen transportation, and inflammatory response in an experimental model of metabolic acidosis produced by hemorrhage-induced hypovolemia followed by an infusion of lactic acid. Methods and Results: Anesthetized pigs were subjected to hypovolemia for 30 minutes. The animals then received a bolus infusion of sabiporide (3 mg/kg) or vehicle, followed by an infusion of lactic acid for 2 hours. The animals were continuously monitored for additional 3 hours. Hypovolemia followed by a lactic acid infusion resulted in a severe metabolic acidosis with blood pH falling to 6.8. In association with production of the acidemia, there was an excessive increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Treatment with sabiporide significantly attenuated the increase in PAP by 38% and PVR by 67%, as well as significantly improved cardiac output by 51%. Sabiporide treatment also improved mixed venous blood oxygen saturation (55% in sabiporide group vs. 28% in control group), and improved systemic blood oxygen delivery by 36%. In addition, sabiporide treatment reduced plasma levels of TNF-alpha (by 33%), IL-6 (by 63%), troponin-I (by 54%), ALT (by 34%), AST (by 35%), and urea (by 40%). Conclusion: These findings support the possible beneficial effects of sabiporide in the treatment of acute metabolic acidosis and could have implications for the treatment of metabolic acidosis in man.	[Wu, Dongmei] Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA; [Abraham, William M.] Mt Sinai Med Ctr, Div Pulm & Crit Care Med, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju, South Korea; [Kraut, Jeffrey A.] Vet Adm Greater Angeles Healthcare Syst, Div Nephrol Med & Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Jeonbuk National University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	USAMRMC [W81XWH-06-1-0719]; Ministry of Education, Science and Technology [R31-20029, 2012007331]; National Research Foundation of Korea (NRF); honbuk National University, Korea	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); honbuk National University, Korea	This work was supported by a USAMRMC grant W81XWH-06-1-0719 (to DW); and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012007331); and by New Faculty funding from Chonbuk National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 1998, NEW ENGL J MED, V338, P107, DOI 10.1056/NEJM199801083380207; ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CINGOLANI HE, 1975, SURGERY, V77, P427; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Doods H, 2013, J BIOMEDICI IN PRESS; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Karmazyn M, 1999, J THROMB THROMBOLYS, V8, P33, DOI 10.1023/A:1008990530176; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Lin X, 2012, RESUSCITATION; MARSIGLIA JC, 1973, CARDIOVASC RES, V7, P336, DOI 10.1093/cvr/7.3.336; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siesjo BK, 1996, ACT NEUR S, V66, P8; Sikes PJ, 2005, CRIT CARE MED, V33, P605, DOI 10.1097/01.ccm.0000155910.89252.FE; Vaughan-Jones Richard D, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS134, DOI 10.1111/j.1540-8167.2006.00394.x; Webster KA, 1999, J CLIN INVEST, V104, P239; WIKLUND L, 1985, CRIT CARE MED, V13, P109, DOI 10.1097/00003246-198502000-00012; Wu DM, 2000, BASIC RES CARDIOL, V95, P449, DOI 10.1007/s003950070020; Wu DM, 2008, SHOCK, V29, P519, DOI 10.1097/SHK.0b013e318150757a; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	32	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53932	10.1371/journal.pone.0053932	http://dx.doi.org/10.1371/journal.pone.0053932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23437188	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400061
J	Wu, DZ; Cai, SG; Chen, MX; Ye, LZ; Chen, ZH; Zhang, HT; Dai, F; Wu, FB; Zhang, GP				Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Chen, Zhonghua; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping			Tissue Metabolic Responses to Salt Stress in Wild and Cultivated Barley	PLOS ONE			English	Article							PROLINE ACCUMULATION; GAS-CHROMATOGRAPHY; SODIUM-TRANSPORT; ABIOTIC STRESS; DROUGHT STRESS; TOLERANCE; PLANTS; ARABIDOPSIS; HOMEOSTASIS; MANNITOL	A thorough understanding of the mechanisms underlying barley salt tolerance and exploitation of elite genetic resource are essential for utilizing wild barley germplasm in developing barley varieties with salt tolerance. In order to reveal the physiological and molecular difference in salt tolerance between Tibetan wild barley (Hordeum spontaneum) and cultivated barley (Hordeum vulgare), profiles of 82 key metabolites were studies in wild and cultivated barley in response to salinity. According to shoot dry biomass under salt stress, XZ16 is a fast growing and salt tolerant wild barley. The results of metabolite profiling analysis suggested osmotic adjustment was a basic mechanism, and polyols played important roles in developing salt tolerance only in roots, and high level of sugars and energy in roots and active photosynthesis in leaves were important for barley to develop salt tolerance. The metabolites involved in tolerance enhancement differed between roots and shoots, and also between genotypes. Tibetan wild barley, XZ16 had higher chlorophyll content and higher contents of compatible solutes than CM72, while the cultivated barley, CM72 probably enhanced its salt tolerance mainly through increasing glycolysis and energy consumption, when the plants were exposed to high salinity. The current research extends our understanding of the mechanisms involved in barley salt tolerance and provides possible utilization of Tibetan wild barley in developing barley cultivars with salt tolerance.	[Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Zhejiang University; Western Sydney University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	Natural Science Foundation of China [31129005, 31171544]; Natural Science Foundation of Zhejiang Province, China [Z3110054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by Natural Science Foundation of China (31129005 and 31171544), Natural Science Foundation of Zhejiang Province, China (Z3110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2007, PLANTA, V225, P753, DOI 10.1007/s00425-006-0386-x; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Du J, 2008, PLANT J, V56, P653, DOI 10.1111/j.1365-313X.2008.03602.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim HK, 2010, PHYTOCHEM ANALYSIS, V21, P4, DOI 10.1002/pca.1188; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; PHARR DM, 1995, HORTSCIENCE, V30, P1182, DOI 10.21273/HORTSCI.30.6.1182; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Shabala S, 2005, J EXP BOT, V56, P1369, DOI 10.1093/jxb/eri138; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; XU T, 1982, Acta Genetica Sinica, V9, P440; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	54	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55431	10.1371/journal.pone.0055431	http://dx.doi.org/10.1371/journal.pone.0055431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23437188	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600104
J	Yang, Y; Wang, Q				Yang, Yong; Wang, Qi			The Earliest Fleshy Cone of Ephedra from the Early Cretaceous Yixian Formation of Northeast China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GNETALES; AGE; CHLOROPLAST; FOSSIL; MORPHOLOGY; ANGIOSPERM; DISPERSAL; DIVERSITY; PORTUGAL	Bracts of female cones of extant gymnosperm Ephedra (Joint fir) are either colorful and fleshy (section Ephedra), or dry-winged and membranous (section Alatae), or dry and coriaceous (section Asarca), which have played a crucial role in long-distance seed dispersal that is responsible for a wide distribution of the genus in semiarid and arid areas of Eurasia, North Africa, North America, and South America. Recent molecular systematic studies on Ephedra have suggested that the fleshy bracts in character evolution may be plesiomorphic relative to the dry, membranous and coriaceous bracts. However, little is known about when the fleshy bracts of Ephedra have made their debut in the geological past. Herein, we describe a novel, fleshy bract-bearing female cone macrofossil from the Early Cretaceous (ca. 120-125 Ma) Yixian Formation in Liaoning, northeastern China. This cone bears three ellipsoid seeds subtended by only one whorl of fleshy bracts. Each seed has a thin outer envelope and an inner integument that extends upward and passes through the opening of the outer envelope, forming a thin and straight micropylar tube. Such a syndrome shows the closest similarity to an extant triovulate species Ephedra intermedia in the section Ephedra, but the latter bears a whorl of terminal fertile bracts and more than one whorl of inferior sterile bracts, and a thick outer envelope. Hence, we establish a new fossil species Ephedra carnosa. Our discovery provides the first direct macrofossil evidence for the previous molecular systematics of Ephedra, implying that the origin of fleshy bracts in Ephedra should not have been later than that of the membranous and coriaceous bracts by at least the Early Cretaceous.	[Yang, Yong; Wang, Qi] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, Q (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	happyking@ibcas.ac.cn	Yang, Yong/S-1202-2019	Kang, Hong-Yo/0000-0003-0626-5037; Fu, Hung-Chun/0000-0002-0660-9349	National Natural Science Foundation of China [30970177, 30600035, 40830209, 40972015]; State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences [56176G1044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National Natural Science Foundation of China (no. 30970177, 30600035, 40830209, 40972015), the State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences (no. 56176G1044) to WQ and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, STRELITZIA, V20, P1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Caveney S, 2001, AM J BOT, V88, P1199, DOI 10.2307/3558330; Cladera Gerardo, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P49; Duan SY, 1998, SCI CHINA SER D, V41, P14, DOI 10.1007/BF02932415; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Fu LK, 1999, FLORA CHINA, P97; Gifford E.M., 1989, COMP MORPHOLOGY VASC; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guo S.X., 2000, ACTA PALAEONTOLOGICA, V39, P81; Hollander JL, 2010, EVOL ECOL, V24, P333, DOI 10.1007/s10682-009-9309-1; Hollander JL, 2009, INT J PLANT SCI, V170, P323, DOI 10.1086/596334; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krassilov VA, 2009, PALEONTOL J+, V43, P1272, DOI 10.1134/S0031030109100098; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kubitzki K., 1990, FAMILIES GENERA VASC, V1, P378; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Liu HM, 2008, TAXON, V57, P577, DOI 10.2307/25066023; Pearson HHW, 1929, GNETALES; Price RA, 1996, INT J PLANT SCI, V157, pS40, DOI 10.1086/297402; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rydin C, 2006, PLANT SYST EVOL, V262, P239, DOI 10.1007/s00606-006-0481-2; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-183; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Stapf O., 1889, MATHEMATISCH NATURWI, V56, P1; Stevenson D.W., 1993, FLORA N AM, V2, P428; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Yang Y, 2005, BOT BULL ACAD SINICA, V46, P363; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231; Yang Y, 2004, AM J BOT, V91, P361, DOI 10.3732/ajb.91.3.361; Yang Y, 2001, ACTA BOT SIN, V43, P1011; Yang Y., 2002, CHIN ACAD SCI, P1; Yang Y, 2007, TAXON, V56, P1271, DOI 10.2307/25065920; Yang Yong, 2011, Journal of Tropical and Subtropical Botany, V19, P1; [杨永 Yang Yong], 2011, [地质论评, Geological Review], V57, P9; Yang Yong, 2010, Taiwania, V55, P346; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 王鑫, 2010, [科学通报, Chinese Science Bulletin], V55, P675	54	37	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53652	10.1371/journal.pone.0053652	http://dx.doi.org/10.1371/journal.pone.0053652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	24244503	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400058
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 1981, WORK STRESS SOCIAL S; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400094
J	Liu, AH; Gao, F; Kanno, Y; Jordan, MC; Kamiya, Y; Seo, M; Ayele, BT				Liu, Aihua; Gao, Feng; Kanno, Yuri; Jordan, Mark C.; Kamiya, Yuji; Seo, Mitsunori; Ayele, Belay T.			Regulation of Wheat Seed Dormancy by After-Ripening Is Mediated by Specific Transcriptional Switches That Induce Changes in Seed Hormone Metabolism and Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA SEEDS; ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GIBBERELLIN METABOLISM; CONJUGATE HYDROLASES; FLORAL DEVELOPMENT; JASMONIC ACID; CROSS-TALK	Treatments that promote dormancy release are often correlated with changes in seed hormone content and/or sensitivity. To understand the molecular mechanisms underlying the role of after-ripening (seed dry storage) in triggering hormone related changes and dormancy decay in wheat (Triticum aestivum), temporal expression patterns of genes related to abscisic acid (ABA), gibberellin (GA), jasmonate and indole acetic acid (IAA) metabolism and signaling, and levels of the respective hormones were examined in dormant and after-ripened seeds in both dry and imbibed states. After-ripening mediated developmental switch from dormancy to germination appears to be associated with declines in seed sensitivity to ABA and IAA, which are mediated by transcriptional repressions of PROTEIN PHOSPHATASE 2C, SNF1-RELATED PROTEIN KINASE2, ABA INSENSITIVE5 and LIPID PHOSPHATE PHOSPHTASE2, and AUXIN RESPONSE FACTOR and RELATED TO UBIQUITIN1 genes. Transcriptomic analysis of wheat seed responsiveness to ABA suggests that ABA inhibits the germination of wheat seeds partly by repressing the transcription of genes related to chromatin assembly and cell wall modification, and activating that of GA catabolic genes. After-ripening induced seed dormancy decay in wheat is also associated with the modulation of seed IAA and jasmonate contents. Transcriptional control of members of the ALLENE OXIDE SYNTHASE, 3-KETOACYL COENZYME A THIOLASE, LIPOXYGENASE and 12-OXOPHYTODIENOATE REDUCTASE gene families appears to regulate seed jasmonate levels. Changes in the expression of GA biosynthesis genes, GA 20-OXIDASE and GA 3-OXIDASE, in response to after-ripening implicate this hormone in enhancing dormancy release and germination. These findings have important implications in the dissection of molecular mechanisms underlying regulation of seed dormancy in cereals.	[Liu, Aihua; Gao, Feng; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Manitoba; Agriculture & Agri Food Canada; RIKEN	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	b_ayele@umanitoba.ca	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ayele BT, 2012, J PLANT GROWTH REGUL, V31, P235, DOI 10.1007/s00344-011-9234-8; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; BERESTETZKY V, 1991, BIOCHEM PHYSIOL PFL, V187, P13, DOI 10.1016/S0015-3796(11)80178-2; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1989, PLANT PHYSIOL, V91, P775, DOI 10.1104/pp.91.2.775; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kline KG, 2010, PLANT PHYSIOL, V154, P479, DOI 10.1104/pp.110.160846; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MORRIS CF, 1989, PLANT PHYSIOL, V90, P643, DOI 10.1104/pp.90.2.643; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Saavedra L, 2009, PLANT CELL PHYSIOL, V50, P595, DOI 10.1093/pcp/pcp018; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Simpson G. M., 1990, SEED DORMANCY GRASSE; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Rodriguez MV, 2009, ANN BOT-LONDON, V104, P975, DOI 10.1093/aob/mcp184; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yildiz K, 2007, ASIAN J CHEM, V19, P1098; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	104	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56570	10.1371/journal.pone.0056570	http://dx.doi.org/10.1371/journal.pone.0056570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Published, gold, Green Submitted			2022-12-27	WOS:000315184200108
J	Liu, EK; Yan, CR; Mei, XR; Zhang, YQ; Fan, TL				Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing; Fan, Tinglu			Long-Term Effect of Manure and Fertilizer on Soil Organic Carbon Pools in Dryland Farming in Northwest China	PLOS ONE			English	Article							DIFFERENT CROPPING SYSTEMS; SEQUESTRATION RATES; DEPTH DISTRIBUTION; LOESS PLATEAU; MATTER; TILLAGE; MANAGEMENT; FRACTIONS; DYNAMICS; QUALITY	An understanding of the dynamics of soil organic carbon (SOC) as affected by farming practices is imperative for maintaining soil productivity and mitigating global warming. The objectives of this study were to investigate the effects of long-term fertilization on SOC and SOC fractions for the whole soil profile (0-100 cm) in northwest China. The study was initiated in 1979 in Gansu, China and included six treatments: unfertilized control (CK), nitrogen fertilizer (N), nitrogen and phosphorus (P) fertilizers (NP), straw plus N and P fertilizers (NP+S), farmyard manure (FYM), and farmyard manure plus N and P fertilizers (NP+FYM). Results showed that SOC concentration in the 0-20 cm soil layer increased with time except in the CK and N treatments. Long-term fertilization significantly influenced SOC concentrations and storage to 60 cm depth. Below 60 cm, SOC concentrations and storages were statistically not significant between all treatments. The concentration of SOC at different depths in 0-60 cm soil profile was higher under NP+FYM follow by under NP+S, compared to under CK. The SOC storage in 0-60 cm in NP+FYM, NP+S, FYM and NP treatments were increased by 41.3%, 32.9%, 28.1% and 17.9%, respectively, as compared to the CK treatment. Organic manure plus inorganic fertilizer application also increased labile soil organic carbon pools in 0-60 cm depth. The average concentration of particulate organic carbon (POC), dissolved organic carbon (DOC) and microbial biomass carbon (MBC) in organic manure plus inorganic fertilizer treatments (NP+S and NP+FYM) in 0-60 cm depth were increased by 64.9-91.9%, 42.5-56.9%, and 74.7-99.4%, respectively, over the CK treatment. The POC, MBC and DOC concentrations increased linearly with increasing SOC content. These results indicate that long-term additions of organic manure have the most beneficial effects in building carbon pools among the investigated types of fertilization.	[Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Minist Agr Peoples Republ China MOA, Key Lab Dryland Farming g Agr, Beijing, Peoples R China; [Fan, Tinglu] Gansu Acad Agr Sci, Dryland Agr Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Yan, CR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	yancr@ieda.org.cn; zhangyq@ieda.org.cn	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Basic Research Program of China (973 Program) [2012CB955904]; Chinese National Scientific Foundation [31000253, 31170490]; National Key Technologies RD Program [2012BAD09B01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Scientific Foundation; National Key Technologies RD Program(National Key Technology R&D Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Basic Research Program of China (973 Program) (No.2012CB955904), the Chinese National Scientific Foundation (No. 31000253, 31170490), the 12th five-year plan of the National Key Technologies R&D Program (No. 2012BAD09B01). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A, 1965, AM SOC AGRON MADISON, P482; Blair N, 2006, SOIL TILL RES, V91, P39, DOI 10.1016/j.still.2005.11.001; Bronson KF, 1998, ADV SOIL S, P35; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chakraborty A, 2011, BIOL FERT SOILS, V47, P227, DOI 10.1007/s00374-010-0509-1; Chan KY, 1997, SOIL SCI SOC AM J, V61, P1376, DOI 10.2136/sssaj1997.03615995006100050013x; Chapman H.D., 1965, METHODS SOIL ANAL 2, P891; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2007, SOIL TILL RES, V94, P530, DOI 10.1016/j.still.2006.10.001; FAO-UNESCO, 1988, SOIL MAP WORLD; Gami SK, 2009, SOIL TILL RES, V106, P95, DOI 10.1016/j.still.2009.10.003; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; GOYAL S, 1992, SOIL BIOL BIOCHEM, V24, P1081, DOI 10.1016/0038-0717(92)90056-4; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Janzen HH, 1997, DEV SOIL SCI, V25, P277; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; LYNCH JM, 1980, SOIL BIOL BIOCHEM, V12, P547, DOI 10.1016/0038-0717(80)90033-4; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Nayak AK, 2012, FIELD CROP RES, V127, P129, DOI 10.1016/j.fcr.2011.11.011; OCIO JA, 1991, SOIL BIOL BIOCHEM, V23, P655, DOI 10.1016/0038-0717(91)90079-Y; Ouedraogo E, 2007, SOIL TILL RES, V94, P64, DOI 10.1016/j.still.2006.07.001; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verma S, 2007, BIOL FERT SOILS, V44, P235, DOI 10.1007/s00374-007-0207-9; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2005, J PLANT NUTR SOIL SC, V168, P100, DOI 10.1002/jpln.200321295; Xing N., 2001, STUDY DRYLAND AGR N; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhang X, 1998, HYDROL PROCESS, V12, P171, DOI 10.1002/(SICI)1099-1085(199801)12:1&lt;171::AID-HYP570&gt;3.0.CO;2-L	48	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56536	10.1371/journal.pone.0056536	http://dx.doi.org/10.1371/journal.pone.0056536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200099
J	Liu, N; He, S; Ma, L; Ponnusamy, M; Tang, JH; Tolbert, E; Bayliss, G; Zhao, TC; Yan, HD; Zhuang, SG				Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhao, Ting C.; Yan, Haidong; Zhuang, Shougang			Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; OBSTRUCTIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; FACTOR RECEPTOR; ANGIOTENSIN-II; SOLID TUMORS; INJURY	Background: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selective class I HDAC inhibitor, on the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO) and activation of cultured renal interstitial fibroblasts. Methods/Findings: The UUO model was established by ligation of the left ureter and the contralateral kidney was used as a control. At seven days after UUO injury, kidney developed fibrosis as indicated by deposition of collagen fibrils and increased expression of collagen I, fibronectin and alpha-smooth muscle actin (alpha-SMA). Administration of MS-275 inhibited all these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF- beta), increased expression of TGF-beta receptor I, and phosphorylation of Smad-3. MS-275 was also effective in suppressing phosphorylation and expression of epidermal growth factor receptor (EGFR) and its downstream signaling molecule, signal transducer and activator of transcription-3. Moreover, class I HDAC inhibition reduced the number of renal tubular cells arrested in the G2/M phase of the cell cycle, a cellular event associated with TGF-beta1overproduction. In cultured renal interstitial fibroblasts, MS-275 treatment inhibited TGF-beta induced phosphorylation of Smad-3, differentiation of renal fibroblasts to myofibroblasts and proliferation of myofibroblasts. Conclusions and Significance: These results demonstrate that class I HDACs are critically involved in renal fibrogenesis and renal fibroblast activation through modulating TGF-beta and EGFR signaling and suggest that blockade of class I HDAC may be a useful treatment for renal fibrosis.	[Liu, Na; Tang, Jinhua; Yan, Haidong; Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Boston University; Roger Williams Medical Center	Yan, HD (corresponding author), Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China.	yhdcmu@sina.com; szhuang@lifespan.org	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Institutes of Health [DK-085065]; national nature science foundation of China [81270778, 81170638, 81200492]; Pudong New District Foundation of China [PWZxk2010-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national nature science foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New District Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-085065 to SZ), the national nature science foundation of China (81270778 to SZ, 81170638 to HY, 81200492 to NL), and Pudong New District Foundation of China (PWZxk2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fraczek J, 2009, J CELL MOL MED, V13, P2990, DOI 10.1111/j.1582-4934.2009.00831.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	52	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54001	10.1371/journal.pone.0054001	http://dx.doi.org/10.1371/journal.pone.0054001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23468976	Green Submitted, Green Published, gold			2022-12-27	WOS:000313682700073
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
